Citrus Sinensis ID: 015026

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410----
Protein Sequence
MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFKVKTNIVYFFK
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccHHHHcccccccccccccccccccccccccHHHHHHHccccccccccccccccccccccccccccccccccccccccccccEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccHHHHHHHHHHHHHcHHHHHHHHHHHHHcHHHHHHHHHHHHHHHc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHEEccHHccccccEEEEEEEEcccccEEEEHEHHHHHcccHHHHHHHHHHHHHHHHHcccccEEEEEccccccHHEEEEEEEccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccEcccccccHEEEEccccccccEEEccccEEEEccccEEEcccccHHHHcHHHHHHHcccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccHHHcccHHHHHcccccccccccccccEcHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
mgiclsttkvsgsnsgsnnnnanhhrnANKEEAKRRhnhharndtthkhqHQHQERAKNYQQLKTkqhqktnsrrqtgvipcgkrtdfgydkdfdrRYTIGKLlghgqfgytyvatdkangdrVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHlhglvhrdmkpenflfksakedsslkatdfglsdfikpgkkfqDIVGSAYYvapevlkrksgpesdvwsIGVITYILLcgrrpfwdktedGIFKEVlrnkpdfrrkpwpsisnSAKDFVKKLLVKDPRARLTAAQalshpwvreggdaseipiDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFKVKTNIVYFFK
Flexible Loop (DISEMBL)
mgiclsttkvsgsnsgsnnnnanhhRNANKEEAKRRHNHHARndtthkhqhqHQERAKNYQQLktkqhqktnsrrqtgvipcgkrtdfgydkdFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVkkieknkmilpiaveDVKREVKILQAlaghenvvKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLhglvhrdmKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEvlkrksgpesdvwsiGVITYILLCGRRPFWDKTEDGIFKevlrnkpdfrrkpwpsisnsaKDFVKKLLVKDPRARLTaaqalshpwvreggdaSEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFKVKTNIVYFFK
Low Complexity Region (SEG)
MGICLSTTKVsgsnsgsnnnnanhhrnanKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFKVKTNIVYFFK
Disordered region (IsUnstruct)
*****************************************************************************GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK********KATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI**SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFKVKTNIVYFF*
Disordered Region (DISOPRED)
****************************************************************************************GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFK********TNIVYFFK
Disordered Region (DISEMBL)
*********************ANHHRNAN************************************************GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFKVKTNIVYFFK
Disordered Region (DISPRO)
**************************************************************************************DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFKVKTNIVYFFK
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFKVKTNIVYFFK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	414	2.2.26 [Sep-21-2011]
Q7XJR9	571	Calcium-dependent protein	yes	no	0.939	0.681	0.753	1e-175
Q9FKW4	523	Calcium-dependent protein	no	no	0.859	0.680	0.721	1e-167
Q1PE17	534	Calcium-dependent protein	no	no	0.881	0.683	0.721	1e-164
Q9FX86	606	CDPK-related kinase 8 OS=	no	no	0.862	0.589	0.518	1e-103
Q9SCS2	601	CDPK-related kinase 5 OS=	no	no	0.746	0.514	0.573	1e-103
P53681	602	CDPK-related protein kina	N/A	no	0.794	0.546	0.555	1e-102
Q10KY3	600	Calcium/calmodulin-depend	no	no	0.705	0.486	0.585	1e-102
Q9LJL9	599	CDPK-related kinase 2 OS=	no	no	0.729	0.504	0.566	9e-99
Q9LET1	577	CDPK-related kinase 7 OS=	no	no	0.799	0.573	0.526	2e-97
O80673	576	CDPK-related kinase 1 OS=	no	no	0.748	0.538	0.554	3e-97

>sp|Q7XJR9|CDPKG_ARATH Calcium-dependent protein kinase 16 OS=Arabidopsis thaliana GN=CPK16 PE=1 SV=1

 Score =  614 bits (1583), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 305/405 (75%), Positives = 328/405 (80%), Gaps = 16/405 (3%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARN------DTTHKHQHQHQ 54
           MG+C S+   +  +SG N ++ N H +      K R      +         H+ Q +  
Sbjct: 1   MGLCFSS---AAKSSGHNRSSRNPHPHPPLTVVKSRPPRSPCSFMAVTIQKDHRTQPRRN 57

Query: 55  ERAKNYQQLKTKQHQKT-------NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHG 107
             AK      T  H K        N RR    IP GKR DFGY KDFD RYTIGKLLGHG
Sbjct: 58  ATAKKTPTRHTPPHGKVREKVISNNGRRHGETIPYGKRVDFGYAKDFDHRYTIGKLLGHG 117

Query: 108 QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE 167
           QFGYTYVATDK  GDRVAVKKI+K KM +PIAVEDVKREVKILQAL GHENVV+FYNAFE
Sbjct: 118 QFGYTYVATDKKTGDRVAVKKIDKAKMTIPIAVEDVKREVKILQALTGHENVVRFYNAFE 177

Query: 168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP 227
           D N VYI MELCEGGELLDRILA+KDSRY+E+DAAVVVRQML+VAAECHL GLVHRDMKP
Sbjct: 178 DKNSVYIVMELCEGGELLDRILARKDSRYSERDAAVVVRQMLKVAAECHLRGLVHRDMKP 237

Query: 228 ENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIG 287
           ENFLFKS +EDS LKATDFGLSDFIKPGKKF DIVGSAYYVAPEVLKR+SGPESDVWSIG
Sbjct: 238 ENFLFKSTEEDSPLKATDFGLSDFIKPGKKFHDIVGSAYYVAPEVLKRRSGPESDVWSIG 297

Query: 288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
           VI+YILLCGRRPFWDKTEDGIFKEVL+NKPDFRRKPWP+ISNSAKDFVKKLLVKDPRARL
Sbjct: 298 VISYILLCGRRPFWDKTEDGIFKEVLKNKPDFRRKPWPTISNSAKDFVKKLLVKDPRARL 357

Query: 348 TAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           TAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK+SRLKQFALR
Sbjct: 358 TAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKFSRLKQFALR 402

May play a role in signal transduction pathways that involve calcium as a second messenger.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FKW4|CDPKS_ARATH Calcium-dependent protein kinase 28 OS=Arabidopsis thaliana GN=CPK28 PE=1 SV=1

 Score =  589 bits (1519), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 283/392 (72%), Positives = 324/392 (82%), Gaps = 36/392 (9%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNY 60
           MG+C S  +V+G++S          R +++ ++K                          
Sbjct: 1   MGVCFSAIRVTGASSS---------RRSSQTKSK-------------------------- 25

Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
               T    K +++R+TG IPCGKRTDFGY KDF   YTIGKLLGHGQFGYTYVA  + N
Sbjct: 26  -AAPTPIDTKASTKRRTGSIPCGKRTDFGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPN 84

Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           GDRVAVK+++K+KM+LPIAVEDVKREV+IL AL+GHENVV+F+NAFEDD+YVYI MELCE
Sbjct: 85  GDRVAVKRLDKSKMVLPIAVEDVKREVQILIALSGHENVVQFHNAFEDDDYVYIVMELCE 144

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           GGELLDRIL+KK +RY+EKDAAVVVRQML+VA ECHLHGLVHRDMKPENFLFKSA+ DS 
Sbjct: 145 GGELLDRILSKKGNRYSEKDAAVVVRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSP 204

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 300
           LKATDFGLSDFIKPGK+F DIVGSAYYVAPEVLKR+SGPESDVWSIGVITYILLCGRRPF
Sbjct: 205 LKATDFGLSDFIKPGKRFHDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPF 264

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           WD+TEDGIFKEVLRNKPDF RKPW +IS+SAKDFVKKLLVKDPRARLTAAQALSH WVRE
Sbjct: 265 WDRTEDGIFKEVLRNKPDFSRKPWATISDSAKDFVKKLLVKDPRARLTAAQALSHAWVRE 324

Query: 361 GGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           GG+A++IP+DISVLNN+RQFV+YSRLKQFALR
Sbjct: 325 GGNATDIPVDISVLNNLRQFVRYSRLKQFALR 356

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PE17|CDPKI_ARATH Calcium-dependent protein kinase 18 OS=Arabidopsis thaliana GN=CPK18 PE=2 SV=1

 Score =  577 bits (1488), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 283/392 (72%), Positives = 307/392 (78%), Gaps = 27/392 (6%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNY 60
           MG+C S+ K +   +GS N N +        E     N         +HQ          
Sbjct: 1   MGLCFSSPKATRRGTGSRNPNPDSPTQGKASEKVSNKNKKNTKKIQLRHQ---------- 50

Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
                            G IP GKR DFGY KDFD RYTIGKLLGHGQFG+TYVATD  N
Sbjct: 51  -----------------GGIPYGKRIDFGYAKDFDNRYTIGKLLGHGQFGFTYVATDNNN 93

Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           G+RVAVK+I+K KM  PI VEDVKREVKILQAL GHENVV F+NAFED  Y+YI MELC+
Sbjct: 94  GNRVAVKRIDKAKMTQPIEVEDVKREVKILQALGGHENVVGFHNAFEDKTYIYIVMELCD 153

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           GGELLDRILAKKDSRYTEKDAAVVVRQML+VAAECHL GLVHRDMKPENFLFKS +E SS
Sbjct: 154 GGELLDRILAKKDSRYTEKDAAVVVRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEGSS 213

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 300
           LKATDFGLSDFIKPG KFQDIVGSAYYVAPEVLKR+SGPESDVWSIGVITYILLCGRRPF
Sbjct: 214 LKATDFGLSDFIKPGVKFQDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPF 273

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           WDKT+DGIF EV+R KPDFR  PWP+ISN AKDFVKKLLVK+PRARLTAAQALSH WV+E
Sbjct: 274 WDKTQDGIFNEVMRKKPDFREVPWPTISNGAKDFVKKLLVKEPRARLTAAQALSHSWVKE 333

Query: 361 GGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           GG+ASE+PIDISVLNNMRQFVK+SRLKQ ALR
Sbjct: 334 GGEASEVPIDISVLNNMRQFVKFSRLKQIALR 365

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1

 Score =  377 bits (968), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 187/361 (51%), Positives = 238/361 (65%), Gaps = 4/361 (1%)

Query: 36  RHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFD 95
           R   H  +   H      + + K    L       T   ++      G    FG+ K+F 
Sbjct: 88  RRAFHPPSPAKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKRFGFSKEFH 147

Query: 96  RRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
            R  +G+ +G G FGYT  A  K     G  VAVK I K+KM   IA+EDV+REVKILQA
Sbjct: 148 SRVELGEEIGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQA 207

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L+GH+N+V+FY+AFED+  VYIAMELCEGGELLDRILA+   +Y+E DA  V+ Q+L V 
Sbjct: 208 LSGHKNLVQFYDAFEDNANVYIAMELCEGGELLDRILAR-GGKYSENDAKPVIIQILNVV 266

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           A CH  G+VHRD+KPENFL+ S +E+S LKA DFGLSDF++P ++  DIVGSAYYVAPEV
Sbjct: 267 AFCHFQGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 326

Query: 273 LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           L R    E+DVWSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PWP +S+ AK
Sbjct: 327 LHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAK 386

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           DFVK+LL KDPR R++A+QAL HPW+R       IP DI +   M+ +++ S L++ ALR
Sbjct: 387 DFVKRLLFKDPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALR 446

Query: 393 V 393
            
Sbjct: 447 A 447

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1

 Score =  375 bits (963), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 180/314 (57%), Positives = 229/314 (72%), Gaps = 5/314 (1%)

Query: 83  GKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIA 139
           G    FG+ K F  +Y +G  +G G FGYT  A  K     G +VAVK I K KM   IA
Sbjct: 133 GLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKFKKGDNKGQQVAVKVIPKAKMTTAIA 192

Query: 140 VEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK 199
           +EDV+REVKIL+AL+GH N+  FY+A+ED + VYI MELCEGGELLDRIL++   +YTE+
Sbjct: 193 IEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYIVMELCEGGELLDRILSR-GGKYTEE 251

Query: 200 DAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           DA  V+ Q+L V A CHL G+VHRD+KPENFLF S ++ S LKA DFGLSD+++P ++  
Sbjct: 252 DAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSKEDTSQLKAIDFGLSDYVRPDERLN 311

Query: 260 DIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
           DIVGSAYYVAPEVL R    E+D+WS+GVI YILLCG RPFW +TE GIF+ VL+  P F
Sbjct: 312 DIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLCGSRPFWARTESGIFRAVLKADPSF 371

Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ 379
              PWP +S+ A+DFVK+LL KDPR RLTAAQALSHPW+++  DA ++P+DI V   MR 
Sbjct: 372 DDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKDSNDA-KVPMDILVFKLMRA 430

Query: 380 FVKYSRLKQFALRV 393
           +++ S L++ ALR 
Sbjct: 431 YLRSSSLRKAALRA 444

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1

 Score =  372 bits (954), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 186/335 (55%), Positives = 233/335 (69%), Gaps = 6/335 (1%)

Query: 82  CGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPI 138
            G    FG+ K F  ++ +G+ +G G FGYT  A  K     G  VAVK I K KM   I
Sbjct: 132 AGLDKSFGFSKKFGSKFEVGEEVGRGHFGYTCRAKFKKGEFKGQDVAVKVIPKAKMTTAI 191

Query: 139 AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
           A+EDV+REVKIL+AL GH N+V+FY+AFED   VY+ MELCEGGELLDRIL++   +YTE
Sbjct: 192 AIEDVRREVKILRALTGHNNLVQFYDAFEDHTNVYVVMELCEGGELLDRILSR-GGKYTE 250

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
            DA  V+ Q+L V A CHL G+VHRD+KPENFLFKS  EDS LKA DFGLSD++KP ++ 
Sbjct: 251 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFKSKDEDSQLKAIDFGLSDYVKPDERL 310

Query: 259 QDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
            DIVGSAYYVAPEVL R    E+DVWSIGVI+YILLCG RPFW +TE GIF+ VL+    
Sbjct: 311 NDIVGSAYYVAPEVLHRSYSTEADVWSIGVISYILLCGSRPFWARTESGIFRAVLKANLS 370

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMR 378
           F   PWPS+S+ AKDFVK+LL KDPR R+TAAQAL H W++   D  + P+DI V   M+
Sbjct: 371 FDEPPWPSVSSEAKDFVKRLLNKDPRKRMTAAQALCHSWIKNSNDI-KFPLDILVFKLMK 429

Query: 379 QFVKYSRLKQFALR-VTQYFKYTALFKVKTNIVYF 412
            +++ S L++ ALR +++      LF +K   V  
Sbjct: 430 VYMRSSPLRKAALRALSKTLTVDELFYLKEQFVLL 464

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1

 Score =  372 bits (954), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 174/297 (58%), Positives = 224/297 (75%), Gaps = 5/297 (1%)

Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVK 144
           FG+ + F  +Y +G+ +G G FGYT  AT K     GD VAVK I K KM   IA+EDV+
Sbjct: 137 FGFSRHFAAKYELGREVGRGHFGYTCAATCKKGELKGDDVAVKVIPKAKMTTAIAIEDVR 196

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           REV+IL +LAGH N+V+FY+A+ED+  VYI MELC+GGELLDRILA+   +Y+E+DA VV
Sbjct: 197 REVRILSSLAGHSNLVQFYDAYEDEENVYIVMELCKGGELLDRILAR-GGKYSEEDAKVV 255

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           +RQ+L VA+ CHL G+VHRD+KPENFLF S  E+S++K  DFGLSDF+KP ++  DIVGS
Sbjct: 256 MRQILSVASFCHLQGVVHRDLKPENFLFSSKDENSAMKVIDFGLSDFVKPDERLNDIVGS 315

Query: 265 AYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           AYYVAPEVL R  G E+D+WSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PW
Sbjct: 316 AYYVAPEVLHRSYGTEADMWSIGVIVYILLCGSRPFWARTESGIFRAVLKADPSFEEAPW 375

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFV 381
           P++S  AKDFV++LL KD R R+TAAQAL HPW+R G +  ++P+D+ +   MR ++
Sbjct: 376 PTLSAEAKDFVRRLLNKDYRKRMTAAQALCHPWIR-GTEEVKLPLDMIIYRLMRAYI 431

Possesses kinase activity in vitro.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1

 Score =  360 bits (925), Expect = 9e-99,   Method: Compositional matrix adjust.
 Identities = 174/307 (56%), Positives = 222/307 (72%), Gaps = 5/307 (1%)

Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVK 144
           FG+ K+   R  +G+ +G G FGYT  A  K        VAVK I K+KM   I++EDV+
Sbjct: 134 FGFSKELQSRIELGEEIGRGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVR 193

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           REVKIL+AL+GH+N+V+FY+AFED+  VYI MELC GGELLDRILA+   +Y+E DA  V
Sbjct: 194 REVKILRALSGHQNLVQFYDAFEDNANVYIVMELCGGGELLDRILAR-GGKYSEDDAKAV 252

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           + Q+L V A CHL G+VHRD+KPENFL+ S +E+S LK  DFGLSDF++P ++  DIVGS
Sbjct: 253 LIQILNVVAFCHLQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGS 312

Query: 265 AYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           AYYVAPEVL R    E+DVWSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PW
Sbjct: 313 AYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPW 372

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYS 384
           PS+S  AKDFVK+LL KDPR R+TA+QAL HPW+  G    +IP DI +   ++ +++ S
Sbjct: 373 PSLSFEAKDFVKRLLYKDPRKRMTASQALMHPWI-AGYKKIDIPFDILIFKQIKAYLRSS 431

Query: 385 RLKQFAL 391
            L++ AL
Sbjct: 432 SLRKAAL 438

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1

 Score =  356 bits (913), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 181/344 (52%), Positives = 233/344 (67%), Gaps = 13/344 (3%)

Query: 57  AKNYQQLKTKQHQKTNSRRQTGVIPCGKRTD------FGYDKDFDRRYTIGKLLGHGQFG 110
           AK+ + L  ++H        +  IP G   +      FG+ K F   Y I   +G G FG
Sbjct: 79  AKHIRALLARRHGSVKPNEAS--IPEGSECEVGLDKKFGFSKQFASHYEIDGEVGRGHFG 136

Query: 111 YTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE 167
           YT  A  K     G  VAVK I K+KM   IA+EDV+REVKIL+AL GH+N+V+FY+AFE
Sbjct: 137 YTCSAKGKKGSLKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFE 196

Query: 168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP 227
           DD  VYI MELC+GGELLD+IL ++  +Y+E DA  V+ Q+L V A CHL G+VHRD+KP
Sbjct: 197 DDENVYIVMELCQGGELLDKIL-QRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKP 255

Query: 228 ENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIG 287
           ENFLF +  E S LKA DFGLSD+++P ++  DIVGSAYYVAPEVL R  G E+D+WSIG
Sbjct: 256 ENFLFTTKDESSPLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIG 315

Query: 288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
           VI YILLCG RPFW ++E GIF+ VL+ +P+F   PWPS+S  A DFVK+LL KD R RL
Sbjct: 316 VIAYILLCGSRPFWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRL 375

Query: 348 TAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFAL 391
           TAAQAL HPW+  G    +IP D+ +   ++ ++  S L++ AL
Sbjct: 376 TAAQALCHPWLV-GSHELKIPSDMIIYKLVKVYIMSSSLRKSAL 418

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1

 Score =  355 bits (912), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 178/321 (55%), Positives = 224/321 (69%), Gaps = 11/321 (3%)

Query: 80  IPCGKRTD------FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIE 130
           IP GK  +      FG+ K F   Y I   +G G FGYT  A  K     G  VAVK I 
Sbjct: 99  IPEGKECEIGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIP 158

Query: 131 KNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA 190
           K+KM   IA+EDV REVK+L+AL GH+N+V+FY+AFEDD  VYI MELC+GGELLD+IL 
Sbjct: 159 KSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKIL- 217

Query: 191 KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
           ++  +Y+E DA  V+ Q+L V A CHL G+VHRD+KPENFLF +  E S LKA DFGLSD
Sbjct: 218 QRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSD 277

Query: 251 FIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFK 310
           ++KP ++  DIVGSAYYVAPEVL R  G E+D+WSIGVI YILLCG RPFW +TE GIF+
Sbjct: 278 YVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 337

Query: 311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID 370
            VL+ +P+F   PWPS+S  A DFVK+LL KD R RLTAAQAL HPW+  G    +IP D
Sbjct: 338 AVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLV-GSHELKIPSD 396

Query: 371 ISVLNNMRQFVKYSRLKQFAL 391
           + +   ++ ++  + L++ AL
Sbjct: 397 MIIYKLVKVYIMSTSLRKSAL 417

May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	414
449434158	543	PREDICTED: calcium-dependent protein kin	0.929	0.709	0.829	0.0
225431134	558	PREDICTED: calcium-dependent protein kin	0.925	0.686	0.8	0.0
224134094	556	calcium dependent protein kinase 18 [Pop	0.929	0.692	0.799	0.0
350538611	565	calcium-dependent protein kinase [Solanu	0.845	0.619	0.853	0.0
395863620	550	CDPK1 [Fragaria vesca]	0.847	0.638	0.868	0.0
16904224	572	calcium-dependent protein kinase CPK4 [N	0.896	0.648	0.815	1e-180
224074263	557	calcium dependent protein kinase 16 [Pop	0.932	0.692	0.807	1e-180
255561295	575	calcium-dependent protein kinase, putati	0.770	0.554	0.931	1e-178
179399369	563	putative calcium dependent protein kinas	0.908	0.667	0.788	1e-178
325683724	552	calcium-dependent protein kinase [Fragar	0.925	0.693	0.808	1e-178

>gi|449434158|ref|XP_004134863.1| PREDICTED: calcium-dependent protein kinase 28-like [Cucumis sativus] gi|449491358|ref|XP_004158870.1| PREDICTED: calcium-dependent protein kinase 28-like [Cucumis sativus]

 Score =  658 bits (1698), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/392 (82%), Positives = 346/392 (88%), Gaps = 7/392 (1%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNY 60
           MG+C S +KVSGSNS +NN   NHHR  +    +      +  DT+   +  +    +N 
Sbjct: 1   MGVCFSASKVSGSNSNTNNTVVNHHRRGSTANPQ-----PSTTDTSQNQKRPNDNPKRNS 55

Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           QQLK K+  K  SRRQ+GVIPCGKRTDFGY K+FD RYTIGKLLGHGQFGYTYVA DK N
Sbjct: 56  QQLKIKE--KNVSRRQSGVIPCGKRTDFGYHKNFDERYTIGKLLGHGQFGYTYVAIDKGN 113

Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           GDRVAVKKIEKNKMILPIAVEDVKREVKILQ L GHENVV+F+NAFEDD+YVYI MELCE
Sbjct: 114 GDRVAVKKIEKNKMILPIAVEDVKREVKILQELTGHENVVQFHNAFEDDSYVYIVMELCE 173

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           GGELLDRIL+KKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRD+KPENFLFKSAKEDS 
Sbjct: 174 GGELLDRILSKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDLKPENFLFKSAKEDSH 233

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 300
           LKATDFGLSDFIKPGKKF DIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF
Sbjct: 234 LKATDFGLSDFIKPGKKFHDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 293

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           WDKTEDGIFKEVLRNKPDFRRKPWPSIS SAKDF+KKLLVKDPRARLTAAQALSH WVRE
Sbjct: 294 WDKTEDGIFKEVLRNKPDFRRKPWPSISPSAKDFIKKLLVKDPRARLTAAQALSHRWVRE 353

Query: 361 GGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           GGDASEIPIDISVL+NMRQFVKYSRLKQFALR
Sbjct: 354 GGDASEIPIDISVLSNMRQFVKYSRLKQFALR 385

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431134|ref|XP_002267099.1| PREDICTED: calcium-dependent protein kinase 16 [Vitis vinifera] gi|297735013|emb|CBI17375.3| unnamed protein product [Vitis vinifera]

 Score =  656 bits (1692), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/400 (80%), Positives = 344/400 (86%), Gaps = 17/400 (4%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQH---QHQERA 57
           MG CLS TKV  SNS +  N A          A +       + T++K+Q    Q  +R 
Sbjct: 1   MGACLSATKVRSSNSNTTANAA----------ATKNTRPRGSSKTSNKNQQKKPQEGDRN 50

Query: 58  KNYQQLKTKQHQKT----NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTY 113
           ++ QQ +  Q QK     N RR TG+IPCGKRTDFGY KDFD RYTIGKLLGHGQFGYTY
Sbjct: 51  RSNQQHRNPQPQKVKDRANGRRGTGIIPCGKRTDFGYAKDFDARYTIGKLLGHGQFGYTY 110

Query: 114 VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY 173
           VATDKANGDRVAVK+IEKNKMILPIAVEDVKREVKIL+AL GHENVV+F+NAFEDD+YVY
Sbjct: 111 VATDKANGDRVAVKRIEKNKMILPIAVEDVKREVKILEALTGHENVVQFHNAFEDDSYVY 170

Query: 174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK 233
           I MELCEGGELLDRILAKKDSRY+EKDAA VVRQML+VAAECHLHGLVHRDMKPENFLFK
Sbjct: 171 IVMELCEGGELLDRILAKKDSRYSEKDAAKVVRQMLKVAAECHLHGLVHRDMKPENFLFK 230

Query: 234 SAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYIL 293
           S KEDS LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL+RKSGPESDVWSIGVITYIL
Sbjct: 231 STKEDSPLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLRRKSGPESDVWSIGVITYIL 290

Query: 294 LCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           LCG+RPFWDKTEDGIFKEVL+NKPDFRRKPWP+ISN AKDFVKKLLVKDPRARLTAAQAL
Sbjct: 291 LCGKRPFWDKTEDGIFKEVLKNKPDFRRKPWPTISNGAKDFVKKLLVKDPRARLTAAQAL 350

Query: 354 SHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRV 393
           SHPWVREGGDASEIPIDISVL+NMR+FVKYS LKQFALR 
Sbjct: 351 SHPWVREGGDASEIPIDISVLSNMREFVKYSHLKQFALRA 390

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224134094|ref|XP_002327754.1| calcium dependent protein kinase 18 [Populus trichocarpa] gi|222836839|gb|EEE75232.1| calcium dependent protein kinase 18 [Populus trichocarpa]

 Score =  645 bits (1663), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/394 (79%), Positives = 335/394 (85%), Gaps = 9/394 (2%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHK--HQHQHQERAK 58
           MG C ST KVSGSNS   NNN  H R    +   +            +  H HQ+ +   
Sbjct: 1   MGACFSTIKVSGSNS---NNNVIHSRKEPTKPQTKTTKATTATRKKQEVVHHHQNNKNVN 57

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
           N  + K K  +K +S+     IPCGKRTDFGYDKDFD RYTIGKLLGHGQFGYTYVA DK
Sbjct: 58  NEAEKKLKVKEKQSSK----AIPCGKRTDFGYDKDFDMRYTIGKLLGHGQFGYTYVAIDK 113

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
           ANGDRVAVK+IEKNKM+LPIAVEDVKREVKIL+ L GHENVV+FYNA EDD+YVYI MEL
Sbjct: 114 ANGDRVAVKRIEKNKMVLPIAVEDVKREVKILRELTGHENVVQFYNALEDDSYVYIVMEL 173

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
           CEGGELLDRIL+KKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRDMKPENFLFKS K D
Sbjct: 174 CEGGELLDRILSKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDMKPENFLFKSTKGD 233

Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR 298
           S LKATDFGLSDFIKPG+KFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR
Sbjct: 234 SPLKATDFGLSDFIKPGRKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR 293

Query: 299 PFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           PFWDKTEDGIFKEVL+NKPDFRRKPWP+IS SAKDFV KLLVKDPRARLTAAQALSHPWV
Sbjct: 294 PFWDKTEDGIFKEVLKNKPDFRRKPWPTISTSAKDFVNKLLVKDPRARLTAAQALSHPWV 353

Query: 359 REGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           REGG ASEIPIDISVL+NMRQFVKYSRLKQFALR
Sbjct: 354 REGGVASEIPIDISVLSNMRQFVKYSRLKQFALR 387

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350538611|ref|NP_001234607.1| calcium-dependent protein kinase [Solanum lycopersicum] gi|241994912|gb|ACS74732.1| calcium-dependent protein kinase [Solanum lycopersicum]

 Score =  640 bits (1652), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 303/355 (85%), Positives = 328/355 (92%), Gaps = 5/355 (1%)

Query: 38  NHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRR 97
           N     D  + +Q   Q++ +N QQ     + K +SRRQ GVIPCGKRTDFGY KDF++R
Sbjct: 53  NQEGCRDKGNINQKNQQKQPRNSQQ-----NVKPSSRRQGGVIPCGKRTDFGYHKDFEKR 107

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           YTIGKLLGHGQFGYTYVATDK++GDRVAVK+IEKNKM+LPIAVEDVKREVKIL+AL GHE
Sbjct: 108 YTIGKLLGHGQFGYTYVATDKSSGDRVAVKRIEKNKMVLPIAVEDVKREVKILKALGGHE 167

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           NVV+FYN+FEDDNYVYI MELCEGGELLDRIL+KKDSRYTEKDAA+VVRQML+VAAECHL
Sbjct: 168 NVVQFYNSFEDDNYVYIVMELCEGGELLDRILSKKDSRYTEKDAAIVVRQMLKVAAECHL 227

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           HGLVHRDMKPENFLFKS KEDS LKATDFGLSDFI+PGKKFQDIVGSAYYVAPEVLKR+S
Sbjct: 228 HGLVHRDMKPENFLFKSTKEDSPLKATDFGLSDFIRPGKKFQDIVGSAYYVAPEVLKRRS 287

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW +ISNSAKDFVKK
Sbjct: 288 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWSNISNSAKDFVKK 347

Query: 338 LLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           +LVKDPRARLTAAQALSHPWVREGGDASEIP+DISVL+NMRQFVKYSRLKQFALR
Sbjct: 348 ILVKDPRARLTAAQALSHPWVREGGDASEIPLDISVLSNMRQFVKYSRLKQFALR 402

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|395863620|gb|AFN80337.1| CDPK1 [Fragaria vesca]

 Score =  640 bits (1652), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 305/351 (86%), Positives = 321/351 (91%)

Query: 42  RNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIG 101
           R  TT     Q      N  Q K K   K +SR++TGVIPCGKRTDFGYDK+FDRRYTIG
Sbjct: 31  RKQTTRPQPAQTNHHRPNEAQKKNKHKSKQSSRQKTGVIPCGKRTDFGYDKNFDRRYTIG 90

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLGHGQFGYTYVATD++NGDRVAVK I+KNKMILPIAVEDVKREV+ILQALAGHENVV+
Sbjct: 91  KLLGHGQFGYTYVATDRSNGDRVAVKGIDKNKMILPIAVEDVKREVEILQALAGHENVVQ 150

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           F+NA EDD YVYI MELCEGGELLDRIL KKDSRYTEKDAAVVVRQML+VAAECHLHGLV
Sbjct: 151 FFNACEDDTYVYIVMELCEGGELLDRILEKKDSRYTEKDAAVVVRQMLKVAAECHLHGLV 210

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           HRDMKPENFLFKS   DS LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL+RKSGPES
Sbjct: 211 HRDMKPENFLFKSKALDSPLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLRRKSGPES 270

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           DVWSIGVI+YILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP+ISNSAKDFVKKLLVK
Sbjct: 271 DVWSIGVISYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPTISNSAKDFVKKLLVK 330

Query: 342 DPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           DPRARLTAAQALSHPWVREGGDAS+IPIDISVLNNMRQFV+YSRLKQFALR
Sbjct: 331 DPRARLTAAQALSHPWVREGGDASDIPIDISVLNNMRQFVRYSRLKQFALR 381

Source: Fragaria vesca

Species: Fragaria vesca

Genus: Fragaria

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|16904224|gb|AAL30819.1|AF435451_1 calcium-dependent protein kinase CPK4 [Nicotiana tabacum]

 Score =  636 bits (1641), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 305/374 (81%), Positives = 331/374 (88%), Gaps = 3/374 (0%)

Query: 20  NNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQ-TG 78
           N AN    +     K+  +H  +      H+ QHQ++     Q   K+H   N RRQ +G
Sbjct: 33  NKANPPSTSTITSTKQEGSHCNKQKVKDNHKSQHQKQQPRNSQQNVKKH--NNGRRQKSG 90

Query: 79  VIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI 138
           VI CGKRTDFGYDKDFD+R+TIGKLLGHGQFGYTYVAT K+NGDRVAVK+IEKNKM+LPI
Sbjct: 91  VIACGKRTDFGYDKDFDKRFTIGKLLGHGQFGYTYVATHKSNGDRVAVKRIEKNKMVLPI 150

Query: 139 AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
           AVEDVKREVKIL+AL+GHENVV+F NAFEDDNYVYI MELCEGGELLDRILAKKDSRY E
Sbjct: 151 AVEDVKREVKILKALSGHENVVQFNNAFEDDNYVYIVMELCEGGELLDRILAKKDSRYAE 210

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           KDAA+VVRQML+ AA+CHLHGLVHRDMKPENFLFKS+KEDS LKATDFGLSDFI+PGKKF
Sbjct: 211 KDAAIVVRQMLKEAAQCHLHGLVHRDMKPENFLFKSSKEDSPLKATDFGLSDFIRPGKKF 270

Query: 259 QDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
           QDIVGSAYYVAPEVLKR+SGPESD WSIGVITYILLCGRR FWDKTEDGIFKEVLRNKPD
Sbjct: 271 QDIVGSAYYVAPEVLKRRSGPESDEWSIGVITYILLCGRRRFWDKTEDGIFKEVLRNKPD 330

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMR 378
           FRRKPWP+ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP+DISVL+NMR
Sbjct: 331 FRRKPWPTISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPLDISVLSNMR 390

Query: 379 QFVKYSRLKQFALR 392
           QFVKYSRLKQFALR
Sbjct: 391 QFVKYSRLKQFALR 404

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224074263|ref|XP_002304327.1| calcium dependent protein kinase 16 [Populus trichocarpa] gi|222841759|gb|EEE79306.1| calcium dependent protein kinase 16 [Populus trichocarpa]

 Score =  635 bits (1639), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 318/394 (80%), Positives = 341/394 (86%), Gaps = 8/394 (2%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHAR--NDTTHKHQHQHQERAK 58
           MG C ST  +SGSNS +NN  ANH+R    +   R      R   +  H H HQ  +   
Sbjct: 1   MGACFSTINISGSNS-NNNTKANHNRKEPTKPQTRTTKAATRKKQEVVH-HHHQINKNVN 58

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
           N  + K K  +K +S+     IPCGKRTDFGYDKDFD RYTIGKLLGHGQFGYTYVATDK
Sbjct: 59  NEAEKKLKVKEKQSSK----AIPCGKRTDFGYDKDFDIRYTIGKLLGHGQFGYTYVATDK 114

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
            NGDRVAVK+I+KNKM+LPIAVEDVKREV+ILQ L GHENVV+F+NAFEDD+YVYI MEL
Sbjct: 115 GNGDRVAVKRIDKNKMVLPIAVEDVKREVRILQELTGHENVVQFHNAFEDDSYVYIVMEL 174

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
           CEGGELLDRILAKKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRDMKPENFLFKS KED
Sbjct: 175 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDMKPENFLFKSTKED 234

Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR 298
           S LKATDFGLSDFIKPG+KF+DIVGSAYYVAPEVLKR SGPESDVWSIGVITYILLCGRR
Sbjct: 235 SPLKATDFGLSDFIKPGRKFKDIVGSAYYVAPEVLKRNSGPESDVWSIGVITYILLCGRR 294

Query: 299 PFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           PFWDKTEDGIFKEVLRNKPDFRRKPWP+IS SAKDFV+KLLVKDPRARLTAAQALSHPWV
Sbjct: 295 PFWDKTEDGIFKEVLRNKPDFRRKPWPTISTSAKDFVQKLLVKDPRARLTAAQALSHPWV 354

Query: 359 REGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           REGGDASEIPIDISVL+NMRQFVKYSRLKQFALR
Sbjct: 355 REGGDASEIPIDISVLSNMRQFVKYSRLKQFALR 388

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255561295|ref|XP_002521658.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223539049|gb|EEF40645.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  632 bits (1629), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 297/319 (93%), Positives = 308/319 (96%)

Query: 74  RRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK 133
           RR  GVIPCGKRTDFGY KDFD+RY+IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK
Sbjct: 88  RRPGGVIPCGKRTDFGYAKDFDKRYSIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK 147

Query: 134 MILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD 193
           M+LPIAVEDVKREVKILQ LAGHENVV FYNAFEDD++VYI MELCEGGELLDRIL KKD
Sbjct: 148 MVLPIAVEDVKREVKILQELAGHENVVHFYNAFEDDSFVYIVMELCEGGELLDRILLKKD 207

Query: 194 SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
           SRYTEKDAAV+VRQML+VAAECHLHGLVHRDMKPENFLFKS K+DS LKATDFGLSDFIK
Sbjct: 208 SRYTEKDAAVIVRQMLKVAAECHLHGLVHRDMKPENFLFKSTKDDSPLKATDFGLSDFIK 267

Query: 254 PGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
           PGKKFQDIVGSAYYVAPEVLKR+SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL
Sbjct: 268 PGKKFQDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 327

Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISV 373
           RNKPDFRRKPWPSIS+SAKDFVKKLLVKDPR RLTAAQALSHPWVREGG+ASEIPIDISV
Sbjct: 328 RNKPDFRRKPWPSISSSAKDFVKKLLVKDPRVRLTAAQALSHPWVREGGNASEIPIDISV 387

Query: 374 LNNMRQFVKYSRLKQFALR 392
           LNNMRQFVKYSR KQFALR
Sbjct: 388 LNNMRQFVKYSRFKQFALR 406

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|179399369|gb|ACB86621.1| putative calcium dependent protein kinase [Silene vulgaris]

 Score =  631 bits (1628), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 310/393 (78%), Positives = 333/393 (84%), Gaps = 17/393 (4%)

Query: 15  SGSNNNNANHHRNANKEEAKRRHNHHARNDT---------------THKHQHQHQERAKN 59
           SGSN+NN      A K +  RR        T               TH H  +H++ +KN
Sbjct: 4   SGSNSNNTASTSTAGKTKRNRRKPPSMPYTTSGVPSRTSGVPTTTITHYHNDKHRKTSKN 63

Query: 60  YQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKA 119
              +  K  +KT+SRRQ+  IPCGKRTDFGYDKDFD+RY IGKLLGHGQFGYTYVAT+K+
Sbjct: 64  NSNI-IKLREKTSSRRQSS-IPCGKRTDFGYDKDFDKRYIIGKLLGHGQFGYTYVATNKS 121

Query: 120 NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC 179
           NGDRVAVKKI+KNKM LPIAVEDVKREVKIL+AL GHENVV+FYNAFEDDNYVYI MELC
Sbjct: 122 NGDRVAVKKIDKNKMKLPIAVEDVKREVKILKALTGHENVVQFYNAFEDDNYVYIVMELC 181

Query: 180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
           EGGELLDRILAKKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRDMKPENFLFKS KEDS
Sbjct: 182 EGGELLDRILAKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDMKPENFLFKSPKEDS 241

Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP 299
            LKATDFGLSDFI P +KF DIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP
Sbjct: 242 PLKATDFGLSDFINPSRKFTDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP 301

Query: 300 FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           FWDKTEDGIFKEVLRNKPDFRRKPWP+ISNSAKDFV+KLLVKDP  RLTAAQALSH WVR
Sbjct: 302 FWDKTEDGIFKEVLRNKPDFRRKPWPTISNSAKDFVRKLLVKDPLVRLTAAQALSHQWVR 361

Query: 360 EGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           EGG A +IPIDISVL+NMRQFVKYSR+KQFALR
Sbjct: 362 EGGSALDIPIDISVLHNMRQFVKYSRMKQFALR 394

Source: Silene vulgaris

Species: Silene vulgaris

Genus: Silene

Family: Caryophyllaceae

Order: Caryophyllales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|325683724|gb|ADZ44603.1| calcium-dependent protein kinase [Fragaria x ananassa]

 Score =  630 bits (1624), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 317/392 (80%), Positives = 335/392 (85%), Gaps = 9/392 (2%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNY 60
           MG CL+T KV+GSNS +N NN                    R  TT     Q      N 
Sbjct: 1   MGGCLTTAKVTGSNSNTNTNNNPATTTTAVVN---------RKQTTRPPPAQTNHHRANE 51

Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
            Q K K   K +SR++TG+IPCGKRTDFGYDK+FDRRY IGKLLGHGQFGYTYV TD++N
Sbjct: 52  AQKKHKHKPKQSSRQKTGMIPCGKRTDFGYDKNFDRRYMIGKLLGHGQFGYTYVVTDRSN 111

Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           GDRVAVK+I+KNKMILPIAVEDVKREVKILQALAGHENVV+FYNA EDD YVYI MELCE
Sbjct: 112 GDRVAVKRIDKNKMILPIAVEDVKREVKILQALAGHENVVQFYNACEDDTYVYIVMELCE 171

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           GGELLDRIL KKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRDMKPENFLFKS   DS 
Sbjct: 172 GGELLDRILEKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDMKPENFLFKSKALDSP 231

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 300
           LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL+RKSG ESDVWSIGVITYILLCGRRPF
Sbjct: 232 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLRRKSGRESDVWSIGVITYILLCGRRPF 291

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           WDKTEDGIFKEVLRNKPDFRRKPWP+ISNSAKDF KKLLVKDPRARLTAAQALSHPWVRE
Sbjct: 292 WDKTEDGIFKEVLRNKPDFRRKPWPTISNSAKDFAKKLLVKDPRARLTAAQALSHPWVRE 351

Query: 361 GGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           GGDAS+IPIDISVLNNMRQFV+YSRLKQFALR
Sbjct: 352 GGDASDIPIDISVLNNMRQFVRYSRLKQFALR 383

Source: Fragaria x ananassa

Species: Fragaria x ananassa

Genus: Fragaria

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	414
TAIR|locus:2827826	571	CPK16 "AT2G17890" [Arabidopsis	0.835	0.605	0.832	5.6e-155
TAIR|locus:2156947	523	CPK28 "calcium-dependent prote	0.780	0.617	0.845	6.9e-150
TAIR|locus:2012232	606	AT1G49580 [Arabidopsis thalian	0.855	0.584	0.522	1e-93
TAIR|locus:2094053	599	AT3G19100 [Arabidopsis thalian	0.835	0.577	0.515	9.3e-91
TAIR|locus:2062764	595	CRK3 "AT2G46700" [Arabidopsis	0.727	0.505	0.556	1.2e-88
TAIR|locus:2103655	577	AT3G56760 [Arabidopsis thalian	0.799	0.573	0.526	3.2e-88
TAIR|locus:2063197	576	CRK1 "AT2G41140" [Arabidopsis	0.741	0.532	0.560	4.1e-88
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.724	0.568	0.533	7.7e-87
TAIR|locus:2015846	521	CPK33 "calcium-dependent prote	0.710	0.564	0.547	3.3e-86
TAIR|locus:2036783	551	CPK19 "calcium-dependent prote	0.818	0.615	0.495	1.8e-85

TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)]

 Score = 1511 (537.0 bits), Expect = 5.6e-155, P = 5.6e-155
 Identities = 294/353 (83%), Positives = 309/353 (87%)

Query:    47 HKHQHQHQERAKNYQQLKTKQHQKT-------NSRRQTGVIPCGKRTDFGYDKDFDRRYT 99
             H+ Q +    AK      T  H K        N RR    IP GKR DFGY KDFD RYT
Sbjct:    50 HRTQPRRNATAKKTPTRHTPPHGKVREKVISNNGRRHGETIPYGKRVDFGYAKDFDHRYT 109

Query:   100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
             IGKLLGHGQFGYTYVATDK  GDRVAVKKI+K KM +PIAVEDVKREVKILQAL GHENV
Sbjct:   110 IGKLLGHGQFGYTYVATDKKTGDRVAVKKIDKAKMTIPIAVEDVKREVKILQALTGHENV 169

Query:   160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
             V+FYNAFED N VYI MELCEGGELLDRILA+KDSRY+E+DAAVVVRQML+VAAECHL G
Sbjct:   170 VRFYNAFEDKNSVYIVMELCEGGELLDRILARKDSRYSERDAAVVVRQMLKVAAECHLRG 229

Query:   220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGP 279
             LVHRDMKPENFLFKS +EDS LKATDFGLSDFIKPGKKF DIVGSAYYVAPEVLKR+SGP
Sbjct:   230 LVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIKPGKKFHDIVGSAYYVAPEVLKRRSGP 289

Query:   280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             ESDVWSIGVI+YILLCGRRPFWDKTEDGIFKEVL+NKPDFRRKPWP+ISNSAKDFVKKLL
Sbjct:   290 ESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVLKNKPDFRRKPWPTISNSAKDFVKKLL 349

Query:   340 VKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
             VKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK+SRLKQFALR
Sbjct:   350 VKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKFSRLKQFALR 402

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007165 "signal transduction" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0005886 "plasma membrane" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)]

 Score = 1463 (520.1 bits), Expect = 6.9e-150, P = 6.9e-150
 Identities = 273/323 (84%), Positives = 304/323 (94%)

Query:    70 KTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI 129
             K +++R+TG IPCGKRTDFGY KDF   YTIGKLLGHGQFGYTYVA  + NGDRVAVK++
Sbjct:    34 KASTKRRTGSIPCGKRTDFGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPNGDRVAVKRL 93

Query:   130 EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL 189
             +K+KM+LPIAVEDVKREV+IL AL+GHENVV+F+NAFEDD+YVYI MELCEGGELLDRIL
Sbjct:    94 DKSKMVLPIAVEDVKREVQILIALSGHENVVQFHNAFEDDDYVYIVMELCEGGELLDRIL 153

Query:   190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
             +KK +RY+EKDAAVVVRQML+VA ECHLHGLVHRDMKPENFLFKSA+ DS LKATDFGLS
Sbjct:   154 SKKGNRYSEKDAAVVVRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSPLKATDFGLS 213

Query:   250 DFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIF 309
             DFIKPGK+F DIVGSAYYVAPEVLKR+SGPESDVWSIGVITYILLCGRRPFWD+TEDGIF
Sbjct:   214 DFIKPGKRFHDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDRTEDGIF 273

Query:   310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
             KEVLRNKPDF RKPW +IS+SAKDFVKKLLVKDPRARLTAAQALSH WVREGG+A++IP+
Sbjct:   274 KEVLRNKPDFSRKPWATISDSAKDFVKKLLVKDPRARLTAAQALSHAWVREGGNATDIPV 333

Query:   370 DISVLNNMRQFVKYSRLKQFALR 392
             DISVLNN+RQFV+YSRLKQFALR
Sbjct:   334 DISVLNNLRQFVRYSRLKQFALR 356

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)]

 Score = 933 (333.5 bits), Expect = 1.0e-93, P = 1.0e-93
 Identities = 189/362 (52%), Positives = 242/362 (66%)

Query:    36 RHNHHARNDTTHKHQHQHQERAKNYQQLK--TKQHQKTNSRRQTGVIPCGKRTDFGYDKD 93
             R   H  +   H      + + K    L   T+   +   R +   +   KR  FG+ K+
Sbjct:    88 RRAFHPPSPAKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKR--FGFSKE 145

Query:    94 FDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
             F  R  +G+ +G G FGYT  A  K     G  VAVK I K+KM   IA+EDV+REVKIL
Sbjct:   146 FHSRVELGEEIGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKIL 205

Query:   151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
             QAL+GH+N+V+FY+AFED+  VYIAMELCEGGELLDRILA+   +Y+E DA  V+ Q+L 
Sbjct:   206 QALSGHKNLVQFYDAFEDNANVYIAMELCEGGELLDRILAR-GGKYSENDAKPVIIQILN 264

Query:   211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
             V A CH  G+VHRD+KPENFL+ S +E+S LKA DFGLSDF++P ++  DIVGSAYYVAP
Sbjct:   265 VVAFCHFQGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 324

Query:   271 EVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
             EVL R    E+DVWSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PWP +S+ 
Sbjct:   325 EVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSD 384

Query:   331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFA 390
             AKDFVK+LL KDPR R++A+QAL HPW+R       IP DI +   M+ +++ S L++ A
Sbjct:   385 AKDFVKRLLFKDPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAA 444

Query:   391 LR 392
             LR
Sbjct:   445 LR 446

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)]

 Score = 905 (323.6 bits), Expect = 9.3e-91, P = 9.3e-91
 Identities = 183/355 (51%), Positives = 237/355 (66%)

Query:    40 HARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYT 99
             H  +   H      + + K    L   + QK    R+   +   KR  FG+ K+   R  
Sbjct:    90 HPPSPARHIRDVLRRRKEKKEAALPAARQQKEEEEREE--VGLDKR--FGFSKELQSRIE 145

Query:   100 IGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
             +G+ +G G FGYT  A  K        VAVK I K+KM   I++EDV+REVKIL+AL+GH
Sbjct:   146 LGEEIGRGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGH 205

Query:   157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +N+V+FY+AFED+  VYI MELC GGELLDRILA+   +Y+E DA  V+ Q+L V A CH
Sbjct:   206 QNLVQFYDAFEDNANVYIVMELCGGGELLDRILAR-GGKYSEDDAKAVLIQILNVVAFCH 264

Query:   217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
             L G+VHRD+KPENFL+ S +E+S LK  DFGLSDF++P ++  DIVGSAYYVAPEVL R 
Sbjct:   265 LQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS 324

Query:   277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
                E+DVWSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PWPS+S  AKDFVK
Sbjct:   325 YTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVK 384

Query:   337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFAL 391
             +LL KDPR R+TA+QAL HPW+  G    +IP DI +   ++ +++ S L++ AL
Sbjct:   385 RLLYKDPRKRMTASQALMHPWIA-GYKKIDIPFDILIFKQIKAYLRSSSLRKAAL 438

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)]

 Score = 885 (316.6 bits), Expect = 1.2e-88, P = 1.2e-88
 Identities = 172/309 (55%), Positives = 227/309 (73%)

Query:    88 FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDV 143
             FGY K+F  +Y +GK +G G FG+T     K  GD     +AVK I K KM   IA+EDV
Sbjct:   133 FGYGKNFGAKYELGKEVGRGHFGHTCSGRGK-KGDIKDHPIAVKIISKAKMTTAIAIEDV 191

Query:   144 KREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
             +REVK+L++L+GH+ ++K+Y+A ED N VYI MELC+GGELLDRILA+   +Y E DA  
Sbjct:   192 RREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELLDRILAR-GGKYPEDDAKA 250

Query:   204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
             +V Q+L V + CHL G+VHRD+KPENFLF S++EDS LK  DFGLSDFI+P ++  DIVG
Sbjct:   251 IVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVG 310

Query:   264 SAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
             SAYYVAPEVL R    E+D+WSIGVITYILLCG RPFW +TE GIF+ VLR +P++   P
Sbjct:   311 SAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTESGIFRTVLRTEPNYDDVP 370

Query:   324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKY 383
             WPS S+  KDFVK+LL KD R R++A QAL+HPW+R+  D+  IP+DI +   ++ ++  
Sbjct:   371 WPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRD--DSRVIPLDILIYKLVKAYLHA 428

Query:   384 SRLKQFALR 392
             + L++ AL+
Sbjct:   429 TPLRRAALK 437

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010150 "leaf senescence" evidence=IEP

GO:0005516 "calmodulin binding" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)]

 Score = 881 (315.2 bits), Expect = 3.2e-88, P = 3.2e-88
 Identities = 181/344 (52%), Positives = 233/344 (67%)

Query:    57 AKNYQQLKTKQHQKTNSRRQTGVIPCGKRTD------FGYDKDFDRRYTIGKLLGHGQFG 110
             AK+ + L  ++H        +  IP G   +      FG+ K F   Y I   +G G FG
Sbjct:    79 AKHIRALLARRHGSVKPNEAS--IPEGSECEVGLDKKFGFSKQFASHYEIDGEVGRGHFG 136

Query:   111 YTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE 167
             YT  A  K     G  VAVK I K+KM   IA+EDV+REVKIL+AL GH+N+V+FY+AFE
Sbjct:   137 YTCSAKGKKGSLKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFE 196

Query:   168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP 227
             DD  VYI MELC+GGELLD+IL ++  +Y+E DA  V+ Q+L V A CHL G+VHRD+KP
Sbjct:   197 DDENVYIVMELCQGGELLDKIL-QRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKP 255

Query:   228 ENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIG 287
             ENFLF +  E S LKA DFGLSD+++P ++  DIVGSAYYVAPEVL R  G E+D+WSIG
Sbjct:   256 ENFLFTTKDESSPLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIG 315

Query:   288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
             VI YILLCG RPFW ++E GIF+ VL+ +P+F   PWPS+S  A DFVK+LL KD R RL
Sbjct:   316 VIAYILLCGSRPFWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRL 375

Query:   348 TAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFAL 391
             TAAQAL HPW+  G    +IP D+ +   ++ ++  S L++ AL
Sbjct:   376 TAAQALCHPWL-VGSHELKIPSDMIIYKLVKVYIMSSSLRKSAL 418

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0016020 "membrane" evidence=IDA

TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)]

 Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
 Identities = 175/312 (56%), Positives = 220/312 (70%)

Query:    83 GKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIA 139
             G    FG+ K F   Y I   +G G FGYT  A  K     G  VAVK I K+KM   IA
Sbjct:   108 GLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSKMTTAIA 167

Query:   140 VEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK 199
             +EDV REVK+L+AL GH+N+V+FY+AFEDD  VYI MELC+GGELLD+IL ++  +Y+E 
Sbjct:   168 IEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKIL-QRGGKYSED 226

Query:   200 DAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
             DA  V+ Q+L V A CHL G+VHRD+KPENFLF +  E S LKA DFGLSD++KP ++  
Sbjct:   227 DAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSDYVKPDERLN 286

Query:   260 DIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
             DIVGSAYYVAPEVL R  G E+D+WSIGVI YILLCG RPFW +TE GIF+ VL+ +P+F
Sbjct:   287 DIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAEPNF 346

Query:   320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ 379
                PWPS+S  A DFVK+LL KD R RLTAAQAL HPW+  G    +IP D+ +   ++ 
Sbjct:   347 EEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWL-VGSHELKIPSDMIIYKLVKV 405

Query:   380 FVKYSRLKQFAL 391
             ++  + L++ AL
Sbjct:   406 YIMSTSLRKSAL 417

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IDA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010286 "heat acclimation" evidence=IMP

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 868 (310.6 bits), Expect = 7.7e-87, P = 7.7e-87
 Identities = 161/302 (53%), Positives = 219/302 (72%)

Query:    92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
             +D    Y++GK LG GQFG T++ T KA G + A K I K K++    +EDV+REV+I+ 
Sbjct:    67 EDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIMH 126

Query:   152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
              L G  N+V+   A+ED + V++ MELC GGEL DRI+AK    Y+E+ AA ++R ++++
Sbjct:   127 HLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAK--GHYSERAAASLLRTIVQI 184

Query:   212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
                CH  G++HRD+KPENFL  +  E+S LKATDFGLS F KPG+ F+DIVGSAYY+APE
Sbjct:   185 VHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPE 244

Query:   272 VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
             VLKRK GPE+D+WSIGV+ YILLCG  PFW ++E+GIF  +LR   DF   PWPSIS  A
Sbjct:   245 VLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQA 304

Query:   332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFAL 391
             KD VKK+L  DP+ RLTAAQ L+HPW++E G+A ++P+D +V++ ++QF   +  K+ AL
Sbjct:   305 KDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVAL 364

Query:   392 RV 393
             RV
Sbjct:   365 RV 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)]

 Score = 862 (308.5 bits), Expect = 3.3e-86, P = 3.3e-86
 Identities = 162/296 (54%), Positives = 217/296 (73%)

Query:    98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
             YT+ K LG GQFG TY+ T+K+ G R A K I K K++     ED++RE++I+Q L+G  
Sbjct:    73 YTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQP 132

Query:   158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             N+V+F  A+ED+  V + MELC GGEL DRILAK    Y+E+ AA V RQ++ V   CH 
Sbjct:   133 NIVEFKGAYEDEKAVNLVMELCAGGELFDRILAK--GHYSERAAASVCRQIVNVVNICHF 190

Query:   218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
              G++HRD+KPENFL  S  E + +KATDFGLS FI+ G+ ++DIVGSAYYVAPEVLKR+ 
Sbjct:   191 MGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRY 250

Query:   278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
             G E D+WS G+I YILL G  PFW +TE GIF  +L  + DF  +PWPSISNSAKD V++
Sbjct:   251 GKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRR 310

Query:   338 LLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRV 393
             +L +DP+ R++AA+ L HPW+REGG+AS+ PID +VL+ M+QF   ++LK+ AL+V
Sbjct:   311 MLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKV 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2036783 CPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 855 (306.0 bits), Expect = 1.8e-85, P = 1.8e-85
 Identities = 173/349 (49%), Positives = 235/349 (67%)

Query:    61 QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
             ++ K   HQK ++ +Q   I  G+   F   +D   +Y++G+ LG GQFG TY+ T+ ++
Sbjct:    67 EKQKLINHQKQSTLQQPEPI-LGR--PF---EDIKEKYSLGRELGRGQFGITYICTEISS 120

Query:   121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
             G   A K I K K+I     EDV+RE++I+  L+G  N+V+   A+ED   V++ MELCE
Sbjct:   121 GKNFACKSILKRKLIRTKDREDVRREIQIMHYLSGQPNIVEIKGAYEDRQSVHLVMELCE 180

Query:   181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
             GGEL D+I   K   Y+EK AA ++R +++V   CH  G++HRD+KPENFL  S  E SS
Sbjct:   181 GGELFDKIT--KRGHYSEKAAAEIIRSVVKVVQICHFMGVIHRDLKPENFLLSSKDEASS 238

Query:   241 -LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP 299
              LKATDFG+S FI+ GK ++DIVGSAYYVAPEVLKR  G   D+WS GVI YILLCG  P
Sbjct:   239 MLKATDFGVSVFIEEGKVYEDIVGSAYYVAPEVLKRNYGKAIDIWSAGVILYILLCGNPP 298

Query:   300 FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
             FW +T+ GIF+E+LR + DF  +PWPSIS SAKD V+ +L  DP+ R TAAQ L HPW+R
Sbjct:   299 FWAETDKGIFEEILRGEIDFESEPWPSISESAKDLVRNMLKYDPKKRFTAAQVLEHPWIR 358

Query:   360 EGGDASEIPIDISVLNNMRQFVKYSRLKQFALR-VTQYFKYTALFKVKT 407
             EGG+AS+ PID +VL+ M+Q    ++LK+ A + + Q  K   L  +KT
Sbjct:   359 EGGEASDKPIDSAVLSRMKQLRAMNKLKKLAFKFIAQNLKEEELKGLKT 407

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q7XJR9	CDPKG_ARATH	2, ., 7, ., 1, 1, ., 1	0.7530	0.9396	0.6812	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	414
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-97
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-83
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-60
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-59
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-58
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-58
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-56
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-55
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-55
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-53
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-52
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-48
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-46
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-46
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-45
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-45
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-44
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-43
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-42
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-41
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-41
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-41
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-40
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-40
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-40
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-40
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-39
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-39
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-39
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-38
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-37
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-37
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-36
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-36
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-36
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-36
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-36
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-35
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-34
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-34
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-32
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-32
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-32
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-32
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-31
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-31
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-31
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-31
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-31
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-31
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-31
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-30
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-30
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-30
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-30
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-30
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-29
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-29
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-29
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-29
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-29
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-29
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-29
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-29
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-29
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-28
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-28
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-28
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-28
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-28
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-28
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-28
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-28
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-27
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-27
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-27
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-27
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-27
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-27
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-27
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-27
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-27
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-27
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-26
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-26
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-26
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-26
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-26
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-26
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-25
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-25
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-25
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-25
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-25
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-25
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-25
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-25
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-25
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-25
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-25
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-24
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-24
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-24
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-24
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-24
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-24
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-24
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-24
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-23
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-23
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-23
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-23
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-23
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-23
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-23
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-23
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-23
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-23
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-23
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-23
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-23
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-22
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-22
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-22
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-22
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-22
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-22
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-22
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-22
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-22
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-22
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-21
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-21
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-21
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-20
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-20
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-20
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-20
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-19
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-19
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-19
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-19
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-19
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-19
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-18
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-18
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-17
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-17
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-17
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-14
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-06
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
COG4248	637	COG4248, COG4248, Uncharacterized protein with pro	2e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-04
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	5e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.001
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.003
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  290 bits (745), Expect = 3e-97
 Identities = 119/263 (45%), Positives = 159/263 (60%), Gaps = 11/263 (4%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I + LG G FG  Y+A DK  G  VA+K I+K K+      E + RE+KIL+ L  H 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKL-KHP 57

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V+ Y+ FED++ +Y+ ME CEGG+L D +  KK  R +E +A   +RQ+L      H 
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHS 115

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+VHRD+KPEN L     ED  +K  DFGL+  + PG+K    VG+  Y+APEVL  K 
Sbjct: 116 KGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG 172

Query: 278 -GPESDVWSIGVITYILLCGRRPFW-DKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
            G   D+WS+GVI Y LL G+ PF  D     +FK++ + KP F    W  IS  AKD +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLI 231

Query: 336 KKLLVKDPRARLTAAQALSHPWV 358
           +KLLVKDP  RLTA +AL HP+ 
Sbjct: 232 RKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  256 bits (656), Expect = 1e-83
 Identities = 102/267 (38%), Positives = 145/267 (54%), Gaps = 13/267 (4%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + LG G FG  Y A  K  G  VAVK ++K         +  +RE++IL+ L  H 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRL-SHP 58

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V+  +AFED +++Y+ ME CEGG+L D +        +E +A  +  Q+LR     H 
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHS 116

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK-- 274
           +G++HRD+KPEN L     E+  +K  DFGL+   +K        VG+ +Y+APEVL   
Sbjct: 117 NGIIHRDLKPENILLD---ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKPDFRRKPWPSISNSA 331
              GP+ DVWS+GVI Y LL G+ PF  +       + + +L    +F    W S S  A
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           KD +KK L KDP  R TA + L HPW 
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  196 bits (500), Expect = 5e-60
 Identities = 91/292 (31%), Positives = 141/292 (48%), Gaps = 39/292 (13%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
            DF      GK++G G F    +A +K      A+K ++K ++I    V+ VK E ++L 
Sbjct: 1   DDFK----FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L GH  ++K Y  F+D+  +Y  +E    GELL  I  +K     EK       ++L  
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLA 114

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI---------- 261
               H  G++HRD+KPEN L     +D  +K TDFG +  + P    +            
Sbjct: 115 LEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 262 -----------VGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIF 309
                      VG+A YV+PE+L  K +G  SD+W++G I Y +L G+ PF    E   F
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231

Query: 310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA----AQALSHPW 357
           +++L+ +  F     P+    AKD ++KLLV DP+ RL       +  +HP+
Sbjct: 232 QKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  191 bits (487), Expect = 6e-59
 Identities = 91/256 (35%), Positives = 134/256 (52%), Gaps = 44/256 (17%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  Y+A DK  G +VA+K I+K        +E++ RE++IL+ L  H N+VK Y
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--SSLLEELLREIEILKKLN-HPNIVKLY 57

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
             FED+N++Y+ ME CEGG L D +L + + + +E +   ++ Q+L      H +G++HR
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKD-LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVLKRKS--GPE 280
           D+KPEN L  S  ++  +K  DFGLS  +   K   + IVG+  Y+APEVL  K     +
Sbjct: 117 DLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
           SD+WS+GVI Y L                                      KD ++K+L 
Sbjct: 175 SDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ 199

Query: 341 KDPRARLTAAQALSHP 356
           KDP  R +A + L H 
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  190 bits (484), Expect = 4e-58
 Identities = 92/264 (34%), Positives = 138/264 (52%), Gaps = 16/264 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I + +G G FG  Y A  K  G  VA+K I+          E +  E++IL+    H 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE---KKEKIINEIQILKKCK-HP 57

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK+Y ++   + ++I ME C GG L D +L   +   TE   A V +++L+     +L
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLK--GLEYL 114

Query: 218 H--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H  G++HRD+K  N L  S   D  +K  DFGLS  +   K    +VG+ Y++APEV+  
Sbjct: 115 HSNGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING 171

Query: 276 KS-GPESDVWSIGVITYI-LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
           K    ++D+WS+G IT I L  G+ P+ +        ++  N P   R P    S+  KD
Sbjct: 172 KPYDYKADIWSLG-ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW-SDEFKD 229

Query: 334 FVKKLLVKDPRARLTAAQALSHPW 357
           F+KK L K+P  R TA Q L HP+
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  190 bits (484), Expect = 4e-58
 Identities = 87/260 (33%), Positives = 137/260 (52%), Gaps = 17/260 (6%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG   +   K  G   A+K ++K K+I    VE    E  IL  +  H  +VK +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVH 222
            AF+ +  +Y+ +E   GGEL   +   K+ R++E+ A     +++ +A E  H  G+++
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIV-LALEYLHSLGIIY 116

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+KPEN L      D  +K TDFGL+ +    G +     G+  Y+APEVL  K  G  
Sbjct: 117 RDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D WS+GV+ Y +L G+ PF+ +    I++++L++   F   P   +S  A+D +  LL 
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLLQ 229

Query: 341 KDPRARLTAAQA---LSHPW 357
           KDP  RL +  A    +HP+
Sbjct: 230 KDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  184 bits (469), Expect = 8e-56
 Identities = 97/268 (36%), Positives = 139/268 (51%), Gaps = 20/268 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G L+G G FG  Y   +   GD VA+K+I   K I   A++ + +E+ +L+ L  H
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLK-H 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+VK+  + E  + +YI +E  E G L   I  KK   + E   AV V Q+L+  A  H
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLH 116

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
             G++HRD+K  N L     +D  +K  DFG++       K    +VG+ Y++APEV+  
Sbjct: 117 EQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-E 172

Query: 276 KSGP--ESDVWSIGVITYI-LLCGRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPS-ISNS 330
            SG    SD+WS+G  T I LL G  P++D       F+ V  + P     P P  IS  
Sbjct: 173 MSGASTASDIWSLG-CTVIELLTGNPPYYDLNPMAALFRIVQDDHP-----PLPEGISPE 226

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            KDF+ +   KDP  R TA Q L HPW+
Sbjct: 227 LKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  184 bits (469), Expect = 1e-55
 Identities = 89/271 (32%), Positives = 144/271 (53%), Gaps = 20/271 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +T G+LLG G FG  Y+A DK  G+ +AVK +E +       +E ++RE++IL +L  H
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-H 58

Query: 157 ENVVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            N+V++Y +   E+ N + I +E   GG L   +  KK  +  E       RQ+L   A 
Sbjct: 59  PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAY 116

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H +G+VHRD+K  N L  S   D  +K  DFG +     I+ G+    + G+ Y++APE
Sbjct: 117 LHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 272 VLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG--IFKEVLRNKPDFRRKPWPS-I 327
           V++  + G  +D+WS+G     +  G+ P+ +       ++K     +P       P  +
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP----EIPEHL 229

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           S  AKDF++K L +DP+ R TA + L HP++
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  181 bits (463), Expect = 6e-55
 Identities = 86/274 (31%), Positives = 138/274 (50%), Gaps = 32/274 (11%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y I K +G G FG  Y+   K++G    +K+I+ + M      ED   EVKIL+ L  H
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLN-H 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVRQMLRVAAE 214
            N++K+Y +FE+   + I ME  +GG+L  +I  +K     + E+       Q+    A 
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL--CLAL 116

Query: 215 CHLHG--LVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-------IVGS 264
            +LH   ++HRD+KP+N FL      +  +K  DFG+S      K           +VG+
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTS----NGLVKLGDFGIS------KVLSSTVDLAKTVVGT 166

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            YY++PE+ + K    +SD+WS+G + Y L   + PF  +    +  ++L+ +      P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PP 222

Query: 324 WPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHP 356
            PS  S+  ++ V  LL KDP  R + AQ L  P
Sbjct: 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  182 bits (461), Expect = 2e-53
 Identities = 90/299 (30%), Positives = 136/299 (45%), Gaps = 26/299 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I + LG G FG  Y+A D+     VA+K + K        VE   RE++IL +L    
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECH 216
           N+VK Y+ F+D+  +Y+ ME  +GG L D +         +E +A  ++ Q+L      H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-------KFQDIVGSAYYVA 269
             G++HRD+KPEN L     +   +K  DFGL+  +                VG+  Y+A
Sbjct: 119 SKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 270 PEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN---------K 316
           PEVL       +   SD+WS+G+  Y LL G  PF  +       + L+           
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN 375
                     IS +A D +KKLL KDP+ RL+++  LSH  +           D+   +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295

Length = 384

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  174 bits (444), Expect = 6e-52
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 27/267 (10%)

Query: 107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF 166
           G +G  ++A  K+ GD  A+K I+K  MI    V+ V  E  IL   A    VVK Y +F
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS-QAQSPYVVKLYYSF 62

Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           +    +Y+ ME   GG+L    L +      E  A + + +++      H +G++HRD+K
Sbjct: 63  QGKKNLYLVMEYLPGGDL--ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 227 PENFLFKSAKEDSSLKATDFGLSDF---------IKPGKKFQDIVGSAYYVAPEVLKRKS 277
           P+N L  S   +  LK TDFGLS               K+ + IVG+  Y+APEV+  + 
Sbjct: 121 PDNILIDS---NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177

Query: 278 -GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS---ISNSAKD 333
                D WS+G I Y  L G  PF  +T + IF+ +L  K       WP    +S+ A D
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-----IEWPEDVEVSDEAID 232

Query: 334 FVKKLLVKDPRARLTAAQA---LSHPW 357
            + KLLV DP  RL A       +HP+
Sbjct: 233 LISKLLVPDPEKRLGAKSIEEIKNHPF 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  163 bits (416), Expect = 7e-48
 Identities = 82/273 (30%), Positives = 131/273 (47%), Gaps = 28/273 (10%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR-----EVKILQALA 154
             K+LG G  G  Y    K  G   A+KKI        +  ++  R     E+K L++  
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIYALKKI-------HVDGDEEFRKQLLRELKTLRS-C 56

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
               VVK Y AF  +  + I +E  +GG L D  L KK  +  E   A + RQ+L+    
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLAD--LLKKVGKIPEPVLAYIARQILKGLD- 113

Query: 215 CHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAYYVAP 270
            +LH    ++HRD+KP N L  S  E   +K  DFG+S  ++    +    VG+  Y++P
Sbjct: 114 -YLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Query: 271 EVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--I 327
           E ++ +S    +D+WS+G+       G+ PF        F E+++   D      P+   
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           S   +DF+   L KDP+ R +AA+ L HP++++
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  160 bits (406), Expect = 4e-46
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 18/270 (6%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G  G  Y ATD+A G  VA+KK+   K         E +  E+ I++    H N+V 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK------ELIINEILIMKDCK-HPNIVD 79

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +Y+++   + +++ ME  +GG L D I+ +   R  E   A V R++L+     H   ++
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKS-GP 279
           HRD+K +N L      D S+K  DFG +  +   K K   +VG+ Y++APEV+KRK  GP
Sbjct: 139 HRDIKSDNILLSK---DGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195

Query: 280 ESDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
           + D+WS+G++   +  G  P+  +     +F    +  P  +       S   KDF+ K 
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP--EKWSPEFKDFLNKC 253

Query: 339 LVKDPRARLTAAQALSHPWVREGGDASEIP 368
           LVKDP  R +A + L HP++++     E  
Sbjct: 254 LVKDPEKRPSAEELLQHPFLKKACPKEEFA 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  159 bits (404), Expect = 6e-46
 Identities = 90/292 (30%), Positives = 132/292 (45%), Gaps = 39/292 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   +G G  G  + A D+  G+ VA+KK+   ++   I      RE+K LQA   H
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQAC-QH 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             VVK  + F   +   + ME       L  +L  ++    E      +R +L+  A  H
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYMPSD--LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYYVAPEVL- 273
            +G++HRD+KP N L  +   D  LK  DFGL+      +       V + +Y APE+L 
Sbjct: 117 ANGIMHRDLKPANLLISA---DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173

Query: 274 -KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV----------LRNKP 317
             RK  P  D+W++G I   LL G  P +    D      +F+ +          L + P
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232

Query: 318 DF--------RRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           D+        +  P     P  S  A D +K LLV DP  RL+AA+AL HP+
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  158 bits (401), Expect = 3e-45
 Identities = 95/296 (32%), Positives = 134/296 (45%), Gaps = 47/296 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM------ILPIAVEDVKREVKIL 150
           RY  GK LG G +   Y A DK  G  VA+KKI+  +       I   A+    RE+K+L
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLL 56

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           Q L  H N++   + F   + + +  E  E    L++++  K    T  D    +   LR
Sbjct: 57  QELK-HPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLR 113

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVA 269
                H + ++HRD+KP N L  S   D  LK  DFGL+  F  P +K    V + +Y A
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIAS---DGVLKLADFGLARSFGSPNRKMTHQVVTRWYRA 170

Query: 270 PEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----GIFKEVL-----RNKP 317
           PE+L   R  G   D+WS+G I +  L  R PF     D      IF E L      N P
Sbjct: 171 PELLFGARHYGVGVDMWSVGCI-FAELLLRVPFLPGDSDIDQLGKIF-EALGTPTEENWP 228

Query: 318 DFRRKP----------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                P                +P+ S+ A D +++LL  +P  R+TA QAL HP+
Sbjct: 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  157 bits (399), Expect = 5e-45
 Identities = 91/272 (33%), Positives = 138/272 (50%), Gaps = 24/272 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +   K LG G FG   +   K +G   A+K + K K++    VE V  E +ILQ++  H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  Y +F+DD+ +Y+ ME   GGEL   +  +K  R+ E  A     Q++ +A E +L
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVV-LALE-YL 117

Query: 218 H--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H   +V+RD+KPEN L  S   D  +K TDFG +  +K       + G+  Y+APE++  
Sbjct: 118 HSLDIVYRDLKPENLLLDS---DGYIKITDFGFAKRVKGRT--YTLCGTPEYLAPEIILS 172

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKD 333
           K  G   D W++G++ Y +L G  PF+D     I++++L  K  F     PS  S  AKD
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF-----PSFFSPDAKD 227

Query: 334 FVKKLLVKDPRARL-----TAAQALSHPWVRE 360
            ++ LL  D   RL           +HPW   
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  154 bits (390), Expect = 5e-44
 Identities = 90/283 (31%), Positives = 141/283 (49%), Gaps = 40/283 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           R+  G  +G G FG  Y A +   G+ +AVK  +I+ N    P  ++++  E+K+L+ L 
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLK 57

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR----QMLR 210
            H N+VK+Y        VYI ME C GG L + +L      +       V+R    Q+L 
Sbjct: 58  -HPNLVKYYGVEVHREKVYIFMEYCSGGTL-EELL-----EHGRILDEHVIRVYTLQLLE 110

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-----GKKFQDIVGSA 265
             A  H HG+VHRD+KP N        +  +K  DFG +  +K      G++ Q + G+ 
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDH---NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 266 YYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKPD 318
            Y+APEV+        G  +D+WS+G +   +  G+RP W + ++    +F     +KP 
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKP- 225

Query: 319 FRRKPWP---SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
               P P    +S   KDF+ + L  DP+ R TA++ L HP+V
Sbjct: 226 ----PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  151 bits (382), Expect = 5e-43
 Identities = 88/266 (33%), Positives = 132/266 (49%), Gaps = 20/266 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +  G FG  Y+A  ++ GD  A+K ++K+ MI    V +VK E  I+        V K
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 162 FYNAFEDDNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH- 218
            Y +F+  +Y+Y+ ME   GG+   L + L      + ++  A VV     +  E  LH 
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVV-----LGVE-DLHQ 115

Query: 219 -GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G++HRD+KPEN L     +   LK TDFGLS      KKF   VG+  Y+APE +    
Sbjct: 116 RGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVG 169

Query: 278 GPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             + SD WS+G + +  L G  PF  +T D +F  +L  + ++  +     S  A D + 
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229

Query: 337 KLLVKDPRARLTA---AQALSHPWVR 359
           +LL  DP  RL A    +  SHP+ +
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  150 bits (382), Expect = 6e-42
 Identities = 89/293 (30%), Positives = 138/293 (47%), Gaps = 39/293 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + K++G G FG  ++  DK  G   A+K + K+ MI    +  V+ E  IL A A  
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-ADADS 60

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +VK Y +F+D+ ++Y+ ME   GG+L+  +L +KD  + E+ A   + +++      H
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKD-VFPEETARFYIAELVLALDSVH 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQD--------------- 260
             G +HRD+KP+N L      D  +K  DFGL     K   +                  
Sbjct: 119 KLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 261 --------------IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE 305
                          VG+  Y+APEVL+    G E D WS+GVI Y +L G  PF+  T 
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAA-QALSHPW 357
              + +++  K   R  P P +S  A D + +LL  DP  RL +  +  SHP+
Sbjct: 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  146 bits (372), Expect = 2e-41
 Identities = 83/265 (31%), Positives = 131/265 (49%), Gaps = 22/265 (8%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG   +   K+     A+K ++K  ++     E +  E +IL+    H  +VK Y
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
             F+D  Y+Y+ ME C GGEL   +  +    + E  A   +  ++      H  G+++R
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 224 DMKPENFLFKSAKEDSS--LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           D+KPEN L      DS+  +K  DFG +  +K G+K     G+  YVAPE++  K     
Sbjct: 118 DLKPENLLL-----DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172

Query: 281 SDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKK 337
            D WS+G++ Y LL GR PF +  ED   I+ ++L+         +P+ I  +AKD +K+
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQ 229

Query: 338 LLVKDPRARLTAAQA-----LSHPW 357
           LL ++P  RL   +        H W
Sbjct: 230 LLRRNPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 2e-41
 Identities = 97/295 (32%), Positives = 143/295 (48%), Gaps = 48/295 (16%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK-------MILPIAVEDVKREVKIL 150
           Y + K LG G FG  Y+A +K  G+ VA+KK+ K K       M L        REVK L
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNL--------REVKSL 51

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+VK    F +++ +Y   E  E G L   +  +K   ++E     ++ Q+L+
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
             A  H HG  HRD+KPEN L    +    +K  DFGL+  I+    + D V + +Y AP
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAP 167

Query: 271 EVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTE-DGIFK--EVL-----RNKPD-- 318
           E+L R +   S  D+W++G I   L   R  F   +E D ++K   VL     ++ P+  
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227

Query: 319 -------FR---------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                  FR          +  P+ S  A D +K +L  DP+ R TA+QAL HP+
Sbjct: 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 2e-41
 Identities = 86/291 (29%), Positives = 136/291 (46%), Gaps = 41/291 (14%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPI-AVEDVKREVKILQALA 154
           Y   + LG G +G  Y A DK  G+ VA+KKI  +     +P  A+    RE+ +L+ L 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELK 56

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+VK  +    +  +Y+  E C+    L + L K+    +      ++ Q+LR  A 
Sbjct: 57  -HPNIVKLLDVIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
           CH H ++HRD+KP+N L      D  LK  DFGL+  F  P + +   V + +Y APE+L
Sbjct: 114 CHSHRILHRDLKPQNILINR---DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL 170

Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK--EVL--------------- 313
              +      D+WS+G I   ++ G+  F   +E D +FK  ++L               
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230

Query: 314 ---RNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                 P F  K      P +     D + K+L  +P  R++A +AL HP+
Sbjct: 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  146 bits (372), Expect = 1e-40
 Identities = 95/321 (29%), Positives = 148/321 (46%), Gaps = 66/321 (20%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK-------NKMILPIAVEDVKREVKI 149
           RY + K +G G +G    A DK  G +VA+KKI          K IL        RE+K+
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL--------REIKL 52

Query: 150 LQALAGHENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           L+ L  HEN++   +       ED N VYI  EL E    L +++ K     T+      
Sbjct: 53  LRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVI-KSPQPLTDDHIQYF 108

Query: 205 VRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI- 261
           + Q+LR     +LH   ++HRD+KP N L      +  LK  DFGL+  + P +  +   
Sbjct: 109 LYQILR--GLKYLHSANVIHRDLKPSNIL---VNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 262 ---VGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF---------WDK---- 303
              V + +Y APE+L    +     D+WS+G I   LL  R+P           +     
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDYIDQLNLIVEV 222

Query: 304 ----TEDGI-------FKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLT 348
               +E+ +        +  L++ P   +KP     P  S  A D ++K+LV DP+ R+T
Sbjct: 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282

Query: 349 AAQALSHPWVREGGDASEIPI 369
           A +AL+HP++ +  D  + P+
Sbjct: 283 ADEALAHPYLAQLHDPEDEPV 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  144 bits (366), Expect = 2e-40
 Identities = 81/273 (29%), Positives = 134/273 (49%), Gaps = 24/273 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + +++G G     Y A    N ++VA+K+I+  K     +V+++++EV+ +     H 
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCN-HP 59

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQMLRVAAECH 216
           NVVK+Y +F   + +++ M    GG LLD + +        E   A V++++L+     H
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPG----KKFQDIVGSAYYVAPE 271
            +G +HRD+K  N L     ED S+K  DFG+S  +   G    K  +  VG+  ++APE
Sbjct: 120 SNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 272 VLKRKSG--PESDVWSIGVITYI-LLCGRRPFWDKTEDGIFKEVLRNKP-----DFRRKP 323
           V+++  G   ++D+WS G IT I L  G  P+       +    L+N P         K 
Sbjct: 177 VMEQVHGYDFKADIWSFG-ITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +   S S +  +   L KDP  R TA + L H 
Sbjct: 236 Y---SKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  143 bits (363), Expect = 6e-40
 Identities = 91/295 (30%), Positives = 137/295 (46%), Gaps = 48/295 (16%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALA 154
           Y     +G G +G  Y A DK  G+ VA+KKI    +++ I   A+    RE+K+L+ L 
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELN 56

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVA 212
            H N++K  + F     +Y+  E  +    L +++  KD +    E      + Q+L+  
Sbjct: 57  -HPNIIKLLDVFRHKGDLYLVFEFMD--TDLYKLI--KDRQRGLPESLIKSYLYQLLQGL 111

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
           A CH HG++HRD+KPEN L      +  LK  DFGL+  F  P + +   V + +Y APE
Sbjct: 112 AFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPE 168

Query: 272 VLKRKS--GPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--EVL------------ 313
           +L          D+WS+G I   LL  RRP +      D +FK    L            
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELL-SRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227

Query: 314 -------RNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                   + P     P     P+ S  A D + ++L  DP  R+TA QAL+HP+
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  143 bits (363), Expect = 7e-40
 Identities = 85/269 (31%), Positives = 147/269 (54%), Gaps = 19/269 (7%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +ATDK+ G +VAVKK++  K       E +  EV I++    H N+V+ Y
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HPNIVEMY 82

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHR 139

Query: 224 DMKPENFLFKSAKEDSSLKATDFG----LSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           D+K ++ L  S   D  +K +DFG    +S  + P +K   +VG+ Y++APEV+ R   G
Sbjct: 140 DIKSDSILLTS---DGRVKLSDFGFCAQVSKEV-PRRK--SLVGTPYWMAPEVISRLPYG 193

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
            E D+WS+G++   ++ G  P++++      K +  N P   +     +S   + F+ ++
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSPRLRSFLDRM 252

Query: 339 LVKDPRARLTAAQALSHPWVREGGDASEI 367
           LV+DP  R TAA+ L+HP++ + G  S I
Sbjct: 253 LVRDPAQRATAAELLNHPFLAKAGPPSSI 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  142 bits (359), Expect = 3e-39
 Identities = 89/298 (29%), Positives = 132/298 (44%), Gaps = 49/298 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKK---IEKNKMILPIAVEDVKREVKILQAL 153
           +Y +  ++G G +G      +KA G+ VA+KK    E ++ +   A+    REVK+L+ L
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQL 57

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
             HEN+V    AF     +Y+  E  E    ELL+                  + Q+L+ 
Sbjct: 58  R-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS----YIWQLLQA 112

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI--KPGKKFQDIVGSAYYVA 269
            A CH H ++HRD+KPEN L     E   LK  DFG +  +  +P     D V + +Y A
Sbjct: 113 IAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169

Query: 270 PEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK-------------EVL 313
           PE+L      G   DVW+IG I   LL G   F   ++ D ++              E+ 
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229

Query: 314 RNKPDFRRKPWPSI--------------SNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            + P F    +P                S+ A DF+K  L  DP+ RLT  + L HP+
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  140 bits (354), Expect = 5e-39
 Identities = 87/272 (31%), Positives = 138/272 (50%), Gaps = 24/272 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           R+  G+LLG G FG  Y   +  +GD  AVK   +  +      AV+ +++E+ +L  L 
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V++     +++ +YI +EL  GG L  ++L K  S + E    +  RQ+L     
Sbjct: 61  -HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGS-FPEPVIRLYTRQILLGLEY 117

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H    VHRD+K  N L  +   +  +K  DFG++  +      +   GS Y++APEV+ 
Sbjct: 118 LHDRNTVHRDIKGANILVDT---NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 275 RKS--GPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSI--- 327
           ++   G  +D+WS+G  T + +   +P W + E    +FK         R K  P I   
Sbjct: 175 QQGGYGLAADIWSLGC-TVLEMATGKPPWSQLEGVAAVFKIG-------RSKELPPIPDH 226

Query: 328 -SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            S+ AKDF+ K L +DP  R TAA+ L HP+V
Sbjct: 227 LSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 8e-39
 Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 15/285 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +T+ + +G G FG  Y A DK     VA+K I+  +    I  ED+++E++ L      
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQCRS- 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC- 215
             + K+Y +F   + ++I ME C GG  LD +   K  +  E   A ++R++L    E  
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLL-GLEYL 114

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLK 274
           H  G +HRD+K  N L     E+  +K  DFG+S  +     K    VG+ +++APEV+K
Sbjct: 115 HEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 275 RKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
           +    E +D+WS+G+    L  G  P  D     +   + +N P          S   KD
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFKD 229

Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMR 378
           FV   L KDP+ R +A + L H ++++    S + + I  +   +
Sbjct: 230 FVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIKKWK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  138 bits (350), Expect = 3e-38
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 20/270 (7%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F+    IGK    G FG   +   +      A+K + K K +   +V +V  E +ILQ L
Sbjct: 2   FELLRVIGK----GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V  + +F+D+  +Y+ ++L  GG+L   +  K   +++E+     + +++    
Sbjct: 58  N-HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALE 114

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H  G++HRD+KP+N L     E   +  TDF ++  + P        G+  Y+APEVL
Sbjct: 115 YLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVL 171

Query: 274 KRK-SGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFKEVLRNKPDFRRKPWPSISN 329
            R+      D WS+GV  Y  L G+RP+   +    D I  +       +      + S 
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWST 227

Query: 330 SAKDFVKKLLVKDPRARL--TAAQALSHPW 357
            A D + KLL +DP+ RL        +HP+
Sbjct: 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 1e-37
 Identities = 92/299 (30%), Positives = 138/299 (46%), Gaps = 53/299 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G  G  ++   K  G   A+K ++K +MI    V+ V  E +IL  L  H  +  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPT 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD----AAVVVRQMLRVAAE-CH 216
            Y +F+ + Y+ + M+ C GGEL   +  +     +E+     AA V+     +A E  H
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVL-----LALEYLH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS--------------------------- 249
           L G+V+RD+KPEN L     E   +  +DF LS                           
Sbjct: 121 LLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 250 -DFIK--PGKKFQDIVGSAYYVAPEVLKRKSGPESDV--WSIGVITYILLCGRRPFWDKT 304
            +     P  +    VG+  Y+APEV+    G  S V  W++G++ Y +L G  PF    
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL----TAAQALSHPWVR 359
            D  F  +L+ +  F     P +S+SA+D ++KLLVKDP  RL     AA+   HP+ R
Sbjct: 237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  136 bits (343), Expect = 4e-37
 Identities = 96/275 (34%), Positives = 138/275 (50%), Gaps = 24/275 (8%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  Y A  K  G   A K I+         +ED   E+ IL +   H N+V  Y
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDIL-SECKHPNIVGLY 68

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A+  +N ++I +E C+GG L D I+ + +   TE     V RQML      H H ++HR
Sbjct: 69  EAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-IVGSAYYVAPEVL---KRKSGP 279
           D+K  N L      D  +K  DFG+S   K   + +D  +G+ Y++APEV+     K  P
Sbjct: 128 DLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 280 ---ESDVWSIGVITYILLCGRRPFWDKTEDG--IFKEVLRNKPDFRRKP--WPSISNSAK 332
              ++D+WS+G IT I L    P   +      + K +L+++P    +P  W   S+S  
Sbjct: 185 YDYKADIWSLG-ITLIELAQMEPPHHELNPMRVLLK-ILKSEPPTLDQPSKW---SSSFN 239

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           DF+K  LVKDP  R TAA+ L HP+V +  D   I
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAI 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  135 bits (340), Expect = 1e-36
 Identities = 91/277 (32%), Positives = 151/277 (54%), Gaps = 14/277 (5%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT K++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 83

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 141 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  + K    +S S K F+ +LLV+
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFLDRLLVR 256

Query: 342 DPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMR 378
           DP  R TAA+ L HP++ + G  S I + +   N MR
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPPSCI-VPLMRQNRMR 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 3e-36
 Identities = 87/263 (33%), Positives = 132/263 (50%), Gaps = 15/263 (5%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  ++A  K  G+ VA+K+++K+ +     V  V  E  IL      E +VK  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEWLVKLL 67

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            AF+DD Y+Y+AME   GG+   R L       +E  A   + +M       H  G +HR
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDF--RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHR 125

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESD 282
           D+KPENFL  +      +K TDFGLS  I        +VGS  Y+APEVL+ +      D
Sbjct: 126 DLKPENFLIDA---SGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVD 180

Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR----KPWPSISNSAKDFVKKL 338
            WS+G + Y  LCG  PF   T +  ++ +   K   +R     P  ++S+ A D + KL
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL 240

Query: 339 LVKDPRARLTAAQAL-SHPWVRE 360
           +  DP  R  + + + +HP+ +E
Sbjct: 241 I-NDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 4e-36
 Identities = 86/280 (30%), Positives = 141/280 (50%), Gaps = 29/280 (10%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + +++G G +G  Y A  K  G  VA+K ++    I+    E++K E  IL+  + H
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNH 62

Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLD--RILAKKDSRYTEKDAAVVVRQM 208
            N+  FY AF       +D+ +++ MELC GG + D  + L KK  R  E+  A ++R+ 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYY 267
           LR  A  H + ++HRD+K +N L     +++ +K  DFG+S        +    +G+ Y+
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 268 VAPEVLKRKSGPE------SDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR 320
           +APEV+     P+      SDVWS+G IT I L  G+ P  D        ++ RN P   
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLG-ITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238

Query: 321 RKP--WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           + P  W   S    DF+ + L+K+   R    + L HP++
Sbjct: 239 KSPENW---SKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  132 bits (334), Expect = 5e-36
 Identities = 81/277 (29%), Positives = 135/277 (48%), Gaps = 41/277 (14%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I + LG G +G  Y A  K  G  VA+K +   +      ++++ +E+ IL+      
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQ-CDSP 58

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +VK+Y ++  +  ++I ME C  G + D I+   +   TE++ A ++ Q L+     H 
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK 276
           +  +HRD+K  N L     E+   K  DFG+S        K   ++G+ +++APEV++ +
Sbjct: 118 NKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ-E 173

Query: 277 SGPES--DVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR------RKPWPSI 327
            G  +  D+WS+G IT I +  G+ P               +    R       KP P++
Sbjct: 174 IGYNNKADIWSLG-ITAIEMAEGKPP-------------YSDIHPMRAIFMIPNKPPPTL 219

Query: 328 SNSAK------DFVKKLLVKDPRARLTAAQALSHPWV 358
           S+  K      DFVKK LVKDP  R +A Q L HP++
Sbjct: 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 8e-36
 Identities = 87/289 (30%), Positives = 132/289 (45%), Gaps = 44/289 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G +G  Y A +K  G+ VA+KKI  E  K   PI      RE+K+LQ L  H N+V+
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA---IREIKLLQKL-RHPNIVR 62

Query: 162 FYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
                  +    +Y+  E  +    L  +L   + ++TE      ++Q+L      H +G
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHD--LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK--FQDIVGSAYYVAPEVL--KR 275
           ++HRD+K  N L  +   D  LK  DFGL+          + + V + +Y  PE+L    
Sbjct: 121 ILHRDIKGSNILINN---DGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV----------LRNKPDFR- 320
           + GPE D+WS+G I   L  G+  F   TE    + IF+            +   P F  
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237

Query: 321 ---RKPWPS---------ISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
              +KP+           I  SA D + KLL  DP+ R++A QAL H +
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 8e-35
 Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 30/277 (10%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +R  T+G     G FG  ++  D+ +    A+K +   ++I     + V  E ++L+ 
Sbjct: 2   DLERIKTVGT----GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKE 57

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           ++ H  +++ +    D  ++Y+ ME   GGEL   +      R++         +++   
Sbjct: 58  VS-HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCAL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----IVGSAYYV 268
              H   +V+RD+KPEN L      +  +K TDFG +      KK +D    + G+  Y+
Sbjct: 115 EYLHSKEIVYRDLKPENILLDK---EGHIKLTDFGFA------KKLRDRTWTLCGTPEYL 165

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           APEV++ K      D W++G++ Y +L G  PF+D    GI++++L  K +F R     +
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HL 221

Query: 328 SNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVR 359
              AKD +KKLLV D   RL      A    +H W +
Sbjct: 222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  129 bits (325), Expect = 2e-34
 Identities = 86/266 (32%), Positives = 143/266 (53%), Gaps = 13/266 (4%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT+K  G +VAVKK++  K       E +  EV I++    HENVV  Y
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYH-HENVVDMY 85

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +LR  +  H  G++HR
Sbjct: 86  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142

Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L  S   D  +K +DFG  +   K   K + +VG+ Y++APEV+ R   G E 
Sbjct: 143 DIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      + +  N P  R K    +S+  + F+  +LV+
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKDSHKVSSVLRGFLDLMLVR 258

Query: 342 DPRARLTAAQALSHPWVREGGDASEI 367
           +P  R TA + L HP+++  G  S I
Sbjct: 259 EPSQRATAQELLQHPFLKLAGPPSCI 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 4e-34
 Identities = 87/272 (31%), Positives = 133/272 (48%), Gaps = 26/272 (9%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y + + +G G +G  Y A D A G+ VA+K I   K+      E +++E+ +L+    H
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKE-CRH 59

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V ++ ++   + ++I ME C GG L D I        +E   A V R+ L+  A  H
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAYYVAPEVL-- 273
             G +HRD+K  N L     ED  +K  DFG+S  +     K +  +G+ Y++APEV   
Sbjct: 119 ETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 274 KRKSGPES--DVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           +RK G +   D+W++G IT I L   + P +D          L         P P + + 
Sbjct: 176 ERKGGYDGKCDIWALG-ITAIELAELQPPMFDLHP----MRALFLISKSNFPP-PKLKDK 229

Query: 331 AK------DFVKKLLVKDPRARLTAAQALSHP 356
            K      DF+KK L KDP+ R TA + L HP
Sbjct: 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  128 bits (324), Expect = 7e-34
 Identities = 86/297 (28%), Positives = 139/297 (46%), Gaps = 30/297 (10%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           KDFD +  +G+    G FG   V  +KA GD  A+K ++K+ ++    V   + E  IL 
Sbjct: 1   KDFDVKSLVGR----GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL- 55

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +++    + +   AF+D + +Y+ ME   GG+LL  +L + + ++ E  A   + +++  
Sbjct: 56  SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLA 114

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--VGSAYYVA 269
               H  G VHRD+KPEN L         +K  DFG +  +   K       VG+  Y+A
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRT---GHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171

Query: 270 PEVL-------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
           PEVL       K   G E D WS+GVI Y ++ GR PF + T    +  ++  +   +  
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ 379
             P +S+   D ++ LL    + RL       HP+       S+I       NN+R 
Sbjct: 232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF------SKID-----WNNIRN 276

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  123 bits (312), Expect = 1e-32
 Identities = 89/275 (32%), Positives = 129/275 (46%), Gaps = 43/275 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKILQALAGHE 157
           LG G  G       +  G  +AVK I         K IL        RE+ IL       
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQIL--------RELDILHK-CNSP 59

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH- 216
            +V FY AF ++  + I ME  +GG  LD+IL +   R  E+    +   +L+     H 
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGS-LDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVGSAYYVAPEV 272
            H ++HRD+KP N L  S  +   +K  DFG+S     G+      +  VG++ Y+APE 
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPE- 169

Query: 273 LKRKSGP----ESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLR---NKPDFRRKP 323
             R  G     +SD+WS+G+    L  GR P+   +   DGIF E+L+   N+P   R P
Sbjct: 170 --RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNEPP-PRLP 225

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
               S   +DFV   L+KDPR R +  + L HP++
Sbjct: 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  123 bits (310), Expect = 1e-32
 Identities = 87/286 (30%), Positives = 145/286 (50%), Gaps = 43/286 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE-----------KNKMILPIAVEDVKR 145
           ++  G L+G G FG  Y+  + ++G+ +AVK++E           K  M+     + + R
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSML-----DALAR 55

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE---LLDRILAKKDSRYTEKDAA 202
           E+ +L+ L  HEN+V++  +  D +++ I +E   GG    LL+   A     + E    
Sbjct: 56  EIALLKELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-----FEETLVR 109

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPG 255
             VRQ+L+     H  G++HRD+K  N L  +      +K +DFG+S  +       K  
Sbjct: 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDN---KGGIKISDFGISKKLEANSLSTKTN 166

Query: 256 KKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVL 313
                + GS +++APEV+K+ S   ++D+WS+G +   +L G+ PF D T+   IFK   
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226

Query: 314 RNKPDFRRKPWPS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
              P+      PS IS+ A DF++K    D   R TAA+ L HP++
Sbjct: 227 NASPEI-----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  121 bits (306), Expect = 4e-32
 Identities = 72/267 (26%), Positives = 118/267 (44%), Gaps = 16/267 (5%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DF+    IGK    G FG  +    KA+    A+K+I+ +KM      E +  E ++L  
Sbjct: 1   DFEILNKIGK----GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAK 55

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L     ++++Y +F D   + I ME  E G+L   +  ++     E        Q+L   
Sbjct: 56  L-DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPE 271
           A  H   ++HRD+K  N          ++K  D G++  +     F   IVG+ YY++PE
Sbjct: 115 AHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171

Query: 272 VLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISN 329
           + + K   E SDVW++GV+ Y    G+ PF    +  +  +++R        P     S 
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG----VFPPVSQMYSQ 227

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHP 356
                + + L KD R R    Q L +P
Sbjct: 228 QLAQLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  122 bits (307), Expect = 6e-32
 Identities = 80/273 (29%), Positives = 139/273 (50%), Gaps = 21/273 (7%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKI 149
           D  ++YT  + +G G  G  Y A D A G  VA+K++   ++ K  L I    V RE K 
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK- 74

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
                 H N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ L
Sbjct: 75  ------HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 125

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYV 268
           +     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y++
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPS 326
           APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++     ++       P+ +      
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EK 240

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L HP+++
Sbjct: 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  121 bits (304), Expect = 1e-31
 Identities = 81/267 (30%), Positives = 137/267 (51%), Gaps = 19/267 (7%)

Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIE--KNKMILPIAVEDVKREVKILQALAGHEN 158
           GKLLG G FG  Y+  D   G  +AVK++    +       V  ++ E+++L+ L  HE 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HER 65

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V++Y    DD  + I ME   GG + D++  K     TE       RQ+L      H +
Sbjct: 66  IVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP----GKKFQDIVGSAYYVAPEVLK 274
            +VHRD+K  N L  SA    ++K  DFG S  ++     G   + + G+ Y+++PEV+ 
Sbjct: 124 MIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSISNSA 331
            +  G ++DVWS+G  T + +   +P W + E    IFK  +  +P   + P   +S  A
Sbjct: 181 GEGYGRKADVWSVGC-TVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPQLP-SHVSPDA 236

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           ++F+++  V++ + R +A + L H +V
Sbjct: 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  121 bits (305), Expect = 1e-31
 Identities = 80/261 (30%), Positives = 139/261 (53%), Gaps = 13/261 (4%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +A +K +G +VAVK ++  K       E +  EV I++    H+NVV+ Y
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ-HQNVVEMY 84

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            ++     +++ ME  +GG L D +     +R  E+  A V   +L+     H  G++HR
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVLKRKS-GPES 281
           D+K ++ L      D  +K +DFG    I K   K + +VG+ Y++APEV+ R   G E 
Sbjct: 142 DIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++  +     K  LR+ P  + K    IS   +DF++++L +
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNAHKISPVLRDFLERMLTR 257

Query: 342 DPRARLTAAQALSHPWVREGG 362
           +P+ R TA + L HP++ + G
Sbjct: 258 EPQERATAQELLDHPFLLQTG 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  119 bits (301), Expect = 3e-31
 Identities = 82/276 (29%), Positives = 136/276 (49%), Gaps = 31/276 (11%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR-----EVKILQA 152
           Y + + +G G FG       K++G  +  K+I+   M       + ++     EV IL+ 
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM------TEKEKQQLVSEVNILRE 55

Query: 153 LAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAV-VVRQM 208
           L  H N+V++Y+   D  +  +YI ME CEGG+L   I   KK+ +Y E++    ++ Q+
Sbjct: 56  LK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 209 LRVAAECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIV 262
           L    ECH      + ++HRD+KP N +F  A    ++K  DFGL+  +     F +  V
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPAN-IFLDANN--NVKLGDFGLAKILGHDSSFAKTYV 171

Query: 263 GSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           G+ YY++PE L       +SD+WS+G + Y L     PF  + +  +  ++   K  FRR
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--FRR 229

Query: 322 KPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHP 356
              P   S+   + +K +L  DP  R +  + L  P
Sbjct: 230 --IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  120 bits (303), Expect = 4e-31
 Identities = 88/287 (30%), Positives = 138/287 (48%), Gaps = 46/287 (16%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DF+   TI KL+ +G +G  Y+   K    R A+KKI K  +IL   ++ V  E  IL  
Sbjct: 2   DFE---TI-KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDIL-T 56

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGE---LLDRI--LAKKDSRYTEKDAAVVVRQ 207
            A +  VV  + +FE   ++ + ME  EGG+   LL  I  L    +R    +  + +  
Sbjct: 57  FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEY 116

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF--------------IK 253
           +       H +G+VHRD+KP+N L  S      +K TDFGLS                 K
Sbjct: 117 L-------HNYGIVHRDLKPDNLLITSM---GHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 254 PGKKFQD--IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFK 310
             ++F D  + G+  Y+APEV+ R+  G   D W++G+I Y  L G  PF+  T + +F 
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226

Query: 311 EVLRNKPDFRRKPWP----SISNSAKDFVKKLLVKDPRARLTAAQAL 353
           +V+ +  +     WP    ++   A+D + +LL ++P  RL    A 
Sbjct: 227 QVISDDIE-----WPEGDEALPADAQDLISRLLRQNPLERLGTGGAF 268

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  120 bits (303), Expect = 5e-31
 Identities = 102/316 (32%), Positives = 150/316 (47%), Gaps = 49/316 (15%)

Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           FG   +   RY   + +G G FG    A D+  G  VA+KKI K     P+  +   RE+
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYREL 60

Query: 148 KILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD-AA 202
           K+L+ L  HEN++     F +  ED   +Y   EL   G  L R+L    SR  EK    
Sbjct: 61  KLLKHLR-HENIISLSDIFISPLED---IYFVTELL--GTDLHRLL---TSRPLEKQFIQ 111

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
             + Q+LR     H  G+VHRD+KP N L     E+  LK  DFGL+    P  +    V
Sbjct: 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLARIQDP--QMTGYV 166

Query: 263 GSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDK---TEDGIFKEVLRNKP 317
            + YY APE++   +K   E D+WS G I   +L G+  F  K    +  I  ++L   P
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226

Query: 318 DF------------------RRKPWP------SISNSAKDFVKKLLVKDPRARLTAAQAL 353
           D                   +R+P P      +   SA D ++K+LV DP+ R++AA+AL
Sbjct: 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286

Query: 354 SHPWVREGGDASEIPI 369
           +HP++    D ++ P+
Sbjct: 287 AHPYLAPYHDPTDEPV 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  120 bits (302), Expect = 6e-31
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 17/251 (6%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           +G+ LG G FG   +A  K  G+  A+K ++K +++    V+ V +E  IL  L+ H  +
Sbjct: 22  MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFI 80

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH- 218
           V    +F+D+N VY  +E   GGEL   +  +K  R+   D A      L +A E +LH 
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHL--RKAGRFP-NDVAKFYHAELVLAFE-YLHS 136

Query: 219 -GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
             +++RD+KPEN L  +      +K TDFG +  + P + F  + G+  Y+APEV++ K 
Sbjct: 137 KDIIYRDLKPENLLLDN---KGHVKVTDFGFAKKV-PDRTFT-LCGTPEYLAPEVIQSKG 191

Query: 278 -GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
            G   D W++GV+ Y  + G  PF+D T   I++++L  +  F    W      A+D VK
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVK 247

Query: 337 KLLVKDPRARL 347
            LL  D   RL
Sbjct: 248 GLLQTDHTKRL 258

Length = 329

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  118 bits (298), Expect = 7e-31
 Identities = 79/267 (29%), Positives = 127/267 (47%), Gaps = 20/267 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y   ++LG G FG   +     +   V  K++   ++       D   E+ IL  L  H
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQ-H 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N++ +YN F DDN + I ME   GG L D+I+ +K   + E+     + Q++   +  H
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 217 LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF---QDIVGSAYYVAPEV 272
             G++HRD+K  N FL K       +K  DFG+S     G ++   + +VG+ YY++PE+
Sbjct: 119 KAGILHRDIKTLNIFLTK----AGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPEL 172

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
            +      +SD+W++G + Y LL  +R F      + + K V  N       P  S+ +S
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-----YTPVVSVYSS 227

Query: 331 A-KDFVKKLLVKDPRARLTAAQALSHP 356
                V  LL +DP  R TA + L  P
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  117 bits (295), Expect = 2e-30
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 14/266 (5%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
             + I K +G GQF   Y A    +G  VA+KK++  +M+   A +D  +E+ +L+ L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAA 213
           H NV+K+  +F ++N + I +EL + G+L   I    K+     E+       Q+     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEV 272
             H   ++HRD+KP N +F +A     +K  D GL  F          +VG+ YY++PE 
Sbjct: 121 HMHSKRIMHRDIKPAN-VFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 273 LKRKSGPE--SDVWSIGVITYILLCGRRPFW-DKTE-DGIFKEVLRNKPDFRRKPWPSIS 328
           +  ++G    SD+WS+G + Y +   + PF+ DK     + K++   K D+   P    S
Sbjct: 178 I-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EKCDYPPLPADHYS 234

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALS 354
              +D V + +  DP  R   +  L 
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  117 bits (295), Expect = 3e-30
 Identities = 87/267 (32%), Positives = 131/267 (49%), Gaps = 22/267 (8%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIE-KNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  Y A +K  G   A K IE K++  L    ED   E++IL A   H  +VK 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYMVEIEIL-ATCNHPYIVKL 74

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
             AF  D  ++I +E C GG + D I+ + D   TE    V+ RQML      H   ++H
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL---KRKSG 278
           RD+K  N L      D  +K  DFG+S   +K  ++    +G+ Y++APEV+     K  
Sbjct: 134 RDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 279 P---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSISNSAKD 333
           P   ++D+WS+G+    +     P  +     +  ++ +++P    +P  W   S   +D
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW---SMEFRD 247

Query: 334 FVKKLLVKDPRARLTAAQALSHPWVRE 360
           F+K  L K P  R +AAQ L HP+V  
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 5e-30
 Identities = 77/267 (28%), Positives = 130/267 (48%), Gaps = 15/267 (5%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL--AG 155
           Y   +L+G G +G  Y       G  VA+K I  N       V D++REV +L  L  + 
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKII--NLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
             N+ K+Y ++     ++I ME  EGG +  R L K      EK  +V++R++L      
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKA-GPIAEKYISVIIREVLVALKYI 117

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK 274
           H  G++HRD+K  N L  +     ++K  DFG++    +   K    VG+ Y++APEV+ 
Sbjct: 118 HKVGVIHRDIKAANILVTNT---GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174

Query: 275 --RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +    ++D+WS+G+  Y +  G  P+ D         + ++KP   R      S   +
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPP--RLEDNGYSKLLR 232

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
           +FV   L ++P+ RL+A + L   W++
Sbjct: 233 EFVAACLDEEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  117 bits (294), Expect = 6e-30
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 23/278 (8%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
              D ++ +T  + +GHG FG  Y A D    + VA+KK+  +        +D+ +EV+ 
Sbjct: 9   SKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQ 207
           LQ L  H N +++   +  ++  ++ ME C G   ++L+  + KK  +  E + A +   
Sbjct: 69  LQQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQ--EVEIAAICHG 123

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
            L+  A  H H  +HRD+K  N L     E  ++K  DFG +  + P   F   VG+ Y+
Sbjct: 124 ALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSPANSF---VGTPYW 177

Query: 268 VAPEV-LKRKSGP---ESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFRR 321
           +APEV L    G    + DVWS+G IT I L  R+P  F       ++     + P    
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSS 236

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
             W   S+  ++FV   L K P+ R ++ + L H +V 
Sbjct: 237 NDW---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 7e-30
 Identities = 83/299 (27%), Positives = 126/299 (42%), Gaps = 52/299 (17%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----PIAVEDVKREVKILQA 152
           Y     +G G +G  Y A D   G  VA+KK+   ++ L     P++     RE+ +L+ 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLST---LREIALLKQ 54

Query: 153 L--AGHENVVKFYNAF---EDDNY--VYIAMELCEG--GELLDRILAKKDSRYTEKDAAV 203
           L    H N+V+  +       D    + +  E  +      L +         T KD   
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD--- 111

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           ++RQ+LR     H H +VHRD+KP+N L  S   D  +K  DFGL+           +V 
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTS---DGQVKIADFGLARIYSFEMALTSVVV 168

Query: 264 SAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IF-------- 309
           + +Y APEVL + S     D+WS+G I   L   RRP +  T +      IF        
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVIGLPSE 227

Query: 310 ----KEVLRNKPDFRRKP-------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
               + V   +  F            P I     D +KK+L  +P  R++A +AL HP+
Sbjct: 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  117 bits (294), Expect = 9e-30
 Identities = 84/270 (31%), Positives = 137/270 (50%), Gaps = 24/270 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG-HENVV 160
           K+LG G FG   +A  K   +  AVK ++K+ ++    VE    E ++L ALAG H  + 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVL-ALAGKHPFLT 59

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDA---AVVVRQMLRVAAECHL 217
           + ++ F+  + ++  ME   GG+L+  I   +  R+ E  A   A  +   L+     H 
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQF---LHE 114

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            G+++RD+K +N L  S   +  +K  DFG+  + I  G       G+  Y+APE+L  +
Sbjct: 115 RGIIYRDLKLDNVLLDS---EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GP  D W++GV+ Y +L G+ PF    ED +F+ +L ++  + R     +S  AK  +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSIL 227

Query: 336 KKLLVKDPRARL----TAAQAL-SHPWVRE 360
           K  L K+P  RL    T  Q +  HP+ RE
Sbjct: 228 KSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  115 bits (290), Expect = 1e-29
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 47/230 (20%)

Query: 99  TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           T+GK LG G FG                 VAVK ++++       +E+  RE +I++ L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKL- 58

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NVVK      ++  +YI ME  EGG+LL  +   +          + +  +L  A +
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--------KLSLSDLLSFALQ 110

Query: 215 -----CHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
                 +L     +HRD+   N L     E+  +K +DFGLS  +             YY
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YY 158

Query: 268 V-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                       APE LK  K   +SDVWS GV+ + I   G +P+   +
Sbjct: 159 RKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 208

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  116 bits (294), Expect = 1e-29
 Identities = 94/327 (28%), Positives = 136/327 (41%), Gaps = 85/327 (25%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK------ 144
           DK   R+Y I + LG G +G  + A D+   + VA+KKI         A  +        
Sbjct: 2   DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD-------AFRNATDAQRTF 54

Query: 145 REVKILQALAGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           RE+  LQ L  H N+VK  N    E+D  +Y+  E                  Y E D  
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE------------------YMETDLH 96

Query: 203 VVVR--------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL 248
            V+R              Q+L+     H   ++HRD+KP N L  S   D  +K  DFGL
Sbjct: 97  AVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGL 153

Query: 249 SDFIKPGKKFQ------DIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF 300
           +  +   ++        D V + +Y APE+L    +     D+WS+G I   +L G+  F
Sbjct: 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Query: 301 ----------------WDKTEDGI------FKE-VLRNKPDFRRKP----WPSISNSAKD 333
                              + + I      F   +L + P   RKP     P  S+ A D
Sbjct: 214 PGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALD 273

Query: 334 FVKKLLVKDPRARLTAAQALSHPWVRE 360
            +KKLLV +P  RLTA +AL HP+V +
Sbjct: 274 LLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  116 bits (292), Expect = 1e-29
 Identities = 79/267 (29%), Positives = 131/267 (49%), Gaps = 17/267 (6%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG   +A  K +G   AVK ++K+ ++    VE    E +IL     H  + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y  F+  + ++  ME   GG+L+  I  +K  R+ E  A     ++       H  G++
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K +N L      +   K  DFG+  + I  GK      G+  Y+APE+L+    GP
Sbjct: 119 YRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W++GV+ Y +LCG  PF  + ED +F+ +L ++  +    W  +S  A D +K  +
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW--LSQDAVDILKAFM 231

Query: 340 VKDPRARLTA------AQALSHPWVRE 360
            K+P  RL +         L HP+ +E
Sbjct: 232 TKNPTMRLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  117 bits (294), Expect = 2e-29
 Identities = 85/317 (26%), Positives = 139/317 (43%), Gaps = 54/317 (17%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI-AVEDVK---REVK 148
           +   RY     +G G +G    A D   G +VA+KK+ +     P  +    K   RE++
Sbjct: 12  EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-----PFQSAIHAKRTYRELR 66

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +L+ +  HENV+   + F      ED   VY+   L   G  L+ I+  K  + ++    
Sbjct: 67  LLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIV--KCQKLSDDHIQ 121

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            +V Q+LR     H  G++HRD+KP N    +  ED  LK  DFGL+       +    V
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLAR--HTDDEMTGYV 176

Query: 263 GSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGR----------------------- 297
            + +Y APE++          D+WS+G I   LL G+                       
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236

Query: 298 RPFWDKTEDGIFKEVLRNKPDFRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQAL 353
                K      +  +++ P   +K +  +    +  A D ++K+LV DP  R+TAA+AL
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296

Query: 354 SHPWVREGGDASEIPID 370
           +HP++ E  D  + P+ 
Sbjct: 297 AHPYLAEYHDPEDEPVA 313

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  114 bits (287), Expect = 3e-29
 Identities = 82/279 (29%), Positives = 131/279 (46%), Gaps = 35/279 (12%)

Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-------LPIAVEDVKREVKILQAL 153
           G+L+G G +G  Y+A +   G+ +AVK++E    I           V+ ++ E++ L+ L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V++      + Y+ I +E   GG  +   L +   R+ E+       Q+L   A
Sbjct: 66  D-HLNIVQYLGFETTEEYLSIFLEYVPGGS-IGSCL-RTYGRFEEQLVRFFTEQVLEGLA 122

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV---------GS 264
             H  G++HRD+K +N L  +   D   K +DFG+S      KK  DI          GS
Sbjct: 123 YLHSKGILHRDLKADNLLVDA---DGICKISDFGIS------KKSDDIYDNDQNMSMQGS 173

Query: 265 AYYVAPEVLKRKSGPES---DVWSIGVITYILLCGRRPFWDKTE--DGIFK-EVLRNKPD 318
            +++APEV+   S   S   D+WS+G +   +  GRRP W   E    +FK    R+ P 
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPP 232

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                  ++S  A DF+      +P  R TA + L HP+
Sbjct: 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 3e-29
 Identities = 92/293 (31%), Positives = 140/293 (47%), Gaps = 56/293 (19%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHENV 159
           +G G +G  Y A DK  G+ VA+KKI      L    E V     RE+ +L+ L  H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIR-----LETEDEGVPSTAIREISLLKELN-HPNI 60

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRY-TEKDAAVV---VRQMLRVAAE 214
           V+  +    +N +Y+  E       LD  L K  DS   T  D  ++   + Q+L+  A 
Sbjct: 61  VRLLDVVHSENKLYLVFEF------LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD-FIKPGKKFQDIVGSAYYVAPEVL 273
           CH H ++HRD+KP+N L      + +LK  DFGL+  F  P + +   V + +Y APE+L
Sbjct: 115 CHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Query: 274 ---KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--EVL-----------RN 315
              ++ S P  D+WSIG I +  +  RRP +  D   D +F+    L            +
Sbjct: 172 LGSRQYSTP-VDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229

Query: 316 KPDF-------RRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            PD+        R+      P++     D + K+LV DP  R++A  AL HP+
Sbjct: 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  115 bits (288), Expect = 3e-29
 Identities = 80/269 (29%), Positives = 139/269 (51%), Gaps = 13/269 (4%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  + A D A G  VA+K+I   K   P   E +  E+ +++ 
Sbjct: 16  DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--P-KKELIINEILVMKE 72

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L  + N+V F ++F   + +++ ME   GG L D +    ++   E   A V R+ L+  
Sbjct: 73  LK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQAL 128

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y++APE
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   +S  
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPI 244

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            +DF+ + L  D   R +A + L HP+++
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  114 bits (288), Expect = 4e-29
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 32/269 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIA--VEDVKREVKILQALAGHE 157
           ++LG G +G  ++       D  ++   K+ K   I+  A   E  + E ++L+A+    
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  + AF+ D  +++ ++   GGEL   +  ++   +TE +  V + ++  V A  HL
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEI--VLALDHL 121

Query: 218 H--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYYVAPEVL 273
           H  G+++RD+K EN L  S   +  +  TDFGLS      ++ +     G+  Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDS---EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 274 KRKSGPESDV---WSIGVITYILLCGRRPFWDKTEDG-------IFKEVLRNKPDFRRKP 323
           +  SG        WS+GV+T+ LL G  PF   T DG       I + +L++KP F    
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPF---TVDGEQNSQSEISRRILKSKPPFP--- 232

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQA 352
             ++S  A+DF++KLL KDP+ RL A  A
Sbjct: 233 -KTMSAEARDFIQKLLEKDPKKRLGANGA 260

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  114 bits (287), Expect = 5e-29
 Identities = 89/294 (30%), Positives = 130/294 (44%), Gaps = 33/294 (11%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G  G       K  G   A+K I       P   + + RE++I ++      +VK+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTI--TTDPNPDLQKQILRELEINKSCK-SPYIVKYY 65

Query: 164 NAF--EDDNYVYIAMELCEGGELLDRI---LAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
            AF  E  + + IAME CEGG L D I   + K+  R  EK    +   +L+  +  H  
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            ++HRD+KP N L         +K  DFG+S + +          G+++Y+APE ++ K 
Sbjct: 125 KIIHRDIKPSNILLT---RKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKP 179

Query: 278 -GPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLR---NKPDFRRKPWPSI----S 328
               SDVWS+G+    +   R PF  +        E+L    N P+   K  P      S
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
              KDF+K+ L KDP  R T    L HPW++    A           NM +FV 
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK----AQMKKK-----VNMAKFVA 284

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (284), Expect = 8e-29
 Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 46/230 (20%)

Query: 99  TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           T+GK LG G FG     T           VAVK ++++       +E+  RE +I++ L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS--EQQIEEFLREARIMRKL- 58

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+VK      ++  + I ME   GG+LLD +   +    +       +  +L  A +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS-------LSDLLSFALQ 111

Query: 215 -----CHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
                 +L     +HRD+   N L     E+  +K +DFGLS  +             YY
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YY 159

Query: 268 V-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                       APE LK  K   +SDVWS GV+ + I   G  P+   +
Sbjct: 160 KVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS 209

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  114 bits (286), Expect = 1e-28
 Identities = 78/265 (29%), Positives = 128/265 (48%), Gaps = 17/265 (6%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  +I    V     E ++LQ    H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+  + +   ME   GGEL   +   ++  ++E  A     +++      H   +V
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALGYLHSCDVV 117

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 118 YRDLKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R     +S  AK  +  LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLAGLL 230

Query: 340 VKDPRARL-----TAAQALSHPWVR 359
            KDP+ RL      A + + H +  
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  112 bits (281), Expect = 2e-28
 Identities = 73/266 (27%), Positives = 132/266 (49%), Gaps = 13/266 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I K +G G FG  Y+A  K++ +   +K+I+  KM  P+  ++  ++  IL A   H
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKH 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V F+ +F+++  ++I ME C+GG+L+ RI  ++   ++E        Q+       H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 217 LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEVLK 274
              ++HRD+K +N FL K+       K  DFG++  +    +     VG+ YY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGM---VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 275 -RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW-PSISNSAK 332
            R    ++D+WS+G + Y L   + PF    E     +++         P  P+ S   +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPF----EGNNLHQLVLKICQGYFAPISPNFSRDLR 231

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
             + +L    PR R +    L  P++
Sbjct: 232 SLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  114 bits (286), Expect = 2e-28
 Identities = 87/316 (27%), Positives = 139/316 (43%), Gaps = 53/316 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDK--ANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQA 152
           RY + K LG G +G    A +   +  + VA+KKI    +K IL    +   RE+K+L+ 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL---AKRALRELKLLRH 57

Query: 153 LAGHENVVKFY---NAFEDD-NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
             GH+N+   Y     F  + N +Y+  EL E    L +I+ +     T+      + Q+
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQII-RSGQPLTDAHFQSFIYQI 114

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-----IVG 263
           L      H   ++HRD+KP N L  +   D  LK  DFGL+                 V 
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 264 SAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWD-----------------KT 304
           + +Y APE++          DVWS+G I   LL GR+P +                    
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTPD 230

Query: 305 EDGIFK-------EVLRNKPDFRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQAL 353
           E+ + +         +R+ P+  +KP+ SI    +  A D ++KLL  DP  R++  +AL
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290

Query: 354 SHPWVREGGDASEIPI 369
            HP++    D  + P+
Sbjct: 291 EHPYLAIWHDPDDEPV 306

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 2e-28
 Identities = 86/301 (28%), Positives = 137/301 (45%), Gaps = 50/301 (16%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +   K  G   A+KK+ K++M+    V  V+ E  IL A A +  VVK
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL-AEADNPWVVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D+NY+Y+ ME   GG+++  +L KKD+ +TE++    + + +      H  G +
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDT-FTEEETRFYIAETILAIDSIHKLGYI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL---------SDF------IKPGKKFQDI----- 261
           HRD+KP+N L  +      +K +DFGL         ++F        P      I     
Sbjct: 124 HRDIKPDNLLLDA---KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 262 -------------------VGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFW 301
                              VG+  Y+APEV  +     E D WS+GVI Y +L G  PF 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 302 DKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQA---LSHPWV 358
                  +++++  K   +      +S  AKD +K+L   +   RL         SHP+ 
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299

Query: 359 R 359
           +
Sbjct: 300 K 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  111 bits (279), Expect = 3e-28
 Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 19/264 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK--REVKILQALA 154
           +Y + +++G G FG   +     +  + A+K+I      LP +   V+  R+  +L A  
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-----LPKSSSAVEDSRKEAVLLAKM 55

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V F  +FE D ++YI ME C+GG+L+ +I  ++   + E        QM      
Sbjct: 56  KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115

Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEV 272
            H   ++HRD+K +N FL ++ K    +K  DFG +  +  PG      VG+ YYV PE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGK----VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNS 330
            +      +SD+WS+G I Y L   + PF    +   +K ++        KP PS  S  
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYKPLPSHYSYE 227

Query: 331 AKDFVKKLLVKDPRARLTAAQALS 354
            +  +K++  ++PR+R +A   LS
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  111 bits (281), Expect = 4e-28
 Identities = 84/286 (29%), Positives = 134/286 (46%), Gaps = 44/286 (15%)

Query: 107 GQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVKFYN 164
           G +G  Y A DK  G+ VA+KK+  EK K   PI      RE+ IL  L  H N+V    
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS---LREINILLKL-QHPNIVTVKE 71

Query: 165 AF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
                + + +Y+ ME  E  +L   ++      + + +   ++ Q+L   A  H + ++H
Sbjct: 72  VVVGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGP 279
           RD+K  N L  +      LK  DFGL+ ++  P K +  +V + +Y APE+L   ++   
Sbjct: 130 RDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV----LRNKPDF------------ 319
             D+WS+G I   LL  +  F  K+E    + IFK +     +  P F            
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246

Query: 320 -------RRK-PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                  R+K P  S+S++  D + +LL  DP  R++A  AL HP+
Sbjct: 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 6e-28
 Identities = 87/318 (27%), Positives = 138/318 (43%), Gaps = 54/318 (16%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKI 149
           D   RY     +G G +G    AT K  G +VA+KKI   E              RE+KI
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ-----RTLREIKI 56

Query: 150 LQALAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           L+    HEN++   +     +FE  N VYI  EL E    L +++  K    +       
Sbjct: 57  LRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLI--KTQHLSNDHIQYF 111

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP----GKKFQD 260
           + Q+LR     H   ++HRD+KP N L  +      LK  DFGL+    P         +
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLARIADPEHDHTGFLTE 168

Query: 261 IVGSAYYVAPEV-LKRKSGPES-DVWSIGVITYILLCGRRPFWDK--------------- 303
            V + +Y APE+ L  K   ++ D+WS+G I   +L  R  F  K               
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228

Query: 304 -TEDGIF-------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQ 351
            +++ +        +  +++ P   + PW    P+    A D + K+L  +P  R+T  +
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288

Query: 352 ALSHPWVREGGDASEIPI 369
           AL+HP++ +  D S+ P+
Sbjct: 289 ALAHPYLEQYHDPSDEPV 306

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  110 bits (277), Expect = 6e-28
 Identities = 74/275 (26%), Positives = 133/275 (48%), Gaps = 24/275 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + + +L+G+G +G  Y       G   A+K ++    +     E++K+E+ +L+  + H 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63

Query: 158 NVVKFYNAFED------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           N+  +Y AF        D+ +++ ME C  G + D I   K +   E+  A + R++LR 
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAP 270
            +  H H ++HRD+K +N L     E++ +K  DFG+S    +   +    +G+ Y++AP
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180

Query: 271 EVLKRKSGPE------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-KPDFRRKP 323
           EV+     P+      SD+WS+G+    +  G  P  D         + RN  P  + K 
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           W   S   + F++  LVK+   R T  Q + HP++
Sbjct: 241 W---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  111 bits (278), Expect = 7e-28
 Identities = 78/273 (28%), Positives = 137/273 (50%), Gaps = 21/273 (7%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA+K++           +  K+E+ I + 
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--------QQPKKELIINEI 67

Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 124

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 125 LQALDFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ER 240

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L HP+++
Sbjct: 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  110 bits (276), Expect = 1e-27
 Identities = 86/266 (32%), Positives = 131/266 (49%), Gaps = 24/266 (9%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  Y A +K  G   A K I+         +ED   E+ IL A   H N+VK  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDIL-ASCDHPNIVKLL 68

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +AF  +N ++I +E C GG + D ++ + +   TE    VV +Q L      H + ++HR
Sbjct: 69  DAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVL---KRKS 277
           D+K  N LF     D  +K  DFG+S   K  +  Q     +G+ Y++APEV+     K 
Sbjct: 128 DLKAGNILFTL---DGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 278 GP---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSISNSAK 332
            P   ++DVWS+G+    +     P  +     +  ++ +++P    +P  W   S+  K
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSEFK 239

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF+KK L K+  AR T  Q L HP+V
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  111 bits (278), Expect = 2e-27
 Identities = 78/248 (31%), Positives = 124/248 (50%), Gaps = 12/248 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 117

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 118 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 230

Query: 340 VKDPRARL 347
            KDP+ RL
Sbjct: 231 KKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  109 bits (274), Expect = 2e-27
 Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 20/269 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED----VKREVKILQA 152
           +Y   +++G G FG  ++   KA+   V +K+I   +M      +D     + E ++L+ 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-----TKDERLAAQNECQVLKL 55

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L+ H N++++Y  F +D  + I ME   GG L + I  + +S   E        Q+L   
Sbjct: 56  LS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
              H   ++HRD+K +N L    K    +K  DFG+S  +    K   +VG+  Y++PE+
Sbjct: 115 HHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL 172

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--PDFRRKPWPSISN 329
            + K    +SD+W++G + Y L   +R F       +  +++     P   R      S 
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR-----YSP 227

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             +  +  +L  DP  R   +Q ++ P  
Sbjct: 228 DLRQLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  110 bits (277), Expect = 2e-27
 Identities = 92/325 (28%), Positives = 134/325 (41%), Gaps = 73/325 (22%)

Query: 87  DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVK 144
           +F +  +  +   + K+ G G FG  + A  K     VA+KK+  E  K   PI      
Sbjct: 4   EFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---L 59

Query: 145 REVKILQALAGHENVVKF----------YNAFEDDNYVYIAMELCEGGELLDRILAKKDS 194
           RE+KILQ L  HENVV            YN ++     Y+  E CE    L  +L+ K+ 
Sbjct: 60  REIKILQLLK-HENVVNLIEICRTKATPYNRYKGS--FYLVFEFCEHD--LAGLLSNKNV 114

Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIK 253
           ++T  +   V++ +L      H + ++HRDMK  N L     +D  LK  DFGL+  F  
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSL 171

Query: 254 P----GKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVI------------------ 289
                  ++ + V + +Y  PE+L  +R  GP  D+W  G I                  
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231

Query: 290 --TYIL-LCG-----------RRPFWDKTE---DGIFKEVLRNKPDFRRKPWPSISNSAK 332
             T I  LCG           +   + K E       K   R KP  +          A 
Sbjct: 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK-------DPHAL 284

Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
           D + KLLV DP  R+ A  AL+H +
Sbjct: 285 DLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  110 bits (276), Expect = 2e-27
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 19/288 (6%)

Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           GV+   +  D  Y  D +  +     +GHG FG  Y AT+    + VAVKK+  +     
Sbjct: 3   GVVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN 62

Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
              +D+ +EVK LQ L  H N +++   +  ++  ++ ME C G      +L        
Sbjct: 63  EKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSA--SDLLEVHKKPLQ 119

Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E + A +    L+  A  H H ++HRD+K  N L     E   +K  DFG +    P   
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSPANS 176

Query: 258 FQDIVGSAYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKE 311
           F   VG+ Y++APEV+    + +   + DVWS+G IT I L  R+P  F       ++  
Sbjct: 177 F---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI 232

Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
              + P  +   W   ++S + FV   L K P+ R  +A+ L H +VR
Sbjct: 233 AQNDSPTLQSNEW---TDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  109 bits (274), Expect = 3e-27
 Identities = 83/299 (27%), Positives = 136/299 (45%), Gaps = 50/299 (16%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQ 151
           ++   + K+ G G +G  +   ++  G  VA+KK    E + +I  IA+    RE+++L+
Sbjct: 1   EKYEKLSKI-GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLK 55

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQML 209
            L  H N+V     F     +++  E C+   L  L++          +K    ++ Q L
Sbjct: 56  QLK-HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK----IIWQTL 110

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYV 268
           +    CH H  +HRD+KPEN L     +   +K  DFG +  +  PG  + D V + +Y 
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYR 167

Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----------GIF----KE 311
           APE+L    + GP  DVW+IG +   LL G +P W    D           G      ++
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226

Query: 312 VLRNKPDFR---------RKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           +      F+         R+P    +P+IS+ A  F+K  L  DP  RL+  + L HP+
Sbjct: 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  109 bits (275), Expect = 3e-27
 Identities = 73/268 (27%), Positives = 131/268 (48%), Gaps = 18/268 (6%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG   +A  K   +  A+K ++K+ ++    V+    E +IL   A H  +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +  F+  + ++  ME   GG+L+ +I  ++  ++ E  +     ++       H HG++
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGP 279
           +RD+K +N L  +   +   K  DFG+  + I  G       G+  Y+APE+L+  + GP
Sbjct: 119 YRDLKLDNILLDA---EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W++GV+ Y ++ G+ PF    ED +F+ +L +  D     W  +S  A   +K  +
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFM 231

Query: 340 VKDPRARL--TAAQALS-----HPWVRE 360
            K+P  RL   A+Q        HP+ +E
Sbjct: 232 TKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  108 bits (272), Expect = 4e-27
 Identities = 84/292 (28%), Positives = 141/292 (48%), Gaps = 26/292 (8%)

Query: 83  GKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED 142
           GK   F    D    + I + +G G +G  +   +K NG + AVK ++    I     E+
Sbjct: 5   GKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEE 60

Query: 143 VKREVKILQALAGHENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRI--LAKKDSR 195
           ++ E  IL+AL+ H NVVKFY  +     ++ + +++ +ELC GG + D +    K+  R
Sbjct: 61  IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120

Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG 255
             E   A ++ + L      H++  +HRD+K  N L  +   +  +K  DFG+S  +   
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTST 177

Query: 256 KKFQDI-VGSAYYVAPEVLKRKSGPES------DVWSIGVITYILLCGRRPFWDKTEDGI 308
           +  ++  VG+ +++APEV+  +   +S      DVWS+G+    L  G  P  D      
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237

Query: 309 FKEVLRNKPDFRRKP--WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             ++ RN P    +P  W   SN   DF++K L KD   R T +  L H ++
Sbjct: 238 LFKIPRNPPPTLHQPELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  110 bits (275), Expect = 4e-27
 Identities = 78/253 (30%), Positives = 130/253 (51%), Gaps = 21/253 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59

Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 114

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 115 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 170

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSL 226

Query: 335 VKKLLVKDPRARL 347
           +  LL KDP+ RL
Sbjct: 227 LSGLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  109 bits (272), Expect = 5e-27
 Identities = 76/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 68

Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 125

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 241

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L H +++
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  108 bits (270), Expect = 6e-27
 Identities = 82/276 (29%), Positives = 141/276 (51%), Gaps = 30/276 (10%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR------EVKILQ 151
           + +GKLLG G FG  Y+  D   G  +AVK+++ +    P + E  K       E+++L+
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFD----PESPETSKEVNALECEIQLLK 59

Query: 152 ALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
            L  HE +V++Y    D  +  + I ME   GG + D++  K     TE       RQ+L
Sbjct: 60  NLL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQIL 116

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK----PGKKFQDIVGSA 265
              +  H + +VHRD+K  N L  S     ++K  DFG S  ++     G   + + G+ 
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSV---GNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173

Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRK 322
           Y+++PEV+  +  G ++D+WS+G  T + +   +P W + E    IFK  +  +P     
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGC-TVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPVL 230

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           P P +S+  +DF+K++ V + + R +A + L H +V
Sbjct: 231 P-PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  107 bits (269), Expect = 1e-26
 Identities = 74/271 (27%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +++G+G +G  Y       G   A+K ++    +     E++K E+ +L+  + H N+  
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 162 FYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           +Y AF        D+ +++ ME C  G + D +   K +   E   A + R++LR  A  
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK 274
           H H ++HRD+K +N L     E++ +K  DFG+S    +   +    +G+ Y++APEV+ 
Sbjct: 138 HAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194

Query: 275 RKSGPE------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-KPDFRRKPWPSI 327
               P+      SD+WS+G+    +  G  P  D         + RN  P  + K W   
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW--- 251

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           S    DF++  LVK+  +R +  Q L HP++
Sbjct: 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  107 bits (269), Expect = 1e-26
 Identities = 80/280 (28%), Positives = 134/280 (47%), Gaps = 30/280 (10%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV--EDVKREVKILQALAG 155
           + I + +G G +G  Y  T+K +G   AVK ++      PI+   E+++ E  ILQ+L  
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD------PISDVDEEIEAEYNILQSLPN 77

Query: 156 HENVVKFYNAF-EDDNYV----YIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQM 208
           H NVVKFY  F + D  V    ++ +ELC GG + + +  L     R  E   + ++   
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI-VGSAYY 267
           L      H + ++HRD+K  N L  +   +  +K  DFG+S  +   +  ++  VG+ ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 268 VAPEVLKRKSGPES------DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           +APEV+  +   +       DVWS+G+    L  G  P +D        ++ RN P    
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254

Query: 322 KP--WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            P  W     S   F+ + L+KD  AR +    L HP+++
Sbjct: 255 HPEKW---CRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  109 bits (273), Expect = 2e-26
 Identities = 80/266 (30%), Positives = 122/266 (45%), Gaps = 40/266 (15%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR------ 145
           +DFD      K++G G FG   +   K++    A+K + K +MI        KR      
Sbjct: 43  EDFDVI----KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--------KRSDSAFF 90

Query: 146 -EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAA 202
            E + + A A  E +V+ + AF+DD Y+Y+ ME   GG+L++ +     S Y   EK A 
Sbjct: 91  WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-----SNYDIPEKWAR 145

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--- 259
               +++      H  G +HRD+KP+N L         LK  DFG    +K         
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTC--MKMDANGMVRC 200

Query: 260 -DIVGSAYYVAPEVLKRKS-----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
              VG+  Y++PEVLK +      G E D WS+GV  Y +L G  PF+  +  G + +++
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLL 339
            +K          IS  AKD +   L
Sbjct: 261 DHKNSLTFPDDIEISKQAKDLICAFL 286

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  108 bits (271), Expect = 2e-26
 Identities = 91/320 (28%), Positives = 143/320 (44%), Gaps = 63/320 (19%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVK---REVK 148
           D +Y   K +G G +G    A +    ++VA+KKI     N++       D K   RE+K
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-------DAKRTLREIK 56

Query: 149 ILQALAGHENVVKF--------YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           +L+ L  HENV+            AF D   VYI  EL +    L +I+ +     ++  
Sbjct: 57  LLRHLD-HENVIAIKDIMPPPHREAFND---VYIVYELMDTD--LHQII-RSSQTLSDDH 109

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ- 259
               + Q+LR     H   ++HRD+KP N L  +   +  LK  DFGL+        F  
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSEKGDFMT 166

Query: 260 DIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFW---------------- 301
           + V + +Y APE+L   S      DVWS+G I   LL GR+P +                
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITELL 225

Query: 302 ---DKTEDGIF-----KEVLRNKPDFRRKP----WPSISNSAKDFVKKLLVKDPRARLTA 349
               + + G       +  +R+ P   R+     +P  +  A D ++K+LV DP  R+T 
Sbjct: 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV 285

Query: 350 AQALSHPWVREGGDASEIPI 369
            +AL+HP++    D S+ P+
Sbjct: 286 EEALAHPYLASLHDPSDEPV 305

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  106 bits (265), Expect = 4e-26
 Identities = 72/218 (33%), Positives = 114/218 (52%), Gaps = 19/218 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDR-VAVKKIE-------KNKMILPIAVEDVKREVKI 149
           Y + + LG G FG  Y    K NG   +A+K+I        K+K     ++ D+  EV I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQ 207
           ++    H N+V++Y  F +++ +YI M+L EG  L +    L +K  R+TE+    +  Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 208 MLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           M  V A  +LH    +VHRD+ P N +     ED  +  TDFGL+   +P  K   +VG+
Sbjct: 122 M--VLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGT 176

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFW 301
             Y  PE++K +  G ++DVW+ G I Y +   + PF+
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  107 bits (267), Expect = 5e-26
 Identities = 77/255 (30%), Positives = 127/255 (49%), Gaps = 26/255 (10%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA+G   A+K ++K  +I    V     E ++L+    H  +  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59

Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+   +          V+A  +
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI---------VSALDY 110

Query: 217 LHG--LVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVL 273
           LH   +V+RD+K EN +     +D  +K TDFGL  + I      +   G+  Y+APEVL
Sbjct: 111 LHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167

Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           +    G   D W +GV+ Y ++CGR PF+++  + +F+ +L     F R    ++S  AK
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAK 223

Query: 333 DFVKKLLVKDPRARL 347
             +  LL+KDP  RL
Sbjct: 224 SLLSGLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  106 bits (266), Expect = 5e-26
 Identities = 85/300 (28%), Positives = 146/300 (48%), Gaps = 55/300 (18%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y A D+   + +A+KKI   ++++ +   A+    RE+ +L+ +  H N+V
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI----REISLLKEMQ-HGNIV 64

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKK--DSRYTEKDAAVV---VRQMLRVAAEC 215
           +  +    +  +Y+  E       LD  L K    S    K+  ++   + Q+LR  A C
Sbjct: 65  RLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD-FIKPGKKFQDIVGSAYYVAPEVL- 273
           H H ++HRD+KP+N L    +  ++LK  DFGL+  F  P + F   V + +Y APE+L 
Sbjct: 119 HSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFKEVLR--------------N 315
             +  S P  D+WS+G I +  +  ++P +  D   D +FK + R              +
Sbjct: 177 GSRHYSTP-VDIWSVGCI-FAEMVNQKPLFPGDSEIDELFK-IFRILGTPNEETWPGVTS 233

Query: 316 KPDFRRK--PW---------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA 364
            PD++     W         P++  +  D + K+L  DP  R+TA  AL H + ++ GDA
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  105 bits (264), Expect = 5e-26
 Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 48/231 (20%)

Query: 99  TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
            +GK LG G FG     T     +    +VAVK +++         E+   E  I++ L 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS--EEEREEFLEEASIMKKL- 58

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V+          +YI  E   GG+LLD +    +         + ++ +L++A +
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--------LTLKDLLQMALQ 110

Query: 215 -----CHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
                 +L     VHRD+   N L     E+  +K +DFGLS          DI    YY
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSR---------DIYEDDYY 158

Query: 268 V------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                        APE LK  K   +SDVWS GV+ + I   G +P+   +
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 209

Length = 258

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  106 bits (265), Expect = 1e-25
 Identities = 80/264 (30%), Positives = 128/264 (48%), Gaps = 21/264 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           + LG G FG   +AT K N D   VA+K+ EK+K+I    V+ V  E KIL  +  H   
Sbjct: 36  RTLGTGSFGRVILATYK-NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFC 93

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V  Y +F+D++Y+Y+ +E   GGE       +++ R+          Q++ +        
Sbjct: 94  VNLYGSFKDESYLYLVLEFVIGGEFF--TFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSG 278
           +V+RD+KPEN L     +D  +K TDFG +  +    +   + G+  Y+APE+ L    G
Sbjct: 152 IVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVGHG 206

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
             +D W++G+  Y +L G  PF+      I++++L     F +     + N+ K  +KKL
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKL 262

Query: 339 LVKDPRARL-----TAAQALSHPW 357
           L  D   R       A     HPW
Sbjct: 263 LSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  105 bits (263), Expect = 2e-25
 Identities = 85/262 (32%), Positives = 132/262 (50%), Gaps = 32/262 (12%)

Query: 102 KLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALAG 155
           K+LG G FG  ++    T    G   A+K ++K  +     V D    K E  IL A   
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL----KVRDRVRTKMERDIL-AEVN 56

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H  +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    + + L +A + 
Sbjct: 57  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAE-LALALD- 112

Query: 216 HLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
           HLH  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+  Y+APEV
Sbjct: 113 HLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSIS 328
           + R+   +S D WS GV+ + +L G  PF  K        +L+ K   P F       +S
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LS 222

Query: 329 NSAKDFVKKLLVKDPRARLTAA 350
             A+  ++ L  ++P  RL A 
Sbjct: 223 PEAQSLLRALFKRNPANRLGAG 244

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 83/284 (29%), Positives = 128/284 (45%), Gaps = 44/284 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK-----REVKILQALAGHEN 158
           LG G +G  Y    +  G  +A+K+I        + +++ K      E+ IL        
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIR-------LELDESKFNQIIMELDILHKAVSPY- 60

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILA------KKDSRYTEKDAAVVVRQMLRVA 212
           +V FY AF  +  VY+ ME  + G L D++ A              +    VV+ +  + 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
            E   H ++HRD+KP N L     +   +K  DFG+S + +    K    +G   Y+APE
Sbjct: 120 EE---HNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTN--IGCQSYMAPE 171

Query: 272 VLKRKSGP--------ESDVWSIGVITYILLCGRRPFWDKTEDGIFKE---VLRNKPDFR 320
            +K   GP        +SDVWS+G+    +  GR P+  +T   IF +   ++   P   
Sbjct: 172 RIK-SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP-- 228

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA 364
             P    S+ A+DFV K L K P  R T AQ L HPW+ +  +A
Sbjct: 229 TLP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  104 bits (261), Expect = 2e-25
 Identities = 80/266 (30%), Positives = 129/266 (48%), Gaps = 20/266 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H  +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILA--KKD-SRYTEKDAAVVV-RQMLRVAAECHL 217
            Y  F+    ++  ME   GG+L+  I +  K D  R T   A ++   Q L      H 
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFL------HS 114

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEV-LKR 275
            G+V+RD+K +N L  +   D  +K  DFG+  + +    K     G+  Y+APE+ L +
Sbjct: 115 KGIVYRDLKLDNILLDT---DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
           K     D WS GV+ Y +L G+ PF    E+ +F+ +  + P + R  W  ++  AKD +
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDIL 227

Query: 336 KKLLVKDPRARL-TAAQALSHPWVRE 360
            KL V++P  RL        HP+ RE
Sbjct: 228 VKLFVREPERRLGVKGDIRQHPFFRE 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 2e-25
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 39/235 (16%)

Query: 102 KLLGHGQFG--YTYVATDKANGDR-VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           K LG G FG  Y      K      VAVK ++++        +D  +E ++++ L GH N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKL-GHPN 57

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           VV+      ++  +Y+ +E  EGG+LLD +   +    + + + + ++ +L  A +    
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 216 --HLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
             +L     VHRD+   N L     ED  +K +DFGLS  +             YY    
Sbjct: 118 MEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDD---------YYRKKT 165

Query: 269 ---------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
                    APE LK      +SDVWS GV+ + I   G  P+   + + + + +
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  103 bits (258), Expect = 2e-25
 Identities = 85/275 (30%), Positives = 138/275 (50%), Gaps = 32/275 (11%)

Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR------EVKILQALA 154
           GKLLG G FG  Y+  D   G  +A K+++ +    P + E  K       E+++L+ L 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFD----PESPETSKEVSALECEIQLLKNLQ 62

Query: 155 GHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
            HE +V++Y    D  +  + I ME   GG + D++  K     TE       RQ+L   
Sbjct: 63  -HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGM 119

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK----PGKKFQDIVGSAYYV 268
           +  H + +VHRD+K  N L  SA    ++K  DFG S  ++     G   + + G+ Y++
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWP 325
           +PEV+  +  G ++DVWS+G  T + +   +P W + E    IFK  +  +P       P
Sbjct: 177 SPEVISGEGYGRKADVWSLGC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPT--NPQLP 231

Query: 326 S-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           S IS  A+DF+  + V + R R +A + L HP+ +
Sbjct: 232 SHISEHARDFLGCIFV-EARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (262), Expect = 2e-25
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 13/251 (5%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN--VVK 161
           +G G FG  Y    K      A+K + K +++    V     E  IL      E+  +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+ D+ +Y+  +   GGEL   +  +K+ R++E  A   + +++      H + +V
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKPGKKFQDIVGSAYYVAPEVLKRKSG-- 278
           +RD+KPEN L  +      +   DFGLS   +   K      G+  Y+APEVL  + G  
Sbjct: 119 YRDLKPENILLDA---TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
              D WS+GV+ + + CG  PF+ +    +++ +   K  F   P   +S+  + FVK L
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKGL 232

Query: 339 LVKDPRARLTA 349
           L ++P+ RL A
Sbjct: 233 LNRNPQHRLGA 243

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  103 bits (258), Expect = 3e-25
 Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 31/280 (11%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALA 154
           +  G+ LG G F   Y A D   G  +AVK++             VE +++E++++  L 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL- 60

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H ++++   A  +D++  + +E   GG +    L  K   + E        Q+LR  + 
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSV--SHLLSKYGAFKEAVIINYTEQLLRGLSY 118

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG----LSDFIKPGKKFQ-DIVGSAYYVA 269
            H + ++HRD+K  N L  S  +   L+  DFG    L+       +FQ  ++G+  ++A
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEVLRNKPDFRRKP 323
           PEVL+ +  G   DVWS+G +   +   + P W+  +       IFK             
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIFKIASATTA------ 229

Query: 324 WPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            PSI    S   +D   + L   P  R  + + L HP  R
Sbjct: 230 -PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  103 bits (259), Expect = 4e-25
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 56/293 (19%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHENV 159
           +G G +G  Y A +K  G+ VA+KKI      L    E V     RE+ +L+ L  H N+
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHPNI 61

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVR----QMLRVAAE 214
           VK  +    +N +Y+  E       L + L K  D+         +++    Q+L+  A 
Sbjct: 62  VKLLDVIHTENKLYLVFEF------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD-FIKPGKKFQDIVGSAYYVAPEVL 273
           CH H ++HRD+KP+N L      + ++K  DFGL+  F  P + +   V + +Y APE+L
Sbjct: 116 CHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172

Query: 274 ---KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRN-------------- 315
              K  S    D+WS+G I   ++  R  F   +E D +F+ + R               
Sbjct: 173 LGCKYYSTA-VDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-IFRTLGTPDEVVWPGVTS 230

Query: 316 ----KPDF---RRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
               KP F    R+ +    P +    +D + ++L  DP  R++A  AL+HP+
Sbjct: 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  104 bits (260), Expect = 5e-25
 Identities = 80/262 (30%), Positives = 128/262 (48%), Gaps = 12/262 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG   +A  K   +  A+K ++K+ ++    VE    E ++L     H  +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +  F+   +++  ME   GG+L+  I +    R+ E  A     +++      H  G++
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+K +N L     +D  +K  DFG+    +    K     G+  Y+APE+LK +   E
Sbjct: 119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           S D WS GV+ Y +L G+ PF  + ED +F  +L ++P F R  W  IS  AKD + KL 
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLF 231

Query: 340 VKDPRARL-TAAQALSHPWVRE 360
            +DP  RL        HP+ R 
Sbjct: 232 ERDPTKRLGVDGDIRQHPFFRG 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 6e-25
 Identities = 82/272 (30%), Positives = 142/272 (52%), Gaps = 22/272 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAG 155
           + +GKLLG G FG  Y+  D   G  +AVK++  + +       V  ++ E+++L+ L  
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR- 62

Query: 156 HENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           H+ +V++Y    D  +  + I +E   GG + D++  K     TE       RQ+L+  +
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK----PGKKFQDIVGSAYYVA 269
             H + +VHRD+K  N L  SA    ++K  DFG S  I+     G   + + G+ Y+++
Sbjct: 121 YLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPS 326
           PEV+  +  G ++DVWS+   T + +   +P W + E    IFK  +  +P     P   
Sbjct: 178 PEVISGEGYGRKADVWSVAC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPTKPMLP-DG 233

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           +S++ +DF+K++ V++ R R TA   L HP+V
Sbjct: 234 VSDACRDFLKQIFVEEKR-RPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  102 bits (256), Expect = 8e-25
 Identities = 77/290 (26%), Positives = 139/290 (47%), Gaps = 50/290 (17%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  + A ++   + VA+K++   + ++ +   A+    RE+ +L+ L  H+N+V
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELK-HKNIV 62

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVV---VRQMLRVAAECH 216
           + Y+    D  + +  E C      D+ L K  DS   + D  +V   + Q+L+  A CH
Sbjct: 63  RLYDVLHSDKKLTLVFEYC------DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
            H ++HRD+KP+N L     ++  LK  DFGL+  F  P + +   V + +Y  P+VL  
Sbjct: 117 SHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 276 KSGPES--DVWSIGVITYILLCGRRPFWDKTE-----DGIFKEV----------LRNKPD 318
                +  D+WS G I   L    RP +   +       IF+ +          +   PD
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233

Query: 319 FRRKP-------W----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           ++  P            P ++++ +D ++ LLV +P  R++A +AL HP+
Sbjct: 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  102 bits (256), Expect = 9e-25
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 54/292 (18%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G +   Y   ++  G+ VA+K+I    E+      I      RE+ +++ L  HEN+
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI------REISLMKELK-HENI 60

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK---DAAVV---VRQMLRVAA 213
           V+ ++    +N + +  E  +        L K    +  +   D   V     Q+L+  A
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKD------LKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH + ++HRD+KP+N L         LK  DFGL+  F  P   F + V + +Y AP+V
Sbjct: 115 FCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDV 171

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---------------- 314
           L   R      D+WS+G I   ++ GR  F     +    ++ R                
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231

Query: 315 --NKPDFRRKP-------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
              KP F R P       +P       D + +LL  +P  R++A  AL HPW
Sbjct: 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 88/275 (32%), Positives = 135/275 (49%), Gaps = 33/275 (12%)

Query: 102 KLLGHGQFGYTYVA--TDKANGDRVAVKKIEKNKMILPIAVED--VKREVKILQALAGHE 157
           K+LG G +G  +       A+  ++   K+ K   I+    +    K E  IL+A+  H 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V    AF+    +Y+ +E   GGEL   +  +++  + E  A   + ++  +A E HL
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEIS-LALE-HL 116

Query: 218 H--GLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLK 274
           H  G+++RD+KPEN L  +      +K TDFGL  + I  G       G+  Y+APE+L 
Sbjct: 117 HQQGIIYRDLKPENILLDA---QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFW----DKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           R   G   D WS+G + Y +L G  PF      KT D I K  L N P       P ++ 
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLP-------PYLTP 225

Query: 330 SAKDFVKKLLVKDPRARL-----TAAQALSHPWVR 359
            A+D +KKLL ++P +RL      AA+  SHP+ R
Sbjct: 226 EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  102 bits (257), Expect = 1e-24
 Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 42/290 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G +G  Y A D  +G+ VA+KK+  +  +  +PI+     RE+ +L  L  H N+V+
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLR-HPNIVE 70

Query: 162 FYNAFEDD--NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
                     + +++ ME CE  + L  +L    + ++E     ++ Q+LR     H + 
Sbjct: 71  LKEVVVGKHLDSIFLVMEYCE--QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRK 276
           ++HRD+K  N L         LK  DFGL+  +  P K     V + +Y APE+L     
Sbjct: 129 IIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTT 185

Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTE---------------DGIF----------KE 311
                D+W++G I   LL  +     K+E               + I+          K 
Sbjct: 186 YTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245

Query: 312 VLRNKP-DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            L  +P +  +  +P +S +    +  LL+ DP+ R TA +AL   + +E
Sbjct: 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  102 bits (255), Expect = 2e-24
 Identities = 84/309 (27%), Positives = 145/309 (46%), Gaps = 22/309 (7%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           + +D ++ +T  + +GHG FG  Y A D    + VA+KK+  +        +D+ +EVK 
Sbjct: 19  FKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ +  H N +++   +  ++  ++ ME C G      +L        E + A +    L
Sbjct: 79  LQRIK-HPNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGAL 135

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +  A  H H ++HRD+K  N L     E   +K  DFG +    P   F   VG+ Y++A
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPANSF---VGTPYWMA 189

Query: 270 PEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+    + +   + DVWS+G IT I L  R+P  F       ++       P  +   
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV-REGGDASEIPIDISVLNNMRQF-- 380
           W   S+  ++FV   L K P+ R T+ + L H +V RE  +   I +     + +R+   
Sbjct: 249 W---SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDN 305

Query: 381 VKYSRLKQF 389
           ++Y ++K+ 
Sbjct: 306 LQYRKMKKL 314

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  101 bits (254), Expect = 2e-24
 Identities = 83/291 (28%), Positives = 127/291 (43%), Gaps = 43/291 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIE---KNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y A DK  G  VA+KK       + I P A+    RE+ +LQ L+    +V
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL----REISLLQMLSESIYIV 64

Query: 161 KFYNA--FEDDN---YVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           +  +    E+ N    +Y+  E  +    + +D            K     + Q+L+  A
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH HG++HRD+KP+N L    K    LK  D GL   F  P K +   + + +Y APEV
Sbjct: 125 HCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEV-------------L 313
           L          D+WS+G I   +   +  F   +E      IFK +             L
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242

Query: 314 RN-------KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           R+       KP    +  P +S    D ++K+L  DP  R++A  AL+HP+
Sbjct: 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 91/328 (27%), Positives = 138/328 (42%), Gaps = 76/328 (23%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVK--ILQA 152
           +RY   K +G G  G    A D   G  VA+KK+ +     P   V   KR  +  +L  
Sbjct: 16  KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSR-----PFQNVTHAKRAYRELVLMK 70

Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVV 204
           L  H+N++   N F      E+   VY+ MEL +    +++   L  +   Y       +
Sbjct: 71  LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-------L 123

Query: 205 VRQMLRVAAEC---HLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           + QML     C   HLH  G++HRD+KP N + KS   D +LK  DFGL+          
Sbjct: 124 LYQML-----CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMT 175

Query: 260 DIVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDK------T 304
             V + YY APEV+      E+ D+WS+G I   ++ G   F        W+K      T
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235

Query: 305 EDGIFKEVL--------RNKPDFRRKPWPSI-----------------SNSAKDFVKKLL 339
               F   L         N+P +    +  +                 ++ A+D + K+L
Sbjct: 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML 295

Query: 340 VKDPRARLTAAQALSHPWVREGGDASEI 367
           V DP  R++   AL HP++    D SE+
Sbjct: 296 VIDPEKRISVDDALQHPYINVWYDPSEV 323

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =   99 bits (249), Expect = 4e-24
 Identities = 74/270 (27%), Positives = 136/270 (50%), Gaps = 22/270 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y   K +G G FG   +   K +G +  +K+I  +KM  P   E+ ++EV +L  +  H
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-H 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V++  +FE++  +YI M+ CEGG+L  +I A++   + E        Q+       H
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 217 LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEVLK 274
              ++HRD+K +N FL K    D ++K  DFG++  +    +  +  +G+ YY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLTK----DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174

Query: 275 -RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE-VLRNKPDFRRKPWPSI----S 328
            R    +SD+W++G + Y +   +  F    E G  K  VL+      R  +P +    S
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAF----EAGNMKNLVLK----IIRGSYPPVSSHYS 226

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
              ++ V +L  ++PR R +    L   ++
Sbjct: 227 YDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  102 bits (255), Expect = 5e-24
 Identities = 80/306 (26%), Positives = 124/306 (40%), Gaps = 55/306 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +G G FG   +          A+K + K  +++      VK E  IL A A +E VVK
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDIL-AEADNEWVVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D + +Y  M+   GG+++   L  +   + E  A   + ++       H  G +
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMS--LLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL---------SDFIKPGKKF-QD----------- 260
           HRD+KP+N L      D  +K TDFGL         S + + G    QD           
Sbjct: 124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 261 -----------------------IVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCG 296
                                  +VG+  Y+APEVL R    +  D WS+GVI Y +L G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQAL 353
           + PF   T      +V+  +          +S  A D + + L      RL    A +  
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIK 299

Query: 354 SHPWVR 359
           +HP+ +
Sbjct: 300 AHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  100 bits (251), Expect = 5e-24
 Identities = 78/275 (28%), Positives = 127/275 (46%), Gaps = 19/275 (6%)

Query: 87  DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           +  +  D ++ ++  + +GHG FG  Y A D  N + VA+KK+  +        +D+ +E
Sbjct: 6   ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65

Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           V+ LQ L  H N +++   +  ++  ++ ME C G      +L        E + A V  
Sbjct: 66  VRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTH 122

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
             L+  A  H H ++HRD+K  N L     E   +K  DFG +  + P   F   VG+ Y
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPY 176

Query: 267 YVAPEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFR 320
           ++APEV+    + +   + DVWS+G IT I L  R+P  F       ++       P  +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
              W   S   ++FV   L K P+ R T+   L H
Sbjct: 236 SGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.1 bits (247), Expect = 8e-24
 Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 14/266 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + K LG G +G  Y     ++    A+K+++   M      ED   E++IL A   H
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRIL-ASVNH 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVRQMLRVAAE 214
            N++ +  AF D N + I ME    G+L   I  +K  R    E++   +  Q+LR    
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H   ++HRD+K  N +   A +   +K  D G+S  +K       I G+ +Y+APEV K
Sbjct: 119 LHEQKILHRDLKSAN-ILLVANDL--VKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWK 174

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI-SNSAK 332
            +    +SD+WS+G + Y +     PF  ++   +  +V R K      P P I S   +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP----PIPPIYSQDLQ 230

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           +F++ +L   P+ R    + L+ P V
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  100 bits (249), Expect = 9e-24
 Identities = 74/263 (28%), Positives = 136/263 (51%), Gaps = 30/263 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIA--VEDVKREVKILQALAGHE 157
           K+LG G +G  ++    +  D  ++   K+ K   I+  A   E  + E ++L+ +    
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  + AF+ D  +++ ++   GGEL   +  ++  R+ E++  +   +++      H 
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHK 123

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPG-KKFQDIVGSAYYVAPEVLKR 275
            G+++RD+K EN L  S   +  +  TDFGLS +F +   ++     G+  Y+AP++++ 
Sbjct: 124 LGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 276 KSGPES---DVWSIGVITYILLCGRRPFWDKTEDG-------IFKEVLRNKPDFRRKPWP 325
             G      D WS+GV+ Y LL G  PF   T DG       I + +L+++P     P+P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPF---TVDGEKNSQAEISRRILKSEP-----PYP 232

Query: 326 S-ISNSAKDFVKKLLVKDPRARL 347
             +S  AKD +++LL+KDP+ RL
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  100 bits (251), Expect = 9e-24
 Identities = 74/259 (28%), Positives = 127/259 (49%), Gaps = 20/259 (7%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K + +R+   KI     +L  A     RE + +      +
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+D+NY+Y+ M+   GG+LL  +L+K + R  E  A   + +M+      H 
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKR 275
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L+ 
Sbjct: 121 LHYVHRDIKPDNVLLDM---NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 276 ------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
                 K GPE D WS+GV  Y +L G  PF+ ++    + +++ ++  F+   +PS   
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHIT 234

Query: 327 -ISNSAKDFVKKLLVKDPR 344
            +S  AKD +++L+    R
Sbjct: 235 DVSEEAKDLIQRLICSRER 253

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  100 bits (249), Expect = 1e-23
 Identities = 71/248 (28%), Positives = 122/248 (49%), Gaps = 11/248 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG   +A  K  G+  AVK ++K+ +++   VE    E ++L     +  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y  F+   +++  ME   GG+L+  I  K   R+    A     +++      H  G++
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGP 279
           +RD+K +N +      D  +K  DFG+  + +    +     G+  Y+APE+L+  K   
Sbjct: 119 YRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D WS GV+ Y +L G+ PF    ED +F+ +  + P + R  W  I+  +KD ++KL 
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLF 231

Query: 340 VKDPRARL 347
            +DP  RL
Sbjct: 232 ERDPTRRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  100 bits (249), Expect = 1e-23
 Identities = 75/254 (29%), Positives = 126/254 (49%), Gaps = 20/254 (7%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K N D+V   KI     +L  A     RE + +     ++
Sbjct: 3   FEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+D+N +Y+ M+   GG+LL  +L+K + R  E  A   + +M+      H 
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVL-- 273
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L  
Sbjct: 121 LHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 274 ----KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
               K K GPE D WS+GV  Y +L G  PF+ ++    + +++ +K  F+   +P+   
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVT 234

Query: 327 -ISNSAKDFVKKLL 339
            +S  AKD +++L+
Sbjct: 235 DVSEDAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 99.9 bits (249), Expect = 2e-23
 Identities = 82/277 (29%), Positives = 133/277 (48%), Gaps = 22/277 (7%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DF+    I K++G G FG   V   K  G   A+K + K +M L  A     RE + +  
Sbjct: 2   DFE----ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLV 56

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 +   + AF+D+N +Y+ M+   GG+LL  +L+K + R  E  A   + +M+   
Sbjct: 57  NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAI 115

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAP 270
              H  G VHRD+KP+N L     ++  ++  DFG    +      Q    VG+  Y++P
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172

Query: 271 EVL------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           E+L      K + GPE D WS+GV  Y +L G  PF+ ++    + +++ +K  F+  P 
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232

Query: 325 -PSISNSAKDFVKKLLVKDPRARL---TAAQALSHPW 357
              +S  AKD +++L+   P  RL          HP+
Sbjct: 233 VTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  100 bits (249), Expect = 2e-23
 Identities = 75/276 (27%), Positives = 136/276 (49%), Gaps = 28/276 (10%)

Query: 102 KLLGHGQFGYTYV---ATDKANGDRVAVKKIEKNKMILPI-AVEDVKREVKILQALAGHE 157
           K+LG G +G  ++    T    G   A+K ++K  ++     VE  + E  +L+ +    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  + AF+ +  +++ ++   GGE+   +  + +  ++E +      +++      H 
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHK 123

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGK-KFQDIVGSAYYVAPEVLKR 275
            G+V+RD+K EN L  S   +  +  TDFGLS +F+   K +     G+  Y+APE+++ 
Sbjct: 124 LGIVYRDIKLENILLDS---EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 276 KSG--PESDVWSIGVITYILLCGRRPFW----DKTEDGIFKEVLRNKPDFRRKPWPS-IS 328
           K G     D WS+G++ + LL G  PF       T+  + + +L+  P     P+PS I 
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-----PFPSFIG 235

Query: 329 NSAKDFVKKLLVKDPRARLTAA-----QALSHPWVR 359
             A+D + KLL KDP+ RL A      +   HP+ +
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 67/252 (26%), Positives = 121/252 (48%), Gaps = 14/252 (5%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL--AGHENVVK 161
           LG G FG   +A  K  G+  A+K ++K  +I    VE +  E +I +      H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +  F+ +++V   ME   GG+L+  I       ++E  A      ++      H + +V
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI---HTDVFSEPRAVFYAACVVLGLQYLHENKIV 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+K +N L  +   +  +K  DFGL  + +  G +     G+  ++APEVL   S   
Sbjct: 124 YRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +GV+ Y +L G  PF    E+ +F  ++ ++  + R     +S  A   +++LL
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRLL 236

Query: 340 VKDPRARLTAAQ 351
            ++P  RL + +
Sbjct: 237 RRNPERRLGSGE 248

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 99.1 bits (247), Expect = 4e-23
 Identities = 89/312 (28%), Positives = 135/312 (43%), Gaps = 58/312 (18%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RY   + LG G  G  + A D     RVAVKKI    +  P +V+   RE+KI++ 
Sbjct: 2   DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI---VLTDPQSVKHALREIKIIRR 58

Query: 153 LAGHENVVKFYNAFEDDNY--------------VYIAMELCEGGELLDRILAKKDSRYTE 198
           L  H+N+VK Y                      VYI  E  E    L  +L  +    +E
Sbjct: 59  LD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVL--EQGPLSE 113

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP---- 254
           + A + + Q+LR     H   ++HRD+KP N    +  ED  LK  DFGL+  + P    
Sbjct: 114 EHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVLKIGDFGLARIVDPHYSH 171

Query: 255 -GKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE------ 305
            G   + +V + +Y +P +L          D+W+ G I   +L G+  F    E      
Sbjct: 172 KGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230

Query: 306 --DGI-------FKEVLRNKPDF-------RRKPW----PSISNSAKDFVKKLLVKDPRA 345
             + +         E+L   P F        R+P     P ++  A DF++++L  +P  
Sbjct: 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMD 290

Query: 346 RLTAAQALSHPW 357
           RLTA +AL HP+
Sbjct: 291 RLTAEEALMHPY 302

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 99.7 bits (248), Expect = 4e-23
 Identities = 81/264 (30%), Positives = 124/264 (46%), Gaps = 29/264 (10%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR-------EVKIL 150
           Y + K++G G FG   +   K+     A+K + K +MI        KR       E + +
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--------KRSDSAFFWEERDI 96

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            A A    VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++ 
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD--VPEKWARFYTAEVVL 153

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDI-VGSAYYV 268
                H  G +HRD+KP+N L   +     LK  DFG      K G    D  VG+  Y+
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210

Query: 269 APEVLKRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           +PEVLK + G      E D WS+GV  Y +L G  PF+  +  G + +++ +K       
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270

Query: 324 WPSISNSAKDFVKKLLVKDPRARL 347
              IS  AK+ +   L  D   RL
Sbjct: 271 DNDISKEAKNLICAFLT-DREVRL 293

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 97.7 bits (243), Expect = 4e-23
 Identities = 75/270 (27%), Positives = 124/270 (45%), Gaps = 13/270 (4%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           R+Y   ++LG G FG       +A G   A K++EK ++           E +IL+ +  
Sbjct: 3   RQY---RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-N 58

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
            + VV    A+E  + + + + +  GG+L   I    +  + E+ A     ++L    + 
Sbjct: 59  SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK- 274
           H    V+RD+KPEN L     +   ++ +D GL+  I  G+  +  VG+  Y+APEVL  
Sbjct: 119 HRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN 175

Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           ++     D W +G + Y ++ G+ PF  + E    +EV R   +         S  AK  
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI 235

Query: 335 VKKLLVKDPRARL-----TAAQALSHPWVR 359
            K LL KDP+ RL      A +   HP+ R
Sbjct: 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 98.8 bits (246), Expect = 5e-23
 Identities = 89/311 (28%), Positives = 133/311 (42%), Gaps = 53/311 (17%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            RYT  K +G G +G    A DK  G++VA+KK+ +      I  +   RE+ +L+ +  
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQ- 72

Query: 156 HENVVKF---------YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           HENV+            + F+D    Y+ M   +    L +I+       +E     +V 
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQD---FYLVMPYMQTD--LQKIMGHP---LSEDKVQYLVY 124

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N    +  ED  LK  DFGL+       +    V + +
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRW 179

Query: 267 YVAPEVLKR--KSGPESDVWSIGVITYILLCGRR-----------------------PFW 301
           Y APEV+          D+WS+G I   +L G+                         F 
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239

Query: 302 DKTEDGIFKEVLRNKPDFRRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            K ED   K  +++ P + RK     +P  S  A D ++K+L  D   RLTA +AL HP+
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Query: 358 VREGGDASEIP 368
                DA E  
Sbjct: 300 FDSFRDADEET 310

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 94/317 (29%), Positives = 140/317 (44%), Gaps = 52/317 (16%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RY   + +G G +G    A D  +G +VA+KKI     +  +A   + RE+KIL+ 
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRH 60

Query: 153 LAGHENVVKFYNAF----EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
              H+N++   +       D   VY+ M+L E    L  I+   D   TE+     + Q+
Sbjct: 61  FK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHII-HSDQPLTEEHIRYFLYQL 116

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG----LSDFIKPGKKFQ-DIVG 263
           LR     H   ++HRD+KP N L     ED  L+  DFG    LS      K F  + V 
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 264 SAYYVAPEVLKRKSGPES----DVWSIGVITYILLCGRRP-FWDKT-------------- 304
           + +Y APE+L   S PE     D+WS+G I   +L GRR  F  K               
Sbjct: 174 TRWYRAPELL--LSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGS 230

Query: 305 -EDGIFKEV--------LRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQ 351
             + +   +        ++N P  +  PW    P  S  A D + ++L  DP  R+T  Q
Sbjct: 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290

Query: 352 ALSHPWVREGGDASEIP 368
           AL HP++ +  D  + P
Sbjct: 291 ALQHPFLAQYHDPDDEP 307

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 98.9 bits (246), Expect = 6e-23
 Identities = 90/326 (27%), Positives = 143/326 (43%), Gaps = 55/326 (16%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +   K  G   A+K + K  M+    V  ++ E  IL    G   VVK
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+D   +Y+ ME   GG+++  +L KKD+   E     +   +L + A  H  G +
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMT-LLMKKDTLSEEATQFYIAETVLAIDA-IHQLGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----------------FQDI---- 261
           HRD+KP+N L  +      +K +DFGL   +K   +                FQ++    
Sbjct: 124 HRDIKPDNLLLDAK---GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 262 ----------------VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKT 304
                           VG+  Y+APEV  +    +  D WS+GVI Y +L G  PF  +T
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAA---QALSHPWVREG 361
               +++V+  K      P   IS  AKD + +    D   R+ +    +  SHP+  EG
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF-EG 298

Query: 362 GD-------ASEIPIDISVLNNMRQF 380
            D        + IPI+I  +++   F
Sbjct: 299 VDWGHIRERPAAIPIEIKSIDDTSNF 324

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 97.5 bits (243), Expect = 6e-23
 Identities = 84/299 (28%), Positives = 132/299 (44%), Gaps = 65/299 (21%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGHENV 159
           L+G G +G       K  G  VA+KK    E +KM+  IA+    RE+++L+ L  HEN+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM----REIRMLKQLR-HENL 62

Query: 160 V----------KFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           V          + Y  FE  D+ V   +E    G  LD    +K            + Q+
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRK-----------YLFQI 109

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYY 267
           LR    CH H ++HRD+KPEN L   +     +K  DFG +  +  PG+ + D V + +Y
Sbjct: 110 LRGIEFCHSHNIIHRDIKPENILVSQSG---VVKLCDFGFARTLAAPGEVYTDYVATRWY 166

Query: 268 VAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVL-------RNKP 317
            APE+L    K G   D+W++G +   +L G   F  D   D ++  +        R++ 
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226

Query: 318 DFRRKP-------------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            F++ P                   +P +S    D  K+ L  DP  R +++Q L H +
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 97.0 bits (241), Expect = 8e-23
 Identities = 74/272 (27%), Positives = 130/272 (47%), Gaps = 22/272 (8%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  Y   D    + VA+K I+  +      +ED+++E+ +L  
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQ 58

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 + ++Y ++     ++I ME   GG  LD +   K     E   A ++R++L+  
Sbjct: 59  -CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 115 DYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 272 VLKRKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI--- 327
           V+K+ +   ++D+WS+G+    L  G  P  D     +   + +N P       P++   
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------PTLEGQ 224

Query: 328 -SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            S   K+FV+  L KDPR R TA + L H ++
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 77/262 (29%), Positives = 120/262 (45%), Gaps = 10/262 (3%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG       KA G   A KK++K ++      +    E KIL        +V   
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKVSSRFIVSLA 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            AFE  + + + M L  GG+L   I    +  + E  A     Q++      H   +V+R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES-D 282
           D+KPEN L     +  +++ +D GL+  +K GKK +   G+  Y+APEVL+ +    S D
Sbjct: 120 DLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176

Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKD 342
            +++G   Y ++ GR PF  + E    +E+ R   +   +     S  AKD  + LL KD
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236

Query: 343 PRARL-----TAAQALSHPWVR 359
           P  RL     +A +   HP  +
Sbjct: 237 PEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 90/315 (28%), Positives = 136/315 (43%), Gaps = 55/315 (17%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I +++G G +G    A D   G++VA+KKI      +  A   + RE+K+L+ L  H
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLR-H 58

Query: 157 ENVVKFY--------NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
            ++V+            F+D   +Y+  EL E  +L   I A  D   T +     + Q+
Sbjct: 59  PDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDD--LTPEHHQFFLYQL 112

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI---KPGKKF-QDIVGS 264
           LR     H   + HRD+KP+N L   A  D  LK  DFGL+       P   F  D V +
Sbjct: 113 LRALKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169

Query: 265 AYYVAPEV---LKRKSGPESDVWSIGVITYILLCGRRPFWDK------------------ 303
            +Y APE+      K  P  D+WSIG I   +L G+  F  K                  
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229

Query: 304 -TEDGI-------FKEVLRNKP--DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            T   +       +   +R K    F +K +P+    A   +++LL  DP+ R TA +AL
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEAL 288

Query: 354 SHPWVREGGDASEIP 368
           + P+ +        P
Sbjct: 289 ADPYFKGLAKVEREP 303

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 76/289 (26%), Positives = 133/289 (46%), Gaps = 37/289 (12%)

Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
             ++ YD++ +R      +LG G +G  Y A D +   R+A+K+I +        V+ + 
Sbjct: 2   EYEYEYDENGER-----VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLH 53

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E+ +   L  H N+V++  +  ++ +  I ME   GG L   +L  K     + +  ++
Sbjct: 54  EEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTII 111

Query: 205 --VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQ 259
              +Q+L      H + +VHRD+K +N L  +      +K +DFG S     I P    +
Sbjct: 112 FYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGINPCT--E 167

Query: 260 DIVGSAYYVAPEVLK---RKSGPESDVWSIGVITYILLCGRRPFWDKTED-------GIF 309
              G+  Y+APEV+    R  G  +D+WS+G     +  G+ PF +  E        G+F
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF 227

Query: 310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           K +    P+       S+S  AK+F+ +    DP  R +A   L  P++
Sbjct: 228 K-IHPEIPE-------SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 96.6 bits (240), Expect = 3e-22
 Identities = 72/250 (28%), Positives = 122/250 (48%), Gaps = 11/250 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  KA     AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+  + +Y  ++   GGEL   +  +++  + E  A     ++       H   +V
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIV 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L  S      +  TDFGL  + I+         G+  Y+APEVL ++    
Sbjct: 119 YRDLKPENILLDS---QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +G + Y +L G  PF+ +    ++  +L NKP  + K  P+I+NSA+  ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-NKP-LQLK--PNITNSARHLLEGLL 231

Query: 340 VKDPRARLTA 349
            KD   RL A
Sbjct: 232 QKDRTKRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 95.0 bits (236), Expect = 3e-22
 Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 36/279 (12%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK--------REVK 148
           RY + + LG G FG  Y+  DK           E+ K++  I V ++         +E +
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKK------AVAEERLKVLKEIPVGELNPNETVQANQEAQ 54

Query: 149 ILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVV 205
           +L  L  H  +VKF+ +F E D +  I  E CEG +L  ++  L       +E       
Sbjct: 55  LLSKLD-HPAIVKFHASFLERDAFCIIT-EYCEGRDLDCKLEELKHTGKTLSENQVCEWF 112

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGS 264
            Q+L      H   ++HRD+K +N   K    ++ LK  DFG+S  +           G+
Sbjct: 113 IQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGT 168

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            YY++PE LK +    +SD+WS+G I Y + C    F  +    +   ++         P
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-------P 221

Query: 324 WPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            PS+    S      ++ +L KDP  R +AA+ L +P++
Sbjct: 222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 96.6 bits (240), Expect = 4e-22
 Identities = 80/264 (30%), Positives = 126/264 (47%), Gaps = 29/264 (10%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR-------EVKIL 150
           Y + K++G G FG   +   K++    A+K + K +MI        KR       E + +
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI--------KRSDSAFFWEERDI 96

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            A A    VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++ 
Sbjct: 97  MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYD--VPEKWAKFYTAEVVL 153

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDI-VGSAYYV 268
                H  GL+HRD+KP+N L     +   LK  DFG      + G    D  VG+  Y+
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI 210

Query: 269 APEVLKRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           +PEVLK + G      E D WS+GV  + +L G  PF+  +  G + +++ +K       
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270

Query: 324 WPSISNSAKDFVKKLLVKDPRARL 347
              IS  AK+ +   L  D   RL
Sbjct: 271 DVEISKHAKNLICAFLT-DREVRL 293

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 46/292 (15%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDV 143
           Y  D +    +G  +G G  G  Y    K  G  +AVK++      E+NK IL       
Sbjct: 10  YPADLNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRIL------- 61

Query: 144 KREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL----CEGGELLDRILAKKDSRYTEK 199
             ++ ++        +VK Y  F  D+ V+I MEL     +  +LL RI          K
Sbjct: 62  -MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD--KLLKRIQGPIPEDILGK 118

Query: 200 DAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
               +V+ +  +  +   HG++HRD+KP N L        ++K  DFG+S  +   K   
Sbjct: 119 MTVAIVKALHYLKEK---HGVIHRDVKPSNILLD---ASGNVKLCDFGISGRLVDSKAKT 172

Query: 260 DIVGSAYYVAPEVLK-RKSGPE----SDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVL 313
              G A Y+APE +      P+    +DVWS+G+    L  G+ P+ + KTE  +  ++L
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232

Query: 314 RNKPDFRRKPWPSISNSA------KDFVKKLLVKDPRARLTAAQALSHPWVR 359
           + +P       PS+  +         FV   L KD R R    + L HP++R
Sbjct: 233 QEEP-------PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 95.1 bits (237), Expect = 6e-22
 Identities = 85/314 (27%), Positives = 119/314 (37%), Gaps = 63/314 (20%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQ 151
           R Y I   LG G FG  Y A     G  VA+KKI    EK+    PI      RE+KIL+
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITAL---REIKILK 62

Query: 152 ALAGHENVVKFYNAF--------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
            L  H NVV   +               VY+     +    L  +L     + TE     
Sbjct: 63  KLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD--LSGLLENPSVKLTESQIKC 119

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-----KPGK-- 256
            + Q+L      H + ++HRD+K  N L  +      LK  DFGL+         P    
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDN---QGILKIADFGLARPYDGPPPNPKGGG 176

Query: 257 -----KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE---- 305
                K+ ++V + +Y  PE+L  +R+     D+W IG +   +   R     K++    
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236

Query: 306 DGIFK-------------EVLRNKPDFR-RKPWPSI--SNSAK------DFVKKLLVKDP 343
             IFK               L           +P        K      D + KLL  DP
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296

Query: 344 RARLTAAQALSHPW 357
             RLTA+ AL HP+
Sbjct: 297 YKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 94.3 bits (234), Expect = 7e-22
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 13/271 (4%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           R+Y   ++LG G FG       +A G   A KK+EK ++           E +IL+ +  
Sbjct: 3   RQY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-N 58

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
              VV    A+E  + + + + L  GG+L   I    ++ + E  A     ++     + 
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H   +V+RD+KPEN L     +   ++ +D GL+  +  G+  +  VG+  Y+APEV+K 
Sbjct: 119 HQERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 175

Query: 276 KSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           +    S D W++G + Y ++ G+ PF  + +    +EV R   + + +     S  A+  
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235

Query: 335 VKKLLVKDPRARL-----TAAQALSHPWVRE 360
            K LL KDP+ RL      A +   HP  ++
Sbjct: 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 69/249 (27%), Positives = 123/249 (49%), Gaps = 13/249 (5%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-VV 160
            +LG G FG   +A  K   +  A+K ++K+ +I    VE    E ++L AL G    + 
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL-ALPGKPPFLT 64

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + ++ F+  + +Y  ME   GG+L+  I  ++  ++ E  A     ++       H  G+
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPE-VLKRKSG 278
           ++RD+K +N +  +   +  +K  DFG+  + I  GK  +   G+  Y+APE +  +  G
Sbjct: 123 IYRDLKLDNVMLDA---EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
              D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGL 235

Query: 339 LVKDPRARL 347
           L K P  RL
Sbjct: 236 LTKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 94.0 bits (234), Expect = 9e-22
 Identities = 80/298 (26%), Positives = 131/298 (43%), Gaps = 65/298 (21%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILP-IAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y   +K  G  VA+KKI  E  +  +P  A+    RE+ +L+ L  H N+V
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI----REISLLKELQ-HPNIV 62

Query: 161 KFYNAFEDDNYVYIAMELCE-----------GGELLDRILAKKDSRYTEKDAAVVVRQML 209
              +    ++ +Y+  E               G+ +D  L K    Y          Q+L
Sbjct: 63  CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS---YL--------YQIL 111

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYV 268
           +    CH   ++HRD+KP+N L  +      +K  DFGL+  F  P + +   V + +Y 
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDN---KGVIKLADFGLARAFGIPVRVYTHEVVTLWYR 168

Query: 269 APEVL---KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK------------- 310
           APEVL    R S P  D+WSIG I +  +  ++P +  D   D +F+             
Sbjct: 169 APEVLLGSPRYSTP-VDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226

Query: 311 ---EVLRN--------KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                L +        K    R    ++     D ++K+L+ DP  R++A +AL+HP+
Sbjct: 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 93.6 bits (232), Expect = 9e-22
 Identities = 81/282 (28%), Positives = 133/282 (47%), Gaps = 32/282 (11%)

Query: 93  DFDRR-----YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           D  RR     + + + +G G +G  Y A +   G+  A+K I+    + P     V ++ 
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQE 56

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            I+     H N+V ++ ++   + ++I ME C GG L D  +       +E   A V R+
Sbjct: 57  IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAYVSRE 114

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAY 266
            L+     H  G +HRD+K  N L     ++  +K  DFG+S  I     K +  +G+ Y
Sbjct: 115 TLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPY 171

Query: 267 YVAPEV--LKRKSGPES--DVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFR- 320
           ++APEV  ++RK G     D+W++G+    L   + P +D      +F   L  K +F+ 
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQP 228

Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                +  W   SNS   FVK  L K+P+ R TA + L HP+
Sbjct: 229 PKLKDKMKW---SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 95.1 bits (236), Expect = 1e-21
 Identities = 87/327 (26%), Positives = 142/327 (43%), Gaps = 51/327 (15%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +   K  G   A+K + K  M+    V  ++ E  IL   A    VVK
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL-VEADSLWVVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+D   +Y+ ME   GG+++  +L KKD+  TE++    + + +      H  G +
Sbjct: 66  MFYSFQDKLNLYLIMEFLPGGDMMT-LLMKKDT-LTEEETQFYIAETVLAIDSIHQLGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----------------FQDI---- 261
           HRD+KP+N L  S      +K +DFGL   +K   +                FQ++    
Sbjct: 124 HRDIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 262 ----------------VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKT 304
                           VG+  Y+APEV  +    +  D WS+GVI Y +L G  PF  +T
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK-DPRARLTAAQALSHPWVREGGD 363
               +K+V+  K      P   IS  AKD + +   + + R      + +      EG D
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300

Query: 364 -------ASEIPIDISVLNNMRQFVKY 383
                   + IPI+I  +++   F ++
Sbjct: 301 WEHIRERPAAIPIEIKSIDDTSNFDEF 327

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 79/305 (25%), Positives = 125/305 (40%), Gaps = 55/305 (18%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQALA 154
           + I   +G G +G  Y A DK  G+ VA+KK+  +  K   PI A+    RE+KIL+ L 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI----REIKILRQLN 64

Query: 155 GHENVVKFYNAFEDDNYV----------YIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            H N+V       D              Y+  E  +    L  +L      ++E      
Sbjct: 65  -HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD--LMGLLESGLVHFSEDHIKSF 121

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK--FQDIV 262
           ++Q+L     CH    +HRD+K  N L  +  +   +K  DFGL+      +   + + V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKV 178

Query: 263 GSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF-------------------- 300
            + +Y  PE+L  + + GP  DVWS G I   L   ++P                     
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELISRLCGSP 237

Query: 301 ----WDKTEDGIFKEVLRNKPDFRRK---PWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
               W       +   ++ K  +RR+    +  I   A D +  +L  DP  R TA +AL
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297

Query: 354 SHPWV 358
           + PW+
Sbjct: 298 NSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 47/286 (16%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE---KNKMILPIAVEDVKREVKILQALA 154
           +T G++LG G +G  Y       G  +AVK++E    N +      E ++ EV +L++L 
Sbjct: 2   WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGG---ELLDRILAKKD---SRYTEKDAAVVVRQM 208
            H N+V++     DDN + I ME   GG    +L+R     +    +YT        +Q+
Sbjct: 61  -HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYT--------KQI 111

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDI 261
           L   A  H + +VHRD+K  N +      +  +K  DFG +  +             + +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 262 VGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF- 319
            G+ Y++APEV+     G +SD+WSIG   + +  G+ P            + R    F 
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL---------ASMDRLAAMFY 219

Query: 320 ---RRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
               R   P +    S +A DFV   L +D   R +A Q L H ++
Sbjct: 220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 88/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 75

Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 131

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 132 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAP 186

Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKPD---FRRKP 323
           E++          D+WS+G I   LL GR  F         K +LR    P     ++  
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246

Query: 324 WPSISN----------------------SAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
             S  N                       A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306

Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 307 HDPDDEPV 314

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 8/208 (3%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K +G GQF   Y AT   +   VA+KK++  +M+   A +D  +E+ +L+ L  H 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           NV+K+ ++F +DN + I +EL + G+L   I    K+     E+       Q+       
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIVGSAYYVAPEVLK 274
           H   ++HRD+KP N    +      +K  D GL  F          +VG+ YY++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFW 301
                 +SD+WS+G + Y +   + PF+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 94.7 bits (235), Expect = 4e-21
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 28/216 (12%)

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVRQML 209
           A   H  +VK ++ F+ D+ + + ME   GG+L  +I  +      + E +  ++  Q++
Sbjct: 120 AACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIV 179

Query: 210 RVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV------ 262
               E H   ++HRD+K  N FL  +      +K  DFG S      K++ D V      
Sbjct: 180 LALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFS------KQYSDSVSLDVAS 229

Query: 263 ---GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
              G+ YY+APE+ +RK    ++D+WS+GVI Y LL   RPF   ++  I ++VL  K D
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD 289

Query: 319 FRRKPWP-SISNSAKDFVKKLLVKDPRARLTAAQAL 353
               P+P  +S+  K  +  LL K+P  R T  Q L
Sbjct: 290 ----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 93.5 bits (232), Expect = 4e-21
 Identities = 86/311 (27%), Positives = 141/311 (45%), Gaps = 54/311 (17%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE----DVKREVKILQA 152
           RY   K +G G +G    A D+  G +VA+KK+ +     P   E       RE+++L+ 
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-----PFQSELFAKRAYRELRLLKH 70

Query: 153 LAGHENVVKFYNAFEDD------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  HENV+   + F  D      +  Y+ M     G  L +++  K  + +E     +V 
Sbjct: 71  MK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM--KHEKLSEDRIQFLVY 125

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML+     H  G++HRD+KP N    +  ED  LK  DFGL+   +   +    V + +
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--QTDSEMTGYVVTRW 180

Query: 267 YVAPEVLKR--KSGPESDVWSIGVITYILLCGR-----------------------RPFW 301
           Y APEV+          D+WS+G I   +L G+                       + F 
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240

Query: 302 DKTEDGIFKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            K +    K  ++  P FR+K +    P+ +  A + ++K+LV D  +R+TAA+AL+HP+
Sbjct: 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Query: 358 VREGGDASEIP 368
             E  D  +  
Sbjct: 301 FEEFHDPEDET 311

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 92.2 bits (229), Expect = 9e-21
 Identities = 77/252 (30%), Positives = 129/252 (51%), Gaps = 15/252 (5%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  KA+G   AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL- 220
            + +F+  + +Y  ++   GGEL   +  +++  + E  A     ++   +A  +LH L 
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAEI--ASALGYLHSLN 116

Query: 221 -VHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSG 278
            ++RD+KPEN L  S      +  TDFGL  + I+  K      G+  Y+APEVL+++  
Sbjct: 117 IIYRDLKPENILLDS---QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 279 PES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
             + D W +G + Y +L G  PF+ +    ++  +L NKP  R KP  +IS SA+  ++ 
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL-NKP-LRLKP--NISVSARHLLEG 229

Query: 338 LLVKDPRARLTA 349
           LL KD   RL A
Sbjct: 230 LLQKDRTKRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 91.3 bits (226), Expect = 9e-21
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQ 58

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 59  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 115 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P      +   S  
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKP 228

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 85/310 (27%), Positives = 132/310 (42%), Gaps = 59/310 (19%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +A         A+K + K  ++L   V  VK E  IL A A +E VV+
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL-AEADNEWVVR 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D + +Y  M+   GG+++  ++  +   + E  A   + ++       H  G +
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFPEDLARFYIAELTCAVESVHKMGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL--------------------------------- 248
           HRD+KP+N L      D  +K TDFGL                                 
Sbjct: 124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 249 -----SDFIKP-----GKKFQ-----DIVGSAYYVAPEVLKRKSGPE-SDVWSIGVITYI 292
                 D +KP      ++ Q      +VG+  Y+APEVL R    +  D WS+GVI Y 
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240

Query: 293 LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TA 349
           +L G+ PF  +T      +V+  +      P   +S  A D + K L + P  RL    A
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGA 299

Query: 350 AQALSHPWVR 359
            +  +HP+ +
Sbjct: 300 DEIKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 8/208 (3%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K +G GQF   Y AT   +G  VA+KK++   ++   A  D  +E+ +L+ L  H 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 62

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           NV+K+Y +F +DN + I +EL + G+L  + +   K+     EK       Q+       
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVLK 274
           H   ++HRD+KP N    +      +K  D GL  F          +VG+ YY++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFW 301
                 +SD+WS+G + Y +   + PF+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 93.3 bits (232), Expect = 2e-20
 Identities = 82/290 (28%), Positives = 126/290 (43%), Gaps = 42/290 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I +L+G G  G  Y+A D     RVA+KKI ++    P+  +   RE KI   L  H
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-H 61

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRV--- 211
             +V  Y+   D + VY  M   EG  L  L + + +K+S   E      V   L +   
Sbjct: 62  PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 212 ----AAECHLHGLVHRDMKPENFL----------------FKSAKED--SSLKATDFGL- 248
                   H  G++HRD+KP+N L                FK  +E+    +   +  + 
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 249 -SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTED 306
            S    PGK    IVG+  Y+APE L      ES D++++GVI Y +L    P+  + + 
Sbjct: 182 YSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY--RRKK 235

Query: 307 G---IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           G    +++V+ +  +    P+  I         K L  DP  R ++ Q L
Sbjct: 236 GRKISYRDVILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 90.1 bits (223), Expect = 4e-20
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 11/251 (4%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG   +A  K   +  A+K ++K+ +I    VE    E ++L        + + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           ++ F+  + +Y  ME   GG+L+  I  ++  ++ E  A     ++       H  G+++
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N +  S   +  +K  DFG+  + +  G   +   G+  Y+APE++  +  G  
Sbjct: 125 RDLKLDNVMLDS---EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L+ 
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMT 237

Query: 341 KDPRARLTAAQ 351
           K P  RL    
Sbjct: 238 KHPSKRLGCGP 248

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 78/274 (28%), Positives = 119/274 (43%), Gaps = 43/274 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-----VKREVKILQALAGHEN 158
           +G G  G  Y    +  G   A+K I  N        ED     + RE++IL+    H N
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRD-VNHPN 133

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           VVK ++ F+ +  + + +E  +GG L    +A       E+  A V RQ+L   A  H  
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD------EQFLADVARQILSGIAYLHRR 187

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVLK--- 274
            +VHRD+KP N L  SAK   ++K  DFG+S  + +        VG+  Y++PE +    
Sbjct: 188 HIVHRDIKPSNLLINSAK---NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 275 ---RKSGPESDVWSIGVITYILLCGRRPF-------WDKTEDGIFKEVLRNKPDFRRKPW 324
                 G   D+WS+GV       GR PF       W      I    +   P+      
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMSQPPE----AP 297

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            + S   + F+   L ++P  R +A Q L HP++
Sbjct: 298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 90.1 bits (223), Expect = 4e-20
 Identities = 68/249 (27%), Positives = 125/249 (50%), Gaps = 13/249 (5%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-VV 160
            +LG G FG   +A  K   +  A+K ++K+ +I    VE    E ++L AL+G    + 
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVL-ALSGKPPFLT 64

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + ++ F+  + +Y  ME   GG+L+ +I  ++  R+ E  A     ++       H  G+
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           ++RD+K +N +  S   +  +K  DFG+  + +  G   +   G+  Y+APE++  +  G
Sbjct: 123 IYRDLKLDNVMLDS---EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
              D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGL 235

Query: 339 LVKDPRARL 347
           + K P  RL
Sbjct: 236 MTKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 67/281 (23%), Positives = 135/281 (48%), Gaps = 38/281 (13%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKILQALAGHENVV 160
           +++G G +    +   K   +R+   K+ K +++     ++ V+ E  + +  + H  +V
Sbjct: 1   RVIGRGSYAKVLLVRLKKT-ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59

Query: 161 KFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
             ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +  +       
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL------- 112

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLK 274
           H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+  Y+APE+L+
Sbjct: 113 HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLRNKPDFRRKPW 324
            +  G   D W++GV+ + ++ GR PF            TED +F+ +L  +    R   
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 226

Query: 325 PSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 227 -SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 11/250 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  K +G   AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+    +Y  ++   GGEL   +  +++  + E  A     ++       H   +V
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSINIV 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L  S      +  TDFGL  + I          G+  Y+APEV++++    
Sbjct: 119 YRDLKPENILLDSQ---GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +G + Y +L G  PF+ +    ++  +L      R    P  S +A   +++LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELL 231

Query: 340 VKDPRARLTA 349
            KD + RL A
Sbjct: 232 EKDRQRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 89.8 bits (223), Expect = 7e-20
 Identities = 76/334 (22%), Positives = 137/334 (41%), Gaps = 63/334 (18%)

Query: 93  DFDRRYT-IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK------- 144
               RY   G  LG G +G    A D   G  VA+KK++  ++   +  +          
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 145 ----REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
               RE+KI+  +  HEN++   + + + +++ + M++      L +++ +K  R TE  
Sbjct: 65  FTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRK-IRLTESQ 120

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS----------- 249
              ++ Q+L      H    +HRD+ P N    S       K  DFGL+           
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDT 177

Query: 250 ----DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF--- 300
               + ++  ++    V + +Y APE+L    K     D+WS+G I   LL G+  F   
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237

Query: 301 --------------------W-DKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
                               W    +  ++ E    KP   +  +P+ S+ A D ++ LL
Sbjct: 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297

Query: 340 VKDPRARLTAAQALSHPWVREGG---DASEIPID 370
             +P  R++A +AL H + +      D S++P +
Sbjct: 298 KLNPLERISAKEALKHEYFKSDPLPCDPSQLPFN 331

Length = 335

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 90.7 bits (225), Expect = 1e-19
 Identities = 84/285 (29%), Positives = 134/285 (47%), Gaps = 32/285 (11%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
            K+  ++Y I ++LG G  G    A   ++G+  AVK ++   M         + EV  L
Sbjct: 27  AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCL 85

Query: 151 ------QALAGHENVVKFYNAFEDDNYVYIAMEL--CEGGELLDRI--LAKKDSRYTEKD 200
                   +  HE+  K  +    +N + IA+ L     G+L   I   AK +  + E +
Sbjct: 86  LNCDFFSIVKCHEDFAK-KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP------ 254
           A ++  Q+L      H   ++HRD+K  N L  S   +  +K  DFG S           
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDV 201

Query: 255 GKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEV 312
           G+ F    G+ YYVAPE+ +RK    ++D++S+GV+ Y LL  +RPF     DG   +EV
Sbjct: 202 GRTF---CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DGENMEEV 253

Query: 313 LRNKPDFRRKPWP-SISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +      R  P P SIS   ++ V  LL  DP+ R ++++ L+ P
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 10/261 (3%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL+ +     VV 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + +  GG+L   I    +  + E+ A     ++     +     +V
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ +D GL+  I  G+  +  VG+  Y+APEV+  +    S
Sbjct: 125 YRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W +G + Y ++ G+ PF  + E    +EV R   + + +     S  AK   + LL 
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241

Query: 341 KDPRARL-----TAAQALSHP 356
           K+P+ RL      AA    HP
Sbjct: 242 KNPKERLGCRGNGAAGVKQHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 88/304 (28%), Positives = 136/304 (44%), Gaps = 63/304 (20%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G+G FG  +  TD  +G RVA+KK+      L ++ + V RE+K+L     H+NV+   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL-VSCKRVFRELKMLCFFK-HDNVLSAL 65

Query: 164 NA--------FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           +         FE+   +Y+  EL +    L +I+       +     V + Q+LR     
Sbjct: 66  DILQPPHIDPFEE---IYVVTELMQSD--LHKIIVSP-QPLSSDHVKVFLYQILRGLKYL 119

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---QDIVGSAYYVAPEV 272
           H  G++HRD+KP N L  S   +  LK  DFGL+   +P +     Q++V + YY APE+
Sbjct: 120 HSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEI 175

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPF-----------------------WDKTEDG 307
           L   R      D+WS+G I   LL  R  F                            +G
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235

Query: 308 IFKEVLRNKPDFRRKPWPSIS----------NSAKDFVKKLLVKDPRARLTAAQALSHPW 357
               +LR       KP PS+           + A   + ++LV DP  R++AA AL+HP+
Sbjct: 236 ARAHILRGPH----KP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Query: 358 VREG 361
           + EG
Sbjct: 291 LDEG 294

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 22/272 (8%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQ 58

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++     ++I ME   GG  LD + A     + E   A +++++L+  
Sbjct: 59  -CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 115 DYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI--- 327
           V+++ +   ++D+WS+G+    L  G  P  D     +   + +N P       P++   
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------PTLTGE 224

Query: 328 -SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            S   K+F+   L KDP  R TA + L H ++
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 85/317 (26%), Positives = 132/317 (41%), Gaps = 57/317 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +A         A+K + K  ++    V  VK E  IL A A +E VVK
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNEWVVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D + +Y  M+   GG+++  ++  +   + E  A   + ++       H  G +
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKMGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL--------------------SDFIKPGKKFQDI 261
           HRD+KP+N L      D  +K TDFGL                     D ++P   + D+
Sbjct: 124 HRDIKPDNILIDL---DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 262 ----------------------------VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYI 292
                                       VG+  Y+APEVL RK   +  D WS+GVI + 
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240

Query: 293 LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL--VKDPRARLTAA 350
           +L G+ PF   T      +V+  +      P   +S  A D + KL    ++   R  A 
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300

Query: 351 QALSHPWVREGGDASEI 367
              +HP+  E   +S+I
Sbjct: 301 DIKAHPFFSEVDFSSDI 317

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 80/310 (25%), Positives = 133/310 (42%), Gaps = 59/310 (19%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +   K  G   A+K + K++M     +  VK E  +L A +    VV 
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSPWVVS 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D  Y+Y+ ME   GG+L+  +L K D+ ++E      + + +      H  G +
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMT-MLIKYDT-FSEDVTRFYMAECVLAIEAVHKLGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-------------------------------- 249
           HRD+KP+N L         +K +DFGLS                                
Sbjct: 124 HRDIKPDNILIDR---GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 250 -----------DFIKPGKKFQDI-----VGSAYYVAPEV-LKRKSGPESDVWSIGVITYI 292
                      D I   KK + +     VG+  Y+APE+ L++  G E D WS+G I + 
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 293 LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TA 349
            L G  PF  +     +++++  +          +S  A+D +++L+  +   RL    A
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299

Query: 350 AQALSHPWVR 359
            +  SHP+ R
Sbjct: 300 HEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 87.7 bits (217), Expect = 3e-19
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 11/250 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  K++G   AVK ++K  ++       +  E  +L     H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+    +Y  ++   GGEL   +  +++  + E  A     ++       H   ++
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L  S      +  TDFGL  + ++P +      G+  Y+APEVL+++    
Sbjct: 119 YRDLKPENILLDS---QGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +G + Y +L G  PF+ +    ++  +L              + +A D +  LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLL 231

Query: 340 VKDPRARLTA 349
            KD R RL A
Sbjct: 232 HKDQRRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 87.4 bits (216), Expect = 5e-19
 Identities = 90/319 (28%), Positives = 138/319 (43%), Gaps = 61/319 (19%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVKREVKILQA 152
           +RY   K +G G  G    A D   G  VAVKK+ +   N+       +   RE+ +L+ 
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKC 76

Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 77  V-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELD----HERMSYLLY 130

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRY 187

Query: 267 YVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF--------WDKTEDGI--------- 308
           Y APEV L        D+WS+G I   L+ G   F        W+K  + +         
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247

Query: 309 -FKEVLR----NKPD---------FRRKPWPSIS-------NSAKDFVKKLLVKDPRARL 347
             +  +R    N+P          F    +PS S       + A+D + K+LV DP  R+
Sbjct: 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307

Query: 348 TAAQALSHPWVREGGDASE 366
           +  +AL HP++    D +E
Sbjct: 308 SVDEALRHPYITVWYDPAE 326

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 86.7 bits (214), Expect = 9e-19
 Identities = 87/324 (26%), Positives = 136/324 (41%), Gaps = 69/324 (21%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 71

Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 72  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMELD----HERMSYLLY 126

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 183

Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 239

Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299

Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++  +AL HP++    D +E+
Sbjct: 300 AKRISVDEALQHPYINVWYDPAEV 323

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 10/264 (3%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL+ +     VV 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 64

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + L  GG+L   I    +  + E+ A     ++     + H   +V
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPE 280
           +RD+KPEN L     +   ++ +D GL+  I  G+  +  VG+  Y+APEV+K  +    
Sbjct: 125 YRDLKPENILLD---DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W +G + Y ++ G+ PF  + E    +EV R   + + +     S +A+   ++LL 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241

Query: 341 KDPRARL-----TAAQALSHPWVR 359
           KDP  RL      A +  +HP+ R
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 86.3 bits (213), Expect = 1e-18
 Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 46/308 (14%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            RY     +G G +G    A D     +VAVKK+ +    L I      RE+++L+ +  
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMK- 72

Query: 156 HENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           HENV+   + F      E+ N VY+   L   G  L+ I+  K  + +++    ++ Q+L
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV--KCQKLSDEHVQFLIYQLL 128

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           R     H  G++HRD+KP N    +  ED  L+  DFGL+   +   +    V + +Y A
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILDFGLAR--QADDEMTGYVATRWYRA 183

Query: 270 PEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----NKPDFRRK- 322
           PE++          D+WS+G I   LL G+  F         K ++       P+  +K 
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243

Query: 323 -------------PWPSISNS---------AKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                          P              A D ++K+LV D   R++A++AL+HP+  +
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303

Query: 361 GGDASEIP 368
             D  + P
Sbjct: 304 YHDPEDEP 311

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 46/295 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQA 152
           ++ +  ++G G +G       K   + VA+KK + ++       E+VK    RE+K+L+ 
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE-----ENEEVKETTLRELKMLRT 56

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L   EN+V+   AF     +Y+  E  E   L   +L +  +    +     + Q+++  
Sbjct: 57  LK-QENIVELKEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPEKVRSYIYQLIKAI 113

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSAYYVAP 270
             CH + +VHRD+KPEN L      +  LK  DFG +  +  G    + + V + +Y +P
Sbjct: 114 HWCHKNDIVHRDIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 271 E-VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK-------------EVLRN 315
           E +L    G   D+WS+G I   L  G+  F  ++E D +F              ++  +
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230

Query: 316 KPDFRRKPWPSISNSAK--------------DFVKKLLVKDPRARLTAAQALSHP 356
            P F    +P++++                 D +K LL  +P  R    Q L+HP
Sbjct: 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 88/302 (29%), Positives = 130/302 (43%), Gaps = 65/302 (21%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE----NV 159
           LG G  G       + +G  +A K I     I P     + RE+K+L     HE     +
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVL-----HECNSPYI 61

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-- 217
           V FY AF  D  + I ME  +GG  LD++L KK  R  E     +   +LR     +L  
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPENILGKISIAVLR--GLTYLRE 117

Query: 218 -HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEV 272
            H ++HRD+KP N L  S  E   +K  DFG+S     G+    +    VG+  Y++PE 
Sbjct: 118 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 169

Query: 273 LK-RKSGPESDVWSIGVITYILLCGRRP------------FWDKTEDGIFKEVLR----N 315
           L+      +SD+WS+G+    +  GR P            F     +G  KE  R    +
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229

Query: 316 KPDFRR-------------KPWPSI-----SNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            PD  R             +P P +     S+  +DFV K L K+P+ R    +   HP+
Sbjct: 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289

Query: 358 VR 359
           ++
Sbjct: 290 IK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 72/255 (28%), Positives = 110/255 (43%), Gaps = 54/255 (21%)

Query: 145 REVKILQALAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           RE++I+     HE     +V FY AF ++N + + ME  + G L DRI          K 
Sbjct: 52  RELQIM-----HECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIY---------KK 96

Query: 201 AAVVVRQMLRVAAECHLHGL---------VHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
              +  ++L   A   + GL         +HRD+KP N L  S  +   +K  DFG+S  
Sbjct: 97  GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVS-- 151

Query: 252 IKPGKKFQDI----VGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTED 306
              G+    I    VG++ Y++PE ++  K   +SDVWS+G+    L  G+ PF     D
Sbjct: 152 ---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208

Query: 307 --------GIFKEVLR--NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
                   GI   + +   +P   R P        +DFV   L+KDP  R T  Q  + P
Sbjct: 209 DDGQDDPMGILDLLQQIVQEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267

Query: 357 WVREGGDASEIPIDI 371
              +        +D+
Sbjct: 268 PFIQA--LRASNVDL 280

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 85/319 (26%), Positives = 135/319 (42%), Gaps = 61/319 (19%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78

Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELD----HERMSYLLY 133

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190

Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGI--------- 308
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K  + +         
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250

Query: 309 -----FKEVLRNKPDFR----RKPWPSI------------SNSAKDFVKKLLVKDPRARL 347
                 +  + N+P +      K +P +            ++ A+D + K+LV D   R+
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310

Query: 348 TAAQALSHPWVREGGDASE 366
           +  +AL HP++    D SE
Sbjct: 311 SVDEALQHPYINVWYDPSE 329

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 63/261 (24%), Positives = 125/261 (47%), Gaps = 30/261 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +++G G +    +   K N    A+K ++K  +     ++ V+ E  + +  + +  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            ++ F+  + +++ +E   GG+L+      R L ++ +R+   +  + +  +       H
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL-------H 113

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLK- 274
             G+++RD+K +N L      D  +K TD+G+  + + PG       G+  Y+APE+L+ 
Sbjct: 114 ERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWD--------KTEDGIFKEVLRNKPDFRRKPWPS 326
            + G   D W++GV+ + ++ GR PF D         TED +F+ +L       R     
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPF-DIITDNPDMNTEDYLFQVILEKPIRIPR----F 225

Query: 327 ISNSAKDFVKKLLVKDPRARL 347
           +S  A   +K  L KDP+ RL
Sbjct: 226 LSVKASHVLKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 81/291 (27%), Positives = 128/291 (43%), Gaps = 46/291 (15%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK--REVKILQALAGHE 157
           +GK+ G G F     A  +  G   A+K ++K+      ++E V   RE++ L+ L+ H 
Sbjct: 4   LGKI-GEGTFSEVLKAQSRKTGKYYAIKCMKKHFK----SLEQVNNLREIQALRRLSPHP 58

Query: 158 NVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAA 213
           N+++      D     + +  EL +   L + I   K  +    EK     + Q+L+   
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELMDM-NLYELI---KGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H +G+ HRD+KPEN L K    D  LK  DFG    I     + + + + +Y APE L
Sbjct: 115 HMHRNGIFHRDIKPENILIK----DDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170

Query: 274 KRKS--GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK--EVL---RNKPDFRRKPW- 324
                 GP+ D+W++G + + +L     F    E D I K  +VL     +   + +   
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230

Query: 325 ------------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                             P+ S    D +KKLL  DP  R+TA QAL HP+
Sbjct: 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.4 bits (206), Expect = 5e-18
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 13/266 (4%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG       +A G   A KK+ K ++      E    E +IL A      +V   
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRIL-AKVHSRFIVSLA 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            AF+    + + M +  GG+L   I  + +++  + E  A     Q++      H   ++
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L      D +++ +D GL+  +K G+ K +   G+  ++APE+L+ +    
Sbjct: 120 YRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           S D +++GV  Y ++  R PF  + E    KE+ +   +         S ++K F + LL
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236

Query: 340 VKDPRARL-----TAAQALSHPWVRE 360
            KDP  RL           +HP  R+
Sbjct: 237 AKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)

Query: 126 VKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL 185
           V+KI K K    I       E  + Q +  + N +K Y +        + M+  + G+L 
Sbjct: 45  VQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97

Query: 186 DRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
           D  L KK+ + +E +   ++RQ++    + H H ++H D+K EN L+  AK+   +   D
Sbjct: 98  D--LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD--RIYLCD 153

Query: 246 FGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDK 303
           +GL   I  P     D  G+  Y +PE +K  +   S D W++GV+TY LL G+ PF + 
Sbjct: 154 YGLCKIIGTPSC--YD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209

Query: 304 TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT 348
            ++ +  E L  +   +     ++S +A DFV+ +L  +   RLT
Sbjct: 210 EDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT 254

Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 74/267 (27%), Positives = 131/267 (49%), Gaps = 21/267 (7%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + +G G +G  Y A +   G+  AVK I   K+        +++E+ +++    H 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECK-HC 66

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V ++ ++     ++I ME C GG L D  +       +E   A V R+ L+  A  H 
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAYYVAPEV--LK 274
            G +HRD+K  N L     ++  +K  DFG++  I     K +  +G+ Y++APEV  ++
Sbjct: 125 KGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 275 RKSGPES--DVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF---RRKPWPSIS 328
           +  G     D+W++G+    L   + P +D      +F   L +K +F   + K     S
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQPPKLKDKTKWS 238

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSH 355
           ++  +FVK  L K+P+ R TA + L+H
Sbjct: 239 STFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 26/265 (9%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG       K  G   A KK++K ++      +    E +IL+ +     +V   
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-----HLH 218
            AFE   ++ + M L  GG+L   I       Y   +  + + +++  +A+      HLH
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHI-------YNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 219 --GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              +V+RDMKPEN L     +  + + +D GL+  +K GK      G+  Y+APE+LK +
Sbjct: 113 SMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169

Query: 277 SGPES-DVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKPWPSISNSA 331
                 D +++G   Y ++ GR PF D  E    + + +  L ++  F  +   + +  +
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEES 226

Query: 332 KDFVKKLLVKDPRARLTAAQALSHP 356
           KD  +  L K P  RL + +    P
Sbjct: 227 KDICRLFLAKKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 23/263 (8%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG       +      A+K I K  ++    V     E  +L A      +V   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVL-AQVNCPFIVPLK 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVH 222
            +F+    +Y+ +    GGEL   +  +++ R+    A     ++L  A E  H   +++
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELL-CALENLHKFNVIY 116

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDF-IKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           RD+KPEN L         +   DFGL    +K   K     G+  Y+APE+L      ++
Sbjct: 117 RDLKPENILLDYQ---GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKDFVKK 337
            D W++GV+ Y +L G  PF+D+  + +++++L+     PD            AKD +  
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD-------GFDRDAKDLLIG 226

Query: 338 LLVKDPRARL---TAAQALSHPW 357
           LL +DP  RL    A +  +HP+
Sbjct: 227 LLSRDPTRRLGYNGAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 46/290 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALAG--HENV 159
           +G G +G  Y A D  +G  VA+K  +++ N+  LP++     REV +L+ L    H N+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST---VREVALLKRLEAFDHPNI 64

Query: 160 VKFYNA-----FEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           V+  +       + +  V +  E  +      LD++        T KD   ++RQ LR  
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD---LMRQFLRGL 121

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
              H + +VHRD+KPEN L  S      +K  DFGL+           +V + +Y APEV
Sbjct: 122 DFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFW------DK-----------TEDGIFKEVLR 314
           L + +     D+WS+G I +  +  R+P +      D+            ED   ++V  
Sbjct: 179 LLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237

Query: 315 NKPDFR-RKPW------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            +  F  R P       P I  S    + ++L  +P  R++A +AL HP+
Sbjct: 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 9e-17
 Identities = 87/326 (26%), Positives = 127/326 (38%), Gaps = 76/326 (23%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKAN--GDRVAVKKIEKNKM----ILPIAVEDVKREVKIL 150
           +Y I   +G G +G  Y A  K    G   A+KK + +K     I   A     RE+ +L
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALL 56

Query: 151 QALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           + L  HENVV     F +     VY+  +  E  +L   I   K  R  +     +   M
Sbjct: 57  RELK-HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII---KFHR--QAKRVSIPPSM 109

Query: 209 LRVAAECHLHGL--------VHRDMKPENFLFKS-AKEDSSLKATDFGLSD-FIKPGKKF 258
           ++      L+G+        +HRD+KP N L      E   +K  D GL+  F  P K  
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 259 QD---IVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED------- 306
            D   +V + +Y APE+L   R      D+W+IG I   LL     F  +          
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229

Query: 307 ------GIFK-----------------EVLRNKPDFRRKPWPS----------ISNSAK- 332
                  IF+                 E      DF+ K +PS              ++ 
Sbjct: 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289

Query: 333 -DFVKKLLVKDPRARLTAAQALSHPW 357
            D ++KLL  DP  R+TA +AL HP+
Sbjct: 290 FDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 82.1 bits (202), Expect = 1e-16
 Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 45/299 (15%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKILQ 151
           Y + K +G+G+FG  ++   K   +    K I      E+ K  L I V +V RE+K   
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEV-NVMRELK--- 70

Query: 152 ALAGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQ 207
               H+N+V++ + F  + +  +YI ME C+ G+L   I    K   +  E     + RQ
Sbjct: 71  ----HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126

Query: 208 MLRVAAECHL-------HGLVHRDMKPENFLF--------KSAKEDSSL------KATDF 246
           +L   A CH          ++HRD+KP+N           K   + ++L      K  DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186

Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGP---ESDVWSIGVITYILLCGRRPFWDK 303
           GLS  I         VG+ YY +PE+L  ++     +SD+W++G I Y L  G+ PF   
Sbjct: 187 GLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246

Query: 304 TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG 362
                    L+  PD    P    S      +K LL    + R +A Q L +  ++  G
Sbjct: 247 NNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302

Length = 1021

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 67/275 (24%), Positives = 130/275 (47%), Gaps = 26/275 (9%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +++G G +    +   K      A+K I+K  +     ++ V+ E  + +  + H  +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++ F+ ++ ++  +E   GG+L+  +  ++  +  E+ A     ++       H  G++
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K +N L  +   +  +K TD+G+  + I+PG       G+  Y+APE+L+ +  G 
Sbjct: 119 YRDLKLDNVLLDA---EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 280 ESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
             D W++GV+ + ++ GR PF            TED +F+ +L  +    R    S+S  
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231

Query: 331 AKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
           A   +K  L KDP+ RL            SHP+ R
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 71/286 (24%), Positives = 120/286 (41%), Gaps = 43/286 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   +    K   + VA+K+I  E  +     A+    REV +L+ L  H N+V 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVSLLKNLK-HANIVT 67

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++    +  + +  E  +    L + L    +  +  +  + + Q+LR  + CH   ++
Sbjct: 68  LHDIIHTERCLTLVFEYLDSD--LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVL---KRKS 277
           HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P+VL      S
Sbjct: 126 HRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------------------N 315
            P  D+W +G I Y +  GR  F   T       + R                       
Sbjct: 183 TP-IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241

Query: 316 KPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            P +R +P     P +     D +  LL+ + ++R++A  AL H +
Sbjct: 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 78/301 (25%), Positives = 119/301 (39%), Gaps = 70/301 (23%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHENV 159
           LG G +   Y    K  G  VA+K+I           E       RE  +L+ L  H N+
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLE------HEEGAPFTAIREASLLKDLK-HANI 65

Query: 160 VKFYNAFEDD---NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV----VR----QM 208
           V  ++          V+         E LD  L     +Y +     +    VR    Q+
Sbjct: 66  VTLHDIIHTKKTLTLVF---------EYLDTDL----KQYMDDCGGGLSMHNVRLFLFQL 112

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYY 267
           LR  A CH   ++HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKTYSNEVVTLWY 169

Query: 268 VAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-----DGIFK---------- 310
             P+VL    +     D+W +G I Y +  GR  F   T+       IF+          
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229

Query: 311 -EVLRNK-------PDFRRKP----WPSIS--NSAKDFVKKLLVKDPRARLTAAQALSHP 356
             V  N        P +  +P     P +      ++   K L  +P+ R++AA+A+ HP
Sbjct: 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289

Query: 357 W 357
           +
Sbjct: 290 Y 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 41/291 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   Y    K   + VA+K+I  E  +     A+    REV +L+ L  H N+V 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK-HANIVT 68

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++    +  + +  E  +  + L + L    +     +  + + Q+LR    CH   ++
Sbjct: 69  LHDIIHTEKSLTLVFEYLD--KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVL--KRKSG 278
           HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P++L       
Sbjct: 127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------------------NK 316
            + D+W +G I Y +  GR  F   T +     + R                      N 
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243

Query: 317 PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD 363
           P +R        P + +   + + KLL  + R R++A +A+ HP+    G+
Sbjct: 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 30/228 (13%)

Query: 99  TIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           T  K LG GQFG   V   K  G   VA+K I +  M    + +D   E K++  L+ H 
Sbjct: 7   TFLKELGSGQFGV--VHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HP 59

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK--DAAVVVRQMLRVAAEC 215
           N+V+ Y        ++I  E    G LL+ +  +K    TE   D    V + +      
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES- 118

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYV 268
             +G +HRD+   N L     ED+ +K +DFGL+ ++         G KF        + 
Sbjct: 119 --NGFIHRDLAARNCL---VGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-----PVKWA 168

Query: 269 APEVLKR-KSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
            PEV    +   +SDVWS GV+ + +   G+ P+   +   + + V  
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 62/270 (22%), Positives = 122/270 (45%), Gaps = 23/270 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQAL 153
           Y   +++G G +G   +   + +G +  +KK+      L  A    ++    E ++L  L
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN-----LRNASRRERKAAEQEAQLLSQL 56

Query: 154 AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             H N+V +  ++E +D  +YI M  CEGG+L  ++  +K     E        Q+    
Sbjct: 57  K-HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 213 AECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-IVGSAYYVAP 270
              H   ++HRD+K +N FL ++    + +K  D G++  ++        ++G+ YY++P
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRT----NIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171

Query: 271 EVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK-PDFRRKPWPSIS 328
           E+   K    +SDVW++G   Y +   +  F  K  + +   ++  K P   +   P + 
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
               + +  +L K P  R +    L  P++
Sbjct: 232 ----ELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 64/231 (27%), Positives = 95/231 (41%), Gaps = 46/231 (19%)

Query: 95  DRRYTIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
            R     K LG G FG      Y       G++VAVK +  N         D +RE++IL
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEIL 60

Query: 151 QALAGHENVVKFYNAFEDD--NYVYIAMELCEGGELLD-------RILAKKDSRYTEKDA 201
           + L  HEN+VK+    E      + + ME    G L D       +I  K+   ++ +  
Sbjct: 61  RTLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ-- 117

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
             + + M  + ++      +HRD+   N L +S   +  +K +DFGL+  +   K +   
Sbjct: 118 --ICKGMDYLGSQ----RYIHRDLAARNILVES---EDLVKISDFGLAKVLPEDKDY--- 165

Query: 262 VGSAYYV-----------APEVLK-RKSGPESDVWSIGVITYILLCGRRPF 300
               YYV           APE L+  K    SDVWS GV  Y L     P 
Sbjct: 166 ----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 78/278 (28%), Positives = 116/278 (41%), Gaps = 41/278 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR---EVKILQALAGHENVV 160
           LG G +G          G  +AVK+I        +  ++ KR   ++ I          V
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRAT-----VNSQEQKRLLMDLDISMRSVDCPYTV 63

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDA----AVVVRQMLRVAAE 214
            FY A   +  V+I ME+ +    LD+   K         +D     AV + + L     
Sbjct: 64  TFYGALFREGDVWICMEVMDTS--LDKFYKKVYDKGLTIPEDILGKIAVSIVKALE---- 117

Query: 215 CHLH---GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAP 270
            +LH    ++HRD+KP N L      +  +K  DFG+S   +    K  D  G   Y+AP
Sbjct: 118 -YLHSKLSVIHRDVKPSNVL---INRNGQVKLCDFGISGYLVDSVAKTIDA-GCKPYMAP 172

Query: 271 EVLKRKSGPE-----SDVWSIGVITYI-LLCGRRPF--WDKTEDGIFKEVLRNKPDFRRK 322
           E +  +   +     SDVWS+G IT I L  GR P+  W KT     K+V+       + 
Sbjct: 173 ERINPELNQKGYDVKSDVWSLG-ITMIELATGRFPYDSW-KTPFQQLKQVVEEPSP--QL 228

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           P    S   +DFV K L K+ + R    + L HP+   
Sbjct: 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 47/291 (16%)

Query: 104 LGHGQFGYTYVATDKANGDR-VAVKKI--EKNKMILPIAVEDVKREVKILQALAG--HEN 158
           +G G +G  + A D  NG R VA+K++  +  +  +P++     REV +L+ L    H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLRHLETFEHPN 65

Query: 159 VVKFYNA-----FEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           VV+ ++       + +  + +  E  +      LD++        T KD   ++ Q+LR 
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD---MMFQLLRG 122

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V + +Y APE
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPE 179

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED-----GIF------------KEVL 313
           VL + S     D+WS+G I +  +  R+P +  + D      I             ++V 
Sbjct: 180 VLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 314 RNKPDFRRKPW-------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
             +  F  K           I    KD + K L  +P  R++A  ALSHP+
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 77/280 (27%), Positives = 115/280 (41%), Gaps = 43/280 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---DVKREVKILQALAGHENVV 160
           LGHG  G  Y A        +AVK I      L I VE    +  E++IL        ++
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP-----LDITVELQKQIMSELEILYKCDS-PYII 62

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
            FY AF  +N + I  E  +GG L   +  K       + A  VV+ +       +L  L
Sbjct: 63  GFYGAFFVENRISICTEFMDGGSL--DVYRKIPEHVLGRIAVAVVKGL------TYLWSL 114

Query: 221 --VHRDMKPENFLFKSAKEDSSLKATDFGLSDFI--KPGKKFQDIVGSAYYVAPE-VLKR 275
             +HRD+KP N L  +  +   +K  DFG+S  +     K +   VG+  Y+APE +   
Sbjct: 115 KILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGE 168

Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP----------DFRRKPWP 325
           + G  SDVWS+G+    L  GR P+       I K      P          D    P  
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQ-----IQKNQGSLMPLQLLQCIVDEDPPVLPVG 223

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
             S     F+ + + K P+ R      + HP++ +  D +
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN 263

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 73/304 (24%), Positives = 129/304 (42%), Gaps = 42/304 (13%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   +    K   + VA+K+I  E  +     A+    REV +L+ L  H N+V 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVSLLKDLK-HANIVT 68

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++    D  + +  E  +    L + +    +  +  +  + + Q+LR  A CH   ++
Sbjct: 69  LHDIVHTDKSLTLVFEYLDKD--LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKS--G 278
           HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P+VL   S   
Sbjct: 127 HRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------------------NK 316
            + D+W +G I + +  GR  F   T +     + R                      N 
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243

Query: 317 PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE-GGDASEIPIDI 371
           P ++ +P     P +     + + K L  + + R++A +A+ H + R  G     +P  I
Sbjct: 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPESI 303

Query: 372 SVLN 375
           S+ +
Sbjct: 304 SIFS 307

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 74.1 bits (182), Expect = 6e-15
 Identities = 69/230 (30%), Positives = 95/230 (41%), Gaps = 47/230 (20%)

Query: 102 KLLGHGQFGYTYVAT------DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
             LG G FG  Y  T        +   RVAVK + K       A +  K+E      L  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG------ATDQEKKEFLKEAHLMS 54

Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQM-LR 210
              H N+VK       +   YI MEL EGG+LL  +  A+ +           +  + L 
Sbjct: 55  NFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114

Query: 211 VAAECH----LHGLVHRDMKPENFLFKSAKEDSS--LKATDFGLSDFIKPGKKFQDIVGS 264
           VA  C     +H  +HRD+   N L      D+   +K  DFGL+         +DI  S
Sbjct: 115 VAKGCVYLEQMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKS 164

Query: 265 AYY------------VAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
            YY            +APE L   K   +SDVWS GV+ + IL  G++P+
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 87/323 (26%), Positives = 135/323 (41%), Gaps = 62/323 (19%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 4   DDDFEKISE----LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL 57

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK---DAAVVVRQ 207
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E+     ++ V +
Sbjct: 58  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 114

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
            L    E   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  Y
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSY 168

Query: 268 VAPEVLK-RKSGPESDVWSIGVITYILLCGRRPF--WDKTE-DGIFKEVLRNKP---DFR 320
           ++PE L+      +SD+WS+G+    +  GR P    D  E + +F   +   P   +  
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228

Query: 321 RKP----------------------------------WPSISNSA--KDFVKKLLVKDPR 344
            +P                                   PS    A  +DFV K L+K+P 
Sbjct: 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPA 288

Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   +A E+
Sbjct: 289 ERADLKQLMVHAFIKR-SEAEEV 310

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 6/152 (3%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K +  G FG  Y+   K N    AVK ++K  MI    V  V+ E   L AL+   
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALSKSP 64

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  Y + +  N VY+ ME   GG++  + L      + E+ A   + ++       H 
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDV--KSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
           HG++HRD+KP+N L  +   +  +K TDFGLS
Sbjct: 123 HGIIHRDLKPDNMLISN---EGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 69/241 (28%), Positives = 103/241 (42%), Gaps = 41/241 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           + LG GQFG  +      N   VAVK ++   M      +D   E +I++ L  H  +++
Sbjct: 12  RKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQ 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC------ 215
            Y     +  +YI  EL + G LL+  L     R      A+ + Q++ +AA+       
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLE-YLQGGAGR------ALKLPQLIDMAAQVASGMAY 118

Query: 216 -HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-------PGKKFQDIVGSAYY 267
                 +HRD+   N L     E++  K  DFGL+  IK        G KF        +
Sbjct: 119 LEAQNYIHRDLAARNVL---VGENNICKVADFGLARVIKEDIYEAREGAKF-----PIKW 170

Query: 268 VAPE-VLKRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
            APE  L  +   +SDVWS G+ +T I+  GR P+   T      EVL+      R P P
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQQVDQGYRMPCP 226

Query: 326 S 326
            
Sbjct: 227 P 227

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++        +VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 12  IGSGQFGLVWLGY-WLEKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLY 65

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               + + + +  E  E G L D + A++     E    +   V   M  + +      +
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN----V 121

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---APEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ + V   +PEV    K
Sbjct: 122 IHRDLAARNCL---VGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSK 177

Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + + +
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 69/211 (32%), Positives = 99/211 (46%), Gaps = 15/211 (7%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF+R       LG G  G       K +G  +A K I     I P     + RE+++L
Sbjct: 4   DDDFERISE----LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL 57

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                   +V FY AF  D  + I ME  +GG  LD++L K+  R  E+    V   +LR
Sbjct: 58  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KEAKRIPEEILGKVSIAVLR 114

Query: 211 -VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
            +A     H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  Y++
Sbjct: 115 GLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMS 170

Query: 270 PEVLK-RKSGPESDVWSIGVITYILLCGRRP 299
           PE L+      +SD+WS+G+    L  GR P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 33/231 (14%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           TI K++G G+FG       K  G +   VA+K +     +K ++       D   E  I+
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-------DFLTEASIM 59

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D+ L + D ++T       +  MLR
Sbjct: 60  GQFD-HPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFT----VGQLVGMLR 113

Query: 211 -VAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--- 263
            +A+          VHRD+   N L  S   +   K +DFGLS  ++  +      G   
Sbjct: 114 GIASGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKI 170

Query: 264 SAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
              + APE +  RK    SDVWS G++ + ++  G RP+WD +   + K V
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 33/219 (15%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F +RY    ++LG G FG    Y Y   +   G+ VAVK +++            K+E+ 
Sbjct: 1   FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEIN 58

Query: 149 ILQALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL+ L  HEN+VK+     +     + + ME    G L D         Y  K    + +
Sbjct: 59  ILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD---------YLPKHKLNLAQ 108

Query: 207 QMLRVAAEC----HLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-- 258
            +L     C    +LH    +HRD+   N L  +   D  +K  DFGL+  +  G ++  
Sbjct: 109 LLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYR 165

Query: 259 --QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILL 294
             +D     ++ A E LK  K    SDVWS GV  Y LL
Sbjct: 166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 66/312 (21%), Positives = 113/312 (36%), Gaps = 72/312 (23%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA----- 152
             IGK        +  +A  K     VAVKKI  +           K ++K+LQ      
Sbjct: 4   TLIGKCFEDLMIVH--LAKHKPTNTLVAVKKINLDSC--------SKEDLKLLQQEIITS 53

Query: 153 -LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR- 210
               H N++ +  +F  D+ +Y+   L   G   D +     + + E    + +  +L+ 
Sbjct: 54  RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKD 109

Query: 211 -VAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGS 264
            + A  ++H  G +HR +K  + L          K    GL      IK GK+ + +   
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164

Query: 265 A-------YYVAPEVLK---RKSGPESDVWSIGVITYILLCGRRPFWDK------TED-- 306
                    +++PEVL+   +    +SD++S+G+    L  G  PF D        E   
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR 224

Query: 307 ---------GIFKEVLRNKPDFRRK---PWPSISNSAK----------DFVKKLLVKDPR 344
                      +     +    R     P    S               FV+  L +DP 
Sbjct: 225 GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284

Query: 345 ARLTAAQALSHP 356
           +R +A+Q L+H 
Sbjct: 285 SRPSASQLLNHS 296

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 48/221 (21%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG--- 155
            +G  +G G+FG   +   +  G +VAVK +              K +    QA      
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKCL--------------KDDSTAAQAFLAEAS 52

Query: 156 ------HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
                 H N+V+        N +YI  E    G L+D +        +   A + + Q L
Sbjct: 53  VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-------RSRGRAVITLAQQL 105

Query: 210 RVA-----AECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
             A        +L     VHRD+   N L     ED   K +DFGL+   K   + QD  
Sbjct: 106 GFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLA---KEASQGQDSG 159

Query: 263 G-SAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
                + APE L+ +K   +SDVWS G++ + I   GR P+
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 73/278 (26%), Positives = 117/278 (42%), Gaps = 38/278 (13%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQALAGHE 157
            +G G FG       K +G  +AVK+I     EK +  L + ++ V R            
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC-------P 63

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTE----KDAAVVVRQMLRV 211
            +VKFY A   +   +I MEL +    +    +     S   E    K A   V+     
Sbjct: 64  YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK----- 118

Query: 212 AAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYY 267
            A  +L     ++HRD+KP N L      + ++K  DFG+S   +    K +D  G   Y
Sbjct: 119 -ALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRD-AGCRPY 173

Query: 268 VAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRR 321
           +APE +   +       SDVWS+G+  Y +  G+ P+  W+   D + + V  + P    
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
                 S S  +F+   L+KD   R    + L HP+++
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 54/233 (23%)

Query: 104 LGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++        + + + VAVK +++       A +D +RE ++L     HEN
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKE--TASNDARKDFEREAELLTNF-QHEN 69

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLD---------RILAKKDSRYTEKDAAVVVRQML 209
           +VKFY    + +   +  E  E G+L             L   DS   E    + + Q+L
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE----LTLSQLL 125

Query: 210 RVAAEC-----HLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
           ++A +      +L     VHRD+   N L      D  +K  DFG+S         +D+ 
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCL---VGYDLVVKIGDFGMS---------RDVY 173

Query: 263 GSAYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
            + YY            + PE ++ RK   ESDVWS GV+ + I   G++P++
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 20/222 (9%)

Query: 99  TIGKLLGHGQFGYTYVAT-DKANGDRVAVK-KIEKNKMILPIAVEDVKREVKILQALAGH 156
           T+G+ +G GQFG  Y         +++AV  K  KN     +  E   +E  I++    H
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-EKFLQEAYIMRQF-DH 66

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AEC 215
            ++VK      ++  V+I MEL   GEL   +   K S     D A ++    +++ A  
Sbjct: 67  PHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSL----DLASLILYSYQLSTALA 121

Query: 216 HLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS--AYYVAPE 271
           +L     VHRD+   N L  S      +K  DFGLS +++    ++   G     ++APE
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 272 VLK-RKSGPESDVWSIGVITY-ILLCGRRPF-WDKTEDGIFK 310
            +  R+    SDVW  GV  + IL+ G +PF   K  D I +
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 54/293 (18%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   Y    K NG  VA+K  ++++ +     A+    RE  +L+ L  H N+V 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLK-HANIVL 67

Query: 162 FYNAFEDDN-----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            ++           + Y+  +LC+        + K       ++  + + Q+LR  +  H
Sbjct: 68  LHDIIHTKETLTLVFEYVHTDLCQ-------YMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKR 275
              ++HRD+KP+N L     E   LK  DFGL+     P   + + V + +Y  P+VL  
Sbjct: 121 QRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 276 KSGPES--DVWSIGVITYILLCGRRPF--WDKTEDGIFKEVL-------------RNKPD 318
            +   +  D+W +G I   ++ G   F      +D + +  L              + P 
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237

Query: 319 FR------------RKPWPSIS--NSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           F+            R+ W  +S  N A+D   KLL   P+ RL+A  ALSH +
Sbjct: 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 79/285 (27%), Positives = 118/285 (41%), Gaps = 32/285 (11%)

Query: 86  TDFGYDK--DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED 142
           T   YD   +F R   + GK LG G FG    AT        AV K+   KM+ P A   
Sbjct: 22  TQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAV-KMLKPTAHSS 80

Query: 143 VKR----EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
            +     E+KI+  L  HEN+V    A      + +  E C  G+LL+ +  K++S  T 
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           +D      Q+ +  A       +HRD+   N L    K    +K  DFGL+  I     +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSNY 197

Query: 259 QDIV-GSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKE 311
             +V G+A     ++APE +       ESDVWS G++ + I   G  P+     D  F +
Sbjct: 198 --VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255

Query: 312 VLRN-----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
           +++      +P+        I  +  D        DP  R T  Q
Sbjct: 256 LIKEGYRMAQPEHAPAEIYDIMKTCWDA-------DPLKRPTFKQ 293

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 68/272 (25%), Positives = 112/272 (41%), Gaps = 33/272 (12%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I +++G G+FG       K  G R   VA+K ++          E  +R+     ++ G 
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG------YTEKQRRDFLSEASIMGQ 61

Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM---LR 210
             H N++           V I  E  E G L D  L + D ++T      ++R +   ++
Sbjct: 62  FDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS------ 264
             +E +    VHRD+   N L  S   +   K +DFGLS F++          S      
Sbjct: 121 YLSEMNY---VHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174

Query: 265 AYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
             + APE +  RK    SDVWS G++ + ++  G RP+WD +   +   +   + D+R  
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI---EQDYRLP 231

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           P      +    +     KD  AR    Q +S
Sbjct: 232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 27/219 (12%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKR 145
           ++K F +R    + LG G FG   +      GD     VAVK ++       IA  D+K+
Sbjct: 1   FEKRFLKRI---RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKK 55

Query: 146 EVKILQALAGHENVVKFYNAFEDD--NYVYIAMELCEGG---ELLDRILAKKDSRYTEKD 200
           E++IL+ L  HEN+VK+     +D  N + + ME    G   E L R   K + +   K 
Sbjct: 56  EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-- 258
           A  + + M  + +  +    VHRD+   N L +S   +  +K  DFGL+  I+  K++  
Sbjct: 115 AVQICKGMDYLGSRQY----VHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEYYT 167

Query: 259 --QDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITYILL 294
              D+    ++ APE L + K    SDVWS GV  Y LL
Sbjct: 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.0 bits (166), Expect = 6e-13
 Identities = 67/240 (27%), Positives = 99/240 (41%), Gaps = 46/240 (19%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVK 148
              I K++G G+FG       K  G R   VA+K +     EK +        D   E  
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-------RDFLSEAS 57

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           I+     H N++           V I  E  E G L D  L K D ++T     + +  M
Sbjct: 58  IMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFT----VIQLVGM 111

Query: 209 LRVAAECHLH----GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           LR  A    +    G VHRD+   N L  S   +   K +DFGLS      +  +D   +
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNS---NLVCKVSDFGLS------RVLEDDPEA 162

Query: 265 AY----------YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           AY          + APE +  RK    SDVWS G++ + ++  G RP+W+ +   + K +
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 16/210 (7%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +  T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMKLS- 57

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           HE +V+ Y        +YI  E    G LL+  L +   R+       + + +    A  
Sbjct: 58  HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN-YLREHGKRFQPSQLLEMCKDVCEGMAYL 116

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---APEV 272
                +HRD+   N L         +K +DFGLS ++    ++   VGS + V    PEV
Sbjct: 117 ESKQFIHRDLAARNCLVDD---QGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEV 172

Query: 273 LKR-KSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + +   G+ P+
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 17/221 (7%)

Query: 144 KREVKILQALAGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +RE  +   L  H N+V   ++ E     ++   E   G  L + + A  D      +  
Sbjct: 26  RRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAA--DGALPAGETG 82

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-- 260
            ++ Q+L   A  H  G+VHRD+KP+N +          K  DFG+   + PG +  D  
Sbjct: 83  RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVA 141

Query: 261 -------IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
                  ++G+  Y APE L+ +   P SD+++ G+I    L G+R     +   I  + 
Sbjct: 142 TLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQ 201

Query: 313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           L +  D    PW +  +     ++K L KDPR R  +A AL
Sbjct: 202 L-SPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPAL 240

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 32/212 (15%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+G+++G G+FG   V   +  G +VAVK I+ +     +  +    E  ++  L  H+N
Sbjct: 9   TLGEIIGEGEFGA--VLQGEYTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKN 60

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           +V+        N +YI MEL   G L++ +        T   A V V Q+L+ + +    
Sbjct: 61  LVRLLGVILH-NGLYIVMELMSKGNLVNFL-------RTRGRALVSVIQLLQFSLDVAEG 112

Query: 216 --HLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAP 270
             +L    LVHRD+   N L     ED   K +DFGL+   + G    D       + AP
Sbjct: 113 MEYLESKKLVHRDLAARNIL---VSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAP 166

Query: 271 EVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           E LK +K   +SDVWS GV+ + +   GR P+
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 66/208 (31%), Positives = 92/208 (44%), Gaps = 40/208 (19%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGHE 157
           + +G G FG  Y    K N + VAVK     +  LP    D+KR    E +IL+    H 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTE-VAVKTC---RSTLP---PDLKRKFLQEAEILKQYD-HP 52

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK-------DAAVVVRQMLR 210
           N+VK          +YI MEL  GG LL   L KK +R T K       DAA     M  
Sbjct: 53  NIVKLIGVCVQKQPIYIVMELVPGGSLLT-FLRKKKNRLTVKKLLQMSLDAAA---GMEY 108

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD------FIKPGKKFQDIVGS 264
           + ++      +HRD+   N L     E++ LK +DFG+S       +       Q  +  
Sbjct: 109 LESKN----CIHRDLAARNCL---VGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK- 160

Query: 265 AYYVAPEVLKR-KSGPESDVWSIGVITY 291
             + APE L   +   ESDVWS G++ +
Sbjct: 161 --WTAPEALNYGRYTSESDVWSYGILLW 186

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 50/231 (21%)

Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK +   K     A +D +RE ++L  L  H++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQ-HQH 68

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--DSRYTE--KDAA---VVVRQMLRV 211
           +V+FY    +   + +  E    G+L +R L     D++     +D A   + + QML +
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 212 AAE-----CHLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           A++      +L  L  VHRD+   N L     +   +K  DFG+S         +DI  +
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCL---VGQGLVVKIGDFGMS---------RDIYST 175

Query: 265 AYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
            YY            + PE +L RK   ESD+WS GV+ + I   G++P++
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 70/248 (28%), Positives = 107/248 (43%), Gaps = 38/248 (15%)

Query: 102 KLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKILQAL 153
           K++G G+FG  +    K  G +   VA+K +     EK +       +D   E  I+   
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-------QDFLSEASIMGQF 63

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR--V 211
           + H N+++            I  E  E G L D+ L   D  ++    +  +  MLR   
Sbjct: 64  S-HHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFS----SYQLVGMLRGIA 117

Query: 212 AAECHLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVGSA-- 265
           A   +L  +  VHRD+   N L  S  E    K +DFGLS  ++  P   +    G    
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLE---CKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 266 YYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            + APE +  RK    SDVWS G++ + ++  G RP+WD +      EV++   D  R P
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAINDGFRLP 230

Query: 324 WPSISNSA 331
            P    SA
Sbjct: 231 APMDCPSA 238

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 68

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLH--GL 220
                +   YI  E    G LLD +   ++    E +A V++    +++ A  +L     
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 126 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 29/202 (14%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHE 157
           +LLG G FG  +  T K +   VAVK  +++   LP   +++K     E +IL+    H 
Sbjct: 1   ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED---LP---QELKIKFLSEARILKQY-DHP 52

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA---AE 214
           N+VK          +YI MEL  GG+ L  +  KKD   T++    +V+  L  A   A 
Sbjct: 53  NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQ----LVKFALDAAAGMAY 108

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS----DFIKPGKKFQDIVGSAYYVAP 270
                 +HRD+   N L     E++ LK +DFG+S    D I      + I     + AP
Sbjct: 109 LESKNCIHRDLAARNCL---VGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAP 163

Query: 271 EVLKR-KSGPESDVWSIGVITY 291
           E L   +   ESDVWS G++ +
Sbjct: 164 EALNYGRYSSESDVWSYGILLW 185

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 37/206 (17%)

Query: 102 KLLGHGQFGYTYVAT-DKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           K LG G FG         + G    VAVK ++ +K  L   ++D  +E  I+ +L  HEN
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK--LSDIMDDFLKEAAIMHSLD-HEN 57

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA---AEC 215
           +++ Y        + +  EL   G LLDR+   +         + +    +++A      
Sbjct: 58  LIRLYGVVLTHPLMMVT-ELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------- 268
                +HRD+   N L  S  +   +K  DFGL   +   +         +YV       
Sbjct: 114 ESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNED--------HYVMEEHLKV 162

Query: 269 -----APEVLK-RKSGPESDVWSIGV 288
                APE L+ R     SDVW  GV
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGV 188

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 30/217 (13%)

Query: 94  FDRRYTIG-KLLGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F+ R+    + LG G FG      Y       G+ VAVKK++ +       + D +RE++
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIE 57

Query: 149 ILQALAGHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRILAKK---DSRYTEKDA 201
           IL++L  H+N+VK+    Y+A      + + ME    G L D +   +   D R     A
Sbjct: 58  ILKSLQ-HDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           + + + M  + ++ +    VHRD+   N L +S   ++ +K  DFGL+  +   K++  +
Sbjct: 115 SQICKGMEYLGSKRY----VHRDLATRNILVES---ENRVKIGDFGLTKVLPQDKEYYKV 167

Query: 262 V----GSAYYVAPEVL-KRKSGPESDVWSIGVITYIL 293
                   ++ APE L + K    SDVWS GV+ Y L
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 39/244 (15%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +T+ + LG G FG  +    K N  RVA+K ++ + ++     +D ++EV+ L+ L  H+
Sbjct: 8   FTLERKLGSGYFGEVWEGLWK-NRVRVAIKILKSDDLL---KQQDFQKEVQALKRLR-HK 62

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE--- 214
           +++  +        VYI  EL E G LL   L   + +       + V  ++ +A +   
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLA-FLRSPEGQ------VLPVASLIDMACQVAE 115

Query: 215 --CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----- 265
              +L     +HRD+   N L     ED   K  DFGL+  IK     +D+  S+     
Sbjct: 116 GMAYLEEQNSIHRDLAARNIL---VGEDLVCKVADFGLARLIK-----EDVYLSSDKKIP 167

Query: 266 -YYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
             + APE         +SDVWS G++ Y +   G+ P+       ++ ++        R 
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG----YRM 223

Query: 323 PWPS 326
           P P+
Sbjct: 224 PCPA 227

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 50/293 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHE 157
           + LG G +   Y    + NG  VA+K I           E V     RE  +L+ L  H 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMK------TEEGVPFTAIREASLLKGLK-HA 63

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V  ++       +    E       L + + +        +  + + Q+LR  A  H 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHTD--LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRK 276
             ++HRD+KP+N L     E   LK  DFGL+     P + +   V + +Y  P+VL   
Sbjct: 122 QHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 277 S--GPESDVWSIGVITYILLCGRRPF-------------WD----KTED---GIFKEVLR 314
           +      D+W  G I   +L G+  F             W      TED   G+ K +  
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK-LPN 237

Query: 315 NKPDFRRKP--------WPSISN--SAKDFVKKLLVKDPRARLTAAQALSHPW 357
            KP++            W  +S    A+D   ++L+  P+ R++A  AL HP+
Sbjct: 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 42/211 (19%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           YT+ K L  G  G  +VAT     D V +K  +K   ++         E  +LQ +  H 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLI---------EAMLLQNV-NHP 117

Query: 158 NVVK-----FYNA--------FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           +V++        A        +  D Y Y               L K+        A ++
Sbjct: 118 SVIRMKDTLVSGAITCMVLPHYSSDLYTY---------------LTKRSRPLPIDQALII 162

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
            +Q+L      H   ++HRD+K EN           +   D G + F      F  + G+
Sbjct: 163 EKQILEGLRYLHAQRIIHRDVKTENIFINDV---DQVCIGDLGAAQFPVVAPAFLGLAGT 219

Query: 265 AYYVAPEVLKR-KSGPESDVWSIGVITYILL 294
               APEVL R K   ++D+WS G++ + +L
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 35/216 (16%)

Query: 100 IGKLLGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           + + LG GQFG  ++ T   NG  +VAVK ++   M    + E   +E +I++ L  H+ 
Sbjct: 10  LERKLGAGQFGEVWMGT--WNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDK 62

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD-----AAVVVRQMLRVAA 213
           +V+ Y    ++  +YI  E    G LLD  L   + +          AA +   M  + +
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLD-FLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-------GKKFQDIVGSAY 266
                  +HRD+   N L     E+   K  DFGL+  I+        G KF        
Sbjct: 122 R----NYIHRDLAARNIL---VGENLVCKIADFGLARLIEDDEYTAREGAKF-----PIK 169

Query: 267 YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           + APE     +   +SDVWS G++   I+  GR P+
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 24/208 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++AT   +  +VAVK ++   M    +VE    E  +++ L  H+ +VK
Sbjct: 12  KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
             +A      +YI  E    G LLD + + + S+           Q+    A       +
Sbjct: 66  L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L  ++      K  DFGL+  I       + G KF        + APE + 
Sbjct: 125 HRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 176

Query: 275 RKSGP-ESDVWSIGV-ITYILLCGRRPF 300
             S   +SDVWS G+ +  I+  GR P+
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 17/210 (8%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
             K+LG G FG  Y       G++    VA+K + +     P A +++  E  ++ A   
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVM-ASVD 67

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H +VV+            I  +L   G LLD +   KD     +       Q+ +  +  
Sbjct: 68  HPHVVRLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYL 125

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPE- 271
               LVHRD+   N L K+      +K TDFGL+  +   +K     G      ++A E 
Sbjct: 126 EEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 272 VLKRKSGPESDVWSIGVITYILLC-GRRPF 300
           +L R    +SDVWS GV  + L+  G +P+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 61/238 (25%), Positives = 90/238 (37%), Gaps = 52/238 (21%)

Query: 99  TIGKLLGHGQFGYTYVATDKA-NGDRV--AVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           T+ + LGHG FG  Y    +  +GD V   V      +        D   E  I+     
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN- 67

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLR 210
           H+N+V+      +    +I +EL  GG+L      +R   ++ S  T KD     R    
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD--- 124

Query: 211 VAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           VA  C     +  +HRD+   N L          K  DFG++         +DI  ++YY
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYY 175

Query: 268 VAPEVLKRKSG----------PE----------SDVWSIGVITY-ILLCGRRPFWDKT 304
                  RK G          PE          +DVWS GV+ + I   G  P+  +T
Sbjct: 176 -------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 80/363 (22%), Positives = 157/363 (43%), Gaps = 61/363 (16%)

Query: 64  KTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR 123
           K  + +++++          K  D   ++  ++ Y +G ++G+G FG  Y A      ++
Sbjct: 34  KLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEK 93

Query: 124 VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF--------EDDNYVYIA 175
           VA+KK+ ++        +   RE+ I++ L  H N++   + +        E + ++ + 
Sbjct: 94  VAIKKVLQDP-------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVV 145

Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAV---VVR----QMLRVAAECHLHGLVHRDMKPE 228
           M      E + + + K    Y   + A+   +V+    Q+ R  A  H   + HRD+KP+
Sbjct: 146 M------EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQ 199

Query: 229 NFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES--DVWSI 286
           N L        +LK  DFG +  +  G++    + S +Y APE++   +   +  D+WS+
Sbjct: 200 NLLIDP--NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSL 257

Query: 287 GVITYILLCGRRPFWDK----------------TEDGIFKEVLRNKPDFR---------R 321
           G I   ++ G   F  +                TED + KE+  N  D +         +
Sbjct: 258 GCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL-KEMNPNYADIKFPDVKPKDLK 316

Query: 322 KPWPS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS-EIPIDISVLNNMRQ 379
           K +P    + A +F+ + L  +P  RL   +AL+ P+  +  D   ++P  I  L ++  
Sbjct: 317 KVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFN 376

Query: 380 FVK 382
           F  
Sbjct: 377 FCD 379

Length = 440

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 26/234 (11%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG  ++   +A   +VA+K I +  M    + ED   E K++  L+ H  
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPK 60

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE-CHL 217
           +V+ Y        +YI  E  E G LL+  L ++  + + KD  + + Q +    E    
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLN-YLRQRQGKLS-KDMLLSMCQDVCEGMEYLER 118

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAP 270
           +  +HRD+   N L  S      +K +DFG++ ++         G KF        +  P
Sbjct: 119 NSFIHRDLAARNCLVSST---GVVKVSDFGMTRYVLDDEYTSSSGAKF-----PVKWSPP 170

Query: 271 EVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
           EV    K   +SDVWS GV+ + +   G+ PF  K+   + + + R    +R K
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++     N  +VAVK ++   M    +V+    E  +++ L  H+ +V+
Sbjct: 12  KKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVR 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y     +  +YI  E    G LLD + + +  +           Q+    A       +
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L     E    K  DFGL+  I       + G KF        + APE + 
Sbjct: 126 HRDLRAANVL---VSESLMCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 177

Query: 275 RKSGP-ESDVWSIGVITY-ILLCGRRPF 300
             S   +SDVWS G++ Y I+  G+ P+
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 28/233 (12%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++        +VA+K +++  M    + E    E  +++ L  H  +V+
Sbjct: 12  KKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVR 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y A      +YI  E  E G L+D +   +  + T      +  Q+    A       +
Sbjct: 66  LY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-------GKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L     E    K  DFGL+  I+        G KF        + APE + 
Sbjct: 125 HRDLRAANIL---VSETLCCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAIN 176

Query: 275 RKS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             +   +SDVWS G+ +T I+  GR P+   T      EV++N     R P P
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNLERGYRMPRP 225

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 68/257 (26%), Positives = 112/257 (43%), Gaps = 36/257 (14%)

Query: 80  IPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVA----TDKANGDR---VAVKKIEKN 132
           +P   R +F  DK      T+GK LG G FG   +A     DK        VAVK ++ +
Sbjct: 4   LPEDPRWEFSRDK-----LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD 58

Query: 133 KMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK 192
                ++  D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++
Sbjct: 59  ATEKDLS--DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 116

Query: 193 --------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
                         D + T KD      Q+ R          +HRD+   N L     E+
Sbjct: 117 PPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL---VTEN 173

Query: 239 SSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-IL 293
           + +K  DFGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I 
Sbjct: 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233

Query: 294 LCGRRPFWDKTEDGIFK 310
             G  P+     + +FK
Sbjct: 234 TLGGSPYPGIPVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 68/252 (26%), Positives = 118/252 (46%), Gaps = 17/252 (6%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN---V 159
           ++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    +   +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFI 59

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V    AF   + +   ++L  GG+L   +   +   ++EK+      +++      H   
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKSG 278
           +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL++ + 
Sbjct: 118 VVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTA 172

Query: 279 PES--DVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
            +S  D +S+G + + LL G  PF   KT+D    E+ R       +   S S   K  +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTVNVELPDSFSPELKSLL 230

Query: 336 KKLLVKDPRARL 347
           + LL +D   RL
Sbjct: 231 EGLLQRDVSKRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 33/241 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVE----DVKREVK 148
           R  +GK LG G FG   +A     DK   +RV    +   KM+   A E    D+  E++
Sbjct: 19  RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV---KMLKSDATEKDLSDLISEME 75

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DS 194
           +++ +  H+N++    A   D  +Y+ +E    G L + + A++              + 
Sbjct: 76  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135

Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DF 251
           + + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHH 192

Query: 252 IKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIF 309
           I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +F
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252

Query: 310 K 310
           K
Sbjct: 253 K 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 56/254 (22%), Positives = 103/254 (40%), Gaps = 60/254 (23%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV-------KR-----E 146
           T+ + LG G FG  Y             K + K +    +A++ V       +R     E
Sbjct: 9   TLIRELGQGSFGMVYEGL---------AKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59

Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVV 205
             +++    H +VV+            + MEL   G+L   + +++ ++          +
Sbjct: 60  ASVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 206 RQMLRVAAE-----CHLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           ++ +++AAE      +L     VHRD+   N +     ED ++K  DFG++         
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCM---VAEDLTVKIGDFGMT--------- 166

Query: 259 QDIVGSAYY------------VAPEVLKRKSG---PESDVWSIGVITY-ILLCGRRPFWD 302
           +DI  + YY            +APE LK   G    +SDVWS GV+ + +     +P+  
Sbjct: 167 RDIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224

Query: 303 KTEDGIFKEVLRNK 316
            + + + K V+   
Sbjct: 225 LSNEEVLKFVIDGG 238

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 82/318 (25%), Positives = 127/318 (39%), Gaps = 68/318 (21%)

Query: 101 GKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           G  +G G +G+ Y A  K   D    A+K+IE   + +        RE+ +L+ L  H N
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC-----REIALLRELK-HPN 59

Query: 159 VVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------VVRQML 209
           V+     F    D  V++  +  E  +L   I   + S+  +K   +       ++ Q+L
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118

Query: 210 RVAAECHLHGLVHRDMKPENFL-FKSAKEDSSLKATDFGLSDF----IKPGKKFQDIVGS 264
                 H + ++HRD+KP N L      E   +K  D G +      +KP      +V +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGR-------------RPFWDKTEDGIF 309
            +Y APE+L   R      D+W+IG I   LL                 PF     D IF
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238

Query: 310 K----------EVLRNKP-------DFRRKPWPS-----------ISNSAKDFV--KKLL 339
                      E +R  P       DFRR  + +           +   +K F+  +KLL
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298

Query: 340 VKDPRARLTAAQALSHPW 357
             DP  R+T+ QAL  P+
Sbjct: 299 TMDPTKRITSEQALQDPY 316

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 73/258 (28%), Positives = 112/258 (43%), Gaps = 31/258 (12%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG+GQFG  ++ T   N  +VAVK ++   M    + E    E +I++ L  H+ +V+
Sbjct: 12  KKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQ 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGL 220
            Y A   +  +YI  E    G LLD  L   + R  +    V +  Q+    A       
Sbjct: 66  LY-AVVSEEPIYIVTEYMSKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV- 272
           +HRD++  N L     +    K  DFGL+  I       + G KF        + APE  
Sbjct: 124 IHRDLRSANIL---VGDGLVCKIADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAA 175

Query: 273 LKRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN-S 330
           L  +   +SDVWS G+ +T ++  GR P+       + ++V R      R P P     S
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCPQDCPIS 231

Query: 331 AKDFVKKLLVKDPRARLT 348
             + + +   KDP  R T
Sbjct: 232 LHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 39/206 (18%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVKILQALAGHENVVKF 162
           +G G FG  +    +A+   VAVK   +    LP  ++    +E +IL+  + H N+V+ 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYS-HPNIVRL 58

Query: 163 YNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
                    +YI MEL +GG+ L        R+  K+  +  E  AA     M  + ++ 
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAA----GMEYLESKH 114

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY--------- 266
                +HRD+   N L     E + LK +DFG+S      ++ +D V ++          
Sbjct: 115 ----CIHRDLAARNCL---VTEKNVLKISDFGMS------REEEDGVYASTGGMKQIPVK 161

Query: 267 YVAPEVLKR-KSGPESDVWSIGVITY 291
           + APE L   +   ESDVWS G++ +
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLW 187

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 67/255 (26%), Positives = 117/255 (45%), Gaps = 23/255 (9%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN---V 159
           ++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    +   +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFI 59

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V    AF   + +   ++L  GG+L   +   +   ++E +      +++      H   
Sbjct: 60  VCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRF 117

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKSG 278
           +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL++   
Sbjct: 118 VVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVA 172

Query: 279 PES--DVWSIGVITYILLCGRRPFWD-KTEDG--IFKEVLRNKPDFRRKPWP-SISNSAK 332
            +S  D +S+G + + LL G  PF   KT+D   I +  L    +      P S S   +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-----LPDSFSPELR 227

Query: 333 DFVKKLLVKDPRARL 347
             ++ LL +D   RL
Sbjct: 228 SLLEGLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 67/250 (26%), Positives = 102/250 (40%), Gaps = 47/250 (18%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGHEN 158
           ++G G FG    A  K +G    ++     K +   A +D  R    E+++L  L  H N
Sbjct: 2   VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA----------VVVRQM 208
           ++    A E   Y+Y+A+E    G LLD +   + SR  E D A          +  +Q+
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 209 LRVAAECHLHGL--------VHRDMKPENFLFKSAKEDSSLKATDFGLS--DFIKPGKKF 258
           L  AA+    G+        +HRD+   N L     E+   K  DFGLS    +   K  
Sbjct: 115 LHFAADV-ARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKKTM 170

Query: 259 QDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPF--------WDKTEDGI 308
             +     ++A E L        SDVWS GV+ + I+  G  P+        ++K   G 
Sbjct: 171 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 228

Query: 309 FKEVLRNKPD 318
             E   N  D
Sbjct: 229 RLEKPLNCDD 238

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 31/240 (12%)

Query: 97  RYTIGKLLGHGQFGYTYVA------TDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKI 149
           R T+GK LG G FG   +A       DK N    VAVK ++ +     ++  D+  E+++
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS--DLVSEMEM 70

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG 255
            T KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+  +   
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL---VTEDNVMKIADFGLARDVHNI 187

Query: 256 KKFQDIVGS---AYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
             ++          ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 32/235 (13%)

Query: 93  DFDR-RYTIGKLLGHGQFGYTYVA----TDKANGDR---VAVKKIEKNKMILPIAVEDVK 144
           +F R R  +GK LG G FG    A     DK+  D+   VAVK ++ N     +A  D+ 
Sbjct: 8   EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA--DLI 65

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------------ 192
            E+++++ +  H+N++        +  +Y+ +E    G L + + A++            
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 193 --DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS- 249
             + + + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+ 
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL---VTEDNVMKIADFGLAR 182

Query: 250 --DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
               I   KK  +      ++APE L  R    +SDVWS G++ + I   G  P+
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 61/274 (22%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGHEN 158
           ++G G FG    A  K +G ++        KM+   A E+  R    E+++L  L  H N
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA----------VVVRQM 208
           ++    A E+  Y+YIA+E    G LLD +   + SR  E D A          +  +Q+
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 209 LRVAAECH--LHGL-----VHRDMKPENFLFKSAKEDSSLKATDFGLS--DFIKPGKKFQ 259
           L+ A++    +  L     +HRD+   N L     E+ + K  DFGLS  + +   K   
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVL---VGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 260 DIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPF--------WDKTEDG-- 307
            +     ++A E L       +SDVWS GV+ + I+  G  P+        ++K   G  
Sbjct: 179 RL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236

Query: 308 -------------IFKEVLRNKPDFRRKPWPSIS 328
                        + ++  R++P + R P+  IS
Sbjct: 237 MEKPRNCDDEVYELMRQCWRDRP-YERPPFAQIS 269

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 60.5 bits (146), Expect = 2e-10
 Identities = 73/257 (28%), Positives = 112/257 (43%), Gaps = 33/257 (12%)

Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  +VA+K ++   M      E   +E +I++ L  H+ +V  
Sbjct: 14  LGQGCFGEVWMGT--WNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPL 66

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y A   +  +YI  E    G LLD  L + D +Y +    V +  Q+    A       +
Sbjct: 67  Y-AVVSEEPIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     ++   K  DFGL+  I       + G KF        + APE  L
Sbjct: 125 HRDLRAANIL---VGDNLVCKIADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 176

Query: 274 KRKSGPESDVWSIGVI-TYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSA 331
             +   +SDVWS G++ T ++  GR P+       + ++V R      R P P     S 
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----YRMPCPQGCPESL 232

Query: 332 KDFVKKLLVKDPRARLT 348
            + +K    KDP  R T
Sbjct: 233 HELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 49/239 (20%)

Query: 96  RRYTIGKLLGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           R   + + LG G FG  ++A     +   +   VAVK ++   +    A +D +RE ++L
Sbjct: 5   RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELL 61

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-------DSRYTEKDAAV 203
             L  HE++VKFY    D + + +  E  + G+L   + A         D +  +    +
Sbjct: 62  TNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120

Query: 204 VVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
            + QML +A++      +L     VHRD+   N L  +   +  +K  DFG+S       
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS------- 170

Query: 257 KFQDIVGSAYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
             +D+  + YY            + PE ++ RK   ESDVWS GVI + I   G++P++
Sbjct: 171 --RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 79/318 (24%), Positives = 126/318 (39%), Gaps = 68/318 (21%)

Query: 101 GKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           G  +G G +G+ Y A  K   D    A+K+IE   + +        RE+ +L+ L  H N
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC-----REIALLRELK-HPN 59

Query: 159 VVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------VVRQML 209
           V+     F    D  V++  +  E  +L   I   + S+  +K   +       ++ Q+L
Sbjct: 60  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118

Query: 210 RVAAECHLHGLVHRDMKPENFL-FKSAKEDSSLKATDFGLSDF----IKPGKKFQDIVGS 264
                 H + ++HRD+KP N L      E   +K  D G +      +KP      +V +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGR-------------RPFWDKTEDGIF 309
            +Y APE+L   R      D+W+IG I   LL                 P+     D IF
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238

Query: 310 K----------EVLRNKP-------DFRRKPWPSIS-------------NSAKDFVKKLL 339
                      E ++  P       DFRR  + + S             + A   ++KLL
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298

Query: 340 VKDPRARLTAAQALSHPW 357
             DP  R+T+ QA+  P+
Sbjct: 299 TMDPIKRITSEQAMQDPY 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 74/257 (28%), Positives = 110/257 (42%), Gaps = 33/257 (12%)

Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 14  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 66

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y A   +  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 67  Y-AVVSEEPIYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 125 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 176

Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSA 331
             +   +SDVWS G+ +T +   GR P+       +  +V R      R P P     S 
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----YRMPCPPECPESL 232

Query: 332 KDFVKKLLVKDPRARLT 348
            D + +   K+P  R T
Sbjct: 233 HDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 58/247 (23%)

Query: 93  DFDR-RYTIGKLLGHGQFGY----TYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKRE 146
           +  R R T+GK LG G FG       V  D  N    VAVK ++ +     ++  D+  E
Sbjct: 8   ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS--DLVSE 65

Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-------------- 192
           +++++ +  H+N++        +  +Y+ +E    G L D + A++              
Sbjct: 66  MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125

Query: 193 DSRYTEKD----AAVVVRQMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG 247
           +   T+KD    A  V R M  +A++ C     +HRD+   N L     ED  +K  DFG
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKC-----IHRDLAARNVL---VTEDHVMKIADFG 177

Query: 248 LSDFIKPGKKFQDIVGSAYY------------VAPEVL-KRKSGPESDVWSIGVITY-IL 293
           L+         +DI    YY            +APE L  R    +SDVWS GV+ + I 
Sbjct: 178 LA---------RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Query: 294 LCGRRPF 300
             G  P+
Sbjct: 229 TLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 59/246 (23%), Positives = 107/246 (43%), Gaps = 46/246 (18%)

Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVK--REVKI 149
           + T+ + LG G FG  Y   A D   G+   RVAVK + ++  +     E ++   E  +
Sbjct: 7   KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEASV 62

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQM 208
           ++    H +VV+            + MEL   G+L   + + + ++          +++M
Sbjct: 63  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 209 LRVAAE-----CHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           +++AAE      +L+    VHRD+   N +      D ++K  DFG++         +DI
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCM---VAHDFTVKIGDFGMT---------RDI 169

Query: 262 VGSAYY------------VAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDG 307
             + YY            +APE LK       SD+WS GV+ + I     +P+   + + 
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229

Query: 308 IFKEVL 313
           + K V+
Sbjct: 230 VLKFVM 235

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 52/201 (25%), Positives = 76/201 (37%), Gaps = 33/201 (16%)

Query: 104 LGHGQFGYT---YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LGHG FG                VAVK +++  +      ++  RE  ++  L  H  +V
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQL-DHPCIV 59

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           +     + +  + + MEL   G LL  +  KK       D   +  Q+    A       
Sbjct: 60  RLIGVCKGEPLMLV-MELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESKHF 116

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY------------V 268
           VHRD+   N L  +       K +DFG+S  +  G        S YY             
Sbjct: 117 VHRDLAARNVLLVN---RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPLKWY 165

Query: 269 APEVLK-RKSGPESDVWSIGV 288
           APE +   K   +SDVWS GV
Sbjct: 166 APECINYGKFSSKSDVWSYGV 186

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 54/256 (21%)

Query: 104 LGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK ++        A +D  RE ++L  L  HE+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEH 68

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGEL--------LDRILAKKDSRYTEKDAAVVVRQMLR 210
           +VKFY    + + + +  E  + G+L         D +L  + +R  E    +   QML 
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE----LTQSQMLH 124

Query: 211 VAAECHL-------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           +A +             VHRD+   N L     E+  +K  DFG+S         +D+  
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCL---VGENLLVKIGDFGMS---------RDVYS 172

Query: 264 SAYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIF 309
           + YY            + PE ++ RK   ESDVWS+GV+ + I   G++P++  + + + 
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232

Query: 310 KEVLRNKPDFRRKPWP 325
           + + + +   R +  P
Sbjct: 233 ECITQGRVLQRPRTCP 248

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 57.2 bits (138), Expect = 9e-09
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 10/101 (9%)

Query: 261 IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
           I+G+  Y+APE+L  K  GP  D W++GV  +  L G  PF D+T   +F+ +L      
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN----- 594

Query: 320 RRKPWP----SISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           R  PWP     +S +A++ ++ LL  DP  R    +   HP
Sbjct: 595 RDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 40/230 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDR-----VAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
             LG G+FG  ++A  K   +      V VK ++K K        + +RE+ + + L+ H
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLS-H 67

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC- 215
           +NVV+      +    Y+ +E  + G+L   + A K      K   +  +Q + +  +  
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 216 ----HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY-- 267
               HL     VHRD+   N L  S      +K +   LS         +D+  S YY  
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSS---QREVKVSLLSLS---------KDVYNSEYYKL 175

Query: 268 ---------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTED 306
                    +APE V +     +SDVWS GV+ + +   G  PF+  +++
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE 225

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 48/280 (17%)

Query: 103 LLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           ++G G FG    A  K +G R+  A+K++++       A +D  R    E+++L  L  H
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE------YASKDDHRDFAGELEVLCKLGHH 67

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----------R 206
            N++    A E   Y+Y+A+E    G LLD +   + SR  E D A  +          +
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQ 124

Query: 207 QMLRVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-- 257
           Q+L  AA+             +HRD+   N L     E+   K  DFGLS     G++  
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLSR----GQEVY 177

Query: 258 FQDIVGS--AYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVL 313
            +  +G     ++A E L        SDVWS GV+ + I+  G  P+   T   +++++ 
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237

Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           +    +R +   +  +   D +++   + P  R + AQ L
Sbjct: 238 QG---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 27/232 (11%)

Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPI 138
           PC   +          +Y I   L  G  G  +V T   +  R  V VK +   K     
Sbjct: 77  PCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----- 131

Query: 139 AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL--CEGGELLDRILAKKDSRY 196
                 RE+ IL+ ++ H  ++   +A+   + V + M    C+    +DR         
Sbjct: 132 ---TPGREIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS-----GPL 182

Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG----LSDFI 252
             + A  + R++L   A  H  G++HRD+K EN +F    E++ L   DFG    L    
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAACKLDAHP 239

Query: 253 KPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDK 303
              + +    G+    +PE+L       ++D+WS G++ + +       + K
Sbjct: 240 DTPQCY-GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290

Length = 392

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 28/216 (12%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           K+     TIGK    G+FG   +   +  G++VAVK I+ +        +    E  ++ 
Sbjct: 6   KELKLLQTIGK----GEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMT 54

Query: 152 ALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            L  H N+V+      E+   +YI  E    G L+D + ++  S         +++  L 
Sbjct: 55  QLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLD 110

Query: 211 VA-AECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAY 266
           V  A  +L     VHRD+   N L     ED+  K +DFGL+   K     QD       
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVK 164

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPF 300
           + APE L+ K    +SDVWS G++ + I   GR P+
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 68/298 (22%)

Query: 100 IGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           +GK LG G+FG    AT      +A    VAVK +++N       + D+  E  +L+ + 
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVN 61

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI----------LAKKDSRYTEKDAAVV 204
            H +V+K Y A   D  + + +E  + G L   +          L    +R +       
Sbjct: 62  -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 205 VR------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI 252
            R            Q+ R         LVHRD+   N L    ++   +K +DFGLS  +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLSRDV 177

Query: 253 KPG----KKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF------ 300
                  K+ +  +    ++A E L       +SDVWS GV+ + I+  G  P+      
Sbjct: 178 YEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236

Query: 301 --WDKTEDG---------------IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
             ++  + G               +     + +PD R    P+ ++ +K+  +K++VK
Sbjct: 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR----PTFADISKEL-EKMMVK 289

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 43/222 (19%)

Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV--KILQALAGHEN 158
            KLLG G FG  +       GD + +          P+A++ ++     +  Q +  H  
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKI----------PVAIKTIQDRSGRQTFQEITDHML 61

Query: 159 VVKFYNAFEDDNYVYIAMELCEG------------GELLDRILAKKDSRYTEKDAAVVVR 206
            +       D  Y+   + +C G            G LLD +   +DS     D   ++ 
Sbjct: 62  AMGSL----DHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSL----DPQRLLN 113

Query: 207 QMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQD 260
             +++A   +    H +VHR++   N L KS   DS ++  DFG++D + P  K   + +
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSE 170

Query: 261 IVGSAYYVAPE-VLKRKSGPESDVWSIGVITYILLC-GRRPF 300
                 ++A E +L  +   +SDVWS GV  + ++  G  P+
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 17/196 (8%)

Query: 104 LGHGQFGYT---YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG          K   ++    KI KN    P   +++ RE  ++Q L  +  +V
Sbjct: 3   LGSGNFGTVKKGMYKMKK--SEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIV 59

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           +     E ++++ + MEL E G L ++ L K +   TEK+   +V Q+            
Sbjct: 60  RMIGICEAESWMLV-MELAELGPL-NKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNF 116

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY----VAPEVLK-R 275
           VHRD+   N L  +       K +DFGLS  +   + +        +     APE +   
Sbjct: 117 VHRDLAARNVLLVT---QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 276 KSGPESDVWSIGVITY 291
           K   +SDVWS GV+ +
Sbjct: 174 KFSSKSDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 62/249 (24%), Positives = 97/249 (38%), Gaps = 56/249 (22%)

Query: 93  DFDR-RYTIGKLLGHGQFGYTYVAT---------------DKANGDR-VAVKKIEKNKMI 135
           +F R      + LG GQFG  ++                 D A+    VAVK +  +   
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE----LLDRILAK 191
              A ED  +EVKIL  L+   N+ +       D  + + ME  E G+    L   +   
Sbjct: 61  --NAREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117

Query: 192 KDSRYTEK--DAAVVVRQMLRVAAEC-HL--HGLVHRDMKPENFLFKSAKEDSSLKATDF 246
                  K    + ++    ++A+   +L     VHRD+   N L      + ++K  DF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADF 174

Query: 247 GLSDFIKPGKKFQDIVGSAYY------VAP-------EVLKRKSGPESDVWSIGVITY-I 292
           G+S         +++  S YY        P        VL  K   +SDVW+ GV  + I
Sbjct: 175 GMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 293 L-LCGRRPF 300
           L LC  +P+
Sbjct: 226 LTLCREQPY 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 59/250 (23%), Positives = 109/250 (43%), Gaps = 40/250 (16%)

Query: 97  RYTIGKLLGHGQFGYTY------VATDKANGDRVAVKKIEKNKMILPIAVEDVK--REVK 148
           + T+ + LG G FG  Y      V  D+    RVA+K + +   +     E ++   E  
Sbjct: 7   KITMSRELGQGSFGMVYEGIAKGVVKDEPE-TRVAIKTVNEAASMR----ERIEFLNEAS 61

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQ 207
           +++    H +VV+            + MEL   G+L   + + + +       A   +++
Sbjct: 62  VMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 208 MLRVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKP 254
           M+++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + 
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRK 177

Query: 255 GKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           G K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V
Sbjct: 178 GGKG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234

Query: 313 ----LRNKPD 318
               L +KPD
Sbjct: 235 MEGGLLDKPD 244

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 21/206 (10%)

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V  +     ++ V++ ++  EGG+L   I   K     E+       +M+      H 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS--KFLNIPEECVKRWAAEMVVALDALHR 103

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+V RD+ P N L         ++ T F     ++     + +     Y APEV     
Sbjct: 104 EGIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGISE 158

Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             E+ D WS+G I + LL G +   +    GI      N P++       +S  A+  ++
Sbjct: 159 ETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEW-------VSEEARSLLQ 210

Query: 337 KLLVKDPRARLTAAQA-----LSHPW 357
           +LL  +P  RL A  A      SHP+
Sbjct: 211 QLLQFNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.4 bits (113), Expect = 1e-06
 Identities = 38/143 (26%), Positives = 52/143 (36%), Gaps = 24/143 (16%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
             KLL  G     Y+       +   +K              D +REV ILQ LA     
Sbjct: 2   SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSR-----EKGADREREVAILQLLARKGLP 54

Query: 160 V-KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           V K   + E D + Y+ ME  EG  L       + S   ++D A  + ++L       LH
Sbjct: 55  VPKVLASGESDGWSYLLMEWIEGETL------DEVSEEEKEDIAEQLAELLA-----KLH 103

Query: 219 -----GLVHRDMKPENFLFKSAK 236
                 L H D+ P N L    K
Sbjct: 104 QLPLLVLCHGDLHPGNILVDDGK 126

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 48/231 (20%)

Query: 104 LGHGQFGYTYVA--TDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  Y    T          VA+K +++N    P   ++ ++E +++  L  H N
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPN 69

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAK---KDSRYTEKDAAVV----VRQMLRV 211
           +V        +    +  E    G+L + ++      D      D  V         L +
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 212 AAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           A +      +L  H  VHRD+   N L     E  ++K +DFGLS         +DI  +
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCL---VGEGLTVKISDFGLS---------RDIYSA 177

Query: 265 AYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
            YY            + PE +L  K   ESD+WS GV+ + I   G +P++
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 67/237 (28%), Positives = 103/237 (43%), Gaps = 25/237 (10%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G+ V +    K  N+   P A  +   E  I+ ++  H ++
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHL 71

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V+          + +  +L   G LLD +   KD+  ++      V Q+ +         
Sbjct: 72  VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV-QIAKGMMYLEERR 129

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-R 275
           LVHRD+   N L KS    + +K TDFGL+  ++  +K  +  G      ++A E +  R
Sbjct: 130 LVHRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 276 KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF----RRKPWPSI 327
           K   +SDVWS GV  + L+  G +P+     DGI     R  PD      R P P I
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPY-----DGI---PTREIPDLLEKGERLPQPPI 235

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 17/208 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y      +G+     VA+K + +N    P A +++  E  ++ A  G  
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVM-AGVGSP 69

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            V +          V +  +L   G LLD +   KD R   +D      Q+ +  +    
Sbjct: 70  YVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEE 127

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPE-VL 273
             LVHRD+   N L KS    + +K TDFGL+  +   +      G      ++A E +L
Sbjct: 128 VRLVHRDLAARNVLVKSP---NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 274 KRKSGPESDVWSIGVITYILLC-GRRPF 300
            R+   +SDVWS GV  + L+  G +P+
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 29/223 (13%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            +GK+LG G+FG         +     +VAVK + K  +     +E+   E   ++    
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD- 59

Query: 156 HENVVKFYN-AFEDDNYVYIAMELC-----EGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           H NV+K     FE  +   I   +      + G+L   +L    SR       + ++ +L
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY---SRLGGLPEKLPLQTLL 116

Query: 210 RVAAECHL-------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
           +   +  L          +HRD+   N +    +ED ++   DFGLS  I  G  ++   
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGR 173

Query: 263 GSAY---YVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
            +     ++A E L  R    +SDVW+ GV  + I   G+ P+
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 15/186 (8%)

Query: 110 GYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD 169
           G       K   +R+  K++ K      I +E+   E+  L  L  HEN++K       +
Sbjct: 181 GVNSTNQGKPKCERLIAKRV-KAGSRAAIQLEN---EILALGRL-NHENILKIEEILRSE 235

Query: 170 NYVYIAMELCE---GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
              Y+  +  +      + D     KD    ++  A++ +Q+L      H   L+HRD+K
Sbjct: 236 ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIM-KQLLCAVEYIHDKKLIHRDIK 294

Query: 227 PENFLFKSAKEDSSLKATDFG-LSDFIKPGKKFQ-DIVGSAYYVAPEVLKRKSGPE-SDV 283
            EN        D  +   DFG    F K  + F    VG+    +PE+L      E +D+
Sbjct: 295 LENIFLNC---DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDI 351

Query: 284 WSIGVI 289
           WS G+I
Sbjct: 352 WSCGLI 357

Length = 501

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 29/239 (12%)

Query: 102 KLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++    VA+K++ +     P A +++  E  ++ A   + 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 69

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y   +  V + + +    E
Sbjct: 70  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYLEE 127

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPE 271
             L   VHRD+   N L K+ +    +K TDFGL+  +   +K     G      ++A E
Sbjct: 128 RRL---VHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181

Query: 272 -VLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPSI 327
            +L R    +SDVWS GV  + L+  G +P+     DGI   E+        R P P I
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEISSILEKGERLPQPPI 235

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 56/229 (24%), Positives = 86/229 (37%), Gaps = 30/229 (13%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALA- 154
            I ++LG G+FG       K    R   VA+         L     D +R   + +AL  
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIH-------TLRAGCSDKQRRGFLAEALTL 60

Query: 155 ---GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
               H N+V+        N + I  E    G  LD  L K + +      A  +  ML  
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLV----AGQLMGMLPG 115

Query: 212 AAECHLH----GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS--A 265
            A    +    G VH+ +     L  S   D   K + F      K    +  + G    
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172

Query: 266 YYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
            + APE ++       SDVWS G++ + ++  G RP+WD +   + K V
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 31/94 (32%), Positives = 44/94 (46%), Gaps = 7/94 (7%)

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---F 258
             V RQ+L      H  G++HRD+K EN +  +  ED  L   DFG + F +        
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFH 319

Query: 259 QDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY 291
             I G+    APEVL      P  D+WS G++ +
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 76/327 (23%), Positives = 128/327 (39%), Gaps = 49/327 (14%)

Query: 10  VSGSNSGSNNNNANH--HRNANKEEAKR------RHNHHARNDTTHKHQHQHQERAKNYQ 61
               NS   NN+A+     + +   A+R      R    + +    K         +   
Sbjct: 26  ALSGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATT 85

Query: 62  QLKTKQHQKTNSRRQ--TGVIPCGKRTD------FGYDKDFD-RRYTIGKLLGHGQFGYT 112
              T        +++  T  +P   R +       G D D   +R+ I  LLG G FG  
Sbjct: 86  TPTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKV 145

Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL-----AGHENVVKFYNAFE 167
             A D+   +  AVK I +N   +P    D K E++ ++ +     A    ++K    F+
Sbjct: 146 VEAWDRKRKEYCAVK-IVRN---VPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201

Query: 168 DDN-YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH--LHGLVHRD 224
           ++  ++ I M    G  LLD I+  K   ++ +  A ++ Q        H  LH L+H D
Sbjct: 202 NETGHMCIVMPK-YGPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTELH-LMHTD 257

Query: 225 MKPENFLFKSAK-------------EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
           +KPEN L +++              +   ++  D G             IV + +Y +PE
Sbjct: 258 LKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--GCCDERHSRTAIVSTRHYRSPE 315

Query: 272 V-LKRKSGPESDVWSIGVITYILLCGR 297
           V L       +D+WS+G I Y L  G+
Sbjct: 316 VVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 20/118 (16%)

Query: 200 DAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           D   + R +LR     H + ++HRD+K EN +F +   D  L   DFG + F  P     
Sbjct: 183 DILAIERSVLRAIQYLHENRIIHRDIKAEN-IFINHPGDVCLG--DFGAACF--P----V 233

Query: 260 DIVGSAYY--------VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
           DI  + YY         APE+L R   GP  D+WS G++ + +       ++K  DG+
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK--DGL 289

Length = 391

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 31/92 (33%), Positives = 42/92 (45%), Gaps = 7/92 (7%)

Query: 100 IGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
            GK LG G FG    AT      + N  RVAVK ++ +        E +  E+KIL  L 
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLG 99

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLD 186
            H+N+V    A      V +  E C  G+LL+
Sbjct: 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLN 131

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 33/217 (15%)

Query: 80  IPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA 139
           +P   R +F  D        +G++LG G FG     T         V K+   KM+ P A
Sbjct: 26  LPYDSRWEFPRD-----GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAV-KMLKPTA 79

Query: 140 VEDVKR----EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD-- 193
               K+    E+KI+  L  H N+V    A      +YI  E C  G+L++ +   +D  
Sbjct: 80  RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139

Query: 194 -SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFL---FKSAKEDSSLKATD---F 246
            SR+ EK              +  + G+   D    +++   F++  +   +K  D   +
Sbjct: 140 LSRHPEKP-----------KKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188

Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDV 283
                IK   K+ DI  S Y         K   +S+V
Sbjct: 189 VPMLEIKEASKYSDIQRSNYDRPAS---YKGSNDSEV 222

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 49/238 (20%), Positives = 100/238 (42%), Gaps = 35/238 (14%)

Query: 102 KLLGHGQFGYTYVA--TDKANGDRVAVKKIEKNKMILPIAVEDVK--REVKILQALAGHE 157
           K +G+G FG   +          +V VK++  +  +     E +K   E +  ++L  H 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ----EQMKFLEEAQPYRSLQ-HS 55

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA---E 214
           N+++      +     + ME C  G+L   + + + +     D   + R    +A     
Sbjct: 56  NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD-------FIKPGKKFQDIVGSAYY 267
            H +  +H D+   N L  +   D ++K  D+GLS        ++ P + +  +     +
Sbjct: 116 LHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL----RW 168

Query: 268 VAPEVLKRKSG--------PESDVWSIGVITYILL-CGRRPFWDKTEDGIFKEVLRNK 316
           +APE++    G         ES+VWS+GV  + L   G +P+   +++ +    +R +
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ 226

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 10/104 (9%)

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           V R +    A  H HG V  D+   +FL     +   + +  F ++     G      VG
Sbjct: 122 VARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA---NGTLHLCPVG 178

Query: 264 SAYYVAPEVLKRKS------GPESDVWSIGVITY-ILLCGRRPF 300
            + +  PE+    S          D + + V+ + +L  GR P+
Sbjct: 179 VSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY 222

Length = 637

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 33/226 (14%)

Query: 98  YTIGKLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           +T+G++LG G+FG    A   ++  +  +VAVK + K  +     +E+  RE   ++   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF- 58

Query: 155 GHENVVKFYNAF---EDDNYVYIAM---ELCEGGELLDRILAKKDSRYTEKDAAV----V 204
            H NV+K             + I M      + G+L   +L    SR  E+   +    +
Sbjct: 59  DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM---SRIGEEPFTLPLQTL 115

Query: 205 VRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           VR M+ +A+          +HRD+   N +     E+ ++   DFGLS  I  G  ++  
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQ- 171

Query: 262 VGSAYYVAPEVLKRKS------GPESDVWSIGVITY-ILLCGRRPF 300
            G A  +  + L  +S         SDVW+ GV  + I+  G+ P+
Sbjct: 172 -GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 38/216 (17%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV----------EDVKREVKILQAL 153
           LG G FG            +  V K+ K ++ + I V          +++ RE +I+  L
Sbjct: 3   LGSGNFGCV----------KKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL 52

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             +  +V+     E +  + + ME+  GG L   +  KKD          VV  M +V+ 
Sbjct: 53  D-NPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSN----VVELMHQVSM 106

Query: 214 EC-HLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY--- 267
              +L G   VHRD+   N L  +       K +DFGLS  +     +     +  +   
Sbjct: 107 GMKYLEGKNFVHRDLAARNVLLVNQH---YAKISDFGLSKALGADDSYYKARSAGKWPLK 163

Query: 268 -VAPE-VLKRKSGPESDVWSIGVITYILLC-GRRPF 300
             APE +  RK    SDVWS G+  +     G++P+
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 31/127 (24%), Positives = 48/127 (37%), Gaps = 29/127 (22%)

Query: 158 NVVKFYNAFEDDNYVYIA-------------MELCEGGELLDRILAKKDSRYTEKDAAVV 204
           N  +F   F+DD  VY+              ME  +G ++ D    K      ++ A ++
Sbjct: 214 NAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELL 273

Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           VR    Q+LR        G  H D  P N L    + D  +   DFG+   + P  KF+ 
Sbjct: 274 VRAFLRQLLR-------DGFFHADPHPGNIL---VRSDGRIVLLDFGIVGRLDP--KFRR 321

Query: 261 IVGSAYY 267
            +     
Sbjct: 322 YLAELLL 328

Length = 517

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 18/198 (9%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           ++  G+ G +Y      NG +  VK+I     I    + D+ +    LQ    H N+VK 
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK----LQ----HPNIVKL 748

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
                 +   Y+  E  EG   L  +L         K A  + + +  +   C    +V 
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKN-LSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE-S 281
            ++ PE  +    K++  L+ +  GL       K F     S+ YVAPE  + K   E S
Sbjct: 808 -NLSPEKIII-DGKDEPHLRLSLPGL--LCTDTKCFI----SSAYVAPETRETKDITEKS 859

Query: 282 DVWSIGVITYILLCGRRP 299
           D++  G+I   LL G+ P
Sbjct: 860 DIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 29/106 (27%), Positives = 45/106 (42%), Gaps = 26/106 (24%)

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE--------- 271
           VHRD+   N L     E+  +K  DFGLS         ++I  + YY A E         
Sbjct: 152 VHRDLATRNCL---VGENMVVKIADFGLS---------RNIYSADYYKASENDAIPIRWM 199

Query: 272 ----VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
               +   +   ESDVW+ GV+ + I   G +P++    + +   V
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV 245

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 53/192 (27%), Positives = 72/192 (37%), Gaps = 45/192 (23%)

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           V+RQ+L    + H  G+VHRD+KPEN L      D  +K  DFG +  +  G  F  + G
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLYG 370

Query: 264 --SAYYVAPEVL-KRKSGPESDVWSIGVI--TYILLCGRRPFWDKTEDGI---------- 308
                Y  PE L   +S P +   ++  +   +  L GR   +D    G+          
Sbjct: 371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPEL 430

Query: 309 --------FKEVLRN-KPDFRRKPWPSISNSAKDF-------------VKKLLVKDP--- 343
                   F   LR    D  R  W        DF               KL+ K     
Sbjct: 431 RPVANIRLFNTELRQYDNDLNR--WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQAN 488

Query: 344 RARLTAAQALSH 355
           R RL+  QALSH
Sbjct: 489 RGRLSVGQALSH 500

Length = 507

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 40/118 (33%), Positives = 60/118 (50%), Gaps = 15/118 (12%)

Query: 93  DFDR-RYTIGKLLGHGQFGYTYVAT----DKANG-DRVAVKKIEKNKMILPIAVED--VK 144
           +F R R  +GK+LGHG FG    A+    DK +  + VAVK +++       A E   + 
Sbjct: 3   EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT----ASEHKALM 58

Query: 145 REVKILQALAGHENVVKFYNAFEDDN-YVYIAMELCEGGELLDRILAKKD--SRYTEK 199
            E+KIL  +  H NVV    A    N  + + +E C+ G L + + AK++  S Y EK
Sbjct: 59  SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 45/185 (24%), Positives = 70/185 (37%), Gaps = 42/185 (22%)

Query: 89  GYD----KDFDRR---YTIGKLLGHGQFGYTYVATDKANGDRVAVK----------KIEK 131
           GYD        +R     IG  +G G+    YVA D   G +VAVK          K+++
Sbjct: 77  GYDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKR 135

Query: 132 NKMILP---------IAVEDVKREVKILQALAGHE-NVVKFYNAFEDDNYVYIAMELCEG 181
           N+  L          ++    +RE + LQ L      V K        N   + ME  EG
Sbjct: 136 NRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPI----AWNRHAVVMEYIEG 191

Query: 182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL 241
            EL          R   ++   ++ ++L    + +  G+VH D+   N L     ED  +
Sbjct: 192 VEL-------YRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNIL---VTEDGDI 241

Query: 242 KATDF 246
              D+
Sbjct: 242 VVIDW 246

Length = 304

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 44/187 (23%), Positives = 72/187 (38%), Gaps = 43/187 (22%)

Query: 94  FDRRYT-----IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV- 147
           F   +      +GK LG G FG  Y    KA+   V  +  ++ K +L  A E    E+ 
Sbjct: 125 FRPSFKKDDFVLGKKLGEGAFGVVY----KASL--VNKQSKKEGKYVLKKATEYGAVEIW 178

Query: 148 ---KILQALAGHENVVKFYNAFEDDNYVYIAMELC-----EGGELLDRILAKKDSRYT-- 197
              ++ +A     +   F   F +        E       EG   L  ++  K+  Y   
Sbjct: 179 MNERVRRACPN--SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236

Query: 198 --------------EKDAAVV---VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
                         E++  ++   +RQ+L      H  G+VHRD+KP+N +F  ++   S
Sbjct: 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF--SEGSGS 294

Query: 241 LKATDFG 247
            K  D G
Sbjct: 295 FKIIDLG 301

Length = 566

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 22/203 (10%)

Query: 114 VATDKANGDRVAVKKIE----KNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD 169
           +A  K  G+ V V++I      N+M     V  ++ E+ +   L  H N+V +   F  D
Sbjct: 18  LARYKPTGEYVTVRRINLEACTNEM-----VTFLQGELHV-SKLFNHPNIVPYRATFIAD 71

Query: 170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN 229
           N +++       G   D I        +E   A +++ +L+     H  G VHR +K  +
Sbjct: 72  NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASH 131

Query: 230 FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI-------VGSAYYVAPEVLKRK---SGP 279
            L  S      L      LS  I  G++ + +       V    +++PEVL++       
Sbjct: 132 ILI-SVDGKVYLSGLRSNLS-MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 189

Query: 280 ESDVWSIGVITYILLCGRRPFWD 302
           +SD++S+G+    L  G  PF D
Sbjct: 190 KSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 54/246 (21%), Positives = 105/246 (42%), Gaps = 49/246 (19%)

Query: 104 LGHGQFGYTYVAT--DKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG  +FG  Y       A G++   VA+K + K+K   P+  E+ K E  ++++   H N
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLR-EEFKHEA-MMRSRLQHPN 69

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK---DSRYTEKDAAV-----------V 204
           +V        +  + +    C   +L + ++ +    D   T+ D  V           +
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           V Q+         H +VH+D+   N L     +  ++K +D GL         F+++  +
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVL---VFDKLNVKISDLGL---------FREVYAA 177

Query: 265 AYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
            YY            ++PE ++  K   +SD+WS GV+ + +   G +P+   +   +  
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI- 236

Query: 311 EVLRNK 316
           E++RN+
Sbjct: 237 EMIRNR 242

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 41/126 (32%), Positives = 55/126 (43%), Gaps = 18/126 (14%)

Query: 86  TDFGYDK--DFDR-RYTIGKLLGHGQFGYTYVATD----KANGD-RVAVKKIEKNKMILP 137
           T   YD   +F R R + GK LG G FG    AT     K++    VAV      KM+ P
Sbjct: 22  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAV------KMLKP 75

Query: 138 IA----VEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD 193
            A     E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+D
Sbjct: 76  SAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRD 135

Query: 194 SRYTEK 199
           S    K
Sbjct: 136 SFICPK 141

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	414
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
PRK12274	218	serine/threonine protein kinase; Provisional	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
PRK10345	210	hypothetical protein; Provisional	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
smart00090	237	RIO RIO-like kinase.	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
KOG3087	229	consensus Serine/threonine protein kinase [General	99.49
KOG1243	690	consensus Protein kinase [General function predict	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.41
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.22
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.21
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.12
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.08
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.9
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.72
PRK09902	216	hypothetical protein; Provisional	98.71
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.7
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.67
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.57
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.56
PF01636	239	APH: Phosphotransferase enzyme family This family	98.52
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.51
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.45
PLN02876	822	acyl-CoA dehydrogenase	98.39
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.37
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.25
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.21
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.15
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.12
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.05
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.87
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.83
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.78
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.76
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.72
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.7
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.69
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.57
KOG2270	520	consensus Serine/threonine protein kinase involved	97.48
PLN02236	344	choline kinase	97.44
PRK05231	319	homoserine kinase; Provisional	97.42
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.35
PRK12396	409	5-methylribose kinase; Reviewed	97.32
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.27
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.26
PRK10593	297	hypothetical protein; Provisional	97.24
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.22
PLN02756	418	S-methyl-5-thioribose kinase	97.09
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.92
PTZ00384	383	choline kinase; Provisional	96.87
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.76
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.71
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.58
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.48
PRK11768	325	serine/threonine protein kinase; Provisional	96.03
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.89
PTZ00296	442	choline kinase; Provisional	95.75
PRK06148	1013	hypothetical protein; Provisional	94.98
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.09
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.4

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-65  Score=474.81  Aligned_cols=273  Identities=36%  Similarity=0.630  Sum_probs=246.3

Q ss_pred             CccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC----hHhHHHHHHHHHHHHHccCCCCceEEE
Q 015026           88 FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL----PIAVEDVKREVKILQALAGHENVVKFY  163 (414)
Q Consensus        88 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~E~~il~~l~~hpnIv~~~  163 (414)
                      ....+.+.+.|.+.+.||+|+||.|-+|..+.||+.||||++.+.....    ......+.+|++||++|. |||||+++
T Consensus       164 ~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~  242 (475)
T KOG0615|consen  164 KVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIK  242 (475)
T ss_pred             cCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEe
Confidence            3445667888999999999999999999999999999999997755432    113345789999999995 99999999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCcee
Q 015026          164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (414)
Q Consensus       164 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (414)
                      ++|+.++..||||||++||+|++.+..+  +.+.+...+.+++||+.||.|||+.||+||||||+|||+..+.++..+||
T Consensus       243 d~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  243 DFFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             eeeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence            9999999999999999999999999655  57889999999999999999999999999999999999997767789999


Q ss_pred             eccccccccCCCCccccCCCCCccccchhccccC----CCCcchhHHHHHHHHHhhCCCCCCCCCchh-hhHHHhhcCCC
Q 015026          244 TDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPD  318 (414)
Q Consensus       244 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~  318 (414)
                      +|||+|++......+.+.||||.|.|||++.+..    ..++||||+|||||-+++|.+||.+...+. +.++|.++...
T Consensus       321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA  400 (475)
T ss_pred             cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence            9999999998888889999999999999987542    448899999999999999999999887666 88999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +-+..|..+|+++.+||..||..||++|||++|+|+||||+....
T Consensus       401 f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  401 FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            999999999999999999999999999999999999999996543

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-63  Score=432.80  Aligned_cols=308  Identities=30%  Similarity=0.609  Sum_probs=284.4

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.+.|.+.+.||+|.|+.||++.+..||+.+|+|+|....... ...+.+.+|++|.+.|+ ||||+++.+.+......
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcC-CCcEeehhhhhccccee
Confidence            46678999999999999999999999999999999987655433 36788999999999996 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |||+|++.|++|..-+..+  ..++|..+-.+++||++||.|+|.+||||||+||+|+|+.+..+..-+||+|||+|...
T Consensus        86 ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999999999888655  46899999999999999999999999999999999999998777788999999999988


Q ss_pred             CCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .++......+|||.|||||+++. .++..+|||+.|||||.|+.|++||++.+...+++.|+.+..+++.+.|+.+++++
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            87777788999999999999875 46899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCCHHHHHHHHHHhhhcHHHHHHHHHHHHhhhcceee
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFK  404 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~  404 (414)
                      ++||++||..||.+|+|+.|+|+|||+.+....+......+..+.|++|....+||...|.++..-+..+++.
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s~r~~s~~~  316 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIATRNLSTTP  316 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHhccccccCC
Confidence            9999999999999999999999999999877766666677899999999999999999999999988888766

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-61  Score=464.09  Aligned_cols=260  Identities=35%  Similarity=0.634  Sum_probs=242.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|...+.||+|||+.||.+++..+|+.||+|+|.+.....+...+.+.+||+|.+.|. |||||+++++|++.+++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence            67999999999999999999999999999999999988888889999999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +|+|..++|.+++.  ..+.++|.+++.+++||+.||.|||+++|||||||..|+|++   ++.+|||+|||||.....+
T Consensus        97 LELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~---~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   97 LELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN---ENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec---CcCcEEecccceeeeecCc
Confidence            99999999999885  456899999999999999999999999999999999999999   6889999999999988744


Q ss_pred             -CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                       +...++||||.|.|||++.. ..+.++||||+||++|-||+|++||...+-.+++..|..+...+|.    .+|.++++
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~d  247 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKD  247 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHH
Confidence             66779999999999999875 4699999999999999999999999999999999999998877765    78999999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      ||.+||..||.+|||++++|.|+||+.+....
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~  279 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLDHPFFKSGFTPA  279 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence            99999999999999999999999997654443

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-58  Score=441.47  Aligned_cols=303  Identities=54%  Similarity=0.916  Sum_probs=277.3

Q ss_pred             cccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      ....+...|++.+.||+|.||.||+|.++.||+.+|+|++.+.........+.+.+|+.||+.+.+|||||.++++|++.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            45567788999999999999999999999999999999998877655556789999999999997799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC-CCCceeecccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE-DSSLKATDFGL  248 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~-~~~vkl~DFG~  248 (414)
                      ..+++|||+|.||+|++.+...   .+++..+..+++|++.|+.|||+.||+||||||+|+|+....+ ++.+|++|||+
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            9999999999999999999776   3999999999999999999999999999999999999986543 45899999999


Q ss_pred             ccccCCCCccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      |............+||+.|+|||++. ..++..+||||+||++|.|++|.+||++.++.+....+..+...|....|+.+
T Consensus       186 a~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i  265 (382)
T KOG0032|consen  186 AKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI  265 (382)
T ss_pred             ceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence            99988877888999999999999998 67899999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCCHHHHHHHHHHhhhcHHHHHHHHHHH
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQ  395 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  395 (414)
                      +..+++||.+||..||.+|+|+.++|+|||++........+.+......++++...+++++.+++...
T Consensus       266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (382)
T KOG0032|consen  266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLA  333 (382)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999999877777677777777788888888888877655443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-58  Score=423.76  Aligned_cols=256  Identities=31%  Similarity=0.603  Sum_probs=234.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||.++.+.|++.+|+|++.+.........+....|..||..+. ||+||.++..|++++.+|||
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEEE
Confidence            56999999999999999999999999999999999888777777889999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc-cCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~-~~~  254 (414)
                      +||+.||+|+.+|  ++.+.++|..++.++..|+.||.|||++|||||||||+|||++   .+|+|+|+|||+++. ...
T Consensus       104 ld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd---~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD---EQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec---CCCcEEEeccccchhcccC
Confidence            9999999999998  5567899999999999999999999999999999999999999   799999999999984 455


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      +....++|||+.|||||++.+ .++.++|+||||+++|||++|.+||.+.+...+++.|...+...+.   .-++.++++
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ard  255 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARD  255 (357)
T ss_pred             CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHH
Confidence            566678999999999998765 5799999999999999999999999999999999999988733332   248899999


Q ss_pred             HHHHhhcCCccccC----CHHHHhCCccccc
Q 015026          334 FVKKLLVKDPRARL----TAAQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rp----s~~elL~hp~f~~  360 (414)
                      ||.++|+.||++|.    ++.++-+||||..
T Consensus       256 ll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence            99999999999995    7899999999986

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-57  Score=434.59  Aligned_cols=257  Identities=37%  Similarity=0.672  Sum_probs=237.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|..++.||+|+|++|++|+++.+++.+|||++.+.....+...+.+.+|-.+|.+|.+||.|++||-.|.|+..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            46999999999999999999999999999999999888777777888999999999998899999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||+++|+|+++|  .+.+.|++..++.++.+|+.||+|||++||||||||||||||+   .++++||+|||.|+.+.+.
T Consensus       153 Le~A~nGdll~~i--~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd---~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  153 LEYAPNGDLLDLI--KKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD---KDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEecCCCcHHHHH--HHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc---CCCcEEEeeccccccCChh
Confidence            9999999999999  5568899999999999999999999999999999999999999   7999999999999876432


Q ss_pred             Cc--------------cccCCCCCccccchhccccC-CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          256 KK--------------FQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       256 ~~--------------~~~~~gt~~y~aPE~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      ..              ..+++||..|.+||++.... ++.+|||+||||||.|+.|.+||.+.++--++++|+.-...|+
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            11              14589999999999988664 8999999999999999999999999999999999999877776


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .    .+++.+.+||+++|..||++|+|+.+|.+||||...
T Consensus       308 ~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  308 E----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             C----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence            4    788999999999999999999999999999999863

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-57  Score=412.69  Aligned_cols=256  Identities=30%  Similarity=0.447  Sum_probs=224.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-EEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-YVYIA  175 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-~~~lv  175 (414)
                      +.+.++.||+|+.|+||+|+++.|++.+|+|+|...  .++...+++.+|+++++.+ +||+||.+|+.|.++. .++|+
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEee
Confidence            567788999999999999999999999999999443  3566889999999999999 5999999999999988 59999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+||+|.+.+..  .+.++|.....++.+++.||.|||+ ++||||||||+|||++   ..|.|||||||.+.....
T Consensus       157 mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN---skGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN---SKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec---cCCCEEeccccccHHhhh
Confidence            999999999998844  4789999999999999999999995 9999999999999999   589999999999988765


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCC-----CchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDK-----TEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      . ...+.+||..|||||.+.+ .|+.++||||||+.++||.+|+.||...     ...+++..|..+.+.-.  +-..+|
T Consensus       232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l--P~~~fS  308 (364)
T KOG0581|consen  232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL--PEGEFS  308 (364)
T ss_pred             h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC--CcccCC
Confidence            5 6688999999999998876 5799999999999999999999999774     33456666666433211  112489


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +++++||..||++||.+|||+.|+|+|||++....
T Consensus       309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            99999999999999999999999999999996543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-57  Score=438.26  Aligned_cols=259  Identities=33%  Similarity=0.617  Sum_probs=238.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +-|++++.||.|+-|.|.+|++..||+.+|||+|.+...........+.+||-||+.+. ||||+++|++|++..++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence            45899999999999999999999999999999998875555556778999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||++||.|++++.+.  +++++.++.++++||+.|+.|||..+|+||||||+|+||+   ..+.|||+|||+|..-.++
T Consensus        91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd---~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD---VKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---cccCEeeeccceeecccCC
Confidence            9999999999999654  6899999999999999999999999999999999999999   4556999999999988888


Q ss_pred             CccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .-+.+.||+|+|.|||++.|..  +.++||||+|||||.||+|+.||++.+...++.++.++....+    ..+|+++++
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQd  241 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQD  241 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHH
Confidence            8888999999999999998764  8899999999999999999999999999999999999987666    479999999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      ||.+||..||.+|+|.+||+.|||+......
T Consensus       242 LLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  242 LLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             HHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence            9999999999999999999999999975443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-57  Score=400.86  Aligned_cols=253  Identities=32%  Similarity=0.592  Sum_probs=236.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||.|+||.|-+++++.+|..+|+|++++.....-...+...+|..+|+.+. ||+++++++.|.+.+.+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEE
Confidence            35899999999999999999999999999999999887776677888999999999996 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||.|+.++  ++.+++++..++.++.||+.||+|||+++|++|||||||||||   .+|.+||+|||+|+.....
T Consensus       123 meyv~GGElFS~L--rk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD---~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYL--RKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD---QNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EeccCCccHHHHH--HhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec---cCCcEEEEeccceEEecCc
Confidence            9999999999999  5567899999999999999999999999999999999999999   6999999999999887643


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                        ..+.||||.|+|||++..+ ++.++|.|||||++|||+.|.+||.+.+...++++|+.+...||.    .+++++++|
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdL  271 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDL  271 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHH
Confidence              6789999999999988765 688899999999999999999999999999999999999988875    689999999


Q ss_pred             HHHhhcCCcccc-----CCHHHHhCCccccc
Q 015026          335 VKKLLVKDPRAR-----LTAAQALSHPWVRE  360 (414)
Q Consensus       335 i~~~L~~dp~~R-----ps~~elL~hp~f~~  360 (414)
                      |.++|+.|-.+|     ....++..||||+.
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence            999999999999     46789999999996

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-56  Score=413.65  Aligned_cols=264  Identities=31%  Similarity=0.599  Sum_probs=236.0

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|.+.+.||.|+||+||+|+++.++..||||.|.+... ....++.+..|+.+|+.++ |||||.+++++..++.+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEE
Confidence            3579999999999999999999999999999999988764 4557788999999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec-CCC--CCceeeccccccc
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KED--SSLKATDFGLSDF  251 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~-~~~--~~vkl~DFG~a~~  251 (414)
                      |||||.||+|.+++..  .+.+++..++.++.||+.||++||+++||||||||.||||+.. ..+  ..+||+|||+|+.
T Consensus        87 VMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999954  4589999999999999999999999999999999999999864 222  6799999999999


Q ss_pred             cCCCCccccCCCCCccccchhc-cccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ..+.....+.||+|.|||||++ .++|+-++|+||+|+|+|+|++|+.||...+..+++..+.++....+. ....+++.
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-~~~~~s~~  243 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-LPAELSNP  243 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc-hhhhccCc
Confidence            9988888899999999999998 678999999999999999999999999999999988877666543332 22356777


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ..+|+...|..+|.+|.+..+-+.|+++.....
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~  276 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANPQ  276 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence            889999999999999999999999999987543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-56  Score=427.50  Aligned_cols=258  Identities=38%  Similarity=0.724  Sum_probs=232.7

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC--hHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL--PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ..++|.+++.||+|+||+|+.|.+..+|+.||+|++++.....  ....+.+.+|+.+++.+..||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4468999999999999999999999999999999877652221  12456777999999999669999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCC-CCceeecccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED-SSLKATDFGLSD  250 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~-~~vkl~DFG~a~  250 (414)
                      +|+||||+.||+|++++..  .+++.|.+++.+++||+.|++|||++||+||||||+|||++.   + +.+||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~---~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDG---NEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecC---CCCCEEEecccccc
Confidence            9999999999999999966  578999999999999999999999999999999999999994   4 899999999999


Q ss_pred             cc-CCCCccccCCCCCccccchhccccC---CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          251 FI-KPGKKFQDIVGSAYYVAPEVLKRKS---GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       251 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .. .......+.|||+.|+|||++.+..   +.++||||+||+||.|++|+.||.+.+...++..|..+...++.    .
T Consensus       170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~  245 (370)
T KOG0583|consen  170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----Y  245 (370)
T ss_pred             ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----C
Confidence            88 4666778999999999999998743   68899999999999999999999998888899998888776664    3


Q ss_pred             C-CHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          327 I-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       327 ~-s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      + |+++++||.+||..||.+|+|+.+++.||||+.
T Consensus       246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            4 999999999999999999999999999999997

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.9e-56  Score=424.08  Aligned_cols=259  Identities=32%  Similarity=0.573  Sum_probs=233.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|+++++||+|+||.||+|+.+.||..+|+|++.+..+.....++.++.|-++|... +.|+||++|..|++..++|||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEE
Confidence            5699999999999999999999999999999999998888778889999999999996 699999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-  254 (414)
                      |||++||++..+|..  .+.|++..++.++.+++.|++.||+.|+|||||||+|+|||   ..|++||+||||+..... 
T Consensus       220 MEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD---~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID---AKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec---CCCCEeeccccccchhhhh
Confidence            999999999999844  46899999999999999999999999999999999999999   699999999999843210 


Q ss_pred             ---------------------C--C-----c-------------------cccCCCCCccccchhcccc-CCCCcchhHH
Q 015026          255 ---------------------G--K-----K-------------------FQDIVGSAYYVAPEVLKRK-SGPESDVWSI  286 (414)
Q Consensus       255 ---------------------~--~-----~-------------------~~~~~gt~~y~aPE~~~~~-~~~~~Diwsl  286 (414)
                                           .  .     .                   ....+|||.|||||++.+. |+..+|+|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 0  0     0                   1135899999999998765 6999999999


Q ss_pred             HHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccC---CHHHHhCCcccccc
Q 015026          287 GVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVREG  361 (414)
Q Consensus       287 G~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---s~~elL~hp~f~~~  361 (414)
                      |||+||||.|.+||.+.+..+++++|......+..+.-..++++++|||.+||+ ||.+|.   .++||.+||||+..
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            999999999999999999999999999887666655556788999999999999 999998   59999999999963

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.1e-56  Score=397.07  Aligned_cols=258  Identities=29%  Similarity=0.528  Sum_probs=223.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|+.+.++|+|+||+||+|+++.||+.||||++..+. .++...+-..+||++|++|+ |||+|.++++|.....++||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence            46899999999999999999999999999999985443 34556677789999999996 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-C
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~  254 (414)
                      +|||+. ++++.+.+.. ..+++..++.+++|++.|+.|||++++|||||||+||||+   .++.+||||||+|+... +
T Consensus        80 FE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCC
Confidence            999975 6666665443 5689999999999999999999999999999999999999   69999999999999877 6


Q ss_pred             CCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh--------------cCCC
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--------------NKPD  318 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~--------------~~~~  318 (414)
                      +..+..++.|.||+|||++-|  .|++++||||+||++.||++|.+.|.+.++-+.+..|..              ..+-
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            777889999999999998766  579999999999999999999999999887665554433              1111


Q ss_pred             C-----C--------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          319 F-----R--------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       319 ~-----~--------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      |     +        +..++.++.-+.+|+++||..||.+|++.+|+|.||||..
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            1     1        1124567888999999999999999999999999999954

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-57  Score=397.16  Aligned_cols=264  Identities=32%  Similarity=0.627  Sum_probs=241.4

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC-----ChHhHHHHHHHHHHHHHccCCCCceEEEEEE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----LPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~  166 (414)
                      +.+-..|.--+.||.|..++|.++.++.+|..+|+|+|......     .....+.-..|++||+++.+||+|+++.++|
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            34445688889999999999999999999999999998643221     1233556678999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      +.+..+++|+|+|+.|.|+|++  ...-.+|+...++|++||++|++|||.++|+||||||+|||++   ++..+||+||
T Consensus        93 es~sF~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld---dn~~i~isDF  167 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD---DNMNIKISDF  167 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec---cccceEEecc
Confidence            9999999999999999999999  4446799999999999999999999999999999999999999   6889999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhccc-------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR-------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |+|..+..+..+...||||+|.|||.+..       .|+.++|+||+|||+|.|+.|.+||+.....-+++.|..++..|
T Consensus       168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF  247 (411)
T KOG0599|consen  168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF  247 (411)
T ss_pred             ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence            99999999999999999999999998752       45788999999999999999999999999889999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ..+.|.++|...++||.+||+.||.+|+|++|+|.||||..
T Consensus       248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            99999999999999999999999999999999999999954

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-56  Score=417.89  Aligned_cols=263  Identities=32%  Similarity=0.497  Sum_probs=227.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-E
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-Y  171 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-~  171 (414)
                      .+.++|.++++||.|+||.||+|+.+.+|+.||||.+++.-. .-+. -.=.||+..|++|..|||||++.+++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            356789999999999999999999999999999999876432 2111 223689999999966999999999998877 9


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +|+|||||+ .+|++.+.++ ...|++..++.|++||+.||+|+|.+|+.||||||||||+.   ....|||+|||+|+.
T Consensus        85 L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   85 LYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLARE  159 (538)
T ss_pred             EeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccc
Confidence            999999996 5999988777 78899999999999999999999999999999999999998   377899999999999


Q ss_pred             cCCCCccccCCCCCccccchhcc--ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC-------
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-------  322 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------  322 (414)
                      +.+...++.++.|.||+|||++.  +.|+.+.||||+|||++|+.+-++.|.|.++-+.+.+|...-......       
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            99999999999999999999865  457899999999999999999999999998877666664422111111       


Q ss_pred             -------------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          323 -------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       323 -------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                         ..+..++++.+||.+||.+||.+||||.++|+||||+...
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                               1345788999999999999999999999999999999643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-54  Score=407.56  Aligned_cols=265  Identities=28%  Similarity=0.467  Sum_probs=229.6

Q ss_pred             cccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      +.....+.|+.+++||+|+||.||+|++..||+.||+|+|..+.... ....-..+||.||++| +||||+++.+...+.
T Consensus       111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l-~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRL-DHPNIIKLEEIVTSK  188 (560)
T ss_pred             ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhc-CCCcccceeeEEEec
Confidence            34445567999999999999999999999999999999998766433 3445567999999999 599999999988765


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        +.+|||+|||+. +|.-++ ....-.|++.+++.|++||+.||+|||.+||+|||||.+||||+   ++|.+||+|||
T Consensus       189 ~~~siYlVFeYMdh-DL~GLl-~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid---n~G~LKiaDFG  263 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDH-DLSGLL-SSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID---NNGVLKIADFG  263 (560)
T ss_pred             CCceEEEEEecccc-hhhhhh-cCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc---CCCCEEecccc
Confidence              789999999976 666655 34456899999999999999999999999999999999999999   68999999999


Q ss_pred             cccccCCCC--ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCC
Q 015026          248 LSDFIKPGK--KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       248 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  323 (414)
                      ||+++....  .+...+.|.||+|||++.|  .|+.++|+||+||||.||++|++.|.+.++.+.+..|.+-........
T Consensus       264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            999776544  4677889999999999876  479999999999999999999999999999999999877655544444


Q ss_pred             CC-------------------------CCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          324 WP-------------------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       324 ~~-------------------------~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      |+                         .+++.+.+|+..||..||.+|.||.++|.++||+..
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence            43                         257789999999999999999999999999999653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.4e-54  Score=376.67  Aligned_cols=260  Identities=31%  Similarity=0.496  Sum_probs=225.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|..++.||+|.||.||+|++..||+.||||+|........ ......+||+.|+.++ ||||+.++++|...+.+.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence            479999999999999999999999999999999987654333 2345679999999996 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||++. +|...+ +.+...++..+++.|+.+++.||+|||++.|+||||||.|+|++   .++.+||+|||+|+.+.+.
T Consensus        80 fEfm~t-dLe~vI-kd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   80 FEFMPT-DLEVVI-KDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             EEeccc-cHHHHh-cccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCC
Confidence            999975 666655 44557899999999999999999999999999999999999999   5899999999999988755


Q ss_pred             Cc-cccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCC-------
Q 015026          256 KK-FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP-------  325 (414)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-------  325 (414)
                      .. ....+-|.+|+|||++.|  .|+..+||||.|||+.||+.|.+-|.+.++-+.+..|.+.-.......||       
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            44 334488999999998865  47999999999999999999999999999888888877654444444443       


Q ss_pred             -----------------CCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          326 -----------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       326 -----------------~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                       ..++++.+|+.+||..||.+|+|+.|+|+|+||+...
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                             3466789999999999999999999999999999743

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-53  Score=413.14  Aligned_cols=256  Identities=26%  Similarity=0.495  Sum_probs=236.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|+++++||+|+||+|+++..+.+++.+|||++++.........+....|.+|+....+||.++.++..|+..+++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            56999999999999999999999999999999999998888889999999999999998899999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-C
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~  254 (414)
                      |||+.||++..+   .....+++..++.|+..|+.||.|||++||||||||.+|||+|   .+|++||+|||+++..- .
T Consensus       448 mey~~Ggdm~~~---~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD---~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  448 MEYVAGGDLMHH---IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD---TEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEecCCCcEEEE---EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc---ccCcEEecccccccccCCC
Confidence            999999994432   3457899999999999999999999999999999999999999   68999999999998643 5


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      +....++||||.|||||++.+ .|+.++|+|||||+||||+.|..||.+.++++++..|+...+.++.    .+|.++.+
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~  597 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIA  597 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHH
Confidence            567789999999999999875 5799999999999999999999999999999999999998877664    78999999


Q ss_pred             HHHHhhcCCccccCC-----HHHHhCCcccccc
Q 015026          334 FVKKLLVKDPRARLT-----AAQALSHPWVREG  361 (414)
Q Consensus       334 li~~~L~~dp~~Rps-----~~elL~hp~f~~~  361 (414)
                      +++++|..||++|..     +++|..||||+..
T Consensus       598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            999999999999985     5889999999963

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-53  Score=406.45  Aligned_cols=254  Identities=30%  Similarity=0.574  Sum_probs=230.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|.+.+.||+|+||.||+|+.+.|.+.||+|.+++.... ....+.+.+|++|++.|+ |||||.++++|+...++++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence            4689999999999999999999999999999999887643 346788999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +|||.| +|..++  ...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++   ..+.+|+||||+|+....+
T Consensus        80 te~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   80 TEYAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             ehhhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhhcccC
Confidence            999987 999988  5567899999999999999999999999999999999999999   6899999999999987665


Q ss_pred             Cc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 KK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .. ...+.|||.|||||++.+. ++..+|+||+|||+|||++|++||...+...+.+.|......++    +.++.++..
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----~~~S~~f~n  229 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----STASSSFVN  229 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----ccccHHHHH
Confidence            54 3467899999999988765 58899999999999999999999999988888888888765444    378999999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      |++.+|.+||.+|+|+.+++.|||.+..
T Consensus       230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  230 FLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHHhhcChhhcccHHHHhcChHHhhh
Confidence            9999999999999999999999999863

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-53  Score=391.81  Aligned_cols=257  Identities=32%  Similarity=0.623  Sum_probs=239.0

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ....+|++.+.||+|.||+|-+|.+...|+.||||.|+++...+.+..-.+++||+||..| +||||+.+|++|++.+.+
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceE
Confidence            3456899999999999999999999999999999999999888888888999999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      .|||||..+|+|++++  ...+.|++.+++.+++||+.|+.|||.++++|||||.+|||+|   .++++||+|||++..+
T Consensus       129 vivMEYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD---~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD---QNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEEEecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec---CCCCeeeeccchhhhh
Confidence            9999999999999999  4457899999999999999999999999999999999999999   6899999999999998


Q ss_pred             CCCCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ....-+.++||+|.|.+||+++|.+  ++++|-|||||+||.|+.|.+||++.+...++++|..+...-     |.-|..
T Consensus       204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE-----P~~PSd  278 (668)
T KOG0611|consen  204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE-----PETPSD  278 (668)
T ss_pred             ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC-----CCCCch
Confidence            8888889999999999999999875  899999999999999999999999999999999998875432     345678


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +.-||+-||-.||.+|.|++++-.|=|+.-
T Consensus       279 A~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  279 ASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            999999999999999999999999999864

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-52  Score=387.58  Aligned_cols=260  Identities=31%  Similarity=0.556  Sum_probs=237.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|++++.||.|.-|+||+|....++..+|+|++++..+.......+++.|-+||+.+ +||.++.+|..|+.+...|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence            3589999999999999999999999999999999998877667788899999999999 699999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC--
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~--  253 (414)
                      ||||+||+|.....++..+.+++..++.++..++.||+|||-.|||+||||||||||.   ++|+|.|+||.|+....  
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr---edGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR---EDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe---cCCcEEeeeccccccCCCC
Confidence            9999999999999999999999999999999999999999999999999999999999   79999999999863210  


Q ss_pred             --------------------------------C-C----------------------CccccCCCCCccccchhcccc-C
Q 015026          254 --------------------------------P-G----------------------KKFQDIVGSAYYVAPEVLKRK-S  277 (414)
Q Consensus       254 --------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~-~  277 (414)
                                                      . .                      ......+||-.|.|||++.|. .
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                      011246899999999999886 5


Q ss_pred             CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCC----HHHHh
Q 015026          278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT----AAQAL  353 (414)
Q Consensus       278 ~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps----~~elL  353 (414)
                      +.++|+|+|||++|||+.|..||.+.+..+.+.+|+...+.|+..+  .++..++|||+++|.+||++|..    |.||-
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            8999999999999999999999999999999999999998888764  78899999999999999999998    99999


Q ss_pred             CCcccccc
Q 015026          354 SHPWVREG  361 (414)
Q Consensus       354 ~hp~f~~~  361 (414)
                      +||||+..
T Consensus       391 ~HpFF~gV  398 (459)
T KOG0610|consen  391 RHPFFEGV  398 (459)
T ss_pred             cCccccCC
Confidence            99999964

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-53  Score=369.03  Aligned_cols=256  Identities=32%  Similarity=0.620  Sum_probs=238.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|-||.||+|+.+.++-.||+|++.++.........++.+|++|-..|+ ||||+++|++|.+...+||+
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence            56999999999999999999999999999999998887666666788999999999996 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||..+|+|+..+.......+++..++.+++|++.||.|+|.++||||||||+|+|++   -.+.+||+|||.+.... .
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecC-C
Confidence            9999999999999877888999999999999999999999999999999999999999   47899999999997665 4


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      ....++|||..|.+||...+. .+..+|+|++|++.||++.|.+||...+..+.+++|.+....++    ..++.++.||
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl  252 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL  252 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence            556789999999999998876 58889999999999999999999999999999999999877666    4799999999


Q ss_pred             HHHhhcCCccccCCHHHHhCCccccc
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      |.+||..+|.+|.+..|++.|||...
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHh
Confidence            99999999999999999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-54  Score=379.39  Aligned_cols=247  Identities=30%  Similarity=0.539  Sum_probs=216.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEE-EEEcCC-EEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN-AFEDDN-YVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~-~~~~~~-~~~  173 (414)
                      ..|+|+++||.|+||+||++.+..+|..||.|.|.-. .....+.+.+..|+.+|++|. |||||++++ .|..++ .++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhH
Confidence            4699999999999999999999999999999999844 345668889999999999995 999999998 455444 499


Q ss_pred             EEEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          174 IAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHL--HG--LVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~--~~--iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                      ||||||.+|+|...+...  ..+.++|..++.++.|++.||..||+  ..  |+||||||.||+|+   .+|.|||+|||
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~---~~gvvKLGDfG  173 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT---ANGVVKLGDFG  173 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc---CCCceeeccch
Confidence            999999999999988543  44679999999999999999999999  44  99999999999999   68999999999


Q ss_pred             cccccCCCCcc-ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          248 LSDFIKPGKKF-QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       248 ~a~~~~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      ++++......+ .+++|||.||+||.+.+ .|+.++||||+||++|||+.-.+||.+.+-.++.++|.++..  ++-+-.
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~--~~~p~~  251 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY--PPLPDE  251 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC--CCCcHH
Confidence            99998766554 47899999999998765 579999999999999999999999999988888889988743  222223


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCH
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTA  349 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~  349 (414)
                      -.|.++..||..|+.+||+.||+.
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCc
Confidence            578899999999999999999984

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-52  Score=390.39  Aligned_cols=259  Identities=34%  Similarity=0.566  Sum_probs=216.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC--EEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--YVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~--~~~  173 (414)
                      ..+..++.||+|+||.||++.+..+|+..|||.+.....  + ..+.+.+|+.+|++|+ |||||+++|......  .++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~-~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--P-TSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--h-hHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeE
Confidence            357889999999999999999999999999999876532  1 2677999999999997 999999999754443  799


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      |+|||++||+|.+++..... .+++..++.+.+||++||+|||++|||||||||+|||++.  .++.+||+|||++....
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~--~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP--SNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC--CCCeEEeccCccccccc
Confidence            99999999999999966654 8999999999999999999999999999999999999993  16899999999998665


Q ss_pred             C----CCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCC-CchhhhHHHhhcCCCCCCCCCCC
Q 015026          254 P----GKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       254 ~----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .    ........||+.|||||++....  .+++|||||||++.||+||+.||... ...+.+-.+.... ..+ .....
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ip~~  247 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-EIPDS  247 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-CCCcc
Confidence            3    12234678999999999988433  35999999999999999999999873 3333333333333 112 33346


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +|+++++||.+||..||++||||.++|.|||......
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999999986543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-52  Score=377.24  Aligned_cols=261  Identities=28%  Similarity=0.426  Sum_probs=221.6

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--CCEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYV  172 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~~~  172 (414)
                      .+.|+.+..|++|+||.||+|+|+.|++.||+|+++.+........ ...+||.+|.+++ |||||.+-++...  -+.+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~-H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKAR-HPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcC-CCCeeeeEEEEecccccee
Confidence            3569999999999999999999999999999999976553322222 3468999999996 9999999998764  4579


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |||||||+. +|...+.. ..++++..+++.++.|++.||+|||.+.|+||||||+|+|+.   ..|.+||+|||+|+.+
T Consensus       153 y~VMe~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAREY  227 (419)
T ss_pred             eeeHHHHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhhh
Confidence            999999975 77766643 347899999999999999999999999999999999999999   6899999999999988


Q ss_pred             CCC-CccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC---
Q 015026          253 KPG-KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS---  326 (414)
Q Consensus       253 ~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~---  326 (414)
                      .+. ..+...+.|.+|+|||++.+.  |+.+.|+||+|||+.||+++++.|.+.++.+.+.+|.+.-.......||+   
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            765 446778899999999988764  68999999999999999999999999999888888766433333333322   


Q ss_pred             -------------------------CCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          327 -------------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       327 -------------------------~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                               +++...+|+..+|.+||.+|.||+|+|.|+||.+.+
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence                                     457889999999999999999999999999999843

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-52  Score=382.79  Aligned_cols=268  Identities=32%  Similarity=0.542  Sum_probs=222.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----  168 (414)
                      ....+|..++.||.|+||.|+.+.++.||+.||||++... .......++..+|+.+|+.++ |+||+.+++++..    
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRD   96 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccccccc
Confidence            3456778789999999999999999999999999998632 223456778889999999996 9999999999865    


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                       -+.+|+|+|+| +-+|...+  ...+.+++.++..+++||+.||.|+|+.+|+||||||.|+|++   .+..+||+|||
T Consensus        97 ~f~DvYiV~elM-etDL~~ii--k~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~DFG  170 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQII--KSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICDFG  170 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHH--HcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEecccc
Confidence             35799999999 45777766  3334599999999999999999999999999999999999999   68889999999


Q ss_pred             cccccCC---CCccccCCCCCccccchhcc--ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh--------
Q 015026          248 LSDFIKP---GKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--------  314 (414)
Q Consensus       248 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~--------  314 (414)
                      +|+...+   ...++.++.|.+|+|||++.  ..|+.+.||||+|||+.||++|++.|.+.+.-..+..|+.        
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            9998764   44457789999999999864  4578999999999999999999999988765544443322        


Q ss_pred             ---------------cCCCCCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCC
Q 015026          315 ---------------NKPDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP  368 (414)
Q Consensus       315 ---------------~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~  368 (414)
                                     ..+..+..    .++..++.+.+|+++||..||.+|+|++|+|+||||...-+.+..|
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence                           22222222    2467899999999999999999999999999999999765554443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-52  Score=401.74  Aligned_cols=261  Identities=31%  Similarity=0.541  Sum_probs=227.4

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..+....|...++||+|+-|.||.|+...+++.||||.+......   ..+-+.+|+.+|+.++ |+|||.+++.|...+
T Consensus       268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLH-HPNIVNFLDSYLVGD  343 (550)
T ss_pred             CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhcc-chHHHHHHHHhcccc
Confidence            355667899999999999999999999999999999999876542   4577899999999996 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .+|+||||++||+|.|.+..   ..++|.+++.|++.++.||+|||.+||||||||.+|||++   .++.|||+|||++.
T Consensus       344 eLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFca  417 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCA  417 (550)
T ss_pred             eeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeee
Confidence            99999999999999998733   3589999999999999999999999999999999999999   68889999999998


Q ss_pred             ccCCCC-ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh-cCCCCCCCCCCCC
Q 015026          251 FIKPGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-NKPDFRRKPWPSI  327 (414)
Q Consensus       251 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~  327 (414)
                      .+.... ...+++|||.|||||++.. .|++++||||||+++.||+-|.+||...+.-..+..|.. +.+.+  ..+..+
T Consensus       418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l--k~~~kl  495 (550)
T KOG0578|consen  418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL--KNPEKL  495 (550)
T ss_pred             ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc--CCcccc
Confidence            775544 5678999999999998875 579999999999999999999999987655444444433 33333  334689


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      |+++++||.+||+.|+.+|++|.|||+||||+..+.
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            999999999999999999999999999999965443

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-52  Score=391.58  Aligned_cols=259  Identities=34%  Similarity=0.637  Sum_probs=224.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh-----------HhHHHHHHHHHHHHHccCCCCceEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----------IAVEDVKREVKILQALAGHENVVKFY  163 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~~hpnIv~~~  163 (414)
                      -+.|++++.||+|.||+|-+|++..+++.||||++.+......           ...+.+.+||.||++|. |||||+|+
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~Li  174 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKLI  174 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEEE
Confidence            3579999999999999999999999999999999976432211           12468999999999995 99999999


Q ss_pred             EEEEcC--CEEEEEEeccCCCChHHHHHhccCCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC
Q 015026          164 NAFEDD--NYVYIAMELCEGGELLDRILAKKDSR-YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       164 ~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~-l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                      ++..+.  +.+|||+|||..|.+...   ..... +++.+++.|+++++.||+|||.+|||||||||+|+||+   .+++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---SDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---CCCc
Confidence            999764  689999999999887542   23345 99999999999999999999999999999999999999   5799


Q ss_pred             ceeeccccccccCC------CCccccCCCCCccccchhccc-c----CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhh
Q 015026          241 LKATDFGLSDFIKP------GKKFQDIVGSAYYVAPEVLKR-K----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIF  309 (414)
Q Consensus       241 vkl~DFG~a~~~~~------~~~~~~~~gt~~y~aPE~~~~-~----~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  309 (414)
                      |||+|||.+.....      ...+...+|||.|+|||+..+ .    .+.+.||||+||+||+|+.|..||.+....+++
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            99999999876522      222345799999999997654 2    278899999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .+|+.....|+..  +.+.+++++||.+||++||.+|++..++..|||.....
T Consensus       329 ~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  329 DKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             HHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            9999988877764  36889999999999999999999999999999998753

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-52  Score=394.32  Aligned_cols=265  Identities=32%  Similarity=0.637  Sum_probs=242.7

Q ss_pred             cccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      ++..+.+-|.+.+.||+|.|++|-+|++..||+.||||+|++..+. ......+.+|++.|+.++ |||||++|++....
T Consensus        12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQ   89 (864)
T ss_pred             cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhc-CcCeeeeeehhccc
Confidence            4555677899999999999999999999999999999999988764 446778999999999985 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      ..+|||+|+-+||+|+++|.... ..++|..++.++.||+.|+.|||+..+|||||||+||.+..  +-|.|||+|||++
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE--KlGlVKLTDFGFS  166 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE--KLGLVKLTDFGFS  166 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee--ecCceEeeecccc
Confidence            99999999999999999997654 56999999999999999999999999999999999999874  6899999999999


Q ss_pred             cccCCCCccccCCCCCccccchhcccc-C-CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          250 DFIKPGKKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ..+.++..+.+.||+..|.|||++.|. | .+++||||||||||.|+||.+||...++.+.+..|+.-+...+.    .+
T Consensus       167 Nkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hv  242 (864)
T KOG4717|consen  167 NKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HV  242 (864)
T ss_pred             ccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hh
Confidence            999999999999999999999987765 4 67899999999999999999999999999999999988766553    68


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +.++++||.+||..||++|.|.++|..++|++....
T Consensus       243 S~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  243 SKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             hHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            999999999999999999999999999999996543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.9e-51  Score=383.73  Aligned_cols=260  Identities=27%  Similarity=0.429  Sum_probs=220.0

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.+. |+||+.+++.+.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEE
Confidence            788999999999999999999999999999987654333334456789999999995 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~  257 (414)
                      |+++|+|.+.+.......+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~---~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD---DRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeCCCcEEcCCCCe
Confidence            99999998887655555789999999999999999999999999999999999998   578899999999987655545


Q ss_pred             cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHH
Q 015026          258 FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (414)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (414)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+..............+++++.+||.
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            556789999999998765 5688999999999999999999999876654333333322222222333468999999999


Q ss_pred             HhhcCCccccCC-----HHHHhCCcccccc
Q 015026          337 KLLVKDPRARLT-----AAQALSHPWVREG  361 (414)
Q Consensus       337 ~~L~~dp~~Rps-----~~elL~hp~f~~~  361 (414)
                      +||+.||.+||+     ++++++||||...
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            999999999997     8999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-51  Score=380.91  Aligned_cols=263  Identities=28%  Similarity=0.488  Sum_probs=231.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ..|++.+.||.|..++||+|+..-+++.||||++..+....  ..+.+++|+..++.+ +||||+.++..|..+..+|+|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEe
Confidence            46999999999999999999999999999999998776543  478999999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-C
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~  254 (414)
                      |.||.+|++++.+...-...++|..+..|+++++.||.|||.+|.||||||+.||||+   .+|.|||+|||.+...- .
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~---~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID---SDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc---CCCcEEEcCceeeeeeccc
Confidence            9999999999999877777799999999999999999999999999999999999999   69999999999865432 2


Q ss_pred             CC----ccccCCCCCccccchhcc---ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC------CC
Q 015026          255 GK----KFQDIVGSAYYVAPEVLK---RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF------RR  321 (414)
Q Consensus       255 ~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~------~~  321 (414)
                      +.    .+++.+||++|||||++.   ..|+.++||||||++..||.+|..||......+++..-+++.+..      +.
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            22    235679999999999954   357999999999999999999999999888888777777776542      22


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      .....++.+++.+|..||+.||++||||+++|+|+||+.....
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            2334577889999999999999999999999999999976543

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-52  Score=373.73  Aligned_cols=272  Identities=36%  Similarity=0.619  Sum_probs=238.9

Q ss_pred             cccccceee-ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           92 KDFDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        92 ~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..|.+.|++ .+.||+|+|+.|-.++...+|..+|||+|++..   ...+.++.+|++++.++++|+||++++++|+++.
T Consensus        73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            335566776 468999999999999999999999999998864   3578899999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .+|||||-|.||+|+.+|..  ...++|.++..+.++|+.||.|||.+||+||||||+|||....+.-.-|||+||.+..
T Consensus       150 ~FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             eEEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence            99999999999999999954  4579999999999999999999999999999999999999865555679999999875


Q ss_pred             ccCC--------CCccccCCCCCccccchhcc---c---cCCCCcchhHHHHHHHHHhhCCCCCCCCCc-----------
Q 015026          251 FIKP--------GKKFQDIVGSAYYVAPEVLK---R---KSGPESDVWSIGVITYILLCGRRPFWDKTE-----------  305 (414)
Q Consensus       251 ~~~~--------~~~~~~~~gt~~y~aPE~~~---~---~~~~~~DiwslG~il~elltg~~Pf~~~~~-----------  305 (414)
                      .+.-        ...+.+.+|+..|||||+..   +   .|+.++|.||||||||.|++|.+||.+...           
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C  307 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC  307 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence            5432        22345679999999999753   2   368899999999999999999999976532           


Q ss_pred             ----hhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCC
Q 015026          306 ----DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP  368 (414)
Q Consensus       306 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~  368 (414)
                          ..+++.|..+..+|+.+.|..+|.++++||..+|..|+.+|.++.++++|||++.......++
T Consensus       308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp  374 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP  374 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence                357888999999999999999999999999999999999999999999999999866554444

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-52  Score=370.89  Aligned_cols=267  Identities=33%  Similarity=0.629  Sum_probs=238.3

Q ss_pred             cccceeec-eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----
Q 015026           94 FDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (414)
Q Consensus        94 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----  168 (414)
                      +.++|.+- ++||-|-.|+|..+.++.||+.+|+|++...        ...++|+++.-...+|||||.++++|++    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            45667774 5899999999999999999999999988533        3456788877667789999999999864    


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      ...+.+|||+|+||+|+..+.++..+.++|.++..|++||+.|+.|||+.+|+||||||+|+|......+..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            56789999999999999999988888999999999999999999999999999999999999999877888999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCC----chhhhHHHhhcCCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~  323 (414)
                      |+.......+.+.|-||.|.|||++.. +++..+|+||+||++|.|+||.+||+.+.    ..++-.+|..+...|+.+.
T Consensus       211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE  290 (400)
T KOG0604|consen  211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE  290 (400)
T ss_pred             ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence            998777777788999999999999875 57888999999999999999999998753    4567888999999999999


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCC
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP  368 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~  368 (414)
                      |..+|++++++|+.+|..+|.+|.|+.++++|||+.........+
T Consensus       291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tp  335 (400)
T KOG0604|consen  291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTP  335 (400)
T ss_pred             HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCC
Confidence            999999999999999999999999999999999998765544333

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-51  Score=386.11  Aligned_cols=252  Identities=29%  Similarity=0.543  Sum_probs=222.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+.+++||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEEE
Confidence            6899999999999999999999999999999997644333335567889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~---~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEEecCcchhccCC-
Confidence            99999999998844  45789999999999999999999999999999999999998   5789999999999765432 


Q ss_pred             ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (414)
                       ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......++.    .+++.+++||
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li  229 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLI  229 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHH
Confidence             2356899999999987754 588999999999999999999999988888888888777655443    5688999999


Q ss_pred             HHhhcCCccccCC-----HHHHhCCccccc
Q 015026          336 KKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       336 ~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      .+||+.||.+||+     +++++.||||..
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            9999999999995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-50  Score=390.87  Aligned_cols=253  Identities=31%  Similarity=0.567  Sum_probs=222.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+. ||||+++++.+.+++.+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEE
Confidence            46999999999999999999999999999999997654333345677899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        97 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---NKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---CCCCEEEeeccCceEcCCC
Confidence            999999999998854  45789999999999999999999999999999999999998   5789999999999865432


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                        ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++    ..++..+.+|
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  245 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDL  245 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHH
Confidence              2356899999999988654 58899999999999999999999988877777777777654433    2478899999


Q ss_pred             HHHhhcCCccccCC-----HHHHhCCccccc
Q 015026          335 VKKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       335 i~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      |.+||+.||.+||+     +++++.||||..
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            99999999999997     799999999986

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3e-50  Score=393.17  Aligned_cols=259  Identities=27%  Similarity=0.466  Sum_probs=219.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.++..+ +||||+++++.+.+...+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence            3689999999999999999999999999999999765443344567788999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.....
T Consensus        80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~---~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          80 MEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             EcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCCEEEeeccCccccccc
Confidence            999999999998854  45799999999999999999999999999999999999998   5789999999998754321


Q ss_pred             C------------------------------------ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCC
Q 015026          256 K------------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRR  298 (414)
Q Consensus       256 ~------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~  298 (414)
                      .                                    .....+||+.|+|||++.+ .++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            0                                    0124589999999998765 46889999999999999999999


Q ss_pred             CCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccc---cCCHHHHhCCcccccc
Q 015026          299 PFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRA---RLTAAQALSHPWVREG  361 (414)
Q Consensus       299 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~---Rps~~elL~hp~f~~~  361 (414)
                      ||.+.+..+.+..+.........+....+++++++||.+|+. +|.+   ||+++|+++||||...
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            999888888888877644333333334588999999999876 4554   5899999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-50  Score=388.42  Aligned_cols=249  Identities=31%  Similarity=0.545  Sum_probs=217.4

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.+. ||||+++++.+...+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654333445567889999999995 99999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~~  260 (414)
                      ++|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+++... .......
T Consensus        80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          80 GELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD---KDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEeeCCCCcccccCCCcccc
Confidence            999988843  45789999999999999999999999999999999999998   57889999999987532 2233445


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+.......+......++    ..+++++.+||.+||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L  230 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLL  230 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHc
Confidence            789999999998865 468999999999999999999999988877777777766654443    368899999999999


Q ss_pred             cCCccccC-----CHHHHhCCccccc
Q 015026          340 VKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       340 ~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      ..||++||     ++.++++||||..
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            99999999     8999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-50  Score=392.01  Aligned_cols=258  Identities=30%  Similarity=0.550  Sum_probs=221.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++++.||+|+||+||+|.+..+|+.||||++.............+.+|+.+|+.+. ||||+++++++.+++.+++||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEEE
Confidence            6999999999999999999999999999999997654333445667889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD---AKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEeecccceeccccc
Confidence            99999999998854  35699999999999999999999999999999999999998   58899999999986542211


Q ss_pred             ---------------------------------------ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhC
Q 015026          257 ---------------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCG  296 (414)
Q Consensus       257 ---------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg  296 (414)
                                                             .....+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence                                                   0113579999999998764 468999999999999999999


Q ss_pred             CCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCC---HHHHhCCcccccc
Q 015026          297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT---AAQALSHPWVREG  361 (414)
Q Consensus       297 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps---~~elL~hp~f~~~  361 (414)
                      ..||.+.+..+.+..+......+..+....+++++.+||.+||. +|.+|++   +.+++.||||+..
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99999888777777776654444333334689999999999997 9999998   9999999999763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-50  Score=386.34  Aligned_cols=257  Identities=32%  Similarity=0.525  Sum_probs=222.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++..+. ||||+++++++.+.+..|+||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEE
Confidence            6999999999999999999999999999999997654333335667889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++|++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEEEeCcCCccccc--
Confidence            99999999998843  45789999999999999999999999999999999999998   578999999999976543  


Q ss_pred             ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCC----CCCCHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW----PSISNSA  331 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~  331 (414)
                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+..+.+    ..+++++
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence            3345689999999998765 4688999999999999999999999888777777666554332222222    2578999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .+||.+||..+|.+||++.+++.||||...
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            999999999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-52  Score=386.11  Aligned_cols=259  Identities=28%  Similarity=0.501  Sum_probs=228.1

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      ...|...+.||+|+||.||+|.+..+++.||||+++.+...  ...+++++|+.+|.++. +|||.++|+.|..+..+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHH
Confidence            34688889999999999999999999999999999877643  36788999999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      +||||.||++.+.+  .....+.+.++..++++++.||.|||..+.+|||||+.|||+.   .++.|||+|||.+.....
T Consensus        89 iMey~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHHHhcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeec
Confidence            99999999999988  4445569999999999999999999999999999999999999   569999999999977654


Q ss_pred             CCc-cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKK-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ... ..+++|||.|||||++.+ .|+.++||||||++.+||++|.+|+.+.....++..|-+..+....   ..+|+.++
T Consensus       164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~k  240 (467)
T KOG0201|consen  164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFK  240 (467)
T ss_pred             hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHH
Confidence            433 378999999999999986 6799999999999999999999999988886666666555433222   36889999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      +||..||++||+.||||.++|.|+|++..+..
T Consensus       241 EFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~  272 (467)
T KOG0201|consen  241 EFVEACLDKNPEFRPSAKELLKHKFIKRAKKT  272 (467)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhhHHHHhcCCc
Confidence            99999999999999999999999999984433

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-49  Score=390.37  Aligned_cols=259  Identities=30%  Similarity=0.455  Sum_probs=217.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.+. ||||+++++.+.+.+.+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999997655444445678899999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-  255 (414)
                      ||++||+|.+++..  ...+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++...... 
T Consensus        81 E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~---~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          81 DYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID---LDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC---CCCCEEEeeCcCCccccccc
Confidence            99999999998854  35689999999999999999999999999999999999998   5789999999997532100 


Q ss_pred             -----------------------------------------------CccccCCCCCccccchhccc-cCCCCcchhHHH
Q 015026          256 -----------------------------------------------KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIG  287 (414)
Q Consensus       256 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG  287 (414)
                                                                     ......+||+.|+|||++.+ .++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence                                                           00124579999999998765 468899999999


Q ss_pred             HHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcC--CccccCCHHHHhCCcccccc
Q 015026          288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK--DPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       288 ~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dp~~Rps~~elL~hp~f~~~  361 (414)
                      |++|||++|..||.+.+..+....+.........+....+++++.+||.+|+..  +|..|+++.+++.||||+..
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999999988777666666654433333334446899999999997654  44559999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.5e-50  Score=386.17  Aligned_cols=254  Identities=31%  Similarity=0.556  Sum_probs=221.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC-CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      +.|.+.+.||+|+||.||+|.+..++ ..||+|++...........+.+.+|+.+++.+. ||||+++++++.+++.+++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEEE
Confidence            46999999999999999999876655 689999987654333445677889999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++||+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus       109 v~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEecCCCCeecCC
Confidence            9999999999998854  35789999999999999999999999999999999999998   578999999999987543


Q ss_pred             CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .  ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+....+..+......++    +.+++++.+
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  257 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKH  257 (340)
T ss_pred             C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHH
Confidence            2  3456899999999987654 68899999999999999999999998887777777777654443    357899999


Q ss_pred             HHHHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          334 FVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       334 li~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      +|.+||+.||.+|+     +++++++||||...
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999995     89999999999863

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.4e-50  Score=366.57  Aligned_cols=263  Identities=30%  Similarity=0.469  Sum_probs=221.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCC-ceEEEEEEEcCC----
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-VVKFYNAFEDDN----  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpn-Iv~~~~~~~~~~----  170 (414)
                      ..|..+++||+|+||+||+|+++.+|+.||+|++...... +..-....+|+.+|+.|+ |+| ||.+++++...+    
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence            4588888999999999999999999999999999766432 123345579999999995 999 999999998766    


Q ss_pred             --EEEEEEeccCCCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          171 --YVYIAMELCEGGELLDRILAKKD--SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                        .+++|+||++ -+|..++.....  ..++...++.+++||+.||+|||+++|+||||||.||||+   +.+.+||+||
T Consensus        89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEeeecc
Confidence              8999999996 488888855432  3678899999999999999999999999999999999999   5899999999


Q ss_pred             ccccccC-CCCccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCC
Q 015026          247 GLSDFIK-PGKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       247 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  323 (414)
                      |+|+... +...+..-++|.+|+|||++.+.  |+...||||+|||++||+++++.|.+.++.+.+..|.+.-.......
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9998766 34446778999999999988764  68899999999999999999999999998877777765333322222


Q ss_pred             CC--------------------------CCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          324 WP--------------------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       324 ~~--------------------------~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      ||                          ..+++..+++.+||+.+|.+|.|+..+|.||||......
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            22                          234578999999999999999999999999999976443

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-49  Score=389.27  Aligned_cols=258  Identities=29%  Similarity=0.484  Sum_probs=223.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+++.+++|
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEE
Confidence            4699999999999999999999999999999999764433333455678999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         122 MEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc---CCCCEEEEeccceeeccCC
Confidence            999999999998743   3589999999999999999999999999999999999998   5889999999999765433


Q ss_pred             C--ccccCCCCCccccchhccc-----cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          256 K--KFQDIVGSAYYVAPEVLKR-----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .  .....+||+.|+|||++.+     .++.++|||||||++|||++|+.||.+.+....+..+.........+....+|
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence            2  2245689999999998754     25789999999999999999999999988888888887755444433444689


Q ss_pred             HHHHHHHHHhhcCCccc--cCCHHHHhCCccccc
Q 015026          329 NSAKDFVKKLLVKDPRA--RLTAAQALSHPWVRE  360 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~--Rps~~elL~hp~f~~  360 (414)
                      .++.+||.+||+.+|.+  |+|++++++||||+.
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            99999999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-49  Score=390.78  Aligned_cols=258  Identities=31%  Similarity=0.502  Sum_probs=220.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+.+++.+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence            589999999999999999999999999999999765433344567889999999999 5999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-  255 (414)
                      ||++||+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... 
T Consensus        81 E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~---~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          81 DYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEeECCCCccccccc
Confidence            99999999998854  35689999999999999999999999999999999999998   5889999999997432100 


Q ss_pred             -----------------------------------------------CccccCCCCCccccchhccc-cCCCCcchhHHH
Q 015026          256 -----------------------------------------------KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIG  287 (414)
Q Consensus       256 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG  287 (414)
                                                                     ......+||+.|+|||++.+ .++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           00123579999999998764 468999999999


Q ss_pred             HHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCC---HHHHhCCcccccc
Q 015026          288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT---AAQALSHPWVREG  361 (414)
Q Consensus       288 ~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps---~~elL~hp~f~~~  361 (414)
                      |++|||++|+.||.+.+..+....+.........+....+++++.++|.+|+ .||.+|++   ++++++||||+..
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            9999999999999988777777777665444444445678999999999986 59999997   9999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-49  Score=380.64  Aligned_cols=248  Identities=26%  Similarity=0.490  Sum_probs=216.5

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (414)
                      ||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+++..++||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            69999999999999999999999999765433344567788999999999 59999999999999999999999999999


Q ss_pred             hHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-CCccccCC
Q 015026          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIV  262 (414)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~~~~~  262 (414)
                      |.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.... .......+
T Consensus        80 L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          80 LFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD---YQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC---CCCcEEEEECcccccCccCCCcccccc
Confidence            9998854  45789999999999999999999999999999999999998   578999999999875432 22334568


Q ss_pred             CCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcC
Q 015026          263 GSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK  341 (414)
Q Consensus       263 gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  341 (414)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+......++    ..+++++.+||.+||..
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~  230 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCC
Confidence            99999999987654 68899999999999999999999998888778877776654443    36889999999999999


Q ss_pred             CccccC---CHHHHhCCcccccc
Q 015026          342 DPRARL---TAAQALSHPWVREG  361 (414)
Q Consensus       342 dp~~Rp---s~~elL~hp~f~~~  361 (414)
                      ||.+||   ++.++|.||||...
T Consensus       231 dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCCcCCC
Confidence            999997   58999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-49  Score=390.01  Aligned_cols=257  Identities=27%  Similarity=0.498  Sum_probs=216.8

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|.+++.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+...+|+||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEE
Confidence            689999999999999999999999999999998765433344567788999999999 5999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++||+|.+++..  ...+++..++.++.||+.||+|||+.||+||||||+|||++   .++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeeccccccccccc
Confidence            99999999998853  45789999999999999999999999999999999999998   57899999999985321100


Q ss_pred             ------------------------------------------------ccccCCCCCccccchhccc-cCCCCcchhHHH
Q 015026          257 ------------------------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIG  287 (414)
Q Consensus       257 ------------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG  287 (414)
                                                                      .....+||+.|+|||++.+ .++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence                                                            0012579999999998765 468999999999


Q ss_pred             HHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCcccc---CCHHHHhCCccccc
Q 015026          288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR---LTAAQALSHPWVRE  360 (414)
Q Consensus       288 ~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---ps~~elL~hp~f~~  360 (414)
                      |++|||++|..||.+....+.+..+.........+....++.++.+||.+||. +|.+|   +++.+++.||||..
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            99999999999998887777777776543333222333578999999999998 77765   59999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-49  Score=390.70  Aligned_cols=257  Identities=28%  Similarity=0.474  Sum_probs=218.5

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+|+.+. ||||+++++.+.+++.+++||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEEE
Confidence            5999999999999999999999999999999987543322334567889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-  255 (414)
                      ||++||+|.+++..  .+.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|...... 
T Consensus        81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC---CCCCEEEEeCCCCccccccc
Confidence            99999999999844  45789999999999999999999999999999999999998   5789999999997432100 


Q ss_pred             -------------------------------------------CccccCCCCCccccchhcccc-CCCCcchhHHHHHHH
Q 015026          256 -------------------------------------------KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITY  291 (414)
Q Consensus       256 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~  291 (414)
                                                                 ......+||+.|+|||++.+. ++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                       001235799999999988654 688999999999999


Q ss_pred             HHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccC---CHHHHhCCccccc
Q 015026          292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVRE  360 (414)
Q Consensus       292 elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---s~~elL~hp~f~~  360 (414)
                      +|++|+.||.+....+....+..............+++++.++|.+|+ .+|.+|+   ++.++++||||+.
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            999999999988777766666654444444444578999999999987 5999999   9999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.1e-49  Score=373.79  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=211.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||.|+||+||+|.+..+++.||+|++.....  ......+.+|+.+++.+. ||||+++++++..++..++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence            469999999999999999999999999999999865432  123456778999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        82 ~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          82 FEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKSVP  156 (288)
T ss_pred             EeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEECcCcceeeccCC
Confidence            999975 888877443 34578999999999999999999999999999999999998   5789999999998765332


Q ss_pred             C-ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-----------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (414)
                      . ......||+.|+|||++.+  .++.++||||+||++|+|++|++||.+.+..+.+..+.........           
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence            2 2345678999999998754  3688999999999999999999999887766555444332111000           


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          322 ---------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       322 ---------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                                     ...+.+++++++||.+||+.||.+|||++|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                           0123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.9e-49  Score=380.90  Aligned_cols=249  Identities=29%  Similarity=0.539  Sum_probs=216.3

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++.+...+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654433445677889999999995 99999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-CCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~~~  260 (414)
                      |+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        80 g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          80 GELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---CCCcEEEecCcCCccCCCccccccc
Confidence            999888743  45789999999999999999999999999999999999998   578999999999875322 223345


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+......++    ..+++++.+||.+||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L  230 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLL  230 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHc
Confidence            689999999998864 468999999999999999999999988877777776665544433    368899999999999


Q ss_pred             cCCccccC-----CHHHHhCCccccc
Q 015026          340 VKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       340 ~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      ..||++|+     ++.++++||||..
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            99999997     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-49  Score=380.54  Aligned_cols=250  Identities=30%  Similarity=0.559  Sum_probs=217.3

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||+||+|.++.+++.||||++.+.........+.+..|+.++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999997654333345667788999998876799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~~  260 (414)
                      |+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~---~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeeCCCCeecCcCCCcccc
Confidence            999988843  45799999999999999999999999999999999999998   57899999999987532 2233345


Q ss_pred             CCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+++..+......++    ..+++++.+||.+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L  231 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFM  231 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHc
Confidence            6899999999988654 58899999999999999999999998888888888877654433    357899999999999


Q ss_pred             cCCccccCCH------HHHhCCccccc
Q 015026          340 VKDPRARLTA------AQALSHPWVRE  360 (414)
Q Consensus       340 ~~dp~~Rps~------~elL~hp~f~~  360 (414)
                      +.||.+||++      ++++.||||..
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            9999999998      99999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.6e-49  Score=387.01  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=221.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+.+++.+|+|
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            5799999999999999999999999999999999764433333456688999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         122 MEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEEecccceecccC
Confidence            999999999998843   3589999999999999999999999999999999999998   5789999999999876433


Q ss_pred             C--ccccCCCCCccccchhcccc-----CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          256 K--KFQDIVGSAYYVAPEVLKRK-----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .  .....+||+.|+|||++.+.     ++.++|||||||++|+|++|+.||.+.+..+.+..+......+..+....++
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  275 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS  275 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence            2  22466899999999988642     5789999999999999999999999888877888887655433333334679


Q ss_pred             HHHHHHHHHhhcCCccc--cCCHHHHhCCcccccc
Q 015026          329 NSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~--Rps~~elL~hp~f~~~  361 (414)
                      +.++++|.+||..++.+  |+++.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99999999999866554  8999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-49  Score=386.11  Aligned_cols=258  Identities=33%  Similarity=0.615  Sum_probs=223.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|.+.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.++..+. ||||+++++++.+++.+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence            36999999999999999999999999999999997654333345677889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          80 MEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEeecCCCCccCccc
Confidence            9999999999988544  6799999999999999999999999999999999999998   5789999999999765433


Q ss_pred             C------------------------------ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCC
Q 015026          256 K------------------------------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT  304 (414)
Q Consensus       256 ~------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~  304 (414)
                      .                              ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                              23356799999999987654 6889999999999999999999998888


Q ss_pred             chhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCC-HHHHhCCccccc
Q 015026          305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT-AAQALSHPWVRE  360 (414)
Q Consensus       305 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps-~~elL~hp~f~~  360 (414)
                      ..+....+......+..+....+++++.+||.+||. ||.+||+ +.++|+||||+.
T Consensus       235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            777777776633333333334589999999999997 9999999 999999999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.1e-49  Score=379.94  Aligned_cols=249  Identities=31%  Similarity=0.548  Sum_probs=216.4

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+. ||||+++++.+...+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654333345567788999999995 99999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~~  260 (414)
                      |+|..++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          80 GELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc---CCCCEEecccHHhccccCCCCcccc
Confidence            999888743  45789999999999999999999999999999999999998   57899999999987532 2233345


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+......++    ..+++++.+||.+||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L  230 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLL  230 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHc
Confidence            689999999998764 468899999999999999999999988887777777766554443    368899999999999


Q ss_pred             cCCccccC-----CHHHHhCCccccc
Q 015026          340 VKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       340 ~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      ..||.+||     ++.++++||||..
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            99999998     9999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.1e-49  Score=378.54  Aligned_cols=255  Identities=26%  Similarity=0.468  Sum_probs=220.8

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++++.||+|+||.||+|.+..+++.||||++.+.........+.+..|+.++..+..|++|+.+++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            48899999999999999999999999999999976543334456778899999999964567889999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PG  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~  255 (414)
                      ||++||+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... ..
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---AEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---CCCCEEEeecCcceecCCCC
Confidence            99999999988843  45789999999999999999999999999999999999998   57899999999986532 22


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+......++    ..+++++.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~l  231 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSI  231 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence            333456899999999988754 58899999999999999999999998888888888876654443    3688999999


Q ss_pred             HHHhhcCCccccCCH-----HHHhCCccccc
Q 015026          335 VKKLLVKDPRARLTA-----AQALSHPWVRE  360 (414)
Q Consensus       335 i~~~L~~dp~~Rps~-----~elL~hp~f~~  360 (414)
                      |.+||..||.+|+++     .++++||||..
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999999999999986     89999999985

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-48  Score=369.53  Aligned_cols=260  Identities=28%  Similarity=0.452  Sum_probs=219.6

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.+ +||||+++++.+..++.+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence            388999999999999999999999999999998765433333445677899999999 4999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++||+|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++   +++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC---CCCCEEEeeCCCceecCCCC
Confidence            999999999888655556799999999999999999999999999999999999998   57899999999998765544


Q ss_pred             ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (414)
                      .....+|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+............+.+++.+.+||
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            4455689999999998764 468889999999999999999999987665444333332222222223346889999999


Q ss_pred             HHhhcCCccccC-----CHHHHhCCccccc
Q 015026          336 KKLLVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       336 ~~~L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      .+||..||.+||     +++++++||||..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            999999999999     9999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-49  Score=389.11  Aligned_cols=262  Identities=30%  Similarity=0.442  Sum_probs=221.5

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-----CCceEEEEE
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-----ENVVKFYNA  165 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-----pnIv~~~~~  165 (414)
                      .+.+..+|.+++.||+|+||.|.+|.+..|++.||||+|+...    ....+...|+.+|..|+.|     -|||+++++
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            3445568999999999999999999999999999999997654    3667778999999999633     599999999


Q ss_pred             EEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          166 FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       166 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      |...++.|||+|++ +-+|++++..++...++...++.++.||+.||.+||+.||||+|||||||||... ....|||+|
T Consensus       257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVID  334 (586)
T KOG0667|consen  257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVID  334 (586)
T ss_pred             cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEe
Confidence            99999999999999 5699999999988999999999999999999999999999999999999999854 345899999


Q ss_pred             cccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC------
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD------  318 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~------  318 (414)
                      ||+|.+...  ...+++-+..|+|||++.| .++.+.||||||||++||++|.+.|.+.++.+.+..|..-...      
T Consensus       335 FGSSc~~~q--~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  335 FGSSCFESQ--RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             cccccccCC--cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999987643  3338899999999998765 5799999999999999999999999998887766655331100      


Q ss_pred             ---------CCC--------------------------------CCCC------------CCCHHHHHHHHHhhcCCccc
Q 015026          319 ---------FRR--------------------------------KPWP------------SISNSAKDFVKKLLVKDPRA  345 (414)
Q Consensus       319 ---------~~~--------------------------------~~~~------------~~s~~~~~li~~~L~~dp~~  345 (414)
                               |..                                ...|            .-...+.+||.+||.+||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                     000                                0001            11235689999999999999


Q ss_pred             cCCHHHHhCCccccc
Q 015026          346 RLTAAQALSHPWVRE  360 (414)
Q Consensus       346 Rps~~elL~hp~f~~  360 (414)
                      |+|+.++|+||||+.
T Consensus       493 R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  493 RITPAQALNHPFLTG  507 (586)
T ss_pred             cCCHHHHhcCccccc
Confidence            999999999999994

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.1e-49  Score=377.53  Aligned_cols=250  Identities=27%  Similarity=0.501  Sum_probs=217.5

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||.||+|.+..+|+.||+|++.+.........+.+..|+.++..+.+||||+++++++.+++.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999999999999999997654333445667788999998876799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-CCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~~~  260 (414)
                      ++|...+..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD---AEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeecccceecccCCccccc
Confidence            999988843  45789999999999999999999999999999999999998   578999999999875432 223345


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......++    ..+++++.+||.+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L  231 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFM  231 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHh
Confidence            679999999998765 468899999999999999999999998888888888877654433    357899999999999


Q ss_pred             cCCccccC-------CHHHHhCCccccc
Q 015026          340 VKDPRARL-------TAAQALSHPWVRE  360 (414)
Q Consensus       340 ~~dp~~Rp-------s~~elL~hp~f~~  360 (414)
                      ..||++||       ++.++++||||..
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            99999999       9999999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-49  Score=376.60  Aligned_cols=248  Identities=27%  Similarity=0.393  Sum_probs=211.5

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCE-EEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-EEEEE
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDR-VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-YVYIA  175 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~-vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-~~~lv  175 (414)
                      ..+.+.||.|+||+||+|.+.  |+. ||||++......... .+.|.+|+.+|.+|+ |||||+++|++.++. ..+||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEEE
Confidence            455667999999999999764  556 999999765543333 789999999999995 999999999999887 79999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEEeecCCCC-CceeeccccccccC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG-LVHRDMKPENFLFKSAKEDS-SLKATDFGLSDFIK  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~-iiHrDlkp~NIll~~~~~~~-~vkl~DFG~a~~~~  253 (414)
                      |||+++|+|.+++.......++...+..++.||+.|++|||+++ ||||||||+|||++   .+. ++||+|||+++...
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCCccceeec
Confidence            99999999999997654678999999999999999999999999 99999999999999   565 99999999998765


Q ss_pred             CC-CccccCCCCCccccchhcccc---CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          254 PG-KKFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      .. .......||+.|||||++.+.   ++.++||||||+++|||+||+.||.+.....+...+.........  ....++
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~--p~~~~~  273 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI--PKECPP  273 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--CccCCH
Confidence            43 334457899999999999854   799999999999999999999999988876666666544332221  124889


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+.+||.+||..||.+||+..+++.
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999999875

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-48  Score=368.91  Aligned_cols=257  Identities=26%  Similarity=0.382  Sum_probs=211.3

Q ss_pred             ceeeceeeeecCceEEEEEEECC-CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEE-----c
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFE-----D  168 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~-----~  168 (414)
                      +|++.+.||+|+||+||+|.+.. +|+.||+|++....... .....+.+|+.+++.+.  +||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            69999999999999999999854 46889999986543222 22345567888887763  4999999999885     3


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      ...+++||||++ ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~---~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc---CCCCEEEccccc
Confidence            456999999996 5899988665556789999999999999999999999999999999999998   578999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC------
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR------  321 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~------  321 (414)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+.........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            987655444456789999999998754 4688999999999999999999999988777766666543211100      


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          322 -----------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       322 -----------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                                       ...+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             0124578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.7e-50  Score=366.91  Aligned_cols=258  Identities=30%  Similarity=0.519  Sum_probs=218.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--C---
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--N---  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~---  170 (414)
                      -.|.-.+++|.|+||.||.|....+++.||||++-.+...       -.+|+.+|+.+ +|||||++.-+|...  +   
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKL-DHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhc-CCcCeeeEEEEEEecCCCchh
Confidence            3588899999999999999999999999999998655422       24799999988 599999999888532  2   


Q ss_pred             EEEEEEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          171 YVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      +..+||||++. +|.+.+...  ....++.-.++-+++||++||.|||+.||+||||||.|+|+|.  +.+.+||||||.
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~--~tg~LKicDFGS  172 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP--DTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC--CCCeEEeccCCc
Confidence            45689999974 888887532  3467899999999999999999999999999999999999996  679999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC----------
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------  316 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~----------  316 (414)
                      |+....++...++..|..|+|||.+.|  .|+.+.||||.|||+.||+-|.+.|.|.+..+.+..|++.-          
T Consensus       173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            999888888788999999999998876  47899999999999999999999999988877766665421          


Q ss_pred             --C--------CCCCCCC-----CCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          317 --P--------DFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       317 --~--------~~~~~~~-----~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                        +        .+....|     ..+++++.+|+.++|.++|.+|.++.|+|.||||.+....
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence              1        1111122     3478999999999999999999999999999999976544

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-48  Score=375.69  Aligned_cols=256  Identities=26%  Similarity=0.452  Sum_probs=222.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+..|..++..+..||+|+.+++++.+.+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48899999999999999999999999999999976543333455667788899888867899999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PG  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~  255 (414)
                      ||++||+|.+.+..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... ..
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---CCCcEEEccCCCceecCCCC
Confidence            99999999988843  35689999999999999999999999999999999999998   57899999999987543 22


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+++..+......++    ..++.++.+|
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  231 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  231 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence            333467899999999987654 68999999999999999999999998888888888877655443    3688999999


Q ss_pred             HHHhhcCCccccCCH-----HHHhCCcccccc
Q 015026          335 VKKLLVKDPRARLTA-----AQALSHPWVREG  361 (414)
Q Consensus       335 i~~~L~~dp~~Rps~-----~elL~hp~f~~~  361 (414)
                      |.+||+.||.+|+++     .++++||||...
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999984     899999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.8e-49  Score=380.34  Aligned_cols=259  Identities=29%  Similarity=0.503  Sum_probs=222.5

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|.+.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+.+++||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEE
Confidence            589999999999999999999999999999999865443344567788999999998 5999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++||+|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC---CCCCEEeccCCCCeECCCCC
Confidence            999999999988543 35799999999999999999999999999999999999998   57899999999998764433


Q ss_pred             cc--ccCCCCCccccchhcc-------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          257 KF--QDIVGSAYYVAPEVLK-------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       257 ~~--~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ..  ....||+.|+|||++.       ..++.++|||||||++|+|++|..||.+......+..+.........+..+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            22  2357999999999875       23578899999999999999999999888777777777665433333333468


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ++++.+||.+||. ||.+|||+.+++.||||...
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999999999998 99999999999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.6e-49  Score=383.77  Aligned_cols=258  Identities=28%  Similarity=0.500  Sum_probs=219.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..+ +||||+++++.+.+.+.+++||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999764433344567788999999999 5999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~---~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEeeccCCccccccc
Confidence            99999999998844  45789999999999999999999999999999999999998   57899999999986542210


Q ss_pred             ------------------------------------ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCC
Q 015026          257 ------------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRP  299 (414)
Q Consensus       257 ------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~P  299 (414)
                                                          .....+||+.|+|||++.+ .++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence                                                0124579999999998765 468899999999999999999999


Q ss_pred             CCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccC---CHHHHhCCcccccc
Q 015026          300 FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVREG  361 (414)
Q Consensus       300 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---s~~elL~hp~f~~~  361 (414)
                      |.+.+..+.+..+.........+....+++++++||.+|+. ||.+|+   ++.++++||||...
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            99888877777776544333222223578999999999874 999998   58999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-48  Score=376.65  Aligned_cols=250  Identities=25%  Similarity=0.462  Sum_probs=211.0

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998755444445677889999999997799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc-CCCCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~-~~~~~~~~  260 (414)
                      |+|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++... ........
T Consensus        81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEECcCccccccccCCCcccc
Confidence            999988743  45799999999999999999999999999999999999998   5789999999998753 22333456


Q ss_pred             CCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc---------hhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          261 IVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE---------DGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      .+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.....         ......+......++    ..++.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~  231 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVK  231 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHH
Confidence            7899999999988754 68899999999999999999999963211         123333444333222    367899


Q ss_pred             HHHHHHHhhcCCccccCC------HHHHhCCccccc
Q 015026          331 AKDFVKKLLVKDPRARLT------AAQALSHPWVRE  360 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps------~~elL~hp~f~~  360 (414)
                      +.+||.+||+.||.+|++      ++++++||||..
T Consensus       232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999999999997      789999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-48  Score=374.49  Aligned_cols=251  Identities=28%  Similarity=0.504  Sum_probs=214.5

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||.||+|.+..+|+.||+|++.+.........+.+..|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997653322234566778888888766799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~~  260 (414)
                      |+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEeCccCCCeecccCCCceec
Confidence            999988844  35789999999999999999999999999999999999998   57899999999987532 2223345


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+....+.++    ..++.++.+||.+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l  231 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLF  231 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHc
Confidence            789999999998865 468899999999999999999999998887777777766544333    257899999999999


Q ss_pred             cCCccccCCH-HHHhCCcccccc
Q 015026          340 VKDPRARLTA-AQALSHPWVREG  361 (414)
Q Consensus       340 ~~dp~~Rps~-~elL~hp~f~~~  361 (414)
                      ..||++||++ +++++||||...
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCC
Confidence            9999999998 588899999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-48  Score=374.69  Aligned_cols=253  Identities=27%  Similarity=0.491  Sum_probs=217.3

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEEcCCEEEEE
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      |++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++..+.  +||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            688999999999999999999999999999997654333345567778877765332  499999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-  254 (414)
                      |||++|++|...+.   ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... 
T Consensus        81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~---~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD---TEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCcEEeCcccCCccCCCC
Confidence            99999999988773   34699999999999999999999999999999999999998   578999999999875332 


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......++    ..+++++.+
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  230 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAIS  230 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHH
Confidence            223345789999999998765 458899999999999999999999998888888877777655433    367899999


Q ss_pred             HHHHhhcCCccccC-----CHHHHhCCccccc
Q 015026          334 FVKKLLVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      +|.+||..||.+||     ++.++++||||+.
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            99999999999999     7999999999986

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-48  Score=374.20  Aligned_cols=251  Identities=30%  Similarity=0.523  Sum_probs=214.6

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||+||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++..++.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654333345566677888887766799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-CCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~~~  260 (414)
                      |+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC---CCCCEEEccCcCCeECCCCCCcccc
Confidence            999988843  45799999999999999999999999999999999999998   578999999999976432 233345


Q ss_pred             CCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+++..+....+.++    ..++.++.+||.+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l  231 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLF  231 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHc
Confidence            6899999999988654 68899999999999999999999998888777777766544333    357899999999999


Q ss_pred             cCCccccCCH-HHHhCCcccccc
Q 015026          340 VKDPRARLTA-AQALSHPWVREG  361 (414)
Q Consensus       340 ~~dp~~Rps~-~elL~hp~f~~~  361 (414)
                      ..||.+||++ .+++.||||...
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCCC
Confidence            9999999986 488899999853

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-48  Score=368.48  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=209.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++...+.+++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEE
Confidence            369999999999999999999999999999999875432 2234567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++++.+.. +.. ....+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++......
T Consensus        79 ~e~~~~~~l~~-~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          79 FEYVEKNMLEL-LEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             EecCCCCHHHH-HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCccccccc
Confidence            99998866544 332 335689999999999999999999999999999999999998   5789999999999876432


Q ss_pred             C--ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC--------------CC
Q 015026          256 K--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--------------PD  318 (414)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~--------------~~  318 (414)
                      .  ......||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+....+....              +.
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            2  2334679999999998765 46889999999999999999999998766544333222111              00


Q ss_pred             C-----CC---------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 F-----RR---------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 ~-----~~---------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      +     +.         .....+|+++.+||++||+.||++|||++++|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0     00         0112378889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.5e-48  Score=376.44  Aligned_cols=255  Identities=27%  Similarity=0.504  Sum_probs=212.6

Q ss_pred             ceeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCC-ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .|++++.||+|+||+||+|++.   .+|+.||+|++.+.... .....+.+..|+.+++.+.+||||+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4899999999999999999864   57899999998754321 1234567889999999997799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---CCCCEEEeeCcCCccc
Confidence            999999999999998854  35689999999999999999999999999999999999998   5789999999999764


Q ss_pred             CCC--CccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCch----hhhHHHhhcCCCCCCCCC
Q 015026          253 KPG--KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       253 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~  324 (414)
                      ...  ......+||+.|+|||++.+.  ++.++|||||||++|+|++|..||......    .....+....+.    ..
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~  231 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP----FP  231 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC----CC
Confidence            332  223356899999999998753  578899999999999999999999754332    233333333322    22


Q ss_pred             CCCCHHHHHHHHHhhcCCccccC-----CHHHHhCCccccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      +.+++.+.+||.+||..||++||     +++++++||||+.
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            46889999999999999999999     8899999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.4e-49  Score=377.61  Aligned_cols=249  Identities=30%  Similarity=0.542  Sum_probs=215.4

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654333345567788999999995 99999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ  259 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~  259 (414)
                      |+|..++..  ...+++..++.++.||+.||.|||+ .||+||||||+|||++   .++.+||+|||++.... ......
T Consensus        80 ~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          80 GELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC---CCCCEEEecCCCCeecCCCCcccc
Confidence            999988743  4578999999999999999999997 7999999999999998   57899999999987532 233334


Q ss_pred             cCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 015026          260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (414)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.+||.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~  230 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGL  230 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHH
Confidence            5689999999998865 468899999999999999999999988877777777665554443    35889999999999


Q ss_pred             hcCCccccC-----CHHHHhCCccccc
Q 015026          339 LVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       339 L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      |+.||++|+     ++.++++||||..
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            999999997     9999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.8e-48  Score=381.30  Aligned_cols=259  Identities=28%  Similarity=0.475  Sum_probs=221.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+.+++.+++|
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEE
Confidence            5799999999999999999999999999999998754333333456678999999999 499999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         122 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCceeEcCcC
Confidence            999999999998743   3589999999999999999999999999999999999998   5789999999999865432


Q ss_pred             C--ccccCCCCCccccchhcccc-----CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          256 K--KFQDIVGSAYYVAPEVLKRK-----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .  .....+||+.|+|||++.+.     ++.++|||||||++|+|++|..||.+.+....+..+......+..+..+.++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence            2  22356899999999988642     5789999999999999999999999888877888887655444444445789


Q ss_pred             HHHHHHHHHhhcCCccc--cCCHHHHhCCcccccc
Q 015026          329 NSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~--Rps~~elL~hp~f~~~  361 (414)
                      .++++||.+||..++.+  |++++++++||||+..
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            99999999999844443  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.5e-48  Score=369.14  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=207.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.....  ......+.+|+.+++.+. ||||+++++++.++...++|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEE
Confidence            579999999999999999999999999999999865432  122345678999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        82 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          82 FEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVP  156 (303)
T ss_pred             EECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECCCCcceeccCC
Confidence            99995 5888877543 35689999999999999999999999999999999999998   5788999999998754322


Q ss_pred             -CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhhcCC--------------
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKP--------------  317 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~--------------  317 (414)
                       ......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.... +.+..+.....              
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             22345678999999998754  3578899999999999999999999875432 22222211100              


Q ss_pred             CCCCC------------CC--CCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          318 DFRRK------------PW--PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       318 ~~~~~------------~~--~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .+...            .+  ...++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            00000            00  1245788999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.9e-48  Score=373.67  Aligned_cols=251  Identities=29%  Similarity=0.517  Sum_probs=217.0

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.+.+||||+++++++.+.+.+++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998654333345667788999998886799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~~  260 (414)
                      |+|.+++..  ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC---CCCcEEecccCCCeecCcCCCcccc
Confidence            999988743  35799999999999999999999999999999999999998   57899999999986532 2223345


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+......++    ..+++++.+||.+||
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l  231 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFL  231 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHc
Confidence            679999999998865 468899999999999999999999988887777777766554433    357899999999999


Q ss_pred             cCCccccCCH-----HHHhCCcccccc
Q 015026          340 VKDPRARLTA-----AQALSHPWVREG  361 (414)
Q Consensus       340 ~~dp~~Rps~-----~elL~hp~f~~~  361 (414)
                      ..||.+|||+     .+++.||||+..
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999     999999999763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-48  Score=374.24  Aligned_cols=259  Identities=30%  Similarity=0.478  Sum_probs=208.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC-----CE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----NY  171 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~-----~~  171 (414)
                      +|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.+. ||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence            58999999999999999999999999999999864321 1224456889999999995 99999999987543     35


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +|+||||+. ++|.+.+..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus        79 ~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kL~Dfg~~~~  152 (338)
T cd07859          79 IYVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEccCccccc
Confidence            899999995 688888743  35689999999999999999999999999999999999998   588999999999975


Q ss_pred             cCCCC----ccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh----------
Q 015026          252 IKPGK----KFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------  314 (414)
Q Consensus       252 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~----------  314 (414)
                      .....    .....+||+.|+|||++.+   .++.++|||||||++|+|++|++||.+.+....+..+..          
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            43211    1235689999999998764   568899999999999999999999977654332221111          


Q ss_pred             -----------------cCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          315 -----------------NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       315 -----------------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                       ..+......++.+++++.++|.+||..||++|||++++|+||||+....
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                             1111111223567889999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.6e-48  Score=388.00  Aligned_cols=257  Identities=23%  Similarity=0.408  Sum_probs=209.4

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC-----
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~-----  169 (414)
                      ..+|++++.||+|+||.||+|.+..+++.||||++....       ....+|+.+|+.+. |||||++++++...     
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeecccccC
Confidence            457999999999999999999999999999999886432       22357999999995 99999999876432     


Q ss_pred             ---CEEEEEEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceee
Q 015026          170 ---NYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (414)
Q Consensus       170 ---~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (414)
                         ..+++||||+++ +|.+++..  .....+++..++.++.||+.||.|||++||+||||||+|||++.  .++.+||+
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~vkL~  213 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTLKLC  213 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCceeee
Confidence               257799999975 77776642  23467999999999999999999999999999999999999984  34579999


Q ss_pred             ccccccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC----
Q 015026          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD----  318 (414)
Q Consensus       245 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----  318 (414)
                      |||+|+...........+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+......    
T Consensus       214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9999987765555556789999999998764  4688999999999999999999999887766555554432110    


Q ss_pred             -------------CCCC--------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          319 -------------FRRK--------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       319 -------------~~~~--------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                   ++..        .....|+++.+||.+||.+||.+|||+.|+|.||||....
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                         1100        0123678999999999999999999999999999998643

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.2e-48  Score=372.91  Aligned_cols=250  Identities=25%  Similarity=0.464  Sum_probs=209.9

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+.+||||+++++++..++.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998764444455677889999998886799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~~  260 (414)
                      |+|..++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++... .......
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~---~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCCEEEeeCCccccccCCCCcccc
Confidence            999888743  45799999999999999999999999999999999999998   57899999999987532 2233345


Q ss_pred             CCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCC---------chhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          261 IVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT---------EDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      .+||+.|+|||++.+. ++.++|||||||++|+|++|+.||....         ...+...+......++    ..++.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~  231 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVK  231 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHH
Confidence            7899999999988654 5889999999999999999999995311         1112333444333322    367899


Q ss_pred             HHHHHHHhhcCCccccCC------HHHHhCCccccc
Q 015026          331 AKDFVKKLLVKDPRARLT------AAQALSHPWVRE  360 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps------~~elL~hp~f~~  360 (414)
                      +.+||.+||+.||.+||+      +.++++||||+.
T Consensus       232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999999999998      579999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.7e-48  Score=370.50  Aligned_cols=251  Identities=29%  Similarity=0.503  Sum_probs=213.8

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||+||+|.+..+++.||||++.............+..|..++..+.+||||+++++++.+.+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997653222234556677888888765799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-CCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~~~  260 (414)
                      |+|.+++..  ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEccCCcceECCCCCCceee
Confidence            999998843  35689999999999999999999999999999999999998   578899999999875322 223345


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+....+.++    ..++.++.+||.+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l  231 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLF  231 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHh
Confidence            689999999998765 468899999999999999999999988887777777665544333    257889999999999


Q ss_pred             cCCccccCCHH-HHhCCcccccc
Q 015026          340 VKDPRARLTAA-QALSHPWVREG  361 (414)
Q Consensus       340 ~~dp~~Rps~~-elL~hp~f~~~  361 (414)
                      ..||.+||++. ++++||||...
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCC
Confidence            99999999996 89999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.9e-48  Score=370.55  Aligned_cols=256  Identities=25%  Similarity=0.442  Sum_probs=220.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|+..+.||+|+||+||+|.+..+|+.||+|++.+.........+.+..|+.++..+.+||+|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            37888999999999999999999999999999976543333455677889999998876788999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-  255 (414)
                      ||++||+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... 
T Consensus        81 Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~---~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeccccccccCCCC
Confidence            99999999998843  45799999999999999999999999999999999999998   5789999999998754322 


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......+..+......++    ..++.++.++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  231 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSI  231 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence            223456799999999988654 68899999999999999999999998888888888877654433    3678999999


Q ss_pred             HHHhhcCCccccCC-----HHHHhCCcccccc
Q 015026          335 VKKLLVKDPRARLT-----AAQALSHPWVREG  361 (414)
Q Consensus       335 i~~~L~~dp~~Rps-----~~elL~hp~f~~~  361 (414)
                      +.+||..||.+|++     ..++++||||...
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            99999999999997     5799999999863

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.6e-48  Score=363.02  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=209.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEEc-----C
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFED-----D  169 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~~-----~  169 (414)
                      +|++.+.||+|+||+||+|.+..+|+.||+|.+...... ......+.+|+.+++.+.  +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            589999999999999999999999999999998654321 112334567888777663  59999999998764     3


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      ..+++||||+++ +|.+++.......+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccCcc
Confidence            568999999975 888888665556689999999999999999999999999999999999998   5788999999999


Q ss_pred             cccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC----------
Q 015026          250 DFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD----------  318 (414)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----------  318 (414)
                      .............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+......          
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            87655444456688999999998754 4688999999999999999999999877666555554331100          


Q ss_pred             ------CC-------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 ------FR-------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 ------~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                            +.       ....+.++.++.+||.+||+.||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  00       01124578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.6e-48  Score=371.74  Aligned_cols=249  Identities=27%  Similarity=0.491  Sum_probs=211.4

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHH-HHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI-LQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      +.||+|+||+||+|.+..+|+.||||++.+...........+..|..+ ++.+ +||||+++++.+.+.+.+++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            469999999999999999999999999976543223334455666654 5667 59999999999999999999999999


Q ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCccc
Q 015026          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ  259 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~  259 (414)
                      ||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... ......
T Consensus        80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeccCCCcccccCCCccc
Confidence            9999998844  45789999999999999999999999999999999999998   57899999999987532 223334


Q ss_pred             cCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 015026          260 DIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (414)
                      ..+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+.......    .+.+++++.++|.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~  230 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL----KPNISVSARHLLEGL  230 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHH
Confidence            56899999999987654 6889999999999999999999999888777777777654433    246799999999999


Q ss_pred             hcCCccccCCH----HHHhCCccccc
Q 015026          339 LVKDPRARLTA----AQALSHPWVRE  360 (414)
Q Consensus       339 L~~dp~~Rps~----~elL~hp~f~~  360 (414)
                      |+.||.+||++    .++++||||..
T Consensus       231 l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         231 LQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             hhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            99999999998    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-47  Score=361.21  Aligned_cols=253  Identities=27%  Similarity=0.429  Sum_probs=208.4

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (414)
                      ||+|+||+||+|.+..+|+.||+|++...........+.+..|+.+++.+ +||||+++++++..+..+++||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            69999999999999999999999998765433333456778899999999 59999999999999999999999999999


Q ss_pred             hHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-cccc
Q 015026          184 LLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQD  260 (414)
Q Consensus       184 L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-~~~~  260 (414)
                      |.+.+...  ....+++..+..++.||+.||.|||++||+||||||+||+++   .++.++|+|||++....... ....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCCCccccc
Confidence            98877432  345689999999999999999999999999999999999998   57889999999997654432 2335


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      ..||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.......+....+.+++++.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            679999999998765 4588999999999999999999999765443222222221111112222468899999999999


Q ss_pred             cCCccccC-----CHHHHhCCccccc
Q 015026          340 VKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       340 ~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      +.||++||     +++++++||||+.
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            99999999     8899999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-47  Score=369.44  Aligned_cols=260  Identities=27%  Similarity=0.492  Sum_probs=217.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||++.+..+++.||+|++.+.........+.+.+|+.++..+ +||||+.+++++.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence            3699999999999999999999999999999999764333334556788999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             EecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---CCCCEEEEECCceeecCCC
Confidence            9999999999988542 45689999999999999999999999999999999999998   5789999999998765433


Q ss_pred             Ccc--ccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-CCCCC
Q 015026          256 KKF--QDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPS  326 (414)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~  326 (414)
                      ...  ...+||+.|+|||++.      +.++.++|||||||++|+|++|+.||.+.+..+.+..+......+.. ...+.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence            222  2357999999999885      23578899999999999999999999888777777766654332221 12345


Q ss_pred             CCHHHHHHHHHhhcCCccc--cCCHHHHhCCccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRA--RLTAAQALSHPWVRE  360 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~--Rps~~elL~hp~f~~  360 (414)
                      +++++++||.+||+.++.+  |+++.++++||||..
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            8999999999999765544  789999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-49  Score=374.33  Aligned_cols=257  Identities=28%  Similarity=0.481  Sum_probs=234.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE-EEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY-VYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~-~~l  174 (414)
                      +.|..++.+|+|+||.+++++++.++..+|+|.|.......+ ..+...+|+.++++++ |||||.+++.|..++. ++|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence            469999999999999999999999999999999988776544 4568899999999996 9999999999988777 999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||+||+||+|.+.+.+.+...++++.+..|+.||+.|+.|||+++|+|||||+.|||++   .++.|||+|||+|+...+
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCC
Confidence            99999999999999888888999999999999999999999999999999999999999   577889999999999887


Q ss_pred             CC-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .. ...+++|||.||+||++.+. |+.++|||||||++|||++-+++|.+.+...+..+|.+......   ....+.+++
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl---p~~ys~el~  235 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL---PSMYSSELR  235 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC---CccccHHHH
Confidence            76 56789999999999998875 69999999999999999999999999999999999988773222   246889999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      .+|..||..+|..||++.++|.+|.+..
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            9999999999999999999999999874

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.2e-48  Score=369.69  Aligned_cols=251  Identities=31%  Similarity=0.549  Sum_probs=213.7

Q ss_pred             ceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCC-ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026          101 GKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      ++.||+|+||.||+|++.   .+++.||+|++...... .......+.+|+.+|+.+. ||||+++++.+..++.+|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence            367999999999999864   57889999998754321 1223456789999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-C
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-G  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-~  255 (414)
                      ||++|++|.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.... .
T Consensus        80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          80 EYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             eCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEeeCcCCeecccCC
Confidence            99999999998843  45788999999999999999999999999999999999998   578999999999875332 2


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      ......+||+.|+|||++.+. ++.++|||||||++|||++|+.||.+......+..+......++    +.+++++.+|
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  230 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDL  230 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence            233456899999999987654 58899999999999999999999988877777777776654333    4678999999


Q ss_pred             HHHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          335 VKKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       335 i~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      |.+||..||++||     ++.+++.||||...
T Consensus       231 i~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2e-47  Score=360.83  Aligned_cols=257  Identities=26%  Similarity=0.460  Sum_probs=216.6

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.+. |++|+.+++.+.+.+.+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEE
Confidence            3788899999999999999999999999999987654433334566788999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++   .++.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeccceeecCCCc
Confidence            999999999988655555799999999999999999999999999999999999998   57789999999997765444


Q ss_pred             ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh---hhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ......|+..|+|||++.+ .++.++||||+||++|+|++|..||.+.....   ....+....   .......+++++.
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  233 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSPDAR  233 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCHHHH
Confidence            4455689999999998764 46889999999999999999999997654322   222222211   1222346889999


Q ss_pred             HHHHHhhcCCccccCC-----HHHHhCCccccc
Q 015026          333 DFVKKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      +||.+||+.||.+|||     ++|+++||||..
T Consensus       234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            9999999999999999     999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=374.60  Aligned_cols=266  Identities=34%  Similarity=0.580  Sum_probs=241.5

Q ss_pred             cccccceee--ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           92 KDFDRRYTI--GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        92 ~~~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      -++..-|+|  .+.||.|.||+||-|+++.+|+.||||+|++.+.... ....+++|+.||+.+. ||.||.+--.|+..
T Consensus       558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~-HPGiV~le~M~ET~  635 (888)
T KOG4236|consen  558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLH-HPGIVNLECMFETP  635 (888)
T ss_pred             hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcC-CCCeeEEEEeecCC
Confidence            345556776  5799999999999999999999999999998876543 4478999999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      +.+++|||-+ .|+.++.|.....+++++...+.++.||+.||.|||-++|+|+||||+|||+.+...-..+||||||+|
T Consensus       636 ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  636 ERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             ceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccce
Confidence            9999999999 568899998888899999999999999999999999999999999999999998777889999999999


Q ss_pred             cccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          250 DFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      +++....-..+++|||.|.|||++..+ +...-|+||.|||+|--++|..||.  ..+++-.+|.+....++..+|..++
T Consensus       715 RiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~eis  792 (888)
T KOG4236|consen  715 RIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSEIS  792 (888)
T ss_pred             eecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhhcC
Confidence            999877777789999999999998765 5677799999999999999999994  3456777888888999999999999


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +++.+||..+|+..-++|.|++..|.|||+++..
T Consensus       793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            9999999999999999999999999999999753

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-48  Score=373.98  Aligned_cols=249  Identities=28%  Similarity=0.519  Sum_probs=212.4

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      ||+|+||+||+|.+..+|+.||+|++.+..............|..++..+.  +||||+.+++.+.....+|+||||++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999999999999999987644332334445566777777664  699999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-CCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~~~  260 (414)
                      |+|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEecCCcCcCCCCCCCCccC
Confidence            99998884  346799999999999999999999999999999999999998   578999999999875322 233446


Q ss_pred             CCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 015026          261 IVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (414)
                      .+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+......++.   ..+++++.+||.+|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~  232 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGL  232 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHH
Confidence            789999999998764  3588999999999999999999999988877777777766554433   35789999999999


Q ss_pred             hcCCccccC----CHHHHhCCccccc
Q 015026          339 LVKDPRARL----TAAQALSHPWVRE  360 (414)
Q Consensus       339 L~~dp~~Rp----s~~elL~hp~f~~  360 (414)
                      |..||.+||    ++.++++||||..
T Consensus       233 L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         233 LNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             cCCCHHHCCCCCCCHHHHhcCccccC
Confidence            999999998    7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-47  Score=368.20  Aligned_cols=251  Identities=25%  Similarity=0.436  Sum_probs=210.5

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++..+.+||||+.+++++.+.+.+++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999999999999999998765444445677889999999997799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCcccc
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~~  260 (414)
                      |+|..++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---CCCCEEEeccccceeccCCCCceec
Confidence            999988743  35799999999999999999999999999999999999998   57889999999987532 2333456


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCc-------hhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE-------DGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|..||.....       ......+......+    ...++..+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~  231 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI----PRFLSVKAS  231 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC----CCCCCHHHH
Confidence            789999999998765 468899999999999999999999964321       12233333332222    235789999


Q ss_pred             HHHHHhhcCCccccCC------HHHHhCCcccccc
Q 015026          333 DFVKKLLVKDPRARLT------AAQALSHPWVREG  361 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps------~~elL~hp~f~~~  361 (414)
                      ++|.+||..||++|++      ++++++||||...
T Consensus       232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            9999999999999998      4799999999863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.7e-47  Score=357.72  Aligned_cols=260  Identities=28%  Similarity=0.451  Sum_probs=220.3

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |+..+.||.|+||+||+|.+..+++.||+|.+.............+.+|+.+++.+. |+||+.+++.+..++..++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEEE
Confidence            778899999999999999999999999999987654333334556788999999995 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~  257 (414)
                      |+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++   .++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcceecCCCCc
Confidence            99999999888665555799999999999999999999999999999999999998   567899999999976654444


Q ss_pred             cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHH
Q 015026          258 FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (414)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (414)
                      .....|++.|+|||++.+ .++.++|+|||||++|+|++|..||.+.........+............+.+++++.+|+.
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            456689999999998754 4688999999999999999999999877655444444333322233334568899999999


Q ss_pred             HhhcCCccccCC-----HHHHhCCcccccc
Q 015026          337 KLLVKDPRARLT-----AAQALSHPWVREG  361 (414)
Q Consensus       337 ~~L~~dp~~Rps-----~~elL~hp~f~~~  361 (414)
                      +||+.||.+||+     +.+++.||||...
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            999999999999     8899999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-47  Score=374.92  Aligned_cols=253  Identities=22%  Similarity=0.376  Sum_probs=204.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|.+++.||+|+||.||+|.+..+++.||+|...         ...+.+|+.+|+.|. ||||++++++|......++|
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEEE
Confidence            57999999999999999999999999999999653         234678999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-  254 (414)
                      +|++. ++|..++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|..... 
T Consensus       162 ~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        162 LPRYK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---CCCCEEEEeCCcccccccc
Confidence            99995 688888744  35689999999999999999999999999999999999998   578899999999975322 


Q ss_pred             -CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCc-------hhhhHHHhhcCCC-------
Q 015026          255 -GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE-------DGIFKEVLRNKPD-------  318 (414)
Q Consensus       255 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~~-------  318 (414)
                       .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.....       ...+..++.....       
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence             123345689999999998765 468899999999999999999988754321       1112212111000       


Q ss_pred             ---------------------CCCCCC---CCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          319 ---------------------FRRKPW---PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       319 ---------------------~~~~~~---~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                                           .....|   ..++.++.+||.+||+.||.+|||+.|+|+||||+.....
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                                 000011   1356789999999999999999999999999999875443

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.4e-47  Score=365.05  Aligned_cols=258  Identities=27%  Similarity=0.376  Sum_probs=213.6

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++++.||+|+||.||+|.+..+|..||+|++....  .+...+.+.+|+.+|+.+. ||||+++++++.+++.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence            357999999999999999999999999999999987542  2345678999999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||||++|++|.+++..  ...+++..+..++.|++.||.|||+. +|+||||||+|||++   .++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          81 CMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc---CCCcEEEccCccccccc
Confidence            9999999999998844  34689999999999999999999986 699999999999998   57889999999987654


Q ss_pred             CCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC----------------
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------------  316 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~----------------  316 (414)
                      .. ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||......++...+-...                
T Consensus       156 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             cc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence            32 23456799999999988754 6889999999999999999999997654433221110000                


Q ss_pred             ----------------------------CCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          317 ----------------------------PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       317 ----------------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                                  ...+......+++++.+||.+||..||++|||+.++|+||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                        000111112468899999999999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-49  Score=354.05  Aligned_cols=256  Identities=31%  Similarity=0.559  Sum_probs=235.1

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|..+++||+|.||+|.+|+.+.+|+.+|||+++++-.........-..|-++|+..+ ||.+..+...|+..+.+|+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEE
Confidence            357899999999999999999999999999999998877666666777788999999996 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc-cC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IK  253 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~-~~  253 (414)
                      ||||..||.|+-++  .....+++..++.+...|+.||.|||+.+||+||||.+|.|++   ++|+|||+|||+++. +.
T Consensus       246 VMeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD---kDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  246 VMEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD---KDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec---cCCceEeeecccchhccc
Confidence            99999999999888  4456799999999999999999999999999999999999999   799999999999974 55


Q ss_pred             CCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .+....+.||||.|.|||++.. .|+.++|+|.+||++|||+||+.||...+.+.++..|+-....|+.    .++++++
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAk  396 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAK  396 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHH
Confidence            5667789999999999999975 5799999999999999999999999999999999999988888876    6899999


Q ss_pred             HHHHHhhcCCccccC-----CHHHHhCCccccc
Q 015026          333 DFVKKLLVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       333 ~li~~~L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      .|+..+|..||.+|.     .+.|+.+|+||..
T Consensus       397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            999999999999997     6899999999986

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-47  Score=371.81  Aligned_cols=255  Identities=27%  Similarity=0.401  Sum_probs=208.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ..|++++.||+|+||+||+|.+..+|+.||||++....  .......+.+|+.+++.+. ||||+++++++.+.+.+++|
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEEE
Confidence            46888999999999999999999999999999986543  2345678899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+.      ...++..+..++.||+.||.|||++||+||||||+|||++   +++.+||+|||++......
T Consensus       151 ~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        151 LEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN---SAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             EecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEcccccceecccc
Confidence            999999988642      2456788899999999999999999999999999999998   5789999999999875432


Q ss_pred             C-ccccCCCCCccccchhcccc------CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          256 K-KFQDIVGSAYYVAPEVLKRK------SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~------~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      . .....+||..|+|||++...      .+.++|||||||++|||++|+.||......+....+..............++
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence            2 23456899999999987432      2568999999999999999999997443322222211111111222234688


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .++.+||.+||..||++|||+.|+|+||||....
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999999999999998753

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-47  Score=368.25  Aligned_cols=249  Identities=27%  Similarity=0.482  Sum_probs=211.4

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHH-HHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI-LQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      +.||+|+||+||+|.+..+|+.||+|++.+...........+..|..+ ++.+ +||||+++++.+..++..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence            469999999999999999999999999976533333344556666654 5567 59999999999999999999999999


Q ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCccc
Q 015026          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ  259 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~  259 (414)
                      ||+|..++.  ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... ......
T Consensus        80 ~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~---~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          80 GGELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEeecCCcccCCCCCCCcc
Confidence            999998874  345799999999999999999999999999999999999998   57899999999987532 223334


Q ss_pred             cCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 015026          260 DIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (414)
                      ..+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+++..+.......+    +.++.++.++|.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~l  230 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEEL  230 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHH
Confidence            56899999999987654 68899999999999999999999998887777777776543332    46889999999999


Q ss_pred             hcCCccccCCH----HHHhCCccccc
Q 015026          339 LVKDPRARLTA----AQALSHPWVRE  360 (414)
Q Consensus       339 L~~dp~~Rps~----~elL~hp~f~~  360 (414)
                      |..||.+||++    .+++.||||..
T Consensus       231 l~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         231 LEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             hccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            99999999987    58999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.2e-47  Score=365.83  Aligned_cols=260  Identities=27%  Similarity=0.464  Sum_probs=218.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||++.+..+++.||+|++.+...........+..|+.++..+ +||+|+++++.+.+.+.+++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence            3689999999999999999999999999999998654332333455688899999998 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~---~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             EeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEeecchheecccC
Confidence            9999999999998543 34689999999999999999999999999999999999998   5789999999998754332


Q ss_pred             Cc--cccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-CCCCC
Q 015026          256 KK--FQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPS  326 (414)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~  326 (414)
                      ..  ....+||+.|+|||++.      +.++.++|||||||++|||++|+.||.+.+..+.+..+......+.. .....
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence            22  23467999999999875      24688999999999999999999999988877777777665433322 12346


Q ss_pred             CCHHHHHHHHHhhcCCccc--cCCHHHHhCCccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRA--RLTAAQALSHPWVRE  360 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~--Rps~~elL~hp~f~~  360 (414)
                      +++++.+||.+||+.++.+  |++++++++||||..
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            8999999999999765554  689999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-48  Score=370.20  Aligned_cols=245  Identities=27%  Similarity=0.427  Sum_probs=213.5

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .+++++.||+|.||+||.|.+..+ ..||+|.+....+    ..+.|.+|+.+|++|+ |++||++++++..+..+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEEEE
Confidence            467789999999999999987543 3799999976543    3467889999999996 999999999999988999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      |||+.|+|.+++.......+...+...++.||++|++||+++++|||||.+.|||++   ++..|||+|||+|+.+.++.
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccCCCc
Confidence            999999999999876678899999999999999999999999999999999999999   68899999999999655433


Q ss_pred             ccccCCC---CCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          257 KFQDIVG---SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       257 ~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                       +....|   -..|+|||++. +..+.++|||||||+|+||+| |+.||.+.+..++++.+.++..-   +..+.+|+++
T Consensus       358 -Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl---p~P~~CP~~v  433 (468)
T KOG0197|consen  358 -YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL---PRPEGCPDEV  433 (468)
T ss_pred             -eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC---CCCCCCCHHH
Confidence             222223   34699999876 667999999999999999999 99999999999999999887643   3335799999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+++..||..+|++|||.+.+..
T Consensus       434 Y~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  434 YELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHhhCCcccCCCHHHHHH
Confidence            99999999999999999986553

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.3e-47  Score=366.23  Aligned_cols=260  Identities=27%  Similarity=0.472  Sum_probs=218.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+++..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            3699999999999999999999999999999998764332333456688899999998 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD---MNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             EeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---CCCCEEEEeccceeeccCC
Confidence            9999999999988543 35789999999999999999999999999999999999998   5788999999999765433


Q ss_pred             Ccc--ccCCCCCccccchhccc------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC-CCCCCC
Q 015026          256 KKF--QDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-RKPWPS  326 (414)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~  326 (414)
                      ...  ...+||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+.+..+.+..+......++ ...+..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD  235 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence            222  23579999999998764      467899999999999999999999988777777777765443222 122346


Q ss_pred             CCHHHHHHHHHhhcCCccc--cCCHHHHhCCccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRA--RLTAAQALSHPWVRE  360 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~--Rps~~elL~hp~f~~  360 (414)
                      +++++.+||.+||+.++++  |++++++++||||..
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            7899999999999976654  579999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.4e-47  Score=355.49  Aligned_cols=250  Identities=27%  Similarity=0.428  Sum_probs=209.2

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (414)
                      ||+|+||.||++.++.+|+.||+|++.............+..|+.+++.+ +||||+++++.+.++..+++||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            69999999999999999999999998754432222344566799999999 59999999999999999999999999999


Q ss_pred             hHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCC
Q 015026          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG  263 (414)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~g  263 (414)
                      |.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++   .++.++|+|||++.............|
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---CCCCEEEeeceeeeecCCCceeeccCC
Confidence            99888665556789999999999999999999999999999999999998   578899999999987665444455679


Q ss_pred             CCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch----hhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 015026          264 SAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (414)
Q Consensus       264 t~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (414)
                      ++.|+|||++.+ .++.++|||||||++|+|++|..||.+....    ++..........+   ....+++++.+||.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHHHHH
Confidence            999999998754 4688999999999999999999999765432    2223333222221   2246889999999999


Q ss_pred             hcCCccccCCH----HHHhCCccccc
Q 015026          339 LVKDPRARLTA----AQALSHPWVRE  360 (414)
Q Consensus       339 L~~dp~~Rps~----~elL~hp~f~~  360 (414)
                      |+.||.+||++    ++++.||||+.
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcC
Confidence            99999999999    67889999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4e-47  Score=365.58  Aligned_cols=249  Identities=27%  Similarity=0.476  Sum_probs=209.6

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHH-HHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK-ILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      +.||+|+||+||+|.+..+++.||+|++.+...........+..|.. +++.+ +||||+++++++...+.+++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999997643222223344455554 45667 59999999999999999999999999


Q ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCccc
Q 015026          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ  259 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~  259 (414)
                      |++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... ......
T Consensus        80 ~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~---~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          80 GGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEEccCCCCcccccCCCCcc
Confidence            9999998843  45688999999999999999999999999999999999998   57899999999987532 223344


Q ss_pred             cCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 015026          260 DIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (414)
                      ..+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......+    .+.+++++.++|.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~  230 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGL  230 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHH
Confidence            67899999999987654 6889999999999999999999999888877777776654332    247899999999999


Q ss_pred             hcCCccccCCHH----HHhCCccccc
Q 015026          339 LVKDPRARLTAA----QALSHPWVRE  360 (414)
Q Consensus       339 L~~dp~~Rps~~----elL~hp~f~~  360 (414)
                      |+.||.+||++.    ++++|+||..
T Consensus       231 l~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         231 LQKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             cccCHHHCCCCCCCHHHHhcCcccCC
Confidence            999999999876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.6e-47  Score=361.85  Aligned_cols=260  Identities=25%  Similarity=0.424  Sum_probs=213.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|.+......  .....+.+|+.+++.+. ||||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence            4699999999999999999999999999999998754321  23345678999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        83 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          83 FEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSVP  157 (309)
T ss_pred             EeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECccccceecCCC
Confidence            999975 888877543 34589999999999999999999999999999999999998   5789999999998764332


Q ss_pred             C-ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC--------------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------  318 (414)
                      . ......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+......              
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            2 2334578999999998754  4588999999999999999999999877665554444321110              


Q ss_pred             -----CCC-------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          319 -----FRR-------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       319 -----~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                           ++.       ...+.+++++.+||.+||..||.+|||+.|+|.||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence                 000       112357889999999999999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-47  Score=366.95  Aligned_cols=248  Identities=29%  Similarity=0.527  Sum_probs=213.2

Q ss_pred             eeeeecCceEEEEEEE---CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEec
Q 015026          102 KLLGHGQFGYTYVATD---KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (414)
                      +.||+|+||.||++++   ..+|+.||+|++...... ......+.+|+.+|+++. ||||+++++++.+++.+|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence            5799999999999976   467899999999764321 223456778999999995 99999999999999999999999


Q ss_pred             cCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-Cc
Q 015026          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KK  257 (414)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-~~  257 (414)
                      +++|+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... ..
T Consensus        80 ~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          80 LRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC---CCCcEEEeeccCCcccCCCCCc
Confidence            999999998843  45789999999999999999999999999999999999998   5789999999998765433 23


Q ss_pred             cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHH
Q 015026          258 FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (414)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (414)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+....+......++    ..+++++.+||.
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  230 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLR  230 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            3456899999999988654 58899999999999999999999988877777777776654433    357899999999


Q ss_pred             HhhcCCccccCC-----HHHHhCCccccc
Q 015026          337 KLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       337 ~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      +||+.||.+||+     +.+++.||||..
T Consensus       231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         231 ALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            999999999999     778999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.3e-47  Score=364.06  Aligned_cols=249  Identities=27%  Similarity=0.472  Sum_probs=209.6

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHH-HHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK-ILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+..|.. +++.+ +||||+++++.+.+.+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999999999999999997654322334455666665 56777 59999999999999999999999999


Q ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCccc
Q 015026          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ  259 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~  259 (414)
                      |++|...+..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... ......
T Consensus        80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          80 GGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEccCCCCccCCCCCCccc
Confidence            9999887743  45789999999999999999999999999999999999998   57899999999987532 223334


Q ss_pred             cCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 015026          260 DIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (414)
                      ..+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+....+..+......++    +..+.++.++|.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~  230 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGL  230 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHH
Confidence            56899999999987654 68899999999999999999999998877777777766543332    35788999999999


Q ss_pred             hcCCccccCCH----HHHhCCccccc
Q 015026          339 LVKDPRARLTA----AQALSHPWVRE  360 (414)
Q Consensus       339 L~~dp~~Rps~----~elL~hp~f~~  360 (414)
                      |+.||.+||++    .++++||||..
T Consensus       231 l~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         231 LHKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             ccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            99999999976    49999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=398.30  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=229.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|.|+++||+|+||.|.+++.+.|++.||+|++.+-.+........|..|-+||.-- +.+.|+.++-.|.++.++|+|
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEE
Confidence            4699999999999999999999999999999999875544444667788999999776 699999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|..++  .+...+|+..++.|+..|+.||.-||+.|+|||||||+|||||   ..|+|||+|||.+-.+..+
T Consensus       154 MdY~pGGDlltLl--Sk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld---~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLL--SKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD---KSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EecccCchHHHHH--hhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec---ccCcEeeccchhHHhcCCC
Confidence            9999999999988  4444899999999999999999999999999999999999999   6999999999988665533


Q ss_pred             C--ccccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          256 K--KFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      .  .....+|||.|.+||++.      +.|++.+|+||+||++|||++|..||+..+-.+.+.+|...+..+..+....+
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence            3  234679999999999973      45799999999999999999999999999999999999987554444444579


Q ss_pred             CHHHHHHHHHhhcCCccccCC---HHHHhCCcccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLT---AAQALSHPWVREG  361 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps---~~elL~hp~f~~~  361 (414)
                      |+++++||.++++ +|..|..   ++++-.||||.+.
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence            9999999999998 6999998   9999999999863

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-47  Score=370.94  Aligned_cols=257  Identities=35%  Similarity=0.598  Sum_probs=235.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      ...|.+.+.||+|.|++|.+|++..||..||||.|++..... ...+.+.+|+++|+.| +|||||+++.+.+.+..+|+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEE
Confidence            356999999999999999999999999999999999887644 4556699999999999 59999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+.+|++++++.  +.+...+..++.++.|++.|++|||+++|||||||++||||+   .+..+||+|||++.++..
T Consensus       133 V~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~---~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  133 VMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD---ENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc---cccceeeeccccceeecc
Confidence            999999999999994  456788899999999999999999999999999999999999   577899999999999998


Q ss_pred             CCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      +....+.||++.|.|||++.+..  ++++|+||+|+++|-|++|..||.+.+-.++-..++.++...+.    .++.++.
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce  283 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCE  283 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhH
Confidence            88889999999999999998753  89999999999999999999999999998888888888766654    4788999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +||+++|..+|.+|++.++++.|.|.....
T Consensus       284 ~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  284 DLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             HHHHHhhccCccccCCHHHhhhhcccchhh
Confidence            999999999999999999999999997543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-46  Score=367.55  Aligned_cols=257  Identities=30%  Similarity=0.464  Sum_probs=207.8

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++...    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCcc
Confidence            44689999999999999999999999999999999865432 2334567789999999995 99999999998654    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        ..+|+||||+++ +|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~---~~~~~kl~Dfg  168 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  168 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEecCC
Confidence              357999999975 5666552    3488999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh------------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR------------  314 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~------------  314 (414)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+..            
T Consensus       169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            9976554444456789999999998765 468899999999999999999999987654333222211            


Q ss_pred             ----------cCCCCCCC----------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          315 ----------NKPDFRRK----------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       315 ----------~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                                ..+.++..                .....++++.+||.+||..||++|||+.|+|.||||..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                      11111110                00124578999999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-46  Score=377.85  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=202.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc-----CCCCceEEEEEEEcC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-----GHENVVKFYNAFEDD  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----~hpnIv~~~~~~~~~  169 (414)
                      .++|++++.||+|+||+||+|.+..+++.||||++....    .....+..|+.+++.+.     +|++|+.++++|..+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            468999999999999999999999999999999986432    23445667888888774     245688999988754


Q ss_pred             -CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecC-----------
Q 015026          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAK-----------  236 (414)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~-----------  236 (414)
                       ..+++|||++ |++|.+++..  .+.+++..++.++.||+.||.|||+ .|||||||||+|||++..+           
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence             5789999998 7789988854  3579999999999999999999998 5999999999999998422           


Q ss_pred             --CCCCceeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHh
Q 015026          237 --EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL  313 (414)
Q Consensus       237 --~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~  313 (414)
                        +...+||+|||++....  ......+||+.|+|||++.+ .++.++|||||||++|||++|++||.+.+..+.+..+.
T Consensus       281 ~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence              11259999999875432  22345789999999998765 46889999999999999999999998776654444332


Q ss_pred             hcCCCCCC---------------------------C---------CCC--CCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          314 RNKPDFRR---------------------------K---------PWP--SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       314 ~~~~~~~~---------------------------~---------~~~--~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .....++.                           .         .+.  ..++.+.+||.+||++||.+|||++|+|+|
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            21111100                           0         000  013457899999999999999999999999


Q ss_pred             cccccc
Q 015026          356 PWVREG  361 (414)
Q Consensus       356 p~f~~~  361 (414)
                      |||...
T Consensus       439 p~~~~~  444 (467)
T PTZ00284        439 PYVLKY  444 (467)
T ss_pred             cccccc
Confidence            999874

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.1e-46  Score=366.00  Aligned_cols=256  Identities=29%  Similarity=0.451  Sum_probs=210.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-----E
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----Y  171 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-----~  171 (414)
                      .|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++....     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence            3788999999999999999999999999999886432 22234567889999999995 999999999998776     8


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .|+|+||+. ++|.+.+.  ....+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++..
T Consensus        79 ~~lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~a~~  152 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN---SNCVLKICDFGLARV  152 (372)
T ss_pred             EEEEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC---CCCCEEeccccceee
Confidence            999999996 57888773  345799999999999999999999999999999999999998   578999999999976


Q ss_pred             cCCC--CccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhc------------
Q 015026          252 IKPG--KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN------------  315 (414)
Q Consensus       252 ~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~------------  315 (414)
                      ....  .......+|+.|+|||++.+.  ++.++|||||||++|+|++|+.||.+.+....+..+...            
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            5432  223345789999999988653  588899999999999999999999877665544443221            


Q ss_pred             -----------CCCCCC-----CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          316 -----------KPDFRR-----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       316 -----------~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                                 ....+.     ......++++.+||.+||+.||.+|||+.++|.||||..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence                       000000     112346789999999999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.2e-47  Score=351.06  Aligned_cols=254  Identities=40%  Similarity=0.690  Sum_probs=210.9

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |++++.||+|+||+||+|.+..+++.||+|++....... .......+|+.+++.+ +||||+++++++.+....++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence            789999999999999999999999999999998764321 2223345699999999 59999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc-CCCC
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGK  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~-~~~~  256 (414)
                      ++++++|.+++.  ....+++..+..++.||+.||.+||+.||+|+||||+||+++   +++.++|+|||.+... ....
T Consensus        79 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~---~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   79 YCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD---ENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             EETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---TTSEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccc--cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence            999999999885  345789999999999999999999999999999999999999   6889999999998763 3344


Q ss_pred             ccccCCCCCccccchhcc--ccCCCCcchhHHHHHHHHHhhCCCCCCCCCc---hhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          257 KFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ......+|+.|+|||++.  ...+.++||||||+++|+|++|..||.....   ......................+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL  233 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence            455678999999999987  4568999999999999999999999987732   22333332211111111111234789


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .++|.+||+.||++|||+.++++||||
T Consensus       234 ~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  234 RDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.1e-46  Score=374.42  Aligned_cols=255  Identities=28%  Similarity=0.462  Sum_probs=219.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCC-CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKAN-GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      ..|.+.+.||+|+||.||+|.+..+ ++.||+|.+....   ......+.+|+.+|+.+. |||||++++++..++.+||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEEE
Confidence            4599999999999999999998877 7889999775432   334567788999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          175 AMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ||||++||+|.+++...  ....+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCceec
Confidence            99999999999887532  345689999999999999999999999999999999999998   5789999999999876


Q ss_pred             CCCCc---cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          253 KPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       253 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .....   ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+++..+..+....   ....++
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~s  296 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPVS  296 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccCC
Confidence            43322   3456799999999988654 6889999999999999999999998888777777776654321   123578


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +++.+||.+||..||++||++.++|.|||++.
T Consensus       297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            99999999999999999999999999999974

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.9e-46  Score=386.97  Aligned_cols=266  Identities=27%  Similarity=0.468  Sum_probs=219.4

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--  168 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--  168 (414)
                      .+...++|++++.||.|+||+||+|.+..++..||+|++..... .......+..|+.+|+.|. |||||+++++|.+  
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecC
Confidence            34455789999999999999999999999999999999876543 2345677899999999995 9999999998854  


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeecCCCCCcEEEeec----
Q 015026          169 DNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLH-------GLVHRDMKPENFLFKSA----  235 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~-------~iiHrDlkp~NIll~~~----  235 (414)
                      ...+||||||+++++|.++|...  ....+++..++.|+.||+.||.|||+.       +||||||||+||||+..    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            46799999999999999988542  235799999999999999999999995       49999999999999742    


Q ss_pred             ----------CCCCCceeeccccccccCCCCccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCC
Q 015026          236 ----------KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWD  302 (414)
Q Consensus       236 ----------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~  302 (414)
                                .....+||+|||++............+||+.|+|||++.+   .++.++||||||||||+|++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      1234589999999987655444456689999999998753   368899999999999999999999976


Q ss_pred             CCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ......+...+...+.   .+.+..+.++.+||..||..+|.+||++.++|.|||++..
T Consensus       246 ~~~~~qli~~lk~~p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        246 ANNFSQLISELKRGPD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCcHHHHHHHHhcCCC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            6554444333333332   2234678999999999999999999999999999999854

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5e-46  Score=362.24  Aligned_cols=258  Identities=28%  Similarity=0.448  Sum_probs=208.7

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.+. ||||+++++++...    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccccc
Confidence            44689999999999999999999999999999999865432 2334567789999999995 99999999988643    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        ...++||||+++ +|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~---~~~~~kl~Dfg  164 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  164 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC---CCCCEEEeeCc
Confidence              357999999975 6666652    2488999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh------------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR------------  314 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~------------  314 (414)
                      +++............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+..            
T Consensus       165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             ccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            99876555445567899999999987654 68899999999999999999999987654433322221            


Q ss_pred             ----------cCCCCC----------------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          315 ----------NKPDFR----------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       315 ----------~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                ..+.+.                .......+.++.+||.+||..||++|||+.|+|+||||...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                      111100                00111245678999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.9e-46  Score=352.22  Aligned_cols=259  Identities=25%  Similarity=0.422  Sum_probs=212.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|.+.+.||.|+||.||+|.+..+++.||+|.+.....  ......+.+|+.+++.+. ||||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence            469999999999999999999999999999999865432  123445778999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++ ++|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+||+++   .++.+||+|||++......
T Consensus        83 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          83 FEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIP  157 (301)
T ss_pred             Eeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC---CCCcEEECcCcchhccCCC
Confidence            99997 5888877543 34689999999999999999999999999999999999998   5789999999998764322


Q ss_pred             C-ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC--------------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------  318 (414)
                      . ......+++.|+|||++.+.  ++.++|||||||++|+|++|++||.+.+..+....+......              
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            2 22345678999999987643  578899999999999999999999877655444333221110              


Q ss_pred             -----CC-------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          319 -----FR-------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       319 -----~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                           ++       ....+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                 00       001235788999999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.3e-46  Score=361.95  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=209.8

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.+. ||||+++++++...    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeeccccccc
Confidence            34689999999999999999999999999999999865432 2234567789999999995 99999999987543    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        ..+|+||||+++ +|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG  171 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  171 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC---CCCcEEEEeCC
Confidence              458999999965 6777663    2478999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC----------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------  316 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~----------  316 (414)
                      +++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..++...          
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9987655444456789999999998765 45889999999999999999999998876655554443311          


Q ss_pred             ------------CCCCC----------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          317 ------------PDFRR----------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       317 ------------~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                                  +.+..                ......++++++||.+||..||.+|||+.++|+||||..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                        11100                001123567899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.3e-46  Score=356.94  Aligned_cols=251  Identities=27%  Similarity=0.423  Sum_probs=194.3

Q ss_pred             ceeeeecCceEEEEEEEC--CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--CCEEEEEE
Q 015026          101 GKLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVYIAM  176 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~~~~lv~  176 (414)
                      +++||+|+||+||+|.++  .+++.||+|.+....     ....+.+|+.+|+.+. ||||+++++++..  +..+++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence            457999999999999965  467899999986543     2345678999999995 9999999998854  56789999


Q ss_pred             eccCCCChHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec-CCCCCceeecccc
Q 015026          177 ELCEGGELLDRILAK-------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGL  248 (414)
Q Consensus       177 e~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DFG~  248 (414)
                      ||+. ++|.+++...       ....+++..++.++.||+.||.|||+.||+||||||+|||++.. ...+.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            9995 5888776432       12358999999999999999999999999999999999999632 2467899999999


Q ss_pred             ccccCCCC----ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCch---------hhhHHHh
Q 015026          249 SDFIKPGK----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED---------GIFKEVL  313 (414)
Q Consensus       249 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~---------~~~~~i~  313 (414)
                      ++......    .....+||+.|+|||++.+  .++.++||||+||++|+|++|++||.....+         ..+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            97654321    2345689999999998765  3688999999999999999999999654321         1111111


Q ss_pred             hcCCC---------------------CC-------------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          314 RNKPD---------------------FR-------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       314 ~~~~~---------------------~~-------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .....                     +.             .......+.++.+||.+||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            10000                     00             00011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.3e-46  Score=357.54  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=211.2

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||.|+||.||+|.+..+|..+|+|.+....  .+.....+.+|+++++.+. ||||++++++|.+.+.+++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence            357999999999999999999999999999999886542  2345677899999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||||++|++|.+++..  ...+++..+..++.||+.||.|||+. +|+||||||+|||++   .++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          81 CMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcchhhh
Confidence            9999999999998844  35689999999999999999999985 799999999999998   57789999999987653


Q ss_pred             CCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHH--------------------
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV--------------------  312 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i--------------------  312 (414)
                      .. ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...........+                    
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             hh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence            32 22456799999999988754 588899999999999999999999755432221110                    


Q ss_pred             ------------------------hhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          313 ------------------------LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       313 ------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                              .....  +......++.++.+||.+||+.||++|||+.|++.||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                    00000  000112367889999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-45  Score=373.91  Aligned_cols=260  Identities=27%  Similarity=0.468  Sum_probs=220.7

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC--
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~--  170 (414)
                      ...++|.+.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.++..+. |+||+++++.+....  
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceeccccc
Confidence            345689999999999999999999999999999999976543 3345677889999999994 999999988775322  


Q ss_pred             ------EEEEEEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          171 ------YVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       171 ------~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                            .+++||||+++|+|.+++...  ....+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCCCEE
Confidence                  478999999999999988543  235689999999999999999999999999999999999998   578999


Q ss_pred             eeccccccccCCC---CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC
Q 015026          243 ATDFGLSDFIKPG---KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (414)
Q Consensus       243 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~  318 (414)
                      |+|||+++.....   ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~  263 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD  263 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            9999999765432   223456899999999998754 688999999999999999999999888777777777655432


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      .   ..+.+++++.+||.+||..||.+||++.++++|||++.
T Consensus       264 ~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        264 P---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            1   23468899999999999999999999999999999875

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-45  Score=345.74  Aligned_cols=257  Identities=28%  Similarity=0.505  Sum_probs=213.6

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----  168 (414)
                      +..+.|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.+.+||||+++++.+..    
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            34567999999999999999999999999999999986543    2345678999999998669999999999864    


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                        ...+++||||+++++|.+++.......+++..+..++.|++.||.|||+++|+||||+|+||+++   +++.++|+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---~~~~~~l~Df  155 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDF  155 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---CCCCEEEccC
Confidence              24689999999999999988665556789999999999999999999999999999999999998   5788999999


Q ss_pred             ccccccCCC-CccccCCCCCccccchhccc------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          247 GLSDFIKPG-KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       247 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |++...... .......|++.|+|||++.+      .++.++|||||||++|+|++|..||.+.........+....  .
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~  233 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--A  233 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--C
Confidence            998765432 22345679999999998742      35778999999999999999999997655443333332221  1


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .......++.++.+||.+||..||.+|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            222234678899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-46  Score=362.56  Aligned_cols=259  Identities=29%  Similarity=0.483  Sum_probs=209.7

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +.++|.+++.||.|+||+||+|.+..+++.||||++..... .......+.+|+.+|+.+. ||||+++++++...    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccccc
Confidence            34679999999999999999999999999999999865422 2234456779999999995 99999999987543    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        ...++++|++ |++|.+.+.   ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg  163 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFG  163 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC---CCCCEEEcCCc
Confidence              4579999998 778877662   34699999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC---------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---------  316 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~---------  316 (414)
                      ++.....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+....         
T Consensus       164 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         164 LARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             cceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9986543  2345689999999998765  46889999999999999999999998765444333332211         


Q ss_pred             --------------CCCCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          317 --------------PDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       317 --------------~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                    +..+..    .+...++.+.+||.+||..||.+|||+.|+|.||||.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                          001110    12245677899999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-45  Score=348.71  Aligned_cols=253  Identities=33%  Similarity=0.572  Sum_probs=221.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+++++.+. ||||+++++++.+++.+++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEE
Confidence            6899999999999999999999999999999987654434445677899999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+|+||+|+||+++   .++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEeeCCCccccCCC-
Confidence            999999999988443  6799999999999999999999999999999999999998   5788999999999876544 


Q ss_pred             ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (414)
                       ....+|++.|+|||.+.+ ..+.++||||||+++|+|++|..||...........+......++    ..+++.+.++|
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li  229 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLI  229 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHH
Confidence             345679999999998754 457889999999999999999999987776666666665544333    35689999999


Q ss_pred             HHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          336 KKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       336 ~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      .+||..||.+|+     +++|+++||||...
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence            999999999999     99999999999763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-48  Score=371.23  Aligned_cols=261  Identities=30%  Similarity=0.455  Sum_probs=224.5

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..+.+.|+..||.|+||+||+|.++.++-..|.|+|...   .....+++.-||+||..+ +||+||++++.|..++.++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceE
Confidence            445689999999999999999999999988999998654   345788999999999999 5999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc-
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-  252 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~-  252 (414)
                      |+.|||.||-....+.+. +..|.+.++..+++|+|+||.|||+++|||||||+.|||++   -+|.|+|+|||.+... 
T Consensus       106 iliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             EEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccch
Confidence            999999999887777654 46799999999999999999999999999999999999999   5899999999987443 


Q ss_pred             CCCCccccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .......+++|||+|||||++.      ..|+.++||||||+.|.||..+.+|....+...++-+|.+..|.-... ...
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS~  260 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PSH  260 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cch
Confidence            2233456789999999999863      346889999999999999999999998888877777777665432221 134


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      .+..+.||+.+||..||+.||++.++|.||||+....
T Consensus       261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             hhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            6788999999999999999999999999999996543

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-45  Score=351.82  Aligned_cols=259  Identities=34%  Similarity=0.595  Sum_probs=223.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+..|+.+++.+. ||||+++++.+.+....++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEE
Confidence            6899999999999999999999999999999998765443345677899999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+.|++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||+++   .++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhcccccc
Confidence            999999999988655556799999999999999999999999999999999999998   57899999999986543211


Q ss_pred             ------------------------------ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc
Q 015026          257 ------------------------------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE  305 (414)
Q Consensus       257 ------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~  305 (414)
                                                    ......||..|+|||++.+. ++.++||||||+++|+|++|..||.+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          11234789999999987654 58899999999999999999999988887


Q ss_pred             hhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCC----HHHHhCCcccccc
Q 015026          306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT----AAQALSHPWVREG  361 (414)
Q Consensus       306 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps----~~elL~hp~f~~~  361 (414)
                      ...+..+......++..  ..+++++.++|.+||..||++|||    ++++|.||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         238 DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            77777776554433322  237899999999999999999999    9999999999864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-47  Score=364.84  Aligned_cols=266  Identities=26%  Similarity=0.445  Sum_probs=230.8

Q ss_pred             ccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           89 GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        89 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      -+.++....|.-++.||.|+||-||-|++..+.+.||||++.-..........++..|+..|++|. |||+|.+.++|..
T Consensus        19 F~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLr   97 (948)
T KOG0577|consen   19 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLR   97 (948)
T ss_pred             HccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeec
Confidence            344566667888999999999999999999999999999998766666677889999999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      +...|||||||-| +-.|.+ +-..+++-+.++..|..+.+.||.|||+++.||||||..|||++   +.+.|||+|||.
T Consensus        98 e~TaWLVMEYClG-SAsDll-eVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGS  172 (948)
T KOG0577|consen   98 EHTAWLVMEYCLG-SASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGS  172 (948)
T ss_pred             cchHHHHHHHHhc-cHHHHH-HHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccc
Confidence            9999999999965 656654 33456899999999999999999999999999999999999999   799999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      |....+   .++++|||.|||||++.    |.|+-++||||||+++.||.-.++|+..++....+..|..+.++...  -
T Consensus       173 Asi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s  247 (948)
T KOG0577|consen  173 ASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--S  247 (948)
T ss_pred             hhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--C
Confidence            977654   35779999999999863    67899999999999999999999999988888777777666543222  2


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      +..|+.+..||..||++-|.+|||.+++|.|+|........
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence            35678899999999999999999999999999998754433

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.8e-45  Score=345.51  Aligned_cols=256  Identities=26%  Similarity=0.418  Sum_probs=208.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++.+. ||||+++++++.+++..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence            488999999999999999999999999999998654321 223467789999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          177 ELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||++ ++|.+++.... ...+++..++.++.||+.||.|||+.||+||||+|+||+++   .++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---CCCcEEECcccceeecCCC
Confidence            9997 58888775433 25689999999999999999999999999999999999998   5789999999998765332


Q ss_pred             C-ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC--------------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------  318 (414)
                      . ......+++.|+|||++.+.  ++.++|||||||++|+|++|++||.+.........+......              
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            2 22334678999999987643  478899999999999999999999876543332222111100              


Q ss_pred             -----------CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 -----------FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 -----------~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                                 ........+++++.+||.+||+.||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                       0011234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-45  Score=339.89  Aligned_cols=255  Identities=28%  Similarity=0.480  Sum_probs=213.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC--hHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL--PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.|.+.+.||+|++|.||+|.+..+++.||+|.+.......  ......+.+|+.+++.+ +||||+++++++.++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence            35899999999999999999999999999999986543221  12346788999999999 5999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +|+||++|++|.+.+..  ...+++..+..++.||+.||.|||+.||+||||+|+||+++   +++.++|+|||++....
T Consensus        81 ~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          81 IFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceecc
Confidence            99999999999998844  35689999999999999999999999999999999999998   57899999999987653


Q ss_pred             CCCc----cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          254 PGKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       254 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      ....    .....|+..|+|||++.+. .+.++||||||+++|+|++|+.||.+.........+......  ......++
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~  233 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSHVS  233 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCccCC
Confidence            3211    1345688999999988654 588999999999999999999999876555444444333221  12224688


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .++.++|.+||..+|.+|||+.++|+||||
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         234 PDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2e-45  Score=355.64  Aligned_cols=252  Identities=26%  Similarity=0.368  Sum_probs=202.7

Q ss_pred             cceeeceeeeecCceEEEEEEE-----CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC-
Q 015026           96 RRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-  169 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~-  169 (414)
                      ++|++.+.||.|+||.||+|.+     ..+++.||+|++....  .......+.+|+.++..+.+||||+++++++... 
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            5799999999999999999975     2455789999986432  2234567899999999996699999999988754 


Q ss_pred             CEEEEEEeccCCCChHHHHHhcc---------------------------------------------------------
Q 015026          170 NYVYIAMELCEGGELLDRILAKK---------------------------------------------------------  192 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~---------------------------------------------------------  192 (414)
                      ..+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46899999999999999886432                                                         


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc---cccCCCCCc
Q 015026          193 ---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY  266 (414)
Q Consensus       193 ---~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~  266 (414)
                         ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||+++.......   .....+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               12477888999999999999999999999999999999998   578999999999976533221   123456788


Q ss_pred             cccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCcc
Q 015026          267 YVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR  344 (414)
Q Consensus       267 y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  344 (414)
                      |+|||++.+ .++.++|||||||++|||++ |..||.+....+.+...+.......  ....+++++.+||.+||..||.
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--APENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCChh
Confidence            999998754 46899999999999999997 9999987665444433333222211  2246788999999999999999


Q ss_pred             ccCCHHHHhC
Q 015026          345 ARLTAAQALS  354 (414)
Q Consensus       345 ~Rps~~elL~  354 (414)
                      +|||+.++++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.3e-45  Score=339.32  Aligned_cols=257  Identities=29%  Similarity=0.495  Sum_probs=218.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||.|+||+||+|.+..++..+|+|++......  .....+.+|+.+++.+. ||||+++++.+..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence            3689999999999999999999899999999998654432  25678899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          176 MELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      +|+++|++|.+++..... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++   +++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHHHhcc
Confidence            999999999999865433 5689999999999999999999999999999999999998   578899999999876544


Q ss_pred             CCcc-----ccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCC--CC
Q 015026          255 GKKF-----QDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WP  325 (414)
Q Consensus       255 ~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~  325 (414)
                      ....     ....|+..|+|||.+...  .+.++|+|||||++|+|++|+.||...+....+..+....+......  +.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            3221     345789999999987654  68899999999999999999999987766666666555433221111  24


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .+++++.++|.+||..||++|||+.+++.||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            678999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.3e-45  Score=336.63  Aligned_cols=254  Identities=22%  Similarity=0.467  Sum_probs=215.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-CCEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNYVYIA  175 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-~~~~~lv  175 (414)
                      .|++.+.||.|++|.||++.+..+++.||+|.+..... .....+.+.+|+.+++.+. |||++++++.+.. ...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence            48999999999999999999999999999999865432 2334567889999999995 9999999998764 4568999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.......+++.++..++.||+.||.+||+.||+||||||+||+++   .++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~---~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe---cCCcEEEecccceEEeccc
Confidence            9999999999998765556789999999999999999999999999999999999998   5789999999999766432


Q ss_pred             C-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 K-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      . ......|++.|+|||++.+. ++.++||||||+++++|++|..||...+.......+..+...   .....+++++.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHHH
Confidence            2 23345789999999987654 588999999999999999999999877665555555544321   122468899999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ||.+||+.||++|||+.+++.||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-47  Score=347.78  Aligned_cols=268  Identities=29%  Similarity=0.407  Sum_probs=220.5

Q ss_pred             cCccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-----CCceE
Q 015026           87 DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-----ENVVK  161 (414)
Q Consensus        87 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-----pnIv~  161 (414)
                      -+...+.+..+|.+...+|+|+||.|-.+.+..++..||||+++.-.    ...+...-|+++|+++..+     --+|+
T Consensus        80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~  155 (415)
T KOG0671|consen   80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQ  155 (415)
T ss_pred             EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence            34456778899999999999999999999999999999999986543    3667778899999999423     24788


Q ss_pred             EEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec------
Q 015026          162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA------  235 (414)
Q Consensus       162 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~------  235 (414)
                      +.+||+..++++||+|.+ |-++++++.++...+++..+++.|++||+++++|||+.+++|.||||+|||+.+.      
T Consensus       156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence            999999999999999999 7799999998888999999999999999999999999999999999999999541      


Q ss_pred             -----------CCCCCceeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCC
Q 015026          236 -----------KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDK  303 (414)
Q Consensus       236 -----------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~  303 (414)
                                 .++..|+|+|||.|++...  ...+++.|..|+|||++.+ .++.++||||+||||+|+++|...|+..
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                       1245699999999987543  3467899999999998766 6899999999999999999999999887


Q ss_pred             Cchh---hhHHHhhcCCCC-------------CCCCCCC-----------------------CC---HHHHHHHHHhhcC
Q 015026          304 TEDG---IFKEVLRNKPDF-------------RRKPWPS-----------------------IS---NSAKDFVKKLLVK  341 (414)
Q Consensus       304 ~~~~---~~~~i~~~~~~~-------------~~~~~~~-----------------------~s---~~~~~li~~~L~~  341 (414)
                      ...+   +++.|+...|..             ....|++                       .+   .++.|||++||.+
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            7655   333333211100             0001111                       11   2467999999999


Q ss_pred             CccccCCHHHHhCCcccccc
Q 015026          342 DPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       342 dp~~Rps~~elL~hp~f~~~  361 (414)
                      ||.+|+|+.|+|.||||...
T Consensus       393 DP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  393 DPARRITLREALSHPFFARL  412 (415)
T ss_pred             CccccccHHHHhcCHHhhcC
Confidence            99999999999999999864

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-44  Score=335.38  Aligned_cols=254  Identities=26%  Similarity=0.444  Sum_probs=218.5

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|.+.+.||+|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.+. ||||+++++.+.+.+..++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence            37888999999999999999999999999999875433 2346678899999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++|++|.+++.......+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCcc
Confidence            999999999998765556799999999999999999999999999999999999998   57899999999987655432


Q ss_pred             c-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          257 K-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       257 ~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      . .....|++.|+|||++.+. ++.++||||||+++++|++|+.||...+.......+........   ...++.++.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQL  232 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence            2 2345789999999987654 58899999999999999999999988776666666655432211   12578899999


Q ss_pred             HHHhhcCCccccCCHHHHhCCccc
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      |.+||+.+|++||++.+++.|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-44  Score=335.24  Aligned_cols=255  Identities=25%  Similarity=0.442  Sum_probs=220.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.+. ||||+++++.+..++..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence            489999999999999999999999999999999765432 345678899999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++|++|.+++.......+++..+..++.|++.||.|||++||+|+||+|+||+++.  .+..+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecCCCc
Confidence            9999999999986655566899999999999999999999999999999999999974  34568999999998766554


Q ss_pred             ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (414)
                      ......|+..|+|||.+.+. .+.++||||||+++|+|++|..||.+.+.......+......   .....++.++.++|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHHHHH
Confidence            44556789999999988654 588999999999999999999999887766666555544321   12235788999999


Q ss_pred             HHhhcCCccccCCHHHHhCCccc
Q 015026          336 KKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       336 ~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .+||..||.+|||+.|+++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.3e-45  Score=342.42  Aligned_cols=257  Identities=28%  Similarity=0.510  Sum_probs=213.3

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE-----
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-----  167 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~-----  167 (414)
                      ...+.|++.+.||.|+||.||+|.+..+++.||+|++....    .....+..|+.+++.+.+||||+++++++.     
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            34568999999999999999999999999999999886542    244678899999999977999999999884     


Q ss_pred             -cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          168 -DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       168 -~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                       ....+++||||+++|+|.+++.......+++..+..++.||+.||.|||+.||+|+||+|+||+++   +++.++|+||
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~df  165 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDF  165 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeC
Confidence             346789999999999999988766666789999999999999999999999999999999999998   5788999999


Q ss_pred             ccccccCCC-CccccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          247 GLSDFIKPG-KKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       247 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |++...... .......|++.|+|||.+.      ..++.++|||||||++|+|++|..||.+.........+.....  
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--  243 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--  243 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--
Confidence            998765422 2234567999999999874      2357789999999999999999999976654433333322211  


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .......++.++.+||.+||..||.+|||+.|+|.||||
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            111223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-45  Score=360.18  Aligned_cols=254  Identities=21%  Similarity=0.352  Sum_probs=204.6

Q ss_pred             ccccceeeceeeeecCceEEEEEEEC--CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ....+|.+++.||.|+||.||+|...  .++..||+|.+...        ....+|+.+|+.+. ||||+++++++....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence            34567999999999999999999754  45678999987543        23457999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++|||++. ++|.+++  .....+++..+..++.||+.||.|||++||+||||||+|||++   .++.++|+|||++.
T Consensus       160 ~~~lv~e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---~~~~~~l~DfG~a~  233 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLGDFGAAC  233 (392)
T ss_pred             EEEEEehhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEccCcccc
Confidence            9999999995 6888888  3446799999999999999999999999999999999999998   57899999999987


Q ss_pred             ccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch---hhhHHHhhcC----CCC
Q 015026          251 FIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED---GIFKEVLRNK----PDF  319 (414)
Q Consensus       251 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~i~~~~----~~~  319 (414)
                      .......   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....   ..+..+....    ..+
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            6543222   234679999999998865 4688999999999999999999999765432   2222222110    000


Q ss_pred             CC------------------C--CC------CCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          320 RR------------------K--PW------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       320 ~~------------------~--~~------~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +.                  .  ..      ..++.++.+||.+||..||++|||+.++|.||||...
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            00                  0  00      1346788999999999999999999999999999863

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-45  Score=340.27  Aligned_cols=258  Identities=30%  Similarity=0.523  Sum_probs=218.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+.....  ......+.+|+.+++.+. ||||+++++.+.++..+++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence            368899999999999999999999999999999875432  234567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||+++++|.+++..   ..+++..+..++.||+.||.|||+.+++|+||+|+||+++   .++.++|+|||++......
T Consensus        78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          78 MEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEcccccceeeccc
Confidence            999999999998843   2789999999999999999999999999999999999998   5789999999999876543


Q ss_pred             -CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                       .......|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+....+...  ....+++++.+
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  229 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSL--EGNKFSKPFKD  229 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCC--cccccCHHHHH
Confidence             23345678999999998765 468999999999999999999999977665555544444322111  11227889999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      +|.+||..||++|||++++++||||......
T Consensus       230 ~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         230 FVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            9999999999999999999999999875544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-44  Score=341.20  Aligned_cols=256  Identities=28%  Similarity=0.512  Sum_probs=210.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++......++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence            369999999999999999999999999999998865432 1223456789999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++++.|...+.  ....+++..++.++.||+.||.|||+.|++||||||+||+++   .++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          79 FEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             EeccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---CCCcEEECccccceecCCC
Confidence            99999887766552  334689999999999999999999999999999999999998   5788999999999876543


Q ss_pred             C-ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC--------------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------  318 (414)
                      . ......++..|+|||++.+  .++.++||||||+++|+|++|..||.+....+....+......              
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            3 2334578899999998764  3578999999999999999999999876654433332211000              


Q ss_pred             -----CCC--------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 -----FRR--------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 -----~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                           .+.        ..++.++..+.+||.+||+.||++|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                 000        0124578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=8.5e-45  Score=341.29  Aligned_cols=253  Identities=30%  Similarity=0.459  Sum_probs=211.5

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (414)
                      ||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.+. ||||+++++.+...+..|+||||++|++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            699999999999999999999999987654333334556778999999995 9999999999999999999999999999


Q ss_pred             hHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCC
Q 015026          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG  263 (414)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~g  263 (414)
                      |.+++.......+++..+..++.||+.||.|||+.|++||||+|+||+++   +++.++|+|||++.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccCcchhhhccCCccccccC
Confidence            99988665555799999999999999999999999999999999999998   578999999999877654444445678


Q ss_pred             CCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCC
Q 015026          264 SAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKD  342 (414)
Q Consensus       264 t~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  342 (414)
                      +..|+|||.+.+ .++.++||||||+++|+|++|+.||...........+.......+....+.+++++.++|.+||+.|
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            899999998754 4688999999999999999999999766542222233222222223333467899999999999999


Q ss_pred             ccccC-----CHHHHhCCccccc
Q 015026          343 PRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       343 p~~Rp-----s~~elL~hp~f~~  360 (414)
                      |.+||     ++.+++.||||..
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhc
Confidence            99999     9999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.8e-45  Score=350.35  Aligned_cols=257  Identities=22%  Similarity=0.309  Sum_probs=205.4

Q ss_pred             eceeeeec--CceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026          100 IGKLLGHG--QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus       100 ~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      ++++||+|  +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence            56789999  789999999999999999999876532 233556788999999999 59999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-C
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-K  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-~  256 (414)
                      |+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.++++|||.+...... .
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhccccccc
Confidence            99999999988655455689999999999999999999999999999999999998   5778999999865332111 0


Q ss_pred             -------ccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC-------
Q 015026          257 -------KFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-------  319 (414)
Q Consensus       257 -------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-------  319 (414)
                             ......++..|+|||++.+   .++.++|||||||++|+|++|+.||.+.................       
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   0112356788999999864   36889999999999999999999997654433322222111000       


Q ss_pred             -----------------------------------CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          320 -----------------------------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       320 -----------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                                         .......+++++.+||.+||+.||++|||++++|+||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                               000111356789999999999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-44  Score=341.58  Aligned_cols=259  Identities=27%  Similarity=0.474  Sum_probs=216.0

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ...+|++.+.||.|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.+ +||||+++++.+..+...+
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEE
Confidence            34589999999999999999999999999999999876543   2346788999999999 5999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||++|++|.+++..   ..+++.++..++.|++.||.|||+.||+||||||+||+++   .++.++|+|||++....
T Consensus        94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~---~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEECccccchhcc
Confidence            99999999999998743   3588999999999999999999999999999999999998   57899999999987654


Q ss_pred             CCCc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          254 PGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       254 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .... .....|++.|+|||.+.+. .+.++|||||||++|+|++|+.||...........+..... ........++..+
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  246 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIF  246 (296)
T ss_pred             ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccCHHH
Confidence            3322 2345789999999987654 58899999999999999999999987665443333322211 1111224678899


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      .+||.+||..||.+|||+.++++||||.....
T Consensus       247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            99999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-44  Score=340.45  Aligned_cols=263  Identities=30%  Similarity=0.499  Sum_probs=212.4

Q ss_pred             CccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE
Q 015026           88 FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (414)
Q Consensus        88 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~  167 (414)
                      +....+..++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+.+||||+++++++.
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            3344556788999999999999999999999999999999876432    133567889999999966999999999873


Q ss_pred             -----cCCEEEEEEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC
Q 015026          168 -----DDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       168 -----~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                           .++.+++||||++|++|.+++..  .....+++..+..++.|++.||.|||+.+|+||||||+||+++   .++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCC
Confidence                 45679999999999999987743  2335688999999999999999999999999999999999998   5778


Q ss_pred             ceeeccccccccCCCC-ccccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHh
Q 015026          241 LKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL  313 (414)
Q Consensus       241 vkl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~  313 (414)
                      +||+|||++....... ......|++.|+|||++.      ..++.++||||+||++|+|++|..||.+......+..+.
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~  242 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP  242 (286)
T ss_pred             EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence            9999999987654322 223457999999999874      235789999999999999999999997765544333332


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       314 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ..... ........+..+.+||.+||+.||++|||+.++++|+||
T Consensus       243 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         243 RNPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            22111 111112357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-44  Score=340.26  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=208.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++++ +||||+++++.+...+..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEE
Confidence            5788999999999999999999999999999986542  233556788999999999 5999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|..+      ..+++..+..++.||+.||.|||+.||+|+||||+|||++   .++.++|+|||++...... 
T Consensus        79 e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~---~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          79 EFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             ecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC---CCCCEEEeeCCcceecccc-
Confidence            99999988653      2478999999999999999999999999999999999998   5789999999999765432 


Q ss_pred             ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch-------hhhHHHhhcCCCCCCCCCCCCC
Q 015026          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED-------GIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .....+||..|+|||++.+ .++.++||||||+++|+|++|..||......       +....+....  .+.......+
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  226 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFS  226 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCC
Confidence            2345689999999998765 4688999999999999999999999653221       1112222111  1122234578


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +++.++|.+||+.||.+||++++++.||||....
T Consensus       227 ~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         227 EKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            8999999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.1e-44  Score=343.43  Aligned_cols=257  Identities=29%  Similarity=0.483  Sum_probs=217.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|++.+.||.|+||.||++.+..+++.||+|.+.............+.+|+.+++.+. ||||+++++.+..++.+++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999987654333345667889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++|++|.+++..  ...+++..+..++.|++.||.|||+.|++||||||+||+++   .++.++|+|||+++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCccccCcCc
Confidence            99999999998844  35789999999999999999999999999999999999998   57899999999886421100


Q ss_pred             ----------------ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          257 ----------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       257 ----------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                                      ......|+..|+|||.+.+ ..+.++|||||||++|+|++|..||.+....+.+..+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                            0112467889999998654 56889999999999999999999998877777777766654433


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCC---HHHHhCCccccc
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLT---AAQALSHPWVRE  360 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps---~~elL~hp~f~~  360 (414)
                      +... +.++.++.++|.+||+.||++||+   +.++|+||||..
T Consensus       236 ~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         236 PEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             CCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            3322 257899999999999999999998   799999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.6e-44  Score=332.66  Aligned_cols=254  Identities=28%  Similarity=0.474  Sum_probs=220.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|+||.||.+++..+++.+++|.+..... .......+.+|+.+++.+ +||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence            58999999999999999999999999999999875443 234566788999999999 5999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++   +++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEccccc
Confidence            999999999998765556789999999999999999999999999999999999998   57889999999987654433


Q ss_pred             -ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          257 -KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                       ......|++.|+|||.+.+. ++.++||||||+++|+|++|..||......+....+........   .+.++.++.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV---VSVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence             23456789999999987654 58889999999999999999999988777777777765543221   25678999999


Q ss_pred             HHHhhcCCccccCCHHHHhCCccc
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      |.+||..+|.+||++.++|+|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-44  Score=338.55  Aligned_cols=253  Identities=28%  Similarity=0.464  Sum_probs=209.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.+ +||||+++++.+...+.+++|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEE
Confidence            47999999999999999999999999999999986543   22345678899999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++..  .+.+++..+..++.||+.||.|||+.|++|+||||+||+++   .++.++|+|||++......
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          85 MEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeEccCc
Confidence            999999999998743  45799999999999999999999999999999999999998   5788999999998654322


Q ss_pred             -CccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-CCCCCCCH
Q 015026          256 -KKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPSISN  329 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~  329 (414)
                       .......|++.|+|||++.    +.++.++|||||||++|+|++|..||...................+. .....++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence             1223557999999999863    34678999999999999999999999766544333333222211111 11124678


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~  357 (414)
                      .+.++|.+||..||++|||++++++|||
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.1e-44  Score=342.25  Aligned_cols=264  Identities=28%  Similarity=0.485  Sum_probs=218.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +...+|++.+.||.|+||.||+|.+..+|+.||+|.+.....   ...+.+.+|+.+++.+ +||||+++++.+..++..
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEE
Confidence            345689999999999999999999999999999999875432   2346688999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||++|++|.+++..   ..+++..+..++.|++.||.|||+.||+||||||+||+++   .++.++|+|||++...
T Consensus        92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEECcCccceEc
Confidence            999999999999998743   4578999999999999999999999999999999999998   5789999999998765


Q ss_pred             CCCCc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          253 KPGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       253 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ..... .....|++.|+|||.+.+. ++.++|||||||++|+|++|..||.+.+.......+..... ........++..
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  244 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPERLSAV  244 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC-CCCCCccccCHH
Confidence            43322 2345789999999987654 58899999999999999999999977654333322222211 111122357888


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI  367 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~  367 (414)
                      +.+||.+||..||.+||++.+++.||||.........
T Consensus       245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (297)
T cd06656         245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSL  281 (297)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhccccccccc
Confidence            9999999999999999999999999999976655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-44  Score=337.69  Aligned_cols=257  Identities=30%  Similarity=0.522  Sum_probs=213.2

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC---
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~---  170 (414)
                      ..++|++.+.||.|++|.||+|.+..+++.+|+|++....    ...+.+.+|+.+++.+.+||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            4578999999999999999999999999999999987543    245678999999999967999999999986544   


Q ss_pred             ---EEEEEEeccCCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          171 ---YVYIAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                         .+++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEECC
Confidence               5899999999999998875433  46789999999999999999999999999999999999998   578899999


Q ss_pred             cccccccCCCC-ccccCCCCCccccchhccc------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC
Q 015026          246 FGLSDFIKPGK-KFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (414)
Q Consensus       246 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~  318 (414)
                      ||++....... ......|++.|+|||++..      .++.++|||||||++|+|++|..||.+.........+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            99987654322 2234678999999998743      2467899999999999999999999876555555555443221


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .. ......+.++.+||.+||..||++|||+.+++.|||+
T Consensus       237 ~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            11 1112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-44  Score=341.23  Aligned_cols=256  Identities=32%  Similarity=0.504  Sum_probs=213.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.+. ||||+++++++.++...++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence            489999999999999999999999999999998765422 234567899999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+ +++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++   .++.++|+|||++.......
T Consensus        79 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          79 EYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             ccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccCCC
Confidence            999 999999875443 5689999999999999999999999999999999999998   47889999999987664432


Q ss_pred             --ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC-------------
Q 015026          257 --KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-------------  319 (414)
Q Consensus       257 --~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-------------  319 (414)
                        ......|+..|+|||.+.+.  .+.++||||+|+++|+|++|.+||.+....+.+..+.......             
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence              23456789999999987543  4789999999999999999988887766555544443321100             


Q ss_pred             ------CC-------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          320 ------RR-------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       320 ------~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                            +.       ...+..+.++.+||.+||..||++|||++++|.||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                  00       11235678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.7e-44  Score=343.26  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=210.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||.||++.+..+|..+|+|.+....  .+.....+.+|+++++.+ +||||+++++.+.+++.+++||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEe
Confidence            5899999999999999999999999999999886532  234566788999999999 5999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||++|++|.+++..  ...+++..+..++.||+.||.|||+ .+++||||||+|||++   .++.+||+|||++......
T Consensus        79 ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          79 EHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             eccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCccccccc
Confidence            99999999998844  3678999999999999999999997 6999999999999998   5788999999998765332


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC----------------
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD----------------  318 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----------------  318 (414)
                       .....+|++.|+|||++.+. ++.++||||||+++|+|++|..||...+.......+......                
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence             22456899999999987654 578899999999999999999999654432221111100000                


Q ss_pred             ------------------CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          319 ------------------FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       319 ------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                        .+..+...++.++.+||.+||..||++|||+.+++.||||...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                              0011112367889999999999999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.8e-44  Score=340.32  Aligned_cols=260  Identities=30%  Similarity=0.455  Sum_probs=217.0

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..+.|++++.||.|+||.||+|.+..+++.||+|.+...   .....+.+.+|+.+++.+. ||||+++++.+..++.++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence            446799999999999999999999999999999998654   2345677889999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||++|++|...+... ...+++..+..++.||+.||.|||+.||+||||||+||+++   .++.++|+|||++....
T Consensus        86 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          86 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAKNV  161 (292)
T ss_pred             EEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc---CCCCEEEccCccceecc
Confidence            999999999998776443 35689999999999999999999999999999999999998   57899999999886543


Q ss_pred             CC-CccccCCCCCccccchhccc------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          254 PG-KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .. .......+++.|+|||++.+      .++.++|||||||++|+|++|..||...+....+..+....... ......
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  240 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPSK  240 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCcc
Confidence            22 22345578999999998742      24678999999999999999999998776655555554432211 111235


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ++.++.++|.+||..||++||++.++++||||....
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            788999999999999999999999999999997543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-45  Score=352.23  Aligned_cols=255  Identities=29%  Similarity=0.506  Sum_probs=203.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ..|+++++||.||.+.||++.... .+.+|+|++.... .++.....+.+|+.+|.+|++|.+||++|++-..++.+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            469999999999999999998644 4566777654332 34567889999999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||-+ .+|...|. ......+.-.++.+..|||.|+.++|.+||||.||||.|+|+.    .|.+||+|||.|..+...
T Consensus       439 mE~Gd-~DL~kiL~-k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  439 MECGD-IDLNKILK-KKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             eeccc-ccHHHHHH-hccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCcc
Confidence            99864 47766663 3444555568999999999999999999999999999999997    789999999999887654


Q ss_pred             Cc---cccCCCCCccccchhccc------------cCCCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHHHhhcCCCC
Q 015026          256 KK---FQDIVGSAYYVAPEVLKR------------KSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPDF  319 (414)
Q Consensus       256 ~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~~  319 (414)
                      ..   ..+.+||+.||+||.+..            +.+.++||||||||||+|+.|++||..-.. -.-+..|.....+.
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI  592 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence            33   246799999999998731            136789999999999999999999954321 11222233322211


Q ss_pred             CCCCCCCCC--HHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          320 RRKPWPSIS--NSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       320 ~~~~~~~~s--~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .   ++.+|  .++.++++.||..||++|||+.++|+|||+...
T Consensus       593 e---fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  593 E---FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             c---ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            2   22232  349999999999999999999999999999863

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=336.13  Aligned_cols=252  Identities=32%  Similarity=0.535  Sum_probs=211.2

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++....+||||+++++.+...+.+++|+||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999999999999999987644322223344556666655554799999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccC
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI  261 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  261 (414)
                      ++|.+++..  ...+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++.....   ....
T Consensus        82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~---~~~~  153 (260)
T cd05611          82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLE---NKKF  153 (260)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceeccc---cccC
Confidence            999998843  35789999999999999999999999999999999999998   578899999999876433   2345


Q ss_pred             CCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhc
Q 015026          262 VGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV  340 (414)
Q Consensus       262 ~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  340 (414)
                      .|++.|+|||.+.+. ++.++||||||+++|+|++|..||...+....+..+......++......+++++.++|.+||.
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            789999999987654 5889999999999999999999998877777777666655554444445689999999999999


Q ss_pred             CCccccCCH---HHHhCCcccccc
Q 015026          341 KDPRARLTA---AQALSHPWVREG  361 (414)
Q Consensus       341 ~dp~~Rps~---~elL~hp~f~~~  361 (414)
                      .||++||++   +|+|.||||...
T Consensus       234 ~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         234 MDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             CCHHHccCCCcHHHHHcChHhhcC
Confidence            999999955   799999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.2e-45  Score=353.90  Aligned_cols=250  Identities=23%  Similarity=0.361  Sum_probs=199.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ..|++++.||+|+||.||+|.+..+++.||+|+.....         ...|+.+++.+. ||||+++++++......++|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence            36999999999999999999999999999999754332         246999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +|++. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       136 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        136 LPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---DVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEecCccccccccC
Confidence            99995 5888887543 45789999999999999999999999999999999999998   5788999999999765444


Q ss_pred             CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCC-CCCCCch---------hhhHHHhhcC----CCCC
Q 015026          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRP-FWDKTED---------GIFKEVLRNK----PDFR  320 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~P-f~~~~~~---------~~~~~i~~~~----~~~~  320 (414)
                      .......||+.|+|||++.+ .++.++|||||||++|||+++..| |.+....         ..+..++...    ..++
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            44456789999999998765 468899999999999999985444 4332111         1111111100    0011


Q ss_pred             C--------------------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          321 R--------------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       321 ~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      .                          .....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            0                          001245677889999999999999999999999999974

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.5e-45  Score=343.47  Aligned_cols=255  Identities=27%  Similarity=0.500  Sum_probs=206.0

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.+. ||||+++++++.+.+..++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence            58899999999999999999999999999999865432 1223456778999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++ ++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++.......
T Consensus        79 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          79 EYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             ecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---CCCcEEECccchhhccCCCC
Confidence            9996 5788877543 35689999999999999999999999999999999999998   57899999999987654322


Q ss_pred             -ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCC-CchhhhHHHhhcC--------------CC
Q 015026          257 -KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNK--------------PD  318 (414)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~i~~~~--------------~~  318 (414)
                       ......+++.|+|||++.+.  ++.++|||||||++|+|++|..||... +..+.+..+....              +.
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence             22345688999999987653  478999999999999999998886443 3333333322110              00


Q ss_pred             C------C-----CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 F------R-----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 ~------~-----~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      +      +     ....+.+++++.+||.+||..||.+|||+++++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0      0     01123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-46  Score=348.37  Aligned_cols=258  Identities=27%  Similarity=0.474  Sum_probs=227.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|+.-++||+|+||.||-+..+.||+.+|.|.+.+.............+|..||+++. .+.||.+-..|+..+.+++|
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence            45788889999999999999999999999999998766555555667889999999995 89999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +..|.||+|.-+|.......+++..++.++.+|+.||++||+.+||+|||||+|||+|   +.|+|.|+|.|+|..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD---d~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD---DHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec---cCCCeEeeccceEEecCCC
Confidence            9999999999888666666899999999999999999999999999999999999999   7999999999999999888


Q ss_pred             CccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCCCch----hhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          256 KKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ......+||.+|||||++. +.|+...|+|||||++|||+.|..||....+.    ++-+.++.....+    ...+|++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey----~~kFS~e  416 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY----SDKFSEE  416 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc----ccccCHH
Confidence            8888889999999999876 45899999999999999999999999766543    3334444443333    3579999


Q ss_pred             HHHHHHHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          331 AKDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      +++|++.+|..||.+|.     .+.++.+||||+..
T Consensus       417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            99999999999999997     56799999999963

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.1e-44  Score=336.51  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=208.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .....+.+|+.+++.+. ||||+++++.+..++..++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEE
Confidence            4579999999999999999999999999999999865432   23456889999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++..  ...+++..+..++.|++.||.|||+.||+||||+|+||+++   .++.++|+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          84 CMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEECcCccceeecc
Confidence            9999999999998843  35789999999999999999999999999999999999998   577899999999976543


Q ss_pred             CC-ccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-CCCCCCC
Q 015026          255 GK-KFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPSIS  328 (414)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s  328 (414)
                      .. ......|++.|+|||.+.    ...+.++|||||||++|+|++|..||...........+.......+. .....++
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS  238 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccC
Confidence            22 223457899999999874    23577899999999999999999999655433322222222111111 1113468


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCcc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~  357 (414)
                      .++.+||.+||..||++|||++++|+|+|
T Consensus       239 ~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         239 STFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            89999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.2e-44  Score=340.06  Aligned_cols=261  Identities=30%  Similarity=0.512  Sum_probs=219.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|++.+.||.|++|.||+|.+..+|+.||+|.+.....   ...+.+.+|+.+++.+. ||||+++++.+.....+++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEEE
Confidence            579999999999999999999999999999999865432   24567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||+++++|.+++..   ..+++.++..++.|++.||.|||+.|++|+||+|+||+++   .++.+||+|||++......
T Consensus        95 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~---~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          95 MEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG---MDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccchhcccc
Confidence            999999999988743   3589999999999999999999999999999999999998   5788999999998765433


Q ss_pred             Cc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 KK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .. .....|++.|+|||.+.+. .+.++|||||||++|+|++|..||.+.........+...... .......+++.+.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  247 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPIFRD  247 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHHHHH
Confidence            22 2345789999999987654 688999999999999999999999877665444444333221 11123468899999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccccCCCCC
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEI  367 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~  367 (414)
                      ||.+||..||.+|||+.+++.||||.........
T Consensus       248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~  281 (296)
T cd06655         248 FLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSL  281 (296)
T ss_pred             HHHHHhhcChhhCCCHHHHhhChHhhhccccccC
Confidence            9999999999999999999999999976554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.9e-45  Score=337.27  Aligned_cols=253  Identities=28%  Similarity=0.504  Sum_probs=216.5

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++++ +||||+++++.+.++...++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence            489999999999999999999999999999999866544445678899999999999 5999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+.|++|.+++...  ..+++..+..++.||+.||.|||++|++|+||+|+||+++   +++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          80 DLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             eCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc---CCCCEEEeecccccccCCCc
Confidence            999999999988443  5789999999999999999999999999999999999998   57899999999988765544


Q ss_pred             ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc--hhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      ......|+..|+|||.+.+. .+.++|+||||+++|+|++|..||...+.  ...+......   ......+.++.++.+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  231 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADVLYPATWSTEAID  231 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccccCcccCcHHHHH
Confidence            44556789999999987654 58899999999999999999999987764  2222222221   112222467899999


Q ss_pred             HHHHhhcCCccccCCH--HHHhCCccc
Q 015026          334 FVKKLLVKDPRARLTA--AQALSHPWV  358 (414)
Q Consensus       334 li~~~L~~dp~~Rps~--~elL~hp~f  358 (414)
                      +|.+||..||.+||++  .|+++||||
T Consensus       232 ~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         232 AINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.2e-44  Score=339.73  Aligned_cols=241  Identities=17%  Similarity=0.233  Sum_probs=205.2

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----CCEEEEEEe
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DNYVYIAME  177 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----~~~~~lv~e  177 (414)
                      ..||+|++|.||+|..  +|+.||||++...........+.+.+|+.+|+++. ||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            4699999999999976  68999999997655444444678889999999995 9999999999876    457899999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      |++||+|.+++..  ...+++.....++.|++.||.|||+ .+++||||||+|||++   +++.+||+|||+++......
T Consensus       103 y~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        103 YCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             eCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHhhhcccc
Confidence            9999999999844  4578999999999999999999998 4999999999999998   57899999999987654322


Q ss_pred             ccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                        ...+||+.|+|||++.+   .++.++|||||||++|||++|..||.+.+..+++..+......++.+  ...++++.+
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~  253 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKC  253 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHH
Confidence              24578999999999864   56899999999999999999999999888777777776554433221  257899999


Q ss_pred             HHHHhhcCCccccCCHHHHhC
Q 015026          334 FVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~  354 (414)
                      ||.+||+.||++|||+.+++.
T Consensus       254 li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHH
Confidence            999999999999999999985

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.6e-44  Score=340.78  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=209.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE----
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY----  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~----  171 (414)
                      ++|++.+.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.+.+||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            3689999999999999999999999999999987654321 12345678899999999767999999999876655    


Q ss_pred             -EEEEEeccCCCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          172 -VYIAMELCEGGELLDRILAKK---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       172 -~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                       .|+||||+++ +|.+++....   ...+++..++.++.||+.||.|||++||+||||+|+||+++.  .++.+||+|||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~dfg  156 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIADLG  156 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEeecc
Confidence             8999999986 7888875433   246899999999999999999999999999999999999983  37889999999


Q ss_pred             cccccCCC-CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC----
Q 015026          248 LSDFIKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR----  320 (414)
Q Consensus       248 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----  320 (414)
                      ++...... .......+++.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+.+..+........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98754322 22233467889999998754  358899999999999999999999987766554444333111000    


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          321 --------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       321 --------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                                          ....+.+++++.+||.+||..||.+||++.++|.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                011245788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.7e-44  Score=332.60  Aligned_cols=254  Identities=25%  Similarity=0.528  Sum_probs=218.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|+||.||++.+..+|+.||+|.+..... .......+.+|+.+++.+. ||||+++++++...+..++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence            58999999999999999999999999999999875433 2335568899999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+.+.......+++..+..++.|++.||.|||++|++|+||+|+||+++   .++.++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~---~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEEeeccceeecCcch
Confidence            999999999988665555789999999999999999999999999999999999998   57789999999987654332


Q ss_pred             c-cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          257 K-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       257 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      . .....|++.|+|||++.+ ..+.++|+|||||++++|++|..||......+....+..+....   ....++.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHH
Confidence            2 224568899999998765 45789999999999999999999998777766766666554321   124678899999


Q ss_pred             HHHhhcCCccccCCHHHHhCCccc
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      |.+||+.+|.+||++.+++.||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=339.00  Aligned_cols=258  Identities=33%  Similarity=0.508  Sum_probs=217.3

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||.|+||.||+|.+..++..||+|++...   .....+.+.+|+.+++.+. ||||+++++.+..+...++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence            35799999999999999999999889999999998643   2345677889999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++... ...+++..++.++.|++.||.|||+.||+|+||+|+||+++   .++.++|+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~---~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          80 LIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT---LDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC---CCCCEEEccCccchhhcc
Confidence            99999999998887543 35699999999999999999999999999999999999998   578999999998865433


Q ss_pred             C-CccccCCCCCccccchhccc------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          255 G-KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       255 ~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      . .......|++.|+|||++..      .++.++||||||+++|+|++|+.||.+......+..+........ .....+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  234 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKW  234 (280)
T ss_pred             cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccC
Confidence            2 22234578999999998742      246789999999999999999999987766665555554432111 112357


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +.++.++|.+||..||.+||++.++|+||||...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            8899999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-44  Score=339.70  Aligned_cols=261  Identities=28%  Similarity=0.390  Sum_probs=214.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||.||+|.+..+|..||+|.+....  .+.....+.+|+.+++.+ +||||+++++.+...+.+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEE
Confidence            36899999999999999999999999999999886432  233457888999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          176 MELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      |||++|++|..++.... ...+++..+..++.||+.||.|||+ .||+||||||+||+++   .++.+||+|||++....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCccccc
Confidence            99999999988774321 2368999999999999999999997 5999999999999998   47889999999987654


Q ss_pred             CCCccccCCCCCccccchhcccc-------CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .. ......|++.|+|||.+.+.       ++.++|||||||++|+|++|..||...........+.......+....+.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence            32 22345788999999987532       36789999999999999999999976655444433322111112223346


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +++++.+||.+||..+|.+||++.+++.||||.....
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            8899999999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.6e-44  Score=341.39  Aligned_cols=263  Identities=30%  Similarity=0.438  Sum_probs=214.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC--ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      +|.+.+.||.|+||.||+|.+..+|+.||||.+......  .......+..|+.+++.+. ||||+++++++.+.+..++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence            488899999999999999999999999999999765432  1223456778999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++   .++.++|+|||++.....
T Consensus        80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGS  154 (298)
T ss_pred             EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceeeeeccC
Confidence            99999 889999885432 3699999999999999999999999999999999999998   578999999999977654


Q ss_pred             CC-ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC-----------
Q 015026          255 GK-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-----------  320 (414)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-----------  320 (414)
                      .. ......+++.|+|||.+.+  .++.++|||||||++|+|++|.+||.+....+.+..+........           
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            32 2334467889999998754  357889999999999999999888877666554444432211000           


Q ss_pred             -------------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          321 -------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       321 -------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                                   ...+..++.++.+||.+||..||++|||+.++|.||||++.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence                         001234578899999999999999999999999999999865544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.7e-44  Score=337.02  Aligned_cols=257  Identities=32%  Similarity=0.487  Sum_probs=215.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      -|++.+.||.|+||.||+|.+..++..+|+|.+....   ....+.+.+|+.+++.+ +||||+++++.+..++..++|+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEE
Confidence            4788999999999999999999999999999886432   34567788999999999 4999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-  255 (414)
                      ||+++++|...+.. ....+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++...... 
T Consensus        82 e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          82 EFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---cCCCEEEccccccccccccc
Confidence            99999999887644 235789999999999999999999999999999999999998   5788999999998654322 


Q ss_pred             CccccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          256 KKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      .......|++.|+|||++.      ..++.++|||||||++|+|++|.+||...+..+....+........ .....++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCccccCH
Confidence            2234467899999999874      2246789999999999999999999987766655555544432211 11235788


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ++.+||.+||..||.+||++.++++||||+...
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            999999999999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.1e-44  Score=336.94  Aligned_cols=259  Identities=29%  Similarity=0.488  Sum_probs=212.9

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC---
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~---  169 (414)
                      +..++|.+.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+.+||||+++++++...   
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            45678999999999999999999999999999999986532    13456788999999996799999999988643   


Q ss_pred             --CEEEEEEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          170 --NYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                        +.+++||||++|++|.+++..  .....+++..++.++.|++.||.|||+.|++||||||+||+++   .++.+||+|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEee
Confidence              468999999999999988743  2345689999999999999999999999999999999999998   577899999


Q ss_pred             cccccccCCCC-ccccCCCCCccccchhcccc------CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC
Q 015026          246 FGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRK------SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (414)
Q Consensus       246 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~  318 (414)
                      ||++....... ......|+..|+|||++...      .+.++|||||||++|+|++|+.||......+.+..+......
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  251 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP  251 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence            99987654322 22345789999999987532      478999999999999999999999876655544444433221


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      . .......+.++.+||.+||..||++||++.++++||||+
T Consensus       252 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 T-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             C-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            1 111234677899999999999999999999999999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-44  Score=334.06  Aligned_cols=253  Identities=30%  Similarity=0.514  Sum_probs=211.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC------hHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL------PIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      +|.+...||.|++|.||+|.+..+++.||+|.+.......      ....+.+.+|+.+++.+. ||||+++++++....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence            4778899999999999999999999999999886543221      123467889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++|+||+++++|.+++..  ...+++..+..++.|++.||.|||+.|++||||+|+||+++   .++.++|+|||++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~---~~~~~~l~dfg~~~  154 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISK  154 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---CCCCEEecccCCCc
Confidence            99999999999999998843  35789999999999999999999999999999999999998   57899999999987


Q ss_pred             ccCCCC-------ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC
Q 015026          251 FIKPGK-------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (414)
Q Consensus       251 ~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~  322 (414)
                      ......       ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||.+.........+....   ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~  231 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SPE  231 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CCc
Confidence            664211       1123568899999998765 45788999999999999999999998765544444433321   112


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ....++.++.++|.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            224678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-47  Score=338.57  Aligned_cols=264  Identities=25%  Similarity=0.486  Sum_probs=224.2

Q ss_pred             cccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      +.+...+.|.++++||+|+||.||+|.++.+|..||||.+..+.     ..+.+..||.|++++. .|++|++|+.|-..
T Consensus        27 L~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~-S~yVVKYYGSYFK~  100 (502)
T KOG0574|consen   27 LNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCK-SKYVVKYYGSYFKH  100 (502)
T ss_pred             hcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcC-CchhhhhhhhhccC
Confidence            34445567999999999999999999999999999999987653     6788999999999994 99999999998888


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      ..++||||||..|++.+.+.. ....+++.++..+++.-+.||+|||...-||||||..|||++   .+|..||+|||.|
T Consensus       101 sDLWIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN---T~G~AKLADFGVA  176 (502)
T KOG0574|consen  101 SDLWIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN---TDGIAKLADFGVA  176 (502)
T ss_pred             CceEeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc---ccchhhhhhcccc
Confidence            889999999999999987754 457899999999999999999999999999999999999998   6899999999999


Q ss_pred             cccCCC-CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhc-CCCCCCCCCCC
Q 015026          250 DFIKPG-KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-KPDFRRKPWPS  326 (414)
Q Consensus       250 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  326 (414)
                      ....+. ...++++|||.|||||++.. .|...+||||||+...||.-|++||.+-.....+-.|-.. .+.|..  ...
T Consensus       177 GQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~K--PE~  254 (502)
T KOG0574|consen  177 GQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKK--PEE  254 (502)
T ss_pred             chhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCC--hHh
Confidence            765432 23568899999999999875 5788999999999999999999999776554333222222 122222  124


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      .|+++.+||++||.+.|++|-||.++++|||.+..+..+
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence            678899999999999999999999999999999865543

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2e-44  Score=345.16  Aligned_cols=251  Identities=27%  Similarity=0.425  Sum_probs=192.8

Q ss_pred             ceeeeecCceEEEEEEECC--CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE--cCCEEEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--DDNYVYIAM  176 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~--~~~~~~lv~  176 (414)
                      +.+||+|+||+||+|.+..  ++..||+|.+....     ....+.+|+.+++.+. ||||+++++++.  .+..+++|+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence            3579999999999998654  66789999886543     2245678999999995 999999999885  456789999


Q ss_pred             eccCCCChHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec-CCCCCceeecccc
Q 015026          177 ELCEGGELLDRILAK-------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGL  248 (414)
Q Consensus       177 e~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DFG~  248 (414)
                      ||+. ++|.+++...       ....+++..++.++.||+.||.|||+.||+||||||+|||+... ..++.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            9996 4777776421       12358899999999999999999999999999999999999532 2567899999999


Q ss_pred             ccccCCCC----ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh---------hhHHHh
Q 015026          249 SDFIKPGK----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDG---------IFKEVL  313 (414)
Q Consensus       249 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---------~~~~i~  313 (414)
                      ++......    ......||+.|+|||++.+  .++.++|||||||++|||+||.+||....++.         .+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            98654322    2335678999999998765  35889999999999999999999997543211         111111


Q ss_pred             hc--------------CCCCC--------------------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          314 RN--------------KPDFR--------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       314 ~~--------------~~~~~--------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ..              .+.++                    .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00              00000                    00011235568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.1e-46  Score=359.06  Aligned_cols=261  Identities=25%  Similarity=0.452  Sum_probs=223.2

Q ss_pred             cccccce-eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCC-CChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           92 KDFDRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        92 ~~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .+...+| +...+||+|+|-+||+|.|..+|-.||.-.+..... ..+...++|..|+.+|+.|+ |||||++|+.|.+.
T Consensus        35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDT  113 (632)
T ss_pred             cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecC
Confidence            3344566 456789999999999999999999998776643322 24556789999999999995 99999999999875


Q ss_pred             C--EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceeec
Q 015026          170 N--YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       170 ~--~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      .  .+.+|+|++.+|+|..|+  .+.+.++...++.|++||+.||.|||++.  |||||||.+||+|+.  ..|.|||+|
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~--kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG--~~G~VKIGD  189 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYR--KKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG--NLGEVKIGD  189 (632)
T ss_pred             CCceeeeeeecccCCcHHHHH--HHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC--CcCceeecc
Confidence            4  488999999999999998  45567899999999999999999999985  999999999999984  789999999


Q ss_pred             cccccccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCC-CCchhhhHHHhhcCCCCCCCCC
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      +|||....... ...++|||.|||||++...|...+||||||+++.||+|+..||.. .+...+++++..+..+-.... 
T Consensus       190 LGLAtl~r~s~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k-  267 (632)
T KOG0584|consen  190 LGLATLLRKSH-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK-  267 (632)
T ss_pred             hhHHHHhhccc-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc-
Confidence            99998876543 345899999999999999999999999999999999999999965 466788999988865322211 


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                       --.+++++||.+||.. .+.|||+.|+|.||||...
T Consensus       268 -V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  268 -VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence             2367899999999999 9999999999999999975

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4e-44  Score=342.13  Aligned_cols=261  Identities=26%  Similarity=0.402  Sum_probs=211.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--CEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYV  172 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~~~  172 (414)
                      .++|++.+.||.|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++++. ||||+++++++.+.  +.+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence            357999999999999999999999999999999986543221 12334568999999995 99999999998754  578


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+.+ +|.+++... ...+++..+..++.||+.||.|||+.|++||||||+||+++   .++.+||+|||++...
T Consensus        84 ~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~kL~dfg~~~~~  158 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccceeeec
Confidence            999999964 788877543 35689999999999999999999999999999999999998   5789999999999876


Q ss_pred             CCCC-ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC--------
Q 015026          253 KPGK-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR--------  321 (414)
Q Consensus       253 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------  321 (414)
                      .... ......+++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.........        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            5432 2233456888999998764  3588999999999999999999999888776666655442111000        


Q ss_pred             -----------CC-------CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          322 -----------KP-------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       322 -----------~~-------~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                 ..       ...+++++.+||.+||+.||++|||+.++|.||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                       00       123578899999999999999999999999999998543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.9e-44  Score=339.79  Aligned_cols=256  Identities=28%  Similarity=0.469  Sum_probs=210.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|++++.||.|++|.||+|++..+|+.||||.+..... .......+.+|+.+++.+. ||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence            38899999999999999999999999999998865432 2223457889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+. ++|.+++.......+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.+||+|||++.......
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~---~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEeeccchhhcccCc
Confidence            9996 5888888666567789999999999999999999999999999999999998   57899999999987654322


Q ss_pred             -ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC---------------
Q 015026          257 -KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD---------------  318 (414)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~---------------  318 (414)
                       ......+++.|+|||++.+.  .+.++||||||+++|+|+||+.||.+.++......+......               
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             22344678899999987653  477899999999999999999999876654443333321110               


Q ss_pred             ---CCC-------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 ---FRR-------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 ---~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                         ++.       ...+.++++++++|.+||+.||.+|||+.++|.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence               000       1123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.7e-44  Score=337.23  Aligned_cols=253  Identities=30%  Similarity=0.471  Sum_probs=206.9

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--CEEEEE
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVYIA  175 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~~~~lv  175 (414)
                      |++.+.||+|+||.||+|.+..+++.||+|++......  .......+|+.+++++.+||||+++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC--chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            67889999999999999999999999999988654321  12233457999999997799999999999887  899999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||++ ++|.+.+.... ..+++..+..++.||+.||.|||+.|++||||+|+||+++   . +.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccC
Confidence            99997 58888875432 5689999999999999999999999999999999999998   4 89999999999876554


Q ss_pred             CccccCCCCCccccchhcc--ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC----------------
Q 015026          256 KKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP----------------  317 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~----------------  317 (414)
                      .......+++.|+|||++.  +..+.++|||||||++|+|++|..||.+.+..+.+..+.....                
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            4445567899999999764  3358899999999999999999999987765544443322110                


Q ss_pred             --CCCCC-------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          318 --DFRRK-------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       318 --~~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                        .++..       ..+.++.++.+||.+||.+||++|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence              00000       013568899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.2e-44  Score=338.75  Aligned_cols=262  Identities=26%  Similarity=0.446  Sum_probs=213.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||.|++|+||+|.+..+|+.||+|.+...... ....+.+.+|+.+++.+. ||||+++++++.+....++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence            4699999999999999999999999999999998654322 223466789999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++ ++|.+++.......+++..++.++.||+.||.|||++|++||||+|+||+++.  .++.+||+|||++......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence            99996 58888876555555788999999999999999999999999999999999984  3567999999999765332


Q ss_pred             -CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-----------
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (414)
                       .......|++.|+|||++.+  .++.++|||||||++|+|++|..||......+.+.++.........           
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             22234567899999998765  3578899999999999999999999877665554444321110000           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          322 --------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       322 --------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                    ...+.+++++.++|.+||+.||++||++.+++.||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                          01245788999999999999999999999999999998643

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.4e-44  Score=334.09  Aligned_cols=256  Identities=28%  Similarity=0.494  Sum_probs=211.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC-------ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-------LPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.+......       .....+.+.+|+.+++.+. ||||+++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            588999999999999999999999999999988542211       1112456889999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      +..++||||++|++|.+++...  ..+++..+..++.||+.||.|||++|++||||+|+||+++   .++.++|+|||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~---~~~~~~l~d~~~~  155 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD---ADGICKISDFGIS  155 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---CCCeEEEeecccc
Confidence            9999999999999999988443  5789999999999999999999999999999999999998   5789999999998


Q ss_pred             cccCCCC---ccccCCCCCccccchhcccc---CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhc--CCCCCC
Q 015026          250 DFIKPGK---KFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRR  321 (414)
Q Consensus       250 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~  321 (414)
                      .......   ......|+..|+|||.+...   ++.++|+||||+++|+|++|..||......+....+...  ...++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP  235 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence            7543211   12345689999999987643   588999999999999999999999765544433333222  222333


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ...+.++.++.++|.+||..||.+|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            3445678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.4e-44  Score=336.44  Aligned_cols=256  Identities=26%  Similarity=0.455  Sum_probs=215.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ..|+..+.||.|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.+ +||||+++++.+.++...++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEE
Confidence            468889999999999999999999999999999875432  23567889999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++|++|.+++..   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++   .++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          81 MEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccCC
Confidence            999999999998742   4689999999999999999999999999999999999998   5778999999999765443


Q ss_pred             Cc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 KK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .. .....++..|+|||++.+. .+.++|+|||||++|+|++|..||.+.........+....   +......++..+.+
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  231 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKE  231 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHH
Confidence            22 2345688999999987654 5889999999999999999999998766555444433222   12222357788999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +|.+||..+|.+||++.+++.||||.....
T Consensus       232 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         232 FIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            999999999999999999999999986543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=359.06  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=215.0

Q ss_pred             eeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCC
Q 015026          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGG  182 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg  182 (414)
                      +||+|.||+||-|+|..|...+|||.|....   ....+.+..||.+.+.|+ |.|||+++|.+..++.+-|.||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            6999999999999999999999999986543   245678899999999996 999999999999999999999999999


Q ss_pred             ChHHHHHhccCCCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-CCccc
Q 015026          183 ELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQ  259 (414)
Q Consensus       183 ~L~~~l~~~~~~~l--~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-~~~~~  259 (414)
                      +|.+++. .+.+++  .|..+..+.+||++||.|||++.|||||||-+|||++.  -.|.+||+|||.++.... +.-..
T Consensus       658 SLSsLLr-skWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT--ySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  658 SLSSLLR-SKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT--YSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             cHHHHHH-hccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee--ccceEEecccccchhhccCCcccc
Confidence            9998774 456777  88999999999999999999999999999999999985  678999999999876543 33345


Q ss_pred             cCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHH
Q 015026          260 DIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (414)
                      ++.||..|||||++..   .|+.++|||||||.+.||.||++||.......... ..-+....-++....+|.+++.||.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-FkVGmyKvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-FKVGMYKVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-hhhcceecCCCCcHHHHHHHHHHHH
Confidence            7899999999999974   47999999999999999999999997654432211 1111111222223468889999999


Q ss_pred             HhhcCCccccCCHHHHhCCcccccccCCCC
Q 015026          337 KLLVKDPRARLTAAQALSHPWVREGGDASE  366 (414)
Q Consensus       337 ~~L~~dp~~Rps~~elL~hp~f~~~~~~~~  366 (414)
                      +|+.+||.+||+|.++|.+||++..+....
T Consensus       814 rcFepd~~~R~sA~~LL~DpFlq~~~kk~r  843 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQDPFLQHNNKKPR  843 (1226)
T ss_pred             HHcCCCcccCccHHHhccCcccccCCCCCC
Confidence            999999999999999999999997755443

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.4e-44  Score=335.92  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=200.9

Q ss_pred             eeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHc--cCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL--AGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l--~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      .||+|+||.||++.+..+|+.+|+|.+.+.............+|..+++.+  .+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998765433222333344555444433  259999999999999999999999999


Q ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcccc
Q 015026          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD  260 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~  260 (414)
                      |++|.+++..  ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.++|+|||++....... ...
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~---~~~~~~l~dfg~~~~~~~~~-~~~  154 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK-PHA  154 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---CCCCEEEccCCcceeccccC-ccC
Confidence            9999988743  35699999999999999999999999999999999999998   57899999999987554322 234


Q ss_pred             CCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 015026          261 IVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (414)
                      ..||+.|+|||.+..  .++.++||||+||++|+|++|..||.+...... ..+............+.+++++.++|.+|
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGL  233 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHH
Confidence            579999999998753  358899999999999999999999975432211 11111111122223346889999999999


Q ss_pred             hcCCccccC-----CHHHHhCCcccccc
Q 015026          339 LVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       339 L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      |..||.+||     |+.++++||||+..
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            999999999     69999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-45  Score=330.55  Aligned_cols=266  Identities=29%  Similarity=0.423  Sum_probs=209.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC----EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-CC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-~~  170 (414)
                      ..|++++.||+|.||.||+|..+.++.    .+|||.+..+...... ....-+|+.+++.|+ ||||+.+..+|.. +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELK-HPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhc-CCcchhHHHHHhccCc
Confidence            359999999999999999997665543    6899998765432222 234568999999996 9999999999876 88


Q ss_pred             EEEEEEeccCCCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec-CCCCCceeecc
Q 015026          171 YVYIAMELCEGGELLDRILA---KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDF  246 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DF  246 (414)
                      .+++++||.+. +|...|.-   .....++...++.|+.||++|+.|||++-|+||||||.|||+..+ .+.|.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999999975 78877732   233579999999999999999999999999999999999999843 34589999999


Q ss_pred             ccccccCCCC----ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCch---------hhhHH
Q 015026          247 GLSDFIKPGK----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED---------GIFKE  311 (414)
Q Consensus       247 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~---------~~~~~  311 (414)
                      |+++.+.+.-    ....++.|.+|+|||++.|  .|+++.||||+|||+.||+|-.+.|.+..+.         +.+..
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999875432    2345788999999998765  4799999999999999999999999664321         22333


Q ss_pred             HhhcCCCCCCCCCCC---------------------------------CCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          312 VLRNKPDFRRKPWPS---------------------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       312 i~~~~~~~~~~~~~~---------------------------------~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      |..--.......||.                                 -++.+.+|+.+||+.||.+|+|++++|+|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            333221112222221                                 24558899999999999999999999999999


Q ss_pred             ccccCC
Q 015026          359 REGGDA  364 (414)
Q Consensus       359 ~~~~~~  364 (414)
                      ++..-.
T Consensus       341 ~~d~lp  346 (438)
T KOG0666|consen  341 TEDPLP  346 (438)
T ss_pred             ccCCCC
Confidence            986443

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.5e-44  Score=332.68  Aligned_cols=250  Identities=31%  Similarity=0.541  Sum_probs=212.6

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (414)
                      ||.|++|.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++.+.++..+++|+||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            69999999999999999999999999766544444567899999999999 59999999999999999999999999999


Q ss_pred             hHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCC
Q 015026          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG  263 (414)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~g  263 (414)
                      |.+++..  ...+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++.............|
T Consensus        80 L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~~~~~~~  154 (262)
T cd05572          80 LWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQKTWTFCG  154 (262)
T ss_pred             HHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccccccccC
Confidence            9998844  34689999999999999999999999999999999999998   578999999999987655433445678


Q ss_pred             CCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCC--chhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhc
Q 015026          264 SAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT--EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV  340 (414)
Q Consensus       264 t~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  340 (414)
                      ++.|+|||.+.+ .++.++|+||||+++|+|++|..||....  ....+..+.........  ....++++.++|.+||.
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~  232 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLR  232 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC--CcccCHHHHHHHHHHcc
Confidence            999999998754 46889999999999999999999998776  44455555532221111  12458899999999999


Q ss_pred             CCccccCC-----HHHHhCCcccccc
Q 015026          341 KDPRARLT-----AAQALSHPWVREG  361 (414)
Q Consensus       341 ~dp~~Rps-----~~elL~hp~f~~~  361 (414)
                      .||++||+     +.|+++||||+..
T Consensus       233 ~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         233 RNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             CChhhCcCCcccCHHHHhcChhhhCC
Confidence            99999999     9999999999853

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9e-44  Score=331.81  Aligned_cols=254  Identities=28%  Similarity=0.445  Sum_probs=209.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC---ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +|++.+.||.|+||+||+|.+ .+|+.+|+|.+......   .......+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence            478899999999999999986 57889999988654321   1234567889999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +|+||++|++|.+++.+  ...+++..+..++.|++.||.|||+.||+|+||+|+||+++   .++.++|+|||++....
T Consensus        79 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          79 IFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---CCCeEEeccchhhHhhh
Confidence            99999999999998844  34689999999999999999999999999999999999998   57899999999987542


Q ss_pred             C-------CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          254 P-------GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       254 ~-------~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      .       ........|+..|+|||++.+. ++.++||||||+++|+|++|..||......+....+....... .....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  232 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-PRLPD  232 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-CCCCC
Confidence            1       1122345789999999987654 5789999999999999999999997665444333333221111 12234


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .++.++.++|.+||..+|.+||++.++|.||||
T Consensus       233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            688999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-44  Score=357.16  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=201.8

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....         ..+.+|+.+|+.|. |||||++++++..++..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence            3479999999999999999999999999999996422         23568999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |||++. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus       238 v~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        238 VLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---CCCCEEEcccCCceeccc
Confidence            999995 6888887543 34699999999999999999999999999999999999998   578899999999976543


Q ss_pred             CCc---cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc--------hhhhHHHhhcCC---CC
Q 015026          255 GKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE--------DGIFKEVLRNKP---DF  319 (414)
Q Consensus       255 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~i~~~~~---~~  319 (414)
                      ...   ....+||+.|+|||++.+. ++.++|||||||++|||++|..|+.....        ..+.+.+.....   .+
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            221   2246799999999987654 68899999999999999998766543221        122222221110   01


Q ss_pred             ------------------------CCCCCC---CCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          320 ------------------------RRKPWP---SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       320 ------------------------~~~~~~---~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                                              ....|.   .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                    111122   35678999999999999999999999999999974

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.6e-44  Score=339.72  Aligned_cols=259  Identities=23%  Similarity=0.345  Sum_probs=209.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|...+.||+|+||.||++.+..+|+.||+|.+.....  ......+.+|+.++.++.+||||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            46777899999999999999999999999999875432  2356678899999999966999999999999999999999


Q ss_pred             eccCCCChHHH---HHhccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          177 ELCEGGELLDR---ILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       177 e~~~gg~L~~~---l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ||+.+ ++.++   +.......+++..+..++.|++.||+|||+. +|+||||||+||+++   .++.+||+|||++...
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecchhHHh
Confidence            99864 54443   3333446799999999999999999999974 999999999999998   5778999999999765


Q ss_pred             CCCCccccCCCCCccccchhcccc----CCCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHHHhhcC-CCCCCCCCCC
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNK-PDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~  326 (414)
                      ..........|++.|+|||++.+.    ++.++|||||||++|+|++|+.||..... .+....+.... +.........
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            544333455789999999988654    68899999999999999999999965542 12222222221 2222222245


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ++.++.+||.+||+.||.+|||+.+++.||||...
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            88999999999999999999999999999999853

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=330.19  Aligned_cols=255  Identities=30%  Similarity=0.490  Sum_probs=213.4

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++.....   ...+.+.+|+.+++.+ +||||+++++.+.+...+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEE
Confidence            3579999999999999999999999999999999875432   2567889999999999 59999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      +|||+++++|.+++... ...+++..+..++.|++.||.|||++||+|+||+|+||+++   .++.+||+|||++.....
T Consensus        78 ~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---CCCCEEECccccchhhhh
Confidence            99999999999887543 25789999999999999999999999999999999999999   578899999999876543


Q ss_pred             CC-ccccCCCCCccccchhccc----cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-CCCCCCC
Q 015026          255 GK-KFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPSIS  328 (414)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s  328 (414)
                      .. ......++..|+|||.+.+    ..+.++||||||+++|+|++|..||.+.........+......... .....++
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence            22 2345678999999998754    4578899999999999999999999876655444443333111111 1123467


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCcc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~  357 (414)
                      .++.+||.+||..||.+|||+.+++.|||
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            88999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3e-44  Score=338.67  Aligned_cols=256  Identities=27%  Similarity=0.474  Sum_probs=210.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.+. ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEE
Confidence            3689999999999999999999999999999988654322 234567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||++++.|.++..  ....+++..+..++.||+.||.|||+.||+|+||+|+||+++   .++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~---~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          79 FEFVDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             EecCCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCcEEEEeeeeeeeccCC
Confidence            99999888777553  234589999999999999999999999999999999999998   5789999999998765433


Q ss_pred             C-ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC-------------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-------------  319 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-------------  319 (414)
                      . ......++..|+|||++.+  ..+.++||||||+++|+|++|++||......+....+......+             
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence            2 2334678999999998764  35788999999999999999999997665443333322111000             


Q ss_pred             ------C--------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          320 ------R--------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       320 ------~--------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                            +        ...++.++..+.+|+.+||..||.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                  0        01134678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.4e-43  Score=328.26  Aligned_cols=255  Identities=32%  Similarity=0.534  Sum_probs=212.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.+. ||||+++++.+...+.+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence            589999999999999999999999999999998765432 346788999999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+.||+|+||+|+||+++   .++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          79 EYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             ecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCCCC
Confidence            99999999998843  34688999999999999999999999999999999999998   57899999999987654332


Q ss_pred             c-----cccCCCCCccccchhcccc----CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          257 K-----FQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       257 ~-----~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      .     .....+++.|+|||++.+.    .+.++||||||+++|+|++|..||.....................+.+..+
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccccc
Confidence            2     2235788999999987643    578899999999999999999999765433222222222211122223356


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ++.+.++|.+||+.||.+|||+.+++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            8899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.5e-43  Score=328.36  Aligned_cols=250  Identities=28%  Similarity=0.508  Sum_probs=213.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+.....  ....+.+.+|+.+++.+. ||||+++++.+.+++.+++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            48899999999999999999999999999999865432  235677889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++   .++.++|+|||++.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC---CCCcEEEcccCcceeecccc
Confidence            999999999988665666789999999999999999999999999999999999998   57889999999987654322


Q ss_pred             -ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          257 -KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                       ......|++.|+|||++.+. ++.++|+||||+++|+|++|..||...+.......+..+....   ....++..+.+|
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---LPSHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC---CCcccCHHHHHH
Confidence             22346789999999988654 6889999999999999999999998776666665555443221   123578899999


Q ss_pred             HHHhhcCCccccCCHHHHhCC
Q 015026          335 VKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~h  355 (414)
                      |.+||+.||.+|||+.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-43  Score=333.77  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=207.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||.||+|.+..+|+.||||++......  .....+..|+.++.+..+||||+++++++..++.+++||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            589999999999999999999999999999998764321  233455667776544447999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          177 ELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       177 e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||++ ++|.+++...  ....+++..++.++.||+.||.|||++ +++||||||+||+++   .++.+||+|||++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~---~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN---RNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecccccccc
Confidence            9996 5777766432  235689999999999999999999997 999999999999998   57899999999998764


Q ss_pred             CCCccccCCCCCccccchhccc-----cCCCCcchhHHHHHHHHHhhCCCCCCCCC-chhhhHHHhhcCCCCCCCCCCCC
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKR-----KSGPESDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      .........|+..|+|||.+.+     .++.++|+|||||++|+|++|..||.... ..+.+..+.....  +..+...+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~  233 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEKF  233 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCcccc
Confidence            4333334578999999998753     34788999999999999999999996532 2233333333211  11112357


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      |.++.++|.+||..+|.+||++.+++.||||....
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            89999999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-44  Score=344.73  Aligned_cols=261  Identities=30%  Similarity=0.479  Sum_probs=208.3

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +.++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.++ ||||+++++++...    
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES   79 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence            4568999999999999999999999999999999986422  2234566788999999995 99999999887543    


Q ss_pred             -CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                       ...++|+||+.+ +|.+.+.   ...+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||+
T Consensus        80 ~~~~~lv~e~~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~  152 (336)
T cd07849          80 FNDVYIVQELMET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TNCDLKICDFGL  152 (336)
T ss_pred             cceEEEEehhccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEECcccc
Confidence             358999999964 7877663   34699999999999999999999999999999999999998   578999999999


Q ss_pred             ccccCCCCc----cccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhc-------
Q 015026          249 SDFIKPGKK----FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-------  315 (414)
Q Consensus       249 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~-------  315 (414)
                      +........    .....||+.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.........+...       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            876543221    234578999999998643  4688999999999999999999999765443322222110       


Q ss_pred             ----------------CCCCCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          316 ----------------KPDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       316 ----------------~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                                      .+.....    ..+.+++++.+||.+||+.||.+|||+.++++||||......
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                            0000000    124567889999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.4e-44  Score=339.08  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=210.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--CEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~~~~  173 (414)
                      +.|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.+. ||||+++++++...  ...+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence            4699999999999999999999999999999998755432 223345678999999995 99999999998877  8999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +|+||+++ +|.+.+.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++   .++.++|+|||++....
T Consensus        83 lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN---NRGILKICDFGLAREYG  157 (293)
T ss_pred             EEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCcEEEeecCceeecc
Confidence            99999975 8888775433 4689999999999999999999999999999999999998   57899999999987665


Q ss_pred             CC-CccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC-----------
Q 015026          254 PG-KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-----------  319 (414)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----------  319 (414)
                      .. .......+++.|+|||.+.+.  .+.++||||||+++|+|++|..||.+......+..+.......           
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            43 333455688999999987653  4789999999999999999999998776655544443211100           


Q ss_pred             ---------------CCCCCCC--CCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          320 ---------------RRKPWPS--ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       320 ---------------~~~~~~~--~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                                     .....+.  +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                           0011222  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=335.03  Aligned_cols=255  Identities=26%  Similarity=0.439  Sum_probs=204.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||.|++|.||+|.+..+++.||||.+......  .....+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence            5699999999999999999999999999999998654321  12345678999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||+++.....
T Consensus        82 ~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          82 FEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKSVP  156 (291)
T ss_pred             EecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---CCCCEEECccccccccCCC
Confidence            999975 8988875443 4789999999999999999999999999999999999998   5788999999998654321


Q ss_pred             C-ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCC-chhhhHHHhhcCCC-------------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPD-------------  318 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~-~~~~~~~i~~~~~~-------------  318 (414)
                      . ......++..|+|||++.+  .++.++||||+|+++|+|++|..||.+.. ..+.+..+.+....             
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            1 1223457889999998754  35788999999999999999999997654 22222222110000             


Q ss_pred             ------C-------CCCCCCCCC--HHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 ------F-------RRKPWPSIS--NSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 ------~-------~~~~~~~~s--~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                            +       .....+.++  .++.++|.+||+.||++|||+.++|.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                  0       000112344  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.2e-44  Score=332.03  Aligned_cols=258  Identities=23%  Similarity=0.397  Sum_probs=209.8

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC---ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      .|+..+.||+|++|.||+|.+..+++.||+|++......   .....+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence            378889999999999999999999999999998653321   1224578899999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +|+||++|++|.+++..  ...+++..+..++.||+.||.|||++|++|+||+|+||+++.  .+..+||+|||++....
T Consensus        80 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          80 LFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccc
Confidence            99999999999998843  357899999999999999999999999999999999999973  33469999999987654


Q ss_pred             CCCc-----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC-CCCCCCCCC
Q 015026          254 PGKK-----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-DFRRKPWPS  326 (414)
Q Consensus       254 ~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~  326 (414)
                      ....     .....|+..|+|||.+.+ .++.++||||+|+++|+|++|..||...........+..... .......+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            3211     123568899999998764 458899999999999999999999965543332222222111 111222235


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      +++++.+++.+||..||.+|||+.+++.||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            788999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-43  Score=329.02  Aligned_cols=252  Identities=29%  Similarity=0.515  Sum_probs=212.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+....     ..+.+.+|+.+++.+ +||||+++++.+.+....+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEE
Confidence            57999999999999999999999889999999986542     267899999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||+++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          77 MEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcccC
Confidence            999999999998743 235789999999999999999999999999999999999998   5778999999998876543


Q ss_pred             C-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 K-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      . ......|+..|+|||.+.+. .+.++||||||+++|+|++|+.||...........+...... .......++.++.+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFND  231 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHH
Confidence            3 23345689999999987654 578999999999999999999999776554433333222111 11112357789999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      +|.+||+.||.+|||+.++|.||||
T Consensus       232 ~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         232 FVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-43  Score=329.25  Aligned_cols=254  Identities=28%  Similarity=0.488  Sum_probs=207.0

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC--ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--CCEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYV  172 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~~~  172 (414)
                      .|.+.+.||+|+||.||+|.+..+|..||+|++......  .......+.+|+.+++.+. ||||+++++.+.+  ...+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence            588999999999999999999999999999988654321  2234567889999999995 9999999998865  4678


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++++||+++++|.+++..  ...+++..+..++.||+.||.|||+.+|+||||+|+||+++   .++.+||+|||++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEccCCCcccc
Confidence            999999999999998844  34689999999999999999999999999999999999998   5778999999998754


Q ss_pred             CCC----CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          253 KPG----KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       253 ~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ...    .......|+..|+|||.+.+. ++.++|||||||++|+|++|+.||.+.........+.....  .......+
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~  234 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--NPQLPSHI  234 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC--CCCCchhc
Confidence            321    112335689999999987654 58899999999999999999999987654444433332211  11112356


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      ++.+.++| +||..+|++||+++|+++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            78899999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-43  Score=331.09  Aligned_cols=249  Identities=25%  Similarity=0.424  Sum_probs=199.4

Q ss_pred             cceeeceee--eecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           96 RRYTIGKLL--GHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        96 ~~y~~~~~l--G~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.|++.+.+  |.|+||.||++.++.++..+|+|.+.......        .|+.+...+.+||||+++++.+...+..+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            346666655  99999999999999999999999986543211        13333333446999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC-Cceeecccccccc
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLSDFI  252 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~-~vkl~DFG~a~~~  252 (414)
                      +||||++|++|.+++...  ..+++..+..++.||+.||.|||+.|++||||||+||+++.   ++ .++|+|||++...
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR---AKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC---CCCeEEEecCccceec
Confidence            999999999999988543  47999999999999999999999999999999999999984   44 8999999998765


Q ss_pred             CCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ...   ....|+..|+|||++.+ .++.++||||||+++|+|++|..||.......................++.+++.+
T Consensus       161 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T PHA03390        161 GTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA  237 (267)
T ss_pred             CCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence            432   23468999999998865 46888999999999999999999998654433211111111112223334689999


Q ss_pred             HHHHHHhhcCCccccCC-HHHHhCCccccc
Q 015026          332 KDFVKKLLVKDPRARLT-AAQALSHPWVRE  360 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps-~~elL~hp~f~~  360 (414)
                      .+||.+||+.||.+||+ ++++|+||||..
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999999996 599999999963

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-44  Score=361.21  Aligned_cols=250  Identities=29%  Similarity=0.497  Sum_probs=210.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEE-EEEc------
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN-AFED------  168 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~-~~~~------  168 (414)
                      .+++|.+.|.+|||+.||+|.+...|..||+|++-..   +..+.+.+.+||++|+.|++|||||.+++ ....      
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3688999999999999999999988899999988654   45688999999999999999999999999 3321      


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceeecc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      .-.++|+||||.||.|.|++..+-...|++.+++.|++|+++|+.+||...  |||||||-|||||.   .++..|||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDF  190 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDF  190 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCcc
Confidence            236889999999999999998777777999999999999999999999998  99999999999999   5889999999


Q ss_pred             ccccccCCCC-ccc---------cCCCCCccccchhcc---cc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHH
Q 015026          247 GLSDFIKPGK-KFQ---------DIVGSAYYVAPEVLK---RK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV  312 (414)
Q Consensus       247 G~a~~~~~~~-~~~---------~~~gt~~y~aPE~~~---~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i  312 (414)
                      |.|.-.-... ...         ...-|+.|+|||++.   +. .++++|||+|||+||-|+....||.+....    .|
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aI  266 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AI  266 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eE
Confidence            9986422111 111         124699999999864   33 489999999999999999999999765433    45


Q ss_pred             hhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcc
Q 015026          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~  357 (414)
                      +.+...++.  .+.++..+++||..||+.||.+||++.+++.+-+
T Consensus       267 lng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  267 LNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             EeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            566655554  3678999999999999999999999999988443

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.9e-44  Score=348.55  Aligned_cols=252  Identities=25%  Similarity=0.313  Sum_probs=204.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC-----CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG-----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++.+.||+|+||.||+|.+..+|     ..||+|++.....  ......+.+|+.+++.+.+|||||++++.+...+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            47999999999999999999865443     5799999875432  2345678899999999956999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc----------------------------------------------------------
Q 015026          171 YVYIAMELCEGGELLDRILAKK----------------------------------------------------------  192 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~----------------------------------------------------------  192 (414)
                      .+++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999885421                                                          


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcc---c
Q 015026          193 ----------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---Q  259 (414)
Q Consensus       193 ----------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~---~  259 (414)
                                ...+++..++.++.||+.||.|||++||+||||||+|||++   +++.+||+|||+++........   .
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcceeecc
Confidence                      12478889999999999999999999999999999999998   5788999999999765433221   1


Q ss_pred             cCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHH
Q 015026          260 DIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK  337 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  337 (414)
                      ...+++.|+|||++. +.++.++|||||||++|+|++ |+.||........+..+........  ....+++++.++|.+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~  350 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMKM  350 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHHH
Confidence            233567899999875 457899999999999999997 9999987665544444444332221  123468999999999


Q ss_pred             hhcCCccccCCHHHHhC
Q 015026          338 LLVKDPRARLTAAQALS  354 (414)
Q Consensus       338 ~L~~dp~~Rps~~elL~  354 (414)
                      ||+.||.+|||+.++++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=317.20  Aligned_cols=261  Identities=25%  Similarity=0.395  Sum_probs=224.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      ..+.+..||.|+.|.||+++.+.+|...|||.+.+..  .....+++...++++....+.|+||+.+|+|..+..++|.|
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            3566788999999999999999999999999998765  34567888999999888767899999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |.|..  -.+.+...-.++++|..+-.+...++.||.||-+ +||||||+||+|||+|   +.|.|||||||.+...-++
T Consensus       171 elMs~--C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD---e~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  171 ELMST--CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHH--HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc---cCCCEEeecccccceeecc
Confidence            99853  3555555566789999999999999999999975 6899999999999999   7899999999999887666


Q ss_pred             CccccCCCCCccccchhccc----cCCCCcchhHHHHHHHHHhhCCCCCCCC-CchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      .......|-+.|||||-+..    .|+..+||||||+.++||.||..||.+. .+.+++..+++..+..... -..+|+.
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~-~~gFSp~  324 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG-HMGFSPD  324 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc-ccCcCHH
Confidence            66667789999999998753    4678899999999999999999999875 5668888888866533222 2349999


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      +.+|+..||.+|+.+||...++|+|||+.......
T Consensus       325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             HHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence            99999999999999999999999999999765543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-43  Score=347.87  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=204.2

Q ss_pred             cceeeceeeeecCceEEEEEEE-----CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++.+.||+|+||+||+|.+     ..++..||||++.....  ....+.+.+|+.+|+.+.+||||+++++++.+.+
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            4799999999999999999974     35677899999864432  2345678899999999966999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc----------------------------------------------------------
Q 015026          171 YVYIAMELCEGGELLDRILAKK----------------------------------------------------------  192 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~----------------------------------------------------------  192 (414)
                      ..++||||++||+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999885432                                                          


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc
Q 015026          193 ---------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (414)
Q Consensus       193 ---------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~  257 (414)
                                     ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCccc
Confidence                           12478888999999999999999999999999999999998   577899999999976543322


Q ss_pred             c---ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          258 F---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       258 ~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .   ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+..........+......  ......+.++.
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~  347 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--LSPECAPSEMY  347 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC--CCCCCCCHHHH
Confidence            1   12345667999998765 46899999999999999998 999998765544444443332211  11234678999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +||.+||+.||++|||+.++++
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.5e-43  Score=335.40  Aligned_cols=259  Identities=27%  Similarity=0.460  Sum_probs=215.2

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +...+|.+.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~   90 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTA   90 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeE
Confidence            34567999999999999999999999999999999987554444445567899999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++|+||++ |++.+.+.. ....+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.++|+|||++...
T Consensus        91 ~lv~e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~~~~~kL~dfg~~~~~  165 (307)
T cd06607          91 WLVMEYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLV  165 (307)
T ss_pred             EEEHHhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---CCCCEEEeecCcceec
Confidence            99999997 577776643 235689999999999999999999999999999999999998   5789999999998765


Q ss_pred             CCCCccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      ...   ....|++.|+|||++.    +.++.++||||||+++|+|++|..||.+.........+.....  +.......+
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  240 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWS  240 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhC
Confidence            432   3457889999999873    3468899999999999999999999987765554444433221  111112467


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .++.++|.+||..||.+||++.+++.||||....
T Consensus       241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            8899999999999999999999999999998644

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.8e-43  Score=326.58  Aligned_cols=254  Identities=28%  Similarity=0.502  Sum_probs=215.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE--cCCEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--DDNYVYI  174 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~--~~~~~~l  174 (414)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++..... .....+.+..|+.+++.+. ||||+++++.+.  .+...++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence            48899999999999999999999999999999876543 3445677889999999995 999999999775  3567899


Q ss_pred             EEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          175 AMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECH-----LHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH-----~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                      +|||+++++|.+++...  ....+++..++.++.||+.||.|||     +.+++|+||+|+||+++   .++.+||+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEeccc
Confidence            99999999999988543  2457899999999999999999999     89999999999999998   57899999999


Q ss_pred             cccccCCCCc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          248 LSDFIKPGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       248 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      ++........ .....|++.|+|||.+.+. .+.++|+||||+++++|++|..||...........+......   ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---RIPY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC---CCcc
Confidence            9987654443 3456799999999987654 578899999999999999999999887765555555544321   1223


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .++.++.+++.+||..+|.+||++.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            678899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.5e-43  Score=327.24  Aligned_cols=255  Identities=27%  Similarity=0.501  Sum_probs=208.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCC--CChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--CCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--ILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~~  171 (414)
                      ..|++.+.||+|+||.||+|.+..+|+.||||.+.....  ......+.+.+|+.+++.+. ||||+++++.+.+  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            368999999999999999999999999999998864321  12234678899999999995 9999999998876  357


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++||||++|++|.+++..  ...+++..+..++.||+.||.|||+.||+|+||+|+||+++   .++.++|+|||++..
T Consensus        81 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~Dfg~~~~  155 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---CCCCEEECcCccccc
Confidence            8899999999999998843  34688999999999999999999999999999999999998   578999999999875


Q ss_pred             cCCC----CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPG----KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ....    .......|+..|+|||++.+ ..+.++|||||||++|+|++|+.||.+.........+.....  .....+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~  233 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPH  233 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchh
Confidence            4321    12234578999999998754 468899999999999999999999977654444443332211  1112235


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      ++..+.++|.+||. +|++||+++++++|||+.
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            77889999999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2e-43  Score=327.49  Aligned_cols=255  Identities=27%  Similarity=0.520  Sum_probs=215.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|.+.+.||.|+||.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++ ||||+++++.+.+....++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence            48899999999999999999999999999999876432 2234567889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+++.......+++..+..++.||+.||.|||+.+++|+||+|+||+++.  ++..+||+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence            9999999999987655556899999999999999999999999999999999999984  23457999999987664433


Q ss_pred             c-cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          257 K-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       257 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      . .....|++.|+|||++.+ .++.++|+||||+++++|++|..||...+..+....+......   ...+.++.++.++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHHHHH
Confidence            2 223468999999998754 4688999999999999999999999877665555555443322   2234678899999


Q ss_pred             HHHhhcCCccccCCHHHHhCCccc
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      |.+||..+|++|||+.+++.||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.6e-44  Score=337.64  Aligned_cols=262  Identities=31%  Similarity=0.545  Sum_probs=217.0

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.+.|.....||.|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.+. ||||+++++.+...+..+
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELW   95 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEE
Confidence            3345666778999999999999999999999999986532   235567889999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||+++++|.+++.   ...+++..+..++.||+.||.|||++||+||||||+||+++   +++.++|+|||++....
T Consensus        96 lv~e~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kL~dfg~~~~~~  169 (292)
T cd06658          96 VVMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             EEEeCCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccCcchhhcc
Confidence            9999999999988773   24689999999999999999999999999999999999998   57899999999987543


Q ss_pred             CCC-ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          254 PGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       254 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ... ......|++.|+|||.+.+ .++.++||||||+++|||++|..||.+......+..+....... ......++..+
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  248 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-VKDSHKVSSVL  248 (292)
T ss_pred             cccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-cccccccCHHH
Confidence            222 2234578999999998765 46889999999999999999999998776655555444332211 11223578899


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccCCCC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE  366 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~  366 (414)
                      .++|.+||..||.+|||++++++||||......+.
T Consensus       249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         249 RGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence            99999999999999999999999999997665553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-43  Score=329.28  Aligned_cols=256  Identities=29%  Similarity=0.511  Sum_probs=212.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEEcCCEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+.  .||||+++++++.++...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4788899999999999999999999999999986542  2235567889999999995  49999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++|++|.+++..   ..+++..+..++.||+.||.|||+.||+|+||+|+||+++   .++.++|+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          80 IMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCC
Confidence            9999999999988733   3689999999999999999999999999999999999999   578999999999877654


Q ss_pred             CC-ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          255 GK-KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .. ......|+..|+|||.+.+.  ++.++|+|||||++|+|++|..||.+.........+....  .+......++.++
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  231 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGYSKLL  231 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccCCHHH
Confidence            32 22345799999999987543  4789999999999999999999997665443333222221  1111122378899


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .+++.+||..||.+||++.+++.||||+...
T Consensus       232 ~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         232 REFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            9999999999999999999999999998644

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.9e-43  Score=335.65  Aligned_cols=256  Identities=29%  Similarity=0.438  Sum_probs=202.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-----
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-----  170 (414)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+....... .....+.+|+.+++.+. ||||+++++++....     
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCC-CCCccceEEEEecccccccC
Confidence            46999999999999999999999999999999886543211 22345568999999995 999999999886543     


Q ss_pred             ---EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                         ..++||||+. ++|.+.+... ...+++..++.++.||+.||.|||++|++|+||||+||+++   .++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCcEEECcCC
Confidence               4699999996 4787776433 34689999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCC-----ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          248 LSDFIKPGK-----KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       248 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      ++.......     ......++..|+|||.+.+.  .+.++||||||+++|+|++|..||.+.........+......++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            987653322     12345678899999987653  57889999999999999999999987665443333322111111


Q ss_pred             CCCC----------------------------CCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          321 RKPW----------------------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       321 ~~~~----------------------------~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ...+                            ...++.+.+||.+||..||.+|||++++|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            1000                            0135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.2e-43  Score=343.43  Aligned_cols=257  Identities=28%  Similarity=0.458  Sum_probs=207.0

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +.++|++.+.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+++.+. ||||++++++|...    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCcc
Confidence            34679999999999999999999999999999999865322 2234566778999999994 99999999988643    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        ...|+||||+. ++|.+.+..    .+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~---~~~~~kL~Dfg  163 (353)
T cd07850          92 EFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  163 (353)
T ss_pred             ccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEccCc
Confidence              35799999996 488887632    289999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC----------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------  316 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~----------  316 (414)
                      ++.............|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+....          
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9987655444445678999999998765 46889999999999999999999997765443333332210          


Q ss_pred             ------------CCCCCC-----------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          317 ------------PDFRRK-----------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       317 ------------~~~~~~-----------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                                  +.....                 .....++++.+||.+||+.||++|||+.|+|.||||..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                        000000                 01124567899999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-43  Score=342.28  Aligned_cols=264  Identities=31%  Similarity=0.459  Sum_probs=211.2

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +.++|.+.+.||+|+||+||+|.+..+|+.||||.+..... .......+.+|+.+++.+ +||||+++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCccchHHheecccccc
Confidence            34679999999999999999999999999999999865322 222345677899999999 499999999987643    


Q ss_pred             -CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                       ...++|+||+. ++|.+++.  ....+++..+..++.||+.||.|||+++++||||||+||+++   .++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~  154 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGL  154 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECcCcc
Confidence             35899999995 68888774  345799999999999999999999999999999999999998   578899999999


Q ss_pred             ccccCCC-CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh-----------
Q 015026          249 SDFIKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-----------  314 (414)
Q Consensus       249 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~-----------  314 (414)
                      +...... .......|+..|+|||.+.+  ..+.++|||||||++|+|++|+.||.+.+.......+..           
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            9765433 22345578999999998753  468899999999999999999999976543322221111           


Q ss_pred             ------------cCCCCC----CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          315 ------------NKPDFR----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       315 ------------~~~~~~----~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                                  ..+...    ....+.+++++.+||.+||+.||++|||+.++|+||||......+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence                        000000    012346889999999999999999999999999999998654433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-43  Score=325.05  Aligned_cols=254  Identities=31%  Similarity=0.485  Sum_probs=212.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCC--CChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      +|+..+.||+|+||+||+|.+..+++.||+|.+.....  ......+.+.+|+.+++.+ +||||+++++++.+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence            47788999999999999999988999999999865332  1233567889999999999 59999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |+||+++++|.+++..  ...+++..+..++.||+.||.|||+.||+|+||+|+||+++   .++.+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~---~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          80 FLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD---TNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccceeccc
Confidence            9999999999998843  34689999999999999999999999999999999999998   578999999999877654


Q ss_pred             CCccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ........|++.|+|||.+...  ++.++|+||||+++|+|++|..||...........+....  ......+.+++++.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  232 (258)
T cd06632         155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDEAK  232 (258)
T ss_pred             cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHHHH
Confidence            4434556789999999987543  6889999999999999999999997765444333333211  11122346789999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCccc
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      +++.+||..+|.+||++.+++.|||+
T Consensus       233 ~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         233 DFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            99999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4e-43  Score=334.44  Aligned_cols=253  Identities=22%  Similarity=0.270  Sum_probs=202.2

Q ss_pred             cceeeceeeeecCceEEEEEEECC----------------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCc
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA----------------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV  159 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnI  159 (414)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++..+. ||||
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni   81 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPNI   81 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCCe
Confidence            579999999999999999997532                34479999886543  2345677899999999995 9999


Q ss_pred             eEEEEEEEcCCEEEEEEeccCCCChHHHHHhcc-----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 015026          160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-----------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVH  222 (414)
Q Consensus       160 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiH  222 (414)
                      +++++++.+.+..++||||+++++|.+++....                 ...+++..+..++.||+.||.|||+.||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999885421                 124677889999999999999999999999


Q ss_pred             cCCCCCcEEEeecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh--C
Q 015026          223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC--G  296 (414)
Q Consensus       223 rDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt--g  296 (414)
                      |||||+|||++   .++.+||+|||++........   .....++..|+|||++. +.++.++||||||+++|+|++  +
T Consensus       162 ~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         162 RDLATRNCLVG---ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cCcchhheEEc---CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999998   578999999999976543321   12345678999999865 456899999999999999986  6


Q ss_pred             CCCCCCCCchhhhHHHhhc---C-CCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          297 RRPFWDKTEDGIFKEVLRN---K-PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       297 ~~Pf~~~~~~~~~~~i~~~---~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..||.+....+....+...   . ........+.++..+.+||.+||..||.+|||+.++..
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            7888776655554443221   1 11111122457889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.6e-44  Score=331.33  Aligned_cols=255  Identities=28%  Similarity=0.450  Sum_probs=212.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+.....  ......+.+|+++++.+. ||||+++++.+...+..++|+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEE
Confidence            57888999999999999999999999999999876532  245677889999999996 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||+++++|.+++.... ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++   .++.++|+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHH
Confidence            9999999999885433 678999999999999999999999 9999999999999998   5788999999998765432


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCC-----chhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT-----EDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      .. ....|+..|+|||.+.+. ++.++||||||+++|+|++|..||....     ..+....+......  ......+++
T Consensus       155 ~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  231 (265)
T cd06605         155 LA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGKFSP  231 (265)
T ss_pred             Hh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhhcCH
Confidence            22 226789999999987654 5889999999999999999999997542     12223333322211  111112788


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ++.++|.+||..||.+|||+.+++.||||+..
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            99999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.5e-43  Score=327.35  Aligned_cols=253  Identities=26%  Similarity=0.457  Sum_probs=209.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.+. ||||+++++.+.+.+..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence            46999999999999999999999999999999887654444556677899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          176 MELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||+++++|.+++...  ....+++..+..++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccceecc
Confidence            9999999998877432  234589999999999999999999999999999999999998   57889999999987754


Q ss_pred             CCCc-cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCc--hhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          254 PGKK-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       254 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      .... .....|++.|+|||.+.+ ..+.++||||||+++|+|++|..||.....  ......+...  .++......++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhhcCH
Confidence            3322 234578999999998764 468889999999999999999999965532  2333333221  122222335778


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+.++|.+||..+|++||++.++++
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHH
Confidence            8999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=333.56  Aligned_cols=255  Identities=32%  Similarity=0.511  Sum_probs=208.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++..++..++|+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEE
Confidence            69999999999999999999999999999998865432 2234578899999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++++.+.... . ....+++..+..++.||+.||.|||+.|++|+||+|+||+++   +++.+||+|||++.......
T Consensus        80 e~~~~~~l~~~~-~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          80 EYVERTLLELLE-A-SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             ecCCCCHHHHHH-h-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccccCCCc
Confidence            999876555443 2 335689999999999999999999999999999999999998   58899999999988765443


Q ss_pred             --ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC--------------CC
Q 015026          257 --KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--------------PD  318 (414)
Q Consensus       257 --~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~--------------~~  318 (414)
                        ......++..|+|||++.+.  ++.++||||||+++|+|++|.+||.+....+.+..+....              ..
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence              33456789999999987654  4789999999999999999999997665443332221100              00


Q ss_pred             C-----CC---------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 F-----RR---------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 ~-----~~---------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      +     +.         .....++.++.+||++||..||++|||+++++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0     00         0111248889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-43  Score=331.94  Aligned_cols=259  Identities=25%  Similarity=0.374  Sum_probs=214.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++....  .....+.+.+|+.+++.+. ||||+++++.+...+.+++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence            46999999999999999999999999999999886543  2345678899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |||+++++|.+++..  .+.+++..+..++.+++.||.|||+ .+++||||+|+||+++   +++.++|+|||++.....
T Consensus        82 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          82 MEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN---SRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             EecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC---CCCcEEEccCCcccchhh
Confidence            999999999888743  4578999999999999999999997 6999999999999998   578899999999865432


Q ss_pred             CCccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCCCch-----------hhhHHHhhcCCCCCCC
Q 015026          255 GKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTED-----------GIFKEVLRNKPDFRRK  322 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~  322 (414)
                      . .....+|+..|+|||++. +..+.++|||||||++|+|++|..||......           +....+.....  +..
T Consensus       157 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (284)
T cd06620         157 S-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRL  233 (284)
T ss_pred             h-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCC
Confidence            2 223567999999999865 45688999999999999999999999765442           22223332211  111


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      ....++.++.+||.+||+.||.+|||+.|+++||||.......
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~  276 (284)
T cd06620         234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS  276 (284)
T ss_pred             CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence            1123778999999999999999999999999999997655443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.4e-43  Score=330.02  Aligned_cols=248  Identities=25%  Similarity=0.374  Sum_probs=200.0

Q ss_pred             eeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHH---HHccCCCCceEEEEEEEcCCEEEEEEecc
Q 015026          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL---QALAGHENVVKFYNAFEDDNYVYIAMELC  179 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il---~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (414)
                      .||+|+||.||+|.+..+++.||+|.+.+...........+..|..++   +.. +||+|+.+++.+.+.+.+++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence            489999999999999999999999998765433222222334444443   334 5999999999999999999999999


Q ss_pred             CCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccc
Q 015026          180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ  259 (414)
Q Consensus       180 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~  259 (414)
                      +|++|.+++..  ...+++..++.++.|++.||.|||+.+|+||||||+||+++   .++.++|+|||++...... ...
T Consensus        80 ~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~-~~~  153 (278)
T cd05606          80 NGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KPH  153 (278)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCcc-CCc
Confidence            99999988743  45799999999999999999999999999999999999998   5788999999998765432 223


Q ss_pred             cCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCc---hhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          260 DIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      ..+|+..|+|||++.+  .++.++||||+||++|+|++|+.||.+...   ...........    ......++.++.++
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~l  229 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----VELPDSFSPELRSL  229 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC----CCCCCcCCHHHHHH
Confidence            5579999999999863  368899999999999999999999976632   22222222211    22223578999999


Q ss_pred             HHHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          335 VKKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       335 i~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      |.+||..||.+||     ++.++++||||...
T Consensus       230 i~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            9999999999999     99999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3e-43  Score=331.50  Aligned_cols=255  Identities=25%  Similarity=0.467  Sum_probs=210.0

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|++|.||+|.+..+|+.||||++.....  ......+.+|+.+++.+. ||||+++++.+.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence            48899999999999999999999999999999875432  223456778999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          177 ELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||+++ +|.+++.... ...+++..+..++.||+.||.|||+.|++||||+|+||+++   .++.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~---~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCcEEEeecchhhhhcCC
Confidence            99975 8888775432 24689999999999999999999999999999999999998   5788999999998765332


Q ss_pred             C-ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-----------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (414)
                      . ......+++.|+|||++.+.  ++.++|||||||++|+|++|..||.+.+..+.+..+.........           
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            2 22345678999999987543  478899999999999999999999887766655554432110000           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          322 --------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       322 --------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                                    ...+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                          0113457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.3e-43  Score=341.87  Aligned_cols=260  Identities=32%  Similarity=0.498  Sum_probs=209.4

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +..+|.+.+.||.|+||.||+|.+..+|+.||+|++.....   ...+.+.+|+.+++.+ +||||+++++.+...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence            45789999999999999999999999999999999865542   3456788999999999 499999999876543    


Q ss_pred             ----------CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC
Q 015026          170 ----------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       170 ----------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~  239 (414)
                                ...++|+||++ ++|.+++.   ...+++..++.++.||+.||.|||+.||+||||||+||+++.  .+.
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~~~  152 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDL  152 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCc
Confidence                      35899999997 58887763   246899999999999999999999999999999999999974  456


Q ss_pred             CceeeccccccccCCCCc----cccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHh
Q 015026          240 SLKATDFGLSDFIKPGKK----FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL  313 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~  313 (414)
                      .+||+|||++........    .....|+..|+|||.+.+  .++.++|||||||++|+|++|+.||.+....+....++
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            799999999876532211    123467899999997643  35789999999999999999999998776555444443


Q ss_pred             hcCCCCC----------------------C----CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          314 RNKPDFR----------------------R----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       314 ~~~~~~~----------------------~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ...+...                      .    ...+.++.++.+||.+||+.||.+|||+.++|.||||+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            3211100                      0    012357889999999999999999999999999999986433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=337.17  Aligned_cols=260  Identities=29%  Similarity=0.480  Sum_probs=204.6

Q ss_pred             ceeeceeeeecCceEEEEEEECC--CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--CEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYV  172 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~~~  172 (414)
                      +|++.+.||+|+||.||+|.+..  +++.||+|.+...........+.+.+|+.+++.+. ||||+++++++.+.  ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            48899999999999999999988  89999999987643222234466788999999995 99999999999988  889


Q ss_pred             EEEEeccCCCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee-cCCCCCceeecccc
Q 015026          173 YIAMELCEGGELLDRILAKK---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS-AKEDSSLKATDFGL  248 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~-~~~~~~vkl~DFG~  248 (414)
                      ++||||+++ +|.+.+....   ...+++..++.++.||+.||.|||+.+|+||||||+||+++. ...++.+||+|||+
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999999965 7777664322   236899999999999999999999999999999999999983 12278899999999


Q ss_pred             ccccCCCCc----cccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh---------hhHHHh
Q 015026          249 SDFIKPGKK----FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDG---------IFKEVL  313 (414)
Q Consensus       249 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---------~~~~i~  313 (414)
                      +........    ....++++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.....         .+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            876543221    234578999999998764  35889999999999999999999997654332         111111


Q ss_pred             hcC--------------C-------CCCCCCCC------------CCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          314 RNK--------------P-------DFRRKPWP------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       314 ~~~--------------~-------~~~~~~~~------------~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ...              +       .......+            ..+.++.++|.+||..||++|||+.+++.||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            000              0       00001111            466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=298.81  Aligned_cols=258  Identities=27%  Similarity=0.482  Sum_probs=218.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|.-.++||+|.||+||+|++..+++.||+|.++.....+ ..-....+||-+|+.|+ |.|||+++++...++.+-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelk-hknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence            4677789999999999999999999999999997654332 23456689999999996 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      |||.. +|..+. ..-.+.+..+.++.++.|++.||.|+|++++.||||||.|.||+   .++++||+|||+|+-..-..
T Consensus        81 e~cdq-dlkkyf-dslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin---~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   81 EFCDQ-DLKKYF-DSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN---RNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HHhhH-HHHHHH-HhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---cCCcEEecccchhhhcCCce
Confidence            99964 666554 34457789999999999999999999999999999999999998   68999999999998766444


Q ss_pred             c-cccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC------
Q 015026          257 K-FQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS------  326 (414)
Q Consensus       257 ~-~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~------  326 (414)
                      . +..-+.|.+|++|.++.|.  ++...|+||.|||+.|+.. |++.|.+.+.++.+..|...-.......||.      
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            3 3445779999999998764  6888999999999999987 9999999999888888876544444444433      


Q ss_pred             -------------------CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          327 -------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       327 -------------------~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                         ++...++|++++|.-+|.+|++++++|+||||...
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                               33456899999999999999999999999999864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-45  Score=338.23  Aligned_cols=256  Identities=27%  Similarity=0.488  Sum_probs=230.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|..+.+||+|+||+|-+|..+.|.+.+|||++++.-.......+--..|-++|.....-|.+++++..|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            35888999999999999999999999999999998876666556666678888887776678999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc-cCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~-~~~  254 (414)
                      |||+.||+|...+  +..+.+.|..+..++..|+-||-|||++|||+||||.+||+++   .+++|||+|||+++. +-.
T Consensus       429 MEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd---~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  429 MEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec---cCCceEeeecccccccccC
Confidence            9999999999988  5567899999999999999999999999999999999999999   589999999999864 344


Q ss_pred             CCccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .....+.||||.|+|||++. ..|+..+|+||+||+||||+.|.+||.+.+++++++.|......++.    .+|.++.+
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~  579 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVA  579 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHH
Confidence            55667899999999999865 56799999999999999999999999999999999999998877775    78999999


Q ss_pred             HHHHhhcCCccccCCH-----HHHhCCccccc
Q 015026          334 FVKKLLVKDPRARLTA-----AQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rps~-----~elL~hp~f~~  360 (414)
                      +++.+|.+.|.+|..+     .++-.||||+.
T Consensus       580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            9999999999999744     68889999985

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.9e-43  Score=331.61  Aligned_cols=251  Identities=20%  Similarity=0.305  Sum_probs=210.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC-----CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG-----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.+++.+. ||||+++++++.+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence            36899999999999999999876555     679999886443  3345677899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC
Q 015026          171 YVYIAMELCEGGELLDRILAKKD--------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~  236 (414)
                      ..+++|||+++++|.+++.....              ..+++..+..++.||+.||.|||+.|++|+||||+||+++   
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~---  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc---
Confidence            99999999999999998865321              4588899999999999999999999999999999999998   


Q ss_pred             CCCCceeeccccccccCCCC---ccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHH
Q 015026          237 EDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  311 (414)
                      +++.++|+|||++.......   ......+++.|+|||.+. +.++.++|||||||++|||++ |..||.+....++...
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            57889999999987653322   123446788999999765 456889999999999999998 9999998887777766


Q ss_pred             HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +......   .....+|+++.+|+.+||+.||.+||++.+++++
T Consensus       239 i~~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6554322   1224688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.8e-43  Score=328.80  Aligned_cols=254  Identities=28%  Similarity=0.468  Sum_probs=213.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +-|++.+.||.|+||.||+|.+..+++.||+|.+.....  ......+.+|+.+++.+. ||||+++++.+..+...++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence            458889999999999999999999999999998765432  234567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.   ...+++..+..++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||++......
T Consensus        81 ~e~~~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~---~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          81 MEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---CCCCEEEeecccceecccc
Confidence            99999999998873   24689999999999999999999999999999999999998   5788999999998765432


Q ss_pred             C-ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 K-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      . ......|+..|+|||.+.+ ..+.++|+|||||++|+|++|..||...........+.....   ......++.++.+
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  231 (277)
T cd06641         155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKE  231 (277)
T ss_pred             hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHH
Confidence            2 1234578999999998765 457889999999999999999999977665544444433221   1122357889999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +|.+||..+|.+||++.+++.||||...
T Consensus       232 ~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         232 FVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            9999999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-43  Score=331.69  Aligned_cols=253  Identities=35%  Similarity=0.657  Sum_probs=218.0

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+.+||||+++++++.+.+..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            69999999999999999999999999999999876544444556788999999999955999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      |++++++|.+++..  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          82 EYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccccccCCcc
Confidence            99999999998854  34799999999999999999999999999999999999998   57899999999987654322


Q ss_pred             ---------------------ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh
Q 015026          257 ---------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR  314 (414)
Q Consensus       257 ---------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~  314 (414)
                                           ......|+..|+|||++.+ ..+.++||||||++++++++|..||........+..+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence                                 1223567899999998764 468889999999999999999999988776666666654


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCH----HHHhCCccc
Q 015026          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA----AQALSHPWV  358 (414)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~----~elL~hp~f  358 (414)
                      ....++    ..+++.+.+||.+||+.||.+|||+    +++++||||
T Consensus       237 ~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 LEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             cCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            433332    3578899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-43  Score=331.75  Aligned_cols=255  Identities=29%  Similarity=0.485  Sum_probs=208.7

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |++.+.||.|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++.+. ||||+++++++.+++..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence            67889999999999999999999999999998755322 223456788999999995 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-  256 (414)
                      |++ ++|.+++.......+++..+..++.||+.||.|||+++++||||+|+||+++   .++.++|+|||++....... 
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc
Confidence            995 6899888655445789999999999999999999999999999999999998   47899999999987543222 


Q ss_pred             ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC------------------
Q 015026          257 KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK------------------  316 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~------------------  316 (414)
                      ......+++.|+|||++.+.  ++.++||||||+++|+|++|.+||.+.+....+..+.+..                  
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            22334678999999987643  4788999999999999999999998766544333332210                  


Q ss_pred             ---CCC----CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          317 ---PDF----RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       317 ---~~~----~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                         +..    .....+.++.++.++|.+||+.||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence               000    011234677899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.3e-43  Score=365.10  Aligned_cols=255  Identities=28%  Similarity=0.408  Sum_probs=206.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.......+...+.+.+|+.+++.+. ||||+++++++.+++..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence            47999999999999999999999999999999997654444455678999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          176 MELCEGGELLDRILAKK---------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      |||++|++|.+++....         ...++...+..++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd---~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG---LFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc---CCCCEEEEec
Confidence            99999999999885321         12356677889999999999999999999999999999998   5788999999


Q ss_pred             ccccccCCC-------------------CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCch
Q 015026          247 GLSDFIKPG-------------------KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED  306 (414)
Q Consensus       247 G~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~  306 (414)
                      |++......                   ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            999765211                   011235799999999987654 688999999999999999999999775443


Q ss_pred             hhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          307 GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       307 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ..........+ ....++..+|+.+.+++.+||..||++||+..+.+.+
T Consensus       238 ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33222111111 1112234688999999999999999999887766643

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.1e-43  Score=330.46  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=203.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|++.+.||+|+||.||+|.+..+|+.||+|++.....  ......+.+|+.+++.+. |+||+++++++.++...++|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence            579999999999999999999999999999999865432  123345678999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||+. ++|.+.+... ...+++..+..++.||+.||.|||+.||+|+||||+||+++   .++.++|+|||+++.....
T Consensus        82 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          82 FEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAKSIP  156 (291)
T ss_pred             Eeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---CCCcEEEeccccccccCCC
Confidence            99995 6887776543 34678899999999999999999999999999999999998   5789999999998754322


Q ss_pred             -CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhhc--------------CC
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRN--------------KP  317 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~~--------------~~  317 (414)
                       .......+++.|+|||.+.+  .++.++|||||||++|+|++|..||.+.... +.+..+...              .+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence             22234567999999998765  3578899999999999999999999765432 222221110              00


Q ss_pred             CCCCC------------CCC--CCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          318 DFRRK------------PWP--SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       318 ~~~~~------------~~~--~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .+...            .+.  ..+.++.+++.+||..||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00000            011  125688999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.2e-43  Score=327.23  Aligned_cols=249  Identities=19%  Similarity=0.271  Sum_probs=206.9

Q ss_pred             cceeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+|++.+.||+|+||.||+|.+.   ..+..||+|.+....  .......+.+|+.+++.+ +||||+++++++..++..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCc
Confidence            46999999999999999999765   456689999987543  233456788999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.|++||||||+|||++   .++.++|+|||.+...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~---~~~~~~l~dfg~~~~~  157 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc---CCCcEEECCCcccccc
Confidence            9999999999999888543 35789999999999999999999999999999999999998   5789999999987654


Q ss_pred             CCCCccc--cCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          253 KPGKKFQ--DIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       253 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .......  ...++..|+|||++. +.++.++|||||||++||+++ |..||.+.+..+....+.....   .+....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  234 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR---LPAPRNCP  234 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---CCCCCCCC
Confidence            3222222  234567899999875 456889999999999999775 9999998887777776655432   12234688


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+.+++.+||+.+|.+||+++++++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.7e-43  Score=324.35  Aligned_cols=254  Identities=28%  Similarity=0.462  Sum_probs=215.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|++.+.||.|++|.||+|.+..+|+.||+|++.....  +.....+.+|+.++..+. ||||+++++.+...+..++|+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence            58899999999999999999999999999999876532  135678999999999996 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||+++++|.+++...  ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++   .++.++|+|||++......
T Consensus        79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~---~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENT  153 (264)
T ss_pred             EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC---CCCCEEEccCccceecccC
Confidence            999999999998543  678999999999999999999999 9999999999999998   5789999999998876543


Q ss_pred             Ccc-ccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCC---chhhhHHHhhcCCCCCCCCCCC-CCH
Q 015026          256 KKF-QDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFKEVLRNKPDFRRKPWPS-ISN  329 (414)
Q Consensus       256 ~~~-~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~-~s~  329 (414)
                      ... ....++..|+|||.+.+. ++.++|+||||+++|+|++|..||....   ..+....+.....   ...... ++.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (264)
T cd06623         154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---PSLPAEEFSP  230 (264)
T ss_pred             CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---CCCCcccCCH
Confidence            332 256789999999987654 5789999999999999999999997764   2333334432221   111123 788


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .+.++|.+||..+|++|||+.++++||||+..
T Consensus       231 ~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         231 EFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            99999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.8e-43  Score=325.74  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=210.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.+. ||||+++++++..++.+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEE
Confidence            35889999999999999999999999999999886542    24567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++   +++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCccccccccc
Confidence            9999999999998665556789999999999999999999999999999999999998   5789999999999776443


Q ss_pred             Ccc--ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KKF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ...  ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+.....   ......+++++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  234 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPKV  234 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHH
Confidence            221  12234668999998764 46889999999999999998 9999988776666666554321   22234688999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .++|.+||+.||++|||+.++++
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-43  Score=328.43  Aligned_cols=256  Identities=28%  Similarity=0.430  Sum_probs=210.2

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEEcCCE----
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFEDDNY----  171 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~~~~~----  171 (414)
                      |++.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.+.  +||||+++++++.+...    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            67889999999999999999989999999998754322 223455677888887774  49999999999987766    


Q ss_pred             -EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          172 -VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       172 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                       ++++|||+.+ +|.+++.......+++..++.++.||+.||.|||+.+++|+||+|+||+++   .++.+||+|||++.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccCcce
Confidence             9999999975 888887655545699999999999999999999999999999999999999   46899999999997


Q ss_pred             ccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC-----------
Q 015026          251 FIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD-----------  318 (414)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-----------  318 (414)
                      ............++..|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......           
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            7654444445568999999998765 4588999999999999999999999888776666655442110           


Q ss_pred             -----CC-------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 -----FR-------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 -----~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                           ++       ....+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                 00       00112456788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-42  Score=327.15  Aligned_cols=256  Identities=31%  Similarity=0.564  Sum_probs=215.0

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|...+.||.|++|.||++.+..+++.+|+|++....   ....+.+.+|+.+++.+ +||||+++++++...+..++|+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEE
Confidence            4566679999999999999999999999999886432   23456688999999999 4999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++|++|.+++..   ..+++..+..++.||+.||.|||++||+||||+|+||+++   .++.++|+|||++.......
T Consensus        96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc---CCCcEEEcccccchhhccCC
Confidence            99999999998844   4689999999999999999999999999999999999998   57899999999887554322


Q ss_pred             -ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          257 -KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                       ......|++.|+|||.+.+. ++.++||||||+++|+|++|..||...+.......+....+.... ....++..+.+|
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l  248 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLRSF  248 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHHHH
Confidence             22345789999999987654 688999999999999999999999877666666655544322211 123478899999


Q ss_pred             HHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      |.+||..||++|||+.++++||||....+
T Consensus       249 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         249 LDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHHcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999999987554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-43  Score=333.44  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=212.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|.+.+.||.|+||.||+|.+..+++.||+|.+.....  ....+.+.+|+.+++.+. ||||+++++.+..++..++|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEEE
Confidence            468888999999999999999999999999998865432  235578899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||+++++|.+++.   ...+++..+..++.||+.||.|||++|++|+||+|+||+++   +++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          81 MEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEccCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCc
Confidence            99999999998873   24689999999999999999999999999999999999998   5788999999998765433


Q ss_pred             Cc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 KK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .. .....|+..|+|||.+.+. ++.++|||||||++|+|++|..||.+.........+.....   ......++.++.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  231 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---PTLEGQYSKPFKE  231 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC---CCCCcccCHHHHH
Confidence            21 2235688999999987654 57899999999999999999999976655444433332221   1112357788999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +|.+||..+|.+||++.+++.||||...
T Consensus       232 li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         232 FVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             HHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            9999999999999999999999999753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.7e-43  Score=330.88  Aligned_cols=263  Identities=28%  Similarity=0.494  Sum_probs=217.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|.+.+.||.|+||.||++.+..++..||+|.+.....   ...+.+.+|+.+++.+. ||||+++++.+...+..++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEE
Confidence            3689999999999999999999999999999999864332   24567889999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |+||+++++|.+++..   ..+++..+..++.|++.||.|||++|++|+||+|+||+++   .++.++|+|||++.....
T Consensus        94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcceecccc
Confidence            9999999999998843   3578999999999999999999999999999999999998   578899999998865543


Q ss_pred             CC-ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .. ......|++.|+|||.+.+ ..+.++||||||+++|+|++|..||...+.......+..... ........++..+.
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  246 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFR  246 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHH
Confidence            32 2234578999999998754 468899999999999999999999977655443333322211 11112335788999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCcccccccCCCCCC
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP  368 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~  368 (414)
                      ++|.+||..+|.+||++.+++.||||+.....+..+
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~  282 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLT  282 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcCccccccc
Confidence            999999999999999999999999999876655544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.2e-43  Score=333.14  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=204.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCE--EEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.|++.+.||+|+||.||+|.+..++..  +|+|.+...  ........+.+|+.++.++.+||||+++++++...+.++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            3689999999999999999999888765  466665432  223456678899999999966999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC
Q 015026          174 IAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~  239 (414)
                      +||||+++++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++   .++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~---~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec---CCC
Confidence            9999999999999885432              23578999999999999999999999999999999999998   578


Q ss_pred             CceeeccccccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCC
Q 015026          240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      .+||+|||++.............++..|+|||.+.+. ++.++|||||||++|+|++ |..||.+....+....+.... 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-  240 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  240 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence            8999999998643221111222346679999987654 5889999999999999998 999998777666665553321 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                        .......+++++.+||.+||+.+|++||++.++|.+
T Consensus       241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              111223578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3e-43  Score=339.87  Aligned_cols=263  Identities=32%  Similarity=0.497  Sum_probs=210.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE----cCC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE----DDN  170 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~----~~~  170 (414)
                      .++|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+|+.+. ||||+++++++.    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCc
Confidence            3679999999999999999999999999999999865432 2234567788999999995 999999999875    345


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .+++||||+. ++|.+++.  ....+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        82 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~~~  155 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGMAR  155 (334)
T ss_pred             eEEEEEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEecccccce
Confidence            7899999995 58888773  345699999999999999999999999999999999999998   58899999999987


Q ss_pred             ccCCCCc-----cccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh---------
Q 015026          251 FIKPGKK-----FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---------  314 (414)
Q Consensus       251 ~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~---------  314 (414)
                      .......     .....|+..|+|||.+.+  .++.++|||||||++|+|++|+.||.+.+....+..+..         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            6432211     124578999999998754  368899999999999999999999977654332222111         


Q ss_pred             --------------cCCCCCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          315 --------------NKPDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       315 --------------~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                                    ..+.....    ..+.+++++.++|.+||+.||++|||+.+++.||||.......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                          11111111    1245789999999999999999999999999999998655443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.5e-42  Score=330.01  Aligned_cols=262  Identities=27%  Similarity=0.452  Sum_probs=218.4

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .+....|...+.||+|+||.||+|++..+|..||+|.+.............+.+|+.+++.+. |||++++++++.++..
T Consensus        21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   99 (317)
T cd06635          21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHT   99 (317)
T ss_pred             CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCe
Confidence            344556899999999999999999999999999999987654444455677899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+.| +|.+.+... ...+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.++|+|||++..
T Consensus       100 ~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~---~~~~~kl~dfg~~~~  174 (317)
T cd06635         100 AWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASI  174 (317)
T ss_pred             EEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---CCCCEEEecCCCccc
Confidence            9999999975 777766433 45689999999999999999999999999999999999998   578899999999875


Q ss_pred             cCCCCccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ....   ....|++.|+|||.+.    +..+.++|||||||++|+|++|..||.+.........+......  ......+
T Consensus       175 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  249 (317)
T cd06635         175 ASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--TLQSNEW  249 (317)
T ss_pred             cCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--CCCCccc
Confidence            4332   3457899999999863    34688999999999999999999999877665555555544321  1122357


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      ++.+.+||.+||+.+|.+||++.+++.|+|+......
T Consensus       250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             cHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence            7889999999999999999999999999999765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-42  Score=326.47  Aligned_cols=260  Identities=30%  Similarity=0.448  Sum_probs=209.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--CCEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~~~~  173 (414)
                      ++|+..+.||.|++|.||+|.+..+++.||+|.+.....  ......+.+|+++++.+. ||||++++++|.+  .+.++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEE
Confidence            368899999999999999999999999999999875432  235677899999999995 9999999998864  45789


Q ss_pred             EEEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          174 IAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +||||++|++|.+++..  .....+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeecccccc
Confidence            99999999999887643  2345689999999999999999999999999999999999998   577899999999875


Q ss_pred             cCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCc-----hhhhHHHhhcCC-CCCCCCC
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE-----DGIFKEVLRNKP-DFRRKPW  324 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~-----~~~~~~i~~~~~-~~~~~~~  324 (414)
                      ..... .....++..|+|||.+.+ .++.++||||||+++|+|++|..||.....     .+....+..... .......
T Consensus       155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            43322 234568899999998764 468899999999999999999999976522     223333332111 1111111


Q ss_pred             --CCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          325 --PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       325 --~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                        ...++++.+||.+||..||.+|||+.|++.||||+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence              13467899999999999999999999999999997543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1e-42  Score=329.19  Aligned_cols=256  Identities=27%  Similarity=0.523  Sum_probs=210.6

Q ss_pred             ceeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCC-ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .|++.+.||.|+||.||+|.+.   .+|+.||+|++...... .....+.+.+|+.+++.+.+||||+.+++.+..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3789999999999999999874   47899999998654321 1223467789999999997799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++|+||+++++|.+++..  ...+++..+..++.||+.||.|||+.|++||||+|+|||++   .++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC---CCCCEEEeeCccceec
Confidence            999999999999998854  35689999999999999999999999999999999999998   5789999999998765


Q ss_pred             CCCC--ccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh----hhHHHhhcCCCCCCCC
Q 015026          253 KPGK--KFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDG----IFKEVLRNKPDFRRKP  323 (414)
Q Consensus       253 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~  323 (414)
                      ....  ......|+..|+|||.+.+   ..+.++||||||+++|+|++|..||.......    +...+....+.+    
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  231 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----  231 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----
Confidence            4322  2234678999999998764   34788999999999999999999996543322    222232222222    


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      .+.+++.+.+++.+||..||.+||     ++++++.||||...
T Consensus       232 ~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            235788999999999999999997     89999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-44  Score=344.43  Aligned_cols=261  Identities=29%  Similarity=0.481  Sum_probs=226.9

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      -+..|..++.||-|+||+|.++...+|...+|+|.+++...........+..|-+||... +.+.||+||-.|.+++.+|
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceE
Confidence            345689999999999999999999999999999999887766666777889999999998 6999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc-
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-  252 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~-  252 (414)
                      +||||++||++..+|++.  +-|+|..++.++..+..|+++.|..|+|||||||+|||||   .+|+|||+||||+.-+ 
T Consensus       706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID---rdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc---cCCceeeeeccccccce
Confidence            999999999999999654  6899999999999999999999999999999999999999   6999999999998432 


Q ss_pred             --------CCCC----------------------------------ccccCCCCCccccchhccc-cCCCCcchhHHHHH
Q 015026          253 --------KPGK----------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVI  289 (414)
Q Consensus       253 --------~~~~----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~i  289 (414)
                              ..+.                                  .....+||+.|+|||++.. .++..+|+||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence                    1110                                  0123589999999998764 57889999999999


Q ss_pred             HHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccC---CHHHHhCCcccccc
Q 015026          290 TYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVREG  361 (414)
Q Consensus       290 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---s~~elL~hp~f~~~  361 (414)
                      ||||+.|++||.+.+..+...++++-...+.-.+..++|.++.++|.++.+ +++.|.   .++|+-.||||+..
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence            999999999999998888877777665555555667899999999999876 688887   56789999999964

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-43  Score=328.25  Aligned_cols=254  Identities=31%  Similarity=0.501  Sum_probs=210.2

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--CEEEEE
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVYIA  175 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~~~~lv  175 (414)
                      |++.+.||.|+||.||+|.+..+|+.+|+|++.... ........+.+|+.+++.+. |||++++++++.+.  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence            678899999999999999999999999999997653 22234567889999999995 99999999999887  899999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +||+++ +|.+++... ...+++..+..++.||+.||+|||+.|++|+||+|+||+++   +++.++|+|||++......
T Consensus        79 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~---~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          79 FEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             eccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc---CCCCEEEccccceeeccCC
Confidence            999975 888877443 25789999999999999999999999999999999999999   5889999999999776543


Q ss_pred             C--ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCC-------
Q 015026          256 K--KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW-------  324 (414)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------  324 (414)
                      .  ......++..|+|||.+.+  .++.++||||||+++|+|++|+.||.+.+....+..+...........|       
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            2  2334567889999997654  3588999999999999999999999887766655555442211111111       


Q ss_pred             -------------------CC-CCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          325 -------------------PS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       325 -------------------~~-~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                                         .. +++++.++|.+||..||.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                               12 27889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.3e-42  Score=319.83  Aligned_cols=254  Identities=31%  Similarity=0.538  Sum_probs=218.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|.+.+.||.|+||.||++.+..+++.||+|++..... .......+.+|+++++.+. |||++++++.+......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence            48899999999999999999999999999999876543 2345677899999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          177 ELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |++++++|.+++....  ...+++..+..++.+|+.||.|||+.|++|+||+|+||+++   .++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceeeccc
Confidence            9999999999886543  46799999999999999999999999999999999999998   578999999999977544


Q ss_pred             CC-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .. ......|++.|+|||.+.+. .+.++|+||+|+++++|++|..||......+............   ....++.++.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence            33 23345789999999986544 5888999999999999999999998777666666665543221   1236788999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCccc
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      +++.+||..+|++|||+.++|.||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5e-43  Score=325.77  Aligned_cols=249  Identities=34%  Similarity=0.579  Sum_probs=212.6

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (414)
                      ||.|+||.||+|.+..+|+.+|+|++...........+.+.+|+.+++.+. ||||+++++.+..+...++|+||++|++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999999999999999987654433446678899999999995 9999999999999999999999999999


Q ss_pred             hHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-------
Q 015026          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-------  256 (414)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-------  256 (414)
                      |.+++...  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++.......       
T Consensus        80 L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          80 LASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---CCCCEEEEecccchhcccCcccccccc
Confidence            99988543  4789999999999999999999999999999999999998   57899999999987643321       


Q ss_pred             --ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          257 --KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       257 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                        ......++..|+|||.+.+ ..+.++||||||+++|+|++|..||......+....+......++..  ..+++++.+
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  232 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAID  232 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHH
Confidence              2234578899999998754 46889999999999999999999998887777777766644333221  235899999


Q ss_pred             HHHHhhcCCccccCCH---HHHhCCccccc
Q 015026          334 FVKKLLVKDPRARLTA---AQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rps~---~elL~hp~f~~  360 (414)
                      +|.+||+.+|.+|||+   .++|+||||+.
T Consensus       233 ~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         233 LISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            9999999999999999   99999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.5e-43  Score=331.25  Aligned_cols=258  Identities=30%  Similarity=0.533  Sum_probs=214.9

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |.....||.|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.+ +||||+++++.+..++..++|+|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEe
Confidence            4555679999999999999999999999999865432   2346688999999999 49999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-  256 (414)
                      |+++++|.+.+..   ..+++..++.++.||+.||.|||+.|++||||+|+||+++   .++.+||+|||++....... 
T Consensus        99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~---~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc---cCCcEEEeechhHhhcccccc
Confidence            9999999886632   4689999999999999999999999999999999999998   57899999999987554322 


Q ss_pred             ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (414)
                      ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+..... .....+..++..+.++|
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i  251 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNAHKISPVLRDFL  251 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-CCccccCCCCHHHHHHH
Confidence            2234679999999998765 468899999999999999999999987766555554443322 22223346788999999


Q ss_pred             HHhhcCCccccCCHHHHhCCcccccccCCCC
Q 015026          336 KKLLVKDPRARLTAAQALSHPWVREGGDASE  366 (414)
Q Consensus       336 ~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~  366 (414)
                      .+||+.||.+||++.++++||||........
T Consensus       252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         252 ERMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             HHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence            9999999999999999999999987554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-42  Score=335.63  Aligned_cols=259  Identities=31%  Similarity=0.506  Sum_probs=211.3

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC---
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~---  170 (414)
                      +.++|++.+.||+|+||.||+|.+..+|..||||++.... ........+.+|+.+++.+. ||||+++++++....   
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcccc
Confidence            4568999999999999999999999999999999986432 22334567889999999995 999999999987543   


Q ss_pred             ---EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                         .+++||||+ |++|.+++.   ...+++..++.++.||+.||.|||+.||+||||||+||+++   .++.++|+|||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg  163 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFG  163 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecc
Confidence               468999999 778887763   34689999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC-------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD-------  318 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-------  318 (414)
                      ++......  .....+++.|+|||.+.+  ..+.++|+||||+++|+|++|..||.+......+..+......       
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         164 LARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             cccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98765432  234578999999998764  3678899999999999999999999876554444333221110       


Q ss_pred             ----------------CC----CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          319 ----------------FR----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       319 ----------------~~----~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                      +.    ...++.+++++.++|.+||..||++|||+.+++.||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                            10    0122467888999999999999999999999999999986433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1e-42  Score=336.25  Aligned_cols=264  Identities=25%  Similarity=0.405  Sum_probs=211.6

Q ss_pred             ccccceee-ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChH-----------hHHHHHHHHHHHHHccCCCCce
Q 015026           93 DFDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI-----------AVEDVKREVKILQALAGHENVV  160 (414)
Q Consensus        93 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~E~~il~~l~~hpnIv  160 (414)
                      ++.++|.. .+.||.|+||+||+|.+..+++.||||++.........           ....+.+|+.+++.+. ||||+
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv   83 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIM   83 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cccee
Confidence            34567865 57799999999999999999999999998654322100           1124678999999995 99999


Q ss_pred             EEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC
Q 015026          161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                      ++++++..++..++||||+. ++|.+++..  ...+++..+..++.||+.||.|||+.||+|+||+|+||+++   .++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~~~~  157 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKGI  157 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---CCCC
Confidence            99999999999999999996 588888743  45689999999999999999999999999999999999998   5789


Q ss_pred             ceeeccccccccCC---------------CCccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCC
Q 015026          241 LKATDFGLSDFIKP---------------GKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDK  303 (414)
Q Consensus       241 vkl~DFG~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~  303 (414)
                      ++|+|||++.....               ........+++.|+|||.+.+.  ++.++|||||||++|+|++|..||.+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999876541               1112234578899999987653  478899999999999999999999887


Q ss_pred             CchhhhHHHhhcCCCCCCC------------------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          304 TEDGIFKEVLRNKPDFRRK------------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       304 ~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      ...+.+..+..........                        ..+..+.++.++|.+||+.||++|||++|+|.||||+
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            7666555443321111110                        1134578899999999999999999999999999998


Q ss_pred             cccC
Q 015026          360 EGGD  363 (414)
Q Consensus       360 ~~~~  363 (414)
                      ....
T Consensus       318 ~~~~  321 (335)
T PTZ00024        318 SDPL  321 (335)
T ss_pred             CCCC
Confidence            6543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-44  Score=343.12  Aligned_cols=249  Identities=27%  Similarity=0.407  Sum_probs=211.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +...+.+.||+|.||+||+|.+.  | .||||++..... .+...+.|++|+.++++-+ |.||+-+.|++..+.. .||
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-AII  465 (678)
T ss_pred             HHhhccceeccccccceeecccc--c-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-eee
Confidence            45678899999999999999765  3 599999977654 4558899999999999996 9999999999998887 999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc---
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI---  252 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~---  252 (414)
                      +.+|+|-+|+.++.-.+ ..|.......|++||+.|+.|||.++|||||||..|||+.   +++.|||+|||++...   
T Consensus       466 TqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~---~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH---EDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             ehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc---cCCcEEEecccceeeeeee
Confidence            99999999999886544 5688899999999999999999999999999999999998   5799999999998653   


Q ss_pred             CCCCccccCCCCCccccchhccc----cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC-CCCCCCC
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-RKPWPSI  327 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~  327 (414)
                      ....-+....|...|||||+++.    .+++.+||||||||+|||+||..||.....+.++-.+-++....+ .....+.
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~  621 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC  621 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence            22333455678899999999864    358899999999999999999999997777777777766633222 1223456


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.++++|+..||.+++++||+..+||.
T Consensus       622 pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  622 PKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            779999999999999999999999887

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1e-42  Score=327.17  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=209.5

Q ss_pred             cceeeceeeeecCceEEEEEEECC-----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      +.|.+.+.||+|+||.||+|.+..     +++.||+|++....  .....+.+.+|+++|+.+. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence            458999999999999999998743     46789999886543  2335678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCC
Q 015026          171 YVYIAMELCEGGELLDRILAKK------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED  238 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~  238 (414)
                      ..++||||++|++|.+++....            ...+++..+..++.||+.||.|||++|++||||||+||+++   .+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc---CC
Confidence            9999999999999999985432            24578899999999999999999999999999999999998   57


Q ss_pred             CCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHh
Q 015026          239 SSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVL  313 (414)
Q Consensus       239 ~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~  313 (414)
                      +.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            8999999999876433221   123456788999998764 46889999999999999998 999998887777777776


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       314 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+.....   ...++..+.++|.+||+.||.+||++.|+++
T Consensus       239 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5543222   2468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.6e-42  Score=322.59  Aligned_cols=247  Identities=23%  Similarity=0.373  Sum_probs=208.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.++||+|+||.||+|.+. ++..||+|.+....    ...+.+.+|+.+++.+. ||||+++++.+.+.+..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEE
Confidence            46999999999999999999864 56789999876533    24567899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.......+++..+..++.||+.||.|||+.+++||||||+||+++   .++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCccceecCCC
Confidence            9999999999998766666789999999999999999999999999999999999998   5788999999999876433


Q ss_pred             Cc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..  .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+....   ..+....++.++
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  233 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---RMPRMENCPDEL  233 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHH
Confidence            21  123345678999998764 46889999999999999998 999998877666666665442   222334688999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+++.+||..+|++||+++++++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.9e-42  Score=321.43  Aligned_cols=249  Identities=27%  Similarity=0.439  Sum_probs=202.2

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      ...||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++ ||||+++++++..++..++|+||++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCC
Confidence            357999999999999999999999999886543   235568899999999995 9999999999999999999999999


Q ss_pred             CCChHHHHHhccCCCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc-
Q 015026          181 GGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-  257 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l--~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~-  257 (414)
                      +++|.+++.... ..+  ++..+..++.||+.||.|||+.||+||||||+||+++.  .++.++|+|||++........ 
T Consensus        89 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          89 GGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             CCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCCCc
Confidence            999999885432 334  78889999999999999999999999999999999973  356899999999876543222 


Q ss_pred             cccCCCCCccccchhcccc---CCCCcchhHHHHHHHHHhhCCCCCCCCCchhh-hHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          258 FQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .....|++.|+|||.+.+.   ++.++||||||+++|+|++|..||........ ......  ..........+++++.+
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  243 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPESLSAEAKN  243 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hccCCCCCcccCHHHHH
Confidence            2345689999999987542   57899999999999999999999965433211 111110  01111122357889999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      |+.+||..+|.+|||+.+++.||||
T Consensus       244 li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         244 FILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.3e-42  Score=328.87  Aligned_cols=260  Identities=28%  Similarity=0.443  Sum_probs=216.1

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .+..+.|...+.||+|+||+||+|++..+|+.||+|++.............+.+|+.+++.+. |||++++++++.+...
T Consensus        17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   95 (313)
T cd06633          17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHT   95 (313)
T ss_pred             CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCE
Confidence            344456888889999999999999999999999999987654444445567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+. +++.+.+... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.+||+|||++..
T Consensus        96 ~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---~~~~~kL~dfg~~~~  170 (313)
T cd06633          96 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASK  170 (313)
T ss_pred             EEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---CCCCEEEeecCCCcc
Confidence            999999996 5777766433 35689999999999999999999999999999999999998   578899999998864


Q ss_pred             cCCCCccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ..   ......|+..|+|||++.    +..+.++|||||||++|+|++|..||.+.........+.....  +....+.+
T Consensus       171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~  245 (313)
T cd06633         171 SS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEW  245 (313)
T ss_pred             cC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCcccc
Confidence            32   223567899999999873    3467889999999999999999999987765555554443322  22222456


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +..+.+||.+||+.+|.+||++.+++.||||....
T Consensus       246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            78899999999999999999999999999999643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-43  Score=356.48  Aligned_cols=265  Identities=21%  Similarity=0.265  Sum_probs=196.2

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCC-CEEEEEE--------------eeccCCCChHhHHHHHHHHHHHHHccCC
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANG-DRVAVKK--------------IEKNKMILPIAVEDVKREVKILQALAGH  156 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~--------------i~~~~~~~~~~~~~~~~E~~il~~l~~h  156 (414)
                      ..+.++|++++.||+|+||+||+|..+... ..+++|.              +.+...........+.+|+.+|+.+. |
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence            445678999999999999999998764322 2222221              11111112234567889999999995 9


Q ss_pred             CCceEEEEEEEcCCEEEEEEeccCCCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEe
Q 015026          157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (414)
Q Consensus       157 pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~  233 (414)
                      ||||++++++.+.+..|+|+|++. ++|.+++....   ........++.++.||+.||.|||++||+||||||+|||++
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            999999999999999999999995 57888775432   12344677889999999999999999999999999999998


Q ss_pred             ecCCCCCceeeccccccccCCCCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCC---chh
Q 015026          234 SAKEDSSLKATDFGLSDFIKPGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT---EDG  307 (414)
Q Consensus       234 ~~~~~~~vkl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~---~~~  307 (414)
                         .++.+||+|||++........  ....+||+.|+|||++.+ .++.++|||||||++|||++|..|+....   ...
T Consensus       302 ---~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        302 ---CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ---CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence               578999999999987654322  234689999999998765 46889999999999999999876543322   112


Q ss_pred             hhHHHhhcCC----CCCCC------------------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          308 IFKEVLRNKP----DFRRK------------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       308 ~~~~i~~~~~----~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      .+.+++....    .++..                        ....++.++.++|.+||+.||.+|||+.|+|.||||.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            2222221110    00000                        0013566788899999999999999999999999998


Q ss_pred             cc
Q 015026          360 EG  361 (414)
Q Consensus       360 ~~  361 (414)
                      ..
T Consensus       459 ~~  460 (501)
T PHA03210        459 AE  460 (501)
T ss_pred             cC
Confidence            64

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.7e-43  Score=335.81  Aligned_cols=257  Identities=19%  Similarity=0.304  Sum_probs=203.7

Q ss_pred             eeeeec--CceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEecc
Q 015026          102 KLLGHG--QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (414)
Q Consensus       102 ~~lG~G--~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (414)
                      ..||+|  +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||++++++|..++..++|+||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence            356666  999999999999999999999875443 2345678899999999995 999999999999999999999999


Q ss_pred             CCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-c-
Q 015026          180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-K-  257 (414)
Q Consensus       180 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-~-  257 (414)
                      .+++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++   .++.++++|||.+....... . 
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCccc
Confidence            999999988665555689999999999999999999999999999999999998   57889999998653321110 0 


Q ss_pred             ------cccCCCCCccccchhcccc---CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC--------
Q 015026          258 ------FQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR--------  320 (414)
Q Consensus       258 ------~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--------  320 (414)
                            .....++..|+|||++.+.   ++.++|||||||++|+|++|..||.+..........+...+..+        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                  0112356679999998653   57899999999999999999999977655444333322211000        


Q ss_pred             -----------------------------------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          321 -----------------------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       321 -----------------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                                         ......+++.+.+||.+||+.||++|||+.++|+||||.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                               0011235678999999999999999999999999999986443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=342.33  Aligned_cols=236  Identities=27%  Similarity=0.416  Sum_probs=203.9

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      ++-||.|+.|-||+|+  ..++.||||+++.-          -..+|+-|++|+ ||||+.+.++|.....+|||||||.
T Consensus       129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~el----------kETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGR--LHNETVAVKKVREL----------KETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeee--ccCceehhHHHhhh----------hhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence            5669999999999996  45789999987432          145888899995 9999999999999999999999999


Q ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcccc
Q 015026          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD  260 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~  260 (414)
                      .|.|.+.+  +....+.......|..+|+.|+.|||.+.|||||||.-||||.   .+..|||+|||.++........-.
T Consensus       196 ~GqL~~VL--ka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STkMS  270 (904)
T KOG4721|consen  196 QGQLYEVL--KAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTKMS  270 (904)
T ss_pred             cccHHHHH--hccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhhhh
Confidence            99999988  4556789999999999999999999999999999999999999   578999999999987655444446


Q ss_pred             CCCCCccccchhccccC-CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          261 IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      ++||..|||||+++..+ +.++|||||||||||||||..||.+-+...++.-+-.+...++.  ....|+-++=||+.||
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv--PstcP~GfklL~Kqcw  348 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV--PSTCPDGFKLLLKQCW  348 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC--cccCchHHHHHHHHHH
Confidence            89999999999998775 99999999999999999999999877776666555444433332  2468889999999999


Q ss_pred             cCCccccCCHHHHhCCc
Q 015026          340 VKDPRARLTAAQALSHP  356 (414)
Q Consensus       340 ~~dp~~Rps~~elL~hp  356 (414)
                      +-.|+.||++.++|.|-
T Consensus       349 ~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  349 NSKPRNRPSFRQILLHL  365 (904)
T ss_pred             hcCCCCCccHHHHHHHH
Confidence            99999999999999874

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-42  Score=323.93  Aligned_cols=253  Identities=28%  Similarity=0.478  Sum_probs=209.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|.+.+.||.|+||.||+|.+..+|+.+|||.+.............+.+|+.+++.+ +||||+++++.+..++..++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence            3588999999999999999999999999999988765444444567888999999999 499999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          176 MELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      |||++|++|.+++...  ....+++..++.++.||+.||.|||+.|++|+||||+||+++   .++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEECcchhhhccc
Confidence            9999999999987532  235689999999999999999999999999999999999998   57889999999987654


Q ss_pred             CCCc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCch--hhhHHHhhcCCCCCCCCCCCCCH
Q 015026          254 PGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       254 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      .... .....|+..|+|||++.+. .+.++||||||+++|+|++|..||.+....  +....+...  .++......+++
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence            3322 2345789999999987654 578899999999999999999999765432  223333222  122223345788


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.++|.+||..||.+|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-43  Score=336.71  Aligned_cols=262  Identities=31%  Similarity=0.484  Sum_probs=216.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-----E
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----Y  171 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-----~  171 (414)
                      +|++.+.||.|++|.||+|.+..+|+.||||++..... .....+.+.+|+.+++.+. ||||+++++++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence            58999999999999999999999999999999865421 2335577899999999995 999999999987765     7


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +|+||||++ ++|.+.+..  ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.++|+|||++..
T Consensus        79 ~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---~~~~~~L~dfg~~~~  152 (330)
T cd07834          79 VYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---SNCDLKICDFGLARG  152 (330)
T ss_pred             eEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccCceEe
Confidence            999999997 478887743  34799999999999999999999999999999999999998   578999999999987


Q ss_pred             cCCCC----ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC---
Q 015026          252 IKPGK----KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK---  322 (414)
Q Consensus       252 ~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~---  322 (414)
                      .....    ......+++.|+|||++.+.  .+.++||||||+++|+|++|.+||.+.+..+.+..+..........   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            65432    23456789999999987654  5889999999999999999999998877666555554422111100   


Q ss_pred             ------------------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCC
Q 015026          323 ------------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE  366 (414)
Q Consensus       323 ------------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~  366 (414)
                                              ..+.++.++.+||.+||+.||.+|||+.+++.||||......+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~  300 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED  300 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence                                    12346888999999999999999999999999999987665543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-42  Score=324.92  Aligned_cols=254  Identities=22%  Similarity=0.304  Sum_probs=208.7

Q ss_pred             cceeeceeeeecCceEEEEEEECC-----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      +.|.+.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.+. ||||+++++++.+..
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   82 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFERL   82 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            569999999999999999999877     77889999876432  2334567889999999995 999999999999888


Q ss_pred             EEEEEEeccCCCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          171 YVYIAMELCEGGELLDRILAKKD-----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      ..++||||++|++|.+++.....     ..+++..+..++.||+.||.|||+++++||||||+||+++..++...+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            99999999999999998855432     2588999999999999999999999999999999999998644456799999


Q ss_pred             cccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          246 FGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       246 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      ||++........   .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+.+..+....+.....   
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---  239 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR---  239 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc---
Confidence            999976532211   11223456899999875 457899999999999999997 9999988777666655544322   


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ......++.++.+++.+||+.||++|||+.++++|
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11224678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-42  Score=329.24  Aligned_cols=258  Identities=28%  Similarity=0.464  Sum_probs=208.6

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC---
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~---  170 (414)
                      ..++|++.+.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++ ||||+++++++.+..   
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhh
Confidence            345799999999999999999999999999999998754321 223456778999999995 999999999887654   


Q ss_pred             -------EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCcee
Q 015026          171 -------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (414)
Q Consensus       171 -------~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (414)
                             .+++|+||+++ ++...+... ...+++..+..++.||+.||.|||+.||+|+||+|+||+++   +++.+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~kl  157 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKL  157 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCcEEe
Confidence                   89999999976 777766433 45689999999999999999999999999999999999998   5789999


Q ss_pred             eccccccccCCCC--ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          244 TDFGLSDFIKPGK--KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       244 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      +|||++.......  ......++..|+|||.+.+  ..+.++|||||||++|+|++|++||......+.+..+.......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999987654332  2223456888999998754  35789999999999999999999998766555544443321110


Q ss_pred             CC--------------------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          320 RR--------------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       320 ~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ..                          ..+..+|..+.++|.+||..||.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00                          1123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.7e-42  Score=316.19  Aligned_cols=253  Identities=32%  Similarity=0.535  Sum_probs=213.5

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--CEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVYI  174 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~~~~l  174 (414)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.+++++. ||||+++++.+.+.  ..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence            478889999999999999999999999999998765432 346788999999999995 99999999999988  89999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |+||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||.+.....
T Consensus        79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          79 FLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccc
Confidence            99999999999988544  3789999999999999999999999999999999999999   478999999999987765


Q ss_pred             CCc---cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          255 GKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       255 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ...   .....++..|+|||.+.+. .+.++||||||+++|+|++|..||..... ......+... . ........++.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~  231 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS-G-EPPEIPEHLSE  231 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc-C-CCcCCCcccCH
Confidence            443   3456789999999987655 68899999999999999999999976652 2222222211 1 11122235688


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ++.++|.+||..||++||++.+++.||||
T Consensus       232 ~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         232 EAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.1e-42  Score=319.91  Aligned_cols=246  Identities=24%  Similarity=0.395  Sum_probs=205.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|... ++..+|+|.+.....    ..+.+.+|+.+++.+. ||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence            35889999999999999999875 456899998764432    3467889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccCCC
Confidence            99999999999885433 4689999999999999999999999999999999999998   5788999999998765432


Q ss_pred             Ccc--ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KKF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ...  ....++..|+|||++.+ .++.++||||||+++|+|++ |+.||...+..+.+..+.........   ...+.++
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~  230 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTV  230 (256)
T ss_pred             ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHH
Confidence            221  12345668999998764 46889999999999999999 99999888877777777665432221   2467889


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+|+.+||..||.+|||+.++++
T Consensus       231 ~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         231 YEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-42  Score=337.29  Aligned_cols=261  Identities=30%  Similarity=0.505  Sum_probs=213.2

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE--
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY--  171 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~--  171 (414)
                      +.++|.+.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...+.  
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhcccccc
Confidence            45689999999999999999999999999999998865321 223446678899999999 59999999988766554  


Q ss_pred             ----EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          172 ----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       172 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                          .++|+||+ |++|.+++..   ..+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.++|+|||
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~dfg  163 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFG  163 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEcccc
Confidence                89999999 6799887743   4689999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC-----
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-----  320 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-----  320 (414)
                      ++......  .....++..|+|||.+.+  ..+.++|||||||++|+|++|+.||.+....+.+..+.......+     
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         164 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             cccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            99765432  345578999999998754  457899999999999999999999987765555544433211100     


Q ss_pred             ------------------C----CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          321 ------------------R----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       321 ------------------~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                                        .    .....+++++.+||.+||+.||.+|||+.+++.||||.......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence                              0    01134688999999999999999999999999999998755443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8e-44  Score=309.74  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=205.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-----CC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-----DN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-----~~  170 (414)
                      .||++.+.||+|||+.||++++..++..+|+|+|....   ....+...+|++..+++ +||||++++++...     ..
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCce
Confidence            58999999999999999999999999999999997654   34678889999999999 49999999886533     34


Q ss_pred             EEEEEEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceeecc
Q 015026          171 YVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      ..||+++|...|+|.+.+.+.  ++..++|.++..|+.+|++||++||+..  ++||||||.|||+.   +.+.++|+||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~  173 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDL  173 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEec
Confidence            599999999999999988554  3446999999999999999999999998  99999999999998   5789999999


Q ss_pred             ccccccCCC----Cc------cccCCCCCccccchhcccc----CCCCcchhHHHHHHHHHhhCCCCCCCCCc--hhhhH
Q 015026          247 GLSDFIKPG----KK------FQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTE--DGIFK  310 (414)
Q Consensus       247 G~a~~~~~~----~~------~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~  310 (414)
                      |.++...-.    ..      ...-..|..|+|||.+.-+    .+.++|||||||+||.|+.|..||.-.-.  ..+.-
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            998754311    11      1123568899999998643    48899999999999999999999953221  11222


Q ss_pred             HHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+..+...++...  .+|+.+.+||+.||+.||.+||++.+++.+
T Consensus       254 Av~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  254 AVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            3334444444443  389999999999999999999999999863

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.6e-42  Score=335.04  Aligned_cols=254  Identities=25%  Similarity=0.340  Sum_probs=203.5

Q ss_pred             ccceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-  168 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-  168 (414)
                      .++|++.+.||.|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.+++.+.+||||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            357999999999999999999743     345789999886432  223456778999999999669999999998764 


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccC-------------------------------------------------------
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKD-------------------------------------------------------  193 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~-------------------------------------------------------  193 (414)
                      +..+++|+||+++++|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            5678999999999999998854321                                                       


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc---cccCCCCCc
Q 015026          194 ----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY  266 (414)
Q Consensus       194 ----~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~  266 (414)
                          ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.++|+|||++........   .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                2578999999999999999999999999999999999998   578899999999987533221   223456778


Q ss_pred             cccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCcc
Q 015026          267 YVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR  344 (414)
Q Consensus       267 y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  344 (414)
                      |+|||++. ..++.++|||||||++|+|++ |..||.+....+.+...+.......  .....++++.+++.+||+.+|+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC--CCccCCHHHHHHHHHHccCChh
Confidence            99999765 457899999999999999998 9999987655444444433322111  1235778999999999999999


Q ss_pred             ccCCHHHHhCC
Q 015026          345 ARLTAAQALSH  355 (414)
Q Consensus       345 ~Rps~~elL~h  355 (414)
                      +||++.++++|
T Consensus       319 ~RPs~~ell~~  329 (337)
T cd05054         319 DRPTFSELVEI  329 (337)
T ss_pred             hCcCHHHHHHH
Confidence            99999999873

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.7e-42  Score=319.09  Aligned_cols=253  Identities=27%  Similarity=0.477  Sum_probs=209.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||.|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++++ +|+||+++++.+...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence            4699999999999999999999999999999998755444445577899999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          176 MELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      |||+++++|.+++...  ....+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---CCCcEEEeccceeeecc
Confidence            9999999999988542  235689999999999999999999999999999999999998   57889999999987654


Q ss_pred             CCC-ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch--hhhHHHhhcCCCCCCCCCCCCCH
Q 015026          254 PGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       254 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ... ......|++.|+|||.+.+ .++.++|||||||++|+|++|..||......  +....+....  ++..+...++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CCCCChhhcCH
Confidence            332 2234578999999998764 4688999999999999999999999654321  2333333221  12222236788


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.2e-42  Score=327.21  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=205.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC--EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.+....  .....+.+.+|+.++.++.+||||+++++++...+.++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            469999999999999999999887775  46888775321  23345678999999999966999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC
Q 015026          174 IAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~  239 (414)
                      +|+||+++++|.+++....              ...+++..+..++.||+.||+|||++||+||||||+|||++   .++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC---CCC
Confidence            9999999999999985432              13588999999999999999999999999999999999998   578


Q ss_pred             CceeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCC
Q 015026          240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      .+||+|||++..............+..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            899999999864322111112233557999998765 46889999999999999997 9999988877777666654321


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                         ......+++++.+||.+||..||.+|||++++++
T Consensus       237 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  270 (297)
T cd05089         237 ---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISV  270 (297)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               1122358899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.8e-42  Score=339.89  Aligned_cols=253  Identities=23%  Similarity=0.317  Sum_probs=204.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCC-----CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKAN-----GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .++|.+++.||+|+||+||+|.+...     +..||||++....  .....+.+.+|+.+|+.+..||||+++++++.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            35799999999999999999987533     3469999986542  2334577899999999995599999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcc---------------------------------------------------------
Q 015026          170 NYVYIAMELCEGGELLDRILAKK---------------------------------------------------------  192 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~---------------------------------------------------------  192 (414)
                      +.++||||||++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999999875431                                                         


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec
Q 015026          193 -------------------------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA  235 (414)
Q Consensus       193 -------------------------------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~  235 (414)
                                                           ...+++..+..++.||+.||.|||+.+|+||||||+|||++  
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~--  271 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA--  271 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe--
Confidence                                                 12477888999999999999999999999999999999998  


Q ss_pred             CCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhH
Q 015026          236 KEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFK  310 (414)
Q Consensus       236 ~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~  310 (414)
                       .++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+......+.
T Consensus       272 -~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         272 -QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             -CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence             577899999999976533221   223457788999998754 46889999999999999997 999998765544443


Q ss_pred             HHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .........  .....++.++.++|.+||+.||++|||+.++.+
T Consensus       351 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSGYRM--AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcCCCC--CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333332221  222467889999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-42  Score=318.35  Aligned_cols=254  Identities=28%  Similarity=0.491  Sum_probs=209.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccC--CCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--CE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK--MILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~~  171 (414)
                      ..|++.+.||+|+||.||+|.+..+|+.||+|.+....  .........+.+|+.+++.+. ||||+++++.+.+.  ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            46999999999999999999999999999999875432  122345678899999999995 99999999988753  56


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++|+||+++++|.+++..  ...+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++..
T Consensus        81 ~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~  155 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECccccccc
Confidence            8999999999999998844  34588999999999999999999999999999999999998   577899999999976


Q ss_pred             cCCC----CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPG----KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ....    .......|+..|+|||++.+. .+.++|+|||||++|+|++|+.||.+.........+....  ......+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~  233 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLPDG  233 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCCcc
Confidence            5321    122345789999999987654 5889999999999999999999998765544444443221  11222356


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      +++++.++|.+||. +|..||++.+++.|||.
T Consensus       234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            88999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4e-42  Score=326.29  Aligned_cols=259  Identities=25%  Similarity=0.361  Sum_probs=210.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|++.+.||.|+||.||+|.+..+++.||||.+.....  ......+..|+.++..+.+||||+++++++.+....++|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            468999999999999999999999999999999875432  224456677888777776799999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |||+. ++|.+.+... ...+++..+..++.||+.||.|||+ .||+||||+|+||+++   .++.+||+|||++.....
T Consensus        93 ~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~---~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          93 MELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc---CCCCEEECccccchhccC
Confidence            99985 4666655432 3578999999999999999999997 6999999999999998   578999999999876654


Q ss_pred             CCccccCCCCCccccchhcccc-----CCCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHHHhhcCCCCCCCCCCCCC
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRK-----SGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      ........+++.|+|||.+.+.     .+.++||||||+++|+|++|+.||..... .+.+..+........ .....++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  246 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFS  246 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCCC
Confidence            4333445688899999987643     57889999999999999999999965332 334444444332111 1112478


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .++.+||.+||..||.+||++++++.||||....
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            8999999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=325.40  Aligned_cols=255  Identities=33%  Similarity=0.519  Sum_probs=210.5

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |.+.+.||.|++|+||+|.+..+++.||||.+......  .......+|+..++.+.+||||+++++++.+++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67889999999999999999999999999988654321  1233455799999999669999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~  257 (414)
                      |+ +++|.+.+.......+++..+..++.||+.+|.|||++|++|+||+|+||+++   .++.++|+|||++........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---GPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCCEEEeecccceeccCCCC
Confidence            99 78999988665545789999999999999999999999999999999999999   588999999999987665545


Q ss_pred             cccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC---------------
Q 015026          258 FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR---------------  320 (414)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------------  320 (414)
                      .....|+..|+|||++.+  .++.++|+||||+++++|++|.+||......+.+..+........               
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            556678999999998743  358899999999999999999999987765554443332111000               


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          321 -----------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       321 -----------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                                 ....+..+.++.+||.+||+.||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                       00112346789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.1e-42  Score=331.70  Aligned_cols=259  Identities=29%  Similarity=0.430  Sum_probs=206.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCC--CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----CC
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKAN--GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DN  170 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----~~  170 (414)
                      +|++.+.||+|+||.||+|.+..+  +..||+|++..... .....+.+.+|+.+++.+.+||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            488999999999999999999888  89999999864321 222456678899999999779999999986532    35


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .+++++||+. ++|.+.+.  ....+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++.
T Consensus        80 ~~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---~~~~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---ADCELKICDFGLAR  153 (332)
T ss_pred             cEEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc---CCCCEEeCcCCCce
Confidence            6889999985 68888874  345789999999999999999999999999999999999998   57889999999997


Q ss_pred             ccCCCC-----ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC------
Q 015026          251 FIKPGK-----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP------  317 (414)
Q Consensus       251 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~------  317 (414)
                      ......     ......||+.|+|||.+.+  .++.++||||+||++|+|++|.+||.+.+....+..+.....      
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            654321     1234578999999998654  458899999999999999999999987654443333222110      


Q ss_pred             -----------------CCC----CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          318 -----------------DFR----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       318 -----------------~~~----~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                       ..+    ...++.++.++.+||.+||+.||.+|||+.+++.||||.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence                             000    112345688999999999999999999999999999998543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.2e-42  Score=322.85  Aligned_cols=252  Identities=20%  Similarity=0.312  Sum_probs=205.3

Q ss_pred             ccceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.+. ||||+++++++...
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~   81 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG   81 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence            457999999999999999999864     245679999885432  2234566889999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCc
Q 015026          170 NYVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL  241 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v  241 (414)
                      ...++||||+++++|.+++....        ...+++..+..++.|++.||.|||+.|++||||||+||+++   .++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCCE
Confidence            99999999999999999885432        12357788899999999999999999999999999999998   57889


Q ss_pred             eeeccccccccCCCCcc---ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcC
Q 015026          242 KATDFGLSDFIKPGKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNK  316 (414)
Q Consensus       242 kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~  316 (414)
                      +|+|||++.........   ....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+....
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG  238 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999998754332211   12355788999998764 46889999999999999999 799998877766666555543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       317 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ...   ....+++.+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            211   123578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=314.98  Aligned_cols=252  Identities=34%  Similarity=0.586  Sum_probs=214.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|++|.||++.+..+++.||+|.+...... ....+.+.+|+++++.+. |||++++++++.+.+..++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence            488999999999999999999999999999998765432 245678999999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||+|+||+++   .++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          79 EYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             ecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCc
Confidence            999999999988543  6789999999999999999999999999999999999998   47899999999998765433


Q ss_pred             c-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          257 K-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       257 ~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                      . .....|+..|+|||.+.+. .+.++||||+|+++|+|++|..||...........+....   .....+.+++++.++
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  230 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD---HPPLPEGISPELKDF  230 (254)
T ss_pred             ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---CCCCCCCCCHHHHHH
Confidence            2 2345789999999987644 5788999999999999999999998766544444433221   112234678999999


Q ss_pred             HHHhhcCCccccCCHHHHhCCccc
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      |.+||..+|++|||+.+++.||||
T Consensus       231 i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         231 LMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHhCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.4e-42  Score=324.11  Aligned_cols=249  Identities=23%  Similarity=0.367  Sum_probs=207.3

Q ss_pred             cceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..|.+.+.||+|+||+||++.+.     .++..+|+|.+....   ......+.+|+.+++.+. ||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence            46899999999999999999852     345679999886532   345677899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC
Q 015026          171 YVYIAMELCEGGELLDRILAKK-----------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~-----------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~  239 (414)
                      .+++||||+++++|.+++....           ...+++..+..++.||+.||+|||++|++||||||+||+++   .++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~---~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cCC
Confidence            9999999999999999885432           13489999999999999999999999999999999999998   578


Q ss_pred             CceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhh
Q 015026          240 SLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLR  314 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~  314 (414)
                      .+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999976543221   123345788999998765 46889999999999999998 9999988777777777765


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +....   ....++.++.+|+.+||+.||.+|||+.+++.
T Consensus       238 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            54221   12357889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-44  Score=332.31  Aligned_cols=274  Identities=30%  Similarity=0.483  Sum_probs=224.4

Q ss_pred             CCCcCccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChH----hHHHHHHHHHHHHHccCCCCc
Q 015026           84 KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI----AVEDVKREVKILQALAGHENV  159 (414)
Q Consensus        84 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~~E~~il~~l~~hpnI  159 (414)
                      ....|.....+.++|-++.+||+|+|+.||+|.|....++||+|+-..+..+.+.    ..+...+|.+|.+.| +||.|
T Consensus       451 dnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRI  529 (775)
T KOG1151|consen  451 DNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRI  529 (775)
T ss_pred             chhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Cccee
Confidence            3445556667888999999999999999999999999999999986555444332    344567899999999 69999


Q ss_pred             eEEEEEEE-cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEEeecC
Q 015026          160 VKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       160 v~~~~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~--~iiHrDlkp~NIll~~~~  236 (414)
                      |++|++|. +.+.+|-|+|||+|.+|.-++  .....+++.+++.|+.||+.||.||.+.  .|||.||||.|||+.+..
T Consensus       530 VKlYDyfslDtdsFCTVLEYceGNDLDFYL--KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt  607 (775)
T KOG1151|consen  530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYL--KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT  607 (775)
T ss_pred             eeeeeeeeeccccceeeeeecCCCchhHHH--HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence            99999986 667899999999999998887  4456799999999999999999999986  599999999999999777


Q ss_pred             CCCCceeeccccccccCCCCc--------cccCCCCCccccchhcc-c----cCCCCcchhHHHHHHHHHhhCCCCCCCC
Q 015026          237 EDSSLKATDFGLSDFIKPGKK--------FQDIVGSAYYVAPEVLK-R----KSGPESDVWSIGVITYILLCGRRPFWDK  303 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~DiwslG~il~elltg~~Pf~~~  303 (414)
                      .-|.|||+|||+++.+++...        .....||.||++||++- +    +.+.++||||+|||+|.++.|+.||...
T Consensus       608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            788999999999988754321        23468999999999863 3    2378899999999999999999999765


Q ss_pred             Cc-hhhhHH--HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          304 TE-DGIFKE--VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       304 ~~-~~~~~~--i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .. .+++..  |++. .+...++-|.+++++++||++||++--++|..+.++..||+|...
T Consensus       688 qsQQdILqeNTIlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  688 QSQQDILQENTILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhHHHHHhhhchhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            33 333332  2222 222333446899999999999999999999999999999999853

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=344.62  Aligned_cols=248  Identities=32%  Similarity=0.497  Sum_probs=212.9

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.+.|.+...+|.|+|+.|-.+.+..+++..++|++.+..       .+..+|+.++....+||||+++.+.+.+..+.
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCcee
Confidence            35678999999999999999999999999999999997652       22356888888888999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |+|||.+.|+.+.+.+....   ....++..|+++|+.|+.|||++|||||||||+|||++  +..++++|+|||.++..
T Consensus       392 ~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             eeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhC
Confidence            99999999999999885543   23378888999999999999999999999999999995  26889999999999876


Q ss_pred             CCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...  ..+.+-|..|.|||++.. .+++++||||||++||+|++|+.||...... ++...+.....  .    ..+|++
T Consensus       467 ~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~--s----~~vS~~  538 (612)
T KOG0603|consen  467 ERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF--S----ECVSDE  538 (612)
T ss_pred             chh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc--c----cccCHH
Confidence            654  445677999999999875 4699999999999999999999999877665 44544443322  2    479999


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +++||+.||+.||.+||++.+++.||||..
T Consensus       539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  539 AKDLLQQLLQVDPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             HHHHHHHhccCChhhCcChhhhccCcchhc
Confidence            999999999999999999999999999943

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.2e-41  Score=313.59  Aligned_cols=251  Identities=33%  Similarity=0.553  Sum_probs=212.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|.+.+.||.|++|.||+|.+..+++.+++|++.....   .....+.+|+.+++.+. ||||+++++.+......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence            37888999999999999999998999999999876532   35678899999999996 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++|++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++   +++.++|+|||.+.......
T Consensus        77 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          77 EFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             ecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeeccccccccccc
Confidence            9999999998875432 5789999999999999999999999999999999999998   57899999999998765543


Q ss_pred             ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCC-CCCCHHHHHH
Q 015026          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW-PSISNSAKDF  334 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~s~~~~~l  334 (414)
                      ......|+..|+|||.+.+. .+.++||||||+++|+|++|..||...+.......+....  .+.... ..++..+.++
T Consensus       153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  230 (253)
T cd05122         153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPGLRNPEKWSDEFKDF  230 (253)
T ss_pred             cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC--CCCcCcccccCHHHHHH
Confidence            33456789999999987654 5889999999999999999999997765444443333321  111111 1247899999


Q ss_pred             HHHhhcCCccccCCHHHHhCCcc
Q 015026          335 VKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~  357 (414)
                      |.+||+.||++|||+.++|.|||
T Consensus       231 i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         231 LKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-42  Score=321.98  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=211.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ..|++.+.||.|+||.||+|.+.. +..+|+|++....   ......+.+|+.+++.+. ||||+++++++.+....++|
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEEE
Confidence            469999999999999999999877 8899999987543   224567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.......+++..+..++.||+.||.|||+.||+|+||+|+||+++   +++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhhcCCc
Confidence            9999999999999766667789999999999999999999999999999999999998   5789999999999765432


Q ss_pred             Cc-cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          256 KK-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .. .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+.+..+....   .......+++++.
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  234 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY---RMPCPAKCPQEIY  234 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC---cCCCCCCCCHHHH
Confidence            21 123345678999998754 46889999999999999998 899998877777777666432   2222346889999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++|.+||+.||.+|||+.++++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.1e-42  Score=325.70  Aligned_cols=252  Identities=26%  Similarity=0.337  Sum_probs=208.0

Q ss_pred             cceeeceeeeecCceEEEEEEE-----CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|.+.+.||+|+||.||+|.+     ..++..||+|.+....  .....+.+.+|+.+++++.+||||+++++.+...+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            5799999999999999999975     3345689999886543  23355778999999999956999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||+++|+|.+++.......+++..+..++.||+.||.|||+++|+|+||||+|||++   .++.++|+|||++.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECCCcccc
Confidence            999999999999999998655545589999999999999999999999999999999999998   57789999999997


Q ss_pred             ccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          251 FIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       251 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      .......   .....++..|+|||.+.+ .++.++||||+||++|+|++ |..||.+....+.+.........  .....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~  267 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--MAQPE  267 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc--CCCCC
Confidence            6543221   122346788999998754 46889999999999999998 99999877666555444443221  12223


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..++++.+|+.+||..+|++|||+.+++.
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            57889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-42  Score=334.59  Aligned_cols=259  Identities=32%  Similarity=0.521  Sum_probs=209.2

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC-----
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~-----  169 (414)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++...     
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcC-CCCccchhheecccccCCC
Confidence            4579999999999999999999999999999999865422 2223456789999999995 99999999988654     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                       ..+++|+||+.+ +|...+    ...+++..+..++.|++.||.|||+.||+||||||+||+++   .++.+||+|||+
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~---~~~~~kL~dfg~  163 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGL  163 (342)
T ss_pred             CceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCCC
Confidence             356999999964 666544    24689999999999999999999999999999999999998   578999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC----------
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------  316 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~----------  316 (414)
                      +.....  ......|++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.+....+..+....          
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            876432  2234578999999998764  36889999999999999999999998776544444333211          


Q ss_pred             -------------CCCCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          317 -------------PDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       317 -------------~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                                   +..+..    .++..++++.+||.+||+.||.+||++.+++.||||.......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence                         111111    1245778899999999999999999999999999999765543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.4e-42  Score=326.09  Aligned_cols=260  Identities=28%  Similarity=0.452  Sum_probs=215.3

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .....|...+.||.|+||.||+|++..+++.||+|.+.............+.+|+.+++.+. |||++++++++......
T Consensus        12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA   90 (308)
T ss_pred             CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCee
Confidence            34456888999999999999999999999999999987543333445567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++|+||+. |++.+.+... ...+++..+..++.|++.||.|||+.+++||||+|+||+++   .++.++|+|||++...
T Consensus        91 ~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCcccceee
Confidence            99999996 5777766433 35689999999999999999999999999999999999998   5789999999998765


Q ss_pred             CCCCccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      ...   ....|++.|+|||.+.    +..+.++|||||||++|+|++|..||......+....+.....  +......++
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  240 (308)
T cd06634         166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWS  240 (308)
T ss_pred             cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCccccc
Confidence            432   3457899999999864    3467899999999999999999999977665544444443322  111123578


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ..+.+||.+||..+|.+||++.+++.|||+.....
T Consensus       241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            89999999999999999999999999999987533

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-42  Score=317.97  Aligned_cols=245  Identities=33%  Similarity=0.605  Sum_probs=212.1

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (414)
                      ||.|+||.||++.+..+++.+|+|++.............+..|+.+++.+. ||||+++++.+..+...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999999899999999998765544446678899999999995 9999999999999999999999999999


Q ss_pred             hHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-CccccCC
Q 015026          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIV  262 (414)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~  262 (414)
                      |.+++...  ..+++..+..++.||+.||.|||+.+++|+||+|+||+++   .++.++|+|||++...... .......
T Consensus        80 L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          80 LFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCCcccCCc
Confidence            99988443  4689999999999999999999999999999999999998   5778999999998776443 2334567


Q ss_pred             CCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcC
Q 015026          263 GSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK  341 (414)
Q Consensus       263 gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  341 (414)
                      |+..|+|||.+.+. .+.++|+||||+++|+|++|..||...........+......++    ..++..+.++|.+||..
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQK  230 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcC
Confidence            89999999987654 57889999999999999999999977766666666665433322    34688999999999999


Q ss_pred             CccccCCH---HHHhCCccc
Q 015026          342 DPRARLTA---AQALSHPWV  358 (414)
Q Consensus       342 dp~~Rps~---~elL~hp~f  358 (414)
                      ||++||++   +++++||||
T Consensus       231 ~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCcccHHHHHhCCCC
Confidence            99999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.3e-42  Score=322.35  Aligned_cols=262  Identities=32%  Similarity=0.533  Sum_probs=218.9

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +..+.|++.+.||.|++|.||+|.+..++..||+|++.....    ..+.+.+|+.+++.+. ||||+++++.+......
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence            455679999999999999999999998999999999875432    4567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++|+||++|++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++   .++.++|+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~  166 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---CCCCEEECccchhhhh
Confidence            99999999999999885543 3789999999999999999999999999999999999998   5788999999988654


Q ss_pred             CCCC-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          253 KPGK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       253 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      .... ......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||...........+...... .......++.+
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  245 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPE  245 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHH
Confidence            3322 22345688999999987654 588999999999999999999999876655544444333221 11122347889


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      +.++|.+||+.+|.+|||+.+++.||||...+..
T Consensus       246 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  279 (286)
T cd06614         246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK  279 (286)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence            9999999999999999999999999999985443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.7e-42  Score=333.60  Aligned_cols=264  Identities=31%  Similarity=0.472  Sum_probs=212.0

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--CC
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DN  170 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~  170 (414)
                      .+.++|.+.+.||.|+||.||+|.+..+|+.+|+|++..... .......+.+|+.+++++.+||||+++++++..  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            456789999999999999999999999999999998864322 223445677899999999559999999998864  34


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||++ ++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g~~~  155 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR  155 (337)
T ss_pred             eEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccchh
Confidence            7899999997 488887743   2688999999999999999999999999999999999998   68899999999987


Q ss_pred             ccCCCC------ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC-----
Q 015026          251 FIKPGK------KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-----  317 (414)
Q Consensus       251 ~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-----  317 (414)
                      ......      ......||+.|+|||.+.+  ..+.++||||||+++|+|++|+.||.+....+....+.....     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            654322      2234578999999998754  357899999999999999999999977655443333222111     


Q ss_pred             ----------------------CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          318 ----------------------DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       318 ----------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                                            .......+.++.++.++|.+||+.||.+|||+.++++||||......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                                  00111234578899999999999999999999999999999875443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.1e-42  Score=322.94  Aligned_cols=256  Identities=21%  Similarity=0.313  Sum_probs=207.5

Q ss_pred             cceeeceeeeecCceEEEEEEECC-----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++.+. ||||+++++++.+..
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   82 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKGQ   82 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCC
Confidence            579999999999999999997652     34579999876443  2234456788999999994 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          171 YVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                      ..++||||+++|+|.+++....        ...++...+..++.||+.||.|||++||+||||||+||+++   .++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcEE
Confidence            9999999999999999985432        12346678899999999999999999999999999999998   578899


Q ss_pred             eeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCC
Q 015026          243 ATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       243 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      |+|||+++.......   .....++..|+|||.+.+ ..+.++|||||||++|||++ |..||.+....+....+.....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999876533221   112345678999998764 56889999999999999998 8999988776666665554322


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC------Cccccc
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS------HPWVRE  360 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~------hp~f~~  360 (414)
                      ..   .....++.+.+++.+||+.||++|||+.++++      ||||..
T Consensus       240 ~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         240 LD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            11   11356789999999999999999999999987      888875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.6e-42  Score=325.43  Aligned_cols=258  Identities=33%  Similarity=0.575  Sum_probs=214.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|....+||+|+||.||++.+..+|+.||||++....   ......+.+|+.+++.+. ||||+++++.+...+..++||
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEE
Confidence            3455578999999999999999999999999885432   235567889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+++.   ...+++..+..++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||++.......
T Consensus        97 e~~~~~~L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          97 EFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             ecCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEcccccceeccccc
Confidence            9999999988763   24589999999999999999999999999999999999998   57889999999987654322


Q ss_pred             -ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          257 -KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                       ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+....+....+....+... .....+++++.++
T Consensus       171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l  249 (292)
T cd06657         171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL-KNLHKVSPSLKGF  249 (292)
T ss_pred             ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc-CCcccCCHHHHHH
Confidence             2234578999999998754 468899999999999999999999987766555554443332211 1234678899999


Q ss_pred             HHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      |.+||..||.+||++.+++.||||......+
T Consensus       250 i~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         250 LDRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             HHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence            9999999999999999999999999766433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.3e-42  Score=332.66  Aligned_cols=259  Identities=31%  Similarity=0.486  Sum_probs=208.3

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++ ||||+++++++...    
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   92 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccccc
Confidence            44789999999999999999999999999999999865322 2223566788999999995 99999999988643    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        ...+++++++ |++|.+.+.   ...+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||
T Consensus        93 ~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~dfg  165 (345)
T cd07877          93 EFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFG  165 (345)
T ss_pred             ccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc---CCCCEEEeccc
Confidence              3478888887 778887663   23589999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC---------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---------  316 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~---------  316 (414)
                      ++.....  ......|++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+......+..+....         
T Consensus       166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         166 LARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             ccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            9876432  2345678999999998755  35789999999999999999999997765544433332211         


Q ss_pred             --------------CCCCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          317 --------------PDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       317 --------------~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                    ...+..    .+...++++.+||.+||..||.+||++.+++.||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                          011110    11245788999999999999999999999999999986544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.8e-42  Score=322.47  Aligned_cols=251  Identities=19%  Similarity=0.303  Sum_probs=206.2

Q ss_pred             cceeeceeeeecCceEEEEEEEC----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ..|++.+.||+|+||+||+|.+.    .++..||+|.+....  .......+.+|+.+++.+. ||||+++++++..+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence            35899999999999999999853    456789999986432  2345567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC
Q 015026          172 VYIAMELCEGGELLDRILAKK---------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~---------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~  236 (414)
                      .++||||+++++|.+++....               ...+++..+..++.||+.||.|||++||+||||||+|||++   
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~---  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc---
Confidence            999999999999999885332               12478889999999999999999999999999999999998   


Q ss_pred             CCCCceeeccccccccCCCC---ccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHH
Q 015026          237 EDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  311 (414)
                      .++.+||+|||++.......   ......++..|+|||.+. +.++.++|||||||++|+|++ |..||.+.....+...
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            57789999999997653322   123345677899999876 446889999999999999998 9999988766655555


Q ss_pred             HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +..... .  .....+++.+.+++.+||+.||.+||++.+++++
T Consensus       239 ~~~~~~-~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQL-L--PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCc-C--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            544332 1  2234678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.9e-42  Score=357.80  Aligned_cols=149  Identities=31%  Similarity=0.497  Sum_probs=135.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|.+++.||.|+||+||+|.+..+++.||||++.............+..|+.+++.+. ||||+++++.+.....+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999997765555556678899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      |||+.|++|.+++..  .+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCCc
Confidence            999999999998843  35689999999999999999999999999999999999998   57899999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.4e-42  Score=328.45  Aligned_cols=257  Identities=28%  Similarity=0.396  Sum_probs=204.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC-----
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~-----  169 (414)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.+. ||||+++++.+.+.     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence            367999999999999999999999999999999986543211 12345678999999995 99999999987543     


Q ss_pred             ---CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          170 ---NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       170 ---~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                         ..+++|+||+.+ +|...+.. ....+++..+..++.||++||.|||+.||+|+||||+||+++   .++.++|+||
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~---~~~~~~l~df  159 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIADF  159 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECcC
Confidence               357999999965 67766643 345799999999999999999999999999999999999998   5789999999


Q ss_pred             ccccccCCCC------------ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHH
Q 015026          247 GLSDFIKPGK------------KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV  312 (414)
Q Consensus       247 G~a~~~~~~~------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i  312 (414)
                      |++.......            ......|++.|+|||.+.+  .++.++|||||||++|+|++|++||.+.+.......+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9987643221            1123467889999998754  3588999999999999999999999887766555544


Q ss_pred             hhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          313 LRNKPDFRR--------------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       313 ~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .........                          ..+..+++++.++|.+||..||.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            332111000                          0112355788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=317.41  Aligned_cols=247  Identities=24%  Similarity=0.323  Sum_probs=206.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|++|.||+|.+. +++.||+|.+.....    ..+.+.+|+.+++.+. ||||+++++++...+..++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeeee
Confidence            56999999999999999999875 456899999865432    3466889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++   .++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKED  156 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEEccCC
Confidence            9999999999998665555789999999999999999999999999999999999998   5788999999999876532


Q ss_pred             Ccc--ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KKF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ...  ....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||.+.........+.....   ......++..+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR---MPCPPGCPKEL  233 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHHH
Confidence            211  11223457999998764 46889999999999999999 9999988776666666654422   11224678999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+++.+||+.||.+||++.+++.
T Consensus       234 ~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         234 YDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.8e-42  Score=319.01  Aligned_cols=246  Identities=26%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+..+ ..||+|.+.....    ..+.+.+|+.+++.+. ||||+++++.+.. ...++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEEE
Confidence            5799999999999999999988665 4699999875432    3457889999999995 9999999998754 558999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++|+|.+++.......+++..+..++.|++.||.|||+.+|+||||||+||+++   +++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeecccc
Confidence            9999999999998655455689999999999999999999999999999999999998   5788999999999765433


Q ss_pred             Ccc--ccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KKF--QDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ...  ....++..|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+.....   ......++..+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  232 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPESL  232 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC---CCCccccCHHH
Confidence            221  2334667899999865 456889999999999999999 8999988777666666554322   11224678999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+||.+||+.||++||++.++++
T Consensus       233 ~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         233 HDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.4e-42  Score=317.65  Aligned_cols=247  Identities=24%  Similarity=0.367  Sum_probs=205.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|++.+.||+|+||+||+|.+.. +..+|+|.+.....    ..+.+.+|+.+++.+. ||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence            358999999999999999998654 44699998865432    3466889999999995 99999999999998999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+.+++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++   .++.+||+|||++......
T Consensus        78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCCEEECCCccceecCCC
Confidence            99999999999885433 3689999999999999999999999999999999999998   5789999999998765433


Q ss_pred             Ccc--ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KKF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ...  ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+.........   ...++.+
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  230 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKV  230 (256)
T ss_pred             ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHH
Confidence            221  12345678999998864 56889999999999999998 99999877776666666655433222   3467899


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+++.+||..||.+||++.+++.+
T Consensus       231 ~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         231 YAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHHh
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.1e-42  Score=328.71  Aligned_cols=262  Identities=33%  Similarity=0.513  Sum_probs=210.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-CCE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNY  171 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-~~~  171 (414)
                      .+.++|.+.+.||.|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+++.+. ||||++++++|.. ...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   84 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLED   84 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCc
Confidence            456789999999999999999999999999999998865322 2234567889999999995 9999999998865 567


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++|+||+ +++|.+.+.   ...+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.++|+|||++..
T Consensus        85 ~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---~~~~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLARI  157 (328)
T ss_pred             EEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---CCCCEEeCccccccc
Confidence            89999998 568877663   24588999999999999999999999999999999999998   578999999999875


Q ss_pred             cCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh---------------
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---------------  314 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~---------------  314 (414)
                      ...  ......+++.|+|||.+.+  .++.++||||||+++|+|++|+.||.+.........+.+               
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            432  2244578899999998754  468899999999999999999999976553222111110               


Q ss_pred             --------cC----CCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          315 --------NK----PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       315 --------~~----~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                              ..    ........+.+++++.++|.+||+.+|++|||+.+++.||||.......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence                    00    0000112245788999999999999999999999999999998765543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.3e-42  Score=323.76  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=208.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC-----CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG-----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++.+.||+|+||.||++.+...+     ..+|+|.+....  .......+.+|+.+++.+.+||||+++++++..++
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            57999999999999999999876443     689999886543  23345678899999999956999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC
Q 015026          171 YVYIAMELCEGGELLDRILAK--------------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~  236 (414)
                      .+++||||+++|+|.+++...              ....+++..+..++.||+.||.|||++||+||||||+|||++   
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~---  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc---
Confidence            999999999999999988542              245689999999999999999999999999999999999998   


Q ss_pred             CCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHH
Q 015026          237 EDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  311 (414)
                      .++.+||+|||+++.......   .....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            578999999999986543321   112335678999998654 46889999999999999997 9999988776666665


Q ss_pred             HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +..... .  ......+.++.+|+.+||..||.+|||+.+++++
T Consensus       247 ~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         247 LKEGYR-M--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHcCCc-C--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            554321 1  1223578899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=323.59  Aligned_cols=254  Identities=33%  Similarity=0.515  Sum_probs=210.3

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |.+.+.||.|++|.||+|.+..+|+.+|+|.+..... .+.....+.+|+.+++.+. ||||+++++++.++...++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence            5678899999999999999999999999999865443 2234567889999999995 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-  256 (414)
                      |+++ +|.+.+... ...+++..+..++.||+.||.|||+.||+|+||+|+||+++   .++.++|+|||.+....... 
T Consensus        79 ~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          79 FMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             ccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---CCCcEEEeeeeeeEecCCCcc
Confidence            9975 888877543 35789999999999999999999999999999999999998   57899999999987765443 


Q ss_pred             ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC---------------
Q 015026          257 KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF---------------  319 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------------  319 (414)
                      ......++..|+|||.+.+  ..+.++||||||+++|+|++|+.||.+.+..+.+..+.......               
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            3334578899999998754  35889999999999999999999998776655444433221110               


Q ss_pred             ----C-------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          320 ----R-------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       320 ----~-------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                          +       ...++.++.++.++|.+||..||.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                0       01123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=317.41  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=207.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCC---CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++|++.+.||+|+||+||+|.+..+   ...||+|++....  .......+.+|+.+++.+. ||||+++++.+...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence            4689999999999999999988654   4579999886543  2345667889999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++++|.+++... .+.+++..+..++.|++.||.|||++||+|+||||+||+++   .++.++|+|||++...
T Consensus        81 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~  156 (266)
T cd05033          81 MIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccchhhcc
Confidence            9999999999999988543 34789999999999999999999999999999999999998   5788999999999876


Q ss_pred             CCCC-ccc--cCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          253 KPGK-KFQ--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       253 ~~~~-~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      .... ...  ...+++.|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+......   +.....
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---PPPMDC  233 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence            4211 111  2344678999998764 46889999999999999998 99999877766666666544221   122357


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ++.+.+|+.+||+.+|++||++.+++++
T Consensus       234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         234 PSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            8899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=316.10  Aligned_cols=245  Identities=26%  Similarity=0.387  Sum_probs=208.6

Q ss_pred             eeeeecCceEEEEEEECCC---CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEec
Q 015026          102 KLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (414)
                      +.||+|+||.||+|.+...   +..||+|.+......  ...+.+.+|+.+++.+. ||||+++++++.....+++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            4699999999999999866   889999998765432  24678999999999996 99999999999999999999999


Q ss_pred             cCCCChHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          179 CEGGELLDRILAKK-------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       179 ~~gg~L~~~l~~~~-------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++++|.+++....       ...+++..++.++.||+.||.|||++|++||||+|+||+++   .++.++|+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC---CCCcEEEcccccccc
Confidence            99999999885532       36789999999999999999999999999999999999999   578999999999987


Q ss_pred             cCCCC---ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .....   ......+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+....+.....   ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPKPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence            65432   2334567889999998765 56889999999999999999 6999988877777777665322   122246


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +|+++.+++.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            78999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=319.62  Aligned_cols=250  Identities=22%  Similarity=0.309  Sum_probs=207.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCC-----CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKAN-----GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|.+.+.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.+++.+ +||||+++++++....
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~   82 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCC
Confidence            5799999999999999999988644     3789999986443  223456788999999999 5999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          171 YVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                      ..++||||+++++|.+++....        ...+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~---~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc---CCCCEE
Confidence            9999999999999999885432        23467889999999999999999999999999999999998   578999


Q ss_pred             eeccccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCC
Q 015026          243 ATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       243 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      |+|||+++.......   .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH  239 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence            999999876543221   22345678999999875 456889999999999999998 9999988777776666653321


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .   ......+.++.++|.+||+.+|++|||+.++++
T Consensus       240 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 L---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1   112346899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-41  Score=316.89  Aligned_cols=247  Identities=26%  Similarity=0.355  Sum_probs=204.4

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+.....    ..+.+.+|+.+++.+. ||||+++++++. ....++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCCcEE
Confidence            357999999999999999999865 566799999876442    3456889999999995 999999999875 456899


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++   +++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccC
Confidence            99999999999998665556789999999999999999999999999999999999998   578899999999976543


Q ss_pred             CCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...  .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+....+.....   .......+..
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR---MPCPQDCPIS  231 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHH
Confidence            221  122345668999998654 46889999999999999999 9999988776666666654321   1222467889


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.+|+.+||..||++|||+.++++
T Consensus       232 ~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         232 LHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.3e-42  Score=327.63  Aligned_cols=249  Identities=22%  Similarity=0.301  Sum_probs=202.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCE----EEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .+|++.+.||+|+||+||+|.+..+|+.    ||+|++....  .....+.+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence            4699999999999999999998766664    8999886432  2345677889999999995 99999999988765 4


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++|+||+++|+|.+++... ...+++..+..++.||+.||+|||+.||+||||||+|||++   .++.+||+|||+++.
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---~~~~~kl~DfG~a~~  158 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  158 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---CCCcEEEcccccccc
Confidence            77999999999999988653 34688999999999999999999999999999999999998   578899999999987


Q ss_pred             cCCCCcc---ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPGKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .......   ....++..|+|||++.+ .++.++|||||||++|||++ |..||.+....+.. .+.......+.  .+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~--~~~  235 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ--PPI  235 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC--CCC
Confidence            6543322   12334678999998764 46889999999999999997 99999876555443 33333222222  245


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+.++.+++.+||..||.+||++.+++.+
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            77899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=316.58  Aligned_cols=246  Identities=23%  Similarity=0.361  Sum_probs=203.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||+|+||.||+|.+. ++..+|+|++.....    ....+.+|+.+++.+. ||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEE
Confidence            5889999999999999999875 466899998865432    2356788999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||++|++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||+++......
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---CCCcEEECCcccceeccccc
Confidence            9999999999886543 3689999999999999999999999999999999999998   57889999999987654322


Q ss_pred             ccc--cCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          257 KFQ--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       257 ~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ...  ...++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+.....   .......+.++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  231 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---LYRPKLAPTEVY  231 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCHHHH
Confidence            111  1223457999998764 56889999999999999999 8999987776666666554322   122245789999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCC
Q 015026          333 DFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +++.+||..+|++|||+.++++.
T Consensus       232 ~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         232 TIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-41  Score=322.40  Aligned_cols=253  Identities=21%  Similarity=0.249  Sum_probs=206.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC----------------CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCc
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG----------------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV  159 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnI  159 (414)
                      .+|++++.||+|+||.||+|.+..++                ..||+|.+.....  ....+.+.+|+.+++.+. ||||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i   81 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLS-DPNI   81 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcC-CCCE
Confidence            47999999999999999999876544                4589998865432  245678899999999995 9999


Q ss_pred             eEEEEEEEcCCEEEEEEeccCCCChHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 015026          160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKK---------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENF  230 (414)
Q Consensus       160 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI  230 (414)
                      +++++++..++..++|||++++++|.+++....         ...+++..+..++.|++.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999885533         12689999999999999999999999999999999999


Q ss_pred             EEeecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh--CCCCCCCCC
Q 015026          231 LFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC--GRRPFWDKT  304 (414)
Q Consensus       231 ll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt--g~~Pf~~~~  304 (414)
                      +++   .++.++|+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++  |..||....
T Consensus       162 li~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         162 LVG---KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eec---CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            998   568999999999876543321   224456789999998764 67899999999999999998  788997776


Q ss_pred             chhhhHHHhhc----CCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          305 EDGIFKEVLRN----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       305 ~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ....+..+...    .........+.+++++.+||.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            66666555432    111111122356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-41  Score=315.33  Aligned_cols=243  Identities=23%  Similarity=0.346  Sum_probs=199.2

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      +.||+|+||.||+|.+..+|+.||+|.+....  .......+.+|+.+++.+ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            36899999999999999999999999875432  234567789999999999 599999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccc--
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--  259 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~--  259 (414)
                      ++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||+++   .++.+||+|||++..........  
T Consensus        78 ~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          78 GDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             CcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CCCcEEECccccCcccccccccccC
Confidence            9999988533 34689999999999999999999999999999999999998   57789999999987544321111  


Q ss_pred             -cCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHH
Q 015026          260 -DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (414)
Q Consensus       260 -~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (414)
                       ...++..|+|||.+.+ .++.++||||||+++|+|++ |..||...........+.....   .......+..+.+|+.
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~  230 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---LPCPELCPDAVYRLME  230 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---CCCcccCCHHHHHHHH
Confidence             1122456999998754 46889999999999999998 9999977666555554444322   1222357889999999


Q ss_pred             HhhcCCccccCCHHHHhC
Q 015026          337 KLLVKDPRARLTAAQALS  354 (414)
Q Consensus       337 ~~L~~dp~~Rps~~elL~  354 (414)
                      +||+.||++|||+.++++
T Consensus       231 ~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         231 RCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.4e-42  Score=323.04  Aligned_cols=256  Identities=29%  Similarity=0.522  Sum_probs=208.5

Q ss_pred             ceeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCC-ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .|++.+.||+|++|.||+|.+.   .+++.||||++.+.... .....+.+.+|+.++..+.+||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3889999999999999999864   46789999998754321 1224466889999999997799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++++|.+++..  ...+++..++.++.|++.||.|||+.|++||||+|+||+++   .++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEEECcccccc
Confidence            999999999999998854  35689999999999999999999999999999999999998   5788999999998765


Q ss_pred             CCCCc--cccCCCCCccccchhcccc---CCCCcchhHHHHHHHHHhhCCCCCCCCCch----hhhHHHhhcCCCCCCCC
Q 015026          253 KPGKK--FQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       253 ~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~  323 (414)
                      .....  .....|+..|+|||.+.+.   .+.++||||||+++|+|++|..||......    +....+....+    ..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~  231 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP----PF  231 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC----CC
Confidence            43322  2235689999999987643   578899999999999999999999644322    22233333322    22


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCC---HHHHhCCcccccc
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLT---AAQALSHPWVREG  361 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps---~~elL~hp~f~~~  361 (414)
                      ...++.++.++|.+||+.||++|||   +.++|+||||+..
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            2357889999999999999999998   5678999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.6e-41  Score=315.86  Aligned_cols=247  Identities=23%  Similarity=0.351  Sum_probs=206.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .+.|+++++||+|+||.||+|... +++.||+|.+.....    ....+.+|+.+++.+. ||||+++++++. .+..++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcEE
Confidence            457999999999999999999864 578899999875442    3467889999999995 999999999875 456899


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++   .++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCcceeecCC
Confidence            99999999999998766666789999999999999999999999999999999999998   578899999999876542


Q ss_pred             CCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...  .....++..|+|||++.+ .++.++||||||+++|+|++ |+.||.+.+..+....+.....   .......+.+
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNCPEE  231 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCHH
Confidence            221  123346678999998764 45889999999999999999 9999988777666666544322   1222457889


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.++|.+||..+|++|||+++++.
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         232 LYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.8e-42  Score=322.34  Aligned_cols=249  Identities=18%  Similarity=0.259  Sum_probs=207.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCC-----CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKAN-----GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      +|++.+.||+|+||+||+|.+..+     +..||+|++....  .....+.+.+|+.++..+. ||||+++++++.....
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCc
Confidence            588999999999999999987543     5789999986443  2334567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC
Q 015026          172 VYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~  237 (414)
                      .++++||+.+++|.+++....              ...+++..+..++.|++.||.|||++||+||||||+||+++   +
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---D  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---C
Confidence            999999999999999884321              23578889999999999999999999999999999999998   5


Q ss_pred             CCCceeeccccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHH
Q 015026          238 DSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV  312 (414)
Q Consensus       238 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i  312 (414)
                      ++.+||+|||+++.......   .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+....+....+
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            77899999999876533221   22345678999999865 557889999999999999998 89999887777777777


Q ss_pred             hhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .......   ....++.++.+|+.+||+.+|.+||++.+++.
T Consensus       240 ~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         240 RNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            6654321   12468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-42  Score=320.36  Aligned_cols=247  Identities=28%  Similarity=0.429  Sum_probs=201.3

Q ss_pred             eeceeeeecCceEEEEEEEC----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           99 TIGKLLGHGQFGYTYVATDK----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .+.+.||.|+||.||+|...    ..+..|+||.+...  ......+.+.+|+++++++ +||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence            46788999999999999987    44568999998442  2344578899999999999 59999999999998888999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |+||+++|+|.+++.......+++..+..|+.||+.||.|||+++++|+||+|+|||++   .++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccc
Confidence            99999999999999776567899999999999999999999999999999999999999   588999999999987632


Q ss_pred             CCc---cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          255 GKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       255 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ...   .....+...|+|||++.+. ++.++||||||+++|||++ |+.||.+....++...+.......   ....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence            221   1234567789999998654 6889999999999999999 789998887777777775543311   2245789


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+.++|.+||..||.+|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-41  Score=314.72  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=215.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.+. ||||+++++++.+....++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence            488999999999999999999999999999998765432 334567789999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          177 ELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||+++++|.+++....  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++   .++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence            9999999999885522  35689999999999999999999999999999999999999   477899999999977654


Q ss_pred             CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      . ......|++.|+|||.+.+. ++.++|+||||+++|+|++|+.||...+..+....+......  . ....++.++.+
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--P-IPPIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--C-CchhhCHHHHH
Confidence            4 33345789999999987654 578899999999999999999999887766555555443321  1 11357889999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      +|.+||..+|.+||++.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.5e-41  Score=324.02  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=205.5

Q ss_pred             cceeeceeeeecCceEEEEEEECC-------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ++|.+.+.||+|+||.||+|.+..       ++..+|+|.+....  .......+.+|+.+++.+.+||||+++++++..
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            579999999999999999998643       23569999887542  233456788999999999669999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee
Q 015026          169 DNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~  234 (414)
                      .+..++||||+++|+|.+++....              ...+++..+..++.||+.||.|||++|++||||||+||+++ 
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-  174 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-  174 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc-
Confidence            999999999999999999986542              13588899999999999999999999999999999999998 


Q ss_pred             cCCCCCceeeccccccccCCCCcc---ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhh
Q 015026          235 AKEDSSLKATDFGLSDFIKPGKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (414)
Q Consensus       235 ~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~  309 (414)
                        .++.+||+|||++.........   ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+..
T Consensus       175 --~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         175 --EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             --CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence              5789999999998765432211   12234578999998765 46889999999999999998 89999876665555


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+.....   ......++.++.+||.+||..+|.+|||+.+++.
T Consensus       253 ~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         253 KLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             HHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            55544321   1222467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.3e-42  Score=326.69  Aligned_cols=257  Identities=23%  Similarity=0.342  Sum_probs=200.6

Q ss_pred             eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEec
Q 015026           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (414)
                      .+++.+|  ++|.||++++..+|+.||||++..... .....+.+.+|+.+++.++ ||||+++++++.+.+..+++|||
T Consensus         5 ~i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           5 LIGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhhHhhc--CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEec
Confidence            3444444  445566666677999999999876532 2346678999999999995 99999999999999999999999


Q ss_pred             cCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc-
Q 015026          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-  257 (414)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~-  257 (414)
                      +++++|.+++.......+++..+..++.||+.||.|||+++|+||||||+||+++   .++.+||+|||.+........ 
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeecccccc
Confidence            9999999988765556789999999999999999999999999999999999998   578999999998865432111 


Q ss_pred             -------cccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC-------C-
Q 015026          258 -------FQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD-------F-  319 (414)
Q Consensus       258 -------~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-------~-  319 (414)
                             .....++..|+|||++.+   .++.++||||+||++|+|++|..||.+............+...       . 
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                   123467889999998865   3678999999999999999999999765543322221111100       0 


Q ss_pred             ----------------------CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          320 ----------------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       320 ----------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                            .......++.++.+||.+||..||++|||+.++|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                  0000012346788999999999999999999999999998543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=338.97  Aligned_cols=256  Identities=29%  Similarity=0.503  Sum_probs=233.0

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      ..+++..||-|+||.|=++........+|+|++++....+....+.+..|-+||..++ .|.||++|-.|.+..++|++|
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhH
Confidence            4677889999999999999876666569999999888877778899999999999996 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      |-|-||+|...+  +..+.+.+..++.++..+++|++|||++|||+|||||+|.+++   .+|-+||.|||+|+.+..+.
T Consensus       500 EaClGGElWTiL--rdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd---~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  500 EACLGGELWTIL--RDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD---NRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HhhcCchhhhhh--hhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec---cCCceEEeehhhHHHhccCC
Confidence            999999999988  5557899999999999999999999999999999999999999   68999999999999999999


Q ss_pred             ccccCCCCCccccchhc-cccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHH
Q 015026          257 KFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (414)
                      ...++||||.|.|||++ +...+.++|.||||+++|||++|.+||.+.+...++..|+++.-....+  ..++..+.+||
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Li  652 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLI  652 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHH
Confidence            99999999999999975 5567899999999999999999999999999999999999876433222  36889999999


Q ss_pred             HHhhcCCccccCC-----HHHHhCCccccc
Q 015026          336 KKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       336 ~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      +++...+|.+|..     +.||-.|.||..
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            9999999999985     899999999975

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-41  Score=323.35  Aligned_cols=251  Identities=23%  Similarity=0.345  Sum_probs=205.8

Q ss_pred             cceeeceeeeecCceEEEEEEECC-------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ++|.+++.||+|+||.||+|.+..       .+..||+|.+....  .......+.+|+.+++.+.+||||+++++++.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            579999999999999999997632       34569999886532  233566788999999999669999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee
Q 015026          169 DNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~  234 (414)
                      .+.+++||||+++|+|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||++ 
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-  168 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT-  168 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc-
Confidence            999999999999999999986532              23588899999999999999999999999999999999998 


Q ss_pred             cCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhh
Q 015026          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (414)
Q Consensus       235 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~  309 (414)
                        .++.+||+|||+++.......   .....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.+
T Consensus       169 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         169 --EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             --CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              578899999999976543221   112234567999998764 46889999999999999999 99999887766666


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+.....   ......++.++.+||.+||..||.+|||+.+++.
T Consensus       247 ~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         247 KLLREGHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHcCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            66554321   1122467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=316.72  Aligned_cols=249  Identities=20%  Similarity=0.307  Sum_probs=203.3

Q ss_pred             eeeceeeeecCceEEEEEEECCC---CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE---
Q 015026           98 YTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY---  171 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~---  171 (414)
                      |.+.+.||+|+||.||+|....+   +..||+|.+..... .......+.+|+.+++.+ +||||+++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence            56788999999999999987643   47899999875432 234567789999999999 49999999998765443   


Q ss_pred             ---EEEEEeccCCCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceee
Q 015026          172 ---VYIAMELCEGGELLDRILAKK----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (414)
Q Consensus       172 ---~~lv~e~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (414)
                         .++|+||+++++|..++....    ...+++..+..++.||+.||.|||+.||+||||||+||+++   +++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC---CCCeEEEC
Confidence               899999999999998875432    23689999999999999999999999999999999999998   57899999


Q ss_pred             ccccccccCCCCcc---ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCC
Q 015026          245 DFGLSDFIKPGKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       245 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |||+++........   ....++..|+|||.+.+ .++.++|||||||++|||++ |..||.+....+.+..+...... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL-  234 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            99999865433221   12235678999998764 46889999999999999999 99999887777776666554321 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                        .....+++++.+++.+||+.||.+|||+.+++.
T Consensus       235 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         235 --KQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             --CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              122467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-43  Score=315.78  Aligned_cols=256  Identities=24%  Similarity=0.469  Sum_probs=225.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|+++.+||+|+|++|.+++.+.|.+.+|+|+++++-..+++..+.++.|-.+..+..+||.+|.++..|..+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            35999999999999999999999999999999999988888888999999999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc-cCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~-~~~  254 (414)
                      .||++||+|.-++.  ....+|++.++.+...|+.||.|||+.|||+||||.+|+|++   ..+++||+|+|+++. +.+
T Consensus       330 ieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld---aeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc---cCCceeecccchhhcCCCC
Confidence            99999999988884  446799999999999999999999999999999999999999   589999999999875 566


Q ss_pred             CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCC-------CC-chhhhHHHhhcCCCCCCCCCC
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWD-------KT-EDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~-------~~-~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      +....++||||.|.|||++++. |+..+|+|+|||+++||+.|+.||.-       .+ ++-+++-|+......+.    
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----  480 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----  480 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----
Confidence            6777899999999999999875 79999999999999999999999942       22 23344445544433333    


Q ss_pred             CCCHHHHHHHHHhhcCCccccC------CHHHHhCCccccc
Q 015026          326 SISNSAKDFVKKLLVKDPRARL------TAAQALSHPWVRE  360 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rp------s~~elL~hp~f~~  360 (414)
                      .+|-.+..+++..|++||.+|.      ...++-.|+||+.
T Consensus       481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            5677788999999999999996      4679999999985

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-44  Score=313.37  Aligned_cols=261  Identities=28%  Similarity=0.478  Sum_probs=213.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE--------
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--------  167 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~--------  167 (414)
                      ..|+...+||+|.||+||+|+.+.+|+.||+|++..+..... .-....+|+++|..|+ |+|++.+++.|.        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG-fpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG-FPITALREIKILQLLK-HENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC-CcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCccc
Confidence            468888999999999999999999999999997754322111 2234568999999995 999999998774        


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                      +...+|+||.+|+. +|.-.+ .+....++..+++.++.++++||.|+|+..|+|||+||+|+||+   .++.+||+|||
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlL-sn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilklADFG  169 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLL-SNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKLADFG  169 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHh-cCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEeeccc
Confidence            23469999999975 676665 23346799999999999999999999999999999999999999   68999999999


Q ss_pred             cccccCCC-----CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          248 LSDFIKPG-----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       248 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      +++.+...     ..+...+.|.+|++||.+.|  .++++.|||..|||+.||.+|.+.|.+.++...+..|..-...+.
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99754322     23455677999999998765  479999999999999999999999999888777666655444444


Q ss_pred             CCCCCCC-------------------------------CHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          321 RKPWPSI-------------------------------SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       321 ~~~~~~~-------------------------------s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ...||++                               ++++.+|+.+||..||.+|++++++|+|.||+....
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            4444431                               346789999999999999999999999999997543

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-41  Score=314.70  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=203.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||.|++|.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.+++.+. ||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCcEEE
Confidence            5699999999999999999987655 4699998765432    3467889999999995 9999999998754 568899


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||+++   +++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~---~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCeEEECCCccceEccCC
Confidence            9999999999998665555689999999999999999999999999999999999998   5788999999999765432


Q ss_pred             Cc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..  .....++..|+|||.+.+ ..+.++||||||+++|+|++ |..||.+....+....+.....   ......++..+
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---MPCPQGCPESL  232 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHHH
Confidence            21  123346678999998764 46889999999999999999 9999988777666666554321   12234678999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+++.+||..||.+||+++++++
T Consensus       233 ~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         233 HELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999886

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.3e-41  Score=316.61  Aligned_cols=249  Identities=20%  Similarity=0.299  Sum_probs=201.7

Q ss_pred             eeeceeeeecCceEEEEEEECCCCC--EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc------C
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------D  169 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~------~  169 (414)
                      |.+++.||+|+||.||+|.+..++.  .||+|.+.... ......+.+.+|+.+++.+. ||||+++++.+..      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence            3567889999999999999887776  69999886543 23345678899999999994 9999999997642      2


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          170 NYVYIAMELCEGGELLDRILAK----KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      ...++||||+++|+|.+++...    ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc---CCCCEEECC
Confidence            3578999999999999887432    224588999999999999999999999999999999999998   578999999


Q ss_pred             cccccccCCCCcc---ccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          246 FGLSDFIKPGKKF---QDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       246 FG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      ||++.........   ....+++.|+|||.+.+. ++.++||||||+++|+|++ |..||.+....+....+......  
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--  233 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL--  233 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            9999876433221   123456789999987654 6889999999999999999 89999877666666665544321  


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                       ...+.++..+.++|.+||+.||.+|||+.++++
T Consensus       234 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  266 (272)
T cd05075         234 -KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC  266 (272)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             122467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.9e-41  Score=313.42  Aligned_cols=243  Identities=23%  Similarity=0.348  Sum_probs=203.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEE-EcCCEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF-EDDNYVYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~-~~~~~~~l  174 (414)
                      .+|.+.+.||+|+||.||++..  .|..||+|.+....     ..+.+.+|+.+++.+. ||||+++++++ ..++..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence            3689999999999999999965  47889999885432     3467889999999995 99999999975 45677999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |+||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++   +++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc---CCCcEEecCCccceeccc
Confidence            99999999999998765555689999999999999999999999999999999999998   578999999999876433


Q ss_pred             CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ..  ....++..|+|||++.+. ++.++|||||||++|+|++ |+.||......+....+.....   ....+.+++.+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence            22  233456789999987654 6889999999999999997 9999987766666665544322   222346789999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++|.+||..||++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.6e-42  Score=347.85  Aligned_cols=249  Identities=22%  Similarity=0.376  Sum_probs=214.5

Q ss_pred             ceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .....+.||+|+||+||+|+..     .....||||.++...  +.....+|++|+++|..|. |||||+++|+|..++.
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREGDP  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCCe
Confidence            4567789999999999999753     233579999987654  4458899999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcc--------CC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC
Q 015026          172 VYIAMELCEGGELLDRILAKK--------DS----RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~--------~~----~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~  239 (414)
                      +++|+|||..|+|-++|....        +.    +|+..+...|+.||+.|+.||-++.+|||||-+.|+||.   ++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---ENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cce
Confidence            999999999999999996532        12    388999999999999999999999999999999999998   788


Q ss_pred             CceeeccccccccCCCCcccc---CCCCCccccchh-ccccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhh
Q 015026          240 SLKATDFGLSDFIKPGKKFQD---IVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLR  314 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~~~~~---~~gt~~y~aPE~-~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~  314 (414)
                      .|||+|||+++.+-+.+.+..   ..--.+|||||. +.++++.++||||+||+|||+++ |+.||.+.+.+++++.|..
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            999999999988765444332   123468999995 56889999999999999999998 9999999999999999988


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.. +..  ..+.|.++.+|+..||+.+|++||++.||-.
T Consensus       721 g~l-L~~--Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  721 GQL-LSC--PENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             CCc-ccC--CCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            876 332  2478999999999999999999999999753

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.9e-41  Score=313.72  Aligned_cols=241  Identities=24%  Similarity=0.308  Sum_probs=197.9

Q ss_pred             eeeecCceEEEEEEE--CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          103 LLGHGQFGYTYVATD--KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      .||+|+||.||+|.+  ..++..+|+|++.... ......+.+.+|+.+++.+ +||||+++++++.. ...++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCC
Confidence            589999999999964  4677899999886443 2344567889999999999 59999999998764 46789999999


Q ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcc--
Q 015026          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF--  258 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~--  258 (414)
                      +++|.+++..  ...+++..+..++.||+.||.|||++||+||||||.||+++   .++.+||+|||++.........  
T Consensus        79 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          79 LGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCCCCeee
Confidence            9999998843  35689999999999999999999999999999999999998   5788999999999765433221  


Q ss_pred             --ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          259 --QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       259 --~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                        ....++..|+|||.+.. ..+.++|||||||++|||++ |..||.+....+....+..+..   ....+.+++++.+|
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l~~l  230 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---MECPQRCPPEMYDL  230 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHHHH
Confidence              12234678999998764 45789999999999999998 9999988776666666654432   11224688999999


Q ss_pred             HHHhhcCCccccCCHHHHhC
Q 015026          335 VKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~  354 (414)
                      |.+||+.||++||++.+|..
T Consensus       231 i~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         231 MKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHhccCchhCcCHHHHHH
Confidence            99999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.6e-41  Score=319.92  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=205.9

Q ss_pred             cceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .+|.+.+.||+|+||.||+|.+.     .++..+|+|.+....   ....+.+.+|+.+++.+. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence            45899999999999999999854     345568999875432   234567899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC
Q 015026          171 YVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~  236 (414)
                      ..++||||+++++|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++   
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~---  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---
Confidence            9999999999999999985432              23488999999999999999999999999999999999998   


Q ss_pred             CCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHH
Q 015026          237 EDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  311 (414)
                      .++.++|+|||++........   .....|+..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            578999999999976543221   123456889999998764 45889999999999999998 9999988777666665


Q ss_pred             HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.......   .....|..+.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            55443221   22357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.5e-41  Score=318.33  Aligned_cols=249  Identities=21%  Similarity=0.339  Sum_probs=205.8

Q ss_pred             cceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .+|.+.++||+|+||.||+|...     .++..+|+|.+....   ......+.+|+++++.+ +||||+++++++.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVL-QHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCC
Confidence            46888999999999999999643     356689999876432   34567899999999999 4999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC
Q 015026          171 YVYIAMELCEGGELLDRILAKKD-------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~-------------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~  237 (414)
                      ..++||||+++++|.+++.....             ..+++..+..++.||+.||.|||+.|++||||||+|||++   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---Q  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---C
Confidence            99999999999999998864321             3588999999999999999999999999999999999998   5


Q ss_pred             CCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHH
Q 015026          238 DSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV  312 (414)
Q Consensus       238 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i  312 (414)
                      ++.+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |.+||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            78999999999875433221   123345788999998764 46889999999999999998 99999877766666666


Q ss_pred             hhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ......   .....+++.+.+||.+||+.||.+||++.+++.
T Consensus       238 ~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            554322   122367899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-41  Score=313.21  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=208.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|.+.+.||.|+||.||+|.+. .+..||||.+.....    ..+.+.+|+.+++.+. ||||+++++++......++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceEE
Confidence            357999999999999999999975 457899999875432    3467889999999995 9999999999999899999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECccccceeccc
Confidence            99999999999998665556789999999999999999999999999999999999998   578999999999876543


Q ss_pred             CCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...  .....++..|+|||.+.+ ..+.++||||||+++|+|++ |+.||.+......+..+.....   .......+.+
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR---MPRPPNCPEE  232 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHH
Confidence            211  112234568999998765 46889999999999999998 9999988777777776655432   1222356889


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.+++.+||..+|.+||++.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         233 LYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-41  Score=316.02  Aligned_cols=245  Identities=24%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             eeeeecCceEEEEEEECCCCC--EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEecc
Q 015026          102 KLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (414)
                      +.||+|+||.||+|.+..++.  .+|+|.+....  .....+.+.+|+.++.++.+||||+++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            358999999999999988876  46888775322  23455678899999999966999999999999999999999999


Q ss_pred             CCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          180 EGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       180 ~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      ++++|.+++....              ...+++..+..++.|++.||+|||+.|++||||||+||+++   .++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc---CCCeEEECC
Confidence            9999999986432              13578999999999999999999999999999999999998   578999999


Q ss_pred             cccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCC
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  323 (414)
                      ||++..............+..|+|||++.. .++.++|||||||++|+|++ |..||.+.+..+.+..+....   ....
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---CCCC
Confidence            999864322111112234567999998754 46889999999999999997 999998877666666654432   1112


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ...++.++.+|+.+||..||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=369.10  Aligned_cols=256  Identities=32%  Similarity=0.563  Sum_probs=217.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      -++.-...||.|.||.||.|.+..+|+..|+|-|...... ......+.+|+.+|..+ +|||+|++||+-.+.+.++|.
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHHHHHH
Confidence            3566778999999999999999999999999988654433 44667789999999999 499999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||||+||+|.+.+  ..++..+|...+.+..|++.|+.|||++|||||||||+||+++   .+|.+|++|||.|..+..+
T Consensus      1313 MEyC~~GsLa~ll--~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld---~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLL--EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD---FNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHhccCcHHHHH--HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee---cCCcEEeecccceeEecCc
Confidence            9999999999988  4455677888889999999999999999999999999999999   5789999999999877654


Q ss_pred             C-----ccccCCCCCccccchhccccC----CCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHHHhhcC-CCCCCCCC
Q 015026          256 K-----KFQDIVGSAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNK-PDFRRKPW  324 (414)
Q Consensus       256 ~-----~~~~~~gt~~y~aPE~~~~~~----~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~i~~~~-~~~~~~~~  324 (414)
                      .     ....++||+.|||||++.+..    .-++||||||||+.||+||+.||...+. -.++..+-.+. |.+|    
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P---- 1463 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP---- 1463 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc----
Confidence            3     345789999999999987643    6689999999999999999999966543 34444554443 3333    


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ..+|++.++||.+||..||+.|.++.|+|+|.|-+...
T Consensus      1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence            24999999999999999999999999999999976543

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=319.92  Aligned_cols=254  Identities=30%  Similarity=0.508  Sum_probs=209.4

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |++.+.||+|++|.||+|++..+++.||+|++..... .....+.+..|+.+++.+. ||||+++++++.+....++|+|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence            5677889999999999999999999999999876531 2234567788999999995 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-  256 (414)
                      |++ ++|.+++.... ..+++..+..++.|++.||.|||+.||+||||+|+||+++   +++.++|+|||++....... 
T Consensus        79 ~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          79 YCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             CcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---CCCCEEEecCCcccccCCCcc
Confidence            997 58998885542 4689999999999999999999999999999999999998   57899999999987654432 


Q ss_pred             ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC-----------------
Q 015026          257 KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-----------------  317 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-----------------  317 (414)
                      ......++..|+|||.+.+  ..+.++|||||||++|+|++|..||.+....+.+..+.....                 
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            2334566888999998754  458899999999999999999999987765554444332110                 


Q ss_pred             -CCC-------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          318 -DFR-------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       318 -~~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                       .++       ....+.++..+.++|.+||..||++||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             000       01234567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.8e-41  Score=320.84  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=207.5

Q ss_pred             ccceeeceeeeecCceEEEEEEEC-------CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDK-------ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~  167 (414)
                      .++|.+.+.||+|+||.||+|.+.       .++..||+|.+....  .......+.+|+.+++.+.+||||+++++.+.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            357999999999999999999752       234579999886432  23456778999999999966999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEe
Q 015026          168 DDNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (414)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~  233 (414)
                      .....++||||+++++|.+++....              ...++...+..++.||+.||.|||++||+||||||+||+++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence            9999999999999999999986532              23578888999999999999999999999999999999998


Q ss_pred             ecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhh
Q 015026          234 SAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (414)
Q Consensus       234 ~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~  308 (414)
                         .++.+||+|||+++.......   .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..++
T Consensus       172 ---~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         172 ---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             ---CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence               578999999999976543221   123346778999998754 46889999999999999998 8899988777777


Q ss_pred             hHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ...+......   .....++.++.+||.+||..+|.+|||+.++++
T Consensus       249 ~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         249 FKLLKEGHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             HHHHHcCCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            6666544321   112467899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-41  Score=316.46  Aligned_cols=254  Identities=27%  Similarity=0.457  Sum_probs=208.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC--ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      +|.+.+.||+|+||.||++.+..++..+++|++......  .......+..|+.+++.+. ||||+++++.+.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence            589999999999999999999888777777766532211  1223445678999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          175 AMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |+||+++++|.+.+..  .....+++..++.++.|++.||.|||+.|++|+||+|+||+++    ++.++|+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence            9999999999888754  2345789999999999999999999999999999999999997    356999999998765


Q ss_pred             CCCC-ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          253 KPGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       253 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      .... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.........+......   .....++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC---CCcchhcHH
Confidence            4332 2335678999999998754 3577899999999999999999999776655555555443221   112357889


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      +.++|.+||..||++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=334.23  Aligned_cols=255  Identities=24%  Similarity=0.356  Sum_probs=213.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCC---E-EEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGD---R-VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~-vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +-.+.++||+|+||.||+|..+..+.   . ||+|...............+.+|+++++.| +|||||++||+......+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCcc
Confidence            45567999999999999998766433   3 899988764444566889999999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      +||||+|.||+|.++|..... .++..+...++.+.+.||+|||++++|||||-..|+|++   .+..+||+|||+++..
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccCC
Confidence            999999999999999965543 699999999999999999999999999999999999998   4667899999998765


Q ss_pred             CCCCccccC-CCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          253 KPGKKFQDI-VGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       253 ~~~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ......... .--..|+|||.+. +.+++++|||||||++||+++ |..||.+....++...|..+....+  ..+..|.
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~--~~~~~p~  390 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP--IPSKTPK  390 (474)
T ss_pred             cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC--CCCCCHH
Confidence            422111111 2346899999876 457899999999999999999 8999999999888888855443222  2246788


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ++..++.+|+..||++|||+.++.+  ++..
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~  419 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKK--KLEA  419 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHH--HHHH
Confidence            9999999999999999999999887  5443

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-41  Score=328.43  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=200.6

Q ss_pred             cceeeceeeeecCceEEEEEEE-----CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-C
Q 015026           96 RRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-D  169 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-~  169 (414)
                      ++|++.+.||+|+||+||+|.+     ..+++.||||++.....  ......+.+|+.+|..+.+||||+++++++.. +
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            5799999999999999999984     35678999999865432  23456788999999999768999999998764 4


Q ss_pred             CEEEEEEeccCCCChHHHHHhccC--------------------------------------------------------
Q 015026          170 NYVYIAMELCEGGELLDRILAKKD--------------------------------------------------------  193 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~--------------------------------------------------------  193 (414)
                      ..+++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            578999999999999998854321                                                        


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc---cccC
Q 015026          194 ---------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDI  261 (414)
Q Consensus       194 ---------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~  261 (414)
                               ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++........   ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcchhhcCCC
Confidence                     2367788899999999999999999999999999999998   578999999999876432211   1223


Q ss_pred             CCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          262 VGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       262 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                      .++..|+|||++.+ .++.++||||||+++|+|++ |..||.+...................  ...+++++.+++.+||
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~cl  319 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC--CCCCCHHHHHHHHHHc
Confidence            45678999998654 46889999999999999997 99999776544333333322221111  1246788999999999


Q ss_pred             cCCccccCCHHHHhCC
Q 015026          340 VKDPRARLTAAQALSH  355 (414)
Q Consensus       340 ~~dp~~Rps~~elL~h  355 (414)
                      +.||.+|||+.++++|
T Consensus       320 ~~~p~~Rps~~eil~~  335 (343)
T cd05103         320 HGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=311.53  Aligned_cols=244  Identities=24%  Similarity=0.363  Sum_probs=206.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|++.+.||.|+||.||+|..  .|+.||+|.+.....    ..+.+.+|+.+++.+. ||||+++++++.+....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence            4689999999999999999976  478999999865432    4677899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++   .++.+||+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---CCCCEEEcccccccccccc
Confidence            9999999999998665555789999999999999999999999999999999999998   5788999999999776322


Q ss_pred             CccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .  ....++..|+|||.+. +.++.++||||||+++|+|++ |..||......++...+.....   ......+++++.+
T Consensus       156 ~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  230 (256)
T cd05039         156 Q--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYK  230 (256)
T ss_pred             c--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHH
Confidence            2  2334566799999875 456889999999999999997 9999987766665555544321   1222467899999


Q ss_pred             HHHHhhcCCccccCCHHHHhC
Q 015026          334 FVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~  354 (414)
                      +|.+||..+|.+|||+.+++.
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.9e-41  Score=313.92  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=206.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC---EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+....  .....+.+.+|+.+++.+. ||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence            468999999999999999998865543   79999886543  2335678899999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+|||++   .++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~~~~~  156 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCccccc
Confidence            9999999999999988543 35689999999999999999999999999999999999998   5789999999999765


Q ss_pred             CCCCcc----ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKKF----QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ......    ....++..|+|||.+.+ .++.++|+||||+++|++++ |..||.+....+....+.....   .+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~  233 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR---LPAPMD  233 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc---CCCCCC
Confidence            432211    12233568999998764 56889999999999999886 9999988776666666654421   122246


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +++.+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         234 CPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            7889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.2e-41  Score=315.93  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=195.5

Q ss_pred             cce-eeceeeeecCceEEEEEE----ECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--
Q 015026           96 RRY-TIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--  168 (414)
Q Consensus        96 ~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--  168 (414)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+....  .......+.+|+.+|+.+. ||||+++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            455 999999999999998864    34578899999986542  2234567889999999995 9999999998765  


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      ...+++||||+++++|.+++..   ..+++..+..++.|++.||.|||++||+||||||+|||++   .++.++|+|||+
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~  153 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGL  153 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEeeccc
Confidence            3468999999999999998843   3589999999999999999999999999999999999998   578999999999


Q ss_pred             ccccCCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch--hh------------h
Q 015026          249 SDFIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED--GI------------F  309 (414)
Q Consensus       249 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~------------~  309 (414)
                      +........    .....++..|+|||.+.+ ..+.++||||||+++|+|++|..||......  +.            .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL  233 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence            976543322    112345677999998764 4688999999999999999999998543321  00            0


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .........  ......++.++.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         234 IELLERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            011111111  1112357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.1e-41  Score=314.86  Aligned_cols=248  Identities=23%  Similarity=0.295  Sum_probs=202.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC----EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .+|++.+.||.|+||+||+|.+..+|+    .||+|++....  .......+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~   82 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-T   82 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-C
Confidence            468999999999999999999877776    48999886442  3345677889999999995 99999999988754 4


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++++||+++|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++   +++.+||+|||+++.
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~  158 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGLARL  158 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCceee
Confidence            78999999999999988543 35689999999999999999999999999999999999998   577899999999987


Q ss_pred             cCCCCcc---ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPGKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .......   ....+++.|+|||.+.+ .++.++|||||||++|||++ |..||.......+...+..... .  ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~  235 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-L--PQPPI  235 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-C--CCCcc
Confidence            6433221   12234678999998754 46889999999999999998 9999976665555444433221 1  12246


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+.++.++|.+||..||++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=327.11  Aligned_cols=255  Identities=26%  Similarity=0.361  Sum_probs=200.1

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-  170 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-  170 (414)
                      ....+.|.-...||+|+||.||+|.-. +|..||||++.......   ..+|.+|+.+|.+++ |||+|+++|+|.+.+ 
T Consensus        71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~  145 (361)
T KOG1187|consen   71 RKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCLEGGE  145 (361)
T ss_pred             HHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEecCCc
Confidence            345567888889999999999999864 45899999876654211   455999999999996 999999999999988 


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~---iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                      ..+||+|||++|+|.+++.......++|.....|+.+++.||+|||+..   ||||||||+|||+|   ++...||+|||
T Consensus       146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD---~~~~aKlsDFG  222 (361)
T KOG1187|consen  146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD---EDFNAKLSDFG  222 (361)
T ss_pred             eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC---CCCCEEccCcc
Confidence            5999999999999999996654338899999999999999999999854   99999999999999   68999999999


Q ss_pred             cccccCC-CCccccC-CCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCCC---chhhhH---HHhhcC--
Q 015026          248 LSDFIKP-GKKFQDI-VGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFK---EVLRNK--  316 (414)
Q Consensus       248 ~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~---~~~~~~---~i~~~~--  316 (414)
                      +|+.... ....... .||.+|+|||.+. +..+.++|||||||+|.||+||+.|.....   +..+..   ..+...  
T Consensus       223 La~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~  302 (361)
T KOG1187|consen  223 LAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL  302 (361)
T ss_pred             CcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence            9977654 3333333 8999999999875 677999999999999999999998886532   111111   111111  


Q ss_pred             CCCCCCC-C-CCCC--HH---HHHHHHHhhcCCccccCCHHHHhC
Q 015026          317 PDFRRKP-W-PSIS--NS---AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       317 ~~~~~~~-~-~~~s--~~---~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .....+. . ...+  .+   +..+..+|+..+|..||++.+++.
T Consensus       303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            0111111 1 1222  22   567889999999999999999754

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.2e-41  Score=310.20  Aligned_cols=247  Identities=27%  Similarity=0.411  Sum_probs=208.2

Q ss_pred             eeceeeeecCceEEEEEEECCCC----CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           99 TIGKLLGHGQFGYTYVATDKANG----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .+.+.||.|+||.||+|.+..++    ..||+|++.....  ....+.+..|+.+++.+ +||||+++++++.+.+..++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEE
Confidence            56788999999999999998766    8999999865432  22567889999999999 69999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++.......+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++.....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---cCCeEEEcccCCceeccc
Confidence            99999999999988654433389999999999999999999999999999999999998   577999999999977654


Q ss_pred             CCccc--cCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GKKFQ--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      .....  ...+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...+.......+.......   ....++.+
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  232 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP---KPENCPPE  232 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCHH
Confidence            32222  1336789999998754 46889999999999999998 899998877777777666544322   22357899


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.+++.+||..||++|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=318.45  Aligned_cols=253  Identities=20%  Similarity=0.266  Sum_probs=202.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC--------------CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG--------------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK  161 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~--------------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~  161 (414)
                      ++|++.+.||+|+||.||+|.+..++              ..||+|.+....  .....+.+.+|+++++.+. ||||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence            57999999999999999999875432              258999886542  2345677999999999995 999999


Q ss_pred             EEEEEEcCCEEEEEEeccCCCChHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 015026          162 FYNAFEDDNYVYIAMELCEGGELLDRILAKK----------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFL  231 (414)
Q Consensus       162 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIl  231 (414)
                      +++++...+..++||||+++++|.+++....          ...+++..+..++.||+.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999885432          123688899999999999999999999999999999999


Q ss_pred             EeecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh--CCCCCCCCCc
Q 015026          232 FKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC--GRRPFWDKTE  305 (414)
Q Consensus       232 l~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt--g~~Pf~~~~~  305 (414)
                      ++   .++.+||+|||++........   .....++..|+|||++. +.++.++|||||||++|+|++  |..||...+.
T Consensus       162 l~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 VG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             Ec---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            98   577899999999876533221   12234577899999765 457899999999999999988  7788887766


Q ss_pred             hhhhHHHhhcC----CCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          306 DGIFKEVLRNK----PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       306 ~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+....+....    ........+.+++.+.+|+.+||..||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            55554443211    00111122357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.6e-41  Score=330.54  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=204.2

Q ss_pred             cceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|.+++.||+|+||.||+|++.     .+++.||+|++.....  ....+.+.+|+.+|..+..||||+++++++...+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            46889999999999999999864     3456899999965432  2344578899999999955999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccC---------------------------------------------------------
Q 015026          171 YVYIAMELCEGGELLDRILAKKD---------------------------------------------------------  193 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~---------------------------------------------------------  193 (414)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999864321                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee
Q 015026          194 ---------------------------------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       194 ---------------------------------------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~  234 (414)
                                                             ..+++..+..++.||+.||.|||+.+|+||||||+|||++ 
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~-  273 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC-  273 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe-
Confidence                                                   2367778899999999999999999999999999999998 


Q ss_pred             cCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhh
Q 015026          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (414)
Q Consensus       235 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~  309 (414)
                        .++.+||+|||+++.......   .....+++.|+|||.+.+ .++.++|||||||++|||++ |..||......+..
T Consensus       274 --~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         274 --EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             --CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence              578899999999976432221   123467889999998764 46889999999999999998 89999776655554


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ...+......  .....++.++.+||.+||..+|.+||++.+++.
T Consensus       352 ~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~  394 (401)
T cd05107         352 YNAIKRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH  394 (401)
T ss_pred             HHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4444332211  122457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.1e-41  Score=323.32  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=206.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCC-------CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKAN-------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      .+|++++.||+|+||.||+|.+...       +..||+|.+....  .....+.+.+|+.+++++.+||||+++++++..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            4699999999999999999986432       2368999876432  234567889999999999669999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee
Q 015026          169 DNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~  234 (414)
                      .+.+++|+||+++|+|.+++....              ...++...+..++.||+.||.|||++||+||||||+|||++ 
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~-  168 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-  168 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc-
Confidence            999999999999999999986532              23477888999999999999999999999999999999998 


Q ss_pred             cCCCCCceeeccccccccCCCCcc---ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhh
Q 015026          235 AKEDSSLKATDFGLSDFIKPGKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (414)
Q Consensus       235 ~~~~~~vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~  309 (414)
                        .++.+||+|||+++........   ....++..|+|||++.+ .++.++||||||+++|+|++ |..||.+....+..
T Consensus       169 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         169 --EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             --CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence              5788999999999765432211   12334567999998755 46889999999999999998 89999887777766


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ..+.....   .......+.++.+||.+||..+|.+|||+.+++.+
T Consensus       247 ~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         247 KLLKEGHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            66654322   11223578899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.6e-41  Score=312.49  Aligned_cols=248  Identities=24%  Similarity=0.376  Sum_probs=205.8

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCC---EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      .|++.+.||+|+||.||+|.+..+++   .||||.+....  .......+..|+.+++.+. ||||+++++++.++...+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCceE
Confidence            58999999999999999999887765   59999886532  3445678999999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||+++++|.+++... .+.+++..+..++.|++.||.|||++|++|+||||+||+++   .++.+||+|||++....
T Consensus        82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~---~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          82 IITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---CCCcEEECCCccccccc
Confidence            999999999999887543 35689999999999999999999999999999999999998   57899999999987654


Q ss_pred             CCCcc---ccCC---CCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          254 PGKKF---QDIV---GSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       254 ~~~~~---~~~~---gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      .....   ....   ++..|+|||.+.+ .++.++|||||||++|||++ |..||.+....+....+....   ..+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~  234 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---RLPPPM  234 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---cCCCcc
Confidence            32211   1111   2457999998764 46889999999999999886 999998877766666664332   222234


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .++.++.+++.+||..+|.+||++.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.7e-41  Score=316.49  Aligned_cols=249  Identities=25%  Similarity=0.330  Sum_probs=202.8

Q ss_pred             ceeeceeeeecCceEEEEEEECC-----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....  .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence            37888999999999999998753     23568998876543  2334577899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 015026          172 VYIAMELCEGGELLDRILAKK----------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN  229 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N  229 (414)
                      .++|+||+.+++|.+++....                      ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            999999999999999875321                      2357889999999999999999999999999999999


Q ss_pred             EEEeecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCC
Q 015026          230 FLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKT  304 (414)
Q Consensus       230 Ill~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~  304 (414)
                      ||++   +++.+||+|||+++.......   .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+..
T Consensus       158 ill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEc---CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9998   578999999999876533221   123345778999997654 46889999999999999998 999998777


Q ss_pred             chhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       305 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..++...+....   .......++.++.+++.+||+.||++||++.++++
T Consensus       235 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGY---RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCC---CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            666555544332   11222467889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-40  Score=309.52  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=204.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||.||+|.+. .+..+|+|.+....    ...+.+.+|+.+++.+. |+||+++++.+.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeEE
Confidence            467999999999999999999864 45679999876432    24567889999999995 9999999999887 77899


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++.......+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceeeccC
Confidence            99999999999998765556788999999999999999999999999999999999998   578999999999876543


Q ss_pred             CCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...  .....++..|+|||++.+ .++.++|+|||||++|+|++ |..||.+.+.......+.....   ......++.+
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENCPEE  231 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---CCCcccCCHH
Confidence            221  122345677999998765 45889999999999999998 9999988776666655544322   2223468899


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.+++.+||..||++||++.+++.
T Consensus       232 ~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         232 LYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.5e-41  Score=315.79  Aligned_cols=250  Identities=20%  Similarity=0.277  Sum_probs=206.3

Q ss_pred             cceeeceeeeecCceEEEEEEECC-----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++.+.||+|+||.||+|.+..     ++..||+|++....  .......+.+|+.+++.+ +||||+++++++.++.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~   81 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVGK   81 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCC
Confidence            569999999999999999998743     67889999886543  234567789999999999 5999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 015026          171 YVYIAMELCEGGELLDRILAKK--------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENF  230 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI  230 (414)
                      ..++|+||+++++|.+++....                    ...+++..+..++.||+.||.|||+.|++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999986432                    12478889999999999999999999999999999999


Q ss_pred             EEeecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCc
Q 015026          231 LFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTE  305 (414)
Q Consensus       231 ll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~  305 (414)
                      +++   .++.++|+|||++........   .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+...
T Consensus       162 l~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         162 LVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             Eec---CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            998   578999999999875432221   12234567799999865 456889999999999999997 8899988777


Q ss_pred             hhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       306 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+....+......   .....++.++.+||.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            7766666544321   112357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-40  Score=309.45  Aligned_cols=241  Identities=21%  Similarity=0.294  Sum_probs=196.3

Q ss_pred             eeeecCceEEEEEEEC--CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          103 LLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++++. ||||+++++++.. ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            3899999999999765  445679999886542  2345677899999999995 9999999998864 56899999999


Q ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcc--
Q 015026          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF--  258 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~--  258 (414)
                      +++|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++   .++.+||+|||++.........  
T Consensus        78 ~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          78 GGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---CCCcEEeccCCccccccCCcccee
Confidence            99999887543 35789999999999999999999999999999999999998   5789999999998765433221  


Q ss_pred             --ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          259 --QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       259 --~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                        ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+...   ...+..++++.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l  230 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL---DCPAECPPEMYAL  230 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCHHHHHH
Confidence              11233578999998764 46889999999999999996 99999887776666655554321   1224578999999


Q ss_pred             HHHhhcCCccccCCHHHHhC
Q 015026          335 VKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~  354 (414)
                      |.+||..||++||++.++++
T Consensus       231 i~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         231 MKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=309.17  Aligned_cols=241  Identities=22%  Similarity=0.312  Sum_probs=197.9

Q ss_pred             eeeeecCceEEEEEEECCCC---CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEec
Q 015026          102 KLLGHGQFGYTYVATDKANG---DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (414)
                      +.||+|+||.||+|.+..++   ..||+|.+......  ...+.+.+|+.+++.+ +||||+++++++.. ...++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEe
Confidence            46999999999999876655   78999998765432  3556788999999999 59999999998764 468999999


Q ss_pred             cCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcc
Q 015026          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF  258 (414)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~  258 (414)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+|||++   .++.+||+|||++.........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~---~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---CCCcEEeccccccceeecCCcc
Confidence            9999999998543  3789999999999999999999999999999999999998   5789999999999766433321


Q ss_pred             c----cCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          259 Q----DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       259 ~----~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .    ...++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+......   .....++..+.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  228 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIY  228 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHH
Confidence            1    1123467999998764 46889999999999999998 99999877666665555444321   22346788999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++|.+||..||++||++.++++
T Consensus       229 ~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         229 SIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999886

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-40  Score=309.32  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=203.1

Q ss_pred             eeeeecCceEEEEEEECC-CCC--EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEec
Q 015026          102 KLLGHGQFGYTYVATDKA-NGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (414)
                      +.||+|++|.||+|.+.. .++  .||||.+......  ...+.+.+|+.+++++. ||||+++++.+.+ ...++|+||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            368999999999998865 333  6999998765432  46678999999999995 9999999999988 889999999


Q ss_pred             cCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc-
Q 015026          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-  257 (414)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~-  257 (414)
                      +++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++   .++.+||+|||++........ 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc
Confidence            9999999998665435689999999999999999999999999999999999999   468999999999987644221 


Q ss_pred             ---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          258 ---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       258 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                         .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...+..+....+........  ....+|..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence               113457789999998765 56889999999999999998 9999987777766666654322222  1235788999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +++.+||+.+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-40  Score=313.06  Aligned_cols=248  Identities=21%  Similarity=0.304  Sum_probs=199.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCE----EEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ++|++++.||+|+||+||+|.+..+|+.    |++|.+....  .......+..|+.+++.+ +||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-Cc
Confidence            4689999999999999999998877774    6777664321  123446778888899999 59999999998754 45


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++|+||+++|+|.+++... ...+++..+..++.||+.||.|||+.|++||||||+|||++   .++.+||+|||+++.
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---~~~~~kl~Dfg~~~~  158 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADL  158 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEEcCCcccee
Confidence            78899999999999988543 35689999999999999999999999999999999999998   578999999999976


Q ss_pred             cCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ......   .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+.........+..+.. ..  ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~  235 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER-LA--QPQI  235 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CC--CCCC
Confidence            533221   22345778899999875 457899999999999999998 9999987765544443433221 11  1123


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+.++.+++.+||..||.+|||+.|++.
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         236 CTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            5678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-40  Score=309.96  Aligned_cols=249  Identities=21%  Similarity=0.331  Sum_probs=205.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC---EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +.|+..+.||+|+||.||+|.+..++.   .+|+|.+....  .....+.+.+|+.+++.+. ||||+++.+++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence            358889999999999999999876665   79999886542  2334677889999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++   .++.+||+|||++...
T Consensus        82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~  157 (268)
T cd05063          82 MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCccceec
Confidence            9999999999999888543 35789999999999999999999999999999999999998   5788999999998765


Q ss_pred             CCCCcc--c--cCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKKF--Q--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~~--~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ......  .  ....+..|+|||++.+ .++.++|||||||++|+|++ |..||...+..+....+.....   .+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~  234 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR---LPAPMD  234 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC---CCCCCC
Confidence            432211  1  1223457999998764 46889999999999999997 9999988777777766654321   112235


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+.++.+++.+||..||.+||++.++++
T Consensus       235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         235 CPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            7889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-40  Score=311.23  Aligned_cols=248  Identities=23%  Similarity=0.296  Sum_probs=205.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC----EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .+|++.+.||+|+||+||+|.+..+|+    .||+|.+.....  ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-Cc
Confidence            468999999999999999999877765    589998765532  34567788999999999 49999999999887 78


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++|+||+++|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||+++.
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kL~dfg~~~~  158 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  158 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc---CCCeEEECCCccccc
Confidence            99999999999999988543 34589999999999999999999999999999999999998   577899999999987


Q ss_pred             cCCCCccc---cCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPGKKFQ---DIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ........   ...++..|+|||.+. +.++.++||||||+++||+++ |..||.+....++...+..... ++  ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~  235 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LP--QPPI  235 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CC--CCCC
Confidence            65332211   122356799999875 456889999999999999998 9999988776666666654332 11  1234


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+.++.+++.+||..||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            6788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-40  Score=307.85  Aligned_cols=242  Identities=25%  Similarity=0.400  Sum_probs=202.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|++.+.||+|+||.||++.  .+++.||+|.+....     ..+.+.+|+.+++.+. ||||+++++++.... .++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHNG-LYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCC-cEEE
Confidence            458999999999999999985  578899999886432     3467889999999995 999999999987654 7999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++   .++.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceecccc
Confidence            9999999999998665555689999999999999999999999999999999999998   5788999999998754322


Q ss_pred             CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                        ......+..|+|||.+.+ .++.++|||||||++|+|++ |+.||.+....+....+....   .......+++++.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---RMEPPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---CCCCCCcCCHHHHH
Confidence              123344678999998764 56889999999999999997 999998877666655554432   22233568899999


Q ss_pred             HHHHhhcCCccccCCHHHHhC
Q 015026          334 FVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.+||+.+|.+||++.+++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999886

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.5e-40  Score=309.43  Aligned_cols=246  Identities=19%  Similarity=0.288  Sum_probs=193.4

Q ss_pred             eeeeecCceEEEEEEEC--CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEecc
Q 015026          102 KLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (414)
                      +.||+|+||.||+|...  .++..+|+|.+.....  ......+.+|+.+++.+. ||||+++++.+.+....++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence            35899999999999754  3556799998865432  234457889999999995 999999999999999999999999


Q ss_pred             CCCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          180 EGGELLDRILAKK---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       180 ~gg~L~~~l~~~~---~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ++|+|.+++....   ....++..+..++.|++.||.|||+.|++||||||+||+++   .++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCcc
Confidence            9999999885432   22456778889999999999999999999999999999998   57889999999986543322


Q ss_pred             c---cccCCCCCccccchhcccc--------CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhc-CCCCCCCC
Q 015026          257 K---FQDIVGSAYYVAPEVLKRK--------SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRN-KPDFRRKP  323 (414)
Q Consensus       257 ~---~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~  323 (414)
                      .   .....|++.|+|||++.+.        ++.++||||||+++|+|++ |..||......+........ ...++.+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1   1234678899999987532        3678999999999999996 99999776655544333222 22222221


Q ss_pred             C-CCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          324 W-PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       324 ~-~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      . ...++.+.+++.+|+ .+|.+|||+++++.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            1 246788999999999 68999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.9e-40  Score=311.03  Aligned_cols=252  Identities=21%  Similarity=0.368  Sum_probs=207.7

Q ss_pred             cceeeceeeeecCceEEEEEEECC-----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++.+.||.|+||+||+|+.+.     +.+.||+|.+....  .....+.+.+|+.+++.+. ||||+++++++.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence            468999999999999999999754     34679999876543  1225677899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCcee
Q 015026          171 YVYIAMELCEGGELLDRILAKKD-------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (414)
                      ..++||||+++++|.+++.....       ..+++..+..++.||+.||.|||+.||+||||||+||+++   .++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEE
Confidence            99999999999999999865432       2689999999999999999999999999999999999998   5788999


Q ss_pred             eccccccccCCCC--ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCC
Q 015026          244 TDFGLSDFIKPGK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       244 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      +|||++.......  ......++..|+|||.+.+ ..+.++||||||+++|+|++ |..||.+......+..+......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999986543221  2234456788999998654 46888999999999999998 899998776666666655443332


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .  ....++..+.+++.+||+.||.+|||+.+++..
T Consensus       239 ~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 P--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             C--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            2  224678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.8e-40  Score=306.55  Aligned_cols=245  Identities=22%  Similarity=0.404  Sum_probs=203.8

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +|++.+.||.|+||.||+|.+. .+..+|+|.+.....    ....+.+|+.+++.+. ||||+++++++......++|+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEEE
Confidence            5889999999999999999875 467899998865432    3456889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      ||+++++|.+++... ...+++..+..++.|++.||.|||+.+++|+||||+||+++   .++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          79 EFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecccCc
Confidence            999999999887543 34688999999999999999999999999999999999998   57889999999987653322


Q ss_pred             c--cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          257 K--FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       257 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .  .....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+..+...+..   ...+..+.
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVY  231 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHH
Confidence            1  11234567899999876 456888999999999999998 99999877766666666544322221   23678999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +|+.+||+.+|.+|||+.++++
T Consensus       232 ~l~~~~l~~~p~~Rp~~~~~l~  253 (256)
T cd05112         232 ELMQHCWKERPEDRPSFSLLLH  253 (256)
T ss_pred             HHHHHHcccChhhCCCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.6e-40  Score=313.89  Aligned_cols=254  Identities=19%  Similarity=0.275  Sum_probs=201.2

Q ss_pred             ccceeeceeeeecCceEEEEEEECC----------------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKA----------------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN  158 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpn  158 (414)
                      .++|++.+.||+|+||+||+|.+..                ++..||+|++....  .......+.+|+.+++.+. |||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence            3579999999999999999986432                34469999886542  2345678899999999995 999


Q ss_pred             ceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 015026          159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN  229 (414)
Q Consensus       159 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N  229 (414)
                      |+++++++...+..++||||+++++|.+++.....         ..+++..+..++.||+.||.|||+.|++||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            99999999999999999999999999998855321         246788999999999999999999999999999999


Q ss_pred             EEEeecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh--CCCCCCCC
Q 015026          230 FLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC--GRRPFWDK  303 (414)
Q Consensus       230 Ill~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt--g~~Pf~~~  303 (414)
                      ||++   .++.++|+|||++........   .....+++.|+|||+.. +.++.++|||||||++|||++  |..||...
T Consensus       161 ili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9998   578999999999876533221   12234467899999754 557899999999999999998  78999776


Q ss_pred             CchhhhHHHhh---cC-CCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          304 TEDGIFKEVLR---NK-PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       304 ~~~~~~~~i~~---~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +..+.......   .. .....+..+.+++.+.+|+.+||+.||.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66554443321   10 00111112357789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.2e-42  Score=295.71  Aligned_cols=254  Identities=28%  Similarity=0.555  Sum_probs=212.2

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--CEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYV  172 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~~~  172 (414)
                      .++|++.+++|+|.+++||.|.+..+++.++||+++.      ...+.+.+|+.||+.|++||||++++++..++  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            3579999999999999999999999999999998854      46688999999999999999999999998764  568


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      .||+||+.+.+.....     ..++...++.++.+|+.||.|||+.||.|||+||.|++|+.  +...++|+|+|+|.+.
T Consensus       111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchHhhc
Confidence            8999999887655433     46888999999999999999999999999999999999996  5678999999999999


Q ss_pred             CCCCccccCCCCCccccchhcc--ccCCCCcchhHHHHHHHHHhhCCCCCCCC-CchhhhHHHhh-------------cC
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLR-------------NK  316 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~i~~-------------~~  316 (414)
                      -++..++..+.+..|..||++-  ..+...-|+|||||+|..|+..+.||... +..+.+.+|.+             -.
T Consensus       184 Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  184 HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            9998888889999999999875  35688899999999999999999998543 33222222211             00


Q ss_pred             ----C-------CCCCCCCC---------CCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          317 ----P-------DFRRKPWP---------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       317 ----~-------~~~~~~~~---------~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                          +       ......|.         -.++++.+|+.++|..|..+|+||.|++.||||...
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                0       11122221         157899999999999999999999999999999753

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-40  Score=308.96  Aligned_cols=245  Identities=20%  Similarity=0.303  Sum_probs=192.9

Q ss_pred             eeeecCceEEEEEEECC--CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          103 LLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      .||+|+||+||+|....  ....+|+|.+....  .......+.+|+.+++.+ +||||+++++.+......++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCC
Confidence            58999999999996432  34578888775432  233456788999999999 59999999999999999999999999


Q ss_pred             CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc
Q 015026          181 GGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (414)
Q Consensus       181 gg~L~~~l~~~~~---~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~  257 (414)
                      +|+|.+++.....   ...++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT---ADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec---CCCcEEEeccccccccccchh
Confidence            9999999865432   2346788899999999999999999999999999999998   578999999999865432211


Q ss_pred             ---cccCCCCCccccchhccc--------cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcC-CCCCCCC-
Q 015026          258 ---FQDIVGSAYYVAPEVLKR--------KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNK-PDFRRKP-  323 (414)
Q Consensus       258 ---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~-  323 (414)
                         .....+++.|+|||++..        ..+.++|||||||++|+|++ |..||......+.+..+.... ..++.+. 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL  235 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence               123356778999998642        34778999999999999999 888997776665555544432 2222222 


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ...+++.+.+++..|+ .||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2357888999999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.9e-40  Score=303.80  Aligned_cols=242  Identities=25%  Similarity=0.331  Sum_probs=199.0

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      ++||+|+||.||+|... ++..||+|++....  .......+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence            36899999999999864 68899999886542  233455788999999999 599999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcc--c
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF--Q  259 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~--~  259 (414)
                      ++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++   .++.+||+|||++.........  .
T Consensus        77 ~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          77 GDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceeccccccccCC
Confidence            9999987543 34688999999999999999999999999999999999998   5788999999998754332211  1


Q ss_pred             cCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHH
Q 015026          260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK  337 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  337 (414)
                      ...++..|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+....   .......++..+.+++.+
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~  229 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---RMSCPQKCPDDVYKVMQR  229 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHHHHHHHH
Confidence            2234567999998764 46889999999999999998 999998776666555554432   122234688999999999


Q ss_pred             hhcCCccccCCHHHHhC
Q 015026          338 LLVKDPRARLTAAQALS  354 (414)
Q Consensus       338 ~L~~dp~~Rps~~elL~  354 (414)
                      ||..+|++||++.++++
T Consensus       230 ~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         230 CWDYKPENRPKFSELQK  246 (250)
T ss_pred             HcccCcccCCCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-40  Score=311.72  Aligned_cols=249  Identities=27%  Similarity=0.350  Sum_probs=198.2

Q ss_pred             ceeeceeeeecCceEEEEEEE----CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--C
Q 015026           97 RYTIGKLLGHGQFGYTYVATD----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--N  170 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~  170 (414)
                      -|++++.||+|+||.||+|..    ..++..||+|.+....  .......+.+|+.+++.+. ||||+++++++.+.  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence            478999999999999999974    4578899999986443  2345678999999999995 99999999998765  6


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||++|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++   .++.++|+|||++.
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~  157 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK  157 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCcccc
Confidence            789999999999999987543 24689999999999999999999999999999999999998   57889999999998


Q ss_pred             ccCCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch--------------hhhHH
Q 015026          251 FIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED--------------GIFKE  311 (414)
Q Consensus       251 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------------~~~~~  311 (414)
                      .......    .....|+..|+|||++.+ .++.++|||||||++|+|+++..|+......              .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            6543322    124567778999998654 4688999999999999999987775332110              00111


Q ss_pred             HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ......  ..+.+..++..+.+||.+||+.||.+|||+.+++.
T Consensus       238 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         238 VLEEGK--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             HHHcCc--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            111111  11223468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=333.16  Aligned_cols=270  Identities=29%  Similarity=0.496  Sum_probs=231.2

Q ss_pred             CCcCccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEE
Q 015026           85 RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN  164 (414)
Q Consensus        85 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~  164 (414)
                      ..++....+..+.|++.+.||.|.+|.||+++++.+|+.+|+|+......    .-+.+..|.+||+.+.+|||++.+|+
T Consensus         8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg   83 (953)
T KOG0587|consen    8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYG   83 (953)
T ss_pred             ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEE
Confidence            34455556677889999999999999999999999999999998876542    34677889999999999999999999


Q ss_pred             EEE-----cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC
Q 015026          165 AFE-----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       165 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~  239 (414)
                      +|.     .++.+|||||||.||+..|++....+..+.|..+..|++.++.||.+||.+.++|||||-.|||++   +++
T Consensus        84 ~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~  160 (953)
T KOG0587|consen   84 AFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENA  160 (953)
T ss_pred             EEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccC
Confidence            884     357899999999999999999877788999999999999999999999999999999999999999   689


Q ss_pred             CceeeccccccccCCC-CccccCCCCCccccchhccc------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHH
Q 015026          240 SLKATDFGLSDFIKPG-KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV  312 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i  312 (414)
                      .|||+|||.+...... ....+.+|||.|||||++..      .++..+|+||||++..||.-|.+|+.++-....+-.|
T Consensus       161 ~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I  240 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  240 (953)
T ss_pred             cEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence            9999999998776543 34567899999999999863      2466799999999999999999999888776665555


Q ss_pred             hhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .++.+. ....+..-+.++.+||..||.+|-.+||+..++|.|||+++..
T Consensus       241 pRNPPP-kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  241 PRNPPP-KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             CCCCCc-cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            554321 2223456778999999999999999999999999999999543

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.5e-40  Score=307.79  Aligned_cols=248  Identities=24%  Similarity=0.351  Sum_probs=203.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCC---CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+|.+.+.||+|+||.||+|.+...   ...||||......  .....+.+.+|+.+++.+. ||||+++++++.+. ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~-~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITEN-PV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcCC-Cc
Confidence            4688999999999999999987544   3468999875442  2345678899999999995 99999999988764 57


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++++|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+||+++   .++.++|+|||++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~  157 (270)
T cd05056          82 WIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence            8999999999999998543 33589999999999999999999999999999999999998   5789999999998765


Q ss_pred             CCCCccc--cCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          253 KPGKKFQ--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       253 ~~~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .......  ...++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+....+......   ...+.++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  234 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence            4432221  2234567999998764 46889999999999999986 99999888776666665544322   2235688


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .++.++|.+||..+|.+|||+.+++.
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.4e-40  Score=309.56  Aligned_cols=250  Identities=20%  Similarity=0.248  Sum_probs=204.5

Q ss_pred             cceeeceeeeecCceEEEEEEECC----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-CC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-~~  170 (414)
                      ++|++.+.||+|+||.||+|.+..    ++..||+|++....  .....+.+.+|+.+++.+ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGE   82 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCC
Confidence            579999999999999999999876    35789999876432  344567789999999999 59999999998765 57


Q ss_pred             EEEEEEeccCCCChHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceee
Q 015026          171 YVYIAMELCEGGELLDRILAKKD------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (414)
                      ..++++||+++++|.+++.....      ..+++..+..++.||+.||.|||+++++||||||+||+++   .++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEEC
Confidence            78999999999999998855322      4589999999999999999999999999999999999998   57899999


Q ss_pred             ccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCC
Q 015026          245 DFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       245 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |||+++.......   .....++..|+|||++.+ .++.++||||||+++|++++ |+.||.+....++...+.... .+
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~  238 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RL  238 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CC
Confidence            9999976533221   122345678999998764 46889999999999999998 999998776655554444332 11


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                        .....+++++.+++.+||..||++|||+.+++.
T Consensus       239 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 --AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              122357889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.1e-41  Score=310.94  Aligned_cols=241  Identities=17%  Similarity=0.255  Sum_probs=191.6

Q ss_pred             eeeeecCceEEEEEEECCCCCE-------EEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026          102 KLLGHGQFGYTYVATDKANGDR-------VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~-------vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      +.||.|+||.||+|.+..++..       ||+|.+....   ....+.+..|+.+++.+. ||||+++++++..+...++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence            3689999999999988665543       8888875432   234567889999999995 9999999999999899999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC-----CCCceeeccccc
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE-----DSSLKATDFGLS  249 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~-----~~~vkl~DFG~a  249 (414)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++..+.     .+.++++|||++
T Consensus        77 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999999885433 36899999999999999999999999999999999999985321     123799999988


Q ss_pred             cccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCC-CCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          250 DFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGR-RPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ......   ....++..|+|||++.+  .++.++|||||||++|+|++|. .||........ ..+......++    ..
T Consensus       156 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~----~~  227 (258)
T cd05078         156 ITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLP----AP  227 (258)
T ss_pred             cccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCC----CC
Confidence            654332   23568899999998865  3588999999999999999985 66654443322 22333332222    24


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+.++.+||.+||+.||++|||++++++.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         228 KWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            56789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-40  Score=303.47  Aligned_cols=242  Identities=25%  Similarity=0.333  Sum_probs=199.5

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      ++||.|+||.||+|.+.. ++.||+|.+.....  ......+.+|+++++.+. ||||+++++++.+....++||||++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            369999999999999877 99999998865432  235678899999999995 99999999999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcc---
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---  258 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~---  258 (414)
                      ++|.+++... ...+++..+..++.+++.||.|||+++++||||+|+||+++   .++.++|+|||++.........   
T Consensus        77 ~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          77 GSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---CCCcEEEeeccccccccCCcceecc
Confidence            9999988543 34688999999999999999999999999999999999998   5789999999998765422111   


Q ss_pred             ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHH
Q 015026          259 QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (414)
Q Consensus       259 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (414)
                      ....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+.........+....   .......++.++.+++.
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~  229 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY---RMPAPQLCPEEIYRLML  229 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC---CCCCCccCCHHHHHHHH
Confidence            11233567999998754 56889999999999999999 899997776655555443321   11122467889999999


Q ss_pred             HhhcCCccccCCHHHHhC
Q 015026          337 KLLVKDPRARLTAAQALS  354 (414)
Q Consensus       337 ~~L~~dp~~Rps~~elL~  354 (414)
                      +||..+|.+|||+.++++
T Consensus       230 ~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         230 QCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6e-40  Score=306.66  Aligned_cols=253  Identities=28%  Similarity=0.503  Sum_probs=208.2

Q ss_pred             eeeceeeeecCceEEEEEEECC-CCCEEEEEEeeccCC-------CChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           98 YTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKM-------ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~-------~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      |++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+.+|+.++....+||||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            7889999999999999999887 678999998754321       12334566778999887644699999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          170 NYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      +..++||||++|++|.+.+..  .....+++..++.++.|++.||.|||+ .|++|+||+|+||+++   .++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCCcEEEecc
Confidence            999999999999999988743  234568999999999999999999996 7899999999999998   5789999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      |++.............|+..|+|||.+.+. .+.++||||||+++|+|++|+.||...........+......  .....
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~  236 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--PLPEG  236 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--cCCcc
Confidence            999876554444566789999999987654 688999999999999999999999776665555555443322  11123


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+++++.++|.+||..||++||++.|+..+
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            578899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-40  Score=304.43  Aligned_cols=228  Identities=22%  Similarity=0.328  Sum_probs=186.9

Q ss_pred             cCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCChHH
Q 015026          107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD  186 (414)
Q Consensus       107 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~  186 (414)
                      |.+|+||+|.+..+|+.||+|.+....        ...+|...+... .||||+++++++.+....++||||++||+|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999987643        123344455555 49999999999999999999999999999999


Q ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCc
Q 015026          187 RILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY  266 (414)
Q Consensus       187 ~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~  266 (414)
                      ++...  ..+++..+..++.||+.||.|||+.||+||||||+||+++   .++.++|+|||.+......  .....++..
T Consensus        75 ~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df~~~~~~~~~--~~~~~~~~~  147 (237)
T cd05576          75 HISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDS--CDGEAVENM  147 (237)
T ss_pred             HHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecccchhccccc--cccCCcCcc
Confidence            88543  4689999999999999999999999999999999999998   5788999999987655432  234466788


Q ss_pred             cccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccc
Q 015026          267 YVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRA  345 (414)
Q Consensus       267 y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~  345 (414)
                      |+|||.+.+ .++.++||||+|+++|+|++|+.||...... .     ......  ...+.+++.+.++|.+||+.||++
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~  219 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTL--NIPEWVSEEARSLLQQLLQFNPTE  219 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----cccccc--CCcccCCHHHHHHHHHHccCCHHH
Confidence            999998764 4688999999999999999999987543211 0     000011  111357889999999999999999


Q ss_pred             cCCH-----HHHhCCccc
Q 015026          346 RLTA-----AQALSHPWV  358 (414)
Q Consensus       346 Rps~-----~elL~hp~f  358 (414)
                      ||++     +++++||||
T Consensus       220 R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         220 RLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             hcCCCccchHHHHcCCCC
Confidence            9996     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.7e-40  Score=308.00  Aligned_cols=246  Identities=25%  Similarity=0.359  Sum_probs=198.2

Q ss_pred             eeeecCceEEEEEEECCCC------CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026          103 LLGHGQFGYTYVATDKANG------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .||+|+||.||+|.+...+      +.+|||.+....  .......+.+|+.+++.+. ||||+++++++.+....++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEEE
Confidence            5899999999999876544      689999875432  1234567889999999995 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC--CCCCceeeccccc
Q 015026          177 ELCEGGELLDRILAKK-----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLS  249 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DFG~a  249 (414)
                      ||+++++|.+++....     ...+++..+..++.||+.||.|||+.+++|+||+|+||+++...  ....++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999999986532     23478899999999999999999999999999999999998522  1237999999998


Q ss_pred             cccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          250 DFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       250 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      ........   .....++..|+|||++.+ ..+.++|||||||++|+|++ |..||......+....+.....   ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~  235 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR---LQKP  235 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc---cCCc
Confidence            76533221   123356788999998764 56889999999999999998 9999987666555555443221   1222


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+|+.+.+||.+||..+|.+||++.++++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            467899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-39  Score=307.63  Aligned_cols=249  Identities=25%  Similarity=0.395  Sum_probs=196.3

Q ss_pred             cceeeceeeeecCceEEEEEE----ECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--C
Q 015026           96 RRYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--D  169 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~  169 (414)
                      .+|++++.||+|+||.||+|.    +..++..||+|.+....   ....+.+.+|+.+++.+. ||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence            368999999999999999997    44678899999986542   345678899999999995 9999999997643  4


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      ..+++|+||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~  155 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---SENRVKIGDFGLT  155 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---CCCeEEECCCccc
Confidence            5689999999999999988543 24689999999999999999999999999999999999998   5788999999999


Q ss_pred             cccCCCCcc----ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh---------------hh
Q 015026          250 DFIKPGKKF----QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG---------------IF  309 (414)
Q Consensus       250 ~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---------------~~  309 (414)
                      .........    ....++..|+|||++.+ .++.++|||||||++|||++|..|+......-               .+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            876443221    11223456999998765 46889999999999999999887764332110               01


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+......+  .....++.++.+||.+||..+|++|||+.+++.
T Consensus       236 ~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         236 IELLKNNGRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHhcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1112221111  122467889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.4e-40  Score=305.38  Aligned_cols=241  Identities=18%  Similarity=0.197  Sum_probs=188.7

Q ss_pred             eeeeecCceEEEEEEECCC------------CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026          102 KLLGHGQFGYTYVATDKAN------------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~------------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      +.||+|+||.||+|+...+            ...||+|++....   ......+..|+.+++.+. ||||+++++++..+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            3589999999999975322            2358889876542   234557888999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC----CCCceeec
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE----DSSLKATD  245 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~----~~~vkl~D  245 (414)
                      ...++||||+++++|..++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++..+.    ...++++|
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999998777643 3456899999999999999999999999999999999999974221    12389999


Q ss_pred             cccccccCCCCccccCCCCCccccchhcc--ccCCCCcchhHHHHHHHHHh-hCCCCCCCCCchhhhHHHhhcCCCCCCC
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILL-CGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~  322 (414)
                      ||++......   ....|+..|+|||++.  ..++.++|||||||++|+|+ +|..||......+.. ........    
T Consensus       156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~----  227 (262)
T cd05077         156 PGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM----  227 (262)
T ss_pred             CCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc----
Confidence            9998654322   3456888999999875  34688999999999999998 588888765443322 22222111    


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .....++++.+||.+||+.||.+||++.+|+.+
T Consensus       228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            112346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=342.99  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=213.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC-----EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD-----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..-.++..||+|+||.||.|....-..     .||||.+.+..  +.....+|.+|..+|+.+ +|||||+++|++.+..
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCC
Confidence            456788999999999999998654332     38999887653  456788999999999999 5999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          171 YVYIAMELCEGGELLDRILAKK-----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      ..+|++|||+||+|..+|.+..     ...++..+...++.||+.|+.||+++++|||||-+.|+||+   +...|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEcc
Confidence            9999999999999999996652     34688999999999999999999999999999999999999   578999999


Q ss_pred             cccccccCCCCccc---cCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          246 FGLSDFIKPGKKFQ---DIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       246 FG~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      ||+|+.+.....+.   ...--..|||||.+. +..+.++|||||||+|||++| |..||.+.+..+++..+..+. .  
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R--  922 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R--  922 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c--
Confidence            99999654332211   112235799999876 667999999999999999999 999999999999998787776 2  


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      -.....+|+.+.++|..||+.+|++||+...|++
T Consensus       923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            2333578899999999999999999999999987

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=329.63  Aligned_cols=248  Identities=28%  Similarity=0.456  Sum_probs=198.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC------C
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD------N  170 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~------~  170 (414)
                      .+...+.||+||||.||+++++.||+.||||.+.....  ....+..-+|+++|++|. |||||+++++-+..      .
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccc
Confidence            45667889999999999999999999999999876543  345677889999999995 99999999876543      3


Q ss_pred             EEEEEEeccCCCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC-CCCCceeecccc
Q 015026          171 YVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGL  248 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DFG~  248 (414)
                      ...+|||||.||+|+..+.+.. ...|++.+...++.++..||.|||++|||||||||.||++-... ....-||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            5789999999999999885433 34699999999999999999999999999999999999998543 234569999999


Q ss_pred             ccccCCCCccccCCCCCccccchhcc--ccCCCCcchhHHHHHHHHHhhCCCCCCCCCc----hhhhHHHhhcCCCCC--
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFR--  320 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~--  320 (414)
                      |+..+++..+.+++||+.|.+||++.  +.++..+|.|||||++|+++||..||-....    .++...++..++...  
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            99999999999999999999999987  4567889999999999999999999954322    233333333222110  


Q ss_pred             ---------------CCCCCCCCHH----HHHHHHHhhcCCccccC
Q 015026          321 ---------------RKPWPSISNS----AKDFVKKLLVKDPRARL  347 (414)
Q Consensus       321 ---------------~~~~~~~s~~----~~~li~~~L~~dp~~Rp  347 (414)
                                     .+....+++.    +-..+..+|..+|++|-
T Consensus       251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                           0001123332    34678889999999998

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-39  Score=302.82  Aligned_cols=243  Identities=23%  Similarity=0.293  Sum_probs=192.4

Q ss_pred             eeeeecCceEEEEEEECC---CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE-cCCEEEEEEe
Q 015026          102 KLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-DDNYVYIAME  177 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~-~~~~~~lv~e  177 (414)
                      +.||+|+||.||+|.+..   .+..||||.+....  .....+.+.+|+.+++.+ +||||+++++++. .++..++|+|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence            368999999999998654   33579999875432  234567888999999999 5999999999765 4667899999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-  256 (414)
                      |+.+++|.+++... ...+++..+..++.||+.||.|||+.+++||||||+|||++   .++.+||+|||+++...... 
T Consensus        78 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          78 YMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCccccccccCCcc
Confidence            99999999988543 34467888899999999999999999999999999999998   57889999999987543221 


Q ss_pred             ----ccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          257 ----KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       257 ----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                          ......++..|+|||.+. ..++.++|||||||++|||++ |.+||......+....+.......   ....+++.
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL---QPEYCPDP  230 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCHH
Confidence                112335677899999875 456889999999999999999 567777666555555554432211   11346889


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.+++.+||..+|++||++.+++.
T Consensus       231 ~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         231 LYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.2e-40  Score=340.68  Aligned_cols=256  Identities=30%  Similarity=0.472  Sum_probs=198.0

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc------
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------  168 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~------  168 (414)
                      -.+|+.++.||+||||.||+|+++-+|+.||||+|....  .......+.+|+.+|.+| +|||||++|..|.+      
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccc
Confidence            346788999999999999999999999999999997664  344667889999999999 59999998754200      


Q ss_pred             ------------------------------------------------------------------------C-------
Q 015026          169 ------------------------------------------------------------------------D-------  169 (414)
Q Consensus       169 ------------------------------------------------------------------------~-------  169 (414)
                                                                                              +       
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                    0       


Q ss_pred             ----------------------------------CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q 015026          170 ----------------------------------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC  215 (414)
Q Consensus       170 ----------------------------------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~L  215 (414)
                                                        ..+||=||||+...+.+++.++... -.....++++++|++||.|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence                                              1367889999876665555333221 14678999999999999999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-------------------CCCccccCCCCCccccchhccc-
Q 015026          216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-------------------PGKKFQDIVGSAYYVAPEVLKR-  275 (414)
Q Consensus       216 H~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-  275 (414)
                      |+.|||||||||.||+++   .+..|||+|||+|+...                   +....++.+||..|+|||++.+ 
T Consensus       714 H~~giIHRDLKP~NIFLd---~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFLD---SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCceeeccCCcceeEEc---CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999999999999999999   68899999999997621                   0113456799999999999864 


Q ss_pred             ---cCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHH
Q 015026          276 ---KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ  351 (414)
Q Consensus       276 ---~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~e  351 (414)
                         .++.++|||||||||+||+.   ||....+. .++..+.++..+.+...+..--+.-..+|+.||+.||.+||||.|
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence               46889999999999999994   57544332 344444443333331112222244578999999999999999999


Q ss_pred             HhCCccccc
Q 015026          352 ALSHPWVRE  360 (414)
Q Consensus       352 lL~hp~f~~  360 (414)
                      +|++.||..
T Consensus       868 LL~s~llpp  876 (1351)
T KOG1035|consen  868 LLNSELLPP  876 (1351)
T ss_pred             HhhccCCCc
Confidence            999999974

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-39  Score=302.77  Aligned_cols=238  Identities=17%  Similarity=0.193  Sum_probs=189.7

Q ss_pred             eeeeecCceEEEEEEECCCC----------CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026          102 KLLGHGQFGYTYVATDKANG----------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~----------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      +.||+|+||.||+|.+..++          ..|++|.+.....    ....+.+|+.+++.+. ||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence            36899999999999998777          3578887654321    2577889999999995 9999999999887 77


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC----CCCCceeeccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK----EDSSLKATDFG  247 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~----~~~~vkl~DFG  247 (414)
                      .++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++...    ....+||+|||
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            899999999999999885543 2689999999999999999999999999999999999998422    11269999999


Q ss_pred             cccccCCCCccccCCCCCccccchhcccc---CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCC
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  323 (414)
                      ++.....   .....++..|+|||++.+.   ++.++||||||+++|+|++ |..||......+....... ....+.  
T Consensus       154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~--  227 (259)
T cd05037         154 IPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPM--  227 (259)
T ss_pred             ccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCC--
Confidence            9876543   2234677889999998654   6889999999999999999 6888876654333322221 111111  


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                        .....+.++|.+||..+|.+|||+.++++
T Consensus       228 --~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 --PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             --CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence              12378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-39  Score=306.06  Aligned_cols=240  Identities=17%  Similarity=0.191  Sum_probs=189.8

Q ss_pred             eeeecCceEEEEEEECCC------------------------CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCC
Q 015026          103 LLGHGQFGYTYVATDKAN------------------------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN  158 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~------------------------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpn  158 (414)
                      .||+|+||.||+|....+                        ...||+|++....   ......+.+|+.+++.+. |||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence            599999999999975322                        2358899886432   224456788999999995 999


Q ss_pred             ceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC--
Q 015026          159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--  236 (414)
Q Consensus       159 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~--  236 (414)
                      |+++++++.+....++||||+++|+|..++.. ..+.+++..+..++.||+.||.|||+.||+||||||+|||++..+  
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999999877743 345789999999999999999999999999999999999997421  


Q ss_pred             --CCCCceeeccccccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHh-hCCCCCCCCCchhhhHH
Q 015026          237 --EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILL-CGRRPFWDKTEDGIFKE  311 (414)
Q Consensus       237 --~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~ell-tg~~Pf~~~~~~~~~~~  311 (414)
                        ....+||+|||++......   ....++..|+|||.+.+  .++.++|||||||++|||+ +|..||.+....+... 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-  232 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-  232 (274)
T ss_pred             cCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-
Confidence              2235899999987543221   23467888999998754  3688999999999999985 6999998765544332 


Q ss_pred             HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +.......+    ...++++.++|.+||+.+|.+|||+.++|++
T Consensus       233 ~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         233 FYEKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            222222222    2345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.9e-39  Score=302.31  Aligned_cols=245  Identities=18%  Similarity=0.282  Sum_probs=192.9

Q ss_pred             eeeecCceEEEEEEECCC--CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          103 LLGHGQFGYTYVATDKAN--GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      .||+|+||+||+|.....  ...+++|.+....  .....+.+.+|+.+++.+ +||||+++++.+.+....++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCC
Confidence            599999999999975433  2356677665432  223567889999999999 59999999999999999999999999


Q ss_pred             CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC--
Q 015026          181 GGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--  256 (414)
Q Consensus       181 gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~--  256 (414)
                      +|+|.+++....  ....++..+..++.||+.||.|||+.+++||||||+|||++   .++.++|+|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc---CCccEEecccccccccCcchhh
Confidence            999999886532  23467778889999999999999999999999999999998   57889999999986432211  


Q ss_pred             -ccccCCCCCccccchhccc--------cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCC-CCCC-CCC
Q 015026          257 -KFQDIVGSAYYVAPEVLKR--------KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP-DFRR-KPW  324 (414)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~-~~~~-~~~  324 (414)
                       .....+|+..|+|||++..        ..+.++|||||||++|||++ |..||......+.+..+..... .... ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence             1234578899999998742        23678999999999999997 6788877776666666554432 2222 222


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+++.+.+++..|| .+|++||++.++++
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            357888999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.9e-39  Score=303.89  Aligned_cols=249  Identities=20%  Similarity=0.333  Sum_probs=200.3

Q ss_pred             eeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC----
Q 015026           98 YTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN----  170 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~----  170 (414)
                      |.+.+.||+|+||.||+|.+.   .+++.||||++.... ......+.+.+|+.+++.+. ||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            677889999999999999864   357899999986543 23345677899999999995 999999999886432    


Q ss_pred             --EEEEEEeccCCCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceee
Q 015026          171 --YVYIAMELCEGGELLDRILAKK----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (414)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (414)
                        ..++++||+.+|+|.+++....    ...+++..+..++.||+.||+|||+.||+||||||+||+++   .++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCCCEEEC
Confidence              3478999999999988774322    23578999999999999999999999999999999999998   57889999


Q ss_pred             ccccccccCCCCc---cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCC
Q 015026          245 DFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       245 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |||+++.......   .....+++.|++||.+.+. .+.++|||||||++|+|++ |.+||.+....+....+...... 
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-  234 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL-  234 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence            9999876543221   1233456789999987654 5788999999999999999 89999877666666655544321 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                        ...+..++.+.+++.+||+.+|++|||+.+++.
T Consensus       235 --~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         235 --KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              112457789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2e-39  Score=308.96  Aligned_cols=249  Identities=22%  Similarity=0.285  Sum_probs=200.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC----EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      +.|++.+.||+|+||.||+|.+..+|.    .||+|.+....  .......+.+|+.+++.+ +||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-C
Confidence            458899999999999999999887776    46888775432  233445688999999999 599999999988754 4


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++|+||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||+++.
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~~~  158 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLARL  158 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEcccccccc
Confidence            67999999999999988543 34688999999999999999999999999999999999998   577899999999986


Q ss_pred             cCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ......   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+ .....++  ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~--~~~~  235 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLP--QPPI  235 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCC--CCCC
Confidence            543222   123445778999998764 46889999999999999997 99999776554443333 3222222  2245


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+..+.+++.+||..||++||++.+++..
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-39  Score=304.40  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=200.2

Q ss_pred             cceeeceeeeecCceEEEEEEEC----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--C
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--D  169 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~  169 (414)
                      +.|++.+.||+|+||.||+|...    .+++.||+|++......  ...+.+.+|+.+++.+. ||||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence            35788899999999999999864    34789999998765432  35678999999999995 9999999999877  6


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      ...++||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~  156 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISDFGLA  156 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccccc
Confidence            68999999999999999885433 3589999999999999999999999999999999999998   5789999999999


Q ss_pred             cccCCCCcc----ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh--------------hhH
Q 015026          250 DFIKPGKKF----QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG--------------IFK  310 (414)
Q Consensus       250 ~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--------------~~~  310 (414)
                      .........    ....++..|+|||.+.+ .++.++||||||+++|+|++|..||.......              ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            876532221    12345567999998754 46889999999999999999999986543221              111


Q ss_pred             HHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+......+  ....++.++.+|+.+||..+|.+|||+.++++
T Consensus       237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         237 ELLKEGERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHcCCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2222222221  22356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=307.47  Aligned_cols=146  Identities=27%  Similarity=0.400  Sum_probs=130.2

Q ss_pred             CCCCCcCccccccc-cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC----
Q 015026           82 CGKRTDFGYDKDFD-RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH----  156 (414)
Q Consensus        82 ~~~~~~~~~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h----  156 (414)
                      .+........+.|. .+|.+.++||.|.|++||+|.|..+.+.||+|+++...    ...+....||++|++++.+    
T Consensus        63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~  138 (590)
T KOG1290|consen   63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPND  138 (590)
T ss_pred             cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCC
Confidence            45556666778888 89999999999999999999999999999999997654    3567778999999998743    


Q ss_pred             ---CCceEEEEEEE----cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCC
Q 015026          157 ---ENVVKFYNAFE----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPE  228 (414)
Q Consensus       157 ---pnIv~~~~~~~----~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~  228 (414)
                         ..||+|++.|.    .+.+++||+|++ |.+|+.+|.....+.++...++.|++|||.||.|||+ .||||.||||+
T Consensus       139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPE  217 (590)
T KOG1290|consen  139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPE  217 (590)
T ss_pred             CCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcc
Confidence               47999999996    457899999999 8899999999999999999999999999999999996 69999999999


Q ss_pred             cEEE
Q 015026          229 NFLF  232 (414)
Q Consensus       229 NIll  232 (414)
                      |||+
T Consensus       218 NvLl  221 (590)
T KOG1290|consen  218 NVLL  221 (590)
T ss_pred             eeee
Confidence            9999

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.4e-39  Score=305.28  Aligned_cols=250  Identities=17%  Similarity=0.224  Sum_probs=184.9

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCC---CCEEEEEEeeccCCCChHhH--------HHHHHHHHHHHHccCCCCceE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAV--------EDVKREVKILQALAGHENVVK  161 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~--------~~~~~E~~il~~l~~hpnIv~  161 (414)
                      ....+|++.+.||+|+||+||+|.+..+   +..+|+|+............        .....+...+..+ +|++|+.
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCc
Confidence            3456899999999999999999998877   66788886433221100000        0112233344455 5999999


Q ss_pred             EEEEEEcCC----EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC
Q 015026          162 FYNAFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (414)
Q Consensus       162 ~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~  237 (414)
                      +++.+....    ..++++|++. .++.+.+..  ....++..++.++.||+.||.|||+.+|+||||||+|||++   .
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~  161 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---G  161 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---C
Confidence            998765433    4578888874 466655532  23467888999999999999999999999999999999998   5


Q ss_pred             CCCceeeccccccccCCCC--------ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchh-
Q 015026          238 DSSLKATDFGLSDFIKPGK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDG-  307 (414)
Q Consensus       238 ~~~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~-  307 (414)
                      ++.++|+|||+|+......        ......||+.|+|||++.+. ++.++|||||||++|||++|..||.+..... 
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            7789999999997653211        11234799999999987654 6889999999999999999999998764322 


Q ss_pred             hh--------HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          308 IF--------KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       308 ~~--------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..        ..+....     ...+..++++.+++..|+..+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhHHHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            21        2222211     123456889999999999999999999999875

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=321.41  Aligned_cols=319  Identities=22%  Similarity=0.311  Sum_probs=247.1

Q ss_pred             CCCCccccccchHHHHhhhcccCCCCCCCcchhhHHHHHHHHHHHHHhhhhhcccccccCcccCCCCCcCccccccccce
Q 015026           19 NNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRY   98 (414)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y   98 (414)
                      ...+-|++.+....++.+-....++.+.....|+|..-+..+-........+.....--++.|.-  ..|...   ..+.
T Consensus       195 eGRVyHYRINt~~dgK~yvt~EsrF~TLaELVHHHStvADGLittLhYPApK~nKptvygvSPn~--DkWEme---RtdI  269 (1157)
T KOG4278|consen  195 EGRVYHYRINTDNDGKMYVTQESRFRTLAELVHHHSTVADGLITTLHYPAPKKNKPTVYGVSPNA--DKWEME---RTDI  269 (1157)
T ss_pred             cceEEEEEeeccCCccEEEeehhhhhHHHHHHhhccccccceeEeeeccCccCCCCceeeecCCc--chhhcc---chhe
Confidence            55666777777777777766666777766666666554443333222222222221111111111  111111   1234


Q ss_pred             eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEec
Q 015026           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (414)
                      ..-.+||.|.||.||.|.++.-.-.||||.++.+.+    ..+.|..|+.+|+.+. |||+|+++++|..+..+|||+||
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEEEec
Confidence            566799999999999999999888999999976654    6789999999999995 99999999999999999999999


Q ss_pred             cCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcc
Q 015026          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF  258 (414)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~  258 (414)
                      |..|+|++++.+-....++.-....++.||..|++||..+++|||||-..|+|+.   ++..||++|||+++++..+.. 
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTY-  420 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTY-  420 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCce-
Confidence            9999999999877767778888889999999999999999999999999999998   789999999999998865433 


Q ss_pred             ccCCC---CCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          259 QDIVG---SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       259 ~~~~g---t~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      ..-.|   ..-|.|||-+. ...+.++|||+|||+|||+.| |-.||.+-+-..++..+.++   ++......+++.+.+
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg---yRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG---YRMDGPEGCPPKVYE  497 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc---ccccCCCCCCHHHHH
Confidence            22233   45699999664 567999999999999999998 99999888777777666554   344444689999999


Q ss_pred             HHHHhhcCCccccCCHHHHhC
Q 015026          334 FVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~  354 (414)
                      |+..||+++|.+||+..|+-+
T Consensus       498 LMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHHH
Confidence            999999999999999998754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.6e-39  Score=326.19  Aligned_cols=257  Identities=22%  Similarity=0.299  Sum_probs=177.6

Q ss_pred             ccceeeceeeeecCceEEEEEEECCC----CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEE-----
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKAN----GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNA-----  165 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~-----  165 (414)
                      .++|.+.+.||+|+||.||+|.+..+    +..||+|++.....     .+....| . ++... +.+++.+...     
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e-~-l~~~~-~~~~~~~~~~~~~~~  202 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE-R-VRRAC-PNSCADFVYGFLEPV  202 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH-H-HHhhc-hhhHHHHHHhhhccc
Confidence            45799999999999999999999988    99999998754321     1111111 1 11221 2233222211     


Q ss_pred             -EEcCCEEEEEEeccCCCChHHHHHhccCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 015026          166 -FEDDNYVYIAMELCEGGELLDRILAKKDS------------------RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK  226 (414)
Q Consensus       166 -~~~~~~~~lv~e~~~gg~L~~~l~~~~~~------------------~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlk  226 (414)
                       ...+...++|+||+.+++|.+++......                  ...+..+..++.||+.||.|||+.||+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             24567899999999999999988543211                  11234567899999999999999999999999


Q ss_pred             CCcEEEeecCCCCCceeeccccccccCCCC--ccccCCCCCccccchhcccc-----------------------CCCCc
Q 015026          227 PENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSAYYVAPEVLKRK-----------------------SGPES  281 (414)
Q Consensus       227 p~NIll~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----------------------~~~~~  281 (414)
                      |+|||++.  .++.+||+|||+|+......  .....+||+.|+|||.+...                       +..++
T Consensus       283 P~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            99999983  35789999999997654322  23457899999999965321                       23356


Q ss_pred             chhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhc-CC-----------CCCC------CCCCCCCHHHHHHHHHhhcCCc
Q 015026          282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-KP-----------DFRR------KPWPSISNSAKDFVKKLLVKDP  343 (414)
Q Consensus       282 DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~-~~-----------~~~~------~~~~~~s~~~~~li~~~L~~dp  343 (414)
                      |||||||+||||+++..|+...  ...+...+.. ..           ....      ......+...++||.+||+.||
T Consensus       361 DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            9999999999999977665322  1111111110 00           0000      0011123456799999999999


Q ss_pred             cccCCHHHHhCCcccccccC
Q 015026          344 RARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       344 ~~Rps~~elL~hp~f~~~~~  363 (414)
                      ++|||+.++|+||||.....
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999987544

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=295.23  Aligned_cols=262  Identities=24%  Similarity=0.311  Sum_probs=214.3

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      .+-+..||.|+||+|++..++.+|+..|||.|+....  .....++..|.+...+-.+.||||++||..-.++..||.||
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            3446789999999999999999999999999987653  45678899999988888889999999999888888999999


Q ss_pred             ccCCCChHH---HHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          178 LCEGGELLD---RILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       178 ~~~gg~L~~---~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +|+ .+|..   ++.......++|..+..|....+.||.||-+ ..|||||+||+|||++   ..|.|||||||.+....
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld---r~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD---RHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe---cCCCEeeecccchHhHH
Confidence            995 34432   2233445679999999999999999999975 6899999999999999   68999999999987765


Q ss_pred             CCCccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCC-chhhhHHHhhcCCCCCCCC--CCCC
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPDFRRKP--WPSI  327 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~--~~~~  327 (414)
                      ++-....-.|-..|||||-+..   .+..++||||||++|||+.||..|+.+-+ ..+.+..+..+.+......  .-.+
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~  299 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY  299 (361)
T ss_pred             HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence            5444444578899999998753   36889999999999999999999997653 3445555555554332222  1247


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      +..+..+|..||.+|-+.||...+++.+||++......
T Consensus       300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~  337 (361)
T KOG1006|consen  300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG  337 (361)
T ss_pred             CHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence            88999999999999999999999999999999765544

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=311.25  Aligned_cols=245  Identities=25%  Similarity=0.419  Sum_probs=208.5

Q ss_pred             eeceeeeecCceEEEEEEECC--CCC--EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           99 TIGKLLGHGQFGYTYVATDKA--NGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~--~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .+.+.||.|.||.||+|....  .|+  .||||+.+.+..  +...+.|..|..+++.+ +|||||+++|+|.+. ..+|
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-ceeE
Confidence            446789999999999997643  233  589998876653  45689999999999999 599999999999865 4899


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |||+++-|.|..++..++ ..++......++.||+.||.|||+..+|||||-..|||+.+   ...|||+|||+++.+.+
T Consensus       468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS---p~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS---PQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC---cceeeecccchhhhccc
Confidence            999999999999997655 46899999999999999999999999999999999999984   67899999999999887


Q ss_pred             CCccccCCC--CCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GKKFQDIVG--SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...+....|  ..-|||||.++ ...+.++|||-|||.+||++. |..||.+-...+++-.+.++..   .+..+.+|+.
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR---lP~P~nCPp~  620 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER---LPCPPNCPPA  620 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC---CCCCCCCChH
Confidence            766655455  34699999876 557999999999999999987 9999999888888777766653   2233578999


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +..|+.+||.+||.+||...++..
T Consensus       621 LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  621 LYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHHHhccCcccCCcHHHHHH
Confidence            999999999999999999887654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.2e-40  Score=312.75  Aligned_cols=263  Identities=26%  Similarity=0.433  Sum_probs=219.4

Q ss_pred             cccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc-----CCCCceEEEE
Q 015026           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-----GHENVVKFYN  164 (414)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----~hpnIv~~~~  164 (414)
                      +.+.+..+|.+....|+|-||+|..|.+...|..||||+|..+..    -.+.-+.|++||++|.     +--|+++++.
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            345677899999999999999999999999999999999987643    3455578999999996     2468999999


Q ss_pred             EEEcCCEEEEEEeccCCCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCcee
Q 015026          165 AFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (414)
Q Consensus       165 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (414)
                      .|...+++|||+|.+ ..+|.+.+.... .-.|....++.|+.||+.||..|-..||+|.||||+|||++.  ....+||
T Consensus       502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--~k~iLKL  578 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--SKNILKL  578 (752)
T ss_pred             HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc--Ccceeee
Confidence            999999999999998 468999885432 235888999999999999999999999999999999999984  4678999


Q ss_pred             eccccccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC
Q 015026          244 TDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (414)
Q Consensus       244 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~  322 (414)
                      ||||.|..+..+. ...+..+..|+|||++.|. |+...|+||.||.||||.||+..|.+.+...++.....-+..|+..
T Consensus       579 CDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K  657 (752)
T KOG0670|consen  579 CDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK  657 (752)
T ss_pred             ccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence            9999998876544 3556677889999987765 6899999999999999999999999998888777665544444421


Q ss_pred             C-------------------------------------------------CCCCC-------HHHHHHHHHhhcCCcccc
Q 015026          323 P-------------------------------------------------WPSIS-------NSAKDFVKKLLVKDPRAR  346 (414)
Q Consensus       323 ~-------------------------------------------------~~~~s-------~~~~~li~~~L~~dp~~R  346 (414)
                      .                                                 .+.++       ..+.+||.+||..||++|
T Consensus       658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence            1                                                 01122       247899999999999999


Q ss_pred             CCHHHHhCCccccc
Q 015026          347 LTAAQALSHPWVRE  360 (414)
Q Consensus       347 ps~~elL~hp~f~~  360 (414)
                      .|+.++|.||||++
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999975

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=321.88  Aligned_cols=247  Identities=25%  Similarity=0.404  Sum_probs=216.4

Q ss_pred             eeeceeeeecCceEEEEEEECCCCC---EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      ..|.++||.|.||+|+.|+.+..|+   .||||.++...  .+..+.+|..|+.||-++ +||||++|.|+......+.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEE
Confidence            5788999999999999999887774   69999997654  356788999999999999 59999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |+|||++|+|..+|..+. +.++..+..-+++.|+.|+.||-+.|+|||||-+.|||++   .+..+|++|||+++...+
T Consensus       708 iTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN---snLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec---cceEEEeccccceeeccc
Confidence            999999999999886655 6699999999999999999999999999999999999999   488999999999998865


Q ss_pred             CCc--cccCCC--CCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          255 GKK--FQDIVG--SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       255 ~~~--~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      +..  +.+.-|  ..+|.|||.+. ++.+.++||||+||++||.++ |..|||+.++.++++.|..+.   +-++..++|
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy---RLPpPmDCP  860 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY---RLPPPMDCP  860 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc---CCCCCCCCc
Confidence            442  222323  36899999875 667999999999999999776 999999999999999998874   333445789


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+.+|+.-||++|-.+||...+|+.
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            99999999999999999999999876

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.6e-38  Score=311.76  Aligned_cols=260  Identities=22%  Similarity=0.286  Sum_probs=188.3

Q ss_pred             ccceeeceeeeecCceEEEEEEEC----------------CCCCEEEEEEeeccCCCCh-----------HhHHHHHHHH
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDK----------------ANGDRVAVKKIEKNKMILP-----------IAVEDVKREV  147 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vaiK~i~~~~~~~~-----------~~~~~~~~E~  147 (414)
                      .++|++.++||+|+||+||+|.+.                ..++.||||.+........           ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            457999999999999999999752                3456799999864321100           0112233577


Q ss_pred             HHHHHccCCCC-----ceEEEEEEEc--------CCEEEEEEeccCCCChHHHHHhccC---------------------
Q 015026          148 KILQALAGHEN-----VVKFYNAFED--------DNYVYIAMELCEGGELLDRILAKKD---------------------  193 (414)
Q Consensus       148 ~il~~l~~hpn-----Iv~~~~~~~~--------~~~~~lv~e~~~gg~L~~~l~~~~~---------------------  193 (414)
                      .++.++. |.+     +++++++|..        .+..+||+||+++++|.+++.....                     
T Consensus       224 ~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        224 YMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            7777775 444     3666776642        3568999999999999998753211                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCcccc--CCCCCccccc
Q 015026          194 -SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAP  270 (414)
Q Consensus       194 -~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~--~~gt~~y~aP  270 (414)
                       ..+++..++.++.||+.||.|||+.+|+||||||+|||++   .++.+||+|||++...........  ..+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             1245677889999999999999999999999999999998   567899999999976544333332  2348999999


Q ss_pred             hhcccc---------------------C--CCCcchhHHHHHHHHHhhCCC-CCCCCCch-----------hhhHHHhhc
Q 015026          271 EVLKRK---------------------S--GPESDVWSIGVITYILLCGRR-PFWDKTED-----------GIFKEVLRN  315 (414)
Q Consensus       271 E~~~~~---------------------~--~~~~DiwslG~il~elltg~~-Pf~~~~~~-----------~~~~~i~~~  315 (414)
                      |++...                     +  ....||||+|||+|+|++|.. ||.+....           ..++.+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            986421                     1  124799999999999999876 77532111           111122222


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhcCCc---cccCCHHHHhCCccccc
Q 015026          316 KPDFRRKPWPSISNSAKDFVKKLLVKDP---RARLTAAQALSHPWVRE  360 (414)
Q Consensus       316 ~~~~~~~~~~~~s~~~~~li~~~L~~dp---~~Rps~~elL~hp~f~~  360 (414)
                      .  +....++.+++.+++|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       460 ~--~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 K--YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             C--CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            2  2333567789999999999999866   68999999999999964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-37  Score=284.39  Aligned_cols=242  Identities=44%  Similarity=0.764  Sum_probs=203.7

Q ss_pred             CceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCChHHH
Q 015026          108 QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDR  187 (414)
Q Consensus       108 ~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~  187 (414)
                      +||.||+|.+..+|+.+|+|++.......  ..+.+.+|+..++.+ +|+||+++++.+......++++|++++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            58999999999899999999987654322  167899999999999 599999999999999999999999999999998


Q ss_pred             HHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCcc
Q 015026          188 ILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY  267 (414)
Q Consensus       188 l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y  267 (414)
                      +....  .+++..+..++.+++.+|.+||+.+++|+||+|.||+++   .++.++|+|||.+.............++..|
T Consensus        78 ~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T smart00220       78 LKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVGTPEY  152 (244)
T ss_pred             HHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccccccccCCcCC
Confidence            85432  389999999999999999999999999999999999998   4689999999999877655455667889999


Q ss_pred             ccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCC-CCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccc
Q 015026          268 VAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRA  345 (414)
Q Consensus       268 ~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~  345 (414)
                      +|||.+. ...+.++||||||+++++|++|..||.. .........+....... ......++.++.+++.+||..+|++
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~  231 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-PPPEWKISPEAKDLIRKLLVKDPEK  231 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-ccccccCCHHHHHHHHHHccCCchh
Confidence            9999876 4568899999999999999999999977 34444444443333222 1122227889999999999999999


Q ss_pred             cCCHHHHhCCccc
Q 015026          346 RLTAAQALSHPWV  358 (414)
Q Consensus       346 Rps~~elL~hp~f  358 (414)
                      ||++.++++||||
T Consensus       232 Rp~~~~~~~~~~~  244 (244)
T smart00220      232 RLTAEEALQHPFF  244 (244)
T ss_pred             ccCHHHHhhCCCC
Confidence            9999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=303.75  Aligned_cols=254  Identities=23%  Similarity=0.304  Sum_probs=210.0

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ......+.++||+|-||.|-+|.- ..+..||+|+++....  .....+|.+||++|.+|+ |||||+++++|..++.++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchH
Confidence            345678899999999999999974 3468999999976643  346789999999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +|+||++.|+|.+++.+..-.........+|+.||+.|++||.+.++|||||.+.|+|++   .+.++||+|||+++..-
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~---~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD---GEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec---CcccEEecCcccccccc
Confidence            999999999999999766433345566778999999999999999999999999999999   78999999999999765


Q ss_pred             CCCccc---cCCCCCccccchh-ccccCCCCcchhHHHHHHHHHhh--CCCCCCCCCchhhhHHHhhcCCCCCC----CC
Q 015026          254 PGKKFQ---DIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLC--GRRPFWDKTEDGIFKEVLRNKPDFRR----KP  323 (414)
Q Consensus       254 ~~~~~~---~~~gt~~y~aPE~-~~~~~~~~~DiwslG~il~ellt--g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~  323 (414)
                      ++..+.   ..+-..+|||||. +.++.+.++|+|+||+++||+++  ...||...+.+.+.++.-.-......    ..
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence            544332   2345678999995 67889999999999999999764  88999888887776654332211111    12


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+-++..+.++|.+||..|..+|||.+++..
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            2357889999999999999999999999865

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=311.78  Aligned_cols=255  Identities=25%  Similarity=0.346  Sum_probs=217.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC-C--EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG-D--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +..++.++||+|+||.|++|.+...+ +  .||||.+......  ....+|.+|+.+|.+|. |||+|++||+..+ ..+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence            45678889999999999999886533 3  5899999766543  37889999999999995 9999999999988 668


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      .||+|++++|+|++.+.......|.......++.||+.|+.||.++++|||||-..|+|+.+   ...|||+||||.+-.
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceecc
Confidence            89999999999999998766778889999999999999999999999999999999999984   678999999999988


Q ss_pred             CCCCccccCCC----CCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKKFQDIVG----SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~~~~~~g----t~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ..++.+..+.+    -..|+|||.++ +..+.++|||++||++|||++ |..||.+..-..+++.|-.+.. ++.  .+.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-LpR--Pk~  339 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-LPR--PKY  339 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-CCC--CCC
Confidence            76665543332    34699999987 457999999999999999999 9999999998888888874432 222  246


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +|+++.+++..||..+|.+|||+..|.+.-++.+
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            8899999999999999999999999987666654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-39  Score=318.48  Aligned_cols=252  Identities=30%  Similarity=0.508  Sum_probs=200.5

Q ss_pred             eeeceeeeecCceE-EEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           98 YTIGKLLGHGQFGY-TYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        98 y~~~~~lG~G~~g~-V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      |.-.+.+|.|+-|+ ||+|.  ..|+.||||.+-.+      ......+|+..|+...+|||||++|+.-.+....||..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            44467899999985 89996  56889999987543      34567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC--CCCCceeecccccccc
Q 015026          177 ELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLSDFI  252 (414)
Q Consensus       177 e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DFG~a~~~  252 (414)
                      |.|. .+|.+++...  ..........+.++.|++.||++||+.+||||||||.||||+..+  ....++|+|||+++..
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9995 5999988542  111122245688999999999999999999999999999998532  3357899999999887


Q ss_pred             CCCC----ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGK----KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ..+.    ...+..||-+|+|||++... ...++||+|+|||+|+.++ |..||.+..+.  -.+|+.+........ +.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~-~~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE-PL  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec-cC
Confidence            6543    24567899999999998765 4678999999999999998 59999766443  234555554433221 11


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ...++.+||.+||.+||..||+|.++|.||+|+..
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            12289999999999999999999999999999963

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=284.95  Aligned_cols=254  Identities=30%  Similarity=0.504  Sum_probs=205.6

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC-----
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~-----  169 (414)
                      ..+|.-+..+|.|+- .|..+.|.-++++||+|++...... ....++..+|..++..+. |+||++++.+|...     
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-Cccchhhhhhhhhhhhhc-ccceeeeeeccCccccHHH
Confidence            357888999999998 7888999999999999988655332 234566789999999995 99999999999643     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                       ...|+|||+|. .+|...+.    -.+.-..+..++.|++.|+.|||+.||+||||||+||++.   .+..+||.|||+
T Consensus        93 ~~e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~dfg~  164 (369)
T KOG0665|consen   93 FQEVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILDFGL  164 (369)
T ss_pred             HHhHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeeccchh
Confidence             46899999995 58888775    2366788999999999999999999999999999999998   588999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh-------------
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------------  314 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~-------------  314 (414)
                      |+.....-..+.++.|..|+|||++-+ .+.+.+||||+||++.||++|...|.+.+.-+.+.++..             
T Consensus       165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            987666556778999999999998654 467889999999999999999999987664433333222             


Q ss_pred             ---------cCC---------CCCCCCCC-------CCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          315 ---------NKP---------DFRRKPWP-------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       315 ---------~~~---------~~~~~~~~-------~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                               +.+         .++...|+       .-+..+++|+.+||..||++|.|++++|+|||++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                     111         11111121       1234689999999999999999999999999997

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=285.37  Aligned_cols=254  Identities=29%  Similarity=0.433  Sum_probs=203.3

Q ss_pred             eceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-----EEEE
Q 015026          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----YVYI  174 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-----~~~l  174 (414)
                      -.+.||.|+||.||.+.|..+|+.||+|++..-. ..-...+.+.+|+.+|..++ |.|++..+++.....     .+|+
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHHH
Confidence            3467999999999999999999999999885432 22345678899999999996 999999998876543     4678


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |+|+|.. +|...+  -..+.++...++-+++||+.||.|||+.+|.||||||.|.|++   .+..+||||||+|+..+.
T Consensus       135 ~TELmQS-DLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELMQS-DLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHh-hhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEecccccccccch
Confidence            8898854 666655  3456899999999999999999999999999999999999998   488999999999987654


Q ss_pred             CC--ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh----------------
Q 015026          255 GK--KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------------  314 (414)
Q Consensus       255 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~----------------  314 (414)
                      ..  .+..-+.|..|+|||++.|  .|+.+.||||.|||+.||+..+..|...+.-+.+..|..                
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            33  3344567999999998865  479999999999999999999999988776554444322                


Q ss_pred             -------cCCCCCCCC-------CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          315 -------NKPDFRRKP-------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       315 -------~~~~~~~~~-------~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                             .....+...       ...-..+...++..||.+||++|++..+++.|+++.++
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                   111111100       01123468899999999999999999999999999864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.3e-37  Score=289.71  Aligned_cols=255  Identities=31%  Similarity=0.500  Sum_probs=203.6

Q ss_pred             cccceeeceeeeecCceEEEEEEECC---CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      +.+.|.++++||.|+|++||++.+..   .++.||+|.|....     ...++.+|+++|..+.++.||+++.+.+..++
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            44568999999999999999999887   78899999987654     34678999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ...+|+||++..+..++.     ..++..+++.+++.++.||.++|.+|||||||||.|+|.+.  ..+.-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~-----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLY-----RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHH-----hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhHH
Confidence            999999999998888776     24678999999999999999999999999999999999986  56778899999986


Q ss_pred             ccC-----------------C--CC--------------------------ccccCCCCCccccchhcccc--CCCCcch
Q 015026          251 FIK-----------------P--GK--------------------------KFQDIVGSAYYVAPEVLKRK--SGPESDV  283 (414)
Q Consensus       251 ~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~~~--~~~~~Di  283 (414)
                      ..+                 .  +.                          ......||++|+|||++...  .++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            210                 0  00                          01124799999999998754  4788999


Q ss_pred             hHHHHHHHHHhhCCCCCCCCCch-hhhHH---------------------------------HhhcCCCC----------
Q 015026          284 WSIGVITYILLCGRRPFWDKTED-GIFKE---------------------------------VLRNKPDF----------  319 (414)
Q Consensus       284 wslG~il~elltg~~Pf~~~~~~-~~~~~---------------------------------i~~~~~~~----------  319 (414)
                      ||.|||+..+++++.||.....+ +.+.+                                 +......+          
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            99999999999999999533221 00000                                 00000000          


Q ss_pred             ---CCCCC-CCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          320 ---RRKPW-PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       320 ---~~~~~-~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                         ....+ ...+..+.+|+.+||..||.+|+||+++|.||||..
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence               00111 124558999999999999999999999999999984

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=324.57  Aligned_cols=239  Identities=20%  Similarity=0.269  Sum_probs=182.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ..|.....||+|+||.||+|.+..+|..||||++.....       ....|+.++++++ |||||++++++.+++..++|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEE
Confidence            346677899999999999999999999999998864331       1134688899995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH---~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |||+++|+|.+++.     .+++..+..++.||+.||+|||   +.+|+||||||+||+++   .+...++. ||.+...
T Consensus       762 ~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        762 HEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGLL  832 (968)
T ss_pred             EeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-ecccccc
Confidence            99999999999883     3789999999999999999999   66999999999999998   35555554 6654432


Q ss_pred             CCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCc--hhhhHHHh---hc-------CCCC
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVL---RN-------KPDF  319 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~~i~---~~-------~~~~  319 (414)
                      ...   ....||+.|+|||++.+ .++.++|||||||++|||+||+.||.....  ..+.....   ..       .+..
T Consensus       833 ~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        833 CTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             ccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence            211   23478999999998765 468899999999999999999999954321  11111100   00       0000


Q ss_pred             CCC--CCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          320 RRK--PWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       320 ~~~--~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ...  .......++.+++.+||+.||++|||+.|+++
T Consensus       910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  946 (968)
T PLN00113        910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK  946 (968)
T ss_pred             cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence            000  00011225678999999999999999999987

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=287.72  Aligned_cols=200  Identities=35%  Similarity=0.636  Sum_probs=176.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHH-----HHHHHHHHHHHcc--CCCCceEEEEEEEcC
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVKREVKILQALA--GHENVVKFYNAFEDD  169 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~-----~~~~E~~il~~l~--~hpnIv~~~~~~~~~  169 (414)
                      .|..++.+|.|+||.|++|.++.....|+||.|.+++...+...+     .+-.||.||..|.  .|+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            499999999999999999999999999999999887655443332     3567999999994  399999999999999


Q ss_pred             CEEEEEEecc-CCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 NYVYIAMELC-EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 ~~~~lv~e~~-~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      +++||+||-. +|.+|++++.  ....++|.+++.|++|++.|+++||+.||||||||-+|+.++   .+|.+||+|||.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd---~~g~~klidfgs  716 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD---SNGFVKLIDFGS  716 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEe---cCCeEEEeeccc
Confidence            9999999976 4779999984  345799999999999999999999999999999999999999   589999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWD  302 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~  302 (414)
                      |...+++ .+..++||..|.|||++.|..  +.+-|||+||++||.++....||+.
T Consensus       717 aa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9877654 567889999999999999863  8899999999999999999999853

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=294.29  Aligned_cols=259  Identities=28%  Similarity=0.458  Sum_probs=220.7

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +..++|+++..+|.|+||.||+++++.+++..|+|+++....   ....-++.|+-+++.++ |||||.+++.|.....+
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence            456789999999999999999999999999999999987653   24566789999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      +|.||||.||+|.+..  .-.+.+++.++....+..+.||+|||+.|-+|||||-.|||++   +.+.||++|||.+..+
T Consensus        88 wicMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQI  162 (829)
T ss_pred             EEEEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhh
Confidence            9999999999998855  5568899999999999999999999999999999999999999   6899999999988665


Q ss_pred             CCC-CccccCCCCCccccchhc----cccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC-CCCC
Q 015026          253 KPG-KKFQDIVGSAYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-PWPS  326 (414)
Q Consensus       253 ~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~  326 (414)
                      ... .+...++||+.|||||+.    .+.|...+|||++|+...|+---.+|..+.-....+..+.+..+..+.. ....
T Consensus       163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k  242 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK  242 (829)
T ss_pred             hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc
Confidence            432 234578999999999974    4678999999999999999988778876665555555555444333322 2234


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      -++.+.+|++.+|..+|++|||++.+|.|||...
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            6788999999999999999999999999999974

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=295.19  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=207.0

Q ss_pred             eeeceeeeecCceEEEEEEEC----C---CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           98 YTIGKLLGHGQFGYTYVATDK----A---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~----~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..+.+.||.|+||.|++|.-.    .   ....||||.+.....  ....+.+..|+++|+.+..||||+.+++++...+
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            366779999999999999633    1   134699998865543  2577899999999999988999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc------------C--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC
Q 015026          171 YVYIAMELCEGGELLDRILAKK------------D--SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~------------~--~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~  236 (414)
                      .+++|+||+..|+|.+++....            .  ..++..+...++.||+.|++||++..+|||||-+.|||+.   
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~---  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT---  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec---
Confidence            9999999999999999997654            0  1388999999999999999999999999999999999999   


Q ss_pred             CCCCceeeccccccccCCCCccc--cCCCC--Cccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCC-chhhh
Q 015026          237 EDSSLKATDFGLSDFIKPGKKFQ--DIVGS--AYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKT-EDGIF  309 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~~~~--~~~gt--~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~-~~~~~  309 (414)
                      ++..+||+|||+|+.......+.  ...|+  ..|||||.+.. .++.++|||||||+||||++ |..||.+.. ..+++
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            57899999999998765444332  12222  34999998876 56999999999999999999 999998855 55565


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +.+..+...   ......++++.++++.||..+|++||+..++..  +|..
T Consensus       533 ~~l~~G~r~---~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~  578 (609)
T KOG0200|consen  533 EFLKEGNRM---EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK  578 (609)
T ss_pred             HHHhcCCCC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence            545444322   222356899999999999999999999999887  5543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=267.83  Aligned_cols=246  Identities=24%  Similarity=0.385  Sum_probs=190.1

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHH--ccCCCCceEEEEEEEcC--
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA--LAGHENVVKFYNAFEDD--  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~~hpnIv~~~~~~~~~--  169 (414)
                      +..+..+.+.||+|.||+||+|.  ..|+.||||++...      ..+.+.+|.+|.+.  |+ |+||+.+++.-..+  
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLR-HENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSR------DERSWFRETEIYQTVMLR-HENILGFIAADNKDNG  279 (513)
T ss_pred             hhheeEEEEEecCccccceeecc--ccCCceEEEEeccc------chhhhhhHHHHHHHHHhc-cchhhhhhhccccCCC
Confidence            45678899999999999999996  56899999998654      34667889988875  54 99999999865432  


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEEeecCCCC
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--------GLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~--------~iiHrDlkp~NIll~~~~~~~  239 (414)
                        ..++||++|.+.|+|+|++.+   ..++......++.-++.||++||..        .|+|||||..|||+.   .++
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK---kn~  353 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNG  353 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc---cCC
Confidence              469999999999999999955   4689999999999999999999963        499999999999998   689


Q ss_pred             CceeeccccccccCCCC-----ccccCCCCCccccchhccccC-------CCCcchhHHHHHHHHHhhC----------C
Q 015026          240 SLKATDFGLSDFIKPGK-----KFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCG----------R  297 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~~DiwslG~il~elltg----------~  297 (414)
                      .+-|+|+|||-......     ..+..+||.+|||||++....       ...+||||||.|+||+...          .
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            99999999996554332     235679999999999987543       3458999999999999753          5


Q ss_pred             CCCCCCCc----hhhhHHHhhcC--CCCCCCCCCCCC--HHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          298 RPFWDKTE----DGIFKEVLRNK--PDFRRKPWPSIS--NSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       298 ~Pf~~~~~----~~~~~~i~~~~--~~~~~~~~~~~s--~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +||.+..+    .+.++++.-..  .+..+..|...+  ..+-.+++.||..+|..|.||--+-.
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            78876432    22333332211  111222333332  24568899999999999999866543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=245.69  Aligned_cols=213  Identities=25%  Similarity=0.334  Sum_probs=178.1

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      ...+..||+|++|.|=+.++..+|...|+|.+...-  .....++..+|+++.....++|.+|.+|+.+-.+..++|.||
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            445667999999999999999999999999986543  245677888999998888889999999999999999999999


Q ss_pred             ccCCCChHHHHH--hccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          178 LCEGGELLDRIL--AKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       178 ~~~gg~L~~~l~--~~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      .|+. +|..+..  -..++.++|.-+-+|+..++.||.|||++ .+||||+||+||||+   .+|.||+||||.+....+
T Consensus       126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn---~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN---YDGQVKICDFGISGYLVD  201 (282)
T ss_pred             Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc---cCCcEEEcccccceeehh
Confidence            9953 5543332  13567899999999999999999999975 899999999999999   689999999999987765


Q ss_pred             CCccccCCCCCccccchhccc-----cCCCCcchhHHHHHHHHHhhCCCCCCC-CCchhhhHHHhhcC
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-----KSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNK  316 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~i~~~~  316 (414)
                      +....--.|-..|||||.+..     .|+-++||||||+.+.||.+++.||.. .++.+.++++....
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            544333578889999998763     467799999999999999999999964 46667777776654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=271.40  Aligned_cols=246  Identities=27%  Similarity=0.398  Sum_probs=189.8

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc-CCCCceEEEEEEEcCC----E
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-GHENVVKFYNAFEDDN----Y  171 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-~hpnIv~~~~~~~~~~----~  171 (414)
                      ...+.++||+|.||.||+|.  -+++.||||++..      ...+.+.+|-+|.+... .|+||+++++.-....    .
T Consensus       211 pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             chhhHHHhhcCccceeehhh--ccCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            46778899999999999995  5679999999854      35678888888876531 5999999998765544    8


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEEeecCCCCCce
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH---------GLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~---------~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                      ++||+||.+.|+|.+++..+   .+++....+|+.-|+.||+|||+-         .|+|||||..|||+.   .+.++-
T Consensus       283 ywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK---~DlTcc  356 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK---NDLTCC  356 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc---cCCcEE
Confidence            99999999999999999543   589999999999999999999973         599999999999998   689999


Q ss_pred             eeccccccccCCCCc---cccCCCCCccccchhccccCC-------CCcchhHHHHHHHHHhhCCCCC------------
Q 015026          243 ATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRKSG-------PESDVWSIGVITYILLCGRRPF------------  300 (414)
Q Consensus       243 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-------~~~DiwslG~il~elltg~~Pf------------  300 (414)
                      |+|||+|..+..+..   ....+||.+|||||++.+...       .+.||||+|.|||||++...-+            
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf  436 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF  436 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence            999999987654332   335799999999999987542       2479999999999999864433            


Q ss_pred             C-----CCCchhhhHHHhhcC--CCCCCCCCCC--CCHHHHHHHHHhhcCCccccCCHH------HHhCCcc
Q 015026          301 W-----DKTEDGIFKEVLRNK--PDFRRKPWPS--ISNSAKDFVKKLLVKDPRARLTAA------QALSHPW  357 (414)
Q Consensus       301 ~-----~~~~~~~~~~i~~~~--~~~~~~~~~~--~s~~~~~li~~~L~~dp~~Rps~~------elL~hp~  357 (414)
                      .     ..+.+++...+...+  |.++. .|..  -...+.+.+..||..||+.|.|+.      ..|.|+|
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~-~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPD-AWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChh-hhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            2     112233333343332  22221 2222  224578999999999999999985      3345665

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=259.03  Aligned_cols=257  Identities=28%  Similarity=0.427  Sum_probs=203.4

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEE-EEEcCCE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN-AFEDDNY  171 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~-~~~~~~~  171 (414)
                      ++.+.|.|.+.||+|.||.+-+|.++.+.+.+++|.+.+...    ..++|.+|...--.|..|.||+..|+ .|+..+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            356789999999999999999999999999999999976543    67889999998777878999999987 4788889


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++++||++.|+|.+-+-   ...+-|...+.++.|+++||.|+|++++||||||.+||||-.. +...|||||||+.+.
T Consensus        97 YvF~qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRK  172 (378)
T ss_pred             EEEeeccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccc
Confidence            999999999999988773   2468899999999999999999999999999999999999743 456999999999876


Q ss_pred             cCCCCccccCCCCCccccchhccc----c--CCCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHH---HhhcCCCCCC
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKR----K--SGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKE---VLRNKPDFRR  321 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~----~--~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~---i~~~~~~~~~  321 (414)
                      .+..-  ...--+..|.+||+...    .  ..+.+|||.||+|+|.++||++||+.... +.-+.+   .......-.+
T Consensus       173 ~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P  250 (378)
T KOG1345|consen  173 VGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP  250 (378)
T ss_pred             cCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence            44322  22334567999997542    2  36789999999999999999999975432 222222   2222222222


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCcccc---CCHHHHhCCcccc
Q 015026          322 KPWPSISNSAKDFVKKLLVKDPRAR---LTAAQALSHPWVR  359 (414)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~R---ps~~elL~hp~f~  359 (414)
                      ..+..+++.+..+.++-|.++|++|   -++.......|..
T Consensus       251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            2344588999999999999999999   5666555666654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=283.57  Aligned_cols=246  Identities=25%  Similarity=0.358  Sum_probs=206.1

Q ss_pred             eeeceeeeecCceEEEEEEECCCCC----EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      .+..++||.|+||+||+|.+.-.|+    +||||++.....  +.+...+..|+-+|..| +|||++++++++.... +-
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HH
Confidence            4567899999999999998865565    589998866543  34678899999999999 5999999999998766 88


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||++|+++|+|.+++...+ ..+-......|..||+.|+.|||.++++||||-+.|||+.   ....|||+|||+|+...
T Consensus       774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccC
Confidence            9999999999999997643 5688899999999999999999999999999999999998   57899999999998876


Q ss_pred             CCCc-cccCCC--CCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          254 PGKK-FQDIVG--SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       254 ~~~~-~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .... +....|  -+.|||=|.+. ..++.++|||||||.+||++| |..|+.+...+++-..+..+.. +..+  +..+
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqP--piCt  926 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQP--PICT  926 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCC--CCcc
Confidence            5433 222222  45688888765 567999999999999999999 9999999888877766666554 3332  4678


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      -++.-++.+||-.|+..||+++++..
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHH
Confidence            89999999999999999999998765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=8.1e-32  Score=240.19  Aligned_cols=212  Identities=42%  Similarity=0.739  Sum_probs=184.2

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (414)
                      ||.|++|.||++.+..+|+.+++|++.......  ..+.+.+|+.+++.+. |++|+++++++......++++|+++|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999998889999999987654211  3577899999999995 9999999999999999999999999999


Q ss_pred             hHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-ccccCC
Q 015026          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIV  262 (414)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~  262 (414)
                      |.+++.... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++.  .++.++|+|||.+....... ......
T Consensus        78 l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          78 LKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--CCCcEEEecCCceEEccCCcchhhccc
Confidence            999875432 46899999999999999999999999999999999999983  16889999999987654432 133456


Q ss_pred             CCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhc
Q 015026          263 GSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV  340 (414)
Q Consensus       263 gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  340 (414)
                      +...|++||.+..  ..+.++|+|++|+++++|                                   ..+.+++.+||+
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence            8889999998876  568899999999999998                                   478999999999


Q ss_pred             CCccccCCHHHHhCCc
Q 015026          341 KDPRARLTAAQALSHP  356 (414)
Q Consensus       341 ~dp~~Rps~~elL~hp  356 (414)
                      .||.+||++.++++++
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=5.2e-31  Score=238.65  Aligned_cols=212  Identities=41%  Similarity=0.694  Sum_probs=178.3

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+......  ...+.+.+|+..++.+ +|+|++++++.+......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence            56788999999999999999988999999998765422  2567889999999999 49999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-  256 (414)
                      ++++++|.+++..... .+++..+..++.+++.+|.+||+.+++|+||+|.||+++   .++.++|+|||++....... 
T Consensus        78 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       78 YCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             ccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCccc
Confidence            9999999998854321 188999999999999999999999999999999999998   46899999999988765443 


Q ss_pred             -ccccCCCCCccccchhcc-c-cCCCCcchhHHHHHHHHHhhCCCCCCC-CC-chhhhHHHhhcC
Q 015026          257 -KFQDIVGSAYYVAPEVLK-R-KSGPESDVWSIGVITYILLCGRRPFWD-KT-EDGIFKEVLRNK  316 (414)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~elltg~~Pf~~-~~-~~~~~~~i~~~~  316 (414)
                       ......++..|++||.+. . ..+.++|+|+||+++++|++|+.||.. .. ..++.+.+..+.
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence             334567889999999873 2 346789999999999999999999977 33 335555555544

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.7e-31  Score=285.36  Aligned_cols=198  Identities=21%  Similarity=0.271  Sum_probs=146.8

Q ss_pred             CCceEEEEEE-------EcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 015026          157 ENVVKFYNAF-------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN  229 (414)
Q Consensus       157 pnIv~~~~~~-------~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N  229 (414)
                      +||+.++++|       .....+++++|++ +++|.+++.. ....+++.+++.+++||+.||.|||++||+||||||+|
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~N  110 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSC  110 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchh
Confidence            5777777766       2334678889988 5699998843 24569999999999999999999999999999999999


Q ss_pred             EEEeec----------------CCCCCceeeccccccccCCC-----------------CccccCCCCCccccchhccc-
Q 015026          230 FLFKSA----------------KEDSSLKATDFGLSDFIKPG-----------------KKFQDIVGSAYYVAPEVLKR-  275 (414)
Q Consensus       230 Ill~~~----------------~~~~~vkl~DFG~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~-  275 (414)
                      |||+..                ..++.+||+|||+++.....                 ......+||++|||||++.+ 
T Consensus       111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~  190 (793)
T PLN00181        111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS  190 (793)
T ss_pred             EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence            999631                23567888888887643210                 00112468999999998764 


Q ss_pred             cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       276 ~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .++.++|||||||+||||++|.+|+....  ..+..+....  .+... ....+.+.+++.+||.+||.+||++.|+|+|
T Consensus       191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        191 SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence            57899999999999999999999875322  1222222111  11111 1123567789999999999999999999999


Q ss_pred             cccccc
Q 015026          356 PWVREG  361 (414)
Q Consensus       356 p~f~~~  361 (414)
                      |||...
T Consensus       266 ~~~~~~  271 (793)
T PLN00181        266 EFINEP  271 (793)
T ss_pred             hhhhhh
Confidence            999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-29  Score=229.38  Aligned_cols=250  Identities=20%  Similarity=0.244  Sum_probs=201.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC-----CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE-cC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG-----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-DD  169 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~-~~  169 (414)
                      .|+++...+-+|.||.||.|.+.+..     +.|-+|.+....  ++.....+..|.-+|..+. |||+..+.+++. +.
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDY  360 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCc-CCCccceeEEEeecc
Confidence            46788888999999999999776543     346677775443  4557788899999999996 999999999875 55


Q ss_pred             CEEEEEEeccCCCChHHHHHh-----c-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCcee
Q 015026          170 NYVYIAMELCEGGELLDRILA-----K-KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~-----~-~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (414)
                      ...+.++.++.-|+|..++..     . ..+.++..+...++.|+..|++|||++||||.||-..|.+|+   +...|||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId---d~LqVkl  437 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID---DQLQVKL  437 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh---hheeEEe
Confidence            678889999988999998851     1 224577788899999999999999999999999999999999   6789999


Q ss_pred             eccccccccCCCCccc---cCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCC
Q 015026          244 TDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPD  318 (414)
Q Consensus       244 ~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~  318 (414)
                      +|=.+++..-+.+...   .---...||+||.+. ..++.++|+|||||++|||+| |+.|+.+-++.++...+.++..-
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl  517 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL  517 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence            9999998654332111   011234699999775 567999999999999999999 99999888888877777766432


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                         ...-++|+++..++.-||..+|++||+.+|+..
T Consensus       518 ---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  518 ---AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence               222478999999999999999999999999764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.7e-30  Score=265.01  Aligned_cols=261  Identities=27%  Similarity=0.412  Sum_probs=198.3

Q ss_pred             cce-eeceeeeecCceEEEEEEECCCCCEEEEEEeecc---CCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKN---KMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      +.| .....+|.|++|.|+.+......+.++.|.....   ..........+..|.-+-..|. |||++..+..+.+...
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDG  395 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhccc
Confidence            445 4567899999999988888777776777755421   1111112222666777777785 9999888877766666


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .+-+||||++ +|+..+.+.  ..+...++-.++.||+.||.|||+.||.||||||+|+++.   .++.+||+|||.+..
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCccee
Confidence            6666999999 999988543  4788999999999999999999999999999999999999   578999999999876


Q ss_pred             cCCC-----CccccCCCCCccccchhcccc-C-CCCcchhHHHHHHHHHhhCCCCCCCCCchhhh-HHHh----hcCCCC
Q 015026          252 IKPG-----KKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIF-KEVL----RNKPDF  319 (414)
Q Consensus       252 ~~~~-----~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~-~~i~----~~~~~~  319 (414)
                      ....     ......+|+..|+|||++.+. + ....||||.|++++.|++|+.||.-....+.. ....    .....-
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~  549 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG  549 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence            5322     234578999999999988765 4 45689999999999999999999654332221 1110    011111


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +...+..++.+.+.+|.+||++||.+|.|+++|++.+||+....
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            22234457888999999999999999999999999999997544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-27  Score=229.54  Aligned_cols=254  Identities=23%  Similarity=0.294  Sum_probs=196.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCC-CEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc---CCCCceEEEEEE-EcCCE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALA---GHENVVKFYNAF-EDDNY  171 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~---~hpnIv~~~~~~-~~~~~  171 (414)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|+........   ...+..|+.++..+.   +-+++..+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            7999999999999999999988775 578888776543211   125778999999886   236999999999 58889


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC--CCCCceeeccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLS  249 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DFG~a  249 (414)
                      .+|||+.+ |.+|.++......+.++...+..++.|++.+|++||+.|++||||||+|+++....  +...+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 88999977666668899999999999999999999999999999999999998532  2257999999999


Q ss_pred             cccC---CCC-------c-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC
Q 015026          250 DFIK---PGK-------K-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       250 ~~~~---~~~-------~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      +...   ...       . .....||..|+++.+..+. .+...|+||++.++.+++.|..||.+.........+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8321   111       1 1235599999999987765 58999999999999999999999976654333333333222


Q ss_pred             CCCCC-CCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          318 DFRRK-PWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       318 ~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..... .....+.++.++...+-..+...+|....+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            22221 22345567778877777788888888877655

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=4.3e-27  Score=223.35  Aligned_cols=257  Identities=36%  Similarity=0.581  Sum_probs=206.9

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCC-CceEEEEEEEcCCEEEEEE
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-NVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hp-nIv~~~~~~~~~~~~~lv~  176 (414)
                      |.+.+.||.|+||.||.+.+.   ..+|+|.+.............+.+|+.++..+. |+ +|+.+++.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence            788899999999999999887   789999987765444335788999999999996 66 8999999998888899999


Q ss_pred             eccCCCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC-CceeeccccccccCC
Q 015026          177 ELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLSDFIKP  254 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~-~vkl~DFG~a~~~~~  254 (414)
                      +++.++++.+.+..... ..+++..+..++.|++.++.|+|+.+++||||||+||+++.   .+ .++++|||.+.....
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~---~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR---DGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC---CCCeEEEeccCcceecCC
Confidence            99999999966533221 26899999999999999999999999999999999999983   44 799999999875543


Q ss_pred             CC-------ccccCCCCCccccchhccc----cCCCCcchhHHHHHHHHHhhCCCCCCCCCc----hhhhHHHhhcCCC-
Q 015026          255 GK-------KFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPD-  318 (414)
Q Consensus       255 ~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~-  318 (414)
                      ..       .....+||..|+|||.+.+    ......|+||+|++++++++|..||.....    ......+...... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            32       3467789999999998875    457889999999999999999999877653    3444444433322 


Q ss_pred             CCCCCCCCC----CHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          319 FRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       319 ~~~~~~~~~----s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .........    ...+.+++.+++..+|..|.+..+...++|....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            222111111    2578999999999999999999999998777653

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.3e-28  Score=215.48  Aligned_cols=163  Identities=26%  Similarity=0.337  Sum_probs=128.0

Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccC
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI  261 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  261 (414)
                      |+|.+++... ...+++..++.++.||+.||.|||+.+      ||+|||++   .++.+|+  ||++.......    .
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~~----~   64 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPEQ----S   64 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeecccc----C
Confidence            6888888543 456999999999999999999999999      99999998   5788888  99988764432    2


Q ss_pred             CCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHHHhhcCCCCCCC---CCCCCCH--HHHHH
Q 015026          262 VGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPDFRRK---PWPSISN--SAKDF  334 (414)
Q Consensus       262 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~---~~~~~s~--~~~~l  334 (414)
                      .||+.|||||++.+ .++.++|||||||++|||++|+.||..... ...+..+..........   ....+++  ++.++
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            68999999998765 468899999999999999999999976543 23333333332221111   1112333  69999


Q ss_pred             HHHhhcCCccccCCHHHHhCCccccc
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      |.+||..||.+||++.+++.|+|+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-27  Score=215.24  Aligned_cols=203  Identities=24%  Similarity=0.443  Sum_probs=172.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      -.|+++++||+|+||+.+.|++..++++||||.-....     ..-+++.|.+..+.|.+.+.|+.+|-+...+.+..||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            36999999999999999999999999999999654332     2346788999999998899999999888899999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec--CCCCCceeeccccccccC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA--KEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~--~~~~~vkl~DFG~a~~~~  253 (414)
                      +|++ |.+|.|++ +--+..|+...+..++.||+.-++|+|++.+|.|||||+|+||...  .+...|.|+|||+|+...
T Consensus       103 idLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  103 IDLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hhhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            9998 77877754 4556789999999999999999999999999999999999999742  234578999999998765


Q ss_pred             CCC--------ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc
Q 015026          254 PGK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE  305 (414)
Q Consensus       254 ~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~  305 (414)
                      +..        ...+..||.+||+=....|. .+..-|+-|||-++++.|.|..||.+...
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            443        23467899999998765444 58889999999999999999999987543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=208.41  Aligned_cols=245  Identities=20%  Similarity=0.305  Sum_probs=192.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|+++++||.|+||.+|+|....+|+.||||+-....     ..-.+..|..+.+.|++-..|+.+..+..+..+..+|
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            57999999999999999999999999999999654332     2235678999999998889999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||++ |.+|.+++ .--...++...+..++-|++.-++|+|.+++|||||||+|+|+.-......+.|+|||+|+...+.
T Consensus        90 MdLL-GPsLEdLf-nfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~  167 (341)
T KOG1163|consen   90 MDLL-GPSLEDLF-NFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI  167 (341)
T ss_pred             eecc-CccHHHHH-HHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence            9998 77887765 334567899999999999999999999999999999999999986556677999999999876443


Q ss_pred             Cc--------cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc---hhhhHHHhhcCCCCC-CC
Q 015026          256 KK--------FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPDFR-RK  322 (414)
Q Consensus       256 ~~--------~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~-~~  322 (414)
                      ..        -....||..|.+-....+. .+...|+-|+|.+|.++..|..||++...   ..-+++|...+...+ ..
T Consensus       168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~  247 (341)
T KOG1163|consen  168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV  247 (341)
T ss_pred             cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH
Confidence            22        2356899999987765543 47788999999999999999999988644   334555555443322 22


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccC
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARL  347 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rp  347 (414)
                      .+..+|.++.-.+.-|=..-=++-|
T Consensus       248 LC~G~P~EF~myl~Y~R~L~F~E~P  272 (341)
T KOG1163|consen  248 LCKGFPAEFAMYLNYCRGLGFEEKP  272 (341)
T ss_pred             HhCCCcHHHHHHHHHHhhcCCCCCC
Confidence            3456777777666666443333334

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.8e-27  Score=228.64  Aligned_cols=165  Identities=20%  Similarity=0.260  Sum_probs=129.6

Q ss_pred             cccceeeceeeeecCceEEEEEEECC-CCCEEEEEEeeccCC--CChHhHHHHHHHHHHHHHccCCCCceE-EEEEEEcC
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKM--ILPIAVEDVKREVKILQALAGHENVVK-FYNAFEDD  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~~hpnIv~-~~~~~~~~  169 (414)
                      +.+.|.+.+.||+|+||+||+|.+.. +++.||||++.....  ......+.+.+|+++|+.|. |+||+. +++.    
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~----   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT----   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc----
Confidence            45679999999999999999998876 678889998753311  12335677999999999995 999985 5432    


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEEeecCCCCCceeecccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDM-KPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDl-kp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      +..||||||++|++|.. +  ..   ..   ...++.|++.||.|||+.||+|||| ||+|||++   .++.+||+|||+
T Consensus        91 ~~~~LVmE~~~G~~L~~-~--~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiDFGl  158 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-A--RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVIDFQL  158 (365)
T ss_pred             CCcEEEEEccCCCCHHH-h--Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEECcc
Confidence            45899999999999862 2  11   11   1468899999999999999999999 99999997   467899999999


Q ss_pred             ccccCCCC---------ccccCCCCCccccchhccc
Q 015026          249 SDFIKPGK---------KFQDIVGSAYYVAPEVLKR  275 (414)
Q Consensus       249 a~~~~~~~---------~~~~~~gt~~y~aPE~~~~  275 (414)
                      |+......         .....++++.|+|||.+..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            98654322         1235678899999998853

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-29  Score=243.74  Aligned_cols=241  Identities=28%  Similarity=0.483  Sum_probs=205.0

Q ss_pred             eeeecCceEEEEEEE---CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEecc
Q 015026          103 LLGHGQFGYTYVATD---KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (414)
                      .+|+|+||.|+++..   ...|..+|+|+..+......... .-..|..++....+||.+|++...++.+...++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999998742   35567799998866543322222 45678888888877999999999999999999999999


Q ss_pred             CCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccc
Q 015026          180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ  259 (414)
Q Consensus       180 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~  259 (414)
                      .||+|...+  .....+.+...+.+...++-+++++|+.+|+|||+|++||+++   .+|++++.|||+++..-..+.. 
T Consensus        80 rgg~lft~l--~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld---~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   80 RGGDLFTRL--SKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL---LEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             ccchhhhcc--ccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec---ccCccccCCchhhhHhHhhhhc-
Confidence            999998877  5556788899999999999999999999999999999999999   6899999999999876444332 


Q ss_pred             cCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhh
Q 015026          260 DIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (414)
Q Consensus       260 ~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (414)
                        |||..|||||+++ .....+|.||+|+++++|+||..||..    ++...|.+....++.    .++.++.+++..++
T Consensus       154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLF  222 (612)
T ss_pred             --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHH
Confidence              9999999999999 567899999999999999999999977    778888887766665    57789999999999


Q ss_pred             cCCccccCCH-----HHHhCCcccccc
Q 015026          340 VKDPRARLTA-----AQALSHPWVREG  361 (414)
Q Consensus       340 ~~dp~~Rps~-----~elL~hp~f~~~  361 (414)
                      ..+|..|.-.     .++++|+||+..
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchheee
Confidence            9999999754     799999999863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=5e-26  Score=232.76  Aligned_cols=223  Identities=29%  Similarity=0.502  Sum_probs=176.7

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ....|..++.|..|+||-||.++++.+.+++|+| +.+....       +++   +|... +.|.+|             
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a-~npfvv-------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFA-GNPFVV-------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---ccccc-CCccee-------------
Confidence            4457999999999999999999999999999994 5544321       111   33333 466665             


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                              |+-...+  ...+.++...        +.+++|||+.||+|||+||+|.+|+   .-|++|++|||+++...
T Consensus       136 --------gDc~tll--k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 --------GDCATLL--KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             --------chhhhhc--ccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhh
Confidence                    2333333  2334455443        7899999999999999999999999   47899999999986531


Q ss_pred             CC--------------Cc--cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC
Q 015026          254 PG--------------KK--FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK  316 (414)
Q Consensus       254 ~~--------------~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~  316 (414)
                      -.              ..  -..+||||.|+|||++. ..|+..+|+|++|+|+||.+-|+.||.+.+.++++..++...
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            10              00  12469999999999764 569999999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhcCCccccC---CHHHHhCCcccccccC
Q 015026          317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVREGGD  363 (414)
Q Consensus       317 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---s~~elL~hp~f~~~~~  363 (414)
                      ..+++.. ..++++++++|..+|..+|..|.   .+-++.+|+||+...-
T Consensus       275 i~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  275 IEWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             ccccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence            8888874 46889999999999999999995   6778889999996543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=7.8e-25  Score=201.97  Aligned_cols=236  Identities=23%  Similarity=0.368  Sum_probs=152.5

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccC---------CCCceEEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG---------HENVVKFYNAFE  167 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~---------hpnIv~~~~~~~  167 (414)
                      .+...+.||.|+++.||.+.+..||+.+|+|+............+.+.+|.-....+.+         |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            46778899999999999999999999999998865553344466777777655444322         323333333321


Q ss_pred             ------------cCC-----EEEEEEeccCCCChHHHHH---hccCCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 015026          168 ------------DDN-----YVYIAMELCEGGELLDRIL---AKKDSR--YTEKDAAVVVRQMLRVAAECHLHGLVHRDM  225 (414)
Q Consensus       168 ------------~~~-----~~~lv~e~~~gg~L~~~l~---~~~~~~--l~~~~~~~i~~qil~~L~~LH~~~iiHrDl  225 (414)
                                  +.+     +.+++|+-+. ++|.+.+.   ......  +.......+..|++..+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                        111     2367788774 57776652   222221  112223455589999999999999999999


Q ss_pred             CCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCccccchhccc---------cCCCCcchhHHHHHHHHHhhC
Q 015026          226 KPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR---------KSGPESDVWSIGVITYILLCG  296 (414)
Q Consensus       226 kp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~elltg  296 (414)
                      +|+|++++   .+|.++|+||+.......  .......+..|.+||....         .++.+.|.|+||+++|.|.||
T Consensus       172 ~~~nfll~---~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLD---QDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEc---CCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999   689999999997755432  2222345678999997543         247788999999999999999


Q ss_pred             CCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCcccc
Q 015026          297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR  346 (414)
Q Consensus       297 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R  346 (414)
                      ..||...........        ....+..+|+.+++||..||+.||.+|
T Consensus       247 ~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999976544322221        112234788999999999999999998

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1.1e-24  Score=192.72  Aligned_cols=142  Identities=20%  Similarity=0.215  Sum_probs=110.0

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChH-----------------------hHHHHHHHHHHHHHccCCC
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI-----------------------AVEDVKREVKILQALAGHE  157 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~-----------------------~~~~~~~E~~il~~l~~hp  157 (414)
                      .+.||+|+||.||+|.+. +|+.||||+++........                       .......|+.++..+. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            467999999999999986 8999999999764321100                       0123346999999995 77


Q ss_pred             CceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEEeecC
Q 015026          158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       158 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~L-H~~~iiHrDlkp~NIll~~~~  236 (414)
                      ++..........  .+|||||++|+++.....  ....+++..+..++.||+.+|.++ |+.||+||||||+|||++   
T Consensus        80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---  152 (190)
T cd05147          80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---  152 (190)
T ss_pred             CCCCCcEEEecC--CEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE---
Confidence            764433322222  389999999887765432  235789999999999999999999 799999999999999998   


Q ss_pred             CCCCceeecccccccc
Q 015026          237 EDSSLKATDFGLSDFI  252 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~  252 (414)
                       ++.++|+|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             367999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=1.4e-24  Score=194.58  Aligned_cols=176  Identities=15%  Similarity=0.127  Sum_probs=133.8

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHH------HHHHHHHHHHccCCCCceEEEEE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED------VKREVKILQALAGHENVVKFYNA  165 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~------~~~E~~il~~l~~hpnIv~~~~~  165 (414)
                      +-+.++|++++.||.|+||.||++.+  ++..+|||++.......+.....      +.+|+..+.+|. ||+|+.+.++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~  103 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDF  103 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEe
Confidence            34668999999999999999999754  46789999997654444444334      579999999995 9999999988


Q ss_pred             EEcC--------CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC
Q 015026          166 FEDD--------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (414)
Q Consensus       166 ~~~~--------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~  237 (414)
                      +...        +..+|||||++|.+|.+..      .+++    ..+.+++.+|..||+.|++|||++|+||+++   .
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~  170 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---K  170 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---C
Confidence            6643        3589999999999997753      1233    3466999999999999999999999999998   3


Q ss_pred             CCCceeeccccccccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHh
Q 015026          238 DSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILL  294 (414)
Q Consensus       238 ~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~ell  294 (414)
                      ++ ++|+|||.............          =++...+..++|+||||+.+..+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence            55 99999998765432211110          012334567899999999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4.6e-24  Score=187.36  Aligned_cols=189  Identities=18%  Similarity=0.266  Sum_probs=144.2

Q ss_pred             eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh-HhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      .+...|++|+||+|+.+..  .+.+++.+.+........ .+...+.+|+++|++|.+|++|++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4567899999999998754  677888887765543221 2234688999999999767999999986    34699999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDM-KPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDl-kp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      |+.|.+|...+.        .. ...++.|++.+|.++|++||+|||| ||+|||++   .++.++|+|||+|.......
T Consensus        79 yI~G~~L~~~~~--------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         79 YLAGAAMYQRPP--------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             eecCccHHhhhh--------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcc
Confidence            999988865331        11 2357889999999999999999999 79999998   57789999999997554332


Q ss_pred             cc--------------ccCCCCCccccchhcc--ccCC-CCcchhHHHHHHHHHhhCCCCCCCCCc
Q 015026          257 KF--------------QDIVGSAYYVAPEVLK--RKSG-PESDVWSIGVITYILLCGRRPFWDKTE  305 (414)
Q Consensus       257 ~~--------------~~~~gt~~y~aPE~~~--~~~~-~~~DiwslG~il~elltg~~Pf~~~~~  305 (414)
                      ..              .-...++.|++|+...  ...+ ...+.++.|+-+|.++|+..|+++..+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            10              0123688889998533  2233 556888999999999999999877654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.6e-24  Score=196.73  Aligned_cols=190  Identities=24%  Similarity=0.410  Sum_probs=141.1

Q ss_pred             CCCCceEEEEEEEc---------------------------CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHH
Q 015026          155 GHENVVKFYNAFED---------------------------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ  207 (414)
Q Consensus       155 ~hpnIv~~~~~~~~---------------------------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~q  207 (414)
                      .|||||.+..+|.+                           +..+|+||-..+ .+|.+++..+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHH
Confidence            59999999887632                           235899998875 4888888543   4678888999999


Q ss_pred             HHHHHHHHHHcCCeecCCCCCcEEEeecC-CCCCceeeccccccccCC-------CCccccCCCCCccccchhccccC--
Q 015026          208 MLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSDFIKP-------GKKFQDIVGSAYYVAPEVLKRKS--  277 (414)
Q Consensus       208 il~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DFG~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~--  277 (414)
                      +++|+.|||.+||.|||||.+|||+.-++ +-..+.|+|||.+---+.       ....-..-|...-||||+....+  
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            99999999999999999999999997542 234578999997632111       11122456888899999976433  


Q ss_pred             -----CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHH
Q 015026          278 -----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAA  350 (414)
Q Consensus       278 -----~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~  350 (414)
                           ..++|.|+.|.+.||+++...||++..+..+-..-.+.. . .+.....+++.+++|+..+|+.||++|+++.
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~-q-LPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES-Q-LPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh-h-CCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                 558999999999999999999998854432211111100 0 1112236788999999999999999999875

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=3.6e-23  Score=183.36  Aligned_cols=145  Identities=19%  Similarity=0.218  Sum_probs=113.0

Q ss_pred             eceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC-----------------------hHhHHHHHHHHHHHHHccCC
Q 015026          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----------------------PIAVEDVKREVKILQALAGH  156 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~E~~il~~l~~h  156 (414)
                      +.+.||+|++|.||+|.+. +|+.||||++.......                       ......+..|+..+.++. |
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~   78 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-E   78 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-h
Confidence            3568999999999999987 89999999987652110                       001233468999999995 8


Q ss_pred             CCceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeec
Q 015026          157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSA  235 (414)
Q Consensus       157 pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~  235 (414)
                      ++|.....+....  .+|||||++|+++......  ...+++..+..++.|++.+|.++|+ .||+||||||+|||++  
T Consensus        79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--  152 (190)
T cd05145          79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--  152 (190)
T ss_pred             CCCCCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE--
Confidence            9885544433332  4899999998865443322  3467889999999999999999999 9999999999999997  


Q ss_pred             CCCCCceeeccccccccCC
Q 015026          236 KEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       236 ~~~~~vkl~DFG~a~~~~~  254 (414)
                        ++.++|+|||++.....
T Consensus       153 --~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 --DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             --CCCEEEEEcccceecCC
Confidence              57899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-23  Score=186.20  Aligned_cols=241  Identities=17%  Similarity=0.208  Sum_probs=190.5

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      ..++.+|.+...|+.|+|++  .|..+++|++..... .+...++|..|.-.|+-+. ||||+.+++.|..+.++.++..
T Consensus       192 lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW--QGNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhccCCCcccccccc--cCcchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeee
Confidence            45667899999999999975  466688887755432 3445678889999998885 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC-Cee-cCCCCCcEEEeecCCCCCcee--eccccccccC
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG-LVH-RDMKPENFLFKSAKEDSSLKA--TDFGLSDFIK  253 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~-iiH-rDlkp~NIll~~~~~~~~vkl--~DFG~a~~~~  253 (414)
                      ||+-|+|+..+....+--....++.+++.+|+.|+.|||+.. ++- --|....++|+   ++.+.+|  +|--++-. .
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid---edltarismad~kfsfq-e  343 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID---EDLTARISMADTKFSFQ-E  343 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec---chhhhheecccceeeee-c
Confidence            999999999997776666788899999999999999999975 443 36888899998   4555554  34332211 1


Q ss_pred             CCCccccCCCCCccccchhccccC----CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                           ....-.|.||+||.+...+    -.++|+|||++++|||.|...||.+-+..+.-.+|.-..  ++....|.++.
T Consensus       344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg--lrv~ippgis~  416 (448)
T KOG0195|consen  344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG--LRVHIPPGISR  416 (448)
T ss_pred             -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc--ccccCCCCccH
Confidence                 1224478999999987654    457899999999999999999999888877655553322  33445578999


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHh
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQAL  353 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL  353 (414)
                      .+..|+.-|++.||.+||..+.++
T Consensus       417 hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  417 HMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999999887654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=215.36  Aligned_cols=239  Identities=24%  Similarity=0.312  Sum_probs=173.3

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccC-CCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK-MILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ...-....+...|++ .... .+||++.+.-+.......|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence            57788899999999999998643 54 8999875543 222233344445555 3344 599999998887777888999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc--C
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI--K  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~--~  253 (414)
                      -+|.. -+|+|.+  .-...+...+.+.|+.||+.||.-+|..||+|+|||.+||||++   -.=+.|+||..-+..  .
T Consensus       100 Rqyvk-hnLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS---WNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS---WNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHh-hhhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee---echhhhhcccccCCccCC
Confidence            99985 4899988  33456788889999999999999999999999999999999995   345789999865432  1


Q ss_pred             C--CCccc----cCCCCCccccchhccc------------cCCCCcchhHHHHHHHHHhh-CCCCCCCC-------Cchh
Q 015026          254 P--GKKFQ----DIVGSAYYVAPEVLKR------------KSGPESDVWSIGVITYILLC-GRRPFWDK-------TEDG  307 (414)
Q Consensus       254 ~--~~~~~----~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~ellt-g~~Pf~~~-------~~~~  307 (414)
                      .  +..+.    +..--.+|.|||-+..            ..+++.||||+||+++||++ |++||.-.       ....
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~  253 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD  253 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence            1  11121    2223347999997632            02567899999999999999 89999310       0011


Q ss_pred             hhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       308 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ..+.+++..          -+..++.+|..|++.||++|.+|++.|+.
T Consensus       254 ~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111222211          12368999999999999999999999984

>PRK10345 hypothetical protein; Provisional

Probab=99.89  E-value=3.9e-22  Score=178.12  Aligned_cols=138  Identities=22%  Similarity=0.360  Sum_probs=108.9

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc----CCCCceEEEEEEEcCC---EEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA----GHENVVKFYNAFEDDN---YVY  173 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~----~hpnIv~~~~~~~~~~---~~~  173 (414)
                      .+.||+|+||.||.  ++.++.. +||++.....   ...+.+.+|+.+++.|.    +||||++++++++.+.   .++
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            46799999999995  7777766 6998876432   24567899999999994    3799999999998763   434


Q ss_pred             -EEEec--cCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCCcEEEeecC-CCCCceeec-cc
Q 015026          174 -IAMEL--CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHGLVHRDMKPENFLFKSAK-EDSSLKATD-FG  247 (414)
Q Consensus       174 -lv~e~--~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L-~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~D-FG  247 (414)
                       +|+||  +.+++|.+++.+   ..+++.  ..++.|++.++ +|||+++|+||||||+|||++..+ .+..++|+| ||
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence             78999  557999999943   245555  46688888888 999999999999999999998533 334899999 45


Q ss_pred             cc
Q 015026          248 LS  249 (414)
Q Consensus       248 ~a  249 (414)
                      ..
T Consensus       156 ~~  157 (210)
T PRK10345        156 ES  157 (210)
T ss_pred             Cc
Confidence            43

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=9.8e-22  Score=205.06  Aligned_cols=197  Identities=25%  Similarity=0.358  Sum_probs=158.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .+.|.|.+.||+|+||+||+|.+.. |+.||+|+=.....++=....++..-++ ++.   -+-|+.+...+...+.-+|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHccCCccee
Confidence            3579999999999999999999876 9999999865544433222222322222 111   3566667776777778899


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec----CCCCCceeecccccc
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA----KEDSSLKATDFGLSD  250 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~----~~~~~vkl~DFG~a~  250 (414)
                      |+||.+.|+|++++  +..+.+++..+..+..|||..++.||..+|||+||||+|+||...    .+..-++|+|||.+-
T Consensus       772 v~ey~~~Gtlld~~--N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLI--NTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeccccccHHHhh--ccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            99999999999998  566788999999999999999999999999999999999999642    234569999999884


Q ss_pred             c---cCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCC
Q 015026          251 F---IKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRR  298 (414)
Q Consensus       251 ~---~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~  298 (414)
                      .   ..++..+...++|-.+-.+|...|. |+..+|.|.|+.+++.||.|+.
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            4   4556678888999999999998775 6999999999999999999865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=5.9e-23  Score=209.83  Aligned_cols=262  Identities=27%  Similarity=0.473  Sum_probs=211.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECC-CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ...|.+.+.||+|+|+.|-.+.... +...+|.|.+.... ........+..|..+-+.+.+|+|++.+++...+....+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            3468889999999999999887643 33456777664433 223345666778888888866999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEeecCCCC-Cceeeccccccc
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-LHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLSDF  251 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH-~~~iiHrDlkp~NIll~~~~~~~-~vkl~DFG~a~~  251 (414)
                      ++++|..|+++++.+........+...+..++.|+..++.|+| ..++.||||||+|.+++   ..+ .++++|||+|..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhcc
Confidence            9999999999988764333226778889999999999999999 99999999999999998   455 899999999976


Q ss_pred             cCC----CCccccCCC-CCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh-hhHHHhhcCCCCCCCC
Q 015026          252 IKP----GKKFQDIVG-SAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKP  323 (414)
Q Consensus       252 ~~~----~~~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~  323 (414)
                      ...    .......+| ++.|+|||...+  ...+..|+||+|+++.-+++|..|+....... .+.........+...+
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence            544    223346788 999999998776  34888999999999999999999997654432 2233333334445667


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      |..++....+++.++|..+|..|.+.+++-.+||+..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCChhhhhcccccccCCchhccccccccccccccc
Confidence            8899999999999999999999999999999999987

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=8.1e-21  Score=173.60  Aligned_cols=146  Identities=24%  Similarity=0.231  Sum_probs=113.7

Q ss_pred             ceeeceeeeecCceEEEEEE-ECCCCCEEEEEEeeccCCCC-------------------h--HhHHHHHHHHHHHHHcc
Q 015026           97 RYTIGKLLGHGQFGYTYVAT-DKANGDRVAVKKIEKNKMIL-------------------P--IAVEDVKREVKILQALA  154 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~i~~~~~~~-------------------~--~~~~~~~~E~~il~~l~  154 (414)
                      -|.+.+.||+|+||.||+|. +..+|+.||+|++.......                   +  .....+.+|+.+++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 67899999999987543110                   0  01234678999999995


Q ss_pred             CC--CCceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEE
Q 015026          155 GH--ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG-LVHRDMKPENFL  231 (414)
Q Consensus       155 ~h--pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~-iiHrDlkp~NIl  231 (414)
                       +  ..++++++.   . ..++||||++|++|.....  ....+....+..++.||+.+|.+||+.| |+||||||+||+
T Consensus       109 -~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      109 -EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             -hcCCCCCeeeEe---c-CceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence             4  334455542   2 3589999999988766542  2234666778899999999999999999 999999999999


Q ss_pred             EeecCCCCCceeeccccccccC
Q 015026          232 FKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       232 l~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ++    ++.++|+|||.+....
T Consensus       182 i~----~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH----DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE----CCCEEEEEChhhhccC
Confidence            97    5689999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.6e-19  Score=161.25  Aligned_cols=137  Identities=26%  Similarity=0.365  Sum_probs=112.6

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh-----HhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +.||+|++|.||+|.+  .|..|++|+........+     .....+.+|+.++..+. |++|+....++.+.+..++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence            5799999999999976  677899997654332111     12346788999999995 899887777777777889999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      ||++|++|.+.+...     .. ....++.+++.+|.++|+.|++|+|++|.|||++    ++.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            999999999887332     12 7889999999999999999999999999999998    56799999998865

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-19  Score=177.75  Aligned_cols=199  Identities=26%  Similarity=0.340  Sum_probs=157.7

Q ss_pred             HHccCCCCceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCC-eecCCCCCc
Q 015026          151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL-VHRDMKPEN  229 (414)
Q Consensus       151 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~i-iHrDlkp~N  229 (414)
                      +.+ .|.|+.++++.+.++...++|.+||..|+|.|.+.. ....++..-...++++|+.||.|||...| .|+.|++.|
T Consensus         2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN   79 (484)
T ss_pred             ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence            456 499999999999999999999999999999998854 45678888899999999999999998876 999999999


Q ss_pred             EEEeecCCCCCceeeccccccccCCC---CccccCCCCCccccchhcccc--------CCCCcchhHHHHHHHHHhhCCC
Q 015026          230 FLFKSAKEDSSLKATDFGLSDFIKPG---KKFQDIVGSAYYVAPEVLKRK--------SGPESDVWSIGVITYILLCGRR  298 (414)
Q Consensus       230 Ill~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~elltg~~  298 (414)
                      .+++   ....+||+|||+.......   .......-...|.|||.+.+.        .+.+.||||+|++++|+++...
T Consensus        80 Clvd---~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   80 CLVD---SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             ceee---eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            9999   5889999999998765421   111122234579999998753        3667999999999999999999


Q ss_pred             CCCCCCc----hhhhHHHhh-cCCCCCCCCCC--CCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          299 PFWDKTE----DGIFKEVLR-NKPDFRRKPWP--SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       299 Pf~~~~~----~~~~~~i~~-~~~~~~~~~~~--~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ||.....    +++...+.. ....+.+..+.  .+++++..++..||..+|..||+++++-.
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            9976322    345555555 33223332221  45667999999999999999999998764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1.9e-20  Score=180.40  Aligned_cols=177  Identities=24%  Similarity=0.419  Sum_probs=135.0

Q ss_pred             CEEEEEEeccCCCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 NYVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      .++||.|++|.-.+|.+++..+ .....+...+..++.|+..|++|   +|.+|||+||.||+..   .+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence            4689999999999999999643 33456778899999999999999   9999999999999998   567899999999


Q ss_pred             ccccCCCC-------ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCC
Q 015026          249 SDFIKPGK-------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       249 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      ........       .....+||.+||+||.+.+ .++.++||||||+||+|++. =..+|..   ...+..+..+.  +
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~--i  477 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGI--I  477 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCC--C
Confidence            87655443       4456789999999999885 57999999999999999997 2222211   11222222222  2


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ++..+.+.| +-..|+..||.+.|.+||++.+.--|+|.
T Consensus       478 p~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  478 PPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ChHHhhcCc-HHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            222222333 45689999999999999988777677764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=3.2e-19  Score=159.16  Aligned_cols=139  Identities=24%  Similarity=0.313  Sum_probs=108.0

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC-------------------hHhHHHHHHHHHHHHHccCCC-
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-------------------PIAVEDVKREVKILQALAGHE-  157 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-------------------~~~~~~~~~E~~il~~l~~hp-  157 (414)
                      |.+.+.||.|+||.||++... +|+.||||++.......                   .........|+.++..+. ++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence            778899999999999999874 79999999876532100                   011224678999999995 66 


Q ss_pred             -CceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC
Q 015026          158 -NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       158 -nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~  236 (414)
                       .++..++    ....++||||++|++|.....        ......++.+|+.++.++|+.||+||||+|+||+++   
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---  159 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---  159 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc---
Confidence             4455544    234689999999998866431        134667899999999999999999999999999998   


Q ss_pred             CCCCceeeccccccccC
Q 015026          237 EDSSLKATDFGLSDFIK  253 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~  253 (414)
                      +++.++|+|||++....
T Consensus       160 ~~~~~~liDfg~~~~~~  176 (198)
T cd05144         160 DDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCcEEEEECCccccCC
Confidence            57899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=7.6e-19  Score=156.77  Aligned_cols=133  Identities=26%  Similarity=0.363  Sum_probs=105.1

Q ss_pred             eeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh-----HhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      .||+|+||+||+|.  .+|..|++|+........+     .....+.+|+.++..+. |+++.....++......++|||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence            38999999999997  4678899998654322111     12466789999999996 7766544444555666789999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      |++|++|.+.+....      .   .++.+++.+|.+||+.|++|+|++|+||+++    ++.++++|||++..
T Consensus        78 ~~~g~~l~~~~~~~~------~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN------D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcH------H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence            999999988763221      0   8899999999999999999999999999997    57899999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.3e-18  Score=178.00  Aligned_cols=142  Identities=23%  Similarity=0.291  Sum_probs=112.7

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC-----ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----LPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ....|...+.||+|+||+||+|.+..  ..+++|+.......     .....+.+.+|+.+++.+. |++|+....++.+
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~  407 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVD  407 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEe
Confidence            34456778999999999999997643  34555543221111     1123456889999999995 9999888777777


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      ....++||||++|++|.+++.          ....++.+++.+|.+||+.||+||||||+|||++    ++.++|+|||+
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGl  473 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGL  473 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCcc
Confidence            777899999999999998773          3567899999999999999999999999999994    56899999999


Q ss_pred             cccc
Q 015026          249 SDFI  252 (414)
Q Consensus       249 a~~~  252 (414)
                      ++..
T Consensus       474 a~~~  477 (535)
T PRK09605        474 GKYS  477 (535)
T ss_pred             cccC
Confidence            8763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=2.3e-18  Score=152.07  Aligned_cols=141  Identities=25%  Similarity=0.276  Sum_probs=100.8

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHH---------------------HHHHHHHHHHHccCC-CC
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------------------DVKREVKILQALAGH-EN  158 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~---------------------~~~~E~~il~~l~~h-pn  158 (414)
                      .+.||+|+||+||+|.+. +|+.||||++............                     ....|...+..+..+ ..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999976 8999999998754322111111                     114677777777422 23


Q ss_pred             ceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCC
Q 015026          159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKE  237 (414)
Q Consensus       159 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~  237 (414)
                      ++++++.    ...++||||++|+.+........  .. ...+..++.+++.++.++|. .||+|+||||+||+++    
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh--hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----
Confidence            5555543    23589999999854432211111  01 16788999999999999999 9999999999999998    


Q ss_pred             CCCceeeccccccccC
Q 015026          238 DSSLKATDFGLSDFIK  253 (414)
Q Consensus       238 ~~~vkl~DFG~a~~~~  253 (414)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            6789999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=7.5e-17  Score=147.71  Aligned_cols=139  Identities=17%  Similarity=0.249  Sum_probs=103.8

Q ss_pred             ceeee-ecCceEEEEEEECCCCCEEEEEEeeccCC----------CChHhHHHHHHHHHHHHHccCCCCc--eEEEEEEE
Q 015026          101 GKLLG-HGQFGYTYVATDKANGDRVAVKKIEKNKM----------ILPIAVEDVKREVKILQALAGHENV--VKFYNAFE  167 (414)
Q Consensus       101 ~~~lG-~G~~g~V~~~~~~~~~~~vaiK~i~~~~~----------~~~~~~~~~~~E~~il~~l~~hpnI--v~~~~~~~  167 (414)
                      ...|| .|+.|+||.+..  .+..++||.+.....          ........+.+|+.++..|. |++|  +..+++..
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~  112 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARV  112 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeee
Confidence            34687 889999999875  377899997753221          11223456789999999995 8775  67776643


Q ss_pred             cC-C---EEEEEEeccCC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          168 DD-N---YVYIAMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       168 ~~-~---~~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                      .. .   ..++|||+++| .+|.+++..   ..+++.    .+.+|+.+|.+||+.||+||||||+|||++   .++.++
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~  182 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFW  182 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEE
Confidence            32 2   23599999997 688777632   345554    367899999999999999999999999998   356899


Q ss_pred             eecccccccc
Q 015026          243 ATDFGLSDFI  252 (414)
Q Consensus       243 l~DFG~a~~~  252 (414)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999988663

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.3e-16  Score=134.75  Aligned_cols=133  Identities=29%  Similarity=0.359  Sum_probs=111.1

Q ss_pred             eceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEEEEEEcCCEEEEEEec
Q 015026          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVYIAMEL  178 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~~~~~~~~~~lv~e~  178 (414)
                      +++.||.|.++.||++....  ..+++|.+.....     ...+..|+.+++.+..+ +++++++.++...+..++++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            45779999999999998643  6899998755431     45688999999999733 6999999988888899999999


Q ss_pred             cCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH---GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~---~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      ++|+.+...         +......++.+++.+|..+|..   +++|+||+|+||+++   +.+.++++|||.+..
T Consensus        75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence            998776542         5566778899999999999985   799999999999998   467899999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.7e-17  Score=163.00  Aligned_cols=258  Identities=26%  Similarity=0.328  Sum_probs=200.6

Q ss_pred             cccceeeceeeee--cCceEEEEEEE--CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           94 FDRRYTIGKLLGH--GQFGYTYVATD--KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      +...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-... ...+.....=.+|+...+.+..|++.++.+..++..
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccC
Confidence            4456788899999  99999999988  888999999973221 111223333456777777887899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHH----HHHHHHHcCCeecCCCCCcEEEeecCCC-CCceee
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR----VAAECHLHGLVHRDMKPENFLFKSAKED-SSLKAT  244 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~----~L~~LH~~~iiHrDlkp~NIll~~~~~~-~~vkl~  244 (414)
                      +..++-+|+| |.+|..+.. .....+++..++..+.+...    ||..+|+.+++|-|+||+||++..   + ..++++
T Consensus       191 ~~lfiqtE~~-~~sl~~~~~-~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~---~~~s~~~~  265 (524)
T KOG0601|consen  191 GILFIQTELC-GESLQSYCH-TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTS---DWTSCKLT  265 (524)
T ss_pred             Ccceeeeccc-cchhHHhhh-cccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccc---ccceeecC
Confidence            9999999999 467777653 33456899999999999999    999999999999999999999983   5 789999


Q ss_pred             ccccccccCCCCcc------ccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC
Q 015026          245 DFGLSDFIKPGKKF------QDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (414)
Q Consensus       245 DFG~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~  318 (414)
                      |||+...+.+....      ....|...|++||+.++.++...||+++|.++.+..+|..++...... .+..+-...  
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~--  342 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY--  342 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc--
Confidence            99998877655421      223678889999999999999999999999999999887665433111 111111111  


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      .+.+.+...+.++...+..|++.+|..|+++..+++|++...
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            222333456677778999999999999999999999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=1.2e-17  Score=171.87  Aligned_cols=260  Identities=24%  Similarity=0.379  Sum_probs=204.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.+.+.+.+-.|+++.++.+.-..+|-..++|+............+.+..+-.++-.- .+|-++...-.+......+||
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchh
Confidence            4577888999999999999988788877777766554443333344455555554333 257777665556667889999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC--
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~--  253 (414)
                      ++|+.|++|...+.  ..+..+++.++.+...+..++++||...+.|||++|.|+|+.   .++..+++|||......  
T Consensus       883 ~~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hHHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccccccc
Confidence            99999999998873  345678888899999999999999999999999999999998   68999999998432210  


Q ss_pred             -----C---C----------------------CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCC
Q 015026          254 -----P---G----------------------KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWD  302 (414)
Q Consensus       254 -----~---~----------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~  302 (414)
                           .   .                      .......||+.|.+||.+.+ ..+..+|+|++|++++|.++|.+||.+
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                 0   0                      01123579999999997665 468999999999999999999999999


Q ss_pred             CCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHH---HHhCCccccccc
Q 015026          303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAA---QALSHPWVREGG  362 (414)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~---elL~hp~f~~~~  362 (414)
                      .....+++.+......++.-+ ...+.++++++.++|..+|.+|..+.   ++-.||||+...
T Consensus      1038 ~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             cchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            999999988887765444322 24788999999999999999999888   889999999643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=3.2e-14  Score=141.37  Aligned_cols=145  Identities=21%  Similarity=0.243  Sum_probs=97.1

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC---------------------------h----HhHH------HH
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---------------------------P----IAVE------DV  143 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---------------------------~----~~~~------~~  143 (414)
                      .+.||.|++|.||+|+. .+|+.||||+.+..-...                           .    ....      ++
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            36799999999999986 479999999975431000                           0    0000      23


Q ss_pred             HHHHHHHHHcc----CCCCceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHH-HHHHHHHc
Q 015026          144 KREVKILQALA----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR-VAAECHLH  218 (414)
Q Consensus       144 ~~E~~il~~l~----~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~-~L~~LH~~  218 (414)
                      .+|+..+..+.    ++++|.-..-+....+..+|||||++|++|.+....... ..   ....++..++. .+..+|..
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC
Confidence            44555555442    344433222222334457999999999999876533211 12   23456666665 46789999


Q ss_pred             CCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       219 ~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      |++|+|++|.||+++   .++.++|+|||++....
T Consensus       277 g~~H~D~hPgNilv~---~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 GFFHADLHPGNIFVL---KDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceeCCCCcccEEEC---CCCcEEEEeCCCeeECC
Confidence            999999999999998   57899999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=8.5e-14  Score=122.37  Aligned_cols=143  Identities=15%  Similarity=0.123  Sum_probs=103.7

Q ss_pred             ceeeeecCceEEEEEEECC------CCCEEEEEEeeccCC-------------------CChHhHHHH----HHHHHHHH
Q 015026          101 GKLLGHGQFGYTYVATDKA------NGDRVAVKKIEKNKM-------------------ILPIAVEDV----KREVKILQ  151 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~------~~~~vaiK~i~~~~~-------------------~~~~~~~~~----~~E~~il~  151 (414)
                      ...||.|--+.||.|....      .+..+|||+.+....                   ........+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998653      357899997532110                   001123333    38999999


Q ss_pred             HccCC-CCceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCc
Q 015026          152 ALAGH-ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVHRDMKPEN  229 (414)
Q Consensus       152 ~l~~h-pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~L-H~~~iiHrDlkp~N  229 (414)
                      ++... -++++++++    ...+|||||+.++.+.....  ....+++..+..+..+++.+|..| |..||||+||++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            98633 567777764    45689999997654432221  123456667788899999999998 89999999999999


Q ss_pred             EEEeecCCCCCceeeccccccccC
Q 015026          230 FLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       230 Ill~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||+.    ++.+.|+|||.+....
T Consensus       156 IL~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEE----CCcEEEEECCCceeCC
Confidence            9997    4679999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.53  E-value=6e-15  Score=148.42  Aligned_cols=149  Identities=21%  Similarity=0.270  Sum_probs=96.4

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCC--------------------------CCh-----HhHHHHHH
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--------------------------ILP-----IAVEDVKR  145 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------------------------~~~-----~~~~~~~~  145 (414)
                      .|+. +.||.|++|.||+|+.+.+|+.||||++++.-.                          ..+     ...+.+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 789999999999999988899999999865410                          000     11222333


Q ss_pred             ------HHHHHHHcc---CCCCceEEEEEEE-cCCEEEEEEeccCCCChHHHHHhccCC----CCCHHHHHHHHHHHHHH
Q 015026          146 ------EVKILQALA---GHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDS----RYTEKDAAVVVRQMLRV  211 (414)
Q Consensus       146 ------E~~il~~l~---~hpnIv~~~~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~~~----~l~~~~~~~i~~qil~~  211 (414)
                            |+..+.++.   .+...+.+-.+|. ..+..+|||||++|+++.+.......+    .+.+..+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence                  444444432   1333333333332 245678999999999997743212212    244444555555554  


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeec-CCCCCceeeccccccccC
Q 015026          212 AAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       212 L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DFG~a~~~~  253 (414)
                           ..|++|+|++|.||+++.+ ...+.++++|||++....
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 5999999999999999842 122489999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.51  E-value=8.4e-14  Score=120.70  Aligned_cols=129  Identities=19%  Similarity=0.207  Sum_probs=96.1

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      ++.|+.|.++.||++...  +..|++|+......    ....+..|+.+++.+.+...+++++....  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            457899999999999754  77899998754321    12345789999999863333455665443  33579999999


Q ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL-----VHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~i-----iHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      |.++.+.          ......++.+++.+|..||+.++     +|+|++|.||+++    ++.++++|||.+..
T Consensus        75 G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence            9877542          01123567899999999999985     9999999999998    45789999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=4.6e-15  Score=135.37  Aligned_cols=236  Identities=17%  Similarity=0.179  Sum_probs=154.9

Q ss_pred             EEEEEEECCCCCEEEEEEee----ccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC-----CEEEEEEeccCC
Q 015026          111 YTYVATDKANGDRVAVKKIE----KNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----NYVYIAMELCEG  181 (414)
Q Consensus       111 ~V~~~~~~~~~~~vaiK~i~----~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~-----~~~~lv~e~~~g  181 (414)
                      .||++.+...|..|+.-.+.    ++....+..++   .-..-|-++- |.|||+++.++.+.     ....+++|||..
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~---~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymss  156 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRR---AVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSS  156 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHH---HHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccc
Confidence            46666666666666544432    11111122222   2233444564 99999999988653     458899999999


Q ss_pred             CChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceeeccccccccC---C
Q 015026          182 GELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK---P  254 (414)
Q Consensus       182 g~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~---~  254 (414)
                      |++..+|.+.+  ...++...+++|+-||+.||.|||+..  |+|+++..+-|++.   .++.||+.---......   .
T Consensus       157 gs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq---~ngLIkig~~ap~s~h~s~~~  233 (458)
T KOG1266|consen  157 GSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ---HNGLIKIGSVAPDSTHPSVNS  233 (458)
T ss_pred             hhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec---CCceEEecccCccccchhhhh
Confidence            99999996543  346888899999999999999999985  99999999999998   57777764221111100   0


Q ss_pred             C--CccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCC-CCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 G--KKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      .  .....-.|-++|.|||.=. ...+-++|||+||....+|.-|..-- .+.+.-+.-..+.+.....       -...
T Consensus       234 ~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l-------en~l  306 (458)
T KOG1266|consen  234 TREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL-------ENGL  306 (458)
T ss_pred             hhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec-------cCcc
Confidence            0  0111234678899999533 23466899999999999998876532 1222111111121111100       0112


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      -.+++.+||+..|..||++.++|.||.+-+
T Consensus       307 qr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  307 QRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             ccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            357899999999999999999999998765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.49  E-value=9.7e-13  Score=111.49  Aligned_cols=150  Identities=20%  Similarity=0.259  Sum_probs=113.2

Q ss_pred             eceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh-----HhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .+..|-+|+-+.|+++.  ..|+.++||.=.......|     ....+-.+|+++|.++. --.|.-..-++.+...-.|
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence            56778999999999995  6788888885332222222     23456778999999885 4455544445777777889


Q ss_pred             EEeccCC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          175 AMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       175 v~e~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      +|||++| -++.+++...........-...++++|-+.+.-||..+|||+||..+||++.+.+....+.|+|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999987 46677776554433334444789999999999999999999999999999998777777799999998653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.46  E-value=1.3e-12  Score=130.04  Aligned_cols=182  Identities=19%  Similarity=0.258  Sum_probs=136.0

Q ss_pred             eeeceeeeecCceEEE-EEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           98 YTIGKLLGHGQFGYTY-VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~-~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      |.+ ...+-++.+ +| .|..+.++.+|.|.+.+....   ...+.+.+-++-|+.|+ ||||+++++.++.++..|||+
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEe
Confidence            555 334444444 44 466678899999998876543   34566788899999996 999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH-~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |-+.  .|..++.+     +....+...+.||+.||.||| ..+++|++|....|+++   ..|..||++|.++......
T Consensus        89 ErV~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn---~~GeWkLggle~v~~~~~~  158 (690)
T KOG1243|consen   89 ERVR--PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN---ESGEWKLGGLELVSKASGF  158 (690)
T ss_pred             eccc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc---CCCcEEEeeeEEEeccccC
Confidence            9985  55666633     347778888999999999997 67899999999999999   7899999999987654332


Q ss_pred             Cc-cccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhC
Q 015026          256 KK-FQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG  296 (414)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg  296 (414)
                      .. .....---.|..|+.+... .-..|.|-|||++++++.|
T Consensus       159 ~~~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  159 NAPAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CcccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence            21 1111222235666543321 1346999999999999998

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.1e-13  Score=136.27  Aligned_cols=252  Identities=17%  Similarity=0.164  Sum_probs=182.7

Q ss_pred             cccceeeceeeeecCceEEEEEEEC-CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDK-ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ...+|..+..||.|.|+.|+.+... .++..+++|.+....... .....-..|+-+...+.-|.+++..+..|......
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~-~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF-ASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch-HhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            4457888999999999999987655 677789999775543322 22233356777777777799999998888777778


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |+-.|||+++++...+  .-...+.+...+++..|++.++.++|+..++|+|+||+||++..+  ++..++.|||.....
T Consensus       342 ~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~--~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND--GFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc--hhhhhcccccccccc
Confidence            8999999999876655  333467888999999999999999999999999999999999842  278899999987532


Q ss_pred             CCCCccccCCCCCccc-cchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          253 KPGKKFQDIVGSAYYV-APEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~-aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      .-  ......+..+++ .+|++...  ...++|++|||.-+.+.++|...-+....   ...+..+.    ....+....
T Consensus       418 ~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~----~p~~~~~~~  488 (524)
T KOG0601|consen  418 AF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD----TPNLPGLKL  488 (524)
T ss_pred             ce--ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc----ccCCCchHH
Confidence            11  111223344455 35554433  47889999999999999998654222111   11122221    111234457


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      ++..+.+.++..|+..||.+.++..|+=|-
T Consensus       489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  489 QLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            888999999999999999999998887654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=5e-12  Score=107.69  Aligned_cols=136  Identities=25%  Similarity=0.316  Sum_probs=99.5

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChH-----hHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI-----AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~-----~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      ..+++|+-+.+|.+..  -|..+++|.=.+.....+.     ..+.-.+|+.++.++. --.|.-.+=+..+.....|+|
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence            3578999999999854  4556777753322222222     2344568999999885 445544444456677788999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||++|..|.+.+...         ...+++.+-..+.-||..||||+||.++||++.    ++.+.++|||++.+..
T Consensus        79 e~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~s~  142 (204)
T COG3642          79 EYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEFSD  142 (204)
T ss_pred             EEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccccc
Confidence            999998888887433         256777788888899999999999999999998    4559999999997643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=3e-11  Score=109.22  Aligned_cols=143  Identities=29%  Similarity=0.450  Sum_probs=104.4

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccC-CCCceEEEEEEEcC---CEEEEEEe
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG-HENVVKFYNAFEDD---NYVYIAME  177 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~-hpnIv~~~~~~~~~---~~~~lv~e  177 (414)
                      +.||.|..+.||++.... |+.+++|........  .....+..|+.+++.+.. +..+++++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            568999999999998643 678999987554321  134567899999999963 24467777766553   36789999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL----------------------------------------  217 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~----------------------------------------  217 (414)
                      |++|.++.+.+..   ..+++.....++.+++.+|..||+                                        
T Consensus        81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9999887664411   346667777777777777777773                                        


Q ss_pred             ----------------cCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          218 ----------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       218 ----------------~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                                      ..++|+|+.|.||+++.. .++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                            235899999999999831 145688999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.22  E-value=3.6e-10  Score=109.66  Aligned_cols=254  Identities=17%  Similarity=0.228  Sum_probs=171.0

Q ss_pred             ceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE----cCCEEEEEEeccCC-CC
Q 015026          109 FGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE----DDNYVYIAMELCEG-GE  183 (414)
Q Consensus       109 ~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~----~~~~~~lv~e~~~g-g~  183 (414)
                      -.+.|++....+|..|++|.+...+...+   ...-.-+++++++. |+|||++.++|.    .+..+++|++|.++ ++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            45799999999999999999944332222   22234577889995 999999999886    35679999999985 57


Q ss_pred             hHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          184 LLDRILAKK-------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       184 L~~~l~~~~-------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      |+++.....             ....+|..+|.++.||..||.++|+.|+..+-|.|.+||++   .+.+|+|..-|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEeccccee
Confidence            777664432             23467899999999999999999999999999999999998   34588888877776


Q ss_pred             ccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCC-chhh-hHHHhhcCCCCCCCCCCCCC
Q 015026          251 FIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKT-EDGI-FKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~-~~~~-~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .+..+.           .+|  +.  .-.+-|.=.||.+++.|.||..--+..+ ..+. +..|.           +.++
T Consensus       442 vl~~d~-----------~~~--le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS  495 (655)
T KOG3741|consen  442 VLQEDP-----------TEP--LE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYS  495 (655)
T ss_pred             eecCCC-----------Ccc--hh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhh
Confidence            654432           011  11  1345689999999999999854321111 1111 22221           3567


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCC---cccccccCCCCCCCCHHH-HHHHHHHhhhcHHHHHHHHHHHHhhh
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSH---PWVREGGDASEIPIDISV-LNNMRQFVKYSRLKQFALRVTQYFKY  399 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~h---p~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~~~~~~  399 (414)
                      .+++++|.-+...++++ -++.+++.+   -||......   ....+. ...+.+-....||-++.+.+.-..-+
T Consensus       496 ~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~---q~~~d~mE~~Ls~emENGRLfRll~Kln~I~dR  566 (655)
T KOG3741|consen  496 TDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESV---QLKTDVMETELSREMENGRLFRLLLKLNFIDDR  566 (655)
T ss_pred             HHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhH---HHHHHHHHHHHHHHHhcchHHHHHHHHhhhccC
Confidence            88999999999988887 688888764   344321111   101111 12233334456666666665544433

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=1.5e-11  Score=123.11  Aligned_cols=154  Identities=21%  Similarity=0.236  Sum_probs=112.6

Q ss_pred             HHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccc----------cCCCCCccccchhccc
Q 015026          207 QMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ----------DIVGSAYYVAPEVLKR  275 (414)
Q Consensus       207 qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~----------~~~gt~~y~aPE~~~~  275 (414)
                      +.++|+.|+|. .++||++|.|++|.++   ..+..||+.|+++....++..+.          -..-...|.|||++.+
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n---a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVN---ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeec---cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34499999996 4899999999999999   68999999999987655432211          1123557999998776


Q ss_pred             c-CCCCcchhHHHHHHHHHh-hCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHh
Q 015026          276 K-SGPESDVWSIGVITYILL-CGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL  353 (414)
Q Consensus       276 ~-~~~~~DiwslG~il~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL  353 (414)
                      . .+.++|++|+|+++|.+. .|+..+........+.........-....-..+|+++++=|.++|..++.-||++.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            5 488999999999999998 56666655433322222111110001111247899999999999999999999999999


Q ss_pred             CCcccccccC
Q 015026          354 SHPWVREGGD  363 (414)
Q Consensus       354 ~hp~f~~~~~  363 (414)
                      ..|||+...-
T Consensus       264 ~~~ff~D~~~  273 (700)
T KOG2137|consen  264 SIPFFSDPGL  273 (700)
T ss_pred             cccccCCchh
Confidence            9999997543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=2.8e-09  Score=101.15  Aligned_cols=241  Identities=20%  Similarity=0.228  Sum_probs=158.3

Q ss_pred             eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEE------Ec-CCE
Q 015026           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ED-DNY  171 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~------~~-~~~  171 (414)
                      .....||+|+-+.+|-.-  .-+. .+.|+...-.   +....+   -+..|...-+||-+-.-+.|=      .+ ...
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d-~VAKIYh~Pp---pa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRD-QVAKIYHAPP---PAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecc--hhhc-hhheeecCCC---chHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            456789999999999763  2222 3447665432   112222   222233333566543312111      12 233


Q ss_pred             EEEEEeccCCCChHHHH-----HhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          172 VYIAMELCEGGELLDRI-----LAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l-----~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      +-++|..++|..-...+     .++......+....+.++.|+.+..-||..|.+-+|+.++|+|+.   +++.|.|+|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcc
Confidence            77888888775322222     122334567888999999999999999999999999999999998   6889999986


Q ss_pred             ccccccCCCCccccCCCCCccccchhcc-----c-cCCCCcchhHHHHHHHHHhhC-CCCCCCCC----chhhhH-HHhh
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK-----R-KSGPESDVWSIGVITYILLCG-RRPFWDKT----EDGIFK-EVLR  314 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~~DiwslG~il~elltg-~~Pf~~~~----~~~~~~-~i~~  314 (414)
                      ..-.....+..+...+|.+.|.+||.-+     + .-+...|.|.||+++|+++.| +.||.+-.    ...-++ .|..
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            6544445555666789999999999643     2 226678999999999999985 99997532    111122 2211


Q ss_pred             c------------CCCCCCCCCCCCCHHHHHHHHHhhcCC--ccccCCHHH
Q 015026          315 N------------KPDFRRKPWPSISNSAKDFVKKLLVKD--PRARLTAAQ  351 (414)
Q Consensus       315 ~------------~~~~~~~~~~~~s~~~~~li~~~L~~d--p~~Rps~~e  351 (414)
                      +            .+.....+|.-+++++..|..+|+...  +.-|||++.
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            1            122223345568899999999999753  558998863

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.12  E-value=4.2e-10  Score=98.61  Aligned_cols=130  Identities=25%  Similarity=0.280  Sum_probs=83.6

Q ss_pred             EEEEEEECCCCCEEEEEEeeccC-----------------------CCChHhHHHHHHHHHHHHHccCC-CCceEEEEEE
Q 015026          111 YTYVATDKANGDRVAVKKIEKNK-----------------------MILPIAVEDVKREVKILQALAGH-ENVVKFYNAF  166 (414)
Q Consensus       111 ~V~~~~~~~~~~~vaiK~i~~~~-----------------------~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~~~  166 (414)
                      .||.|.. ..|..+|+|+.....                       ...........+|.+.|..+... -++++++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899986 457799999753311                       11122345678999999999633 2577777553


Q ss_pred             EcCCEEEEEEeccC--CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCcEEEeecCCCCCcee
Q 015026          167 EDDNYVYIAMELCE--GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (414)
Q Consensus       167 ~~~~~~~lv~e~~~--gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~-LH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (414)
                          ..+|||||++  |..+.. +...   .++......++.+++..+.. +|..||+|+||.+.|||++    ++.+.|
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~i  147 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYI  147 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE
T ss_pred             ----CCEEEEEecCCCccchhh-HHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEE
Confidence                2469999998  655543 3221   12245567888888886554 6899999999999999998    348999


Q ss_pred             eccccccccC
Q 015026          244 TDFGLSDFIK  253 (414)
Q Consensus       244 ~DFG~a~~~~  253 (414)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=2.5e-09  Score=99.21  Aligned_cols=138  Identities=17%  Similarity=0.130  Sum_probs=94.2

Q ss_pred             EEEEEEECCCCCEEEEEEeeccCCCC---h-----HhHHHHHHHHHHHHHccCCCCc--eEEEEEEEc-----CCEEEEE
Q 015026          111 YTYVATDKANGDRVAVKKIEKNKMIL---P-----IAVEDVKREVKILQALAGHENV--VKFYNAFED-----DNYVYIA  175 (414)
Q Consensus       111 ~V~~~~~~~~~~~vaiK~i~~~~~~~---~-----~~~~~~~~E~~il~~l~~hpnI--v~~~~~~~~-----~~~~~lv  175 (414)
                      .|.++.  ..|+.|.||.........   .     .....+.+|...+..|. .-+|  +.++.+.+.     ...-+||
T Consensus        37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEE
Confidence            355553  356788888653322100   0     01123678988888874 2233  334444432     2357899


Q ss_pred             EeccCCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec----CCCCCceeecccccc
Q 015026          176 MELCEGG-ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA----KEDSSLKATDFGLSD  250 (414)
Q Consensus       176 ~e~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~----~~~~~vkl~DFG~a~  250 (414)
                      ||++++. +|.+++........+......++.+++..+.-||..||+|+||++.|||++.+    .++..+.|+||+.+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999876 78777643223455677888999999999999999999999999999999841    345789999999875


Q ss_pred             c
Q 015026          251 F  251 (414)
Q Consensus       251 ~  251 (414)
                      .
T Consensus       194 ~  194 (268)
T PRK15123        194 I  194 (268)
T ss_pred             c
Confidence            3

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.08  E-value=9.2e-10  Score=99.44  Aligned_cols=139  Identities=27%  Similarity=0.293  Sum_probs=105.9

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeec-------------------cCCCChHhHHHHHHHHHHHHHccCC-C
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK-------------------NKMILPIAVEDVKREVKILQALAGH-E  157 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~-------------------~~~~~~~~~~~~~~E~~il~~l~~h-p  157 (414)
                      +.++.+||-|--|.||.|.+. .|.++|||.=+.                   ...+........++|.++|..|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567889999999999999875 688999995211                   0111123456678999999999633 3


Q ss_pred             CceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC
Q 015026          158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (414)
Q Consensus       158 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~  237 (414)
                      .|++.+++    +.-.+|||+++|..|...-       +....+..++..|+.-+.-+-..||||+|+.+-||+++   +
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~  237 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---E  237 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---c
Confidence            67777764    5568999999997775422       24555667777888877777799999999999999999   6


Q ss_pred             CCCceeeccccccc
Q 015026          238 DSSLKATDFGLSDF  251 (414)
Q Consensus       238 ~~~vkl~DFG~a~~  251 (414)
                      ++.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            88999999986644

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=4.4e-08  Score=87.79  Aligned_cols=111  Identities=22%  Similarity=0.239  Sum_probs=82.7

Q ss_pred             HHHHHHHHHHHHHccC-CCCceEEEEEEEcC----CEEEEEEeccCCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q 015026          140 VEDVKREVKILQALAG-HENVVKFYNAFEDD----NYVYIAMELCEGG-ELLDRILAKKDSRYTEKDAAVVVRQMLRVAA  213 (414)
Q Consensus       140 ~~~~~~E~~il~~l~~-hpnIv~~~~~~~~~----~~~~lv~e~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~  213 (414)
                      .....+|...+..|.. .=.+++.+.+.+..    ...+||+|+++|. +|.+++....  ..+......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            3456788888777741 12234555555432    3468999999884 6777774322  2667788999999999999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       214 ~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      -||+.||+|+|++|.|||++..+....+.|+||+-++..
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999996444458999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.72  E-value=2e-07  Score=82.73  Aligned_cols=141  Identities=21%  Similarity=0.309  Sum_probs=90.7

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHH------HHHHHHHHHHHcc--CCCCceEEEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE------DVKREVKILQALA--GHENVVKFYNA  165 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~------~~~~E~~il~~l~--~hpnIv~~~~~  165 (414)
                      +...|.+.+.+-......|.+.  ..+|+.+++|..............      ...+++..+..+.  +--....++-+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4567888898888887777766  456788999976543221111111      1223444333332  12222222222


Q ss_pred             -----EEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC
Q 015026          166 -----FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       166 -----~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                           +.-....+|||||++|..|.+..      .+++    .+...|.+++.-||+.|+.|+|..|.|++++    ++.
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCc
Confidence                 22234567899999998876643      1232    3456677889999999999999999999998    455


Q ss_pred             ceeecccccc
Q 015026          241 LKATDFGLSD  250 (414)
Q Consensus       241 vkl~DFG~a~  250 (414)
                      ++++||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.71  E-value=2.7e-07  Score=81.61  Aligned_cols=143  Identities=15%  Similarity=0.132  Sum_probs=100.6

Q ss_pred             eecCceEEEEEEECCCCCEEEEEEeecc---CCCChHhHHHHHHHHHHHHHccCC-CCceEEEEEEE---c--CCEEEEE
Q 015026          105 GHGQFGYTYVATDKANGDRVAVKKIEKN---KMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFE---D--DNYVYIA  175 (414)
Q Consensus       105 G~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~~~~---~--~~~~~lv  175 (414)
                      |+||.+-|+....  .|+.+-+|.-...   ....|.....|.+|+..|..|... -.++++. ++.   .  .-.-+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            6788888988753  3446888875311   111144667889999999988521 1244544 332   1  2347899


Q ss_pred             EeccCC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          176 MELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       176 ~e~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +|-+.| .+|.+++......+.++.....++.+++.+|.-||+.|+.|+|+-+.||+++..+ ...|.++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence            997754 4676666444344567888889999999999999999999999999999998422 34599999986653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.70  E-value=2e-09  Score=106.88  Aligned_cols=243  Identities=18%  Similarity=0.223  Sum_probs=168.0

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCC-ceEEEEEEEcCCEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpn-Iv~~~~~~~~~~~~~lv  175 (414)
                      -|.....+++|+++++++.+...+...+ .+++...        ....-++++|.++ +||| .+..++-++.+...+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~  312 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIP  312 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHc-cCCCCcccccccCCcccccchh
Confidence            3566677999999999999765555444 6655432        3456689999999 5999 77777778888899999


Q ss_pred             EeccCCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          176 MELCEGG-ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       176 ~e~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ++++.++ +....+ ....-.+.+-+...+.+.-+.+++++|+.-=+|||    ||+..    ++.++..||+.......
T Consensus       313 ~~i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  313 MRICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hhhhcCCccccccC-ChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcccCc
Confidence            9999887 222111 11112244455566777888899999998888999    88876    57789999998877665


Q ss_pred             CCccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhc--CCCCCC-CCCCCCCHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRR-KPWPSISNS  330 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~-~~~~~~s~~  330 (414)
                      .....+..+|+.++|||+.. +.+....|.|++|+-..+|.-|.+|-.....  ....+-.+  .+.... ..|...  .
T Consensus       384 ~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~--~  459 (829)
T KOG0576|consen  384 TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPV--F  459 (829)
T ss_pred             ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCcc--c
Confidence            55566789999999999765 4567788999999988888878777533111  00000000  000000 111111  1


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      -.++...|+..-|..|+..-.++-|.+|..-+
T Consensus       460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             ccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            12467789999999999999999999998643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.69  E-value=3.9e-07  Score=82.81  Aligned_cols=73  Identities=19%  Similarity=0.210  Sum_probs=55.2

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEEEEEEcCCEEEEEEeccC
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      ..||.|..+.||+.    .|..+++|......     ....+.+|.++++.+... -.+++.+++..+.+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            46899999999984    24567888765422     234578999999998633 235788888888888899999999


Q ss_pred             CCC
Q 015026          181 GGE  183 (414)
Q Consensus       181 gg~  183 (414)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.67  E-value=2e-07  Score=93.71  Aligned_cols=145  Identities=20%  Similarity=0.229  Sum_probs=93.6

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCC--------------------------CC-h----HhHHH------HH
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--------------------------IL-P----IAVED------VK  144 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------------------------~~-~----~~~~~------~~  144 (414)
                      +.|+.++-|.||+|+.+ +|+.||||+.+..-.                          .. .    +..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            68999999999999974 499999998644210                          00 0    01111      23


Q ss_pred             HHHHHHHHc----cCCCCceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHH-HHHHHHcC
Q 015026          145 REVKILQAL----AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV-AAECHLHG  219 (414)
Q Consensus       145 ~E~~il~~l----~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~-L~~LH~~~  219 (414)
                      +|...+.++    ++.|+|.-..-+++-.+.-.|+|||++|..+.+...... ..++..   .++..++.+ +.-+=..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence            344444433    244555433334455667899999999998888753333 334432   233333332 23344589


Q ss_pred             CeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       220 iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ++|.|..|.||++.   .++.+.+.|||+...+.+
T Consensus       286 ffHaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVR---SDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEe---cCCcEEEEcCcceecCCH
Confidence            99999999999999   578999999999876543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.57  E-value=1e-06  Score=79.14  Aligned_cols=141  Identities=20%  Similarity=0.191  Sum_probs=97.3

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh---------------------HhHHHHHHHHHHHHHccC-CCC
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---------------------IAVEDVKREVKILQALAG-HEN  158 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---------------------~~~~~~~~E~~il~~l~~-hpn  158 (414)
                      ...|+.|--+.||+|.. .++..+|+|+.........                     ........|...|+++.. +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677888889999974 5688999998754221110                     112234578888877742 345


Q ss_pred             ceEEEEEEEcCCEEEEEEeccCCCCh-HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecC
Q 015026          159 VVKFYNAFEDDNYVYIAMELCEGGEL-LDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       159 Iv~~~~~~~~~~~~~lv~e~~~gg~L-~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~  236 (414)
                      +++.+.+.    ...|||||+..... .-.|   +.-.+...++..+..+++..+.-|-. .++||+||..-|||+.   
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~---  201 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH---  201 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE---
Confidence            56666543    24799999954311 1111   12234444788899999999988876 9999999999999997   


Q ss_pred             CCCCceeeccccccccC
Q 015026          237 EDSSLKATDFGLSDFIK  253 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~  253 (414)
                       ++.+.|+|||.|....
T Consensus       202 -~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 -DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CCeEEEEECccccccC
Confidence             6789999999886654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.56  E-value=4.3e-07  Score=96.35  Aligned_cols=207  Identities=19%  Similarity=0.227  Sum_probs=141.0

Q ss_pred             HHHHHHHHHHHHccCCCCceEEEEEEEcCCEE----EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q 015026          141 EDVKREVKILQALAGHENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH  216 (414)
Q Consensus       141 ~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~----~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH  216 (414)
                      ....-|+..+..+. |+|++.++.+-......    .+..|+|.+.++...+  ..-+..+....+.+..+++.||.|+|
T Consensus       227 ~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHH
Confidence            33455777778885 99999999886544322    2345788888888877  44567899999999999999999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCCCceee--ccccccccCCCCccccCCCCCccccchhccccC---CCCcchhHHHHHHH
Q 015026          217 LHGLVHRDMKPENFLFKSAKEDSSLKAT--DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS---GPESDVWSIGVITY  291 (414)
Q Consensus       217 ~~~iiHrDlkp~NIll~~~~~~~~vkl~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~DiwslG~il~  291 (414)
                      +....|.-|...-..-......+.+.++  ||+.+.............-+..+-|||......   ....|+|++|.++.
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            9966555554442221111234556666  888877665544433444556677888766544   33469999999999


Q ss_pred             HHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       292 elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      .+..|..+-.-   ......++..          ....+..+.+.+|+.-++++|+++.+++.|||.+....
T Consensus       384 ~~~~~~~i~~~---~~~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  384 QLSQGEDISEK---SAVPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             hhhhcCccccc---ccchhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence            99987554210   0011111110          11126788999999999999999999999999986543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.52  E-value=1.9e-06  Score=78.16  Aligned_cols=79  Identities=27%  Similarity=0.280  Sum_probs=57.7

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEEEEEE---cCCEEEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFE---DDNYVYIAM  176 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~~~~---~~~~~~lv~  176 (414)
                      ++.|+.|..+.||++....  ..+++|.....     .....+.+|..+++.|..+ ..+++++....   .....+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4679999999999998654  48999986443     3567788999999988644 23567776443   344689999


Q ss_pred             eccCCCChHH
Q 015026          177 ELCEGGELLD  186 (414)
Q Consensus       177 e~~~gg~L~~  186 (414)
                      ++++|.++..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.51  E-value=1.3e-06  Score=80.42  Aligned_cols=75  Identities=19%  Similarity=0.191  Sum_probs=55.3

Q ss_pred             eeecCc-eEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCC
Q 015026          104 LGHGQF-GYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGG  182 (414)
Q Consensus       104 lG~G~~-g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg  182 (414)
                      |-.|.. +.||++..  .+..+++|......      ...+.+|+.+++.+.++--+++++++....+..++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            445555 78999864  34678888764432      2356789999999976666778888887777789999999997


Q ss_pred             ChHH
Q 015026          183 ELLD  186 (414)
Q Consensus       183 ~L~~  186 (414)
                      ++..
T Consensus        78 ~l~~   81 (244)
T cd05150          78 PAAA   81 (244)
T ss_pred             cHhH
Confidence            7654

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=1.5e-06  Score=73.98  Aligned_cols=134  Identities=24%  Similarity=0.322  Sum_probs=93.0

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      -+..+.||+|.+|.||+|.  ..|..+|+|+-..+.     ....+..|+++|..+.+----.++|.+-.    .++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEee--ccCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence            3567889999999999996  457799999765443     56788999999999964333456665433    345699


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCC-CCcEEEeecCCCCCceeeccccccccCC
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK-PENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlk-p~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |+.|-+|.+.....     .    +.-+..++++---|-..||-|..|. |..++|.   ++..+.|+||..|++...
T Consensus        93 ~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv---~~~~~~iIDFd~At~k~~  158 (201)
T COG2112          93 YIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV---NDRDVYIIDFDSATFKKK  158 (201)
T ss_pred             hhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe---cCCcEEEEEccchhhccC
Confidence            99998887654210     1    2223345555555778899999885 4444444   355899999999875443

>PLN02876 acyl-CoA dehydrogenase

Probab=98.39  E-value=4.4e-06  Score=90.17  Aligned_cols=81  Identities=30%  Similarity=0.438  Sum_probs=58.2

Q ss_pred             ceeeeecCceEEEEEEECCCC--CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCc--eEEEEEEEcC---CEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANG--DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV--VKFYNAFEDD---NYVY  173 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnI--v~~~~~~~~~---~~~~  173 (414)
                      ++.|+.|.++.+|+......+  ..+++|+.......  .....+.+|+.+|+.|..|++|  ++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            467899999999998764432  36777876443221  1235688999999999646655  7888887764   4688


Q ss_pred             EEEeccCCCC
Q 015026          174 IAMELCEGGE  183 (414)
Q Consensus       174 lv~e~~~gg~  183 (414)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999999864

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.37  E-value=1.1e-05  Score=70.82  Aligned_cols=129  Identities=25%  Similarity=0.280  Sum_probs=91.0

Q ss_pred             cceeeceeeeecCc-eEEEEEEECCCCCEEEEEEeec---cCC-------C--C------hHhHHHHHHHHHHHHHcc--
Q 015026           96 RRYTIGKLLGHGQF-GYTYVATDKANGDRVAVKKIEK---NKM-------I--L------PIAVEDVKREVKILQALA--  154 (414)
Q Consensus        96 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vaiK~i~~---~~~-------~--~------~~~~~~~~~E~~il~~l~--  154 (414)
                      ..++.++.||.|+- |.||++.  -.|+.+|+|+...   ...       .  .      ......|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57899999999999 9999996  5678999998321   000       0  0      023346778888777765  


Q ss_pred             CCCCc--eEEEEEEEcC------------------CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q 015026          155 GHENV--VKFYNAFEDD------------------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE  214 (414)
Q Consensus       155 ~hpnI--v~~~~~~~~~------------------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~  214 (414)
                      ++.++  |+.+|+..-.                  ....||.||++...           .+..    .-+.+|++-|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHH
Confidence            24455  9999987211                  23568888887643           1222    235567777889


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       215 LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      +|..||+-+|+++.|..=        -||+|||.+
T Consensus       180 ~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HHHCCeeeccCccccccC--------CEEEecccC
Confidence            999999999999999972        289999964

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.25  E-value=3.3e-05  Score=68.33  Aligned_cols=134  Identities=18%  Similarity=0.244  Sum_probs=93.6

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCC-------------ChHhHHHHHHHHHHHHHcc-----CCCCceEEE
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-------------LPIAVEDVKREVKILQALA-----GHENVVKFY  163 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-------------~~~~~~~~~~E~~il~~l~-----~hpnIv~~~  163 (414)
                      ..||+|+.=.||.-  +. ....+||++......             .....++..+|+.....+.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46999999999964  33 345678988765400             0113456677777766663     378999999


Q ss_pred             EEEEcCCEEEEEEeccCC------CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC
Q 015026          164 NAFEDDNYVYIAMELCEG------GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (414)
Q Consensus       164 ~~~~~~~~~~lv~e~~~g------g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~  237 (414)
                      |+.+.+.-.-+|+|.+..      -+|.+++.+   +.+++    .+...+-+-..||-+++|+.+||+|.||++....+
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            999998888999998742      366777622   23444    33333444457889999999999999999986544


Q ss_pred             CC-Cceeec
Q 015026          238 DS-SLKATD  245 (414)
Q Consensus       238 ~~-~vkl~D  245 (414)
                      .. .+.|+|
T Consensus       157 ~~~~lvlID  165 (199)
T PF10707_consen  157 GEFRLVLID  165 (199)
T ss_pred             CceEEEEEe
Confidence            44 677777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.21  E-value=9.3e-06  Score=81.65  Aligned_cols=146  Identities=19%  Similarity=0.237  Sum_probs=89.9

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCC----------------------------ChHhHHHHHHHHHHH---
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----------------------------LPIAVEDVKREVKIL---  150 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~----------------------------~~~~~~~~~~E~~il---  150 (414)
                      +.||..+.|.|++|+-+. |+.||||+-+..-..                            .++..+.+..|++.+   
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            689999999999999765 999999974331100                            001112222233222   


Q ss_pred             ---HHcc---CCCC------ceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHH-HHHHH
Q 015026          151 ---QALA---GHEN------VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHL  217 (414)
Q Consensus       151 ---~~l~---~hpn------Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L-~~LH~  217 (414)
                         .+++   .|-+      |+++|-  .-...-.|+||||+|..+.|.-.-.+ ..++...+   +..+.++. +-|=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i---~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDI---LNKLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHH---HHHHHHHHHHHHHh
Confidence               2221   1444      444442  33456789999999987766432222 23455433   33333332 23345


Q ss_pred             cCCeecCCCCCcEEEeec-CCCCCceeeccccccccCC
Q 015026          218 HGLVHRDMKPENFLFKSA-KEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       218 ~~iiHrDlkp~NIll~~~-~~~~~vkl~DFG~a~~~~~  254 (414)
                      .|++|+|=.|.||++.+. ..+..+.+-|||+...+..
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            789999999999999954 2467899999999876543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.15  E-value=2.8e-05  Score=70.99  Aligned_cols=76  Identities=25%  Similarity=0.304  Sum_probs=50.4

Q ss_pred             ceeeeecCceEEEEEEECC-CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEecc
Q 015026          101 GKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (414)
                      ++.|..|-...||++.... .++.|++|+......    ..-...+|+.+++.+..+.-.++++..+..    .+||||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence            4568888888999996443 356888997643321    112335799999988644445666654432    3799999


Q ss_pred             CCCCh
Q 015026          180 EGGEL  184 (414)
Q Consensus       180 ~gg~L  184 (414)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.12  E-value=1.3e-05  Score=73.22  Aligned_cols=74  Identities=20%  Similarity=0.206  Sum_probs=47.5

Q ss_pred             eeeeecCce-EEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC--CCceEEEEEEEcC---CEEEEE
Q 015026          102 KLLGHGQFG-YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH--ENVVKFYNAFEDD---NYVYIA  175 (414)
Q Consensus       102 ~~lG~G~~g-~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h--pnIv~~~~~~~~~---~~~~lv  175 (414)
                      +.|+.|+.. .||+.     +..+++|......     ....+.+|..+|..|..+  -.++++++.....   ...++|
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            467766666 58876     2347778644321     345789999999988643  1345555544332   245889


Q ss_pred             EeccCCCChH
Q 015026          176 MELCEGGELL  185 (414)
Q Consensus       176 ~e~~~gg~L~  185 (414)
                      |++++|.++.
T Consensus        73 ~~~i~G~~l~   82 (235)
T cd05155          73 YRWLEGETAT   82 (235)
T ss_pred             EEeecCCCCC
Confidence            9999987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.05  E-value=5.7e-05  Score=73.96  Aligned_cols=81  Identities=21%  Similarity=0.325  Sum_probs=56.4

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCC----CChHhHHHHHHHHHHHHHccCC--CCceEEEEEEEcCCEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM----ILPIAVEDVKREVKILQALAGH--ENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~~~~~E~~il~~l~~h--pnIv~~~~~~~~~~~~~l  174 (414)
                      .+.||.|.++.||++.+...++.|+||.-.....    .-+...++...|.+.|+.+..+  .++++++.+  ++...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            3579999999999999854445899997432110    0022456778899999887533  467788765  4466789


Q ss_pred             EEeccCCCC
Q 015026          175 AMELCEGGE  183 (414)
Q Consensus       175 v~e~~~gg~  183 (414)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.87  E-value=0.00012  Score=69.64  Aligned_cols=76  Identities=16%  Similarity=0.168  Sum_probs=50.3

Q ss_pred             eeeeecCceEEEEEEECC------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026          102 KLLGHGQFGYTYVATDKA------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|..|--..||++....      .++.+++|+......    ......+|..++..+..+--.++++..+.+    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            456677777899886533      257899998654321    223557899999888644444566665542    358


Q ss_pred             EeccCCCChH
Q 015026          176 MELCEGGELL  185 (414)
Q Consensus       176 ~e~~~gg~L~  185 (414)
                      +||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.83  E-value=7.3e-05  Score=65.76  Aligned_cols=102  Identities=22%  Similarity=0.221  Sum_probs=78.8

Q ss_pred             HHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 015026          144 KREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQMLRVAAECHL---HG  219 (414)
Q Consensus       144 ~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qil~~L~~LH~---~~  219 (414)
                      ..|.-+|+.+.+.+++++++|+|-.    ++|.||...+++...... .....-++..+..|+.++++.+.+++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            4588899999866899999999843    678999987665321000 111235799999999999999999987   35


Q ss_pred             CeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       220 iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      +.-.|++|+|+-++   +++.+|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVN---DDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEe---CCCcEEEEechhcchh
Confidence            77789999999999   5789999999876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.78  E-value=0.00041  Score=64.23  Aligned_cols=135  Identities=19%  Similarity=0.123  Sum_probs=77.0

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCC
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (414)
                      +..|-.+.+|++.  .+++.+++|........   ..-...+|..+++.+..+.-.++++....    -++|+||++|..
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            5667788899886  45678888875433211   10134789999999864423345554432    368999999866


Q ss_pred             hHH--------------HHHhcc-----CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCCeecCCC
Q 015026          184 LLD--------------RILAKK-----DSRYTE-KDAAVVVRQM---------LRVAAECHL--------HGLVHRDMK  226 (414)
Q Consensus       184 L~~--------------~l~~~~-----~~~l~~-~~~~~i~~qi---------l~~L~~LH~--------~~iiHrDlk  226 (414)
                      +..              .+.+-.     ...++. ..+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            431              111111     111121 1222222222         111222221        248999999


Q ss_pred             CCcEEEeecCCCCCceeeccccccc
Q 015026          227 PENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       227 p~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      |.||+++.   ++ +.|+||+.|..
T Consensus       155 ~~Nil~~~---~~-~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVTP---QG-LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEeC---CC-CEEEeccccCc
Confidence            99999983   33 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.76  E-value=3e-05  Score=72.28  Aligned_cols=138  Identities=22%  Similarity=0.309  Sum_probs=98.0

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeecc-------------------CCCChHhHHHHHHHHHHHHHccCCC
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKN-------------------KMILPIAVEDVKREVKILQALAGHE  157 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-------------------~~~~~~~~~~~~~E~~il~~l~~hp  157 (414)
                      -+.++..||-|--+.||++.+ ..|++.++|.=+..                   ..+.-..+-...+|...|+.|..|-
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            367889999999999999986 45888888852111                   1111122334567888898886543


Q ss_pred             -CceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC
Q 015026          158 -NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       158 -nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~  236 (414)
                       -+++.++    .+.-++|||++.|-+|...-        ....+..+...++.-+--|-.+|+||+|..-=||+++   
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~--------~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---  236 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVR--------HVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---  236 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeee--------ecCChHHHHHHHHHHHHHHHHcCceecccchheeEEe---
Confidence             3444444    35678999999998776432        1223445666677777789999999999999999998   


Q ss_pred             CCCCceeecccccc
Q 015026          237 EDSSLKATDFGLSD  250 (414)
Q Consensus       237 ~~~~vkl~DFG~a~  250 (414)
                      +++.++++||--.-
T Consensus       237 dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMV  250 (465)
T ss_pred             cCCCEEEeechHhh
Confidence            68889999997543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.72  E-value=0.00026  Score=66.99  Aligned_cols=140  Identities=19%  Similarity=0.149  Sum_probs=82.4

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEEEE------EEcCCEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNA------FEDDNYVY  173 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~~------~~~~~~~~  173 (414)
                      ++.|..|....+|++..  .+..+++|+....      ....+..|+.++..|..+ -.+++++..      ....+..+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            45677888889999853  3446888977531      234567788888888532 125555432      23345678


Q ss_pred             EEEeccCCCChHH----H---H-------Hhcc-C--CC------CCHHH----------HHHHHHHHHHHHHHHHH---
Q 015026          174 IAMELCEGGELLD----R---I-------LAKK-D--SR------YTEKD----------AAVVVRQMLRVAAECHL---  217 (414)
Q Consensus       174 lv~e~~~gg~L~~----~---l-------~~~~-~--~~------l~~~~----------~~~i~~qil~~L~~LH~---  217 (414)
                      +|+++++|..+..    .   +       .... .  ..      .....          .......+..++.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999866421    0   0       0000 0  00      00000          00011123334445443   


Q ss_pred             ----cCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          218 ----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       218 ----~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                          .++||+|+.|.||+++   ++..+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence                4799999999999998   345568999997743

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.70  E-value=3.1e-06  Score=91.91  Aligned_cols=214  Identities=15%  Similarity=0.014  Sum_probs=138.9

Q ss_pred             hHHHHHHHHHHHHHccCCCCceEEEEEEEc--CCEEEEEEeccCCCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHH
Q 015026          139 AVEDVKREVKILQALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKD--SRYTEKDAAVVVRQMLRVAAE  214 (414)
Q Consensus       139 ~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qil~~L~~  214 (414)
                      ..+....|.+-++... |+++...+.-..+  ....+.+++++.+|.+++.+.....  ..+.+.-+.....+.+.+..-
T Consensus      1272 lkemll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred             HHHhhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence            3445556666666675 9999877765543  3457889999999999998865432  233344444444454777777


Q ss_pred             HHHc-----CCeecCCCCCcEEEeecCCCCCceeeccccccccC-CCCccccCCCCCccccchhcccc-CCCCcchhHHH
Q 015026          215 CHLH-----GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIG  287 (414)
Q Consensus       215 LH~~-----~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG  287 (414)
                      +|+.     -.+|++||+-|.+|.   .+..||++++|+.+... .........+++.|++|++.+.- .+.++|+|..|
T Consensus      1351 ~ls~tnlg~T~v~~~Lkf~lpmIV---tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIV---TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRS 1427 (2724)
T ss_pred             hhhcccCCccchhhhhhhhcccee---cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHH
Confidence            7754     268999999999998   57889999999998332 22234456789999999988764 45569999999


Q ss_pred             HHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       288 ~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      +.+|+..-|..+|-.... ..+..++.+...+.-+.  -.|.++-.....+|-..-..||.-...+.-+.|.
T Consensus      1428 ~~ly~rs~~n~~fi~flq-~~Lkgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIFFLQ-PALKGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHHhcccHHHHHHHH-HHHcCcccccccccccc--cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            999999988888722111 11112222221111111  1133444444455555566777777777766655

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.69  E-value=0.00031  Score=67.47  Aligned_cols=77  Identities=17%  Similarity=0.210  Sum_probs=50.9

Q ss_pred             eeeecCceEEEEEEECCCCCEEEEEEee----ccCCCChHhHHHHHHHHHHHHHccCC-C-CceEEEEEEEcCCEEEEEE
Q 015026          103 LLGHGQFGYTYVATDKANGDRVAVKKIE----KNKMILPIAVEDVKREVKILQALAGH-E-NVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~----~~~~~~~~~~~~~~~E~~il~~l~~h-p-nIv~~~~~~~~~~~~~lv~  176 (414)
                      .||.|....||++.+...++.|+||.-.    .....-+...++..-|...|+.+... | .++++|  +.++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence            4799999999999976444689999632    11111133455666788888876433 3 455665  34556667999


Q ss_pred             eccCC
Q 015026          177 ELCEG  181 (414)
Q Consensus       177 e~~~g  181 (414)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.57  E-value=0.00085  Score=63.94  Aligned_cols=141  Identities=18%  Similarity=0.123  Sum_probs=80.2

Q ss_pred             eceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEEEE------EEcCCEE
Q 015026          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNA------FEDDNYV  172 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~~------~~~~~~~  172 (414)
                      .++.++.|....+|++.. .+| .+++|+.....     ..+.+..|+.++..|.++ -.+++++..      ....+..
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            356678888889999863 334 57788764421     124456677888777422 124444432      1234667


Q ss_pred             EEEEeccCCCChH----H-------H---HHhccCC---C----CCHHHH-----H----------HHHHHHHHHHHHHH
Q 015026          173 YIAMELCEGGELL----D-------R---ILAKKDS---R----YTEKDA-----A----------VVVRQMLRVAAECH  216 (414)
Q Consensus       173 ~lv~e~~~gg~L~----~-------~---l~~~~~~---~----l~~~~~-----~----------~i~~qil~~L~~LH  216 (414)
                      ++|+||++|.++.    +       .   +.....+   .    ......     .          .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            8999999985431    1       1   1100000   0    000000     0          00112333455553


Q ss_pred             H-------cCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          217 L-------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       217 ~-------~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .       .++||+|+.+.||+++   +++.+.|+||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence            2       5899999999999998   34556899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.48  E-value=0.0014  Score=62.53  Aligned_cols=144  Identities=20%  Similarity=0.216  Sum_probs=98.0

Q ss_pred             eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCC---------------------CChH--hHHHHHHHHHHHHHccC
Q 015026           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM---------------------ILPI--AVEDVKREVKILQALAG  155 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---------------------~~~~--~~~~~~~E~~il~~l~~  155 (414)
                      .|...|..|--+-||.|. ..+|..+|||+...+-+                     ..|.  ..-....|++-|+++. 
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-  224 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-  224 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-
Confidence            455678899999999997 47788899997632110                     0111  1223567888888884 


Q ss_pred             CCCceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEEee
Q 015026          156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       156 hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~L-H~~~iiHrDlkp~NIll~~  234 (414)
                      ...|+-.--+..  ..-.|||+|+.....-.-  ..+...++...+..+-.|++.-+.-| +..++||.||.--|+|+. 
T Consensus       225 ~aGIP~PePIlL--k~hVLVM~FlGrdgw~aP--kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  225 NAGIPCPEPILL--KNHVLVMEFLGRDGWAAP--KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-  299 (520)
T ss_pred             hcCCCCCCceee--ecceEeeeeccCCCCcCc--ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence            444432111111  235789999953221111  12345688888999999999888877 567999999999999997 


Q ss_pred             cCCCCCceeecccccccc
Q 015026          235 AKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       235 ~~~~~~vkl~DFG~a~~~  252 (414)
                         +|.+.|+|.+-+.-.
T Consensus       300 ---dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 ---DGKLYIIDVSQSVEH  314 (520)
T ss_pred             ---CCEEEEEEccccccC
Confidence               789999999977543

>PLN02236 choline kinase

Probab=97.44  E-value=0.0019  Score=62.58  Aligned_cols=141  Identities=11%  Similarity=0.139  Sum_probs=82.6

Q ss_pred             ceeeeecCceEEEEEEECC----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKA----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +..|-.|--..+|++....    +++.|++|+.....   ....+ -.+|..+++.+..+.--+++++.+..+    .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            4456567888999986432    34689999765432   11222 267999999987554456677766443    589


Q ss_pred             eccCCCChHHH----------H----H---hcc--CC--CCCHHHHHHHHHHH-----------------HHHHHHH---
Q 015026          177 ELCEGGELLDR----------I----L---AKK--DS--RYTEKDAAVVVRQM-----------------LRVAAEC---  215 (414)
Q Consensus       177 e~~~gg~L~~~----------l----~---~~~--~~--~l~~~~~~~i~~qi-----------------l~~L~~L---  215 (414)
                      ||++|.++...          +    .   ...  ..  ......+..++.++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99987665321          0    0   000  00  11122333333222                 1111122   


Q ss_pred             -H----HcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          216 -H----LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       216 -H----~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                       .    ...++|+|+++.||+++.  .++.+.|+||..|..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~--~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDE--ETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeC--CCCcEEEEeehhccc
Confidence             1    225799999999999983  346799999998754

>PRK05231 homoserine kinase; Provisional

Probab=97.42  E-value=0.0036  Score=59.94  Aligned_cols=76  Identities=18%  Similarity=0.074  Sum_probs=45.7

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEEE------EEEcCCEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYN------AFEDDNYVY  173 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~------~~~~~~~~~  173 (414)
                      .+.|+.|....+|.+.. .+| .+++|+.. ..     ..+.+..|+.+++.|..+ -.+++++.      +....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~-~~-----~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFE-RL-----TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEe-CCC-cEEEEEec-cC-----ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            34577888889999864 334 68889775 11     123445566666666311 12334432      123356689


Q ss_pred             EEEeccCCCCh
Q 015026          174 IAMELCEGGEL  184 (414)
Q Consensus       174 lv~e~~~gg~L  184 (414)
                      +++||++|..+
T Consensus        99 ~l~~~l~G~~~  109 (319)
T PRK05231         99 AIVTFLEGKWP  109 (319)
T ss_pred             EEEEecCCCCC
Confidence            99999998643

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.35  E-value=0.0019  Score=62.27  Aligned_cols=141  Identities=16%  Similarity=0.163  Sum_probs=79.4

Q ss_pred             ceeeeecCceEEEEEEECCC---CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026          101 GKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      ++.|..|--..+|++.....   +..|++|+......    ..-.-.+|..+++.+..+.--+++++++. .+   +|.+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~   90 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS   90 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence            34565577778998864332   33788997654321    11223579999999864433356666653 22   5899


Q ss_pred             ccCCCChHH----------HH----HhccCCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 015026          178 LCEGGELLD----------RI----LAKKDSR------Y-TEKDAAVVVRQM----------------------LRVAAE  214 (414)
Q Consensus       178 ~~~gg~L~~----------~l----~~~~~~~------l-~~~~~~~i~~qi----------------------l~~L~~  214 (414)
                      |++|.+|..          .+    .+-....      . ....+..+..++                      ..-+..
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            998765521          11    0001101      1 122233333222                      111222


Q ss_pred             H----HHcC----CeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          215 C----HLHG----LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       215 L----H~~~----iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +    ...+    ++|+||.+.|||++.  +++.++++||..|..
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~--~~~~l~lID~EYag~  213 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNE--DEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeC--CCCcEEEEcccccCC
Confidence            2    1122    699999999999973  356899999998754

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.32  E-value=0.0015  Score=63.70  Aligned_cols=78  Identities=22%  Similarity=0.257  Sum_probs=53.4

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEe----eccCCCChHhHHHHHHHHHHHHHccCC-C-CceEEEEEEEcCCEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQALAGH-E-NVVKFYNAFEDDNYVYI  174 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i----~~~~~~~~~~~~~~~~E~~il~~l~~h-p-nIv~~~~~~~~~~~~~l  174 (414)
                      .+.||.|.-..||++.+...++.|+||.-    +... .-+...++..-|.++|+.+... | .++++|  +.++....+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~-swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISD-EFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCC-CCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhH
Confidence            56799999999999987544567999963    2111 1134566777888988876432 3 466666  345566778


Q ss_pred             EEeccCC
Q 015026          175 AMELCEG  181 (414)
Q Consensus       175 v~e~~~g  181 (414)
                      |||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            9999854

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.27  E-value=0.0018  Score=60.62  Aligned_cols=30  Identities=27%  Similarity=0.439  Sum_probs=24.1

Q ss_pred             CCeecCCCCCcEEEeecCCCCC-ceeeccccccc
Q 015026          219 GLVHRDMKPENFLFKSAKEDSS-LKATDFGLSDF  251 (414)
Q Consensus       219 ~iiHrDlkp~NIll~~~~~~~~-vkl~DFG~a~~  251 (414)
                      .++|+|+.|.|||++.   ++. +-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~---~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDE---DARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeC---CCCEEEEECcHhccc
Confidence            4799999999999983   244 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.26  E-value=0.0015  Score=64.72  Aligned_cols=165  Identities=22%  Similarity=0.234  Sum_probs=103.7

Q ss_pred             HHHHHHHHHHHHccCCCCceEEEEEEEc-CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 015026          141 EDVKREVKILQALAGHENVVKFYNAFED-DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG  219 (414)
Q Consensus       141 ~~~~~E~~il~~l~~hpnIv~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~  219 (414)
                      .++.-...+++.+. |+|..+.+++-.. .....+|+|++ +.+|.+.+......   ...             ++ .+|
T Consensus        27 ~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~---~~s-------------~~-~~~   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK---DES-------------LL-AHG   87 (725)
T ss_pred             HHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc---hhh-------------hc-ccc
Confidence            34566778889996 9999999987754 34588899999 56888877544311   110             00 122


Q ss_pred             CeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCC
Q 015026          220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP  299 (414)
Q Consensus       220 iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~P  299 (414)
                      +.|     -|          .++++| -++...      ....               ++++||||+|.++.++..|...
T Consensus        88 ~~~-----~~----------~~~~td-~~~t~~------~~~~---------------~pKsdVwsl~~i~~el~L~~~l  130 (725)
T KOG1093|consen   88 VLH-----LN----------IIYITD-HFLTKY------PSPI---------------GPKSDVWSLGFIILELYLGISL  130 (725)
T ss_pred             cce-----eh----------hhhccc-cccccC------CCCC---------------CcchhhhhHHHHHHHHHHhhHH
Confidence            221     12          233344 111000      1111               2499999999999999999887


Q ss_pred             CCCCCchhhhHHHhhcCCCCCCCC--------CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          300 FWDKTEDGIFKEVLRNKPDFRRKP--------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       300 f~~~~~~~~~~~i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +......+..+.+.+-........        .-..+....++..+|+-..|..||...++.+++-|.+.
T Consensus       131 ~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  131 EAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            765555444444433221110000        01244556789999999999999999999999999986

>PRK10593 hypothetical protein; Provisional

Probab=97.24  E-value=0.0026  Score=60.27  Aligned_cols=104  Identities=12%  Similarity=0.042  Sum_probs=75.4

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC--CCceEEEEEEEc---CCEEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH--ENVVKFYNAFED---DNYVYIA  175 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h--pnIv~~~~~~~~---~~~~~lv  175 (414)
                      .+.||.|..+.||.... .++ .+.+|..+...     ....+..|...|+.|..+  ..++++++++.+   .+..+||
T Consensus        19 ~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         19 VECISEQPYAALWALYD-SQG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeecCCccceeEEEEEc-CCC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            45799999999999853 223 46677643211     235788999999999754  468889988754   3668999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH  218 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~  218 (414)
                      ||+++|+++.+ .      ..+......+..+++.+|.-||+.
T Consensus        92 mE~i~G~~~~~-~------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         92 LERLRGVSVEA-P------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EeccCCEecCC-C------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            99999987764 1      123445667778888999999975

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.22  E-value=0.0028  Score=60.11  Aligned_cols=149  Identities=19%  Similarity=0.227  Sum_probs=82.4

Q ss_pred             eceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccC-CCCceEEEEEEEcCC--EEEEEE
Q 015026          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG-HENVVKFYNAFEDDN--YVYIAM  176 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~-hpnIv~~~~~~~~~~--~~~lv~  176 (414)
                      +.+.+..|....+|...+  +++.+++. ... ............+|..+++.+.. -.-+...++.|.++.  ..+.||
T Consensus        29 ~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          29 IVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             eeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            334444444445555543  37788888 332 11122345667889999998843 223445566665554  779999


Q ss_pred             eccCCCChHH----------HHH--------hcc----------C--CCCCHHHHHHHHHHH--------------HHHH
Q 015026          177 ELCEGGELLD----------RIL--------AKK----------D--SRYTEKDAAVVVRQM--------------LRVA  212 (414)
Q Consensus       177 e~~~gg~L~~----------~l~--------~~~----------~--~~l~~~~~~~i~~qi--------------l~~L  212 (414)
                      +|++|..+.+          +..        .-.          .  ......++..+..+.              ..-.
T Consensus       105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~  184 (321)
T COG3173         105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI  184 (321)
T ss_pred             EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence            9998842221          111        000          0  000111111111111              1223


Q ss_pred             HHHHHc--------CCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          213 AECHLH--------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       213 ~~LH~~--------~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      .+|+.+        .++|+|+.+.||++++   ...+=+.||+++..-++.
T Consensus       185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~---~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDP---GRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHHHhcCCCcCCCceeeeCCcccCCEEEeC---CCeeEEEeccccccCCcH
Confidence            455443        4799999999999994   444889999998765443

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.09  E-value=0.0086  Score=58.74  Aligned_cols=77  Identities=18%  Similarity=0.272  Sum_probs=51.7

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC----hHhHHHHHHHHHHHHHccCC--CCceEEEEEEEcCCEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL----PIAVEDVKREVKILQALAGH--ENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~E~~il~~l~~h--pnIv~~~~~~~~~~~~~l  174 (414)
                      .+.||.|....||++.+.  +..++||.-.......    +....+-..|...|+.+...  .++++++.++.  +..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            567999999999999863  4568899754211100    12344555678888766422  47888887766  44678


Q ss_pred             EEeccCC
Q 015026          175 AMELCEG  181 (414)
Q Consensus       175 v~e~~~g  181 (414)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999977

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.92  E-value=0.021  Score=54.29  Aligned_cols=29  Identities=28%  Similarity=0.541  Sum_probs=24.5

Q ss_pred             cCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       218 ~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .++||+|+.+.||+++   . +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence            4789999999999998   2 568899999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PTZ00384 choline kinase; Provisional

Probab=96.87  E-value=0.0084  Score=58.81  Aligned_cols=78  Identities=26%  Similarity=0.227  Sum_probs=48.5

Q ss_pred             eceeeeecCceEEEEEEECCC-CCE-----EEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026          100 IGKLLGHGQFGYTYVATDKAN-GDR-----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~-~~~-----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      .++.|..|--+.+|++..... +..     |.++.... .  .. ..-.-.+|+.+++.|..+---+++++.+..    +
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~--~~-l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g  125 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-Y--NS-LVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F  125 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-C--Cc-eEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence            345566688889999864332 122     44443211 1  11 111235799999999766666788887753    5


Q ss_pred             EEEeccCCCChH
Q 015026          174 IAMELCEGGELL  185 (414)
Q Consensus       174 lv~e~~~gg~L~  185 (414)
                      +|.||++|.+|.
T Consensus       126 ~l~efIeGr~l~  137 (383)
T PTZ00384        126 TIQEWVEGNTMG  137 (383)
T ss_pred             EEEEEeccccCC
Confidence            899999987653

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.76  E-value=0.0029  Score=56.67  Aligned_cols=121  Identities=18%  Similarity=0.183  Sum_probs=59.9

Q ss_pred             CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCChHH-------HH-----
Q 015026          121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RI-----  188 (414)
Q Consensus       121 ~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~-------~l-----  188 (414)
                      ++.|++++......    ..-.-..|..+++.+..+-.-+++++.+.++    +|.||++|.+|..       .+     
T Consensus         2 ~~~~~~Ri~g~~t~----~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~   73 (211)
T PF01633_consen    2 PEKYLVRIPGEGTE----NFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAK   73 (211)
T ss_dssp             TSEEEEEEEESCGC----SHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcc----cccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHH
Confidence            46788887755421    2345568999999887555556777765443    5679987655321       11     


Q ss_pred             -----HhccC----C-CCCHHHHHHH----------------------HHHHHHHHHHHHH--------cCCeecCCCCC
Q 015026          189 -----LAKKD----S-RYTEKDAAVV----------------------VRQMLRVAAECHL--------HGLVHRDMKPE  228 (414)
Q Consensus       189 -----~~~~~----~-~l~~~~~~~i----------------------~~qil~~L~~LH~--------~~iiHrDlkp~  228 (414)
                           .....    . .-....+..+                      +..+..-+..+.+        ..++|+||.|.
T Consensus        74 ~l~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~  153 (211)
T PF01633_consen   74 LLAKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPG  153 (211)
T ss_dssp             HHHHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGG
T ss_pred             HHHHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccc
Confidence                 00000    0 0001112222                      1112222222221        24799999999


Q ss_pred             cEEEeecCCCCCceeeccccccc
Q 015026          229 NFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       229 NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      |||++.  .++.++|+||..|..
T Consensus       154 Nil~~~--~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  154 NILINN--KDGEVKLIDFEYAGY  174 (211)
T ss_dssp             GEEETS--SSSCEEE--GTT-EE
T ss_pred             cEEecc--CCCeEEEecHHHHhh
Confidence            999921  578999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.71  E-value=0.0064  Score=58.81  Aligned_cols=62  Identities=16%  Similarity=0.144  Sum_probs=46.4

Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHH-HHHHcCCeecCCCCCcEEEee
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA-ECHLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~-~LH~~~iiHrDlkp~NIll~~  234 (414)
                      ....|+-+|..|.++..++..   ...++...+.++.-...||- -|---+++|.|+.|.||++..
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ccceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            345677889999888888733   34566677777777777764 445568999999999999974

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.58  E-value=0.0083  Score=56.42  Aligned_cols=76  Identities=24%  Similarity=0.213  Sum_probs=49.9

Q ss_pred             eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEEcCCEEEEEE
Q 015026           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      +-.+.|+.|..+.+|+..  .+++.+.||+-...      ....+..|..-|+.|.  .--.+++++.+....+..+|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            345678999999999986  77788999976522      3466888999999883  2455778888887777779999


Q ss_pred             eccCCC
Q 015026          177 ELCEGG  182 (414)
Q Consensus       177 e~~~gg  182 (414)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            999866

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.48  E-value=0.022  Score=54.43  Aligned_cols=104  Identities=13%  Similarity=0.245  Sum_probs=70.0

Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                      ..+.|++|++- |+++. .+     ..-..+++..++.+.+..+.-+..+ ..-||||...||||+    +|.|.|+||-
T Consensus       298 ~~y~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId----~GnvtLIDfk  366 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID----EGNVTLIDFK  366 (488)
T ss_pred             ceEEEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee----cCceEEEEee
Confidence            44677888875 55543 22     1234678888999888887777654 689999999999998    7899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccccCCCCcchhHHH
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIG  287 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG  287 (414)
                      +++...+..    .+-....--|-.+.|..+..-|||-+-
T Consensus       367 lsRl~~~q~----~isy~rldhp~lF~G~dd~QFeIYrlM  402 (488)
T COG5072         367 LSRLSYSQG----IISYNRLDHPDLFNGVDDYQFEIYRLM  402 (488)
T ss_pred             eeecccCCc----eeeccccCchhhhcCccceeeeHHHHH
Confidence            998532221    122223334555566556666766543

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.03  E-value=0.21  Score=47.95  Aligned_cols=72  Identities=18%  Similarity=0.165  Sum_probs=43.6

Q ss_pred             cCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEE---E--EEEcCCEEEEEEeccC
Q 015026          107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFY---N--AFEDDNYVYIAMELCE  180 (414)
Q Consensus       107 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~---~--~~~~~~~~~lv~e~~~  180 (414)
                      +.-..||.+.. .+|..+++|+......    ....+..|+..+..|..+ -.++...   +  ....++..+.|+++++
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            44567898864 4566799997754321    345677788888877532 1122211   1  1233567888999998


Q ss_pred             CCC
Q 015026          181 GGE  183 (414)
Q Consensus       181 gg~  183 (414)
                      |..
T Consensus       111 G~~  113 (325)
T PRK11768        111 GRA  113 (325)
T ss_pred             CCC
Confidence            764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.89  E-value=0.12  Score=49.21  Aligned_cols=30  Identities=27%  Similarity=0.418  Sum_probs=26.1

Q ss_pred             CCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       219 ~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      ++||+|+.+.|||++   +++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~---~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYD---ETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEc---CCCCEEEEEhhhccc
Confidence            799999999999998   466789999997754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00296 choline kinase; Provisional

Probab=95.75  E-value=0.093  Score=52.55  Aligned_cols=77  Identities=14%  Similarity=0.077  Sum_probs=48.0

Q ss_pred             eceeeeecCceEEEEEEECC--------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026          100 IGKLLGHGQFGYTYVATDKA--------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      -++.|..|--..+|++....        .++.|.+++.-....    ..-.-..|..+++.+..+---.++++.+..   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te----~lIdR~~E~~v~~~ls~~gi~P~l~~~f~g---  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD----ELYNPISEFEVYKTMSKYRIAPQLLNTFSG---  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc----ceeCHHHHHHHHHHHHHCCCCCceEEEeCC---
Confidence            45667777778899887542        256788887644321    111335688888888643333466665532   


Q ss_pred             EEEEEeccCCCCh
Q 015026          172 VYIAMELCEGGEL  184 (414)
Q Consensus       172 ~~lv~e~~~gg~L  184 (414)
                       +.|.||++|.+|
T Consensus       182 -g~I~efi~g~~l  193 (442)
T PTZ00296        182 -GRIEEWLYGDPL  193 (442)
T ss_pred             -CEEEEeeCCccC
Confidence             457899988644

>PRK06148 hypothetical protein; Provisional

Probab=94.98  E-value=0.37  Score=53.58  Aligned_cols=142  Identities=15%  Similarity=0.213  Sum_probs=76.1

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CC--ceEEEE--------EEEc-C
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-EN--VVKFYN--------AFED-D  169 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pn--Iv~~~~--------~~~~-~  169 (414)
                      +.|+ |..-.+|++.. .+|..+++|+.....     ....+..|..+|..|..+ +.  +.+++-        .... +
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~  103 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD  103 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence            4564 45677888864 457789999886542     223344566666655422 22  223221        1111 2


Q ss_pred             C--EEEEEEeccCCCChHHH-------HH----------h--c--cC----CCCCH-----------------HHHHHHH
Q 015026          170 N--YVYIAMELCEGGELLDR-------IL----------A--K--KD----SRYTE-----------------KDAAVVV  205 (414)
Q Consensus       170 ~--~~~lv~e~~~gg~L~~~-------l~----------~--~--~~----~~l~~-----------------~~~~~i~  205 (414)
                      +  ..+-+++|++|..+.+.       +.          .  .  ..    ..+.+                 ...+.++
T Consensus       104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l  183 (1013)
T PRK06148        104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV  183 (1013)
T ss_pred             CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence            2  56778999999766541       00          0  0  00    00001                 1122333


Q ss_pred             HHHHHHHHH-----HH--HcCCeecCCCCCcEEEeecCCCCCce-eeccccccc
Q 015026          206 RQMLRVAAE-----CH--LHGLVHRDMKPENFLFKSAKEDSSLK-ATDFGLSDF  251 (414)
Q Consensus       206 ~qil~~L~~-----LH--~~~iiHrDlkp~NIll~~~~~~~~vk-l~DFG~a~~  251 (414)
                      .+++..+.-     +.  ..++||+|+.+.|||++.+... .+. |+|||.+..
T Consensus       184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~-~isGiIDFgDa~~  236 (1013)
T PRK06148        184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGE-RISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCc-ceEEEEECccccc
Confidence            334333321     21  2479999999999999843211 454 999998754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.09  E-value=0.23  Score=44.51  Aligned_cols=115  Identities=14%  Similarity=0.179  Sum_probs=71.2

Q ss_pred             cCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCChHH
Q 015026          107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD  186 (414)
Q Consensus       107 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~  186 (414)
                      |+-++.-.++.+- | +..+|++.......  ....+.++.+++.++.   .|+++..  .+.-.+-+++|.|-....  
T Consensus        73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~--~~~~y~nky~v~Armh---GilrL~N--Dn~~~yGvIlE~Cy~~~i--  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCI--NDALYFNKYRVFARMH---GILRLKN--DNNYKYGVILERCYKIKI--  141 (308)
T ss_pred             CCceEEEEecccc-c-hhhhhhccCCCccc--chhhhhhhhhHHHHhh---heeEeec--CCCceeEEEEeeccCccc--
Confidence            3444444443322 3 45667775543321  2345678899988763   6787773  244457789999843211  


Q ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--cCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          187 RILAKKDSRYTEKDAAVVVRQMLRVAAECHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       187 ~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~--~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                               .+.    .++.-=+.+|.-.|+  .+.+|+|-.|+||+.+   ..|.+||.|-+.
T Consensus       142 ---------~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D---~~G~lKlVDP~~  189 (308)
T PF07387_consen  142 ---------NFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCD---KFGYLKLVDPVC  189 (308)
T ss_pred             ---------chh----HHHHHhHHHHHHhhccCCCeecCCCChhheeec---CCCCEEecChhh
Confidence                     011    111112456777884  4699999999999999   689999999774

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.40  E-value=0.65  Score=41.90  Aligned_cols=76  Identities=20%  Similarity=0.177  Sum_probs=53.3

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEEcCCEEEEEEecc
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFEDDNYVYIAMELC  179 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~~~~~~~lv~e~~  179 (414)
                      +.+..|.--..|.+.+  ....+-+|+-..      .....+..|+.-|+.+.  +.-.+.+++.+..+.++.|+||||+
T Consensus        22 ~~v~gG~inea~~v~d--g~~~~FvK~n~~------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L   93 (286)
T COG3001          22 EEVSGGDINEAWRLRD--GTDPFFVKCNQR------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL   93 (286)
T ss_pred             cccCCccccceeEeec--CCcceEEEecch------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence            3466666666676643  334677886433      24567888888777764  2356788998889999999999999


Q ss_pred             CCCChH
Q 015026          180 EGGELL  185 (414)
Q Consensus       180 ~gg~L~  185 (414)
                      +.+.+.
T Consensus        94 ~~~~~d   99 (286)
T COG3001          94 PTGPLD   99 (286)
T ss_pred             cCCCCC
Confidence            875543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	414
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-57
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-57
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-57
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-57
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-56
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-55
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-55
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-55
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-55
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-55
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-54
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-54
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-53
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-53
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-52
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-52
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-52
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-52
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-52
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-50
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-49
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-46
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-44
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-43
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-43
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-43
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-43
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-43
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-43
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-43
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-43
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-43
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-43
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-43
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-42
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-42
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-42
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-42
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-42
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-42
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-42
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-42
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-42
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-42
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-42
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-42
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-42
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-42
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-42
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-42
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-42
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-42
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-42
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-42
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-42
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-42
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-42
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-42
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-42
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-41
3soa_A	444	Full-Length Human Camkii Length = 444		2e-41
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-41
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-41
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-41
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-41
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-41
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-40
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-40
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-39
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-39
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-39
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-38
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-38
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-38
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-38
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-37
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-37
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-37
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-37
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-37
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-37
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-37
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-36
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-36
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-36
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-36
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-36
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-36
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-36
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-36
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-36
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-36
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-36
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-36
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-35
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-35
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-35
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-34
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-34
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-34
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-34
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-34
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-34
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-33
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-33
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-33
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-33
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-33
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-33
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-33
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-33
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-33
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-33
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-33
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-33
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-33
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-33
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-33
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-33
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-33
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-33
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-33
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-32
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-32
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-32
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-32
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-32
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-32
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-32
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-32
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-32
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-32
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-32
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-32
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-32
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-32
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-32
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-32
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-32
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-32
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-32
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-32
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-32
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-32
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-32
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-32
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-32
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-32
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-32
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-32
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-32
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-32
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-32
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-32
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-32
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-32
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-32
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-31
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-31
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-31
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-31
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-31
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-31
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-31
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-31
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-31
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-31
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-31
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-31
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-31
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-31
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-31
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-31
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-31
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-31
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-31
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-31
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-31
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-31
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-31
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-31
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-31
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-31
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-31
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-31
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-31
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-31
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-31
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-31
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-31
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-31
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-31
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-31
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-31
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-31
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-31
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-31
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-31
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-31
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-31
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-31
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-30
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-30
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-30
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-30
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-30
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-30
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-30
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-30
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-29
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-29
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-29
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-29
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-29
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-29
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-29
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-29
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-29
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-29
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-28
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-27
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-27
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-27
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-26
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-26
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-26
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-26
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-25
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-25
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-25
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-25
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-25
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-25
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-25
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-25
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-24
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-24
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-24
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-24
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-24
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-24
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-24
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-24
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-24
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-24
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-24
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-24
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-24
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-24
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-23
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-23
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-23
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-23
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-23
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-23
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-23
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-23
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-23
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-23
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-23
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-23
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-23
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-23
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-23
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-22
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-22
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-22
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-22
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-22
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-22
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-22
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-22
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-22
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-22
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-22
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-22
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-22
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-22
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-22
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-22
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-22
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-22
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-22
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-22
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-22
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-22
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-22
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-22
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-22
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-22
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-22
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-22
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-22
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-22
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-22
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-22
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-22
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-22
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-22
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-22
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-22
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-22
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-22
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-22
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-22
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-22
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-22
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-22
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-22
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-22
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-22
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-22
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-22
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-22
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-22
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-22
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-22
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-22
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-22
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-22
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-22
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-22
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-21
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-21
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-21
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-21
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-21
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-21
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-21
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-21
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-21
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-21
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-21
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-21
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-21
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-21
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-21
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-21
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-21
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-21
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-21
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-21
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-21
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-21
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-21
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-20
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-20
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-20
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-20
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-20
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-20
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-20
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-20
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-20
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-20
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-20
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-20
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-20
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-20
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-20
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-20
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-20
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-20
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-20
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-20
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-20
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-20
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-20
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-20
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-20
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-20
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-20
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-20
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-20
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-20
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-20
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-20
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-20
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-20
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-20
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-20
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-20
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-20
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-20
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-20
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-20
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-20
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-20
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-20
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-20
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-20
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-20
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-20
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-20
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-20
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-20
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-20
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-20
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-20
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-20
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-20
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-20
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-19
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-19
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-19
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-19
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-19
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-19
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-19
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-19
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-19
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-19
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-19
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-19
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-19
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-19
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-19
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-19
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-19
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-19
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-19
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-19
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-19
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-19
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-19
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-19
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-19
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-19
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-19
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-19
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-19
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-19
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-19
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-19
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-19
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-19
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-19
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-19
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-19
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-19
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-19
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-19
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-19
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-19
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-19
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-19
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-19
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-19
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-19
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-19
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-19
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-19
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-19
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-19
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-19
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-19
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-19
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-19
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-19
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-19
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-19
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-19
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-19
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-19
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-19
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-19
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-19
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-19
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-19
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-19
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-19
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-19
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-19
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-19
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-19
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-19
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-18
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-18
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-18
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-18
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-18
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-18
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-18
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-18
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-18
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-18
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-18
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-18
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-18
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-18
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-18
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-18
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-18
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-18
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-18
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-18
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-18
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-18
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-18
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-18
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-18
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-18
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-18
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-18
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-18
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-18
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-18
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-18
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-18
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-18
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-18
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-18
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-18
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-18
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-18
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-18
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-18
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-18
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-18
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-18
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-18
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		9e-18
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-17
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-17
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-17
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-17
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-17
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-17
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-17
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-17
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-17
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-17
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-17
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-16
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-16
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-15
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-15
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-15
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-15
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-15
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-15
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-15
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-15
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-15
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-15
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-15
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-15
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-15
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-15
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-13
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-12
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		4e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-12
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		4e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-12
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		6e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-12
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		6e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		8e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-10
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		3e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-10
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-09
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		7e-09
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		3e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-07
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		3e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-06
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		1e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-06
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		1e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-05
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-05
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-05

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  219 bits (559), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 122/302 (40%), Positives = 174/302 (57%), Gaps = 8/302 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 84  -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 140
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN----NMRQFVKYSRLKQF 389
            ++K+L   P  R++A  AL H W+ +     +I +D+  L+    N+RQF    +L Q 
Sbjct: 261 LIRKMLTYVPSMRISARDALDHEWI-QTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQA 319
Query: 390 AL 391
           AL
Sbjct: 320 AL 321

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  219 bits (559), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 122/302 (40%), Positives = 174/302 (57%), Gaps = 8/302 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 48  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 108 -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 164
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 165 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 224
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 225 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 284
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN----NMRQFVKYSRLKQF 389
            ++K+L   P  R++A  AL H W++      +I +D+  L+    N+RQF    +L Q 
Sbjct: 285 LIRKMLTYVPSMRISARDALDHEWIQT-YTKEQISVDVPSLDNAILNIRQFQGTQKLAQA 343
Query: 390 AL 391
           AL
Sbjct: 344 AL 345

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  219 bits (559), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 122/302 (40%), Positives = 174/302 (57%), Gaps = 8/302 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 47  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 107 -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 163
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 164 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 223
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 224 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 283
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN----NMRQFVKYSRLKQF 389
            ++K+L   P  R++A  AL H W++      +I +D+  L+    N+RQF    +L Q 
Sbjct: 284 LIRKMLTYVPSMRISARDALDHEWIQT-YTKEQISVDVPSLDNAILNIRQFQGTQKLAQA 342
Query: 390 AL 391
           AL
Sbjct: 343 AL 344

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  219 bits (558), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 125/315 (39%), Positives = 172/315 (54%), Gaps = 16/315 (5%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK----NKMILPIAV 140
           R +  +   F  RY I  +LG G FG      D+      AVK I K    NK       
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----DT 65
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR----EGGDASEIPIDISVLNN 376
              W +IS+ AKD ++K+L   P  R+TA Q L HPW++    E    S++P   S + N
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTN 302
Query: 377 MRQFVKYSRLKQFAL 391
           +RQF    +L Q AL
Sbjct: 303 IRQFQAEKKLAQAAL 317

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  216 bits (550), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 122/302 (40%), Positives = 172/302 (56%), Gaps = 8/302 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+ K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 84  -DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 140
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 141 YXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL 200
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN----NMRQFVKYSRLKQF 389
            ++K L   P  R++A  AL H W++      +I +D+  L+    N+RQF    +L Q 
Sbjct: 261 LIRKXLTYVPSXRISARDALDHEWIQTYT-KEQISVDVPSLDNAILNIRQFQGTQKLAQA 319
Query: 390 AL 391
           AL
Sbjct: 320 AL 321

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  213 bits (543), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 115/299 (38%), Positives = 170/299 (56%), Gaps = 7/299 (2%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY   K LG G +G   +  DK  G   A+K I+K+ +        +  EV +L+ L  H
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL-DH 63
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N++K Y  FED    Y+ ME+  GGEL D I+ ++  +++E DAAV+++Q+L      H
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVLSGTTYLH 121
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VHRD+KPEN L +S   D+ +K  DFGLS   + G K ++ +G+AYY+APEVL++K
Sbjct: 122 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK 181
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
              + DVWS GVI YILLCG  PF  +T+  I K V + K  F    W  +S+ AK  VK
Sbjct: 182 YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVK 241
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPID----ISVLNNMRQFVKYSRLKQFAL 391
            +L  +P  R++A +AL+HPW+ +        +        L NM++F    +L Q A+
Sbjct: 242 LMLTYEPSKRISAEEALNHPWIVKFCSQKHTDVGKHALTGALGNMKKFQSSQKLAQAAM 300

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  213 bits (543), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 160/268 (59%), Gaps = 12/268 (4%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV---KREVKI 149
           D ++ YT+   +G G +G   +A  K    R A KKI K        VEDV   K+E++I
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK------YFVEDVDRFKQEIEI 76
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           +++L  H N+++ Y  FED+  +Y+ MELC GGEL +R++ K+  R  E DAA +++ +L
Sbjct: 77  MKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR--ESDAARIMKDVL 133
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
              A CH   + HRD+KPENFLF +   DS LK  DFGL+   KPGK  +  VG+ YYV+
Sbjct: 134 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 193
Query: 270 PEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           P+VL+   GPE D WS GV+ Y+LLCG  PF   T+  +  ++      F  K W ++S 
Sbjct: 194 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 253
Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPW 357
            A+  +++LL K P+ R+T+ QAL H W
Sbjct: 254 QAESLIRRLLTKSPKQRITSLQALEHEW 281

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  213 bits (542), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 160/268 (59%), Gaps = 12/268 (4%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV---KREVKI 149
           D ++ YT+   +G G +G   +A  K    R A KKI K        VEDV   K+E++I
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK------YFVEDVDRFKQEIEI 59
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           +++L  H N+++ Y  FED+  +Y+ MELC GGEL +R++ K+  R  E DAA +++ +L
Sbjct: 60  MKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR--ESDAARIMKDVL 116
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
              A CH   + HRD+KPENFLF +   DS LK  DFGL+   KPGK  +  VG+ YYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 270 PEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           P+VL+   GPE D WS GV+ Y+LLCG  PF   T+  +  ++      F  K W ++S 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 236
Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPW 357
            A+  +++LL K P+ R+T+ QAL H W
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEW 264

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  211 bits (538), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 115/294 (39%), Positives = 174/294 (59%), Gaps = 8/294 (2%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G +G   +  DK      A+K I K   +   +   +  EV +L+ L  H N++K
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLL-DHPNIMK 100
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y+ FED    Y+ ME  +GGEL D I+ +   ++ E DAAV+++Q+L      H H +V
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           HRD+KPEN L +S ++D+ +K  DFGLS   +  KK ++ +G+AYY+APEVL++K   + 
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKC 218
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           DVWSIGVI +ILL G  PF  +T+  I ++V + K  F    W ++S  AKD +K++L  
Sbjct: 219 DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQF 278
Query: 342 DPRARLTAAQALSHPWVREGGDASEIPIDI----SVLNNMRQFVKYSRLKQFAL 391
           D + R++A QAL HPW++E     E  I++    + + NMR+F    +L Q AL
Sbjct: 279 DSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAAL 332

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  211 bits (536), Expect = 8e-55,   Method: Compositional matrix adjust.
 Identities = 111/266 (41%), Positives = 157/266 (59%), Gaps = 3/266 (1%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 90  -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 146
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 147 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 206
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 207 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 266
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVR 359
            ++K+L   P  R++A  AL H W++
Sbjct: 267 LIRKMLTYVPSMRISARDALDHEWIQ 292

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 118/298 (39%), Positives = 171/298 (57%), Gaps = 7/298 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D  + +   + LG G F    +A +KA G   AVK I K    L      ++ E+ +L+
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKA--LKGKESSIENEIAVLR 75
Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            +  HEN+V   + +E  N++Y+ M+L  GGEL DRI+ K    YTEKDA+ ++RQ+L  
Sbjct: 76  KIK-HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEK--GFYTEKDASTLIRQVLDA 132
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H  G+VHRD+KPEN L+ S  E+S +  +DFGLS     G       G+  YVAPE
Sbjct: 133 VYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE 192
Query: 272 VLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           VL +K   ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+S
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDS 252
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
           AKDF++ L+ KDP  R T  QA  HPW+  G  A    I  SV   +R+    S+ +Q
Sbjct: 253 AKDFIRNLMEKDPNKRYTCEQAARHPWIA-GDTALNKNIHESVSAQIRKNFAKSKWRQ 309

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  209 bits (533), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 109/269 (40%), Positives = 159/269 (59%), Gaps = 3/269 (1%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           Y +    RY   K LG G +G   +  DK  G   A+K I+K+ +        +  EV +
Sbjct: 15  YFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAV 74
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           L+ L  H N++K Y  FED    Y+ ME+  GGEL D I+ ++  +++E DAAV+++Q+L
Sbjct: 75  LKQL-DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVL 131
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H H +VHRD+KPEN L +S   D+ +K  DFGLS   + G K ++ +G+AYY+A
Sbjct: 132 SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 191
Query: 270 PEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           PEVL++K   + DVWS GVI YILLCG  PF  +T+  I K V + K  F    W  +S+
Sbjct: 192 PEVLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSD 251
Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            AK  VK +L  +P  R++A +AL+HPW+
Sbjct: 252 EAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 113/279 (40%), Positives = 155/279 (55%), Gaps = 12/279 (4%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK----NKMILPIAV 140
           R +  +   F  RY I  +LG G FG      D+      AVK I K    NK       
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----DT 65
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
              W +IS+ AKD ++K+L   P  R+TA Q L HPW++
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 113/279 (40%), Positives = 155/279 (55%), Gaps = 12/279 (4%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK----NKMILPIAV 140
           R +  +   F  RY I  +LG G FG      D+      AVK I K    NK       
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----DT 65
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
              W +IS+ AKD ++K+L   P  R+TA Q L HPW++
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  203 bits (516), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 107/264 (40%), Positives = 160/264 (60%), Gaps = 8/264 (3%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           + +   ++LG G F   ++   +  G   A+K I+K+      ++E+   E+ +L+ +  
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIK- 64
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           HEN+V   + +E   + Y+ M+L  GGEL DRIL +    YTEKDA++V++Q+L      
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYL 122
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H +G+VHRD+KPEN L+ + +E+S +  TDFGLS   + G       G+  YVAPEVL +
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181
Query: 276 KSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           K   ++ D WSIGVITYILLCG  PF+++TE  +F+++     +F    W  IS SAKDF
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 335 VKKLLVKDPRARLTAAQALSHPWV 358
           +  LL KDP  R T  +ALSHPW+
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWI 265

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 116/292 (39%), Positives = 166/292 (56%), Gaps = 7/292 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y    +LG G F    +A DK     VA+K I K    L      ++ E+ +L  +  H 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEA--LEGKEGSMENEIAVLHKIK-HP 76
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V   + +E   ++Y+ M+L  GGEL DRI+ K    YTE+DA+ ++ Q+L      H 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 134
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPEVL +K 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+SAKDF++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
            L+ KDP  R T  QAL HPW+  G  A +  I  SV   +++    S+ KQ
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 116/292 (39%), Positives = 166/292 (56%), Gaps = 7/292 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y    +LG G F    +A DK     VA+K I K    L      ++ E+ +L  +  H 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEA--LEGKEGSMENEIAVLHKIK-HP 76
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V   + +E   ++Y+ M+L  GGEL DRI+ K    YTE+DA+ ++ Q+L      H 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 134
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPEVL +K 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+SAKDF++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
            L+ KDP  R T  QAL HPW+  G  A +  I  SV   +++    S+ KQ
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 119/309 (38%), Positives = 170/309 (55%), Gaps = 16/309 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y    +LG G F    +A DK     VA+K I K    L      ++ E+ +L  +  H 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKA--LEGKEGSMENEIAVLHKIK-HP 76
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V   + +E   ++Y+ M+L  GGEL DRI+ K    YTE+DA+ ++ Q+L      H 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 134
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPEVL +K 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+SAKDF++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFA-LRVTQ 395
            L+ KDP  R T  QAL HPW+           D ++  N+ Q V     K FA  +  Q
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWIAG---------DTALDKNIHQSVSEQIKKNFAKSKWKQ 305
Query: 396 YFKYTALFK 404
            F  TA+ +
Sbjct: 306 AFNATAVVR 314

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  201 bits (510), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 111/275 (40%), Positives = 158/275 (57%), Gaps = 8/275 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D    Y    +LG G F    +A DK     VA+K I K    L      ++ E+ +L 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEA--LEGKEGSMENEIAVLH 71
Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            +  H N+V   + +E   ++Y+ M+L  GGEL DRI+ K    YTE+DA+ ++ Q+L  
Sbjct: 72  KIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDA 128
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H  G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 272 VLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           VL +K   ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+S
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
           AKDF++ L+ KDP  R T  QAL HPW+   GD +
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPWI--AGDTA 281

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  195 bits (496), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 169/302 (55%), Gaps = 18/302 (5%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEK-----------NKMILPIAVEDVKREVKILQA 152
           LG G +G   +  +K      A+K I+K           NK I     E++  E+ +L++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH-EEIYNEISLLKS 102
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L  H N++K ++ FED  Y Y+  E  EGGEL ++I+ +   ++ E DAA +++Q+L   
Sbjct: 103 L-DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGI 159
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
              H H +VHRD+KPEN L ++     ++K  DFGLS F     K +D +G+AYY+APEV
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV 219
Query: 273 LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           LK+K   + DVWS GVI YILLCG  PF  + +  I K+V + K  F    W +IS+ AK
Sbjct: 220 LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGG---DASEIPIDISVLNNMRQFVKYSRLKQF 389
           + +K +L  D   R TA +AL+  W+++     + S+       L+NMR+F    +L Q 
Sbjct: 280 ELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQA 339
Query: 390 AL 391
           A+
Sbjct: 340 AI 341

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  191 bits (486), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 104/257 (40%), Positives = 151/257 (58%), Gaps = 10/257 (3%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G     Y    K      A+K ++K      +  + V+ E+ +L  L+ H N++K  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLS-HPNIIKLK 114
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
             FE    + + +EL  GGEL DRI+ K    Y+E+DAA  V+Q+L   A  H +G+VHR
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESD 282
           D+KPEN L+ +   D+ LK  DFGLS  ++     + + G+  Y APE+L+  + GPE D
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 283 VWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           +WS+G+ITYILLCG  PF+D+  D  +F+ +L  +  F    W  +S +AKD V+KL+V 
Sbjct: 233 MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 342 DPRARLTAAQALSHPWV 358
           DP+ RLT  QAL HPWV
Sbjct: 293 DPKKRLTTFQALQHPWV 309

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 160/279 (57%), Gaps = 6/279 (2%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
           R +  +    D  +   + LG G FG  ++  ++++G    +K I K++  +P+  E ++
Sbjct: 11  RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIE 68
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAA 202
            E+++L++L  H N++K +  FED + +YI ME CEGGELL+RI++   +    +E   A
Sbjct: 69  AEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            +++QM+   A  H   +VH+D+KPEN LF+     S +K  DFGL++  K  +   +  
Sbjct: 128 ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA 187
Query: 263 GSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
           G+A Y+APEV KR    + D+WS GV+ Y LL G  PF   + + + ++    +P++  +
Sbjct: 188 GTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE 247
Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
             P ++  A D +K++L KDP  R +AAQ L H W ++ 
Sbjct: 248 CRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 3   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 62
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 63  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 118
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 119 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 178
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 238
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 239 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 64  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 119
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 64  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 119
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 64  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 119
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 155/267 (58%), Gaps = 8/267 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y +G+ LG GQF        K  G   A K I+K ++      ++ E+++REV IL+ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++  ++ FE+   V + +EL  GGEL D  LA+K+S  TE +A   ++Q+L     
Sbjct: 67  -HPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKES-LTEDEATQFLKQILDGVHY 123
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L      +  +K  DFG++  I+ G +F++I G+  +VAPE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF  +T+      +     DF  + + + S  AK
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
           DF+++LLVKDP+ R+T AQ+L H W++
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 10  YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 69
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 70  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 125
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 126 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 185
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 245
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 246 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 157/273 (57%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           +D +  Y +G+ LG GQF        K  G   A K I+K ++      ++ E+++REV 
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H N++  ++ FE+   V + +EL  GGEL D  LA+K+S  TE +A   ++Q+
Sbjct: 68  ILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKES-LTEDEATQFLKQI 124
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L      +  +K  DFG++  I+ G +F++I G+  +
Sbjct: 125 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 184
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF  +T+      +     DF  + + +
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 244
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+  AQ+L H W++
Sbjct: 245 TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA++ I K K  +  A E     +V+
Sbjct: 143 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 202
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 203 TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 258
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 259 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 318
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 378
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 379 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA++ I K K  +  A E     +V+
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 189 TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 244
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 154/267 (57%), Gaps = 8/267 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y +G+ LG GQF        K  G   A K I+K ++      ++ E+++REV IL+ + 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++  ++ FE+   V + +EL  GGEL D  LA+K+S  TE +A   ++Q+L     
Sbjct: 88  -HPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKES-LTEDEATQFLKQILDGVHY 144
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L      +  +K  DFG++  I+ G +F++I G+  +VAPE++
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF  +T+      +     DF  + + + S  AK
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 264
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
           DF+++LLVKDP+ R+  AQ+L H W++
Sbjct: 265 DFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 165/295 (55%), Gaps = 12/295 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALA 154
           Y + + LG G F           G   A K I   K+    +  D   ++RE +I + L 
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL----SARDHQKLEREARICRLLK 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L     
Sbjct: 62  -HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILESVNH 118
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVL 273
           CHL+G+VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           ++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLK 387
           D + K+L  +P  R+TA++AL HPW+ +    + +      ++ +++F    +LK
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLK 293

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 165/295 (55%), Gaps = 12/295 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALA 154
           Y + + LG G F           G   A K I   K+    +  D   ++RE +I + L 
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL----SARDHQKLEREARICRLLK 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L     
Sbjct: 62  -HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILESVNH 118
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVL 273
           CHL+G+VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           ++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLK 387
           D + K+L  +P  R+TA++AL HPW+ +    + +      ++ +++F    +LK
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLK 293

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 106/298 (35%), Positives = 165/298 (55%), Gaps = 9/298 (3%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYS 384
            S  AKDF+++LLVKDP+ R+T   +L HPW++       +    S + NM +F K++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV-NMEKFKKFA 300

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 152/266 (57%), Gaps = 8/266 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF++KLLVK+ R RLT  +AL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 152/266 (57%), Gaps = 8/266 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF++KLLVK+ R RLT  +AL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 92/286 (32%), Positives = 159/286 (55%), Gaps = 9/286 (3%)
Query: 77  TGVIPCGKRTDFGYDKD--FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM 134
           TG    G+ ++F  +    F   Y + + LG G F        K  G   A K I   K+
Sbjct: 8   TGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL 67
Query: 135 ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS 194
                 + ++RE +I + L  H N+V+ +++ +++++ Y+  +L  GGEL + I+A++  
Sbjct: 68  SAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-- 123
Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
            Y+E DA+  ++Q+L   A CH +G+VHR++KPEN L  S  + +++K  DFGL+  +  
Sbjct: 124 FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 255 GKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
            + +    G+  Y++PEVLK+   S P  D+W+ GVI YILL G  PFWD+ +  ++ ++
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
Query: 313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
                D+    W +++  AK  +  +L  +P+ R+TA QAL  PW+
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 152/266 (57%), Gaps = 8/266 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF++KLLVK+ R RLT  +AL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 152/266 (57%), Gaps = 8/266 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF++KLLVK+ R RLT  +AL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 152/266 (57%), Gaps = 8/266 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF++KLLVK+ R RLT  +AL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 151/266 (56%), Gaps = 8/266 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       +  E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HPNIITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF++KLLVK+ R RLT  +AL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 152/270 (56%), Gaps = 12/270 (4%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
           F   Y + + LG G F           G   A K I   K+    +  D   ++RE +I 
Sbjct: 20  FQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL----SARDHQKLEREARIC 75
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L 
Sbjct: 76  RLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILE 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVA 269
               CH  G+VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 192
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PEVL++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 252
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             AKD + K+L  +P  R+TAA+AL HPW+
Sbjct: 253 PEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/279 (35%), Positives = 154/279 (55%), Gaps = 18/279 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQAL 153
           Y I + LG G FG  +  T++A G+  A K +    E +K       E V++E++ +  L
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-------ETVRKEIQTMSVL 105
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V  ++AFEDDN + +  E   GGEL +++ A + ++ +E +A   +RQ+ +   
Sbjct: 106 R-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLC 163
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H +  VH D+KPEN +F + K  + LK  DFGL+  + P +  +   G+A + APEV 
Sbjct: 164 HMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 222
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           + K  G  +D+WS+GV++YILL G  PF  + +D   + V     +     +  IS   K
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 282
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREG---GDASEIP 368
           DF++KLL+ DP  R+T  QAL HPW+  G   G  S+IP
Sbjct: 283 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 321

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 66  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 122
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 66  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 122
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 98/279 (35%), Positives = 154/279 (55%), Gaps = 18/279 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQAL 153
           Y I + LG G FG  +  T++A G+  A K +    E +K       E V++E++ +  L
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-------ETVRKEIQTMSVL 211
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V  ++AFEDDN + +  E   GGEL +++ A + ++ +E +A   +RQ+ +   
Sbjct: 212 R-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H +  VH D+KPEN +F + K  + LK  DFGL+  + P +  +   G+A + APEV 
Sbjct: 270 HMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           + K  G  +D+WS+GV++YILL G  PF  + +D   + V     +     +  IS   K
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREG---GDASEIP 368
           DF++KLL+ DP  R+T  QAL HPW+  G   G  S+IP
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 427

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 151/267 (56%), Gaps = 7/267 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + LG G F        K  G   A K I   K+      + ++RE +I + L
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V+ +++ +++++ Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L   A
Sbjct: 62  Q-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIA 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH +G+VHR++KPEN L  S  + +++K  DFGL+  +   + +    G+  Y++PEVL
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 178
Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           K+   S P  D+W+ GVI YILL G  PFWD+ +  ++ ++     D+    W +++  A
Sbjct: 179 KKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 237
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           K  +  +L  +P+ R+TA QAL  PW+
Sbjct: 238 KSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 151/267 (56%), Gaps = 7/267 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + LG G F        K  G   A K I   K+      + ++RE +I + L
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V+ +++ +++++ Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L   A
Sbjct: 63  Q-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIA 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH +G+VHR++KPEN L  S  + +++K  DFGL+  +   + +    G+  Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           K+   S P  D+W+ GVI YILL G  PFWD+ +  ++ ++     D+    W +++  A
Sbjct: 180 KKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           K  +  +L  +P+ R+TA QAL  PW+
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 151/267 (56%), Gaps = 7/267 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + LG G F        K  G   A K I   K+      + ++RE +I + L
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V+ +++ +++++ Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L   A
Sbjct: 63  Q-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIA 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH +G+VHR++KPEN L  S  + +++K  DFGL+  +   + +    G+  Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           K+   S P  D+W+ GVI YILL G  PFWD+ +  ++ ++     D+    W +++  A
Sbjct: 180 KKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           K  +  +L  +P+ R+TA QAL  PW+
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 93/309 (30%), Positives = 165/309 (53%), Gaps = 17/309 (5%)
Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           ++L   Q + T +     + P  +  D+   K+F ++Y    ++G G          +A 
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 121 GDRVAVKKIE-KNKMILPIAVEDVK----REVKILQALAGHENVVKFYNAFEDDNYVYIA 175
           G   AVK +E   + + P  +E+V+    RE  IL+ +AGH +++   +++E  +++++ 
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
            +L   GEL D +  K     +EK+   ++R +L   +  H + +VHRD+KPEN L    
Sbjct: 179 FDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-- 234
Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGV 288
            ++  ++ +DFG S  ++PG+K +++ G+  Y+APE+LK          G E D+W+ GV
Sbjct: 235 -DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
Query: 289 ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT 348
           I + LL G  PFW + +  + + ++  +  F    W   S++ KD + +LL  DP ARLT
Sbjct: 294 ILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT 353
Query: 349 AAQALSHPW 357
           A QAL HP+
Sbjct: 354 AEQALQHPF 362

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 154/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V +  EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 163/305 (53%), Gaps = 12/305 (3%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
           F   Y + + LG G F           G   A   I   K+    +  D   ++RE +I 
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL----SARDHQKLEREARIC 64
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L 
Sbjct: 65  RLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILE 121
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVA 269
               CH  G+VHR++KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PEVL++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
             AKD + K+L  +P  R+TAA+AL HPW+      +        ++ +++F    +LK 
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKG 301
Query: 389 FALRV 393
             L V
Sbjct: 302 AILTV 306

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG G+F       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 152/266 (57%), Gaps = 12/266 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALA 154
           Y + + +G G F           G   A K I   K+    +  D   ++RE +I + L 
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKL----SARDHQKLEREARICRLLK 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L     
Sbjct: 62  -HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLH 118
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVL 273
           CH  G+VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++PEVL
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           ++++ G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++  AK
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           + + ++L  +P  R+TA +AL HPWV
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPWV 264

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 154/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG G F       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 102/325 (31%), Positives = 174/325 (53%), Gaps = 20/325 (6%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP--IAVEDVKREVK 148
           D  F+  Y + +++G G F       ++  G + AVK ++  K      ++ ED+KRE  
Sbjct: 19  DVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVR 206
           I   L  H ++V+    +  D  +Y+  E  +G +L   I+ + D+   Y+E  A+  +R
Sbjct: 79  ICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL------SDFIKPGKKFQD 260
           Q+L     CH + ++HRD+KPEN L  S +  + +K  DFG+      S  +  G+    
Sbjct: 138 QILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR---- 193
Query: 261 IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
            VG+ +++APEV+KR+  G   DVW  GVI +ILL G  PF+  T++ +F+ +++ K   
Sbjct: 194 -VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKM 251
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD-ASEIPIDISVLNNMR 378
             + W  IS SAKD V+++L+ DP  R+T  +AL+HPW++E    A +I +  +V   +R
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETV-EQLR 310
Query: 379 QFVKYSRLKQFALRVTQYFKYTALF 403
           +F    +LK   L      K+ + +
Sbjct: 311 KFNARRKLKGAVLAAVSSHKFNSFY 335

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 105/288 (36%), Positives = 157/288 (54%), Gaps = 11/288 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I + LG G FG  +   +KA G RV V K        P+    VK E+ I+  L  H 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATG-RVFVAKFINTPY--PLDKYTVKNEISIMNQLH-HP 108
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            ++  ++AFED   + + +E   GGEL DRI A +D + +E +    +RQ        H 
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           H +VH D+KPEN + ++ K+ SS+K  DFGL+  + P +  +    +A + APE++ R+ 
Sbjct: 168 HSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 278 -GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
            G  +D+W+IGV+ Y+LL G  PF  + +    + V R   +F    + S+S  AKDF+K
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIP--IDISVLNNMRQFVK 382
            LL K+PR RLT   AL HPW++  GD S +   I  S  N +RQ +K
Sbjct: 287 NLLQKEPRKRLTVHDALEHPWLK--GDHSNLTSRIPSSRYNKIRQKIK 332

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 92/299 (30%), Positives = 160/299 (53%), Gaps = 12/299 (4%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
           F   Y + + LG G F        K      A K I   K+    +  D   ++RE +I 
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL----SARDHQKLEREARIC 84
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  + Q+L 
Sbjct: 85  RLLK-HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIHQILE 141
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVA 269
                H H +VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++
Sbjct: 142 SVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLS 201
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PEVL++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVT 261
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLK 387
             AK+ + ++L  +P  R+TA QAL HPWV +    + +      +  +R+F    +LK
Sbjct: 262 PEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLK 320

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/335 (30%), Positives = 177/335 (52%), Gaps = 12/335 (3%)
Query: 76  QTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI 135
            +G++P G   D   D  F+  Y + +++G G F       ++  G + AVK ++  K  
Sbjct: 8   SSGLVPRGSMAD--DDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 65
Query: 136 LP--IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD 193
               ++ ED+KRE  I   L  H ++V+    +  D  +Y+  E  +G +L   I+ + D
Sbjct: 66  SSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 124
Query: 194 SR--YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-D 250
           +   Y+E  A+  +RQ+L     CH + ++HRD+KP   L  S +  + +K   FG++  
Sbjct: 125 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 184
Query: 251 FIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIF 309
             + G      VG+ +++APEV+KR+  G   DVW  GVI +ILL G  PF+  T++ +F
Sbjct: 185 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLF 243
Query: 310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD-ASEIP 368
           + +++ K     + W  IS SAKD V+++L+ DP  R+T  +AL+HPW++E    A +I 
Sbjct: 244 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIH 303
Query: 369 IDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALF 403
           +  +V   +R+F    +LK   L      K+ + +
Sbjct: 304 LPETV-EQLRKFNARRKLKGAVLAAVSSHKFNSFY 337

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 147/264 (55%), Gaps = 13/264 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +G LLG G F   Y A     G  VA+K I+K  M     V+ V+ EVKI   L  H 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           ++++ YN FED NYVY+ +E+C  GE ++R L  +   ++E +A   + Q++      H 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGE-MNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRK 276
           HG++HRD+   N L      + ++K  DFGL+  +K P +K   + G+  Y++PE+  R 
Sbjct: 131 HGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 277 S-GPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           + G ESDVWS+G + Y LL GR PF  D  ++ + K VL    D+    + SI   AKD 
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---ADYEMPSFLSI--EAKDL 242
Query: 335 VKKLLVKDPRARLTAAQALSHPWV 358
           + +LL ++P  RL+ +  L HP++
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  158 bits (399), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 106/303 (34%), Positives = 154/303 (50%), Gaps = 37/303 (12%)
Query: 94  FDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           F+  Y +  +LLG G +     A    NG   AVK IEK       +   V REV+ L  
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQA---GHSRSRVFREVETLYQ 66
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             G++N+++    FEDD   Y+  E  +GG +L  I  +K   + E++A+ VVR +    
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI--QKQKHFNEREASRVVRDVAAAL 124
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--------VGS 264
              H  G+ HRD+KPEN L +S ++ S +K  DF L   +K       I         GS
Sbjct: 125 DFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 265 AYYVAPEVLKRKSGPES------DVWSIGVITYILLCGRRPF---------WDKTE---- 305
           A Y+APEV++  +   +      D+WS+GV+ YI+L G  PF         WD+ E    
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRV 244
Query: 306 --DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD 363
             + +F+ +   K +F  K W  IS+ AKD + KLLV+D + RL+AAQ L HPWV+  G 
Sbjct: 245 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ--GQ 302
Query: 364 ASE 366
           A E
Sbjct: 303 APE 305

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 151/269 (56%), Gaps = 15/269 (5%)
Query: 98  YTIGK--LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           YT+ K  +LG G+FG  +   + A G ++A K I+   M      E+VK E+ ++  L  
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQL-D 144
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAA 213
           H N+++ Y+AFE  N + + ME  +GGEL DRI+   D  Y  TE D  + ++Q+     
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIR 201
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H   ++H D+KPEN L  + ++   +K  DFGL+   KP +K +   G+  ++APEV+
Sbjct: 202 HMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV 260
Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
                S P +D+WS+GVI Y+LL G  PF    +      +L  + D   + +  IS  A
Sbjct: 261 NYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           K+F+ KLL+K+   R++A++AL HPW+ +
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 98/320 (30%), Positives = 170/320 (53%), Gaps = 10/320 (3%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP--IAVEDVKREVK 148
           D  F+  Y + +++G G F       ++  G + AVK ++  K      ++ ED+KRE  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVR 206
           I   L  H ++V+    +  D  +Y+  E  +G +L   I+ + D+   Y+E  A+  +R
Sbjct: 79  ICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSA 265
           Q+L     CH + ++HRD+KP   L  S +  + +K   FG++    + G      VG+ 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           +++APEV+KR+  G   DVW  GVI +ILL G  PF+  T++ +F+ +++ K     + W
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQW 256
Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD-ASEIPIDISVLNNMRQFVKY 383
             IS SAKD V+++L+ DP  R+T  +AL+HPW++E    A +I +  +V   +R+F   
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETV-EQLRKFNAR 315
Query: 384 SRLKQFALRVTQYFKYTALF 403
            +LK   L      K+ + +
Sbjct: 316 RKLKGAVLAAVSSHKFNSFY 335

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 94/289 (32%), Positives = 145/289 (50%), Gaps = 19/289 (6%)
Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           G++P G   +      F   Y + + +G G +        KA     AVK I+K+K    
Sbjct: 13  GLVPRGSHMNL----VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK---- 64
Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
               D   E++IL     H N++   + ++D  +VY+  EL  GGELLD+IL +K   ++
Sbjct: 65  ---RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFS 119
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLF-KSAKEDSSLKATDFGLSDFIKPGK 256
           E++A+ V+  + +     H  G+VHRD+KP N L+   +     L+  DFG +  ++   
Sbjct: 120 EREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179
Query: 257 KF-QDIVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDG---IFKE 311
                   +A +VAPEVLKR+   E  D+WS+G++ Y +L G  PF +   D    I   
Sbjct: 180 GLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTR 239
Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           +   K       W ++S +AKD V K+L  DP  RLTA Q L HPWV +
Sbjct: 240 IGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 141/271 (52%), Gaps = 15/271 (5%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + +G G +        KA     AVK I+K+K        D   E++IL   
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRY 72
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++   + ++D  YVY+  EL +GGELLD+IL +K   ++E++A+ V+  + +   
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVE 130
Query: 214 ECHLHGLVHRDMKPENFLF-KSAKEDSSLKATDFGLSDFIKP-GKKFQDIVGSAYYVAPE 271
             H  G+VHRD+KP N L+   +    S++  DFG +  ++           +A +VAPE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFW---DKTEDGIFKEVLRNKPDFRRKPWPSI 327
           VL+R+      D+WS+GV+ Y +L G  PF    D T + I   +   K       W S+
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           S++AKD V K+L  DP  RLTAA  L HPW+
Sbjct: 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 128/227 (56%), Gaps = 12/227 (5%)
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E   +EV IL+ ++GH N+++  + +E + + ++  +L + GEL D +  K     +EK+
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKE 125
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
              ++R +L V    H   +VHRD+KPEN L     +D ++K TDFG S  + PG+K ++
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 261 IVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
           + G+  Y+APE+++          G E D+WS GVI Y LL G  PFW + +  + + ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                F    W   S++ KD V + LV  P+ R TA +AL+HP+ ++
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 139/273 (50%), Gaps = 15/273 (5%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + +G G +        KA     AVK I+K+K        D   E++IL   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRY 77
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++   + ++D  +VY+  EL  GGELLD+IL +K   ++E++A+ V+  + +   
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVE 135
Query: 214 ECHLHGLVHRDMKPENFLF-KSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPE 271
             H  G+VHRD+KP N L+   +     L+  DFG +  ++           +A +VAPE
Sbjct: 136 YLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPE 195
Query: 272 VLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKPDFRRKPWPSI 327
           VLKR+   E  D+WS+G++ Y +L G  PF +   D    I   +   K       W ++
Sbjct: 196 VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTV 255
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           S +AKD V K+L  DP  RLTA Q L HPWV +
Sbjct: 256 SETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 128/227 (56%), Gaps = 12/227 (5%)
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E   +EV IL+ ++GH N+++  + +E + + ++  +L + GEL D +  K     +EK+
Sbjct: 55  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKE 112
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
              ++R +L V    H   +VHRD+KPEN L     +D ++K TDFG S  + PG+K ++
Sbjct: 113 TRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLRE 169
Query: 261 IVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
           + G+  Y+APE+++          G E D+WS GVI Y LL G  PFW + +  + + ++
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 229
Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                F    W   S++ KD V + LV  P+ R TA +AL+HP+ ++
Sbjct: 230 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 127/227 (55%), Gaps = 12/227 (5%)
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E   +EV IL+ ++GH N+++  + +E + + ++  +L + GEL D +  K     +EK+
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKE 125
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
              ++R +L V    H   +VHRD+KPEN L     +D ++K TDFG S  + PG+K + 
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLRS 182
Query: 261 IVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
           + G+  Y+APE+++          G E D+WS GVI Y LL G  PFW + +  + + ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                F    W   S++ KD V + LV  P+ R TA +AL+HP+ ++
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 139/271 (51%), Gaps = 15/271 (5%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + +G G +        KA     AVK I+K+K        D   E++IL   
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK-------RDPTEEIEILLRY 72
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++   + ++D  YVY+  EL +GGELLD+IL +K   ++E++A+ V+  + +   
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTITKTVE 130
Query: 214 ECHLHGLVHRDMKPENFLF-KSAKEDSSLKATDFGLSDFIKPGKKFQDI-VGSAYYVAPE 271
             H  G+VHRD+KP N L+   +    S++  DFG +  ++           +A +VAPE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPE 190
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFW---DKTEDGIFKEVLRNKPDFRRKPWPSI 327
           VL+R+      D+WS+GV+ Y  L G  PF    D T + I   +   K       W S+
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           S++AKD V K L  DP  RLTAA  L HPW+
Sbjct: 251 SDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 145/291 (49%), Gaps = 20/291 (6%)
Query: 91  DKDFDRRYTIG---KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           D  F + Y +    K LG G F        K +    AVK I K          + ++E+
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEI 56
Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
             L+   GH N+VK +  F D  + ++ MEL  GGEL +RI  KK   ++E +A+ ++R+
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRK 114
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIVGSAY 266
           ++   +  H  G+VHRD+KPEN LF    ++  +K  DFG +    P  +  +    + +
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWD-------KTEDGIFKEVLRNKPD 318
           Y APE+L +    ES D+WS+GVI Y +L G+ PF          +   I K++ +    
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234
Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           F  + W ++S  AKD ++ LL  DP  RL  +    + W+++G   S  P+
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL 285

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 143/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VA+K I+K ++  P +++ + REV+I++ L  H 
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 130 KRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 242
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           K+ LV +P  R T  Q +   W+  G +  E+
Sbjct: 243 KRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 274

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 143/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VA+K I+K ++  P +++ + REV+I++ L  H 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NHP 74
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     G+  Y APE+   K+
Sbjct: 133 KRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 245
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           K+ LV +P  R T  Q +   W+  G +  E+
Sbjct: 246 KRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 143/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAV+ I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K  +  GS  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 95/285 (33%), Positives = 142/285 (49%), Gaps = 18/285 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G  LG G FG   V   +  G +VAVK + + K+     V  ++RE++ L+ L  H 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHP 76
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y      + +++ ME   GGEL D I   K+ R  EK++  + +Q+L     CH 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHR 134
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L  +     + K  DFGLS+ +  G+  +   GS  Y APEV+  + 
Sbjct: 135 HMVVHRDLKPENVLLDAHM---NAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRL 191
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN---KPDFRRKPWPSISNSAK 332
            +GPE D+WS GVI Y LLCG  PF D     +FK++       P +       ++ S  
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY-------LNPSVI 244
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNM 377
             +K +L  DP  R T      H W ++       P D S  + M
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTM 289

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 140/281 (49%), Gaps = 26/281 (9%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G  G       +  G + A+K +  +           ++EV      +G  ++V 
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVC 67
Query: 162 FYNAFEDDNY----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             + +E+ ++    + I ME  EGGEL  RI  + D  +TE++AA ++R +       H 
Sbjct: 68  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           H + HRD+KPEN L+ S ++D+ LK TDFG +         Q    + YYVAPEVL    
Sbjct: 128 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVL---- 182
Query: 278 GPE-----SDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRNKPDFRRKPWPSIS 328
           GPE      D+WS+GVI YILLCG  PF+  T      G+ + +   +  F    W  +S
Sbjct: 183 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 242
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
             AK  ++ LL  DP  RLT  Q ++HPW+ +     + P+
Sbjct: 243 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 283

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 140/281 (49%), Gaps = 26/281 (9%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G  G       +  G + A+K +  +           ++EV      +G  ++V 
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVC 86
Query: 162 FYNAFEDDNY----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             + +E+ ++    + I ME  EGGEL  RI  + D  +TE++AA ++R +       H 
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           H + HRD+KPEN L+ S ++D+ LK TDFG +         Q    + YYVAPEVL    
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVL---- 201
Query: 278 GPE-----SDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRNKPDFRRKPWPSIS 328
           GPE      D+WS+GVI YILLCG  PF+  T      G+ + +   +  F    W  +S
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
             AK  ++ LL  DP  RLT  Q ++HPW+ +     + P+
Sbjct: 262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAV+ I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 100/320 (31%), Positives = 148/320 (46%), Gaps = 52/320 (16%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--ILPIAVEDVKREVKIL 150
           +  ++Y +   +G G +G   VA +       A+K + KNK+  I P  VE +K EV+++
Sbjct: 23  ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+ + Y  +ED+ Y+ + MELC GG LLD++    D   T K A  VV+  + 
Sbjct: 83  KKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS-TGKCAMDVVKTQIC 140
Query: 211 VAAEC---------------------------------------HLHGLVHRDMKPENFL 231
              EC                                       H  G+ HRD+KPENFL
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 232 FKSAKEDSSLKATDFGLS-DFIKPGKK----FQDIVGSAYYVAPEVLKRKS---GPESDV 283
           F S  +   +K  DFGLS +F K             G+ Y+VAPEVL   +   GP+ D 
Sbjct: 201 F-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 284 WSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDP 343
           WS GV+ ++LL G  PF    +     +VL  K  F    +  +S  A+D +  LL ++ 
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319
Query: 344 RARLTAAQALSHPWVREGGD 363
             R  A +AL HPW+ +  D
Sbjct: 320 DERFDAMRALQHPWISQFSD 339

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     G+  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 140/265 (52%), Gaps = 19/265 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I + LG G FG   +AT      +VA+K I +  +        V+RE+  L+ L  H 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+       + + +E   GGEL D I+ KK  R TE +     +Q++     CH 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHR 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     ++ ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 127 HKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS G++ Y++L GR PF D+    +FK+V   +   PDF       +S  A+
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-------LSPGAQ 236
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             +++++V DP  R+T  +    PW
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPW 261

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 136/268 (50%), Gaps = 18/268 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G  LG G FG   +   +  G +VAVK + + K+     V  +KRE++ L+ L  H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y         ++ ME   GGEL D I   K  R  E +A  + +Q+L     CH 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYIC--KHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L  +     + K  DFGLS+ +  G+  +D  GS  Y APEV+  + 
Sbjct: 130 HMVVHRDLKPENVLLDA---HMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRL 186
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE D+WS GVI Y LLCG  PF D+    +FK++   +   P++       ++ S  
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY-------LNRSVA 239
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVRE 360
             +  +L  DP  R T      H W ++
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 141/272 (51%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I++ L  H 
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 66
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A       EK+A    RQ++     CH 
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 125 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 181
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 237
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 238 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 269

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/268 (33%), Positives = 135/268 (50%), Gaps = 18/268 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G  LG G FG   +   +  G +VAVK + + K+     V  +KRE++ L+ L  H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y         ++ ME   GGEL D I   K  R  E +A  + +Q+L     CH 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYIC--KHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L  +     + K  DFGLS+ +  G+  +   GS  Y APEV+  + 
Sbjct: 130 HMVVHRDLKPENVLLDA---HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 186
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE D+WS GVI Y LLCG  PF D+    +FK++   +   P++       ++ S  
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY-------LNRSVA 239
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVRE 360
             +  +L  DP  R T      H W ++
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 104/296 (35%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVKILQALAGHENVVK 161
           +LG G         +       AVK IEK     P  +   V REV++L    GH NV++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
               FE+++  Y+  E   GG +L  I   K   + E +A+VVV+ +       H  G+ 
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--------VGSAYYVAPEVL 273
           HRD+KPEN L +   + S +K  DFGL   IK       I         GSA Y+APEV+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 274 KRKSGPES------DVWSIGVITYILLCGRRPF---------WDKTE------DGIFKEV 312
           +  S   S      D+WS+GVI YILL G  PF         WD+ E      + +F+ +
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
              K +F  K W  IS +AKD + KLLV+D + RL+AAQ L HPWV+     + +P
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 144/279 (51%), Gaps = 19/279 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I K LG G FG   +A     G +VA+K I K  +        ++RE+  L+ L  H 
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HP 64
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+  +  + + + +E   G EL D I+ +   + +E++A    +Q++     CH 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR 121
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     E  ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 122 HKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS GVI Y++LC R PF D++   +FK +   +   P F       +S  A 
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPGAA 231
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDI 371
             +K++L+ +P  R++  + +   W +       +P D+
Sbjct: 232 GLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLLPPDL 270

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 140/267 (52%), Gaps = 19/267 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I K LG G FG   +A     G +VA+K I K  +        ++RE+  L+ L  H 
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HP 74
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+  +  + + + +E   G EL D I+ +   + +E++A    +Q++     CH 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     E  ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 132 HKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 188
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS GVI Y++LC R PF D++   +FK +   +   P F       +S  A 
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPGAA 241
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
             +K++L+ +P  R++  + +   W +
Sbjct: 242 GLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 140/267 (52%), Gaps = 19/267 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I K LG G FG   +A     G +VA+K I K  +        ++RE+  L+ L  H 
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+  +  + + + +E   G EL D I+ +   + +E++A    +Q++     CH 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR 130
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     E  ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 131 HKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 187
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS GVI Y++LC R PF D++   +FK +   +   P F       +S  A 
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPGAA 240
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
             +K++L+ +P  R++  + +   W +
Sbjct: 241 GLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 144/279 (51%), Gaps = 19/279 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I K LG G FG   +A     G +VA+K I K  +        ++RE+  L+ L  H 
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+  +  + + + +E   G EL D I+ +   + +E++A    +Q++     CH 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR 125
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     E  ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 126 HKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 182
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS GVI Y++LC R PF D++   +FK +   +   P F       +S  A 
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPGAA 235
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDI 371
             +K++L+ +P  R++  + +   W +       +P D+
Sbjct: 236 GLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLLPPDL 274

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 103/296 (34%), Positives = 144/296 (48%), Gaps = 36/296 (12%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVKILQALAGHENVVK 161
           +LG G         +       AVK IEK     P  +   V REV++L    GH NV++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
               FE+++  Y+  E   GG +L  I   K   + E +A+VVV+ +       H  G+ 
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--------VGSAYYVAPEVL 273
           HRD+KPEN L +   + S +K  DF L   IK       I         GSA Y+APEV+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 274 KRKSGPES------DVWSIGVITYILLCGRRPF---------WDKTE------DGIFKEV 312
           +  S   S      D+WS+GVI YILL G  PF         WD+ E      + +F+ +
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
              K +F  K W  IS +AKD + KLLV+D + RL+AAQ L HPWV+     + +P
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 144/272 (52%), Gaps = 12/272 (4%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKI 149
           K+   +Y I + LG G+FG  +   + ++      K  K++    +L      VK+E+ I
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISI 54
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           L  +A H N++  + +FE    + +  E   G ++ +RI         E++    V Q+ 
Sbjct: 55  LN-IARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVC 112
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H H + H D++PEN ++++ +  S++K  +FG +  +KPG  F+ +  +  Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PEV +       +D+WS+G + Y+LL G  PF  +T   I + ++  +  F  + +  IS
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             A DFV +LLVK+ ++R+TA++AL HPW+++
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 143/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++  P +++ + REV+I++ L  H 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLN-PTSLQKLFREVRIMKIL-NHP 74
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L      D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 133 KYIVHRDLKAENLLLDG---DMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKK 189
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 245
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KKLLV +P  R +  Q +   W+  G +  E+
Sbjct: 246 KKLLVLNPIKRGSLEQIMKDRWMNVGHEEEEL 277

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 137/272 (50%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I + L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIXKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+  E   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH--GRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     G+  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+   S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YXSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q     W   G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIXKDRWXNVGHEDDEL 276

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 138/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +          +   + YYVAPEVL   
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVL--- 189
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 190 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 28  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 79
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 80  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 139
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 140 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 196
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 197 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 255
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 256 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 300

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 27  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 78
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 79  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 138
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 139 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 195
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 196 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 254
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 255 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 299

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 118
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 235
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 236 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 339

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 191
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 192 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 22  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 73
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 74  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 133
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 134 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 190
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 191 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 249
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 250 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 294

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 73  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 124
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 125 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 184
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 185 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 241
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 242 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 300
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 301 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 345

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 29  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 80
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 81  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 140
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 141 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 197
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 198 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 256
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 257 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 301

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 191
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 192 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 189
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 190 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 149/269 (55%), Gaps = 14/269 (5%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 92
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 93  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 149
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 150 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 265
Query: 342 DPRARLTAAQALSHPWV-REGGDASEIPI 369
           DP  R TAA+ L HP++ + G  AS +P+
Sbjct: 266 DPAQRATAAELLKHPFLAKAGPPASIVPL 294

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 149/269 (55%), Gaps = 14/269 (5%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 83
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 140
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 141 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 256
Query: 342 DPRARLTAAQALSHPWV-REGGDASEIPI 369
           DP  R TAA+ L HP++ + G  AS +P+
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPPASIVPL 285

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 137/284 (48%), Gaps = 25/284 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V+
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVR 89
Query: 162 FYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H 
Sbjct: 90  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 149
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
             + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL    
Sbjct: 150 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 205
Query: 278 GPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSIS 328
           GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +S
Sbjct: 206 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 265
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
              K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 266 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 309

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 149/269 (55%), Gaps = 14/269 (5%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 87
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 88  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 144
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 145 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 260
Query: 342 DPRARLTAAQALSHPWV-REGGDASEIPI 369
           DP  R TAA+ L HP++ + G  AS +P+
Sbjct: 261 DPAQRATAAELLKHPFLAKAGPPASIVPL 289

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 149/269 (55%), Gaps = 14/269 (5%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 94
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 95  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 151
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 152 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 267
Query: 342 DPRARLTAAQALSHPWV-REGGDASEIPI 369
           DP  R TAA+ L HP++ + G  AS +P+
Sbjct: 268 DPAQRATAAELLKHPFLAKAGPPASIVPL 296

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 149/269 (55%), Gaps = 14/269 (5%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 137
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 138 NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 194
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 195 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 252 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 310
Query: 342 DPRARLTAAQALSHPWV-REGGDASEIPI 369
           DP  R TAA+ L HP++ + G  AS +P+
Sbjct: 311 DPAQRATAAELLKHPFLAKAGPPASIVPL 339

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 146/266 (54%), Gaps = 13/266 (4%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 214
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 215 NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 271
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 272 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 329 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 387
Query: 342 DPRARLTAAQALSHPWVREGGDASEI 367
           DP  R TAA+ L HP++ + G  + I
Sbjct: 388 DPAQRATAAELLKHPFLAKAGPPASI 413

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 137/275 (49%), Gaps = 3/275 (1%)
Query: 88  FGYDKDFDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           F   ++F+  Y +  K LG G+F        K+ G   A K ++K +       E +  E
Sbjct: 20  FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHE 78
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           + +L+       V+  +  +E+ + + + +E   GGE+    L +     +E D   +++
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           Q+L      H + +VH D+KP+N L  S      +K  DFG+S  I    + ++I+G+  
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE 198
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           Y+APE+L        +D+W+IG+I Y+LL    PF  +     +  + +   D+  + + 
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           S+S  A DF++ LLVK+P  R TA   LSH W+++
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I  A+
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NAM 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 154/302 (50%), Gaps = 34/302 (11%)
Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           ++L +KQ  + + +RQ  +            +DF+    IG+ LG G+FG  Y+A +K +
Sbjct: 15  EELASKQKNEESKKRQWAL------------EDFE----IGRPLGKGKFGNVYLAREKQS 58
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
              +A+K + K ++        ++REV+I Q+   H N+++ Y  F D   VY+ +E   
Sbjct: 59  KFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAP 117
Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
            G +   +  +K S++ E+  A  + ++    + CH   ++HRD+KPEN L  SA E   
Sbjct: 118 LGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--- 172
Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRP 299
           LK  DFG S    P  +  D+ G+  Y+ PE+++ R    + D+WS+GV+ Y  L G+ P
Sbjct: 173 LKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 300 FWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           F   T    +K + R +   PDF       ++  A+D + +LL  +P  R    + L HP
Sbjct: 232 FEANTYQETYKRISRVEFTFPDF-------VTEGARDLISRLLKHNPSQRPMLREVLEHP 284
Query: 357 WV 358
           W+
Sbjct: 285 WI 286

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    GE+   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 236
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 146/283 (51%), Gaps = 23/283 (8%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G +  +  + DFD    IG+ LG G+FG  Y+A ++ +   +A+K + K ++      
Sbjct: 2   PLGSKRQWTLE-DFD----IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE 56
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             ++REV+I Q+   H N+++ Y  F D   VY+ +E    G +   +  +K SR+ E+ 
Sbjct: 57  HQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQR 113
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            A  + ++    + CH   ++HRD+KPEN L  S  E   LK  DFG S    P  +   
Sbjct: 114 TATYITELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWS-VHAPSSRRTT 169
Query: 261 IVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--- 316
           + G+  Y+ PE+++ R    + D+WS+GV+ Y  L G  PF   T    ++ + R +   
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF 229
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           PDF       ++  A+D + +LL  +   RLT A+ L HPW++
Sbjct: 230 PDF-------VTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    GE+   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRM 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 146/283 (51%), Gaps = 23/283 (8%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G +  +  + DFD    IG+ LG G+FG  Y+A ++ +   +A+K + K ++      
Sbjct: 2   PLGSKRQWTLE-DFD----IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE 56
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             ++REV+I Q+   H N+++ Y  F D   VY+ +E    G +   +  +K SR+ E+ 
Sbjct: 57  HQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQR 113
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            A  + ++    + CH   ++HRD+KPEN L  S  E   LK  DFG S    P  +   
Sbjct: 114 TATYITELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWS-VHAPSSRRDT 169
Query: 261 IVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--- 316
           + G+  Y+ PE+++ R    + D+WS+GV+ Y  L G  PF   T    ++ + R +   
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF 229
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           PDF       ++  A+D + +LL  +   RLT A+ L HPW++
Sbjct: 230 PDF-------VTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 60
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 61  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 117
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 118 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 228
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 229 WKKIDSAPLALLHKILVENPSARIT 253

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 89/254 (35%), Positives = 130/254 (51%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F  T +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 149 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 261
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 262 LVEKLLVLDATKRL 275

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 153/302 (50%), Gaps = 34/302 (11%)
Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           ++L +KQ  + + +RQ  +            +DF+    IG+ LG G+FG  Y+A +K +
Sbjct: 6   EELASKQKNEESKKRQWAL------------EDFE----IGRPLGKGKFGNVYLAREKQS 49
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
              +A+K + K ++        ++REV+I Q+   H N+++ Y  F D   VY+ +E   
Sbjct: 50  KFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAP 108
Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
            G +   +  +K S++ E+  A  + ++    + CH   ++HRD+KPEN L  SA E   
Sbjct: 109 LGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--- 163
Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRP 299
           LK  DFG S    P  +   + G+  Y+ PE+++ R    + D+WS+GV+ Y  L G+ P
Sbjct: 164 LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222
Query: 300 FWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           F   T    +K + R +   PDF       ++  A+D + +LL  +P  R    + L HP
Sbjct: 223 FEANTYQETYKRISRVEFTFPDF-------VTEGARDLISRLLKHNPSQRPMLREVLEHP 275
Query: 357 WV 358
           W+
Sbjct: 276 WI 277

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 153/302 (50%), Gaps = 34/302 (11%)
Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           ++L +KQ  + + +RQ  +            +DF+    IG+ LG G+FG  Y+A +K +
Sbjct: 15  EELASKQKNEESKKRQWAL------------EDFE----IGRPLGKGKFGNVYLAREKQS 58
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
              +A+K + K ++        ++REV+I Q+   H N+++ Y  F D   VY+ +E   
Sbjct: 59  KFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAP 117
Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
            G +   +  +K S++ E+  A  + ++    + CH   ++HRD+KPEN L  SA E   
Sbjct: 118 LGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--- 172
Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRP 299
           LK  DFG S    P  +   + G+  Y+ PE+++ R    + D+WS+GV+ Y  L G+ P
Sbjct: 173 LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 300 FWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           F   T    +K + R +   PDF       ++  A+D + +LL  +P  R    + L HP
Sbjct: 232 FEANTYQETYKRISRVEFTFPDF-------VTEGARDLISRLLKHNPSQRPMLREVLEHP 284
Query: 357 WV 358
           W+
Sbjct: 285 WI 286

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDS-----XQEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  ++ G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 148 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 260
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 261 LVEKLLVLDATKRL 274

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 148 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 260
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 261 LVEKLLVLDATKRL 274

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 74
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 133 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 245
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 246 LVEKLLVLDATKRL 259

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 135/265 (50%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G  G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 93
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 152 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 264
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 265 LVEKLLVLDATKRL 278

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 70
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 128
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 129 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM 184
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 237
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 67
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 125
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 126 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 181
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 234
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 235 LISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS  +S D+W++G I Y L+ G  PF    E  IF ++++ + DF  K +P     A+D
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 149 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 261
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 262 LVEKLLVLDATKRL 275

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 130/258 (50%), Gaps = 14/258 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 239
Query: 334 FVKKLLVKDPRARLTAAQ 351
            V+KLLV D   RL   +
Sbjct: 240 LVEKLLVLDATKRLGCEE 257

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 130/258 (50%), Gaps = 14/258 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 67
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 125
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 126 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 238
Query: 334 FVKKLLVKDPRARLTAAQ 351
            V+KLLV D   RL   +
Sbjct: 239 LVEKLLVLDATKRLGCEE 256

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM 183
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 236
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KKVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWSCH-APSSRRTTLSGTLDYLPPEMIEGRM 183
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 236
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 149 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 261
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 262 LVEKLLVLDATKRL 275

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 137/265 (51%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE ++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRX 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF ++++ + DF  K +P     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 149 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 261
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 262 LVEKLLVLDATKRL 275

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/258 (34%), Positives = 130/258 (50%), Gaps = 14/258 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 128 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 240
Query: 334 FVKKLLVKDPRARLTAAQ 351
            V+KLLV D   RL   +
Sbjct: 241 LVEKLLVLDATKRLGCEE 258

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 70
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 128
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 129 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 241
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 242 LVEKLLVLDATKRL 255

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 93
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 152 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 264
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 265 LVEKLLVLDATKRL 278

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 97
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 156 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 268
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 269 LVEKLLVLDATKRL 282

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 72
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 130
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 131 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 239
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 240 LISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 137/265 (51%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K     +A+K + K ++        ++REV+I Q+   H 
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 65
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 123
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 124 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 232
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 233 LISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 133/265 (50%), Gaps = 12/265 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK + + VAVK IE+ + I     E+VKRE+   ++L  H
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----DENVKREIINHRSLR-H 73
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   + CH
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 131
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK  DFG S       + +  VG+  Y+APEVL +K
Sbjct: 132 AMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 190
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   F++ +       +    +  IS   +
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             + ++ V DP  R++  +  +H W
Sbjct: 251 HLISRIFVADPAKRISIPEIRNHEW 275

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 137/268 (51%), Gaps = 16/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DFD    IG+ LG G+FG  Y+A +K N   +A+K + K+++        ++RE++I Q+
Sbjct: 16  DFD----IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI-QS 70
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++ YN F D   +Y+ +E    GEL   +  +K  R+ E+ +A  + ++    
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADAL 128
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
             CH   ++HRD+KPEN L     E   LK  DFG S    P  + + + G+  Y+ PE+
Sbjct: 129 HYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWS-VHAPSLRRRXMCGTLDYLPPEM 184
Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           ++ K+  E  D+W  GV+ Y  L G  PF   +     + ++     F     P +S+ +
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 240
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVR 359
           KD + KLL   P  RL     + HPWV+
Sbjct: 241 KDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 70
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 128
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  +FG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 129 KRVIHRDIKPENLLLGSAGE---LKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 184
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 237
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  +FG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 137/263 (52%), Gaps = 12/263 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   VA+K + K+++        ++RE++I QA   H 
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEI-QAHLHHP 83
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ YN F D   +Y+ +E    GEL   +  +K   + E+  A ++ ++      CH 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCTFDEQRTATIMEELADALMYCHG 141
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN           LK  DFG S    P  + + + G+  Y+ PE+++ R 
Sbjct: 142 KKVIHRDIKPEN---LLLGLKGELKIADFGWSVH-APSLRRKTMCGTLDYLPPEMIEGRM 197
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
              + D+W IGV+ Y LL G  PF   + +  ++ +++    F      S+   A+D + 
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPA----SVPTGAQDLIS 253
Query: 337 KLLVKDPRARLTAAQALSHPWVR 359
           KLL  +P  RL  AQ  +HPWVR
Sbjct: 254 KLLRHNPSERLPLAQVSAHPWVR 276

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 131/285 (45%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKXLQD--------CPKARREVELHWRASQCPHIV 118
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I  E  +GGEL  RI  + D  +TE++A+ + + +       H
Sbjct: 119 RIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH 178
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 235
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D WS+GVI YILLCG  PF+         G    +   + +F    W  +
Sbjct: 236 -GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEV 294
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R T  +  +HPW+ +     + P+  S
Sbjct: 295 SEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTS 339

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 133/265 (50%), Gaps = 12/265 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK + + VAVK IE+ + I     E+VKRE+   ++L  H
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----DENVKREIINHRSLR-H 74
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   + CH
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK   FG S       + +D VG+  Y+APEVL +K
Sbjct: 133 AMQVCHRDLKLENTLLDGSPA-PRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKK 191
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   F++ +       +    +  IS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             + ++ V DP  R++  +  +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 132/265 (49%), Gaps = 12/265 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK + + VAVK IE+ + I      +VKRE+   ++L  H
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----AANVKREIINHRSLR-H 74
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   + CH
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK  DFG S       + +  VG+  Y+APEVL +K
Sbjct: 133 AMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   F++ +       +    +  IS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             + ++ V DP  R++  +  +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + G LL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 275 RKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS  +S D+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 95
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 154 KGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF    +P     A+D
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFP----KARD 266
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 267 LVEKLLVLDATKRL 280

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/323 (28%), Positives = 163/323 (50%), Gaps = 29/323 (8%)
Query: 60  YQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKA 119
           +Q +    H++  +  Q  V P   R    Y  +F +       +G G  G   +AT+K 
Sbjct: 19  FQSMSRVSHEQFRAALQLVVSPGDPRE---YLANFIK-------IGEGSTGIVCIATEKH 68
Query: 120 NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC 179
            G +VAVKK++  K       E +  EV I++    H+NVV  Y+++   + +++ ME  
Sbjct: 69  TGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYH-HDNVVDMYSSYLVGDELWVVMEFL 124
Query: 180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
           EGG L D +     +R  E+  A V   +LR  +  H  G++HRD+K ++ L  S   D 
Sbjct: 125 EGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS---DG 178
Query: 240 SLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGR 297
            +K +DFG  +   K   K + +VG+ Y++APEV+ R   G E D+WS+G++   ++ G 
Sbjct: 179 RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238
Query: 298 RPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            P++++      + +  + P  R K    +S+  + F+  +LV++P  R TA + L HP+
Sbjct: 239 PPYFNEPPLQAMRRIRDSLPP-RVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHPF 297
Query: 358 VREGGDASEIPIDISVLNNMRQF 380
           ++  G  S       ++  MRQ+
Sbjct: 298 LKLAGPPS------CIVPLMRQY 314

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 88/290 (30%), Positives = 146/290 (50%), Gaps = 12/290 (4%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P  +  D   D    +RY  G+ LG G F   Y  TD    +  A K + K+ ++ P   
Sbjct: 11  PLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK 70
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E +  E+ I ++L  + +VV F+  FEDD++VY+ +E+C    LL+  L K+    TE +
Sbjct: 71  EKMSTEIAIHKSL-DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPE 127
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ 259
           A   +RQ ++     H + ++HRD+K  N       +D  +K  DFGL+  I+  G++ +
Sbjct: 128 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKK 184
Query: 260 DIVGSAYYVAPEVLKRKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
           D+ G+  Y+APEVL +K    E D+WS+G I Y LL G+ PF        +  + +N+  
Sbjct: 185 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS 244
Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
             R     I+  A   ++++L  DP  R + A+ L+  +   G     +P
Sbjct: 245 VPR----HINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 290

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 88/290 (30%), Positives = 146/290 (50%), Gaps = 12/290 (4%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P  +  D   D    +RY  G+ LG G F   Y  TD    +  A K + K+ ++ P   
Sbjct: 27  PLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK 86
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E +  E+ I ++L  + +VV F+  FEDD++VY+ +E+C    LL+  L K+    TE +
Sbjct: 87  EKMSTEIAIHKSL-DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPE 143
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ 259
           A   +RQ ++     H + ++HRD+K  N       +D  +K  DFGL+  I+  G++ +
Sbjct: 144 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKK 200
Query: 260 DIVGSAYYVAPEVLKRKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
           D+ G+  Y+APEVL +K    E D+WS+G I Y LL G+ PF        +  + +N+  
Sbjct: 201 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS 260
Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
             R     I+  A   ++++L  DP  R + A+ L+  +   G     +P
Sbjct: 261 VPRH----INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 132/265 (49%), Gaps = 12/265 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK + + VAVK IE+ + I     E+VKRE+   ++L  H
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----DENVKREIINHRSLR-H 74
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   + CH
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK   FG S       + +  VG+  Y+APEVL +K
Sbjct: 133 AMQVCHRDLKLENTLLDGSPA-PRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   F++ +       +    +  IS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             + ++ V DP  R++  +  +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/268 (30%), Positives = 136/268 (50%), Gaps = 16/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DFD    I + LG G+FG  Y+A +K N   +A+K + K+++        ++RE++I Q+
Sbjct: 15  DFD----IVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI-QS 69
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++ YN F D   +Y+ +E    GEL   +  +K  R+ E+ +A  + ++    
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADAL 127
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
             CH   ++HRD+KPEN L     E   LK  DFG S    P  + + + G+  Y+ PE+
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWS-VHAPSLRRRXMCGTLDYLPPEM 183
Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           ++ K+  E  D+W  GV+ Y  L G  PF   +     + ++     F     P +S+ +
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 239
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVR 359
           KD + KLL   P  RL     + HPWV+
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 132/270 (48%), Gaps = 22/270 (8%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY   K +G G FG   +  DK   + VAVK IE+   I     E+V+RE+   ++L  H
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLR-H 75
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q+L   + CH
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERIC--NAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK  DFG S       + +  VG+  Y+APEVL R+
Sbjct: 134 SMQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------NKPDFRRKPWPSI 327
              G  +DVWS GV  Y++L G  PF D  E   +++ ++       + PD  R     I
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-----I 247
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           S      + ++ V DP  R++  +  +H W
Sbjct: 248 SPECCHLISRIFVADPATRISIPEIKTHSW 277

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 82
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 141 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 198 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 252
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 253 QTDPTARPTINELLNDEFFTSGYIPARLPI 282

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 82
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 141 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 198 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 252
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 253 QTDPTARPTINELLNDEFFTSGYIPARLPI 282

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 86
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 144
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 145 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 201
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 202 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 256
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 257 QTDPTARPTINELLNDEFFTSGYIPARLPI 286

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 145/290 (50%), Gaps = 12/290 (4%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P  +  D   D    +RY  G+ LG G F   Y  TD    +  A K + K+ ++ P   
Sbjct: 27  PLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK 86
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E +  E+ I ++L  + +VV F+  FEDD++VY+ +E+C    LL+  L K+    TE +
Sbjct: 87  EKMSTEIAIHKSL-DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPE 143
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ 259
           A   +RQ ++     H + ++HRD+K  N       +D  +K  DFGL+  I+  G++ +
Sbjct: 144 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKK 200
Query: 260 DIVGSAYYVAPEVLKRKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
            + G+  Y+APEVL +K    E D+WS+G I Y LL G+ PF        +  + +N+  
Sbjct: 201 TLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS 260
Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
             R     I+  A   ++++L  DP  R + A+ L+  +   G     +P
Sbjct: 261 VPRH----INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 145/290 (50%), Gaps = 12/290 (4%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P  +  D   D    +RY  G+ LG G F   Y  TD    +  A K + K+ ++ P   
Sbjct: 27  PLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK 86
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E +  E+ I ++L  + +VV F+  FEDD++VY+ +E+C    LL+  L K+    TE +
Sbjct: 87  EKMSTEIAIHKSL-DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPE 143
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ 259
           A   +RQ ++     H + ++HRD+K  N       +D  +K  DFGL+  I+  G++ +
Sbjct: 144 ARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKK 200
Query: 260 DIVGSAYYVAPEVLKRKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
            + G+  Y+APEVL +K    E D+WS+G I Y LL G+ PF        +  + +N+  
Sbjct: 201 XLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS 260
Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
             R     I+  A   ++++L  DP  R + A+ L+  +   G     +P
Sbjct: 261 VPRH----INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 132/270 (48%), Gaps = 22/270 (8%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK   + VAVK IE+ + I     E+VKRE+   ++L  H
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKI----DENVKREIINHRSLR-H 74
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   +  H
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYAH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK  DFG S       + +  VG+  Y+APEVL +K
Sbjct: 133 AMQVAHRDLKLENTLLDGSPA-PRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKK 191
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-------KPDFRRKPWPSI 327
              G  +DVWS GV  Y++L G  PF D  E   F++ +          PD+       I
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVH-----I 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           S   +  + ++ V DP  R++  +  +H W
Sbjct: 247 SPECRHLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 80
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 138
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 139 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 196 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 250
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 251 QTDPTARPTINELLNDEFFTSGYIPARLPI 280

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 104
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 162
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 163 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 220 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 274
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 275 QTDPTARPTINELLNDEFFTSGYIPARLPI 304

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 106
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 164
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 165 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 222 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 276
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 277 QTDPTARPTINELLNDEFFTSGYIPARLPI 306

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 138/261 (52%), Gaps = 13/261 (4%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +A +K +G +VAVK ++  K       E +  EV I++    H NVV+ Y
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ-HFNVVEMY 108
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            ++     +++ ME  +GG L D +      R  E+  A V   +L+  A  H  G++HR
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVLKRKS-GPES 281
           D+K ++ L      D  +K +DFG    I K   K + +VG+ Y++APEV+ R     E 
Sbjct: 166 DIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++  +     K  LR+ P  + K    +S   +DF++++LV+
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNSHKVSPVLRDFLERMLVR 281
Query: 342 DPRARLTAAQALSHPWVREGG 362
           DP+ R TA + L HP++ + G
Sbjct: 282 DPQERATAQELLDHPFLLQTG 302

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 36/280 (12%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG                     A E    K
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTGEK 174
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
                D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +S   K
Sbjct: 175 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 234
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
             ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 235 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 130/278 (46%), Gaps = 24/278 (8%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-----VKR 145
           + ++ ++Y+    LG G FG+ + A DK     V VK I+K K++    +ED     V  
Sbjct: 19  EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI-LAKKDSRYTEKDAAVV 204
           E+ IL  +  H N++K  + FE+  +  + ME  + G  LD      +  R  E  A+ +
Sbjct: 79  EIAILSRVE-HANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
            RQ++       L  ++HRD+K EN +     ED ++K  DFG + +++ GK F    G+
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGT 192
Query: 265 AYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
             Y APEVL      GPE ++WS+GV  Y L+    PF +          L    +    
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------LEETVEAAIH 242
Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           P   +S      V  LL   P  R T  + ++ PWV +
Sbjct: 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 21/268 (7%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA--VEDVKREVKILQALAGHENVVK 161
           LG G +G  Y A  K  G  VA+K++       P+   ++++ +E+ I+Q      +VVK
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQV-------PVESDLQEIIKEISIMQQ-CDSPHVVK 88
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +Y ++  +  ++I ME C  G + D I+  ++   TE + A +++  L+     H    +
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           HRD+K  N L  +   +   K  DFG++        K   ++G+ +++APEV++      
Sbjct: 148 HRDIKAGNILLNT---EGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC 204
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSISNSAKDFVKK 337
            +D+WS+G+    +  G+ P+ D         +  N P   RKP  W   S++  DFVK+
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW---SDNFTDFVKQ 261
Query: 338 LLVKDPRARLTAAQALSHPWVREGGDAS 365
            LVK P  R TA Q L HP+VR     S
Sbjct: 262 CLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 133/269 (49%), Gaps = 18/269 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I + LG G FG  ++   + NG   A+K ++K  ++    VE    E +++ ++  H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE-RLMLSIVTHP 66
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +++ +  F+D   +++ M+  EGGEL    L +K  R+    A     ++       H 
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFS--LLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
             +++RD+KPEN L     ++  +K TDFG + ++ P   +  + G+  Y+APEV+  K 
Sbjct: 125 KDIIYRDLKPENILL---DKNGHIKITDFGFAKYV-PDVTYX-LCGTPDYIAPEVVSTKP 179
Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             +S D WS G++ Y +L G  PF+D      ++++L  +  F     P  +   KD + 
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 235
Query: 337 KLLVKDPRARLTAAQ-----ALSHPWVRE 360
           +L+ +D   RL   Q       +HPW +E
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 139/288 (48%), Gaps = 24/288 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + + +L+G+G +G  Y       G   A+K ++    +     E++K+E+ +L+  + H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81
Query: 158 NVVKFYNAFED------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           N+  +Y AF        D+ +++ ME C  G + D I   K +   E+  A + R++LR 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAP 270
            +  H H ++HRD+K +N L     E++ +K  DFG+S    +   +    +G+ Y++AP
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 271 EVLKRKSGPE------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK-PDFRRKP 323
           EV+     P+      SD+WS+G+    +  G  P  D         + RN  P  + K 
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258
Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDI 371
           W   S   + F++  LVK+   R    Q + HP++R+  +  ++ I +
Sbjct: 259 W---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQL 303

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 129/267 (48%), Gaps = 17/267 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG   +A  K  GD  AVK ++K+ ++    VE    E +IL     H  + +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +  F+  + ++  ME   GG+L+  I  +K  R+ E  A     +++      H  G++
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGII 146
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK-SGP 279
           +RD+K +N L      +   K  DFG+  + I  G       G+  Y+APE+L+    GP
Sbjct: 147 YRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W++GV+ Y +LCG  PF  + ED +F+ +L ++  +    W  +   A   +K  +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW--LHEDATGILKSFM 259
Query: 340 VKDPRARLTAAQ------ALSHPWVRE 360
            K+P  RL +         L HP+ +E
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 72
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 73  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 130
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 131 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 187
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 243
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 244 KKDPKQRLGGGPS 256

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 74
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 132
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 133 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGR 189
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 245
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 246 KKDPKQRLGGGPS 258

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 132/277 (47%), Gaps = 20/277 (7%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D D +  + I   LG G FG  Y A +K  G   A K IE         +ED   E++IL
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEIL 70
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            A   H  +VK   A+  D  ++I +E C GG + D I+ + D   TE    VV RQML 
Sbjct: 71  -ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLE 128
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVA 269
                H   ++HRD+K  N L      +  ++  DFG+S   +K  +K    +G+ Y++A
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185
Query: 270 PEVL---KRKSGP---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+     K  P   ++D+WS+G+    +     P  +     +  ++ ++ P     P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245
Query: 324 --WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             W   S   +DF+K  L K+P  R +AAQ L HP+V
Sbjct: 246 SKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 132/277 (47%), Gaps = 20/277 (7%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D D +  + I   LG G FG  Y A +K  G   A K IE         +ED   E++IL
Sbjct: 6   DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEIL 62
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            A   H  +VK   A+  D  ++I +E C GG + D I+ + D   TE    VV RQML 
Sbjct: 63  -ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLE 120
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVA 269
                H   ++HRD+K  N L      +  ++  DFG+S   +K  +K    +G+ Y++A
Sbjct: 121 ALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 177
Query: 270 PEVL---KRKSGP---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+     K  P   ++D+WS+G+    +     P  +     +  ++ ++ P     P
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 237
Query: 324 --WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             W   S   +DF+K  L K+P  R +AAQ L HP+V
Sbjct: 238 SKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 137/273 (50%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 68
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 125
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K  ++VG+ Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSEMVGTPYW 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 241
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L H +++
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 25/270 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           IG+L G G FG  Y A +K      A K I+         +ED   E+ IL A   H N+
Sbjct: 42  IGEL-GDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDIL-ASCDHPNI 96
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           VK  +AF  +N ++I +E C GG + D ++ + +   TE    VV +Q L      H + 
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKRK 276
           ++HRD+K  N LF     D  +K  DFG+S   K  +  Q     +G+ Y++APEV+  +
Sbjct: 156 IIHRDLKAGNILFTL---DGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 277 SGPE------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSIS 328
           +  +      +DVWS+G+    +     P  +     +  ++ +++P    +P  W   S
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---S 267
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           ++ KDF+KK L K+  AR T +Q L HP+V
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 25/270 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           IG+L G G FG  Y A +K      A K I+         +ED   E+ IL A   H N+
Sbjct: 42  IGEL-GDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDIL-ASCDHPNI 96
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           VK  +AF  +N ++I +E C GG + D ++ + +   TE    VV +Q L      H + 
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKRK 276
           ++HRD+K  N LF     D  +K  DFG+S   K  +  Q     +G+ Y++APEV+  +
Sbjct: 156 IIHRDLKAGNILFTL---DGDIKLADFGVS--AKNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 277 SGPE------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSIS 328
           +  +      +DVWS+G+    +     P  +     +  ++ +++P    +P  W   S
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---S 267
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           ++ KDF+KK L K+  AR T +Q L HP+V
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 25/270 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           IG+L G G FG  Y A +K      A K I+         +ED   E+ IL A   H N+
Sbjct: 42  IGEL-GDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDIL-ASCDHPNI 96
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           VK  +AF  +N ++I +E C GG + D ++ + +   TE    VV +Q L      H + 
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKRK 276
           ++HRD+K  N LF     D  +K  DFG+S   K  +  Q     +G+ Y++APEV+  +
Sbjct: 156 IIHRDLKAGNILFTL---DGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 277 SGPE------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSIS 328
           +  +      +DVWS+G+    +     P  +     +  ++ +++P    +P  W   S
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---S 267
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           ++ KDF+KK L K+  AR T +Q L HP+V
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 68
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 125
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 241
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L H +++
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 68
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 125
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 241
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L H +++
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 95/332 (28%), Positives = 147/332 (44%), Gaps = 62/332 (18%)
Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           KR  +    DF     +  LLG G +G    AT K  G+ VA+KKIE      P+     
Sbjct: 3   KRIVYNISSDFQ----LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRT 56
Query: 144 KREVKILQALAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
            RE+KIL+    HEN++  +N     +FE+ N VYI  EL +    L R+++ +    ++
Sbjct: 57  LREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQ--MLSD 111
Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI------ 252
                 + Q LR     H   ++HRD+KP N L  S   +  LK  DFGL+  I      
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAAD 168
Query: 253 --KPGKK---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDK-- 303
             +P  +     + V + +Y APEV+    K     DVWS G I   L   RRP +    
Sbjct: 169 NSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD 227
Query: 304 -----------------------TEDGIFKEVLRNKPDFRRKP----WPSISNSAKDFVK 336
                                   E    +E +++ P +   P    +P ++    D ++
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           ++LV DP  R+TA +AL HP+++   D ++ P
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPNDEP 319

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 95/332 (28%), Positives = 147/332 (44%), Gaps = 62/332 (18%)
Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           KR  +    DF     +  LLG G +G    AT K  G+ VA+KKIE      P+     
Sbjct: 3   KRIVYNISSDFQ----LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRT 56
Query: 144 KREVKILQALAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
            RE+KIL+    HEN++  +N     +FE+ N VYI  EL +    L R+++ +    ++
Sbjct: 57  LREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQ--MLSD 111
Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI------ 252
                 + Q LR     H   ++HRD+KP N L  S   +  LK  DFGL+  I      
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAAD 168
Query: 253 --KPGKK---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDK-- 303
             +P  +     + V + +Y APEV+    K     DVWS G I   L   RRP +    
Sbjct: 169 NSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD 227
Query: 304 -----------------------TEDGIFKEVLRNKPDFRRKP----WPSISNSAKDFVK 336
                                   E    +E +++ P +   P    +P ++    D ++
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           ++LV DP  R+TA +AL HP+++   D ++ P
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPNDEP 319

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 95/332 (28%), Positives = 147/332 (44%), Gaps = 62/332 (18%)
Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           KR  +    DF     +  LLG G +G    AT K  G+ VA+KKIE      P+     
Sbjct: 3   KRIVYNISSDFQ----LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRT 56
Query: 144 KREVKILQALAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
            RE+KIL+    HEN++  +N     +FE+ N VYI  EL +    L R+++ +    ++
Sbjct: 57  LREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQ--MLSD 111
Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI------ 252
                 + Q LR     H   ++HRD+KP N L  S   +  LK  DFGL+  I      
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAAD 168
Query: 253 --KPGKK---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDK-- 303
             +P  +     + V + +Y APEV+    K     DVWS G I   L   RRP +    
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD 227
Query: 304 -----------------------TEDGIFKEVLRNKPDFRRKP----WPSISNSAKDFVK 336
                                   E    +E +++ P +   P    +P ++    D ++
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           ++LV DP  R+TA +AL HP+++   D ++ P
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPNDEP 319

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 21/256 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 215
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 270
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 271 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 326
Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK  
Sbjct: 327 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 382
Query: 335 VKKLLVKDPRARLTAA 350
           +  LL KDP+ RL   
Sbjct: 383 LSGLLKKDPKQRLGGG 398

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 129/256 (50%), Gaps = 27/256 (10%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 212
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+   +          V+A  +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI---------VSALDY 263
Query: 217 LHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
           LH    +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEV
Sbjct: 264 LHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320
Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           L+    G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   A
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEA 376
Query: 332 KDFVKKLLVKDPRARL 347
           K  +  LL KDP+ RL
Sbjct: 377 KSLLSGLLKKDPKQRL 392

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 21/256 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 72
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 127
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 128 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED 183
Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK  
Sbjct: 184 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 239
Query: 335 VKKLLVKDPRARLTAA 350
           +  LL KDP+ RL   
Sbjct: 240 LSGLLKKDPKQRLGGG 255

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 69
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 126
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 127 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 242
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + + H +++
Sbjct: 243 LSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 21/256 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 73
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 128
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 129 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED 184
Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK  
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 240
Query: 335 VKKLLVKDPRARLTAA 350
           +  LL KDP+ RL   
Sbjct: 241 LSGLLKKDPKQRLGGG 256

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 21/256 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 74
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 129
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 130 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED 185
Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK  
Sbjct: 186 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 241
Query: 335 VKKLLVKDPRARLTAA 350
           +  LL KDP+ RL   
Sbjct: 242 LSGLLKKDPKQRLGGG 257

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 135/289 (46%), Gaps = 43/289 (14%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIE---KNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y A D + G  VA+K+I    +++ I   A+    RE+ +L+ L  H N+V
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELH-HPNIV 82
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
              +    +  + +  E  E    L ++L +  +   +    + + Q+LR  A CH H +
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKS 277
           +HRD+KP+N L  S   D +LK  DFGL+  F  P + +   V + +Y AP+VL   +K 
Sbjct: 141 LHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL--------RNKPD----------- 318
               D+WSIG I   ++ G+  F   T+D    ++         R  P            
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 319 ---FRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              F +KPW    P       D +  +L  DP  R++A  A++HP+ ++
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 135/289 (46%), Gaps = 43/289 (14%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIE---KNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y A D + G  VA+K+I    +++ I   A+    RE+ +L+ L  H N+V
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELH-HPNIV 82
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
              +    +  + +  E  E    L ++L +  +   +    + + Q+LR  A CH H +
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKS 277
           +HRD+KP+N L  S   D +LK  DFGL+  F  P + +   V + +Y AP+VL   +K 
Sbjct: 141 LHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL--------RNKPD----------- 318
               D+WSIG I   ++ G+  F   T+D    ++         R  P            
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 319 ---FRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              F +KPW    P       D +  +L  DP  R++A  A++HP+ ++
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 69
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 126
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HR++K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 127 LQALEFLHSNQVIHRNIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 242
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + + H +++
Sbjct: 243 LSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           G++K    ++ + K+LG G FG  ++    +  D     A+K ++K  + +   V   K 
Sbjct: 18  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKM 76
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  IL  +  H  +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    +
Sbjct: 77  ERDILVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 133
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
            ++       H  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGT 190
Query: 265 AYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFR 320
             Y+APEV+ R+   +S D WS GV+ + +L G  PF  K        +L+ K   P F 
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF- 249
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA 350
                 +S  A+  ++ L  ++P  RL A 
Sbjct: 250 ------LSPEAQSLLRMLFKRNPANRLGAG 273

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           G++K    ++ + K+LG G FG  ++    +  D     A+K ++K  + +   V   K 
Sbjct: 17  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKM 75
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  IL  +  H  +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    +
Sbjct: 76  ERDILVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 132
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
            ++       H  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGT 189
Query: 265 AYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFR 320
             Y+APEV+ R+   +S D WS GV+ + +L G  PF  K        +L+ K   P F 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF- 248
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA 350
                 +S  A+  ++ L  ++P  RL A 
Sbjct: 249 ------LSPEAQSLLRMLFKRNPANRLGAG 272

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           G++K    ++ + K+LG G FG  ++    +  D     A+K ++K  + +   V   K 
Sbjct: 17  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKM 75
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  IL  +  H  +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    +
Sbjct: 76  ERDILVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 132
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
            ++       H  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGT 189
Query: 265 AYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFR 320
             Y+APEV+ R+   +S D WS GV+ + +L G  PF  K        +L+ K   P F 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF- 248
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA 350
                 +S  A+  ++ L  ++P  RL A 
Sbjct: 249 ------LSPEAQSLLRMLFKRNPANRLGAG 272

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 133/292 (45%), Gaps = 39/292 (13%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA----------------- 139
           +YT+   +G G +G   +A ++ +    A+K + K K+I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 140 ------VEDVKREVKILQALAGHENVVKFYNAFEDDN--YVYIAMELCEGGELLDRILAK 191
                 +E V +E+ IL+ L  H NVVK     +D N  ++Y+  EL   G +++    K
Sbjct: 74  IQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 192 KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
                +E  A    + +++     H   ++HRD+KP N L     ED  +K  DFG+S+ 
Sbjct: 133 P---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNE 186
Query: 252 IKPGKKF-QDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTED 306
            K       + VG+  ++APE L       SG   DVW++GV  Y  + G+ PF D+   
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 307 GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            +  ++     +F  +P   I+   KD + ++L K+P +R+   +   HPWV
Sbjct: 247 CLHSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 128/266 (48%), Gaps = 12/266 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + + K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   +  F+    ++  ME   GG+L+  I  +   ++    A     +++      H 
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS 137
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV-LKR 275
            G+V+RD+K +N L     +D  +K  DFG+  + +    K  +  G+  Y+APE+ L +
Sbjct: 138 KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
           K     D WS GV+ Y +L G+ PF  + E+ +F  +  + P + R  W  +   AKD +
Sbjct: 195 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--LEKEAKDLL 250
Query: 336 KKLLVKDPRARLTAAQAL-SHPWVRE 360
            KL V++P  RL     +  HP  RE
Sbjct: 251 VKLFVREPEKRLGVRGDIRQHPLFRE 276

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 22/270 (8%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
           G +K     + + K+LG G FG  ++    T   +G   A+K ++K  + +   V   K 
Sbjct: 21  GSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVR-TKM 79
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  IL A   H  VVK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    +
Sbjct: 80  ERDIL-ADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 136
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
            ++       H  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+
Sbjct: 137 AELALGLDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAYSFCGT 193
Query: 265 AYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFR 320
             Y+APEV+ R+    S D WS GV+ + +L G  PF  K        +L+ K   P F 
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQF- 252
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA 350
                 +S  A+  ++ L  ++P  RL + 
Sbjct: 253 ------LSTEAQSLLRALFKRNPANRLGSG 276

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 92
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 150
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     E   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 151 YRDLKPENLLI---DEQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 205
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 206 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 260
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 261 QVDLTKRF 268

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 127/266 (47%), Gaps = 12/266 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + + K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   +  F+    ++  ME   GG+L+  I  +   ++    A     +++      H 
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV-LKR 275
            G+V+RD+K +N L     +D  +K  DFG+  + +    K     G+  Y+APE+ L +
Sbjct: 137 KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
           K     D WS GV+ Y +L G+ PF  + E+ +F  +  + P + R  W  +   AKD +
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--LEKEAKDLL 249
Query: 336 KKLLVKDPRARLTAAQAL-SHPWVRE 360
            KL V++P  RL     +  HP  RE
Sbjct: 250 VKLFVREPEKRLGVRGDIRQHPLFRE 275

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LAGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LXGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 98
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 156
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 157 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 266
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 267 QVDLTKRF 274

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 184
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 185 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 294
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 295 QVDLTKRF 302

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFGL+  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMI---DQQGYIKVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 128/243 (52%), Gaps = 15/243 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKD 342
             D
Sbjct: 274 QVD 276

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFAEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 100
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 158
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 159 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 213
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 214 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 268
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 269 QVDLTKRF 276

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 184
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K       + G+  Y+APE++  K   ++
Sbjct: 185 YRDLKPENLLI---DQQGYIQVTDFGFAKRVKGAT--WTLCGTPEYLAPEIILSKGYNKA 239
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 294
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 295 QVDLTKRF 302

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 64
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I   +    +L D I  +      E+ A     Q
Sbjct: 65  LKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITER--GALQEELARSFFWQ 122
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 179
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 230
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 231 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 184
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 185 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 294
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 295 QVDLTKRF 302

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 98
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 156
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 157 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 266
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 267 QVDLTKRF 274

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLII---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIIISKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 144/280 (51%), Gaps = 23/280 (8%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D++  YTIG     G +G       K++G  +  K+++   M      + +  EV +L+
Sbjct: 6   EDYEVLYTIGT----GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLR 60
Query: 152 ALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQM 208
            L  H N+V++Y+   D  +  +YI ME CEGG+L   I    K+ +Y +++  + V   
Sbjct: 61  ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 209 LRVAA-ECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDI 261
           L +A  ECH      H ++HRD+KP N +F   K++  +K  DFGL+  +   + F ++ 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDEDFAKEF 176
Query: 262 VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
           VG+ YY++PE + R S  E SD+WS+G + Y L     PF   ++  +  ++   K  FR
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR 234
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           R P+   S+   + + ++L      R +  + L +P + E
Sbjct: 235 RIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 133/285 (46%), Gaps = 40/285 (14%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + +++G G       A      ++VA+K+I   K     +++++ +E++ +     H 
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQ-CHHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLD---RILAK---KDSRYTEKDAAVVVRQMLRV 211
           N+V +Y +F   + +++ M+L  GG +LD    I+AK   K     E   A ++R++L  
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG------KKFQDIVGSA 265
               H +G +HRD+K  N L     ED S++  DFG+S F+  G      K  +  VG+ 
Sbjct: 134 LEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 266 YYVAPEVLKRKSGPE--SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            ++APEV+++  G +  +D+WS G+    L  G  P+       +    L+N P      
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP------ 244
Query: 324 WPSISNSAKD-------------FVKKLLVKDPRARLTAAQALSH 355
            PS+    +D              +   L KDP  R TAA+ L H
Sbjct: 245 -PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   ++ TDFGL+  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMI---DQQGYIQVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 20  KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 79
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 80  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 139 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 194
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 195 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF         +E++R +  FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 254 DIPFEHD------EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 357 WVRE 360
           W+++
Sbjct: 304 WMQD 307

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 143/304 (47%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 5   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 65  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 123
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 124 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 179
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 180 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF     D   +E++R +  FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 239 DIPF---EHD---EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 357 WVRE 360
           W+++
Sbjct: 289 WMQD 292

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 133/285 (46%), Gaps = 40/285 (14%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + +++G G       A      ++VA+K+I   K     +++++ +E++ +     H 
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQ-CHHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLD---RILAK---KDSRYTEKDAAVVVRQMLRV 211
           N+V +Y +F   + +++ M+L  GG +LD    I+AK   K     E   A ++R++L  
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG------KKFQDIVGSA 265
               H +G +HRD+K  N L     ED S++  DFG+S F+  G      K  +  VG+ 
Sbjct: 129 LEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 266 YYVAPEVLKRKSGPE--SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            ++APEV+++  G +  +D+WS G+    L  G  P+       +    L+N P      
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP------ 239
Query: 324 WPSISNSAKD-------------FVKKLLVKDPRARLTAAQALSH 355
            PS+    +D              +   L KDP  R TAA+ L H
Sbjct: 240 -PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 283

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 19/275 (6%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           +  D ++ ++  + +GHG FG  Y A D  N + VA+KK+  +        +D+ +EV+ 
Sbjct: 48  FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 107
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L  H N +++   +  ++  ++ ME C G      +L        E + A V    L
Sbjct: 108 LQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGAL 164
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +  A  H H ++HRD+K  N L     E   +K  DFG +  + P   F   VG+ Y++A
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMA 218
Query: 270 PEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+    + +   + DVWS+G IT I L  R+P  F       ++       P  +   
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 277
Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           W   S   ++FV   L K P+ R T+   L H +V
Sbjct: 278 W---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 142/267 (53%), Gaps = 30/267 (11%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIA--VEDVKREVKILQAL 153
           + + K+LG G +G  ++    +  D  ++   K+ K   I+  A   E  + E ++L+ +
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
                +V  + AF+ +  +++ ++   GGEL   +  ++  R+TE +  + V +++    
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALE 173
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIK-PGKKFQDIVGSAYYVAPE 271
             H  G+++RD+K EN L  S   +  +  TDFGLS +F+    ++  D  G+  Y+AP+
Sbjct: 174 HLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 272 VLK-RKSGPES--DVWSIGVITYILLCGRRPFWDKTEDG-------IFKEVLRNKPDFRR 321
           +++   SG +   D WS+GV+ Y LL G  PF   T DG       I + +L+++P    
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPF---TVDGEKNSQAEISRRILKSEP---- 283
Query: 322 KPWP-SISNSAKDFVKKLLVKDPRARL 347
            P+P  +S  AKD +++LL+KDP+ RL
Sbjct: 284 -PYPQEMSALAKDLIQRLLMKDPKKRL 309

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 142/280 (50%), Gaps = 23/280 (8%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D++  YTIG     G +G       K++G  +  K+++   M      + +  EV +L+
Sbjct: 6   EDYEVLYTIGT----GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLR 60
Query: 152 ALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQM 208
            L  H N+V++Y+   D  +  +YI ME CEGG+L   I    K+ +Y +++  + V   
Sbjct: 61  ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 209 LRVAA-ECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDI 261
           L +A  ECH      H ++HRD+KP N +F   K++  +K  DFGL+  +     F +  
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDTSFAKTF 176
Query: 262 VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
           VG+ YY++PE + R S  E SD+WS+G + Y L     PF   ++  +  ++   K  FR
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR 234
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           R P+   S+   + + ++L      R +  + L +P + E
Sbjct: 235 RIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 19/275 (6%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           +  D ++ ++  + +GHG FG  Y A D  N + VA+KK+  +        +D+ +EV+ 
Sbjct: 9   FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L  H N +++   +  ++  ++ ME C G      +L        E + A V    L
Sbjct: 69  LQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGAL 125
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +  A  H H ++HRD+K  N L     E   +K  DFG +  + P   F   VG+ Y++A
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMA 179
Query: 270 PEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+    + +   + DVWS+G IT I L  R+P  F       ++       P  +   
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           W   S   ++FV   L K P+ R T+   L H +V
Sbjct: 239 W---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+AP ++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPAIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 91
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 149
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 150 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKGYNKA 204
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 259
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 260 QVDLTKRF 267

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 20  KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 79
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 80  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 139 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 194
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 195 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF         +E++R +  FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 254 DIPFEHD------EEIIRGQVFFRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 357 WVRE 360
           W+++
Sbjct: 304 WMQD 307

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 141/296 (47%), Gaps = 29/296 (9%)
Query: 78  GVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKN 132
           G  PC      +   G +K+  + +Y +G LLG G FG  Y     ++   VA+K +EK+
Sbjct: 1   GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 60
Query: 133 KMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLD 186
           ++     LP     V  EV +L+ + +G   V++  + FE  D++V I        +L D
Sbjct: 61  RISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 119
Query: 187 RILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF 246
            I  +      E+ A     Q+L     CH  G++HRD+K EN L    +    LK  DF
Sbjct: 120 FITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDF 175
Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKT 304
           G    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG  PF    
Sbjct: 176 GSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---E 231
Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            D   +E++R +  FR++    +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 232 HD---EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 25  KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 84
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 85  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 143
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 144 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 199
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 200 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF         +E++R +  FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 259 DIPFEHD------EEIIRGQVFFRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 308
Query: 357 WVRE 360
           W+++
Sbjct: 309 WMQD 312

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 142/280 (50%), Gaps = 23/280 (8%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D++  YTIG     G +G       K++G  +  K+++   M      + +  EV +L+
Sbjct: 6   EDYEVLYTIGT----GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLR 60
Query: 152 ALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQM 208
            L  H N+V++Y+   D  +  +YI ME CEGG+L   I    K+ +Y +++  + V   
Sbjct: 61  ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 209 LRVAA-ECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDI 261
           L +A  ECH      H ++HRD+KP N +F   K++  +K  DFGL+  +     F +  
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDTSFAKAF 176
Query: 262 VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
           VG+ YY++PE + R S  E SD+WS+G + Y L     PF   ++  +  ++   K  FR
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR 234
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           R P+   S+   + + ++L      R +  + L +P + E
Sbjct: 235 RIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 65
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 123
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 180
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 231
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 232 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 63
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 64  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 121
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 122 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 178
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 179 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 229
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 230 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 263

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 65
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 123
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 180
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 231
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 232 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 21/273 (7%)
Query: 98  YTIGKLLGHGQFGYTYVA--TDKANGDRVAVKKIEKNKMILPIA--VEDVKREVKILQAL 153
           + + ++LG G +G  +       AN  ++   K+ K  MI+  A      K E  IL+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V    AF+    +Y+ +E   GGEL  ++  +++  + E  A   + ++     
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMALG 135
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
             H  G+++RD+KPEN +         +K TDFGL  + I  G       G+  Y+APE+
Sbjct: 136 HLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           L R     + D WS+G + Y +L G  PF  +       ++L+ K +      P ++  A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEA 248
Query: 332 KDFVKKLLVKDPRARLT-----AAQALSHPWVR 359
           +D +KKLL ++  +RL      A +  +HP+ R
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMID---QQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 64
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 65  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 122
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 179
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 230
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 231 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 127/256 (49%), Gaps = 20/256 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K N D+V   KI     +L  A     RE + +      +
Sbjct: 76  FEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+DDN +Y+ M+   GG+LL  +L+K + R  E+ A   + +M+      H 
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVL-- 273
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L  
Sbjct: 194 LHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 274 ----KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
               K + GPE D WS+GV  Y +L G  PF+ ++    + +++ +K  F+   +P+   
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPTQVT 307
Query: 327 -ISNSAKDFVKKLLVK 341
            +S +AKD +++L+  
Sbjct: 308 DVSENAKDLIRRLICS 323

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 99
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 157
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 214
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 265
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 266 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 60
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 118
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 175
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 226
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 227 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 21/273 (7%)
Query: 98  YTIGKLLGHGQFGYTYVA--TDKANGDRVAVKKIEKNKMILPIA--VEDVKREVKILQAL 153
           + + ++LG G +G  +       AN  ++   K+ K  MI+  A      K E  IL+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V    AF+    +Y+ +E   GGEL  ++  +++  + E  A   + ++     
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMALG 135
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
             H  G+++RD+KPEN +         +K TDFGL  + I  G       G+  Y+APE+
Sbjct: 136 HLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEI 192
Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           L R     + D WS+G + Y +L G  PF  +       ++L+ K +      P ++  A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEA 248
Query: 332 KDFVKKLLVKDPRARLT-----AAQALSHPWVR 359
           +D +KKLL ++  +RL      A +  +HP+ R
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 79
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 80  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 137
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 194
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 245
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 246 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 60
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 118
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 119 VLEAVRHCHNXGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 175
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 226
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 227 -VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 65
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 123
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 180
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 231
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 232 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     + K
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 140/296 (47%), Gaps = 29/296 (9%)
Query: 78  GVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKN 132
           G  PC      +   G +K+  + +Y +G LLG G FG  Y     ++   VA+K +EK+
Sbjct: 1   GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 60
Query: 133 KMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLD 186
           ++     LP     V  EV +L+ + +G   V++  + FE  D++V I        +L D
Sbjct: 61  RISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 119
Query: 187 RILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF 246
            I  +      E+ A     Q+L     CH  G++HRD+K EN L    +    LK  DF
Sbjct: 120 FITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDF 175
Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKT 304
           G    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG  PF    
Sbjct: 176 GSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---E 231
Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            D   +E++R +  FR++    +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 232 HD---EEIIRGQVFFRQR----VSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQD 280

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 140/296 (47%), Gaps = 29/296 (9%)
Query: 78  GVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKN 132
           G  PC      +   G +K+  + +Y +G LLG G FG  Y     ++   VA+K +EK+
Sbjct: 1   GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 60
Query: 133 KMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLD 186
           ++     LP     V  EV +L+ + +G   V++  + FE  D++V I        +L D
Sbjct: 61  RISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 119
Query: 187 RILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF 246
            I  +      E+ A     Q+L     CH  G++HRD+K EN L    +    LK  DF
Sbjct: 120 FITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDF 175
Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKT 304
           G    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG  PF    
Sbjct: 176 GSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---E 231
Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            D   +E++R +  FR++    +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 232 HD---EEIIRGQVFFRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     + K
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+   +APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEALAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K++G G FG   +   K+     A+K + K +MI          E  I+ A A   
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 129
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++      H 
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD--VPEKWARFYTAEVVLALDAIHS 186
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVGSAYYVAPEVL 273
            G +HRD+KP+N L   +     LK  DFG    +K  K    +    VG+  Y++PEVL
Sbjct: 187 MGFIHRDVKPDNMLLDKS---GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 274 KRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           K + G      E D WS+GV  Y +L G  PF+  +  G + +++ +K          IS
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301
Query: 329 NSAKDFVKKLLVKDPRARL 347
             AK+ +   L  D   RL
Sbjct: 302 KEAKNLICAFLT-DREVRL 319

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 79
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 80  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 137
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 194
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 245
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 246 -VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 87
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 88  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 145
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 146 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 202
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 203 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 253
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 254 -VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 287

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K++G G FG   +   K+     A+K + K +MI          E  I+ A A   
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 134
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++      H 
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD--VPEKWARFYTAEVVLALDAIHS 191
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVGSAYYVAPEVL 273
            G +HRD+KP+N L   +     LK  DFG    +K  K    +    VG+  Y++PEVL
Sbjct: 192 MGFIHRDVKPDNMLLDKS---GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 274 KRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           K + G      E D WS+GV  Y +L G  PF+  +  G + +++ +K          IS
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 306
Query: 329 NSAKDFVKKLLVKDPRARL 347
             AK+ +   L  D   RL
Sbjct: 307 KEAKNLICAFLT-DREVRL 324

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K++G G FG   +   K+     A+K + K +MI          E  I+ A A   
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 134
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++      H 
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD--VPEKWARFYTAEVVLALDAIHS 191
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVGSAYYVAPEVL 273
            G +HRD+KP+N L   +     LK  DFG    +K  K    +    VG+  Y++PEVL
Sbjct: 192 MGFIHRDVKPDNMLLDKS---GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 274 KRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           K + G      E D WS+GV  Y +L G  PF+  +  G + +++ +K          IS
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 306
Query: 329 NSAKDFVKKLLVKDPRARL 347
             AK+ +   L  D   RL
Sbjct: 307 KEAKNLICAFLT-DREVRL 324

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +G G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   +K  DFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 134/315 (42%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL A
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLA 79
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 80  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 134
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +    S LK  DFGL+    P         + V 
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTT---SDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPFWDK-----------------T 304
           + +Y APE++    G     D+WS+G I   +L  R  F  K                  
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 305 ED---GI---FKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           ED   GI    +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 252 EDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 312 HPYLAQYYDPSDEPI 326

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 6   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 66  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 124
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 125 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 180
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 181 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 240 DIPF-EHDEEIIGGQVF-----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 357 WVRE 360
           W+++
Sbjct: 290 WMQD 293

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 5   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 65  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 123
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 124 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 179
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 180 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 239 DIPF-EHDEEIIGGQVF-----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 357 WVRE 360
           W+++
Sbjct: 289 WMQD 292

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 125/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     + K
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLMID---QQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 6   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 66  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 124
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 125 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 180
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 181 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 240 DIPF-EHDEEIIGGQVF-----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 357 WVRE 360
           W+++
Sbjct: 290 WMQD 293

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 5   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 65  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 123
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 124 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 179
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 180 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 239 DIPF-EHDEEIIGGQVF-----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 357 WVRE 360
           W+++
Sbjct: 289 WMQD 292

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 124/257 (48%), Gaps = 15/257 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K++G G FG   +   KA+    A+K + K +MI          E  I+ A A   
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 135
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++      H 
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYD--VPEKWAKFYTAEVVLALDAIHS 192
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDI-VGSAYYVAPEVLKR 275
            GL+HRD+KP+N L     +   LK  DFG      + G    D  VG+  Y++PEVLK 
Sbjct: 193 MGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 276 KSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           + G      E D WS+GV  + +L G  PF+  +  G + +++ +K          IS  
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKH 309
Query: 331 AKDFVKKLLVKDPRARL 347
           AK+ +   L  D   RL
Sbjct: 310 AKNLICAFLT-DREVRL 325

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 96/350 (27%), Positives = 139/350 (39%), Gaps = 83/350 (23%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D+   R+Y + K LG G +G  + + D+  G+ VAVKKI  +        +   RE+ IL
Sbjct: 4   DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMIL 62
Query: 151 QALAGHENVVKFYNAFEDDN-----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
             L+GHEN+V   N    DN      V+  ME      +   IL     +Y       VV
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-------VV 115
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---------------- 249
            Q+++V    H  GL+HRDMKP N L  +   +  +K  DFGLS                
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 250 ------DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF- 300
                 +F        D V + +Y APE+L    K     D+WS+G I   +LCG+  F 
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232
Query: 301 ----------------WDKTED---------GIFKEVLRNKPDFRR-------------- 321
                           +   ED             E L+ K + R+              
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 322 ---KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
               P    +  A D + KLL  +P  R++A  AL HP+V    + +E P
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 6   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 66  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 124
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 125 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 180
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 181 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 240 DIPF-EHDEEIIGGQVF-----FRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 357 WVRE 360
           W+++
Sbjct: 290 WMQD 293

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 5   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 65  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 123
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 124 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 179
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 180 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 239 DIPF-EHDEEIIGGQVF-----FRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 357 WVRE 360
           W+++
Sbjct: 289 WMQD 292

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 134/303 (44%), Gaps = 49/303 (16%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGH 156
           IGK+ G G +G  +   ++  G  VA+KK    E + +I  IA+    RE+++L+ L  H
Sbjct: 8   IGKI-GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQLK-H 61
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V     F     +++  E C+   L +  L +      E     +  Q L+    CH
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHE--LDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVL-- 273
            H  +HRD+KPEN L     + S +K  DFG +  +  P   + D V + +Y +PE+L  
Sbjct: 120 KHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG----IFKEVL-----RNKPDFRRKPW 324
             + GP  DVW+IG +   LL G  P W    D     + ++ L     R++  F    +
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235
Query: 325 -------------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW---VREGG 362
                              P+IS  A   +K  L  DP  RLT  Q L HP+   +RE  
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295
Query: 363 DAS 365
           D +
Sbjct: 296 DLA 298

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 6   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 66  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 124
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 125 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 180
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 181 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 240 DIPF-EHDEEIIGGQVF-----FRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 357 WVRE 360
           W+++
Sbjct: 290 WMQD 293

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 60
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 118
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 175
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF +  E+ I  +V      FR++   
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVF-----FRQR--- 226
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 227 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           + LG G FG   +   K  G+  A+K ++K K++    +E    E +I QA+     +VK
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ +E   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   +K  DFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +G G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GG++   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   +K  DFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +G G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GG++   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   +K  DFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 20/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K N +R+   KI     +L  A     RE + +      +
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMK-NTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+D+N++Y+ M+   GG+LL  +L+K + +  E  A   + +M+      H 
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLL-TLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKR 275
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L+ 
Sbjct: 194 LHYVHRDIKPDNVLLDV---NGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 250
Query: 276 ------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
                 K GPE D WS+GV  Y +L G  PF+ ++    + +++ ++  F+   +PS   
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHVT 307
Query: 327 -ISNSAKDFVKKLLVKDPR 344
            +S  AKD +++L+    R
Sbjct: 308 DVSEEAKDLIQRLICSRER 326

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 20/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K N +R+   KI     +L  A     RE + +      +
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMK-NTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+D+N++Y+ M+   GG+LL  +L+K + +  E  A   + +M+      H 
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLL-TLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKR 275
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L+ 
Sbjct: 210 LHYVHRDIKPDNVLLDV---NGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 266
Query: 276 ------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
                 K GPE D WS+GV  Y +L G  PF+ ++    + +++ ++  F+   +PS   
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHVT 323
Query: 327 -ISNSAKDFVKKLLVKDPR 344
            +S  AKD +++L+    R
Sbjct: 324 DVSEEAKDLIQRLICSRER 342

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 126/261 (48%), Gaps = 18/261 (6%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG   +     +G +  +K+I  ++M      E+ +REV +L  +  H N+V++ 
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMK-HPNIVQYR 89
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            +FE++  +YI M+ CEGG+L  RI A+K   + E        Q+       H   ++HR
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEVLKRKS-GPES 281
           D+K +N       +D +++  DFG++  +    +  +  +G+ YY++PE+ + K    +S
Sbjct: 150 DIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKS 206
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI----SNSAKDFVKK 337
           D+W++G + Y L   +  F   +   +  +++          +P +    S   +  V +
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-------FPPVSLHYSYDLRSLVSQ 259
Query: 338 LLVKDPRARLTAAQALSHPWV 358
           L  ++PR R +    L   ++
Sbjct: 260 LFKRNPRDRPSVNSILEKGFI 280

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 89/315 (28%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL A
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLA 79
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 80  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 134
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 252 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 312 HPYLAQYYDPSDEPI 326

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 136/309 (44%), Gaps = 47/309 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +  + Y     +G G +G    A DK +G++VA+KK+ +      I  +   RE+ +L+ 
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKH 79
Query: 153 LAGHENVVKFYNAFEDDNYV------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  HENV+   + F   + +      Y+ M   +    L +I+  K   ++E+    +V 
Sbjct: 80  MQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGLK---FSEEKIQYLVY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML+     H  G+VHRD+KP N    +  ED  LK  DFGL+       +    V + +
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRW 188
Query: 267 YVAPEVLKR--KSGPESDVWSIGVITYILLCGRR-----------------------PFW 301
           Y APEV+          D+WS+G I   +L G+                         F 
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 302 DKTEDGIFKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            K  D   K  +++ P   RK +    P  S  A D ++K+L  D   RLTAAQAL+HP+
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 358 VREGGDASE 366
                D  E
Sbjct: 309 FEPFRDPEE 317

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 131/299 (43%), Gaps = 54/299 (18%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG+G +   Y   +K  G  VA+K  K++  +     A+    RE+ +++ L  HEN+V+
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELK-HENIVR 67
Query: 162 FYNAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVR-QMLRVAAECHLH 218
            Y+    +N + +  E  +    + +D        R  E +     + Q+L+  A CH +
Sbjct: 68  LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KR 275
            ++HRD+KP+N L     +   LK  DFGL+  F  P   F   V + +Y AP+VL   R
Sbjct: 128 KILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSR 184
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP----WPSISNSA 331
                 D+WS G I   ++ G +P +  T D   +E L+   D    P    WPS++   
Sbjct: 185 TYSTSIDIWSCGCILAEMITG-KPLFPGTND---EEQLKLIFDIMGTPNESLWPSVTKLP 240
Query: 332 K------------------------------DFVKKLLVKDPRARLTAAQALSHPWVRE 360
           K                              DF+  LL  +P  RL+A QAL HPW  E
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 127/296 (42%), Gaps = 58/296 (19%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +   G+  A+KKI   K    I    + RE+ IL+ L  H N+VK Y
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTI-REISILKELK-HSNIVKLY 66
Query: 164 NAFEDDNYVYIAME-----------LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +       + +  E           +CEGG  L+ + AK             + Q+L   
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS-----------FLLQLLNGI 113
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
           A CH   ++HRD+KP+N L     E   LK  DFGL+  F  P +K+   V + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 272 VL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           VL   +K     D+WS+G I   ++ G   F   +E      + R       K WP+++ 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 330 -------------------------SAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                                    S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L D + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 134/301 (44%), Gaps = 57/301 (18%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + LG G++   + A +  N ++V VK      ++ P+    +KRE+KIL+ L G  
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKNKIKREIKILENLRGGP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAVVVRQMLRVA 212
           N++   +  +D         +     L+   +   D +      T+ D    + ++L+  
Sbjct: 93  NIITLADIVKD--------PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKAL 144
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
             CH  G++HRD+KP N +     E   L+  D+GL++F  PG+++   V S Y+  PE+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFW------------------DKTEDGIFKEV 312
           L   +      D+WS+G +   ++  + PF+                  +   D I K  
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 313 LRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +   P F        RK W           +S  A DF+ KLL  D ++RLTA +A+ HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 357 W 357
           +
Sbjct: 323 Y 323

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 127/296 (42%), Gaps = 58/296 (19%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +   G+  A+KKI   K    I    + RE+ IL+ L  H N+VK Y
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTI-REISILKELK-HSNIVKLY 66
Query: 164 NAFEDDNYVYIAME-----------LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +       + +  E           +CEGG  L+ + AK             + Q+L   
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS-----------FLLQLLNGI 113
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
           A CH   ++HRD+KP+N L     E   LK  DFGL+  F  P +K+   V + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 272 VL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           VL   +K     D+WS+G I   ++ G   F   +E      + R       K WP+++ 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 330 -------------------------SAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                                    S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 58/296 (19%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +   G+  A+KKI   K    I    + RE+ IL+ L  H N+VK Y
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTI-REISILKELK-HSNIVKLY 66
Query: 164 NAFEDDNYVYIAME-----------LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +       + +  E           +CEGG  L+ + AK             + Q+L   
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS-----------FLLQLLNGI 113
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
           A CH   ++HRD+KP+N L     E   LK  DFGL+  F  P +K+   + + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 272 VL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           VL   +K     D+WS+G I   ++ G   F   +E      + R       K WP+++ 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 330 -------------------------SAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                                    S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 136/309 (44%), Gaps = 47/309 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +  + Y     +G G +G    A DK +G++VA+KK+ +      I  +   RE+ +L+ 
Sbjct: 39  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKH 97
Query: 153 LAGHENVVKFYNAFEDDNYV------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  HENV+   + F   + +      Y+ M   +    L +I+  +   ++E+    +V 
Sbjct: 98  MQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGME---FSEEKIQYLVY 151
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML+     H  G+VHRD+KP N    +  ED  LK  DFGL+       +    V + +
Sbjct: 152 QMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRW 206
Query: 267 YVAPEVLKR--KSGPESDVWSIGVITYILLCGRR-----------------------PFW 301
           Y APEV+          D+WS+G I   +L G+                         F 
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266
Query: 302 DKTEDGIFKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            K  D   K  +++ P   RK +    P  S  A D ++K+L  D   RLTAAQAL+HP+
Sbjct: 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326
Query: 358 VREGGDASE 366
                D  E
Sbjct: 327 FEPFRDPEE 335

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KSQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  EDS LK  DFGL        +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDSELKILDFGLCRHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 122/250 (48%), Gaps = 11/250 (4%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG   +A  K   +  A+K ++K+ +I    VE    E ++L  L     + + 
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           ++ F+  + +Y  ME   GG+L+  I  ++  ++ E  A     ++       H  G+++
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISIGLFFLHKRGIIY 143
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N +  S   +  +K  DFG+  + +  G   ++  G+  Y+APE++  +  G  
Sbjct: 144 RDLKLDNVMLDS---EGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKS 200
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L+ 
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMT 256
Query: 341 KDPRARLTAA 350
           K P  RL   
Sbjct: 257 KHPAKRLGCG 266

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 79
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 80  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 134
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 252 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 312 HPYLEQYYDPSDEPI 326

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 14  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 66
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 67  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 124
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 125 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 182
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 242
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 243 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 303 AHSFFDELRDPN 314

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 136/308 (44%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 86
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 142
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  EDS LK  DFGL+       +    V + +Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNL---AVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 318 HDPDDEPV 325

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 28  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 85
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 86  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 140
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 141 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 257
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 258 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 317
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 318 HPYLEQYYDPSDEPI 332

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 32  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 84
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 85  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 142
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 143 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 200
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 201 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 260
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 261 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 320
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 321 AHSFFDELRDPN 332

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 17  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 69
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 70  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 127
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 128 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 185
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 245
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 246 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 306 AHSFFDELRDPN 317

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 136/308 (44%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 82
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 138
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  EDS LK  DFGL+       +    V + +Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNL---AVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 314 HDPDDEPV 321

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 97
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 98  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 152
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 269
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 270 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 329
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 330 HPYLEQYYDPSDEPI 344

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 21  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 73
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 74  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 131
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 132 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 189
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 190 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 249
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 250 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 309
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 310 AHSFFDELRDPN 321

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 75
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 76  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 130
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 247
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 248 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 307
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 308 HPYLEQYYDPSDEPI 322

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 122/250 (48%), Gaps = 11/250 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  KA     AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+  + +Y  ++   GGEL   +  +++  + E  A     ++       H   +V
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L  S      +  TDFGL  + I+         G+  Y+APEVL ++    
Sbjct: 162 YRDLKPENILLDS---QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +G + Y +L G  PF+ +    ++  +L NKP  + K  P+I+NSA+  ++ LL
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-NKP-LQLK--PNITNSARHLLEGLL 274
Query: 340 VKDPRARLTA 349
            KD   RL A
Sbjct: 275 QKDRTKRLGA 284

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 82
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 83  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 137
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 254
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 255 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 314
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 315 HPYLEQYYDPSDEPI 329

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 82
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 83  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 137
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 254
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 255 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 314
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 315 HPYLEQYYDPSDEPI 329

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 26  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 83
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 84  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 138
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 139 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 255
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 256 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 315
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 316 HPYLEQYYDPSDEPI 330

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 17  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 74
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 75  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 129
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 130 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 246
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 247 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 306
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 307 HPYLEQYYDPSDEPI 321

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 141/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ + K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 47  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 99
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 100 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 157
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 216 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 336 AHSFFDELRDPN 347

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 47  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 99
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 100 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 157
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 336 AHSFFDELRDPN 347

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYXQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 75
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 76  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 130
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQ 247
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 248 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 307
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 308 HPYLEQYYDPSDEPI 322

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 25  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 77
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 78  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 135
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 136 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 193
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 253
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 314 AHSFFDELRDPN 325

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 25  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 77
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 78  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 135
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 136 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 193
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 253
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 314 AHSFFDELRDPN 325

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 86
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 142
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 258 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 318 HDPDDEPV 325

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 26  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 78
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 79  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 136
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 137 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 194
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 195 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 254
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 255 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 314
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 315 AHSFFDELRDPN 326

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 18  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 70
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 71  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 128
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 129 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 186
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 187 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 246
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 247 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 307 AHSFFDELRDPN 318

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 123/268 (45%), Gaps = 14/268 (5%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
           R D GY+   + R  I K +G GQF   Y A    +G  VA+KK++   ++   A  D  
Sbjct: 23  RPDMGYNTLANFR--IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAA 202
           +E+ +L+ L  H NV+K+Y +F +DN + I +EL + G+L   I    K+     E+   
Sbjct: 81  KEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDI 261
               Q+       H   ++HRD+KP N    +      +K  D GL  F          +
Sbjct: 140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 262 VGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPD 318
           VG+ YY++PE +       +SD+WS+G + Y +   + PF+    +   + K++   + D
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCD 254
Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRAR 346
           +   P    S   +  V   +  DP  R
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 70
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L D + A   +          + Q+L+  A CH H ++HR
Sbjct: 71  DVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 130 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 246
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 247 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ + K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 41  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 93
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 94  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 151
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 152 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 209
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 210 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 269
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 270 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 329
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 330 AHSFFDELRDPN 341

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L D + A   +          + Q+L+  A CH H ++HR
Sbjct: 72  DVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 131 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 247
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 248 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 142/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 49  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 101
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 102 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 159
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 160 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 217
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 218 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 277
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 278 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 337
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 338 AHSFFDELRDPN 349

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 46/307 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 92  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 144
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 145 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 202
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 203 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 260
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 261 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 320
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 321 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 380
Query: 354 SHPWVRE 360
           +H +  E
Sbjct: 381 AHSFFDE 387

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 46/307 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 51  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 103
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 104 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 161
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 162 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 219
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 220 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 279
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 280 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 339
Query: 354 SHPWVRE 360
           +H +  E
Sbjct: 340 AHSFFDE 346

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 136/308 (44%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 76
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K ++ T+     ++ Q+LR
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCAKLTDDHVQFLIYQILR 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 308 HDPDDEPV 315

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KCQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 76
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 187
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 308 HDPDDEPV 315

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 40/288 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV---VRQMLRVAAECHLHGL 220
           +    +N +Y+  E       +D       S  T     ++   + Q+L+  A CH H +
Sbjct: 72  DVIHTENKLYLVFEFLS----MDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKS 277
           +HRD+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +  
Sbjct: 128 LHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR--- 320
               D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++   
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 321 --------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                    K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 134/313 (42%), Gaps = 58/313 (18%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RY   K LG G  G  + A D     RVA+KKI       P +V+   RE+KI++ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRR 64
Query: 153 LAGHENVVKFY-------NAFEDD-------NYVYIAMELCEGGELLDRILAKKDSRYTE 198
           L  H+N+VK +       +   DD       N VYI  E  E     D     +     E
Sbjct: 65  L-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLE 119
Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP---- 254
           + A + + Q+LR     H   ++HRD+KP N    +  ED  LK  DFGL+  + P    
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPHYSH 177
Query: 255 -GKKFQDIVGSAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPFWDKTEDGIFKE 311
            G   + +V + +Y +P +L   +      D+W+ G I   +L G+  F    E    + 
Sbjct: 178 KGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236
Query: 312 VLRNKPDFRR----------------------KP----WPSISNSAKDFVKKLLVKDPRA 345
           +L + P                          KP     P IS  A DF++++L   P  
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 346 RLTAAQALSHPWV 358
           RLTA +ALSHP++
Sbjct: 297 RLTAEEALSHPYM 309

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 40/288 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV---VRQMLRVAAECHLHGL 220
           +    +N +Y+  E       +D       S  T     ++   + Q+L+  A CH H +
Sbjct: 70  DVIHTENKLYLVFEFLS----MDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKS 277
           +HRD+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +  
Sbjct: 126 LHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR--- 320
               D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++   
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 321 --------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                    K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ K    + I  +   RE+++L+ +  H
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSI-IHAKRTYRELRLLKHMK-H 92
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 148
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 149 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 324 HDPDDEPV 331

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 86
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 142
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 318 HDPDDEPV 325

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA++KI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KXQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KXQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 76
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 308 HDPDDEPV 315

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 70  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 129 DLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 245
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 246 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 90
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 146
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 147 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 201
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 261
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 262 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 322 HDPDDEPV 329

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGXVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 130/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 97
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VY+   L  G +L   +   K    +       + Q
Sbjct: 98  FR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL---KTQHLSNDHICYFLYQ 152
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPF-----WDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F      D+     GI      
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 269
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 270 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 329
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 330 HPYLEQYYDPSDEPI 344

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 82
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 138
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 314 HDPDDEPV 321

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 91
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 147
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 148 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 202
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 323 HDPDDEPV 330

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 86
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 142
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 318 HDPDDEPV 325

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 103
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 159
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 160 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 214
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 335 HDPDDEPV 342

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 103
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 159
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 160 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMXGYVATRWYRAP 214
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 335 HDPDDEPV 342

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 70
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 71  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 130 DLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 246
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 247 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 79
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 135
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 136 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 190
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 250
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 251 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 311 HDPDDEPV 318

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 85
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 141
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 142 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 317 HDPDDEPV 324

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 78
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 134
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 135 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 189
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 249
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 250 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 310 HDPDDEPV 317

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 82
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 138
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 314 HDPDDEPV 321

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 91
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 147
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 148 GLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 202
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 323 HDPDDEPV 330

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 92
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 148
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 149 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 324 HDPDDEPV 331

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 92
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 148
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 149 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 324 HDPDDEPV 331

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 77
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 133
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 134 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 188
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 309 HDPDDEPV 316

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 77
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 133
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 134 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 188
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 309 HDPDDEPV 316

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 76
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 308 HDPDDEPV 315

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 82
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 138
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 314 HDPDDEPV 321

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 27/283 (9%)
Query: 87  DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           D+ YD++ DR      +LG G +G  Y   D +N  R+A+K+I +         + +  E
Sbjct: 18  DYEYDENGDRV-----VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEE 69
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS-RYTEKDAAVVV 205
           + + + L  H+N+V++  +F ++ ++ I ME   GG L   + +K    +  E+      
Sbjct: 70  IALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD---FIKPGKKFQDIV 262
           +Q+L      H + +VHRD+K +N L  +      LK +DFG S     I P    +   
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYS--GVLKISDFGTSKRLAGINPCT--ETFT 184
Query: 263 GSAYYVAPEVL---KRKSGPESDVWSIGVITYILLCGRRPFWDKTED--GIFK-EVLRNK 316
           G+  Y+APE++    R  G  +D+WS+G     +  G+ PF++  E    +FK  + +  
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH 244
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           P+       S+S  AK F+ K    DP  R  A   L   +++
Sbjct: 245 PEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 128/267 (47%), Gaps = 14/267 (5%)
Query: 87  DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           D   D +FD  + I + +G G FG   +          A+K + K K +    V +V +E
Sbjct: 7   DENEDVNFDH-FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE 65
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           ++I+Q L  H  +V  + +F+D+  +++ ++L  GG+L  R   +++  + E+   + + 
Sbjct: 66  LQIMQGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFIC 122
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           +++          ++HRDMKP+N L     E   +  TDF ++  +    +   + G+  
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 267 YVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
           Y+APE+   + G       D WS+GV  Y LL GRRP+  ++     KE++    +    
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTF-ETTVV 237
Query: 323 PWPSI-SNSAKDFVKKLLVKDPRARLT 348
            +PS  S      +KKLL  +P  R +
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQRFS 264

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 27/283 (9%)
Query: 87  DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           D+ YD++ DR      +LG G +G  Y   D +N  R+A+K+I +         + +  E
Sbjct: 4   DYEYDENGDRV-----VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEE 55
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS-RYTEKDAAVVV 205
           + + + L  H+N+V++  +F ++ ++ I ME   GG L   + +K    +  E+      
Sbjct: 56  IALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 114
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD---FIKPGKKFQDIV 262
           +Q+L      H + +VHRD+K +N L  +      LK +DFG S     I P    +   
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLINTYS--GVLKISDFGTSKRLAGINPCT--ETFT 170
Query: 263 GSAYYVAPEVL---KRKSGPESDVWSIGVITYILLCGRRPFWDKTED--GIFK-EVLRNK 316
           G+  Y+APE++    R  G  +D+WS+G     +  G+ PF++  E    +FK  + +  
Sbjct: 171 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH 230
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           P+       S+S  AK F+ K    DP  R  A   L   +++
Sbjct: 231 PEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ + K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L      + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 76  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 134
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 135 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA 191
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 192 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 251
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 252 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 70  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 129 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 245
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 246 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 135/288 (46%), Gaps = 40/288 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV---VRQMLRVAAECHLHGL 220
           +    +N +Y+  E        D       S  T     ++   + Q+L+  A CH H +
Sbjct: 72  DVIHTENKLYLVFEFLHQ----DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKS 277
           +HRD+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +  
Sbjct: 128 LHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR--- 320
               D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++   
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 321 --------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                    K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 70  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 129 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 185
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 245
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 246 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 70  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 129 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 245
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 246 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 70
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 71  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 130 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 246
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 247 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 72
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 73  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 131
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 132 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 188
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 189 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 248
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 249 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 72
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 73  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 131
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 132 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 188
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 189 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 248
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 249 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 72  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 131 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 247
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 248 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 70
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 71  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 130 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 246
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 247 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 72  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 131 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 247
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 248 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  D+GL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDYGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 76  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 134
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 135 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 191
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 192 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 251
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 252 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 129/292 (44%), Gaps = 45/292 (15%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKI 149
           +RY     LG GQF   Y A DK     VA+KKI      E    I   A+    RE+K+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKL 65
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L+ H N++   +AF   + + +  +  E    L+ I+       T       +   L
Sbjct: 66  LQELS-HPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYV 268
           +     H H ++HRD+KP N L     E+  LK  DFGL+  F  P + +   V + +Y 
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYR 179
Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----GIFKEV--------- 312
           APE+L   R  G   D+W++G I   LL  R PF     D      IF+ +         
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 313 -LRNKPDFRR-KPWPSI---------SNSAKDFVKKLLVKDPRARLTAAQAL 353
            + + PD+   K +P I          +   D ++ L + +P AR+TA QAL
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 119/250 (47%), Gaps = 11/250 (4%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG   ++  K   +  AVK ++K+ +I    VE    E ++L        + + 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           ++ F+  + +Y  ME   GG+L+  I  ++  R+ E  A     ++          G+++
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N +  S   +  +K  DFG+  + I  G   +   G+  Y+APE++  +  G  
Sbjct: 466 RDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L+ 
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMT 578
Query: 341 KDPRARLTAA 350
           K P  RL   
Sbjct: 579 KHPGKRLGCG 588

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 126/296 (42%), Gaps = 43/296 (14%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGHENV 159
           L+G G +G      +K  G  VA+KK    + +KM+  IA+    RE+K+L+ L  HEN+
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM----REIKLLKQLR-HENL 86
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V      +     Y+  E  +   L D  L      Y      +   Q++     CH H 
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF--QIINGIGFCHSHN 144
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRK 276
           ++HRD+KPEN L     +   +K  DFG +     PG+ + D V + +Y APE+L    K
Sbjct: 145 IIHRDIKPENIL---VSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 277 SGPESDVWSIGVITYILLCGRRPF-WDKTEDGIF-------------KEVLRNKPDF--- 319
            G   DVW+IG +   +  G   F  D   D ++             +E+    P F   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 320 ------RRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
                  R+P    +P +S    D  KK L  DP  R   A+ L H + +  G A 
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE 317

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 139/290 (47%), Gaps = 44/290 (15%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVV---VRQMLRVAAECHLH 218
           +    +N +Y+  E       +D+ L K    S  T     ++   + Q+L+  A CH H
Sbjct: 72  DVIHTENKLYLVFEH------VDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--R 275
            ++HRD+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +
Sbjct: 126 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR- 320
                 D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++ 
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 321 ----------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                      K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 91/321 (28%), Positives = 138/321 (42%), Gaps = 65/321 (20%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVKREVKILQA 152
           +RY   K +G G  G    A D   G  VAVKK+ +   N+       +   RE+ +L+ 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKC 77
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 78  V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIHMELD----HERMSYLLY 131
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 132 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTASTNFMMTPYVVTRY 188
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDK------TEDGIFKE 311
           Y APEV+      E+ D+WS+G I   L+ G   F        W+K      T    F  
Sbjct: 189 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMA 248
Query: 312 VLRNKPDFR-----RKPWPSI---------------------SNSAKDFVKKLLVKDPRA 345
            L  +P  R     R  +P I                     ++ A+D + K+LV DP  
Sbjct: 249 AL--QPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDK 306
Query: 346 RLTAAQALSHPWVREGGDASE 366
           R++  +AL HP++    D +E
Sbjct: 307 RISVDEALRHPYITVWYDPAE 327

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 135/288 (46%), Gaps = 40/288 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV---VRQMLRVAAECHLHGL 220
           +    +N +Y+  E        D       S  T     ++   + Q+L+  A CH H +
Sbjct: 68  DVIHTENKLYLVFEHVHQ----DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKS 277
           +HRD+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +  
Sbjct: 124 LHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR--- 320
               D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++   
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 321 --------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                    K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  + CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 119/250 (47%), Gaps = 11/250 (4%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG   ++  K   +  AVK ++K+ +I    VE    E ++L        + + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           ++ F+  + +Y  ME   GG+L+  I  ++  R+ E  A     ++          G+++
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 144
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N +  S   +  +K  DFG+  + I  G   +   G+  Y+APE++  +  G  
Sbjct: 145 RDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L+ 
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMT 257
Query: 341 KDPRARLTAA 350
           K P  RL   
Sbjct: 258 KHPGKRLGCG 267

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 26/285 (9%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 24  DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 77
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 78  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 134
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 135 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 187
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---NKPDFRRK 322
           Y++PE L+      +SD+WS+G+    +  GR P    +      E+L    N+P   + 
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPP-PKL 246
Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           P    S   +DFV K L+K+P  R    Q + H +++   DA E+
Sbjct: 247 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR-SDAEEV 290

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 46/307 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    + D  +G ++AVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 109
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 165
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 166 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 220
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------------- 314
           E++          D+WS+G I   LL GR  F         ++++R              
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMP 280
Query: 315 ---------NKPDFRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                    + P   ++ +  +    +  A D ++K+LV D   R+TA++AL+HP+  + 
Sbjct: 281 SHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQY 340
Query: 362 GDASEIP 368
            D  + P
Sbjct: 341 HDPDDEP 347

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 125/282 (44%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D  +   VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N +  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   + D +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 77
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 78  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 132
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 189
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 245
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 246 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 305
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 306 AKRISVDDALQHPYINVWYDPAEV 329

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 20  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 56
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 57  SVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 114
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 115 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 171 LKPSNL---AVNEDCELKILDFGLARHTD--DEMXGXVATRWYRAPEIMLNWMHYNQTVD 225
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 226 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 285
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 286 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 339

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 307 AKRISVDDALQHPYINVWYDPAEV 330

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 116
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 171
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 284
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 345 AKRISVDDALQHPYINVWYDPAEV 368

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKIL 150
           +DFD    + +++G G +    +   K   DR+   K+ K +++     ++ V+ E  + 
Sbjct: 20  QDFD----LLRVIGRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVF 74
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVV 205
           +  + H  +V  ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +
Sbjct: 75  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 134
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
             +       H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+
Sbjct: 135 NYL-------HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGT 184
Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLR 314
             Y+APE+L+ +  G   D W++GV+ + ++ GR PF            TED +F+ +L 
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 244
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            +    R    S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 245 KQIRIPR----SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR 291

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 20  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 56
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 57  SVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 114
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 115 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 171 LKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVD 225
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 226 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 285
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 286 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 339

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 139/323 (43%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+GVI   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 71
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD----HERMSYLLY 126
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 239
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 300 AKRISVDDALQHPYINVWYDPAEV 323

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 116
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 171
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 284
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 345 AKRISVDDALQHPYINVWYDPAEV 368

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 72
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 127
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 240
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 241 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 300
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 301 AKRISVDDALQHPYINVWYDPAEV 324

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 307 AKRISVDDALQHPYINVWYDPAEV 330

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 19  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 55
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 56  SVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 113
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 114 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 169
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 170 LKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVD 224
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 225 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 284
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 285 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 338

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKIL 150
           +DFD    + +++G G +    +   K   DR+   K+ K +++     ++ V+ E  + 
Sbjct: 5   QDFD----LLRVIGRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVF 59
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVV 205
           +  + H  +V  ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +
Sbjct: 60  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 119
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
             +       H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+
Sbjct: 120 NYL-------HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGT 169
Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLR 314
             Y+APE+L+ +  G   D W++GV+ + ++ GR PF            TED +F+ +L 
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 229
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            +    R    S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 230 KQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 72
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 127
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 240
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 241 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 300
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 301 AKRISVDDALQHPYINVWYDPAEV 324

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 71
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 126
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 239
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 300 AKRISVDDALQHPYINVWYDPAEV 323

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 26/288 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
           F+  Y +G LLG G FG  +      +  +VA+K I +N+++    + D      EV +L
Sbjct: 29  FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 151 Q---ALAGHENVVKFYNAFEDDNYVYIAME-LCEGGELLDRILAKKDSRYTEKDAAVVVR 206
               A  GH  V++  + FE      + +E      +L D I  K      E  +     
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFG 146
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           Q++     CH  G+VHRD+K EN L    +     K  DFG    +   + + D  G+  
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRR--GCAKLIDFGSGALLH-DEPYTDFDGTRV 203
Query: 267 YVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           Y  PE + R       + VWS+G++ Y ++CG  PF     D   +E+L  +  F     
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF---ERD---QEILEAELHFPAH-- 255
Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
             +S      +++ L   P +R +  + L  PW++    A ++P++ S
Sbjct: 256 --VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT--PAEDVPLNPS 299

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 307 AKRISVDDALQHPYINVWYDPAEV 330

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 79
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 134
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 247
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 248 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 307
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 308 AKRISVDDALQHPYINVWYDPAEV 331

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 307 AKRISVDDALQHPYINVWYDPAEV 330

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 22/286 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAV-KKIEKNKMILPIAVEDVKREVKILQALAG 155
           +Y +G LLG G +G      D     R AV    +K    +P    +VK+E+++L+ L  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64
Query: 156 HENVVKFYNAF--EDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           H+NV++  +    E+   +Y+ ME C  G  E+LD +  K   R+    A     Q++  
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---RFPVCQAHGYFCQLIDG 121
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQDIVGSAYYV 268
               H  G+VH+D+KP N L  +     +LK +  G+++ + P       +   GS  + 
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 269 APEV---LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
            PE+   L   SG + D+WS GV  Y +  G  PF       +F+ + +          P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDI 371
            +S    D +K +L  +P  R +  Q   H W R+    +E P+ I
Sbjct: 239 PLS----DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPI 280

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKIL 150
           +DFD    + +++G G +    +   K   DR+   K+ K +++     ++ V+ E  + 
Sbjct: 9   QDFD----LLRVIGRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVF 63
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVV 205
           +  + H  +V  ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +
Sbjct: 64  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
             +       H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+
Sbjct: 124 NYL-------HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGT 173
Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLR 314
             Y+APE+L+ +  G   D W++GV+ + ++ GR PF            TED +F+ +L 
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            +    R    S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 234 KQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 79
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 134
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 247
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 248 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 307
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 308 AKRISVDDALQHPYINVWYDPAEV 331

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+ KI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+ KI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK   FGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILGFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DF L+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFYLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 20  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 56
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 57  SVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 114
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 115 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 171 LKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVD 225
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 226 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 285
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 286 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 339

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 139/323 (43%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+GVI   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 135/282 (47%), Gaps = 36/282 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG+G  G T V      G  VAVK++  +     IA+     E+K+L     H NV++
Sbjct: 39  KILGYGSSG-TVVFQGSFQGRPVAVKRMLID--FCDIAL----MEIKLLTESDDHPNVIR 91
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT-----EKDAAVVVRQMLRVAAECH 216
           +Y +   D ++YIA+ELC    L D + +K  S        E +   ++RQ+    A  H
Sbjct: 92  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 217 LHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKPGK-----KFQDI 261
              ++HRD+KP+N L  ++           E+  +  +DFGL   +  G+        + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 262 VGSAYYVAPEVL----KRKSGPESDVWSIG-VITYILLCGRRPFWDK--TEDGIFKEVLR 314
            G++ + APE+L    KR+     D++S+G V  YIL  G+ PF DK   E  I + +  
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF- 269
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +  + +     S+   A D + +++  DP  R TA + L HP
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 19  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 55
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 56  SVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 113
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 114 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 169
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 170 LKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVD 224
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 225 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 284
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 285 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 338

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 135/282 (47%), Gaps = 36/282 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG+G  G T V      G  VAVK++  +     IA+     E+K+L     H NV++
Sbjct: 39  KILGYGSSG-TVVFQGSFQGRPVAVKRMLID--FCDIAL----MEIKLLTESDDHPNVIR 91
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT-----EKDAAVVVRQMLRVAAECH 216
           +Y +   D ++YIA+ELC    L D + +K  S        E +   ++RQ+    A  H
Sbjct: 92  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 217 LHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKPGK-----KFQDI 261
              ++HRD+KP+N L  ++           E+  +  +DFGL   +  G+        + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 262 VGSAYYVAPEVL----KRKSGPESDVWSIG-VITYILLCGRRPFWDK--TEDGIFKEVLR 314
            G++ + APE+L    KR+     D++S+G V  YIL  G+ PF DK   E  I + +  
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF- 269
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +  + +     S+   A D + +++  DP  R TA + L HP
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKIL 150
           +DFD    + +++G G +    +   K   DR+   ++ K +++     ++ V+ E  + 
Sbjct: 52  QDFD----LLRVIGRGSYAKVLLVRLKKT-DRIYAMRVVKKELVNDDEDIDWVQTEKHVF 106
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVV 205
           +  + H  +V  ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 166
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
             +       H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+
Sbjct: 167 NYL-------HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGT 216
Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLR 314
             Y+APE+L+ +  G   D W++GV+ + ++ GR PF            TED +F+ +L 
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            +    R    S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 277 KQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G F    V   K  G   A+K + K  M+    V   + E  +L       
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRR 121
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            + + + AF+D+NY+Y+ ME   GG+LL  +L+K   R   + A   + +++      H 
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--VGSAYYVAPEVLK- 274
            G VHRD+KP+N L         ++  DFG    ++     + +  VG+  Y++PE+L+ 
Sbjct: 181 LGYVHRDIKPDNILLDRC---GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 275 -------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW--P 325
                     GPE D W++GV  Y +  G+ PF+  +    + +++  K +    P    
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK-EHLSLPLVDE 296
Query: 326 SISNSAKDFVKKLLVKDPRARL---TAAQALSHPW 357
            +   A+DF+++LL   P  RL    A    +HP+
Sbjct: 297 GVPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPF 330

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 133/300 (44%), Gaps = 46/300 (15%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G    A D   G +VA+KK+ +      +  +   RE+++L+ +  HENV+   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMR-HENVIGLL 90
Query: 164 NAFEDDNYV------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           + F  D  +      Y+ M     G  L +++  K  +  E     +V QML+     H 
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFM--GTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHA 146
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-- 275
            G++HRD+KP N    +  ED  LK  DFGL+   +   +    V + +Y APEV+    
Sbjct: 147 AGIIHRDLKPGNL---AVNEDCELKILDFGLAR--QADSEMXGXVVTRWYRAPEVILNWM 201
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--------------------- 314
           +     D+WS+G I   ++ G+  F         KE+++                     
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 315 --NKPDFRRKPWPSISNSAK----DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
               P+  +K + SI  +A     + ++K+LV D   R+TA +AL+HP+     D  + P
Sbjct: 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 321

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 138/320 (43%), Gaps = 63/320 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVKREVKILQA 152
           +RY   K +G G  G    A D   G  VAVKK+ +   N+       +   RE+ +L+ 
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKC 79
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 80  V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIHMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRY 190
Query: 267 YVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF--------WDKTEDGI--------- 308
           Y APEV L        D+WS+G I   L+ G   F        W+K  + +         
Sbjct: 191 YRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMA 250
Query: 309 -FKEVLRNKPDFRRKPWPSI---------------------SNSAKDFVKKLLVKDPRAR 346
             +  +RN  + R K +P I                     ++ A+D + K+LV DP  R
Sbjct: 251 ALQPTVRNYVENRPK-YPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKR 309
Query: 347 LTAAQALSHPWVREGGDASE 366
           ++  +AL HP++    D +E
Sbjct: 310 ISVDEALRHPYITVWYDPAE 329

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV----KREV 147
           K  + RY I   LG G     Y+A D     +VA+K I     I P   E+     +REV
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI----FIPPREKEETLKRFEREV 62
Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV-- 205
                L+ H+N+V   +  E+D+  Y+ ME  EG  L         S Y E    + V  
Sbjct: 63  HNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTL---------SEYIESHGPLSVDT 112
Query: 206 -----RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
                 Q+L      H   +VHRD+KP+N L  S K   +LK  DFG++  +      Q 
Sbjct: 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK---TLKIFDFGIAKALSETSLTQT 169
Query: 261 --IVGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLRNK 316
             ++G+  Y +PE  K ++  E +D++SIG++ Y +L G  PF  +T   I  K +  + 
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           P+        I  S  + + +   KD   R    Q +
Sbjct: 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  D GL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDAGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+         +  V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++C +  F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
            F +K  P++ N                                   A+D + K+LV D 
Sbjct: 247 AFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 137/284 (48%), Gaps = 28/284 (9%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 8   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 61
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 62  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 118
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +   +   + VG+  
Sbjct: 119 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DEMANEFVGTRS 171
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFK--EVLRNKPDFRRKP 323
           Y++PE L+      +SD+WS+G+    +  GR P   +    IF+  + + N+P   + P
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFELLDYIVNEPP-PKLP 227
Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
               S   +DFV K L+K+P  R    Q + H +++   DA E+
Sbjct: 228 SAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR-SDAEEV 270

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  D GL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDGGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  D GL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDRGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 137/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+         +  V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++C +  F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 136/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 83
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 84  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 138
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 195
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++C +  F        W+K    + +++    P
Sbjct: 196 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK----VIEQLGTPCP 251
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 252 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 311
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 312 SKRISVDEALQHPYINVWYDPSE 334

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 136/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 72
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 73  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 127
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++C +  F        W+K    + +++    P
Sbjct: 185 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK----VIEQLGTPCP 240
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 241 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 300
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 301 SKRISVDEALQHPYINVWYDPSE 323

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 40/286 (13%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG+G  G T V      G  VAVK++  +     IA+     E+K+L     H NV++
Sbjct: 21  KILGYGSSG-TVVFQGSFQGRPVAVKRMLID--FCDIAL----MEIKLLTESDDHPNVIR 73
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT-----EKDAAVVVRQMLRVAAECH 216
           +Y +   D ++YIA+ELC    L D + +K  S        E +   ++RQ+    A  H
Sbjct: 74  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 217 LHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKPGK-----KFQDI 261
              ++HRD+KP+N L  ++           E+  +  +DFGL   +  G+        + 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 262 VGSAYYVAPEVL--------KRKSGPESDVWSIG-VITYILLCGRRPFWDK--TEDGIFK 310
            G++ + APE+L        KR+     D++S+G V  YIL  G+ PF DK   E  I +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
            +  +  + +     S+   A D + +++  DP  R TA + L HP
Sbjct: 253 GIF-SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 40/286 (13%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG+G  G T V      G  VAVK++  +     IA+     E+K+L     H NV++
Sbjct: 21  KILGYGSSG-TVVFQGSFQGRPVAVKRMLID--FCDIAL----MEIKLLTESDDHPNVIR 73
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT-----EKDAAVVVRQMLRVAAECH 216
           +Y +   D ++YIA+ELC    L D + +K  S        E +   ++RQ+    A  H
Sbjct: 74  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 217 LHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKPGK-----KFQDI 261
              ++HRD+KP+N L  ++           E+  +  +DFGL   +  G+        + 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 262 VGSAYYVAPEVL--------KRKSGPESDVWSIG-VITYILLCGRRPFWDK--TEDGIFK 310
            G++ + APE+L        KR+     D++S+G V  YIL  G+ PF DK   E  I +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
            +  +  + +     S+   A D + +++  DP  R TA + L HP
Sbjct: 253 GIF-SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 127
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 128 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXX 181
Query: 258 F---QDIVGSAYYVAPEVLKRKSGPES------------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K  S                DVWS+G I Y +  G+ PF  
Sbjct: 182 XVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 240
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISN-SAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 241 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 89/337 (26%), Positives = 139/337 (41%), Gaps = 51/337 (15%)
Query: 74  RRQTGV---IPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE 130
           RR  GV   +P       G   D   RYT  + +G G +G    A D     RVA+KKI 
Sbjct: 18  RRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS 77
Query: 131 KNKMILPIAVEDVKREVKILQALAGHENVVKF-----YNAFEDDNYVYIAMELCEGGELL 185
             +       +   RE++IL     HENV+        +  E    VYI  +L E    L
Sbjct: 78  PFEH--QTYCQRTLREIQILLRFR-HENVIGIRDILRASTLEAMRDVYIVQDLMETD--L 132
Query: 186 DRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
            ++L  K  + +       + Q+LR     H   ++HRD+KP N L  +      LK  D
Sbjct: 133 YKLL--KSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTT---CDLKICD 187
Query: 246 FGLSDFIKPGKK----FQDIVGSAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRP 299
           FGL+    P         + V + +Y APE++    G     D+WS+G I   +L  R  
Sbjct: 188 FGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247
Query: 300 F-----WDKTED--GIF----------------KEVLRNKPDFRRKPW----PSISNSAK 332
           F      D+     GI                 +  L++ P   +  W    P   + A 
Sbjct: 248 FPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKAL 307
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           D + ++L  +P  R+T  +AL+HP++ +  D ++ P+
Sbjct: 308 DLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPV 344

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 138/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 127
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 128 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 181
Query: 258 F---QDIVGSAYYVAPEVLKRKSGPES------------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K  S                DVWS+G I Y +  G+ PF  
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 240
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISN-SAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 241 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 50  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 108
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 109 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 162
Query: 258 F---QDIVGSAYYVAPEVLKRKSGPES------------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K  S                DVWS+G I Y +  G+ PF  
Sbjct: 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 221
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISN-SAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 222 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 138/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 124/282 (43%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D  +   VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N L  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANILISAT---NAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 45
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 46  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 103
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 104 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 160 PSNL---AVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 23/267 (8%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LGHG  G T V     +   VAVK+I      LP       REV++L+    H NV+++
Sbjct: 31  VLGHGAEG-TIVYRGMFDNRDVAVKRI------LPECFSFADREVQLLRESDEHPNVIRY 83
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +   +D  + YIA+ELC     L   + +KD  +   +   +++Q     A  H   +VH
Sbjct: 84  FCTEKDRQFQYIAIELC--AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141
Query: 223 RDMKPENFLFKSAKEDSSLKA--TDFGLSDFIKPGK----KFQDIVGSAYYVAPEVLKR- 275
           RD+KP N L         +KA  +DFGL   +  G+    +   + G+  ++APE+L   
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 276 -KSGP--ESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR-RKPWPSISNS 330
            K  P    D++S G + Y ++  G  PF    +      +L          P       
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--ANILLGACSLDCLHPEKHEDVI 259
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPW 357
           A++ ++K++  DP+ R +A   L HP+
Sbjct: 260 ARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 137/291 (47%), Gaps = 32/291 (10%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF--WDKTED-----GIFK--EVLRNK 316
           Y++PE L+      +SD+WS+G+    +  GR P    D  ED      IF+  + + N+
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNE 228
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           P   + P    S   +DFV K L+K+P  R    Q + H +++   DA E+
Sbjct: 229 PP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR-SDAEEV 277

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 45
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 46  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 103
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 104 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 160 PSNL---AVNEDCELKILDFGLARHT--ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 53  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 111
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 112 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 165
Query: 258 F---QDIVGSAYYVAPEVLKRKSGPES------------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K  S                DVWS+G I Y +  G+ PF  
Sbjct: 166 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 224
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISN-SAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 225 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 45
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 46  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 103
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 104 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 160 PSNL---AVNEDCELKILDFGLARHT--ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 85/315 (26%), Positives = 131/315 (41%), Gaps = 69/315 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWV 358
             R++   AL HP++
Sbjct: 307 AKRISVDDALQHPYI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 137/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 97  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 156 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 209
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 210 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 268
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISN-SAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 269 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 49  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 107
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 108 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 161
Query: 258 F---QDIVGSAYYVAPEVLKRKSGPES------------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K  S                DVWS+G I Y +  G+ PF  
Sbjct: 162 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 220
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISN-SAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 221 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 97  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 156 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 209
Query: 258 F---QDIVGSAYYVAPEVLKRKSGPES------------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K  S                DVWS+G I Y +  G+ PF  
Sbjct: 210 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 268
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISN-SAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 269 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 97  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 156 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 209
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 268
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISN-SAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 269 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 145/352 (41%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P                      +G G +G  
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQ-NLSP----------------------IGSGAYGSV 43
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 44  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 101
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 102 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 157
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 158 PSNL---AVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 324

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 45
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 46  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 103
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 104 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 160 PSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G  G  Y     ++   V
Sbjct: 20  KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGSGSVYSGIRVSDNLPV 79
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQALA-GHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ ++ G   V++  + FE  D++V I    
Sbjct: 80  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 139 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 194
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 195 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF         +E++R +  FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 254 DIPFEHD------EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 357 WVRE 360
           W+++
Sbjct: 304 WMQD 307

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 43
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 44  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 101
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 102 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 157
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 158 PSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 324

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D  +   VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N +  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 43
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 44  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 101
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 102 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 157
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 158 PSNL---AVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 324

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/322 (26%), Positives = 133/322 (41%), Gaps = 69/322 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDAS 365
             R++   AL HP++    D +
Sbjct: 307 AKRISVDDALQHPYINVWYDPA 328

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 136/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 134/298 (44%), Gaps = 47/298 (15%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           YT  K++G+G FG  + A      D VA+KK+ ++K           RE++I++ +  H 
Sbjct: 42  YTNCKVIGNGSFGVVFQA-KLVESDEVAIKKVLQDKRF-------KNRELQIMR-IVKHP 92
Query: 158 NVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR----QML 209
           NVV     FY+  +  + V++ + L    E + R  ++  ++  +    ++++    Q+L
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRA-SRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           R  A  H  G+ HRD+KP+N L         LK  DFG +  +  G+     + S YY A
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPP--SGVLKLIDFGSAKILIAGEPNVSXICSRYYRA 209
Query: 270 PEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR------------- 314
           PE++   +   +  D+WS G +   L+ G+  F  ++      E+++             
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269
Query: 315 -------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                    P  R  P+     P     A D + +LL   P ARLTA +AL HP+  E
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 22/261 (8%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG  Y   D    + VA+K I+  +      +ED+++E+ +L        + +++
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQ-CDSPYITRYF 83
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            ++     ++I ME   GG  LD +   K     E   A ++R++L+     H    +HR
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERKIHR 140
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSGP-ES 281
           D+K  N L     E   +K  DFG++  +   + K    VG+ +++APEV+K+ +   ++
Sbjct: 141 DIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI----SNSAKDFVKK 337
           D+WS+G+    L  G  P  D     +   + +N P       P++    S   K+FV+ 
Sbjct: 198 DIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------PTLEGQHSKPFKEFVEA 250
Query: 338 LLVKDPRARLTAAQALSHPWV 358
            L KDPR R TA + L H ++
Sbjct: 251 CLNKDPRFRPTAKELLKHKFI 271

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 80
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 135
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFVVTRY 192
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 193 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPCP 248
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 249 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 308
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 309 SKRISVDEALQHPYINVWYDPSE 331

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 79
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 134
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPCP 247
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 308 SKRISVDEALQHPYINVWYDPSE 330

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 87/338 (25%), Positives = 146/338 (43%), Gaps = 63/338 (18%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK---REVK 148
           K+ DR + + ++ G G FG   +  +K+ G  VA+KK+          ++D +   RE++
Sbjct: 20  KEMDR-FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQ 68
Query: 149 ILQALA--GHENVVK----FYNAFEDDN---YVYIAMELCEGGELLDRILAKKDSRYTEK 199
           I+Q LA   H N+V+    FY   E D    Y+ + ME     + L R       R    
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAP 126
Query: 200 DAAVV---VRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
              ++   + Q++R     HL    + HRD+KP N L   A  D +LK  DFG +  + P
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKLCDFGSAKKLSP 184
Query: 255 GKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
            +     + S YY APE++   +      D+WS+G I   ++ G   F      G   E+
Sbjct: 185 SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244
Query: 313 LR----NKPDFRRK----------------PWPSI--------SNSAKDFVKKLLVKDPR 344
           +R       +  RK                PW ++        +  A D +  LL   P 
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304
Query: 345 ARLTAAQALSHPWVREGGD-ASEIPIDISVLNNMRQFV 381
            R+   +AL HP+  E  D A+++P +  +  ++ +F+
Sbjct: 305 ERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFL 342

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQ 76
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 77  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 132
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 133 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 189
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P        + S  
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG---NYSKP 246
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQ 61
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 62  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 117
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 118 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 174
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P        + S  
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG---NYSKP 231
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 232 LKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQ 61
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 62  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 117
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 118 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 174
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P        + S  
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG---NYSKP 231
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 232 LKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 20/237 (8%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 11  DGQITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 65
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L   + A  ++++  K    + RQ  R    
Sbjct: 66  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDY 123
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED+++K  DFGL+          +F+ + GS  ++APE
Sbjct: 124 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 180
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRN--KPDFRR 321
           V++ + S P   +SDV++ G++ Y L+ G+ P+ +    D I + V R    PD  +
Sbjct: 181 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 237

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 123/282 (43%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D      VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N +  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 24  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQ 81
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 82  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 137
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 138 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 194
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P      +   S  
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKP 251
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 252 LKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 89/349 (25%), Positives = 144/349 (41%), Gaps = 95/349 (27%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-IAVEDVKREVKILQALAGH 156
           Y I  L+G G +GY Y+A DK     VA+KK+  N+M    I  + + RE+ IL  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKS- 84
Query: 157 ENVVKFYNAFEDDNY-----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           + +++ Y+    D+      +YI +E+ +      + L K     TE+    ++  +L  
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDL---KKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI----------------KPG 255
               H  G++HRD+KP N L     +D S+K  DFGL+  I                +PG
Sbjct: 142 ENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 256 -------KKFQDIVGSAYYVAPE--VLKRKSGPESDVWSIGVITYILL----------CG 296
                  K+    V + +Y APE  +L+       D+WS G I   LL            
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 297 RRPFW----------DKTEDGIFKEVLR---------------------NKPDF------ 319
           R P +          D+    + ++  R                     NKP+       
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318
Query: 320 --RRKP------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              RKP      +PSIS+   + ++ +L  +P  R+T  QAL HP++++
Sbjct: 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 46/300 (15%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G    A D     +VAVKK+ +    L I      RE+++L+ L  HENV+   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHLK-HENVIGLL 93
Query: 164 NAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           + F      ED + VY+   L   G  L+ I+  K    +++    +V Q+LR     H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIV--KSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-- 275
            G++HRD+KP N    +  EDS L+  DFGL+   +  ++    V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNV---AVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL---------------------- 313
                 D+WS+G I   LL G+  F         K ++                      
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 314 -RNKPDFRRKPWPSISNSAK----DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            ++ P   +K   SI   A     D + ++LV D   R++AA+AL+H +  +  D  + P
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 17/291 (5%)
Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           G++P G             RY +G++LG G     ++A D      VAVK +  +    P
Sbjct: 13  GLVPRGSH--MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP 70
Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKD 193
                 +RE +   AL  H  +V  Y+  E +       YI ME  +G  L D  +   +
Sbjct: 71  SFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTE 127
Query: 194 SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
              T K A  V+    +     H +G++HRD+KP N +  +    +++K  DFG++  I 
Sbjct: 128 GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIA 184
Query: 254 PG----KKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
                  +   ++G+A Y++PE  +  S    SDV+S+G + Y +L G  PF   +   +
Sbjct: 185 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 244
Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
             + +R  P         +S      V K L K+P  R   A  +    VR
Sbjct: 245 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 295

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 20/237 (8%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 23  DGQITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR 78
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L   + A  ++++  K    + RQ  R    
Sbjct: 79  -HVNILLFM-GYSTKPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDY 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED+++K  DFGL+          +F+ + GS  ++APE
Sbjct: 136 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRN--KPDFRR 321
           V++ + S P   +SDV++ G++ Y L+ G+ P+ +    D I + V R    PD  +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D      VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y   E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N +  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 20/237 (8%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 23  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 77
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L   + A  ++++  K    + RQ  R    
Sbjct: 78  RHVNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDY 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED+++K  DFGL+          +F+ + GS  ++APE
Sbjct: 136 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRN--KPDFRR 321
           V++ + S P   +SDV++ G++ Y L+ G+ P+ +    D I + V R    PD  +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G +G  + A ++   + VA+K++  + +   +P       RE+ +L+ L  H+N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELK-HKNIVR 65
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVV---VRQMLRVAAECHL 217
            ++    D  + +  E C      D+ L K  DS   + D  +V   + Q+L+    CH 
Sbjct: 66  LHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--K 274
             ++HRD+KP+N L     E   LK  DFGL+  F  P + +   V + +Y  P+VL   
Sbjct: 120 RNVLHRDLKPQNLLINRNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLR--------------NKPDF 319
           +      D+WS G I   L    RP +   + D   K + R                PD+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 320 RRKPW-----------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           +  P            P ++ + +D ++ LL  +P  R++A +AL HP+  +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 46/300 (15%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G    A D     +VAVKK+ +    L I      RE+++L+ L  HENV+   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHLK-HENVIGLL 93
Query: 164 NAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           + F      ED + VY+   L   G  L+ I+  K    +++    +V Q+LR     H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIV--KCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-- 275
            G++HRD+KP N    +  EDS L+  DFGL+   +  ++    V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNV---AVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL---------------------- 313
                 D+WS+G I   LL G+  F         K ++                      
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 314 -RNKPDFRRKPWPSISNSAK----DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            ++ P   +K   SI   A     D + ++LV D   R++AA+AL+H +  +  D  + P
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 62/301 (20%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G FG  + A  +  G +VA+KK+  E  K   PI      RE+KILQ L  HENVV 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQLLK-HENVVN 81
Query: 162 F----------YNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQML 209
                      YN  +    +Y+  + CE     LL  +L K    +T  +   V++ +L
Sbjct: 82  LIEICRTKASPYNRCKGS--IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 135
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGS 264
                 H + ++HRDMK  N L      D  LK  DFGL+      K     ++ + V +
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
            +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       +
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252
Query: 323 PWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQALS 354
            WP++ N                             A D + KLLV DP  R+ +  AL+
Sbjct: 253 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 355 H 355
           H
Sbjct: 313 H 313

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 130/272 (47%), Gaps = 22/272 (8%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 20  DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQ 77
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++   + ++I ME   GG  LD + A     + E   A +++++L+  
Sbjct: 78  -CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGL 133
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 134 DYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 190
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI--- 327
           V+++ +   ++D+WS+G+    L  G  P  D     +   + +N P       P++   
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------PTLVGD 243
Query: 328 -SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            + S K+F+   L KDP  R TA + L H ++
Sbjct: 244 FTKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 62/301 (20%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G FG  + A  +  G +VA+KK+  E  K   PI      RE+KILQ L  HENVV 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQLLK-HENVVN 80
Query: 162 F----------YNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQML 209
                      YN  +    +Y+  + CE     LL  +L K    +T  +   V++ +L
Sbjct: 81  LIEICRTKASPYNRCKGS--IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 134
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGS 264
                 H + ++HRDMK  N L      D  LK  DFGL+      K     ++ + V +
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
            +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       +
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251
Query: 323 PWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQALS 354
            WP++ N                             A D + KLLV DP  R+ +  AL+
Sbjct: 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311
Query: 355 H 355
           H
Sbjct: 312 H 312

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 62/301 (20%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G FG  + A  +  G +VA+KK+  E  K   PI      RE+KILQ L  HENVV 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQLLK-HENVVN 81
Query: 162 F----------YNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQML 209
                      YN  +    +Y+  + CE     LL  +L K    +T  +   V++ +L
Sbjct: 82  LIEICRTKASPYNRCKGS--IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 135
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGS 264
                 H + ++HRDMK  N L      D  LK  DFGL+      K     ++ + V +
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
            +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       +
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252
Query: 323 PWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQALS 354
            WP++ N                             A D + KLLV DP  R+ +  AL+
Sbjct: 253 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 355 H 355
           H
Sbjct: 313 H 313

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 62/301 (20%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G FG  + A  +  G +VA+KK+  E  K   PI      RE+KILQ L  HENVV 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQLLK-HENVVN 81
Query: 162 F----------YNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQML 209
                      YN  +    +Y+  + CE     LL  +L K    +T  +   V++ +L
Sbjct: 82  LIEICRTKASPYNRCKAS--IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 135
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGS 264
                 H + ++HRDMK  N L      D  LK  DFGL+      K     ++ + V +
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
            +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       +
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252
Query: 323 PWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQALS 354
            WP++ N                             A D + KLLV DP  R+ +  AL+
Sbjct: 253 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 355 H 355
           H
Sbjct: 313 H 313

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G +G  + A ++   + VA+K++  + +   +P       RE+ +L+ L  H+N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELK-HKNIVR 65
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVV---VRQMLRVAAECHL 217
            ++    D  + +  E C      D+ L K  DS   + D  +V   + Q+L+    CH 
Sbjct: 66  LHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--K 274
             ++HRD+KP+N L     E   LK  +FGL+  F  P + +   V + +Y  P+VL   
Sbjct: 120 RNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLR--------------NKPDF 319
           +      D+WS G I   L    RP +   + D   K + R                PD+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 320 RRKPW-----------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           +  P            P ++ + +D ++ LL  +P  R++A +AL HP+  +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 46/300 (15%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G    A D     +VAVKK+ +    L I      RE+++L+ L  HENV+   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHLK-HENVIGLL 85
Query: 164 NAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           + F      ED + VY+   L   G  L+ I+  K    +++    +V Q+LR     H 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM--GADLNNIV--KCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-- 275
            G++HRD+KP N    +  ED  L+  DFGL+   +  ++    V + +Y APE++    
Sbjct: 142 AGIIHRDLKPSNV---AVNEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 196
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL---------------------- 313
                 D+WS+G I   LL G+  F         K ++                      
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 314 -RNKPDFRRKPWPSISNSAK----DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            ++ P   +K   SI   A     D + ++LV D   R++AA+AL+H +  +  D  + P
Sbjct: 257 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 316

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 10/261 (3%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL+ +     VV 
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 248
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + L  GG+L   I     + + E  A     ++     + H   +V
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ +D GL+  +  G+  +  VG+  Y+APEV+K +    S
Sbjct: 309 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W++G + Y ++ G+ PF  + +    +EV R   +   +     S  A+    +LL 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 341 KDPRARL-----TAAQALSHP 356
           KDP  RL     +A +   HP
Sbjct: 426 KDPAERLGCRGGSAREVKEHP 446

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 10/261 (3%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL+ +     VV 
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 248
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + L  GG+L   I     + + E  A     ++     + H   +V
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ +D GL+  +  G+  +  VG+  Y+APEV+K +    S
Sbjct: 309 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W++G + Y ++ G+ PF  + +    +EV R   +   +     S  A+    +LL 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 341 KDPRARL-----TAAQALSHP 356
           KDP  RL     +A +   HP
Sbjct: 426 KDPAERLGCRGGSAREVKEHP 446

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 47/303 (15%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR-VAVKKI--EKNKMILPIAVEDVKREVKILQ 151
           D++Y     +G G +G  + A D  NG R VA+K++  +  +  +P++     REV +L+
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLR 66
Query: 152 ALAG--HENVVKFYNAF-----EDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAA 202
            L    H NVV+ ++       + +  + +  E  +      LD++        T KD  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD-- 124
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++ Q+LR     H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V
Sbjct: 125 -MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVV 180
Query: 263 GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEV--LRN 315
            + +Y APEVL + S     D+WS+G I +  +  R+P +  + D    G   +V  L  
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 316 KPDFRR------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           + D+ R                  K    I    KD + K L  +P  R++A  ALSHP+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 358 VRE 360
            ++
Sbjct: 300 FQD 302

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/333 (23%), Positives = 144/333 (43%), Gaps = 86/333 (25%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK---REVKILQA 152
           ++Y++GK LG G FG      D  +G R A+KK+          ++D +   RE+ I++ 
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----------LQDPRYKNRELDIMKV 56
Query: 153 LAGHENVVKFYNAF--------------EDDN------------------------YVYI 174
           L  H N++K  + F              +D N                        Y+ +
Sbjct: 57  L-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 175 AMELCEGGELLDRILAK--KDSRYTEKD-AAVVVRQMLRVAAECHLHGLVHRDMKPENFL 231
            ME     + L ++L    +  R    +  ++ + Q+ R     H  G+ HRD+KP+N L
Sbjct: 116 IMEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 232 FKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVI 289
             S  +D++LK  DFG +  + P +     + S +Y APE++    +  P  D+WSIG +
Sbjct: 174 VNS--KDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 290 TYILLCGRRPFWDKTE-DGIFK-----------EVLRNKPDFRRKPWPSI---------- 327
              L+ G+  F  +T  D + +           +++R  P +    +P++          
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291
Query: 328 ---SNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
               + A D ++++L  +P  R+   +A++HP+
Sbjct: 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 47/303 (15%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR-VAVKKI--EKNKMILPIAVEDVKREVKILQ 151
           D++Y     +G G +G  + A D  NG R VA+K++  +  +  +P++     REV +L+
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLR 66
Query: 152 ALAG--HENVVKFYNAF-----EDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAA 202
            L    H NVV+ ++       + +  + +  E  +      LD++        T KD  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD-- 124
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++ Q+LR     H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V
Sbjct: 125 -MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVV 180
Query: 263 GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEV--LRN 315
            + +Y APEVL + S     D+WS+G I +  +  R+P +  + D    G   +V  L  
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 316 KPDFRR------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           + D+ R                  K    I    KD + K L  +P  R++A  ALSHP+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 358 VRE 360
            ++
Sbjct: 300 FQD 302

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 79  ILQNLCGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 130
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 131 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 248
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 249 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 308
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 309 TALEAMTHPYFQQ 321

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF- 162
           LG G FGY      +  G++VA+K+  +   + P   E    E++I++ L  H NVV   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL-NHPNVVSAR 79
Query: 163 -----YNAFEDDNYVYIAMELCEGGELLDRI--------LAKKDSRYTEKDAAVVVRQML 209
                      ++   +AME CEGG+L   +        L +   R    D +  +R + 
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL- 138
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H + ++HRD+KPEN + +   +    K  D G +  +  G+   + VG+  Y+A
Sbjct: 139 ------HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 270 PEVLKRKSGPES-DVWSIGVITYILLCGRRPF 300
           PE+L++K    + D WS G + +  + G RPF
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF- 162
           LG G FGY      +  G++VA+K+  +   + P   E    E++I++ L  H NVV   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL-NHPNVVSAR 78
Query: 163 -----YNAFEDDNYVYIAMELCEGGELLDRI--------LAKKDSRYTEKDAAVVVRQML 209
                      ++   +AME CEGG+L   +        L +   R    D +  +R + 
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL- 137
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H + ++HRD+KPEN + +   +    K  D G +  +  G+   + VG+  Y+A
Sbjct: 138 ------HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 270 PEVLKRKSGPES-DVWSIGVITYILLCGRRPF 300
           PE+L++K    + D WS G + +  + G RPF
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 137/300 (45%), Gaps = 47/300 (15%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR-VAVKKI--EKNKMILPIAVEDVKREVKILQ 151
           D++Y     +G G +G  + A D  NG R VA+K++  +  +  +P++     REV +L+
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLR 66
Query: 152 ALAG--HENVVKFYNAF-----EDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAA 202
            L    H NVV+ ++       + +  + +  E  +      LD++        T KD  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD-- 124
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++ Q+LR     H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V
Sbjct: 125 -MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVV 180
Query: 263 GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEV--LRN 315
            + +Y APEVL + S     D+WS+G I +  +  R+P +  + D    G   +V  L  
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 316 KPDFRR------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           + D+ R                  K    I    KD + K L  +P  R++A  ALSHP+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLCGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLCGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 80  ILQNLCGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 131
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 132 YIYELLKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVA 189
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 190 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 249
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 250 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 309
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 310 TALEAMTHPYFQQ 322

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLMGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 79  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 130
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 131 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 248
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 249 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 308
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 309 TALEAMTHPYFQQ 321

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 107/228 (46%), Gaps = 20/228 (8%)
Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
            G     +  + +  +LG G     +    K  GD  A+K       + P+ V+   RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREF 58
Query: 148 KILQALAGHENVVKFYNAFEDDNYV---YIAMELCEGGELLDRILAKKDSRY--TEKDAA 202
           ++L+ L  H+N+VK + A E++       + ME C  G L   +L +  + Y   E +  
Sbjct: 59  EVLKKL-NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFL 115
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL-KATDFGLSDFIKPGKKFQDI 261
           +V+R ++        +G+VHR++KP N +    ++  S+ K TDFG +  ++  ++F  +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 262 VGSAYYVAPEVLKR---------KSGPESDVWSIGVITYILLCGRRPF 300
            G+  Y+ P++ +R         K G   D+WSIGV  Y    G  PF
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 111/236 (47%), Gaps = 46/236 (19%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALAGHEN 158
           + LG G FG  + A +K +    A+K+I      LP   +A E V REVK L  L  H  
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIR-----LPNRELAREKVMREVKALAKLE-HPG 64
Query: 159 VVKFYNAFEDDN------------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +V+++NA+ + N            Y+YI M+LC    L D +  +      E++ +V + 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLH 122
Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI-- 261
             L++A      H  GL+HRD+KP N  F     D  +K  DFGL   +   ++ Q +  
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 262 -----------VGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE 305
                      VG+  Y++PE +   S   + D++S+G+I + LL    PF  + E
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQME 232

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 41/291 (14%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   Y    K   + VA+K+I  E  +     A+    REV +L+ L  H N+V 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK-HANIVT 64
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++    +  + +  E  +    L + L    +     +  + + Q+LR  A CH   ++
Sbjct: 65  LHDIIHTEKSLTLVFEYLDKD--LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKS--G 278
           HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P++L   +   
Sbjct: 123 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------------------NK 316
            + D+W +G I Y +  GR  F   T +     + R                      N 
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239
Query: 317 PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD 363
           P +R +      P + +   D + KLL  + R R++A  A+ HP+    G+
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L    L K+     E  A   + Q L      H   ++H 
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQ--LVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHG 190
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV------GSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P    +D++      G+  ++APE VL R 
Sbjct: 191 DVKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
              + DVWS   +   +L G  P+       +  ++    P  R  P PS +      ++
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIP-PSCAPLTAQAIQ 307
Query: 337 KLLVKDPRARLTAAQ 351
           + L K+P  R++AA+
Sbjct: 308 EGLRKEPIHRVSAAE 322

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 99  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 150
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 151 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 208
Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------------DK 303
           S Y+  PE+L   +      D+WS+G +   ++  + PF+                  D 
Sbjct: 209 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 268
Query: 304 TEDGIFKEVLRNKPDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
               + K  +   P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 269 LNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 328
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 329 TALEAMTHPYFQQ 341

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +  +LG G     +    K  GD  A+K       + P+ V+   RE ++L+ L  H+
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NHK 67
Query: 158 NVVKFYNAFEDDNYV---YIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVA 212
           N+VK + A E++       + ME C  G L   +L +  + Y   E +  +V+R ++   
Sbjct: 68  NIVKLF-AIEEETTTRHKVLIMEFCPCGSLY-TVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSL-KATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
                +G+VHR++KP N +    ++  S+ K TDFG +  ++  ++F  + G+  Y+ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 272 VLKR---------KSGPESDVWSIGVITYILLCGRRPF 300
           + +R         K G   D+WSIGV  Y    G  PF
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 21/255 (8%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L    L K+     E  A   + Q L      H   ++H 
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQ--LVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHG 209
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQD---IVGSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P   GK       I G+  ++APE VL R 
Sbjct: 210 DVKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
              + DVWS   +   +L G  P+       +  ++    P  R  P PS +      ++
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIP-PSCAPLTAQAIQ 326
Query: 337 KLLVKDPRARLTAAQ 351
           + L K+P  R++AA+
Sbjct: 327 EGLRKEPIHRVSAAE 341

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N L     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 130/307 (42%), Gaps = 61/307 (19%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQ 151
            DR   I KL G G +G  Y A D    + VA+K+I  E  +  +P       REV +L+
Sbjct: 33  IDRYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP---GTAIREVSLLK 88
Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR----- 206
            L  H N+++  +    ++ +++  E  E              +Y +K+  V +R     
Sbjct: 89  ELQ-HRNIIELKSVIHHNHRLHLIFEYAE----------NDLKKYMDKNPDVSMRVIKSF 137
Query: 207 --QMLRVAAECHLHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKKFQDI 261
             Q++     CH    +HRD+KP+N L     A E   LK  DFGL+  F  P ++F   
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 262 VGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK--EVLRNK 316
           + + +Y  PE+L   R      D+WSI  I   +L     F   +E D +FK  EVL   
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GL 256
Query: 317 PDFRRKPWPSIS---NSAKDFVK-----------------------KLLVKDPRARLTAA 350
           PD     WP ++   +  + F K                        +L  DP  R++A 
Sbjct: 257 PD--DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314
Query: 351 QALSHPW 357
            AL HP+
Sbjct: 315 NALEHPY 321

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 127/291 (43%), Gaps = 51/291 (17%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG    A +  +    A+KKI   +  L   + +V     +L A   H+ VV++
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-----MLLASLNHQYVVRY 67
Query: 163 YNAF-EDDNYV------------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           Y A+ E  N+V            +I ME CE G L D I ++  ++  + +   + RQ+L
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-EYWRLFRQIL 126
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFIK------PGK 256
              +  H  G++HRD+KP N       E  ++K  DFGL+       D +K      PG 
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 257 --KFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
                  +G+A YVA EVL        + D++S+G+I + ++    PF    E     + 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240
Query: 313 LRN-----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           LR+      PDF            K  ++ L+  DP  R  A   L+  W+
Sbjct: 241 LRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 138/306 (45%), Gaps = 40/306 (13%)
Query: 72  NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-- 129
           +S +QTG +  G +    Y  + +    +G++ G G  G  +    +  G  +AVK++  
Sbjct: 5   SSGKQTGYLTIGGQR---YQAEINDLENLGEM-GSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 130 ----EKNKMILPIAVEDVKREVKILQALAGHEN--VVKFYNAFEDDNYVYIAMEL---CE 180
               E+NK IL          + +   L  H+   +V+ +  F  +  V+IAMEL   C 
Sbjct: 61  SGNKEENKRIL----------MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC- 109
Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
             +L  R+      R   K    +V+ +  +  +   HG++HRD+KP N L     E   
Sbjct: 110 AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILL---DERGQ 163
Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPE----SDVWSIGVITYILL 294
           +K  DFG+S  +   K      G A Y+APE +     + P+    +DVWS+G+    L 
Sbjct: 164 IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 295 CGRRPFWD-KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            G+ P+ + KT+  +  +VL+ +P          S   + FVK  L KD R R    + L
Sbjct: 224 TGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM-GFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
Query: 354 SHPWVR 359
            H +++
Sbjct: 283 EHSFIK 288

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 128 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 185
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 306 YDHQSRLTAREAMEHPY 322

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/325 (25%), Positives = 140/325 (43%), Gaps = 56/325 (17%)
Query: 89  GYDKDFD--RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
            +D  FD    Y I + +G+G +G    A  +  G +VA+KKI  N   +    +   RE
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRE 103
Query: 147 VKILQALAGHENVVKF---------YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
           +KIL+    H+N++           Y  F+    VY+ ++L E    L +I+       T
Sbjct: 104 LKILKHFK-HDNIIAIKDILRPTVPYGEFKS---VYVVLDLMESD--LHQIIHSSQP-LT 156
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI--KPG 255
            +     + Q+LR     H   ++HRD+KP N L     E+  LK  DFG++  +   P 
Sbjct: 157 LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCTSPA 213
Query: 256 KK---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKT------ 304
           +      + V + +Y APE++    +     D+WS+G I   +L  R+ F  K       
Sbjct: 214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ 273
Query: 305 ---------EDGIFKEV--------LRNKPDFRRKPW----PSISNSAKDFVKKLLVKDP 343
                       + + V        +++ P  +  PW    P     A   + ++L  +P
Sbjct: 274 LIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEP 333
Query: 344 RARLTAAQALSHPWVREGGDASEIP 368
            AR++AA AL HP++ +  D  + P
Sbjct: 334 SARISAAAALRHPFLAKYHDPDDEP 358

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 128 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 185
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 306 YDHQSRLTAREAMEHPY 322

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 184
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 305 YDHQSRLTAREAMEHPY 321

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 134 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 191
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 192 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 251
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 252 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 311
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 312 YDHQSRLTAREAMEHPY 328

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 122/254 (48%), Gaps = 16/254 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
              AFE    + + M +  GG++   I  + + +  + E  A     Q++      H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSG 278
           +++RD+KPEN L     +D +++ +D GL+  +K G+ K +   G+  ++APE+L  +  
Sbjct: 310 IIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 279 PES-DVWSIGVITYILLCGRRPF---WDKTEDGIFKE-VLRNKPDFRRKPWPSISNSAKD 333
             S D +++GV  Y ++  R PF    +K E+   K+ VL     +  K     S ++KD
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSPASKD 422
Query: 334 FVKKLLVKDPRARL 347
           F + LL KDP  RL
Sbjct: 423 FCEALLQKDPEKRL 436

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 122/254 (48%), Gaps = 16/254 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
              AFE    + + M +  GG++   I  + + +  + E  A     Q++      H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSG 278
           +++RD+KPEN L     +D +++ +D GL+  +K G+ K +   G+  ++APE+L  +  
Sbjct: 310 IIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 279 PES-DVWSIGVITYILLCGRRPF---WDKTEDGIFKE-VLRNKPDFRRKPWPSISNSAKD 333
             S D +++GV  Y ++  R PF    +K E+   K+ VL     +  K     S ++KD
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSPASKD 422
Query: 334 FVKKLLVKDPRARL 347
           F + LL KDP  RL
Sbjct: 423 FCEALLQKDPEKRL 436

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 122/254 (48%), Gaps = 16/254 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
              AFE    + + M +  GG++   I  + + +  + E  A     Q++      H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSG 278
           +++RD+KPEN L     +D +++ +D GL+  +K G+ K +   G+  ++APE+L  +  
Sbjct: 310 IIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 279 PES-DVWSIGVITYILLCGRRPF---WDKTEDGIFKE-VLRNKPDFRRKPWPSISNSAKD 333
             S D +++GV  Y ++  R PF    +K E+   K+ VL     +  K     S ++KD
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSPASKD 422
Query: 334 FVKKLLVKDPRARL 347
           F + LL KDP  RL
Sbjct: 423 FCEALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 122/254 (48%), Gaps = 16/254 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
              AFE    + + M +  GG++   I  + + +  + E  A     Q++      H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSG 278
           +++RD+KPEN L     +D +++ +D GL+  +K G+ K +   G+  ++APE+L  +  
Sbjct: 310 IIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 279 PES-DVWSIGVITYILLCGRRPF---WDKTEDGIFKE-VLRNKPDFRRKPWPSISNSAKD 333
             S D +++GV  Y ++  R PF    +K E+   K+ VL     +  K     S ++KD
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSPASKD 422
Query: 334 FVKKLLVKDPRARL 347
           F + LL KDP  RL
Sbjct: 423 FCEALLQKDPEKRL 436

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 140/324 (43%), Gaps = 56/324 (17%)
Query: 90  YDKDFD--RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           +D  FD    Y I + +G+G +G    A  +  G +VA+KKI  N   +    +   RE+
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLREL 105
Query: 148 KILQALAGHENVVKF---------YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
           KIL+    H+N++           Y  F+    VY+ ++L E    L +I+       T 
Sbjct: 106 KILKHFK-HDNIIAIKDILRPTVPYGEFKS---VYVVLDLMESD--LHQII-HSSQPLTL 158
Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI--KPGK 256
           +     + Q+LR     H   ++HRD+KP N L     E+  LK  DFG++  +   P +
Sbjct: 159 EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCTSPAE 215
Query: 257 K---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKT------- 304
                 + V + +Y APE++    +     D+WS+G I   +L  R+ F  K        
Sbjct: 216 HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL 275
Query: 305 --------EDGIFKEV--------LRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPR 344
                      + + V        +++ P  +  PW    P     A   + ++L  +P 
Sbjct: 276 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS 335
Query: 345 ARLTAAQALSHPWVREGGDASEIP 368
           AR++AA AL HP++ +  D  + P
Sbjct: 336 ARISAAAALRHPFLAKYHDPDDEP 359

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 112/285 (39%), Gaps = 32/285 (11%)
Query: 89  GYDKD-----FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           GYD       F + +     LGHG +G  +    K +G   AVK+     M      +D 
Sbjct: 45  GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR----SMSPFRGPKDR 100
Query: 144 KR---EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
            R   EV   + +  H   V+   A+E+   +Y+  ELC  G  L +      +   E  
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC--GPSLQQHCEAWGASLPEAQ 158
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
               +R  L   A  H  GLVH D+KP N            K  DFGL   +      + 
Sbjct: 159 VWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP---RGRCKLGDFGLLVELGTAGAGEV 215
Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR-----PFWDKTEDGIFKEVLRN 315
             G   Y+APE+L+   G  +DV+S+G+    + C          W +   G        
Sbjct: 216 QEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL------ 269
Query: 316 KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            P+F       +S+  +  +  +L  DP+ R TA   L+ P +R+
Sbjct: 270 PPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 9   DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 63
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 64  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 121
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 122 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 178
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 179 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 34  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 88
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 89  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 146
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 147 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 203
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 204 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 7   DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 62  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 120 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 12  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 66
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 67  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 125 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           DK F   +   +L+G G FG  + A  + +G    +K+++ N        E  +REVK L
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKAL 58
Query: 151 QALAGHENVVKFYNAFEDDNY----------------VYIAMELCEGGELLDRILAKKDS 194
             L  H N+V +   ++  +Y                ++I ME C+ G L   I  ++  
Sbjct: 59  AKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
           +  +  A  +  Q+ +     H   L++RD+KP N      K+   +K  DFGL   +K 
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKN 174
Query: 255 GKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILL--CG----RRPFWDKTEDG 307
             K     G+  Y++PE +  +  G E D++++G+I   LL  C        F+    DG
Sbjct: 175 DGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
Query: 308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           I  ++   K               K  ++KLL K P  R   ++ L
Sbjct: 235 IISDIFDKKE--------------KTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 35  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 89
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 90  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 148 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 204
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 12  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 66
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 67  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 125 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 7   DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 62  RHVNILLFM-GYSTAPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 120 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 34/283 (12%)
Query: 90  YDKDFDRRYT-IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           + K+ D  Y  I +++G G+FG       KA G +   VA+K ++          E  +R
Sbjct: 7   FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY------TERQRR 60
Query: 146 EVKILQALAG---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           E     ++ G   H N+++      +   V I  E  E G L D  L   D ++T     
Sbjct: 61  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLV 119
Query: 203 VVVRQM---LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-- 257
            ++R +   +R  AE      VHRD+   N L  S   +   K +DFGLS F++      
Sbjct: 120 GMLRGIASGMRYLAE---MSYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEENSSDP 173
Query: 258 -FQDIVGSAY---YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKE 311
            +   +G      + APE +  RK    SD WS G++ + ++  G RP+WD +   +   
Sbjct: 174 TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINA 233
Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           +   + D+R  P P    S    +     KD  AR    Q +S
Sbjct: 234 I---EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVS 273

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 27  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 81
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 82  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 139
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 140 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 196
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 197 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 35  DGQITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 89
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 90  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 148 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 204
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 7   DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 62  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 120 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 176
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 51/291 (17%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG    A +  +    A+KKI   +  L   + +V     +L A   H+ VV++
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-----MLLASLNHQYVVRY 67
Query: 163 YNAF-EDDNYV------------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           Y A+ E  N+V            +I ME CE   L D I ++  ++  + +   + RQ+L
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD-EYWRLFRQIL 126
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFIK------PGK 256
              +  H  G++HRD+KP N       E  ++K  DFGL+       D +K      PG 
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 257 --KFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
                  +G+A YVA EVL        + D++S+G+I + ++    PF    E     + 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240
Query: 313 LRN-----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           LR+      PDF            K  ++ L+  DP  R  A   L+  W+
Sbjct: 241 LRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 136/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 32  DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 85
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 86  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 142
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 143 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 195
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF-----------------WDKTED-- 306
           Y++PE L+      +SD+WS+G+    +  GR P                   D  E   
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 314
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 315 ERADLKQLMVHAFIKR-SDAEEV 336

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 118/283 (41%), Gaps = 34/283 (12%)
Query: 90  YDKDFDRRYT-IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           + K+ D  Y  I +++G G+FG       KA G +   VA+K ++          E  +R
Sbjct: 9   FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY------TERQRR 62
Query: 146 EVKILQALAG---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           E     ++ G   H N+++      +   V I  E  E G L D  L   D ++T     
Sbjct: 63  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLV 121
Query: 203 VVVRQM---LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
            ++R +   +R  AE      VHRD+   N L  S   +   K +DFGLS F++      
Sbjct: 122 GMLRGIASGMRYLAE---MSYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEENSSDP 175
Query: 260 DIVGS------AYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKE 311
               S        + APE +  RK    SD WS G++ + ++  G RP+WD +   +   
Sbjct: 176 TETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINA 235
Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           +   + D+R  P P    S    +     KD  AR    Q +S
Sbjct: 236 I---EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVS 275

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 136/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 67  DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 120
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 121 HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 177
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 178 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRS 230
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF-----------------WDKTED-- 306
           Y++PE L+      +SD+WS+G+    +  GR P                   D  E   
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 290
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 291 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSAVFSLEFQDFVNKCLIKNPA 349
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 350 ERADLKQLMVHAFIKR-SDAEEV 371

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 136/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF-----------------WDKTED-- 306
           Y++PE L+      +SD+WS+G+    +  GR P                   D  E   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 288 ERADLKQLMVHAFIKR-SDAEEV 309

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 136/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF-----------------WDKTED-- 306
           Y++PE L+      +SD+WS+G+    +  GR P                   D  E   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 288 ERADLKQLMVHAFIKR-SDAEEV 309

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 136/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF-----------------WDKTED-- 306
           Y++PE L+      +SD+WS+G+    +  GR P                   D  E   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 288 ERADLKQLMVHAFIKR-SDAEEV 309

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 136/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF-----------------WDKTED-- 306
           Y++PE L+      +SD+WS+G+    +  GR P                   D  E   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 288 ERADLKQLMVHAFIKR-SDAEEV 309

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF+R       LG G  G       + +G  +A K I     I P     + RE+++L
Sbjct: 15  DDDFERISE----LGAGNGGVVTKVQHRPSGLIMARKLIHLE--IKPAIRNQIIRELQVL 68
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                   +V FY AF  D  + I ME  +GG  LD++L K+  R  E+    V   +LR
Sbjct: 69  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KEAKRIPEEILGKVSIAVLR 125
Query: 211 VAAEC-HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
             A     H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  Y+A
Sbjct: 126 GLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSYMA 181
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPF 300
           PE L+      +SD+WS+G+    L  GR P 
Sbjct: 182 PERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 126/296 (42%), Gaps = 63/296 (21%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQ 151
           R  + ++L  G F + Y A D  +G   A+K++     EKN+ I+        +EV  ++
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII--------QEVCFMK 80
Query: 152 ALAGHENVVKFYNAF-----EDDN---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
            L+GH N+V+F +A      E D       +  ELC+G   L   L K +SR       V
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ--LVEFLKKMESRGPLSCDTV 138
Query: 204 --VVRQMLRVAAECHLH----GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
             +  Q  R     H+H     ++HRD+K EN L  +     ++K  DFG +  I     
Sbjct: 139 LKIFYQTCRAVQ--HMHRQKPPIIHRDLKVENLLLSN---QGTIKLCDFGSATTIS---H 190
Query: 258 FQDIVGSA----------------YYVAPEVLKRKS----GPESDVWSIGVITYILLCGR 297
           + D   SA                 Y  PE++   S    G + D+W++G I Y+L   +
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
Query: 298 RPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            PF    EDG    ++  K  +   P  +        ++ +L  +P  RL+ A+ +
Sbjct: 251 HPF----EDGAKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 120/276 (43%), Gaps = 51/276 (18%)
Query: 118 KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-----ENVVKFYNAFEDDNYV 172
           K+N D++++K             +D K E++I+  +        E ++  Y+       V
Sbjct: 75  KSNNDKISIKS----------KYDDFKNELQIITDIKNEYCLTCEGIITNYDE------V 118
Query: 173 YIAMELCEGGELL--DRILAKKDSRYTEKDAAVVVRQMLR--VAAECHLHG---LVHRDM 225
           YI  E  E   +L  D      D  YT      V++ +++  + +  ++H    + HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 226 KPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS---GPESD 282
           KP N L     ++  +K +DFG S+++   KK +   G+  ++ PE    +S   G + D
Sbjct: 179 KPSNIL---MDKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK-------------PDFRRKPWPS--- 326
           +WS+G+  Y++     PF  K         +R K             P   +K   S   
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF 294
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG 362
           +SN   DF+K  L K+P  R+T+  AL H W+ +  
Sbjct: 295 LSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 123/304 (40%), Gaps = 61/304 (20%)
Query: 86  TDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
           T +  DK F   +   +L+G G FG  + A  + +G    +++++ N        E  +R
Sbjct: 2   TKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-------EKAER 54
Query: 146 EVKILQALAGHENVVKFYNAFEDDNY-----------------------------VYIAM 176
           EVK L  L  H N+V +   ++  +Y                             ++I M
Sbjct: 55  EVKALAKL-DHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQM 113
Query: 177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK 236
           E C+ G L   I  ++  +  +  A  +  Q+ +     H   L+HRD+KP N      K
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTK 173
Query: 237 EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILL- 294
           +   +K  DFGL   +K   K     G+  Y++PE +  +  G E D++++G+I   LL 
Sbjct: 174 Q---VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 230
Query: 295 -CG----RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA 349
            C        F+    DGI  ++   K               K  ++KLL K P  R   
Sbjct: 231 VCDTAFETSKFFTDLRDGIISDIFDKK--------------EKTLLQKLLSKKPEDRPNT 276
Query: 350 AQAL 353
           ++ L
Sbjct: 277 SEIL 280

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 104 LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG    Y Y  T+   G+ VAVK +++     P      +RE++IL+ L  HE++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREIEILRTLY-HEHI 72
Query: 160 VKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV--RQMLRVAAEC 215
           VK+    ED  +  V + ME    G L D +      R+    A +++  +Q+    A  
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYL 127
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----QDIVGSAYYVAPE 271
           H    +HR +   N L  +   D  +K  DFGL+  +  G ++    +D     ++ APE
Sbjct: 128 HAQHYIHRALAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 184
Query: 272 VLKR-KSGPESDVWSIGVITYILL 294
            LK  K    SDVWS GV  Y LL
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 104 LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG    Y Y  T+   G+ VAVK +++     P      +RE++IL+ L  HE++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREIEILRTLY-HEHI 73
Query: 160 VKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV--RQMLRVAAEC 215
           VK+    ED  +  V + ME    G L D +      R+    A +++  +Q+    A  
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYL 128
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----QDIVGSAYYVAPE 271
           H    +HR +   N L  +   D  +K  DFGL+  +  G ++    +D     ++ APE
Sbjct: 129 HAQHYIHRALAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 185
Query: 272 VLKR-KSGPESDVWSIGVITYILL 294
            LK  K    SDVWS GV  Y LL
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELL 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           RY     +G G +G  Y A D  +G  VA+K  ++   +  LPI+     REV +L+ L 
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST---VREVALLRRLE 61
Query: 155 G--HENVVKFYNAFEDDNY-----VYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVV 205
              H NVV+  +            V +  E  +      LD+         T KD   ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD---LM 118
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
           RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +V + 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALDPVVVTL 175
Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV-LRNKPD 318
           +Y APEVL + +     D+WS+G I +  +  R+P +    +      IF  + L  + D
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 234
Query: 319 FRR--------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           + R              +P     P +  S    + ++L  +P  R++A +AL H ++
Sbjct: 235 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           RY     +G G +G  Y A D  +G  VA+K  ++   +  LPI+     REV +L+ L 
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST---VREVALLRRLE 61
Query: 155 G--HENVVKFYNAFEDDNY-----VYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVV 205
              H NVV+  +            V +  E  +      LD+         T KD   ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD---LM 118
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
           RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +V + 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALAPVVVTL 175
Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV-LRNKPD 318
           +Y APEVL + +     D+WS+G I +  +  R+P +    +      IF  + L  + D
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 234
Query: 319 FRR--------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           + R              +P     P +  S    + ++L  +P  R++A +AL H ++
Sbjct: 235 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 136/300 (45%), Gaps = 55/300 (18%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + LG G++   + A +  N +RV VK ++  K       + +KREVKIL+ L G  
Sbjct: 40  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKK------KKIKREVKILENLRGGT 93
Query: 158 NVVKFYNAFED--DNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++K  +  +D       +  E     +   L +IL   D R+        + ++L+   
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRF-------YMYELLKALD 146
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH  G++HRD+KP N +    ++   L+  D+GL++F  P +++   V S Y+  PE+L
Sbjct: 147 YCHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 204
Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----------------GIFKEV-L 313
              +      D+WS+G +   ++  R PF+   ++                 G  K+  +
Sbjct: 205 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 264
Query: 314 RNKPDFR-------RKPWPS---------ISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
              P F        RK W +         +S  A D + KLL  D + RLTA +A+ HP+
Sbjct: 265 DLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 83/353 (23%), Positives = 139/353 (39%), Gaps = 100/353 (28%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-IAVEDVKREVKILQALAGH 156
           Y I  L+G G +GY Y+A DK     VA+KK+  N+M    I  + + RE+ IL  L   
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKV--NRMFEDLIDCKRILREITILNRLKS- 86
Query: 157 ENVVKFYNAFEDDNY-----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           + +++ ++    ++      +YI +E+ +      + L K     TE+    ++  +L  
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLEIADSDL---KKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK------------------ 253
               H  G++HRD+KP N L     +D S+K  DFGL+  I                   
Sbjct: 144 EKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENE 200
Query: 254 -PG-------KKFQDIVGSAYYVAPE--VLKRKSGPESDVWSIGVITYILL--------- 294
            PG       K+    V + +Y APE  +L+       D+WS G I   LL         
Sbjct: 201 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINN 260
Query: 295 -CGRRPFW---------------------DKTEDGIFKEVLRNKP--------------- 317
              R P +                     ++ +  I   V+   P               
Sbjct: 261 PTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKY 320
Query: 318 ----------DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                     D  +K + SIS    D ++ +L  + + R+T  +ALSHP++++
Sbjct: 321 IKLFPTRDGIDLSKK-YSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKD 372

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 31/273 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQALAGHEN 158
           +G G +G       K +G  +AVK+I     EK +  L + ++ V R        +    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS-------SDCPY 82
Query: 159 VVKFYNAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +V+FY A   +   +I MEL      +    + +  D    E+    +   +  V A  H
Sbjct: 83  IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT--LATVKALNH 140
Query: 217 LH---GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
           L     ++HRD+KP N L   +    ++K  DFG+S   +    K +D  G   Y+APE 
Sbjct: 141 LKENLKIIHRDIKPSNILLDRS---GNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPER 196
Query: 273 LKRKSGPE-----SDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWP 325
           +   +  +     SDVWS+G+  Y L  GR P+  W+   D + + V  + P        
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             S S  +FV   L KD   R    + L HP++
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 55/300 (18%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + LG G++   + A +  N +RV VK ++          + +KREVKIL+ L G  
Sbjct: 45  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPV------KKKKIKREVKILENLRGGT 98
Query: 158 NVVKFYNAFED--DNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++K  +  +D       +  E     +   L +IL   D R+        + ++L+   
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRF-------YMYELLKALD 151
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH  G++HRD+KP N +    ++   L+  D+GL++F  P +++   V S Y+  PE+L
Sbjct: 152 YCHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 209
Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----------------GIFKEV-L 313
              +      D+WS+G +   ++  R PF+   ++                 G  K+  +
Sbjct: 210 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 269
Query: 314 RNKPDFR-------RKPWPS---------ISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
              P F        RK W +         +S  A D + KLL  D + RLTA +A+ HP+
Sbjct: 270 DLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G+R    Y +       +   +G G FG  Y    K +GD VAVK I K     P   
Sbjct: 21  PRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVY--KGKWHGD-VAVK-ILKVVDPTPEQF 76
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           +  + EV +L+    H N++ F      DN + I  + CEG  L    L  +++++    
Sbjct: 77  QAFRNEVAVLRK-TRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKH-LHVQETKFQMFQ 133
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKK 257
              + RQ  +     H   ++HRDMK  N       E  ++K  DFGL+         ++
Sbjct: 134 LIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRWSGSQQ 190
Query: 258 FQDIVGSAYYVAPEVLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
            +   GS  ++APEV++ + + P   +SDV+S G++ Y L+ G  P+
Sbjct: 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           RY     +G G +G  Y A D  +G  VA+K  ++   +  LPI+     REV +L+ L 
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST---VREVALLRRLE 61
Query: 155 G--HENVVKFYNAFEDDNY-----VYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVV 205
              H NVV+  +            V +  E  +      LD+         T KD   ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD---LM 118
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
           RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +V + 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALFPVVVTL 175
Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV-LRNKPD 318
           +Y APEVL + +     D+WS+G I +  +  R+P +    +      IF  + L  + D
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 234
Query: 319 FRR--------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           + R              +P     P +  S    + ++L  +P  R++A +AL H ++
Sbjct: 235 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I +++G G+FG       K  G R   VA+K ++          E  +R+     ++ G 
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGY------TEKQRRDFLCEASIMGQ 100
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H NVV           V I +E  E G L D  L K D ++T      ++R +     
Sbjct: 101 FDHPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMR 159
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYVA 269
                G VHRD+   N L  S   +   K +DFGLS  I+  P   +    G     + A
Sbjct: 160 YLADMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTA 216
Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           PE ++ RK    SDVWS G++ + ++  G RP+WD +   + K +
Sbjct: 217 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 261

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/352 (23%), Positives = 143/352 (40%), Gaps = 74/352 (21%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G    F  +   D RY + + LG G F   ++A D  N   VA+K +  +K    +  
Sbjct: 4   PGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYT 59
Query: 141 EDVKREVKILQAL----------AGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRI 188
           E  + E+K+LQ +           G  +++K  + F  +  N V++ M     GE L  +
Sbjct: 60  EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 119
Query: 189 LAKKDSR-----YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL-- 241
           + K + R     Y ++ +  ++  +  +   C   G++H D+KPEN L +      +L  
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 176
Query: 242 -KATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRP 299
            K  D G + +    + + + + +  Y +PEVL     G  +D+WS   + + L+ G   
Sbjct: 177 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234
Query: 300 F-------WDKTEDGIFK--EVLRNKPDF----------------------RRKPWP--- 325
           F       + K +D I +  E+L   P +                      + K WP   
Sbjct: 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294
Query: 326 ----------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
                       +    DF+  +L  DPR R  A   ++HPW+++     EI
Sbjct: 295 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 346

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 127/301 (42%), Gaps = 49/301 (16%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE-----KNKMILPIAVEDVKREVKILQ 151
           RY     +G G +G  Y A D  +G  VA+K +           LPI+     REV +L+
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST---VREVALLR 66
Query: 152 ALAG--HENVVKFYNAFEDDNY-----VYIAMELCEGG--ELLDRILAKKDSRYTEKDAA 202
            L    H NVV+  +            V +  E  +      LD+         T KD  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD-- 124
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +V
Sbjct: 125 -LMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALTPVV 180
Query: 263 GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV-LRN 315
            + +Y APEVL + +     D+WS+G I +  +  R+P +    +      IF  + L  
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 316 KPDFRR--------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           + D+ R              +P     P +  S    + ++L  +P  R++A +AL H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 358 V 358
           +
Sbjct: 300 L 300

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 104 LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG    Y Y  T+   G+ VAVK ++ +    P      K+E+ IL+ L  HE++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLY-HEHI 78
Query: 160 VKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV--RQMLRVAAEC 215
           +K+    ED  +  + + ME    G L D +      R++   A +++  +Q+    A  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYL 133
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----QDIVGSAYYVAPE 271
           H    +HR++   N L  +   D  +K  DFGL+  +  G ++    +D     ++ APE
Sbjct: 134 HAQHYIHRNLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 272 VLKR-KSGPESDVWSIGVITYILL 294
            LK  K    SDVWS GV  Y LL
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELL 214

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/352 (23%), Positives = 143/352 (40%), Gaps = 74/352 (21%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G    F  +   D RY + + LG G F   ++A D  N   VA+K +  +K    +  
Sbjct: 4   PGGFHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYT 59
Query: 141 EDVKREVKILQAL----------AGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRI 188
           E  + E+K+LQ +           G  +++K  + F  +  N V++ M     GE L  +
Sbjct: 60  EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 119
Query: 189 LAKKDSR-----YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL-- 241
           + K + R     Y ++ +  ++  +  +   C   G++H D+KPEN L +      +L  
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 176
Query: 242 -KATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRP 299
            K  D G + +    + + + + +  Y +PEV L    G  +D+WS   + + L+ G   
Sbjct: 177 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234
Query: 300 F-------WDKTEDGIFK--EVLRNKPDF----------------------RRKPWP--- 325
           F       + K +D I +  E+L   P +                      + K WP   
Sbjct: 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294
Query: 326 ----------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
                       +    DF+  +L  DPR R  A   ++HPW+++     EI
Sbjct: 295 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 346

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 104 LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG    Y Y  T+   G+ VAVK ++ +    P      K+E+ IL+ L  HE++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLY-HEHI 78
Query: 160 VKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV--RQMLRVAAEC 215
           +K+    ED  +  + + ME    G L D +      R++   A +++  +Q+    A  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYL 133
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----QDIVGSAYYVAPE 271
           H    +HR++   N L  +   D  +K  DFGL+  +  G ++    +D     ++ APE
Sbjct: 134 HSQHYIHRNLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 272 VLKR-KSGPESDVWSIGVITYILL 294
            LK  K    SDVWS GV  Y LL
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G+ +G G FG  +  T+  N  +VA+K  E  +   P  + D  R  K+L    G  
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAP-QLRDEYRTYKLLAGCTGIP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           NV  F    ++  +  + ++L   G  L+ +L     +++ K  A+  +QML      H 
Sbjct: 69  NVYYF---GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 123
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYY 267
             LV+RD+KP+NFL    ++K  + +   DFG+  F +        P ++ +++ G+A Y
Sbjct: 124 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 183
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           ++    L R+     D+ ++G +    L G  P+
Sbjct: 184 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 217

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 27/242 (11%)
Query: 72  NSRRQTGVIPCGKRTDFGYDKD-----------FDRRYTIGKLLGHGQFGYTYVATDKAN 120
           N++++ G+   G   + GYD D              RY + K++G G FG    A D   
Sbjct: 64  NAKKRQGMT--GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKV 121
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----NVVKFYNAFEDDNYVYIA 175
              VA+K +   K     A E    E++IL+ L   +     NV+     F   N++ + 
Sbjct: 122 HQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177
Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
            EL     L + I   K   ++          +L+     H + ++H D+KPEN L K  
Sbjct: 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ- 235
Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILL 294
           +  S +K  DFG S +    ++    + S +Y APEV L  + G   D+WS+G I   LL
Sbjct: 236 QGRSGIKVIDFGSSCYEH--QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 295 CG 296
            G
Sbjct: 294 TG 295

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G+ +G G FG  +  T+  N  +VA+K  E  +   P  + D  R  K+L    G  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAP-QLRDEYRTYKLLAGCTGIP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           NV  F    ++  +  + ++L   G  L+ +L     +++ K  A+  +QML      H 
Sbjct: 70  NVYYF---GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYY 267
             LV+RD+KP+NFL    ++K  + +   DFG+  F +        P ++ +++ G+A Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           ++    L R+     D+ ++G +    L G  P+
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 27/238 (11%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I +++G G+FG       K  G R   VA+K ++          E  +R+     ++ G 
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY------TEKQRRDFLSEASIMGQ 90
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H NV+           V I  E  E G L D  L + D ++T      ++R +     
Sbjct: 91  FDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK---PGKKFQDIVGSAY---Y 267
                  VHRD+   N L  S   +   K +DFGLS F++       +   +G      +
Sbjct: 150 YLADMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 206
Query: 268 VAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            APE ++ RK    SDVWS G++ + ++  G RP+WD T   +   +   + D+R  P
Sbjct: 207 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPP 261

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 27/242 (11%)
Query: 72  NSRRQTGVIPCGKRTDFGYDKD-----------FDRRYTIGKLLGHGQFGYTYVATDKAN 120
           N++++ G+   G   + GYD D              RY + K++G G FG    A D   
Sbjct: 64  NAKKRQGMT--GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKV 121
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----NVVKFYNAFEDDNYVYIA 175
              VA+K +   K     A E    E++IL+ L   +     NV+     F   N++ + 
Sbjct: 122 HQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177
Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
            EL     L + I   K   ++          +L+     H + ++H D+KPEN L K  
Sbjct: 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ- 235
Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILL 294
           +  S +K  DFG S +    ++    + S +Y APEV L  + G   D+WS+G I   LL
Sbjct: 236 QGRSGIKVIDFGSSCYEH--QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 295 CG 296
            G
Sbjct: 294 TG 295

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 27/242 (11%)
Query: 72  NSRRQTGVIPCGKRTDFGYDKD-----------FDRRYTIGKLLGHGQFGYTYVATDKAN 120
           N++++ G+   G   + GYD D              RY + K++G G FG    A D   
Sbjct: 64  NAKKRQGMT--GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKV 121
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----NVVKFYNAFEDDNYVYIA 175
              VA+K +   K     A E    E++IL+ L   +     NV+     F   N++ + 
Sbjct: 122 HQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177
Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
            EL     L + I   K   ++          +L+     H + ++H D+KPEN L K  
Sbjct: 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ- 235
Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILL 294
           +  S +K  DFG S +    ++    + S +Y APEV L  + G   D+WS+G I   LL
Sbjct: 236 QGRSGIKVIDFGSSCYEH--QRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 295 CG 296
            G
Sbjct: 294 TG 295

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK-MILPIAVEDVKREVKILQALAGHE 157
           T+ +++G G FG  Y A     GD VAVK    +    +   +E+V++E K+  A+  H 
Sbjct: 10  TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLF-AMLKHP 66
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQMLRVAAECH 216
           N++        +  + + ME   GG L +R+L+ K+       + AV + + +    +  
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSL-----KATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
           +  ++HRD+K  N L     E+  L     K TDFGL+       K     G+  ++APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPE 184
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPF 300
           V++       SDVWS GV+ + LL G  PF
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 104 LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG    Y Y  T+   G+ VAVK ++ +    P      K+E+ IL+ L  HE++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEIDILRTLY-HEHI 95
Query: 160 VKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV--RQMLRVAAEC 215
           +K+    ED     + + ME    G L D +      R++   A +++  +Q+    A  
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----QDIVGSAYYVAPE 271
           H    +HRD+   N L  +   D  +K  DFGL+  +  G +     +D     ++ APE
Sbjct: 151 HAQHYIHRDLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 272 VLKR-KSGPESDVWSIGVITYILL 294
            LK  K    SDVWS GV  Y LL
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELL 231

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHE 157
           + +++G G FG   V   K     VA+K+IE         VE        L+ L+   H 
Sbjct: 13  VEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVE--------LRQLSRVNHP 62
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQMLRVAAECH 216
           N+VK Y A    N V + ME  EGG L + +  A+    YT   A     Q  +  A  H
Sbjct: 63  NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 217 LH---GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
                 L+HRD+KP N L  +    + LK  DFG +  I+      +  GSA ++APEV 
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVF 176
Query: 274 KRKSGPE-SDVWSIGVITYILLCGRRPF 300
           +  +  E  DV+S G+I + ++  R+PF
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G+ +G G FG  Y+ TD A G+ VA+K +E  K   P     +  E KI + + G 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHP----QLHIESKIYKMMQGG 62
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL   G  L+ +      +++ K   ++  QM+      H
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           +    L  +     D+ S+G +      G  P+
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHE 157
           + +++G G FG   V   K     VA+K+IE         VE        L+ L+   H 
Sbjct: 12  VEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVE--------LRQLSRVNHP 61
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQMLRVAAECH 216
           N+VK Y A    N V + ME  EGG L + +  A+    YT   A     Q  +  A  H
Sbjct: 62  NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 217 LH---GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
                 L+HRD+KP N L  +    + LK  DFG +  I+      +  GSA ++APEV 
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVF 175
Query: 274 KRKSGPE-SDVWSIGVITYILLCGRRPF 300
           +  +  E  DV+S G+I + ++  R+PF
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G+ +G G FG  Y+ TD A G+ VA+K +E  K   P     +  E KI + + G 
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHP----QLHIESKIYKMMQGG 64
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL   G  L+ +      +++ K   ++  QM+      H
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           +    L  +     D+ S+G +      G  P+
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQALAG 155
           G++LG G FG     T +  G+ + +K++     E  +  L        +EVK+++ L  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL--------KEVKVMRCLE- 65
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H NV+KF      D  +    E  +GG L   I+   DS+Y         + +    A  
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI--------------KPG-KKFQD 260
           H   ++HRD+   N L    +E+ ++   DFGL+  +              KP  KK   
Sbjct: 125 HSMNIIHRDLNSHNCL---VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 261 IVGSAYYVAPEVLKRKSGPES-DVWSIGVI 289
           +VG+ Y++APE++  +S  E  DV+S G++
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 111/256 (43%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI ME    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVMEYMSKGCLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 46/237 (19%)
Query: 104 LGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G F   Y+AT +      +++A+K +      + IA E     ++ L    G +NV+
Sbjct: 29  IGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAE-----LQCLTVAGGQDNVM 83
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
                F  +++V IAM   E    LD +     +  + ++    +  + +     H  G+
Sbjct: 84  GVKYCFRKNDHVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGI 138
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSD-----------FIKPGKKFQDI-------- 261
           VHRD+KP NFL+    +  +L   DFGL+            F++   + +          
Sbjct: 139 VHRDVKPSNFLYNRRLKKYAL--VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSIC 196
Query: 262 ----------VGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTED 306
                      G+  + APEVL +     +  D+WS GVI   LL GR PF+  ++D
Sbjct: 197 LSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 51/291 (17%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG    A +  +    A+KKI   +  L   +     EV +L +L  H+ VV++
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS----EVXLLASL-NHQYVVRY 67
Query: 163 YNAF-EDDNYV------------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           Y A+ E  N+V            +I  E CE   L D I ++  ++  + +   + RQ+L
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD-EYWRLFRQIL 126
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFIK------PGK 256
              +  H  G++HR++KP N       E  ++K  DFGL+       D +K      PG 
Sbjct: 127 EALSYIHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 257 --KFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
                  +G+A YVA EVL        + D +S+G+I +  +    PF    E     + 
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILKK 240
Query: 313 LRN-----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           LR+      PDF            K  ++ L+  DP  R  A   L+  W+
Sbjct: 241 LRSVSIEFPPDFDDNK----XKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           TI +++G G+FG       K  G R   VA+K +     EK +        D   E  I+
Sbjct: 25  TIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR-------RDFLGEASIM 77
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N++           V I  E  E G L D  L K D ++T      ++R +  
Sbjct: 78  GQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISA 135
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 136 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 192
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + APE +  RK    SDVWS G++ + ++  G RP+W+ T   + K V
Sbjct: 193 WTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAV 240

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 111/256 (43%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI +E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVIEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 111/256 (43%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI +E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVIEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEXTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 120/282 (42%), Gaps = 35/282 (12%)
Query: 89  GYDKDFD---RRYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           G  +D++    R  +G+ +G GQFG  +  +     N       K  KN         D 
Sbjct: 3   GSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDS 56
Query: 144 KREVKILQALA----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK 199
            RE  + +AL      H ++VK       +N V+I MELC  GEL   +  +K   Y+  
Sbjct: 57  VREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLD 112
Query: 200 DAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
            A++++       A  +L     VHRD+   N L  S   +  +K  DFGLS +++    
Sbjct: 113 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTY 169
Query: 258 FQDIVG--SAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVL 313
           ++   G     ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   + 
Sbjct: 170 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 229
Query: 314 RNKPDFRRKPW-PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
             +    R P  P+   +    + K    DP  R R T  +A
Sbjct: 230 NGE----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 267

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 86
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 203
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 93  DFDRR--YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----E 146
           +FD R     G  +G G FG  Y      N   VAVKK+     ++ I  E++K+    E
Sbjct: 26  NFDERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAA---MVDITTEELKQQFDQE 80
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +K++ A   HEN+V+      D + + +       G LLDR+     +          + 
Sbjct: 81  IKVM-AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA 139
Query: 207 QMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----- 260
           Q         H +  +HRD+K  N L   A    + K +DFGL+   +  +KF       
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLA---RASEKFAQTVMXX 193
Query: 261 -IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG 296
            IVG+  Y+APE L+ +  P+SD++S GV+   ++ G
Sbjct: 194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 120/297 (40%), Gaps = 35/297 (11%)
Query: 67  QHQKTNSRRQTGVIPCGKRTDFGYDKDF----DRRYTIGKLLGHGQFGYTYVATDKANGD 122
           +H      R T V P  K    G  KD          +   LG G FG  ++ T   NG 
Sbjct: 152 KHADGLCHRLTNVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGT--WNGT 209
Query: 123 -RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG 181
            RVA+K ++   M    + E   +E ++++ L  HE +V+ Y    ++  +YI  E    
Sbjct: 210 TRVAIKTLKPGNM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSK 263
Query: 182 GELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           G LLD  L  +  +Y      V +  Q+    A       VHRD++  N L     E+  
Sbjct: 264 GSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL---VGENLV 319
Query: 241 LKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGV-ITY 291
            K  DFGL   I       + G KF        + APE  L  +   +SDVWS G+ +T 
Sbjct: 320 CKVADFGLGRLIEDNEYTARQGAKF-----PIKWTAPEAALYGRFTIKSDVWSFGILLTE 374
Query: 292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT 348
           +   GR P+       +  +V R    +R    P    S  D + +   KDP  R T
Sbjct: 375 LTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKDPEERPT 428

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 64
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 120
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 233
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 264

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVCEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 93  DFDRR--YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----E 146
           +FD R     G  +G G FG  Y      N   VAVKK+     ++ I  E++K+    E
Sbjct: 26  NFDERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAA---MVDITTEELKQQFDQE 80
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +K++ A   HEN+V+      D + + +       G LLDR+     +          + 
Sbjct: 81  IKVM-AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA 139
Query: 207 QMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----- 260
           Q         H +  +HRD+K  N L   A    + K +DFGL+   +  +KF       
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLA---RASEKFAQTVMXS 193
Query: 261 -IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG 296
            IVG+  Y+APE L+ +  P+SD++S GV+   ++ G
Sbjct: 194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 93  DFDRR--YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----E 146
           +FD R     G  +G G FG  Y      N   VAVKK+     ++ I  E++K+    E
Sbjct: 20  NFDERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAA---MVDITTEELKQQFDQE 74
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +K++ A   HEN+V+      D + + +       G LLDR+     +          + 
Sbjct: 75  IKVM-AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA 133
Query: 207 QMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----- 260
           Q         H +  +HRD+K  N L   A    + K +DFGL+   +  +KF       
Sbjct: 134 QGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLA---RASEKFAQXVMXX 187
Query: 261 -IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG 296
            IVG+  Y+APE L+ +  P+SD++S GV+   ++ G
Sbjct: 188 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 92
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 93  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 148
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 149 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 261
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 262 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 292

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 27/238 (11%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I +++G G+FG       K  G R   VA+K ++          E  +R+     ++ G 
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY------TEKQRRDFLSEASIMGQ 64
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H NV+           V I  E  E G L D  L + D ++T      ++R +     
Sbjct: 65  FDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK---PGKKFQDIVGSAY---Y 267
                  VHR +   N L  S   +   K +DFGLS F++       +   +G      +
Sbjct: 124 YLADMNYVHRALAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 180
Query: 268 VAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            APE ++ RK    SDVWS G++ + ++  G RP+WD T   +   +   + D+R  P
Sbjct: 181 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPP 235

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 61
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 62  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 117
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 230
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 64
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 120
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 233
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 264

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 120/292 (41%), Gaps = 51/292 (17%)
Query: 38  NHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRR 97
           +H A     H    QH       +  + KQH   +S + T  +P         D     R
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQH---HSSKPTASMPRPHS-----DWQIPDR 54
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I  L+G G +G+   A DK     VA+KKI +    L I  + + RE+ IL  L  H+
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL-IDCKRILREIAILNRL-NHD 112
Query: 158 NVVKFYNA-----FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +VVK  +       E  + +Y+ +E+ +      + L +     TE     ++  +L   
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDF---KKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPG-------------- 255
              H  G++HRD+KP N L     +D S+K  DFGL+   D+ + G              
Sbjct: 170 KYVHSAGILHRDLKPANCL---VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 256 -----------KKFQDIVGSAYYVAPE--VLKRKSGPESDVWSIGVITYILL 294
                      ++    V + +Y APE  +L+       DVWSIG I   LL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 15  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 67
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 68  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 125
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 126 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 177
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 234
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 235 DLMCQCWRKDPEERPT 250

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 17  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 69
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 70  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 128 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 179
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 236
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 237 DLMCQCWRKDPEERPT 252

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 66
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 67  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 122
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 123 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           ++APE +  R+    SDVW  GV  + IL+ G +PF
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 69
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 70  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 125
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 238
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 192 LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 244
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 245 YAVVSEEP-IYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 303 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 354
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 411
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 412 DLMCQCWRKEPEERPT 427

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 112/252 (44%), Gaps = 23/252 (9%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 275 LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 327
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y A   +  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 328 Y-AVVSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 385
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV-LKRKS 277
           HRD++  N L     E+   K  DFGL+  I+   ++    G+ +   + APE  L  + 
Sbjct: 386 HRDLRAANIL---VGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 278 GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  D + 
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMC 498
Query: 337 KLLVKDPRARLT 348
           +   K+P  R T
Sbjct: 499 QCWRKEPEERPT 510

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 71
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 188
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 121/297 (40%), Gaps = 35/297 (11%)
Query: 67  QHQKTNSRRQTGVIPCGKRTDFGYDKDF----DRRYTIGKLLGHGQFGYTYVATDKANGD 122
           +H      R T V P  K    G  KD          +   LG G FG  ++ T   NG 
Sbjct: 151 KHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGT--WNGT 208
Query: 123 -RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG 181
            RVA+K ++   M    + E   +E ++++ L  HE +V+ Y    ++  +YI  E    
Sbjct: 209 TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSK 262
Query: 182 GELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           G LLD  L  +  +Y      V +  Q+    A       VHRD++  N L     E+  
Sbjct: 263 GSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL---VGENLV 318
Query: 241 LKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGV-ITY 291
            K  DFGL+  I       + G KF        + APE  L  +   +SDVWS G+ +T 
Sbjct: 319 CKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAALYGRFTIKSDVWSFGILLTE 373
Query: 292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT 348
           +   GR P+       +  +V R    +R    P    S  D + +   K+P  R T
Sbjct: 374 LTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERPT 427

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 18  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 75
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 192
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 252

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 21  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 78
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 79  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 195
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 255

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 109/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD+   N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLAAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ +  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKIR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVTEYMSKGCLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 22  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 79
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 196
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 256

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 28/251 (11%)
Query: 78  GVIPCGK-RTDFGYDKDFD-RRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKI--- 129
           G++P G  +T   + K+ D    +I K++G G+FG       K    +   VA+K +   
Sbjct: 13  GLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 72
Query: 130 --EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDR 187
             EK +        D   E  I+     H N+++          V I  E  E G L D 
Sbjct: 73  YTEKQR-------RDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DS 123
Query: 188 ILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG 247
            L K D+++T      ++R +          G VHRD+   N L  S   +   K +DFG
Sbjct: 124 FLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFG 180
Query: 248 LSDFIK--PGKKFQDIVG--SAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFW 301
           LS  ++  P   +    G     + +PE +  RK    SDVWS G++ + ++  G RP+W
Sbjct: 181 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 240
Query: 302 DKTEDGIFKEV 312
           + +   + K V
Sbjct: 241 EMSNQDVIKAV 251

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 127
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 244
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 86
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 203
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I  L+G G FG    A D+   + VA+K I+  K  L       + EV++L+ +  H
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL----NQAQIEVRLLELMNKH 110
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDR----ILAKKDSR-----YTEKDAAVVVRQ 207
           +  +K+Y      ++++    LC   E+L      +L   + R      T K A  +   
Sbjct: 111 DTEMKYYIVHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L +A       ++H D+KPEN L  + K  S++K  DFG S   + G++    + S +Y
Sbjct: 170 LLFLATP--ELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS--CQLGQRIYQXIQSRFY 224
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTE 305
            +PEV L        D+WS+G I   +  G   F    E
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I  L+G G FG    A D+   + VA+K I+  K  L       + EV++L+ +  H
Sbjct: 36  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL----NQAQIEVRLLELMNKH 91
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDR----ILAKKDSR-----YTEKDAAVVVRQ 207
           +  +K+Y      ++++    LC   E+L      +L   + R      T K A  +   
Sbjct: 92  DTEMKYYIVHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 150
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L +A       ++H D+KPEN L  + K  S++K  DFG S   + G++    + S +Y
Sbjct: 151 LLFLATP--ELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS--CQLGQRIYQXIQSRFY 205
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTE 305
            +PEV L        D+WS+G I   +  G   F    E
Sbjct: 206 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 19  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 71
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 72  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 129
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 130 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 181
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 238
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 239 DLMCQCWRKEPEERPT 254

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 192 LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 244
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 245 YAVVSEEP-IYIVGEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 303 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 354
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 411
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 412 DLMCQCWRKEPEERPT 427

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 86
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 203
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 31/245 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDR----VAVKKI-----EKNKMILPIAVEDVKREVKILQA 152
           K++G G+FG  Y    K +  +    VA+K +     EK ++       D   E  I+  
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-------DFLGEAGIMGQ 102
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
            + H N+++          + I  E  E G L D+ L +KD  ++      ++R +    
Sbjct: 103 FS-HHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                   VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 161 KYLANMNYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           APE +  RK    SDVWS G++ + ++  G RP+W+ +      EV++   D  R P P 
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAINDGFRLPTPM 273
Query: 327 ISNSA 331
              SA
Sbjct: 274 DCPSA 278

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 444
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   ++   A++++     
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 613
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 86
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 203
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 130
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L   I  K+     E  A   + Q L      H   ++H 
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 188
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQD---IVGSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P   GK       I G+  ++APE V+ + 
Sbjct: 189 DVKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 277 SGPESDVWSIGVITYILLCGRRPF 300
              + D+WS   +   +L G  P+
Sbjct: 247 CDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 23  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 75
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 76  YAVVSEEP-IYIVTEYMNKGSLLD-FLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 134 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 185
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 242
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 243 DLMCQCWRKEPEERPT 258

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 23  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 75
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 76  YAVVSEEP-IYIVTEYMNKGSLLD-FLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 134 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEWTARQGAKF-----PIKWTAPEAAL 185
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 242
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 243 DLMCQCWRKEPEERPT 258

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 17/257 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +++ +++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTG 248
Query: 158 N---VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 306
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
            H   +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL
Sbjct: 307 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 361
Query: 274 KRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           ++    +S  D +S+G + + LL G  PF   KT+D    E+ R       +   S S  
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPE 419
Query: 331 AKDFVKKLLVKDPRARL 347
            +  ++ LL +D   RL
Sbjct: 420 LRSLLEGLLQRDVNRRL 436

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD  ++    R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 33  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 90
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 91  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 148
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 149 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 207
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 208 --KICDFGLARHIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 295 -CGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 265 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 320

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI +E    G LLD +   ++    E +A V++    ++++          
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 138 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 17/257 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +++ +++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTG 249
Query: 158 N---VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 307
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
            H   +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL
Sbjct: 308 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 362
Query: 274 KRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           ++    +S  D +S+G + + LL G  PF   KT+D    E+ R       +   S S  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPE 420
Query: 331 AKDFVKKLLVKDPRARL 347
            +  ++ LL +D   RL
Sbjct: 421 LRSLLEGLLQRDVNRRL 437

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 17/257 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +++ +++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTG 249
Query: 158 N---VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 307
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
            H   +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL
Sbjct: 308 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 362
Query: 274 KRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           ++    +S  D +S+G + + LL G  PF   KT+D    E+ R       +   S S  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPE 420
Query: 331 AKDFVKKLLVKDPRARL 347
            +  ++ LL +D   RL
Sbjct: 421 LRSLLEGLLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 17/257 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +++ +++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTG 249
Query: 158 N---VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 307
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
            H   +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL
Sbjct: 308 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 362
Query: 274 KRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           ++    +S  D +S+G + + LL G  PF   KT+D    E+ R       +   S S  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPE 420
Query: 331 AKDFVKKLLVKDPRARL 347
            +  ++ LL +D   RL
Sbjct: 421 LRSLLEGLLQRDVNRRL 437

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 64
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   ++   A++++     
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++     +   G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           ++APE +  R+    SDVW  GV  + IL+ G +PF
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 100
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 159 GMKYLSDMGFVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  YV   K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 94
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E  A V++    ++++          
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYL---RECNREEVTAVVLLYMATQISSAMEYLEKKNF 151
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLKRKS 277
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   +
Sbjct: 152 IHRDLAARNCL---VGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNT 207
Query: 278 -GPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 73
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E  A V++    ++++          
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  F    G+ +   + APE L   K
Sbjct: 131 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNK 186
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 38/234 (16%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 100
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---- 266
                   G VHRD+   N L  S   +   K +DFGL      G+  +D   +AY    
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGL------GRVLEDDPEAAYTTRG 209
Query: 267 ------YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
                 + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 76
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 134 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNK 189
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 77
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 135 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNK 190
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 84  KRTDFGYDKDFDRR------YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           K T +G   ++D+        T+   LG GQ+G  Y    K     VAVK ++++ M   
Sbjct: 241 KPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--- 297
Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
             VE+  +E  +++ +  H N+V+       +   YI  E    G LLD +   ++    
Sbjct: 298 -EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ 352
Query: 198 EKDAAVVVRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
           E +A V++    ++++          +HR++   N L     E+  +K  DFGLS  +  
Sbjct: 353 EVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL---VGENHLVKVADFGLSRLMT- 408
Query: 255 GKKFQDIVGSAY---YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           G  +    G+ +   + APE L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 409 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 138 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 133 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 87  DFGYDK-DFDRR-YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
           D  YDK + +R   T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  
Sbjct: 4   DPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFL 59
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           +E  +++ +  H N+V+       +   YI  E    G LLD +   ++    E +A V+
Sbjct: 60  KEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVL 115
Query: 205 VRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           +    ++++          +HRD+   N L     E+  +K  DFGLS  +  G  +   
Sbjct: 116 LYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAH 171
Query: 262 VGSAY---YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
            G+ +   + APE L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 79
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 137 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLSDFIKPGKKFQDIVGS---AYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+  I     +++         ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 100
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 133 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI +E    G LLD +   ++    E  A V++    ++++          
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 133 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 64
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   ++   A++++     
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  +      +K  DFGLS +++    ++   G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSAT---DCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           ++APE +  R+    SDVW  GV  + IL+ G +PF
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 100
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 159 GMKYLSDMGAVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 100
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 46  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 98
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 99  GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 156
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 157 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 261

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI +E    G LLD +   ++    E  A V++    ++++          
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 133 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 100
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 118/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDK--DFDR-RYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD   +F R R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 10  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 67
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 68  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 184
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 185 --KICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 295 -CGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 242 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 100
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 100
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I  L+G G FG    A D+   + VA+K I+  K  L       + EV++L+ +  H
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL----NQAQIEVRLLELMNKH 110
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDR----ILAKKDSR-----YTEKDAAVVVRQ 207
           +  +K+Y      ++++    LC   E+L      +L   + R      T K A  +   
Sbjct: 111 DTEMKYYIVHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L +A       ++H D+KPEN L  + K   ++K  DFG S   + G++    + S +Y
Sbjct: 170 LLFLATP--ELSIIHCDLKPENILLCNPKR-XAIKIVDFGSS--CQLGQRIYQXIQSRFY 224
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTE 305
            +PEV L        D+WS+G I   +  G   F    E
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD  ++    R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 28  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 85
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 86  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 143
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 144 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 202
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 203 --KICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 295 -CGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 260 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 315

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 88
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 146 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 201
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 202 FSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 55/254 (21%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            +G+ +G G FG  +    +A+   VAVK   +   + P       +E +IL+  + H N
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPN 173
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ----MLRVAAE 214
           +V+          +YI MEL +GG+ L   L  + +R   K    +V      M  + ++
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY-------- 266
           C     +HRD+   N L     E + LK +DFG+S      ++  D V +A         
Sbjct: 233 C----CIHRDLAARNCL---VTEKNVLKISDFGMS------REEADGVXAASGGLRQVPV 279
Query: 267 -YVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
            + APE L   +   ESDVWS G++           W+    G               P+
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGIL----------LWETFSLGA-------------SPY 316
Query: 325 PSISN-SAKDFVKK 337
           P++SN   ++FV+K
Sbjct: 317 PNLSNQQTREFVEK 330

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD  ++    R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 33  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 90
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 91  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 148
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 149 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 207
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 208 --KICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 295 -CGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 265 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 320

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 71
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 72  GQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 71
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 72  GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 77
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 135 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 190
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 18  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 127
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 128 IHRDLAARNCL---VGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 183
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 93  DFDRR--YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----E 146
           +FD R     G   G G FG  Y      N   VAVKK+     ++ I  E++K+    E
Sbjct: 17  NFDERPISVGGNKXGEGGFGVVYKGY--VNNTTVAVKKL---AAMVDITTEELKQQFDQE 71
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +K+  A   HEN+V+      D + + +       G LLDR+     +          + 
Sbjct: 72  IKV-XAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIA 130
Query: 207 QMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----- 260
           Q         H +  +HRD+K  N L   A    + K +DFGL+   +  +KF       
Sbjct: 131 QGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLA---RASEKFAQXVXXS 184
Query: 261 -IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG 296
            IVG+  Y APE L+ +  P+SD++S GV+   ++ G
Sbjct: 185 RIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 444
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   ++   A++++     
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  +      +K  DFGLS +++    ++   G     
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSAT---DCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           ++APE +  R+    SDVW  GV  + IL+ G +PF
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+ K LG GQFG   +   K   D VAVK I++  M    + ++  +E + +  L+ H  
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPK 64
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHL 217
           +VKFY     +  +YI  E    G LL+ +  +   +  E    + +   +    A    
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK 274
           H  +HRD+   N L      D  +K +DFG++ ++    ++   VG+ +   + APEV  
Sbjct: 123 HQFIHRDLAARNCL---VDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFH 178
Query: 275 R-KSGPESDVWSIGVITY-ILLCGRRPF 300
             K   +SDVW+ G++ + +   G+ P+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 129
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 246
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 307 PGIPVEELFK 316

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L   I  K+     E  A   + Q L      H   ++H 
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQD---IVGSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P   GK       I G+  ++APE V+ + 
Sbjct: 175 DVKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 277 SGPESDVWSIGVITYILLCGRRPF 300
              + D+WS   +   +L G  P+
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 26/231 (11%)
Query: 84  KRTDFGYDKDFDRR------YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           K T +G   ++D+        T+   LG GQ+G  Y    K     VAVK ++++ M   
Sbjct: 202 KPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--- 258
Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
             VE+  +E  +++ +  H N+V+       +   YI  E    G LLD +   ++    
Sbjct: 259 -EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ 313
Query: 198 EKDAAVVVRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
           E  A V++    ++++          +HR++   N L     E+  +K  DFGLS  +  
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL---VGENHLVKVADFGLSRLMT- 369
Query: 255 GKKFQDIVGSAY---YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           G  +    G+ +   + APE L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 15  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 124
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 125 IHRDLAARNCL---VGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD  ++    R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 26  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 83
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 84  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 141
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 142 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 200
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 201 --KICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 295 -CGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 258 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 313

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 132
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L   I  K+     E  A   + Q L      H   ++H 
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 190
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQD---IVGSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P   GK       I G+  ++APE V+ + 
Sbjct: 191 DVKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 248
Query: 277 SGPESDVWSIGVITYILLCGRRPF 300
              + D+WS   +   +L G  P+
Sbjct: 249 CDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 138 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 13  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 66
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 122
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 123 IHRDLAARNCL---VGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I K++G G+FG       K  G R   VA+K ++          +  +R+     ++ G 
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG------YTDKQRRDFLSEASIMGQ 86
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++           V I  E  E G L D  L K D R+T      ++R +     
Sbjct: 87  FDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYVA 269
                  VHRD+   N L  S   +   K +DFG+S  ++  P   +    G     + A
Sbjct: 146 YLSDMSAVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 202
Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           PE +  RK    SDVWS G++ + ++  G RP+WD +   + K +
Sbjct: 203 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 247

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I K++G G+FG       K  G R   VA+K ++          +  +R+     ++ G 
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG------YTDKQRRDFLSEASIMGQ 71
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++           V I  E  E G L D  L K D R+T      ++R +     
Sbjct: 72  FDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYVA 269
                  VHRD+   N L  S   +   K +DFG+S  ++  P   +    G     + A
Sbjct: 131 YLSDMSYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 187
Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           PE +  RK    SDVWS G++ + ++  G RP+WD +   + K +
Sbjct: 188 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 232

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E  A V++    ++++          
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 133 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 16  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 125
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 126 IHRDLAARNCL---VGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I K++G G+FG       K  G R   VA+K ++          +  +R+     ++ G 
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG------YTDKQRRDFLSEASIMGQ 65
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++           V I  E  E G L D  L K D R+T      ++R +     
Sbjct: 66  FDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYVA 269
                  VHRD+   N L  S   +   K +DFG+S  ++  P   +    G     + A
Sbjct: 125 YLSDMSYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 181
Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           PE +  RK    SDVWS G++ + ++  G RP+WD +   + K +
Sbjct: 182 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E  A V++    ++++          
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 133 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 36/275 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG  +    + +G   A+K+  K  +   +  ++  REV     L  H +VV+++
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R     H   LV
Sbjct: 76  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 222 HRDMKPEN-FLFKSAKEDSSLKATD----------FGLSDF--IKPGKKFQDIVGSAYYV 268
           H D+KP N F+ +++  +++ +  D          F + D   +      Q   G + ++
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 195
Query: 269 APEVLKRKSG--PESDVWSIGVITYILLCGRRPF------WDKTEDGIFKEVLRNKPDFR 320
           A EVL+      P++D++++  +T +   G  P       W +   G    + +      
Sbjct: 196 ANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQ------ 248
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                 +S    + +K ++  DP  R +A   + H
Sbjct: 249 -----VLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 55/254 (21%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            +G+ +G G FG  +    +A+   VAVK   +   + P       +E +IL+  + H N
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPN 173
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ----MLRVAAE 214
           +V+          +YI MEL +GG+ L   L  + +R   K    +V      M  + ++
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY-------- 266
           C     +HRD+   N L     E + LK +DFG+S      ++  D V +A         
Sbjct: 233 C----CIHRDLAARNCL---VTEKNVLKISDFGMS------REEADGVYAASGGLRQVPV 279
Query: 267 -YVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
            + APE L   +   ESDVWS G++           W+    G               P+
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGIL----------LWETFSLGA-------------SPY 316
Query: 325 PSISN-SAKDFVKK 337
           P++SN   ++FV+K
Sbjct: 317 PNLSNQQTREFVEK 330

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEED 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 36/275 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG  +    + +G   A+K+  K  +   +  ++  REV     L  H +VV+++
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R     H   LV
Sbjct: 76  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 222 HRDMKPEN-FLFKSAKEDSSLKATD----------FGLSDF--IKPGKKFQDIVGSAYYV 268
           H D+KP N F+ +++  +++ +  D          F + D   +      Q   G + ++
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 195
Query: 269 APEVLKRKSG--PESDVWSIGVITYILLCGRRPF------WDKTEDGIFKEVLRNKPDFR 320
           A EVL+      P++D++++  +T +   G  P       W +   G    + +      
Sbjct: 196 ANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQ------ 248
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                 +S    + +K ++  DP  R +A   + H
Sbjct: 249 -----VLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E  A V++    ++++          
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNF 137
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 138 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 36/275 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG  +    + +G   A+K+  K  +   +  ++  REV     L  H +VV+++
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R     H   LV
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 137
Query: 222 HRDMKPEN-FLFKSAKEDSSLKATD----------FGLSDF--IKPGKKFQDIVGSAYYV 268
           H D+KP N F+ +++  +++ +  D          F + D   +      Q   G + ++
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 197
Query: 269 APEVLKRKSG--PESDVWSIGVITYILLCGRRPF------WDKTEDGIFKEVLRNKPDFR 320
           A EVL+      P++D++++  +T +   G  P       W +   G    + +      
Sbjct: 198 ANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQ------ 250
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                 +S    + +K ++  DP  R +A   + H
Sbjct: 251 -----VLSQEFTELLKVMIHPDPERRPSAMALVKH 280

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 18  EFPRDKLTLGKPLGEGCFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 70
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 71  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 130
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 131 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVL---VTENNVMKIAD 187
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 188 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 248 PGIPVEELFK 257

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I++  M    + +D   E +++  L+ H  +V+ Y
Sbjct: 35  IGSGQFGLVHLGY-WLNKDKVAIKTIKEGSM----SEDDFIEEAEVMMKLS-HPKLVQLY 88
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 144
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 145 IHRDLAARNCL---VGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSR 200
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 237

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y +G+ +G G FG  Y+  + A+G+ VA+K +E  K   P     +  E K  + + G 
Sbjct: 10  KYRLGRKIGSGSFGDIYLGANIASGEEVAIK-LECVKTKHP----QLHIESKFYKMMQGG 64
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL   G  L+ +      +++ K   ++  QM+      H
Sbjct: 65  VGIPSIKWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           +    L  +     D+ S+G +      G  P+
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 76
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI +E    G LLD +   ++    E +A V++    ++++          
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G       G+ +   + APE L   K
Sbjct: 134 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNK 189
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 36/275 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG  +    + +G   A+K+  K  +   +  ++  REV     L  H +VV+++
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 73
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R     H   LV
Sbjct: 74  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 133
Query: 222 HRDMKPEN-FLFKSAKEDSSLKATD----------FGLSDF--IKPGKKFQDIVGSAYYV 268
           H D+KP N F+ +++  +++ +  D          F + D   +      Q   G + ++
Sbjct: 134 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 193
Query: 269 APEVLKRKSG--PESDVWSIGVITYILLCGRRPF------WDKTEDGIFKEVLRNKPDFR 320
           A EVL+      P++D++++  +T +   G  P       W +   G    + +      
Sbjct: 194 ANEVLQENYTHLPKADIFALA-LTVVXAAGAEPLPRNGDQWHEIRQGRLPRIPQ------ 246
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                 +S    + +K ++  DP  R +A   + H
Sbjct: 247 -----VLSQEFTELLKVMIHPDPERRPSAMALVKH 276

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 17/224 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           ++ +G+ +G G FG  Y+ T+    + VA+K +E  K   P  + + K   +ILQ   G 
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESK-IYRILQGGTGI 65
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            NV  F    E D Y  + M+L   G  L+ +      + + K   ++  QM+      H
Sbjct: 66  PNVRWF--GVEGD-YNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    +  + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE 311
           +    L  +     D+ S+G +    L G  P W   + G  K+
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQ 223

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 20  EFPRDKLTLGKPLGEGCFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 72
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 73  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 132
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 133 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 189
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 250 PGIPVEELFK 259

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           +I K++G G+FG       K    +   VA+K +     EK +        D   E  I+
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-------RDFLGEASIM 100
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D  L K D+++T      ++R +  
Sbjct: 101 GQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGL+  ++  P   +    G     
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G++VAVK ++       IA  D+K+E++IL+ L  HEN+
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKKEIEILRNLY-HENI 73
Query: 160 VKFYNAFEDD--NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           VK+     +D  N + + ME    G L    L K  ++   K       Q+ +       
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSL-KEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----QDIVGSAYYVAPEVL 273
              VHRD+   N L +S   +  +K  DFGL+  I+  K+      D     ++ APE L
Sbjct: 133 RQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 274 -KRKSGPESDVWSIGVITYILL 294
            + K    SDVWS GV  + LL
Sbjct: 190 MQSKFYIASDVWSFGVTLHELL 211

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 23  EFPRDKLTLGKPLGEGCFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 75
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 76  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 135
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 136 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 192
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 193 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 253 PGIPVEELFK 262

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQFG  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 73
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E  A V++    ++++          
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G       G+ +   + APE L   K
Sbjct: 131 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNK 186
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G++VAVK ++       IA  D+K+E++IL+ L  HEN+
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKKEIEILRNLY-HENI 85
Query: 160 VKFYNAFEDD--NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           VK+     +D  N + + ME    G L    L K  ++   K       Q+ +       
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSL-KEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----QDIVGSAYYVAPEVL 273
              VHRD+   N L +S   +  +K  DFGL+  I+  K+      D     ++ APE L
Sbjct: 145 RQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 274 -KRKSGPESDVWSIGVITYILL 294
            + K    SDVWS GV  + LL
Sbjct: 202 MQSKFYIASDVWSFGVTLHELL 223

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 109/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 16  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 68
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  + I  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 69  YAVVSEEP-IXIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 126
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 127 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEXTARQGAKF-----PIKWTAPEAAL 178
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 235
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 236 DLMCQCWRKEPEERPT 251

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 101/214 (47%), Gaps = 16/214 (7%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 15  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
               +   + +  E  E G L D +  ++     E    + +  +    A      ++HR
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEASVIHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RKSGP 279
           D+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +   
Sbjct: 128 DLAARNCL---VGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 280 ESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
           +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ ++  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMRIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 34/266 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVATDK-ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +Y +   + HG  G+ Y+A D+  NG  V +K +  +      A+   +R+     A   
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQ---FLAEVV 137
Query: 156 HENVVKFYNAFE-----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           H ++V+ +N  E      D   YI ME   GG+ L R    K  +    +A   + ++L 
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKR---SKGQKLPVAEAIAYLLEILP 193
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
             +  H  GLV+ D+KPEN +      +  LK  D G    I     F  + G+  + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRI---NSFGYLYGTPGFQAP 246
Query: 271 EVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE--VLRNKPDFRRKPWPSIS 328
           E+++      +D++++G     L         +  DG+ ++  VL+    + R       
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGR------- 299
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALS 354
                 +++ +  DPR R T A+ +S
Sbjct: 300 -----LLRRAIDPDPRQRFTTAEEMS 320

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 80
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E +A V++    ++++          
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G       G+ +   + APE L   K
Sbjct: 138 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNK 193
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 73
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI +E    G LLD +   ++    E  A V++    ++++          
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G       G+ +   + APE L   K
Sbjct: 131 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNK 186
Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 22/228 (9%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           R  I K++G G  G       +  G R   VA+K ++          E  +R+     ++
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY------TERQRRDFLSEASI 103
Query: 154 AG---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            G   H N+++            I  E  E G L D  L   D ++T      ++R +  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDS---NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + APE +  R     SDVWS GV+ + +L  G RP+W+ T   +   V
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 81/329 (24%), Positives = 133/329 (40%), Gaps = 80/329 (24%)
Query: 97  RYTIGKLLGHGQFGYTYVATD-KANGDRVA---VKKIEKNKMILPIAVEDVKREVKILQA 152
           RY I   LG G FG      D +  G RVA   +K +EK K       E  + E+ +L+ 
Sbjct: 34  RYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYK-------EAARLEINVLEK 86
Query: 153 L----AGHENV-VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           +      ++N+ V+ ++ F+   ++ I+ EL  G    D +       Y       +  Q
Sbjct: 87  INEKDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSA-----------KEDSSLKAT-----DFGLSDF 251
           + +     H + L H D+KPEN LF ++           +++ S+K+T     DFG + F
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF 205
Query: 252 IKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTED---- 306
               +    IV + +Y APEV L+       DVWSIG I +    G   F  +T D    
Sbjct: 206 --DHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLF--QTHDNREH 261
Query: 307 -GIFKEVLRNKPD------------FR-RKPWPSISNSAK-------------------- 332
             + + +L   P             +R R  W   +++ +                    
Sbjct: 262 LAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEH 321
Query: 333 ----DFVKKLLVKDPRARLTAAQALSHPW 357
               D ++ +L  +P  RLT  +AL HP+
Sbjct: 322 HQLFDLIESMLEYEPAKRLTLGEALQHPF 350

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 109/257 (42%), Gaps = 29/257 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG+GQFG  ++ T   N  +VA+K ++   M    + E    E +I++ L  H+ +V+
Sbjct: 15  KRLGNGQFGEVWMGTWNGN-TKVAIKTLKPGTM----SPESFLEEAQIMKKLK-HDKLVQ 68
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y A   +  +YI  E    G LLD +   +       +   +  Q+    A       +
Sbjct: 69  LY-AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPE-VL 273
           HRD++  N L  +       K  DFGL+  I       + G KF        + APE  L
Sbjct: 128 HRDLRSANILVGNG---LICKIADFGLARLIEDNEXTARQGAKF-----PIKWTAPEAAL 179
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSA 331
             +   +SDVWS G+ +T ++  GR P+       + ++V R      R P P     S 
Sbjct: 180 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCPQDCPISL 235
Query: 332 KDFVKKLLVKDPRARLT 348
            + +     KDP  R T
Sbjct: 236 HELMIHCWKKDPEERPT 252

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR---EVKILQALAGHENVV 160
           LG G +G         +G  +AVK+I        +  ++ KR   ++ I          V
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRAT-----VNSQEQKRLLMDLDISMRTVDCPFTV 113
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC----- 215
            FY A   +  V+I MEL      +D  L K   +  +K   +    + ++A        
Sbjct: 114 TFYGALFREGDVWICMEL------MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 167
Query: 216 HLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           HLH    ++HRD+KP N L  +  +   +K  DFG+S ++          G   Y+APE 
Sbjct: 168 HLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDSVAKTIDAGCKPYMAPER 224
Query: 273 L-----KRKSGPESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWP 325
           +     ++    +SD+WS+G+    L   R P+  W      + + V    P     P  
Sbjct: 225 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PAD 281
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
             S    DF  + L K+ + R T  + + HP+
Sbjct: 282 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 313

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  H
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV-------RQML 209
           EN+V    A      V +  E C  G+LL+ +  ++ SR  E D A  +       R +L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 210 RVAAECHLHGL--------VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
             +++    G+        +HRD+   N L  +       K  DFGL+  I     +  +
Sbjct: 168 HFSSQVA-QGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-V 222
Query: 262 VGSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            G+A     ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  H
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV-------RQML 209
           EN+V    A      V +  E C  G+LL+ +  ++ SR  E D A  +       R +L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTASTRDLL 167
Query: 210 RVAAECHLHGL--------VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
             +++    G+        +HRD+   N L  +       K  DFGL+  I     +  +
Sbjct: 168 HFSSQVA-QGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-V 222
Query: 262 VGSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            G+A     ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 60
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 120 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 64
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 65  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 123
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 124 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +     G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 65
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 125 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 52/285 (18%)
Query: 96  RRYTIGKLLGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           R   + + LG G FG  ++A     +   +   VAVK ++   +    A +D +RE ++L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELL 71
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-------DSRYTEKDAAV 203
             L  HE++VKFY    D + + +  E  + G+L   + A         D +  +    +
Sbjct: 72  TNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 204 VVRQMLRVAAE-----CHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
            + QML +A++      +L     VHRD+   N L  +   +  +K  DFG+S       
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS------- 180
Query: 257 KFQDIVGSAYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWD 302
             +D+  + YY            + PE ++ RK   ESDVWS GVI + I   G++P++ 
Sbjct: 181 --RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 238
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
            +   + + + + +   R +  P       D +     ++P+ RL
Sbjct: 239 LSNTEVIECITQGRVLERPRVCP---KEVYDVMLGCWQREPQQRL 280

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 71
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 130
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 131 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMY 186
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR---EVKILQALAGHENVV 160
           LG G +G         +G  +AVK+I        +  ++ KR   ++ I          V
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRAT-----VNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC----- 215
            FY A   +  V+I MEL      +D  L K   +  +K   +    + ++A        
Sbjct: 70  TFYGALFREGDVWICMEL------MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 216 HLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           HLH    ++HRD+KP N L  +  +   +K  DFG+S ++          G   Y+APE 
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
Query: 273 L-----KRKSGPESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWP 325
           +     ++    +SD+WS+G+    L   R P+  W      + + V    P     P  
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PAD 237
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
             S    DF  + L K+ + R T  + + HP+
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  H
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRI-------LAKKDSRYTE-KDAAVVVRQM 208
           EN+V    A      V +  E C  G+LL+ +       L K+D R  E +D      Q+
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY-- 266
            +  A       +HRD+   N L  +       K  DFGL+  I     +  + G+A   
Sbjct: 170 AQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-VKGNARLP 225
Query: 267 --YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
             ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 226 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 80
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 140 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  H
Sbjct: 43  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRI-------LAKKDSRYTE-KDAAVVVRQM 208
           EN+V    A      V +  E C  G+LL+ +       L K+D R  E +D      Q+
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY-- 266
            +  A       +HRD+   N L  +       K  DFGL+  I     +  + G+A   
Sbjct: 162 AQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-VKGNARLP 217
Query: 267 --YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
             ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++AT   +  +VAVK ++   M    +VE    E  +++ L  H+ +VK
Sbjct: 188 KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVK 241
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +     +  +YI  E    G LLD + + + S+           Q+    A       +
Sbjct: 242 LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 300
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           HRD++  N L  ++      K  DFGL+   + G KF        + APE +   S   +
Sbjct: 301 HRDLRAANILVSASL---VCKIADFGLA---RVGAKF-----PIKWTAPEAINFGSFTIK 349
Query: 281 SDVWSIGVITY-ILLCGRRPF 300
           SDVWS G++   I+  GR P+
Sbjct: 350 SDVWSFGILLMEIVTYGRIPY 370

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++     N  +VAVK ++   M    +V+    E  +++ L  H+ +V+
Sbjct: 19  KRLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVR 72
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y     +  +YI  E    G LLD + + +  +           Q+    A       +
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 132
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L     E    K  DFGL+  I       + G KF        + APE + 
Sbjct: 133 HRDLRAANVL---VSESLMCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 184
Query: 275 RKS-GPESDVWSIGVITY-ILLCGRRPFWDKT 304
                 +SDVWS G++ Y I+  G+ P+  +T
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIPYPGRT 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +     G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 115/244 (47%), Gaps = 37/244 (15%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREV 147
           +D  F++   IG+L+G G+FG  Y    + +G+ VA++   IE++       ++  KREV
Sbjct: 28  WDIPFEQ-LEIGELIGKGRFGQVY--HGRWHGE-VAIRLIDIERDN---EDQLKAFKREV 80
Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK---DSRYTEKDAAVV 204
              +    HENVV F  A     ++ I   LC+G  L   +   K   D   T + A  +
Sbjct: 81  MAYRQ-TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL---SDFIKPGK---KF 258
           V+ M       H  G++H+D+K +N  + + K    +  TDFGL   S  ++ G+   K 
Sbjct: 140 VKGM----GYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKL 191
Query: 259 QDIVGSAYYVAPEVLKRKS----------GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
           +   G   ++APE++++ S             SDV+++G I Y L     PF  +  + I
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251
Query: 309 FKEV 312
             ++
Sbjct: 252 IWQM 255

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 22/228 (9%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           R  I K++G G  G       +  G R   VA+K ++          E  +R+     ++
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY------TERQRRDFLSEASI 103
Query: 154 AG---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            G   H N+++            I  E  E G L D  L   D ++T      ++R +  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P        G     
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDS---NLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIR 219
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + APE +  R     SDVWS GV+ + +L  G RP+W+ T   +   V
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 31/234 (13%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++     N  +VAVK ++   M    +V+    E  +++ L  H+ +V+
Sbjct: 18  KKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVR 71
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y     +  +YI  E    G LLD + + +  +           Q+    A       +
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 131
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L     E    K  DFGL+  I       + G KF        + APE + 
Sbjct: 132 HRDLRAANVL---VSESLMCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 183
Query: 275 RKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV--------LRNKPD 318
                 +S+VWS G++ Y I+  G+ P+  +T   +   +        + N PD
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPD 237

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 119/323 (36%), Gaps = 68/323 (21%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D   G R    KI KN   +    E  + E+++L+ L   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTT 71
Query: 157 E-----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +       V+    FE   ++ I  EL  G    D I       +       +  Q+ + 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 212 AAECHLHGLVHRDMKPENFLF-----------KSAKEDSSL-----KATDFGLSDFIKPG 255
               H + L H D+KPEN LF           K  +++ +L     K  DFG + +    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DD 188
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIG--VITYILLCGRRPFWDKTED-GIFKE 311
           +    +V + +Y APEV L        DVWSIG  +I Y L     P  D  E   + + 
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 312 VLRNKPDFR-------------RKPWPSISNSAK------------------------DF 334
           +L   P                R  W   S++ +                        D 
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 335 VKKLLVKDPRARLTAAQALSHPW 357
           ++K+L  DP  R+T  +AL HP+
Sbjct: 309 IQKMLEYDPAKRITLREALKHPF 331

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 31  LGAGQFGEVWMGY--YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 83
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 84  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 142
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 143 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 194
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 243

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 80
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++   ++    VGS +   +  PEVL  
Sbjct: 140 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEETSS-VGSKFPVRWSPPEVLMY 195
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++AT   +  +VAVK ++   M    +VE    E  +++ L  H+ +VK
Sbjct: 194 KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVK 247
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +     +  +YI  E    G LLD + + + S+           Q+    A       +
Sbjct: 248 LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L  ++      K  DFGL+  I       + G KF        + APE + 
Sbjct: 307 HRDLRAANILVSASL---VCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 358
Query: 275 RKS-GPESDVWSIGVITY-ILLCGRRPF 300
             S   +SDVWS G++   I+  GR P+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 27  LGAGQFGEVWMGY--YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 79
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 80  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 138
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 139 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 190
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 239

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 29  LGAGQFGEVWMGY--YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 81
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 82  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 140
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 141 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 192
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 241

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++AT   +  +VAVK ++   M    +VE    E  +++ L  H+ +VK
Sbjct: 21  KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVK 74
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + A      +YI  E    G LLD + + + S+           Q+    A       +
Sbjct: 75  LH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L  ++      K  DFGL+  I       + G KF        + APE + 
Sbjct: 134 HRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 185
Query: 275 RKS-GPESDVWSIGVITY-ILLCGRRPF 300
             S   +SDVWS G++   I+  GR P+
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 27  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 79
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 80  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 138
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 139 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 190
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 239

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 30  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 82
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 83  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 141
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 142 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 193
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 242

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKILQALAG 155
           K +G G FG  +      +   VA+K +       + +MI     ++ +REV I+  L  
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE--KFQEFQREVFIMSNL-N 81
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H N+VK Y      N   + ME    G+L  R+L K          +V +R ML +A   
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGI 135
Query: 216 HLH-----GLVHRDMKPENFLFKSAKEDSSL--KATDFGLSDFIKPGKKFQDIVGSAYYV 268
                    +VHRD++  N   +S  E++ +  K  DFGLS   +       ++G+  ++
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWM 193
Query: 269 APEVL---KRKSGPESDVWSIGVITYILLCGRRPF 300
           APE +   +     ++D +S  +I Y +L G  PF
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 26  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 79  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 137
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 138 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 189
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 238

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 21  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 73
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 74  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 133 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 184
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 23  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 75
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 76  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 134
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 135 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 186
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 235

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 22  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 74
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 75  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 133
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 134 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 185
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 234

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 16  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 68
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 69  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 127
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 128 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 179
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 228

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 21  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 73
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 74  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 133 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 184
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 21  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 73
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 74  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 133 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 184
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 103 LLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           ++G G FG    A  K +G R+  A+K++++       A +D  R    E+++L  L  H
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE------YASKDDHRDFAGELEVLCKLGHH 85
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----------R 206
            N++    A E   Y+Y+A+E    G LLD +   + SR  E D A  +          +
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQ 142
Query: 207 QMLRVAAECHLHGL--------VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           Q+L  AA+    G+        +HRD+   N L     E+   K  DFGLS   +   K 
Sbjct: 143 QLLHFAADVA-RGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKK 198
Query: 259 QDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNK 316
                   ++A E L        SDVWS GV+ + I+  G  P+   T   +++++ +  
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 257
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +R +   +  +   D +++   + P  R + AQ L
Sbjct: 258 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 103 LLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           ++G G FG    A  K +G R+  A+K++++       A +D  R    E+++L  L  H
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE------YASKDDHRDFAGELEVLCKLGHH 75
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----------R 206
            N++    A E   Y+Y+A+E    G LLD +   + SR  E D A  +          +
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQ 132
Query: 207 QMLRVAAECHLHGL--------VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           Q+L  AA+    G+        +HRD+   N L     E+   K  DFGLS   +   K 
Sbjct: 133 QLLHFAADVA-RGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKK 188
Query: 259 QDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNK 316
                   ++A E L        SDVWS GV+ + I+  G  P+   T   +++++ +  
Sbjct: 189 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 247
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +R +   +  +   D +++   + P  R + AQ L
Sbjct: 248 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 19/235 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L+  E
Sbjct: 6   FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPIKSRAP----QLHLEYRFYKQLSATE 60
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            V + Y       Y  + +EL   G  L+ +    D  +T K   ++  Q++      H 
Sbjct: 61  GVPQVYYFGPXGKYNAMVLELL--GPSLEDLFDLCDRTFTLKTVLMIAIQLITRMEYVHT 118
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYY 267
             L++RD+KPENFL      K   ++   DFGL+ ++I P  K        + + G+A Y
Sbjct: 119 KSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 178
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           ++    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 179 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 232

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 118/323 (36%), Gaps = 68/323 (21%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D   G R    KI KN   +    E  + E+++L+ L   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTT 71
Query: 157 E-----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +       V+    FE   ++ I  EL  G    D I       +       +  Q+ + 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 212 AAECHLHGLVHRDMKPENFLF-----------KSAKEDSSL-----KATDFGLSDFIKPG 255
               H + L H D+KPEN LF           K  +++ +L     K  DFG + +    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DD 188
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIG--VITYILLCGRRPFWDKTED-GIFKE 311
           +    +V   +Y APEV L        DVWSIG  +I Y L     P  D  E   + + 
Sbjct: 189 EHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 312 VLRNKPDFR-------------RKPWPSISNSAK------------------------DF 334
           +L   P                R  W   S++ +                        D 
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 335 VKKLLVKDPRARLTAAQALSHPW 357
           ++K+L  DP  R+T  +AL HP+
Sbjct: 309 IQKMLEYDPAKRITLREALKHPF 331

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 65
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++    GS +   +  PEVL  
Sbjct: 125 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMY 180
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 127/321 (39%), Gaps = 68/321 (21%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           G  +G G +G+ Y A  K   D    A+K+IE   + +        RE+ +L+ L  H N
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLRELK-HPN 79
Query: 159 VVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------VVRQML 209
           V+     F    D  V++  +  E  +L   I   + S+  +K   +       ++ Q+L
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 210 RVAAECHLHGLVHRDMKPENFL-FKSAKEDSSLKATDFGLSDF----IKPGKKFQDIVGS 264
                 H + ++HRD+KP N L      E   +K  D G +      +KP      +V +
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGR-------------RPFWDKTEDGIF 309
            +Y APE+L   R      D+W+IG I   LL                 P+     D IF
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258
Query: 310 K----------EVLRNKP-------DFRRKPWPSIS-------------NSAKDFVKKLL 339
                      E ++  P       DFRR  + + S             + A   ++KLL
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318
Query: 340 VKDPRARLTAAQALSHPWVRE 360
             DP  R+T+ QA+  P+  E
Sbjct: 319 TMDPIKRITSEQAMQDPYFLE 339

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 54/256 (21%)
Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK ++        A +D  RE ++L  L  HE+
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEH 76
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGEL--------LDRILAKKDSRYTEKDAAVVVRQMLR 210
           +VKFY    + + + +  E  + G+L         D +L  + +  TE   +    QML 
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS----QMLH 132
Query: 211 VAAECHL-------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           +A +             VHRD+   N L     E+  +K  DFG+S         +D+  
Sbjct: 133 IAQQIAAGMVYLASQHFVHRDLATRNCL---VGENLLVKIGDFGMS---------RDVYS 180
Query: 264 SAYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIF 309
           + YY            + PE ++ RK   ESDVWS+GV+ + I   G++P++  + + + 
Sbjct: 181 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240
Query: 310 KEVLRNKPDFRRKPWP 325
           + + + +   R +  P
Sbjct: 241 ECITQGRVLQRPRTCP 256

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 73
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 74  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+F  +        ++ APE
Sbjct: 131 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELF 211

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 17  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 69
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 70  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 128
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           R+++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 129 RNLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 180
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 229

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 104/255 (40%), Gaps = 52/255 (20%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV------------EDVKREV 147
            GK+LG G FG    AT  A G       I K  + + +AV            E +  E+
Sbjct: 49  FGKVLGSGAFGKVMNAT--AYG-------ISKTGVSIQVAVKMLKEKADSSEREALMSEL 99
Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD-------------- 193
           K++  L  HEN+V    A      +Y+  E C  G+LL+ + +K++              
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 194 -------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF 246
                  +  T +D      Q+ +          VHRD+   N L    K    +K  DF
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK---VVKICDF 216
Query: 247 GLSDFIKPGKKFQDIVGSAY----YVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           GL+  I     +  + G+A     ++APE L +     +SDVWS G++ + I   G  P+
Sbjct: 217 GLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 301 WDKTEDGIFKEVLRN 315
                D  F ++++N
Sbjct: 276 PGIPVDANFYKLIQN 290

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 81/323 (25%), Positives = 121/323 (37%), Gaps = 68/323 (21%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D A G      KI +N   +    E  + E+ +L+ +   
Sbjct: 29  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEK 85
Query: 157 ENVVKFYNAFEDD-----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +   KF      D      ++ IA EL  G    + +       Y       +  Q+   
Sbjct: 86  DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 144
Query: 212 AAECHLHGLVHRDMKPENFLF------------KSAKE----DSSLKATDFGLSDFIKPG 255
               H + L H D+KPEN LF            KS +E    ++S++  DFG + F    
Sbjct: 145 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 202
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFKEV 312
           +    IV + +Y  PEV L+       DVWSIG I +    G   F   +  E  +  E 
Sbjct: 203 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 262
Query: 313 L--------------------------RNKPDFRR-----KPWPS--ISNSAK-----DF 334
           +                           N  D R      KP  S  + +S +     D 
Sbjct: 263 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 322
Query: 335 VKKLLVKDPRARLTAAQALSHPW 357
           ++++L  DP  R+T A+AL HP+
Sbjct: 323 MRRMLEFDPAQRITLAEALLHPF 345

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT----YVATDKANGDRVAVKKIEKNK 133
           G++P G      ++   +R     + LG G FG      Y       G+ VAVKK++ + 
Sbjct: 13  GLVPRGSHNMTQFE---ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 69
Query: 134 MILPIAVEDVKREVKILQALAGHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRIL 189
                 + D +RE++IL++L  H+N+VK+    Y+A   +  + + ME    G L D  L
Sbjct: 70  ---EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YL 122
Query: 190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
            K   R           Q+ +          +HRD+   N L ++   ++ +K  DFGL+
Sbjct: 123 QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLT 179
Query: 250 DFIKPGKKFQDI----VGSAYYVAPEVL-KRKSGPESDVWSIGVITYILL 294
             +   K+   +        ++ APE L + K    SDVWS GV+ Y L 
Sbjct: 180 KVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 103 LLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           ++G G FG    A  K +G R+  A+K++++       A +D  R    E+++L  L  H
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE------YASKDDHRDFAGELEVLCKLGHH 82
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----------R 206
            N++    A E   Y+Y+A+E    G LLD +   + SR  E D A  +          +
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQ 139
Query: 207 QMLRVAAECHLHGL--------VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           Q+L  AA+    G+        +HR++   N L     E+   K  DFGLS   +   K 
Sbjct: 140 QLLHFAADVA-RGMDYLSQKQFIHRNLAARNIL---VGENYVAKIADFGLSRGQEVYVKK 195
Query: 259 QDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNK 316
                   ++A E L        SDVWS GV+ + I+  G  P+   T   +++++ +  
Sbjct: 196 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 254
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +R +   +  +   D +++   + P  R + AQ L
Sbjct: 255 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 81/323 (25%), Positives = 121/323 (37%), Gaps = 68/323 (21%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D A G      KI +N   +    E  + E+ +L+ +   
Sbjct: 52  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEK 108
Query: 157 ENVVKFYNAFEDD-----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +   KF      D      ++ IA EL  G    + +       Y       +  Q+   
Sbjct: 109 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 167
Query: 212 AAECHLHGLVHRDMKPENFLF------------KSAKE----DSSLKATDFGLSDFIKPG 255
               H + L H D+KPEN LF            KS +E    ++S++  DFG + F    
Sbjct: 168 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 225
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFKEV 312
           +    IV + +Y  PEV L+       DVWSIG I +    G   F   +  E  +  E 
Sbjct: 226 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 285
Query: 313 L--------------------------RNKPDFRR-----KPWPS--ISNSAK-----DF 334
           +                           N  D R      KP  S  + +S +     D 
Sbjct: 286 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 345
Query: 335 VKKLLVKDPRARLTAAQALSHPW 357
           ++++L  DP  R+T A+AL HP+
Sbjct: 346 MRRMLEFDPAQRITLAEALLHPF 368

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D A G      KI +N   +    E  + E+ +L+ +   
Sbjct: 20  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEK 76
Query: 157 ENVVKFYNAFEDD-----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +   KF      D      ++ IA EL  G    + +       Y       +  Q+   
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 212 AAECHLHGLVHRDMKPENFLF------------KSAKE----DSSLKATDFGLSDFIKPG 255
               H + L H D+KPEN LF            KS +E    ++S++  DFG + F    
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 193
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITY 291
           +    IV + +Y  PEV L+       DVWSIG I +
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 230

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKILQALAG 155
           K +G G FG  +      +   VA+K +       + +MI     ++ +REV I+  L  
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE--KFQEFQREVFIMSNL-N 81
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H N+VK Y      N   + ME    G+L  R+L K          +V +R ML +A   
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGI 135
Query: 216 HLH-----GLVHRDMKPENFLFKSAKEDSSL--KATDFGLSDFIKPGKKFQDIVGSAYYV 268
                    +VHRD++  N   +S  E++ +  K  DFG S   +       ++G+  ++
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWM 193
Query: 269 APEVL---KRKSGPESDVWSIGVITYILLCGRRPF 300
           APE +   +     ++D +S  +I Y +L G  PF
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT----YVATDKANGDRVAVKKIEKNK 133
           G++P G      ++   +R     + LG G FG      Y       G+ VAVKK++ + 
Sbjct: 13  GLVPRGSHNMTQFE---ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 69
Query: 134 MILPIAVEDVKREVKILQALAGHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRIL 189
                 + D +RE++IL++L  H+N+VK+    Y+A   +  + + ME    G L D  L
Sbjct: 70  ---EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YL 122
Query: 190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
            K   R           Q+ +          +HRD+   N L ++   ++ +K  DFGL+
Sbjct: 123 QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLT 179
Query: 250 DFIKPGKKFQDI----VGSAYYVAPEVL-KRKSGPESDVWSIGVITYILL 294
             +   K+   +        ++ APE L + K    SDVWS GV+ Y L 
Sbjct: 180 KVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKILQALAG 155
           K +G G FG  +      +   VA+K +       + +MI     ++ +REV I+  L  
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE--KFQEFQREVFIMSNL-N 81
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H N+VK Y      N   + ME    G+L  R+L K          +V +R ML +A   
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGI 135
Query: 216 HLH-----GLVHRDMKPENFLFKSAKEDSSL--KATDFGLSDFIKPGKKFQDIVGSAYYV 268
                    +VHRD++  N   +S  E++ +  K  DF LS   +       ++G+  ++
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWM 193
Query: 269 APEVL---KRKSGPESDVWSIGVITYILLCGRRPF 300
           APE +   +     ++D +S  +I Y +L G  PF
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 29/225 (12%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAG 155
            GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDA 201
           HEN+V    A      V +  E C  G+LL+ +  K+              + + + +D 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
                Q+ +  A       +HRD+   N L  +       K  DFGL+  I     +  +
Sbjct: 169 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNY-IV 224
Query: 262 VGSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            G+A     ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 225 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG  + A  + +G  VAVK + +        V +  REV I++ L  H N+V F 
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLR-HPNIVLFM 100
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-----HLH 218
            A      + I  E    G L  R+L K  +R    +     R+ L +A +      +LH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDE-----RRRLSMAYDVAKGMNYLH 154
Query: 219 G----LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---QDIVGSAYYVAPE 271
                +VHRD+K  N L     +  ++K  DFGLS        F   +   G+  ++APE
Sbjct: 155 NRNPPIVHRDLKSPNLL---VDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPE 209
Query: 272 VLK-RKSGPESDVWSIGVITYILLCGRRPF 300
           VL+   S  +SDV+S GVI + L   ++P+
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 72
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 73  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 130 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELF 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 76
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 77  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 134 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELF 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 71
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 72  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 129 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELF 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 73
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 74  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 131 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 77
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 78  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 135 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 192 SLTESKFSVASDVWSFGVVLYELF 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 79
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 80  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 137 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 194 SLTESKFSVASDVWSFGVVLYELF 217

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 78
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 79  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 136 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 193 SLTESKFSVASDVWSFGVVLYELF 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 104
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 105 VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 162 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELF 242

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 73
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 74  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 131 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELF 211

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 80
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 81  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 138 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 195 SLTESKFSVASDVWSFGVVLYELF 218

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 74
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 75  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HR++   N L ++   ++ +K  DFGL+  +   K++  +        ++ APE
Sbjct: 132 GTKRYIHRNLATRNILVEN---ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELF 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQ G  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 21  LGAGQAGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 73
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 74  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 133 RDLRAANIL---VSDTLSCKIADFGLARLIEDAEXTAREGAKF-----PIKWTAPEAINY 184
Query: 276 KS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 32/228 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 28  RLNLGKPLGRGAFGQV-IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDA-------AVV 204
           +  H NVV    A  +    + + +E C+ G L   + +K++     KD          +
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 205 VRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFIKP 254
           +    +VA           +HRD+   N L     E + +K  DFGL+       D+++ 
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 255 GKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 204 G----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 94/231 (40%), Gaps = 36/231 (15%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  H
Sbjct: 36  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--------------------LAKKDSRY 196
           EN+V    A      V +  E C  G+LL+ +                    L K+D R 
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 197 TE-KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG 255
            E +D      Q+ +  A       +HRD+   N L  +       K  DFGL+  I   
Sbjct: 155 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMND 211
Query: 256 KKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
             +  + G+A     ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 212 SNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG  + A  + +G  VAVK + +        V +  REV I++ L  H N+V F 
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLR-HPNIVLFM 100
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-----HLH 218
            A      + I  E    G L  R+L K  +R    +     R+ L +A +      +LH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDE-----RRRLSMAYDVAKGMNYLH 154
Query: 219 G----LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKPGKKFQDIVGSAYYVAPEVL 273
                +VHR++K  N L     +  ++K  DFGLS          +   G+  ++APEVL
Sbjct: 155 NRNPPIVHRNLKSPNLL---VDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
Query: 274 K-RKSGPESDVWSIGVITYILLCGRRPF 300
           +   S  +SDV+S GVI + L   ++P+
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 38/225 (16%)
Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK +++       A +D +RE ++L  L  H++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQ-HQH 81
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVV-----VRQMLRV 211
           +V+F+    +   + +  E    G+L +R L     D++       V      + Q+L V
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 212 AAEC-----HLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGKKF 258
           A++      +L GL  VHRD+   N L     +   +K  DFG+S      D+ + G + 
Sbjct: 141 ASQVAAGMVYLAGLHFVHRDLATRNCL---VGQGLVVKIGDFGMSRDIYSTDYYRVGGR- 196
Query: 259 QDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
              +    ++ PE +L RK   ESDVWS GV+ + I   G++P++
Sbjct: 197 --TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 76
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L +  L K   R           Q+ +     
Sbjct: 77  VKYKGVCYSAGRRN--LKLIMEFLPYGSLRE-YLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 134 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELF 214

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 38/225 (16%)
Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK +++       A +D +RE ++L  L  H++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQ-HQH 75
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVV-----VRQMLRV 211
           +V+F+    +   + +  E    G+L +R L     D++       V      + Q+L V
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 212 AAEC-----HLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGKKF 258
           A++      +L GL  VHRD+   N L     +   +K  DFG+S      D+ + G + 
Sbjct: 135 ASQVAAGMVYLAGLHFVHRDLATRNCL---VGQGLVVKIGDFGMSRDIYSTDYYRVGGR- 190
Query: 259 QDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
              +    ++ PE +L RK   ESDVWS GV+ + I   G++P++
Sbjct: 191 --TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 38/225 (16%)
Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK +++       A +D +RE ++L  L  H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQ-HQH 104
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVV-----VRQMLRV 211
           +V+F+    +   + +  E    G+L +R L     D++       V      + Q+L V
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 212 AAEC-----HLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGKKF 258
           A++      +L GL  VHRD+   N L     +   +K  DFG+S      D+ + G + 
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCL---VGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 259 QDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
              +    ++ PE +L RK   ESDVWS GV+ + I   G++P++
Sbjct: 221 MLPI---RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 76
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D + A  + R           Q+ +     
Sbjct: 77  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYL 133
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 134 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELF 214

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 40/232 (17%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 28  RLNLGKPLGRGAFGQV-IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD----------- 200
           +  H NVV    A  +    + + +E C+ G L   + +K++     KD           
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 201 ---AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------D 250
              +  V + M  +A+       +HRD+   N L     E + +K  DFGL+       D
Sbjct: 147 ICYSFQVAKGMEFLASR----KXIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 199
Query: 251 FIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           +++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 200 YVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  H N+V+  
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLL 252
Query: 164 NAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHG-- 219
               E+   +YI  E    G L+D + ++  S         +++  L V  A  +L G  
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEGNN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAPEVLK-RKS 277
            VHRD+   N L     ED+  K +DFGL+   K     QD       + APE L+ +K 
Sbjct: 310 FVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 363
Query: 278 GPESDVWSIGVITY-ILLCGRRPF 300
             +SDVWS G++ + I   GR P+
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPY 387

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 100/244 (40%), Gaps = 45/244 (18%)
Query: 93  DFDRR-YTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           +F R+   +GK LG G+FG    AT      +A    VAVK +++N    P  + D+  E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSE 76
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGEL---------------------L 185
             +L+ +  H +V+K Y A   D  + + +E  + G L                      
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 186 DRILAKKDSR-YTEKDA---AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL 241
              L   D R  T  D    A  + Q ++  AE     LVHRD+   N L     E   +
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---SLVHRDLAARNIL---VAEGRKM 189
Query: 242 KATDFGLSDFI----KPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITY-ILLCG 296
           K +DFGLS  +       K+ Q  +   +     +       +SDVWS GV+ + I+  G
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 297 RRPF 300
             P+
Sbjct: 250 GNPY 253

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 104 LGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG   +      GD     VAVK+++ +    P    D +RE++IL+AL  H + 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL--HSDF 72
Query: 160 VKFYNAFE---DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  Y           + + ME    G L D  L +  +R       +   Q+ +      
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEV 272
               VHRD+   N L +S   ++ +K  DFGL+  +   K +  +        ++ APE 
Sbjct: 132 SRRCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 273 LKRKS-GPESDVWSIGVITYILL 294
           L       +SDVWS GV+ Y L 
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 35/272 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR---EVKILQALAGHENVV 160
           LG G +G         +G   AVK+I        +  ++ KR   ++ I          V
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRAT-----VNSQEQKRLLXDLDISXRTVDCPFTV 96
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC----- 215
            FY A   +  V+I  EL       D  L K   +  +K   +    + ++A        
Sbjct: 97  TFYGALFREGDVWICXEL------XDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 150
Query: 216 HLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           HLH    ++HRD+KP N L  +  +   +K  DFG+S ++          G   Y APE 
Sbjct: 151 HLHSKLSVIHRDVKPSNVLINALGQ---VKXCDFGISGYLVDDVAKDIDAGCKPYXAPER 207
Query: 273 L-----KRKSGPESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWP 325
           +     ++    +SD+WS+G+    L   R P+  W      + + V    P     P  
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PAD 264
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
             S    DF  + L K+ + R T  +   HP+
Sbjct: 265 KFSAEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 100/244 (40%), Gaps = 45/244 (18%)
Query: 93  DFDRR-YTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           +F R+   +GK LG G+FG    AT      +A    VAVK +++N    P  + D+  E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSE 76
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGEL---------------------L 185
             +L+ +  H +V+K Y A   D  + + +E  + G L                      
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 186 DRILAKKDSR-YTEKDA---AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL 241
              L   D R  T  D    A  + Q ++  AE     LVHRD+   N L     E   +
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNIL---VAEGRKM 189
Query: 242 KATDFGLSDFI----KPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITY-ILLCG 296
           K +DFGLS  +       K+ Q  +   +     +       +SDVWS GV+ + I+  G
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 297 RRPF 300
             P+
Sbjct: 250 GNPY 253

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 104 LGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG   +      GD     VAVK+++ +    P    D +RE++IL+AL  H + 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL--HSDF 73
Query: 160 VKFYNAFE---DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  Y           + + ME    G L D  L +  +R       +   Q+ +      
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLG 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEV 272
               VHRD+   N L +S   ++ +K  DFGL+  +   K +  +        ++ APE 
Sbjct: 133 SRRCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 273 LKRKS-GPESDVWSIGVITYILL 294
           L       +SDVWS GV+ Y L 
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELF 212

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  H N+V+  
Sbjct: 29  IGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLL 80
Query: 164 NAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHG-- 219
               E+   +YI  E    G L+D + ++  S         +++  L V  A  +L G  
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEGNN 137
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAPEVLK-RKS 277
            VHRD+   N L     ED+  K +DFGL+   K     QD       + APE L+ +K 
Sbjct: 138 FVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 191
Query: 278 GPESDVWSIGVITY-ILLCGRRPF 300
             +SDVWS G++ + I   GR P+
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 104 LGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG   +      GD     VAVK+++ +    P    D +RE++IL+AL  H + 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL--HSDF 85
Query: 160 VKFYNAFE---DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  Y           + + ME    G L D  L +  +R       +   Q+ +      
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEV 272
               VHRD+   N L +S   ++ +K  DFGL+  +   K +  +        ++ APE 
Sbjct: 145 SRRCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 273 LKRKS-GPESDVWSIGVITYILL 294
           L       +SDVWS GV+ Y L 
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELF 224

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 20/234 (8%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL-AGHEN 158
           +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L +  E 
Sbjct: 4   VGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPIKSRAP----QLHLEYRFYKQLGSAGEG 58
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           + + Y       Y  + +EL   G  L+ +    D  +T K   ++  Q+L      H  
Sbjct: 59  LPQVYYFGPXGKYNAMVLELL--GPSLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSK 116
Query: 219 GLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYYV 268
            L++RD+KPENFL   +  K++  +   DFGL+ ++I P  K        + + G+A Y+
Sbjct: 117 NLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYM 176
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           +    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 177 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 229

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 36/232 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 30  RLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------- 203
           +  H NVV    A  +    + + +E C+ G L   + +K++     K+A          
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 204 ---VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------D 250
              ++    +VA           +HRD+   N L     E + +K  DFGL+       D
Sbjct: 149 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 205
Query: 251 FIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           +++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 206 YVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  H N+V+  
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLL 65
Query: 164 NAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHG-- 219
               E+   +YI  E    G L+D + ++  S         +++  L V  A  +L G  
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEGNN 122
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAPEVLK-RKS 277
            VHRD+   N L     ED+  K +DFGL+   K     QD       + APE L+ +K 
Sbjct: 123 FVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 176
Query: 278 GPESDVWSIGVITY-ILLCGRRPF 300
             +SDVWS G++ + I   GR P+
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPY 200

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 100/235 (42%), Gaps = 19/235 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L   +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAP----QLHLEYRFYKQLGSGD 65
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            + + Y       Y  + +EL   G  L+ +    D  ++ K   ++  Q++      H 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYY 267
             L++RD+KPENFL      K    +   DFGL+ ++I P  K        + + G+A Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           ++    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 237

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 100/244 (40%), Gaps = 45/244 (18%)
Query: 93  DFDRR-YTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           +F R+   +GK LG G+FG    AT      +A    VAVK +++N    P  + D+  E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSE 76
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGEL---------------------L 185
             +L+ +  H +V+K Y A   D  + + +E  + G L                      
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 186 DRILAKKDSR-YTEKDA---AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL 241
              L   D R  T  D    A  + Q ++  AE     LVHRD+   N L     E   +
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNIL---VAEGRKM 189
Query: 242 KATDFGLSDFIKPG----KKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITY-ILLCG 296
           K +DFGLS  +       K+ Q  +   +     +       +SDVWS GV+ + I+  G
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 297 RRPF 300
             P+
Sbjct: 250 GNPY 253

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG   +      GD     VAVK+++ +    P    D +RE++IL+AL  H + 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL--HSDF 69
Query: 160 VKFYNAFE---DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  Y           + + ME    G L D  L +  +R       +   Q+ +      
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV-----GSAYYVAPE 271
               VHRD+   N L +S   ++ +K  DFGL+  + P  K   +V        ++ APE
Sbjct: 129 SRRCVHRDLAARNILVES---EAHVKIADFGLAKLL-PLDKDXXVVREPGQSPIFWYAPE 184
Query: 272 VLKRKS-GPESDVWSIGVITYILL 294
            L       +SDVWS GV+ Y L 
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  H N+V+  
Sbjct: 20  IGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLL 71
Query: 164 NAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHG-- 219
               E+   +YI  E    G L+D + ++  S         +++  L V  A  +L G  
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEGNN 128
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAPEVLKRKS- 277
            VHRD+   N L     ED+  K +DFGL+   K     QD       + APE L+  + 
Sbjct: 129 FVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREAAF 182
Query: 278 GPESDVWSIGVITY-ILLCGRRPF 300
             +SDVWS G++ + I   GR P+
Sbjct: 183 STKSDVWSFGILLWEIYSFGRVPY 206

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 41/234 (17%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 29  RLNLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +  H NVV    A  +    + + +E C+ G L   + +K++     K    + +  L +
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 212 AAECHL----------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------ 249
               HL                   +HRD+   N L     E + +K  DFGL+      
Sbjct: 148 E---HLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKD 201
Query: 250 -DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            D ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 202 PDXVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/318 (21%), Positives = 126/318 (39%), Gaps = 54/318 (16%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--------EKNKMILPIAVEDVKREVKI 149
           YT+ + +  G +G      D + G  VA+K++          N +      + V RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 150 LQALAGHENVVKF---YNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           L     H N++     +  FE+     +Y+  EL      L +++  +    + +     
Sbjct: 83  LNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQYF 139
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           +  +L      H  G+VHRD+ P N L     +++ +   DF L+            V  
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTH 196
Query: 265 AYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKT-----------------E 305
            +Y APE++ +  G     D+WS G +   +   +  F   T                 E
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 306 DGIF------KEVLRNK-PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           D +       ++ LRN   +   + W    P+    A D + K+L  +P+ R++  QAL 
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
Query: 355 HPWVREGGDASEIPIDIS 372
           HP+     D    P+D++
Sbjct: 317 HPYFESLFD----PLDLT 330

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 74/320 (23%), Positives = 129/320 (40%), Gaps = 77/320 (24%)
Query: 83  GKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED 142
           G    F   +   R+ T+ + +G G++G  +  +    G+ VAVK             + 
Sbjct: 24  GSGLPFLVQRTVARQITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDE------KS 75
Query: 143 VKREVKILQA-LAGHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
             RE ++    +  HEN++ F      +      +++     E G L D +      + T
Sbjct: 76  WFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLT 129
Query: 198 EKDAAVVVRQMLRVAAE-CHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDF 246
             D    +R +L +A+   HLH           + HRD+K +N L    K++      D 
Sbjct: 130 TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADL 186
Query: 247 GLSDFIKPGKKFQDI-----VGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILL 294
           GL+          D+     VG+  Y+APEVL          S    D+W+ G++ + + 
Sbjct: 187 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV- 245
Query: 295 CGRRPFWDKTEDGI-------FKEVLRNKPDF----------RRKP-----W---PSISN 329
             RR       +GI       F +V+ N P F          +++P     W   P++++
Sbjct: 246 -ARR----MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTS 300
Query: 330 SAKDFVKKLLVKDPRARLTA 349
            AK  +K+   ++P ARLTA
Sbjct: 301 LAK-LMKECWYQNPSARLTA 319

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 9/191 (4%)
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV 172
           Y A D      VA+K   +     P+     +RE +    L    +VV  ++  E D  +
Sbjct: 51  YEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQ-EPHVVPIHDFGEIDGQL 109
Query: 173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLF 232
           Y+   L  G +L   +  ++        A  +VRQ+       H  G  HRD+KPEN L 
Sbjct: 110 YVDXRLINGVDLAAXL--RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV 167
Query: 233 KSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYYVAPEVLKRKSGP-ESDVWSIGVI 289
            +   D      DFG++      K  Q  + VG+ YY APE          +D++++  +
Sbjct: 168 SA---DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCV 224
Query: 290 TYILLCGRRPF 300
            Y  L G  P+
Sbjct: 225 LYECLTGSPPY 235

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/318 (21%), Positives = 126/318 (39%), Gaps = 54/318 (16%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--------EKNKMILPIAVEDVKREVKI 149
           YT+ + +  G +G      D + G  VA+K++          N +      + V RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 150 LQALAGHENVVKF---YNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           L     H N++     +  FE+     +Y+  EL      L +++  +    + +     
Sbjct: 83  LNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQYF 139
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           +  +L      H  G+VHRD+ P N L     +++ +   DF L+            V  
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTH 196
Query: 265 AYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKT-----------------E 305
            +Y APE++ +  G     D+WS G +   +   +  F   T                 E
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 306 DGIF------KEVLRNK-PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           D +       ++ LRN   +   + W    P+    A D + K+L  +P+ R++  QAL 
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
Query: 355 HPWVREGGDASEIPIDIS 372
           HP+     D    P+D++
Sbjct: 317 HPYFESLFD----PLDLT 330

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + +  E C+ G L   + +K++     K A     
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 189
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D+++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 YKDPDYVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + +  E C+ G L   + +K++     K A     
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 189
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D+++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 YKDPDYVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 36/232 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 28  RLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------- 203
           +  H NVV    A  +    + + +E C+ G L   + +K++     K A          
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 204 ---VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------D 250
              ++    +VA           +HRD+   N L     E + +K  DFGL+       D
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 203
Query: 251 FIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           +++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 204 YVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 98/237 (41%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 60  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 118
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + + +E C+ G L   + +K++     K A     
Sbjct: 119 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 178
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 179 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 235
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D+++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 236 YKDPDYVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 22/141 (15%)
Query: 171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC---HLHGLVHRDMKP 227
           Y+YI M+LC    L D +   +     +++  V +   +++A      H  GL+HRD+KP
Sbjct: 135 YLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 228 ENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI-------------VGSAYYVAPEVLK 274
            N  F     D  +K  DFGL   +   ++ Q +             VG+  Y++PE + 
Sbjct: 193 SNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIH 249
Query: 275 RKS-GPESDVWSIGVITYILL 294
             +   + D++S+G+I + LL
Sbjct: 250 GNNYSHKVDIFSLGLILFELL 270

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 30  RLKLGKPLGRGAFGQV-IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------- 203
           +  H NVV    A  +    + + +E C+ G L   + +K++     K   +        
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 204 -VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFI 252
            ++    +VA           +HRD+   N L     E + +K  DFGL+       D +
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDXV 205
Query: 253 KPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           + G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 206 RKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 19/235 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L   +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAP----QLHLEYRFYKQLGSGD 65
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            + + Y       Y  + +EL   G  L+ +    D  ++ K   ++  Q++      H 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYY 267
             L++RD+KPENFL      K    +   DF L+ ++I P  K        + + G+A Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           ++    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 237

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 104/248 (41%), Gaps = 43/248 (17%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y      +G+ V    A+K + +N    P A +++  E  ++  + G  
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGV-GSP 79
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            V +          V +  +L   G LLD +   +  R   +D      Q+ +  +    
Sbjct: 80  YVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENR-GRLGSQDLLNWCMQIAKGMSYLED 137
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY----------Y 267
             LVHRD+   N L KS      +K TDFGL+       +  DI  + Y          +
Sbjct: 138 VRLVHRDLAARNVLVKSPNH---VKITDFGLA-------RLLDIDETEYHADGGKVPIKW 187
Query: 268 VAPE-VLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF----RR 321
           +A E +L+R+   +SDVWS GV  + L+  G +P+     DGI     R  PD      R
Sbjct: 188 MALESILRRRFTHQSDVWSYGVTVWELMTFGAKPY-----DGIPA---REIPDLLEKGER 239
Query: 322 KPWPSISN 329
            P P I  
Sbjct: 240 LPQPPICT 247

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 19/235 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L   +
Sbjct: 32  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAP----QLHLEYRFYKQLGSGD 86
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            + + Y       Y  + +EL   G  L+ +    D  ++ K   ++  Q++      H 
Sbjct: 87  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 144
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYY 267
             L++RD+KPENFL      K    +   DF L+ ++I P  K        + + G+A Y
Sbjct: 145 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 204
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           ++    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 205 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 258

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 103/239 (43%), Gaps = 25/239 (10%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G+ V +    K  N+   P A  +   E  I+ ++  H ++
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHL 102
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V+          + +  +L   G LL+ +   KD+  ++      V Q+ +         
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV-QIAKGMMYLEERR 160
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-R 275
           LVHRD+   N L KS    + +K TDFGL+  ++  +K  +  G      ++A E +  R
Sbjct: 161 LVHRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 276 KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF----RRKPWPSISN 329
           K   +SDVWS GV  + L+  G +P+     DGI     R  PD      R P P I  
Sbjct: 218 KFTHQSDVWSYGVTIWELMTFGGKPY-----DGIPT---REIPDLLEKGERLPQPPICT 268

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 103/239 (43%), Gaps = 25/239 (10%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G+ V +    K  N+   P A  +   E  I+ ++  H ++
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHL 79
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V+          + +  +L   G LL+ +   KD+  ++      V Q+ +         
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV-QIAKGMMYLEERR 137
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-R 275
           LVHRD+   N L KS    + +K TDFGL+  ++  +K  +  G      ++A E +  R
Sbjct: 138 LVHRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 276 KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF----RRKPWPSISN 329
           K   +SDVWS GV  + L+  G +P+     DGI     R  PD      R P P I  
Sbjct: 195 KFTHQSDVWSYGVTIWELMTFGGKPY-----DGIPT---REIPDLLEKGERLPQPPICT 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + + +E C+ G L   + +K++     K A     
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 189
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 XKDPDXVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 77/307 (25%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R  T+ + +G G++G  +  +    G+ VAVK             +   RE ++    + 
Sbjct: 8   RDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDE------KSWFRETELYNTVML 59
Query: 155 GHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F      +      +++     E G L D +      + T  D    +R +L 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLS 113
Query: 211 VAAE-CHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           +A+   HLH           + HRD+K +N L    K++      D GL+          
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQSTNQL 170
Query: 260 DI-----VGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKTEDG 307
           D+     VG+  Y+APEVL          S    D+W+ G++ + +   RR       +G
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARR----MVSNG 224
Query: 308 I-------FKEVLRNKPDF----------RRKP-----W---PSISNSAKDFVKKLLVKD 342
           I       F +V+ N P F          +++P     W   P++++ AK  +K+   ++
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQN 283
Query: 343 PRARLTA 349
           P ARLTA
Sbjct: 284 PSARLTA 290

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 3   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 54
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 55  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 109
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 166
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 4   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 55
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 56  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 110
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 111 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 167
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 168 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 36/232 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 28  RLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------- 203
           +  H NVV    A  +    + + +E C+ G L   + +K++     K A          
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 204 ---VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------D 250
              ++    +VA           +HRD+   N L     E + +K  DFGL+       D
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 203
Query: 251 FIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 204 XVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 36/232 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 28  RLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------- 203
           +  H NVV    A  +    + + +E C+ G L   + +K++     K A          
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 204 ---VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------D 250
              ++    +VA           +HRD+   N L     E + +K  DFGL+       D
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 203
Query: 251 FIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 204 XVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 96/237 (40%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + +  E C+ G L   + +K++     K A     
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 189
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 XKDPDXVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 6   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 57
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 58  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 112
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 113 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 169
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 170 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 29  RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 80
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 81  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 135
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 136 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 192
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 193 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 42  RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 93
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 148
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 205
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 9   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 60
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 61  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 115
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 172
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 173 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 124/304 (40%), Gaps = 77/304 (25%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LAGHE 157
           T+ + +G G++G  +  +    G+ VAVK             +   RE ++    +  HE
Sbjct: 11  TLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDE------KSWFRETELYNTVMLRHE 62
Query: 158 NVVKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++ F      +      +++     E G L D +      + T  D    +R +L +A+
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIAS 116
Query: 214 E-CHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI- 261
              HLH           + HRD+K +N L    K++      D GL+          D+ 
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 262 ----VGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKTEDGI-- 308
               VG+  Y+APEVL          S    D+W+ G++ + +   RR       +GI  
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARR----MVSNGIVE 227
Query: 309 -----FKEVLRNKPDF----------RRKP-----W---PSISNSAKDFVKKLLVKDPRA 345
                F +V+ N P F          +++P     W   P++++ AK  +K+   ++P A
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSA 286
Query: 346 RLTA 349
           RLTA
Sbjct: 287 RLTA 290

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/291 (21%), Positives = 116/291 (39%), Gaps = 40/291 (13%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           ++ Y   + LG G F Y  +     +G   A+K+I  ++       E+ +RE   +  L 
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREAD-MHRLF 83
Query: 155 GHENVVKF--YNAFEDD--NYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQM 208
            H N+++   Y   E    +  ++ +   + G L + I  L  K +  TE     ++  +
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG- 263
            R     H  G  HRD+KP N L     +   +       +     G +     QD    
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 264 --SAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE------ 311
             +  Y APE+   +S       +DVWS+G + Y ++ G  P+     D +F++      
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-----DMVFQKGDSVAL 258
Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR------LTAAQALSHP 356
            ++N+    +   P  S++    +  ++  DP  R      L+  +AL  P
Sbjct: 259 AVQNQLSIPQS--PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 78
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 79  HVCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 136
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 137 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 224

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 79
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 80  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 137
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 138 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 225

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 80
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 81  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 138
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 139 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 226

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 78
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 79  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 136
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 137 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 224

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 81
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 82  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 139
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 140 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 227

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 77
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 78  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 223

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G++V   V  +E  +   P A +++  E  ++ A   + +V
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVM-ASVDNPHV 113
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAECH 216
            +          V +  +L   G LLD +   KD   S+Y       + + M  +     
Sbjct: 114 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED--- 169
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAPEV 272
              LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +     +
Sbjct: 170 -RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 273 LKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
           L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 257

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 113/273 (41%), Gaps = 32/273 (11%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           ++++T+G++LG G+FG    A  K       +VAVK + K  +I    +E+  RE   ++
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMK 80
Query: 152 ALAGHENVVKFYNAFEDDN------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
               H +V K                  + +   + G+L   +LA   SR  E    + +
Sbjct: 81  EF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA---SRIGENPFNLPL 136
Query: 206 RQMLR--VAAECHLHGL-----VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           + ++R  V   C +  L     +HRD+   N +     ED ++   DFGLS  I  G  +
Sbjct: 137 QTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYY 193
Query: 259 QDIVGSAY---YVAPEVLKRK-SGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVL 313
           +    S     ++A E L        SDVW+ GV  + I+  G+ P+       I+  ++
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253
Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR 346
                 R K  P       D + +    DP+ R
Sbjct: 254 GGN---RLKQPPECMEEVYDLMYQCWSADPKQR 283

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 51/221 (23%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK--REVKILQA-LAGHEN 158
           K +G G++G  ++   K  G++VAVK             E+    RE +I Q  L  HEN
Sbjct: 43  KQIGKGRYGEVWMG--KWRGEKVAVKVF--------FTTEEASWFRETEIYQTVLMRHEN 92
Query: 159 VVKFYNA----FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR-VAA 213
           ++ F  A          +Y+  +  E G L D +      + T  DA  +++     V+ 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSG 146
Query: 214 ECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDI- 261
            CHLH           + HRD+K +N L    K++ +    D GL+  FI    +  DI 
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVKFISDTNEV-DIP 202
Query: 262 ----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
               VG+  Y+ PEVL         +S   +D++S G+I +
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 110/266 (41%), Gaps = 20/266 (7%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G F   Y   D      VA  +++  K+      +  K E + L+ L  H N+V+FY
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEXLKGLQ-HPNIVRFY 91
Query: 164 NAFEDD----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           +++E        + +  EL   G L  +   K+      K      RQ+L+     H   
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTL--KTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 220 --LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
             ++HRD+K +N          S+K  D GL+  +K     + ++G+  + APE  + K 
Sbjct: 150 PPIIHRDLKCDNIFITGPT--GSVKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEEKY 206
Query: 278 GPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRN-KP-DFRRKPWPSISNSAKDF 334
               DV++ G           P+ + +    I++ V    KP  F +   P +    K+ 
Sbjct: 207 DESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV----KEI 262
Query: 335 VKKLLVKDPRARLTAAQALSHPWVRE 360
           ++  + ++   R +    L+H + +E
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 77
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 223

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/302 (21%), Positives = 122/302 (40%), Gaps = 56/302 (18%)
Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIP-------CGKRTDFGYDKDFDRR-YTI 100
           ++ +HQE      +L++ +++ +  R  T +          GK +     K+  R+  T+
Sbjct: 2   YRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITL 61
Query: 101 GKLLGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA- 154
            + LGHG FG  Y        +  +  +VAVK        LP    +      +++AL  
Sbjct: 62  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-------LPEVCSEQDELDFLMEALII 114
Query: 155 ---GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
               H+N+V+           +I +EL  GG+L  +   ++      + +++ +  +L V
Sbjct: 115 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL--KSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 212 AAE--CHLHGL-----VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           A +  C    L     +HRD+   N L          K  DFG++         +DI  +
Sbjct: 173 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRA 223
Query: 265 AYY------------VAPEV-LKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
           +YY            + PE  ++     ++D WS GV+ + I   G  P+  K+   + +
Sbjct: 224 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 283
Query: 311 EV 312
            V
Sbjct: 284 FV 285

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +FD ++    L+GHG FG  Y    + +G +VA+K+        P + + ++     ++ 
Sbjct: 40  NFDHKF----LIGHGVFGKVYKGVLR-DGAKVALKRRT------PESSQGIEEFETEIET 88
Query: 153 LA--GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD----SRYTEKDAAVVVR 206
           L+   H ++V      ++ N + +  +  E G L  R L   D    S   E+   + + 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL-KRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD------ 260
              R     H   ++HRD+K  N L     E+   K TDFG+S   K G +         
Sbjct: 148 AA-RGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGIS---KKGTELDQTHLXXV 200
Query: 261 IVGSAYYVAPE-VLKRKSGPESDVWSIGVITYILLCGR 297
           + G+  Y+ PE  +K +   +SDV+S GV+ + +LC R
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 45/285 (15%)
Query: 69  QKTNSRRQTGVIPCGKRTDFGYDKDF---------DRRYTIGKLLGHGQFGYTYVATDKA 119
           ++ NSR   GV+      ++    D            + T+ + LG G FG  Y    K 
Sbjct: 11  KRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKG 70
Query: 120 -----NGDRVAVKKI-EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY 173
                   RVA+K + E   M   I   +   E  +++    H +VV+            
Sbjct: 71  VVKDEPETRVAIKTVNEAASMRERI---EFLNEASVMKEFNCH-HVVRLLGVVSQGQPTL 126
Query: 174 IAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQMLRVAAEC-------HLHGLVHRDM 225
           + MEL   G+L   + + + +       A   + +M+++A E        + +  VHRD+
Sbjct: 127 VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 186
Query: 226 KPENFLFKSAKEDSSLKATDFGLS------DFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
              N +     ED ++K  DFG++      D+ + G K    +    +++PE LK     
Sbjct: 187 AARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGGKG---LLPVRWMSPESLKDGVFT 240
Query: 279 PESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV----LRNKPD 318
             SDVWS GV+ + I     +P+   + + + + V    L +KPD
Sbjct: 241 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 285

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 16  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 72
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD-AAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 73  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 132 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 189 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 245
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 246 GGLLDKPD 253

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 87
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 88  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 145
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 146 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 233

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 20  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 76
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 77  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 210 RVAAE-------CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 193 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 249
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 250 GGLLDKPD 257

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 15/206 (7%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 78
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 79  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 136
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY-YVAPEVLKRK 276
           +HRD+   N L  +      +K  DFGL   +         Q+     + + APE LK +
Sbjct: 137 IHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 277 S-GPESDVWSIGVITYILLC-GRRPF 300
           +    SD W  GV  + +   G+ P+
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 17/207 (8%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 74
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 75  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA-----YYVAPEVLK- 274
           +HRD+   N L  +      +K  DFGL   + P      ++         + APE LK 
Sbjct: 133 IHRDLAARNLLLATR---DLVKIGDFGLMRAL-PQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 275 RKSGPESDVWSIGVITYILLC-GRRPF 300
           R     SD W  GV  + +   G+ P+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 80
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 81  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 138
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 139 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 226

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 17/207 (8%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 84
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 85  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA-----YYVAPEVLK- 274
           +HRD+   N L  +      +K  DFGL   + P      ++         + APE LK 
Sbjct: 143 IHRDLAARNLLLATR---DLVKIGDFGLMRAL-PQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 275 RKSGPESDVWSIGVITYILLC-GRRPF 300
           R     SD W  GV  + +   G+ P+
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 79
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 80  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 137
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 138 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 225

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 19  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 75
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 76  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 210 RVAAE-------CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 192 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 249 GGLLDKPD 256

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 102
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 103 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 160
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 161 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 248

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 19  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 75
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 76  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 192 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 249 GGLLDKPD 256

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 13  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 69
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 70  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 210 RVAAE-------CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 186 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 242
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 243 GGLLDKPD 250

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 83
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 84  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 141
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 142 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 229

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 80
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 81  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 138
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 139 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 226

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +FD ++    L+GHG FG  Y    + +G +VA+K+        P + + ++     ++ 
Sbjct: 40  NFDHKF----LIGHGVFGKVYKGVLR-DGAKVALKRRT------PESSQGIEEFETEIET 88
Query: 153 LA--GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD----SRYTEKDAAVVVR 206
           L+   H ++V      ++ N + +  +  E G L  R L   D    S   E+   + + 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL-KRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD------ 260
              R     H   ++HRD+K  N L     E+   K TDFG+S   K G +         
Sbjct: 148 AA-RGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGIS---KKGTELGQTHLXXV 200
Query: 261 IVGSAYYVAPE-VLKRKSGPESDVWSIGVITYILLCGR 297
           + G+  Y+ PE  +K +   +SDV+S GV+ + +LC R
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+L  G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 84
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 85  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 142
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 143 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 230

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 17  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 73
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 74  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 133 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 190 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 246
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 247 GGLLDKPD 254

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 77
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 223

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 74
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 75  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY-YVAPEVLK-R 275
           +HRD+   N L  +      +K  DFGL   +         Q+     + + APE LK R
Sbjct: 133 IHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 276 KSGPESDVWSIGVITYILLC-GRRPF 300
                SD W  GV  + +   G+ P+
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 26  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 82
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD-AAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 83  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 210 RVAAE-------CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 199 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 256 GGLLDKPD 263

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 78
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 79  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 136
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY-YVAPEVLK-R 275
           +HRD+   N L  +      +K  DFGL   +         Q+     + + APE LK R
Sbjct: 137 IHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 276 KSGPESDVWSIGVITYILLC-GRRPF 300
                SD W  GV  + +   G+ P+
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 41/214 (19%)
Query: 107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG--HENVVKFYN 164
           G+FG  + A  +   D VAVK       I P+  +   +  + + +  G  HEN+++F  
Sbjct: 26  GRFGCVWKA--QLMNDFVAVK-------IFPLQDKQSWQSEREIFSTPGMKHENLLQFIA 76
Query: 165 AFEDDNYVYIAMELCEG----GELLDRILAKKDSRYTEKDAAVVVRQMLR---------- 210
           A +  + + + + L       G L D +   K +  T  +   V   M R          
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVP 133
Query: 211 -VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI---VGSAY 266
               E H   + HRD K +N L KS   D +    DFGL+   +PGK   D    VG+  
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKS---DLTAVLADFGLAVRFEPGKPPGDTHGQVGTRR 190
Query: 267 YVAPEVL------KRKSGPESDVWSIGVITYILL 294
           Y+APEVL      +R +    D++++G++ + L+
Sbjct: 191 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 81
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 82  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 139
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFG +  +   +K     G      +    
Sbjct: 140 ---RRLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 84
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 85  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 142
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 143 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 230

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 79
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 80  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 137
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFG +  +   +K     G      +    
Sbjct: 138 ---RRLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 225
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	414
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-166
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-161
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-160
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-160
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-160
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-158
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-158
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-158
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-156
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-156
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-154
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-154
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-152
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-150
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-150
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-148
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-148
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-145
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-145
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-143
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-142
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-141
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-140
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-138
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-138
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-138
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-137
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-137
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-135
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-134
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-132
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-128
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-123
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-106
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-104
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-86
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-86
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-85
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-85
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-84
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-83
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-82
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-82
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-80
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-80
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-79
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-78
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-78
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-77
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-77
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-77
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-77
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-77
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-77
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-76
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-75
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-75
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-75
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-74
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-73
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-72
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-72
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-72
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-72
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-71
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-71
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-69
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-67
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-64
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-63
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-62
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-60
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-60
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-57
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-55
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-55
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-54
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-52
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-51
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-50
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-49
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-49
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-49
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-48
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-47
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-47
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-47
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-47
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-46
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-45
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-45
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-45
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-45
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-45
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-45
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-44
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-44
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-43
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-43
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-43
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-42
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-42
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-42
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-42
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-42
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-41
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-41
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-41
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-41
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-41
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-40
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-40
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-40
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-40
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-40
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-40
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-40
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-40
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-39
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-39
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-39
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-39
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-39
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-39
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-39
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-39
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-39
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-39
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-39
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-39
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-39
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-38
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-38
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-38
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-38
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-38
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-37
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-37
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-37
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-37
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-37
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-37
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-37
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-36
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-36
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-36
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-36
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-35
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-35
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-35
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-34
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-34
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-34
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-31
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-31
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-28
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-28
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-28
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-27
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-26
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-26
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-26
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-26
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-25
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-25
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-25
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-20
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-17
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-16
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	2e-12
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	5e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-05
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-08
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-07
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	2e-04
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	2e-04
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	2e-04
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	4e-04

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  473 bits (1219), Expect = e-166
 Identities = 123/317 (38%), Positives = 170/317 (53%), Gaps = 8/317 (2%)

Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
               R +  +   F  RY I  +LG G FG      D+      AVK I K         
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDT 65

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR----EGGDASEIPIDISVLNN 376
              W +IS+ AKD ++K+L   P  R+TA Q L HPW++    E    S++P   S + N
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTN 302

Query: 377 MRQFVKYSRLKQFALRV 393
           +RQF    +L Q AL  
Sbjct: 303 IRQFQAEKKLAQAALLY 319

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  461 bits (1188), Expect = e-161
 Identities = 115/359 (32%), Positives = 180/359 (50%), Gaps = 30/359 (8%)

Query: 48  KHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHG 107
            H H H    +N        +     R++ G                   Y   + LG G
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGMYVRKKEG--------------KIGESYFKVRKLGSG 47

Query: 108 QFGYTYVATDKANGDRVAVKKIEKNKMILPIA----------VEDVKREVKILQALAGHE 157
            +G   +  +K      A+K I+K++                 E++  E+ +L++L  H 
Sbjct: 48  AYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHP 106

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N++K ++ FED  Y Y+  E  EGGEL ++I+ +   ++ E DAA +++Q+L      H 
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK 164

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           H +VHRD+KPEN L ++     ++K  DFGLS F     K +D +G+AYY+APEVLK+K 
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKY 224

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
             + DVWS GVI YILLCG  PF  + +  I K+V + K  F    W +IS+ AK+ +K 
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKL 284

Query: 338 LLVKDPRARLTAAQALSHPWVREG---GDASEIPIDISVLNNMRQFVKYSRLKQFALRV 393
           +L  D   R TA +AL+  W+++     + S+       L+NMR+F    +L Q A+  
Sbjct: 285 MLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF 343

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  459 bits (1183), Expect = e-160
 Identities = 120/305 (39%), Positives = 174/305 (57%), Gaps = 6/305 (1%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
             F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L  H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L  
Sbjct: 82  QL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSG 138

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198

Query: 272 VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           VL      + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SA
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVR---EGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
           KD ++K+L   P  R++A  AL H W++   +   + ++P   + + N+RQF    +L Q
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQ 318

Query: 389 FALRV 393
            AL  
Sbjct: 319 AALLY 323

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  454 bits (1171), Expect = e-160
 Identities = 94/325 (28%), Positives = 169/325 (52%), Gaps = 7/325 (2%)

Query: 72  NSRRQTGVIPCGKRTDFGYDK--DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI 129
           +    TG    G+ ++F  +    F   Y + + LG G F        K  G   A K I
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 130 EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL 189
              K+      + ++RE +I + L  H N+V+ +++ +++++ Y+  +L  GGEL + I+
Sbjct: 63  NTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
           A++   Y+E DA+  ++Q+L   A CH +G+VHR++KPEN L  S  + +++K  DFGL+
Sbjct: 121 ARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178

Query: 250 DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
             +   + +    G+  Y++PEVLK+       D+W+ GVI YILL G  PFWD+ +  +
Sbjct: 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238

Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           + ++     D+    W +++  AK  +  +L  +P+ R+TA QAL  PW+      +   
Sbjct: 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298

Query: 369 IDISVLNNMRQFVKYSRLKQFALRV 393
                ++ +++F    +LK   L  
Sbjct: 299 HRQDTVDCLKKFNARRKLKGAILTT 323

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  453 bits (1167), Expect = e-160
 Identities = 94/309 (30%), Positives = 162/309 (52%), Gaps = 8/309 (2%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVK 148
           D  F+  Y + +++G G F       ++  G + AVK ++  K      ++ ED+KRE  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS--RYTEKDAAVVVR 206
           I   L  H ++V+    +  D  +Y+  E  +G +L   I+ + D+   Y+E  A+  +R
Sbjct: 79  ICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSA 265
           Q+L     CH + ++HRD+KP   L  S +  + +K   FG++    + G      VG+ 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197

Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           +++APEV+KR+  G   DVW  GVI +ILL G  PF+  T++ +F+ +++ K     + W
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQW 256

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYS 384
             IS SAKD V+++L+ DP  R+T  +AL+HPW++E    +        +  +R+F    
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316

Query: 385 RLKQFALRV 393
           +LK   L  
Sbjct: 317 KLKGAVLAA 325

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  454 bits (1171), Expect = e-158
 Identities = 123/351 (35%), Positives = 183/351 (52%), Gaps = 22/351 (6%)

Query: 47  HKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGH 106
           H H H    R   Y Q   +         + G                   Y   K LG 
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKG--------------HLSEMYQRVKKLGS 47

Query: 107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF 166
           G +G   +  DK      A+K I K  +    +   +  EV +L+ L  H N++K Y+ F
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLL-DHPNIMKLYDFF 105

Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           ED    Y+ ME  +GGEL D I+ +   ++ E DAAV+++Q+L      H H +VHRD+K
Sbjct: 106 EDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK 163

Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSI 286
           PEN L +S ++D+ +K  DFGLS   +  KK ++ +G+AYY+APEVL++K   + DVWSI
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSI 223

Query: 287 GVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR 346
           GVI +ILL G  PF  +T+  I ++V + K  F    W ++S  AKD +K++L  D + R
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283

Query: 347 LTAAQALSHPWVREGGDASE----IPIDISVLNNMRQFVKYSRLKQFALRV 393
           ++A QAL HPW++E     E    +P   + + NMR+F    +L Q AL  
Sbjct: 284 ISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLY 334

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  451 bits (1163), Expect = e-158
 Identities = 92/304 (30%), Positives = 161/304 (52%), Gaps = 6/304 (1%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
             F   Y + + LG G F           G   A   I   K+      + ++RE +I +
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICR 65

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L  H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L  
Sbjct: 66  LL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEA 122

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAP 270
              CH  G+VHR++KPEN L  S  + +++K  DFGL+  ++   + +    G+  Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182

Query: 271 EVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           EVL++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++ 
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQF 389
            AKD + K+L  +P  R+TAA+AL HPW+      +        ++ +++F    +LK  
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302

Query: 390 ALRV 393
            L V
Sbjct: 303 ILTV 306

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  445 bits (1147), Expect = e-158
 Identities = 111/280 (39%), Positives = 154/280 (55%), Gaps = 4/280 (1%)

Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
               R +  +   F  RY I  +LG G FG      D+      AVK I K         
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDT 65

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              W +IS+ AKD ++K+L   P  R+TA Q L HPW+++
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  441 bits (1137), Expect = e-156
 Identities = 107/277 (38%), Positives = 163/277 (58%), Gaps = 6/277 (2%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D ++ YT+   +G G +G   +A  K    R A KKI K  +     V+  K+E++I+++
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKS 62

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L  H N+++ Y  FED+  +Y+ MELC GGEL +R++ K+   + E DAA +++ +L   
Sbjct: 63  L-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAV 119

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           A CH   + HRD+KPENFLF +   DS LK  DFGL+   KPGK  +  VG+ YYV+P+V
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179

Query: 273 LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           L+   GPE D WS GV+ Y+LLCG  PF   T+  +  ++      F  K W ++S  A+
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
             +++LL K P+ R+T+ QAL H W  +   +S   +
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  441 bits (1136), Expect = e-156
 Identities = 92/283 (32%), Positives = 159/283 (56%), Gaps = 6/283 (2%)

Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
               R +  +    D  +   + LG G FG  ++  ++++G    +K I K++    + +
Sbjct: 7   HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPM 64

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTE 198
           E ++ E+++L++L  H N++K +  FED + +YI ME CEGGELL+RI++   +    +E
Sbjct: 65  EQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
              A +++QM+   A  H   +VH+D+KPEN LF+     S +K  DFGL++  K  +  
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183

Query: 259 QDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
            +  G+A Y+APEV KR    + D+WS GV+ Y LL G  PF   + + + ++    +P+
Sbjct: 184 TNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
           +  +  P ++  A D +K++L KDP  R +AAQ L H W ++ 
Sbjct: 244 YAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  439 bits (1130), Expect = e-154
 Identities = 115/351 (32%), Positives = 172/351 (49%), Gaps = 14/351 (3%)

Query: 47  HKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDK--DFDRRYTIGKLL 104
           H H H         + L  +      +    G                     + +   L
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61

Query: 105 GHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN 164
           G G     Y    K      A+K ++K         + V+ E+ +L  L+ H N++K   
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKE 115

Query: 165 AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
            FE    + + +EL  GGEL DRI+ K    Y+E+DAA  V+Q+L   A  H +G+VHRD
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRD 173

Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDV 283
           +KPEN L+ +   D+ LK  DFGLS  ++     + + G+  Y APE+L+  + GPE D+
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDM 233

Query: 284 WSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKD 342
           WS+G+ITYILLCG  PF+D+  D  +F+ +L  +  F    W  +S +AKD V+KL+V D
Sbjct: 234 WSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLD 293

Query: 343 PRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRV 393
           P+ RLT  QAL HPWV   G A+      +    +++F    +LK     V
Sbjct: 294 PKKRLTTFQALQHPWVT--GKAANFVHMDTAQKKLQEFNARRKLKAAVKAV 342

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  437 bits (1127), Expect = e-154
 Identities = 80/303 (26%), Positives = 150/303 (49%), Gaps = 12/303 (3%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           K+   +Y I + LG G+FG  +   + ++      K ++            VK+E+ IL 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILN 56

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
               H N++  + +FE    + +  E   G ++ +RI         E++    V Q+   
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEA 114

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H H + H D++PEN ++++ +  S++K  +FG +  +KPG  F+ +  +  Y APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V +       +D+WS+G + Y+LL G  PF  +T   I + ++  +  F  + +  IS  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFA 390
           A DFV +LLVK+ ++R+TA++AL HPW+++  +     +   V+  ++    Y  L +  
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIE----RVSTKVIRTLKHRRYYHTLIKKD 289

Query: 391 LRV 393
           L +
Sbjct: 290 LNM 292

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  434 bits (1118), Expect = e-152
 Identities = 99/365 (27%), Positives = 170/365 (46%), Gaps = 17/365 (4%)

Query: 6   STTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKT 65
                SG ++  N       R         R    A   +      Q        ++L  
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63

Query: 66  KQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVA 125
            Q + T +     + P  +  D+   K+F ++Y    ++G G          +A G   A
Sbjct: 64  AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123

Query: 126 VKKIEKNKMILPI-----AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           VK +E     L         E  +RE  IL+ +AGH +++   +++E  +++++  +L  
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
            GEL D +  K     +EK+   ++R +L   +  H + +VHRD+KPEN L     ++  
Sbjct: 184 KGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQ 238

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYIL 293
           ++ +DFG S  ++PG+K +++ G+  Y+APE+LK          G E D+W+ GVI + L
Sbjct: 239 IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298

Query: 294 LCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           L G  PFW + +  + + ++  +  F    W   S++ KD + +LL  DP ARLTA QAL
Sbjct: 299 LAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQAL 358

Query: 354 SHPWV 358
            HP+ 
Sbjct: 359 QHPFF 363

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  431 bits (1110), Expect = e-150
 Identities = 81/366 (22%), Positives = 148/366 (40%), Gaps = 17/366 (4%)

Query: 38  NHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRR 97
           N   ++            +                  +Q              +   D  
Sbjct: 4   NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
               ++LG G  G      +K   ++ A+K ++             +REV++    +   
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115

Query: 158 NVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           ++V+  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +     
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H   + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235

Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSIS 328
             +      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +S
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
              K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S +    +       ++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 355

Query: 389 FALRVT 394
               + 
Sbjct: 356 MTSALA 361

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  427 bits (1099), Expect = e-150
 Identities = 78/302 (25%), Positives = 145/302 (48%), Gaps = 4/302 (1%)

Query: 92  KDFDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           ++F+  Y +  K LG G+F        K+ G   A K ++K +        ++  E+ +L
Sbjct: 24  ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVL 82

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           +       V+  +  +E+ + + + +E   GGE+    L +     +E D   +++Q+L 
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H + +VH D+KP+N L  S      +K  DFG+S  I    + ++I+G+  Y+AP
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202

Query: 271 EVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           E+L        +D+W+IG+I Y+LL    PF  +     +  + +   D+  + + S+S 
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI-PIDISVLNNMRQFVKYSRLKQ 388
            A DF++ LLVK+P  R TA   LSH W+++    +   P + S  +  +     S   +
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDK 322

Query: 389 FA 390
            +
Sbjct: 323 TS 324

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  421 bits (1086), Expect = e-148
 Identities = 90/284 (31%), Positives = 154/284 (54%), Gaps = 6/284 (2%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
             F   Y + + LG G F        K  G   A K I   K+      + ++RE +I +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICR 60

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L  H N+V+ +++ +++++ Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L  
Sbjct: 61  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILES 117

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
            A CH +G+VHR++KPEN L  S  + +++K  DFGL+  +   + +    G+  Y++PE
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           VLK+       D+W+ GVI YILL G  PFWD+ +  ++ ++     D+    W +++  
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGD-ASEIPIDISV 373
           AK  +  +L  +P+ R+TA QAL  PW+      AS I    +V
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  415 bits (1069), Expect = e-145
 Identities = 103/308 (33%), Positives = 161/308 (52%), Gaps = 15/308 (4%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREV 147
            ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            IL+ +  H NV+  +  +E+   V + +EL  GGEL D +  K+    TE++A   ++Q
Sbjct: 66  SILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQ 122

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS-LKATDFGLSDFIKPGKKFQDIVGSAY 266
           +L      H   + H D+KPEN +          +K  DFGL+  I  G +F++I G+  
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           +VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSR 385
           + S  AKDF+++LLVKDP+ R+T   +L HPW++              L+     V   +
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ-------QALSRKASAVNMEK 295

Query: 386 LKQFALRV 393
            K+FA R 
Sbjct: 296 FKKFAARK 303

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  413 bits (1063), Expect = e-145
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 23/304 (7%)

Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
             +P    T       F   Y   ++LG G          K      AVK I+       
Sbjct: 4   AALPGSHST-----HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58

Query: 138 IAV------EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK 191
            A       E   +EV IL+ ++GH N+++  + +E + + ++  +L + GEL D +  K
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118

Query: 192 KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
                +EK+   ++R +L V    H   +VHRD+KPEN L     +D ++K TDFG S  
Sbjct: 119 V--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQ 173

Query: 252 IKPGKKFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCGRRPFWDKT 304
           + PG+K +++ G+  Y+APE+++          G E D+WS GVI Y LL G  PFW + 
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA 364
           +  + + ++     F    W   S++ KD V + LV  P+ R TA +AL+HP+ ++    
Sbjct: 234 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293

Query: 365 SEIP 368
               
Sbjct: 294 EVRH 297

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  410 bits (1057), Expect = e-143
 Identities = 93/312 (29%), Positives = 145/312 (46%), Gaps = 22/312 (7%)

Query: 93  DFDRRYTIGK-LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
                Y + K +LG G  G       +  G + A+K +  +           ++EV    
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHW 76

Query: 152 ALAGHENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
             +G  ++V   + +E+       + I ME  EGGEL  RI  + D  +TE++AA ++R 
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +       H H + HRD+KPEN L+ S ++D+ LK TDFG +         Q    + YY
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYY 195

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRK 322
           VAPEVL  +      D+WS+GVI YILLCG  PF+  T      G+ + +   +  F   
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS-VLNNMRQFV 381
            W  +S  AK  ++ LL  DP  RLT  Q ++HPW+ +     + P+  + VL   +   
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315

Query: 382 KYSRLKQFALRV 393
               +K+     
Sbjct: 316 D--EVKEEMTSA 325

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  407 bits (1047), Expect = e-142
 Identities = 91/325 (28%), Positives = 153/325 (47%), Gaps = 30/325 (9%)

Query: 91  DKDFDRRYTIG---KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           D  F + Y +    K LG G F        K +    AVK I K          + ++E+
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEI 56

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
             L+   GH N+VK +  F D  + ++ MEL  GGEL +RI  KK   ++E +A+ ++R+
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRK 114

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIVGSAY 266
           ++   +  H  G+VHRD+KPEN LF    ++  +K  DFG +    P  +  +    + +
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED-------GIFKEVLRNKPD 318
           Y APE+L +       D+WS+GVI Y +L G+ PF              I K++ +    
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI--------- 369
           F  + W ++S  AKD ++ LL  DP  RL  +    + W+++G   S  P+         
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSS 294

Query: 370 DISVLNNMR-QFVKYSRLKQFALRV 393
             +V   ++  F  +++ K+    +
Sbjct: 295 GAAVHTCVKATFHAFNKYKREGFCL 319

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  415 bits (1067), Expect = e-141
 Identities = 97/343 (28%), Positives = 160/343 (46%), Gaps = 8/343 (2%)

Query: 42  RNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIG 101
             D   + +    +      + K       ++           +            Y I 
Sbjct: 103 PGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIH 162

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           + LG G FG  +  T++A G+  A K +           E V++E++ +  L  H  +V 
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLR-HPTLVN 218

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++AFEDDN + +  E   GGEL +++  + +   +E +A   +RQ+ +     H +  V
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYV 277

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           H D+KPEN +F + K  + LK  DFGL+  + P +  +   G+A + APEV + K  G  
Sbjct: 278 HLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
           +D+WS+GV++YILL G  PF  + +D   + V     +     +  IS   KDF++KLL+
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396

Query: 341 KDPRARLTAAQALSHPWVREG-GDASEIPIDISVLNNMRQFVK 382
            DP  R+T  QAL HPW+  G     +  I  S    +R  +K
Sbjct: 397 ADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 439

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  401 bits (1033), Expect = e-140
 Identities = 96/283 (33%), Positives = 155/283 (54%), Gaps = 8/283 (2%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREVKI 149
             +  Y +G+ LG GQF        K  G   A K I+K ++      ++ E+++REV I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           L+ +  H N++  ++ FE+   V + +EL  GGEL D +  K+    TE +A   ++Q+L
Sbjct: 62  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQIL 118

Query: 210 RVAAECHLHGLVHRDMKPENFLFKS-AKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                 H   + H D+KPEN +       +  +K  DFG++  I+ G +F++I G+  +V
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           APE++  +  G E+D+WSIGVITYILL G  PF  +T+      +     DF  + + + 
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID 370
           S  AKDF+++LLVKDP+ R+T AQ+L H W++     +    D
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGED 281

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  400 bits (1030), Expect = e-138
 Identities = 105/363 (28%), Positives = 168/363 (46%), Gaps = 10/363 (2%)

Query: 48  KHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIP-CGKRTDFGYDKDFDRRYTIGKLLGH 106
           +  H H       +            +    +      +            Y I + LG 
Sbjct: 2   RGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGS 61

Query: 107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF 166
           G FG  +   +KA G     K I       P+    VK E+ I+  L  H  ++  ++AF
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAF 117

Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           ED   + + +E   GGEL DRI A+ D + +E +    +RQ        H H +VH D+K
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176

Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWS 285
           PEN + ++ K+ SS+K  DFGL+  + P +  +    +A + APE++ R+  G  +D+W+
Sbjct: 177 PENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 235

Query: 286 IGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRA 345
           IGV+ Y+LL G  PF  + +    + V R   +F    + S+S  AKDF+K LL K+PR 
Sbjct: 236 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 295

Query: 346 RLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR--VTQYFKYTALF 403
           RLT   AL HPW++         I  S  N +RQ +K       A +  + +   +++L 
Sbjct: 296 RLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLR 355

Query: 404 KVK 406
           K +
Sbjct: 356 KHR 358

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  396 bits (1019), Expect = e-138
 Identities = 102/312 (32%), Positives = 162/312 (51%), Gaps = 11/312 (3%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREV 147
            +  +  Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            IL+ +  H NV+  ++ +E+   V + +EL  GGEL D +  K+    +E++A   ++Q
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS-LKATDFGLSDFIKPGKKFQDIVGSAY 266
           +L      H   + H D+KPEN +          +K  DFGL+  I+ G +F++I G+  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           +VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + + 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI--PIDISVLNNMRQFVKY 383
             S  AKDF++KLLVK+ R RLT  +AL HPW+    +   +     +  L N R+    
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVR 303

Query: 384 SRLKQFALRVTQ 395
            R K  +  +  
Sbjct: 304 RRWKL-SFSIVS 314

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  395 bits (1016), Expect = e-138
 Identities = 75/311 (24%), Positives = 136/311 (43%), Gaps = 37/311 (11%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           +   D      ++LG G  G      +K   ++ A+K ++             +REV++ 
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELH 64

Query: 151 QALAGHENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              +   ++V+  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +       H   + HRD+KPEN L+ S + ++ LK TDFG                   
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------ 166

Query: 267 YVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRK 322
             A E    K     D+WS+GVI YILLCG  PF+         G+   +   + +F   
Sbjct: 167 --AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
            W  +S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S +    +  +
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE-R 283

Query: 383 YSRLKQFALRV 393
           +  +K+     
Sbjct: 284 WEDVKEEMTSA 294

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  395 bits (1017), Expect = e-137
 Identities = 101/311 (32%), Positives = 147/311 (47%), Gaps = 37/311 (11%)

Query: 90  YDKDFDRRYTIGK-LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           +   F+  Y + + +LG G         +       AVK IEK           V REV+
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVE 62

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           +L    GH NV++    FE+++  Y+  E   GG +L  I  ++   + E +A+VVV+ +
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDV 120

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI------- 261
                  H  G+ HRD+KPEN L +   + S +K  DF L   IK       I       
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 262 -VGSAYYVAPEVLKRKS------GPESDVWSIGVITYILLCGRRPFWDK----------- 303
             GSA Y+APEV++  S          D+WS+GVI YILL G  PF  +           
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240

Query: 304 ----TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
                ++ +F+ +   K +F  K W  IS +AKD + KLLV+D + RL+AAQ L HPWV+
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

Query: 360 EGGDASEIPID 370
             G A E  + 
Sbjct: 301 --GCAPENTLP 309

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  396 bits (1019), Expect = e-137
 Identities = 102/376 (27%), Positives = 179/376 (47%), Gaps = 19/376 (5%)

Query: 20  NNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGV 79
           ++ +HH +      +  +    +N      +  H E  + +      +     S+R + +
Sbjct: 3   HHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSAL 62

Query: 80  I--------PCGKRTDFGYDKDFDRRYTIGKL--LGHGQFGYTYVATDKANGDRVAVKKI 129
                    P   R         +  YT+ K   LG G+FG  +   + A G ++A K I
Sbjct: 63  AVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122

Query: 130 EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL 189
           +   M      E+VK E+ ++  L  H N+++ Y+AFE  N + + ME  +GGEL DRI+
Sbjct: 123 KTRGMKD---KEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178

Query: 190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
            +     TE D  + ++Q+       H   ++H D+KPEN L  + ++   +K  DFGL+
Sbjct: 179 DE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLA 236

Query: 250 DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
              KP +K +   G+  ++APEV+        +D+WS+GVI Y+LL G  PF    +   
Sbjct: 237 RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296

Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
              +L  + D   + +  IS  AK+F+ KLL+K+   R++A++AL HPW+ +    S + 
Sbjct: 297 LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS 356

Query: 369 IDI--SVLNNMRQFVK 382
                +  ++ + FV 
Sbjct: 357 AQKKKNRGSDAQDFVT 372

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  392 bits (1008), Expect = e-135
 Identities = 100/305 (32%), Positives = 158/305 (51%), Gaps = 10/305 (3%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREV 147
            +  +  Y IG+ LG GQF       +K+ G   A K I+K +       +  E+++REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            IL+ +  H N++  ++ +E+   V + +EL  GGEL D +  K+    +E++A   ++Q
Sbjct: 67  SILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS-LKATDFGLSDFIKPGKKFQDIVGSAY 266
           +L      H   + H D+KPEN +          +K  DFGL+  I+ G +F++I G+  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           +VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + + 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI--PIDISVLNNMRQFVKY 383
             S  AKDF++KLLVK+ R RLT  +AL HPW+        +     +  L N ++    
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVR 303

Query: 384 SRLKQ 388
            R K 
Sbjct: 304 RRWKL 308

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  387 bits (996), Expect = e-134
 Identities = 94/315 (29%), Positives = 152/315 (48%), Gaps = 21/315 (6%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
              F   Y + + +G G +        KA     AVK I+K+K        D   E++IL
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEIL 69

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N++   + ++D  YVY+  EL +GGELLD+IL +K   ++E++A+ V+  + +
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITK 127

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKED-SSLKATDFGLSDFIKP-GKKFQDIVGSAYYV 268
                H  G+VHRD+KP N L+     +  S++  DFG +  ++           +A +V
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFW---DKTEDGIFKEVLRNKPDFRRKPW 324
           APEVL+R+      D+WS+GV+ Y +L G  PF    D T + I   +   K       W
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ----- 379
            S+S++AKD V K+L  DP  RLTAA  L HPW+       +  ++     ++ +     
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAA 307

Query: 380 -FVKYSRLKQFALRV 393
            +   +R +   L  
Sbjct: 308 TYSALNRNQSPVLEP 322

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  382 bits (983), Expect = e-132
 Identities = 104/314 (33%), Positives = 160/314 (50%), Gaps = 20/314 (6%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-----VEDVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A       +V+
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 64  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 119

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 265 AYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239

Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ 379
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++        +     + + +
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE------DMKRKFQDLLSE 293

Query: 380 FVKYSRLKQFALRV 393
             + + L Q   + 
Sbjct: 294 ENESTALPQVLAQP 307

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  373 bits (958), Expect = e-128
 Identities = 97/347 (27%), Positives = 148/347 (42%), Gaps = 56/347 (16%)

Query: 68  HQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVK 127
           H   +S R+      G         +  ++Y +   +G G +G   VA +       A+K
Sbjct: 4   HHHHSSGRENLYFQGGSL------LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57

Query: 128 KIEKNKMIL--PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL 185
            + KNK+    P  VE +K EV++++ L  H N+ + Y  +ED+ Y+ + MELC GG LL
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLL 116

Query: 186 DRILAKK--------------------------------------DSRYTEKDAAVVVRQ 207
           D++                                          D    EK  + ++RQ
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIV 262
           +       H  G+ HRD+KPENFLF +  +   +K  DFGLS                  
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235

Query: 263 GSAYYVAPEVLK---RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
           G+ Y+VAPEVL       GP+ D WS GV+ ++LL G  PF    +     +VL  K  F
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF 295

Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE 366
               +  +S  A+D +  LL ++   R  A +AL HPW+ +  D   
Sbjct: 296 ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIY 342

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  364 bits (935), Expect = e-123
 Identities = 100/288 (34%), Positives = 151/288 (52%), Gaps = 14/288 (4%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----PIAVEDVK 144
           Y K     Y + K LG G  G   +A ++    +VA++ I K K  +          +V+
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 189 TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 244

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 265 AYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364

Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++     + 
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 412

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  320 bits (822), Expect = e-106
 Identities = 80/314 (25%), Positives = 140/314 (44%), Gaps = 40/314 (12%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           +++         K+LG+G  G T V      G  VAVK++  +        +    E+K+
Sbjct: 9   FEQSLKNLVVSEKILGYGSSG-TVVFQGSFQGRPVAVKRMLIDFC------DIALMEIKL 61

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS-----RYTEKDAAVV 204
           L     H NV+++Y +   D ++YIA+ELC    L D + +K  S        E +   +
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKP 254
           +RQ+    A  H   ++HRD+KP+N L  ++           E+  +  +DFGL   +  
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 255 GK-----KFQDIVGSAYYVAPEVL--------KRKSGPESDVWSIGVITYILLC-GRRPF 300
           G+        +  G++ + APE+L        KR+     D++S+G + Y +L  G+ PF
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 301 WDK--TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            DK   E  I + +  +  + +     S+   A D + +++  DP  R TA + L HP  
Sbjct: 241 GDKYSRESNIIRGIF-SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

Query: 359 REGGDASEIPIDIS 372
                  E  + +S
Sbjct: 300 WPKSKKLEFLLKVS 313

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  315 bits (809), Expect = e-104
 Identities = 72/311 (23%), Positives = 130/311 (41%), Gaps = 21/311 (6%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +    +LGHG  G T V     +   VAVK+I               REV++L+    H
Sbjct: 25  SFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEH 77

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            NV++++   +D  + YIA+ELC    L + +  +KD  +   +   +++Q     A  H
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLLQQTTSGLAHLH 135

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKA--TDFGLSDFIKPGK----KFQDIVGSAYYVAP 270
              +VHRD+KP N L         +KA  +DFGL   +  G+    +   + G+  ++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 271 EVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           E+L            D++S G + Y ++      + K+       +L         P   
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS--VLNNMRQFVKYS 384
               A++ ++K++  DP+ R +A   L HP+        +   D+S  +           
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVK 315

Query: 385 RLKQFALRVTQ 395
           +L++    V +
Sbjct: 316 QLERGGRAVVK 326

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  265 bits (679), Expect = 2e-86
 Identities = 91/309 (29%), Positives = 150/309 (48%), Gaps = 14/309 (4%)

Query: 64  KTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR 123
           K                P  +  +   D    RRY  G+ LG G F   +  +D    + 
Sbjct: 9   KAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEV 68

Query: 124 VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE 183
            A K + K+ ++ P   E +  E+ I ++LA H++VV F+  FED+++V++ +ELC    
Sbjct: 69  FAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRS 127

Query: 184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA 243
           LL+    +K    TE +A   +RQ++      H + ++HRD+K  N       ED  +K 
Sbjct: 128 LLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKI 182

Query: 244 TDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFW 301
            DFGL+  ++  G++ + + G+  Y+APEVL +K    E DVWSIG I Y LL G+ PF 
Sbjct: 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

Query: 302 DKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                  +  + +N  ++     P  I+  A   ++K+L  DP AR T  + L+  +   
Sbjct: 243 TSCLKETYLRIKKN--EYS---IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

Query: 361 GGDASEIPI 369
           G   + +PI
Sbjct: 298 GYIPARLPI 306

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  263 bits (675), Expect = 3e-86
 Identities = 89/283 (31%), Positives = 146/283 (51%), Gaps = 14/283 (4%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
            D    RRY  G+ LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
            ++LA H++VV F+  FED+++V++ +ELC    LL+    +K    TE +A   +RQ++
Sbjct: 69  HRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 125

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYV 268
                 H + ++HRD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS- 326
           APEVL +K    E DVWSIG I Y LL G+ PF        +  + +N  ++     P  
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYS---IPKH 237

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           I+  A   ++K+L  DP AR T  + L+  +   G   + +PI
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPI 280

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  261 bits (669), Expect = 4e-85
 Identities = 75/306 (24%), Positives = 129/306 (42%), Gaps = 30/306 (9%)

Query: 72  NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK 131
           +    +GV    +   F       R Y+I K +G G     +   ++      A+K +  
Sbjct: 4   HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNL 62

Query: 132 NKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA 190
            +      ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  
Sbjct: 63  EEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL-- 118

Query: 191 KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
           KK       +     + ML      H HG+VH D+KP NFL      D  LK  DFG+++
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 174

Query: 251 FIKPGKKFQD---IVGSAYYVAPEVLKRKS------------GPESDVWSIGVITYILLC 295
            ++P          VG+  Y+ PE +K  S             P+SDVWS+G I Y +  
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

Query: 296 GRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           G+ PF         +   +    P+   +         +D +K  L +DP+ R++  + L
Sbjct: 235 GKTPFQQIINQISKLHAII---DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

Query: 354 SHPWVR 359
           +HP+V+
Sbjct: 292 AHPYVQ 297

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  261 bits (668), Expect = 6e-85
 Identities = 64/304 (21%), Positives = 111/304 (36%), Gaps = 41/304 (13%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
              +  + +  +LG G     +    K  GD  A+K       + P  V+   RE ++L+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLK 62

Query: 152 ALAGHENVVKFYNAFEDDN--YVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQM 208
            L  H+N+VK +   E+    +  + ME C  G L   +          E +  +V+R +
Sbjct: 63  KLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +        +G+VHR++KP N +    +   S  K TDFG +  ++  ++F  + G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 268 VAPEVLKRKS---------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--- 315
           + P++ +R           G   D+WSIGV  Y    G  PF         KEV+     
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 316 ------------------KPDFRRKPWPSISNSAKD----FVKKLLVKDPRARLTAAQAL 353
                                       S+S   +      +  +L  D        Q  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 354 SHPW 357
           +   
Sbjct: 302 AETS 305

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  256 bits (657), Expect = 9e-84
 Identities = 91/267 (34%), Positives = 140/267 (52%), Gaps = 11/267 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + +G LLG G F   Y A     G  VA+K I+K  M     V+ V+ EVKI   L  H
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-H 70

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            ++++ YN FED NYVY+ +E+C  GE+    L  +   ++E +A   + Q++      H
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRY-LKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKR 275
            HG++HRD+   N L         +K  DFGL+  +K P +K   + G+  Y++PE+  R
Sbjct: 130 SHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
            + G ESDVWS+G + Y LL GR PF   T      +V+    D+    +  +S  AKD 
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF--LSIEAKDL 242

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREG 361
           + +LL ++P  RL+ +  L HP++   
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSRN 269

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  256 bits (656), Expect = 8e-83
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 30/297 (10%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
            R Y+I K +G G     +   ++      A+K +   +      ++  + E+  L  L 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQ 65

Query: 155 GH-ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
            H + +++ Y+    D Y+Y+ ME C   +L   +  KK       +     + ML    
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVH 122

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD---IVGSAYYVAP 270
             H HG+VH D+KP NFL      D  LK  DFG+++ ++P          VG+  Y+ P
Sbjct: 123 TIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 271 EVLKRKS------------GPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNK 316
           E +K  S             P+SDVWS+G I Y +  G+ PF         +   +    
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---D 235

Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISV 373
           P+   +         +D +K  L +DP+ R++  + L+HP+V+            + 
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 292

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  254 bits (650), Expect = 2e-82
 Identities = 69/299 (23%), Positives = 120/299 (40%), Gaps = 43/299 (14%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           +   +    +LG G FG    A +  +    A+KKI   +      +  +  EV +L +L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE----KLSTILSEVMLLASL 59

Query: 154 AGHENVVKFYNAFEDDN-------------YVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             H+ VV++Y A+ +                ++I ME CE G L D I    ++   ++D
Sbjct: 60  N-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRD 116

Query: 201 -AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---------- 249
               + RQ+L   +  H  G++HRD+KP N       E  ++K  DFGL+          
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDIL 173

Query: 250 -----DFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWD 302
                +           +G+A YVA EVL        + D++S+G+I + ++        
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTG 231

Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                I K++     +F      +     K  ++ L+  DP  R  A   L+  W+   
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  256 bits (655), Expect = 4e-82
 Identities = 83/395 (21%), Positives = 146/395 (36%), Gaps = 48/395 (12%)

Query: 25  HRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGK 84
           H + +            +     K + QH +          K     N            
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVK------ 54

Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
                      R Y+I K +G G     +   ++      A+K +   +      ++  +
Sbjct: 55  ----------GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYR 102

Query: 145 REVKILQALAGH-ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
            E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK       +   
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL--KKKKSIDPWERKS 159

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--- 260
             + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P         
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDS 215

Query: 261 IVGSAYYVAPEVLKRKS------------GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
            VG+  Y+ PE +K  S             P+SDVWS+G I Y +  G+ PF       I
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-I 274

Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            K      P+   +         +D +K  L +DP+ R++  + L+HP+V+         
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334

Query: 369 IDIS------VLNNMRQFVKYSRLKQFALRVTQYF 397
              +      VL  +      + + + A  + +++
Sbjct: 335 AKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHY 369

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  251 bits (643), Expect = 1e-80
 Identities = 53/363 (14%), Positives = 95/363 (26%), Gaps = 46/363 (12%)

Query: 38  NHHARNDTTHKHQHQHQERAKNYQQLK-TKQHQKTNSRRQTGVIPCGKRTDFGYD-KDFD 95
           +H    D+  +   + +E    Y + +  K+           V P    T         +
Sbjct: 2   SHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE 61

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL-- 153
           R+  + + L  G     ++  D    +  A+K            +E +         L  
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 154 ---------------------AGHENVVKFYNAFEDDNY--VYIAMELCEG-----GELL 185
                                       +     +D       + M             L
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 186 DRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
           D +   +          ++  Q++R+AA     GLVH    P+N        D  L   D
Sbjct: 182 DFVYVFR-GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGD 237

Query: 246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS---GPESDVWSIGVITYILLCGRRPFWD 302
                  K G +         Y   E L   +       + W +G+  Y + C   PF  
Sbjct: 238 VSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 303 KTEDGIFKEVL-----RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            T                           + +  K  + + L  D R RL   +A+  P 
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355

Query: 358 VRE 360
             +
Sbjct: 356 FLQ 358

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  247 bits (632), Expect = 5e-80
 Identities = 78/266 (29%), Positives = 134/266 (50%), Gaps = 12/266 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I   L  H
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-H 68

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 126

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              ++HRD+KPEN L         LK  DFG S    P  +  D+ G+  Y+ PE+++ +
Sbjct: 127 SKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGR 182

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
               + D+WS+GV+ Y  L G+ PF   T    +K + R +  F   P   ++  A+D +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARDLI 238

Query: 336 KKLLVKDPRARLTAAQALSHPWVREG 361
            +LL  +P  R    + L HPW+   
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITAN 264

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  248 bits (634), Expect = 6e-79
 Identities = 64/304 (21%), Positives = 111/304 (36%), Gaps = 41/304 (13%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
              +  + +  +LG G     +    K  GD  A+K       + P  V+   RE ++L+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLK 62

Query: 152 ALAGHENVVKFYNAFEDDN--YVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQM 208
            L  H+N+VK +   E+    +  + ME C  G L   +          E +  +V+R +
Sbjct: 63  KLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +        +G+VHR++KP N +    +   S  K TDFG +  ++  ++F  + G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 268 VAPEVLKRKS---------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP- 317
           + P++ +R           G   D+WSIGV  Y    G  PF         KEV+     
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 318 --------------------DFRRKPWPSISNSAKD----FVKKLLVKDPRARLTAAQAL 353
                                       S+S   +      +  +L  D        Q  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 354 SHPW 357
           +   
Sbjct: 302 AETS 305

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  242 bits (619), Expect = 4e-78
 Identities = 88/267 (32%), Positives = 130/267 (48%), Gaps = 12/267 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G  LG G FG   +   +  G +VAVK + + K+     V  +KRE++ L+    H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-H 70

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            +++K Y         ++ ME   GGEL D I      R  E +A  + +Q+L     CH
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH 128

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VHRD+KPEN L        + K  DFGLS+ +  G+  +   GS  Y APEV+  +
Sbjct: 129 RHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185

Query: 277 --SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
             +GPE D+WS GVI Y LLCG  PF D+    +FK++      F    +  ++ S    
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATL 241

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREG 361
           +  +L  DP  R T      H W ++ 
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQD 268

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  241 bits (618), Expect = 5e-78
 Identities = 82/271 (30%), Positives = 131/271 (48%), Gaps = 16/271 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + + LG G +G   +A ++   + VAVK ++  +       E++K+E+ I + L  H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-H 64

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           ENVVKFY    + N  Y+ +E C GGEL DRI         E DA     Q++      H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH 122

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI---VGSAYYVAPEVL 273
             G+ HRD+KPEN L     E  +LK +DFGL+   +   + + +    G+  YVAPE+L
Sbjct: 123 GIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSISNS 330
           KR+       DVWS G++   +L G  P+   ++    + +           PW  I ++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSA 237

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
               + K+LV++P AR+T        W  + 
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKP 268

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  242 bits (620), Expect = 1e-77
 Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 24/288 (8%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-----VKR 145
           + ++ ++Y+    LG G FG+ + A DK     V VK I+K K++    +ED     V  
Sbjct: 19  EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMEL-CEGGELLDRILAKKDSRYTEKDAAVV 204
           E+ IL  +  H N++K  + FE+  +  + ME    G +L   I      R  E  A+ +
Sbjct: 79  EIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYI 135

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
            RQ++       L  ++HRD+K EN +     ED ++K  DFG + +++ GK F    G+
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGT 192

Query: 265 AYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
             Y APEVL      GPE ++WS+GV  Y L+    PF +       +E +         
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAA--IHPP 244

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID 370
               +S      V  LL   P  R T  + ++ PWV +  + ++   +
Sbjct: 245 YL--VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWE 290

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  240 bits (616), Expect = 1e-77
 Identities = 81/278 (29%), Positives = 138/278 (49%), Gaps = 12/278 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + IG+ LG G+FG  Y+A +K N   +A+K + K+++        ++RE++I   L  H
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-H 73

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+++ YN F D   +Y+ +E    GEL   +  +K  R+ E+ +A  + ++      CH
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH 131

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              ++HRD+KPEN L         LK  DFG S    P  + + + G+  Y+ PE+++ K
Sbjct: 132 ERKVIHRDIKPENLLM---GYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGK 187

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
           +   + D+W  GV+ Y  L G  PF   +     + ++    D +  P+  +S+ +KD +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLI 243

Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISV 373
            KLL   P  RL     + HPWV+        P+  S 
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  243 bits (622), Expect = 1e-77
 Identities = 86/284 (30%), Positives = 132/284 (46%), Gaps = 12/284 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY   K +G G FG   +  DK   + VAVK IE+   I     E+V+RE+   ++L  H
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLR-H 75

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q+L   + CH
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCH 133

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L         LK  DFG S       + +  VG+  Y+APEVL R+
Sbjct: 134 SMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192

Query: 277 --SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   +++ ++      +       IS    
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNN 376
             + ++ V DP  R++  +  +H W  +   A  +    +    
Sbjct: 253 HLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQF 296

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  240 bits (615), Expect = 4e-77
 Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 28/313 (8%)

Query: 65  TKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           TK  Q   +   T   P G +      + F+  Y +G LLG G FG  +      +  +V
Sbjct: 4   TKPLQGPPAPPGTPTPPPGGKDR----EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV 59

Query: 125 AVKKIEKNKMILPIAVED---VKREVKILQAL---AGHENVVKFYNAFEDDNYVYIAMEL 178
           A+K I +N+++    + D      EV +L  +    GH  V++  + FE      + +E 
Sbjct: 60  AIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLER 119

Query: 179 -CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE 237
                +L D I  K      E  +     Q++     CH  G+VHRD+K EN L      
Sbjct: 120 PLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--R 175

Query: 238 DSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLC 295
               K  DFG    +     + D  G+  Y  PE + R       + VWS+G++ Y ++C
Sbjct: 176 RGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234

Query: 296 GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
           G  PF         +E+L    +        +S      +++ L   P +R +  + L  
Sbjct: 235 GDIPFERD------QEILEA--ELHFPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLD 284

Query: 356 PWVREGGDASEIP 368
           PW++   +   + 
Sbjct: 285 PWMQTPAEDVPLN 297

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  241 bits (616), Expect = 5e-77
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 22/295 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y + K +G G F    +A     G  VA+K I+K + + P +++ + REV+I++ L  H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN-H 73

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH 131

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              +VHRD+K EN L      D ++K  DFG S+    G K     G+  Y APE+ + K
Sbjct: 132 QKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188

Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              GPE DVWS+GVI Y L+ G  PF  +    + + VLR    +R   +  +S   ++ 
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY--MSTDCENL 244

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREGGDASEIP---------IDISVLNNMRQF 380
           +K+ LV +P  R T  Q +   W+  G +  E+           D   ++ M   
Sbjct: 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  240 bits (615), Expect = 5e-77
 Identities = 87/304 (28%), Positives = 140/304 (46%), Gaps = 14/304 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + + LG G +G   +A ++   + VAVK ++  +       E++K+E+ I + L  H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-H 64

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           ENVVKFY    + N  Y+ +E C GGEL DRI         E DA     Q++      H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH 122

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI---VGSAYYVAPEVL 273
             G+ HRD+KPEN L     E  +LK +DFGL+   +   + + +    G+  YVAPE+L
Sbjct: 123 GIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           KR+       DVWS G++   +L G  P+ D+  D   +     +      PW  I ++ 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPW-DQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFAL 391
              + K+LV++P AR+T        W  +          ++          +S+  Q  L
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNL 298

Query: 392 RVTQ 395
             + 
Sbjct: 299 DFSP 302

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  242 bits (619), Expect = 9e-76
 Identities = 94/300 (31%), Positives = 141/300 (47%), Gaps = 21/300 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G  LG G FG   V   +  G +VAVK + + K+     V  ++RE++ L+    H
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-H 75

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            +++K Y      + +++ ME   GGEL D I      R  EK++  + +Q+L     CH
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCH 133

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VHRD+KPEN L        + K  DFGLS+ +  G+  +   GS  Y APEV+  +
Sbjct: 134 RHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 190

Query: 277 --SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
             +GPE D+WS GVI Y LLCG  PF D     +FK++      F    +  ++ S    
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQY--LNPSVISL 246

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREGG---------DASEIPIDISVLNNMRQFVKYSR 385
           +K +L  DP  R T      H W ++             S   ID   L  + +  + S 
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSE 306

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  237 bits (607), Expect = 1e-75
 Identities = 91/299 (30%), Positives = 148/299 (49%), Gaps = 21/299 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y I + LG G FG   +AT      +VA+K I +  +        V+RE+  L+ L  H
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-H 68

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            +++K Y+       + + +E   GGEL D I+ KK  R TE +     +Q++     CH
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH 125

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VHRD+KPEN L     ++ ++K  DFGLS+ +  G   +   GS  Y APEV+  K
Sbjct: 126 RHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182

Query: 277 --SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
             +GPE DVWS G++ Y++L GR PF D+    +FK+V      +    +  +S  A+  
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPGAQSL 238

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREGGDASEIP--------IDISVLNNMRQFVKYSR 385
           +++++V DP  R+T  +    PW          P         D  +++ + + + +S 
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSE 297

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  236 bits (603), Expect = 2e-75
 Identities = 72/330 (21%), Positives = 119/330 (36%), Gaps = 27/330 (8%)

Query: 36  RHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFD 95
            H+HH+            Q   +   +  + + + + + +  G  P         +  F 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRP------ESFFQ 56

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           + +     LGHG +G  +    K +G   AVK+        P        EV   + +  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQ 115

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H   V+   A+E+   +Y+  ELC G  L         +   E      +R  L   A  
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H  GLVH D+KP N            K  DFGL   +      +   G   Y+APE+L+ 
Sbjct: 174 HSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230

Query: 276 KSGPESDVWSIGVITYILLCGRRPF-----WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
             G  +DV+S+G+    + C          W +   G                   +S+ 
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF----------TAGLSSE 280

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +  +  +L  DP+ R TA   L+ P +R+
Sbjct: 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  243 bits (620), Expect = 5e-74
 Identities = 65/316 (20%), Positives = 125/316 (39%), Gaps = 32/316 (10%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + + LG G FGY      +  G++VA+K+  +     P   E    E++I++ L  H
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-H 71

Query: 157 ENVVKFYNAFEDDNYV------YIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQML 209
            NVV      +    +       +AME CEGG+L   +          E     ++  + 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H + ++HRD+KPEN + +   +    K  D G +  +  G+   + VG+  Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191

Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PE+L++K      D WS G + +  + G RPF    +   +   +R K +     +  ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251

Query: 329 NS--------------------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA-SEI 367
            +                     + +++ +L+   R R T  Q  +    +      S  
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311

Query: 368 PIDISVLNNMRQFVKY 383
            + +  + + R     
Sbjct: 312 LLSVMNMVSGRVHTYP 327

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  231 bits (591), Expect = 9e-73
 Identities = 54/388 (13%), Positives = 115/388 (29%), Gaps = 69/388 (17%)

Query: 37  HNHHARNDTTHKHQH----------QHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRT 86
           H+HH  +   + +             ++    N +          +S   T +   G+  
Sbjct: 3   HHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPF 62

Query: 87  DFG-YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
                  +  R    G +LG         ATD+  G+   V      +     A++ +K 
Sbjct: 63  RVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 122

Query: 146 EVKILQALA------------------------GHENVVKFYNAFEDDN--YVYIAMELC 179
           EV  L+ L                           + +++      D      +      
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182

Query: 180 EG--GELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
           +       + +   +             +  Q++R+ A  H +GLVH  ++P + +    
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD-- 240

Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS------------GPESDV 283
            +   +  T F                 S  +  PE+  R++                D 
Sbjct: 241 -QRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296

Query: 284 WSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDP 343
           W++G++ Y + C   P       G  + + R+  +        I    +  ++  L    
Sbjct: 297 WALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPK 348

Query: 344 RARLTAAQALSHPWVREGGD--ASEIPI 369
             RL   QA+  P   +     ++ +P+
Sbjct: 349 EDRLLPLQAMETPEYEQLRTELSAALPL 376

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  228 bits (583), Expect = 1e-72
 Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 23/278 (8%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
             Y +   +G G +G       K++G  +  K+++   M      + +  EV +L+ L  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK- 63

Query: 156 HENVVKFYNAFED--DNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRV 211
           H N+V++Y+   D  +  +YI ME CEGG+L   I    K+     E+    V+ Q+   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 212 AAECH-----LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGS 264
             ECH      H ++HRD+KP N FL        ++K  DFGL+  +     F +  VG+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDG----KQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            YY++PE + R S   +SD+WS+G + Y L     PF   ++  +  ++   K       
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----R 235

Query: 324 WPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            P   S+   + + ++L      R +  + L +P + E
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  229 bits (586), Expect = 1e-72
 Identities = 76/327 (23%), Positives = 136/327 (41%), Gaps = 31/327 (9%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQ 108
           H H H       +          ++ +                +  + +Y +G LLG G 
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKE---------KEPLESQYQVGPLLGSGG 55

Query: 109 FGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALA-GHENVVKFYN 164
           FG  Y     ++   VA+K +EK+++     + +   V  EV +L+ ++ G   V++  +
Sbjct: 56  FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115

Query: 165 AFEDDNYVYIAMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            FE  +   + +E  E   +L D I  +      E+ A     Q+L     CH  G++HR
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHR 173

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPES 281
           D+K EN L         LK  DFG    +K    + D  G+  Y  PE ++     G  +
Sbjct: 174 DIKDENILIDL--NRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSA 230

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
            VWS+G++ Y ++CG  PF         +E++R +     +    +S+  +  ++  L  
Sbjct: 231 AVWSLGILLYDMVCGDIPFEHD------EEIIRGQ--VFFRQR--VSSECQHLIRWCLAL 280

Query: 342 DPRARLTAAQALSHPWVREGGDASEIP 368
            P  R T  +  +HPW+++     E  
Sbjct: 281 RPSDRPTFEEIQNHPWMQDVLLPQETA 307

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  229 bits (585), Expect = 4e-72
 Identities = 73/300 (24%), Positives = 141/300 (47%), Gaps = 14/300 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y   + +G G FG   +     +G +  +K+I  ++M      E+ +REV +L  +  H
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMK-H 82

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V++  +FE++  +YI M+ CEGG+L  RI A+K   + E        Q+       H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 217 LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEVLK 274
              ++HRD+K +N FL K    D +++  DFG++  +    +  +  +G+ YY++PE+ +
Sbjct: 143 DRKILHRDIKSQNIFLTK----DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAK 332
            K    +SD+W++G + Y L   +  F   +   +  +++         P     S   +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLR 254

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
             V +L  ++PR R +    L   ++ +  +    P  I+    ++ F K+      A R
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  228 bits (584), Expect = 5e-72
 Identities = 65/324 (20%), Positives = 122/324 (37%), Gaps = 47/324 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK--------------NKMILPIAVED 142
            Y I + L  G+F    +          A+KK EK              +K+ +    +D
Sbjct: 32  DYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 143 VKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------DSRY 196
            K E++I+  +  +E  +       + + VYI  E  E   +L                 
Sbjct: 90  FKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 197 TEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG 255
             +    +++ +L   +  H    + HRD+KP N L     ++  +K +DFG S+     
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESE-YMVD 204

Query: 256 KKFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKE 311
           KK +   G+  ++ PE    +   +G + D+WS+G+  Y++     PF  K +   +F  
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264

Query: 312 VLRNKPDF---------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +     ++                      +SN   DF+K  L K+P  R+T+  AL H 
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324

Query: 357 WVREGGDASEIPIDISVLNNMRQF 380
           W+ +            +    ++ 
Sbjct: 325 WLADTNIEDLREFSKELYKKRKKL 348

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  224 bits (572), Expect = 5e-71
 Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 36/287 (12%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           DK F   +   +L+G G FG  + A  + +G    +K+++ N        E  +REVK L
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKAL 58

Query: 151 QALAGHENVVKFYNAFED----------------DNYVYIAMELCEGGELLDRILAKKDS 194
             L  H N+V +   ++                    ++I ME C+ G L   I  ++  
Sbjct: 59  AKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
           +  +  A  +  Q+ +     H   L++RD+KP N       +   +K  DFGL   +K 
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKN 174

Query: 255 GKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
             K     G+  Y++PE +  +  G E D++++G+I   LL      ++      F ++ 
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232

Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                             K  ++KLL K P  R   ++ L    V +
Sbjct: 233 DGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  224 bits (573), Expect = 8e-71
 Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 22/297 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAG 155
           +Y +G LLG G +G      D     R AVK ++K K+  +P    +VK+E+++L+ L  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64

Query: 156 HENVVKFYN--AFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           H+NV++  +    E+   +Y+ ME C  G  E+LD +  K   R+    A     Q++  
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---RFPVCQAHGYFCQLIDG 121

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYV 268
               H  G+VH+D+KP N L        +LK +  G++            +   GS  + 
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 269 APEVL---KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
            PE+       SG + D+WS GV  Y +  G  PF       +F+ + +    +      
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD- 235

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
                  D +K +L  +P  R +  Q   H W R+    +E P+ I    + +   +
Sbjct: 236 -CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWR 291

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  219 bits (561), Expect = 3e-69
 Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 39/293 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--------------------- 135
           +YT+   +G G +G   +A ++ +    A+K + K K+I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 136 --LPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAK 191
                 +E V +E+ IL+ L  H NVVK     +D  ++++Y+  EL   G +++     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--- 129

Query: 192 KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
                +E  A    + +++     H   ++HRD+KP N L     ED  +K  DFG+S+ 
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNE 186

Query: 252 IKPGKKF-QDIVGSAYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRPFWDKTED 306
            K       + VG+  ++APE L    K  SG   DVW++GV  Y  + G+ PF D+   
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 307 GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            +  ++     +F     P I+   KD + ++L K+P +R+   +   HPWV 
Sbjct: 247 CLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  214 bits (547), Expect = 7e-67
 Identities = 59/315 (18%), Positives = 111/315 (35%), Gaps = 33/315 (10%)

Query: 63  LKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGD 122
           + +  H   +S  +  +   G           ++ Y   + LG G F Y  +     +G 
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGHMVIID-----NKHYLFIQKLGEGGFSYVDLVEGLHDGH 55

Query: 123 RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----NYVYIAMEL 178
             A+K+I  ++       E+ +RE  + +    H N+++       +    +  ++ +  
Sbjct: 56  FYALKRILCHEQ---QDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPF 111

Query: 179 CEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK 236
            + G L + I  L  K +  TE     ++  + R     H  G  HRD+KP N L     
Sbjct: 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD-- 169

Query: 237 EDSSLKATDFGLSDFIKPGKKFQD----------IVGSAYYVAPEVLKRKS----GPESD 282
            +      D G  +      +                +  Y APE+   +S       +D
Sbjct: 170 -EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228

Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKD 342
           VWS+G + Y ++ G  P+    + G     L  +        P  S++    +  ++  D
Sbjct: 229 VWSLGCVLYAMMFGEGPYDMVFQKGDSV-ALAVQNQLSIPQSPRHSSALWQLLNSMMTVD 287

Query: 343 PRARLTAAQALSHPW 357
           P  R      LS   
Sbjct: 288 PHQRPHIPLLLSQLE 302

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  208 bits (532), Expect = 1e-64
 Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 14/279 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + I K +G GQF   Y A    +G  VA+KK++   ++   A  D  +E+ +L+ L  H
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-H 91

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAE 214
            NV+K+Y +F +DN + I +EL + G+L   I    K+     E+       Q+      
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEV 272
            H   ++HRD+KP N F+         +K  D GL  F          +VG+ YY++PE 
Sbjct: 152 MHSRRVMHRDIKPANVFITA----TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSISN 329
           +       +SD+WS+G + Y +   + PF+    +   + K++ +   D+   P    S 
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 265

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
             +  V   +  DP  R                 AS + 
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  208 bits (531), Expect = 2e-63
 Identities = 58/380 (15%), Positives = 117/380 (30%), Gaps = 55/380 (14%)

Query: 23  NHHRNANKEEAKRRHNHHARN-DTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIP 81
           +HH +++  E          +       +  ++    N +          +S   T +  
Sbjct: 3   HHHHHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWN 62

Query: 82  CGKRTDFG-YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
            G+         +  R    G +LG         ATD+  G+   V      +     A+
Sbjct: 63  TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI 122

Query: 141 EDVKREVKILQALAG---------------------HENVVKFYNAFEDDNYVYIAMEL- 178
           + +K EV  L+ L G                          K      D+  +++     
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182

Query: 179 ------CEGGELLDRILAKKDSRYTEKDAAV--VVRQMLRVAAECHLHGLVHRDMKPENF 230
                        + +L+   +  +    A   +  Q++R+ A  H +GLVH  ++P + 
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242

Query: 231 LFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPEVL------KRKSGPE 280
           +     +   +  T F     ++ G      +G  +      A  +L             
Sbjct: 243 VLD---QRGGVFLTGFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W++G+  Y + C   P  D    G  + + R+  +        I    +  ++  L 
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFLR 349

Query: 341 KDPRARLTAAQALSHPWVRE 360
                RL   QA+  P   +
Sbjct: 350 YPKEDRLLPLQAMETPEYEQ 369

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  201 bits (513), Expect = 4e-62
 Identities = 62/288 (21%), Positives = 122/288 (42%), Gaps = 32/288 (11%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
            +   +   + +G G+FG  +    + +G   A+K+ +K      +  ++  REV     
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAV 66

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLR 210
           L  H +VV++++A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 211 VAAECHLHGLVHRDMKPEN-FLFKS---------------AKEDSSLKATDFGLSDFIKP 254
                H   LVH D+KP N F+ ++               A      K  D G    I  
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 255 GKKFQDIVGSAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
            +      G + ++A EVL+      P++D++++  +T +   G  P     +   + E+
Sbjct: 187 PQVE---EGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQ--WHEI 240

Query: 313 LRNKPDFRRKPWPS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            + +        P  +S    + +K ++  DP  R +A   + H  + 
Sbjct: 241 RQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  197 bits (504), Expect = 1e-60
 Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 40/301 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +   + LG G FG  + A +K +    A+K+I        +A E V REVK L  L  H
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE-H 62

Query: 157 ENVVKFYNAFEDDN------------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAV- 203
             +V+++NA+ + N            Y+YI M+LC    L D +  +      E+   + 
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------------D 250
           +  Q+       H  GL+HRD+KP N  F     D  +K  DFGL               
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 251 FIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE-DGI 308
            +    +    VG+  Y++PE +   S   + D++S+G+I + LL    PF  + E    
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236

Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
             +V   K       +          V+ +L   P  R  A   + +    +     +  
Sbjct: 237 LTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293

Query: 369 I 369
           +
Sbjct: 294 L 294

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  197 bits (502), Expect = 5e-60
 Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 39/290 (13%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           + R  + ++L  G F + Y A D  +G   A+K++  N+         + +EV  ++ L+
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLS 83

Query: 155 GHENVVKFYNAF--------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           GH N+V+F +A                +  ELC+G  +      +     +      +  
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143

Query: 207 QMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--- 261
           Q  R     H     ++HRD+K EN L  +     ++K  DFG +  I     +      
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSN---QGTIKLCDFGSATTISHYPDYSWSAQR 200

Query: 262 ----------VGSAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDG 307
                       +  Y  PE++   S    G + D+W++G I Y+L   + PF    EDG
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDG 256

Query: 308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
               ++  K  +   P  +        ++ +L  +P  RL+ A+ +    
Sbjct: 257 AKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  190 bits (484), Expect = 3e-57
 Identities = 76/322 (23%), Positives = 122/322 (37%), Gaps = 31/322 (9%)

Query: 51  HQHQERAKNYQQLKTKQHQ---KTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHG 107
           H     AK +     K  +   +T       +    K  D+ Y ++     T    +G G
Sbjct: 11  HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEV-HWMTHQPRVGRG 69

Query: 108 QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK-REVKILQALAGHENVVKFYNAF 166
            FG  +   DK  G + AVKK+          +E  +  E+     L+    +V  Y A 
Sbjct: 70  SFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLS-SPRIVPLYGAV 119

Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
            +  +V I MEL EGG L    L K+     E  A   + Q L      H   ++H D+K
Sbjct: 120 REGPWVNIFMELLEGGSLGQ--LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177

Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGK------KFQDIVGSAYYVAPEVLKRKS-GP 279
            +N L   + + S     DFG +  ++P            I G+  ++APEV+  K    
Sbjct: 178 ADNVLL--SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235

Query: 280 ESDVWSIGVITYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           + D+WS      + +L G  P+          K +    P  R  P PS +      +++
Sbjct: 236 KVDIWSSC-CMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIP-PSCAPLTAQAIQE 292

Query: 338 LLVKDPRARLTAAQALSHPWVR 359
            L K+P  R +A +        
Sbjct: 293 GLRKEPVHRASAMELRRKVGKA 314

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  186 bits (474), Expect = 1e-55
 Identities = 56/285 (19%), Positives = 96/285 (33%), Gaps = 32/285 (11%)

Query: 95  DRRYTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
            +   +  LLG G F   Y AT     D  N  +  +K  +      P       + ++ 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMER 120

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS---RYTEKDAAVVVR 206
           L+        +KFY+A    N   +  EL   G LL+ I   K++      +        
Sbjct: 121 LKPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKS--------AKEDSSLKATDFGLSDFIK---PG 255
           +ML +  + H   ++H D+KP+NF+  +            + L   D G S  +K    G
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 256 KKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR 314
             F     ++ +   E+L  K    + D + +    Y +L G        E G  K    
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN-EGGECKPEGL 298

Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            +       W        +F   +L       L +   L     +
Sbjct: 299 FRRLPHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKLKK 336

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  184 bits (468), Expect = 2e-55
 Identities = 73/280 (26%), Positives = 128/280 (45%), Gaps = 22/280 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
                 +LG G +G  Y   D +N  R+A+K+I +         + +  E+ + + L  H
Sbjct: 23  ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-H 78

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVRQMLRVAAE 214
           +N+V++  +F ++ ++ I ME   GG L   +L  K       E+      +Q+L     
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKY 137

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVL 273
            H + +VHRD+K +N L  +      LK +DFG S  +       +   G+  Y+APE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195

Query: 274 KRKS---GPESDVWSIGVITYI-LLCGRRPFWDKTEDG--IFK-EVLRNKPDFRRKPWPS 326
            +     G  +D+WS+G  T I +  G+ PF++  E    +FK  + +  P+    P  S
Sbjct: 196 DKGPRGYGKAADIWSLG-CTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI---P-ES 250

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE 366
           +S  AK F+ K    DP  R  A   L   +++      +
Sbjct: 251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  181 bits (461), Expect = 4e-54
 Identities = 90/280 (32%), Positives = 135/280 (48%), Gaps = 32/280 (11%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +DF      GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++ 
Sbjct: 30  EDFK----FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L  H   VK Y  F+DD  +Y  +   + GELL  I  +K   + E        ++  V
Sbjct: 86  RL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEI--V 140

Query: 212 AAECHLH--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLS---DFIKPGKKFQDIVGS 264
           +A  +LH  G++HRD+KPEN L      +    ++ TDFG +          +    VG+
Sbjct: 141 SALEYLHGKGIIHRDLKPENILL-----NEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           A YV+PE+L  KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF   P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P 252

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQA------LSHPW 357
                  A+D V+KLLV D   RL   +        +HP+
Sbjct: 253 -EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  175 bits (446), Expect = 8e-52
 Identities = 78/306 (25%), Positives = 144/306 (47%), Gaps = 32/306 (10%)

Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
              D    +D    + + +L+G+G +G  Y       G   A+K ++    +     E++
Sbjct: 12  DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEI 67

Query: 144 KREVKILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
           K+E+ +L+  + H N+  +Y AF        D+ +++ ME C  G + D I   K +   
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127

Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK- 256
           E+  A + R++LR  +  H H ++HRD+K +N L     E++ +K  DFG+S  +     
Sbjct: 128 EEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVG 184

Query: 257 KFQDIVGSAYYVAPEVLKRKSGPES------DVWSIGVITYI-LLCGRRPFWD----KTE 305
           +    +G+ Y++APEV+     P++      D+WS+G IT I +  G  P  D    +  
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRA- 242

Query: 306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
             +F       P  + K W   S   + F++  LVK+   R    Q + HP++R+  +  
Sbjct: 243 --LFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297

Query: 366 EIPIDI 371
           ++ I +
Sbjct: 298 QVRIQL 303

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  172 bits (437), Expect = 7e-51
 Identities = 58/280 (20%), Positives = 111/280 (39%), Gaps = 21/280 (7%)

Query: 91  DKDFDRRYT-IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
               D R+      +G G F   Y   D      VA  +++  K +     +  K E ++
Sbjct: 20  GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEM 78

Query: 150 LQALAGHENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           L+ L  H N+V+FY+++E        + +  EL   G L      K+      K      
Sbjct: 79  LKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT--YLKRFKVMKIKVLRSWC 135

Query: 206 RQMLRVAAECHLHG----LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           RQ+L+      LH     ++HRD+K +N          S+K  D GL+  +K     + +
Sbjct: 136 RQILK--GLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLAT-LKRASFAKAV 190

Query: 262 VGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFR 320
           +G+  ++APE+ + K     DV++ G+    +     P+ +      I++ V        
Sbjct: 191 IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--P 248

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                      K+ ++  + ++   R +    L+H + +E
Sbjct: 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  172 bits (438), Expect = 1e-50
 Identities = 83/320 (25%), Positives = 143/320 (44%), Gaps = 18/320 (5%)

Query: 52  QHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGY 111
            H     +   L T+     +            R       D          +G G  G 
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVD-QGDPRLLLDSYVKIGEGSTGI 60

Query: 112 TYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY 171
             +A +K +G +VAVK ++  K       E +  EV I++    H NVV+ Y ++     
Sbjct: 61  VCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEE 116

Query: 172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFL 231
           +++ ME  +GG L D +      R  E+  A V   +L+  A  H  G++HRD+K ++ L
Sbjct: 117 LWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSIL 173

Query: 232 FKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVI 289
                 D  +K +DFG    I     K + +VG+ Y++APEV+ R     E D+WS+G I
Sbjct: 174 L---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLG-I 229

Query: 290 TYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
             I ++ G  P++  +    + +      P  +      +S   +DF++++LV+DP+ R 
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS--HKVSPVLRDFLERMLVRDPQERA 287

Query: 348 TAAQALSHPWVREGGDASEI 367
           TA + L HP++ + G    +
Sbjct: 288 TAQELLDHPFLLQTGLPECL 307

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  168 bits (427), Expect = 2e-49
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 17/281 (6%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
             D  ++YT  + +G G  G  Y A D A G  VA++++   +       E +  E+ ++
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVM 71

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           +    + N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ L+
Sbjct: 72  RENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQ 127

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVA 269
                H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y++A
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 270 PEVLKRKS-GPESDVWSIGVITYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPS 326
           PEV+ RK+ GP+ D+WS+G I  I ++ G  P+ ++     ++       P+ +      
Sbjct: 185 PEVVTRKAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EK 241

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           +S   +DF+ + L  D   R +A + L H +++     S +
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSL 282

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  168 bits (427), Expect = 2e-49
 Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 28/290 (9%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D D +  + I   LG G FG  Y A +K  G   A K IE         +ED   E++IL
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEIL 70

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H  +VK   A+  D  ++I +E C GG +   I+ + D   TE    VV RQML 
Sbjct: 71  ATCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLE 128

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVA 269
                H   ++HRD+K  N L      +  ++  DFG+S        K    +G+ Y++A
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185

Query: 270 PEVLKRKSGPES------DVWSIGVITYI-LLCGRRPFWD----KTEDGIFKEVLRNKPD 318
           PEV+  ++  ++      D+WS+G IT I +     P  +    +    + K    + P 
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRV---LLKIAKSDPPT 241

Query: 319 FRRKP-WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
                 W   S   +DF+K  L K+P  R +AAQ L HP+V        +
Sbjct: 242 LLTPSKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKAL 288

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  169 bits (430), Expect = 3e-49
 Identities = 84/330 (25%), Positives = 142/330 (43%), Gaps = 20/330 (6%)

Query: 45  TTHKHQHQHQERAKNYQQLKTKQHQKTN-SRRQTGVIPCGKRTDFGYDKDFDRRYTIGKL 103
           + + H H H       + L  +       +  + G +      +  +  D ++ ++  + 
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +GHG FG  Y A D  N + VA+KK+  +        +D+ +EV+ LQ L  H N +++ 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYR 120

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
             +  ++  ++ ME C G    D +L        E + A V    L+  A  H H ++HR
Sbjct: 121 GCYLREHTAWLVMEYCLGS-ASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS----GP 279
           D+K  N L     E   +K  DFG +  + P   F   VG+ Y++APEV+          
Sbjct: 179 DVKAGNILL---SEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDG 232

Query: 280 ESDVWSIGVITYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           + DVWS+G IT I L   + P ++      ++       P  +   W   S   ++FV  
Sbjct: 233 KVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDS 288

Query: 338 LLVKDPRARLTAAQALSHPWVREGGDASEI 367
            L K P+ R T+   L H +V      + I
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  165 bits (420), Expect = 3e-48
 Identities = 82/282 (29%), Positives = 139/282 (49%), Gaps = 19/282 (6%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
            K  +  + + + LG G +G  Y A  K  G  VA+K++          ++++ +E+ I+
Sbjct: 24  TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIM 78

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           Q      +VVK+Y ++  +  ++I ME C  G + D I+  ++   TE + A +++  L+
Sbjct: 79  QQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLK 136

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVA 269
                H    +HRD+K  N L      +   K  DFG++  +     K   ++G+ +++A
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193

Query: 270 PEVLKRKS-GPESDVWSIGVITYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFR-RKPWP 325
           PEV++       +D+WS+G IT I +  G+ P+ D      IF       P FR  + W 
Sbjct: 194 PEVIQEIGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW- 251

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
             S++  DFVK+ LVK P  R TA Q L HP+VR     S +
Sbjct: 252 --SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSIL 291

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  167 bits (424), Expect = 1e-47
 Identities = 80/317 (25%), Positives = 138/317 (43%), Gaps = 33/317 (10%)

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
              +L   ++     +    ++   K      D DF+      K++G G F    V   K
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRD-DFEIL----KVIGRGAFSEVAVVKMK 83

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
             G   A+K + K  M+    V   + E  +L        + + + AF+D+NY+Y+ ME 
Sbjct: 84  QTGQVYAMKIMNKWDMLKRGEVSCFREERDVL-VNGDRRWITQLHFAFQDENYLYLVMEY 142

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAK 236
             GG+LL  +L+K   R   + A   + ++  V A   +H  G VHRD+KP+N L     
Sbjct: 143 YVGGDLL-TLLSKFGERIPAEMARFYLAEI--VMAIDSVHRLGYVHRDIKPDNILL---- 195

Query: 237 EDSS--LKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKRKS--------GPESDVW 284
            D    ++  DFG    ++     +    VG+  Y++PE+L+           GPE D W
Sbjct: 196 -DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254

Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLLVKDP 343
           ++GV  Y +  G+ PF+  +    + +++  K           +   A+DF+++LL   P
Sbjct: 255 ALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPP 313

Query: 344 RARLTAAQAL---SHPW 357
             RL    A    +HP+
Sbjct: 314 ETRLGRGGAGDFRTHPF 330

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  166 bits (421), Expect = 3e-47
 Identities = 84/313 (26%), Positives = 136/313 (43%), Gaps = 31/313 (9%)

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
           ++  L+  ++      R    I   +      + D++    + K++G G FG   +   K
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAE-DYE----VVKVIGRGAFGEVQLVRHK 91

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
           +     A+K + K +MI          E  I+ A A    VV+ + AF+DD Y+Y+ ME 
Sbjct: 92  STRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQLFYAFQDDRYLYMVMEY 150

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAK 236
             GG+L+  +++       EK A     ++  V A   +H  G +HRD+KP+N L     
Sbjct: 151 MPGGDLV-NLMSNY--DVPEKWARFYTAEV--VLALDAIHSMGFIHRDVKPDNMLL---- 201

Query: 237 EDSS--LKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKRKS-----GPESDVWSIG 287
            D S  LK  DFG    +      +    VG+  Y++PEVLK +      G E D WS+G
Sbjct: 202 -DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260

Query: 288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
           V  Y +L G  PF+  +  G + +++ +K          IS  AK+ +   L  D   RL
Sbjct: 261 VFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRL 319

Query: 348 TAAQAL---SHPW 357
                     H +
Sbjct: 320 GRNGVEEIKRHLF 332

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  162 bits (413), Expect = 3e-47
 Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 16/280 (5%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
             D +  +T  + +G G FG  +   D      VA+K I+  +    I  ED+++E+ +L
Sbjct: 17  KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVL 74

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                   V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+
Sbjct: 75  SQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILK 130

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIVGSAYYVA 269
                H    +HRD+K  N L     E   +K  DFG++  +     K    VG+ +++A
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187

Query: 270 PEVLKRKS-GPESDVWSIGVITYI-LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           PEV+K+ +   ++D+WS+G IT I L  G  P  +     +   + +N P      +   
Sbjct: 188 PEVIKQSAYDSKADIWSLG-ITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY--- 243

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           S   K+FV+  L K+P  R TA + L H ++      +  
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  163 bits (415), Expect = 4e-47
 Identities = 73/304 (24%), Positives = 129/304 (42%), Gaps = 57/304 (18%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
              Y + + LG G++   + A +  N ++V VK ++      P+  + +KRE+KIL+ L 
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLR 88

Query: 155 GHENVVKFYNAFEDD---NYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQML 209
           G  N++   +  +D        +   +    +   L + L   D R+        + ++L
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHV-NNTDFKQLYQTLTDYDIRF-------YMYEIL 140

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +    CH  G++HRD+KP N +         L+  D+GL++F  PG+++   V S Y+  
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 198

Query: 270 PEVL--KRKSGPESDVWSIGVITYILLCGRRPF-------------------------WD 302
           PE+L   +      D+WS+G +   ++  + PF                          D
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258

Query: 303 KTEDGIFKEVLRNKPDFRRKPW---------PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           K    +            RK W           +S  A DF+ KLL  D ++RLTA +A+
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318

Query: 354 SHPW 357
            HP+
Sbjct: 319 EHPY 322

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  159 bits (405), Expect = 4e-46
 Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 28/290 (9%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y + +++G G       A      ++VA+K+I   K     +++++ +E++ +     H
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-H 72

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLD------RILAKKDSRYTEKDAAVVVRQMLR 210
            N+V +Y +F   + +++ M+L  GG +LD           K     E   A ++R++L 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI------KPGKKFQDIVGS 264
                H +G +HRD+K  N L     ED S++  DFG+S F+         K  +  VG+
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 265 AYYVAPEVLKRKSG--PESDVWSIGVITYI-LLCGRRPFWDKTEDGIFKEVLRNKP---- 317
             ++APEV+++  G   ++D+WS G IT I L  G  P+       +    L+N P    
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFG-ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248

Query: 318 --DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
                ++       S +  +   L KDP  R TAA+ L H + ++  +  
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  162 bits (411), Expect = 1e-45
 Identities = 81/318 (25%), Positives = 141/318 (44%), Gaps = 37/318 (11%)

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
           N   L+ +++               K+     + DF+    I K++G G FG   V   K
Sbjct: 42  NNSPLRREKNILEYLEWAKPFTSKVKQMRLHRE-DFE----ILKVIGRGAFGEVAVVKLK 96

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
                 A+K + K +M+        + E  +L      + +   + AF+DDN +Y+ M+ 
Sbjct: 97  NADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLHYAFQDDNNLYLVMDY 155

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAK 236
             GG+LL   L+K + R  E+ A   + +M  V A   +H    VHRD+KP+N L     
Sbjct: 156 YVGGDLLTL-LSKFEDRLPEEMARFYLAEM--VIAIDSVHQLHYVHRDIKPDNILM---- 208

Query: 237 EDSS--LKATDFGLSDFIKPGKKFQDI-----VGSAYYVAPEVLKRKS------GPESDV 283
            D +  ++  DFG         +   +     VG+  Y++PE+L+         GPE D 
Sbjct: 209 -DMNGHIRLADFGSC---LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264

Query: 284 WSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLLVKD 342
           WS+GV  Y +L G  PF+ ++    + +++ +K  F+     + +S +AKD +++L+   
Sbjct: 265 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSR 324

Query: 343 PRARLTAAQAL---SHPW 357
              RL          HP+
Sbjct: 325 EH-RLGQNGIEDFKKHPF 341

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  160 bits (408), Expect = 1e-45
 Identities = 69/280 (24%), Positives = 127/280 (45%), Gaps = 30/280 (10%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
            F+    IGK    G FG   +          A+K + K K +    V +V +E++I+Q 
Sbjct: 16  HFEILRAIGK----GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L  H  +V  + +F+D+  +++ ++L  GG+L  R   +++  + E+   + + ++  V 
Sbjct: 72  LE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICEL--VM 126

Query: 213 AECHLH--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLSDFIKPGKKFQDIVGSAYYV 268
           A  +L    ++HRDMKP+N L      D    +  TDF ++  +    +   + G+  Y+
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILL-----DEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 269 APEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKPDFRR 321
           APE+   + G       D WS+GV  Y LL GRRP+  ++      I          +  
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP- 240

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQAL-SHPWVRE 360
               + S      +KKLL  +P  R +    + + P++ +
Sbjct: 241 ---SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  158 bits (402), Expect = 2e-45
 Identities = 78/306 (25%), Positives = 124/306 (40%), Gaps = 45/306 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQAL 153
           +Y     +G G +G  +   ++  G  VA+KK    E + +I  IA+    RE+++L+ L
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQL 59

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V     F     +++  E C+    +   L +      E     +  Q L+   
Sbjct: 60  K-HPNLVNLLEVFRRKRRLHLVFEYCDHT--VLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH H  +HRD+KPEN L       S +K  DFG +     P   + D V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPENILITK---HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK-------------EVLRN 315
           L    + GP  DVW+IG + +  L    P W      D ++              +V   
Sbjct: 174 LVGDTQYGPPVDVWAIGCV-FAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232

Query: 316 KPDFR-------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG 362
              F                 +P+IS  A   +K  L  DP  RLT  Q L HP+     
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292

Query: 363 DASEIP 368
           +  ++ 
Sbjct: 293 EIEDLA 298

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  157 bits (400), Expect = 5e-45
 Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 32/293 (10%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G       K +G  +AVK+I     +     + +  ++ ++   +    +V+FY
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 164 NAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--- 218
            A   +   +I MEL      +    + +  D    E+    +    ++  A  HL    
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK--ALNHLKENL 145

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            ++HRD+KP N L   +     +K  DFG+S   +    K +D  G   Y+APE +   +
Sbjct: 146 KIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSA 201

Query: 278 GPE-----SDVWSIGVITYI-LLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
             +     SDVWS+G IT   L  GR P+  W+   D + + V  + P          S 
Sbjct: 202 SRQGYDVRSDVWSLG-ITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP 260

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
           S  +FV   L KD   R    + L HP++       E  ++      +  +V 
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFILM---YEERAVE------VACYVC 304

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  157 bits (398), Expect = 7e-45
 Identities = 75/327 (22%), Positives = 139/327 (42%), Gaps = 45/327 (13%)

Query: 72  NSRRQTGVI-PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI- 129
           +S +QTG +   G+R     + D +    +G++ G G  G  +    +  G  +AVK++ 
Sbjct: 5   SSGKQTGYLTIGGQRYQAEIN-DLEN---LGEM-GSGTCGQVWKMRFRKTGHVIAVKQMR 59

Query: 130 -EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI 188
              NK       + +  ++ ++        +V+ +  F  +  V+IAMEL       +++
Sbjct: 60  RSGNKEEN----KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC--AEKL 113

Query: 189 LAKKDSRYTEKDAAVVVRQMLRVAAECHLH---GLVHRDMKPENFLFKSAKEDSSLKATD 245
             +      E+    +   +++  A  +L    G++HRD+KP N L     +   +K  D
Sbjct: 114 KKRMQGPIPERILGKMTVAIVK--ALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCD 168

Query: 246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE------SDVWSIGVITYI-LLCGRR 298
           FG+S  +   K      G A Y+APE +      +      +DVWS+G I+ + L  G+ 
Sbjct: 169 FGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG-ISLVELATGQF 227

Query: 299 PFWDKTEDGIFK---EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
           P+  K     F+   +VL+ +P          S   + FVK  L KD R R    + L H
Sbjct: 228 PY--KNCKTDFEVLTKVLQEEPP-LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284

Query: 356 PWVREGGDASEIPIDISVLNNMRQFVK 382
            +++       + +D      +  + K
Sbjct: 285 SFIKR---YETLEVD------VASWFK 302

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  157 bits (400), Expect = 9e-45
 Identities = 81/327 (24%), Positives = 140/327 (42%), Gaps = 44/327 (13%)

Query: 43  NDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGK 102
           N    K   + +   +   + K    +K  +  Q                 FD      K
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----------DQFD----RIK 47

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKL 106

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GL 220
             +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q+  V    +LH   L
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQI--VLTFEYLHSLDL 162

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV----GSAYYVAPEVLKRK 276
           ++RD+KPEN L         ++ TDFG +      K+ +       G+   +APE++  K
Sbjct: 163 IYRDLKPENLLIDQ---QGYIQVTDFGFA------KRVKGRTWTLCGTPEALAPEIILSK 213

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
                 D W++GV+ Y +  G  PF+      I+++++  K  F   P    S+  KD +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLL 269

Query: 336 KKLLVKDPRARLTAAQA-----LSHPW 357
           + LL  D   R    +       +H W
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  159 bits (403), Expect = 1e-44
 Identities = 89/360 (24%), Positives = 147/360 (40%), Gaps = 57/360 (15%)

Query: 39  HHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRY 98
                 T+     +  ++   +  +K  +  K  S+  T V   G+  D       +  Y
Sbjct: 2   SGRPRTTSFAESCKPVQQPSAFGSMKVSR-DKDGSKVTTVVATPGQGPDR----PQEVSY 56

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++I++ L  H N
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKL-DHCN 108

Query: 159 VVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR----QM 208
           +V+    F      +D+ Y+ + ++     E + R+  +  SR  +    + V+    Q+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVA-RHYSRAKQTLPVIYVKLYMYQL 165

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
            R  A  H  G+ HRD+KP+N L         LK  DFG +  +  G+     + S YY 
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYR 223

Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--EVL--------- 313
           APE++          DVWS G +   LL   +P +  D   D + +  +VL         
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282

Query: 314 --------RNKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                      P  +  PW     P     A     +LL   P ARLT  +A +H +  E
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  156 bits (398), Expect = 1e-44
 Identities = 82/335 (24%), Positives = 133/335 (39%), Gaps = 49/335 (14%)

Query: 72  NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-- 129
           +    +GV    +   F   +    +Y    L+G G +G      +K  G  VA+KK   
Sbjct: 5   HHHHSSGVDLGTENLYFQSME----KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE 60

Query: 130 -EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI 188
            + +KM+  IA+    RE+K+L+ L  HEN+V      +     Y+  E  +    +   
Sbjct: 61  SDDDKMVKKIAM----REIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDHT--ILDD 113

Query: 189 LAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL 248
           L    +    +     + Q++     CH H ++HRD+KPEN L         +K  DFG 
Sbjct: 114 LELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ---SGVVKLCDFGF 170

Query: 249 S-DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DK 303
           +     PG+ + D V + +Y APE+L    K G   DVW+IG +    +    P +  D 
Sbjct: 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCL-VTEMFMGEPLFPGDS 229

Query: 304 TEDGIFK-------------EVLRNKPDFR-------------RKPWPSISNSAKDFVKK 337
             D ++              E+    P F               + +P +S    D  KK
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289

Query: 338 LLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
            L  DP  R   A+ L H + +  G A     ++ 
Sbjct: 290 CLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQ 324

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  153 bits (388), Expect = 1e-43
 Identities = 68/296 (22%), Positives = 134/296 (45%), Gaps = 42/296 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           +Y   + +G G +G  + A ++   + VA+K++  + +   +P  A+    RE+ +L+ L
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKEL 58

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H+N+V+ ++    D  + +  E C+    L +     +     +     + Q+L+   
Sbjct: 59  K-HKNIVRLHDVLHSDKKLTLVFEFCDQD--LKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH   ++HRD+KP+N L      +  LK  +FGL+  F  P + +   V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--EVL-----------RN 315
           L   +      D+WS G I   L    RP +  +  +D + +   +L             
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 316 KPDFRRKP-----------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            PD++  P            P ++ + +D ++ LL  +P  R++A +AL HP+  +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  152 bits (387), Expect = 1e-43
 Identities = 74/296 (25%), Positives = 115/296 (38%), Gaps = 42/296 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +G         +G  +AVK+I    N        + +  ++ I          V 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ----KRLLMDLDISMRTVDCPFTVT 70

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILA---KKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           FY A   +  V+I MEL +    LD+       K     E     +   +++  A  HLH
Sbjct: 71  FYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVK--ALEHLH 126

Query: 219 G---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK 274
               ++HRD+KP N L  +  +   +K  DFG+S   +    K  D  G   Y+APE + 
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDID-AGCKPYMAPERIN 182

Query: 275 RKSGPE-----SDVWSIGVITYI-LLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWPS 326
            +   +     SD+WS+G IT I L   R P+  W      + + V    P      +  
Sbjct: 183 PELNQKGYSVKSDIWSLG-ITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF-- 239

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
            S    DF  + L K+ + R T  + + HP+            D      +  FVK
Sbjct: 240 -SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT---LHESKGTD------VASFVK 285

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  153 bits (389), Expect = 2e-43
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 38/282 (13%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DF     I + LG G FG  ++   + NG   A+K ++K  ++    VE    E  +L  
Sbjct: 7   DFQ----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +  H  +++ +  F+D   +++ M+  EGGEL   +  +K  R+    A     ++    
Sbjct: 63  VT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEV--CL 117

Query: 213 AECHLH--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLSDFIKPGKKFQDIV----GS 264
           A  +LH   +++RD+KPEN L      D +  +K TDFG +      K   D+     G+
Sbjct: 118 ALEYLHSKDIIYRDLKPENILL-----DKNGHIKITDFGFA------KYVPDVTYTLCGT 166

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
             Y+APEV+  K      D WS G++ Y +L G  PF+D      ++++L  +  F   P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P 223

Query: 324 WPSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVRE 360
            P  +   KD + +L+ +D   RL           +HPW +E
Sbjct: 224 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  150 bits (380), Expect = 2e-42
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 10/264 (3%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
            + RY I   LG G     Y+A D     +VA+K I          ++  +REV     L
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           + H+N+V   +  E+D+  Y+ ME  EG  L + I  +     +   A     Q+L    
Sbjct: 69  S-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIK 125

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPE 271
             H   +VHRD+KP+N L      + +LK  DFG++  +      Q   ++G+  Y +PE
Sbjct: 126 HAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

Query: 272 -VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPSISN 329
                 +   +D++SIG++ Y +L G  PF  +T   I  K +  + P+        I  
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242

Query: 330 SAKDFVKKLLVKDPRARLTAAQAL 353
           S  + + +   KD   R    Q +
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEM 266

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  149 bits (379), Expect = 5e-42
 Identities = 76/300 (25%), Positives = 126/300 (42%), Gaps = 46/300 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           RY     LG G +G  Y A D    + VA+K+I  E  +  +P  A+    REV +L+ L
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKEL 90

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
             H N+++  +    ++ +++  E  E    + +D+         + +     + Q++  
Sbjct: 91  Q-HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN-----PDVSMRVIKSFLYQLING 144

Query: 212 AAECHLHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYV 268
              CH    +HRD+KP+N L     A E   LK  DFGL+  F  P ++F   + + +Y 
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204

Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK------------ 310
            PE+L   R      D+WSI  I   +L     F   +E      IF+            
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264

Query: 311 -----EVLRNKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                +  ++ P FR K         + +   D +  +L  DP  R++A  AL HP+   
Sbjct: 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  150 bits (382), Expect = 9e-42
 Identities = 83/338 (24%), Positives = 136/338 (40%), Gaps = 54/338 (15%)

Query: 64  KTKQHQKTNSRRQTGVIPCGKR-----TDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
            T  +   N  +   +    K      +D    +  +  YT  K++G+G FG  + A   
Sbjct: 3   FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------EDDNYV 172
            +   VA+KK+ ++K           RE++I++ +  H NVV     F      +D+ ++
Sbjct: 63  ESD-EVAIKKVLQDK-------RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFL 113

Query: 173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVV---VRQMLRVAAECHLHGLVHRDMKPEN 229
            + +E     E + R               ++   + Q+LR  A  H  G+ HRD+KP+N
Sbjct: 114 NLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171

Query: 230 FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIG 287
            L         LK  DFG +  +  G+     + S YY APE++          D+WS G
Sbjct: 172 LLLDP--PSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG 229

Query: 288 VITYILLCGRRPFWDKTE----DGIFK-------EVLRNK---------PDFRRKPW--- 324
            +   L+ G+  F  ++       I K       E ++           P  R  P+   
Sbjct: 230 CVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKV 289

Query: 325 --PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             P     A D + +LL   P ARLTA +AL HP+  E
Sbjct: 290 FRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  154 bits (391), Expect = 2e-41
 Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 45/296 (15%)

Query: 75  RQTGVIP-CGKRTDFGYD----KDFDRRYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKK 128
              G  P CG    F            +Y +   + HG  G+ Y+A D+  NG  V +K 
Sbjct: 54  ASEGWCPYCGSPYSFLPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK- 112

Query: 129 IEKNKMIL-----PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY-----VYIAMEL 178
                  L       A      E + L  +  H ++V+ +N  E  +       YI ME 
Sbjct: 113 ------GLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEY 165

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
             G  L          +    +A   + ++L   +  H  GLV+ D+KPEN +      +
Sbjct: 166 VGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML----TE 217

Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR 298
             LK  D G          F  + G+  + APE+++      +D++++G     L     
Sbjct: 218 EQLKLIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLP 274

Query: 299 PFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                  +G + + L         P     +S    +++ +  DPR R T A+ +S
Sbjct: 275 TR-----NGRYVDGLPEDD-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  146 bits (370), Expect = 4e-41
 Identities = 83/295 (28%), Positives = 130/295 (44%), Gaps = 42/295 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           +Y   + +G G +G  Y A +   G+  A+KKI  EK    +P   +    RE+ IL+ L
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTI----REISILKEL 57

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+VK Y+       + +  E  +    L ++L   +       A   + Q+L   A
Sbjct: 58  K-HSNIVKLYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH   ++HRD+KP+N L     E   LK  DFGL+  F  P +K+   + + +Y AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK---------------- 310
           L   +K     D+WS+G I   ++ G   F   +E      IF+                
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 311 -EVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +   N   +   PW      +  S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  147 bits (374), Expect = 4e-41
 Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 14/263 (5%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H  +  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGL 220
            +  F+    ++  ME   GG+L+  I  +   ++    A     +++ +  +  H  G+
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEII-LGLQFLHSKGI 139

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           V+RD+K +N L      D  +K  DFG+  + +    K     G+  Y+APE+L  +   
Sbjct: 140 VYRDLKLDNILLDK---DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 196

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
              D WS GV+ Y +L G+ PF  + E+ +F  +  + P + R     +   AKD + KL
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKL 252

Query: 339 LVKDPRARLTAAQAL-SHPWVRE 360
            V++P  RL     +  HP  RE
Sbjct: 253 FVREPEKRLGVRGDIRQHPLFRE 275

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  147 bits (373), Expect = 6e-41
 Identities = 84/316 (26%), Positives = 135/316 (42%), Gaps = 59/316 (18%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVK---REVK 148
            + Y     +G G +G    A DK +G++VA+KK+ +   +++         K   RE+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-------FAKRAYRELL 75

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +L+ +  HENV+   + F       +    Y+ M   +    L +I+     +++E+   
Sbjct: 76  LLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMG---LKFSEEKIQ 129

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            +V QML+     H  G+VHRD+KP N       ED  LK  DFGL+            V
Sbjct: 130 YLVYQMLKGLKYIHSAGVVHRDLKPGNLA---VNEDCELKILDFGLARHADAEMT--GYV 184

Query: 263 GSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF--------WDK--------T 304
            + +Y APEV+          D+WS+G I   +L G+  F          +         
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244

Query: 305 EDGIF-------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            + +        K  +++ P   RK +    P  S  A D ++K+L  D   RLTAAQAL
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304

Query: 354 SHPWVREGGDASEIPI 369
           +HP+     D  E   
Sbjct: 305 THPFFEPFRDPEEETE 320

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  146 bits (371), Expect = 7e-41
 Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 41/295 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALA 154
            Y     LG G +   Y    K   + VA+K+I  E  +     A+    REV +L+ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK 58

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V  ++    +  + +  E  +    L + L    +     +  + + Q+LR  A 
Sbjct: 59  -HANIVTLHDIIHTEKSLTLVFEYLDKD--LKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
           CH   ++HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P++L
Sbjct: 116 CHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172

Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV----------LRNKP 317
                   + D+W +G I Y +  GR  F   T       IF+ +          + +  
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232

Query: 318 DFR------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           +F+                P + +   D + KLL  + R R++A  A+ HP+   
Sbjct: 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  146 bits (371), Expect = 1e-40
 Identities = 83/299 (27%), Positives = 131/299 (43%), Gaps = 45/299 (15%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPI-AVEDVKREVKI 149
           +RY     LG GQF   Y A DK     VA+KKI      + K  +   A+    RE+K+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKL 65

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L+ H N++   +AF   + + +  +  E    L+ I+       T       +   L
Sbjct: 66  LQELS-HPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYV 268
           +     H H ++HRD+KP N L     E+  LK  DFGL+  F  P + +   V + +Y 
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR 179

Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFWD-KTE----DGIFKEV--------- 312
           APE+L   R  G   D+W++G I   LL  R PF    ++      IF+ +         
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238

Query: 313 -LRNKPDFRR-KPW---------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            + + PD+   K +          +  +   D ++ L + +P AR+TA QAL   +   
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  144 bits (366), Expect = 4e-40
 Identities = 89/326 (27%), Positives = 132/326 (40%), Gaps = 66/326 (20%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK---REVKILQ 151
             RY   K LG G  G  + A D     RVA+KKI             VK   RE+KI++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ------SVKHALREIKIIR 63

Query: 152 ALAGHENVVKFYNAF--------------EDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            L  H+N+VK +                  + N VYI  E  E    L  +L +      
Sbjct: 64  RL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGP--LL 118

Query: 198 EKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG 255
           E+ A + + Q+LR     ++H   ++HRD+KP N    +  ED  LK  DFGL+  + P 
Sbjct: 119 EEHARLFMYQLLR--GLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPH 174

Query: 256 KKFQDI----VGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF--------W 301
              +      + + +Y +P +L          D+W+ G I   +L G+  F         
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234

Query: 302 DK--------TEDGI------FKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDP 343
                      E+            +RN      KP     P IS  A DF++++L   P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294

Query: 344 RARLTAAQALSHPWVREGGDASEIPI 369
             RLTA +ALSHP++       + PI
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPMDEPI 320

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  144 bits (365), Expect = 4e-40
 Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 43/296 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           +Y   + +G G +G  Y A D   G  VA+K+I  +     +P  A+    RE+ +L+ L
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAI----REISLLKEL 76

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V   +    +  + +  E  E    L ++L +  +   +    + + Q+LR  A
Sbjct: 77  H-HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH H ++HRD+KP+N L  S   D +LK  DFGL+  F  P + +   V + +Y AP+V
Sbjct: 134 HCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV----------LRNK 316
           L   +K     D+WSIG I   ++ G+  F   T+      IF  +          ++  
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250

Query: 317 PDFR------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           P ++                P       D +  +L  DP  R++A  A++HP+ ++
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  146 bits (369), Expect = 5e-40
 Identities = 66/328 (20%), Positives = 120/328 (36%), Gaps = 74/328 (22%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREV 147
             ++    IGK  G        +A  K  G+ V V++I      N+M+       ++ E+
Sbjct: 25  GCYELLTVIGK--GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV-----TFLQGEL 77

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            + +    H N+V +   F  DN +++       G   D I         E   A +++ 
Sbjct: 78  HVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136

Query: 208 MLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKK------- 257
           +L+  A  ++H  G VHR +K  + L      D  +  +    +   I  G++       
Sbjct: 137 VLK--ALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 258 FQDIVGSAYYVAPEVLKRKS---GPESDVWSIGVITYI-LLCGRRPFWD----------- 302
            +  V    +++PEVL++       +SD++S+G IT   L  G  PF D           
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG-ITACELANGHVPFKDMPATQMLLEKL 250

Query: 303 -------------------------KTEDGIFKEVLRNKPDFRRKPWPSI------SNSA 331
                                        G+   +  + P       PS       S   
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVR 359
             FV++ L ++P AR +A+  L+H + +
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFK 338

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  145 bits (367), Expect = 6e-40
 Identities = 86/349 (24%), Positives = 140/349 (40%), Gaps = 69/349 (19%)

Query: 66  KQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVA 125
             H    +     ++   +   F    D   RYT    +G G +G    A D  N  RVA
Sbjct: 4   HHHMAAAAAAGPEMV---RGQVF----DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVA 56

Query: 126 VKKIE--KNKMILPIAVEDVK---REVKILQALAGHENVVKFYNAF-----EDDNYVYIA 175
           +KKI   +++          +   RE+KIL     HEN++   +       E    VYI 
Sbjct: 57  IKKISPFEHQT-------YCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIV 108

Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFK 233
            +L E    L ++L  K    +       + Q+LR     ++H   ++HRD+KP N L  
Sbjct: 109 QDLMETD--LYKLL--KTQHLSNDHICYFLYQILR--GLKYIHSANVLHRDLKPSNLL-- 160

Query: 234 SAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEVL--KRKSGPESDVWSIG 287
                  LK  DFGL+    P           V + +Y APE++   +      D+WS+G
Sbjct: 161 -LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219

Query: 288 VITYILLCGRRPF--------WDK--------TEDGIF-------KEVLRNKPDFRRKPW 324
            I   +L  R  F         +         +++ +        +  L + P   + PW
Sbjct: 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 279

Query: 325 ----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
               P+  + A D + K+L  +P  R+   QAL+HP++ +  D S+ PI
Sbjct: 280 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  147 bits (372), Expect = 7e-40
 Identities = 80/325 (24%), Positives = 136/325 (41%), Gaps = 67/325 (20%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVK---REVK 148
            +RY   K +G G  G    A D      VA+KK+ +   N+          K   RE+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-------HAKRAYRELV 113

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +++ +  H+N++   N F      E+   VY+ MEL +    L +++  +      +  +
Sbjct: 114 LMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME---LDHERMS 167

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++ QML      H  G++HRD+KP N +    K D +LK  DFGL+            V
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIV---VKSDCTLKILDFGLARTAGTSFMMTPYV 224

Query: 263 GSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF--------WDK--------TE 305
            + YY APEV L        D+WS+G I   ++  +  F        W+K          
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284

Query: 306 DGIFK------EVLRNKPDFRRKPWPSI----------------SNSAKDFVKKLLVKDP 343
           + + K        + N+P +    +P +                ++ A+D + K+LV DP
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344

Query: 344 RARLTAAQALSHPWVREGGDASEIP 368
             R++   AL HP++    D +E+ 
Sbjct: 345 AKRISVDDALQHPYINVWYDPAEVE 369

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  146 bits (371), Expect = 7e-40
 Identities = 85/329 (25%), Positives = 149/329 (45%), Gaps = 30/329 (9%)

Query: 42  RNDTTHKHQ---HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRY 98
           R + T   Q      +++A      ++      +   +  V     +     + +F+   
Sbjct: 96  REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN-EFE--- 151

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
              KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  
Sbjct: 152 -YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF 209

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +     +F+  + +   ME   GGEL   +   ++  ++E  A     ++  V+A  +LH
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEI--VSALDYLH 265

Query: 219 ---GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK 274
               +V+RD+K EN +      D  +K TDFGL  + IK G   +   G+  Y+APEVL+
Sbjct: 266 SEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
               G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK 
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKS 378

Query: 334 FVKKLLVKDPRARLTAAQA-----LSHPW 357
            +  LL KDP+ RL          + H +
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  144 bits (366), Expect = 7e-40
 Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 19/268 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG   +A  K  GD  AVK ++K+ ++    VE    E +IL     H  + +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGL 220
            +  F+  + ++  ME   GG+L+  I  +K  R+ E  A     +++  A    H  G+
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEII-SALMFLHDKGI 145

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           ++RD+K +N L      +   K  DFG+  + I  G       G+  Y+APE+L+    G
Sbjct: 146 IYRDLKLDNVLLDH---EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
           P  D W++GV+ Y +LCG  PF  + ED +F+ +L ++  +       +   A   +K  
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSF 258

Query: 339 LVKDPRARL-----TAAQAL-SHPWVRE 360
           + K+P  RL         A+  HP+ +E
Sbjct: 259 MTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  144 bits (365), Expect = 1e-39
 Identities = 68/268 (25%), Positives = 123/268 (45%), Gaps = 20/268 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
            +LG G FG   ++  K   +  AVK ++K+ +I    VE    E ++L        + +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--G 219
            ++ F+  + +Y  ME   GG+L+  I  ++  R+ E  A     ++        L   G
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEI--AIGLFFLQSKG 141

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS- 277
           +++RD+K +N +  S   +  +K  DFG+  + I  G   +   G+  Y+APE++  +  
Sbjct: 142 IIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 198

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           G   D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K 
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKG 254

Query: 338 LLVKDPRARLTAAQA-----LSHPWVRE 360
           L+ K P  RL            H + R 
Sbjct: 255 LMTKHPGKRLGCGPEGERDIKEHAFFRY 282

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  144 bits (364), Expect = 1e-39
 Identities = 85/376 (22%), Positives = 144/376 (38%), Gaps = 83/376 (22%)

Query: 57  AKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVAT 116
            K  ++L+  + Q+   +R    +   ++     D DF++   I +L G G  G  +  +
Sbjct: 1   GKKLEELELDEQQR---KRLEAFLTQKQKVGELKDDDFEK---ISEL-GAGNGGVVFKVS 53

Query: 117 DKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI 174
            K +G  +A K I  E    I       + RE+++L        +V FY AF  D  + I
Sbjct: 54  HKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 108

Query: 175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG---LVHRDMKPENFL 231
            ME  +GG L    + KK  R  E+    V   +++     +L     ++HRD+KP N L
Sbjct: 109 CMEHMDGGSLDQ--VLKKAGRIPEQILGKVSIAVIK--GLTYLREKHKIMHRDVKPSNIL 164

Query: 232 FKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEVLKRKS-GPESDVWSI 286
             S  E   +K  DFG+S     G+    +    VG+  Y++PE L+      +SD+WS+
Sbjct: 165 VNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216

Query: 287 GVITYILLCGRRPF--------------------WDKTEDGIFKEVLRNKPDFRRKPWPS 326
           G+    +  GR P                      +            NK     +P  +
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276

Query: 327 I--------------------SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE 366
           I                    S   +DFV K L+K+P  R    Q + H +++    +  
Sbjct: 277 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR---SDA 333

Query: 367 IPIDISVLNNMRQFVK 382
             +D         ++ 
Sbjct: 334 EEVD------FAGWLC 343

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  149 bits (377), Expect = 1e-39
 Identities = 75/333 (22%), Positives = 141/333 (42%), Gaps = 21/333 (6%)

Query: 35  RRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDF 94
              N     + +  ++   Q+  +      TK  ++  +   +     G R       DF
Sbjct: 285 EYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLT-DF 343

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           +       +LG G FG   ++  K   +  AVK ++K+ +I    VE    E ++L    
Sbjct: 344 N----FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
               + + ++ F+  + +Y  ME   GG+L+  I  ++  R+ E  A     ++      
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFF 457

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
               G+++RD+K +N +  S   +  +K  DFG+  + I  G   +   G+  Y+APE++
Sbjct: 458 LQSKGIIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514

Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G   D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A 
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAV 570

Query: 333 DFVKKLLVKDPRARLTAAQA-----LSHPWVRE 360
              K L+ K P  RL            H + R 
Sbjct: 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  143 bits (364), Expect = 1e-39
 Identities = 90/340 (26%), Positives = 137/340 (40%), Gaps = 74/340 (21%)

Query: 83  GKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE--KNKMILPIAV 140
            KR  +    +    + +  LLG G +G    AT K  G+ VA+KKIE     +      
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL------ 51

Query: 141 EDVK---REVKILQALAGHENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRILAKK 192
                  RE+KIL+    HEN++  +N       E+ N VYI  EL +    L R+++ +
Sbjct: 52  -FALRTLREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQ 107

Query: 193 DSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
               ++      + Q LR  A   LH   ++HRD+KP N L      +  LK  DFGL+ 
Sbjct: 108 M--LSDDHIQYFIYQTLR--AVKVLHGSNVIHRDLKPSNLL---INSNCDLKVCDFGLAR 160

Query: 251 FIKPGKKFQDIVGSA-----------YYVAPEVL--KRKSGPESDVWSIGVITYILLCGR 297
            I                        +Y APEV+    K     DVWS G I   L   R
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

Query: 298 --------------------RPFWDKTEDGIF----KEVLRNKPDFRRKPW----PSISN 329
                                P  D     I     +E +++ P +   P     P ++ 
Sbjct: 221 PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNP 280

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
              D ++++LV DP  R+TA +AL HP+++   D ++ P 
Sbjct: 281 KGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE 320

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  143 bits (364), Expect = 2e-39
 Identities = 59/323 (18%), Positives = 113/323 (34%), Gaps = 56/323 (17%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-----VEDVK--- 144
                YT+ + +  G +G      D   G  VA+K++                   K   
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 145 REVKILQALAGHENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRILAKKDSRYTEK 199
           RE+++L     H N++   + F        + +Y+  EL      L +++  +    + +
Sbjct: 78  REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQ 134

Query: 200 DAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
                +  +L       LH  G+VHRD+ P N L     +++ +   DF L+        
Sbjct: 135 HIQYFMYHILL--GLHVLHEAGVVHRDLHPGNIL---LADNNDITICDFNLAREDTADAN 189

Query: 258 FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW-------------- 301
               V   +Y APE++   +      D+WS G +   +   R+  +              
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRGSTFYNQLNKIVE 248

Query: 302 ------DKTEDGIFKEVLRN-----KPDFRRKPW----PSISNSAKDFVKKLLVKDPRAR 346
                  +          R+       +   + W    P+    A D + K+L  +P+ R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308

Query: 347 LTAAQALSHPWVREGGDASEIPI 369
           ++  QAL HP+     D  ++  
Sbjct: 309 ISTEQALRHPYFESLFDPLDLTE 331

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  142 bits (361), Expect = 2e-39
 Identities = 78/305 (25%), Positives = 128/305 (41%), Gaps = 52/305 (17%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPI-AVEDVKREVKILQ 151
           ++   + LG+G +   Y   +K  G  VA+K++   K+      P  A+    RE+ +++
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAI----REISLMK 58

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCE---GGELLDRILAKKDSRYTEKDAAVVVRQM 208
            L  HEN+V+ Y+    +N + +  E  +      +  R +                 Q+
Sbjct: 59  ELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYY 267
           L+  A CH + ++HRD+KP+N L     +   LK  DFGL+  F  P   F   V + +Y
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWY 174

Query: 268 VAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK----------- 310
            AP+VL   R      D+WS G I   ++ G+  F    +      IF            
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

Query: 311 --EVLRN-KPDFRRKP------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
               L    P+ +++P               +  +  DF+  LL  +P  RL+A QAL H
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294

Query: 356 PWVRE 360
           PW  E
Sbjct: 295 PWFAE 299

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  143 bits (363), Expect = 2e-39
 Identities = 85/346 (24%), Positives = 138/346 (39%), Gaps = 62/346 (17%)

Query: 65  TKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
              H   +  R T       +T +    +   RY     +G G +G    A D   G RV
Sbjct: 2   AHHHHHHSQERPTFYRQELNKTIW----EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRV 57

Query: 125 AVKKIEK---NKMILPIAVEDVK---REVKILQALAGHENVVKFYNAF------EDDNYV 172
           AVKK+ +   + +         K   RE+++L+ +  HENV+   + F      E+ N V
Sbjct: 58  AVKKLSRPFQSII-------HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDV 109

Query: 173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLF 232
           Y+   L      L+ I+  K  + T+     ++ Q+LR     H   ++HRD+KP N   
Sbjct: 110 YLVTHLMGAD--LNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA- 164

Query: 233 KSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVIT 290
               ED  LK  DFGL+       +    V + +Y APE++          D+WS+G I 
Sbjct: 165 --VNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220

Query: 291 YILLCGR-----------------------RPFWDKTEDGIFKEVLRNKPDFRRKPW--- 324
             LL GR                            K      +  +++     +  +   
Sbjct: 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280

Query: 325 -PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
               +  A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 281 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  142 bits (361), Expect = 3e-39
 Identities = 82/265 (30%), Positives = 131/265 (49%), Gaps = 21/265 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--G 219
              AF+  + +   ME   GGEL   +   ++  +TE+ A     ++  V+A  +LH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEI--VSALEYLHSRD 125

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS- 277
           +V+RD+K EN +      D  +K TDFGL  + I  G   +   G+  Y+APEVL+    
Sbjct: 126 VVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG 238

Query: 338 LLVKDPRARLTAAQA-----LSHPW 357
           LL KDP+ RL    +     + H +
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRF 263

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  141 bits (358), Expect = 4e-39
 Identities = 72/279 (25%), Positives = 115/279 (41%), Gaps = 35/279 (12%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-------PIAVEDVKRE 146
              RY +G++LG G     ++A D  +   VAVK       +L       P      +RE
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK-------VLRADLARDPSFYLRFRRE 62

Query: 147 VKILQALAG--HENVVKFYNAFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKD 200
               Q  A   H  +V  Y+  E +       YI ME  +G  L D +    +   T K 
Sbjct: 63  A---QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKR 117

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL----SDFIKPGK 256
           A  V+    +     H +G++HRD+KP N +       +++K  DFG+    +D      
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVT 174

Query: 257 KFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLR 314
           +   ++G+A Y++PE          SDV+S+G + Y +L G  PF   +   + ++ V R
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-R 233

Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             P         +S      V K L K+P  R   A  +
Sbjct: 234 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  146 bits (370), Expect = 6e-39
 Identities = 69/262 (26%), Positives = 116/262 (44%), Gaps = 10/262 (3%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL        VV 
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVNSRFVVS 248

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + L  GG+L   I     + + E  A     ++     + H   +V
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           +RD+KPEN L         ++ +D GL+  +  G+  +  VG+  Y+APEV+K +     
Sbjct: 309 YRDLKPENILLDD---HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W++G + Y ++ G+ PF  + +    +EV R   +   +     S  A+    +LL 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425

Query: 341 KDPRARL-----TAAQALSHPW 357
           KDP  RL     +A +   HP 
Sbjct: 426 KDPAERLGCRGGSAREVKEHPL 447

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  142 bits (360), Expect = 7e-39
 Identities = 78/328 (23%), Positives = 138/328 (42%), Gaps = 66/328 (20%)

Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVE 141
           +T +    +    Y   + +G G +G    A D   G +VA+KK+ +   +++       
Sbjct: 18  KTAW----EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL------- 66

Query: 142 DVK---REVKILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKK 192
             K   RE+++L+ +  HENV+   + F      +D    Y+ M        L +++  K
Sbjct: 67  FAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD--LGKLM--K 121

Query: 193 DSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
             +  E     +V QML+     ++H  G++HRD+KP N       ED  LK  DFGL+ 
Sbjct: 122 HEKLGEDRIQFLVYQMLK--GLRYIHAAGIIHRDLKPGNLA---VNEDCELKILDFGLAR 176

Query: 251 FIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGR----------- 297
                      V + +Y APEV+    +     D+WS+G I   ++ G+           
Sbjct: 177 QADSEMT--GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234

Query: 298 ------------RPFWDKTEDGIFKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVK 341
                         F  + +    K  ++  P+  +K +     + S  A + ++K+LV 
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294

Query: 342 DPRARLTAAQALSHPWVREGGDASEIPI 369
           D   R+TA +AL+HP+     D  + P 
Sbjct: 295 DAEQRVTAGEALAHPYFESLHDTEDEPQ 322

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  142 bits (360), Expect = 8e-39
 Identities = 72/266 (27%), Positives = 125/266 (46%), Gaps = 23/266 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  KA     AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--G 219
            + +F+  + +Y  ++   GGEL   +  +++  + E  A     ++   +A  +LH   
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEI--ASALGYLHSLN 159

Query: 220 LVHRDMKPENFLFKSAKEDSS--LKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK 276
           +V+RD+KPEN L      DS   +  TDFGL  + I+         G+  Y+APEVL ++
Sbjct: 160 IVYRDLKPENILL-----DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
                 D W +G + Y +L G  PF+ +    ++  +L      +    P+I+NSA+  +
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLL 270

Query: 336 KKLLVKDPRARL----TAAQALSHPW 357
           + LL KD   RL       +  SH +
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVF 296

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  141 bits (356), Expect = 9e-39
 Identities = 57/336 (16%), Positives = 106/336 (31%), Gaps = 79/336 (23%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAV------------KKIEKNKMIL----- 136
           +   +   + +G G FG  + A +K +    A+            +K+ +    L     
Sbjct: 4   YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63

Query: 137 --------------------------------------PIAVEDVKREVKILQALAGHEN 158
                                                 P  ++    +++ +   +  +N
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKN 122

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHL 217
            V          Y+YI M+LC    L D +  +      E    + +  Q+       H 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------------DFIKPGKKFQDIVGS 264
            GL+HRD+KP N  F     D  +K  DFGL                +         VG+
Sbjct: 183 KGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
             Y++PE +   +   + D++S+G+I + LL       ++    I  +V   K       
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--IITDVRNLKFP---LL 294

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +          V+ +L   P  R  A   + +    
Sbjct: 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  141 bits (357), Expect = 1e-38
 Identities = 75/320 (23%), Positives = 128/320 (40%), Gaps = 61/320 (19%)

Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
               +    R+ + ++ G G FG   +  +K+ G  VA+KK+ ++            RE+
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-------FRNREL 67

Query: 148 KILQALA--GHENVVKFYNAF-------EDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
           +I+Q LA   H N+V+  + F         D Y+ + ME     + L R       R   
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVA 125

Query: 199 KDAAVV---VRQMLRVAAECHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
               ++   + Q++R     HL    + HRD+KP N L    + D +LK  DFG +  + 
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLS 183

Query: 254 PGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG---- 307
           P +     + S YY APE++   +      D+WS+G I   ++ G   F  + ++     
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF--RGDNSAGQL 241

Query: 308 --IFKEVL-----------------RNKPDFRRKPW--------PSISNSAKDFVKKLLV 340
             I + VL                  +  + +  PW           +  A D +  LL 
Sbjct: 242 HEIVR-VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300

Query: 341 KDPRARLTAAQALSHPWVRE 360
             P  R+   +AL HP+  E
Sbjct: 301 YLPEERMKPYEALCHPYFDE 320

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  143 bits (362), Expect = 2e-38
 Identities = 84/424 (19%), Positives = 140/424 (33%), Gaps = 113/424 (26%)

Query: 45  TTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLL 104
           ++H+     Q  +     +   Q +    ++     P         D     RY I  L+
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61

Query: 105 GHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK------REVKILQALAGHEN 158
           G G +G+   A DK     VA+KKI +         ED+       RE+ IL  L  H++
Sbjct: 62  GTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRL-NHDH 113

Query: 159 VVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           VVK  +       E  + +Y+ +E+ +      ++  +     TE     ++  +L    
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLF-RTPVYLTELHIKTLLYNLLVGVK 170

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA-------- 265
             H  G++HRD+KP N L     +D S+K  DFGL+  +   +     +  +        
Sbjct: 171 YVHSAGILHRDLKPANCL---VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 266 --------------------YYVAPEVL--KRKSGPESDVWSIGVI----------TYIL 293
                               +Y APE++  +       DVWSIG I              
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287

Query: 294 LCGRRPF--------------------------------------------WDKTEDGIF 309
              R P                                              +  E    
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347

Query: 310 KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
           K  +R  P           P+ S  A   +K++LV +P  R+T  + L+HP+ +E   A 
Sbjct: 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407

Query: 366 EIPI 369
               
Sbjct: 408 VETN 411

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  141 bits (357), Expect = 2e-38
 Identities = 83/328 (25%), Positives = 135/328 (41%), Gaps = 71/328 (21%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVK---REVK 148
            +RY   K +G G  G    A D      VA+KK+ +   N+          K   RE+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-------HAKRAYRELV 76

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +++ +  H+N++   N F      E+   VYI MEL +    L +++         +  +
Sbjct: 77  LMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ---MELDHERMS 130

Query: 203 VVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            ++ QML      HLH  G++HRD+KP N +    K D +LK  DFGL+           
Sbjct: 131 YLLYQMLC--GIKHLHSAGIIHRDLKPSNIV---VKSDCTLKILDFGLARTAGTSFMMTP 185

Query: 261 IVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF--------WDK-------- 303
            V + YY APEV L        D+WS+G I   ++ G   F        W+K        
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245

Query: 304 TEDGIFK------EVLRNKPDFRRKPWPSI----------------SNSAKDFVKKLLVK 341
             + + K        + N+P +    +  +                ++ A+D + K+LV 
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305

Query: 342 DPRARLTAAQALSHPWVREGGDASEIPI 369
           D   R++  +AL HP++    D SE   
Sbjct: 306 DASKRISVDEALQHPYINVWYDPSEAEA 333

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  138 bits (351), Expect = 4e-38
 Identities = 76/303 (25%), Positives = 121/303 (39%), Gaps = 49/303 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPI-AVEDVKREVKIL 150
           RY     +G G +G  Y A D  +G  VA+K +           LPI  V    REV +L
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV----REVALL 65

Query: 151 QAL--AGHENVVKFY-----NAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDA 201
           + L    H NVV+       +  + +  V +  E  +      LD+           +  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAETI 122

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
             ++RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALTPV 179

Query: 262 VGSAYYVAPEVL-KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV---- 312
           V + +Y APEVL +       D+WS+G I   +   +  F   +E      IF  +    
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239

Query: 313 ------LRNKPDFRRKPW---------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                   + P     P          P +  S    + ++L  +P  R++A +AL H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

Query: 358 VRE 360
           + +
Sbjct: 300 LHK 302

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  140 bits (355), Expect = 6e-38
 Identities = 71/335 (21%), Positives = 147/335 (43%), Gaps = 38/335 (11%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIG-----KL 103
           H H H +       + T ++        +G+    +  +            +      ++
Sbjct: 5   HHHHHHD-----YDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRV 59

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +    +   K      A++ ++K  +     ++ V+ E  + +  + H  +V  +
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVH 222
           + F+ ++ ++  +E   GG+L+  +  ++  +  E+ A     ++  +A    H  G+++
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEIS-LALNYLHERGIIY 176

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N L  S   +  +K TD+G+  + ++PG       G+  Y+APE+L+ +  G  
Sbjct: 177 RDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 233

Query: 281 SDVWSIGVITYILLCGRRPFW---------DKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
            D W++GV+ + ++ GR PF            TED +F+ +L  +    R    S+S  A
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 289

Query: 332 KDFVKKLLVKDPRARL-----TAAQAL-SHPWVRE 360
              +K  L KDP+ RL     T    +  HP+ R 
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  138 bits (350), Expect = 1e-37
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 29/274 (10%)

Query: 102 KLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPI-AVEDVKREVKILQALAGHE 157
           ++LG G +G  +     T    G   A+K ++K  ++         K E  IL+    H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-VKHP 81

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V    AF+    +Y+ +E   GGEL  ++  +++  + E  A   + ++    A  HL
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEI--SMALGHL 137

Query: 218 H--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
           H  G+++RD+KPEN +      +    +K TDFGL  + I  G       G+  Y+APE+
Sbjct: 138 HQKGIIYRDLKPENIML-----NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           L R       D WS+G + Y +L G  PF  +       ++L+ K +    P P ++  A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEA 248

Query: 332 KDFVKKLLVKDPRARLTAAQA-----LSHPWVRE 360
           +D +KKLL ++  +RL A         +HP+ R 
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  138 bits (350), Expect = 1e-37
 Identities = 67/277 (24%), Positives = 133/277 (48%), Gaps = 28/277 (10%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +++G G +    +   K      A+K ++K  +     ++ V+ E  + +  + H  +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGL 220
            ++ F+ ++ ++  +E   GG+L+  +  ++  +  E+ A     ++  +A    H  G+
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEIS-LALNYLHERGI 131

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           ++RD+K +N L  S   +  +K TD+G+  + ++PG       G+  Y+APE+L+ +  G
Sbjct: 132 IYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 188

Query: 279 PESDVWSIGVITYILLCGRRPFW---------DKTEDGIFKEVLRNKPDFRRKPWPSISN 329
              D W++GV+ + ++ GR PF            TED +F+ +L  +    R    S+S 
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSV 244

Query: 330 SAKDFVKKLLVKDPRARL-----TAAQAL-SHPWVRE 360
            A   +K  L KDP+ RL     T    +  HP+ R 
Sbjct: 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  136 bits (345), Expect = 1e-37
 Identities = 35/261 (13%), Positives = 68/261 (26%), Gaps = 36/261 (13%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           + RY +    G       + A D A   +VA+  ++   ++    +++       L  + 
Sbjct: 30  NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI- 88

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
               V +  +         +  E   GG L +      D+  +   A   ++ +   A  
Sbjct: 89  DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADA 144

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H  G+      P          D  +                          +      
Sbjct: 145 AHRAGVALSIDHPSRVRV---SIDGDVVLAYPA-------------------TMPDA--- 179

Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW---PSISNSA 331
               P+ D+  IG   Y LL  R P  +           R+      +P      I    
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236

Query: 332 KDFVKKLLVKDPRARLTAAQA 352
                + +  D   R  +   
Sbjct: 237 SAVAARSVQGDGGIRSASTLL 257

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  143 bits (361), Expect = 2e-37
 Identities = 71/333 (21%), Positives = 129/333 (38%), Gaps = 29/333 (8%)

Query: 44  DTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIG-- 101
           +    H  + Q     +Q    +  Q          I   K T F   K+ +    +   
Sbjct: 130 EHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMN 189

Query: 102 -----KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
                +++G G FG  Y       G   A+K ++K ++ +         E  +L  ++  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249

Query: 157 EN--VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 307

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H   +V+RD+KP N L     E   ++ +D GL+      KK    VG+  Y+APEVL+
Sbjct: 308 MHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQ 363

Query: 275 RKSG--PESDVWSIGVITYILLCGRRPFWD---KTEDGIFKEVLRNKPDFRRKPWPSISN 329
           +       +D +S+G + + LL G  PF     K +  I +  L    +       S S 
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSP 419

Query: 330 SAKDFVKKLLVKDPRARL-----TAAQALSHPW 357
             +  ++ LL +D   RL      A +    P+
Sbjct: 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  141 bits (358), Expect = 2e-37
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 25/271 (9%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLH- 218
              AFE    + + M +  GG++   I  + + +  + E  A     Q+  V+   HLH 
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGLEHLHQ 307

Query: 219 -GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK 276
             +++RD+KPEN L      D +++ +D GL+ +      K +   G+  ++APE+L  +
Sbjct: 308 RNIIYRDLKPENVLLDD---DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKPWPSISNSA 331
                 D +++GV  Y ++  R PF  + E      + + VL     +  K     S ++
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSPAS 420

Query: 332 KDFVKKLLVKDPRARL-----TAAQALSHPW 357
           KDF + LL KDP  RL     +     +HP 
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  136 bits (345), Expect = 4e-37
 Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 29/270 (10%)

Query: 102 KLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           K+LG G FG  ++    +        A+K ++K   +        K E  IL     H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-ATLKVRDRVRTKMERDILVE-VNHPF 87

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    + ++    A  HLH
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAEL--ALALDHLH 143

Query: 219 --GLVHRDMKPENFLFKSAKEDSS--LKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
             G+++RD+KPEN L      D    +K TDFGLS + I   KK     G+  Y+APEV+
Sbjct: 144 SLGIIYRDLKPENILL-----DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
            R+     +D WS GV+ + +L G  PF  K        +L+ K          +S  A+
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ 254

Query: 333 DFVKKLLVKDPRARL-----TAAQALSHPW 357
             ++ L  ++P  RL        +   H +
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  136 bits (344), Expect = 4e-37
 Identities = 63/267 (23%), Positives = 106/267 (39%), Gaps = 24/267 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-------PIAVEDVKREVKI 149
            Y + +L+G G  G  Y A D      VA+K       ++       P+    ++RE + 
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALK-------LMSETLSSDPVFRTRMQREART 87

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
              L    +VV  ++  E D  +Y+ M L  G +L   +  ++        A  +VRQ+ 
Sbjct: 88  AGRLQ-EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIG 144

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYY 267
                 H  G  HRD+KPEN L      D      DFG++      K  Q  + VG+ YY
Sbjct: 145 SALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201

Query: 268 VAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APE      +   +D++++  + Y  L G  P+       +   + +  P       P 
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR-PG 260

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQAL 353
           I  +    + + + K+P  R      L
Sbjct: 261 IPVAFDAVIARGMAKNPEDRYVTCGDL 287

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  137 bits (346), Expect = 5e-37
 Identities = 82/338 (24%), Positives = 155/338 (45%), Gaps = 44/338 (13%)

Query: 47  HKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDK-----DFDRRYTIG 101
           H H H+ +  +       +        +  T           G+ +     +F+    + 
Sbjct: 4   HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFE----LL 59

Query: 102 KLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPI-AVEDVKREVKILQALAGHE 157
           K+LG G +G  ++    +    G   A+K ++K  ++      E  + E ++L+ +    
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  + AF+ +  +++ ++   GGEL   +   +  R+TE +  + V ++  V A  HL
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGEI--VLALEHL 175

Query: 218 H--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLS--DFIKPGKKFQDIVGSAYYVAPE 271
           H  G+++RD+K EN L      DS+  +  TDFGLS        ++  D  G+  Y+AP+
Sbjct: 176 HKLGIIYRDIKLENILL-----DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230

Query: 272 VLKRKS---GPESDVWSIGVITYILLCGRRPFW----DKTEDGIFKEVLRNKPDFRRKPW 324
           +++          D WS+GV+ Y LL G  PF       ++  I + +L+++P +   P 
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P- 286

Query: 325 PSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPW 357
             +S  AKD +++LL+KDP+ RL      A +   H +
Sbjct: 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  134 bits (340), Expect = 7e-37
 Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 31/275 (11%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQALA 154
              K +G G FG  +      +   VA+K +     + +  +    ++ +REV I+  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-A 213
            H N+VK Y    +     + ME    G+L    L  K          V +R ML +A  
Sbjct: 82  -HPNIVKLYGLMHNP--PRMVMEFVPCGDLYH-RLLDKAHPIKWS---VKLRLMLDIALG 134

Query: 214 ECHLHG----LVHRDMKPENFLFKSAKEDS--SLKATDFGLSDFIKPGKKFQDIVGSAYY 267
             ++      +VHRD++  N   +S  E++    K  DFGLS           ++G+  +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQW 192

Query: 268 VAPEVLKRKSGP---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           +APE +  +      ++D +S  +I Y +L G  PF + +   I    +  +   R    
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR---- 248

Query: 325 PSISNSAKDFVKKLLVK----DPRARLTAAQALSH 355
           P+I       ++ ++      DP+ R   +  +  
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  134 bits (339), Expect = 1e-36
 Identities = 64/267 (23%), Positives = 117/267 (43%), Gaps = 39/267 (14%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+    H N
Sbjct: 27  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-HVN 81

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           ++ F           I  + CEG  L    L   ++++         ++++ +A +    
Sbjct: 82  ILLFMGYSTAPQL-AIVTQWCEGSSLYH-HLHASETKFEM-------KKLIDIARQTARG 132

Query: 216 ----HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYV 268
               H   ++HRD+K  N       ED+++K  DFGL+          +F+ + GS  ++
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 269 APEVLKRKSGPE----SDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPDFRRKP 323
           APEV++ +        SDV++ G++ Y L+ G+ P+ +    D I + V R         
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG---SLSPD 246

Query: 324 WPSISNSAKDFVKKLLVK----DPRAR 346
              + ++    +K+L+ +        R
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDER 273

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  136 bits (344), Expect = 1e-36
 Identities = 76/346 (21%), Positives = 138/346 (39%), Gaps = 86/346 (24%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
            ++Y++GK LG G FG      D  +G R A+KK+ ++            RE+ I++ L 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLD 58

Query: 155 GHENVVKFYNAF--------------------------------------EDDNYVYIAM 176
            H N++K  + F                                        + Y+ + M
Sbjct: 59  -HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 177 ELCEGGELLDRIL---AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK 233
           E     + L ++L    +          ++ + Q+ R     H  G+ HRD+KP+N L  
Sbjct: 118 EYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175

Query: 234 SAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITY 291
           S  +D++LK  DFG +  + P +     + S +Y APE++    +  P  D+WSIG +  
Sbjct: 176 S--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233

Query: 292 ILLCGRRPFWDKTEDG------IFKEVL-----------------RNKPDFRRKPW---- 324
            L+ G+  F    E        I + ++                    P  + K W    
Sbjct: 234 ELILGKPLF--SGETSIDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290

Query: 325 PSISNS-AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + S A D ++++L  +P  R+   +A++HP+     ++ E  +
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEV 336

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  134 bits (339), Expect = 2e-36
 Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 44/272 (16%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            IG+L+G G+FG  Y    + +G+ VA++ I+  +      ++  KREV   +    HEN
Sbjct: 36  EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HEN 90

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           VV F  A     ++ I   LC+G  L   ++                 +  ++A E    
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYS-VVRDAKIVLDV-------NKTRQIAQEIVKG 142

Query: 216 ----HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGKKFQDIVGSA 265
               H  G++H+D+K +N  +    ++  +  TDFGL          +   K +   G  
Sbjct: 143 MGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 266 YYVAPEVLKRKSGPE----------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN 315
            ++APE++++ S             SDV+++G I Y L     PF  +  + I  ++   
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258

Query: 316 -KPDFRRKPWPSISNSAKDFVKKLLVKDPRAR 346
            KP+  +           D +      +   R
Sbjct: 259 MKPNLSQIGMGK---EISDILLFCWAFEQEER 287

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  134 bits (339), Expect = 4e-36
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 47/301 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATD-KANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQA 152
           +Y     +G G +G  + A D K  G  VA+K++  +  +  +P+  +    REV +L+ 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRH 67

Query: 153 L--AGHENVVKFY-----NAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAV 203
           L    H NVV+ +     +  + +  + +  E  +      LD++    +     +    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           ++ Q+LR     H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V 
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVV 181

Query: 264 SAYYVAPEVL-KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK-------- 310
           + +Y APEVL +       D+WS+G I   +   +  F   ++      I          
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query: 311 -----------EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
                                 K    I    KD + K L  +P  R++A  ALSHP+ +
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

Query: 360 E 360
           +
Sbjct: 302 D 302

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  132 bits (333), Expect = 2e-35
 Identities = 70/261 (26%), Positives = 112/261 (42%), Gaps = 36/261 (13%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            + +++G G FG    A  +     VA+K+IE          +    E++ L  +  H N
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESER-----KAFIVELRQLSRVN-HPN 62

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHL 217
           +VK Y A  +   V + ME  EGG L   +L   +       AA  +   L+ +    +L
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSL-YNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYL 118

Query: 218 H-----GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           H      L+HRD+KP N L       + LK  DFG +  I+      +  GSA ++APEV
Sbjct: 119 HSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEV 174

Query: 273 LKRKSGPE-SDVWSIGVITYILLCGRRPFWD--KTEDGIFKEVLRNKPDFRRKPWPSISN 329
            +  +  E  DV+S G+I + ++  R+PF +       I   V       R    P +  
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---R----PPLIK 227

Query: 330 SAKDFVKKLLV----KDPRAR 346
           +    ++ L+     KDP  R
Sbjct: 228 NLPKPIESLMTRCWSKDPSQR 248

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  131 bits (331), Expect = 3e-35
 Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 26/259 (10%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            I + +G G FG  + A  + +G  VAVK + +        V +  REV I++ L  H N
Sbjct: 40  NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLR-HPN 95

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHL 217
           +V F  A      + I  E    G L   +L K  +R  + D    +     VA    +L
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGARE-QLDERRRLSMAYDVAKGMNYL 153

Query: 218 HG----LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEV 272
           H     +VHR++K  N L     +  ++K  DFGLS          +   G+  ++APEV
Sbjct: 154 HNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

Query: 273 LKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           L+ + S  +SDV+S GVI + L   ++P+ +     +   V       +R     I  + 
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC---KR---LEIPRNL 264

Query: 332 KDFVKKLLVK----DPRAR 346
              V  ++      +P  R
Sbjct: 265 NPQVAAIIEGCWTNEPWKR 283

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  133 bits (337), Expect = 4e-35
 Identities = 80/396 (20%), Positives = 138/396 (34%), Gaps = 114/396 (28%)

Query: 67  QHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAV 126
            H   +S  +  +   G   +          Y I  L+G G +GY Y+A DK     VA+
Sbjct: 2   HHHHHHSSGRENLYFQGI-KNV----HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAI 56

Query: 127 KKIEK---NKMILPIAVEDVK---REVKILQALAGHENVVKFYNAF-----EDDNYVYIA 175
           KK+ +   + +       D K   RE+ IL  L   + +++ Y+          + +YI 
Sbjct: 57  KKVNRMFEDLI-------DCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIV 108

Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFK 233
           +E+ +    L ++  K     TE+    ++  +L    E  +H  G++HRD+KP N L  
Sbjct: 109 LEIADSD--LKKLF-KTPIFLTEEHIKTILYNLLL--GENFIHESGIIHRDLKPANCL-- 161

Query: 234 SAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA-----------------------YYVAP 270
              +D S+K  DFGL+  I   K    +                           +Y AP
Sbjct: 162 -LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220

Query: 271 EVL--KRKSGPESDVWSIGVI----------TYILLCGRRPF----------------WD 302
           E++  +       D+WS G I                 R P                   
Sbjct: 221 ELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKV 280

Query: 303 KTEDG------IF-------------------KEVLRNKPDFRRKPW----PSISNSAKD 333
             +        IF                    + ++  P  +        PSIS+   +
Sbjct: 281 HEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340

Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            ++ +L  +P  R+T  QAL HP++++         
Sbjct: 341 LLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF 376

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  129 bits (326), Expect = 5e-35
 Identities = 71/265 (26%), Positives = 114/265 (43%), Gaps = 33/265 (12%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-ILPIAVEDVKREVKILQALAGHE 157
           T+ +++G G FG  Y A     GD VAVK    +    +   +E+V++E K+   L  H 
Sbjct: 10  TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HP 66

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECH 216
           N++        +  + + ME   GG L   +L+ K          ++V   +++A    +
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGK-----RIPPDILVNWAVQIARGMNY 120

Query: 217 LHG-----LVHRDMKPENFL-----FKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           LH      ++HRD+K  N L           +  LK TDFGL+       K     G+  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYA 179

Query: 267 YVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           ++APEV++     + SDVWS GV+ + LL G  PF       +   V  NK         
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK---LA---L 233

Query: 326 SISNSAKDFVKKLLVK----DPRAR 346
            I ++  +   KL+      DP +R
Sbjct: 234 PIPSTCPEPFAKLMEDCWNPDPHSR 258

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  132 bits (333), Expect = 6e-35
 Identities = 85/363 (23%), Positives = 137/363 (37%), Gaps = 99/363 (27%)

Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVE 141
           R D        R+Y + K LG G +G  + + D+  G+ VAVKKI     N         
Sbjct: 2   RVDR----HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST------- 50

Query: 142 DVK---REVKILQALAGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRY 196
           D +   RE+ IL  L+GHEN+V   N    ++D  VY+  +  E    L  ++  + +  
Sbjct: 51  DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVI--RANIL 106

Query: 197 TEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
                  VV Q+++     +LH  GL+HRDMKP N L      +  +K  DFGLS     
Sbjct: 107 EPVHKQYVVYQLIK--VIKYLHSGGLLHRDMKPSNIL---LNAECHVKVADFGLSRSFVN 161

Query: 255 GKKFQDIVGSA----------------------YYVAPEVL--KRKSGPESDVWSIGVIT 290
            ++  + +  +                      +Y APE+L    K     D+WS+G I 
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

Query: 291 YILLCGRRPFW------------------------DKTEDGIFKEVLRNKPDFRRKPW-- 324
             +L   +P +                        +  +    K ++ +  +        
Sbjct: 222 GEIL-CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSN 280

Query: 325 ------------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE 366
                                +  A D + KLL  +P  R++A  AL HP+V    + +E
Sbjct: 281 KRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNE 340

Query: 367 IPI 369
            P 
Sbjct: 341 EPN 343

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  132 bits (333), Expect = 1e-34
 Identities = 87/363 (23%), Positives = 130/363 (35%), Gaps = 82/363 (22%)

Query: 71  TNSRRQTGVIPCGKRTDFGYDKD-----------FDRRYTIGKLLGHGQFGYTYVATDKA 119
            N++++ G+   G   + GYD D              RY + K++G G FG    A D  
Sbjct: 63  LNAKKRQGMT--GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHK 120

Query: 120 NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----NVVKFYNAFEDDNYVYI 174
               VA+K +   K     A      E++IL+ L   +     NV+     F   N++ +
Sbjct: 121 VHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176

Query: 175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS 234
             EL     L + I   K   ++          +L+     H + ++H D+KPEN L K 
Sbjct: 177 TFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ 235

Query: 235 AKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYIL 293
               S +K  DFG S +    ++    + S +Y APEV L  + G   D+WS+G I   L
Sbjct: 236 QG-RSGIKVIDFGSSCYE--HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292

Query: 294 LCGR-----------------------------------------RPFWDKTEDGIFKEV 312
           L G                                           P +          V
Sbjct: 293 LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSV 352

Query: 313 LRNKPDFRRKPWPSISNSA--------------KDFVKKLLVKDPRARLTAAQALSHPWV 358
           + N    RR        S                DF+K+ L  DP  R+T  QAL HPW+
Sbjct: 353 VLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

Query: 359 REG 361
           R  
Sbjct: 413 RRR 415

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  130 bits (329), Expect = 2e-34
 Identities = 73/345 (21%), Positives = 129/345 (37%), Gaps = 74/345 (21%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           +   D RY + + LG G F   ++A D  N   VA+K +  +K+    A    + E+K+L
Sbjct: 14  EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLL 69

Query: 151 QAL----------AGHENVVKFYNAFE----DDNYVYIAMELCEGGELLDRILAKKDSRY 196
           Q +           G  +++K  + F     +  +V +  E+  G  LL  I   +    
Sbjct: 70  QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128

Query: 197 TEKDAAVVVRQMLRVAAECHLH---GLVHRDMKPENFLFKSAK---EDSSLKATDFGLSD 250
                  + +Q+L      ++H   G++H D+KPEN L +          +K  D G + 
Sbjct: 129 PLIYVKQISKQLLL--GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186

Query: 251 FIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIF 309
           +    + + + + +  Y +PEV L    G  +D+WS   + + L+ G   F         
Sbjct: 187 WY--DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244

Query: 310 K---------EVL------------------------RNKPDFRRKPWPSISNSA----- 331
           K         E+L                        RN    +  P   +         
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304

Query: 332 ------KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID 370
                  DF+  +L  DPR R  A   ++HPW+++     EI + 
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 349

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  128 bits (324), Expect = 7e-34
 Identities = 85/327 (25%), Positives = 124/327 (37%), Gaps = 66/327 (20%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           +Y     +G G FG  + A  +  G +VA+KK+  E  K   PI A+    RE+KILQ L
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL----REIKILQLL 73

Query: 154 AGHENVVKFY--------NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
             HENVV                   +Y+  + CE    L  +L+    ++T  +   V+
Sbjct: 74  K-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD--LAGLLSNVLVKFTLSEIKRVM 130

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
           + +L      H + ++HRDMK  N L         LK  DFGL+      K  Q    + 
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQP---NR 184

Query: 266 Y--------YVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK- 310
           Y        Y  PE+L  +R  GP  D+W  G I   +          TE      I + 
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244

Query: 311 ------------------EVLRNKPDFRRK-----PWPSISNSAKDFVKKLLVKDPRARL 347
                             E L      +RK             A D + KLLV DP  R+
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304

Query: 348 TAAQALSHPWVREGGDASEIPIDISVL 374
            +  AL+H +         +P D+  +
Sbjct: 305 DSDDALNHDFFWS----DPMPSDLKGM 327

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  126 bits (317), Expect = 1e-32
 Identities = 80/326 (24%), Positives = 122/326 (37%), Gaps = 66/326 (20%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D     G  +G G +G+ Y A  K   +    A+K+IE    I   A     RE+ +L+ 
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSAC----REIALLRE 74

Query: 153 LAGHENVVKFYNAFED--DNYVYIAMELCEG--GELLDRILAKKDSRYTEK-DAAVV--- 204
           L  H NV+     F    D  V++  +  E     ++    A K ++   +    +V   
Sbjct: 75  LK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLS-DFIKPGKKFQDIV 262
           + Q+L      H + ++HRD+KP N L      +   +K  D G +  F  P K   D+ 
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 263 GSA---YYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG---------- 307
                 +Y APE+L   R      D+W+IG I   LL     F  + ED           
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253

Query: 308 ---IFK-----------------EVLRNKPDFRRKPW-------------PSISNSAKDF 334
              IF                  E      DFRR  +                 + A   
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313

Query: 335 VKKLLVKDPRARLTAAQALSHPWVRE 360
           ++KLL  DP  R+T+ QA+  P+  E
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPYFLE 339

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  121 bits (306), Expect = 1e-31
 Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 32/247 (12%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
             G++LG G FG     T +  G+ + +K++ +             +EVK+++ L  H N
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA--EC- 215
           V+KF      D  +    E  +GG L   I+   DS+Y        V     +A+     
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWS---QRVSFAKDIASGMAYL 124

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI---------------KPGKKFQD 260
           H   ++HRD+   N L    +E+ ++   DFGL+  +                  KK   
Sbjct: 125 HSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 261 IVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
           +VG+ Y++APE++  R    + DV+S G++   ++       D        +   N   F
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP--RTMDFGLNVRGF 239

Query: 320 RRKPWPS 326
             +  P 
Sbjct: 240 LDRYCPP 246

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  119 bits (301), Expect = 2e-31
 Identities = 46/267 (17%), Positives = 89/267 (33%), Gaps = 43/267 (16%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
                L     G  +    +  G+ + VK ++           D   E   L+  + H N
Sbjct: 13  NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFS-HPN 68

Query: 159 VVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC- 215
           V+    A +     +  +       G L + +    +    +        Q ++ A +  
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQ-------SQAVKFALDMA 121

Query: 216 ----HLHGL----VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
                LH L        +   + +     ED + + +   +    +   +    + +  +
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKFSFQSPGR----MYAPAW 174

Query: 268 VAPEVLKRKSGPE----SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           VAPE L++K        +D+WS  V+ + L+    PF D +   I  +V        R  
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG---LR-- 229

Query: 324 WPSISNSAKDFVKKLL----VKDPRAR 346
            P+I       V KL+     +DP  R
Sbjct: 230 -PTIPPGISPHVSKLMKICMNEDPAKR 255

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  122 bits (307), Expect = 2e-31
 Identities = 78/385 (20%), Positives = 136/385 (35%), Gaps = 81/385 (21%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGY-----DKDFDRRYTIGKL 103
           H H H     +           ++ +++  V   G   D         + +  RY I  L
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSL 61

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----N 158
           +G G FG    A D+   + VA+K I+  K  L  A    + EV++L+ +  H+      
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V     F   N++ +  E+     L D +        +        +QM          
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176

Query: 219 --GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKR 275
              ++H D+KPEN L  + K  S++K  DFG S  +  G++    + S +Y +PEV L  
Sbjct: 177 ELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGM 233

Query: 276 KSGPESDVWSIGVITYILLCG---------------------------------RRPFWD 302
                 D+WS+G I   +  G                                  R F++
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFE 293

Query: 303 KTEDGIF--KEVLRNKPDFRRKPWPSISNSAK-------------------------DFV 335
           K  DG +  K+    K +++      + N                            D +
Sbjct: 294 KLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353

Query: 336 KKLLVKDPRARLTAAQALSHPWVRE 360
            ++L  DP+ R+    AL H + ++
Sbjct: 354 LRMLDYDPKTRIQPYYALQHSFFKK 378

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  112 bits (283), Expect = 3e-28
 Identities = 60/334 (17%), Positives = 104/334 (31%), Gaps = 76/334 (22%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
            +  + + + +G G FG   +     N    AVK + +N           K E  IL+ +
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNI---KKYTRSAKIEADILKKI 88

Query: 154 AGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
              +    N+VK++  F   +++ +  E   G  L + I     + +  +D  +   ++L
Sbjct: 89  QNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAK----------------------EDSSLKATDFG 247
           +         L H D+KPEN L                           + + +K  DFG
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 248 LSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCG---------- 296
            + F         I+ +  Y APEV L       SD+WS G +   L  G          
Sbjct: 208 CATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265

Query: 297 ------------------------RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI----- 327
                                       +   ++               K          
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325

Query: 328 ---SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
                   DF+  +L  DP  R + A+ L H ++
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  112 bits (282), Expect = 4e-28
 Identities = 72/330 (21%), Positives = 114/330 (34%), Gaps = 70/330 (21%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATD-KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
              RY I   LG G FG      D      +VA+K I +N        E  + E+ +L+ 
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNV---GKYREAARLEINVLKK 72

Query: 153 LAGHE-----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           +   +       V   + F    ++ IA EL  G    + +       Y       +  Q
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAK----------------EDSSLKATDFGLSDF 251
           +       H + L H D+KPEN LF +++                +++S++  DFG + F
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191

Query: 252 IKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGR------------- 297
               +    IV + +Y  PEV L+       DVWSIG I +    G              
Sbjct: 192 D--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249

Query: 298 --------------------------RPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
                                        WD+            KP        S+ +  
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309

Query: 332 -KDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             D ++++L  DP  R+T A+AL HP+   
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAG 339

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  111 bits (280), Expect = 7e-28
 Identities = 81/331 (24%), Positives = 117/331 (35%), Gaps = 74/331 (22%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATD-KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
              RY I   LG G FG      D KA G  VAVK + KN        E  + E+++L+ 
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNV---DRYCEAARSEIQVLEH 67

Query: 153 LAGHE-----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L   +       V+    FE   ++ I  EL  G    D I       +       +  Q
Sbjct: 68  LNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQ 126

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAK----------------EDSSLKATDFGLSDF 251
           + +     H + L H D+KPEN LF  +                  +  +K  DFG + +
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186

Query: 252 IKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTED---- 306
               +    +V + +Y APEV L        DVWSIG I      G   F   T D    
Sbjct: 187 D--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF--PTHDSKEH 242

Query: 307 --------GIFKEVLRNKPDFR------RKPWPSISNSAK-------------------- 332
                   G   + +  K   R      R  W   S++ +                    
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302

Query: 333 ----DFVKKLLVKDPRARLTAAQALSHPWVR 359
               D ++K+L  DP  R+T  +AL HP+  
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score =  108 bits (272), Expect = 4e-27
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 19/225 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G+ +G G FG  Y+ TD A G+ VA+K +E  K   P     +  E KI + + G 
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQ----LHIESKIYKMMQGG 64

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL   G  L+ +      +++ K   ++  QM+      H
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

Query: 269 APEVLKRKS-GPESDVWSIG-VITYILLCGRRPFWDKTEDGIFKE 311
           +             D+ S+G V+ Y    G  P W   +    ++
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMY-FNLGSLP-WQGLKAATKRQ 225

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  106 bits (267), Expect = 4e-26
 Identities = 68/306 (22%), Positives = 117/306 (38%), Gaps = 71/306 (23%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALAGHE 157
            + K +G G++G  ++   K  G++VAVK                 RE +I Q  L  HE
Sbjct: 40  QMVKQIGKGRYGEVWMG--KWRGEKVAVKVF------FTTEEASWFRETEIYQTVLMRHE 91

Query: 158 NVVKFYNAFEDDNY----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++ F  A          +Y+  +  E G L D +          K   +  + ML++A 
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----------KSTTLDAKSMLKLAY 141

Query: 214 E-----CHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
                 CHLH           + HRD+K +N L    K++ +    D GL+         
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNE 198

Query: 259 QDI-----VGSAYYVAPEVLKRKSGPES-------DVWSIGVITYILLCGRRPFWDKTED 306
            DI     VG+  Y+ PEVL               D++S G+I + +           E 
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258

Query: 307 GI-FKEVLRNKPDF-----------RRKPWPS--ISNSAKDFVKKLLVK----DPRARLT 348
            + + +++ + P +            R  +P+   S+     + KL+ +    +P +RLT
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318

Query: 349 AAQALS 354
           A +   
Sbjct: 319 ALRVKK 324

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  105 bits (265), Expect = 5e-26
 Identities = 62/306 (20%), Positives = 111/306 (36%), Gaps = 71/306 (23%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALAGHE 157
           T+ + +G G++G  +  +    G+ VAVK             +   RE ++    +  HE
Sbjct: 11  TLLECVGKGRYGEVWRGS--WQGENVAVKIF------SSRDEKSWFRETELYNTVMLRHE 62

Query: 158 NVVKFYNA----FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++ F  +          +++     E G L D +          +   +     LR+  
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----------QLTTLDTVSCLRIVL 112

Query: 214 EC-----HLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
                  HLH           + HRD+K +N L    K++      D GL+         
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQ 169

Query: 259 QDI-----VGSAYYVAPEVLKRKSGPE-------SDVWSIGVITYILLCGRRPFWDKTED 306
            D+     VG+  Y+APEVL      +        D+W+ G++ + +           + 
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229

Query: 307 GI-FKEVLRNKPDF-----------RRKPWPS--ISNSAKDFVKKLLVK----DPRARLT 348
              F +V+ N P F           +R   P+   S+     + KL+ +    +P ARLT
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289

Query: 349 AAQALS 354
           A +   
Sbjct: 290 ALRIKK 295

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  107 bits (268), Expect = 6e-26
 Identities = 66/369 (17%), Positives = 118/369 (31%), Gaps = 110/369 (29%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F+ RY + + LG G F   +++ D      VA+ K+ K+        E    E+++L+++
Sbjct: 35  FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAM-KVVKS---AEHYTETALDEIRLLKSV 90

Query: 154 A-------GHENVVKFYNAFE----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
                     E VV+  + F+    +  ++ +  E+  G  LL  I+             
Sbjct: 91  RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK 149

Query: 203 VVVRQMLRVAAECHLH-GLVHRDMKPENFLFK---------------------------- 233
            +++Q+L+     H    ++H D+KPEN L                              
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 234 ------------------SAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LK 274
                                E   +K  D G + +    K F + + +  Y + EV + 
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEVLIG 267

Query: 275 RKSGPESDVWSIGVITYILLCGRRPF-----------------------------WDK-- 303
                 +D+WS   + + L  G   F                                  
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327

Query: 304 ------TEDGIFKEVLRNKPDFRRKPWPSISN-------SAKDFVKKLLVKDPRARLTAA 350
                 T+ G  K + + KP    +                 DF+  +L   P  R TAA
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387

Query: 351 QALSHPWVR 359
           + L HPW+ 
Sbjct: 388 ECLRHPWLN 396

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  106 bits (265), Expect = 9e-26
 Identities = 65/303 (21%), Positives = 114/303 (37%), Gaps = 71/303 (23%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALAGHE 157
            + + +G G+FG  +    K  G+ VAVK                 RE +I Q  +  HE
Sbjct: 45  VLQESIGKGRFGEVWRG--KWRGEEVAVKIF------SSREERSWFREAEIYQTVMLRHE 96

Query: 158 NVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++ F  A   DN      ++  +  E G L D +              V V  M+++A 
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----------NRYTVTVEGMIKLAL 146

Query: 214 EC-----HLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
                  HLH           + HRD+K +N L    K++ +    D GL+         
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDT 203

Query: 259 QDI-----VGSAYYVAPEVLKRKSGPE-------SDVWSIGVITYILLCGRRPFWDKTED 306
            DI     VG+  Y+APEVL      +       +D++++G++ + +           + 
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263

Query: 307 GI-FKEVLRNKPDF-----------RRKPWPS--ISNSAKDFVKKLLV----KDPRARLT 348
            + + +++ + P              R   P+   S  A   + K++      +  ARLT
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323

Query: 349 AAQ 351
           A +
Sbjct: 324 ALR 326

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  104 bits (262), Expect = 4e-25
 Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 44/227 (19%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            +G+ +G G FG  +    +A+   VAVK   +     P       +E +IL+    H N
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQY-SHPN 173

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           +V+          +YI MEL +GG+ L   L  + +R       + V+ +L++  +    
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTF-LRTEGAR-------LRVKTLLQMVGDAAAG 225

Query: 216 ----HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
                    +HRD+   N L     E + LK +DFG+S         ++     Y     
Sbjct: 226 MEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMS---------REEADGVYAASGG 273

Query: 269 ---------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                    APE L   +   ESDVWS G++ +     G  P+ + +
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score =  103 bits (258), Expect = 6e-25
 Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 19/226 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L   
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQLGSG 64

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           + + + Y       Y  + +EL   G  L+ +    D  ++ K   ++  Q++      H
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 217 LHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFI-------KPGKKFQDIVGSAY 266
              L++RD+KPENFL      K    +   DF L+ ++I        P ++ + + G+A 
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE 311
           Y++      K      D+ ++G +    L G  P W   +    KE
Sbjct: 183 YMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKE 227

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score =  102 bits (256), Expect = 8e-25
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 19/226 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G+ +G G FG  +  T+  N  +VA+K  E  +   P     ++ E +  + LAG 
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQ----LRDEYRTYKLLAGC 65

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +   Y   ++  +  + ++L   G  L+ +L     +++ K  A+  +QML      H
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 217 LHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFI-------KPGKKFQDIVGSAY 266
              LV+RD+KP+NFL    ++K  + +   DFG+   +         P ++ +++ G+A 
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 267 YVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE 311
           Y++    L R+     D+ ++G +    L G  P W   +    K+
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-WQGLKAATNKQ 228

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  103 bits (259), Expect = 9e-25
 Identities = 63/300 (21%), Positives = 107/300 (35%), Gaps = 45/300 (15%)

Query: 36  RHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD-- 93
            H+HH  +  T ++ +         Q  + K  +   S   T   P              
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDL 65

Query: 94  --FDRRY-TIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKR 145
               R+  T+ + LGHG FG  Y    +   N     +VAVK + +          D   
Sbjct: 66  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLM 123

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  I+     H+N+V+           +I +EL  GG+L   +   +      + +++ +
Sbjct: 124 EALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR--PSQPSSLAM 180

Query: 206 RQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
             +L VA +      +L  +  +HRD+   N L          K  DFG++         
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------- 231

Query: 259 QDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
           +DI  + YY              PE         ++D WS GV+ + I   G  P+  K+
Sbjct: 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score =  104 bits (260), Expect = 1e-24
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 17/214 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           ++ +G+ +G G FG  Y+ T+    + VA+K +E  K   P     +  E KI + L G 
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ----LLYESKIYRILQGG 62

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + M+L   G  L+ +      + + K   ++  QM+      H
Sbjct: 63  TGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    +  + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFW 301
           +             D+ S+G +    L G  P W
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  100 bits (252), Expect = 3e-24
 Identities = 62/251 (24%), Positives = 102/251 (40%), Gaps = 53/251 (21%)

Query: 81  PCGKRTD-----FGYDK-DFDRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK 133
           P G +        GY   + D +  T  K LG GQFG       +   D VA+K I++  
Sbjct: 2   PLGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGS 60

Query: 134 MILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD 193
           M    + ++   E K++  L+ HE +V+ Y        ++I  E    G LL+  L +  
Sbjct: 61  M----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMR 114

Query: 194 SRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDF 246
            R+         +Q+L +  +      +L     +HRD+   N L     +   +K +DF
Sbjct: 115 HRFQ-------TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDF 164

Query: 247 GLSDFIKPGKKFQDIVGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-IL 293
           GLS         + ++   Y              PEVL   K   +SD+W+ GV+ + I 
Sbjct: 165 GLS---------RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215

Query: 294 LCGRRPFWDKT 304
             G+ P+   T
Sbjct: 216 SLGKMPYERFT 226

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  100 bits (250), Expect = 8e-24
 Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 69/302 (22%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            + ++   G+FG  + A      + VAVK                + EV  L  +  HEN
Sbjct: 27  QLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDK----QSWQNEYEVYSLPGMK-HEN 79

Query: 159 VVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +++F  A +    V    ++     E G L D +          K   V   ++  +A  
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----------KANVVSWNELCHIAET 129

Query: 215 -----CHLH------------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
                 +LH             + HRD+K +N L    K + +    DFGL+   + GK 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKS 186

Query: 258 FQDI---VGSAYYVAPEVL------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
             D    VG+  Y+APEVL      +R +    D++++G++ + L           ++ +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 309 --FKEVLRNKPDF--------RRKPWPSISNS-AKDFVKKLLVK--------DPRARLTA 349
             F+E +   P           +K  P + +   K     +L +        D  ARL+A
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 350 AQ 351
             
Sbjct: 307 GC 308

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 98.4 bits (246), Expect = 1e-23
 Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 38/222 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  + +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  
Sbjct: 11  TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 64

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-- 216
           +V+ Y    +   + +  E  E G L D  L  +   +  +    +      V       
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSD-YLRTQRGLFAAETLLGMCLD---VCEGMAYL 120

Query: 217 -LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------- 268
               ++HRD+   N L     E+  +K +DFG++         + ++   Y         
Sbjct: 121 EEACVIHRDLAARNCL---VGENQVIKVSDFGMT---------RFVLDDQYTSSTGTKFP 168

Query: 269 ----APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
               +PEV    +   +SDVWS GV+ + +   G+ P+ +++
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 45/230 (19%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            + + LG G FG        A   +   VAVK ++ + +  P A++D  REV  + +L  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE- 214
           H N+++ Y        + +  EL   G LLDR+   +           ++  + R A + 
Sbjct: 80  HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQV 130

Query: 215 ----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                +L     +HRD+   N L  +      +K  DFGL   +             +YV
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALPQNDD--------HYV 179

Query: 269 ------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                       APE LK R     SD W  GV  + +   G+ P+    
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 39/226 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALA 154
              K+LG G FG  Y       G++    VA+K++ +     P A +++  E  ++ ++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVD 75

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            + +V +          V +  +L   G LLD  + +       +       Q   +A  
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQ---IAKG 129

Query: 215 CH---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
            +      LVHRD+   N L    K    +K TDFGL+  +              Y    
Sbjct: 130 MNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGA--------EEKEYHAEG 178

Query: 269 --------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                   A E +  R    +SDVWS GV  + ++  G +P+    
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 65/264 (24%), Positives = 101/264 (38%), Gaps = 51/264 (19%)

Query: 58  KNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD--FDR-RYTIGKLLGHGQFGYTYV 114
           K   Q++ K  +       T + P    T   Y++   F R     GK LG G FG    
Sbjct: 9   KPKYQVRWKIIESYEGNSYTFIDP----TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64

Query: 115 AT----DKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD 169
           AT     K +   +VAVK ++          E +  E+KI+  L  HEN+V    A    
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122

Query: 170 NYVYIAMELCEGGELLD-----RILAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL-- 217
             V +  E C  G+LL+       + + D  +   ++    R +L  +++       L  
Sbjct: 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--------- 268
              +HRD+   N L          K  DFGL+         +DI+  + Y+         
Sbjct: 183 KNCIHRDVAARNVL---LTNGHVAKIGDFGLA---------RDIMNDSNYIVKGNARLPV 230

Query: 269 ---APEVLK-RKSGPESDVWSIGV 288
              APE +       +SDVWS G+
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGI 254

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (250), Expect = 4e-23
 Identities = 73/317 (23%), Positives = 118/317 (37%), Gaps = 62/317 (19%)

Query: 32  EAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSR--RQTGVIPCGKRT--- 86
           E +  H +     +  K     + R     +L    H  T +     T   P  KR    
Sbjct: 148 EGRVYH-YRINTASDGKLYVSSESRFNTLAELV--HHHSTVADGLITTLHYPAPKRNKPT 204

Query: 87  ----DFGYDK-DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
                  YDK + +R   T+   LG GQ+G  Y    K     VAVK ++++ M     V
Sbjct: 205 IYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 260

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--TE 198
           E+  +E  +++ +  H N+V+       +   YI  E    G LLD         Y    
Sbjct: 261 EEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLD---------YLREC 310

Query: 199 KDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
               V    +L +A +      +L     +HR++   N L     E+  +K  DFGLS  
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLS-- 365

Query: 252 IKPGKKFQDIVGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRR 298
                  + + G  Y             APE L   K   +SDVW+ GV+ + I   G  
Sbjct: 366 -------RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 418

Query: 299 PFWDKTEDGIFKEVLRN 315
           P+       +++ + ++
Sbjct: 419 PYPGIDLSQVYELLEKD 435

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 98.2 bits (245), Expect = 5e-23
 Identities = 62/290 (21%), Positives = 104/290 (35%), Gaps = 56/290 (19%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRY-TIGKLLGHG 107
           + H H                   S     V+         +  +      T  K++G G
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLK--------FTTEIHPSCVTRQKVIGAG 55

Query: 108 QFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +FG  Y    K +  +    VA+K ++           D   E  I+   + H N+++  
Sbjct: 56  EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFS-HHNIIRLE 112

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL- 217
                   + I  E  E G L    L +KD  ++       V Q++ +         +L 
Sbjct: 113 GVISKYKPMMIITEYMENGALDK-FLREKDGEFS-------VLQLVGMLRGIAAGMKYLA 164

Query: 218 -HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV-------- 268
               VHRD+   N L      +   K +DFGLS  +      +D   + Y          
Sbjct: 165 NMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRVL------EDDPEATYTTSGGKIPIR 215

Query: 269 --APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
             APE +  RK    SDVWS G++ + ++  G RP+W+ +      EV++
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMK 261

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.4 bits (243), Expect = 8e-23
 Identities = 68/296 (22%), Positives = 103/296 (34%), Gaps = 60/296 (20%)

Query: 47  HKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGK----RTDFGYDKDFDRRY-TIG 101
           H H H    R   Y Q K           Q    P       R    + ++ +     I 
Sbjct: 2   HHHHHHSSGRENLYFQGKL-------PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIE 54

Query: 102 KLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           K++G G  G       +  G R   VA+K ++           D   E  I+     H N
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFD-HPN 111

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE---- 214
           +++            I  E  E G L    L   D ++T       + Q++ +       
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFT-------IMQLVGMLRGVGAG 163

Query: 215 -CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
             +L   G VHRD+   N L      +   K +DFGLS  ++           A Y    
Sbjct: 164 MRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDP-------DAAYTTTG 213

Query: 269 --------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
                   APE +  R     SDVWS GV+ + +L  G RP+W+ T     ++V+ 
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVIS 265

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 50/228 (21%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+ K LG GQFG   +   K     VAVK I++  M    + ++  +E + +  L+ H  
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPK 64

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLD--RILAKKDSRYTEKDAAVVVRQMLRVAAE-- 214
           +VKFY     +  +YI  E    G LL+  R               +   Q+L +  +  
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLR----------SHGKGLEPSQLLEMCYDVC 114

Query: 215 ---CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV- 268
                L  H  +HRD+   N L      D  +K +DFG++         + ++   Y   
Sbjct: 115 EGMAFLESHQFIHRDLAARNCL---VDRDLCVKVSDFGMT---------RYVLDDQYVSS 162

Query: 269 ----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                     APEV    K   +SDVW+ G++ + +   G+ P+   T
Sbjct: 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 48/238 (20%)

Query: 87  DFGYDK-DFDRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
           +F       + +   + + +G G+FG   +      G++VAVK I+ +        +   
Sbjct: 10  EFYRSGWALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT-----AQAFL 62

Query: 145 REVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDA 201
            E  ++  L  H N+V+      E+   +YI  E    G L+D         Y  +   +
Sbjct: 63  AEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD---------YLRSRGRS 112

Query: 202 AVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-- 252
            +    +L+ + +      +L  +  VHRD+   N L     ED+  K +DFGL+     
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS 169

Query: 253 -KPGKKFQDIVGSAYYV---APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
            +   K          V   APE L+ +K   +SDVWS G++ + I   GR P+    
Sbjct: 170 TQDTGKLP--------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 59/236 (25%), Positives = 88/236 (37%), Gaps = 43/236 (18%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F+ R+      LG G FG      Y       G  VAVK++   +   P    D +RE++
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQ 76

Query: 149 ILQALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL+AL   + +VK+           + + ME    G L D  L +  +R       +   
Sbjct: 77  ILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF-LQRHRARLDASRLLLYSS 134

Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           Q   +            VHRD+   N L    + ++ +K  DFGL+  +   K       
Sbjct: 135 Q---ICKGMEYLGSRRCVHRDLAARNIL---VESEAHVKIADFGLAKLLPLDKD------ 182

Query: 264 SAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTE 305
             YYV            APE L       +SDVWS GV+ Y +     +      E
Sbjct: 183 --YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 46/247 (18%)

Query: 90  YDK-DFDRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           YDK + +R   T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEA 60

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            +++ +  H N+V+       +   YI  E    G LLD +        +          
Sbjct: 61  AVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-------AVV 112

Query: 208 MLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           +L +A +      +L     +HRD+   N L     E+  +K  DFGLS  +        
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT------- 162

Query: 261 IVGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDG 307
             G  Y             APE L   K   +SDVW+ GV+ + I   G  P+       
Sbjct: 163 --GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

Query: 308 IFKEVLR 314
           +++ + +
Sbjct: 221 VYELLEK 227

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 61/242 (25%), Positives = 93/242 (38%), Gaps = 48/242 (19%)

Query: 94  FDRRY-TIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKIL 150
            D        ++G G FG    A  K +G R   A+K++++          D   E+++L
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVL 79

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTEKDAAV 203
             L  H N++    A E   Y+Y+A+E    G LLD              +      + +
Sbjct: 80  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139

Query: 204 VVRQMLRVAAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
             +Q+L  AA+      +L     +HRD+   N L     E+   K  DFGLS       
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLS------- 189

Query: 257 KFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWD 302
           + Q+      YV            A E L        SDVWS GV+ + I+  G  P+  
Sbjct: 190 RGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

Query: 303 KT 304
            T
Sbjct: 245 MT 246

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 56/240 (23%), Positives = 94/240 (39%), Gaps = 41/240 (17%)

Query: 92  KDFDRRY-TIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKR 145
           K+  R+  T+ + LGHG FG  Y    +   N     +VAVK + +          D   
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLM 82

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  I+     H+N+V+           +I MEL  GG+L   +   +      + +++ +
Sbjct: 83  EALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR--PSQPSSLAM 139

Query: 206 RQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
             +L VA +      +L  +  +HRD+   N L          K  DFG++         
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------- 190

Query: 259 QDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
           +DI  ++YY              PE         ++D WS GV+ + I   G  P+  K+
Sbjct: 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 93.9 bits (234), Expect = 7e-22
 Identities = 42/230 (18%), Positives = 77/230 (33%), Gaps = 41/230 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGD-------RVAVKKIEKNKMILPIAVEDVKREVKILQ 151
              + LG G F   +    +  GD        V +K ++K         E       ++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMS 67

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L+ H+++V  Y      +   +  E  + G L    L K  +         V +Q   +
Sbjct: 68  KLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDT-YLKKNKNCINILWKLEVAKQ---L 122

Query: 212 AAECH---LHGLVHRDMKPENFL-----FKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           AA  H    + L+H ++  +N L      +       +K +D G+S           ++ 
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---------ITVLP 173

Query: 264 SAYY------VAPEVLK--RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                     V PE ++  +     +D WS G   + I   G +P     
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 59/267 (22%), Positives = 102/267 (38%), Gaps = 57/267 (21%)

Query: 67  QHQKTNSRR--QTGVIPCGKRTDFGYDKDFDR-----RYTIGKLLGHGQFGYTYVATDKA 119
            H K  +    Q   +PC         +            + K LG GQFG  ++AT   
Sbjct: 152 DHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK 211

Query: 120 NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC 179
           +   VAVK ++   M    +VE    E  +++ L  H+ +VK +     +  +YI  E  
Sbjct: 212 HTK-VAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVTKEP-IYIITEFM 264

Query: 180 EGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENF 230
             G LLD         +  +++ +   + +++  +A+       +     +HRD++  N 
Sbjct: 265 AKGSLLD---------FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315

Query: 231 LFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV-----------APEVLK-RKSG 278
           L          K  DFGL+         + I  + Y             APE +      
Sbjct: 316 LV---SASLVCKIADFGLA---------RVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363

Query: 279 PESDVWSIGVITY-ILLCGRRPFWDKT 304
            +SDVWS G++   I+  GR P+   +
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMS 390

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 54/252 (21%)

Query: 90  YDKD---FDRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
           + +D     R    + + LG GQFG  ++     +  +VAVK +++  M    + +    
Sbjct: 3   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSM----SPDAFLA 57

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAAV 203
           E  +++ L  H+ +V+ Y     +  +YI  E  E G L+D         +  T     +
Sbjct: 58  EANLMKQLQ-HQRLVRLYAVVTQEP-IYIITEYMENGSLVD---------FLKTPSGIKL 106

Query: 204 VVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
            + ++L +AA+       +     +HRD++  N L     +  S K  DFGL+       
Sbjct: 107 TINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLA------- 156

Query: 257 KFQDIVGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDK 303
             + I  + Y             APE +       +SDVWS G++   I+  GR P+   
Sbjct: 157 --RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

Query: 304 TEDGIFKEVLRN 315
           T   + + + R 
Sbjct: 215 TNPEVIQNLERG 226

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 96.1 bits (239), Expect = 1e-21
 Identities = 68/317 (21%), Positives = 119/317 (37%), Gaps = 66/317 (20%)

Query: 36  RHNHHARNDTTHKHQHQHQERAKNYQQLKTK--------QHQKTNS----RRQTGVIPCG 83
               +A+      ++ +  +    Y   +T+         +   ++     R T V P  
Sbjct: 191 SDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTS 250

Query: 84  KRTDFGYDKD---FDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA 139
           K    G  KD     R    +   LG G FG  ++ T       VA+K ++   M    +
Sbjct: 251 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----S 305

Query: 140 VEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--T 197
            E   +E ++++ L  HE +V+ Y    ++  +YI  E    G LLD         +   
Sbjct: 306 PEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLD---------FLKG 354

Query: 198 EKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
           E    + + Q++ +AA+      ++     VHRD++  N L     E+   K  DFGL+ 
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL---VGENLVCKVADFGLA- 410

Query: 251 FIKPGKKFQDIVGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGR 297
                   + I  + Y             APE     +   +SDVWS G++   +   GR
Sbjct: 411 --------RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

Query: 298 RPFWDKTEDGIFKEVLR 314
            P+       +  +V R
Sbjct: 463 VPYPGMVNREVLDQVER 479

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 66/265 (24%), Positives = 98/265 (36%), Gaps = 59/265 (22%)

Query: 90  YDKD---FDR-RYTIGKLLGHGQFGYTYVATDKANGD-------RVAVKKIEKNKMILPI 138
           YD     F R R  +GK LG G FG    A   A G         VAVK +++       
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEAD--AFGIDKTATCRTVAVKMLKEGAT--HS 72

Query: 139 AVEDVKREVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLD-------RILA 190
               +  E+KIL  +  H NVV    A  +    + + +E C+ G L           + 
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132

Query: 191 KKDSRYTEKDAAVVVRQMLRVAAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKA 243
            K +        + +  ++  + +       L     +HRD+   N L     E + +K 
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL---LSEKNVVKI 189

Query: 244 TDFGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVIT 290
            DFGL+         +DI     YV            APE +  R    +SDVWS GV+ 
Sbjct: 190 CDFGLA---------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240

Query: 291 Y-ILLCGRRPFWDKTEDGIFKEVLR 314
           + I   G  P+     D   +E  R
Sbjct: 241 WEIFSLGASPYPGVKID---EEFCR 262

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 48/225 (21%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            + + +G G+FG   +      G++VAVK I+ +        +    E  ++  L  H N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLR-HSN 247

Query: 159 VVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAE- 214
           +V+      E+   +YI  E    G L+D         Y  +   + +    +L+ + + 
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVD---------YLRSRGRSVLGGDCLLKFSLDV 298

Query: 215 ----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                +L  +  VHRD+   N L     ED+  K +DFGL+         ++   +    
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---------KEASSTQDTG 346

Query: 269 -------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                  APE L+ +K   +SDVWS G++ + I   GR P+    
Sbjct: 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 47/229 (20%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            +G+ +G GQFG  +     +  +    VA+K  +          E   +E   ++    
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFD- 74

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE- 214
           H ++VK      ++  V+I MELC  GEL   +  +K S        + +  ++  A + 
Sbjct: 75  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQL 125

Query: 215 ----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                +L     VHRD+   N L      +  +K  DFGLS         + +  S YY 
Sbjct: 126 STALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLS---------RYMEDSTYYK 173

Query: 269 -----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                      APE +  R+    SDVW  GV  + IL+ G +PF    
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 58/278 (20%)

Query: 67  QHQKTNS----RRQTGVIPCGKRTDFGYDKD---FDR-RYTIGKLLGHGQFGYTYVATDK 118
            +   ++     R T V P  K    G  KD     R    +   LG G FG  ++ T  
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
               RVA+K ++   M    + E   +E ++++ L  HE +V+ Y    ++  +YI  E 
Sbjct: 207 GTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEE-PIYIVTEY 259

Query: 179 CEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPEN 229
              G LLD         +   E    + + Q++ +AA+      ++     VHRD++  N
Sbjct: 260 MSKGSLLD---------FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 310

Query: 230 FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV-----------APEVLK-RKS 277
            L     E+   K  DFGL+         + I  + Y             APE     + 
Sbjct: 311 IL---VGENLVCKVADFGLA---------RLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358

Query: 278 GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
             +SDVWS G++   +   GR P+       +  +V R
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 47/246 (19%)

Query: 92  KDFDRRY-TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREV 147
           K+ D    +I K++G G+FG       K    +   VA+K ++           D   E 
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEA 97

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            I+     H N+++          V I  E  E G L    L K D+++T       V Q
Sbjct: 98  SIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFT-------VIQ 148

Query: 208 MLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           ++ +         +L   G VHRD+   N L      +   K +DFGL   +      +D
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLGRVL------ED 199

Query: 261 IVGSAYYV----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGI 308
              +AY            +PE +  RK    SDVWS G++ + ++  G RP+W+ +    
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--- 256

Query: 309 FKEVLR 314
            ++V++
Sbjct: 257 -QDVIK 261

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 70/313 (22%), Positives = 104/313 (33%), Gaps = 77/313 (24%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD---FDRRY-TIGKLL 104
           + H H     +Y    T+            +   G       D+D   F+ R+    + L
Sbjct: 4   YHHHHHH---DYDIPTTE-----------NLYFQGAMGSAFEDRDPTQFEERHLKFLQQL 49

Query: 105 GHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           G G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+V
Sbjct: 50  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQ-HDNIV 105

Query: 161 KFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           K+           + + ME    G L D  L K   R           Q   +       
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQ---ICKGMEYL 161

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------- 268
                +HRD+   N L    + ++ +K  DFGL+  +   K+        YY        
Sbjct: 162 GTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDKE--------YYKVKEPGES 210

Query: 269 -----APEVLK-RKSGPESDVWSIGV-----ITYILLCGRRPFWDKTEDGIFKEVLRNKP 317
                APE L   K    SDVWS GV      TYI      P       G          
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG---------- 260

Query: 318 DFRRKPWPSISNS 330
                    +   
Sbjct: 261 ---NDKQGQMIVF 270

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 39/226 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALA 154
              K+LG G FG  Y       G++    VA+K++ +     P A +++  E  ++ ++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVD 75

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            + +V +          V +  +L   G LLD  + +       +       Q   +A  
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQ---IAKG 129

Query: 215 CH---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
            +      LVHRD+   N L    K    +K TDFGL+  +              Y    
Sbjct: 130 MNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGA--------EEKEYHAEG 178

Query: 269 --------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                   A E +  R    +SDVWS GV  + ++  G +P+    
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 61/265 (23%), Positives = 92/265 (34%), Gaps = 60/265 (22%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F+ R+    + LG G FG      Y       G+ VAVKK++ +       + D +RE++
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIE 63

Query: 149 ILQALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL++L  H+N+VK+           + + ME    G L D  L K   R           
Sbjct: 64  ILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTS 121

Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           Q   +            +HRD+   N L    + ++ +K  DFGL+  +   K+      
Sbjct: 122 Q---ICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDKE------ 169

Query: 264 SAYYV------------APEVLK-RKSGPESDVWSIGV-----ITYILLCGRRPFWDKTE 305
             ++             APE L   K    SDVWS GV      TYI      P      
Sbjct: 170 --FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227

Query: 306 DGIFKEVLRNKPDFRRKPWPSISNS 330
            G                   +   
Sbjct: 228 IG-------------NDKQGQMIVF 239

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 63/252 (25%), Positives = 93/252 (36%), Gaps = 52/252 (20%)

Query: 86  TDFGYDKD--FDR-RYTIGKLLGHGQFGYTYVAT----DKANGD-RVAVKKIEKNKMILP 137
           T   YD    F R R + GK LG G FG    AT     K++    VAVK ++ +     
Sbjct: 10  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--L 67

Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD---------RI 188
              E +  E+K+L  L  H N+V    A        +  E C  G+LL+           
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 189 LAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSL 241
                +   + + A+ +  +L  + +       L     +HRD+   N L          
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRIT 184

Query: 242 KATDFGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGV 288
           K  DFGL+         +DI   + YV            APE +       ESDVWS G+
Sbjct: 185 KICDFGLA---------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235

Query: 289 ITY-ILLCGRRP 299
             + +   G  P
Sbjct: 236 FLWELFSLGSSP 247

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 54/252 (21%), Positives = 95/252 (37%), Gaps = 48/252 (19%)

Query: 94  FDR-RYTIGKLLGHGQFGYTY--VATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKI 149
               ++T+G++LG G+FG         +     +VAVK + K  +I    +E+  RE   
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAAC 78

Query: 150 LQALAGHENVVKFY------NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
           ++    H +V K         A        + +   + G+L   +     SR  E    +
Sbjct: 79  MKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL---LASRIGENPFNL 134

Query: 204 VVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
            ++ ++R   +      +L     +HRD+   N +     ED ++   DFGLS       
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM---LAEDMTVCVADFGLS------- 184

Query: 257 KFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWD 302
             + I    YY             A E L        SDVW+ GV  + I+  G+ P+  
Sbjct: 185 --RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242

Query: 303 KTEDGIFKEVLR 314
                I+  ++ 
Sbjct: 243 IENAEIYNYLIG 254

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 91.1 bits (227), Expect = 5e-21
 Identities = 56/225 (24%), Positives = 83/225 (36%), Gaps = 39/225 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            + ++LG G FG  Y      +      VAVK  +K+        E    E  I++ L  
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLD- 71

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H ++VK     E++   +I MEL   GEL    L +  +        +   Q   +    
Sbjct: 72  HPHIVKLIGIIEEEP-TWIIMELYPYGELGHY-LERNKNSLKVLTLVLYSLQ---ICKAM 126

Query: 216 H---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---- 268
                   VHRD+   N L         +K  DFGLS         + I    YY     
Sbjct: 127 AYLESINCVHRDIAVRNIL---VASPECVKLGDFGLS---------RYIEDEDYYKASVT 174

Query: 269 -------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                  +PE +  R+    SDVW   V  + IL  G++PF+   
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 58/284 (20%), Positives = 106/284 (37%), Gaps = 52/284 (18%)

Query: 63  LKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD--FDR-RYTIGKLLGHGQFGYTY--VATD 117
           + +  H   +S   +G++P G        +D   DR    +GK+LG G+FG         
Sbjct: 1   MGSSHHHHHHS---SGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQ 57

Query: 118 KANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY-----NAFEDDNY 171
           +     +VAVK + K        +E+   E   ++    H NV++        + +    
Sbjct: 58  EDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPK 115

Query: 172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRD 224
             + +   + G+L   +     SR       + ++ +L+   +      +L     +HRD
Sbjct: 116 PMVILPFMKYGDLHTYL---LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD 172

Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------------APEV 272
           +   N +    ++D ++   DFGLS         + I    YY             A E 
Sbjct: 173 LAARNCM---LRDDMTVCVADFGLS---------KKIYSGDYYRQGRIAKMPVKWIAIES 220

Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
           L  R    +SDVW+ GV  + I   G  P+       ++  +L 
Sbjct: 221 LADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 93.8 bits (233), Expect = 8e-21
 Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 47/237 (19%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            +G+ +G GQFG  +     +  +    VA+K  +          E   +E   ++    
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQF-D 449

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE- 214
           H ++VK      ++  V+I MELC  GEL   +  +K S        + +  ++  A + 
Sbjct: 450 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFS--------LDLASLILYAYQL 500

Query: 215 ----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                +L     VHRD+   N L      +  +K  DFGLS +++          S YY 
Sbjct: 501 STALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYME---------DSTYYK 548

Query: 269 -----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
                      APE +  R+    SDVW  GV  + IL+ G +PF     + +   +
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 42/236 (17%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F++R+    + LG G FG      Y       G++VAVK ++         + D+K+E++
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIE 75

Query: 149 ILQALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL+ L  HEN+VK+     +D    + + ME    G L +  L K  ++   K       
Sbjct: 76  ILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY-LPKNKNKINLKQQLKYAV 133

Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           Q   +            VHRD+   N L    + +  +K  DFGL+  I+  K+      
Sbjct: 134 Q---ICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKE------ 181

Query: 264 SAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTE 305
             YY             APE L   K    SDVWS GV  + +L            
Sbjct: 182 --YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 71/292 (24%), Positives = 110/292 (37%), Gaps = 61/292 (20%)

Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD--FDR-RYTIGKLLGHG 107
           H+++++ +   QL+  Q   ++      V       ++ YD    F R     GK+LG G
Sbjct: 1   HKYKKQFRYESQLQMVQVTGSSDNEYFYVDF----REYEYDLKWEFPRENLEFGKVLGSG 56

Query: 108 QFGYTYVAT----DKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            FG    AT     K     +VAVK +++         E +  E+K++  L  HEN+V  
Sbjct: 57  AFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNL 114

Query: 163 YNAFEDDNYVYIAMELCEGGELLD--------------RILAKKDSRYTEKDAAVVVRQM 208
             A      +Y+  E C  G+LL+                  +K     E    +    +
Sbjct: 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174

Query: 209 LRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           L  A +       L     VHRD+   N L         +K  DFGL+         +DI
Sbjct: 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVL---VTHGKVVKICDFGLA---------RDI 222

Query: 262 VGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRP 299
           +  + YV            APE L       +SDVWS G++ + I   G  P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 50/257 (19%)

Query: 94  FDR-RYTIGKLLGHGQFGYTYVAT----DKANGD---RVAVKKIEKNKMILPIAVEDVKR 145
             R R  +GK LG G FG   +A     DK   +   +VAVK ++ +       + D+  
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLIS 123

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTE 198
           E+++++ +  H+N++    A   D  +Y+ +E    G L +         L    +    
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 199 KDAAVVVRQMLRVAAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
            +  +  + ++  A +      +L     +HRD+   N L     ED+ +K  DFGL+  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLA-- 238

Query: 252 IKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGR 297
                  +DI    YY             APE L  R    +SDVWS GV+ + I   G 
Sbjct: 239 -------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291

Query: 298 RPFWDKTEDGIFKEVLR 314
            P+     + +FK +  
Sbjct: 292 SPYPGVPVEELFKLLKE 308

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 58/261 (22%), Positives = 99/261 (37%), Gaps = 58/261 (22%)

Query: 94  FDR-RYTIGKLLGHGQFGYTYVAT-------DKANGDRVAVKKIEKNKMILPIAVEDVKR 145
           F R + T+GK LG G FG   +A               VAVK ++ +       + D+  
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVS 89

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTE 198
           E+++++ +  H+N++    A   D  +Y+ +E    G L +         +         
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 199 KDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
            +  +  + ++    +      +L     +HRD+   N L     E++ +K  DFGL+  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIADFGLA-- 204

Query: 252 IKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGV-----ITYIL 293
                  +DI    YY             APE L  R    +SDVWS GV      T   
Sbjct: 205 -------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL-- 255

Query: 294 LCGRRPFWDKTEDGIFKEVLR 314
             G  P+     + +FK +  
Sbjct: 256 --GGSPYPGIPVEELFKLLKE 274

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 64/261 (24%), Positives = 95/261 (36%), Gaps = 54/261 (20%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F +RY    + LG G FG    Y Y  T+   G+ VAVK ++ +    P      K+E+ 
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEID 85

Query: 149 ILQALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL+ L  HE+++K+    ED     + + ME    G L D +              +  +
Sbjct: 86  ILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQ 141

Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           Q   +       H    +HRD+   N L      D  +K  DFGL+  +  G +      
Sbjct: 142 Q---ICEGMAYLHAQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHE------ 189

Query: 264 SAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIF 309
             YY             APE LK  K    SDVWS GV  Y +L          T+    
Sbjct: 190 --YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247

Query: 310 KEVLRNKPDFRRKPWPSISNS 330
             +              ++  
Sbjct: 248 IGI----------AQGQMTVL 258

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 70/329 (21%), Positives = 122/329 (37%), Gaps = 57/329 (17%)

Query: 24  HHRNANKEEAKR---RHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVI 80
           HH ++    A     +     R  T                ++ T+     ++    GV 
Sbjct: 7   HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66

Query: 81  PCGKRTDFGYDK-DFDR-RYTIGKLLGHGQFGYTYVAT----DKANGD---RVAVKKIEK 131
                 D    K +F R + T+GK LG G FG   +A     DK        VAVK ++ 
Sbjct: 67  EYELPED---PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 123

Query: 132 NKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD----- 186
           +       + D+  E+++++ +  H+N++    A   D  +Y+ +E    G L +     
Sbjct: 124 DAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 181

Query: 187 --RILAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKE 237
               +          +  +  + ++    +      +L     +HRD+   N L     E
Sbjct: 182 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTE 238

Query: 238 DSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVW 284
           ++ +K  DFGL+         +DI    YY             APE L  R    +SDVW
Sbjct: 239 NNVMKIADFGLA---------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 289

Query: 285 SIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           S GV+ + I   G  P+     + +FK +
Sbjct: 290 SFGVLMWEIFTLGGSPYPGIPVEELFKLL 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 64/317 (20%), Positives = 107/317 (33%), Gaps = 90/317 (28%)

Query: 99  TIGKLLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALAG 155
            + +L+G G++G  Y    K   +   VAVK             ++   E  I +  L  
Sbjct: 16  KLLELIGRGRYGAVY----KGSLDERPVAVKVFSFANR------QNFINEKNIYRVPLME 65

Query: 156 HENVVKFYNAFEDDNYV-----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           H+N+ +F    E           + ME    G L   +                     R
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----------SLHTSDWVSSCR 115

Query: 211 VAAE-----CHLH-----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
           +A        +LH            + HRD+   N L    K D +   +DFGLS  +  
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTG 172

Query: 255 GKKFQD---------IVGSAYYVAPEVLK--------RKSGPESDVWSIGVITYILLCG- 296
            +  +           VG+  Y+APEVL+          +  + D++++G+I + +    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 297 ------------RRPFWDK-----TEDGIFKEVLRNK--PDFRRKPWPSISNSAKDFVKK 337
                       +  F  +     T + +   V R K  P F    W   S + +   K+
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSL-KE 290

Query: 338 LLVK----DPRARLTAA 350
            +      D  ARLTA 
Sbjct: 291 TIEDCWDQDAEARLTAQ 307

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 43/239 (17%)

Query: 94  FDR-RYTIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKREV 147
             R + T+ + LG G FG  Y  VA      +   RVA+K + +          +   E 
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEA 79

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVVR 206
            +++      +VV+            + MEL   G+L   + + +         A   + 
Sbjct: 80  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 207 QMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           +M+++A E      +L  +  VHRD+   N +     ED ++K  DFG++         +
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMT---------R 186

Query: 260 DIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
           DI  + YY             +PE LK       SDVWS GV+ + I     +P+   +
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 48/236 (20%), Positives = 87/236 (36%), Gaps = 48/236 (20%)

Query: 94  FDRRY-TIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVK 148
           F        K+LG G FG  +       G+     V +K IE        + + V   + 
Sbjct: 10  FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHML 67

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
            + +L  H ++V+        + + +  +    G LLD +   + +        +  + +
Sbjct: 68  AIGSLD-HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA--------LGPQLL 117

Query: 209 LRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           L    +      +L  HG+VHR++   N L    K  S ++  DFG++D + P       
Sbjct: 118 LNWGVQIAKGMYYLEEHGMVHRNLAARNVL---LKSPSQVQVADFGVADLLPP------- 167

Query: 262 VGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                 +           A E +   K   +SDVWS GV  + ++  G  P+    
Sbjct: 168 -DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 38/223 (17%)

Query: 101 GKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            K LG G FG       +       VAVK ++      P   +++  E  ++Q L  +  
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLD-NPY 79

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-- 216
           +V+      +     + ME+ E G L   +  +++    +K+   +V Q   V+      
Sbjct: 80  IVRMI-GICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ---VSMGMKYL 133

Query: 217 -LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------- 268
                VHRD+   N L          K +DFGLS  ++            YY        
Sbjct: 134 EESNFVHRDLAARNVL---LVTQHYAKISDFGLSKALR--------ADENYYKAQTHGKW 182

Query: 269 -----APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                APE +   K   +SDVWS GV+ +     G++P+    
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 53/226 (23%), Positives = 83/226 (36%), Gaps = 39/226 (17%)

Query: 99  TIGKL-LGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            I  + LG G FG       +    +  VA+K +++         E++ RE +I+  L  
Sbjct: 12  LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLD- 68

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           +  +V+          + + ME+  GG L    L  K       +   V   + +V+   
Sbjct: 69  NPYIVRLI-GVCQAEALMLVMEMAGGGPLHKF-LVGKREEIPVSN---VAELLHQVSMGM 123

Query: 216 H---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---- 268
                   VHRD+   N L          K +DFGLS  +            +YY     
Sbjct: 124 KYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKALG--------ADDSYYTARSA 172

Query: 269 --------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                   APE +  RK    SDVWS GV  +  L  G++P+    
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 54/247 (21%), Positives = 91/247 (36%), Gaps = 43/247 (17%)

Query: 90  YDKDFDRRY-TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
                        +++G G FG  Y  T   N  +    AVK + +        V     
Sbjct: 18  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLT 75

Query: 146 EVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           E  I++    H NV+         +    + +   + G+L +  +  +    T KD   +
Sbjct: 76  EGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKD---L 130

Query: 205 VRQMLRVAAEC-HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           +   L+VA    +L     VHRD+   N +     E  ++K  DFGL+         +D+
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCM---LDEKFTVKVADFGLA---------RDM 178

Query: 262 VGSAYYV--------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTE 305
               YY               A E L+ +K   +SDVWS GV+ + ++  G  P+ D   
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238

Query: 306 DGIFKEV 312
             I   +
Sbjct: 239 FDITVYL 245

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 48/245 (19%), Positives = 87/245 (35%), Gaps = 49/245 (20%)

Query: 94  FDRRY-TIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKREV 147
                    + LG  +FG  Y       A G+    VA+K ++          E+ + E 
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEA 63

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTEKD 200
            +   L  H NVV        D  + +    C  G+L +                     
Sbjct: 64  MLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 201 AAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
           +A+     + + A+      +L  H +VH+D+   N L     +  ++K +D GL     
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL---VYDKLNVKISDLGLF---- 175

Query: 254 PGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRP 299
                +++  + YY             APE +   K   +SD+WS GV+ + +   G +P
Sbjct: 176 -----REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

Query: 300 FWDKT 304
           +   +
Sbjct: 231 YCGYS 235

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 60/288 (20%), Positives = 102/288 (35%), Gaps = 60/288 (20%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQ 108
           H H H     +            N   Q+   P GK  D         ++ +GK +G G 
Sbjct: 2   HHHHHHSSGVDLG--------TENLYFQSMPFPEGKVLDDM----EGNQWVLGKKIGSGG 49

Query: 109 FGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN-- 164
           FG  Y+A      ++ A    K+E  +         +  E+K  Q +A  + + K+    
Sbjct: 50  FGLIYLAFPTNKPEKDARHVVKVEYQE------NGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 165 ----------------AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
                            F+  +Y ++ ME    G  L +I   ++  + +     +  +M
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGIRM 160

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI------- 261
           L V    H +  VH D+K  N L    K    +   D+GLS    P    +         
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219

Query: 262 -VGSAYYVAPEVLKRKSGPE----SDVWSIG-VITYILLCGRRPFWDK 303
             G+  + + +  K   G      SDV  +G  +    LCG+ P W++
Sbjct: 220 HNGTIEFTSLDAHK---GVALSRRSDVEILGYCMLR-WLCGKLP-WEQ 262

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 49/244 (20%)

Query: 94  FDR-RYTIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKREV 147
             R    +   LG G FG  +     +         VAVK +   K     A +D +RE 
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREA 94

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD------RILAKKDSRYTEKDA 201
           ++L  L  H+++V+F+    +   + +  E    G+L                       
Sbjct: 95  ELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 202 AVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
            + + Q+L VA++      +L     VHRD+   N L     +   +K  DFG+S     
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL---VGQGLVVKIGDFGMS----- 205

Query: 255 GKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
               +DI  + YY              PE +  RK   ESDVWS GV+ + I   G++P+
Sbjct: 206 ----RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261

Query: 301 WDKT 304
           +  +
Sbjct: 262 YQLS 265

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 57/326 (17%), Positives = 105/326 (32%), Gaps = 43/326 (13%)

Query: 11  SGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQK 70
                G ++++    R +              +      +       K   +    Q   
Sbjct: 3   PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62

Query: 71  TNSRRQTGVIPCGKRTDFGYDKDFDRRY-TIGKLLGHGQFGYTY--VATDKANGD-RVAV 126
           T     + + P   +                 +++G G FG  Y     D        AV
Sbjct: 63  TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122

Query: 127 KKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELL 185
           K + +        V     E  I++  + H NV+         +    + +   + G+L 
Sbjct: 123 KSLNRITD--IGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 186 DRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HL--HGLVHRDMKPENFLFKSAKEDSSLK 242
           +  +  +    T KD   ++   L+VA     L     VHRD+   N +     E  ++K
Sbjct: 180 N-FIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKFVHRDLAARNCM---LDEKFTVK 232

Query: 243 ATDFGLSDFIKPGKKFQDIVGSAYYV--------------APEVLK-RKSGPESDVWSIG 287
             DFGL+         +D+    +                A E L+ +K   +SDVWS G
Sbjct: 233 VADFGLA---------RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 283

Query: 288 VITY-ILLCGRRPFWDKTEDGIFKEV 312
           V+ + ++  G  P+ D     I   +
Sbjct: 284 VLLWELMTRGAPPYPDVNTFDITVYL 309

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 42/239 (17%)

Query: 99  TIGKLLGHGQFGYTY--VATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
              +++G G FG  Y     D+A    + A+K + +        VE   RE  +++ L  
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--MQQVEAFLREGLLMRGLN- 80

Query: 156 HENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           H NV+         +   ++ +     G+LL   +       T KD   ++   L+VA  
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ-FIRSPQRNPTVKD---LISFGLQVARG 136

Query: 215 C-HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
             +L     VHRD+   N +     E  ++K  DFGL+         +DI+   YY    
Sbjct: 137 MEYLAEQKFVHRDLAARNCM---LDESFTVKVADFGLA---------RDILDREYYSVQQ 184

Query: 269 -----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
                      A E L+  +   +SDVWS GV+ + +L  G  P+       +   + +
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 61/236 (25%), Positives = 90/236 (38%), Gaps = 56/236 (23%)

Query: 94  FDR-RYTIGKLLGHGQFGYTYVAT----DKANGD-RVAVKKIEKNKMILPIAVEDVKREV 147
           F R    +GK LG G+FG    AT        G   VAVK +++N    P  + D+  E 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSEF 77

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD---------------RILAKK 192
            +L+ +  H +V+K Y A   D  + + +E  + G L                       
Sbjct: 78  NVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136

Query: 193 DSRYTEKDAAVVVRQMLRVAAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKATD 245
            S     + A+ +  ++  A +      +L    LVHRD+   N L     E   +K +D
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL---VAEGRKMKISD 193

Query: 246 FGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGV 288
           FGLS         +D+     YV            A E L       +SDVWS GV
Sbjct: 194 FGLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 50/245 (20%)

Query: 94  FDRRY-TIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
             RR   + + LG G FG  ++A         +   VAVK ++   +    A +D +RE 
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREA 68

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTEKD 200
           ++L  L  HE++VKFY    D + + +  E  + G+L           +   D +  +  
Sbjct: 69  ELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 201 AAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
             + + QML +A++      +L     VHRD+   N L      +  +K  DFG+S    
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL---VGANLLVKIGDFGMS---- 180

Query: 254 PGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRP 299
                +D+  + YY              PE +  RK   ESDVWS GVI + I   G++P
Sbjct: 181 -----RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

Query: 300 FWDKT 304
           ++  +
Sbjct: 236 WFQLS 240

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 63/328 (19%), Positives = 100/328 (30%), Gaps = 52/328 (15%)

Query: 10  VSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQER--AKNYQQLKTKQ 67
           V      ++              A       A     H     H +R          T +
Sbjct: 236 VEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPE 295

Query: 68  HQKTNSRRQTGVIPCGKRTDFGYDKDF------------DRRYTIGKLLGHGQFGYTYVA 115
             +  S  +   +P           D             D        LG G FG     
Sbjct: 296 PARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQG 355

Query: 116 TDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY 173
             +    +  VA+K +++         E++ RE +I+  L  +  +V+          + 
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQL-DNPYIVRLI-GVCQAEALM 411

Query: 174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH---LHGLVHRDMKPENF 230
           + ME+  GG L    L  K       + A ++ Q   V+           VHR++   N 
Sbjct: 412 LVMEMAGGGPLHKF-LVGKREEIPVSNVAELLHQ---VSMGMKYLEEKNFVHRNLAARNV 467

Query: 231 LFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKS 277
           L          K +DFGLS  +            +YY             APE +  RK 
Sbjct: 468 L---LVNRHYAKISDFGLSKALG--------ADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 278 GPESDVWSIGVITY-ILLCGRRPFWDKT 304
              SDVWS GV  +  L  G++P+    
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 51/253 (20%), Positives = 90/253 (35%), Gaps = 57/253 (22%)

Query: 94  FDR-RYTIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKREV 147
           + R      + +G G FG  +   A      +    VAVK +++          D +RE 
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREA 101

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD---------------RILAKK 192
            ++     + N+VK          + +  E    G+L +                 L+ +
Sbjct: 102 ALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160

Query: 193 DSRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATD 245
               +     +   + L +A +      +L     VHRD+   N L     E+  +K  D
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL---VGENMVVKIAD 217

Query: 246 FGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY- 291
           FGLS         ++I  + YY              PE +   +   ESDVW+ GV+ + 
Sbjct: 218 FGLS---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268

Query: 292 ILLCGRRPFWDKT 304
           I   G +P++   
Sbjct: 269 IFSYGLQPYYGMA 281

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 34/230 (14%), Positives = 63/230 (27%), Gaps = 36/230 (15%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKR-TDFGYDKDFDRRYTIGKLLGHG 107
           H H H     +           T S      +P G   TD        R++ +       
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMTTSLEA---LPTGTVLTDK-----SGRQWKLKSFQTRD 53

Query: 108 QFGYTYVATDKANGD--------RVAVKKIEKNKMILPIAVEDVKREVKILQALA----- 154
             G  Y A   +           + ++K ++     L       +R  K LQ        
Sbjct: 54  NQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLY 112

Query: 155 --GHENVVKFY-NAFEDDNYVYIAMELCEGGELLDRILAKKDSR-YTEKDAAVVVRQMLR 210
                 +          D Y ++ +     G  L   L        +E+    V  ++L 
Sbjct: 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACRLLD 170

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
                H +  VH ++  EN       + S +    +G +       ++  
Sbjct: 171 ALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFA------FRYCP 213

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 44/239 (18%), Positives = 77/239 (32%), Gaps = 45/239 (18%)

Query: 96  RRYTIGKLLGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
             + +G  +G G FG  Y+A         +     VK    +   L         E+K  
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL-------FTELKFY 87

Query: 151 QALAGHENVVKFYNA------------------FEDDNYVYIAMELCEGGELLDRILAKK 192
           Q  A  E + K+                         +Y ++ M+    G  L +I    
Sbjct: 88  QRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN 145

Query: 193 DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI 252
             R++ K    +  ++L +    H H  VH D+K  N L  + K    +   D+GL+   
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYKNPDQVYLVDYGLAYRY 204

Query: 253 KPGKKFQDI--------VGSAYYVAPEV-LKRKSGPESDVWSIG-VITYILLCGRRPFW 301
            P    +           G+  + + +           D+  +G  +    L G  P W
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ-WLTGHLP-W 261

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191

 Score = 64.6 bits (158), Expect = 2e-12
 Identities = 7/41 (17%), Positives = 16/41 (39%)

Query: 353 LSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRV 393
           + H      G  +     I VL N + +    + ++ A+ +
Sbjct: 1   MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTI 41

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197

 Score = 60.7 bits (148), Expect = 5e-11
 Identities = 11/44 (25%), Positives = 20/44 (45%), Gaps = 1/44 (2%)

Query: 351 QALSHPWVRE-GGDASEIPIDISVLNNMRQFVKYSRLKQFALRV 393
               H   RE       + +  ++L N++ F K + LK+ AL +
Sbjct: 3   HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTI 46

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 44/194 (22%), Positives = 71/194 (36%), Gaps = 16/194 (8%)

Query: 90  YDKD---FDR-RYTIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIA----V 140
           YD     F R R  +GK LG G FG    A   A G D+ A  +    KM+   A     
Sbjct: 12  YDASKWEFPRDRLKLGKPLGRGAFGQVIEAD--AFGIDKTATCRTVAVKMLKEGATHSEH 69

Query: 141 EDVKREVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK 199
             +  E+KIL  +  H NVV    A  +    + + +E C+ G L   + +K++     K
Sbjct: 70  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129

Query: 200 DAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLSDFIKPGKK 257
                 RQ         +      D    +    S+   E+ SL   +   +        
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189

Query: 258 F--QDIVGSAYYVA 269
              + ++  ++ VA
Sbjct: 190 LTLEHLICYSFQVA 203

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 34/120 (28%), Positives = 47/120 (39%), Gaps = 31/120 (25%)

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---------- 268
             +HRD+   N L     E + +K  DFGL+         +DI     YV          
Sbjct: 213 KCIHRDLAARNILLS---EKNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLK 260

Query: 269 --APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRN-----KPDF 319
             APE +  R    +SDVWS GV+ + I   G  P+     D  F   L+       PD+
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 320

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 57.9 bits (141), Expect = 1e-09
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 64/247 (25%)

Query: 92  KDFDRRYTIGK--LLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKR-- 145
            +FD R        +G G FG  Y    K   N   VAVKK+     ++ I  E++K+  
Sbjct: 25  NNFDERPISVGGNKMGEGGFGVVY----KGYVNNTTVAVKKL---AAMVDITTEELKQQF 77

Query: 146 --EVKILQALAGHENVVKFYN-AFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKD 200
             E+K++     HEN+V+    + + D+   VY        G LLDR+            
Sbjct: 78  DQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY---VYMPNGSLLDRLSCLDG------- 126

Query: 201 AAVVVRQML----RV-----AAE--CHLH--GLVHRDMKPENFLFKSAKEDSSLKA--TD 245
                   L    R      AA     LH    +HRD+K  N L      D +  A  +D
Sbjct: 127 -----TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL-----DEAFTAKISD 176

Query: 246 FGLSDFIKPGKKFQD------IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP 299
           FGL+   +  +KF        IVG+  Y+APE L+ +  P+SD++S GV+   ++ G   
Sbjct: 177 FGLA---RASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPA 233

Query: 300 FWDKTED 306
             D+  +
Sbjct: 234 V-DEHRE 239

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.4 bits (135), Expect = 5e-09
 Identities = 30/182 (16%), Positives = 54/182 (29%), Gaps = 49/182 (26%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQ 151
           +    + +G G FG  +          VA+K I     +          E++  E+ I +
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 152 ALAG--------HENVVKFYNAF------------------------------EDDNYVY 173
            L+          E  +   +                                  D+ ++
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-LHGLVHRDMKPENFLF 232
           I +E   GG  L+++  K  S      A  ++ Q+    A         HRD+   N L 
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 233 KS 234
           K 
Sbjct: 196 KK 197

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 54.1 bits (131), Expect = 2e-08
 Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 41/219 (18%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG  Y     A+G  VAVK++++ +          + EV+++ ++A H N+++ 
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMI-SMAVHRNLLRL 92

Query: 163 YNAFEDDNY---VYIAMELCEGGELLDRILAKKDSRY-----TEKDAAVVVRQMLRVAA- 213
                       VY        G +   +  + +S+        +  A+        +A 
Sbjct: 93  RGFCMTPTERLLVY---PYMANGSVASCLRERPESQPPLDWPKRQRIALG-------SAR 142

Query: 214 -------ECHLHGLVHRDMKPENFLFKSAKEDSSLKA--TDFGLSDFIKPGKK--FQDIV 262
                   C    ++HRD+K  N L      D   +A   DFGL+  +          + 
Sbjct: 143 GLAYLHDHCDPK-IIHRDVKAANILL-----DEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 263 GSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPF 300
           G+  ++APE L   KS  ++DV+  GV+   L+ G+R F
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 64/237 (27%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
            +FD ++    L+GHG FG  Y    K    +G +VA+K+           +E+ + E++
Sbjct: 39  NNFDHKF----LIGHGVFGKVY----KGVLRDGAKVALKRRTPESSQ---GIEEFETEIE 87

Query: 149 ILQALAGHENVVKFYNAFEDDNY---VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
            L     H ++V      ++ N    +Y   +  E G L    L   D            
Sbjct: 88  TLSFCR-HPHLVSLIGFCDERNEMILIY---KYMENGNLKRH-LYGSDLPTMSMSW---- 138

Query: 206 RQMLRVAAE-----CHLH--GLVHRDMKPENFLFKSAKEDSSLKA--TDFGLSDFIKPGK 256
            Q L +         +LH   ++HRD+K  N L      D +     TDFG+S      K
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-----DENFVPKITDFGIS------K 187

Query: 257 KFQD---------IVGSAYYVAPEVLKR-----KSGPESDVWSIGVITYILLCGRRP 299
           K  +         + G+  Y+ PE   +     KS    DV+S GV+ + +LC R  
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS----DVYSFGVVLFEVLCARSA 240

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 7e-07
 Identities = 59/459 (12%), Positives = 111/459 (24%), Gaps = 158/459 (34%)

Query: 37  HNHHARNDT-THKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFD 95
           H+HH   D  T +HQ+Q+++    ++                          F    +FD
Sbjct: 1   HHHHHHMDFETGEHQYQYKDILSVFED------------------------AF--VDNFD 34

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            +                + + +       +  I    ++   AV    R    L  L+ 
Sbjct: 35  CKDVQDMPKS--------ILSKE------EIDHI----IMSKDAVSGTLRLFWTL--LSK 74

Query: 156 HENVVK-FYNAFEDDNYVYIAMEL---CEGGELL-DRILAKKDSRYTEKDAAV---VVR- 206
            E +V+ F       NY ++   +        ++    + ++D  Y +        V R 
Sbjct: 75  QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134

Query: 207 ----------QMLRVAAECHLHGL-----------VHRDMKPE-NFLFK--------SAK 236
                       LR A    + G+           V    K +    FK           
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194

Query: 237 EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-------LKRKSGPES-----DVW 284
            ++ L+     L           D   +       +       LK K          +V 
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254

Query: 285 SIGVITY------ILLCGR--------------RPFWDKTEDG--------IFKEVLRNK 316
           +            ILL  R                  D             +  + L  +
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314

Query: 317 PDFRRKPWPSISNSAKD---FVKKL---LVKDPRARLTAAQALSHPWVREGGDASEIPID 370
           P         +             +    ++D  A           W     D     I+
Sbjct: 315 PQ-------DLPREVLTTNPRRLSIIAESIRDGLATWD-------NWKHVNCDKLTTIIE 360

Query: 371 ISVLNNMRQFVKYSRLKQFALRVTQYFKYTALFKVKTNI 409
            S+            L+    R  + F   ++F    +I
Sbjct: 361 SSLNV----------LEPAEYR--KMFDRLSVFPPSAHI 387

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score = 41.1 bits (97), Expect = 2e-04
 Identities = 7/26 (26%), Positives = 11/26 (42%)

Query: 368 PIDISVLNNMRQFVKYSRLKQFALRV 393
                 L NM++F    +L Q A+  
Sbjct: 3   HALTGALGNMKKFQSSQKLAQAAMLF 28

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score = 41.1 bits (97), Expect = 2e-04
 Identities = 8/25 (32%), Positives = 17/25 (68%)

Query: 369 IDISVLNNMRQFVKYSRLKQFALRV 393
           I  +VLNNM+ ++K+S ++   + +
Sbjct: 2   ISPNVLNNMKSYMKHSNIRNIIINI 26

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} Length = 359

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 34/143 (23%), Positives = 57/143 (39%), Gaps = 24/143 (16%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV- 160
           +    GQ   T+          V   K      +LP A   ++RE +++ ALAG +  V 
Sbjct: 44  EQFKGGQSNPTFKLVT-PGQTYVMRAKPGPKSKLLPSA-HAIEREYRVMDALAGTDVPVA 101

Query: 161 KFYNAFEDDN------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           K Y   ED++      Y+   ME   G  L D+ L       +  +   +  +M RV A 
Sbjct: 102 KMYALCEDESVIGRAFYI---MEFVSGRVLWDQSLP----GMSPAERTAIYDEMNRVIAA 154

Query: 215 CHLHGLVHRDM------KPENFL 231
             +H + ++ +      KP N+ 
Sbjct: 155 --MHTVDYQAIGLGDYGKPGNYF 175

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 15/113 (13%), Positives = 27/113 (23%), Gaps = 11/113 (9%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
              G            N +                   DV+RE  ++  L G   V K  
Sbjct: 21  DTEGMSPAKVYKLVGENENLYLKMT----DSRYKGTTYDVEREKDMMLWLEGKLPVPKVL 76

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +    D +  + M   +G    +           E+    ++          H
Sbjct: 77  HFERHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFH 122

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	414
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.49
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.24
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.85
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.85
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.54
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.51
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.42
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.35
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.15
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.13
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.01
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.86
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.73
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.67
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.58
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.52
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.48
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.47
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.47
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.45
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.27
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.05
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.05
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.6
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.57
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.54
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.84

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.6e-67  Score=495.09  Aligned_cols=256  Identities=33%  Similarity=0.577  Sum_probs=231.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.|. |||||+++++|++++.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence            46999999999999999999999999999999998654433345678999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||||+||+|.+++..  .+.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+|+.....
T Consensus       111 mEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~---~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          111 LSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc---CCCCEEEEEcCCceecCCC
Confidence            999999999999954  35799999999999999999999999999999999999998   6889999999999876432


Q ss_pred             ---CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 ---KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                         ....+.+||+.|||||++.+. ++.++|||||||++|+|+||++||.+.+..+++..+......++    ..+|+++
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~  261 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKA  261 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHH
Confidence               234578999999999998764 68899999999999999999999999999999999998876655    3689999


Q ss_pred             HHHHHHhhcCCccccCCHHH------HhCCcccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQ------ALSHPWVREG  361 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~e------lL~hp~f~~~  361 (414)
                      ++||.+||+.||++|||++|      +++||||+..
T Consensus       262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            99999999999999999988      5899999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-66  Score=484.10  Aligned_cols=254  Identities=33%  Similarity=0.631  Sum_probs=212.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.+|+.|. |||||++++++.+++.+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence            47999999999999999999999999999999998766555556778999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||| +|+|.+++..  .+.+++.+++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+.....
T Consensus        92 mEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             EECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTCCEEECCSSCC------
T ss_pred             EeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---CCCCEEEeecCCCeecCCC
Confidence            9999 6799999854  46799999999999999999999999999999999999998   5789999999999887766


Q ss_pred             CccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      ....+.+||+.|||||++.+..  +.++|||||||++|+|+||+.||.+.+..+++..+......++    ..+|+++++
T Consensus       166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  241 (275)
T 3hyh_A          166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAG  241 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHH
T ss_pred             CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence            6667789999999999988653  5789999999999999999999999988888888888766554    368999999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCccccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ||.+||+.||++|||++|+|+||||+.
T Consensus       242 li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          242 LIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHHcCccccc
Confidence            999999999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-66  Score=496.59  Aligned_cols=258  Identities=24%  Similarity=0.498  Sum_probs=227.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.|. |||||+++++|.+++.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence            579999999999999999999999999999999987654 3446788999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||||+||+|.+++.......+++..++.|+.||+.||.|||++|||||||||+||||+   .++.|||+|||+|+.....
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC---TTCCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCCEEEcccccceeecCC
Confidence            9999999999999777667789999999999999999999999999999999999998   5889999999999876543


Q ss_pred             C-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 K-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      . ...+.+||+.|||||++.+. ++.++|||||||++|||+||++||.+.+..+++..+......   ..+..+|+++++
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHH
Confidence            2 23467899999999998764 688999999999999999999999999998999988887542   234578999999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ||.+||+.||++|||++|+|+||||+..
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999853

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-65  Score=491.58  Aligned_cols=258  Identities=33%  Similarity=0.574  Sum_probs=229.4

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      ...|++++.||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+|+.|. |||||+++++|.+++.+||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            45799999999999999999999999999999999765432   3456789999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |||||+||+|.+++..   ..+++..++.|+.||+.||+|||++|||||||||+||||+   .++.|||+|||+|+....
T Consensus       149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCS
T ss_pred             EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---CCCCEEEecCcCceecCC
Confidence            9999999999998843   4699999999999999999999999999999999999998   688999999999987654


Q ss_pred             C-CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 G-KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      . ....+.+||+.|||||++.+ .++.++|||||||++|||++|++||.+.+..+++..+....+ .....+..+|++++
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~  301 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLK  301 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHH
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHH
Confidence            3 44567899999999999875 479999999999999999999999999888888888776543 22334567999999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +||.+||+.||++|||+.|+|+||||+....
T Consensus       302 dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          302 GFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            9999999999999999999999999997544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-64  Score=474.17  Aligned_cols=256  Identities=21%  Similarity=0.362  Sum_probs=219.3

Q ss_pred             cce-eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----CC
Q 015026           96 RRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DN  170 (414)
Q Consensus        96 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----~~  170 (414)
                      .+| ++.++||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+|+.|. |||||+++++|.+    ++
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCc
Confidence            344 788899999999999999999999999999976543 3446778999999999995 9999999999865    45


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      .+|||||||+||+|.+++.+  .+.+++..++.|+.||+.||.|||++|  ||||||||+||||+.  .++.+||+|||+
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--~~g~vKl~DFGl  178 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS--TTSCEEECCTTG
T ss_pred             EEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC--CCCCEEEEeCcC
Confidence            68999999999999999954  357999999999999999999999999  999999999999973  468999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchh-hhHHHhhcCCCCCCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  327 (414)
                      |+.... ....+.+||+.|||||++.+.++.++|||||||++|||+||+.||.+..... ++..+.....  +......+
T Consensus       179 a~~~~~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~  255 (290)
T 3fpq_A          179 ATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVA  255 (290)
T ss_dssp             GGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCC
T ss_pred             CEeCCC-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccC
Confidence            986543 3456789999999999999999999999999999999999999998765543 4444444322  11223457


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ++++.+||.+||..||++|||+.|+|+||||++
T Consensus       256 ~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            899999999999999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2e-64  Score=494.68  Aligned_cols=260  Identities=33%  Similarity=0.571  Sum_probs=230.9

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +....|++++.||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+|+.|. |||||+++++|.+++.+
T Consensus       148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~  223 (423)
T 4fie_A          148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL  223 (423)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEE
Confidence            3456799999999999999999999999999999999765432   3456889999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |||||||+||+|.+++..   ..+++.+++.|+.||+.||+|||++|||||||||+||||+   .++.|||+|||+|+.+
T Consensus       224 ~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~---~~g~vKl~DFGla~~~  297 (423)
T 4fie_A          224 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQV  297 (423)
T ss_dssp             EEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---TTCCEEECCCTTCEEC
T ss_pred             EEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEecCccceEC
Confidence            999999999999998843   4699999999999999999999999999999999999998   6889999999999876


Q ss_pred             CCC-CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          253 KPG-KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       253 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ... ....+.+||+.|||||++.+ .++.++|||||||++|||++|++||.+.+..+++..+....+ .....+..+|++
T Consensus       298 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~  376 (423)
T 4fie_A          298 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPS  376 (423)
T ss_dssp             CSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHH
T ss_pred             CCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHH
Confidence            543 44567899999999999875 479999999999999999999999999888888888776543 233445689999


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +++||.+||+.||++|||+.|+|+||||+....
T Consensus       377 ~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          377 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            999999999999999999999999999997544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-64  Score=477.45  Aligned_cols=254  Identities=28%  Similarity=0.503  Sum_probs=218.5

Q ss_pred             cceeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++|++++.||+|+||+||+|++.   .+++.||||++.+..... .....+.+|+.+|+.|. |||||+++++|.+++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            47999999999999999999874   478899999997654322 22346788999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |||||||+||+|.+++..  .+.+++.+++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+..
T Consensus       102 ~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTSCEEEESSEEEEC-
T ss_pred             EEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---CCCCEEecccccceec
Confidence            999999999999999954  35799999999999999999999999999999999999998   6889999999999865


Q ss_pred             CC-CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          253 KP-GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       253 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      .. .....+.+||+.|||||++.+. ++.++|||||||++|||+||++||.+.+..+++..+.+....++    ..+|++
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~  252 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPE  252 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred             cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHH
Confidence            43 3445678999999999998754 68999999999999999999999999999999999988766554    468999


Q ss_pred             HHHHHHHhhcCCccccCC-----HHHHhCCccccc
Q 015026          331 AKDFVKKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      +++||.+||+.||++|||     ++|+++||||+.
T Consensus       253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            999999999999999998     489999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.3e-63  Score=470.28  Aligned_cols=252  Identities=27%  Similarity=0.361  Sum_probs=220.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++.....        .+|+.+|+.|. |||||+++++|.+++.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999999765431        46999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC-CceeeccccccccCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLSDFIKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~-~vkl~DFG~a~~~~~  254 (414)
                      ||||+||+|.+++...  +.+++..++.|+.||+.||.|||++|||||||||+||||+   .++ .+||+|||+|+....
T Consensus       129 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             ECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC--
T ss_pred             EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccC
Confidence            9999999999999543  5799999999999999999999999999999999999998   354 699999999987654


Q ss_pred             CCc------cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          255 GKK------FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       255 ~~~------~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ...      ....+||+.|||||++.+. ++.++|||||||++|||+||++||.+.+..+++..+....+.+. ..++.+
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~  282 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSC  282 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTS
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccC
Confidence            321      2346899999999998765 68899999999999999999999999888888888887765433 234689


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHH-------------hCCccccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQA-------------LSHPWVREGG  362 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~el-------------L~hp~f~~~~  362 (414)
                      |+++.+||.+||+.||.+|||+.|+             |+|||+.+..
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            9999999999999999999999997             6799998643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-61  Score=473.26  Aligned_cols=263  Identities=27%  Similarity=0.429  Sum_probs=223.4

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----  168 (414)
                      ++.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.|. |||||++++++..    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence            345789999999999999999999999999999999976543 3345677889999999995 9999999998753    


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                        .+.+|||||||+ |+|.+++  ...+.+++..++.+++||+.||.|||++|||||||||+|||++   .++.+||+||
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i--~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~---~~~~~Ki~DF  202 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQII--HSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGDF  202 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHH--TSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECCC
T ss_pred             ccCCEEEEEEeCCC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC---CCCCEEEeec
Confidence              467999999996 6799988  4456899999999999999999999999999999999999998   6889999999


Q ss_pred             ccccccCCC-----CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          247 GLSDFIKPG-----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       247 G~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |+|+.....     ....+.+||+.|||||++.+  .++.++||||+|||+|||++|++||.+.+..+.+..|......+
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999865332     23456899999999998765  35889999999999999999999999998888877776533222


Q ss_pred             CCC---------------------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          320 RRK---------------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       320 ~~~---------------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +..                           .++.+|+++.+||.+||..||.+|||+.|+|+||||+....
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            111                           12467899999999999999999999999999999997543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.4e-61  Score=464.54  Aligned_cols=257  Identities=28%  Similarity=0.500  Sum_probs=211.3

Q ss_pred             ccccceeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .+.++|++++.||+|+||+||+|+++   .+++.||||++....     ....+.+|+++|+.+.+|||||+++++|.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            35578999999999999999999875   467899999986543     3456789999999997799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      +.+|||||||+||+|.+++     +.+++.+++.+++||+.||+|||++|||||||||+|||++.  +.+.+||+|||+|
T Consensus        93 ~~~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla  165 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLA  165 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTC
T ss_pred             CEEEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCC
Confidence            9999999999999999988     35899999999999999999999999999999999999984  3478999999999


Q ss_pred             cccCCCC-----------------------------ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCC
Q 015026          250 DFIKPGK-----------------------------KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRR  298 (414)
Q Consensus       250 ~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~  298 (414)
                      +......                             ...+.+||+.|||||++.+.  ++.++||||+|||+|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            7543221                             22356899999999988653  6889999999999999999999


Q ss_pred             CCCCCCc-hhhhHHHhhc--------------------------------------C---C---------CCCCCCCCCC
Q 015026          299 PFWDKTE-DGIFKEVLRN--------------------------------------K---P---------DFRRKPWPSI  327 (414)
Q Consensus       299 Pf~~~~~-~~~~~~i~~~--------------------------------------~---~---------~~~~~~~~~~  327 (414)
                      ||....+ .+.+..|...                                      .   +         ......|+.+
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            9965543 3333332210                                      0   0         0111245678


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      |+++++||.+||+.||++|||++|+|+||||++.
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-59  Score=481.37  Aligned_cols=264  Identities=34%  Similarity=0.622  Sum_probs=240.5

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +-++|++++.||+|+||+||+|.++.+|+.||||++....   ....+.+.+|+.+|+.|. |||||+++++|.+++.+|
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence            4468999999999999999999999999999999997653   345678899999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||||||+||+|.+++... .+.+++.+++.+++||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|+...
T Consensus       231 iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECC
T ss_pred             EEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEcc
Confidence            999999999999988543 3579999999999999999999999999999999999999842 35789999999999988


Q ss_pred             CCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ........+||+.|||||++.+. ++.++|||||||++|+|++|.+||.+.+..+++..+......++...++.+|++++
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            77777788999999999998765 68899999999999999999999999999999999998888888777889999999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      +||.+||+.||.+|||+.|+|+||||+....
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            9999999999999999999999999997543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1e-59  Score=445.04  Aligned_cols=254  Identities=28%  Similarity=0.471  Sum_probs=199.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-----
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-----  170 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....  .....+.+.+|+.+|+.|. |||||+++++|.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence            45999999999999999999999999999999997653  3446678999999999995 999999999986543     


Q ss_pred             -------EEEEEEeccCCCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          171 -------YVYIAMELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       171 -------~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                             .+|||||||+||+|.+++..... ...++..++.|+.||+.||+|||++|||||||||+|||++   .++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---CCCcEE
Confidence                   47999999999999999854321 2245667899999999999999999999999999999998   578999


Q ss_pred             eeccccccccCCCC-------------ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCch-h
Q 015026          243 ATDFGLSDFIKPGK-------------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED-G  307 (414)
Q Consensus       243 l~DFG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~-~  307 (414)
                      |+|||+|+......             ...+.+||+.|||||++.+. ++.++|||||||++|||++   ||.+..+. .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            99999998764322             12346899999999998764 6899999999999999996   88654322 2


Q ss_pred             hhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       308 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .+..+....  ++ +.++..++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       236 ~~~~~~~~~--~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          236 TLTDVRNLK--FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHTTC--CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHhcCC--CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            222332221  11 1223456778999999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.5e-59  Score=475.18  Aligned_cols=254  Identities=24%  Similarity=0.388  Sum_probs=216.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHH---HHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE---VKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E---~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|   +.+++.+ +|||||+++++|.+++.+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEE
Confidence            469999999999999999999999999999999976543222233344455   4455555 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |||||||+||+|.+++..  .+.+++..++.|+.||+.||+|||++|||||||||+||||+   .++.|||+|||+|+..
T Consensus       268 ylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld---~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe---CCCCEEecccceeeec
Confidence            999999999999999954  36799999999999999999999999999999999999999   6889999999999876


Q ss_pred             CCCCccccCCCCCccccchhcc-c-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch---hhhHHHhhcCCCCCCCCCCCC
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLK-R-KSGPESDVWSIGVITYILLCGRRPFWDKTED---GIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ... ...+.+||+.|||||++. + .++.++|||||||++|||++|.+||.+.+..   ++...+......+    +..+
T Consensus       343 ~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~----p~~~  417 (689)
T 3v5w_A          343 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----PDSF  417 (689)
T ss_dssp             SSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC----CTTS
T ss_pred             CCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC----CccC
Confidence            543 346789999999999985 3 4789999999999999999999999865433   3445555554433    3479


Q ss_pred             CHHHHHHHHHhhcCCccccCC-----HHHHhCCccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      |+++++||.+||+.||.+|++     ++|+++||||+.
T Consensus       418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            999999999999999999998     799999999986

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.5e-59  Score=440.88  Aligned_cols=255  Identities=22%  Similarity=0.353  Sum_probs=217.6

Q ss_pred             cceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|.+.+.||+|+||+||+|++.     .++..||||++...   .....+.|.+|+++|++|+ |||||++++++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCC
Confidence            46999999999999999999875     46788999999654   3456788999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC
Q 015026          171 YVYIAMELCEGGELLDRILAK-----------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~-----------~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~  239 (414)
                      .++||||||+||+|.+++...           ....+++.++..|+.||+.||.|||+++||||||||+|||++   .++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~---~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC---CCC
Confidence            999999999999999999653           235799999999999999999999999999999999999998   578


Q ss_pred             CceeeccccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhh
Q 015026          240 SLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLR  314 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~  314 (414)
                      .+||+|||+|+.......   ....+||+.|||||++. +.++.++|||||||++|||+| |+.||.+.+..+++..+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987544322   22357999999999876 457899999999999999998 9999999998888888887


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +...   ...+.+|+++.+||.+||+.||++|||+.+++  +|++...
T Consensus       246 ~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~  288 (299)
T 4asz_A          246 GRVL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLA  288 (299)
T ss_dssp             TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHH
T ss_pred             CCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHH
Confidence            6532   22347899999999999999999999999994  5776543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-58  Score=435.41  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=205.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      +++++.+.||+|+||+||+|++.   ..||||+++... ......+.|.+|+.+|++|+ |||||++++++.+ +.++||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEEE
Confidence            46899999999999999999753   359999986543 24456788999999999995 9999999998765 568999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-  254 (414)
                      ||||+||+|.+++... ...+++..+..|+.||+.||.|||+++||||||||+||||+   +++.+||+|||+|+.... 
T Consensus       110 mEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC----
T ss_pred             EEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceecccC
Confidence            9999999999998543 35799999999999999999999999999999999999999   688999999999987543 


Q ss_pred             --CCccccCCCCCccccchhccc----cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC--CCCCCC
Q 015026          255 --GKKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR--RKPWPS  326 (414)
Q Consensus       255 --~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~  326 (414)
                        .......+||+.|||||++.+    .++.++|||||||++|||+||+.||.+.+....+..++......+  ...++.
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  265 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN  265 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence              223456799999999999853    367899999999999999999999988776655555544332221  233457


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +|+++.+||.+||+.||++|||+.|++++
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999987653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.5e-57  Score=439.63  Aligned_cols=303  Identities=30%  Similarity=0.595  Sum_probs=266.9

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.|. ||||+++++++.+.+
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES  101 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence            34566789999999999999999999999999999999976543 3445678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||++||+|.+.+..  ...+++..+..++.||+.||.|||++||+||||||+|||++....++.+||+|||++.
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999999999998843  4579999999999999999999999999999999999999865556789999999998


Q ss_pred             ccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          251 FIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ...........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+..+...++...|+.+++
T Consensus       180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (362)
T 2bdw_A          180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP  259 (362)
T ss_dssp             CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred             EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            8776666667899999999999876 468899999999999999999999999988888999988888887777888999


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCCHHHHHHHHHHhhhcHHHHHHHHHHHHh
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYF  397 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~  397 (414)
                      ++.+||.+||..||.+|||+.++|+||||...............+..++.|....+++..++..+...
T Consensus       260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  327 (362)
T 2bdw_A          260 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIAT  327 (362)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999865444444455677888999999999998877765443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-57  Score=436.05  Aligned_cols=249  Identities=21%  Similarity=0.316  Sum_probs=209.2

Q ss_pred             cceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|.+.++||+|+||+||+|++.     .+++.||||++...   .....+.|.+|+.+|++|+ |||||+++++|.+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            46889999999999999999865     46889999999653   3456788999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC
Q 015026          171 YVYIAMELCEGGELLDRILAKK-------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~-------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~  237 (414)
                      .++||||||++|+|.+++....             ...+++.++..|+.||+.||.|||+++||||||||+||||+   .
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---Q  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---T
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---C
Confidence            9999999999999999986432             24699999999999999999999999999999999999999   6


Q ss_pred             CCCceeeccccccccCCCC---ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHH
Q 015026          238 DSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV  312 (414)
Q Consensus       238 ~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i  312 (414)
                      ++.+||+|||+|+......   .....+||+.|||||++.+ .++.++|||||||++|||+| |+.||.+.+..+++..+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8899999999998764332   2235689999999998765 47899999999999999999 99999999888888888


Q ss_pred             hhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+...   ...+.+|+++.+||.+||+.||++|||+.|+++
T Consensus       274 ~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          274 TQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             HHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             HcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            776421   223468999999999999999999999999987

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-57  Score=432.51  Aligned_cols=251  Identities=19%  Similarity=0.272  Sum_probs=214.5

Q ss_pred             cceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..+++.+.||+|+||+||+|...     .+++.||||++....  .....+.|.+|+.+|++|+ |||||++++++.+++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECC
Confidence            35889999999999999999853     467899999996543  2335678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC
Q 015026          171 YVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~  236 (414)
                      .++||||||++|+|.+++....              ...+++..+..|+.||+.||.|||+++||||||||+||||+   
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~---  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC---
Confidence            9999999999999999996432              24589999999999999999999999999999999999999   


Q ss_pred             CCCCceeeccccccccCCCC---ccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHH
Q 015026          237 EDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~  311 (414)
                      +++.+||+|||+|+......   .....+||+.|||||++. +.++.++|||||||++|||+| |..||.+.+..+++..
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            57899999999998754322   234568999999999875 567999999999999999998 8999999988888888


Q ss_pred             HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +..+...   +..+.+|+++.+||.+||+.||++|||+.|++++
T Consensus       260 i~~~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7765432   2235789999999999999999999999999863

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.3e-57  Score=448.50  Aligned_cols=296  Identities=31%  Similarity=0.610  Sum_probs=259.7

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++.+++..
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCEE
Confidence            456789999999999999999999999999999999976553 2345677899999999994 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||++||+|.+.+...  ..+++..+..++.||+.||.|||++||+||||||+|||++...+++.+||+|||++...
T Consensus        86 ~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999999998554  57999999999999999999999999999999999999986556789999999999876


Q ss_pred             CCCC-ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          253 KPGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       253 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      .... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+..+...++...|+.+|++
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  243 (444)
T 3soa_A          164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE  243 (444)
T ss_dssp             CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence            5433 3356789999999999876 4789999999999999999999999999999999999999888888888999999


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCCHHHHHHHHHHhhhcHHHHHHHH
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR  392 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  392 (414)
                      +.+||.+||+.||.+|||+.|+|+||||+..............++.+++|...++++..++.
T Consensus       244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~  305 (444)
T 3soa_A          244 AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILT  305 (444)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSC
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999998765444445556778888888888887765543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.9e-57  Score=453.86  Aligned_cols=304  Identities=39%  Similarity=0.651  Sum_probs=271.2

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ..+.++|++.+.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence            346678999999999999999999999999999999997765444446788999999999994 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++||||+.||+|.+.+..  ...+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||++..
T Consensus       101 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999999998854  45799999999999999999999999999999999999997555678999999999988


Q ss_pred             cCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..........+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+..+++..+......+..+.|..+|+++
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence            77666666778999999999999989999999999999999999999999999999999999888877777778899999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccCC---CCCCCCHHHHHHHHHHhhhcHHHHHHHHHHHHhh
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDA---SEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFK  398 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~  398 (414)
                      ++||.+||+.||.+|||+.|+|+||||+.....   ...+.....+.++++|...+++++.++..++...
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~  328 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKL  328 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhcc
Confidence            999999999999999999999999999875432   2345566788899999999999998888776543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-56  Score=453.60  Aligned_cols=303  Identities=39%  Similarity=0.659  Sum_probs=264.4

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ..+.++|++++.||+|+||+||+|.+..+|+.||||++.+.... ......+.+|+.+|+.+. ||||+++++++.+...
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS   95 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCE
Confidence            35678899999999999999999999999999999998654321 124577899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++||||+.|++|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||++..
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999999988654  5799999999999999999999999999999999999998655678899999999988


Q ss_pred             cCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..........+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+.+..+++..+......++.+.|..+|+++
T Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  253 (486)
T 3mwu_A          174 FQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (486)
T ss_dssp             BCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred             CCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence            77666667789999999999999989999999999999999999999999999999999999888877777788899999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccCCCCC----CCCHHHHHHHHHHhhhcHHHHHHHHHHHHhh
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI----PIDISVLNNMRQFVKYSRLKQFALRVTQYFK  398 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~  398 (414)
                      ++||.+||..||.+|||+.++|+||||+........    +.....+.++++|....++++.++..+....
T Consensus       254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l  324 (486)
T 3mwu_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKL  324 (486)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999999876544322    2234567788999999999998888776543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-56  Score=434.88  Aligned_cols=309  Identities=29%  Similarity=0.563  Sum_probs=245.1

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC--ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++......  .....+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDG   99 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            3567899999999999999999999999999999998653211  1123577899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          171 YVYIAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      .+|+||||++|++|.+.+....  ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999999998875432  34589999999999999999999999999999999999998655556799999999


Q ss_pred             ccccCCCCc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          249 SDFIKPGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       249 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      +........ ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+. ..+.+..+......+....|+.
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence            987654432 3467899999999988754 689999999999999999999999875 3456677777666555555678


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCCHHHHHHHHHHhhhcHHHHHHHHHHHHhhhccee
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFKYTALF  403 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~  403 (414)
                      +++++.+||.+||..||.+|||+.++|+||||+..............++.++.+....+++..++..++..++++|+
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFY  335 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC------------------
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcccCC
Confidence            99999999999999999999999999999999875433333334466788899998899999999998888887765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-56  Score=431.84  Aligned_cols=254  Identities=24%  Similarity=0.310  Sum_probs=212.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCC-----CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANG-----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-  168 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-  168 (414)
                      .++|++++.||+|+||+||+|.+..++     +.||||++....  .....+.+.+|+.+|.++.+|||||+++++|.. 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            367999999999999999999876543     579999987543  234567899999999999756999999999865 


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee
Q 015026          169 DNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~  234 (414)
                      ++.++||||||++|+|.+++....              ...+++.++..|+.||+.||.|||+++||||||||+|||++ 
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~-  219 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-  219 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC-
Confidence            467899999999999999996532              24589999999999999999999999999999999999998 


Q ss_pred             cCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhh
Q 015026          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (414)
Q Consensus       235 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~  309 (414)
                        .++.+||+|||+|+.......   ....+||+.|||||++.+ .++.++|||||||++|||+| |+.||.+....+.+
T Consensus       220 --~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          220 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             --GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             --CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              578999999999987644332   235689999999998764 57899999999999999998 99999887665555


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ..++.....+  ...+.+|+++.+||.+||+.||++|||+.|+++|
T Consensus       298 ~~~i~~g~~~--~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCC--CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4444433222  2224689999999999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.2e-56  Score=451.17  Aligned_cols=303  Identities=38%  Similarity=0.652  Sum_probs=263.8

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ..+.++|++++.||+|+||+||+|.+..++..||+|++.+.... ......+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  110 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKRN  110 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCE
Confidence            45667899999999999999999999999999999999765432 223567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++|||||+||+|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999999988554  5699999999999999999999999999999999999998655567899999999988


Q ss_pred             cCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..........+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+....+++..+......++.+.|+.+|+++
T Consensus       189 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          189 FENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             CBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             CCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence            77666667789999999999999889999999999999999999999999999999999999988888888888999999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccCC----CCCCCCHHHHHHHHHHhhhcHHHHHHHHHHHHhh
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDA----SEIPIDISVLNNMRQFVKYSRLKQFALRVTQYFK  398 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~  398 (414)
                      .+||.+||+.||.+|||+.++|+||||+.....    ...+.....+.++++|...+++++.++...+...
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~  339 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKL  339 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhc
Confidence            999999999999999999999999999864322    2344455688999999999999999888776543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.5e-56  Score=433.84  Aligned_cols=267  Identities=36%  Similarity=0.616  Sum_probs=237.2

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC---hHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ..+.++|++++.||+|+||+||+|.+..+|+.||+|++.+.....   ....+.+.+|+.+|+.+. ||||+++++++.+
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~   86 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN   86 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe
Confidence            346678999999999999999999999999999999997654321   123578899999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC-CCCCceeeccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFG  247 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DFG  247 (414)
                      .+.+++||||++||+|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             CCEEEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999999984  446799999999999999999999999999999999999998421 12279999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++...|+.
T Consensus       165 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             SCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             CceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence            9988776666677899999999999875 468899999999999999999999999998889999988877777666778


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +|+++++||.+||..||.+|||+.|+|+||||+..
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            99999999999999999999999999999999853

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.5e-56  Score=449.19  Aligned_cols=305  Identities=35%  Similarity=0.611  Sum_probs=262.7

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh----------HhHHHHHHHHHHHHHccCCCCce
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP----------IAVEDVKREVKILQALAGHENVV  160 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~~E~~il~~l~~hpnIv  160 (414)
                      ...+.++|++++.||+|+||+||+|.+..+++.||||++.+......          ...+.+.+|+.+|+.+. ||||+
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv  109 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNII  109 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCC
Confidence            34577899999999999999999999999999999999976543211          24577899999999995 99999


Q ss_pred             EEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC
Q 015026          161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                      ++++++.+...+++|||||+||+|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+....
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999999988554  56999999999999999999999999999999999999986444457


Q ss_pred             ceeeccccccccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       241 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      +||+|||++............+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+++..+..+...++
T Consensus       188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99999999988776666677899999999999998899999999999999999999999999999999999998887777


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCC---CCCHHHHHHHHHHhhhcHHHHHHHHHHHHh
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI---PIDISVLNNMRQFVKYSRLKQFALRVTQYF  397 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~  397 (414)
                      ...|+.+|+++++||.+||..||.+|||+.|+|+||||+........   ......+.++++|...+++++.++......
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~  347 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSK  347 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHH
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            66678899999999999999999999999999999999875443221   122346788899999999999988877654


Q ss_pred             h
Q 015026          398 K  398 (414)
Q Consensus       398 ~  398 (414)
                      .
T Consensus       348 ~  348 (504)
T 3q5i_A          348 L  348 (504)
T ss_dssp             T
T ss_pred             C
Confidence            4

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.3e-55  Score=421.66  Aligned_cols=294  Identities=36%  Similarity=0.636  Sum_probs=235.1

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||||++....     ..+.+.+|+.+|+.+. ||||+++++++.+.+.
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTE  122 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecCCe
Confidence            456778999999999999999999999999999999987543     3456789999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||++|++|.+++.  ....+++..++.++.||+.||.|||+.||+||||||+|||++....++.+||+|||++..
T Consensus       123 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             EEEEECCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEEEEEeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            999999999999999884  345799999999999999999999999999999999999998544588999999999987


Q ss_pred             cCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh-hhHHHhhcCCCCCCCCCCCCCH
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ..........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+..+......+....++.++.
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            765555566789999999998876 46889999999999999999999998776554 6667777666666666778999


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCCHHHHHHHHHHhhhcHHHHHHHHHHH
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRVTQ  395 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~  395 (414)
                      ++.+||.+||..||++|||+.|+|+||||.......  .........++.+....++++......+
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF--VHMDTAQKKLQEFNARRKLKAAVKAVVA  344 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCC--SCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccch--hhhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999998654332  2334566788888888888887665544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.9e-55  Score=419.03  Aligned_cols=257  Identities=35%  Similarity=0.631  Sum_probs=231.8

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++++.||+|+||.||+|.+..+|+.||||++..... .+...+.+.+|+.+|+.+. ||||+++++++...+.+++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEE
Confidence            3579999999999999999999999999999999976543 3456778899999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTCCGGGSS
T ss_pred             EEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc---CCCCEEEeeccCceecCC
Confidence            99999999999998554  5699999999999999999999999999999999999998   588999999999988776


Q ss_pred             CCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .......+||+.|+|||++.+..  +.++|||||||++|+|++|+.||.+.+..++...+..+...++.    .+++++.
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  242 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCE  242 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHH
Confidence            66677889999999999987654  46899999999999999999999999888888888887655443    5789999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +||.+||..||.+|||++|+|+||||....
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999999998643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-55  Score=420.88  Aligned_cols=263  Identities=29%  Similarity=0.549  Sum_probs=236.7

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++.++|++.+.||+|+||+||+|.+..+|+.||+|++....    .....+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence            45678999999999999999999999999999999986442    35567899999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||++|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||++...
T Consensus        77 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           77 VMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeEC
Confidence            999999999999998843 23469999999999999999999999999999999999999842 2689999999999887


Q ss_pred             CCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++...++.+|+++
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            766666677899999999998765 5889999999999999999999999999888999998888777766677899999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .+||.+||..||.+|||+.|+|+||||+...
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            9999999999999999999999999998653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.7e-55  Score=422.68  Aligned_cols=256  Identities=29%  Similarity=0.541  Sum_probs=224.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.+.+||||+++++++.+.+.+|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999997654333345677889999999987799999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-C
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~  254 (414)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+... .
T Consensus       103 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSCC-
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC---CCCCEEEccccceeecccC
Confidence            9999999999988544  5799999999999999999999999999999999999998   57899999999997633 2


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .......+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+++..+......++.    .+++++.+
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~  253 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATG  253 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHH
Confidence            334456799999999998765 4789999999999999999999999999999999999888765543    58899999


Q ss_pred             HHHHhhcCCccccCCH------HHHhCCccccc
Q 015026          334 FVKKLLVKDPRARLTA------AQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rps~------~elL~hp~f~~  360 (414)
                      ||.+||..||.+||++      +++++||||+.
T Consensus       254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            9999999999999999      89999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.5e-54  Score=413.63  Aligned_cols=255  Identities=31%  Similarity=0.534  Sum_probs=226.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+|+.+. ||||+++++++.+.+.+|+|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999997643222234667889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-C
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~  254 (414)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++... .
T Consensus        84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC---CCCCEEEeeccchhhcccC
Confidence            9999999999988543  5799999999999999999999999999999999999998   57899999999997633 3


Q ss_pred             CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .......+||+.|+|||++.+. ++.++|||||||++|||++|..||.+.+...++..+......++    ..+++++.+
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  234 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS  234 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence            3445678999999999988654 68999999999999999999999999888888888887765544    368999999


Q ss_pred             HHHHhhcCCccccC-----CHHHHhCCccccc
Q 015026          334 FVKKLLVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      ||.+||..||.+||     ++.|+++||||..
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            99999999999999     9999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.4e-54  Score=422.29  Aligned_cols=256  Identities=24%  Similarity=0.480  Sum_probs=221.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..+|..+.+||||++++++|.+.+.+|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            57999999999999999999999999999999998765544445567889999999886799999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc-cCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~-~~~  254 (414)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+. ...
T Consensus       132 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCT
T ss_pred             EEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC---CCCCEEEeecceeeecccC
Confidence            9999999999988543  5799999999999999999999999999999999999998   688999999999986 334


Q ss_pred             CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCC---------chhhhHHHhhcCCCCCCCCC
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT---------EDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~  324 (414)
                      .......+||+.|+|||++.+. ++.++|||||||++|||++|+.||....         ...+...+......++    
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----  282 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----  282 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----
Confidence            4456678999999999988754 6889999999999999999999996432         2234555666554444    


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCH------HHHhCCccccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVRE  360 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~------~elL~hp~f~~  360 (414)
                      ..+++++.+||.+||+.||.+||++      .|+++||||+.
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            3689999999999999999999995      79999999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-54  Score=411.73  Aligned_cols=267  Identities=36%  Similarity=0.631  Sum_probs=234.2

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC---hHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.......   ....+.+.+|+.+|+.+. ||||+++++++.+
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            346678999999999999999999999999999999997654321   124678999999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC-CCCCceeeccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFG  247 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DFG  247 (414)
                      ....++||||++|++|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             CCEEEEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999999884  346799999999999999999999999999999999999998422 22379999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++...++.
T Consensus       164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            9988766556667889999999998875 468899999999999999999999999888888888877766665555567


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +++++.+||.+||..||.+|||+.++|+||||+..
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            89999999999999999999999999999999853

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2e-54  Score=416.51  Aligned_cols=257  Identities=34%  Similarity=0.595  Sum_probs=224.6

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++.............+.+|+.+++.+. ||||+++++++..++..+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence            4468999999999999999999999999999999987543222223457889999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||+ +|+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        86 lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---TTCCEEECCSSCTBTTT
T ss_pred             EEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---CCCCEEEEEeccceecc
Confidence            999999 78999988654  5799999999999999999999999999999999999998   57899999999998877


Q ss_pred             CCCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ........+||+.|+|||++.+..  ++++|||||||++|+|++|..||.+.........+......+    ...+|+++
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~  235 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM----PDFLSPGA  235 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCC----CTTSCHHH
T ss_pred             CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC----cccCCHHH
Confidence            666667789999999999987653  678999999999999999999998877766665554443322    23689999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .+||.+||..||.+|||+.|+++||||+..
T Consensus       236 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          236 QSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            999999999999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.3e-53  Score=397.07  Aligned_cols=268  Identities=32%  Similarity=0.667  Sum_probs=241.1

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++.+++..
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence            466889999999999999999999999999999999976543 3445678899999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||++|++|.+.+...  ..+++..+..++.||+.||.|||+.||+||||||+||+++..+..+.+||+|||++...
T Consensus        81 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999999999988554  56999999999999999999999999999999999999986555667999999999877


Q ss_pred             CCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..........||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.........+......++...+..+++++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            666666678899999999987764 6889999999999999999999999998888888888888777777778899999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      .+||.+||+.||++|||+.|+|+||||+.....
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence            999999999999999999999999999875443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.9e-54  Score=413.38  Aligned_cols=257  Identities=28%  Similarity=0.495  Sum_probs=227.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+..|..++..+.+||||+++++++.+.+.+|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999997653222234567889999999875699999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-C
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~  254 (414)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++... .
T Consensus        97 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCT
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---CCCCEEEeEChhhhhcccC
Confidence            9999999999988543  5699999999999999999999999999999999999998   57899999999997643 2


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+....+.++    ..+++++.+
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  247 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKD  247 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHH
Confidence            334567899999999998765 468999999999999999999999999988888888888765544    358999999


Q ss_pred             HHHHhhcCCccccCCHH-HHhCCcccccc
Q 015026          334 FVKKLLVKDPRARLTAA-QALSHPWVREG  361 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~-elL~hp~f~~~  361 (414)
                      ||.+||..||.+||++. ++++||||+..
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            99999999999999998 99999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-53  Score=415.04  Aligned_cols=265  Identities=35%  Similarity=0.595  Sum_probs=235.6

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.++|++++.||+|+||+||+|.+..+|+.||+|++....   ......+.+|+.+|+.+. ||||+++++++.+...+
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCEE
Confidence            35578999999999999999999999999999999987543   234567899999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||++...
T Consensus       124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceec
Confidence            9999999999999987432 3468999999999999999999999999999999999999732 3578999999999887


Q ss_pred             CCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++...+..+++++
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            665555667899999999988754 6889999999999999999999999988888888888877777777778899999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      .+||.+||..||.+|||+.|+|+||||+....
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            99999999999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-53  Score=398.22  Aligned_cols=266  Identities=34%  Similarity=0.660  Sum_probs=226.6

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ...+.++|.+.+.||+|+||+||+|.+..+|..||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.+..
T Consensus        17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   93 (285)
T 3is5_A           17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYH   93 (285)
T ss_dssp             SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCC-CchHHhHHHheecCC
Confidence            34566789999999999999999999999999999999976542  234678899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          171 YVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      ..++||||++|++|.+.+...  ....+++..++.++.||+.||.|||+.||+||||||+|||++....++.+||+|||+
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            999999999999999988543  346799999999999999999999999999999999999997544678899999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      +.............||+.|+|||++.+.++.++||||||+++|+|++|+.||.+....+....+....+.+... ...++
T Consensus       174 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~  252 (285)
T 3is5_A          174 AELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLT  252 (285)
T ss_dssp             CCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCC
T ss_pred             ceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCC
Confidence            98776655556778999999999998888999999999999999999999999888777777666655444332 23578


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       253 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            99999999999999999999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-53  Score=398.88  Aligned_cols=266  Identities=40%  Similarity=0.758  Sum_probs=239.0

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++.++|++.+.||+|+||+||+|.+..++..||+|++.....   ...+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeE
Confidence            456789999999999999999999999999999999976543   2457789999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+..+..++.+||+|||++...
T Consensus        82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            9999999999999988553  56899999999999999999999999999999999999954446889999999999887


Q ss_pred             CCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ..........||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+......++...+..+++++.
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            76666677889999999999998899999999999999999999999999888888888888877666655667899999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      +||.+||+.||.+|||+.++|+||||+.....
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence            99999999999999999999999999865443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.7e-53  Score=408.04  Aligned_cols=256  Identities=25%  Similarity=0.475  Sum_probs=223.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+.+||||+++++++.+.+.+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46999999999999999999999999999999998776656667788999999999986699999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc-CC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~-~~  254 (414)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.. ..
T Consensus        89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEEeccccccccCC
Confidence            9999999999988543  5799999999999999999999999999999999999998   5789999999999863 23


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCC---------CchhhhHHHhhcCCCCCCCCC
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDK---------TEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      .......+||+.|+|||++.+ .++.++|||||||++|||++|+.||...         ....+...+......++    
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----  239 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----  239 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----
Confidence            344567799999999998875 4688999999999999999999999652         22344555665554443    


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCH------HHHhCCccccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVRE  360 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~------~elL~hp~f~~  360 (414)
                      ..+++++.+||.+||+.||.+||++      .++++||||+.
T Consensus       240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            3689999999999999999999995      89999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-53  Score=408.31  Aligned_cols=281  Identities=27%  Similarity=0.487  Sum_probs=241.5

Q ss_pred             CCCCcCccccccccceeec-eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceE
Q 015026           83 GKRTDFGYDKDFDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK  161 (414)
Q Consensus        83 ~~~~~~~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~  161 (414)
                      .....+...+.+.++|.+. +.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.+.+||||++
T Consensus        15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~   93 (327)
T 3lm5_A           15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVIN   93 (327)
T ss_dssp             -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEE
Confidence            3445566677888999998 8999999999999999999999999998765432 2346788999999999987899999


Q ss_pred             EEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCc
Q 015026          162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL  241 (414)
Q Consensus       162 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v  241 (414)
                      +++++.+.+..++||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++....++.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcE
Confidence            99999999999999999999999998865555789999999999999999999999999999999999999854447899


Q ss_pred             eeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          242 KATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       242 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      ||+|||++............+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+..+......++
T Consensus       174 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  253 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS  253 (327)
T ss_dssp             EECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence            9999999988766655567789999999998875 468899999999999999999999999888888888888777777


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      ...+..+++.+.+||.+||..||.+|||++++|+||||+.....
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence            77778899999999999999999999999999999999875443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-53  Score=405.31  Aligned_cols=253  Identities=27%  Similarity=0.558  Sum_probs=226.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+...+|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEE
Confidence            5699999999999999999999999999999999764322223457788999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... 
T Consensus        85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECSS-
T ss_pred             EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc---CCCCEEEeecCcceecCC-
Confidence            999999999999854  45799999999999999999999999999999999999998   588999999999987543 


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                       .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++    +.+++++.+|
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  233 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDL  233 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence             33467899999999987654 68899999999999999999999999888888888888765544    3688999999


Q ss_pred             HHHhhcCCccccC-----CHHHHhCCccccc
Q 015026          335 VKKLLVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       335 i~~~L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      |.+||..||.+||     +++++++||||+.
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            9999999999999     9999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-53  Score=406.37  Aligned_cols=268  Identities=31%  Similarity=0.602  Sum_probs=210.1

Q ss_pred             ccceeec---eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           95 DRRYTIG---KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        95 ~~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .++|++.   +.||+|+||+||+|.+..+|+.||||++...      ....+.+|+.+++.+.+||||+++++++.++..
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            3467774   7899999999999999999999999998653      346778999999999779999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            9999999999999999854  46799999999999999999999999999999999999998544445899999999986


Q ss_pred             cCCC-CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc-------hhhhHHHhhcCCCCCCC
Q 015026          252 IKPG-KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE-------DGIFKEVLRNKPDFRRK  322 (414)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~  322 (414)
                      .... ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+...       .+++..+..+...++..
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            5433 334567899999999988654 68899999999999999999999976543       35566676666666655


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCC
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID  370 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~  370 (414)
                      .|+.+++++.+||.+||..||.+|||+.++++||||+.....+..+..
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~  286 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLM  286 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCS
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCC
Confidence            566799999999999999999999999999999999987665554443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.7e-54  Score=424.18  Aligned_cols=259  Identities=28%  Similarity=0.475  Sum_probs=225.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.+ +|||||+++++|.+++.+|||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEE
Confidence            5799999999999999999999999999999999753221112234578899999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|......
T Consensus       148 ~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             ECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCTT
T ss_pred             EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC---CCCCEEEeccceeEeeccC
Confidence            999999999998843   3589999999999999999999999999999999999998   6889999999999876544


Q ss_pred             C--ccccCCCCCccccchhcccc-----CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          256 K--KFQDIVGSAYYVAPEVLKRK-----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .  ...+.+||+.|+|||++.+.     ++.++|||||||++|||++|..||.+.+..+.+..+......+..+.++.+|
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            3  23467999999999988643     5689999999999999999999999999888888888765434444456799


Q ss_pred             HHHHHHHHHhhcCCccc--cCCHHHHhCCcccccc
Q 015026          329 NSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~--Rps~~elL~hp~f~~~  361 (414)
                      +++++||.+||..+|.+  ||+++|+++||||+..
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            99999999999999988  9999999999999863

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-53  Score=412.23  Aligned_cols=256  Identities=25%  Similarity=0.446  Sum_probs=227.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+|+.||||++.+.........+.+..|..+|..+.+||||+++++++.+.+.+|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            56999999999999999999999999999999997653322335677889999998886799999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC-C
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~-~  254 (414)
                      |||++||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .
T Consensus       100 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCT
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---CCCcEEEEeCCcccccccC
Confidence            9999999999998543  4699999999999999999999999999999999999998   57899999999997643 3


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .......+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+++..+......++    ..+|+++.+
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  250 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVA  250 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHH
Confidence            334567899999999998865 468899999999999999999999999988889999988766554    368999999


Q ss_pred             HHHHhhcCCccccCC-----HHHHhCCccccc
Q 015026          334 FVKKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      ||.+||..||.+||+     ++++++||||+.
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            999999999999994     699999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-53  Score=410.58  Aligned_cols=261  Identities=34%  Similarity=0.617  Sum_probs=227.1

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||||++.+...       ...+|+.++..+.+||||+++++++.+++.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            356789999999999999999999999999999999976542       2356888998886799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec-CCCCCceeeccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGLSDF  251 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DFG~a~~  251 (414)
                      |+||||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||++..
T Consensus        92 ~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999999998854  4579999999999999999999999999999999999998642 1224699999999987


Q ss_pred             cCCC-CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCC---CchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPG-KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDK---TEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .... ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.   ...+++..+..+...++...|+.
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            6443 334567899999999998764 688999999999999999999999863   44567777888777777777889


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +|+++.+||.+||..||++|||+.++|+||||....
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence            999999999999999999999999999999997543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-52  Score=396.64  Aligned_cols=259  Identities=27%  Similarity=0.478  Sum_probs=223.1

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++......   ..+.+.+|+.+++.+. ||||+++++++..++.++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEEE
Confidence            456899999999999999999999999999999998765432   3567889999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||++||+|.+++...   .+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC---CCCCEEEeeCCCceecC
Confidence            999999999999988543   589999999999999999999999999999999999998   57899999999987765


Q ss_pred             CCC-ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          254 PGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       254 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+...... .......+++.+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIF  246 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHH
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHH
Confidence            432 3456789999999998765 4689999999999999999999999888776665555443321 112234688999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      .+||.+||+.||.+|||+.|+|+||||+....
T Consensus       247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            99999999999999999999999999986543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-52  Score=414.04  Aligned_cols=264  Identities=30%  Similarity=0.572  Sum_probs=218.0

Q ss_pred             cccceeec-eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----
Q 015026           94 FDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (414)
Q Consensus        94 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----  168 (414)
                      +.++|.+. +.||+|+||+||+|.+..+|+.||||++...        ..+.+|+.++.++.+||||++++++|..    
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            44567776 7899999999999999999999999998632        3467899988666679999999999875    


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      ...+||||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            67799999999999999999765556799999999999999999999999999999999999999644478999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch----hhhHHHhhcCCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~  323 (414)
                      ++...........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....    .....+..+...++...
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  290 (400)
T 1nxk_A          211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  290 (400)
T ss_dssp             CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred             ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence            987765555667899999999999864 5688999999999999999999999876543    24566666666777777


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      |..+++++.+||.+||..||.+|||+.|+|+||||.......
T Consensus       291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  332 (400)
T 1nxk_A          291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  332 (400)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSC
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCC
Confidence            788999999999999999999999999999999998654443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-53  Score=405.36  Aligned_cols=246  Identities=22%  Similarity=0.274  Sum_probs=188.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC----E
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN----Y  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~----~  171 (414)
                      ++|.+.+.||+|+||+||+|++  +|+.||||++....    ........|+..+..++ |||||++++++.+++    .
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCceE
Confidence            4689999999999999999986  68999999986542    12222345666666785 999999999997643    6


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEEeecCCCCCcee
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--------GLVHRDMKPENFLFKSAKEDSSLKA  243 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~--------~iiHrDlkp~NIll~~~~~~~~vkl  243 (414)
                      +|||||||+||+|.+++..   ..+++..+..++.|++.||.|||++        +||||||||+||||+   .++.+||
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~---~~~~~Ki  149 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCI  149 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC---TTSCEEE
T ss_pred             EEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC---CCCCEEE
Confidence            8999999999999999854   3589999999999999999999987        999999999999998   6889999


Q ss_pred             eccccccccCCCCc-----cccCCCCCccccchhcccc-------CCCCcchhHHHHHHHHHhhCCCCCCCCCc------
Q 015026          244 TDFGLSDFIKPGKK-----FQDIVGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKTE------  305 (414)
Q Consensus       244 ~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~elltg~~Pf~~~~~------  305 (414)
                      +|||+|+.......     ....+||+.|||||++.+.       ++.++|||||||+||||+||.+||.....      
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~  229 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence            99999987654332     2346899999999998753       45689999999999999999877643221      


Q ss_pred             ---------hhhhHHHhhcCCC--CCCCC-CCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          306 ---------DGIFKEVLRNKPD--FRRKP-WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       306 ---------~~~~~~i~~~~~~--~~~~~-~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                               ..+...+......  ++... ....++.+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                     1122222222111  11100 0112346889999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.2e-53  Score=401.80  Aligned_cols=269  Identities=36%  Similarity=0.591  Sum_probs=220.3

Q ss_pred             ccccccceeec-eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           91 DKDFDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        91 ~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      ...+.++|++. +.||+|+||+||+|.+..+|+.||||++.....   ...+.+.+|+.++.++.+||||+++++++.++
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            44567889995 789999999999999999999999999976532   24577899999999975799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      +.+++||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             CEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            9999999999999999998554  56899999999999999999999999999999999999985444455999999998


Q ss_pred             cccCCC--------CccccCCCCCccccchhccc------cCCCCcchhHHHHHHHHHhhCCCCCCCCCc----------
Q 015026          250 DFIKPG--------KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTE----------  305 (414)
Q Consensus       250 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~----------  305 (414)
                      ......        ......+||+.|+|||++.+      .++.++|||||||++|+|++|..||.+...          
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            765321        12234579999999998863      468999999999999999999999987643          


Q ss_pred             -----hhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          306 -----DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       306 -----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                           ..+...+......++...+..+++++.+||.+||..||.+|||+.|+|+||||+.....
T Consensus       242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred             chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence                 23455666666555544456789999999999999999999999999999999875443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=410.66  Aligned_cols=255  Identities=24%  Similarity=0.493  Sum_probs=223.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+|+.+ +|||||+++++|.+.+.+|+|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEE
Confidence            5799999999999999999999999999999999765433333567889999999999 499999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+.||+|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        94 ~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             ECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---CCCCEEEeccceeeeccCC
Confidence            99999999999884  346799999999999999999999999999999999999998   6889999999999887766


Q ss_pred             CccccCCCCCccccchhccc----cCCCCcchhHHHHHHHHHhhCCCCCCCCCc---hhhhHHHhhcCCCCCCCCCCCCC
Q 015026          256 KKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      ......+||+.|+|||++.+    .++.++|||||||++|+|++|..||.....   .+....+......++    ..++
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s  244 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWS  244 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCC
Confidence            66778899999999999853    368899999999999999999999975433   334444444443333    3688


Q ss_pred             HHHHHHHHHhhcCCccccCC-HHHHhCCccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLT-AAQALSHPWVRE  360 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps-~~elL~hp~f~~  360 (414)
                      +++.+||.+||..||.+||+ ++++++||||..
T Consensus       245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            99999999999999999998 899999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=397.45  Aligned_cols=266  Identities=25%  Similarity=0.355  Sum_probs=218.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC--ChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEEc
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALA--GHENVVKFYNAFED  168 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~~  168 (414)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++......  .......+.+|+.+++.+.  +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3457899999999999999999999999999999998643311  1112345667888877764  49999999999977


Q ss_pred             CC-----EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCcee
Q 015026          169 DN-----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (414)
Q Consensus       169 ~~-----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (414)
                      ..     .+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---TTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEE
Confidence            54     5899999996 5999998766656699999999999999999999999999999999999998   5789999


Q ss_pred             eccccccccCCCCccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC
Q 015026          244 TDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (414)
Q Consensus       244 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~  322 (414)
                      +|||++............+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+..
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999998776666666789999999999875 457899999999999999999999999988887777765532222221


Q ss_pred             C-----------------------CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          323 P-----------------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       323 ~-----------------------~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .                       .+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            1                       235788999999999999999999999999999998654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.4e-53  Score=407.56  Aligned_cols=253  Identities=28%  Similarity=0.498  Sum_probs=226.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.+|+.+ +||||+++++++.+.+.+|+|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEE
Confidence            5799999999999999999999999999999999765432233567788999999999 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC---CCCCEEEcccccceeccCC
Confidence            9999999999998543  5699999999999999999999999999999999999998   5789999999999876433


Q ss_pred             CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                        ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+......++    ..+++++.+|
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  268 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDL  268 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHH
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence              346789999999998765 468899999999999999999999999888888888888765544    3689999999


Q ss_pred             HHHhhcCCccccCC-----HHHHhCCccccc
Q 015026          335 VKKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       335 i~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      |.+||+.||.+||+     ++++++||||..
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            99999999999998     999999999985

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.1e-52  Score=397.21  Aligned_cols=264  Identities=27%  Similarity=0.474  Sum_probs=217.5

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .+.+.++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++.+. ||||+++++++.+++
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSER   92 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSS
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCC
Confidence            3456678999999999999999999985 589999999865432 2234577889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .+++||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLAR  167 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred             EEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---CCCCEEEccCcCce
Confidence            99999999975 888877543 35699999999999999999999999999999999999998   57899999999998


Q ss_pred             ccCCC-CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC-----
Q 015026          251 FIKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----  322 (414)
Q Consensus       251 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-----  322 (414)
                      ..... ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+..........     
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            76432 33445689999999998765  46889999999999999999999999888777666654422111111     


Q ss_pred             ---------------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          323 ---------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       323 ---------------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                           ..+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                 1234778999999999999999999999999999998643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.6e-53  Score=420.96  Aligned_cols=262  Identities=26%  Similarity=0.456  Sum_probs=224.6

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||++++++|.+.+.+||
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEE
Confidence            35799999999999999999999999999999999754322222334478999999999 59999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+....
T Consensus       152 V~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~---~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCT
T ss_pred             EEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc---CCCCEEEcchhhhhhccc
Confidence            99999999999998542 45799999999999999999999999999999999999998   688999999999976644


Q ss_pred             CCc--cccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-CCCC
Q 015026          255 GKK--FQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWP  325 (414)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~  325 (414)
                      ...  ....+||+.|+|||++.      +.++.++|||||||++|||++|+.||.+.+..+.+..+......+.. ..++
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence            332  23468999999999875      34688999999999999999999999999888888888764322221 2235


Q ss_pred             CCCHHHHHHHHHhhcCCccc--cCCHHHHhCCcccccc
Q 015026          326 SISNSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~--Rps~~elL~hp~f~~~  361 (414)
                      .+|+++++||.+||+.+|++  ||+++|+++||||+..
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            68999999999999999988  9999999999999853

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-52  Score=421.50  Aligned_cols=257  Identities=35%  Similarity=0.612  Sum_probs=229.3

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|.+++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. ||||+++++++...+.+++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            357999999999999999999999999999999997653322234567899999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++||+|.+++.  ..+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        94 v~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~---~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           94 VMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---TTCCEEECCCSSCEECCT
T ss_pred             EEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---cCCCeEEEeccchhhccc
Confidence            999999999999884  456799999999999999999999999999999999999998   578999999999988776


Q ss_pred             CCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .......+||+.|+|||++.+..  +.++|||||||++|+|++|..||.+.....++..+..+....+    ..+++++.
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  244 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVI  244 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHH
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHH
Confidence            66667789999999999987653  6789999999999999999999999888888888877654333    35889999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +||.+||..||.+|||+.++++||||+..
T Consensus       245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            99999999999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.8e-52  Score=391.40  Aligned_cols=259  Identities=24%  Similarity=0.433  Sum_probs=216.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.+. ||||+++++++.+++.+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence            479999999999999999999999999999999976543 3335677889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++ ++.+.+.. ..+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             EECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCSC
T ss_pred             EecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceecCCc
Confidence            999975 66666644 346799999999999999999999999999999999999998   5789999999999876433


Q ss_pred             -CccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCC-CCCCchhhhHHHhhcCCCCCC----------
Q 015026          256 -KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRR----------  321 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~----------  321 (414)
                       ......+||+.|+|||++.+.  ++.++|||||||++|+|++|..|| .+.+..+.+..+.........          
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence             334456899999999988653  588999999999999999887775 455555555555432111111          


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          322 ---------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       322 ---------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                     ...+.+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                           1123578899999999999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-52  Score=399.32  Aligned_cols=267  Identities=36%  Similarity=0.616  Sum_probs=232.1

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh---HhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.+++.+. ||||+++++++.+
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   86 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN   86 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence            3456789999999999999999999999999999999976543221   23678899999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC-CCCceeeccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE-DSSLKATDFG  247 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~-~~~vkl~DFG  247 (414)
                      .+..++||||++|++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++..+. ...+||+|||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999999998843  457899999999999999999999999999999999999984211 1279999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+..+......++...++.
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (321)
T 2a2a_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH  244 (321)
T ss_dssp             TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence            9988776666667789999999998875 468899999999999999999999999888888888877665555444467


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus       245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            89999999999999999999999999999999853

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.9e-52  Score=406.01  Aligned_cols=256  Identities=27%  Similarity=0.471  Sum_probs=217.1

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHH-HHccCCCCceEEEEEEEcCCEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL-QALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il-~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|..++ +.+ +||||+++++++.+.+.+|
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEEE
Confidence            35799999999999999999999999999999999876654444556677788774 556 5999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc-
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-  252 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~-  252 (414)
                      +||||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.. 
T Consensus       116 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCBCGGGB
T ss_pred             EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEeeCccccccc
Confidence            999999999999988543  5789999999999999999999999999999999999998   5889999999999863 


Q ss_pred             CCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .........+||+.|+|||++.+. ++.++|||||||++|||++|..||.+.+..+++..+......++    +.+++++
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  266 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSA  266 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHH
Confidence            333445678999999999988754 68899999999999999999999999988888988888765443    4689999


Q ss_pred             HHHHHHhhcCCccccCCH----HHHhCCccccc
Q 015026          332 KDFVKKLLVKDPRARLTA----AQALSHPWVRE  360 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~----~elL~hp~f~~  360 (414)
                      .+||.+||+.||.+||++    .++++||||+.
T Consensus       267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            999999999999999987    69999999985

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.9e-52  Score=406.26  Aligned_cols=264  Identities=33%  Similarity=0.653  Sum_probs=232.8

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC-C----hHhHHHHHHHHHHHHHccCCCCceEEEEEE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-L----PIAVEDVKREVKILQALAGHENVVKFYNAF  166 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~----~~~~~~~~~E~~il~~l~~hpnIv~~~~~~  166 (414)
                      ..+.++|++.+.||.|+||.||+|.+..+|+.||||++...... .    ....+.+.+|+.+++.+.+||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            34557899999999999999999999999999999998764321 1    123567889999999996699999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      ...+..++||||++|++|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---~~~~ikl~Df  244 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQIRLSDF  244 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEEec
Confidence            9999999999999999999988543  5699999999999999999999999999999999999998   5789999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhccc-------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR-------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |++............+||+.|+|||++.+       .++.++|||||||++|+|++|..||.+......+..+......+
T Consensus       245 G~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  324 (365)
T 2y7j_A          245 GFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF  324 (365)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             CcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            99988776666677899999999998753       36789999999999999999999999888877888887776666


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ..+.|..+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus       325 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            55556688999999999999999999999999999999973

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-52  Score=394.00  Aligned_cols=256  Identities=29%  Similarity=0.568  Sum_probs=215.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC-----------------------hHhHHHHHHHHHHHHH
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----------------------PIAVEDVKREVKILQA  152 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~E~~il~~  152 (414)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++.......                       ....+.+.+|+.+|+.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57999999999999999999999999999999997653211                       1124568899999999


Q ss_pred             ccCCCCceEEEEEEEc--CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 015026          153 LAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENF  230 (414)
Q Consensus       153 l~~hpnIv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI  230 (414)
                      +. ||||+++++++.+  ...+++||||+++++|.+++   ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus        93 l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             CC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            95 9999999999986  67899999999999998754   345799999999999999999999999999999999999


Q ss_pred             EEeecCCCCCceeeccccccccCCCC-ccccCCCCCccccchhccccC----CCCcchhHHHHHHHHHhhCCCCCCCCCc
Q 015026          231 LFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTE  305 (414)
Q Consensus       231 ll~~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~DiwslG~il~elltg~~Pf~~~~~  305 (414)
                      |++   .++.+||+|||++....... .....+||+.|+|||++.+..    +.++|||||||++|+|++|..||.+...
T Consensus       169 l~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          169 LVG---EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             EEC---TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEC---CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            998   57899999999998765432 334578999999999987543    6678999999999999999999988877


Q ss_pred             hhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       306 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ......+......++.  .+.+++++.+||.+||..||++|||+.|+|+||||++
T Consensus       246 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            7776666665544332  3578999999999999999999999999999999963

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-52  Score=413.39  Aligned_cols=260  Identities=27%  Similarity=0.472  Sum_probs=222.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEE
Confidence            5799999999999999999999999999999999764322222345578999999999 499999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       140 mE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld---~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCTT
T ss_pred             EcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec---CCCCEEEeechhheeccCC
Confidence            9999999999998543 34799999999999999999999999999999999999998   6889999999999876544


Q ss_pred             Cc--cccCCCCCccccchhcc--------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC-CC
Q 015026          256 KK--FQDIVGSAYYVAPEVLK--------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-PW  324 (414)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~  324 (414)
                      ..  ....+||+.|+|||++.        +.++.++|||||||++|||++|+.||.+.+..+++..+......+..+ ..
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence            33  23568999999999886        346889999999999999999999999998888888887643212111 12


Q ss_pred             CCCCHHHHHHHHHhhcCCcccc---CCHHHHhCCcccccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRAR---LTAAQALSHPWVREG  361 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~R---ps~~elL~hp~f~~~  361 (414)
                      ..+|+++++||.+||+ +|.+|   |+++|+++||||+..
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            4689999999999999 99998   599999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-51  Score=404.13  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=219.1

Q ss_pred             cceeeceeeeec--CceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           96 RRYTIGKLLGHG--QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ++|++++.||+|  +||+||+|.+..+|+.||||++..... .....+.+.+|+.+++.+. |||||++++++.+++.++
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEEE
Confidence            579999999999  999999999999999999999976543 3456778899999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~---~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccccceeec
Confidence            999999999999999776667799999999999999999999999999999999999998   57899999999876432


Q ss_pred             CC--------CccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC---
Q 015026          254 PG--------KKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF---  319 (414)
Q Consensus       254 ~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~---  319 (414)
                      ..        ......+||+.|+|||++.+   .++.++|||||||++|+|++|+.||.+......+..+.......   
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            11        11223589999999999875   46889999999999999999999998876665554443322110   


Q ss_pred             ---------------------------------------CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          320 ---------------------------------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       320 ---------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                                                             ....+..+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                                   01123457889999999999999999999999999999987


Q ss_pred             ccC
Q 015026          361 GGD  363 (414)
Q Consensus       361 ~~~  363 (414)
                      ...
T Consensus       340 ~~~  342 (389)
T 3gni_B          340 IKR  342 (389)
T ss_dssp             C--
T ss_pred             Hhh
Confidence            543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-52  Score=395.42  Aligned_cols=258  Identities=25%  Similarity=0.350  Sum_probs=213.0

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ..+.++|++.++||+|+||+||+|.+..+|+.||||++..... ..........|+..+..+.+||||+++++++.+++.
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            4455789999999999999999999999999999998865433 233445566677777666569999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++||||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---GGGCEEECCCTTCEE
T ss_pred             EEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEccceeeee
Confidence            99999999 67999887654 35699999999999999999999999999999999999998   578999999999987


Q ss_pred             cCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ...........||+.|+|||++.+.++.++|||||||++|||++|..||.+...   ...+.....  +......+++++
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~l  281 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYL--PPEFTAGLSSEL  281 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCC--CHHHHTTSCHHH
T ss_pred             cccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCC--CcccccCCCHHH
Confidence            765555566789999999999998889999999999999999999777654322   223322221  112234688999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      .+||.+||+.||++|||+.|+|+||||+.
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          282 RSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999999975

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.5e-52  Score=405.35  Aligned_cols=262  Identities=34%  Similarity=0.621  Sum_probs=226.9

Q ss_pred             cccceee--ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           94 FDRRYTI--GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        94 ~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ....|.+  .+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+|+.|. ||||+++++++.+.+.
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND  160 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence            3445555  678999999999999999999999999997643   235678999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      ++|||||++|++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||+... .++.+||+|||++..
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARR  238 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET-TTTEEEECCCSSCEE
T ss_pred             EEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC-CCCcEEEEeCCCcee
Confidence            99999999999999988643 3468999999999999999999999999999999999999632 467899999999988


Q ss_pred             cCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ..........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++...++.++++
T Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  318 (373)
T 2x4f_A          239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE  318 (373)
T ss_dssp             CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred             cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence            7766666677899999999988654 578999999999999999999999999888888888887776666667789999


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.1e-52  Score=396.17  Aligned_cols=262  Identities=26%  Similarity=0.436  Sum_probs=207.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.+++.+++|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEE
Confidence            579999999999999999999999999999999975532  223467789999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          176 MELCEGGELLDRILAKK----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      |||++ ++|.+++....    ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc---CCCCEEECcCcccee
Confidence            99997 59998885542    24589999999999999999999999999999999999998   578999999999987


Q ss_pred             cCCC-CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-------
Q 015026          252 IKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-------  321 (414)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------  321 (414)
                      .... ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+.........       
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            6432 33446689999999998865  4688999999999999999999999988877766665442111100       


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          322 -----------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       322 -----------------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                                             .....+++++.+||.+||+.||++|||+.|+|+||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                   0112578899999999999999999999999999999975443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.4e-52  Score=390.44  Aligned_cols=258  Identities=28%  Similarity=0.449  Sum_probs=212.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+ .+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence            4799999999999999999998 6799999999865432 1223467889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        79 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIP  153 (288)
T ss_dssp             EECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHCC-
T ss_pred             EEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEeECccccccCcc
Confidence            999975 888877543 35799999999999999999999999999999999999998   5789999999999765432


Q ss_pred             -CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-----------
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (414)
                       ......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+.........           
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence             23345689999999998864  3688999999999999999999999988776666655432111000           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          322 --------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       322 --------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                    ...+.+++++.+||.+||..||++|||+.|+|+||||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                          0123578999999999999999999999999999999853

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-52  Score=404.69  Aligned_cols=257  Identities=33%  Similarity=0.527  Sum_probs=205.1

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++++.||+|+||+||+|.+..+|+.||||++.....    ..+.+.+|+.+++.+. ||||+++++++.+.+.+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEEE
Confidence            4689999999999999999999999999999999976543    2356789999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++....
T Consensus        94 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           94 IMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC-----
T ss_pred             EEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccccc
Confidence            99999999999988543  469999999999999999999999999999999999999831 234599999999986544


Q ss_pred             CCccccCCCCCccccchhcccc-CC-CCcchhHHHHHHHHHhhCCCCCCCCCchhhh----HHHhhcCCCCCCCCCCCCC
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRK-SG-PESDVWSIGVITYILLCGRRPFWDKTEDGIF----KEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s  328 (414)
                      .......+||+.|+|||++.+. ++ .++|||||||++|+|++|+.||.+......+    ..+......++  ....++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  248 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP--DDIRIS  248 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--TTSCCC
T ss_pred             cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--CcCCCC
Confidence            4445567899999999987654 33 4489999999999999999999876554333    33333333222  234689


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +++.+||.+||..||.+|||+.|+++||||...
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999999999754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3.7e-52  Score=424.14  Aligned_cols=258  Identities=26%  Similarity=0.467  Sum_probs=225.1

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|+.+. |||||++++++.+.+.+|+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEEE
Confidence            357999999999999999999999999999999997653322234567889999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld---~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe---CCCCeEEEecccceeccc
Confidence            99999999999998665555699999999999999999999999999999999999998   578999999999988766


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCc----hhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      .......+||+.|+|||++.+ .++.++|||||||++|||++|..||.+...    ..+...+......++    ..+|+
T Consensus       339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s~  414 (576)
T 2acx_A          339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSP  414 (576)
T ss_dssp             TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCCH
Confidence            666667899999999998876 468999999999999999999999987643    334444444433332    46899


Q ss_pred             HHHHHHHHhhcCCccccC-----CHHHHhCCccccc
Q 015026          330 SAKDFVKKLLVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      ++.+||.+||+.||.+||     +++|+++||||+.
T Consensus       415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            999999999999999999     8999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2e-51  Score=388.37  Aligned_cols=264  Identities=33%  Similarity=0.627  Sum_probs=233.7

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC------ChHhHHHHHHHHHHHHHccCCCCceEEEEEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI------LPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~------~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~  166 (414)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++......      .....+.+.+|+.+++.+.+||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            4557899999999999999999999999999999999754311      1123567889999999997799999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      ...+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~df  168 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDF  168 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc---CCCcEEEecc
Confidence            9999999999999999999998543  5789999999999999999999999999999999999998   5789999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhcc-------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK-------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |++.............||+.|+|||++.       ..++.++||||||+++|+|++|..||.+.........+......+
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            9998876666666778999999999874       235788999999999999999999999888888888888877766


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +...++.+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            666667899999999999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.1e-52  Score=396.85  Aligned_cols=259  Identities=33%  Similarity=0.600  Sum_probs=216.8

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.++|++++.||+|+||+||+|.+..+++.||||++......  ...+.+.+|+.+++.+. ||||+++++++.+++..+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            456899999999999999999999999999999998754321  23467889999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||++|++|.+++  .....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        82 lv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           82 LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEECE
T ss_pred             EEEEcCCCCcHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---CCCCEEEEEeeccceec
Confidence            999999999999987  4455799999999999999999999999999999999999998   57899999999997653


Q ss_pred             CC---CccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhh-hHHHhhcCCCCCCCCCCCC
Q 015026          254 PG---KKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       254 ~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~  327 (414)
                      ..   ......+||+.|+|||++.+..  +.++|||||||++|+|++|..||.+...... +........  ....+..+
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~  234 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKI  234 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGS
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccC
Confidence            22   2234678999999999986543  6689999999999999999999987655433 222222221  22334678


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ++++.+||.+||..||.+|||+.|+++||||....
T Consensus       235 ~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            99999999999999999999999999999998643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-52  Score=409.34  Aligned_cols=261  Identities=33%  Similarity=0.496  Sum_probs=209.2

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--C
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--N  170 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~  170 (414)
                      .+.++|++++.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+|+.+.+||||+++++++..+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            34568999999999999999999999999999999986542 23446677889999999997799999999999754  4


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .+|+||||++ ++|.+.+..   ..+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||+|+
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGLSR  157 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred             EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc---CCCCEEecCCcccc
Confidence            7999999997 588888744   4689999999999999999999999999999999999998   57899999999997


Q ss_pred             ccCC----------------------CCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCch
Q 015026          251 FIKP----------------------GKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED  306 (414)
Q Consensus       251 ~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~  306 (414)
                      ....                      .......+||+.|+|||++.+  .++.++|||||||++|||++|++||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            6532                      112345689999999998865  4688999999999999999999999998877


Q ss_pred             hhhHHHhhcCCCCC--------------------------C-----------------CCCCCCCHHHHHHHHHhhcCCc
Q 015026          307 GIFKEVLRNKPDFR--------------------------R-----------------KPWPSISNSAKDFVKKLLVKDP  343 (414)
Q Consensus       307 ~~~~~i~~~~~~~~--------------------------~-----------------~~~~~~s~~~~~li~~~L~~dp  343 (414)
                      +.+..+........                          .                 .....+++++.+||.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            76666653211100                          0                 0122678999999999999999


Q ss_pred             cccCCHHHHhCCcccccc
Q 015026          344 RARLTAAQALSHPWVREG  361 (414)
Q Consensus       344 ~~Rps~~elL~hp~f~~~  361 (414)
                      .+|||++|+|+||||+..
T Consensus       318 ~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIF  335 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTT
T ss_pred             ccCCCHHHHhCCHHHHHh
Confidence            999999999999999754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3e-52  Score=416.89  Aligned_cols=257  Identities=29%  Similarity=0.512  Sum_probs=216.4

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.+. ||||+++++++.+.+.+++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEEE
Confidence            367999999999999999999999999999999997654333345567789999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||||++||+|.+++...  ..+++..++.++.||+.||.|||+ .||+||||||+|||++   .++.+||+|||+|+...
T Consensus       226 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~---~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             EECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC---SSSCEEECCCCCCCTTC
T ss_pred             EEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC---CCCCEEEccCCCceecc
Confidence            99999999999988543  579999999999999999999998 9999999999999998   57899999999997643


Q ss_pred             -CCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          254 -PGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       254 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                       ........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+...+...+......++    ..+++++
T Consensus       301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~  376 (446)
T 4ejn_A          301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEA  376 (446)
T ss_dssp             C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHH
Confidence             3334557899999999998765 468899999999999999999999999888888888887765544    3688999


Q ss_pred             HHHHHHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          332 KDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      .+||.+||..||.+||     |++|+|+||||...
T Consensus       377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            9999999999999999     99999999999863

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.6e-52  Score=399.95  Aligned_cols=261  Identities=28%  Similarity=0.447  Sum_probs=224.7

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..+...+|++++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. ||||+++++++.+++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           49 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH  127 (348)
T ss_dssp             CSCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             ccchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence            3445577999999999999999999999999999999997665444456678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||+. |+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~  202 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSAS  202 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCB
T ss_pred             eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCce
Confidence            9999999997 5888877543 35799999999999999999999999999999999999998   57899999999997


Q ss_pred             ccCCCCccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          251 FIKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ....   ....+||+.|+|||++.    +.++.++|||||||++|+|++|+.||.+.+..+.+..+.......  .....
T Consensus       203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  277 (348)
T 1u5q_A          203 IMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGH  277 (348)
T ss_dssp             SSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTT
T ss_pred             ecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCC
Confidence            6543   24568999999999873    456889999999999999999999998887766666666554321  22246


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +++.+.+||.+||+.||++|||+.++|+||||....
T Consensus       278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            789999999999999999999999999999998643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.5e-52  Score=389.65  Aligned_cols=264  Identities=41%  Similarity=0.728  Sum_probs=235.1

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.++|++++.||+|+||.||+|.+..+++.||||++...... ....+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEE
Confidence            446799999999999999999999999999999998765432 23567889999999999 4999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||+++++|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+||+++..+.+..+||+|||++....
T Consensus        98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999999999988554  468999999999999999999999999999999999999865556789999999998776


Q ss_pred             CCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .........||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+......++...+..+++++.+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            55555566789999999999888899999999999999999999999998888888888877766665556789999999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ||.+||..||.+|||+.++|+||||+..
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.6e-52  Score=413.86  Aligned_cols=265  Identities=36%  Similarity=0.633  Sum_probs=215.7

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC-----hHhHHHHHHHHHHHHHccCCCCceEEEEEE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----PIAVEDVKREVKILQALAGHENVVKFYNAF  166 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~~hpnIv~~~~~~  166 (414)
                      ..+.++|.+.+.||+|+||+||+|.+..+++.||||++.+.....     ......+.+|+.+|+.+ +||||+++++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  209 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF  209 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence            445678999999999999999999999999999999997643221     12233578999999999 599999999998


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      .. +..++||||+++|+|.+++  .....+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+||
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGT--SSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             ec-CceEEEEEcCCCCcHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence            65 4589999999999999887  34567999999999999999999999999999999999999986555667999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhhcCCCCCC
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRR  321 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~  321 (414)
                      |+++...........+||+.|+|||++.    ..++.++|||||||++|+|++|..||.+.... .....+......+..
T Consensus       287 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~  366 (419)
T 3i6u_A          287 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  366 (419)
T ss_dssp             STTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred             ccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence            9998876665566789999999999875    34567899999999999999999999876544 344455555555544


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ..++.+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus       367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            455678999999999999999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.1e-52  Score=415.48  Aligned_cols=261  Identities=29%  Similarity=0.432  Sum_probs=198.3

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----  168 (414)
                      .+.++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+|+.+. |||||++++++..    
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcc
Confidence            34578999999999999999999999999999999986542 33456678999999999995 9999999999843    


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                       ...+|+||||+ +++|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~~~~kl~DFG  201 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN---QDCSVKVCDFG  201 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECCCT
T ss_pred             cCceEEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC---CCCCEeecccc
Confidence             36799999998 568988883  446799999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCC----------------------------ccccCCCCCccccchhc-c-ccCCCCcchhHHHHHHHHHhh--
Q 015026          248 LSDFIKPGK----------------------------KFQDIVGSAYYVAPEVL-K-RKSGPESDVWSIGVITYILLC--  295 (414)
Q Consensus       248 ~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~ellt--  295 (414)
                      +|+......                            .....+||++|+|||++ . ..++.++||||||||+|||++  
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            998754221                            23456899999999975 3 347899999999999999998  


Q ss_pred             ---------CCCCCCCCCc--------------------hhhhHHHhh-----------------------cCCC----C
Q 015026          296 ---------GRRPFWDKTE--------------------DGIFKEVLR-----------------------NKPD----F  319 (414)
Q Consensus       296 ---------g~~Pf~~~~~--------------------~~~~~~i~~-----------------------~~~~----~  319 (414)
                               |++||.+.+.                    .+.+..+..                       ..+.    .
T Consensus       282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (458)
T 3rp9_A          282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD  361 (458)
T ss_dssp             TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred             cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence                     7777766431                    111111111                       0000    0


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ....++.+++++.+||.+||..||.+|||++|+|+||||+..
T Consensus       362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            112245679999999999999999999999999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-51  Score=400.46  Aligned_cols=265  Identities=23%  Similarity=0.350  Sum_probs=222.0

Q ss_pred             CccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc----CCCCceEEE
Q 015026           88 FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA----GHENVVKFY  163 (414)
Q Consensus        88 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~----~hpnIv~~~  163 (414)
                      +.....+.++|++++.||+|+||+||+|.+..+++.||||++...    ....+.+..|+.+++.+.    +||||++++
T Consensus        27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            444456778999999999999999999999999999999998643    235667788999999995    499999999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec--------
Q 015026          164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA--------  235 (414)
Q Consensus       164 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~--------  235 (414)
                      +++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++..        
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~  181 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT  181 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence            9999999999999999 8999999977766679999999999999999999999999999999999999731        


Q ss_pred             --------------CCCCCceeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCC
Q 015026          236 --------------KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPF  300 (414)
Q Consensus       236 --------------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf  300 (414)
                                    ..++.+||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             EECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             hhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence                          1377899999999986543  2346789999999998765 4689999999999999999999999


Q ss_pred             CCCCchhhhHHHhhcCCCCCC---------------------CCCC---------------------CCCHHHHHHHHHh
Q 015026          301 WDKTEDGIFKEVLRNKPDFRR---------------------KPWP---------------------SISNSAKDFVKKL  338 (414)
Q Consensus       301 ~~~~~~~~~~~i~~~~~~~~~---------------------~~~~---------------------~~s~~~~~li~~~  338 (414)
                      .+....+.+..+......++.                     ..|+                     ..++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            887776665555433221110                     0011                     1236788999999


Q ss_pred             hcCCccccCCHHHHhCCcccc
Q 015026          339 LVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       339 L~~dp~~Rps~~elL~hp~f~  359 (414)
                      |+.||.+|||+.|+|+||||+
T Consensus       340 L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGGGC
T ss_pred             hcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999995

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.5e-51  Score=393.67  Aligned_cols=257  Identities=27%  Similarity=0.511  Sum_probs=213.9

Q ss_pred             ccceeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCC-ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .++|++.+.||+|+||+||+|++.   .+|+.||+|++.+.... .......+.+|+.+|+.+. ||||+++++++...+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence            357999999999999999999985   68999999999765322 1224566789999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .+|+||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCK  169 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTSCEEECCCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---CCCcEEEEeCCccc
Confidence            999999999999999988543  5689999999999999999999999999999999999998   57899999999987


Q ss_pred             ccCC-CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          251 FIKP-GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       251 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++    +.++
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~  245 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLT  245 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence            6432 233456789999999998765 468899999999999999999999999888888888887765443    3688


Q ss_pred             HHHHHHHHHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          329 NSAKDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      +++.+||.+||..||.+||     ++.++++||||+..
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            9999999999999999999     89999999999853

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-51  Score=385.87  Aligned_cols=258  Identities=29%  Similarity=0.577  Sum_probs=222.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEEE
Confidence            57999999999999999999999999999999986543322234567899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++......
T Consensus        88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---TTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---CCCCEEEEeccccccCCcc
Confidence            9999999999988544  5689999999999999999999999999999999999998   5789999999998655433


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                       ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+......++    ..+++++.+|
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  237 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL  237 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence             23456899999999988765 58899999999999999999999998888888877776654443    3588999999


Q ss_pred             HHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      |.+||..||.+|||+.|+|+||||+.....
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCccC
Confidence            999999999999999999999999875543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.4e-51  Score=395.72  Aligned_cols=263  Identities=25%  Similarity=0.403  Sum_probs=210.9

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++..... .....+.+.+|+.+++.+. ||||+++++++.+++.++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEE
Confidence            44689999999999999999999999999999999975542 2234566789999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec--CCCCCceeeccccccc
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA--KEDSSLKATDFGLSDF  251 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~--~~~~~vkl~DFG~a~~  251 (414)
                      +||||++| +|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++..  ...+.+||+|||++..
T Consensus       110 lv~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            99999975 99998854  3569999999999999999999999999999999999999632  1355699999999987


Q ss_pred             cCCC-CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCC---
Q 015026          252 IKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP---  325 (414)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~---  325 (414)
                      .... ......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+...........|+   
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            6432 33445688999999998865  36899999999999999999999999888777766665432221111111   


Q ss_pred             -----------------------CCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          326 -----------------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       326 -----------------------~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                             .+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                                   167899999999999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-52  Score=399.30  Aligned_cols=262  Identities=26%  Similarity=0.418  Sum_probs=212.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++.....  ......+.+|+.+++.+. ||||+++++++.+++..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence            479999999999999999999999999999999865431  112223457999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             EECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---TTCCEEECSSSEEECC---
T ss_pred             ecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---CCCCEEEccCcccccccCC
Confidence            99997 5888887543 45699999999999999999999999999999999999998   5789999999999765432


Q ss_pred             -CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCC---------
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP---------  323 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------  323 (414)
                       ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+...........         
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             23345689999999998765  358899999999999999999999998887777666655322222221         


Q ss_pred             -----------------CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          324 -----------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       324 -----------------~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                                       .+.+++++.+||.+||+.||.+|||++|+|+||||.......
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence                             235788999999999999999999999999999999765543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-52  Score=401.11  Aligned_cols=269  Identities=35%  Similarity=0.637  Sum_probs=226.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCC--CChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .+.++|++.+.||+|+||+||+|.+..+++.||+|++.....  ......+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  101 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhccCC
Confidence            456789999999999999999999999999999999875421  12345678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc--------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 015026          171 YVYIAMELCEGGELLDRILAKK--------------------------------------DSRYTEKDAAVVVRQMLRVA  212 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qil~~L  212 (414)
                      ..++||||++||+|.+++....                                      ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            9999999999999999873100                                      11246788899999999999


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-----ccccCCCCCccccchhccc---cCCCCcchh
Q 015026          213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGSAYYVAPEVLKR---KSGPESDVW  284 (414)
Q Consensus       213 ~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~Diw  284 (414)
                      .|||+.||+||||||+|||++.+ ....+||+|||++.......     ......||+.|+|||++.+   .++.++|||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            99999999999999999999831 23489999999997653211     2345689999999998863   468899999


Q ss_pred             HHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          285 SIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       285 slG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ||||++|+|++|+.||.+....+....+......+....+..+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            9999999999999999999888888888888777766666678999999999999999999999999999999987543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-51  Score=413.09  Aligned_cols=258  Identities=28%  Similarity=0.444  Sum_probs=209.4

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+|+.+ +||||+++++++...    
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccc
Confidence            4568999999999999999999999999999999997643 2344667889999999999 499999999999654    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        ..+||||||+++ +|.+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       138 ~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---~~~~~kl~DFG  209 (464)
T 3ttj_A          138 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  209 (464)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCC
T ss_pred             cCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---CCCCEEEEEEE
Confidence              468999999976 5666662    3489999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC--------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------  318 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------  318 (414)
                      +|+...........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......        
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             CC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9988776656677899999999998765 5688999999999999999999999988876666665442111        


Q ss_pred             --------------CCCCCCC----C------------CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          319 --------------FRRKPWP----S------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       319 --------------~~~~~~~----~------------~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                    +....++    .            .++++.+||.+||..||.+|||++|+|+||||+..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                          1110000    0            14678999999999999999999999999999853

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-51  Score=394.36  Aligned_cols=265  Identities=37%  Similarity=0.640  Sum_probs=219.6

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC-----ChHhHHHHHHHHHHHHHccCCCCceEEEEEE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----LPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~  166 (414)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++......     .......+.+|+.+|+.+ +||||+++++++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~   84 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF   84 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEE
Confidence            34567899999999999999999999999999999998654321     112334578999999999 599999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      ..+. .++||||+++++|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+||
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             cCCc-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            8766 899999999999999884  4567999999999999999999999999999999999999986545567999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhhcCCCCCC
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRR  321 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~  321 (414)
                      |++.............||+.|+|||++.    ..++.++|||||||++|+|++|..||.+.... .+...+......+..
T Consensus       162 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T 2ycf_A          162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  241 (322)
T ss_dssp             TTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred             ccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence            9998776554445668999999999873    34688999999999999999999999876544 344445555444433


Q ss_pred             CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ..+..+++++.+||.+||..||.+|||+.++|+||||+.
T Consensus       242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            344678999999999999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.3e-51  Score=400.26  Aligned_cols=256  Identities=27%  Similarity=0.498  Sum_probs=212.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccC-CCCceEEEEEEEcCCEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG-HENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~-hpnIv~~~~~~~~~~~~~l  174 (414)
                      .+|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|+.|.. ||||+++++++..++.++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            469999999999999999999765 89999999976543 34567889999999999963 6999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||| +.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++.....
T Consensus       134 v~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC--
T ss_pred             EEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccC
Confidence            999 5688999988543  4789999999999999999999999999999999999996    47899999999987643


Q ss_pred             CC---ccccCCCCCccccchhccc------------cCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhhcCCC
Q 015026          255 GK---KFQDIVGSAYYVAPEVLKR------------KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPD  318 (414)
Q Consensus       255 ~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~  318 (414)
                      ..   .....+||+.|+|||++.+            .++.++|||||||++|+|++|+.||.+.... ..+..+......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            32   2345689999999999864            4678899999999999999999999875432 444555544332


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +..  ....++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       287 ~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          287 IEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCC--CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            222  224578999999999999999999999999999998643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-50  Score=381.48  Aligned_cols=264  Identities=31%  Similarity=0.534  Sum_probs=231.0

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ....++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCE
Confidence            34557899999999999999999999999999999999876655566778899999999999 59999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||++|++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~  164 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK  164 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc---CCCCEEEEeccCcee
Confidence            99999999999999987543  5799999999999999999999999999999999999998   578999999999987


Q ss_pred             cCC-CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          252 IKP-GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       252 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ... ........||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+.+..+......++    ..+++
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  240 (294)
T 2rku_A          165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINP  240 (294)
T ss_dssp             CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCH
T ss_pred             cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCH
Confidence            643 2334456899999999988654 58899999999999999999999988887777777766544333    36889


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      ++.+||.+||..||++|||+.++++||||.......
T Consensus       241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence            999999999999999999999999999998765443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-50  Score=402.53  Aligned_cols=263  Identities=29%  Similarity=0.493  Sum_probs=209.1

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC---
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~---  169 (414)
                      .+.++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+|+.+. ||||+++++++...   
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCC
Confidence            35578999999999999999999999999999999997542 33456678999999999995 99999999999765   


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        ..+|+||||+. ++|.+++.  ....+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||
T Consensus       101 ~~~~~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~~kL~DFG  174 (432)
T 3n9x_A          101 KFDELYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVCDFG  174 (432)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCT
T ss_pred             cCCeEEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC---CCCCEEEccCC
Confidence              67999999996 59999884  446799999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCC-----------------------ccccCCCCCccccchhc-c-ccCCCCcchhHHHHHHHHHhhC------
Q 015026          248 LSDFIKPGK-----------------------KFQDIVGSAYYVAPEVL-K-RKSGPESDVWSIGVITYILLCG------  296 (414)
Q Consensus       248 ~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~elltg------  296 (414)
                      +|+......                       .....+||++|+|||++ . ..++.++|||||||++|||++|      
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            998764322                       23567899999999985 3 3478899999999999999984      


Q ss_pred             -----CCCCCCCCc-----------------hhhhHHHh-----------------------hcCCCCCC----CCCCCC
Q 015026          297 -----RRPFWDKTE-----------------DGIFKEVL-----------------------RNKPDFRR----KPWPSI  327 (414)
Q Consensus       297 -----~~Pf~~~~~-----------------~~~~~~i~-----------------------~~~~~~~~----~~~~~~  327 (414)
                           .++|.+.+.                 ...+..+.                       ...+....    ..++.+
T Consensus       255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
T 3n9x_A          255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI  334 (432)
T ss_dssp             SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred             ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence                 444433321                 11111111                       11111111    013568


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ++++.+||.+||..||.+|||++|+|+||||+....
T Consensus       335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            999999999999999999999999999999997543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.9e-51  Score=387.69  Aligned_cols=261  Identities=28%  Similarity=0.477  Sum_probs=214.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEEE
Confidence            57999999999999999999999999999999986654 23445677889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++.  ....+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        81 ~e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           81 FEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             EECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC--
T ss_pred             EEeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---CCCCEEEeeCCCchhccCc
Confidence            99999988888763  345799999999999999999999999999999999999998   5789999999999876533


Q ss_pred             -CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC--------------
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------  318 (414)
                       ......+||+.|+|||++.+  .++.++||||||+++|+|++|..||.+....+....+......              
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence             33346689999999998864  4588999999999999999999999888766555444321100              


Q ss_pred             -----CCCC--------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          319 -----FRRK--------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       319 -----~~~~--------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                           .+..        .++.+++++.+||.+||..||.+|||++|+|+||||+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence                 0000        12468899999999999999999999999999999997544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.9e-51  Score=384.46  Aligned_cols=265  Identities=36%  Similarity=0.651  Sum_probs=225.4

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC---hHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.......   ....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCCe
Confidence            467999999999999999999999999999999987654321   124678999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC-CCCCceeecccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSD  250 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DFG~a~  250 (414)
                      .++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++..+ ....+||+|||++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999998543  4689999999999999999999999999999999999998422 23389999999998


Q ss_pred             ccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          251 FIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......++...++.+++
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            7766555566789999999998865 468899999999999999999999998888777777776655554444567899


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .+.+||.+||..||.+|||+.++|+||||+...
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            999999999999999999999999999998643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-50  Score=389.44  Aligned_cols=265  Identities=32%  Similarity=0.540  Sum_probs=232.2

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      +....++|.+++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  114 (335)
T 2owb_A           36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND  114 (335)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence            4455678999999999999999999999999999999998766555667788999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLAT  189 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred             eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc---CCCCEEEeeccCce
Confidence            999999999999999987543  5799999999999999999999999999999999999998   57899999999998


Q ss_pred             ccCC-CCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          251 FIKP-GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       251 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      .... ........||+.|+|||++.+. ++.++||||||+++|+|++|..||......+.+..+......++    ..++
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~  265 (335)
T 2owb_A          190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHIN  265 (335)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred             ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCC
Confidence            7643 2334457899999999987654 58899999999999999999999988877777777766654433    3678


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      +++.+||.+||..||.+|||+.|+|+||||+......
T Consensus       266 ~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence            9999999999999999999999999999998764433

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.7e-51  Score=430.06  Aligned_cols=256  Identities=25%  Similarity=0.449  Sum_probs=229.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+.........+.+..|..+|..+.+||+|+.+++++.+.+.+|||
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999997643322334567889999999887799999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc-CC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~-~~  254 (414)
                      |||++||+|.+++...  +.+++..++.|+.||+.||.|||++||+||||||+||||+   .++.+||+|||+|+.. ..
T Consensus       421 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~---~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC---SSSCEEECCCTTCEECCCT
T ss_pred             EeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc---CCCcEEEeecceeeccccC
Confidence            9999999999998544  5799999999999999999999999999999999999998   5789999999999863 33


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .......+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+++..+......++.    .+++++.+
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~  571 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVA  571 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHH
T ss_pred             CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHH
Confidence            444567899999999998864 5689999999999999999999999999999999999987766553    68999999


Q ss_pred             HHHHhhcCCccccCCH-----HHHhCCccccc
Q 015026          334 FVKKLLVKDPRARLTA-----AQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rps~-----~elL~hp~f~~  360 (414)
                      ||.+||+.||.+||++     +|+++||||+.
T Consensus       572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            9999999999999998     99999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.1e-51  Score=393.29  Aligned_cols=263  Identities=27%  Similarity=0.434  Sum_probs=220.4

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc------
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------  168 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~------  168 (414)
                      .++|++++.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.+++.+. ||||+++++++..      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence            36899999999999999999999999999999998665432 223456789999999995 9999999999876      


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                        .+.+++||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~kl~Df  168 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADF  168 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCC
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCCEEEccc
Confidence              4578999999975 777777443 35699999999999999999999999999999999999998   5789999999


Q ss_pred             ccccccCC-----CCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          247 GLSDFIKP-----GKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       247 G~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |++.....     .......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.........+......+
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99976542     223345689999999998865  36889999999999999999999999988877777766544444


Q ss_pred             CCCCCCCC----------------------------CHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCC
Q 015026          320 RRKPWPSI----------------------------SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (414)
Q Consensus       320 ~~~~~~~~----------------------------s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~  364 (414)
                      +...++.+                            ++++.+||.+||+.||.+|||+.|+|+||||+.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            44443332                            6789999999999999999999999999999865443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.5e-51  Score=381.12  Aligned_cols=258  Identities=34%  Similarity=0.594  Sum_probs=216.3

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+. ||||+++++++.+.+..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEEE
Confidence            367999999999999999999999999999999987543222234567899999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.....
T Consensus        89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---TTSCEEECCCCGGGCCCC
T ss_pred             EEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---CCCCEEEeecccccccCC
Confidence            99999999999998544  4689999999999999999999999999999999999998   578999999999987765


Q ss_pred             CCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ........||+.|+|||++.+..  +.++||||||+++|+|++|..||.+.........+......++    ..+++++.
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~  239 (276)
T 2h6d_A          164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVA  239 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHH
Confidence            55555678999999999987654  5789999999999999999999988877777777766544332    35789999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +||.+||+.||.+|||+.++++||||+...
T Consensus       240 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          240 TLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence            999999999999999999999999998643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.8e-51  Score=414.06  Aligned_cols=257  Identities=27%  Similarity=0.460  Sum_probs=223.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.+. ||||+++++++.+.+.+|+|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEEEE
Confidence            57999999999999999999999999999999997654322234567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          176 MELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      |||++||+|.+++....  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~---~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe---CCCCEEEeecceeeecc
Confidence            99999999999886543  35699999999999999999999999999999999999998   68899999999998765


Q ss_pred             CCCc-cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc----hhhhHHHhhcCCCCCCCCCCCC
Q 015026          254 PGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       254 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      .... ....+||+.|+|||++.+. ++.++|||||||++|||++|..||.+...    .++...+......++    +.+
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~~  416 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKF  416 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----ccc
Confidence            4433 3456999999999988764 68999999999999999999999987643    445566666554443    468


Q ss_pred             CHHHHHHHHHhhcCCccccCC-----HHHHhCCccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      |+++.+||.+||+.||.+||+     ++++++||||+.
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            999999999999999999995     589999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.2e-51  Score=381.51  Aligned_cols=259  Identities=30%  Similarity=0.576  Sum_probs=225.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEEE
Confidence            57999999999999999999999999999999986543222224567899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---CCCCEEEecccccccCccc
Confidence            9999999999988554  4689999999999999999999999999999999999998   5789999999998765432


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                       ......||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+......++    +.+++++.+|
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  242 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDL  242 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHH
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHH
Confidence             23456899999999988754 68899999999999999999999988887777777776554433    4688999999


Q ss_pred             HHHhhcCCccccCCHHHHhCCcccccccCCC
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f~~~~~~~  365 (414)
                      |.+||..||.+|||+.++++||||+......
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~  273 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRV  273 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence            9999999999999999999999999755443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.3e-50  Score=384.14  Aligned_cols=256  Identities=30%  Similarity=0.532  Sum_probs=221.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ..|...+.||+|+||.||+|.+..+|+.||||++.....   ...+.+.+|+.+++.+. ||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEE
Confidence            358888899999999999999999999999999975542   24567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++|++|.+++.   ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++......
T Consensus       121 ~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~  194 (321)
T 2c30_A          121 MEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKD  194 (321)
T ss_dssp             ECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSS
T ss_pred             EecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCcEEEeeeeeeeecccC
Confidence            99999999999873   34699999999999999999999999999999999999998   5789999999999776443


Q ss_pred             -CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 -KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                       ......+||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+....+....... ......+++++.+
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~  273 (321)
T 2c30_A          195 VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRD  273 (321)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHH
T ss_pred             ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHH
Confidence             233567899999999988654 6889999999999999999999998887777776666543321 1123457899999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ||.+||..||++|||+.++|+||||....
T Consensus       274 li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          274 FLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            99999999999999999999999998643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-50  Score=395.44  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=213.9

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC---
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~---  169 (414)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.+. ||||+++++++...   
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL   99 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCcc
Confidence            35578999999999999999999999999999999986543 23445678899999999995 99999999999765   


Q ss_pred             ---CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          170 ---NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       170 ---~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                         ..+|+||||+ |++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Df  172 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDF  172 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCC
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc---CCCCEEEEee
Confidence               3569999999 8899988744   4689999999999999999999999999999999999998   5789999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC-------
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-------  317 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-------  317 (414)
                      |+++....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+.....       
T Consensus       173 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          173 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99987543  3456789999999998765  578999999999999999999999998877666555543211       


Q ss_pred             ----------------CCCC----CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          318 ----------------DFRR----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       318 ----------------~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                      ....    ..++..++++.+||.+||..||.+|||+.|+|+||||+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                            1111    123567899999999999999999999999999999987543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-50  Score=379.40  Aligned_cols=258  Identities=34%  Similarity=0.609  Sum_probs=197.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEEE
Confidence            46999999999999999999999999999999997543222234577899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---TTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEEeecceeeccCC
Confidence            9999999999988543 35789999999999999999999999999999999999998   5789999999999875432


Q ss_pred             -CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 -KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                       .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||........+..+......    ....++.++.+
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  241 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE----MPSFLSIEAKD  241 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC----CCTTSCHHHHH
T ss_pred             CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC----CccccCHHHHH
Confidence             223456899999999987654 588999999999999999999999877665555544433222    22358899999


Q ss_pred             HHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          334 FVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ||.+||..||.+|||+.++|+||||....
T Consensus       242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999999998643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.6e-51  Score=392.14  Aligned_cols=265  Identities=27%  Similarity=0.430  Sum_probs=222.1

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-  170 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-  170 (414)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.+. ||||+++++++.... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP   86 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEET
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCC
Confidence            456678999999999999999999999999999999998766555666778999999999995 999999999987543 


Q ss_pred             ---EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                         ..|+||||++|++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg  161 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFG  161 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCS
T ss_pred             CCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeecc
Confidence               459999999999999988543  5799999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCC----ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC
Q 015026          248 LSDFIKPGK----KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (414)
Q Consensus       248 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~  322 (414)
                      ++.......    .....+||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+....+.......+..
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  241 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence            997654322    22346799999999987654 5888999999999999999999999888877777777665544444


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ..+.+++++.+||.+||..||.+||++.++|.|+|++...
T Consensus       242 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            4567899999999999999999999999999999998543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.4e-50  Score=376.91  Aligned_cols=257  Identities=21%  Similarity=0.353  Sum_probs=217.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----CCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----~~~  171 (414)
                      ..|++.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+++.+. ||||+++++++..    ...
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCce
Confidence            458999999999999999999999999999999876543 3456788999999999995 9999999998865    467


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      +++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.|  |+||||||+|||++.  .++.+||+|||++
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGG
T ss_pred             EEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeCCCc
Confidence            99999999999999998543  56899999999999999999999999  999999999999973  4779999999999


Q ss_pred             cccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchh-hhHHHhhcCCCCCCCCCCCCC
Q 015026          250 DFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      ...... ......||+.|+|||++.+.++.++||||||+++|+|++|..||.+..... ....+......  .......+
T Consensus       180 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~  256 (290)
T 1t4h_A          180 TLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAI  256 (290)
T ss_dssp             GGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCC
T ss_pred             cccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--cccCCCCC
Confidence            765433 334568999999999999889999999999999999999999998755543 33333333211  11223567


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +++.+||.+||..||.+|||+.++|+||||++.
T Consensus       257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            899999999999999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-50  Score=402.84  Aligned_cols=263  Identities=27%  Similarity=0.395  Sum_probs=217.7

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc-----CCCCceEEEEEE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-----GHENVVKFYNAF  166 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----~hpnIv~~~~~~  166 (414)
                      +.+..+|++++.||+|+||+||+|.+..+++.||||++...    ....+.+.+|+.+++.++     +|+||+++++++
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            44667899999999999999999999999999999999653    235567889999999884     477999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC--ceee
Q 015026          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS--LKAT  244 (414)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~--vkl~  244 (414)
                      ...+.+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.   ++.  +||+
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~---~~~~~vkL~  244 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ---QGRSGIKVI  244 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESS---TTSCCEEEC
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcc---CCCcceEEe
Confidence            99999999999995 69999997776677999999999999999999999999999999999999983   444  9999


Q ss_pred             ccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC---
Q 015026          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR---  320 (414)
Q Consensus       245 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---  320 (414)
                      |||+|.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.......+   
T Consensus       245 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          245 DFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL  322 (429)
T ss_dssp             CCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            9999976543  3346789999999998765 478999999999999999999999998887666555443210000   


Q ss_pred             -----------------C------------------------------C-----CCCCCCHHHHHHHHHhhcCCccccCC
Q 015026          321 -----------------R------------------------------K-----PWPSISNSAKDFVKKLLVKDPRARLT  348 (414)
Q Consensus       321 -----------------~------------------------------~-----~~~~~s~~~~~li~~~L~~dp~~Rps  348 (414)
                                       .                              .     .....++++.+||.+||+.||++|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                             0                              0     00123778999999999999999999


Q ss_pred             HHHHhCCcccccccCC
Q 015026          349 AAQALSHPWVREGGDA  364 (414)
Q Consensus       349 ~~elL~hp~f~~~~~~  364 (414)
                      +.|+|+||||+.....
T Consensus       403 a~e~L~Hpw~~~~~~~  418 (429)
T 3kvw_A          403 PGQALRHPWLRRRLPK  418 (429)
T ss_dssp             HHHHHTSTTTC-----
T ss_pred             HHHHhCChhhccCCCC
Confidence            9999999999975443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.4e-51  Score=392.71  Aligned_cols=254  Identities=31%  Similarity=0.565  Sum_probs=216.9

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh-----HhHHHHHHHHHHHHHccCCCCceEEEEEE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----IAVEDVKREVKILQALAGHENVVKFYNAF  166 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~~hpnIv~~~~~~  166 (414)
                      ..+.++|++.+.||+|+||+||+|.+..+|+.||||++........     ...+.+.+|+.+|+.+. ||||+++++++
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~   98 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIF   98 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            3466789999999999999999999999999999999976543221     13345678999999995 99999999999


Q ss_pred             EcCCEEEEEEeccCCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          167 EDDNYVYIAMELCEGG-ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       167 ~~~~~~~lv~e~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      .+.+.+++||||+.+| +|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~D  173 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLID  173 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECC
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcEEEee
Confidence            9999999999999766 9998884  445799999999999999999999999999999999999998   578999999


Q ss_pred             cccccccCCCCccccCCCCCccccchhcccc-C-CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCC
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  323 (414)
                      ||++............+||+.|+|||++.+. + +.++|||||||++|+|++|..||.....      .....    ...
T Consensus       174 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~----~~~  243 (335)
T 3dls_A          174 FGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAA----IHP  243 (335)
T ss_dssp             CTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTC----CCC
T ss_pred             cccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhc----cCC
Confidence            9999887766666678899999999988754 3 6789999999999999999999965321      11111    112


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ...+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus       244 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            23588999999999999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3e-50  Score=387.65  Aligned_cols=267  Identities=34%  Similarity=0.608  Sum_probs=194.3

Q ss_pred             ccccceeece-eeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc---
Q 015026           93 DFDRRYTIGK-LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED---  168 (414)
Q Consensus        93 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~---  168 (414)
                      .+.++|.+.+ .||+|+||+||+|.+..+|+.||||++....        ...+|+..+..+.+||||+++++++..   
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            4567899965 6999999999999999999999999986531        123344443333369999999999876   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                       ...+++||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             5568999999999999999977666679999999999999999999999999999999999999865557789999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhh----hHHHhhcCCCCCCC
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGI----FKEVLRNKPDFRRK  322 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~----~~~i~~~~~~~~~~  322 (414)
                      ++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......    ...+......++..
T Consensus       177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            99765432 3346689999999998754 457899999999999999999999977655433    33333444445555


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCC
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP  368 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~  368 (414)
                      .+..+++++.+||.+||..||.+|||+.|+|+||||+........+
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~  301 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP  301 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCB
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCc
Confidence            6678999999999999999999999999999999998765444433

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-50  Score=394.89  Aligned_cols=257  Identities=27%  Similarity=0.473  Sum_probs=214.1

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-----  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-----  168 (414)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++......       ..+|+.+++.+. ||||+++++++..     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeecCccc
Confidence            346899999999999999999999999999999998754321       247999999995 9999999999843     


Q ss_pred             ---------------------------------CCEEEEEEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHH
Q 015026          169 ---------------------------------DNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAA  213 (414)
Q Consensus       169 ---------------------------------~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~  213 (414)
                                                       ...+++||||++| +|.+.+..  .....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             3458999999974 87776643  34567999999999999999999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHH
Q 015026          214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITY  291 (414)
Q Consensus       214 ~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~  291 (414)
                      |||++||+||||||+|||++.  .++.+||+|||+|............+||+.|+|||++.+  .++.++|||||||++|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            999999999999999999974  467899999999988766666667889999999998765  3688999999999999


Q ss_pred             HHhhCCCCCCCCCchhhhHHHhhcCC------------CC-----CC---C-----CCCCCCHHHHHHHHHhhcCCcccc
Q 015026          292 ILLCGRRPFWDKTEDGIFKEVLRNKP------------DF-----RR---K-----PWPSISNSAKDFVKKLLVKDPRAR  346 (414)
Q Consensus       292 elltg~~Pf~~~~~~~~~~~i~~~~~------------~~-----~~---~-----~~~~~s~~~~~li~~~L~~dp~~R  346 (414)
                      +|++|+.||.+.+..+.+..++....            .+     +.   .     ....+++++.+||.+||..||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999999998887776666553211            11     10   0     113478899999999999999999


Q ss_pred             CCHHHHhCCcccccc
Q 015026          347 LTAAQALSHPWVREG  361 (414)
Q Consensus       347 ps~~elL~hp~f~~~  361 (414)
                      ||+.|+|+||||+..
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-50  Score=390.13  Aligned_cols=262  Identities=27%  Similarity=0.397  Sum_probs=213.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC--hHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL--PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.......  ....+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCce
Confidence            467999999999999999999999999999999986543211  112346789999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        88 ~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTT
T ss_pred             EEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc---CCCCEEEEecccceec
Confidence            999999976 88877743 335689999999999999999999999999999999999998   5789999999999876


Q ss_pred             CCC-CccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCC------
Q 015026          253 KPG-KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP------  323 (414)
Q Consensus       253 ~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------  323 (414)
                      ... ......+||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+.+..+.+..+...........      
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            432 334567899999999988643  57889999999999999999999998887777777655322111111      


Q ss_pred             ------------------CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          324 ------------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       324 ------------------~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                        ++.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                              135678999999999999999999999999999998754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.1e-50  Score=384.40  Aligned_cols=254  Identities=26%  Similarity=0.504  Sum_probs=212.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--CCEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYV  172 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~~~  172 (414)
                      .++|++++.||+|+||+||+|.+..+|+.||||++...      ..+.+.+|+.+++.+.+||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            36799999999999999999999999999999998643      346789999999999779999999999987  6789


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++++|.+++     ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++..+||+|||++...
T Consensus       109 ~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEEECCCCCCHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCEEC
T ss_pred             EEEEeccCchhHHHHH-----HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCceEc
Confidence            9999999999998876     24899999999999999999999999999999999999983  3348999999999887


Q ss_pred             CCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHHHh-------------hcC
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVL-------------RNK  316 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~i~-------------~~~  316 (414)
                      .........+||+.|+|||++.+  .++.++|||||||++|+|++|..||..... .+.+..+.             ...
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            76666677789999999998765  468899999999999999999999955432 22211111             111


Q ss_pred             CCC--------------------CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          317 PDF--------------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       317 ~~~--------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ...                    .......+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            000                    011112378999999999999999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.2e-50  Score=393.34  Aligned_cols=266  Identities=24%  Similarity=0.365  Sum_probs=219.4

Q ss_pred             CccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCC-----ceEE
Q 015026           88 FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-----VVKF  162 (414)
Q Consensus        88 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpn-----Iv~~  162 (414)
                      +...+.+.++|++.+.||+|+||+||+|.+..+|+.||||++...    ......+.+|+.+++.+..|++     |+.+
T Consensus        46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            344556778999999999999999999999999999999999643    2356778889999998865664     9999


Q ss_pred             EEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEEeecCCCCC
Q 015026          163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH--LHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       163 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH--~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                      ++++...+..++||||++ ++|.+++.......+++..++.++.||+.||.|||  +.||+||||||+|||++. ..++.
T Consensus       122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~  199 (382)
T 2vx3_A          122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSA  199 (382)
T ss_dssp             EEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCC
T ss_pred             eeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCc
Confidence            999999999999999996 59999997766567999999999999999999999  579999999999999963 14678


Q ss_pred             ceeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       241 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      +||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus       200 ~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  277 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP  277 (382)
T ss_dssp             EEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             EEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999999987643  3356789999999998875 46899999999999999999999999888776666654421110


Q ss_pred             C------------------CCCC--------------C---C-------------------------CCHHHHHHHHHhh
Q 015026          320 R------------------RKPW--------------P---S-------------------------ISNSAKDFVKKLL  339 (414)
Q Consensus       320 ~------------------~~~~--------------~---~-------------------------~s~~~~~li~~~L  339 (414)
                      +                  ...|              +   .                         .++++.+||.+||
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  357 (382)
T 2vx3_A          278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML  357 (382)
T ss_dssp             CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred             CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence            0                  0000              0   0                         0136899999999


Q ss_pred             cCCccccCCHHHHhCCcccccc
Q 015026          340 VKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       340 ~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +.||++|||+.|+|+||||+..
T Consensus       358 ~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          358 DYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CSCTTTSCCHHHHTTSGGGCC-
T ss_pred             CCChhhCCCHHHHhcCcccccC
Confidence            9999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.7e-50  Score=379.04  Aligned_cols=264  Identities=26%  Similarity=0.398  Sum_probs=220.1

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .+.+.++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDD   84 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSS
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCC
Confidence            4456789999999999999999999999999999999997665555667788999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .+++||||++|++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAK  159 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCSSST
T ss_pred             eEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEEeCCCcc
Confidence            999999999999999988543  5799999999999999999999999999999999999998   57899999999998


Q ss_pred             ccCCCC--ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC-CCCCCCCCC
Q 015026          251 FIKPGK--KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-DFRRKPWPS  326 (414)
Q Consensus       251 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~  326 (414)
                      ......  .....+||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+.......... .......+.
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T 4eqm_A          160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD  239 (294)
T ss_dssp             TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred             ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccC
Confidence            654332  23356799999999987764 58889999999999999999999988877665555444332 222233457


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +|+.+.++|.+||..||.+||+..+.+.+.|..-
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            8999999999999999999997777777777653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-49  Score=372.47  Aligned_cols=261  Identities=22%  Similarity=0.340  Sum_probs=215.4

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ...+.++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.++..+.+||||+++++++.+++
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            344667899999999999999999999999999999998765432 2356778899999999956999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC------------
Q 015026          171 YVYIAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK------------  236 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~------------  236 (414)
                      ..++||||++|++|.+++....  ...+++..++.++.||+.||.|||++||+||||||+|||++..+            
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            9999999999999999986542  25689999999999999999999999999999999999998433            


Q ss_pred             ----CCCCceeeccccccccCCCCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhH
Q 015026          237 ----EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFK  310 (414)
Q Consensus       237 ----~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~  310 (414)
                          ....+||+|||++......   ....||+.|+|||++.+..  +.++|||||||++|+|++|.+|+....   ...
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~  238 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWH  238 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHH
T ss_pred             cccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHH
Confidence                4557999999999876543   2346999999999987653  468999999999999999998875432   333


Q ss_pred             HHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      .+.....   ......+++++.+||.+||..||.+|||+.++|+||||...
T Consensus       239 ~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          239 EIRQGRL---PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHTTCC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHcCCC---CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            4444332   12224689999999999999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=380.28  Aligned_cols=264  Identities=27%  Similarity=0.500  Sum_probs=218.8

Q ss_pred             ccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           89 GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        89 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      .......++|++++.||+|+||.||+|.+..+|+.||||++.....    ..+.+.+|+.+++.+.+||||+++++++..
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            3344566789999999999999999999999999999999875432    346788999999999669999999999976


Q ss_pred             ------CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          169 ------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       169 ------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                            .+.+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~---~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc---CCCCEE
Confidence                  56899999999999999999766556799999999999999999999999999999999999998   578999


Q ss_pred             eeccccccccCCC-CccccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhc
Q 015026          243 ATDFGLSDFIKPG-KKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN  315 (414)
Q Consensus       243 l~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~  315 (414)
                      |+|||++...... .......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+.........+...
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  249 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  249 (326)
T ss_dssp             ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence            9999998765432 2234568999999999875      34688999999999999999999999887766666555544


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          316 KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       316 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ..  +......+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus       250 ~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          250 PA--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             CC--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cc--ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            32  122234688999999999999999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.2e-50  Score=386.41  Aligned_cols=259  Identities=26%  Similarity=0.430  Sum_probs=213.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEEE
Confidence            579999999999999999999999999999999865542 3445677889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++  .....+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++......
T Consensus       103 ~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          103 FEFVDHTILDDLE--LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EECCSEEHHHHHH--HSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCTTC------
T ss_pred             EecCCcchHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---CCCcEEEEeCCCceeecCC
Confidence            9999998887765  3345799999999999999999999999999999999999998   5789999999999765432


Q ss_pred             -CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC--------------
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------  318 (414)
                       ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+......              
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence             33455689999999998876  4688999999999999999999999888766555444321100              


Q ss_pred             -----CCC--------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          319 -----FRR--------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       319 -----~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                           .+.        ..++.+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                 000        0124678999999999999999999999999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-50  Score=392.78  Aligned_cols=257  Identities=27%  Similarity=0.520  Sum_probs=214.5

Q ss_pred             cceeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCC-ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ++|++++.||+|+||+||+|++.   .+|+.||||++...... .....+.+.+|+.+|+.+.+||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            57999999999999999999984   58999999998653211 112335567899999999779999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCcEEEeeCCCCee
Confidence            99999999999999998554  4699999999999999999999999999999999999998   578999999999976


Q ss_pred             cCCC--CccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCCch----hhhHHHhhcCCCCCCC
Q 015026          252 IKPG--KKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEVLRNKPDFRRK  322 (414)
Q Consensus       252 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~  322 (414)
                      ....  ......+||+.|+|||++.+   .++.++|||||||++|+|++|..||......    .+...+....+.+   
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  285 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---  285 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC---
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC---
Confidence            5322  22335689999999999874   2578899999999999999999999765433    2333444443332   


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                       .+.+++.+.+||.+||..||.+||     |++++++||||...
T Consensus       286 -~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          286 -PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             -CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence             346889999999999999999999     99999999999853

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5e-49  Score=373.13  Aligned_cols=276  Identities=26%  Similarity=0.456  Sum_probs=231.5

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .+..+.|++++.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.+ +||||+++++++.+...
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCe
Confidence            3455789999999999999999999999999999999976543  23567899999999999 59999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||++|++|.+++.   ...+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++..
T Consensus        95 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQ  168 (303)
T ss_dssp             EEEEEECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---CCCCEEEeeccccee
Confidence            999999999999999873   35799999999999999999999999999999999999998   578999999999977


Q ss_pred             cCCCC-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          252 IKPGK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       252 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ..... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+......   .....+++
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  245 (303)
T 3a7i_A          169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSK  245 (303)
T ss_dssp             CBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCH
T ss_pred             cCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCH
Confidence            65432 23456899999999987654 588999999999999999999999887776666666554322   22346889


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCCHHHHHHHHHHh
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFV  381 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~  381 (414)
                      ++.+||.+||..||.+|||+.++++||||........  ...+.++.++++.
T Consensus       246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~--~~~~~~~~~~~~~  295 (303)
T 3a7i_A          246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS--YLTELIDRYKRWK  295 (303)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGG--GGHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCccH--HHHHHHHHHHHhh
Confidence            9999999999999999999999999999986544332  2234445555443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-50  Score=383.99  Aligned_cols=262  Identities=23%  Similarity=0.389  Sum_probs=215.6

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC--
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~--  170 (414)
                      ...++|++.+.||+|+||+||+|.+..+|+.||||++......  ...+.+.+|+.+++.+. ||||+++++++....  
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCc
Confidence            3557899999999999999999999999999999999754422  24567789999999995 999999999998654  


Q ss_pred             EEEEEEeccCCCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec-CCCCCceeecccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGL  248 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DFG~  248 (414)
                      ..++||||++|++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||+... ..++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            78999999999999999865432 339999999999999999999999999999999999998321 2466799999999


Q ss_pred             ccccCCCCccccCCCCCccccchhcc---------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCc----hhhhHHHhhc
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLK---------RKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRN  315 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~i~~~  315 (414)
                      +............+||+.|+|||++.         ..++.++|||||||++|+|++|..||.....    .+.+..+...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            98877666667788999999999875         4568899999999999999999999975433    3445555544


Q ss_pred             CCCC-------------------CC--CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcc
Q 015026          316 KPDF-------------------RR--KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       316 ~~~~-------------------~~--~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~  357 (414)
                      .+..                   +.  .....+++.+.+||.+||+.||++|||++|+|+||-
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            3311                   10  011124557889999999999999999999999874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=384.29  Aligned_cols=257  Identities=26%  Similarity=0.483  Sum_probs=208.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEEEEEEcCCEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~~~~~~~~~~  173 (414)
                      .++|++++.||+|+||+||+|.+ .+++.||||++..... .....+.+.+|+.+|+.+..| |||+++++++.+++.++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            45799999999999999999987 5689999999976543 345668899999999999622 99999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +|||+ .+++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++....
T Consensus        86 lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC-
T ss_pred             EEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccC
Confidence            99995 58899999854  45799999999999999999999999999999999999997    5679999999998764


Q ss_pred             CCCc---cccCCCCCccccchhcc------------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhhcCC
Q 015026          254 PGKK---FQDIVGSAYYVAPEVLK------------RKSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKP  317 (414)
Q Consensus       254 ~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~  317 (414)
                      ....   ....+||+.|+|||++.            +.++.++|||||||++|+|++|+.||.+.... ..+..+.....
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  238 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  238 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence            3322   23568999999999875            34577899999999999999999999765432 23333333222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .  .......++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       239 ~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          239 E--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             C--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             c--cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            1  122234678899999999999999999999999999998643

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.4e-50  Score=391.07  Aligned_cols=257  Identities=28%  Similarity=0.448  Sum_probs=204.7

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC---
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~---  170 (414)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+   
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeeccccccc
Confidence            4468999999999999999999999999999999997543 23445678899999999995 999999999997654   


Q ss_pred             ---EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                         ..++||||+++ +|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       101 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg  172 (371)
T 2xrw_A          101 EFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  172 (371)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCCC
T ss_pred             cccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEEEee
Confidence               78999999975 7888773    3589999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC--------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------  318 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~--------  318 (414)
                      ++............+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......        
T Consensus       173 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          173 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             C----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            99876655455567899999999987654 688999999999999999999999988776666665543211        


Q ss_pred             --------------CCCCC---------CCC-------CCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          319 --------------FRRKP---------WPS-------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       319 --------------~~~~~---------~~~-------~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                                    +....         .+.       .++++.+||.+||..||.+|||++|+|+||||+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                          10000         000       1467899999999999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-49  Score=394.51  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=212.1

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-----  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-----  168 (414)
                      ...+|++.+.||+|+||+||+|.+..+|+.||||++.....       ...+|+.+|+.|. |||||+++++|..     
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence            34579999999999999999999999999999999865432       2347999999995 9999999998843     


Q ss_pred             -CCEEEEEEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          169 -DNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                       ...+++||||+++ +|.+.+..  .....+++..++.++.||+.||.|||++||+||||||+|||++.  +.+.+||+|
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl~D  200 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCD  200 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEECC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEecc
Confidence             2347799999975 66665532  34567999999999999999999999999999999999999984  345789999


Q ss_pred             cccccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhc--------
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--------  315 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~--------  315 (414)
                      ||+++...........+||+.|+|||++.+  .++.++|||||||++|||++|+.||.+.+..+.+.+++..        
T Consensus       201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987765555567789999999998864  4688999999999999999999999988776666555431        


Q ss_pred             ----CCCCCCC-------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          316 ----KPDFRRK-------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       316 ----~~~~~~~-------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                          .+.+...             ..+.+++++.+||.+||..||.+|||+.|+|+||||....
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                1111110             1135688999999999999999999999999999998653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.3e-50  Score=389.52  Aligned_cols=260  Identities=29%  Similarity=0.465  Sum_probs=217.8

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +.++|++++.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+|+.+. ||||+++++++...    
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTT
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCccc
Confidence            3468999999999999999999999999999999987532  3445678899999999995 99999999999654    


Q ss_pred             -CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                       ...++||||+. ++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus       102 ~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~  174 (364)
T 3qyz_A          102 MKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGL  174 (364)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred             cceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---CCCCEEEEeCcc
Confidence             47999999997 589888743   4699999999999999999999999999999999999998   578999999999


Q ss_pred             ccccCCCCc----cccCCCCCccccchhccc-c-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC--
Q 015026          249 SDFIKPGKK----FQDIVGSAYYVAPEVLKR-K-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR--  320 (414)
Q Consensus       249 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--  320 (414)
                      +........    ....+||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+....+.+..+........  
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            986543221    345689999999998643 3 68899999999999999999999998887776666543211110  


Q ss_pred             ---------------------CC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          321 ---------------------RK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       321 ---------------------~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                           ..    ..+.+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                                 00    12467899999999999999999999999999999997533

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-49  Score=371.91  Aligned_cols=259  Identities=33%  Similarity=0.591  Sum_probs=219.2

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence            34679999999999999999999999999999999875542  235678899999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||+++++|.+++  .....+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++....
T Consensus        82 lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           82 LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEECE
T ss_pred             EEEEecCCCcHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc---cCCCEEEeeCCCccccC
Confidence            999999999999887  4445799999999999999999999999999999999999998   57899999999997653


Q ss_pred             CC---CccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchh-hhHHHhhcCCCCCCCCCCCC
Q 015026          254 PG---KKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       254 ~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ..   .......||+.|+|||++.+..  +.++||||||+++|+|++|..||.+..... .+..+......  ...++.+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  234 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKI  234 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGS
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhc
Confidence            22   2234568999999999987543  568999999999999999999998765543 33333332221  2234578


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ++++.+||.+||..||.+|||+.|+++||||+...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            99999999999999999999999999999998643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.7e-50  Score=392.51  Aligned_cols=260  Identities=31%  Similarity=0.488  Sum_probs=201.7

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC---
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~---  169 (414)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.+. ||||+++++++...   
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL  103 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCcc
Confidence            34578999999999999999999999999999999986543 23446678889999999995 99999999998654   


Q ss_pred             ---CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          170 ---NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       170 ---~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                         ..+++|+|++ +++|.+++..   ..+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+||
T Consensus       104 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kL~DF  176 (367)
T 2fst_X          104 EEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDF  176 (367)
T ss_dssp             GGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECC-
T ss_pred             ccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC---CCCCEEEeec
Confidence               5689999999 7899887733   5799999999999999999999999999999999999998   5789999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC-------
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-------  317 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-------  317 (414)
                      |+++....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+.....       
T Consensus       177 G~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          177 GLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99987543  2345789999999998765  568899999999999999999999998877666555543211       


Q ss_pred             ----------------CCCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          318 ----------------DFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       318 ----------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                      ..+..    .++..++++.+||.+||..||.+|||+.|+|+||||.....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                            11111    12457889999999999999999999999999999986533

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.8e-51  Score=399.36  Aligned_cols=251  Identities=19%  Similarity=0.236  Sum_probs=204.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEE-------EE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFY-------NA  165 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~-------~~  165 (414)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+.  +|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            468999999999999999999999999999999998655445556788999995555443  599999998       77


Q ss_pred             EEcCC-----------------EEEEEEeccCCCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015026          166 FEDDN-----------------YVYIAMELCEGGELLDRILAKKD-----SRYTEKDAAVVVRQMLRVAAECHLHGLVHR  223 (414)
Q Consensus       166 ~~~~~-----------------~~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qil~~L~~LH~~~iiHr  223 (414)
                      +.+++                 ..||||||+ +|+|.+++.....     ..+++..+..++.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            76654                 289999999 6799999865321     122347888899999999999999999999


Q ss_pred             CCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCccccchhcccc------------CCCCcchhHHHHHHH
Q 015026          224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK------------SGPESDVWSIGVITY  291 (414)
Q Consensus       224 Dlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------~~~~~DiwslG~il~  291 (414)
                      ||||+|||++   .++.+||+|||+|+...  ......+| +.|+|||++.+.            ++.++|||||||++|
T Consensus       231 Dikp~NIll~---~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          231 YLRPVDIVLD---QRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CCCGGGEEEC---TTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEc---CCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999998   57899999999998643  24456788 999999988654            688999999999999


Q ss_pred             HHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       292 elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +|++|+.||.+.........+...        ++.+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHSSCCC------CCSGGGGSS--------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhhhh--------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            999999999877666555555432        2468899999999999999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.3e-50  Score=385.27  Aligned_cols=256  Identities=26%  Similarity=0.429  Sum_probs=206.2

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC---
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~---  170 (414)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++....  .....+.+.+|+.+|+.+. ||||++++++|.+..   
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence            3467999999999999999999999999999999997544  2345678999999999995 999999999885543   


Q ss_pred             ------------------------------------------------------EEEEEEeccCCCChHHHHHhccC-CC
Q 015026          171 ------------------------------------------------------YVYIAMELCEGGELLDRILAKKD-SR  195 (414)
Q Consensus       171 ------------------------------------------------------~~~lv~e~~~gg~L~~~l~~~~~-~~  195 (414)
                                                                            ..++||||++|++|.+++..... ..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999865432 23


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC-------------ccccCC
Q 015026          196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-------------KFQDIV  262 (414)
Q Consensus       196 l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~-------------~~~~~~  262 (414)
                      .++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......             .....+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            56667899999999999999999999999999999998   57899999999998765432             223467


Q ss_pred             CCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcC
Q 015026          263 GSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK  341 (414)
Q Consensus       263 gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  341 (414)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..|+...  ......+.....   ...+...++++.+||.+||+.
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKF---PLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCC---CHHHHHHCHHHHHHHHHHHCS
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCC---CcccccCChhHHHHHHHHccC
Confidence            9999999998765 4688999999999999999997775221  122222222211   111234567889999999999


Q ss_pred             CccccCCHHHHhCCccccc
Q 015026          342 DPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       342 dp~~Rps~~elL~hp~f~~  360 (414)
                      ||.+|||+.|+|+||||+.
T Consensus       313 ~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCC
T ss_pred             CCCcCCCHHHHhhchhhhc
Confidence            9999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-50  Score=397.69  Aligned_cols=262  Identities=26%  Similarity=0.420  Sum_probs=196.5

Q ss_pred             cccceee-ceeeeecCceEEEEEEEC--CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE--c
Q 015026           94 FDRRYTI-GKLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--D  168 (414)
Q Consensus        94 ~~~~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~--~  168 (414)
                      +.+.|++ +++||+|+||+||+|.+.  .+++.||||++.....     ...+.+|+.+|+.|. ||||+++++++.  .
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEEEEETT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeEEecCC
Confidence            4456887 558999999999999976  5788999999975432     246789999999995 999999999995  4


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec-CCCCC
Q 015026          169 DNYVYIAMELCEGGELLDRILAKK-------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSS  240 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~-------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~  240 (414)
                      ...+++||||+. ++|.+.+....       ...+++..++.++.||+.||.|||++||+||||||+|||+... ..++.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence            778999999996 58888774321       2349999999999999999999999999999999999999532 25789


Q ss_pred             ceeeccccccccCCC----CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCch--------
Q 015026          241 LKATDFGLSDFIKPG----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED--------  306 (414)
Q Consensus       241 vkl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------  306 (414)
                      +||+|||+|+.....    ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....        
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999999876432    23345789999999998865  3688999999999999999999999765542        


Q ss_pred             -hhhHHHhhcCCCCCCCCCC----------------------------------CCCHHHHHHHHHhhcCCccccCCHHH
Q 015026          307 -GIFKEVLRNKPDFRRKPWP----------------------------------SISNSAKDFVKKLLVKDPRARLTAAQ  351 (414)
Q Consensus       307 -~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~li~~~L~~dp~~Rps~~e  351 (414)
                       +.+..+...........|+                                  ..++++.+||.+||..||.+|||++|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence             3333333322111111121                                  22678999999999999999999999


Q ss_pred             HhCCccccccc
Q 015026          352 ALSHPWVREGG  362 (414)
Q Consensus       352 lL~hp~f~~~~  362 (414)
                      +|+||||....
T Consensus       331 ~L~hp~f~~~~  341 (405)
T 3rgf_A          331 AMQDPYFLEDP  341 (405)
T ss_dssp             HHTSGGGTSSS
T ss_pred             HhcChhhccCC
Confidence            99999998753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-49  Score=391.41  Aligned_cols=258  Identities=29%  Similarity=0.438  Sum_probs=210.8

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      ...+|++.+.||+|+||+||+|++..+++ ||+|++......       ..+|+.+++.+. ||||+++++++...    
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEEESSSS
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEecCCCC
Confidence            45689999999999999999999987776 888887654321       236999999995 99999999998543    


Q ss_pred             --CEEEEEEeccCCCChHHHHH--hccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          170 --NYVYIAMELCEGGELLDRIL--AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~--~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                        ..+++||||+++ ++...+.  ......+++..++.++.||+.||.|||++||+||||||+|||++.  .++.+||+|
T Consensus       109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~~kL~D  185 (394)
T 4e7w_A          109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVLKLID  185 (394)
T ss_dssp             SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECC
T ss_pred             CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CCCcEEEee
Confidence              348899999976 4444432  223467999999999999999999999999999999999999983  478899999


Q ss_pred             cccccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC------
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP------  317 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~------  317 (414)
                      ||+|+...........+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+.....      
T Consensus       186 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             CTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999988766666667889999999998865  468899999999999999999999998887666665544210      


Q ss_pred             -----------CCCC--------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          318 -----------DFRR--------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       318 -----------~~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                 .++.        ...+.+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                       0110        012347899999999999999999999999999999987543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.2e-49  Score=378.00  Aligned_cols=265  Identities=26%  Similarity=0.372  Sum_probs=219.6

Q ss_pred             cccceeeceeeeecCceEEEEEEEC-CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEE---
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDK-ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFE---  167 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~---  167 (414)
                      ..++|++++.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+.  +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4468999999999999999999995 678899999987543211 12234567888887773  5999999999987   


Q ss_pred             --cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          168 --DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       168 --~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                        .....++||||++ |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~---~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc---CCCCEEEec
Confidence              5678999999997 5999998766666799999999999999999999999999999999999998   578999999


Q ss_pred             cccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC-----
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-----  319 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----  319 (414)
                      ||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.......     
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            999987654444556789999999998764 46889999999999999999999999888776666665321100     


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          320 ------------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       320 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                        ....++.+++++.+||.+||..||.+|||+.++|+||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                              01123468899999999999999999999999999999987543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=376.89  Aligned_cols=261  Identities=26%  Similarity=0.482  Sum_probs=220.2

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC-ChHhHHHHHHHHHHHHHccCCCCceEEEEEEE--cCC
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFE--DDN  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~--~~~  170 (414)
                      +.++|++++.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.+++.+. ||||+++++++.  +..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence            346899999999999999999999999999999998654311 1234678899999999995 999999999984  456


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||++++ |.+.+.......+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---CCCcEEeecccccc
Confidence            899999999876 77777666667899999999999999999999999999999999999998   57899999999997


Q ss_pred             ccCC---CCccccCCCCCccccchhcccc---CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          251 FIKP---GKKFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       251 ~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      ....   ........||+.|+|||++.+.   .+.++||||||+++|+|++|..||.+....+....+......++    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----  233 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----  233 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence            7542   2223456799999999998753   26789999999999999999999998887777777776654333    


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ..+++++.+||.+||..||.+|||+.++++||||+....
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            368899999999999999999999999999999987544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.6e-50  Score=391.48  Aligned_cols=259  Identities=17%  Similarity=0.179  Sum_probs=200.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc-CCCCceEEE-------EEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-GHENVVKFY-------NAFE  167 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-~hpnIv~~~-------~~~~  167 (414)
                      ..|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.|. +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45999999999999999999999999999999998866545556778889977776664 499988865       4554


Q ss_pred             cC-----------------CEEEEEEeccCCCChHHHHHhccCCCCCHHHH------HHHHHHHHHHHHHHHHcCCeecC
Q 015026          168 DD-----------------NYVYIAMELCEGGELLDRILAKKDSRYTEKDA------AVVVRQMLRVAAECHLHGLVHRD  224 (414)
Q Consensus       168 ~~-----------------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~------~~i~~qil~~L~~LH~~~iiHrD  224 (414)
                      ..                 ..++|||||++ |+|.+++.... ..+++..+      ..++.||+.||.|||++||+|||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            33                 34899999998 79999986542 23444445      67779999999999999999999


Q ss_pred             CCCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCC
Q 015026          225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFW  301 (414)
Q Consensus       225 lkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~  301 (414)
                      |||+|||++   .++.+||+|||+|+.....  .....||+.|+|||++.+   .++.++|||||||++|+|++|+.||.
T Consensus       220 ikp~NIll~---~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFIM---PDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEEC---TTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEEC---CCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            999999998   5789999999999876432  224567799999999864   46889999999999999999999997


Q ss_pred             CCCchh--hhHH---HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          302 DKTEDG--IFKE---VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       302 ~~~~~~--~~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +.....  .+..   .......+....++.+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            764321  1111   11122233333446889999999999999999999999999999999853

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=378.30  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=213.1

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCC---EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..++|++.+.||+|+||+||+|.+..+|+   .||||++....  .....+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            34689999999999999999999986665   49999987543  3446678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||++|++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++.
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSR  199 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCSSCE
T ss_pred             ccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC---CCCCEEECCCCccc
Confidence            999999999999999988543 35799999999999999999999999999999999999998   57899999999998


Q ss_pred             ccCCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          251 FIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       251 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      .......    .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+.....   ....
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~  276 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR---LPAP  276 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---CCCC
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC---CCCC
Confidence            7643321    223456788999998864 46889999999999999999 9999999888888777766532   2223


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+++++.+||.+||..||.+|||+.++++
T Consensus       277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            478999999999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.6e-49  Score=369.99  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=199.8

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+..+...++.+ +||||+++++++.+++..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEEE
Confidence            3579999999999999999999999999999999865432 122333344444456666 59999999999999999999


Q ss_pred             EEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          175 AMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      ||||++| +|.+++..  .....+++..++.++.||+.||.|||++ ||+||||||+||+++   .++.+||+|||++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC---TTCCEEBCCC-----
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecCCccc
Confidence            9999975 88777643  2456799999999999999999999998 999999999999998   578999999999987


Q ss_pred             cCCCCccccCCCCCccccchhcc-----ccCCCCcchhHHHHHHHHHhhCCCCCCCCC-chhhhHHHhhcCCCCCCCCCC
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLK-----RKSGPESDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      ...........||+.|+|||++.     ..++.++||||||+++|+|++|..||.... ....+........  +.....
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  237 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQLPAD  237 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCCCTT
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCcccc
Confidence            76555555668999999999863     235778999999999999999999997643 3333444433322  122234


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            6899999999999999999999999999999998643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.3e-49  Score=390.81  Aligned_cols=266  Identities=23%  Similarity=0.372  Sum_probs=214.5

Q ss_pred             cCccccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc-------CCCCc
Q 015026           87 DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-------GHENV  159 (414)
Q Consensus        87 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-------~hpnI  159 (414)
                      .+...+.+.++|++.+.||+|+||+||+|++..+|+.||||++...    ....+.+.+|+.+++.+.       +||||
T Consensus        28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i  103 (397)
T 1wak_A           28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMV  103 (397)
T ss_dssp             SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred             EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence            3445566778999999999999999999999999999999998643    345678899999999995       27889


Q ss_pred             eEEEEEEE----cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEee
Q 015026          160 VKFYNAFE----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKS  234 (414)
Q Consensus       160 v~~~~~~~----~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~  234 (414)
                      +++++++.    ....+++||||+ +++|.+.+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus       104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~  182 (397)
T 1wak_A          104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV  182 (397)
T ss_dssp             CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred             eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence            99999987    567899999999 67888888776667899999999999999999999998 9999999999999984


Q ss_pred             cC----------------------------------------------CCCCceeeccccccccCCCCccccCCCCCccc
Q 015026          235 AK----------------------------------------------EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV  268 (414)
Q Consensus       235 ~~----------------------------------------------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~  268 (414)
                      .+                                              ....+||+|||++.....  .....+||+.|+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~  260 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYR  260 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGC
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCccc
Confidence            21                                              113799999999987643  244568999999


Q ss_pred             cchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchh------hhHHHhhcCCCCC---------------------
Q 015026          269 APEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDG------IFKEVLRNKPDFR---------------------  320 (414)
Q Consensus       269 aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~i~~~~~~~~---------------------  320 (414)
                      |||++.+. ++.++|||||||++|+|++|+.||.+.+..+      .+..+.......+                     
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            99987654 6889999999999999999999997655322      1122211000000                     


Q ss_pred             ---C--------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          321 ---R--------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       321 ---~--------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                         .              ......++++.+||.+||+.||++|||+.|+|+||||+
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence               0              00012345688999999999999999999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.5e-49  Score=376.33  Aligned_cols=264  Identities=27%  Similarity=0.386  Sum_probs=217.5

Q ss_pred             ccccccceeeceeeeecCceEEEEEEE-CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCC------CceEEE
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATD-KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE------NVVKFY  163 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hp------nIv~~~  163 (414)
                      .+.+.++|++.+.||+|+||+||+|.+ ..+|+.||||++...    ....+.+.+|+.+++.+. |+      +|++++
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~~   83 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQML   83 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEeee
Confidence            445667999999999999999999998 568899999998643    245677899999999985 55      599999


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC------
Q 015026          164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE------  237 (414)
Q Consensus       164 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~------  237 (414)
                      +++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++....      
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999999 889999997766667999999999999999999999999999999999999984211      


Q ss_pred             ----------CCCceeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch
Q 015026          238 ----------DSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED  306 (414)
Q Consensus       238 ----------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~  306 (414)
                                ++.+||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                      56899999999986543  2346689999999998765 4688999999999999999999999887766


Q ss_pred             hhhHHHhhcCCCCCC----------------CCC------------------------CCCCHHHHHHHHHhhcCCcccc
Q 015026          307 GIFKEVLRNKPDFRR----------------KPW------------------------PSISNSAKDFVKKLLVKDPRAR  346 (414)
Q Consensus       307 ~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~dp~~R  346 (414)
                      +....+.......+.                ..|                        ...++++.+||.+||..||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            554443322111110                001                        1234678899999999999999


Q ss_pred             CCHHHHhCCccccccc
Q 015026          347 LTAAQALSHPWVREGG  362 (414)
Q Consensus       347 ps~~elL~hp~f~~~~  362 (414)
                      ||+.|+|+||||+...
T Consensus       321 pt~~ell~hp~f~~~~  336 (339)
T 1z57_A          321 ITLREALKHPFFDLLK  336 (339)
T ss_dssp             CCHHHHTTSGGGGGGG
T ss_pred             cCHHHHhcCHHHHHHh
Confidence            9999999999998643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.5e-49  Score=383.50  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=215.5

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++....  .....+.+.+|+.+++.+. ||||+++++++.+++..+
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCEEE
Confidence            3467999999999999999999999999999999987653  3456778999999999994 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      +||||++|++|.+++...  ..+++..+..++.||+.||.|||+. ||+||||||+|||++   .++.+||+|||++...
T Consensus       108 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCHHH
T ss_pred             EEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---CCCCEEEEECCCCccc
Confidence            999999999999998543  4689999999999999999999996 999999999999998   5789999999998754


Q ss_pred             CCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHH--------------------
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE--------------------  311 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~--------------------  311 (414)
                      ... ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+....                    
T Consensus       183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          183 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             HHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            322 23456899999999988754 68899999999999999999999977654432211                    


Q ss_pred             ----------------------HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          312 ----------------------VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       312 ----------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                            +.....  +......+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                                  111111  1112235788999999999999999999999999999998644

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.4e-49  Score=384.63  Aligned_cols=256  Identities=32%  Similarity=0.507  Sum_probs=212.9

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE-
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV-  172 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~-  172 (414)
                      +.++|.+.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+.. 
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSST
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCcc
Confidence            5578999999999999999999999999999999987543 23445678899999999995 99999999999877654 


Q ss_pred             -----EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          173 -----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       173 -----~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                           ++||||+. ++|.+.+    ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~Dfg  189 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFG  189 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECSTT
T ss_pred             cceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC---CCCCEEEEecC
Confidence                 99999997 5887765    34599999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC-------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD-------  318 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-------  318 (414)
                      ++.....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+......       
T Consensus       190 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          190 LARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            9986543  3345689999999998865  5689999999999999999999999988776666555432111       


Q ss_pred             ----------------CCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          319 ----------------FRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       319 ----------------~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                      ....    .++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                            0110    124578999999999999999999999999999999854

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.4e-49  Score=371.47  Aligned_cols=262  Identities=30%  Similarity=0.454  Sum_probs=217.2

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .++.++|++++.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-C
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCe
Confidence            456678999999999999999999999999999999986543   234678899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++..
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAK  166 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTSCEEECCCHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC---CCCCEEEEECCCCcc
Confidence            99999999999999887543 35699999999999999999999999999999999999998   578999999998754


Q ss_pred             cCC-CCccccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          252 IKP-GKKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       252 ~~~-~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      ... ........||+.|+|||++.      ..++.++||||||+++|+|++|..||...........+........ ...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~  245 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTP  245 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSG
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCc
Confidence            321 11223457999999999873      3457899999999999999999999988877766666665543211 122


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ..++.++.+||.+||..||.+|||+.++++||||+...
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            45788999999999999999999999999999998643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.9e-50  Score=388.03  Aligned_cols=262  Identities=24%  Similarity=0.423  Sum_probs=222.0

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChH--------------hHHHHHHHHHHHHHccCCCC
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI--------------AVEDVKREVKILQALAGHEN  158 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~--------------~~~~~~~E~~il~~l~~hpn  158 (414)
                      ...++|++++.||+|+||.||+|.+  +|+.||||++.........              ..+.+.+|+.+++.+. |||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~  104 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY  104 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence            3456899999999999999999998  8999999998754322111              1278899999999995 999


Q ss_pred             ceEEEEEEEcCCEEEEEEeccCCCChHHH------HHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEE
Q 015026          159 VVKFYNAFEDDNYVYIAMELCEGGELLDR------ILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFL  231 (414)
Q Consensus       159 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~------l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIl  231 (414)
                      |+++++++.+.+..++||||++|++|.++      +.......+++..++.++.||+.||.|||+ .||+||||||+||+
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999987      533336789999999999999999999999 99999999999999


Q ss_pred             EeecCCCCCceeeccccccccCCCCccccCCCCCccccchhcccc--CCC-CcchhHHHHHHHHHhhCCCCCCCCCc-hh
Q 015026          232 FKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK--SGP-ESDVWSIGVITYILLCGRRPFWDKTE-DG  307 (414)
Q Consensus       232 l~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiwslG~il~elltg~~Pf~~~~~-~~  307 (414)
                      ++   .++.+||+|||++...... ......||+.|+|||++.+.  ++. ++||||||+++|+|++|..||..... .+
T Consensus       185 ~~---~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MD---KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EC---TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             Ec---CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            98   5789999999999876443 44567899999999998765  334 89999999999999999999988776 66


Q ss_pred             hhHHHhhcCCCCCCCC---------------CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          308 IFKEVLRNKPDFRRKP---------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       308 ~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ....+......++...               .+.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            6667766554443211               14688999999999999999999999999999999853

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.4e-49  Score=376.32  Aligned_cols=261  Identities=33%  Similarity=0.500  Sum_probs=212.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE-----
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-----  167 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~-----  167 (414)
                      .+.++|++++.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++.+. ||||+++++++.     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCB
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccccc
Confidence            4567899999999999999999999999999999998654   2456778899999999995 999999999873     


Q ss_pred             ---------cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCC
Q 015026          168 ---------DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED  238 (414)
Q Consensus       168 ---------~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~  238 (414)
                               +....++||||++ |+|.+++.   .+.+++..++.++.||+.||.|||++||+||||||+|||++.  ++
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~  157 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--ED  157 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TT
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CC
Confidence                     4478999999997 59998873   357899999999999999999999999999999999999973  46


Q ss_pred             CCceeeccccccccCCC----CccccCCCCCccccchhcc--ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHH
Q 015026          239 SSLKATDFGLSDFIKPG----KKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV  312 (414)
Q Consensus       239 ~~vkl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i  312 (414)
                      +.+||+|||++......    .......||+.|+|||++.  ..++.++|||||||++|+|++|+.||.+....+.+..+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            78999999999875432    2233457899999999875  34688899999999999999999999988776666665


Q ss_pred             hhcCCCCC----------------------C----CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          313 LRNKPDFR----------------------R----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       313 ~~~~~~~~----------------------~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ....+...                      .    ..++.+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            54332111                      0    012468999999999999999999999999999999986543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=371.12  Aligned_cols=261  Identities=28%  Similarity=0.508  Sum_probs=215.5

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      +...++|++.+.||+|+||.||+|.+..+|+.||||++....     ..+.+.+|+.+++.+. ||||+++++++...+.
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCE
Confidence            445678999999999999999999999999999999997643     3466889999999994 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+|+||||+||+++   .++.+||+|||++..
T Consensus        99 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~  174 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             EEEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC---CCCCEEEeecccchh
Confidence            9999999999999998853 346799999999999999999999999999999999999998   578999999999976


Q ss_pred             cCCCC-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          252 IKPGK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       252 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ..... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.........+...... .......+++
T Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  253 (314)
T 3com_A          175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSD  253 (314)
T ss_dssp             CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCH
T ss_pred             hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCH
Confidence            54432 23456899999999987654 688999999999999999999999877665555444443221 1112235789


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ++.+||.+||..||.+|||+.++|+||||+....
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            9999999999999999999999999999987543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.3e-49  Score=380.14  Aligned_cols=260  Identities=26%  Similarity=0.386  Sum_probs=203.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-----
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-----  170 (414)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.....    ......+|+..+..+. ||||+++++++...+     
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCTT
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcC-CCCcccHHHhhhcccccccc
Confidence            579999999999999999999999999999999865432    2234567888888885 999999999986533     


Q ss_pred             --EEEEEEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEEeecCCCCCceee
Q 015026          171 --YVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECH--LHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (414)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH--~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (414)
                        .+++||||+++ +|...+..  .....+++..++.++.||+.||.|||  ++||+||||||+|||++.  .++.+||+
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~~kl~  174 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLKLC  174 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTEEEEC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCcEEEe
Confidence              38899999976 55554432  34567899999999999999999999  999999999999999983  37899999


Q ss_pred             ccccccccCCCCccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC--
Q 015026          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR--  320 (414)
Q Consensus       245 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--  320 (414)
                      |||++............+||+.|+|||++.+.  ++.++|||||||++|+|++|+.||.+.+....+..+.......+  
T Consensus       175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            99999887766666677899999999987543  68899999999999999999999998887766666554211100  


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          321 --------------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       321 --------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                                .......++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence                                      0011225678999999999999999999999999999997644

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.7e-49  Score=373.37  Aligned_cols=262  Identities=27%  Similarity=0.487  Sum_probs=198.4

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.+. ||||+++++++...+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSCEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCcEE
Confidence            3579999999999999999999988999999998865432  234567889999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          175 AMELCEGGELLDRILAK------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~------~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      ||||++|++|.+++...      ....+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc---CCCCEEEEeccc
Confidence            99999999999988541      345689999999999999999999999999999999999998   578999999999


Q ss_pred             ccccCCCC------ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          249 SDFIKPGK------KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       249 a~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      +.......      ......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+..................
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            87654321      1234679999999998864  468899999999999999999999988776665555544332211


Q ss_pred             ------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          321 ------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       321 ------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                            ......+++++.+||.+||..||.+|||+.++++||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence                  122356889999999999999999999999999999998643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.5e-48  Score=375.05  Aligned_cols=261  Identities=32%  Similarity=0.519  Sum_probs=215.0

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC---
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~---  169 (414)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.+. ||||+++++++...   
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCST
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccC
Confidence            45678999999999999999999999999999999986432  3445677889999999995 99999999987654   


Q ss_pred             --CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                        ...++||||+. ++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg  157 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVCDFG  157 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCT
T ss_pred             ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---CCCcEEEEecc
Confidence              77999999997 588888744   4699999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCC-----------ccccCCCCCccccchhcc--ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh
Q 015026          248 LSDFIKPGK-----------KFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR  314 (414)
Q Consensus       248 ~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~  314 (414)
                      ++.......           .....+||+.|+|||++.  ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            997654321           123457999999999864  3468899999999999999999999988776554443322


Q ss_pred             c------------------------CCCCCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          315 N------------------------KPDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       315 ~------------------------~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      .                        .+..+..    .++.+++++.+||.+||..||++|||+.++|+||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            1                        1111111    12468899999999999999999999999999999987543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.1e-48  Score=379.67  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=214.8

Q ss_pred             ccceeeceeeeecCceEEEEEEEC-------CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDK-------ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~  167 (414)
                      .++|++++.||+|+||+||+|.+.       .++..||||++....  .....+.+.+|+.+++.+.+||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            468999999999999999999874       345679999987543  34467789999999999955999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEe
Q 015026          168 DDNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (414)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~  233 (414)
                      +.+.+|+||||++||+|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence            9999999999999999999986543              23589999999999999999999999999999999999998


Q ss_pred             ecCCCCCceeeccccccccCCCC---ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhh
Q 015026          234 SAKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (414)
Q Consensus       234 ~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~  308 (414)
                         .++.+||+|||+++......   ......||+.|+|||++.+ .++.++|||||||++|||++ |..||.+....++
T Consensus       238 ---~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          238 ---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             ---TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             ---CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence               57899999999998654432   2234567889999998765 46889999999999999999 9999998887777


Q ss_pred             hHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +..+.....   ......+++++.+||.+||..||.+|||+.|+++
T Consensus       315 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          315 FKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             HHHHHTTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            776665532   2223468899999999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.3e-48  Score=375.98  Aligned_cols=265  Identities=26%  Similarity=0.371  Sum_probs=217.9

Q ss_pred             ccccccccceeeceeeeecCceEEEEEEECCCC-CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCC------ceE
Q 015026           89 GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN------VVK  161 (414)
Q Consensus        89 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpn------Iv~  161 (414)
                      ...+.+.++|++.+.||+|+||+||+|.+..++ +.||+|++...    ....+.+.+|+.+++.+. |++      ++.
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~   86 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCVL   86 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBCC
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEEE
Confidence            345557789999999999999999999998877 68999998643    235677889999999996 655      999


Q ss_pred             EEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec------
Q 015026          162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA------  235 (414)
Q Consensus       162 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~------  235 (414)
                      +++++...+..++||||+ +++|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++..      
T Consensus        87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence            999999999999999999 6788888877666689999999999999999999999999999999999999422      


Q ss_pred             ----------CCCCCceeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCC
Q 015026          236 ----------KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT  304 (414)
Q Consensus       236 ----------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~  304 (414)
                                ..++.+||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                      1578899999999986443  2345689999999998765 56889999999999999999999998877


Q ss_pred             chhhhHHHhhcCCCCCC----------------CCC------------------------CCCCHHHHHHHHHhhcCCcc
Q 015026          305 EDGIFKEVLRNKPDFRR----------------KPW------------------------PSISNSAKDFVKKLLVKDPR  344 (414)
Q Consensus       305 ~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~dp~  344 (414)
                      ..+.+..+.......+.                ..|                        ...+.++.+||.+||..||.
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            66554443332111110                001                        11245788999999999999


Q ss_pred             ccCCHHHHhCCcccccc
Q 015026          345 ARLTAAQALSHPWVREG  361 (414)
Q Consensus       345 ~Rps~~elL~hp~f~~~  361 (414)
                      +|||+.|+|+||||+..
T Consensus       324 ~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          324 QRITLAEALLHPFFAGL  340 (355)
T ss_dssp             TSCCHHHHTTSGGGGGC
T ss_pred             hCcCHHHHhcChhhcCC
Confidence            99999999999999964

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.9e-48  Score=364.54  Aligned_cols=260  Identities=25%  Similarity=0.464  Sum_probs=220.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE--cCCEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--DDNYV  172 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~--~~~~~  172 (414)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++.  .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence            3579999999999999999999999999999999976543 3446778999999999995 999999999874  46789


Q ss_pred             EEEEeccCCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEEeecCCCCCceeec
Q 015026          173 YIAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHG-----LVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~-----iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      ++||||++|++|.+++....  ...+++..++.++.||+.||.|||+.|     |+||||||+||+++   .++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~---~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---SSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---CCCCEEEec
Confidence            99999999999999986532  345999999999999999999999999     99999999999998   578999999


Q ss_pred             cccccccCCCCc-cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCC
Q 015026          246 FGLSDFIKPGKK-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       246 FG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  323 (414)
                      ||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....++...+..+...   ..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~---~~  236 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RI  236 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CC
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc---cC
Confidence            999977654322 234579999999998765 4688899999999999999999999988877777777665432   12


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ...+++++.+||.+||..||.+|||+.|+|+|+|+....
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            246889999999999999999999999999999998643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-48  Score=379.15  Aligned_cols=261  Identities=22%  Similarity=0.368  Sum_probs=206.3

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC--------ChHhHHHHHHHHHHHHHccCCCCceEEEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--------LPIAVEDVKREVKILQALAGHENVVKFYNA  165 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~~~~~E~~il~~l~~hpnIv~~~~~  165 (414)
                      +.++|++.+.||+|+||.||+|.+.. |+.||||++......        .....+.+.+|+.+++.+. ||||++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~   97 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRDI   97 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceeee
Confidence            45689999999999999999999754 999999998653221        2234578999999999995 9999999999


Q ss_pred             EEc-----CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC
Q 015026          166 FED-----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       166 ~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                      +..     ...+++||||++ |+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~~~~  172 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---DNND  172 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCC
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc---CCCC
Confidence            843     447899999997 588888754 345799999999999999999999999999999999999998   5789


Q ss_pred             ceeeccccccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC-
Q 015026          241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-  317 (414)
Q Consensus       241 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-  317 (414)
                      +||+|||++............+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+..... 
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999999987655555566789999999998764  468899999999999999999999998877666555543111 


Q ss_pred             -----------------------CCCCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          318 -----------------------DFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       318 -----------------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                             ..+..    ..+.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence                                   01111    123568899999999999999999999999999999975

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=381.06  Aligned_cols=262  Identities=21%  Similarity=0.248  Sum_probs=220.5

Q ss_pred             ccccceeeceeeeecCceEEEEEE-----ECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~  167 (414)
                      ...++|++++.||+|+||+||+|.     +..+++.||||++....  .......+.+|+.+++.+. ||||+++++++.
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  144 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSL  144 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence            345689999999999999999999     45677899999986432  3445667889999999995 999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          168 DDNYVYIAMELCEGGELLDRILAKKD-----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                      +....++||||++||+|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            99999999999999999999966432     4589999999999999999999999999999999999998655566799


Q ss_pred             eeccccccccCC---CCccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCC
Q 015026          243 ATDFGLSDFIKP---GKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       243 l~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      |+|||+++....   ........||+.|+|||++. +.++.++|||||||++|||++ |..||.+....++...+.....
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999975422   12233467899999999875 456889999999999999998 9999998888888877776543


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ..   ....+++++.+||.+||+.||.+|||+.+++++.++-.
T Consensus       305 ~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          305 MD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC---CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            22   23468899999999999999999999999999888754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.8e-48  Score=366.96  Aligned_cols=257  Identities=24%  Similarity=0.339  Sum_probs=207.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||+||+|.+  +|+.||||++..... .....+.+.+|+.+++.++ ||||+++++++.+.+..++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTTCCEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCceEE
Confidence            46799999999999999999976  688999999876543 3455678899999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          175 AMELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      ||||++||+|.+++..... ..+++..+..++.||+.||.|||+.|  |+||||||+|||++   .++.+||+|||++..
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC---TTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe---CCCcEEECCCCCCcc
Confidence            9999999999998854321 23899999999999999999999999  99999999999998   578999999999976


Q ss_pred             cCCCC-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          252 IKPGK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       252 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ..... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+....+.......  .....+++
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~  266 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EIPRNLNP  266 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCH
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCccCCH
Confidence            54332 23456899999999988765 6889999999999999999999999888777766664433222  22247899


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC--Cccccc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS--HPWVRE  360 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~--hp~f~~  360 (414)
                      ++.+||.+||..||.+|||+.++++  .++++.
T Consensus       267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999997  455543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-48  Score=367.42  Aligned_cols=255  Identities=27%  Similarity=0.483  Sum_probs=209.3

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-----  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-----  168 (414)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++...    ....+.+.+|+.+++.+. ||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence            456799999999999999999999999999999998653    245678899999999995 9999999998854     


Q ss_pred             --------CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC
Q 015026          169 --------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       169 --------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                              .+..++||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~---~~~~  154 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRN  154 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc---CCCC
Confidence                    46789999999999999998543 34678999999999999999999999999999999999998   5789


Q ss_pred             ceeeccccccccCCC---------------CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCC
Q 015026          241 LKATDFGLSDFIKPG---------------KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDK  303 (414)
Q Consensus       241 vkl~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~  303 (414)
                      +||+|||++......               .......||+.|+|||++.+  .++.++|||||||++|+|++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            999999999765421               22345679999999999875  46889999999999999998   56433


Q ss_pred             -CchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          304 -TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       304 -~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                       ........+......++.......++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             hhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence             233445555555555555555567888999999999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=374.95  Aligned_cols=256  Identities=31%  Similarity=0.515  Sum_probs=211.4

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE--
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY--  171 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~--  171 (414)
                      +.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++.....  
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccccc
Confidence            4568999999999999999999999999999999986543 23445678899999999995 9999999999987653  


Q ss_pred             ----EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          172 ----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       172 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                          +++||||+. ++|.+.+    ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg  171 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFG  171 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTCCEEECSTT
T ss_pred             cceeEEEEecccc-CCHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC---CCCcEEEeecc
Confidence                599999997 5887765    23599999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC---------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---------  316 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~---------  316 (414)
                      ++.....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+....         
T Consensus       172 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          172 LARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             CTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             cccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9976543  2345689999999998765  46889999999999999999999998877665555443311         


Q ss_pred             --------------CCCC----CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          317 --------------PDFR----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       317 --------------~~~~----~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                    +..+    ...++.+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                          1111    12235678999999999999999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.8e-48  Score=362.36  Aligned_cols=258  Identities=26%  Similarity=0.427  Sum_probs=208.8

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      |.....||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.+++.+. ||||+++++++.+.+..++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence            444558999999999999999999999999987653   235677899999999995 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC
Q 015026          178 LCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~  256 (414)
                      |+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.  .++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccCCCC
Confidence            999999999886543 235679999999999999999999999999999999999983  37899999999998764322


Q ss_pred             -ccccCCCCCccccchhcccc---CCCCcchhHHHHHHHHHhhCCCCCCCCCchhh-hHHHhhcCCCCCCCCCCCCCHHH
Q 015026          257 -KFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                       ......||+.|+|||++.+.   ++.++||||||+++|+|++|+.||........ .......  .........+++++
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  255 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAEA  255 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHHH
Confidence             23456899999999988643   57899999999999999999999976543322 1111111  11122234689999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      .+||.+||..||++|||+.++|+||||+....
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            99999999999999999999999999986543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7e-48  Score=368.55  Aligned_cols=263  Identities=22%  Similarity=0.338  Sum_probs=198.7

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCC---EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..++|++++.||+|+||+||+|.+..++.   .||||++...... ....+.+.+|+.+++.+ +||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHC-CCCceehhhceeeccc
Confidence            34679999999999999999999887775   8999998765332 34567899999999999 5999999999998776


Q ss_pred             EE------EEEEeccCCCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC
Q 015026          171 YV------YIAMELCEGGELLDRILAKKD----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       171 ~~------~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                      ..      ++||||+++|+|.+++.....    ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---CCCC
Confidence            55      999999999999998865432    2589999999999999999999999999999999999998   5789


Q ss_pred             ceeeccccccccCCCCcc---ccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhc
Q 015026          241 LKATDFGLSDFIKPGKKF---QDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRN  315 (414)
Q Consensus       241 vkl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~  315 (414)
                      +||+|||++.........   ....+++.|+|||++.+. ++.++|||||||++|+|++ |..||.+....+....+...
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            999999999876443322   234578899999987654 6889999999999999999 99999988888887777665


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhcCCccccCC-------HHHHhCCcccccccCC
Q 015026          316 KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT-------AAQALSHPWVREGGDA  364 (414)
Q Consensus       316 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps-------~~elL~hp~f~~~~~~  364 (414)
                      ...   ...+.+++++.+||.+||..||.+|||       +++++.|||+......
T Consensus       256 ~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          256 NRL---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             CCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             CCC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            422   223578899999999999999999999       7888999999865443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.5e-48  Score=365.97  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=209.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++...   .....+.+.+|+.+++.+. ||||+++++++.+++..++|
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEEE
Confidence            5799999999999999999999999999999988543   3456788999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---TTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---CCCCEEEeecccceecccc
Confidence            9999999999988553 45799999999999999999999999999999999999998   6789999999999765432


Q ss_pred             Ccc---------------ccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhh-----hHHHhh
Q 015026          256 KKF---------------QDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGI-----FKEVLR  314 (414)
Q Consensus       256 ~~~---------------~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~-----~~~i~~  314 (414)
                      ...               ...+||+.|+|||++.+. ++.++||||||+++|+|++|..||........     ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            211               256899999999988764 58899999999999999999999976433211     111111


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      .      ...+.+++++.+||.+||+.||.+|||+.++++  |+..
T Consensus       242 ~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~  279 (310)
T 3s95_A          242 R------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET  279 (310)
T ss_dssp             H------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             c------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence            1      112467889999999999999999999999998  6654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.3e-48  Score=374.64  Aligned_cols=255  Identities=25%  Similarity=0.320  Sum_probs=211.4

Q ss_pred             cccceeeceeeeecCceEEEEEE-----ECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ..++|++++.||+|+||.||+|.     +..+++.||||++....  .....+.+.+|+.+++.+.+||||+++++++.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            34689999999999999999998     55677899999997543  334567899999999999779999999999887


Q ss_pred             CC-EEEEEEeccCCCChHHHHHhccC------------------------------------------------------
Q 015026          169 DN-YVYIAMELCEGGELLDRILAKKD------------------------------------------------------  193 (414)
Q Consensus       169 ~~-~~~lv~e~~~gg~L~~~l~~~~~------------------------------------------------------  193 (414)
                      .+ .+++||||++||+|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            54 59999999999999999865432                                                      


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCC---cccc
Q 015026          194 ----------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK---KFQD  260 (414)
Q Consensus       194 ----------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~---~~~~  260 (414)
                                ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......   ....
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccchhccc
Confidence                      1289999999999999999999999999999999999998   57899999999998654332   2234


Q ss_pred             CCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHh
Q 015026          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (414)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (414)
                      ..||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.+...........  ....+++++.+||.+|
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDC  332 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHH
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHH
Confidence            678999999998764 46889999999999999998 9999988776555555444432222  2246889999999999


Q ss_pred             hcCCccccCCHHHHhCC
Q 015026          339 LVKDPRARLTAAQALSH  355 (414)
Q Consensus       339 L~~dp~~Rps~~elL~h  355 (414)
                      |..||.+|||+.++++|
T Consensus       333 l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHH
Confidence            99999999999999974

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=363.89  Aligned_cols=260  Identities=24%  Similarity=0.366  Sum_probs=197.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+..+..+++.+ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEE
Confidence            579999999999999999999999999999999976542 122233444445566666 599999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |||+ ++. ...+.......+++..++.++.||+.||.|||+. ||+||||||+|||++   .++.+||+|||++.....
T Consensus       103 ~e~~-~~~-~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          103 MELM-GTC-AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             ECCC-SEE-HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC---TTSCEEECCCTTC-----
T ss_pred             Eecc-CCc-HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC---CCCCEEEEECCCchhccC
Confidence            9999 444 4445444456799999999999999999999995 999999999999998   578999999999977655


Q ss_pred             CCccccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCC-CchhhhHHHhhcCCCCCCCCCCCC
Q 015026          255 GKKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ........||+.|+|||++.      ..++.++||||||+++|+|++|..||... ...+.+..+........ .....+
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  256 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHMGF  256 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSSCC
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccCCC
Confidence            55555678999999999974      34578899999999999999999999874 34455556655543222 123468


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ++++.+||.+||..||.+|||+.++++||||+....
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence            999999999999999999999999999999986443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.4e-47  Score=363.33  Aligned_cols=260  Identities=26%  Similarity=0.484  Sum_probs=209.7

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccC-CCCceEEEEEEEcCC
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG-HENVVKFYNAFEDDN  170 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~-hpnIv~~~~~~~~~~  170 (414)
                      ....++|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+++.+.. ||||+++++++.+++
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            334567999999999999999999975 588999999976543 34567889999999999963 699999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||| +.+++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++.
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~  174 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN  174 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred             EEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccc
Confidence            9999999 558899999854  35789999999999999999999999999999999999997    4789999999998


Q ss_pred             ccCCCCc---cccCCCCCccccchhccc------------cCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhh
Q 015026          251 FIKPGKK---FQDIVGSAYYVAPEVLKR------------KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLR  314 (414)
Q Consensus       251 ~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~  314 (414)
                      .......   ....+||+.|+|||++.+            .++.++||||||+++|+|++|..||...... ..+..+..
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            7543322   235679999999999864            4577899999999999999999999765432 33333433


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      .....  ......++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       255 ~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          255 PNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             TTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ccccc--CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            32221  12235678999999999999999999999999999998643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-47  Score=356.77  Aligned_cols=247  Identities=21%  Similarity=0.372  Sum_probs=212.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++.....    ..+.+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEE
Confidence            57999999999999999999986 577899999976543    3467899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---GGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---CCCCEEecccccccccccc
Confidence            9999999999988543 35689999999999999999999999999999999999998   4778999999999865432


Q ss_pred             C--ccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 K--KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .  ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+.......   ....+++++
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  236 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHV  236 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHH
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---CCCcCCHHH
Confidence            2  223456788999999886 456889999999999999999 999999888888777776653322   224578999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+||.+||..||.+|||+.+++++
T Consensus       237 ~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999974

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-47  Score=367.76  Aligned_cols=261  Identities=23%  Similarity=0.340  Sum_probs=193.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHH-HHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK-ILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      ++|++++.||+|+||.||+|.+..+|+.||||++....  .......+..|+. +++.+ +||||+++++++.+++..++
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCceEE
Confidence            57999999999999999999999999999999997643  2334556667776 55555 69999999999999999999


Q ss_pred             EEeccCCCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          175 AMELCEGGELLDRILA---KKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ||||++| +|.+++..   .....+++..+..++.|++.||.|||+. ||+||||||+|||++   .++.+||+|||++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCCCce
Confidence            9999975 77776642   2356799999999999999999999999 999999999999998   57899999999998


Q ss_pred             ccCCCCccccCCCCCccccchhcc-----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHHHhhcC-CCCCCCC
Q 015026          251 FIKPGKKFQDIVGSAYYVAPEVLK-----RKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNK-PDFRRKP  323 (414)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~i~~~~-~~~~~~~  323 (414)
                      ............||+.|+|||++.     ..++.++||||||+++|+|++|..||.+... .+.+..+.... +.+....
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE  254 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence            765554445568999999999873     3468899999999999999999999976432 22233333322 2233333


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                      ...+++++.+||.+||..||.+|||+.++++||||.....
T Consensus       255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence            4568999999999999999999999999999999986543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.4e-48  Score=377.79  Aligned_cols=262  Identities=25%  Similarity=0.434  Sum_probs=209.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc----------CCCCceEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA----------GHENVVKFYN  164 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~----------~hpnIv~~~~  164 (414)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...    ....+.+.+|+.+++.+.          +||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            46899999999999999999999999999999998653    235677889999999884          2799999999


Q ss_pred             EEEcCC----EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEEeecC---
Q 015026          165 AFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAK---  236 (414)
Q Consensus       165 ~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~-~iiHrDlkp~NIll~~~~---  236 (414)
                      ++...+    .+++|||++ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++..+   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            987644    799999999 88999999776667799999999999999999999998 999999999999996421   


Q ss_pred             CCCCceeeccccccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc------hhhh
Q 015026          237 EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE------DGIF  309 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~  309 (414)
                      ..+.+||+|||++.....  .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+...      ...+
T Consensus       173 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            344799999999977643  23456899999999988654 68899999999999999999999976542      2222


Q ss_pred             HHHhhcCCCCCC--------------------------------------CCCCCCCHHHHHHHHHhhcCCccccCCHHH
Q 015026          310 KEVLRNKPDFRR--------------------------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQ  351 (414)
Q Consensus       310 ~~i~~~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~e  351 (414)
                      ..+.......+.                                      ...+.+++++.+||.+||+.||.+|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            222211100000                                      001134567899999999999999999999


Q ss_pred             HhCCcccccccC
Q 015026          352 ALSHPWVREGGD  363 (414)
Q Consensus       352 lL~hp~f~~~~~  363 (414)
                      +|+||||+....
T Consensus       331 ll~hp~f~~~~~  342 (373)
T 1q8y_A          331 LVNHPWLKDTLG  342 (373)
T ss_dssp             HHTCGGGTTCTT
T ss_pred             HhhChhhhcccC
Confidence            999999997544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=372.58  Aligned_cols=254  Identities=24%  Similarity=0.368  Sum_probs=216.8

Q ss_pred             cccceeeceeeeecCceEEEEEEECCC-------CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKAN-------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~  166 (414)
                      ..++|.+.+.||+|+||+||+|.+..+       +..||||++....  .......+.+|+.+++.+.+||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            446899999999999999999997543       3579999987553  3456678999999999996699999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEE
Q 015026          167 EDDNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLF  232 (414)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll  232 (414)
                      ..++..++||||++||+|.+++....              ...+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            99999999999999999999996643              2459999999999999999999999999999999999999


Q ss_pred             eecCCCCCceeeccccccccCCCC---ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchh
Q 015026          233 KSAKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDG  307 (414)
Q Consensus       233 ~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~  307 (414)
                      +   .++.+||+|||++.......   ......||+.|+|||++.+. ++.++|||||||++|+|++ |..||.+....+
T Consensus       225 ~---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          225 T---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             C---TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             c---CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            8   57899999999998765432   23345678899999987654 5889999999999999999 999999888777


Q ss_pred             hhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       308 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +...+......   .....+++++.+||.+||..||++|||+.+++++
T Consensus       302 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          302 LFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77776655322   2224689999999999999999999999999984

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.4e-47  Score=354.05  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=213.1

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||+||+|.+. ++..||+|++.....    ..+.+.+|+.+++.+. ||||+++++++.+.+..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceEE
Confidence            367999999999999999999875 567899999976543    3467899999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++.....
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---TTCCEEECCTTCEEECCT
T ss_pred             EEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---CCCCEEEccCccceecch
Confidence            99999999999988554 34589999999999999999999999999999999999998   578999999999987654


Q ss_pred             CCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...  .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+.........   ...+++
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDT  233 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHH
Confidence            332  223456778999998875 46899999999999999999 99999888887777777665433322   357899


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999974

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-46  Score=355.72  Aligned_cols=250  Identities=28%  Similarity=0.561  Sum_probs=202.3

Q ss_pred             ccccceeec-eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc---
Q 015026           93 DFDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED---  168 (414)
Q Consensus        93 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~---  168 (414)
                      .+.++|.+. +.||+|+||.||+|.+..+|+.||+|++...        ..+.+|+.++.++.+||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            345678887 7899999999999999999999999998642        3567899998666579999999999876   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                       ...+++||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             7789999999999999999977666679999999999999999999999999999999999999964447899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHH----hhcCCCCCCCC
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV----LRNKPDFRRKP  323 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i----~~~~~~~~~~~  323 (414)
                      ++.....                    ..++.++|||||||++|+|++|..||.+.........+    ......++...
T Consensus       166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (299)
T 3m2w_A          166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  225 (299)
T ss_dssp             TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred             ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence            9865432                    23466899999999999999999999776544332222    22222222222


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCC
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID  370 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~  370 (414)
                      +..+++++.+||.+||+.||.+|||+.|+|+||||+........+..
T Consensus       226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~  272 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH  272 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBCS
T ss_pred             cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCCc
Confidence            35689999999999999999999999999999999976655544443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.9e-48  Score=370.31  Aligned_cols=256  Identities=29%  Similarity=0.525  Sum_probs=213.9

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh---HhHHHHHHHHHHHHHcc-CCCCceEEEEEE
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA-GHENVVKFYNAF  166 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~-~hpnIv~~~~~~  166 (414)
                      .+.+.++|++.+.||+|+||.||+|.+..+|+.||||++........   ...+.+.+|+.+++.+. +||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            34566789999999999999999999999999999999976543211   12245678999999996 369999999999


Q ss_pred             EcCCEEEEEEeccCC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          167 EDDNYVYIAMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       167 ~~~~~~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      ..++..++|+|++.+ ++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||++.  +++.+||+|
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~D  193 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLID  193 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEee
Confidence            999999999999986 8999988543  57899999999999999999999999999999999999983  467899999


Q ss_pred             cccccccCCCCccccCCCCCccccchhcccc-C-CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCC
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  323 (414)
                      ||++...... ......||+.|+|||++.+. + +.++||||||+++|+|++|..||....      .+......+    
T Consensus       194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~----  262 (320)
T 3a99_A          194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF----  262 (320)
T ss_dssp             CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC----
T ss_pred             Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc----
Confidence            9999876543 34556899999999987654 3 577899999999999999999996532      223332222    


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ...+++++.+||.+||..||.+|||+.++++||||+..
T Consensus       263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence            24688999999999999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.7e-48  Score=371.91  Aligned_cols=253  Identities=18%  Similarity=0.266  Sum_probs=206.4

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.++|++.+.||+|+||+||+|.+..+|+.||||++.....     .+.+.+|+.+++.|.+||||+++++++.+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            34679999999999999999999999999999999875432     2357899999999966999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC--CCCceeeccccccc
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE--DSSLKATDFGLSDF  251 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~--~~~vkl~DFG~a~~  251 (414)
                      +||||+ |++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++..+.  ...+||+|||++..
T Consensus        82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            999999 99999988543 467999999999999999999999999999999999999984221  12399999999987


Q ss_pred             cCCCCc--------cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhh---hHHHhhcCCCC
Q 015026          252 IKPGKK--------FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGI---FKEVLRNKPDF  319 (414)
Q Consensus       252 ~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---~~~i~~~~~~~  319 (414)
                      ......        ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......   +..+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            543322        2467899999999988764 68899999999999999999999988654433   33333322211


Q ss_pred             CCC-CCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          320 RRK-PWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       320 ~~~-~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.. ....+| ++.+||..||..||.+||+++++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111 112344 8999999999999999999998876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-47  Score=362.36  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=206.3

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      -++|++.+.||+|+||.||+|.+..+++.||+|++.......+...+.+.+|+.+++.+. ||||+++++++..++..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEE
Confidence            357999999999999999999999999999999997665445556788999999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus       112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSCCC------
T ss_pred             EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---CCCCEEEecCccCccccc
Confidence            99999999999988543  5699999999999999999999999999999999999998   578999999999876543


Q ss_pred             CC--ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          255 GK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       255 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..  ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+...... ...+......+....+.+|+++
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l  265 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVAF  265 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCTHH
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCHHH
Confidence            32  2335679999999998765 458899999999999999999999987665433 3333333333333446789999


Q ss_pred             HHHHHHhhcCCccccC-CHHHHhC
Q 015026          332 KDFVKKLLVKDPRARL-TAAQALS  354 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rp-s~~elL~  354 (414)
                      .+||.+||..||.+|| |++++++
T Consensus       266 ~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          266 DAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999999 7877775

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.9e-47  Score=356.51  Aligned_cols=253  Identities=22%  Similarity=0.324  Sum_probs=207.8

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhH----HHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV----EDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~----~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...........    +.+.+|+.+++.+. ||||+++++++.+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCC
Confidence            34689999999999999999999999999999999866543322221    67899999999995 99999999999776


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecC--CCCCceeec
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAK--EDSSLKATD  245 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~--~~~~vkl~D  245 (414)
                      .  ++||||+++++|.+.+... ...+++..++.++.||+.||.|||++|  |+||||||+|||++..+  ....+||+|
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            6  6999999999999988653 457999999999999999999999999  99999999999998422  122389999


Q ss_pred             cccccccCCCCccccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhh--hHHHhhcCCCCC
Q 015026          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGI--FKEVLRNKPDFR  320 (414)
Q Consensus       246 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~i~~~~~~~~  320 (414)
                      ||++.....  ......||+.|+|||++.+   .++.++|||||||++|+|++|..||.+......  ...+....  ..
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~  248 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG--LR  248 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC--CC
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC--CC
Confidence            999975433  3456789999999999843   347889999999999999999999987665443  33333322  22


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ......+++++.+||.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            2333578999999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.4e-47  Score=363.89  Aligned_cols=252  Identities=24%  Similarity=0.356  Sum_probs=213.4

Q ss_pred             ccceeeceeeeecCceEEEEEEEC-------CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDK-------ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~  167 (414)
                      .++|++++.||+|+||+||+|.+.       .++..||||++....  .....+.+.+|+.+++.+.+||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            368999999999999999999975       467789999987543  34466789999999999956999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEe
Q 015026          168 DDNYVYIAMELCEGGELLDRILAKKD--------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (414)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~  233 (414)
                      +.+..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence            99999999999999999999865431              3489999999999999999999999999999999999998


Q ss_pred             ecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhh
Q 015026          234 SAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (414)
Q Consensus       234 ~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~  308 (414)
                         .++.+||+|||++........   .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....++
T Consensus       192 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          192 ---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             ---TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             ---CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence               578999999999987654332   234467889999998764 46889999999999999999 9999988887777


Q ss_pred             hHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ...+......   .....+++++.+||.+||..||.+|||+.++++
T Consensus       269 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          269 FKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             HHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            7766665422   223468899999999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2e-46  Score=356.46  Aligned_cols=255  Identities=27%  Similarity=0.464  Sum_probs=202.6

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+. ||||+++++++...+..+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEE
Confidence            3457999999999999999999999999999999998655555667788999999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          174 IAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +||||+++++|.+++..  .....+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~---~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc---CCCCEEEEeccceee
Confidence            99999999999998854  2346789999999999999999999999999999999999998   578999999999876


Q ss_pred             cCCCC-ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch--hhhHHHhhcCCCCCCCCCCCC
Q 015026          252 IKPGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       252 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....  .....+....  ++......+
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  263 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHY  263 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCTTTS
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCccccc
Confidence            54332 2335679999999998765 4688899999999999999999999765432  3333333322  233333568


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++++.+||.+||..||.+|||+.++++
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999999987

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4e-47  Score=357.09  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=217.8

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..++|++.+.||+|+||+||+|.+..++..||+|++....    ...+.+.+|+.+++.+. ||||+++++++.+++..+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCEE
Confidence            4467999999999999999999999999999999987543    25678899999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||++|++|.+++.......+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++....
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---GGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---CCCCEEEccCccceecc
Confidence            999999999999999776667799999999999999999999999999999999999998   57789999999998765


Q ss_pred             CCCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          254 PGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       254 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ....  .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+.....   ......+++
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  239 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPE  239 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---CCCCCCCCH
Confidence            4332  234567889999998764 46889999999999999999 9999988877776666655432   223357899


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.+||.+||..||.+|||+.++++
T Consensus       240 ~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          240 KVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhCCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.8e-47  Score=360.87  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=214.9

Q ss_pred             ccceeeceeeeecCceEEEEEEE-----CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .++|.+.+.||+|+||.||+|.+     ..+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQD   98 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecC
Confidence            46799999999999999999988     3456899999987543  3456688999999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 015026          170 NYVYIAMELCEGGELLDRILAKKD----------------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP  227 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~----------------------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp  227 (414)
                      +..++||||++|++|.+++.....                      ..+++..++.++.||+.||.|||++||+||||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp  178 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA  178 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence            999999999999999999865432                      3489999999999999999999999999999999


Q ss_pred             CcEEEeecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCC
Q 015026          228 ENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWD  302 (414)
Q Consensus       228 ~NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~  302 (414)
                      +|||++   .++.+||+|||++........   .....||+.|+|||++.+. ++.++||||||+++|+|++ |..||.+
T Consensus       179 ~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          179 RNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             heEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999   578899999999987644322   2345678899999987654 6889999999999999999 9999988


Q ss_pred             CCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .....+...+.....   ......+++++.+||.+||..||.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPERLFNLLKTGHR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGGGHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHhhcCCc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            887777766655432   22235789999999999999999999999999873

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.9e-47  Score=353.38  Aligned_cols=251  Identities=27%  Similarity=0.376  Sum_probs=200.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC-hHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      ++|++.+.||+|+||.||+|.+.  |+.||||++....... ....+.+.+|+.+++.+. ||||+++++++.+++..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceEE
Confidence            57999999999999999999864  8899999986543221 234577899999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEEeecCC-----CCCceeecc
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKE-----DSSLKATDF  246 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~---iiHrDlkp~NIll~~~~~-----~~~vkl~DF  246 (414)
                      ||||++|++|.+++.   ...+++..++.++.||+.||.|||++|   |+||||||+|||++...+     ++.+||+||
T Consensus        84 v~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999988872   457999999999999999999999999   999999999999984222     678999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      |++........ ....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.........+.......+  ...
T Consensus       161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  237 (271)
T 3dtc_A          161 GLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPS  237 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--CCT
T ss_pred             Ccccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--CCc
Confidence            99976554332 356899999999987654 68899999999999999999999988877766666655543322  234


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+++++.+||.+||..||.+|||+.|++++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            688999999999999999999999999873

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5e-47  Score=360.54  Aligned_cols=253  Identities=26%  Similarity=0.328  Sum_probs=214.1

Q ss_pred             ccceeeceeeeecCceEEEEEEE-----CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++.+.+||||+++++++.++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            36899999999999999999985     4577899999997543  2345678999999999995699999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEe
Q 015026          170 NYVYIAMELCEGGELLDRILAKKD----------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~----------------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~  233 (414)
                      +..++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence            999999999999999999865432                2489999999999999999999999999999999999998


Q ss_pred             ecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhh
Q 015026          234 SAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (414)
Q Consensus       234 ~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~  308 (414)
                         .++.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+......
T Consensus       180 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          180 ---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             ---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence               578999999999987654332   224567889999998754 56889999999999999999 9999988776655


Q ss_pred             hHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ...........  .....+++++.+||.+||..||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          257 FYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             HHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCCCC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            55555443222  223468899999999999999999999999987

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3e-47  Score=366.90  Aligned_cols=252  Identities=20%  Similarity=0.253  Sum_probs=214.7

Q ss_pred             cccceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ..++|++++.||+|+||.||+|.+.     .+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++.+
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAV  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcc
Confidence            3468999999999999999999987     455899999987543  3445678999999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 015026          169 DNYVYIAMELCEGGELLDRILAKK----------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK  226 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlk  226 (414)
                      .+..++||||+++++|.+++....                      ...+++..++.++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            999999999999999999986532                      1568999999999999999999999999999999


Q ss_pred             CCcEEEeecCCCCCceeeccccccccCCCC---ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCC
Q 015026          227 PENFLFKSAKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFW  301 (414)
Q Consensus       227 p~NIll~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~  301 (414)
                      |+|||++   .++.+||+|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||.
T Consensus       202 p~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          202 TRNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             GGGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cceEEEC---CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999998   57899999999997653322   2234578999999998764 56889999999999999999 999999


Q ss_pred             CCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          302 DKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       302 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +....+....+......   .....+++++.+||.+||..||.+|||+.++++
T Consensus       279 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          279 GMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCChHHHHHHHhCCCcC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            88888777777665432   122468899999999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=366.74  Aligned_cols=256  Identities=25%  Similarity=0.326  Sum_probs=211.7

Q ss_pred             ccceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .++|++.+.||+|+||.||+|.+.     .++..||||++....  .....+.+.+|+.+++.+.+||||+++++++...
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            468999999999999999999973     456789999987543  2234578899999999995599999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 015026          170 NYVYIAMELCEGGELLDRILAKKD---------------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPE  228 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~  228 (414)
                      +..++||||++||+|.+++.....                     ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            999999999999999999865432                     23799999999999999999999999999999999


Q ss_pred             cEEEeecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCC
Q 015026          229 NFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDK  303 (414)
Q Consensus       229 NIll~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~  303 (414)
                      |||++   .++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.
T Consensus       202 NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          202 NVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99998   578999999999976543322   234567889999998754 56889999999999999998 99999888


Q ss_pred             CchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcc
Q 015026          304 TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       304 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~  357 (414)
                      .....+..+........  ....+++++.+||.+||..||.+|||+.+++++..
T Consensus       279 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          279 PVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            76666666555443222  22468899999999999999999999999998543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-47  Score=360.17  Aligned_cols=255  Identities=20%  Similarity=0.305  Sum_probs=210.4

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++....     ..+.+.+|+.+++.+.+||||+.+++++.+....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            35578999999999999999999999999999999986543     2245788999999997799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC--CCCCceeecccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLSD  250 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DFG~a~  250 (414)
                      ++||||+ |++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++..+  ....+||+|||++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999999 99999988543 34699999999999999999999999999999999999998431  23449999999998


Q ss_pred             ccCCCCc--------cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc---hhhhHHHhhcCCC
Q 015026          251 FIKPGKK--------FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPD  318 (414)
Q Consensus       251 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~  318 (414)
                      .......        .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+...   ...+..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            7654322        3456899999999988754 58899999999999999999999987543   2333333322211


Q ss_pred             C-CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          319 F-RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       319 ~-~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      . .....+.+|+++.+||.+||..||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1 11123468899999999999999999999999886

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.8e-47  Score=354.79  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=209.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++++.||+|+||+||+|.+. ++..||+|++.....    ..+.+.+|+.+++.+. ||||+++++++.+.+..++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEE
Confidence            357999999999999999999875 677899999976543    3467889999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           97 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTSCEEECSTTGGGGBCC
T ss_pred             EEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---CCCCEEEccccccccccc
Confidence            99999999999988543 34699999999999999999999999999999999999998   578999999999986543


Q ss_pred             CC--ccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GK--KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ..  ......||+.|+|||++. ..++.++||||||+++|+|++ |+.||......+....+........   ....++.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  249 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEK  249 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHH
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCHH
Confidence            22  122446788999999876 456889999999999999998 9999998888777777766543222   2457899


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhCC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +.+||.+||..||.+|||+.++++|
T Consensus       250 l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          250 VYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999974

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5e-47  Score=377.60  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=200.6

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ...+.+.|.+.+.||+|+||+||.+ ...+|+.||||++...      ..+.+.+|+.+|+.+.+|||||++++++.+++
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            3445677888999999999999875 4578999999998653      34567899999998756999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCC-----CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec----------
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA----------  235 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~-----l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~----------  235 (414)
                      .++||||||. |+|.+++.......     .++..++.++.||+.||.|||++||+||||||+|||++..          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999996 59999885432211     1233467899999999999999999999999999999742          


Q ss_pred             CCCCCceeeccccccccCCCCc-----cccCCCCCccccchhccc--------cCCCCcchhHHHHHHHHHhh-CCCCCC
Q 015026          236 KEDSSLKATDFGLSDFIKPGKK-----FQDIVGSAYYVAPEVLKR--------KSGPESDVWSIGVITYILLC-GRRPFW  301 (414)
Q Consensus       236 ~~~~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~ellt-g~~Pf~  301 (414)
                      ..+..+||+|||++........     ....+||+.|+|||++.+        .++.++|||||||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence            2356899999999987654321     235689999999998854        45888999999999999999 999997


Q ss_pred             CCCchhhhHHHhhcCCCCCCCC---CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          302 DKTEDGIFKEVLRNKPDFRRKP---WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       302 ~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +....+  ..+.......+...   ...+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            654433  33444433322211   1234678999999999999999999999999999974

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=377.41  Aligned_cols=259  Identities=24%  Similarity=0.401  Sum_probs=211.0

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC--
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~--  170 (414)
                      ...++|++.+.||+|+||+||+|.+..+|+.||||++......  ...+.+.+|+.+++.+. ||||+++++++.+.+  
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCC
Confidence            3557899999999999999999999999999999999754322  24567789999999995 999999999998754  


Q ss_pred             EEEEEEeccCCCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec-CCCCCceeecccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGL  248 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DFG~  248 (414)
                      ..++||||++||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+... ..++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            78999999999999998854332 339999999999999999999999999999999999998321 2456799999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccc---------cCCCCcchhHHHHHHHHHhhCCCCCCCCC----chhhhHHHhhc
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR---------KSGPESDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRN  315 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~elltg~~Pf~~~~----~~~~~~~i~~~  315 (414)
                      +............+||+.|+|||++.+         .++.++|||||||++|+|++|+.||....    ..+.+..+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            988776666667889999999998753         45778999999999999999999996532    33455555554


Q ss_pred             CCCCCC-----------------CC----CCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          316 KPDFRR-----------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       316 ~~~~~~-----------------~~----~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+....                 +.    ...+++.+.++|.+||..||++|||+.++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            432100                 00    0124457889999999999999999999854

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4e-47  Score=364.18  Aligned_cols=261  Identities=21%  Similarity=0.266  Sum_probs=215.8

Q ss_pred             cccceeeceeeeecCceEEEEEE-----ECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ..++|++++.||+|+||.||+|.     +..+++.||||++....  .......+.+|+.+++.+ +||||+++++++.+
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC
Confidence            44689999999999999999998     56788899999986432  344667889999999999 59999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCcee
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKD-----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (414)
                      ....++||||++|++|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999999865432     45899999999999999999999999999999999999986555678999


Q ss_pred             eccccccccCCCC---ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCC
Q 015026          244 TDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPD  318 (414)
Q Consensus       244 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~  318 (414)
                      +|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+......
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999987543322   2234578999999998754 56889999999999999998 99999888777777766655322


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                         .....+++.+.+||.+||..||.+|||+.+++++.|+-.
T Consensus       265 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          265 ---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence               223468899999999999999999999999999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.1e-47  Score=372.40  Aligned_cols=249  Identities=23%  Similarity=0.338  Sum_probs=211.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|.+..+++.||||++....  .....+.+.+|+.+|+.+. ||||+++++++.+++.+++|
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcEEE
Confidence            57999999999999999999999999999999986542  3345567889999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.....
T Consensus       191 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~---~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCEECTTS
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---CCCcEEECcCCCceecCCC
Confidence            9999999999998643 34689999999999999999999999999999999999998   5789999999999765432


Q ss_pred             Ccc---ccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          256 KKF---QDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       256 ~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...   ....+++.|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+..   ......+|++
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  343 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---LPCPELCPDA  343 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC---CCCCTTCCHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHH
Confidence            211   1123567899999876 456889999999999999998 9999988877766666655432   1222468899


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.+||.+||..||.+|||+.++++
T Consensus       344 l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.5e-47  Score=363.22  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=210.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEE--EEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ++|++.+.||+|+||.||+|.+..+|..+  |+|.+....  .....+.+.+|+.+++.+.+||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            57999999999999999999999888865  999886432  23355678999999999956999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC
Q 015026          174 IAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~  239 (414)
                      +||||+++++|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++   .++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc---CCC
Confidence            9999999999999985432              24799999999999999999999999999999999999998   577


Q ss_pred             CceeeccccccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCC
Q 015026          240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      .+||+|||++.............+++.|+|||++.+. ++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            9999999999754433333445678999999988654 5889999999999999998 9999998887777776665432


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                         ......+++++.+||.+||..||.+|||+.+++++
T Consensus       260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               22234688999999999999999999999999984

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-46  Score=353.20  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=201.0

Q ss_pred             cccceeeceeeeecCceEEEEEEECCC---CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..++|++.+.||+|+||+||+|.+..+   +..||+|++....  .....+.+.+|+.+++.+. ||||+++++++. ++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-EN   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-cC
Confidence            346899999999999999999998654   4569999886532  3456778999999999995 999999999985 45


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR  164 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-----
T ss_pred             ccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccccc
Confidence            689999999999999988543 34689999999999999999999999999999999999999   47899999999998


Q ss_pred             ccCCCCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          251 FIKPGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       251 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .......  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+......   ...+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~  241 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPN  241 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCC
Confidence            7654332  223457889999998764 46888999999999999996 99999988887777777665421   22357


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +++++.+||.+||..||.+|||+.++++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          242 CPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8999999999999999999999999886

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4e-47  Score=356.05  Aligned_cols=252  Identities=26%  Similarity=0.451  Sum_probs=214.4

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--  168 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--  168 (414)
                      +..+..+|++.+.||+|+||.||+|.+..+|+.||+|++....       +.+.+|+.+++.+. ||||+++++++..  
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFD   77 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEE
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEeccc
Confidence            3456678999999999999999999999999999999997543       24678999999995 9999999998864  


Q ss_pred             --------------CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee
Q 015026          169 --------------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       169 --------------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~  234 (414)
                                    ...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++ 
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-  156 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-  156 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc-
Confidence                          45689999999999999999766667899999999999999999999999999999999999999 


Q ss_pred             cCCCCCceeeccccccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHh
Q 015026          235 AKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL  313 (414)
Q Consensus       235 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~  313 (414)
                        .++.+||+|||++.............||+.|+|||++.+. ++.++||||||+++|+|++|..||...  ......+.
T Consensus       157 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~  232 (284)
T 2a19_B          157 --DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR  232 (284)
T ss_dssp             --ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred             --CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence              4778999999999887665555667899999999987654 688999999999999999999987432  22233332


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       314 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ...      ....+++++.+||.+||..||.+|||+.++++++|.-..
T Consensus       233 ~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          233 DGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             TTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            221      123578999999999999999999999999999887643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.5e-46  Score=360.31  Aligned_cols=250  Identities=22%  Similarity=0.287  Sum_probs=202.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEE----EEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .++|++.+.||+|+||+||+|.+..+|+.+    |+|.+....  .....+.+.+|+.+++.+. ||||+++++++.+..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            357999999999999999999998888765    777665332  2335678999999999995 999999999998765


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                       .++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK  165 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCccee
Confidence             78899999999999988654 35799999999999999999999999999999999999998   47889999999998


Q ss_pred             ccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          251 FIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       251 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      .......   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+......   ...+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  242 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPP  242 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---CCCc
Confidence            7644332   223467889999998765 46889999999999999999 99999888777666655544321   2234


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .++.++.+||.+||+.||.+|||+.+++.+
T Consensus       243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          243 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            688999999999999999999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2e-46  Score=348.73  Aligned_cols=246  Identities=18%  Similarity=0.210  Sum_probs=210.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC--CEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~--~~~~  173 (414)
                      ++|++.+.||+|+||+||+|.+.  |+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++.+.  +..+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSCE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCeE
Confidence            57999999999999999999874  88999999876542 3445678999999999995 99999999999877  7899


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +||||++||+|.+++.......+++..++.++.||+.||.|||++|  |+||||||+|||++   .++.++|+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKFS  162 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC---TTSCEEEEGGGSCCT
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc---CCcceeEEeccceee
Confidence            9999999999999997655556999999999999999999999999  99999999999998   578899998888754


Q ss_pred             cCCCCccccCCCCCccccchhccccC-C---CCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKRKS-G---PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~---~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ...    ....||+.|+|||++.+.. +   .++||||||+++|+|++|..||.+....+....+.......  ...+.+
T Consensus       163 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~  236 (271)
T 3kmu_A          163 FQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TIPPGI  236 (271)
T ss_dssp             TSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--CCCTTC
T ss_pred             ecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--CCCCCC
Confidence            332    3457899999999987542 3   36999999999999999999999888777766666544322  233578


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++++.+||.+||..||.+|||+.++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-46  Score=358.82  Aligned_cols=258  Identities=20%  Similarity=0.300  Sum_probs=217.7

Q ss_pred             cccceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||||++....  .......+.+|+.+++.+. ||||+++++++.+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   99 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   99 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEcc
Confidence            4568999999999999999999876     467889999987543  3345667899999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCC
Q 015026          169 DNYVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~  240 (414)
                      .+..++||||++||+|.+++....        ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CCCe
Confidence            999999999999999999885432        14578999999999999999999999999999999999998   5789


Q ss_pred             ceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhc
Q 015026          241 LKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRN  315 (414)
Q Consensus       241 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~  315 (414)
                      +||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  256 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence            99999999976543221   234467899999998765 46889999999999999999 89999888877777776665


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC------ccccc
Q 015026          316 KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH------PWVRE  360 (414)
Q Consensus       316 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h------p~f~~  360 (414)
                      ...   .....+++++.+||.+||..||.+|||+.+++++      ++|+.
T Consensus       257 ~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~  304 (322)
T 1p4o_A          257 GLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  304 (322)
T ss_dssp             CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence            432   1224688999999999999999999999999985      66654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.1e-47  Score=355.21  Aligned_cols=249  Identities=15%  Similarity=0.213  Sum_probs=204.2

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCC-------CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANG-------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~  166 (414)
                      ..++|++.+.||+|+||+||+|.+..++       ..||+|++....   ....+.+.+|+.+++.+. ||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   81 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGVC   81 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence            3468999999999999999999998877       469999986543   235678999999999995 99999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC-----CCCc
Q 015026          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE-----DSSL  241 (414)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~-----~~~v  241 (414)
                      .+++..++||||++|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++....     .+.+
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999998553 234899999999999999999999999999999999999985221     1129


Q ss_pred             eeeccccccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          242 KATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       242 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      ||+|||++......   ....||+.|+|||++.+  .++.++||||||+++|+|++|..|+...................
T Consensus       161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (289)
T 4fvq_A          161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL  237 (289)
T ss_dssp             EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC
Confidence            99999998655332   33468999999998864  46889999999999999999655554444443334444433332


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +    ...++++.+||.+||+.||.+|||+.++++
T Consensus       238 ~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  268 (289)
T 4fvq_A          238 P----APKAAELANLINNCMDYEPDHRPSFRAIIR  268 (289)
T ss_dssp             C----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C----CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            2    346788999999999999999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=362.61  Aligned_cols=257  Identities=27%  Similarity=0.515  Sum_probs=203.8

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh---HhHHHHHHHHHHHHHcc---CCCCceEEEEE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA---GHENVVKFYNA  165 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~---~hpnIv~~~~~  165 (414)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++........   .....+.+|+.++..+.   +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            4466789999999999999999999999999999999976543211   12334567999999983   49999999999


Q ss_pred             EEcCCEEEEEEec-cCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceee
Q 015026          166 FEDDNYVYIAMEL-CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (414)
Q Consensus       166 ~~~~~~~~lv~e~-~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (414)
                      +...+..++|+|+ +.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.  .++.+||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl~  182 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLI  182 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEEC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEEE
Confidence            9999999999999 7899999998553  46999999999999999999999999999999999999983  46789999


Q ss_pred             ccccccccCCCCccccCCCCCccccchhccccC--CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC
Q 015026          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (414)
Q Consensus       245 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~  322 (414)
                      |||++...... ......||+.|+|||++.+..  +.++||||||+++|+|++|+.||....      .+......+   
T Consensus       183 dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~---  252 (312)
T 2iwi_A          183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHF---  252 (312)
T ss_dssp             CCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCC---
T ss_pred             EcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCC---
Confidence            99999876543 345678999999999876543  447999999999999999999996432      233332222   


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                       ...+++++.+||.+||..||++|||+.|+++||||+....
T Consensus       253 -~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          253 -PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             -cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence             2468899999999999999999999999999999986443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-46  Score=360.41  Aligned_cols=253  Identities=25%  Similarity=0.330  Sum_probs=213.2

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCC-----EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGD-----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .++|++.+.||+|+||+||+|.+..+++     .||+|++....  .....+.+.+|+.+++.+.+||||+++++++.+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            4679999999999999999999977665     79999987543  3345678999999999995599999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcc------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC
Q 015026          170 NYVYIAMELCEGGELLDRILAKK------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~  237 (414)
                      +..++||||+++|+|.+++....            ...+++..+..++.||+.||.|||++||+||||||+|||++   .
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---N  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---G
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---C
Confidence            99999999999999999986532            34689999999999999999999999999999999999998   5


Q ss_pred             CCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHH
Q 015026          238 DSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV  312 (414)
Q Consensus       238 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i  312 (414)
                      ++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+......+..+
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            78999999999986543322   234567889999998764 56889999999999999998 99999887766666555


Q ss_pred             hhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ........  .....++++.+||.+||..||.+|||+.++++
T Consensus       280 ~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          280 VKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            55443222  22457899999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=377.27  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=197.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .+|.+.+.||+|+||+|+. ....+|+.||||++.....      ..+.+|+.+|+.+.+|||||++++++.+....|||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            4699999999999999764 3457899999999865432      23468999999996699999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCC--CCCceeeccccccccC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE--DSSLKATDFGLSDFIK  253 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~--~~~vkl~DFG~a~~~~  253 (414)
                      ||||. |+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++..+.  ...+||+|||+|....
T Consensus        97 ~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             EECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             EECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            99996 59999885443 34566677899999999999999999999999999999964322  3357799999998765


Q ss_pred             CC----CccccCCCCCccccchhccc----cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          254 PG----KKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       254 ~~----~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      ..    ......+||+.|+|||++.+    .++.++|||||||++|+|++ |..||.......... +............
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~  253 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACSLDCLHPE  253 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCCCTTSCTT
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCCccccCcc
Confidence            33    22345789999999999863    34678999999999999999 999996554433222 2221111111111


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ...+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus       254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            234566899999999999999999999999999975

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-46  Score=380.80  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=216.3

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      ..+|++.+.||+|+||.||+|.+..++..||||++.....    ..+.+.+|+.+|+.+. ||||+++++++.+...++|
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcEEE
Confidence            4579999999999999999999999999999999876532    4577899999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---CCCcEEEeecccceeccC
Confidence            99999999999999766666799999999999999999999999999999999999998   578999999999987644


Q ss_pred             CCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...  .....+++.|+|||++.+ .++.++|||||||++|||++ |..||.+.+..++...+....   .......++++
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  447 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCPEK  447 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---CCCCCTTCCHH
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHH
Confidence            322  223456789999998764 46889999999999999999 999999888777766665442   22233578999


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.+||.+||..||.+|||+.++++
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHH
Confidence            999999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.2e-46  Score=371.95  Aligned_cols=243  Identities=23%  Similarity=0.341  Sum_probs=208.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-EEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-YVYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-~~~l  174 (414)
                      ++|++.+.||+|+||+||+|.+.  |+.||||++....     ..+.+.+|+.+|+.+. ||||+++++++.... .+++
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCceEE
Confidence            57999999999999999999864  7799999997543     4467899999999995 999999999987654 7999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus       265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTSCEEECCCTTCEECC-
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---CCCCEEEeeCCCcccccc
Confidence            99999999999999776555689999999999999999999999999999999999998   578999999999986543


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .  .....+++.|+|||++.+ .++.++|||||||++|||++ |..||.+....++...+..+..   ....+.+|+++.
T Consensus       342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~~~~l~  416 (450)
T 1k9a_A          342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVY  416 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTCCHHHH
T ss_pred             c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHHHH
Confidence            2  223467899999998764 46889999999999999998 9999998888777777766532   223357899999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +||.+||..||.+|||+.+++.
T Consensus       417 ~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          417 DVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999885

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.7e-46  Score=354.34  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=201.3

Q ss_pred             cccceeeceeeeecCceEEEEEE----ECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-  168 (414)
                      ..++|++++.||+|+||+||+|.    +..+|+.||||++...   .....+.+.+|+.+++.+. ||||+++++++.. 
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA   83 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            34689999999999999999998    5678999999998654   2445678999999999995 9999999999854 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                       ...+++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg  159 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFG  159 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCc
Confidence             456899999999999999986543 4589999999999999999999999999999999999999   47889999999


Q ss_pred             cccccCCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch----------------
Q 015026          248 LSDFIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED----------------  306 (414)
Q Consensus       248 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~----------------  306 (414)
                      ++........    .....|++.|+|||++.+ .++.++||||||+++|+|++|..||......                
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            9987644322    223457788999998764 4688999999999999999999998643211                


Q ss_pred             hhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          307 GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       307 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .....+... .  .......+++++.+||.+||..||.+|||+.++++
T Consensus       240 ~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          240 HLIELLKNN-G--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcc-C--cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            111112221 1  22223578999999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.7e-46  Score=352.65  Aligned_cols=253  Identities=20%  Similarity=0.282  Sum_probs=205.4

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEE-EEEEcCCEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY-NAFEDDNYV  172 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~-~~~~~~~~~  172 (414)
                      +.++|++.+.||+|+||.||+|.+..+|+.||||++.....     .+.+.+|+.+++.+. |++++..+ .++......
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHT-TSTTCCCEEEEEEETTEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhh-cCCCCCccccccCCCCce
Confidence            45789999999999999999999999999999999876542     245789999999996 66655444 455778889


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++....++.+||+|||++...
T Consensus        81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            9999999 89999988533 357999999999999999999999999999999999999963335789999999999876


Q ss_pred             CCCCc--------cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCc---hhhhHHHhhcCCCCC
Q 015026          253 KPGKK--------FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPDFR  320 (414)
Q Consensus       253 ~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~  320 (414)
                      .....        .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+...   .+.+..+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            54322        2456899999999988764 68899999999999999999999987433   233444333222111


Q ss_pred             -CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          321 -RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       321 -~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                       ....+.+|+++.+||.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence             1112468899999999999999999999999886

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.5e-46  Score=346.69  Aligned_cols=246  Identities=22%  Similarity=0.365  Sum_probs=211.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEEE
Confidence            57999999999999999999986 677899999976543    3467899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||++|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        82 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             ECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---GGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---CCCCEEEcccccccccccc
Confidence            9999999999988543 35689999999999999999999999999999999999998   5788999999999765432


Q ss_pred             C--ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 K--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .  ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+.......   .....++++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l  234 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHV  234 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC---CCccCcHHH
Confidence            1  1234567889999998864 46889999999999999999 999998888777777776653322   224578999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+||.+||..||.+|||+.++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-46  Score=357.09  Aligned_cols=255  Identities=24%  Similarity=0.314  Sum_probs=210.2

Q ss_pred             cccceeeceeeeecCceEEEEEEE-----CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ..++|++.+.||+|+||+||+|.+     ..+++.||||++....  .....+.+.+|+.+++.+.+||||+++++++..
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            346899999999999999999985     4577899999987543  334567889999999999769999999999876


Q ss_pred             C-CEEEEEEeccCCCChHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEe
Q 015026          169 D-NYVYIAMELCEGGELLDRILAKKD--------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (414)
Q Consensus       169 ~-~~~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~  233 (414)
                      . ..+++||||++|++|.+++.....              ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  182 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence            5 459999999999999999865432              1288999999999999999999999999999999999998


Q ss_pred             ecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhh
Q 015026          234 SAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (414)
Q Consensus       234 ~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~  308 (414)
                         .++.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+.
T Consensus       183 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          183 ---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             ---GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ---CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence               578899999999986543322   234568899999998764 46889999999999999998 9999988765544


Q ss_pred             hHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +..........  .....+++++.++|.+||..||.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44433332221  1224588999999999999999999999999984

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9e-47  Score=361.57  Aligned_cols=249  Identities=20%  Similarity=0.271  Sum_probs=205.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCE----EEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ++|++++.||+|+||+||+|.+..+|+.    ||+|.+.....  ......+.+|+.+++.+. ||||+++++++.+ +.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~   88 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPG-SS   88 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCC-CTTBCCEEEEECB-SS
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC-Cc
Confidence            5799999999999999999999888876    67776643321  123345678999999995 9999999998864 56


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES---SSSCEEECSCSGGGG
T ss_pred             cEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC---CCCeEEECCCCcccc
Confidence            89999999999999988543 35689999999999999999999999999999999999998   578999999999987


Q ss_pred             cCCCC---ccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPGK---KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .....   ......||+.|+|||++. +.++.++|||||||++|+|++ |..||.+....++...+.......   ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~  241 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA---QPQI  241 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC---CCTT
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC---CCCc
Confidence            64432   234567888999999876 456889999999999999999 999999887777766666543221   1235


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ++.++.+||.+||..||.+|||+.+++++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77889999999999999999999999885

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.5e-46  Score=350.63  Aligned_cols=253  Identities=26%  Similarity=0.428  Sum_probs=197.8

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      +-..++|++.+.||+|+||+||+|.+.   ..||+|++.... ......+.+.+|+.+++.+. ||||++++++. ....
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~~   93 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAPQ   93 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSSS
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCCc
Confidence            345568999999999999999999753   359999986554 24456788999999999995 99999999955 5566


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||++|++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++..
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATE  169 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC----
T ss_pred             cEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceeccc
Confidence            89999999999999988433 35699999999999999999999999999999999999999   578999999999976


Q ss_pred             cCC---CCccccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh-cCCCCC-CC
Q 015026          252 IKP---GKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-NKPDFR-RK  322 (414)
Q Consensus       252 ~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~-~~~~~~-~~  322 (414)
                      ...   ........||+.|+|||++.    ..++.++||||||+++|+|++|..||.+....+....... ...... ..
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence            432   22334568999999999875    3357789999999999999999999988766554444433 322221 22


Q ss_pred             CCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ....+|+++.+||.+||..||.+|||+.++++
T Consensus       250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            33468899999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=365.21  Aligned_cols=247  Identities=15%  Similarity=0.203  Sum_probs=201.0

Q ss_pred             ccceeeceeeeecCceEEEEEEECCC--------CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceE-----
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKAN--------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK-----  161 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~-----  161 (414)
                      .++|++.+.||+|+||.||+|.+..+        ++.||||++...        +.+.+|+.+++.+. ||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            46899999999999999999999874        889999998754        35678999999995 999887     


Q ss_pred             ----------EEEEEEc-CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 015026          162 ----------FYNAFED-DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENF  230 (414)
Q Consensus       162 ----------~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NI  230 (414)
                                +++++.. +...++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6777765 78899999999 99999999765456799999999999999999999999999999999999


Q ss_pred             EEeecCCCC--CceeeccccccccCCCC--------ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCC
Q 015026          231 LFKSAKEDS--SLKATDFGLSDFIKPGK--------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRP  299 (414)
Q Consensus       231 ll~~~~~~~--~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~P  299 (414)
                      |++   .++  .+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|+.|
T Consensus       191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            998   455  89999999997654321        1234589999999998876 468899999999999999999999


Q ss_pred             CCCCC-chhhhHHH----hhcCCCCCC--CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          300 FWDKT-EDGIFKEV----LRNKPDFRR--KPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       300 f~~~~-~~~~~~~i----~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      |.+.. ....+...    ......+..  ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            98764 22222222    222222211  122357899999999999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.8e-47  Score=360.92  Aligned_cols=246  Identities=24%  Similarity=0.294  Sum_probs=196.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----CE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----NY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----~~  171 (414)
                      ++|++++.||+|+||+||+|.+.  ++.||||++....    .......+|+.+++.+. ||||+++++++...    ..
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCce
Confidence            47999999999999999999864  7899999986542    24455677999999995 99999999999864    35


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeecCCCCCcEEEeecCCCCCc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH----------GLVHRDMKPENFLFKSAKEDSSL  241 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~----------~iiHrDlkp~NIll~~~~~~~~v  241 (414)
                      +++||||+++|+|.+++..   ..+++..++.++.||+.||.|||+.          ||+||||||+|||++   .++.+
T Consensus        97 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---~~~~~  170 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTA  170 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---TTCCE
T ss_pred             EEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---CCCeE
Confidence            7999999999999999854   3589999999999999999999999          999999999999998   57899


Q ss_pred             eeeccccccccCCCCc---cccCCCCCccccchhccc------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh-----
Q 015026          242 KATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDG-----  307 (414)
Q Consensus       242 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----  307 (414)
                      ||+|||++........   ....+||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+.....     
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            9999999977644322   334689999999999875      23567899999999999999999997654321     


Q ss_pred             -----------hhHHHhhcCCCCC-CCCCC--CCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          308 -----------IFKEVLRNKPDFR-RKPWP--SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       308 -----------~~~~i~~~~~~~~-~~~~~--~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                                 ....+........ ...+.  ..++++.+||.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                       1111111111100 00000  12345999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.6e-47  Score=361.28  Aligned_cols=258  Identities=22%  Similarity=0.315  Sum_probs=208.0

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ....++|++.+.||+|+||+||+|.+ .+|+.||||++....   ....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCe
Confidence            44667899999999999999999996 468999999886543   235678999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          172 VYIAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      .++||||++||+|.+++....  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC---TTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC---CCCCEEEeecccc
Confidence            999999999999999874432  23589999999999999999999999999999999999998   6889999999999


Q ss_pred             cccCCC---CccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHh-------hcC--
Q 015026          250 DFIKPG---KKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL-------RNK--  316 (414)
Q Consensus       250 ~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~-------~~~--  316 (414)
                      ......   .......||+.|+|||++. +.++.++|||||||++|+|++|+.||.+....+....+.       ...  
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            764322   1223456899999999875 456899999999999999999999998765443221110       000  


Q ss_pred             ----CCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcc
Q 015026          317 ----PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       317 ----~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~  357 (414)
                          +.......+..+..+.+++.+||..||++|||+.|++++..
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                01111111234567899999999999999999999997543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.1e-46  Score=374.04  Aligned_cols=248  Identities=24%  Similarity=0.343  Sum_probs=212.0

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..++|++.+.||+|+||+||+|.+. ++..||||++.....    ..+.+.+|+.+|+.+. ||||+++++++. .+.++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCccE
Confidence            4467999999999999999999985 467899999976432    4678999999999995 999999999986 56789


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTCCEEECSTTGGGGBC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC---CCCcEEEeeCCCceEcC
Confidence            999999999999999655445689999999999999999999999999999999999998   57899999999998764


Q ss_pred             CCCc--cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          254 PGKK--FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       254 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ....  .....+|+.|+|||++. +.++.++|||||||++|||++ |+.||.+.+..++...+..+..   ......+++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~~  412 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENCPE  412 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---CCCCTTSCH
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence            3221  12345678999999886 456889999999999999999 9999998888888777766532   222346899


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.+||.+||..||.+|||+.+++.
T Consensus       413 ~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          413 ELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHH
Confidence            9999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.4e-46  Score=365.52  Aligned_cols=249  Identities=23%  Similarity=0.345  Sum_probs=200.7

Q ss_pred             cceeeceeeeecCceEEEEEEEC---CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+|++.+.||+|+||+||+|++.   .++..||||++....  .....+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSC
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCce
Confidence            57999999999999999999876   467789999986543  3456678999999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       122 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred             EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc---CCCCEEECcCcccccc
Confidence            9999999999999988543 35699999999999999999999999999999999999998   5789999999999876


Q ss_pred             CCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .....    .....+|+.|+|||++.+ .++.++|||||||++|||++ |+.||.+....++...+.....   ......
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~  274 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR---LPPPMD  274 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---CCCCTT
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence            43321    112345788999998764 46889999999999999998 9999998887777766655422   222346


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.++.+||.+||+.||.+||++.++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            8899999999999999999999999886

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.7e-46  Score=352.45  Aligned_cols=252  Identities=19%  Similarity=0.278  Sum_probs=202.8

Q ss_pred             ccceeeceeeeecCceEEEEEEECC---CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC-
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-  170 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~-  170 (414)
                      .++|.+.+.||+|+||.||+|.+..   ++..||+|++..... .....+.+.+|+.+++.+. ||||+++++++.+.. 
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC---
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccc
Confidence            3579999999999999999998765   556899999875532 3445678999999999995 999999999997654 


Q ss_pred             ----EEEEEEeccCCCChHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          171 ----YVYIAMELCEGGELLDRILAK----KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       171 ----~~~lv~e~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                          ..++||||+++++|.+++...    ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC---TTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEE
Confidence                359999999999999988532    345699999999999999999999999999999999999998   578999


Q ss_pred             eeccccccccCCCCc---cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCC
Q 015026          243 ATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       243 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      |+|||++........   .....+++.|+|||++.+. ++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            999999976543321   2234678899999987654 5889999999999999999 9999988888777777766542


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                         ......+++++.+||.+||..||.+|||+.++++
T Consensus       268 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  301 (313)
T 3brb_A          268 ---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL  301 (313)
T ss_dssp             ---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               2223568899999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-46  Score=348.19  Aligned_cols=251  Identities=21%  Similarity=0.278  Sum_probs=210.8

Q ss_pred             cceeece-eeeecCceEEEEEEEC--CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGK-LLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||||++....  .....+.+.+|+.+++.+. ||||+++++++. .+..
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~   84 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ-AEAL   84 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE-SSSE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEec-CCCc
Confidence            4677776 9999999999999864  467789999987643  3456788999999999995 999999999994 4568


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeee
Confidence            999999999999998843 345699999999999999999999999999999999999999   4789999999999876


Q ss_pred             CCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .....    .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+......   ...+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~  237 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE  237 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTT
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCCC
Confidence            54322    123457899999998864 46889999999999999998 99999888877777766665321   22357


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~  357 (414)
                      +++++.+||.+||..||.+|||+.+++++.+
T Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            8999999999999999999999999998544

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=355.22  Aligned_cols=251  Identities=21%  Similarity=0.333  Sum_probs=204.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE----cCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE----DDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~----~~~~  171 (414)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...   .....+.+.+|+.+++.+. ||||+++++++.    ....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCce
Confidence            5799999999999999999999999999999998653   2346778899999999994 999999999986    3457


Q ss_pred             EEEEEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          172 VYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      .++||||+++++|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---CCCCEEEEecCcc
Confidence            89999999999999988553  346799999999999999999999999999999999999998   5789999999998


Q ss_pred             cccCCCC----------ccccCCCCCccccchhcccc----CCCCcchhHHHHHHHHHhhCCCCCCCCCc-hhhhHHHhh
Q 015026          250 DFIKPGK----------KFQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLR  314 (414)
Q Consensus       250 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~i~~  314 (414)
                      .......          ......||+.|+|||++.+.    ++.++||||||+++|+|++|..||..... .........
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            7543211          11234689999999998643    48899999999999999999999954211 111222222


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ...  ..+..+.+++++.+||.+||+.||.+|||+.+++++
T Consensus       262 ~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          262 NQL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccC--CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            222  222235789999999999999999999999999984

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=355.84  Aligned_cols=249  Identities=22%  Similarity=0.293  Sum_probs=203.1

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEE----EEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .++|++++.||+|+||+||+|.+..+++.|    |+|.+....  .....+.+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence            357999999999999999999999888865    566554322  2335678899999999995 999999999998765


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                       .++|+|++.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK  165 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC--
T ss_pred             -ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCccee
Confidence             78999999999999988654 35699999999999999999999999999999999999998   47789999999998


Q ss_pred             ccCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          251 FIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       251 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      .......   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+......   ...+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  242 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPP  242 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCc
Confidence            7643322   223457889999998765 46889999999999999999 99999888777776666554322   2234


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .++.++.+||.+||..||.+|||+.++++
T Consensus       243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            68899999999999999999999999997

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-45  Score=349.86  Aligned_cols=251  Identities=25%  Similarity=0.338  Sum_probs=203.1

Q ss_pred             ccceeeceeeeecCceEEEEEE----ECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC-
Q 015026           95 DRRYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~-  169 (414)
                      ..+|++++.||+|+||.||+|.    +..+++.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.+. 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLY-HENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence            4579999999999999999998    567899999999875432  235578899999999995 99999999999876 


Q ss_pred             -CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                       ..+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~  172 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGL  172 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECcccc
Confidence             6789999999999999988554 35699999999999999999999999999999999999998   477999999999


Q ss_pred             ccccCCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCC--------------chhhh
Q 015026          249 SDFIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT--------------EDGIF  309 (414)
Q Consensus       249 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~--------------~~~~~  309 (414)
                      +........    .....||..|+|||++.+ .++.++||||||+++|+|++|..|+....              .....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            987654432    234578889999998765 45788999999999999999999863221              11111


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ........  .....+.+++++.+||.+||..||.+|||+.++++
T Consensus       253 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          253 VNTLKEGK--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccC--CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            11122211  22233578999999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-45  Score=345.47  Aligned_cols=247  Identities=23%  Similarity=0.343  Sum_probs=209.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++++.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.+. ||||+++++++.+ +..++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCC-CcCcceEEEEEcC-CCcEE
Confidence            468999999999999999999975 567899999875432    3567899999999995 9999999998875 45899


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.....
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECSS
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---CCCCEEECCCcccccccC
Confidence            99999999999988544334699999999999999999999999999999999999998   578999999999987654


Q ss_pred             CCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ...  .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+.....   ......++++
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  238 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPDNCPEE  238 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHH
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---CCCcccccHH
Confidence            322  234467889999998864 46889999999999999999 9999988887777777665432   2223468899


Q ss_pred             HHHHHHHhhcCCccccCCHHHHhC
Q 015026          331 AKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +.+||.+||..||++|||+.++++
T Consensus       239 l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          239 LYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999999886

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.1e-46  Score=352.12  Aligned_cols=254  Identities=20%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEE-EEEEcCCE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY-NAFEDDNY  171 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~-~~~~~~~~  171 (414)
                      .+.++|++.+.||+|+||+||+|.+..+++.||||++.....     ...+.+|+.+++.+. |++++..+ .++...+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhc-CCCCCCeeeeecCCCCc
Confidence            355789999999999999999999999999999998765432     235788999999997 66555544 45578889


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||++..
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             eEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            99999999 89999988533 45699999999999999999999999999999999999994333678999999999987


Q ss_pred             cCCCCc--------cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch---hhhHHHhhcCCCC
Q 015026          252 IKPGKK--------FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED---GIFKEVLRNKPDF  319 (414)
Q Consensus       252 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~i~~~~~~~  319 (414)
                      ......        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....   ..+..+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            654322        235689999999998775 4688999999999999999999999875433   2333332222111


Q ss_pred             C-CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          320 R-RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       320 ~-~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      + ......+|+++.+||.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            1 1112467899999999999999999999999987

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.8e-46  Score=355.26  Aligned_cols=250  Identities=24%  Similarity=0.434  Sum_probs=189.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE--------
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--------  167 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~--------  167 (414)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++....   ....+.+.+|+.+++.+.+||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            47999999999999999999999999999999986542   3456788999999999977999999999983        


Q ss_pred             cCCEEEEEEeccCCCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceee
Q 015026          168 DDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKAT  244 (414)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~  244 (414)
                      ....+++||||+. |+|.+++.. .....+++..++.++.||+.||.|||+.|  |+||||||+|||++   .++.+||+
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~---~~~~~kl~  180 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLC  180 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC---TTSCEEBC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC---CCCCEEEe
Confidence            4456899999996 689888854 23456999999999999999999999999  99999999999998   57899999


Q ss_pred             ccccccccCCCCcc-------------ccCCCCCccccchhcc----ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchh
Q 015026          245 DFGLSDFIKPGKKF-------------QDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDG  307 (414)
Q Consensus       245 DFG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~  307 (414)
                      |||++.........             ...+||+.|+|||++.    ..++.++|||||||++|+|++|..||.+.....
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            99999876443221             1456999999999873    235778999999999999999999997655443


Q ss_pred             hhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       308 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      .....    .  ........++.+.+||.+||+.||.+|||+.|++++.+-
T Consensus       261 ~~~~~----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          261 IVNGK----Y--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             ---------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhcCc----c--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            33221    1  122234677889999999999999999999999996543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.4e-45  Score=344.02  Aligned_cols=249  Identities=22%  Similarity=0.288  Sum_probs=206.8

Q ss_pred             ccceeeceeeeecCceEEEEEEECC---CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .++|++.+.||+|+||+||+|.+..   ++..||+|++....  .....+.+.+|+.+++.+. ||||+++++++.++ .
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE-P   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS-S
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC-C
Confidence            3579999999999999999998654   33469999987653  3346678999999999995 99999999998764 4


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRY  162 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGC
T ss_pred             CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCcc
Confidence            68999999999999988553 35689999999999999999999999999999999999998   477999999999987


Q ss_pred             cCCCCc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          252 IKPGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       252 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ......  .....||+.|+|||++.+ .++.++||||||+++|+|++ |+.||......+....+......   .....+
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  239 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---PKPDLC  239 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---CCCTTC
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---CCCCCC
Confidence            654322  234567889999998864 46889999999999999998 99999887777776666554322   122468


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.+.+||.+||..||.+|||+.++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~ell~  266 (281)
T 3cc6_A          240 PPVLYTLMTRCWDYDPSDRPRFTELVC  266 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            899999999999999999999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.2e-46  Score=351.59  Aligned_cols=247  Identities=24%  Similarity=0.369  Sum_probs=196.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHH--ccCCCCceEEEEEEEc--
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA--LAGHENVVKFYNAFED--  168 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~~hpnIv~~~~~~~~--  168 (414)
                      .+.++|++.+.||+|+||+||+|.+  +|+.||||++...      ....+.+|.+++..  + +||||+++++++..  
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTSR   75 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeecccc
Confidence            4567899999999999999999986  6899999998653      34556778888877  6 59999999998643  


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEEeecCCC
Q 015026          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH--------LHGLVHRDMKPENFLFKSAKED  238 (414)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH--------~~~iiHrDlkp~NIll~~~~~~  238 (414)
                        ...+++||||+++|+|.+++.   ...+++..+..++.||+.||.|||        +.||+||||||+|||++   .+
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~---~~  149 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK---KN  149 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC---TT
T ss_pred             CCCceeEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc---CC
Confidence              356899999999999999983   357999999999999999999999        99999999999999998   57


Q ss_pred             CCceeeccccccccCCCCc-----cccCCCCCccccchhcccc-------CCCCcchhHHHHHHHHHhhC----------
Q 015026          239 SSLKATDFGLSDFIKPGKK-----FQDIVGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCG----------  296 (414)
Q Consensus       239 ~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~elltg----------  296 (414)
                      +.+||+|||++........     ....+||+.|+|||++.+.       ++.++|||||||++|||++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            8999999999976543322     2345899999999998764       23689999999999999999          


Q ss_pred             CCCCCCCCch----hhhHHHhhcCCCCCCCC----CCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          297 RRPFWDKTED----GIFKEVLRNKPDFRRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       297 ~~Pf~~~~~~----~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..||.+....    .............+..+    ....++++.+||.+||+.||.+|||+.++++
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            8898664332    22222222111111110    0124567999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.7e-46  Score=363.94  Aligned_cols=258  Identities=17%  Similarity=0.225  Sum_probs=195.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCC-----CCEEEEEEeeccCCCChHh--------HHHHHHHHHHHHHccCCCCc
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKAN-----GDRVAVKKIEKNKMILPIA--------VEDVKREVKILQALAGHENV  159 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~~--------~~~~~~E~~il~~l~~hpnI  159 (414)
                      ...++|++++.||+|+||+||+|.+..+     ++.||||++..........        ...+..|+..++.+ +||||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~i  110 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGV  110 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCS
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCC
Confidence            3456899999999999999999998765     5789999986543100000        01122333444455 39999


Q ss_pred             eEEEEEEEcC----CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec
Q 015026          160 VKFYNAFEDD----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA  235 (414)
Q Consensus       160 v~~~~~~~~~----~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~  235 (414)
                      +++++++...    ...+|||||+ |++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. 
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-  187 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-  187 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-
Confidence            9999998764    5689999999 9999998855 3467999999999999999999999999999999999999983 


Q ss_pred             CCCCCceeeccccccccCCCCc--------cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCch
Q 015026          236 KEDSSLKATDFGLSDFIKPGKK--------FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED  306 (414)
Q Consensus       236 ~~~~~vkl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~  306 (414)
                      ..++.+||+|||+++.......        ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            2368999999999976543211        1345699999999988765 688999999999999999999999865433


Q ss_pred             hhhHHHhhcC-----CCCC--CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          307 GIFKEVLRNK-----PDFR--RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       307 ~~~~~i~~~~-----~~~~--~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..........     ..+.  ......+|+++.+||..||..||.+||++.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2222111100     0000  0011467899999999999999999999999886

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-45  Score=348.24  Aligned_cols=248  Identities=21%  Similarity=0.290  Sum_probs=206.6

Q ss_pred             cceeece-eeeecCceEEEEEEE--CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGK-LLGHGQFGYTYVATD--KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+|++.+ .||+|+||+||+|.+  ..+++.||||++..... .....+.+.+|+.+++.+. ||||+++++++ ..+..
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSSE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCCc
Confidence            5799988 999999999999954  56778999999876532 2345678999999999995 99999999999 55678


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++++|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceee
Confidence            999999999999999854  45699999999999999999999999999999999999999   4779999999999876


Q ss_pred             CCCCcc----ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKKF----QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ......    ....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....++...+.....   ....+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~  244 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAG  244 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTT
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCC
Confidence            543321    22456789999998865 45889999999999999999 9999998887777666655432   122346


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +++++.++|.+||..||.+|||+.++++
T Consensus       245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          245 CPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8999999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-45  Score=352.91  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=205.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCC----CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANG----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ..+|.+.+.||+|+||+||+|.+..++    ..||||++....  .......+.+|+.+++.+. ||||+++++++.+.+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK  119 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCC
Confidence            357999999999999999999887654    359999987543  3445677899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      ..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSR  195 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC--
T ss_pred             CcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---CCCcEEECCCCcch
Confidence            999999999999999988543 45799999999999999999999999999999999999998   57899999999998


Q ss_pred             ccCCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          251 FIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       251 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      .......    .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....++...+.....   ....
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---~~~~  272 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LPTP  272 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc---CCCc
Confidence            7643321    123456889999998764 46889999999999999998 9999988887777777765432   1223


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+++++.+||.+||..||.+||++.++++
T Consensus       273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            468899999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.6e-46  Score=370.60  Aligned_cols=248  Identities=25%  Similarity=0.356  Sum_probs=206.7

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..++|++.+.||+|+||+||+|.+.. +..||||++.....    ..+.+.+|+.+|+.+. ||||+++++++.+ +..+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-CceE
Confidence            34679999999999999999999865 45799999976542    3467899999999995 9999999999876 6689


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC---
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---CCCCEEECCCccceecC
Confidence            999999999999999654456799999999999999999999999999999999999998   57899999999998764


Q ss_pred             CCCc--cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          254 PGKK--FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       254 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ....  .....+++.|+|||++. +.++.++|||||||++|||++ |..||.+....++...+..+..   ....+.+|+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~~  408 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPE  408 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence            3321  22345788999999876 456889999999999999999 9999998888777777765532   222347899


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.+||.+||..||.+|||++++++
T Consensus       409 ~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          409 SLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1e-45  Score=346.01  Aligned_cols=243  Identities=22%  Similarity=0.333  Sum_probs=199.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-CCEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNYVYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-~~~~~l  174 (414)
                      ++|++.+.||+|+||+||+|.+  +|+.||+|++....     ..+.+.+|+.+++.+. ||||+++++++.. .+..++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred             hhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCceEE
Confidence            5799999999999999999976  48899999986543     4577899999999995 9999999998754 457899


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC------
T ss_pred             EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe---CCCcEEEeeccccccccc
Confidence            99999999999998655444489999999999999999999999999999999999998   578999999999876543


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .  .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+....   .......+++++.
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~  244 (278)
T 1byg_A          170 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAVY  244 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---CCCCCTTCCHHHH
T ss_pred             c--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCcccCCHHHH
Confidence            2  234468899999998764 46889999999999999998 999998887777776665542   2223357899999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++|.+||..||.+|||+.++++
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-45  Score=349.63  Aligned_cols=252  Identities=22%  Similarity=0.303  Sum_probs=206.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCC-CChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      .|..++.||+|+||+||+|.+  +++.||+|++..... ......+.+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  108 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLV  108 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEE
Confidence            356678999999999999974  688999999865432 22345678999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          176 MELCEGGELLDRILAK-KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---CCCcEEEeeccccccccc
Confidence            9999999999988643 245699999999999999999999999999999999999998   578999999999976543


Q ss_pred             CCc---cccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh----cCCCC-------C
Q 015026          255 GKK---FQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----NKPDF-------R  320 (414)
Q Consensus       255 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~----~~~~~-------~  320 (414)
                      ...   .....||+.|+|||++.+.++.++||||||+++|+|++|..||.+.........+..    ....+       .
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM  265 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred             ccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence            221   234679999999999988889999999999999999999999987655443333322    11100       0


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .......++.+.++|.+||..||.+|||+.++++
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1111234567899999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.2e-45  Score=345.17  Aligned_cols=249  Identities=22%  Similarity=0.262  Sum_probs=205.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC---CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEE-EcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG---DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF-EDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~-~~~~~  171 (414)
                      .+|++.+.||+|+||+||+|.+..++   ..||+|.+....  .....+.+.+|+.+++.+. ||||+++++++ ..++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCCc
Confidence            46999999999999999999875443   358999886532  3456678999999999995 99999999985 45678


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       102 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARD  177 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSCGGGCC
T ss_pred             eEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC---CCCCEEECccccccc
Confidence            8999999999999998854 345689999999999999999999999999999999999998   678999999999976


Q ss_pred             cCCCC-----ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          252 IKPGK-----KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       252 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      .....     ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+....+....+........   .
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  254 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---P  254 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---C
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---C
Confidence            54322     1234567889999998765 46889999999999999999 6777877777777766666543322   2


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+++++.++|.+||..||.+|||+.++++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            457899999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-45  Score=347.93  Aligned_cols=256  Identities=22%  Similarity=0.344  Sum_probs=204.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECC-CCC--EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKA-NGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .++|++++.||+|+||+||+|.+.. +++  .||||++...........+.+.+|+.+++.+. ||||+++++++..+. 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence            3579999999999999999998643 343  68999987654444456788999999999995 999999999998765 


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++|+||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRA  170 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEE
T ss_pred             ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcccccccc
Confidence            88999999999999988654 24689999999999999999999999999999999999998   477899999999987


Q ss_pred             cCCCCc----cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          252 IKPGKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       252 ~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      ......    .....+|+.|+|||++.+. ++.++||||||+++|+|++ |..||.+....+....+.......+  ...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  248 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPE  248 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CCc
Confidence            654332    2245678899999988654 5889999999999999999 9999998888877777766544332  234


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      .+++++.++|.+||..||.+|||+.++++  ++..
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~  281 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLE  281 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHH
Confidence            78999999999999999999999999997  5543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-45  Score=352.73  Aligned_cols=248  Identities=23%  Similarity=0.348  Sum_probs=205.5

Q ss_pred             cceeeceeeeecCceEEEEEE----ECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE--cC
Q 015026           96 RRYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--DD  169 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~--~~  169 (414)
                      ++|++++.||+|+||.||+|.    +..+++.||||++....   ....+.+.+|+.+++.+ +||||+++++++.  +.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCC
Confidence            579999999999999999998    56789999999987542   34567799999999999 5999999999886  56


Q ss_pred             CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccc
Q 015026          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a  249 (414)
                      ...++||||++|++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA  174 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccc
Confidence            77999999999999999886533 4689999999999999999999999999999999999998   4788999999999


Q ss_pred             cccCCCCc----cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCch---------------hhh
Q 015026          250 DFIKPGKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED---------------GIF  309 (414)
Q Consensus       250 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~---------------~~~  309 (414)
                      ........    .....||+.|+|||++.+. ++.++||||||+++|+|++|..||......               ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            87654332    2345688999999987654 588999999999999999999998654321               111


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+... .  .....+.+++++.+||.+||..||.+|||+.++++
T Consensus       255 ~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          255 ELLEEG-Q--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             HHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhhcc-c--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            122222 1  22233578999999999999999999999999965

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=342.06  Aligned_cols=249  Identities=22%  Similarity=0.258  Sum_probs=204.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC---EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ..|.+.+.||+|+||+||+|.+..+++   .||+|++....  .....+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCC
Confidence            358888999999999999999766655   79999986532  3456778899999999995 99999999999766554


Q ss_pred             -EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          173 -YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       173 -~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                       ++||||+.+++|.+++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++..
T Consensus        98 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARD  173 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECCTTSSCT
T ss_pred             cEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEeCcCCCccc
Confidence             999999999999998854 346789999999999999999999999999999999999998   678999999999976


Q ss_pred             cCCC-----CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhC-CCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          252 IKPG-----KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       252 ~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      ....     .......||+.|+|||.+.+. ++.++||||||+++|+|++| .+||......+....+......   ...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~  250 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL---PQP  250 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC---CCC
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC---CCC
Confidence            5332     222345788999999988764 58899999999999999995 5555555555555555444321   122


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+++++.+||.+||..||.+|||+.++++
T Consensus       251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            468899999999999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=360.94  Aligned_cols=258  Identities=21%  Similarity=0.229  Sum_probs=196.5

Q ss_pred             cccccceeeceeeeecCceEEEEEEECC---CCCEEEEEEeeccCCCCh--------HhHHHHHHHHHHHHHccCCCCce
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILP--------IAVEDVKREVKILQALAGHENVV  160 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~--------~~~~~~~~E~~il~~l~~hpnIv  160 (414)
                      +...++|++.+.||+|+||+||+|.+..   ++..||||++........        .....+.+|+.+++.+. ||||+
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~  111 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIP  111 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcc
Confidence            3345689999999999999999999987   888999999876432100        01223567888888884 99999


Q ss_pred             EEEEEEEc----CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC
Q 015026          161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       161 ~~~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~  236 (414)
                      ++++++..    ....++||||+ |++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.. 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-  187 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-  187 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-
Confidence            99999987    78899999999 99999988443  379999999999999999999999999999999999999842 


Q ss_pred             CCCCceeeccccccccCCCC--------ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchh
Q 015026          237 EDSSLKATDFGLSDFIKPGK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDG  307 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~  307 (414)
                      ..+.+||+|||+++......        ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.....
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            12399999999997653221        12456899999999998765 6889999999999999999999996533221


Q ss_pred             -hhHHHhhc-CCCCCC---C--CCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          308 -IFKEVLRN-KPDFRR---K--PWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       308 -~~~~i~~~-~~~~~~---~--~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                       ........ ....+.   .  ....+++++.+||.+||..||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence             11111111 011110   0  11268899999999999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-46  Score=387.08  Aligned_cols=263  Identities=24%  Similarity=0.387  Sum_probs=211.3

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc------
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------  168 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~------  168 (414)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++....  .....+.+.+|+.+++.+. ||||+++++++..      
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccC
Confidence            367999999999999999999999999999999886542  3456778999999999995 9999999998765      


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                      .+..++||||++||+|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+||+++..+....+||+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            677899999999999999886533 2368999999999999999999999999999999999999964444569999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhh--------------HHH
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIF--------------KEV  312 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~--------------~~i  312 (414)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+              ...
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            9988776666667899999999998864 5688999999999999999999999764322111              011


Q ss_pred             hhcCCCCC------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          313 LRNKPDFR------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       313 ~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ..+...+.      ....+.+++.+.+||.+||..||++|||+.++|+||||+.
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            11111111      1112236788999999999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.5e-45  Score=350.50  Aligned_cols=251  Identities=27%  Similarity=0.352  Sum_probs=203.7

Q ss_pred             ccccce-eeceeeeecCceEEEEEEE----CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE
Q 015026           93 DFDRRY-TIGKLLGHGQFGYTYVATD----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (414)
Q Consensus        93 ~~~~~y-~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~  167 (414)
                      .+.++| ++++.||+|+||+||++..    ..+|+.||||++....  .....+.+.+|+.+++.+. ||||+++++++.
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  103 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCE  103 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEe
Confidence            355566 9999999999999988753    4578899999997653  3456778999999999995 999999999998


Q ss_pred             c--CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeec
Q 015026          168 D--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (414)
Q Consensus       168 ~--~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (414)
                      +  ...+++||||+++++|.+++..   ..+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---~~~~~kl~D  177 (318)
T 3lxp_A          104 DAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGD  177 (318)
T ss_dssp             ETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred             cCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---CCCCEEECC
Confidence            7  4789999999999999998843   3489999999999999999999999999999999999998   578999999


Q ss_pred             cccccccCCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh-------------
Q 015026          246 FGLSDFIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG-------------  307 (414)
Q Consensus       246 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-------------  307 (414)
                      ||++........    .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.......             
T Consensus       178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 3lxp_A          178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV  257 (318)
T ss_dssp             GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred             ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence            999987654432    234568889999998765 46889999999999999999999996542210             


Q ss_pred             -hhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          308 -IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       308 -~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                       .+........  .......+++++.+||.+||..||.+|||+.++++
T Consensus       258 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          258 LRLTELLERGE--RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccc--CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             1111222221  22223568999999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-45  Score=352.41  Aligned_cols=260  Identities=19%  Similarity=0.260  Sum_probs=204.4

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ....++|++.+.||+|+||+||+|.+ .+|+.||||++......  .....+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  101 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTE  101 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSSC
T ss_pred             HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhcc-CCCccceEEEEecCCc
Confidence            34557899999999999999999974 46899999998764321  12236889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          172 VYIAMELCEGGELLDRILAKKD--SRYTEKDAAVVVRQMLRVAAECHLH---GLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qil~~L~~LH~~---~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      .++||||++||+|.+++.....  ..+++..+..++.||+.||.|||++   ||+||||||+|||++   .++.+||+||
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~Df  178 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDF  178 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC---TTCCEEECCC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC---CCCCEEeccC
Confidence            9999999999999999865432  3489999999999999999999999   999999999999998   5789999999


Q ss_pred             ccccccCCCC--ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCC----CchhhhHHHhhcCCC-
Q 015026          247 GLSDFIKPGK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPD-  318 (414)
Q Consensus       247 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~----~~~~~~~~i~~~~~~-  318 (414)
                      |++.......  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...    ............... 
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            9998764322  2345679999999998754 4688999999999999999999999521    111111111111100 


Q ss_pred             ----------CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          319 ----------FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       319 ----------~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                                ......+..++.+.+|+.+||+.||.+|||+.++++|..-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                      0001111234678999999999999999999999996653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=358.33  Aligned_cols=249  Identities=21%  Similarity=0.257  Sum_probs=198.6

Q ss_pred             ccceeeceeeeecCceEEEEE-----EECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccC--CCCceEEEEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG--HENVVKFYNAFE  167 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~--hpnIv~~~~~~~  167 (414)
                      .++|.+.+.||+|+||+||+|     .+..+++.||||++...      ....+.+|+.+++.+..  |+||+.+++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            467999999999999999999     46788999999998654      34567788888888842  899999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee--------cC
Q 015026          168 DDNYVYIAMELCEGGELLDRILAK---KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS--------AK  236 (414)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~--------~~  236 (414)
                      ..+..+|||||++||+|.+++...   ....+++..++.++.||+.||.|||++||+||||||+|||++.        ..
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            999999999999999999998643   3457999999999999999999999999999999999999984        12


Q ss_pred             CCCCceeeccccccccC---CCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHH
Q 015026          237 EDSSLKATDFGLSDFIK---PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV  312 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i  312 (414)
                      .++.+||+|||+|....   ........+||+.|+|||++.+. ++.++|||||||++|||++|+.||.........  +
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~  295 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--P  295 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--E
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--e
Confidence            27899999999996543   33445667899999999988765 689999999999999999999999654322110  0


Q ss_pred             hhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcc
Q 015026          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~  357 (414)
                         ...+..   ...++.+.+++..||+.+|.+|++..+.|.+.+
T Consensus       296 ---~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          296 ---EGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             ---CSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             ---chhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence               011111   124678999999999999999976655555433

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=343.43  Aligned_cols=241  Identities=28%  Similarity=0.430  Sum_probs=193.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|.+  +++.||||++...     ...+.+.+|+.+++.+. ||||+++++++.+.  .++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~--~~lv   77 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACLNP--VCLV   77 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCTTT--TEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCC--cEEE
Confidence            4799999999999999999986  4788999998643     25678899999999995 99999999988743  7899


Q ss_pred             EeccCCCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCeecCCCCCcEEEeecCCCCC-ceeecccccc
Q 015026          176 MELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSS-LKATDFGLSD  250 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qil~~L~~LH~---~~iiHrDlkp~NIll~~~~~~~~-vkl~DFG~a~  250 (414)
                      |||++|++|.+++..... ..+++..+..++.||+.||.|||+   +||+||||||+|||++   .++. +||+|||++.
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTAC  154 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC--
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccccccc
Confidence            999999999999854332 247899999999999999999999   8999999999999998   3454 8999999997


Q ss_pred             ccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchh--hhHHHhhcCCCCCCCCCCCC
Q 015026          251 FIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG--IFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~  327 (414)
                      .....  .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.......  ....+....   .......+
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  229 (307)
T 2eva_A          155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNL  229 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTC
T ss_pred             ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCccccc
Confidence            65432  234579999999998876 46889999999999999999999997654332  222232222   22233578


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.+.+||.+||..||.+|||+.++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-45  Score=357.30  Aligned_cols=249  Identities=22%  Similarity=0.256  Sum_probs=199.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC---CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE-cCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG---DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-DDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~-~~~~  171 (414)
                      ..|++.+.||+|+||+||+|.+..++   ..||+|.+....  .....+.+.+|+.+++.+. ||||+++++++. .++.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence            35889999999999999999875443   368999886432  3346788999999999995 999999999865 4568


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus       166 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARD  241 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC-----
T ss_pred             eEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC---CCCCEEEeecccccc
Confidence            8999999999999998843 345689999999999999999999999999999999999998   578999999999976


Q ss_pred             cCCCC-----ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          252 IKPGK-----KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       252 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      .....     ......||+.|+|||++.+ .++.++|||||||++|+|++ |.+||.+....+....+..+.....   .
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p  318 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---P  318 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---C
T ss_pred             ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            54322     1233567889999998764 46889999999999999999 7888888777777766666543222   2


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+++++.++|.+||..||.+|||+.++++
T Consensus       319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            468899999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.4e-45  Score=372.69  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=211.2

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..++|++.+.||+|+||+||+|.+.. +..||||++.....    ..+.+.+|+.+|+.|. ||||+++++++.+ +.++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-ccce
Confidence            34679999999999999999999865 45799999976542    3467899999999995 9999999999876 6689


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      |||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCTTSTTTCC
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---CCCcEEEcccccceecC
Confidence            999999999999999654445699999999999999999999999999999999999998   57899999999998764


Q ss_pred             CCC--ccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          254 PGK--KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       254 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ...  ......++..|+|||++. +.++.++|||||||++|||++ |+.||.+....+++..+..+..   ......+++
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~~  491 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPE  491 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCH
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence            321  112345778999999875 456889999999999999999 9999998888887777765532   222347899


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.+||.+||..||++|||+.++++
T Consensus       492 ~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          492 SLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.1e-45  Score=366.60  Aligned_cols=255  Identities=18%  Similarity=0.277  Sum_probs=207.9

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++.....     ...+.+|+.+++.|.++++|+.+..++...+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            355789999999999999999999999999999998875542     234788999999998667777787788889999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      +|||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||+....++.+||+|||+++..
T Consensus        79 ~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9999999 89999988533 457999999999999999999999999999999999999953336789999999999876


Q ss_pred             CCCCc--------cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch---hhhHHHhhcCCC-C
Q 015026          253 KPGKK--------FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED---GIFKEVLRNKPD-F  319 (414)
Q Consensus       253 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~i~~~~~~-~  319 (414)
                      .....        ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....   +.+..+...... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            54322        226789999999998775 4688999999999999999999999876543   223333222110 1


Q ss_pred             CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .......+++++.+||..||..||.+||++.++++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            11112467899999999999999999999998776

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-45  Score=364.13  Aligned_cols=249  Identities=20%  Similarity=0.216  Sum_probs=196.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCc---------------
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENV---------------  159 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnI---------------  159 (414)
                      ..|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. | +|+               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchhh
Confidence            45889999999999999999999999999999987544433345678999999999885 5 321               


Q ss_pred             ------eEEEEEEEc-----CCEEEEEEeccCCCChHHHHH-----hccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeec
Q 015026          160 ------VKFYNAFED-----DNYVYIAMELCEGGELLDRIL-----AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR  223 (414)
Q Consensus       160 ------v~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~-----~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHr  223 (414)
                            ..+..++..     ...++++|+++ +++|.+++.     ......+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  111111121     23467788876 679988874     2223457788899999999999999999999999


Q ss_pred             CCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCccccchhcc----------c-cCCCCcchhHHHHHHHH
Q 015026          224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK----------R-KSGPESDVWSIGVITYI  292 (414)
Q Consensus       224 Dlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~----------~-~~~~~~DiwslG~il~e  292 (414)
                      ||||+|||++   .++.+||+|||+++.....  ....+| +.|+|||++.          + .++.++|||||||++|+
T Consensus       236 DiKp~NILl~---~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLD---QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEEC---TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEe---cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            9999999999   5778999999998765432  456688 9999999873          2 24678999999999999


Q ss_pred             HhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          293 LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       293 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      |++|+.||.+....+....+...        +..+|+++.+||.+||..||.+|||+.++++||||+.
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGGSS--------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHHHhh--------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            99999999887766655555432        2367899999999999999999999999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.7e-46  Score=359.81  Aligned_cols=251  Identities=17%  Similarity=0.223  Sum_probs=198.2

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC-----ChHhHHHHHHHHHHHHHcc--------CCCCceE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----LPIAVEDVKREVKILQALA--------GHENVVK  161 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~--------~hpnIv~  161 (414)
                      .++|++++.||+|+||+||+|++  +|+.||||++......     .....+.+.+|+.+++.+.        .|||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35799999999999999999987  7899999999765421     2234578899999999985        4888888


Q ss_pred             EEEEEE------------------------------cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHH
Q 015026          162 FYNAFE------------------------------DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV  211 (414)
Q Consensus       162 ~~~~~~------------------------------~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~  211 (414)
                      +.+++.                              +.+.+||||||+++|++.+.+..   ..+++..++.++.||+.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            887653                              26789999999999988777633   568999999999999999


Q ss_pred             HHHHH-HcCCeecCCCCCcEEEeecCC-----------------CCCceeeccccccccCCCCccccCCCCCccccchhc
Q 015026          212 AAECH-LHGLVHRDMKPENFLFKSAKE-----------------DSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL  273 (414)
Q Consensus       212 L~~LH-~~~iiHrDlkp~NIll~~~~~-----------------~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  273 (414)
                      |.||| ++||+||||||+|||++..+.                 ...+||+|||+|+.....    ..+||+.|+|||++
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence            99999 999999999999999995321                 128999999999876543    34899999999999


Q ss_pred             cccCCCCcchhHHHHH-HHHHhhCCCCCCCCCc-hhhhHHHhhcCC---CCCCCCCCCCCHHHHHHHHHhhcCCccccCC
Q 015026          274 KRKSGPESDVWSIGVI-TYILLCGRRPFWDKTE-DGIFKEVLRNKP---DFRRKPWPSISNSAKDFVKKLLVKDPRARLT  348 (414)
Q Consensus       274 ~~~~~~~~DiwslG~i-l~elltg~~Pf~~~~~-~~~~~~i~~~~~---~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps  348 (414)
                      .+..+.++||||+|++ .+++++|..||.+... ......+.....   ......++.+|+++.+||.+||+.|     |
T Consensus       250 ~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s  324 (336)
T 2vuw_A          250 TGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S  324 (336)
T ss_dssp             CCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred             cCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence            8887889999998777 7788889999843211 112223332111   1111112357889999999999976     9


Q ss_pred             HHHHh-CCcccc
Q 015026          349 AAQAL-SHPWVR  359 (414)
Q Consensus       349 ~~elL-~hp~f~  359 (414)
                      +.|+| +||||+
T Consensus       325 a~e~l~~Hp~f~  336 (336)
T 2vuw_A          325 ATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHCGGGC
T ss_pred             HHHHHhcCCCcC
Confidence            99999 999995

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=347.23  Aligned_cols=252  Identities=22%  Similarity=0.344  Sum_probs=194.7

Q ss_pred             cccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHc-cCCCCceEEEEEEEc
Q 015026           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL-AGHENVVKFYNAFED  168 (414)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~~hpnIv~~~~~~~~  168 (414)
                      ....+.++|++.+.||+|+||.||+|.+.  |+.||||++...      ......+|.+++..+ .+||||+++++++..
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            34456678999999999999999999864  889999998643      233445566665544 159999999999987


Q ss_pred             C----CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEEeecC
Q 015026          169 D----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--------GLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       169 ~----~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~--------~iiHrDlkp~NIll~~~~  236 (414)
                      .    ..+++||||+++|+|.+++..   ..+++..++.++.||+.||.|||+.        ||+||||||+|||++   
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~---  176 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK---  176 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC---
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC---
Confidence            7    789999999999999999844   3689999999999999999999999        999999999999998   


Q ss_pred             CCCCceeeccccccccCCCCc-----cccCCCCCccccchhccccC-CCC------cchhHHHHHHHHHhhC--------
Q 015026          237 EDSSLKATDFGLSDFIKPGKK-----FQDIVGSAYYVAPEVLKRKS-GPE------SDVWSIGVITYILLCG--------  296 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~~------~DiwslG~il~elltg--------  296 (414)
                      .++.+||+|||++........     ....+||+.|+|||++.+.. ...      +|||||||++|||++|        
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            578999999999976543322     13568999999999987654 333      8999999999999999        


Q ss_pred             --CCCCCCCCch----hhhHHHhhcCCCCCCCC----CCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          297 --RRPFWDKTED----GIFKEVLRNKPDFRRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       297 --~~Pf~~~~~~----~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                        ..||......    .............+..+    ...+++++.+||.+||+.||.+|||+.+++++
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence              6777553221    12222221111101000    01355679999999999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.8e-44  Score=374.61  Aligned_cols=243  Identities=22%  Similarity=0.284  Sum_probs=202.8

Q ss_pred             ceeeeecCceEEEEEEE--CCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEec
Q 015026          101 GKLLGHGQFGYTYVATD--KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (414)
                      .+.||+|+||+||+|.+  ..+++.||||++.... ......+.+.+|+.+|+.|. |||||++++++..+ ..++||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~-~~~lv~E~  450 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEM  450 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SEEEEEEC
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-CEEEEEEc
Confidence            34899999999999955  4567899999987543 23345688999999999995 99999999999754 58899999


Q ss_pred             cCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc-
Q 015026          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-  257 (414)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~-  257 (414)
                      +++|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....... 
T Consensus       451 ~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          451 AELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC----
T ss_pred             cCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCccc
Confidence            999999999843  45799999999999999999999999999999999999999   477999999999987654322 


Q ss_pred             ---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          258 ---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       258 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                         .....||+.|+|||++.+ .++.++|||||||++|||++ |..||.+....++...+..+...   .....+++++.
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~  602 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMY  602 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHH
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHH
Confidence               223457889999998865 57889999999999999998 99999998888887777665422   22246899999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +||.+||..||++|||+.++++
T Consensus       603 ~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          603 DLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=371.71  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=206.7

Q ss_pred             cceeece-eeeecCceEEEEEEEC--CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGK-LLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +.+.+.+ .||+|+||+||+|.+.  .++..||||++....  .....+.+.+|+.+|+.+. |||||++++++.. +.+
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SSE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CCe
Confidence            3455555 8999999999999875  355679999997643  2235678999999999995 9999999999987 459


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       411 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTC
T ss_pred             EEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccc
Confidence            9999999999999988543 45699999999999999999999999999999999999999   4789999999999876


Q ss_pred             CCCCcc----ccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKKF----QDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ......    ....+|+.|+|||++. +.++.++|||||||++|||++ |+.||.+....++...+..+..   ....+.
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~  563 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPE  563 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC---CCCCTT
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCCc
Confidence            433221    1234568999999886 457889999999999999998 9999999888888877776542   222346


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHh---CCcccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQAL---SHPWVR  359 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL---~hp~f~  359 (414)
                      +++++.+||.+||..||.+|||+.+++   ++.|+.
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            899999999999999999999999985   444444

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=350.31  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=188.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHH--HHccCCCCceEEEEEEE-----c
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL--QALAGHENVVKFYNAFE-----D  168 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il--~~l~~hpnIv~~~~~~~-----~  168 (414)
                      ++|++++.||+|+||+||+|.+  +++.||||++....      ...+..|..++  ..+ +||||+++++.+.     .
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTS
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheecccccccCC
Confidence            5799999999999999999975  68999999986542      33444455544  346 5999999998653     2


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEEeecCCCC
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH---------GLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~---------~iiHrDlkp~NIll~~~~~~~  239 (414)
                      ...+++||||+++|+|.+++...   ..++..+..++.||+.||.|||+.         ||+||||||+|||++   .++
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---~~~  157 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---NDG  157 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---TTS
T ss_pred             CceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---CCC
Confidence            34689999999999999998443   458999999999999999999999         999999999999998   578


Q ss_pred             CceeeccccccccCCCC---------ccccCCCCCccccchhccc--------cCCCCcchhHHHHHHHHHhhCCCCCCC
Q 015026          240 SLKATDFGLSDFIKPGK---------KFQDIVGSAYYVAPEVLKR--------KSGPESDVWSIGVITYILLCGRRPFWD  302 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~elltg~~Pf~~  302 (414)
                      .+||+|||++.......         .....+||+.|+|||++.+        .++.++|||||||++|||++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            99999999997654321         2235679999999999875        235689999999999999999777643


Q ss_pred             CCc-hhh----------------hHHHhhc---CCCCCCCCCC---CCCHHHHHHHHHhhcCCccccCCHHHHh------
Q 015026          303 KTE-DGI----------------FKEVLRN---KPDFRRKPWP---SISNSAKDFVKKLLVKDPRARLTAAQAL------  353 (414)
Q Consensus       303 ~~~-~~~----------------~~~i~~~---~~~~~~~~~~---~~s~~~~~li~~~L~~dp~~Rps~~elL------  353 (414)
                      ... .+.                .......   .+.++. .++   .+++++.+||.+||..||++|||+.|++      
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            322 110                1111111   111111 111   1345799999999999999999999995      


Q ss_pred             CCccccccc
Q 015026          354 SHPWVREGG  362 (414)
Q Consensus       354 ~hp~f~~~~  362 (414)
                      -++|-++..
T Consensus       317 l~~~~~~~~  325 (336)
T 3g2f_A          317 MMIWERNKS  325 (336)
T ss_dssp             HHCCCC---
T ss_pred             HHHHHhccc
Confidence            467766543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.4e-44  Score=345.41  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=201.0

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHH--ccCCCCceEEEEEEEc
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA--LAGHENVVKFYNAFED  168 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~--l~~hpnIv~~~~~~~~  168 (414)
                      ...+.++|++.+.||+|+||.||+|.+  +|+.||||++...      ....+.+|++++..  + +||||+++++++..
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAADNK  107 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEEEEC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEeeecc
Confidence            345667899999999999999999987  5899999998643      34667889999988  5 59999999999987


Q ss_pred             CC----EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEEeecC
Q 015026          169 DN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH--------LHGLVHRDMKPENFLFKSAK  236 (414)
Q Consensus       169 ~~----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH--------~~~iiHrDlkp~NIll~~~~  236 (414)
                      ..    ..++||||+++|+|.+++..   ..+++..++.++.||+.||.|||        +.||+||||||+|||++   
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~---  181 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---  181 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC---
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC---
Confidence            75    89999999999999999854   36899999999999999999999        89999999999999998   


Q ss_pred             CCCCceeeccccccccCCCC-----ccccCCCCCccccchhccccC-------CCCcchhHHHHHHHHHhhC--------
Q 015026          237 EDSSLKATDFGLSDFIKPGK-----KFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCG--------  296 (414)
Q Consensus       237 ~~~~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~~DiwslG~il~elltg--------  296 (414)
                      .++.+||+|||++.......     ......||+.|+|||++.+..       +.++|||||||++|+|++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            57899999999997765433     224568999999999987643       2579999999999999999        


Q ss_pred             --CCCCCCCCc-----hhhhHHHhhcCCCCCCC-CC--CCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          297 --RRPFWDKTE-----DGIFKEVLRNKPDFRRK-PW--PSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       297 --~~Pf~~~~~-----~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                        ..||.+...     ......+.......... .+  ...++.+.+||.+||+.||.+|||+.+++++
T Consensus       262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence              789876532     12222222221111100 00  1234578999999999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=342.29  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=203.0

Q ss_pred             ccceeeceeeeecCceEEEEEE----ECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC-
Q 015026           95 DRRYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~-  169 (414)
                      .++|++++.||+|+||.||+|.    +..+|+.||||++....   ....+.+.+|+.+++.+. ||||+++++++... 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC--
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecC
Confidence            3579999999999999999998    46789999999987542   346678999999999995 99999999998654 


Q ss_pred             -CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                       ..+++||||+++++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||+
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~  191 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL  191 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTT
T ss_pred             CCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcc
Confidence             3789999999999999988554 34689999999999999999999999999999999999998   478999999999


Q ss_pred             ccccCCCCc----cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCch------------h---h
Q 015026          249 SDFIKPGKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED------------G---I  308 (414)
Q Consensus       249 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~------------~---~  308 (414)
                      +........    .....++..|+|||++.+. ++.++||||||+++|+|++|..||......            .   .
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            987654332    1234678889999987654 588999999999999999999998543110            0   0


Q ss_pred             hHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +...+.....  ....+.+++++.+||.+||..||.+|||+.++++
T Consensus       272 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          272 LIELLKNNGR--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHTTCC--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhcCCC--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1112222211  1223578999999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=345.58  Aligned_cols=252  Identities=22%  Similarity=0.337  Sum_probs=206.0

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++.+.||+|+||.||+|.+..   .||+|++...... ....+.+.+|+.+++.+. ||||+++++++.+.+..++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSCEEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCceEE
Confidence            3579999999999999999998753   4999998754322 223456778999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||++|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++.....
T Consensus       107 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             ECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC----
T ss_pred             EeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcccccc
Confidence            9999999999998743 234689999999999999999999999999999999999997    56899999999865431


Q ss_pred             ------CCccccCCCCCccccchhccc----------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCC
Q 015026          255 ------GKKFQDIVGSAYYVAPEVLKR----------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (414)
Q Consensus       255 ------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~  318 (414)
                            ........||+.|+|||++.+          .++.++||||||+++|+|++|..||.+.........+......
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  261 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP  261 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence                  122334579999999998764          2477899999999999999999999888877777666655332


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      .  .....+++++.+||.+||..||.+|||+.++++  .+..
T Consensus       262 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~  299 (319)
T 2y4i_B          262 N--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEK  299 (319)
T ss_dssp             C--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTT
T ss_pred             C--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHH
Confidence            2  222368889999999999999999999999997  4443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-43  Score=334.09  Aligned_cols=228  Identities=15%  Similarity=0.134  Sum_probs=192.0

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++..+ +||||+++++++.+.+..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcE
Confidence            4567899999999999999999999999999999999876655556678899999999999 499999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |+||||++|++|.+++..    .....++..++.||+.||.|||++||+||||||+|||++   .++.+||+++|     
T Consensus       107 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~-----  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA-----  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC-----
T ss_pred             EEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc-----
Confidence            999999999999998832    246677899999999999999999999999999999999   57889998554     


Q ss_pred             CCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhH---HHhhcCCCCCCCCCCCCCH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFK---EVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~  329 (414)
                                    |++|      ++.++|||||||++|+|++|+.||.+.+..+.+.   ..............+.+++
T Consensus       175 --------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T 3uqc_A          175 --------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF  234 (286)
T ss_dssp             --------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCH
T ss_pred             --------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCH
Confidence                          3333      4778999999999999999999998876544332   1112222111123357899


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhC
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++.+||.+||..||++| |+.++++
T Consensus       235 ~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          235 QISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHHHHHcccCCccC-CHHHHHH
Confidence            99999999999999999 9999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3e-43  Score=366.78  Aligned_cols=249  Identities=23%  Similarity=0.344  Sum_probs=207.7

Q ss_pred             ccceeeceeeeecCceEEEEEEECCC---CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      .++|++.+.||+|+||+||+|.+..+   +..||||++....  .....+.+.+|+.+++.+. ||||+++++++.+ +.
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~-~~  464 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVITE-NP  464 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec-Cc
Confidence            46799999999999999999998654   4579999886532  3445678999999999995 9999999999854 56


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY  540 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCS
T ss_pred             eEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCee
Confidence            89999999999999988543 34689999999999999999999999999999999999999   478999999999987


Q ss_pred             cCCCCcc--ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          252 IKPGKKF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       252 ~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      .......  ....||+.|+|||++.+ .++.++|||||||++|||++ |..||.+....+....+......   ...+.+
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~  617 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNC  617 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---CCCTTC
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCccc
Confidence            6543322  23467889999998764 46889999999999999997 99999988888877777665422   223578


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ++++.+||.+||..||.+|||+.++++
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999885

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-44  Score=375.99  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=204.2

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECC-CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .+.+.++|++.+.||+|+||+||+|.+.. +|+.||||++....  .......+.+|+.+++.+. ||||+++++++...
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHT  151 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeec
Confidence            34566899999999999999999999976 78999999886532  3456678899999999995 99999999999875


Q ss_pred             CE-----EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceee
Q 015026          170 NY-----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (414)
Q Consensus       170 ~~-----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (414)
                      +.     .||||||++|++|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++.    +.+||+
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----~~~kl~  223 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----EQLKLI  223 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS----SCEEEC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC----CcEEEE
Confidence            54     799999999999988662    26999999999999999999999999999999999999983    489999


Q ss_pred             ccccccccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       245 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      |||++......   ...+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.....+.          .....
T Consensus       224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------~~~~~  290 (681)
T 2pzi_A          224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------EDDPV  290 (681)
T ss_dssp             CCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------TTCHH
T ss_pred             ecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccccc----------ccccc
Confidence            99999876543   456899999999999888888999999999999999999998653221110          00011


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      ...++.+.+||.+||..||.+||+..+++.|+|+.
T Consensus       291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            12467899999999999999999999999998875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.7e-37  Score=318.02  Aligned_cols=189  Identities=16%  Similarity=0.094  Sum_probs=137.3

Q ss_pred             eeecCceEEEEEEECCCCCEEEEEEeeccCCC-------ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-------LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      ++.|++|.+..++...+|+.||+|++.+....       .....+.+.+|+++|+++..|+||+++++++++++.+||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            56777887777777788999999999765322       12345679999999999988999999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-  255 (414)
                      ||++|++|.+.+.+  .+.+++.   .|+.||+.||.|||++|||||||||+|||++   .++.|||+|||+|+..... 
T Consensus       322 Eyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~---~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD---ARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             ECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC---TTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC---CCCCEEEeecccCeeCCCCC
Confidence            99999999999944  4567764   4789999999999999999999999999998   6889999999999876543 


Q ss_pred             CccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCC
Q 015026          256 KKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF  300 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf  300 (414)
                      ....+.+||+.|||||++.+.+..++|+||+|+++++|.++..|+
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred             ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence            334567899999999999999889999999999998877664443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=5.8e-30  Score=260.68  Aligned_cols=184  Identities=18%  Similarity=0.164  Sum_probs=142.9

Q ss_pred             eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChH-----hHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI-----AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~-----~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ...+.||+|+||+||+|  ...++.+|+|+........+.     ..+.+.+|+++|+.+. ||||+.+..++...+..+
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence            44678999999999999  456789999987553332221     2456899999999995 999995554555666779


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      |||||++|++|.+++..          +..++.||+.||.|||++||+||||||+|||++   .  .+||+|||+|+...
T Consensus       416 lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECC
Confidence            99999999999998733          668999999999999999999999999999998   3  99999999998875


Q ss_pred             CCCc--------cccCCCCCccccchhccc---cCCCCcchhHHHHHHHHHhhCCCCC
Q 015026          254 PGKK--------FQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPF  300 (414)
Q Consensus       254 ~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~elltg~~Pf  300 (414)
                      ....        ....+||+.|||||++..   .|+..+|+||..+-..+.+.++.+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            4322        135789999999999875   3577789999999888888877766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=1.1e-26  Score=217.56  Aligned_cols=159  Identities=24%  Similarity=0.261  Sum_probs=122.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh---------------HhHHHHHHHHHHHHHccCCCCceE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---------------IAVEDVKREVKILQALAGHENVVK  161 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---------------~~~~~~~~E~~il~~l~~hpnIv~  161 (414)
                      .|.+++.||+|+||.||+|.+ .+|+.||||++........               .....+.+|+.+++.+. |++++.
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~~  168 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPK  168 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCC
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcCe
Confidence            456669999999999999999 8899999999864321110               24567899999999996 555555


Q ss_pred             EEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCc
Q 015026          162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL  241 (414)
Q Consensus       162 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~v  241 (414)
                      +   +.. +..++||||++|++|.+ +        .......++.||+.||.|||++||+||||||+|||++    ++.+
T Consensus       169 ~---~~~-~~~~lvmE~~~g~~L~~-l--------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~v  231 (282)
T 1zar_A          169 V---YAW-EGNAVLMELIDAKELYR-V--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGI  231 (282)
T ss_dssp             E---EEE-ETTEEEEECCCCEEGGG-C--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEE
T ss_pred             E---Eec-cceEEEEEecCCCcHHH-c--------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcE
Confidence            4   433 45699999999999987 3        1123557999999999999999999999999999998    6789


Q ss_pred             eeeccccccccCCCCccccCCCCCccccchhccc-----------cCCCCcchhHH
Q 015026          242 KATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-----------KSGPESDVWSI  286 (414)
Q Consensus       242 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~Diwsl  286 (414)
                      ||+|||+|..            +..++|||.+.+           .++..+|+|.+
T Consensus       232 kl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          232 WIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             EECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             EEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            9999999863            445789998753           34566666643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1.3e-22  Score=187.29  Aligned_cols=141  Identities=16%  Similarity=0.176  Sum_probs=108.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCE--EEEEEeeccCCCC---------------------hHhHHHHHHHHHHHHHc
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMIL---------------------PIAVEDVKREVKILQAL  153 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~i~~~~~~~---------------------~~~~~~~~~E~~il~~l  153 (414)
                      .|.+.+.||+|+||.||+|.+..+|+.  ||||++.......                     ......+.+|+.+|..|
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378999999999999999998778999  9999875432110                     01224688999999999


Q ss_pred             cCCCCc--eEEEEEEEcCCEEEEEEeccCC-C----ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCC
Q 015026          154 AGHENV--VKFYNAFEDDNYVYIAMELCEG-G----ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-LHGLVHRDM  225 (414)
Q Consensus       154 ~~hpnI--v~~~~~~~~~~~~~lv~e~~~g-g----~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH-~~~iiHrDl  225 (414)
                      . |++|  +.+++.    ...+|||||+.+ |    +|.+....     .++..+..++.||+.||.||| +.||+||||
T Consensus       128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl  197 (258)
T 1zth_A          128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADL  197 (258)
T ss_dssp             H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred             H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence            6 7754  445442    246899999942 3    66654421     235578899999999999999 999999999


Q ss_pred             CCCcEEEeecCCCCCceeecccccccc
Q 015026          226 KPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       226 kp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ||+|||++   .  .++|+|||+|...
T Consensus       198 kp~NILl~---~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYI---D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEES---S--SEEECCCTTCEET
T ss_pred             CHHHEEEc---C--cEEEEECcccccC
Confidence            99999998   3  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=2.6e-19  Score=172.58  Aligned_cols=142  Identities=18%  Similarity=0.240  Sum_probs=101.2

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC-----------Ch--------HhHHHHHHHHHHHHHccCCC
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----------LP--------IAVEDVKREVKILQALAGHE  157 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----------~~--------~~~~~~~~E~~il~~l~~hp  157 (414)
                      -|.++..||.|+||.||+|.+ .+|+.||||+++.....           ..        ...-...+|...|.+|. ++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            399999999999999999997 46999999987532110           00        01112346788888884 44


Q ss_pred             Cc--eEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec
Q 015026          158 NV--VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA  235 (414)
Q Consensus       158 nI--v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~  235 (414)
                      ++  ...++.  ..  .+|||||++|++|....        ....+..++.||+.+|.+||+.|||||||||.|||++.+
T Consensus       174 gv~vp~p~~~--~~--~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          174 GFPVPEPIAQ--SR--HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             TCSCCCEEEE--ET--TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred             CCCCCeeeec--cC--ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence            43  233322  12  37999999998875432        123456789999999999999999999999999999853


Q ss_pred             CCC-------CCceeecccccccc
Q 015026          236 KED-------SSLKATDFGLSDFI  252 (414)
Q Consensus       236 ~~~-------~~vkl~DFG~a~~~  252 (414)
                      ++.       ..+.|+||+-+...
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            211       13789999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.49  E-value=1.2e-13  Score=127.06  Aligned_cols=140  Identities=17%  Similarity=0.150  Sum_probs=111.7

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|++...+|.|+.+.||++..  .|..+++|+.......   ....+.+|+.+++.|..+..++++++++.+.+..|+||
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            488888899999999999964  3678999988643211   12358899999999976788999999999999999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---------------------------------------  217 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~---------------------------------------  217 (414)
                      |+++|.+|.+.+       .+......++.++..+|..||+                                       
T Consensus        90 e~i~G~~l~~~~-------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           90 SEADGVLCSEEY-------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             ECCSSEEHHHHC-------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EecCCeehhhcc-------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999987642       1222345788999999999998                                       


Q ss_pred             --------------------cCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          218 --------------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       218 --------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                                          ..++|+|++|.||+++   ++..+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence                                4589999999999997   344567999997743

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=2.1e-12  Score=118.18  Aligned_cols=135  Identities=15%  Similarity=0.106  Sum_probs=98.1

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCC-CceEEEEEEEcCCEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-NVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hp-nIv~~~~~~~~~~~~~lv  175 (414)
                      .|.+....+.|..+.||++.. .+|..+++|+....      ....+.+|+.+++.+..+. .+++++++...++..++|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            355544444666799999953 56778999986543      1245778999999997552 266789888888889999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC------------------------------------
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG------------------------------------  219 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~------------------------------------  219 (414)
                      |||++|.+|.  .  .   ...   ...++.+++..|..||+..                                    
T Consensus        94 ~e~i~G~~l~--~--~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           94 LGEVPGQDLL--S--S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EECCSSEETT--T--S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEecCCcccC--c--C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            9999998873  2  1   111   2356677777777777643                                    


Q ss_pred             ----------------------CeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          220 ----------------------LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       220 ----------------------iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                                            ++|+|++|.||+++   ++..+.|+|||.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence                                  99999999999997   344567999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=2.4e-11  Score=116.99  Aligned_cols=142  Identities=25%  Similarity=0.418  Sum_probs=104.9

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEee--ccCCCChHhHHHHHHHHHHHHHccC-CCCceEEEEEEEcC---CEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIE--KNKMILPIAVEDVKREVKILQALAG-HENVVKFYNAFEDD---NYVYI  174 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~E~~il~~l~~-hpnIv~~~~~~~~~---~~~~l  174 (414)
                      ++.|+.|.++.||++..  .+..+++|+..  .....  .....+.+|+.+++.|.. +..+++++.++.+.   +..|+
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            56789999999999874  34678888765  32211  123567899999999963 35588899888776   45899


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-------------------------------------  217 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-------------------------------------  217 (414)
                      ||||++|..+.+.    ....+++.....++.+++.+|..||+                                     
T Consensus       119 vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          119 IMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9999999877442    12347788889999999999999997                                     


Q ss_pred             ---------------------cCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          218 ---------------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       218 ---------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                                           ..++|+|++|.|||++.++ ...+.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcccccc
Confidence                                 3589999999999998421 12368999998865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.24  E-value=1.2e-11  Score=116.37  Aligned_cols=185  Identities=16%  Similarity=0.239  Sum_probs=125.2

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCC--ceEEEEEEEcCC---EEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN--VVKFYNAFEDDN---YVYIA  175 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpn--Iv~~~~~~~~~~---~~~lv  175 (414)
                      ++.++.|..+.||++.     ..+++|+....     .....+.+|+.+|+.+..+..  ++.++.......   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            3458999999999873     46889975422     346778999999999854433  445555443333   45889


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL--------------------------------------  217 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~--------------------------------------  217 (414)
                      ||+++|.+|.+...    ..++..+...++.+++..|..||+                                      
T Consensus        95 m~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             EECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             EcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            99999988875442    246788888899999999988886                                      


Q ss_pred             --------------------cCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCccccchhcc---
Q 015026          218 --------------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK---  274 (414)
Q Consensus       218 --------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---  274 (414)
                                          ..++|+|++|.||+++.+ ....+.|+||+.+.................-..|+...   
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence                                136999999999999831 14567899999887643322211111110002333221   


Q ss_pred             ccCCC------------CcchhHHHHHHHHHhhCCCCC
Q 015026          275 RKSGP------------ESDVWSIGVITYILLCGRRPF  300 (414)
Q Consensus       275 ~~~~~------------~~DiwslG~il~elltg~~Pf  300 (414)
                      ..|+.            -.+.|++|.++|.+.+|..+|
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11211            158999999999999998887

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.85  E-value=2.5e-08  Score=91.67  Aligned_cols=134  Identities=16%  Similarity=0.185  Sum_probs=98.9

Q ss_pred             eeeecCce-EEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCC
Q 015026          103 LLGHGQFG-YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (414)
Q Consensus       103 ~lG~G~~g-~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (414)
                      .+..|..| .||+......+..+++|+-...      ....+.+|..+|+.|..+--+.+++.++.+.+..++|||+++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            35556555 6999887777788999976432      4567889999999997665678899999999999999999999


Q ss_pred             CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------
Q 015026          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-------------------------------------------  218 (414)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~-------------------------------------------  218 (414)
                      .++.+.....      ......+..++...|.-||+.                                           
T Consensus       105 ~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          105 KTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             EEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            8877654221      122344556666666666641                                           


Q ss_pred             ---------------CCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          219 ---------------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       219 ---------------~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                                     .++|+|+.|.|||++   +++.+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence                           168999999999998   355567999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.85  E-value=4.3e-08  Score=92.10  Aligned_cols=138  Identities=17%  Similarity=0.284  Sum_probs=97.0

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCC--CceEEEEEEE-cCCEEEEEEe
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE--NVVKFYNAFE-DDNYVYIAME  177 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hp--nIv~~~~~~~-~~~~~~lv~e  177 (414)
                      ++.++.|....||++     |..+++|+...     +.....+.+|..+|+.|..+-  .+++++.+.. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            356889999999988     56788887422     235678899999999996432  3566776664 4566789999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH---------------------------------------  218 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~---------------------------------------  218 (414)
                      +++|.++.+...    ..++......++.++...|..||+.                                       
T Consensus        94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            999988876332    1245555566666666666666542                                       


Q ss_pred             ---------------------CCeecCCCCCcEEEeecCCCCC-ceeecccccccc
Q 015026          219 ---------------------GLVHRDMKPENFLFKSAKEDSS-LKATDFGLSDFI  252 (414)
Q Consensus       219 ---------------------~iiHrDlkp~NIll~~~~~~~~-vkl~DFG~a~~~  252 (414)
                                           .++|+|++|.||+++....++. +.|+||+.+...
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                 3499999999999984222345 489999987653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.51  E-value=3.1e-07  Score=89.35  Aligned_cols=81  Identities=16%  Similarity=0.265  Sum_probs=51.4

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCC-CC---hHhHHHHHHHHHHHHHccCC-C-CceEEEEEEEcCCEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-IL---PIAVEDVKREVKILQALAGH-E-NVVKFYNAFEDDNYVYI  174 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~---~~~~~~~~~E~~il~~l~~h-p-nIv~~~~~~~~~~~~~l  174 (414)
                      .+.||.|..+.||++....+++.++||....... ..   +...+.+..|..+|+.+... | .+++++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4579999999999997666678999998643211 00   11234567899999988533 3 34456643  3444689


Q ss_pred             EEeccCCCC
Q 015026          175 AMELCEGGE  183 (414)
Q Consensus       175 v~e~~~gg~  183 (414)
                      |||+++|..
T Consensus       113 vmE~l~g~~  121 (397)
T 2olc_A          113 VMEDLSHLK  121 (397)
T ss_dssp             EECCCTTSE
T ss_pred             EEEeCCCcc
Confidence            999998743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.35  E-value=2.7e-07  Score=88.35  Aligned_cols=86  Identities=9%  Similarity=0.075  Sum_probs=57.2

Q ss_pred             eeceee-eecCceEEEEEEECC------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC--CCceEEEEEEEcC
Q 015026           99 TIGKLL-GHGQFGYTYVATDKA------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH--ENVVKFYNAFEDD  169 (414)
Q Consensus        99 ~~~~~l-G~G~~g~V~~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h--pnIv~~~~~~~~~  169 (414)
                      ...+.| +.|..+.+|++....      ++..+++|+..............+.+|+.+++.|..+  -.+++++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 889999999886430      1567889976433200000113567899999988654  3577888877655


Q ss_pred             ---CEEEEEEeccCCCCh
Q 015026          170 ---NYVYIAMELCEGGEL  184 (414)
Q Consensus       170 ---~~~~lv~e~~~gg~L  184 (414)
                         +..++|||+++|.++
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               457899999998654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.15  E-value=1.8e-05  Score=74.76  Aligned_cols=74  Identities=15%  Similarity=0.266  Sum_probs=42.7

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEEE------EEEcCCEEEE
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYN------AFEDDNYVYI  174 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~------~~~~~~~~~l  174 (414)
                      +.|+.|..+.||++... +| .+++|+....       ...+..|+.+++.|..+ -.+++++.      +....+..++
T Consensus        38 ~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD-SG-AVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EECC----CEEEEEEET-TE-EEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeccccccCcEEEEEeC-CC-CEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            45677788999998753 33 5889988642       13344566666655421 12333332      1234677899


Q ss_pred             EEeccCCCCh
Q 015026          175 AMELCEGGEL  184 (414)
Q Consensus       175 v~e~~~gg~L  184 (414)
                      ||||++|.++
T Consensus       109 l~~~i~G~~~  118 (346)
T 2q83_A          109 VYDWIEGRPF  118 (346)
T ss_dssp             EEECCCCBCC
T ss_pred             EEEeecCccC
Confidence            9999998654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.13  E-value=2e-05  Score=73.94  Aligned_cols=76  Identities=20%  Similarity=0.176  Sum_probs=61.2

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC--CCceEEEEEEEcCCEEEEEEec
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH--ENVVKFYNAFEDDNYVYIAMEL  178 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h--pnIv~~~~~~~~~~~~~lv~e~  178 (414)
                      .+.|+.|....+|++..  ++..+++|+....      ....+..|...|+.|..+  ..+++++.+....+..++|||+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            46789999999999863  5678889976532      356788999999988643  6688899888888899999999


Q ss_pred             cCCCCh
Q 015026          179 CEGGEL  184 (414)
Q Consensus       179 ~~gg~L  184 (414)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.01  E-value=2.6e-05  Score=76.40  Aligned_cols=77  Identities=10%  Similarity=0.094  Sum_probs=45.6

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCC--CC----hHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--IL----PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~----~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .+.||.|..+.||++.  .++..++||.......  ..    ......+..|+..+..-.....+++++.+.  .+..++
T Consensus        39 i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            4578999999999995  3567899994322110  00    012233334443332211234567777655  456789


Q ss_pred             EEecc-CC
Q 015026          175 AMELC-EG  181 (414)
Q Consensus       175 v~e~~-~g  181 (414)
                      |||++ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 77

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.86  E-value=1.8e-05  Score=73.71  Aligned_cols=72  Identities=7%  Similarity=-0.081  Sum_probs=46.1

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEecc-
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC-  179 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~-  179 (414)
                      ++.|+.|....+|++      ..+++|+......    ..-...+|+.+++.+..+.-.++++...  .+.-++|+||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            677999999999998      4588887654211    1112356888888876443335666543  33347899999 


Q ss_pred             CCCCh
Q 015026          180 EGGEL  184 (414)
Q Consensus       180 ~gg~L  184 (414)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.73  E-value=7.9e-05  Score=71.77  Aligned_cols=143  Identities=14%  Similarity=0.132  Sum_probs=84.4

Q ss_pred             ceeeeecCceEEEEEEECC-------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026          101 GKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ++.|..|-...+|++....       +++.+++|+.... .   .......+|..+++.|..+.-.+++++.+.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            3567778888999987542       3578999975321 1   1345566899999988755555777776654    2


Q ss_pred             EEEeccCCCChHH--------------HHH---hcc---CCCC--CHHHHHHHHHHHHH-------------------HH
Q 015026          174 IAMELCEGGELLD--------------RIL---AKK---DSRY--TEKDAAVVVRQMLR-------------------VA  212 (414)
Q Consensus       174 lv~e~~~gg~L~~--------------~l~---~~~---~~~l--~~~~~~~i~~qil~-------------------~L  212 (414)
                      +||||++|.+|..              .+.   ...   ....  -..++..++.++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            8999999855421              111   110   1111  13556666655422                   23


Q ss_pred             HHHH----H----cCCeecCCCCCcEEEeec-CCCCCceeeccccccc
Q 015026          213 AECH----L----HGLVHRDMKPENFLFKSA-KEDSSLKATDFGLSDF  251 (414)
Q Consensus       213 ~~LH----~----~~iiHrDlkp~NIll~~~-~~~~~vkl~DFG~a~~  251 (414)
                      ..|.    .    ..++|+|+.+.||+++.. ...+.+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3332    2    248999999999999842 1136899999998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.67  E-value=0.00011  Score=71.98  Aligned_cols=74  Identities=12%  Similarity=0.080  Sum_probs=51.1

Q ss_pred             ceeeeecCceEEEEEEECC-------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026          101 GKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ++.|+.|....||++....       ++..+++|+.....     ..+.+.+|..+++.|..+.-.+++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            4568889899999997643       35789999773311     113445799999988655444677776543    2


Q ss_pred             EEEeccCCCC
Q 015026          174 IAMELCEGGE  183 (414)
Q Consensus       174 lv~e~~~gg~  183 (414)
                      +|+||++|.+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998743

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.58  E-value=0.00073  Score=62.24  Aligned_cols=79  Identities=19%  Similarity=0.051  Sum_probs=56.0

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC--CCceEEEEEEEcCCEEEEE
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH--ENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h--pnIv~~~~~~~~~~~~~lv  175 (414)
                      ..-++.+|.|..+.||++.. .+|+.|++|+-.....   .....+..|+..|+.|...  -.+++++.+.  .  -++|
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv   88 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA   88 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence            45567899999999999974 6789999997654322   1234578899999998533  2345666542  2  3789


Q ss_pred             EeccCCCCh
Q 015026          176 MELCEGGEL  184 (414)
Q Consensus       176 ~e~~~gg~L  184 (414)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.52  E-value=0.00065  Score=59.38  Aligned_cols=122  Identities=15%  Similarity=0.075  Sum_probs=77.6

Q ss_pred             ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCccccC
Q 015026          183 ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI  261 (414)
Q Consensus       183 ~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH-~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  261 (414)
                      +|.+.|. ..+.+++|+++|.++.|.+.+|.-+- ...-..+=+.|..|++.   .+|.|-+.+ +.+.           
T Consensus        34 SL~eIL~-~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILR-LYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred             cHHHHHH-HcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence            6677664 44679999999999999999987662 22222334557888888   577776653 1110           


Q ss_pred             CCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcC
Q 015026          262 VGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK  341 (414)
Q Consensus       262 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  341 (414)
                      .....+.|||......+.+.=|||||+++|..+-=..|                     ...-..+|+.+.+||..|..-
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence            12334668887654456778899999999998852222                     111136899999999999865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.48  E-value=0.00055  Score=64.05  Aligned_cols=142  Identities=15%  Similarity=0.083  Sum_probs=78.3

Q ss_pred             eceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCC-CceEEEEE------EEcCCEE
Q 015026          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-NVVKFYNA------FEDDNYV  172 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hp-nIv~~~~~------~~~~~~~  172 (414)
                      -.+.|+.|....||++... +| .+++|+.....     ..+.+..|+.+++.|..+. .+++++..      ....+..
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            3466888988999999753 34 68899876521     1234567888888775331 13333321      1234668


Q ss_pred             EEEEeccCCCChH----H----------HHHhcc-C--CC----CCHHHHHHH---------------HHHHHHHHHHHH
Q 015026          173 YIAMELCEGGELL----D----------RILAKK-D--SR----YTEKDAAVV---------------VRQMLRVAAECH  216 (414)
Q Consensus       173 ~lv~e~~~gg~L~----~----------~l~~~~-~--~~----l~~~~~~~i---------------~~qil~~L~~LH  216 (414)
                      ++|+++++|..+.    .          .+.... .  ..    .........               ...+...+..+.
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            9999999986431    0          111110 0  00    111111110               011344455555


Q ss_pred             H-------cCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          217 L-------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       217 ~-------~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .       .+++|+|+.+.|||++   ++..+.|+||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence            3       3689999999999998   344457999997743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.47  E-value=0.00018  Score=68.88  Aligned_cols=75  Identities=15%  Similarity=0.090  Sum_probs=45.6

Q ss_pred             ceeeeecCceEEEEEEECC--------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026          101 GKLLGHGQFGYTYVATDKA--------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      .+.|+.|....+|++....        .+..+++|+......    .......|..+++.|..+.-++++++.+  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            4568888889999997543        136888987643211    1112367888898886443355677554  22  


Q ss_pred             EEEEeccCCCC
Q 015026          173 YIAMELCEGGE  183 (414)
Q Consensus       173 ~lv~e~~~gg~  183 (414)
                      ++|+||++|.+
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.47  E-value=0.00025  Score=66.90  Aligned_cols=142  Identities=14%  Similarity=0.124  Sum_probs=72.2

Q ss_pred             eeeeecCceE-EEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCC-CceEEEEEEEcCCEEEEEEecc
Q 015026          102 KLLGHGQFGY-TYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-NVVKFYNAFEDDNYVYIAMELC  179 (414)
Q Consensus       102 ~~lG~G~~g~-V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hp-nIv~~~~~~~~~~~~~lv~e~~  179 (414)
                      +.|+.|+... +|+... .+|..+++|......      ...+..|+.+++.|..+. .+++++.+..+.+  ++|||++
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l   94 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL   94 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence            3466665554 666642 236677777543321      023456788887775432 3566776543333  6899999


Q ss_pred             CCCChHHHHHhcc------------------------CCCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 015026          180 EGGELLDRILAKK------------------------DSRYTEKDAA-------V-VV------------RQMLRVAAEC  215 (414)
Q Consensus       180 ~gg~L~~~l~~~~------------------------~~~l~~~~~~-------~-i~------------~qil~~L~~L  215 (414)
                      .+..+.+.+....                        ...+......       . +.            ..+...+..+
T Consensus        95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l  174 (333)
T 3csv_A           95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI  174 (333)
T ss_dssp             CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence            7766654331100                        0112221110       0 00            0111222223


Q ss_pred             ------HHcCCeecCCCCCcEEEeecCC-CCCceeecccccccc
Q 015026          216 ------HLHGLVHRDMKPENFLFKSAKE-DSSLKATDFGLSDFI  252 (414)
Q Consensus       216 ------H~~~iiHrDlkp~NIll~~~~~-~~~vkl~DFG~a~~~  252 (414)
                            +...++|+|+.+.||+++.+.. ...+.|+||+.+...
T Consensus       175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence                  1246899999999999973110 157899999988653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.45  E-value=0.00081  Score=63.05  Aligned_cols=76  Identities=14%  Similarity=0.193  Sum_probs=49.2

Q ss_pred             eeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCC-CceEEEEE-----EEcCCEEEEE
Q 015026          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-NVVKFYNA-----FEDDNYVYIA  175 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hp-nIv~~~~~-----~~~~~~~~lv  175 (414)
                      ..|+ |....||++.. .+|+.+++|+......    ....+..|..+++.|..+. .+++++..     ....+..++|
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3566 88889998853 3466799998764321    2356677888888875331 23444432     2235567899


Q ss_pred             EeccCCCC
Q 015026          176 MELCEGGE  183 (414)
Q Consensus       176 ~e~~~gg~  183 (414)
                      +|+++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.27  E-value=0.0017  Score=64.05  Aligned_cols=76  Identities=18%  Similarity=0.156  Sum_probs=49.4

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccC
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      ++.|+.|-...+|++.....+..+++|+...... .  .. .-.+|..+++.|..+.-.+++++.+.  +  .+|+||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E--II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S--CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h--hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            4678889999999998654457888997643211 0  11 12579999999975444467777763  2  25999998


Q ss_pred             CCCh
Q 015026          181 GGEL  184 (414)
Q Consensus       181 gg~L  184 (414)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.05  E-value=0.0023  Score=60.49  Aligned_cols=69  Identities=12%  Similarity=0.122  Sum_probs=44.2

Q ss_pred             eecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC--CCceEEEEE------EEcCCEEEEEE
Q 015026          105 GHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH--ENVVKFYNA------FEDDNYVYIAM  176 (414)
Q Consensus       105 G~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h--pnIv~~~~~------~~~~~~~~lv~  176 (414)
                      |.|....||++.. .+| .+++|+......         ..|+.+++.|..+  |.+++++..      ....+..++||
T Consensus        32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~  100 (339)
T 3i1a_A           32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY  100 (339)
T ss_dssp             TSCSSCEEEEEEC-SSC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred             cCccccceEEEEe-CCC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence            3444689999964 345 899998765431         3566667666422  335555432      23457889999


Q ss_pred             eccCCCCh
Q 015026          177 ELCEGGEL  184 (414)
Q Consensus       177 e~~~gg~L  184 (414)
                      +|++|..+
T Consensus       101 ~~i~G~~~  108 (339)
T 3i1a_A          101 PFIHAPNG  108 (339)
T ss_dssp             ECCCCCBT
T ss_pred             eccCCCcC
Confidence            99998765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.60  E-value=0.0054  Score=59.76  Aligned_cols=76  Identities=17%  Similarity=0.138  Sum_probs=50.4

Q ss_pred             ceeeeecCceEEEEEEECCC-------CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026          101 GKLLGHGQFGYTYVATDKAN-------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ++.|..|--..+|++.....       +..+++++......    ..-+..+|..+++.|..+.-.+++++.+.  +  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~----~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG----KFYDSKVELDVFRYLSNINIAPNIIADFP--E--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc----hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence            45677888889999976521       57899997643211    11123579999988865544566775442  2  6


Q ss_pred             EEEeccCCCCh
Q 015026          174 IAMELCEGGEL  184 (414)
Q Consensus       174 lv~e~~~gg~L  184 (414)
                      +|+||++|.+|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.57  E-value=0.042  Score=53.04  Aligned_cols=32  Identities=28%  Similarity=0.477  Sum_probs=25.9

Q ss_pred             CeecCCCCCcEEEeec---CCCCCceeeccccccc
Q 015026          220 LVHRDMKPENFLFKSA---KEDSSLKATDFGLSDF  251 (414)
Q Consensus       220 iiHrDlkp~NIll~~~---~~~~~vkl~DFG~a~~  251 (414)
                      ++|+|+.+.|||+...   .++..+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999532   2467799999998854

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.54  E-value=1.7  Score=37.71  Aligned_cols=122  Identities=12%  Similarity=0.186  Sum_probs=82.5

Q ss_pred             HHHHHHHHccCCCCceEEEEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecC
Q 015026          145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD  224 (414)
Q Consensus       145 ~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrD  224 (414)
                      .|+.+|..  .||+++.. .+-.+++.+.+.++.-+.+.-+..+     ..++....++++.+|+....++  ..-+|-=
T Consensus        35 ~el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~  104 (215)
T 4ann_A           35 HLMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVN--RTRYTFV  104 (215)
T ss_dssp             GGGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGG--GSSEECC
T ss_pred             HHHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHh--cCceEEE
Confidence            35666654  48999977 5666777777777765533223323     3467888999999888877433  4457778


Q ss_pred             CCCCcEEEeecCCCCCceeeccccccccCCCCccccCCCCCccccchhccccCCCCcchh-HHHHHHHHHhhCCCCC
Q 015026          225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVW-SIGVITYILLCGRRPF  300 (414)
Q Consensus       225 lkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Diw-slG~il~elltg~~Pf  300 (414)
                      |.|+||+++   .++.+++.--|+-..+.+..                     ..+.|.| .+=+++..+++++..|
T Consensus       105 L~P~NL~f~---~~~~p~i~~RGik~~l~P~~---------------------~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          105 LAPDELFFT---RDGLPIAKTRGLQNVVDPLP---------------------VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CSGGGEEEC---TTSCEEESCCEETTTBSCCC---------------------CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EecceEEEc---CCCCEEEEEccCccCCCCCC---------------------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999999   68889998777643322110                     1122333 6778888899998887

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.84  E-value=0.07  Score=52.55  Aligned_cols=63  Identities=10%  Similarity=-0.015  Sum_probs=17.4

Q ss_pred             eceeeeecCceEEEEEEECCCCCEEEE------EEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEE
Q 015026          100 IGKLLGHGQFGYTYVATDKANGDRVAV------KKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vai------K~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~  167 (414)
                      +.+.||   ||.||+|....+..+||+      |....... .......+.+|..+++.+. |||+++.+.+-.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQ-IPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccc-ccccccccccccccccccc-ccccCCCcceEE
Confidence            445666   999999988665568888      66543322 2234456788999988884 999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	414
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-85
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-84
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-82
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-81
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-81
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-79
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-78
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-77
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-77
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-77
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-75
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-75
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-75
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-72
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-71
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-70
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-69
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-68
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-64
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-64
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-64
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-64
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-62
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-62
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-60
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-60
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-60
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-58
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-58
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-57
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-57
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-54
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-54
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-54
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-54
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-50
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-48
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-44
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-17
d1j7la_	263	d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos	0.001

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  261 bits (668), Expect = 1e-85
 Identities = 115/298 (38%), Positives = 165/298 (55%), Gaps = 7/298 (2%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D    Y    +LG G F    +A DK     VA+K I K  +        ++ E+ +L 
Sbjct: 5   EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLH 62

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            +  H N+V   + +E   ++Y+ M+L  GGEL DRI   +   YTE+DA+ ++ Q+L  
Sbjct: 63  KIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDA 119

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H  G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           VL +K      D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+S
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
           AKDF++ L+ KDP  R T  QAL HPW+  G  A +  I  SV   +++    S+ KQ
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 296

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  258 bits (661), Expect = 5e-84
 Identities = 99/287 (34%), Positives = 148/287 (51%), Gaps = 7/287 (2%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y I + LG G FG  +   +KA G     K I       P+    VK E+ I+  L  H
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-H 85

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             ++  ++AFED   + + +E   GGEL DRI   +D + +E +    +RQ        H
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VH D+KPEN +    K+ SS+K  DFGL+  + P +  +    +A + APE++ R+
Sbjct: 145 EHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE 203

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             G  +D+W+IGV+ Y+LL G  PF  + +    + V R   +F    + S+S  AKDF+
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263

Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
           K LL K+PR RLT   AL HPW++         I  S  N +RQ +K
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 310

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  254 bits (650), Expect = 2e-82
 Identities = 96/276 (34%), Positives = 151/276 (54%), Gaps = 10/276 (3%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y I + LG G FG  +  T++A G+  A K +           E V++E++ +  L  H
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLR-H 82

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +V  ++AFEDDN + +  E   GGEL +++ A + ++ +E +A   +RQ+ +     H
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            +  VH D+KPEN +F + K  + LK  DFGL+  + P +  +   G+A + APEV + K
Sbjct: 142 ENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             G  +D+WS+GV++YILL G  PF  + +D   + V     +     +  IS   KDF+
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260

Query: 336 KKLLVKDPRARLTAAQALSHPWVREG---GDASEIP 368
           +KLL+ DP  R+T  QAL HPW+  G   G  S+IP
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  249 bits (638), Expect = 1e-81
 Identities = 85/280 (30%), Positives = 141/280 (50%), Gaps = 18/280 (6%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM------ILPIAVEDVKREV 147
           F   Y   ++LG G          K      AVK I+           +    E   +EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            IL+ ++GH N+++  + +E + + ++  +L + GEL D +   +    +EK+   ++R 
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRA 118

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L V    H   +VHRD+KPEN L     +D ++K TDFG S  + PG+K +++ G+  Y
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175

Query: 268 VAPEVL-------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
           +APE++           G E D+WS GVI Y LL G  PFW + +  + + ++     F 
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              W   S++ KD V + LV  P+ R TA +AL+HP+ ++
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (639), Expect = 4e-81
 Identities = 80/304 (26%), Positives = 148/304 (48%), Gaps = 12/304 (3%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           K+   +Y I + LG G+FG  +   + ++      K ++            VK+E+ IL 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILN 56

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
               H N++  + +FE    + +  E   G ++ +RI         E++    V Q+   
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEA 114

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H H + H D++PEN ++   +  S++K  +FG +  +KPG  F+ +  +  Y APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V +       +D+WS+G + Y+LL G  PF  +T   I + ++  +  F  + +  IS  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFA 390
           A DFV +LLVK+ ++R+TA++AL HPW+++  +     +   V+  ++    Y  L +  
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIE----RVSTKVIRTLKHRRYYHTLIKKD 289

Query: 391 LRVT 394
           L + 
Sbjct: 290 LNMV 293

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  245 bits (626), Expect = 5e-79
 Identities = 79/291 (27%), Positives = 137/291 (47%), Gaps = 17/291 (5%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           +   D      ++LG G  G      +K   ++ A+K ++             +REV++ 
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA--------RREVELH 58

Query: 151 QALAGHENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              +   ++V+  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++
Sbjct: 59  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +       H   + HRD+KPEN L+ S + ++ LK TDFG +              + Y
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRR 321
           YVAPEVL  +      D+WS+GVI YILLCG  PF+         G+   +   + +F  
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
             W  +S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 2e-78
 Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 12/265 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I   L  H
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 65

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              ++HRD+KPEN L  S      LK  DFG S    P  +   + G+  Y+ PE+++ +
Sbjct: 124 SKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGR 179

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
               + D+WS+GV+ Y  L G+ PF   T    +K + R +  F       ++  A+D +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLI 235

Query: 336 KKLLVKDPRARLTAAQALSHPWVRE 360
            +LL  +P  R    + L HPW+  
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPWITA 260

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  239 bits (612), Expect = 3e-77
 Identities = 79/307 (25%), Positives = 140/307 (45%), Gaps = 18/307 (5%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           +  D ++ ++  + +GHG FG  Y A D  N + VA+KK+  +        +D+ +EV+ 
Sbjct: 9   FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L  H N +++   +  ++  ++ ME C G       + KK     E + A V    L
Sbjct: 69  LQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGAL 125

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +  A  H H ++HRD+K  N L     E   +K  DFG +  + P   F   VG+ Y++A
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANSF---VGTPYWMA 179

Query: 270 PEVL----KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           PEV+    + +   + DVWS+G+    L   + P ++         + +N+         
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSG 237

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS-VLNNMRQF--VK 382
             S   ++FV   L K P+ R T+   L H +V      + I   I    + +R+   ++
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 297

Query: 383 YSRLKQF 389
           Y ++K+ 
Sbjct: 298 YRKMKKI 304

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 3e-77
 Identities = 72/278 (25%), Positives = 135/278 (48%), Gaps = 13/278 (4%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++   +       E +  E+ +++ 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRE 73

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              + N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ L+  
Sbjct: 74  N-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQAL 129

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPE 271
              H + ++HRD+K +N L      D S+K TDFG    I     K   +VG+ Y++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N      +    +S  
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAI 245

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            +DF+ + L  D   R +A + L H +++     S + 
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (608), Expect = 6e-77
 Identities = 97/274 (35%), Positives = 152/274 (55%), Gaps = 8/274 (2%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D +  K+    TE++A   ++Q+
Sbjct: 66  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 122

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN +          +K  DFGL+  I  G +F++I G+  +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            S  AKDF+++LLVKDP+ R+T   +L HPW++ 
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (600), Expect = 1e-75
 Identities = 82/280 (29%), Positives = 136/280 (48%), Gaps = 16/280 (5%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D + +  + I   LG G FG  Y A +K      A K I+         +ED   E+ IL
Sbjct: 7   DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDIL 63

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            +   H N+VK  +AF  +N ++I +E C GG  +D ++ + +   TE    VV +Q L 
Sbjct: 64  ASCD-HPNIVKLLDAFYYENNLWILIEFCAGG-AVDAVMLELERPLTESQIQVVCKQTLD 121

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVA 269
                H + ++HRD+K  N LF     D  +K  DFG+S    +  ++    +G+ Y++A
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178

Query: 270 PEVL------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+       R    ++DVWS+G+    +     P  +     +  ++ +++P    +P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD 363
               S++ KDF+KK L K+  AR T +Q L HP+V    +
Sbjct: 239 -SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 5e-75
 Identities = 86/268 (32%), Positives = 130/268 (48%), Gaps = 14/268 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLH 125

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVL 273
             G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L
Sbjct: 126 GKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF           A+
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKAR 238

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVRE 360
           D V+KLLV D   RL   +   +  ++ 
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 7e-75
 Identities = 84/273 (30%), Positives = 134/273 (49%), Gaps = 14/273 (5%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 60

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 61  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 117

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG---KKFQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L        +LK +DFGL+   +     +    + G+  YVAP
Sbjct: 118 YLHGIGITHRDIKPENLLLDE---RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

Query: 271 EVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           E+LKR+       DVWS G++   +L G  P+   ++        + K  +   PW  I 
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKID 233

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
           ++    + K+LV++P AR+T        W  + 
Sbjct: 234 SAPLALLHKILVENPSARITIPDIKKDRWYNKP 266

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (578), Expect = 5e-72
 Identities = 70/267 (26%), Positives = 123/267 (46%), Gaps = 12/267 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +   +  F+    ++  ME   GG+L+  I  +   ++    A     +++      H
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
             G+V+RD+K +N L     +D  +K  DFG+  + +    K     G+  Y+APE+L  
Sbjct: 121 SKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           +      D WS GV+ Y +L G+ PF  + E+ +F  +  + P +       +   AKD 
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDL 233

Query: 335 VKKLLVKDPRARLTAAQA-LSHPWVRE 360
           + KL V++P  RL        HP  RE
Sbjct: 234 LVKLFVREPEKRLGVRGDIRQHPLFRE 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  223 bits (568), Expect = 5e-71
 Identities = 69/269 (25%), Positives = 113/269 (42%), Gaps = 9/269 (3%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D      VAVK +  +    P      +RE +   AL  H
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 66

Query: 157 ENVVKFYNAFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D +    +   T K A  V+    +  
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQAL 124

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG-LSDFIKPGKKFQDIVGSAYYVAPE 271
              H +G++HRD+KP N +  +      +       ++D      +   ++G+A Y++PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
             +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +S  
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVR 359
               V K L K+P  R   A  +    VR
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 1e-70
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 19/272 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +   +G G +G       K++G  +  K+++   M      + +  EV +L+ L  H 
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HP 63

Query: 158 NVVKFYNAFED--DNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAA 213
           N+V++Y+   D  +  +YI ME CEGG+L   I    K+     E+    V+ Q+     
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 214 ECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYY 267
           ECH      H ++HRD+KP N          ++K  DFGL+  +     F +  VG+ YY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           ++PE + R S   +SD+WS+G + Y L     PF   ++  +  ++   K    R+    
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPYR 237

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            S+   + + ++L      R +  + L +P +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 2e-69
 Identities = 55/271 (20%), Positives = 107/271 (39%), Gaps = 16/271 (5%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           R       +G G F   Y   D      VA  +++  K+      +  K E ++L+ L  
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ- 66

Query: 156 HENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           H N+V+FY+++E        + +  EL   G L   +  K+      K      RQ+L+ 
Sbjct: 67  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKG 124

Query: 212 AAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
               H     ++HRD+K +N          S+K  D GL+   K     + ++G+  ++A
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMA 181

Query: 270 PEVLKRKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWPSIS 328
           PE+ + K     DV++ G+    +     P+ +      I++ V                
Sbjct: 182 PEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAI 239

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
              K+ ++  + ++   R +    L+H + +
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 2e-69
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 20/273 (7%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     + +   V  EV +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 151 QAL-AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           + + +G   V++  + FE  +   + +E  E  + L   +  +     E+ A     Q+L
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVL 120

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                CH  G++HRD+K EN L         LK  DFG    +K    + D  G+  Y  
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSP 177

Query: 270 PEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           PE +   R  G  + VWS+G++ Y ++CG  PF          E++R +  FR      +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRV 227

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 3e-68
 Identities = 71/306 (23%), Positives = 113/306 (36%), Gaps = 51/306 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +     LG G  G  +  + K +G  +A K I       P     + RE+++L      
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECN-S 63

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +V FY AF  D  + I ME  +GG L   +  KK  R  E+    V   +++      
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 217 -LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
             H ++HRD+KP N L  S      +K  DFG+S  +         VG+  Y++PE L+ 
Sbjct: 122 EKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQG 177

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTED---GIFKEVLRNKPDF------------ 319
                +SD+WS+G+    +  GR P           +F   +                  
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 320 -------------------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                                     + P    S   +DFV K L+K+P  R    Q + 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

Query: 355 HPWVRE 360
           H +++ 
Sbjct: 298 HAFIKR 303

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-64
 Identities = 62/268 (23%), Positives = 112/268 (41%), Gaps = 19/268 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           + T+G+ +G G FG  Y          VAVK +       P  ++  K EV +L+    H
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-H 63

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N++ F   +     + I  + CEG  L    L   ++++       + RQ  +     H
Sbjct: 64  VNILLFM-GYSTAPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVL 273
              ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 274 KRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--PDFRRKPWPSI 327
           + +       +SDV++ G++ Y L+ G+ P+ +         ++          K   + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSH 355
             + K  + + L K    R    Q L+ 
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  208 bits (529), Expect = 3e-64
 Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 16/273 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-- 154
            +++ +++G G FG  Y       G   A+K ++K ++ +         E  +L  ++  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
               +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 122

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H   +V+RD+KP N L     E   ++ +D GL+      K     VG+  Y+APEVL+
Sbjct: 123 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ 178

Query: 275 RKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           +       +D +S+G + + LL G  PF          E+ R       +   S S   +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELR 237

Query: 333 DFVKKLLVKDPRARLT-----AAQALSHPWVRE 360
             ++ LL +D   RL      A +    P+ R 
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 8e-64
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 17/270 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +   KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHP 65

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +     AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHS 123

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVLKRK 276
             +V+RD+K EN +     +D  +K TDFGL       G   +   G+  Y+APEVL+  
Sbjct: 124 RDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F      ++S  AK  +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236

Query: 336 KKLLVKDPRARL-----TAAQALSHPWVRE 360
             LL KDP+ RL      A + + H +   
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  205 bits (522), Expect = 8e-64
 Identities = 70/269 (26%), Positives = 126/269 (46%), Gaps = 18/269 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I + LG G FG  ++   + NG   A+K ++K  ++    VE    E  +L  +  H 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 64

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +++ +  F+D   +++ M+  EGGEL    L +K  R+    A     ++       H 
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFS--LLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             +++RD+KPEN L     ++  +K TDFG + ++        + G+  Y+APEV+  + 
Sbjct: 123 KDIIYRDLKPENILL---DKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKP 177

Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
                D WS G++ Y +L G  PF+D      ++++L  +  F     P  +   KD + 
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLS 233

Query: 337 KLLVKDPRARL-----TAAQALSHPWVRE 360
           +L+ +D   RL           +HPW +E
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 5e-62
 Identities = 77/306 (25%), Positives = 128/306 (41%), Gaps = 44/306 (14%)

Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQ 65

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLD-RILAKKDSRYTEKDA 201
           I++ L  H N+V+    F      +D+ Y+ + ++          R  ++          
Sbjct: 66  IMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
            + + Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSY 182

Query: 262 VGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----- 314
           + S YY APE++   +      DVWS G +   LL G+  F   +      E+++     
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 315 ---------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                            P  +  PW     P     A     +LL   P ARLT  +A +
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

Query: 355 HPWVRE 360
           H +  E
Sbjct: 303 HSFFDE 308

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 7e-62
 Identities = 86/346 (24%), Positives = 132/346 (38%), Gaps = 50/346 (14%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 62

Query: 153 LAGHENVVKFYNAFEDDN-----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +            VY+   L  G +L   +   K    +       + Q
Sbjct: 63  FR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL---KTQHLSNDHICYFLYQ 117

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVG 263
           +LR     H   ++HRD+KP N L         LK  DFGL+    P         + V 
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 264 SAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR------- 314
           + +Y APE++          D+WS+G I   +L  R  F  K        +L        
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 315 ----------------NKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                           + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

Query: 355 HPWVREGGDASEIPIDISVLNNMRQFVKYS--RLKQFALRVTQYFK 398
           HP++ +  D S+ PI  +      +       +LK+     T  F+
Sbjct: 295 HPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQ 340

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-60
 Identities = 72/288 (25%), Positives = 111/288 (38%), Gaps = 35/288 (12%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL--PIAVEDVKREVKILQALAGHENV 159
             LG GQF   Y A DK     VA+KKI+                RE+K+LQ L  H N+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           +   +AF   + + +  +  E       I+       T       +   L+     H H 
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RK 276
           ++HRD+KP N L     E+  LK  DFGL+  F  P + +   V + +Y APE+L   R 
Sbjct: 121 ILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP----------- 325
            G   D+W++G I   LL         ++      +         + WP           
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 326 -------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                        +  +   D ++ L + +P AR+TA QAL   +   
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  196 bits (499), Expect = 3e-60
 Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 51/302 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y + + LG G++   + A +  N ++V VK ++  K       + +KRE+KIL+ L G 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89

Query: 157 ENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            N++   +  +D       +  E     +             T+ D    + ++L+    
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDY 144

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
           CH  G++HRD+KP N +     E   L+  D+GL++F  PG+++   V S Y+  PE+L 
Sbjct: 145 CHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 202

Query: 275 RKS--GPESDVWSIGVITYILLCGRRPFWDKT------------------EDGIFKEVLR 314
                    D+WS+G +   ++  + PF+                      D I K  + 
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262

Query: 315 NKPDF----------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             P F                  +    +S  A DF+ KLL  D ++RLTA +A+ HP+ 
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

Query: 359 RE 360
             
Sbjct: 323 YT 324

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 6e-60
 Identities = 69/278 (24%), Positives = 130/278 (46%), Gaps = 19/278 (6%)

Query: 97  RYTIGKLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMIL-PIAVEDVKREVKILQA 152
            + + K+LG G +G  ++    +    G   A+K ++K  ++      E  + E ++L+ 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +     +V  + AF+ +  +++ ++   GGEL   +   +  R+TE +  + V +++   
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGEIVLAL 142

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP--GKKFQDIVGSAYYVAP 270
              H  G+++RD+K EN L      +  +  TDFGLS        ++  D  G+  Y+AP
Sbjct: 143 EHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 271 EVLKRKS---GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           ++++          D WS+GV+ Y LL G  PF    E     E+ R            +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259

Query: 328 SNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVRE 360
           S  AKD +++LL+KDP+ RL      A +   H + ++
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (487), Expect = 1e-58
 Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 37/299 (12%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDR-VAVKKIEKNKMILPIAVEDVKREVKILQA 152
            D++Y     +G G +G  + A D  NG R VA+K++               REV +L+ 
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRH 63

Query: 153 LAG--HENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           L    H NVV+ ++       + +  + +  E  +       +    +     +    ++
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMM 122

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
            Q+LR     H H +VHRD+KP+N L  S      +K  DFGL+           +V + 
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTL 179

Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           +Y APEVL + S     D+WS+G I   +   +  F   ++     ++L        + W
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 325 P-----------------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           P                        I    KD + K L  +P  R++A  ALSHP+ ++
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  191 bits (485), Expect = 1e-58
 Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 36/292 (12%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y   + +G G +G  Y A +   G+  A+KKI   K           RE+ IL+ L  H
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELK-H 59

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+VK Y+       + +  E  +    L ++L   +       A   + Q+L   A CH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVL-- 273
              ++HRD+KP+N L      +  LK  DFGL+     P +K+   + + +Y AP+VL  
Sbjct: 118 DRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI------ 327
            +K     D+WS+G I   ++ G   F   +E      + R       K WP++      
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 328 -------------------SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                                S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (487), Expect = 1e-58
 Identities = 75/314 (23%), Positives = 116/314 (36%), Gaps = 50/314 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y     +G G FG  + A  +  G +VA+KK+               RE+KILQ L  H
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLK-H 68

Query: 157 ENVVKFYNAFED--------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           ENVV                   +Y+  + CE              ++T  +   V++ +
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQML 126

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-----FQDIVG 263
           L      H + ++HRDMK  N L      D  LK  DFGL+      K      + + V 
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           + +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 322 KPWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQAL 353
           + WP++ N                             A D + KLLV DP  R+ +  AL
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

Query: 354 SHPWVREGGDASEI 367
           +H +       S++
Sbjct: 304 NHDFFWSDPMPSDL 317

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 5e-58
 Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 19/263 (7%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +   + + +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLR- 58

Query: 156 HENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           H N+V+      E+   +YI  E    G L+D + ++  S             +      
Sbjct: 59  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
              +  VHRD+   N L     ED+  K +DFGL+      +          + APE L+
Sbjct: 119 LEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALR 173

Query: 275 RKS-GPESDVWSIGVITYILL-CGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
            K    +SDVWS G++ + +   GR P+       +   V +    ++         +  
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVY 230

Query: 333 DFVKKLLVKDPRARLTAAQALSH 355
           + +K     D   R +  Q    
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQ 253

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-57
 Identities = 78/308 (25%), Positives = 130/308 (42%), Gaps = 38/308 (12%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +    Y   + +G G +G    A D   G +VA+KK+ +      +  +   RE+++L+ 
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKH 73

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLR 210
           +  HENV+   + F  D  +    +       +   L K  K  +  E     +V QML+
Sbjct: 74  MR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK 132

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H  G++HRD+KP N       ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ--ADSEMTGYVVTRWYRAP 187

Query: 271 EVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------------- 314
           EV+    +     D+WS+G I   ++ G+  F         KE+++              
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247

Query: 315 ---------NKPDFRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                      P+  +K + SI    S  A + ++K+LV D   R+TA +AL+HP+    
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

Query: 362 GDASEIPI 369
            D  + P 
Sbjct: 308 HDTEDEPQ 315

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (476), Expect = 4e-57
 Identities = 56/296 (18%), Positives = 106/296 (35%), Gaps = 24/296 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G+ +G G FG  Y+ TD A G+ VA+K               +  E KI + + G 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGG 62

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL             +  +++ K   ++  QM+      H
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--------DIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +  +  Q        ++ G+A Y 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP---- 323
           +             D+ S+G +      G  P+         ++  R        P    
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAA---QALSHPWVREGGDASEIPIDISVLNN 376
                +    ++          +   +   Q   + + R+G    +   D ++L  
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS-YDYVFDWNMLKF 295

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 5e-57
 Identities = 69/304 (22%), Positives = 114/304 (37%), Gaps = 41/304 (13%)

Query: 86  TDFGYDK--DFDR-RYTIGKLLGHGQFGYTYVATDKANGDR-----VAVKKIEKNKMILP 137
            ++ YD   +F R     GK+LG G FG    AT            VAVK +++      
Sbjct: 24  REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--S 81

Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---- 193
              E +  E+K++  L  HEN+V    A      +Y+  E C  G+LL+ + +K++    
Sbjct: 82  SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141

Query: 194 -----------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK 236
                            +  T +D      Q+ +          VHRD+   N L     
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---T 198

Query: 237 EDSSLKATDFGLSDFIKPGKKF---QDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY- 291
               +K  DFGL+  I     +    +      ++APE L       +SDVWS G++ + 
Sbjct: 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258

Query: 292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
           I   G  P+     D  F ++++N   F+       +      ++     D R R +   
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316

Query: 352 ALSH 355
             S 
Sbjct: 317 LTSF 320

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 1e-56
 Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 34/292 (11%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +   + +G G +G  Y A +K  G+ VA+KKI  +            RE+ +L+ L  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKEL-NH 60

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+VK  +    +N +Y+  E      L   + A   +          + Q+L+  A CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVL-- 273
            H ++HRD+KP+N L      + ++K  DFGL+     P + +   V + +Y APE+L  
Sbjct: 120 SHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS------- 326
            +      D+WS+G I   ++  R  F   +E      + R         WP        
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 327 ------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                             +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 7e-56
 Identities = 66/278 (23%), Positives = 106/278 (38%), Gaps = 21/278 (7%)

Query: 88  FGYDK-DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
              D  +  R    +   LG G FG  ++ T      RVA+K ++   M    + E   +
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM----SPEAFLQ 61

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E ++++ L  HE +V+ Y    ++   YI  E    G LLD +  +            + 
Sbjct: 62  EAQVMKKL-RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 119

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVG 263
            Q+    A       VHRD++  N L     E+   K  DFGL+  I+  +    Q    
Sbjct: 120 AQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKF 176

Query: 264 SAYYVAPEVLKRKS-GPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRR 321
              + APE         +SDVWS G++   L   GR P+       +  +V R    +R 
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRM 233

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALS--HPW 357
              P    S  D + +   K+P  R T     +    +
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 7e-56
 Identities = 57/262 (21%), Positives = 101/262 (38%), Gaps = 17/262 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
            T  K LG GQFG       +     VA+K I++  M    + ++   E K++  L+ HE
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HE 59

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V+ Y        ++I  E    G LL+  L +   R+  +    + + +         
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSAYYVAPEVLKR 275
              +HRD+   N L     +   +K +DFGLS ++   +            +  PEVL  
Sbjct: 119 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 276 KS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                +SD+W+ GV+ + I   G+ P+   T     + + +    +R       S     
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYT 232

Query: 334 FVKKLLVKDPRARLTAAQALSH 355
            +     +    R T    LS+
Sbjct: 233 IMYSCWHEKADERPTFKILLSN 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 8e-56
 Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 23/279 (8%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D++       ++G G FG    A  K +G R+        +        D   E+++L  
Sbjct: 8   DWND-IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--------------LAKKDSRYTE 198
           L  H N++    A E   Y+Y+A+E    G LLD +                   S  + 
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           +        + R          +HRD+   N L     E+   K  DFGLS   +   K 
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKK 183

Query: 259 QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILL-CGRRPFWDKTEDGIFKEVLRNK 316
                   ++A E L        SDVWS GV+ + ++  G  P+   T   +++++ +  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 242

Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
             +R +   +  +   D +++   + P  R + AQ L  
Sbjct: 243 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  182 bits (462), Expect = 3e-55
 Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 15/270 (5%)

Query: 90  YDK-DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           YDK + +R   T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E 
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEA 64

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            +++ +  H N+V+       +   YI  E    G LLD +        +      +  Q
Sbjct: 65  AVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSA 265
           +            +HRD+   N L     E+  +K  DFGLS  +               
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
            + APE L       +SDVW+ GV+ + +       +   +     E+L  + D+R +  
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--EKDYRMERP 238

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                   + ++     +P  R + A+   
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 8e-55
 Identities = 56/270 (20%), Positives = 94/270 (34%), Gaps = 17/270 (6%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQ 151
           ++   + + LG G FG        A   +   VAVK ++ + +  P A++D  REV  + 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +L  H N+++ Y          +  EL   G LLDR+  K    +     +    Q+   
Sbjct: 67  SL-DHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEG 123

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ----DIVGSAYY 267
                    +HRD+   N L         +K  DFGL   +                  +
Sbjct: 124 MGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
            APE LK ++    SD W  GV  + +   G+ P+       I  ++ +      R    
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PE 238

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                  + + +     P  R T       
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (460), Expect = 1e-54
 Identities = 67/279 (24%), Positives = 107/279 (38%), Gaps = 22/279 (7%)

Query: 89  GYDKDFDR-RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVK 144
            + K+ D     I +++G G+FG       K  G R   VA+K ++           D  
Sbjct: 18  EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFL 75

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E  I+     H NV+           V I  E  E G L D  L + D ++T      +
Sbjct: 76  SEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGM 133

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD---- 260
           +R +            VHRD+   N L      +   K +DFGLS F++           
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190

Query: 261 --IVGSAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNK 316
                   + APE ++ RK    SDVWS G++ + ++  G RP+WD T   +   + +  
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-- 248

Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
            D+R  P     ++    +     KD   R    Q ++ 
Sbjct: 249 -DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-54
 Identities = 56/273 (20%), Positives = 107/273 (39%), Gaps = 20/273 (7%)

Query: 89  GYDKDFD---RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
            ++ +++       + + LG GQFG  ++        +VAVK +++  M    + +    
Sbjct: 3   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLA 57

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  +++ L  H+ +V+ Y     +  +YI  E  E G L+D +      + T      + 
Sbjct: 58  EANLMKQLQ-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF--QDIVG 263
            Q+    A       +HRD++  N L          K  DFGL+  I+  +    +    
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKF 172

Query: 264 SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRR 321
              + APE +       +SDVWS G++   ++  GR P+   T   + + + R    +R 
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRM 229

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
               +        ++    + P  R T     S
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  182 bits (462), Expect = 2e-54
 Identities = 71/270 (26%), Positives = 127/270 (47%), Gaps = 18/270 (6%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           ++   K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NF 100

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +VK   +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              L++RD+KPEN L     +   ++ TDFG +  +K   +   + G+   +APE++  K
Sbjct: 159 SLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSK 213

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
                 D W++GV+ Y +  G  PF+      I+++++  K  F        S+  KD +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLL 269

Query: 336 KKLLVKDPRARL-----TAAQALSHPWVRE 360
           + LL  D   R            +H W   
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 3e-54
 Identities = 53/263 (20%), Positives = 105/263 (39%), Gaps = 17/263 (6%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
             T  + +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L  H
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SH 59

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +V+ Y    +   + +  E  E G L D +   +   +  +    +   +    A   
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSAYYVAPEVLK 274
              ++HRD+   N L     E+  +K +DFG++ F+   +            + +PEV  
Sbjct: 119 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 275 -RKSGPESDVWSIGVITYILLCGRRPFW-DKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS GV+ + +    +  + +++   + +++      FR       S    
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVY 232

Query: 333 DFVKKLLVKDPRARLTAAQALSH 355
             +     + P  R   ++ L  
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 5e-54
 Identities = 75/319 (23%), Positives = 129/319 (40%), Gaps = 55/319 (17%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +RY   K +G G  G    A D      VA+KK+ +         +   RE+ +++ +  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCV-N 74

Query: 156 HENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           H+N++   N F      E+   VY+ MEL +       +          +  + ++ QML
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 129

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H  G++HRD+KP N + KS   D +LK  DFGL+            V + YY A
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 270 PE-VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------------- 314
           PE +L        D+WS+G I   ++  +  F  +     + +V+               
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 315 --------NKPDFRRKPWPSI----------------SNSAKDFVKKLLVKDPRARLTAA 350
                   N+P +    +P +                ++ A+D + K+LV DP  R++  
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 351 QALSHPWVREGGDASEIPI 369
            AL HP++    D +E+  
Sbjct: 307 DALQHPYINVWYDPAEVEA 325

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 7e-54
 Identities = 65/293 (22%), Positives = 121/293 (41%), Gaps = 36/293 (12%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y   + +G G +G  + A ++   + VA+K++  +            RE+ +L+ L  H
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELK-H 60

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +N+V+ ++    D  + +  E C+                  +     + Q+L+    CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL-- 273
              ++HRD+KP+N L      +  LK  +FGL+  F  P + +   V + +Y  P+VL  
Sbjct: 119 SRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFRRKPWPS------ 326
            +      D+WS G I   L    RP +     D   K + R       + WPS      
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 327 -------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                              ++ + +D ++ LL  +P  R++A +AL HP+  +
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 7e-53
 Identities = 79/311 (25%), Positives = 125/311 (40%), Gaps = 44/311 (14%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +   RY     +G G +G    A D   G RVAVKK+ +      I  +   RE+++L+ 
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKH 73

Query: 153 LAGHENVVKFYNAFEDDNYV-----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           +  HENV+   + F     +        +    G +L + +   K  + T+     ++ Q
Sbjct: 74  MK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQ 129

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +LR     H   ++HRD+KP N       ED  LK  DFGL+       +    V + +Y
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHT--DDEMTGYVATRWY 184

Query: 268 VAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR----- 320
            APE++          D+WS+G I   LL GR  F         K +LR           
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 321 ----------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
                                    +   +  A D ++K+LV D   R+TAAQAL+H + 
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

Query: 359 REGGDASEIPI 369
            +  D  + P+
Sbjct: 305 AQYHDPDDEPV 315

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-52
 Identities = 71/297 (23%), Positives = 106/297 (35%), Gaps = 36/297 (12%)

Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILP 137
           T   YD  ++    R + GK LG G FG    AT            VAVK ++ +     
Sbjct: 10  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--L 67

Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS--- 194
              E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS   
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 195 -------------RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL 241
                            +D      Q+ +  A       +HRD+   N L          
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRIT 184

Query: 242 KATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGR 297
           K  DFGL+  IK    +    +      ++APE +       ESDVWS G+  + L    
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244

Query: 298 RP-FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
              +     D  F ++++    FR            D +K     DP  R T  Q +
Sbjct: 245 SSPYPGMPVDSKFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-52
 Identities = 58/267 (21%), Positives = 103/267 (38%), Gaps = 22/267 (8%)

Query: 102 KLLGHGQFGYTYVAT--DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           K LG G FG         K     VAVK + KN+   P   +++  E  ++Q L  +  +
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNPYI 70

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V+     E +++  + ME+ E G L   +  +++    +K+   +V Q+           
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----IVGSAYYVAPEVLK- 274
            VHRD+   N L  +       K +DFGLS  ++  + +            + APE +  
Sbjct: 128 FVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 275 RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            K   +SDVWS GV+ +     G++P+       +   + + +   R            D
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGCPREMYD 241

Query: 334 FVKKLLVKDPRARLTAAQ---ALSHPW 357
            +      D   R   A     L + +
Sbjct: 242 LMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 9e-52
 Identities = 62/266 (23%), Positives = 104/266 (39%), Gaps = 18/266 (6%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           R  +G+ +G GQFG  +     +  +    VA+K  +          E   +E   ++  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQF 65

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H ++VK       +N V+I MELC  GEL    L  +          +   Q+    A
Sbjct: 66  -DHPHIVKLIGVIT-ENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALA 122

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYYVAPE 271
                  VHRD+   N L  S   +  +K  DFGLS +++    ++         ++APE
Sbjct: 123 YLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 272 VLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
            +  R+    SDVW  GV  + IL+ G +PF     + +   +   +   R    P+   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPP 236

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSH 355
           +    + K    DP  R    +  + 
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 1e-51
 Identities = 55/274 (20%), Positives = 99/274 (36%), Gaps = 23/274 (8%)

Query: 97  RYTIGKL-LGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQAL 153
              I  + LG G FG       +    +  VA+K +++         E++ RE +I+  L
Sbjct: 9   NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQL 66

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             +  +V+     + +    + ME+  GG L   ++ K++      + A ++ Q+     
Sbjct: 67  -DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMK 123

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----IVGSAYYVA 269
                  VHRD+   N L          K +DFGLS  +     +            + A
Sbjct: 124 YLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           PE +  RK    SDVWS GV  +  L  G++P+       +   + + K   R +  P  
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPEC 237

Query: 328 SNSAKDFVKKLLVKDPRARLTAA---QALSHPWV 358
                  +    +     R       Q +   + 
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-50
 Identities = 60/292 (20%), Positives = 107/292 (36%), Gaps = 31/292 (10%)

Query: 90  YDKDFD---RRYTIGKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIA 139
            D  ++    R  +GK LG G FG   +A              +VAVK ++ +       
Sbjct: 4   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKD 61

Query: 140 VEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
           + D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 62  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + + KD      Q+ R          +HRD+   N L              
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181

Query: 246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDK 303
                 I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+   
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241

Query: 304 TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
             + +FK +       R     + +N     ++      P  R T  Q +  
Sbjct: 242 PVEELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  168 bits (425), Expect = 1e-49
 Identities = 50/273 (18%), Positives = 105/273 (38%), Gaps = 22/273 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G+ +G G FG  +  T+  N  +VA+K   +           ++ E +  + LAG 
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGC 60

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +   Y   ++  +  + ++L   G  L+ +L     +++ K  A+  +QML      H
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 217 LHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLSDFIKPG--------KKFQDIVGSAY 266
              LV+RD+KP+NFL    ++K  + +   DFG+  F +          ++ +++ G+A 
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG----IFKEVLRNKPDFRR 321
           Y++      +      D+ ++G +    L G  P+             +   + +    R
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           +           ++         A         
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 3e-48
 Identities = 56/265 (21%), Positives = 101/265 (38%), Gaps = 16/265 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQALAG 155
           +   K+LG G FG  Y       G++V +    K   +   P A +++  E  ++ ++  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 69

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           + +V +            I  +L   G LLD +   KD     +       Q+ +     
Sbjct: 70  NPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYL 127

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEV 272
               LVHRD+   N L    K    +K TDFGL+  +   +K    +       ++A E 
Sbjct: 128 EDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 273 LKRKS-GPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           +  +    +SDVWS GV  + L+  G +P+       I   + + +   R    P  +  
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTID 241

Query: 331 AKDFVKKLLVKDPRARLTAAQALSH 355
               + K  + D  +R    + +  
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIE 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (402), Expect = 3e-46
 Identities = 50/295 (16%), Positives = 96/295 (32%), Gaps = 42/295 (14%)

Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKRE 146
           ++ R      + +G G FG  + A             VAVK +++          D +RE
Sbjct: 9   EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQRE 66

Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY---------- 196
             ++     + N+VK          + +  E    G+L + + +                
Sbjct: 67  AALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 197 ------------TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT 244
                       +  +   + RQ+    A       VHRD+   N L     E+  +K  
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIA 182

Query: 245 DFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRR-P 299
           DFGLS  I     ++   +      ++ PE +   +   ESDVW+ GV+ + +      P
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242

Query: 300 FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           ++    + +   V             +      + ++    K P  R +      
Sbjct: 243 YYGMAHEEVIYYVRDGN---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 3e-46
 Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 20/268 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQA 152
             T  K++G G+FG  Y    K +  +    VA+K ++           D   E  I+  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQ 65

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          + I  E  E G L   +  +KD  ++      ++R +    
Sbjct: 66  F-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 123

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVGSAYYV 268
                   VHRD+   N L      +   K +DFGLS  ++   +             + 
Sbjct: 124 KYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 269 APEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           APE +  RK    SDVWS G++ + ++  G RP+W+ +   + K +      FR      
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMD 237

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALS 354
             ++    + +   ++   R   A  +S
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 5e-45
 Identities = 53/272 (19%), Positives = 99/272 (36%), Gaps = 21/272 (7%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQ 151
                  +++G G FG  Y  T   N  +    AVK + +        V     E  I++
Sbjct: 26  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMK 83

Query: 152 ALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
             + H NV+         +    + +   + G+L +  +  +    T KD      Q+ +
Sbjct: 84  DFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAK 141

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-----IVGSA 265
                     VHRD+   N +     E  ++K  DFGL+  +   +              
Sbjct: 142 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 266 YYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFW-DKTEDGIFKEVLRNKPDFRRKP 323
            ++A E L+ +K   +SDVWS GV+ + L+    P + D     I   +L+ +   R   
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQ 255

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                +   + + K        R + ++ +S 
Sbjct: 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 2e-44
 Identities = 54/288 (18%), Positives = 108/288 (37%), Gaps = 33/288 (11%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           + T+ + LG G FG  Y    K         RVA+K + +          +   E  +++
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMK 78

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--------YTEKDAAV 203
                 +VV+            + MEL   G+L   + + + +          +      
Sbjct: 79  EF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG---KKFQD 260
           +  ++    A  + +  VHRD+   N +     ED ++K  DFG++  I      +K   
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 261 IVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPD 318
            +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V+     
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-- 252

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS------HPWVRE 360
                  +  +   + ++     +P+ R +  + +S       P  RE
Sbjct: 253 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  154 bits (390), Expect = 5e-44
 Identities = 69/335 (20%), Positives = 122/335 (36%), Gaps = 64/335 (19%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL- 153
           D RY + + LG G F   ++A D  N   VA+K +  +K+      E  + E+K+LQ + 
Sbjct: 12  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVN 67

Query: 154 ---------AGHENVVKFYNAFED---DNYVYIAMELCEGGELLDRILAKKDSRYTEKDA 201
                     G  +++K  + F     +    + +    G  LL  I   +         
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 202 AVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSL-KATDFGLSDFIKPGKKFQ 259
             + +Q+L      H   G++H D+KPEN L +      +L +     L +     + + 
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 260 DIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV------ 312
           + + +  Y +PEVL     G  +D+WS   + + L+ G   F         K+       
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 313 ---------------------------LRNKPDFRRKPWPSI-----------SNSAKDF 334
                                      LRN    +  P   +           +    DF
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           +  +L  DPR R  A   ++HPW+++     EI +
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 4e-42
 Identities = 60/301 (19%), Positives = 107/301 (35%), Gaps = 57/301 (18%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALA 154
           R   + + +G G+FG  +    +  G+ VAVK     +           RE +I Q  + 
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE------RSWFREAEIYQTVML 54

Query: 155 GHENVVKFYNAFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN     +++  +  E G L D +        T +    +      
Sbjct: 55  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTAS 111

Query: 211 VAAECHLH--------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-- 260
             A  H+          + HRD+K +N L    K++ +    D GL+          D  
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA 168

Query: 261 ---IVGSAYYVAPEVLKR-------KSGPESDVWSIGVITYILLCGRRPF---------- 300
               VG+  Y+APEVL         +S   +D++++G++ + +                 
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 301 -----WDKTEDGIFKEVLRNKPDFR---RKPWPSISNSAKDFVKKLLVKDPRARLTAAQA 352
                 D + + + K V   K       R             +++    +  ARLTA + 
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 353 L 353
            
Sbjct: 289 K 289

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 7e-42
 Identities = 67/295 (22%), Positives = 108/295 (36%), Gaps = 36/295 (12%)

Query: 90  YDKD---FDR-RYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAV 140
           YD     F R R  +GK LG G FG    A        A    VAVK +++         
Sbjct: 3   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEH 60

Query: 141 EDVKREVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKD------ 193
             +  E+KIL  +  H NVV    A  +    + + +E C+ G L   + +K++      
Sbjct: 61  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120

Query: 194 --------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                      T +       Q+ +          +HRD+   N L     E + +K  D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICD 177

Query: 246 FGLSDFIKPGKKFQ---DIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRR-PF 300
           FGL+  I     +    D      ++APE +  R    +SDVWS GV+ + +      P+
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                D  F   L+     R   +   +      +      +P  R T ++ + H
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.0 bits (186), Expect = 7e-17
 Identities = 37/205 (18%), Positives = 67/205 (32%), Gaps = 35/205 (17%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM---------------ILPIAVED 142
             IGKL+G G+    +    +       VK  +                      +A+  
Sbjct: 2   DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 143 VKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
            + E + LQ L     V K Y    +     + MEL +           +  R   ++  
Sbjct: 61  ARNEFRALQKLQ-GLAVPKVYAWEGN----AVLMELIDAK---------ELYRVRVENPD 106

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            V+  +L   A+ +  G+VH D+   N L      +  +   DF  S  +   + +++I+
Sbjct: 107 EVLDMILEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGE-EGWREIL 161

Query: 263 GSAYYVAPEVLKRKSGPESDVWSIG 287
                       R    E D+ S  
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINSAI 186

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 1/93 (1%)

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
            DV+RE  ++  L G   V K  +    D +  + M   +G    +    ++      + 
Sbjct: 54  YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIEL 113

Query: 201 AAVVVRQMLRV-AAECHLHGLVHRDMKPENFLF 232
            A  +R    +  ++C     +   +   ++L 
Sbjct: 114 YAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	414
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.73
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.34
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.69
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.35

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-66  Score=486.37  Aligned_cols=292  Identities=39%  Similarity=0.674  Sum_probs=235.7

Q ss_pred             ccccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      .+++.++|++++.||+|+||+||+|+++.+|+.||||++.+....  .....+.+|+.+|+.+. |||||++++++.+++
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYESGG   80 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            456778899999999999999999999999999999999765432  23466889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .+|||||||+||+|.+++..  .+.+++.+++.++.||+.||+|||++||+||||||+|||+....+++.+||+|||+|+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            99999999999999999844  4679999999999999999999999999999999999999865568899999999998


Q ss_pred             ccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          251 FIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      .........+.+||+.|||||++.+. ++.++|||||||++|+|++|..||.+....++...+......++.+.++.+|+
T Consensus       159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  238 (307)
T d1a06a_         159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD  238 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence            87766666778999999999998765 68999999999999999999999999998899999999888887777789999


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCCHHHHHHHHHHhhhcHHHH
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ  388 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  388 (414)
                      ++.+||.+||+.||.+|||++|+|+||||+.... ..........+.+++....+++++
T Consensus       239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  296 (307)
T d1a06a_         239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA-LDKNIHQSVSEQIKKNFAKSKWKQ  296 (307)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC-CCCCCHHHHHHHHHHHSCCCTTTS
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc-cccccchhHHHHHHHHHHHhhhhh
Confidence            9999999999999999999999999999986432 223444555566776655555543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-64  Score=467.41  Aligned_cols=255  Identities=29%  Similarity=0.577  Sum_probs=228.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+. |||||++++++.+++.+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999997654333345678899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||||+||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|......
T Consensus        85 mEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCSCSCCCCC
T ss_pred             EeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec---CCCCEeecccceeeecCCC
Confidence            9999999999998543  5799999999999999999999999999999999999998   5789999999999876543


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                       .....+||+.|||||++.+. ++.++|||||||++|+|++|+.||.+.+..+++..+.+..+.++    +.+|+++.+|
T Consensus       160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  234 (263)
T d2j4za1         160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL  234 (263)
T ss_dssp             -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHH
T ss_pred             -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence             34567899999999998875 58999999999999999999999999988888888887765544    3689999999


Q ss_pred             HHHhhcCCccccCCHHHHhCCcccccc
Q 015026          335 VKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       335 i~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      |.+||+.||++|||++|+|+||||+..
T Consensus       235 i~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            999999999999999999999999853

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-64  Score=465.10  Aligned_cols=258  Identities=33%  Similarity=0.572  Sum_probs=218.5

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.....  ....+.+.+|+.+|+.+. |||||++++++.+++.+||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~i   80 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYL   80 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeEE
Confidence            4579999999999999999999999999999999976543  224567899999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |||||+||+|.+++  .....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+....
T Consensus        81 vmEy~~gg~L~~~l--~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~---~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          81 FLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEECEE
T ss_pred             EEeccCCCcHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---CCCCEEEccchhheeecc
Confidence            99999999999988  4456799999999999999999999999999999999999998   578999999999987643


Q ss_pred             CC---ccccCCCCCccccchhcccc-C-CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCH
Q 015026          255 GK---KFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (414)
Q Consensus       255 ~~---~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (414)
                      ..   .....+||+.|||||++.+. + +.++|||||||++|||++|++||.................. ....++.+|+
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~  234 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDS  234 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGSCH
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccCCH
Confidence            32   24567899999999998765 3 56799999999999999999999876554433333333322 2334567899


Q ss_pred             HHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       330 ~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ++.+||.+||+.||++|||++|+|+||||++.
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         235 APLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            99999999999999999999999999999853

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-63  Score=462.89  Aligned_cols=258  Identities=28%  Similarity=0.484  Sum_probs=225.6

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++......   ..+.+.+|+.+|+.+. |||||+++++|.+++.+|
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence            345799999999999999999999999999999999765432   4577899999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||||||+||+|.+++..   ..+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+...
T Consensus        94 ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC---CCCcEeeccchhheeec
Confidence            99999999999987743   3699999999999999999999999999999999999998   57899999999998765


Q ss_pred             CC-CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          254 PG-KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .. ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+...... ....++.+|+++
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~  246 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIF  246 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHH
T ss_pred             cccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHH
Confidence            43 344567899999999998765 689999999999999999999999988877776666654321 122335789999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ++||.+||+.||.+|||+.|+|+||||+...
T Consensus       247 ~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999999998543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.2e-62  Score=471.33  Aligned_cols=263  Identities=35%  Similarity=0.598  Sum_probs=238.5

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++....   ....+.+.+|+.+|+.|. |||||+++++|.+++.+|
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            4467999999999999999999999999999999997653   235567889999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||||||+||+|.+.+.. ....+++.+++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||+|....
T Consensus       103 ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         103 LILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECC
T ss_pred             EEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecC
Confidence            99999999999987643 34569999999999999999999999999999999999999742 46799999999999887


Q ss_pred             CCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ........+||+.|+|||++.+. ++.++|||||||++|+|+||+.||.+.+..+++..+......++...++.+|+++.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            77767778999999999998765 68999999999999999999999999999999999999888888878889999999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +||.+||+.||.+|||+.|+|+||||+...
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            999999999999999999999999998643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-63  Score=463.65  Aligned_cols=267  Identities=36%  Similarity=0.635  Sum_probs=238.0

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC---hHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      .++.++|++++.||+|+||+||+|+++.+|+.||||++.+.....   ....+.+.+|+.+|+.|. |||||+++++|.+
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~   84 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   84 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence            346678999999999999999999999999999999997654322   224678999999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC-CCCCceeeccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFG  247 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DFG  247 (414)
                      ++.+|||||||+||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++..+ ....+||+|||
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             CCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999999998554  4799999999999999999999999999999999999998532 22369999999


Q ss_pred             cccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      +|............+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......++...++.
T Consensus       163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (293)
T d1jksa_         163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  242 (293)
T ss_dssp             TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence            99988776667778999999999998764 68999999999999999999999999999999999988877766656678


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus       243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999999854

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.3e-62  Score=470.90  Aligned_cols=263  Identities=34%  Similarity=0.625  Sum_probs=238.0

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +-++|++++.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.+|+.|+ |||||++++++.+++.+|
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            4468999999999999999999999999999999997653   345678899999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||||||+||+|.+++... .+.+++..++.++.||+.||.|||++|||||||||+|||++.. .++.+||+|||+|+...
T Consensus       100 ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheecc
Confidence            999999999999988443 3569999999999999999999999999999999999999742 35789999999999887


Q ss_pred             CCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      ........+||+.|||||++.+. ++.++|||||||++|+|++|+.||.+.+..+++..+......++...++.+|++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            77777778999999999998765 68899999999999999999999999999999999988887777766778999999


Q ss_pred             HHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          333 DFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      +||.+||+.||++|||++|+|+||||+...
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999998754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-63  Score=462.79  Aligned_cols=256  Identities=33%  Similarity=0.578  Sum_probs=225.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+++|+++. |||||++++++.+++.+|||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999997654333345678999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||||+||+|.+++...  +.+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+.....
T Consensus        87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~---~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECC--
T ss_pred             EEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC---CCceEEecccccceecccC
Confidence            9999999999988543  5799999999999999999999999999999999999998   5789999999999876432


Q ss_pred             ---CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 ---KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                         ....+.+||+.|||||++.+. ++.++|||||||++|+|++|+.||.+.+..+++..+......++    ..+|+++
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  237 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKA  237 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHH
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHH
Confidence               233467899999999998764 68899999999999999999999999998889999988766554    3689999


Q ss_pred             HHHHHHhhcCCccccCCHHH------HhCCcccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQ------ALSHPWVREG  361 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~e------lL~hp~f~~~  361 (414)
                      ++||.+||+.||++|||++|      +++||||+..
T Consensus       238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            99999999999999999998      5889999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.3e-62  Score=453.40  Aligned_cols=262  Identities=32%  Similarity=0.627  Sum_probs=236.5

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC------hHhHHHHHHHHHHHHHccCCCCceEEEEEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL------PIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~  167 (414)
                      |.++|++++.||+|+||+||+|++..+|+.||||++.+.....      ....+.+.+|+.+|++|..|||||++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            3468999999999999999999999999999999997754332      1234568899999999977999999999999


Q ss_pred             cCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                      +++.+|||||||+||+|.+++..  .+.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~~kl~DFG  155 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFG  155 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCT
T ss_pred             cCcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---CCCCeEEccch
Confidence            99999999999999999999954  35799999999999999999999999999999999999998   68899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc-------cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCC
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  320 (414)
                      +++.+.........+||+.|+|||.+.+       .++.++||||+||++|+|++|+.||.+.+..+....+..+...++
T Consensus       156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~  235 (277)
T d1phka_         156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  235 (277)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            9998876666677899999999998753       247789999999999999999999999998888888998887777


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      ...++.+|+++++||.+||++||++|||++|+|+||||++
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            7777789999999999999999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-62  Score=459.47  Aligned_cols=258  Identities=31%  Similarity=0.473  Sum_probs=225.8

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ..+.|++++.||+|+||+||+|.+..+|+.||||++....   ....+.+.+|+++|+.|. |||||++++++.+++.++
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEE
Confidence            3467999999999999999999999999999999997653   235567889999999995 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      ||||||+||+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|....
T Consensus        86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~---~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECH
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---CCCCEEEEechhhhccC
Confidence            999999999999987543 45799999999999999999999999999999999999998   57899999999997643


Q ss_pred             CC-CccccCCCCCccccchhcc------ccCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          254 PG-KKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .. ....+.+||+.|||||++.      ..++.++|||||||++|+|++|+.||.+.+..+++..+....+... ...+.
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~  240 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSR  240 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGG
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-Ccccc
Confidence            22 2234678999999999874      2357889999999999999999999999988888888887654322 22346


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      +|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            8999999999999999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-62  Score=451.36  Aligned_cols=255  Identities=21%  Similarity=0.359  Sum_probs=218.3

Q ss_pred             cce-eeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----CC
Q 015026           96 RRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DN  170 (414)
Q Consensus        96 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----~~  170 (414)
                      .+| ++.++||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+++|++++ |||||+++++|.+    +.
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCC
Confidence            345 788899999999999999999999999999976553 3445678999999999995 9999999999865    46


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      .+|||||||+||+|.+++...  ..+++..++.++.||+.||+|||+++  |+||||||+|||++.  +++.+||+|||+
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~--~~~~~Kl~DFGl  161 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGL  161 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTG
T ss_pred             EEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC--CCCCEEEeecCc
Confidence            789999999999999998543  57999999999999999999999999  999999999999963  467899999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccccCCCCcchhHHHHHHHHHhhCCCCCCCCCch-hhhHHHhhcCCCCCCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      |+.... ......+||+.|||||++.+.++.++|||||||++|||++|+.||.+.... .+...+..+...  .......
T Consensus       162 a~~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~  238 (270)
T d1t4ha_         162 ATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVA  238 (270)
T ss_dssp             GGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCC
T ss_pred             ceeccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccC
Confidence            986543 334577999999999999999999999999999999999999999776544 444555443321  1122457


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      ++++.+||.+||++||++|||++|+|+||||+
T Consensus       239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            89999999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-62  Score=462.13  Aligned_cols=260  Identities=27%  Similarity=0.432  Sum_probs=228.1

Q ss_pred             cccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      +++...|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|++|. |||||++++++.+++.
T Consensus        11 ~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~   89 (309)
T d1u5ra_          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHT   89 (309)
T ss_dssp             SCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred             cCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCE
Confidence            345567999999999999999999999999999999998776555566788999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +|||||||+||+|..++.  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|..
T Consensus        90 ~~iv~E~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccc
Confidence            999999999998866553  346799999999999999999999999999999999999999   588999999999987


Q ss_pred             cCCCCccccCCCCCccccchhccc----cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCC
Q 015026          252 IKPGKKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ...   ....+||+.|||||++.+    .++.++|||||||++|||++|..||.+.+..+.+..+........  ....+
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~  239 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW  239 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTS
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCC
Confidence            543   345689999999999853    468899999999999999999999998888777777776653322  23468


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      |+++.+||.+||+.||.+|||++|+|+||||....
T Consensus       240 s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            99999999999999999999999999999998643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-61  Score=462.87  Aligned_cols=255  Identities=31%  Similarity=0.535  Sum_probs=229.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.+. |||||+++++|.+++.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence            46999999999999999999999999999999998654333345678899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC-
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-  254 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~-  254 (414)
                      ||||+||+|.+++..  .+.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+|+.... 
T Consensus        84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~---~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSCCT
T ss_pred             eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec---CCCCEEEeecccccccccC
Confidence            999999999998854  35799999999999999999999999999999999999998   578999999999987543 


Q ss_pred             CCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                      .......+||+.|+|||++.+ .++.++|||||||++|||++|++||.+.+..+++..+......++    ..+|+++++
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d  234 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS  234 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHH
Confidence            444567899999999999875 479999999999999999999999999999999999988876554    468999999


Q ss_pred             HHHHhhcCCccccCC-----HHHHhCCccccc
Q 015026          334 FVKKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      ||.+||++||.+||+     ++|+++||||+.
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            999999999999994     999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-61  Score=448.98  Aligned_cols=255  Identities=26%  Similarity=0.468  Sum_probs=213.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--CCEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~~~~  173 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..... .+...+.+.+|+.+|+++. |||||++++++.+  .+.+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            569999999999999999999999999999999987654 3446778999999999995 9999999999865  45689


Q ss_pred             EEEeccCCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEEeecCCCCCceeecc
Q 015026          174 IAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHG-----LVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~~L~~LH~~~-----iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                      ||||||+||+|.+++...  ....+++..++.++.||+.||.|||+.|     ||||||||+|||++   .++.+||+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~---~~~~vkl~DF  158 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDF  158 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC---TTSCEEECCH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC---CCCcEEEeec
Confidence            999999999999988542  3567999999999999999999999976     99999999999998   5789999999


Q ss_pred             ccccccCCCC-ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          247 GLSDFIKPGK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       247 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      |+|+...... .....+||+.|||||++.+. ++.++|||||||++|||+||..||.+.+..++...+..+....   ..
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IP  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CC
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence            9998765433 34567899999999998654 6889999999999999999999999988888888887765432   23


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhCCccc
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f  358 (414)
                      ..+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            4689999999999999999999999999999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-61  Score=460.70  Aligned_cols=262  Identities=29%  Similarity=0.556  Sum_probs=236.5

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++-++|++++.||+|+||+||+|.++.+|+.||||++....    .....+.+|+.+|+.++ |||||+++++|.+++.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            45678999999999999999999999999999999997653    24456889999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |||||||+||+|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.. +...+||+|||+++..
T Consensus        77 ~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhcc
Confidence            9999999999999988432 3469999999999999999999999999999999999999842 3568999999999887


Q ss_pred             CCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      .........+||+.|+|||.+.+. ++.++|||||||++|+|++|..||.+.+..+++..+......++...++.+|+++
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            766666778899999999987654 6889999999999999999999999999999999999988877777777899999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      ++||.+||..||.+|||++|+|+||||+..
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            999999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.3e-61  Score=454.98  Aligned_cols=254  Identities=28%  Similarity=0.556  Sum_probs=228.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.+. |||||++++++.+++.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence            35999999999999999999999999999999997654333345678999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||||+||+|...+.  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.....
T Consensus        83 mE~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~---~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          83 MDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             ECCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECSSC
T ss_pred             eeecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc---CCCCEEEecCccceEeccc
Confidence            99999999998874  445789999999999999999999999999999999999998   5889999999999876543


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                        ..+.+||+.|||||++.+. ++.++|||||||++|+|++|+.||.+.+..+++..+......++    +.+|+++.++
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  231 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDL  231 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence              3467999999999998765 68999999999999999999999999999999999988765543    4689999999


Q ss_pred             HHHhhcCCccccC-----CHHHHhCCcccccc
Q 015026          335 VKKLLVKDPRARL-----TAAQALSHPWVREG  361 (414)
Q Consensus       335 i~~~L~~dp~~Rp-----s~~elL~hp~f~~~  361 (414)
                      |.+||..||.+|+     |++++|+||||+..
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            9999999999996     99999999999863

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-61  Score=461.96  Aligned_cols=269  Identities=29%  Similarity=0.566  Sum_probs=227.4

Q ss_pred             cccceeece-eeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc----
Q 015026           94 FDRRYTIGK-LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (414)
Q Consensus        94 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~----  168 (414)
                      +-++|++++ .||+|+||+||+|++..+|+.||||++...        ..+.+|+.++.++.+|||||+++++|.+    
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            346798875 699999999999999999999999998643        3567899998776579999999999875    


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      ...+|||||||+||+|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++...+.+.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            46799999999999999999765556799999999999999999999999999999999999998666678899999999


Q ss_pred             ccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhH----HHhhcCCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFK----EVLRNKPDFRRKP  323 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~----~i~~~~~~~~~~~  323 (414)
                      |+...........+||+.|||||++.+. ++.++|||||||++|+|+||++||.+.+......    .+......++...
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  240 (335)
T d2ozaa1         161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  240 (335)
T ss_dssp             CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred             eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence            9987776667788999999999998764 6899999999999999999999998776554433    3333444455444


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccCCCCCCCC
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID  370 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~~~~~~~~  370 (414)
                      ++.+|+++.+||.+||+.||++|||+.|+|+||||.........+..
T Consensus       241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~  287 (335)
T d2ozaa1         241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH  287 (335)
T ss_dssp             HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEES
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCcC
Confidence            55789999999999999999999999999999999876554444433

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-61  Score=459.11  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=215.1

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEE
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~l  174 (414)
                      .++|++++.||+|+||+||+|++..+|+.||+|++....  .+...+.+.+|+.+|+.++ |||||+++++|.+++.+||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            468999999999999999999999999999999997653  2345678999999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      |||||+||+|.+++.+.  +.+++..++.++.||+.||.|||+ +||+||||||+|||++   .++.+||+|||+|+...
T Consensus        82 VmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCHHHH
T ss_pred             EEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC---CCCCEEEeeCCCccccC
Confidence            99999999999988543  579999999999999999999997 5999999999999998   57899999999998754


Q ss_pred             CCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHH---------------------
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE---------------------  311 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~---------------------  311 (414)
                      .. ...+.+||+.|||||++.+ .++.++||||+||++|||++|+.||.+.+..+....                     
T Consensus       157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence            32 2346799999999998876 579999999999999999999999977654322110                     


Q ss_pred             ---------------------HhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          312 ---------------------VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       312 ---------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                           +....  .+..+...+|+++++||.+||+.||.+|||++|+|+||||+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                                 00000  01111124688999999999999999999999999999998643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-60  Score=455.89  Aligned_cols=253  Identities=28%  Similarity=0.503  Sum_probs=227.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.+. |||||++++++.+...+++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence            47999999999999999999999999999999997654333345678899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+.||+|.+++...  +.+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+.....
T Consensus       120 ~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~---~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECSSC
T ss_pred             cccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC---CCCCEEeeeceeeeecccc
Confidence            9999999999988554  4799999999999999999999999999999999999998   5789999999999887543


Q ss_pred             CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHHH
Q 015026          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (414)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (414)
                        ....+||+.|||||++.+. ++.++|||||||++|+|+||+.||.+.+...++..+....+.++    ..+|+++.+|
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  268 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDL  268 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHH
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHH
Confidence              3467899999999998765 68899999999999999999999999988888888888765543    4789999999


Q ss_pred             HHHhhcCCccccC-----CHHHHhCCccccc
Q 015026          335 VKKLLVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       335 i~~~L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      |.+||..||.+|+     |++++++||||+.
T Consensus       269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHhhhCHHhccccccccHHHHHcCccccC
Confidence            9999999999995     9999999999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-60  Score=448.92  Aligned_cols=256  Identities=28%  Similarity=0.510  Sum_probs=225.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|+.++....+|||||++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46999999999999999999999999999999997654322334566778888776433699999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||||+||+|.+++..  ...+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.....
T Consensus        82 mEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~---~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec---CCCceeccccchhhhcccc
Confidence            999999999999854  35799999999999999999999999999999999999998   6789999999999865433


Q ss_pred             -CccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          256 -KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                       ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+++..+....+.++    ..+|+++.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d  232 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKD  232 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence             33445789999999998876 468899999999999999999999999999999998888766544    368999999


Q ss_pred             HHHHhhcCCccccCCHH-HHhCCccccc
Q 015026          334 FVKKLLVKDPRARLTAA-QALSHPWVRE  360 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~-elL~hp~f~~  360 (414)
                      ||.+||+.||.+|||+. ++++||||+.
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            99999999999999996 8999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-59  Score=451.94  Aligned_cols=257  Identities=23%  Similarity=0.375  Sum_probs=215.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHH---HHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE---VKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E---~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|   +.+++.+ +|||||+++++|.+++.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence            469999999999999999999999999999999975443222233344455   5555556 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |||||||+||+|.+++...  ..+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~---~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---SSSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc---CCCcEEEeeeceeeec
Confidence            9999999999999998543  5789999999999999999999999999999999999998   5789999999999876


Q ss_pred             CCCCccccCCCCCccccchhcc-c-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHH
Q 015026          253 KPGKKFQDIVGSAYYVAPEVLK-R-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (414)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (414)
                      ... .....+||+.|+|||++. + .++.++|||||||++|||+||+.||.+........ +.......+...++.+|++
T Consensus       158 ~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         158 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             SSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHH
T ss_pred             CCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHH
Confidence            543 345678999999999885 3 36889999999999999999999998766544332 2222333333344579999


Q ss_pred             HHHHHHHhhcCCccccCC-----HHHHhCCccccc
Q 015026          331 AKDFVKKLLVKDPRARLT-----AAQALSHPWVRE  360 (414)
Q Consensus       331 ~~~li~~~L~~dp~~Rps-----~~elL~hp~f~~  360 (414)
                      +.+||.+||+.||++|||     |+|+++||||+.
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            999999999999999999     799999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-59  Score=441.59  Aligned_cols=258  Identities=26%  Similarity=0.365  Sum_probs=213.0

Q ss_pred             eceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCC--hHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEe
Q 015026          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL--PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (414)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (414)
                      .+++||+|+||+||+|+++.+|+.||||++.......  ....+.+.+|+.+|+.+. |||||++++++.+++.+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence            4678999999999999999999999999997544321  112356889999999995 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC-C
Q 015026          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-K  256 (414)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~-~  256 (414)
                      |+.|+++....  .....+++..++.+++||+.||+|||++||+||||||+|||++   .++.+||+|||+|+..... .
T Consensus        81 ~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          81 FMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTTTSCCC
T ss_pred             hhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---CCCccccccCccccccCCCcc
Confidence            99887665544  4456799999999999999999999999999999999999998   6889999999999776443 3


Q ss_pred             ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC------------
Q 015026          257 KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK------------  322 (414)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------  322 (414)
                      .....+||+.|+|||++.+  .++.++|||||||++|||++|.+||.+.+..+.+..+.+........            
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            3456789999999998753  35889999999999999999999999988887777765432111111            


Q ss_pred             ------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          323 ------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       323 ------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                  .++.+++++.+||.+||+.||++||||+|+|+||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence                        12357889999999999999999999999999999987543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=435.19  Aligned_cols=262  Identities=26%  Similarity=0.437  Sum_probs=218.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+++|+++. |||||++++++.+++.+|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence            479999999999999999999999999999999965432 2234577899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+.+ .+.+++.......+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+.....
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~---~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTHHHHHCCC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec---ccCcceeccCCcceeccCC
Confidence            999965 566666666667899999999999999999999999999999999999998   5789999999999876543


Q ss_pred             -CccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCC----------
Q 015026          256 -KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK----------  322 (414)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~----------  322 (414)
                       ......+||+.|+|||++...  ++.++|||||||++|+|++|+.||.+.+..+.+..+..........          
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             344567899999999986543  4788999999999999999999999887766665554322111111          


Q ss_pred             ---------------CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          323 ---------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       323 ---------------~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                     ..+.+|+++++||.+||+.||++|||++|+|+||||++..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                           12356889999999999999999999999999999986544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=431.23  Aligned_cols=253  Identities=29%  Similarity=0.537  Sum_probs=213.6

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCCh---HhHHHHHHHHHHHHHcc-CCCCceEEEEEEEcC
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA-GHENVVKFYNAFEDD  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~il~~l~-~hpnIv~~~~~~~~~  169 (414)
                      +.++|++++.||+|+||+||+|++..+|+.||||++.+......   .....+.+|+.+|+++. .|||||++++++.++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            45689999999999999999999999999999999976543221   12234678999999985 389999999999999


Q ss_pred             CEEEEEEeccCC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 NYVYIAMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 ~~~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      +..++||||+.+ +++.+++..  ...+++.+++.++.||+.||.|||++||+||||||+|||++.  +++.+||+|||+
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DFG~  157 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGS  157 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTT
T ss_pred             CeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECcccc
Confidence            999999999986 577777643  357999999999999999999999999999999999999984  357899999999


Q ss_pred             ccccCCCCccccCCCCCccccchhcccc-C-CCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      |..... ....+.+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.      ..+......++    +.
T Consensus       158 a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~  226 (273)
T d1xwsa_         158 GALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QR  226 (273)
T ss_dssp             CEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SC
T ss_pred             ceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CC
Confidence            987543 344677999999999998654 3 56789999999999999999999653      23444444333    46


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                      +|+++++||.+||+.||++|||++|+|+||||+..
T Consensus       227 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            89999999999999999999999999999999853

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.9e-58  Score=427.96  Aligned_cols=261  Identities=28%  Similarity=0.435  Sum_probs=221.1

Q ss_pred             ccccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC--
Q 015026           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (414)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~--  170 (414)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++.+.....+...+.+.+|+.+|+.+. |||||++++++...+  
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence            35678999999999999999999999999999999998776666667788999999999995 999999999987543  


Q ss_pred             --EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          171 --YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                        .+|||||||+|++|.+++...  +.+++.+++.++.||+.||+|||++||+||||||+|||++   .++.++|+|||.
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~  157 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGI  157 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTT
T ss_pred             CceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhh
Confidence              489999999999999987443  5799999999999999999999999999999999999999   588999999999


Q ss_pred             ccccCCC----CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCC
Q 015026          249 SDFIKPG----KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (414)
Q Consensus       249 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  323 (414)
                      +......    ......+||+.|+|||++.+. +++++|||||||++|+|+||++||.+.+..+.+..++...+..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  237 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGT
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchh
Confidence            8754332    233467899999999998765 68899999999999999999999999888888888888877766666


Q ss_pred             CCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccc
Q 015026          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (414)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~  359 (414)
                      ++.+|+++.+||.+||++||.+||+..+.|.|+|.+
T Consensus       238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            778999999999999999999999554555567764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=430.07  Aligned_cols=264  Identities=26%  Similarity=0.364  Sum_probs=217.2

Q ss_pred             ccceeeceeeeecCceEEEEEEECCC-CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc--CCCCceEEEEEEEc---
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKAN-GDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFED---  168 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--~hpnIv~~~~~~~~---  168 (414)
                      .++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.|.  +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            46899999999999999999999766 5679999987543322 12334567888887763  59999999999853   


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                        ...++++|||++++.+. .........+++..++.++.||+.||+|||++||+||||||+|||++   ..+.+||+||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~---~~~~~kl~df  160 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADF  160 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHH-HHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECSC
T ss_pred             ccCceEEEEEEeccCCchh-hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc---CCCCeeecch
Confidence              45789999999876554 44445567799999999999999999999999999999999999998   5789999999


Q ss_pred             ccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC------
Q 015026          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF------  319 (414)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~------  319 (414)
                      |++............+||+.|+|||++.+ .++.++||||+||++|||++|++||.+.+..+.+..+.......      
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            99987766666678899999999998765 47899999999999999999999999988777766664321100      


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          320 -----------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       320 -----------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                       ....+..+++++.+||.+||++||++|||+.|+|+||||++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence                             01123467899999999999999999999999999999987543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.4e-57  Score=421.89  Aligned_cols=257  Identities=28%  Similarity=0.416  Sum_probs=212.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|+++++||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+|+.+. |||||++++++.+++..+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence            58999999999999999999985 789999999976543 2334578899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +|++.++.+....  ...+.+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+|......
T Consensus        79 ~e~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~---~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          79 FEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIP  153 (286)
T ss_dssp             EECCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHCC-
T ss_pred             EEeehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc---CCCCEEecccccceecccC
Confidence            9999876555544  4457899999999999999999999999999999999999998   5789999999999876543


Q ss_pred             C-ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCC-----------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (414)
                      . ......|++.|+|||++.+.  ++.++|||||||++|||++|+.||.+.++.+.+.++.........           
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            2 33456799999999987643  588999999999999999999999988777666665432111110           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          322 --------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       322 --------------~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                                    ...+.+++++.+||.+||++||++|||++|+|+||||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                          112457889999999999999999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-56  Score=419.27  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=214.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.....    ..+.+.+|+.+|+.|+ |||||++++++.+++.++||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEEE
Confidence            579999999999999999999999999999999876542    4567999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||||++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC---CCCcEEEccccceeecCCC
Confidence            9999999999999777777899999999999999999999999999999999999998   5789999999999876543


Q ss_pred             Cc--cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCC-CchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KK--FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..  .....||+.|+|||++. +.++.++|||||||++|||++|..||... +...+...+..+ .  .....+.+|+++
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~--~~~~~~~~~~~l  245 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-Y--RMERPEGCPEKV  245 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-C--CCCCCTTCCHHH
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-C--CCCCCccchHHH
Confidence            32  23346899999999876 45788999999999999999976665544 444444444333 2  223335789999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCCccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~hp~f~~  360 (414)
                      .+||.+||+.||++|||+.|+++  +|..
T Consensus       246 ~~li~~cl~~dP~~Rps~~ei~~--~L~~  272 (287)
T d1opja_         246 YELMRACWQWNPSDRPSFAEIHQ--AFET  272 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHH--HHHH
Confidence            99999999999999999999976  5544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.8e-56  Score=425.18  Aligned_cols=253  Identities=26%  Similarity=0.493  Sum_probs=212.3

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc--CCEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~--~~~~~  173 (414)
                      ++|+++++||+|+||+||+|++..+|+.||||++...      ..+.+.+|+.+|+.+.+||||++++++|..  ...++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            5799999999999999999999999999999998653      346788999999999779999999999974  45799


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +|||||.+++|....     +.+++..++.++.||+.||.|||++||+||||||+|||++.  +++.+||+|||+|....
T Consensus       109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCEECC
T ss_pred             EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccceecc
Confidence            999999999987643     46999999999999999999999999999999999999984  34579999999999887


Q ss_pred             CCCccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchh-hhHHHhh-------------cCC
Q 015026          254 PGKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLR-------------NKP  317 (414)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~i~~-------------~~~  317 (414)
                      ........+||+.|+|||++.+.  ++.++||||+||++|+|++|+.||....... ....+..             ...
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            77777788999999999987653  5889999999999999999999997654321 1111100             000


Q ss_pred             --------------------CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          318 --------------------DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       318 --------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                          .+.......+++++.+||++||++||++|||++|+|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                                01111223478999999999999999999999999999999864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-56  Score=422.43  Aligned_cols=261  Identities=27%  Similarity=0.416  Sum_probs=212.9

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc------
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------  168 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~------  168 (414)
                      .++|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|+.++ ||||+++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence            36899999999999999999999999999999998765432 235567889999999995 9999999998854      


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecc
Q 015026          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (414)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DF  246 (414)
                        ++.+++||||+.++.+...  ......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~--~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~---~~~~~kl~df  161 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLL--SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADF  161 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHH--TCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCC
T ss_pred             ccCceEEEEEeccCCCccchh--hhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec---CCCcEEeeec
Confidence              4568999999987655433  34556799999999999999999999999999999999999998   5889999999


Q ss_pred             ccccccCCC-----CccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC
Q 015026          247 GLSDFIKPG-----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (414)
Q Consensus       247 G~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~  319 (414)
                      |++......     ......+||+.|+|||++.+  .++.++||||+||++|||++|+.||.+.+..+....+......+
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999765432     22345689999999998764  46899999999999999999999999888777666665543333


Q ss_pred             CCCCCCC----------------------------CCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          320 RRKPWPS----------------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       320 ~~~~~~~----------------------------~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                      ....+..                            .++++.+||.+||++||++|||++|+|+||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p  312 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  312 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence            2222111                            266789999999999999999999999999999643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=425.25  Aligned_cols=253  Identities=25%  Similarity=0.342  Sum_probs=213.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC-----EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD-----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++++.||+|+||+||+|++..+++     .||+|++....  .......+.+|+.+|.++.+|||||++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            579999999999999999999876654     69999886543  22345678999999999966999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 015026          171 YVYIAMELCEGGELLDRILAKKD---------------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN  229 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~N  229 (414)
                      .++||||||+||+|.+++.....                     ..+++..++.++.||+.||+|||++|||||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            99999999999999999865432                     358999999999999999999999999999999999


Q ss_pred             EEEeecCCCCCceeeccccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCC
Q 015026          230 FLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKT  304 (414)
Q Consensus       230 Ill~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~  304 (414)
                      ||++   .++.+||+|||+|+.......   ..+.+||+.|||||++. +.++.++|||||||++|||+| |.+||.+.+
T Consensus       195 ill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         195 VLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             EEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9998   588999999999987654332   23567899999999875 557889999999999999997 899999887


Q ss_pred             chhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       305 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ..+.+.+++.....++  ....+|+++.+||.+||+.||++|||++||++|
T Consensus       272 ~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7777777766654332  234789999999999999999999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=415.64  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|+..   ..||||++..... .+...+.+.+|+.+|++++ |||||++++++.+ +.++||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec-cEEEEE
Confidence            57999999999999999999643   4699999976543 3446788999999999995 9999999998754 568999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      ||||+||+|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++   .++.+||+|||+|+.....
T Consensus        82 ~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          82 TQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC----
T ss_pred             EecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeecccc
Confidence            9999999999988543 35699999999999999999999999999999999999998   6889999999999775432


Q ss_pred             ---CccccCCCCCccccchhccc----cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC--CCCCCCC
Q 015026          256 ---KKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF--RRKPWPS  326 (414)
Q Consensus       256 ---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~  326 (414)
                         .......||+.|||||++.+    .++.++|||||||++|||+||+.||.+.+....+..+.......  .......
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  237 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN  237 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence               23456789999999999853    35778999999999999999999998877665555444433211  1223457


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +|+++.+||.+||..||++|||+.|++++
T Consensus       238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         238 CPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=415.06  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=213.8

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.++ +++.||||++.....    ..+.+.+|+.+|++++ |||||++++++.+ +.++||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEEE
Confidence            57999999999999999999975 577899999976442    4567999999999995 9999999998765 457999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+   +++.+||+|||+|+.....
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~---~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee---cccceeeccccceEEccCC
Confidence            9999999999987655555799999999999999999999999999999999999998   6889999999999887544


Q ss_pred             Cc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhC-CCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..  .....||+.|||||++.+ .++.++|||||||++|||+|| .+||...+..+++..+..+...   ...+.+|+++
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~---~~p~~~~~~l  239 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNCPEEL  239 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHH
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CCcccChHHH
Confidence            32  235679999999998764 578999999999999999995 5566666666677776655322   2234789999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC--Cccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS--HPWVRE  360 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~--hp~f~~  360 (414)
                      .+||.+||+.||++|||++++++  ++||+.
T Consensus       240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            99999999999999999999998  788863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=424.54  Aligned_cols=255  Identities=28%  Similarity=0.433  Sum_probs=212.6

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc------CC
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------DN  170 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~------~~  170 (414)
                      +|+.+++||+|+||+||+|++..+|+.||||++......       ..+|+.+|++|+ |||||+++++|..      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence            699999999999999999999999999999999765422       247999999995 9999999999853      34


Q ss_pred             EEEEEEeccCCCChHHHHH--hccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          171 YVYIAMELCEGGELLDRIL--AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~--~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      +++||||||+++ +.+.+.  ......+++..++.++.||+.||+|||++||+||||||+|||++.  +...+||+|||+
T Consensus        93 ~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECCCTT
T ss_pred             EEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEecccc
Confidence            689999999765 444332  234567999999999999999999999999999999999999984  345899999999


Q ss_pred             ccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCC---------
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP---------  317 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~---------  317 (414)
                      +..........+.+||+.|+|||++.+  .++.++||||+||++|||++|++||.+.+..+.+..+.+...         
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            988776666778899999999998654  468999999999999999999999988877766665543110         


Q ss_pred             --------CCC--------CCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          318 --------DFR--------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       318 --------~~~--------~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                              .++        ....+.+++++.+||.+||..||++|||+.|+|+||||++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                    000        112345789999999999999999999999999999998753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-56  Score=426.21  Aligned_cols=258  Identities=29%  Similarity=0.485  Sum_probs=211.5

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC---
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~---  170 (414)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++.+... .....+.+.+|+.+|+.+. |||||+++++|...+   
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcccc
Confidence            56799999999999999999999999999999999976433 4456778899999999995 999999999997654   


Q ss_pred             ---EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccc
Q 015026          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (414)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG  247 (414)
                         .+|+||||+ |.+|...+.   ...+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~---~~~~~kl~Dfg  166 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFG  166 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCT
T ss_pred             ccceEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc---ccccccccccc
Confidence               579999999 566666553   24699999999999999999999999999999999999998   68899999999


Q ss_pred             cccccCCCCccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC---------
Q 015026          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---------  316 (414)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~---------  316 (414)
                      +|+....  .....+||+.|+|||++.+  .++.++||||+||++|+|++|++||.+.+....+..+....         
T Consensus       167 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         167 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            9987643  3456789999999998754  35889999999999999999999998877655544433211         


Q ss_pred             --------------CCCCC----CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          317 --------------PDFRR----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       317 --------------~~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                    +....    ...+.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                          11111    12346789999999999999999999999999999998643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=411.10  Aligned_cols=254  Identities=21%  Similarity=0.301  Sum_probs=213.6

Q ss_pred             cceeecee-eeecCceEEEEEEECCC--CCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKL-LGHGQFGYTYVATDKAN--GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~-lG~G~~g~V~~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      +.|.+.+. ||+|+||+||+|.++.+  +..||||++....  .....+.+.+|+++|++++ |||||++++++.++ .+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-AL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-eE
Confidence            45788874 99999999999987644  4479999987543  3456788999999999995 99999999998764 58


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      |||||||+||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+..
T Consensus        84 ~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcc
Confidence            999999999999998743 335799999999999999999999999999999999999999   4789999999999876


Q ss_pred             CCCCc----cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKK----FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .....    ....+||+.|+|||++. +.++.++|||||||++|||+| |+.||.+.+..++...+..+..   ....+.
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~  236 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPE  236 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCTT
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCc
Confidence            54332    23457899999999876 456889999999999999998 9999998888888877776543   222357


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHH---hCCccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQA---LSHPWVRE  360 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~el---L~hp~f~~  360 (414)
                      +|+++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            89999999999999999999999888   67888754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-55  Score=414.68  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=203.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC---EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++|++.+.||+|+||+||+|.++.+|+   .||||.+....  .....+.+.+|+.+|++|+ |||||++++++.+++.+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEE
Confidence            469999999999999999999987765   58889876543  3456678999999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++|||||+||+|.+++.. ..+.+++.++..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+..
T Consensus       103 ~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred             EEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC---CCCcEEECCcccceEc
Confidence            999999999999987754 345799999999999999999999999999999999999998   5889999999999876


Q ss_pred             CCCCcc------ccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCC
Q 015026          253 KPGKKF------QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (414)
Q Consensus       253 ~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (414)
                      ......      ....||+.|||||++.+ .++.++|||||||++|||+| |+.||.+.+..+++..+..+..   .+..
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~~~~  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---LPPP  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCC
Confidence            543221      23467999999998764 56889999999999999998 8999999888888887766532   2233


Q ss_pred             CCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ..+|+++.+||.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            5789999999999999999999999999863

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=407.46  Aligned_cols=247  Identities=21%  Similarity=0.370  Sum_probs=202.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|.+. +++.||||++.....    ..+.+.+|+.+++.++ |||||++++++.+++.+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence            46999999999999999999975 567899999976442    3467899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++   .++.+||+|||+|+.....
T Consensus        79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---GGGCEEECSCC--------
T ss_pred             EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---CCCCeEecccchheeccCC
Confidence            9999999999987543 35689999999999999999999999999999999999999   5789999999999876543


Q ss_pred             Cc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..  .....||+.|+|||++.+ .++.++|||||||++|||+| |.+||...+..+++..+..+.....   ....++++
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l  231 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV  231 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHH
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHH
Confidence            32  234679999999998875 56889999999999999999 5777777777777777766543222   24678999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+||.+||+.||++|||++|+++|
T Consensus       232 ~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         232 YQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=423.05  Aligned_cols=260  Identities=28%  Similarity=0.465  Sum_probs=210.4

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC---
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~---  170 (414)
                      +..+|++++.||+|+||+||+|.+..+|+.||||++.+..  .....+.+.+|+.+|+.|. ||||+++++++....   
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTT
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccc
Confidence            4468999999999999999999999999999999997543  3456678899999999995 999999999987543   


Q ss_pred             --EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          171 --YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                        .++++ +++.||+|.+++..   ..+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+
T Consensus        83 ~~~~~l~-~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---~~~~~kl~DfG~  155 (345)
T d1pmea_          83 MKDVYLV-THLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGL  155 (345)
T ss_dssp             CCCEEEE-EECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred             cceEEEE-EeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---CCCCEEEcccCc
Confidence              34555 55668999998843   3699999999999999999999999999999999999998   578999999999


Q ss_pred             ccccCCCC----ccccCCCCCccccchhccc--cCCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcC------
Q 015026          249 SDFIKPGK----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK------  316 (414)
Q Consensus       249 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~------  316 (414)
                      |.......    .....+||+.|+|||++..  .++.++||||+||++|+|++|+.||.+.+..+.........      
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            97654322    2345789999999998743  35788999999999999999999998876654443332211      


Q ss_pred             -----------------CCCCC----CCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          317 -----------------PDFRR----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       317 -----------------~~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                       +....    ..++.+++++++||.+||+.||.+|||++|+|+||||+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                             00011    123568899999999999999999999999999999996544

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=408.21  Aligned_cols=260  Identities=23%  Similarity=0.404  Sum_probs=217.4

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.++ |||||++++++.+....++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence            479999999999999999999999999999999976543 3446788999999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      +|++.|++|..++  ...+.+++..++.++.|++.||+|||++||+||||||+|||++   .++.+||+|||.|......
T Consensus        80 ~~~~~~~~l~~~~--~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~---~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          80 FEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             EECCSEEHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSC
T ss_pred             eeecccccccccc--ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---cCCceeeeecchhhcccCC
Confidence            9999998877766  4557899999999999999999999999999999999999998   5778999999999876543


Q ss_pred             C-ccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCC-CCchhhhHHHhhcCCCC------------
Q 015026          256 K-KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF------------  319 (414)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~------------  319 (414)
                      . ......+++.|+|||++.+.  ++.++|||||||++|||++|+.||.. .+..+.+..+.......            
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence            3 33345678999999987654  58899999999999999999998654 34444444433211110            


Q ss_pred             -------------CCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCccccccc
Q 015026          320 -------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (414)
Q Consensus       320 -------------~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~  362 (414)
                                   .....+.+++++.+||.+||+.||++||||+|+|+||||++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                         1112345788999999999999999999999999999998643

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=411.03  Aligned_cols=247  Identities=22%  Similarity=0.291  Sum_probs=205.0

Q ss_pred             eeeeecCceEEEEEEEC--CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEEecc
Q 015026          102 KLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (414)
Q Consensus       102 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (414)
                      ++||+|+||+||+|.+.  .+++.||||++.... ..+...+.+.+|+.+|++++ |||||++++++.++ ..+||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence            47999999999999864  456789999986543 23456678999999999995 99999999999765 478999999


Q ss_pred             CCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCCCc--
Q 015026          180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK--  257 (414)
Q Consensus       180 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~~~--  257 (414)
                      ++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+.......  
T Consensus        90 ~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          90 ELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccc
Confidence            99999998843  46799999999999999999999999999999999999999   478999999999987654332  


Q ss_pred             --cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHHH
Q 015026          258 --FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (414)
Q Consensus       258 --~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (414)
                        .....||+.|||||++.+ .++.++|||||||++|||+| |+.||.+.+..++...+..+..   ......+|+++.+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~~~~~~~  241 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYD  241 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHHHHH
Confidence              224579999999998764 46889999999999999998 9999999888877777766542   2223478999999


Q ss_pred             HHHHhhcCCccccCCHHHH---hCCcccc
Q 015026          334 FVKKLLVKDPRARLTAAQA---LSHPWVR  359 (414)
Q Consensus       334 li~~~L~~dp~~Rps~~el---L~hp~f~  359 (414)
                      ||.+||+.||.+|||+.++   |+|+|+.
T Consensus       242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         242 LMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            9999999999999999998   4566653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=403.28  Aligned_cols=247  Identities=22%  Similarity=0.347  Sum_probs=215.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|+++++||+|+||+||+|+++ +++.||||++.+...    ..+.+.+|+.+++.++ |||||++++++.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence            46899999999999999999984 778999999987543    3467899999999995 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.....
T Consensus        78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~---~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---TTCCEEECCCSSCCBCSSS
T ss_pred             EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---CCCcEEECcchhheeccCC
Confidence            99999999998875543 5689999999999999999999999999999999999998   5789999999999876543


Q ss_pred             Cc--cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..  .....||+.|+|||++.+ .++.++|||||||++|||+| |+.||.+.+..++...+..+....   .....++++
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l  230 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKV  230 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHH
T ss_pred             CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccHHH
Confidence            32  234679999999998764 56889999999999999998 899999999888888887654322   234688999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhCC
Q 015026          332 KDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .+||.+||+.||++|||++++|+|
T Consensus       231 ~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         231 YTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=419.62  Aligned_cols=260  Identities=27%  Similarity=0.481  Sum_probs=219.3

Q ss_pred             cceeeceeeeecCceEEEEEEE---CCCCCEEEEEEeeccCCC-ChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATD---KANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~---~~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ++|++++.||+|+||+||+|++   +.+|+.||||++.+.... .....+.+.+|+.+|+++.+||||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999987   457899999998654321 112345678999999999755899999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      +++||||+.||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec---CCCCEEEeeccchhh
Confidence            99999999999999988544  5688999999999999999999999999999999999998   578999999999976


Q ss_pred             cCCC--CccccCCCCCccccchhcccc---CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPG--KKFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ....  ....+..|++.|+|||.+.+.   ++.++|||||||+||+|++|+.||.+.+..+....+..............
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            5432  233467899999999987643   47789999999999999999999988877766666655433333333357


Q ss_pred             CCHHHHHHHHHhhcCCccccC-----CHHHHhCCccccc
Q 015026          327 ISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVRE  360 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rp-----s~~elL~hp~f~~  360 (414)
                      +|+++.+||.+||++||.+||     |++|+|+||||+.
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            899999999999999999999     5899999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=403.17  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=209.1

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv  175 (414)
                      ++|++++.||+|+||+||+|++..+ +.||||++.....    ..+.+.+|+.++++++ |||||++++++.+ +.+++|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEEE
Confidence            5799999999999999999998655 5799999975542    3467999999999995 9999999999865 457899


Q ss_pred             EeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCCC
Q 015026          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (414)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~~  255 (414)
                      |||+++|+|..++.......+++.++..++.||+.||.|||++||+||||||+||||+   .++.+||+|||+|+.....
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhccCC
Confidence            9999999999988766666799999999999999999999999999999999999998   5789999999999876443


Q ss_pred             Cc--cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhC-CCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHH
Q 015026          256 KK--FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (414)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (414)
                      ..  .....||+.|+|||++. +.++.++|||||||++|||++| .+||.+....+++..+..+..   .+..+.+|+++
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l  243 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPESL  243 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCHHH
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCCcccCHHH
Confidence            32  23467999999999875 4578899999999999999995 455555566666666665432   22345789999


Q ss_pred             HHHHHHhhcCCccccCCHHHHhC--Cccccccc
Q 015026          332 KDFVKKLLVKDPRARLTAAQALS--HPWVREGG  362 (414)
Q Consensus       332 ~~li~~~L~~dp~~Rps~~elL~--hp~f~~~~  362 (414)
                      .+||.+||+.||++|||+++++.  ++||+...
T Consensus       244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            99999999999999999999988  88998654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=417.25  Aligned_cols=260  Identities=30%  Similarity=0.429  Sum_probs=213.4

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC----
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~----  169 (414)
                      +.++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|+.|. |||||++++++...    
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccc
Confidence            35689999999999999999999999999999999976543 3445677899999999995 99999999998632    


Q ss_pred             -CEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                       ...++|++++.||+|.+++.   .+.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+|++|||+
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~---~~~~~kl~dfg~  167 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGL  167 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCC--
T ss_pred             cCceEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc---ccccccccccch
Confidence             33456667778999999873   35699999999999999999999999999999999999998   578999999999


Q ss_pred             ccccCCCCccccCCCCCccccchhcccc--CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhcCCCC-------
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-------  319 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~-------  319 (414)
                      |....  ....+..||+.|+|||++.+.  ++.++|||||||++|+|++|++||.+.+.......+.......       
T Consensus       168 a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         168 ARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             --CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            97643  334567899999999986543  4789999999999999999999999887766665554332111       


Q ss_pred             ----------------CCC----CCCCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccccC
Q 015026          320 ----------------RRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (414)
Q Consensus       320 ----------------~~~----~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~~~  363 (414)
                                      +..    .+..+++++++||.+||..||.+|||+.|+|+||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                            111    12468899999999999999999999999999999997544

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=400.43  Aligned_cols=249  Identities=23%  Similarity=0.344  Sum_probs=202.7

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC---CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG---DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++|++++.||+|+||+||+|++..++   ..||||++....  .....+.+.+|+.+|++++ |||||++++++.+ +.+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~-~~~   82 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVITE-NPV   82 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CeE
Confidence            57999999999999999999987554   468888875432  3456778999999999995 9999999999864 678


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||+|+..
T Consensus        83 ~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-------
T ss_pred             EEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheec
Confidence            999999999999987654 346799999999999999999999999999999999999999   4789999999999876


Q ss_pred             CCCC--ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCC
Q 015026          253 KPGK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (414)
Q Consensus       253 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (414)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|||++ |.+||.+.+..+++..+..+..   .+.++.+|
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence            5332  2335678999999999864 56889999999999999998 8999999988888888876643   23346799


Q ss_pred             HHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          329 NSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      +++.+||.+||+.||++|||+.|++++
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=414.28  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=202.0

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc------
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------  168 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~------  168 (414)
                      .++|+++++||+|+||+||+|.+..+|+.||||++.+... .......+.+|+.+|+.+. |||||+++++|..      
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccccc
Confidence            3689999999999999999999999999999999976543 3456678899999999995 9999999999953      


Q ss_pred             CCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccc
Q 015026          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~  248 (414)
                      .+.+|+|||||.| ++.+.+    ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+|++|||+
T Consensus        94 ~~~~~iv~Ey~~~-~l~~~~----~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~---~~~~~kl~df~~  165 (355)
T d2b1pa1          94 FQDVYLVMELMDA-NLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGL  165 (355)
T ss_dssp             CCEEEEEEECCSE-EHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC
T ss_pred             CceeEEEEeccch-HHHHhh----hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc---cccceeeechhh
Confidence            4789999999966 455544    24689999999999999999999999999999999999998   578899999999


Q ss_pred             ccccCCCCccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhhc------------
Q 015026          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN------------  315 (414)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~~------------  315 (414)
                      ++...........+||+.|+|||++.+. +++++||||+||++|+|++|++||.+.+.......+...            
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            9887766666778999999999998654 688999999999999999999999887765554444321            


Q ss_pred             ----------CCCCCCCCC----------------CCCCHHHHHHHHHhhcCCccccCCHHHHhCCcccccc
Q 015026          316 ----------KPDFRRKPW----------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (414)
Q Consensus       316 ----------~~~~~~~~~----------------~~~s~~~~~li~~~L~~dp~~Rps~~elL~hp~f~~~  361 (414)
                                ........+                ..+++++.+||.+||..||++||||+|+|+||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                      111111100                1135678999999999999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-53  Score=396.06  Aligned_cols=249  Identities=21%  Similarity=0.307  Sum_probs=201.2

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC----CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ..|++.++||+|+||+||+|.++.++    ..||||++....  .+.....+.+|+.+|+.|+ |||||++++++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence            35999999999999999999987655    369999986543  3345667899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++|||||.++++.+.+.. ....+++.++..++.||+.||.|||+++|+||||||+||||+   .++.+||+|||+|+.
T Consensus        84 ~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          84 MMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC---
T ss_pred             eEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC---CCCeEEEcccchhhc
Confidence            9999999999999887754 346799999999999999999999999999999999999998   588999999999987


Q ss_pred             cCCCCc----cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhC-CCCCCCCCchhhhHHHhhcCCCCCCCCCC
Q 015026          252 IKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (414)
Q Consensus       252 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (414)
                      ......    .....||+.|||||++.+ .++.++|||||||++|||++| .+||.+.+..+++..+..+..   .+...
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---~~~~~  236 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LPTPM  236 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCCT
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC---CCCch
Confidence            644321    234578999999998765 568899999999999999995 455555566666666655432   22234


Q ss_pred             CCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+++++.+||.+||+.||++|||+.|+++
T Consensus       237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            68899999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=402.23  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=206.0

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCC----EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~  171 (414)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|++....  .....+.+.+|+.+|++++ |||||++++++.+++ 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~-   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESSS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC-
Confidence            359999999999999999999988887    57888775432  2345678999999999995 999999999998754 


Q ss_pred             EEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                      .++++|++.+|+|.+.+... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~  160 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHH
T ss_pred             eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeecccccee
Confidence            67888999999999987654 46799999999999999999999999999999999999999   478999999999987


Q ss_pred             cCCCCc---cccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          252 IKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       252 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      ......   .....||+.|+|||++.+ .++.++|||||||++|||+| |.+||.+.+..++...+..+...   +..+.
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~  237 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPI  237 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---CCCTT
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence            654332   234578999999998754 56889999999999999998 89999888877777766665421   22346


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhCCc
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHP  356 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~hp  356 (414)
                      +|+++.+||.+||..||.+|||+.|++.|.
T Consensus       238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         238 CTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            899999999999999999999999999873

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=403.13  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=211.5

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCE--EEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ++|++.+.||+|+||+||+|+++.+|..  ||||++....  .....+.+.+|+.+|+++.+|||||++++++.+++.++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            5699999999999999999999988874  6777765432  23356679999999999956999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCC
Q 015026          174 IAMELCEGGELLDRILAK--------------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~  239 (414)
                      +||||++||+|.+++...              ....+++..+..++.||+.||.|||++||+||||||+|||++   .++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~---~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc---CCC
Confidence            999999999999998543              246799999999999999999999999999999999999998   578


Q ss_pred             CceeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhC-CCCCCCCCchhhhHHHhhcCC
Q 015026          240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       240 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      .+||+|||+|+............||+.|+|||.+.+ .++.++|||||||++|||++| .+||.+.+..+++..+..+..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            999999999987655444456679999999998754 568899999999999999996 467888888888887766532


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                         ...+..+++++.+||.+||+.||++|||+.+++++
T Consensus       245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence               22335789999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=395.73  Aligned_cols=251  Identities=22%  Similarity=0.335  Sum_probs=203.2

Q ss_pred             cceeeceeeeecCceEEEEEEEC-CCCC--EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK-ANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~  172 (414)
                      ++|++.+.||+|+||+||+|+.. .+++  .||||++.+.....+...+.+.+|+.+|++++ |||||++++++.++ .+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeec-ch
Confidence            46999999999999999999864 3333  68999998766555667788999999999995 99999999999764 57


Q ss_pred             EEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeecccccccc
Q 015026          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (414)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~  252 (414)
                      ++||||+++|++.+.+... ...+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~---~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred             heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc---ccceeeccchhhhhc
Confidence            8999999999999887654 356999999999999999999999999999999999999994   779999999999876


Q ss_pred             CCCCc----cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCC
Q 015026          253 KPGKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (414)
Q Consensus       253 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (414)
                      .....    .....|+..|+|||++.+. ++.++|||||||++|||+| |+.||.+.+..+++..+......+  +..+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~  239 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPED  239 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCTT
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--CCccc
Confidence            54332    2245688899999988754 5888999999999999998 899999999998888887765433  23357


Q ss_pred             CCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +|+++.+||.+||..||++|||+.++++
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8999999999999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=398.19  Aligned_cols=253  Identities=24%  Similarity=0.302  Sum_probs=201.7

Q ss_pred             cceeeceeeeecCceEEEEEEECC-----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-C
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-D  169 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-~  169 (414)
                      ++|++++.||+|+||+||+|.+..     +++.||||++....  .....+.+.+|..++.++.+||||+.+++++.. +
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            579999999999999999999754     44689999986543  234567788899999888779999999998765 4


Q ss_pred             CEEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec
Q 015026          170 NYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA  235 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~  235 (414)
                      ..+++|||||++|+|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||++  
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~--  168 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--  168 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC--
Confidence            57899999999999999986542              23589999999999999999999999999999999999998  


Q ss_pred             CCCCCceeeccccccccCCCC---ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhC-CCCCCCCCchhhhH
Q 015026          236 KEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFK  310 (414)
Q Consensus       236 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~~  310 (414)
                       .++.+||+|||+|+......   .....+||+.|+|||++.+ .++.++|||||||++|||++| .+||.+....+.+.
T Consensus       169 -~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         169 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             -GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             -CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             57899999999998654332   2345689999999998765 468899999999999999986 56887776666555


Q ss_pred             HHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      .++.....+  ...+.+++++.+||.+||+.||++|||+.|+++|
T Consensus       248 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         248 RRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            554443322  2234689999999999999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=391.52  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=201.6

Q ss_pred             cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-CCEEEE
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNYVYI  174 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-~~~~~l  174 (414)
                      ++|++++.||+|+||.||+|.+  +|+.||||+++...     ..+.+.+|++++++++ |||||++++++.+ .+.+++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEE
Confidence            4699999999999999999987  47899999996543     4577899999999995 9999999998854 566899


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      ||||+++|+|.+++.......+++..+..++.||+.||.|||+.+|+||||||+|||++   .++.+||+|||+++....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec---CCCCEeecccccceecCC
Confidence            99999999999999665545689999999999999999999999999999999999998   688999999999987543


Q ss_pred             CCccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhhHHHhhcCCCCCCCCCCCCCHHHH
Q 015026          255 GKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (414)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (414)
                      .  .....+|+.|+|||++. +.+++++|||||||++|||+| |++||...+..++...+..+..   ....+.+++++.
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~  230 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVY  230 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHH
T ss_pred             C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCccCCHHHH
Confidence            2  34557899999999875 557889999999999999998 7999988888888887765432   222346889999


Q ss_pred             HHHHHhhcCCccccCCHHHHhC
Q 015026          333 DFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       333 ~li~~~L~~dp~~Rps~~elL~  354 (414)
                      +||.+||..||.+|||+.++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~  252 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLRE  252 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHH
Confidence            9999999999999999999976

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-52  Score=394.55  Aligned_cols=251  Identities=20%  Similarity=0.245  Sum_probs=213.3

Q ss_pred             ccceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcC
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~  169 (414)
                      .++|++++.||+|+||+||+|+++     .+++.||||++....  .....+.+.+|+.+|+.++ ||||+++++++...
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC
Confidence            357999999999999999999875     356789999987543  3445778999999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 015026          170 NYVYIAMELCEGGELLDRILAKK----------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP  227 (414)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp  227 (414)
                      +..++||||+++|+|.+++....                      ...+++..+..++.||+.||.|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999885432                      23488999999999999999999999999999999


Q ss_pred             CcEEEeecCCCCCceeeccccccccCCCC---ccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhC-CCCCCC
Q 015026          228 ENFLFKSAKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCG-RRPFWD  302 (414)
Q Consensus       228 ~NIll~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg-~~Pf~~  302 (414)
                      +|||++   .++.+||+|||+|+...+..   ...+.+||+.|+|||++.+ .++.++|||||||++|||++| .+||.+
T Consensus       169 ~NILld---~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEEC---CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            999999   57899999999998654332   2335679999999998765 568899999999999999998 478988


Q ss_pred             CCchhhhHHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      .+..++...+..+...   .....+|+++.+||.+||+.||++|||+.|+++
T Consensus       246 ~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8888888888766532   223478999999999999999999999999965

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=392.70  Aligned_cols=251  Identities=25%  Similarity=0.384  Sum_probs=209.9

Q ss_pred             cceeeceeeeecCceEEEEEEECCCC-------CEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKANG-------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~  168 (414)
                      ++|++++.||+|+||.||+|++..++       ..||||++....  .......+.+|...+.++.+|||||++++++.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            58999999999999999999876554       369999987643  344567889999999999679999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee
Q 015026          169 DNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~  234 (414)
                      ++.+++|||||++|+|.+++....              ...+++..+..++.||+.||+|||+++||||||||+|||++ 
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~-  169 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-  169 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec-
Confidence            999999999999999999996543              24589999999999999999999999999999999999998 


Q ss_pred             cCCCCCceeeccccccccCCCC---ccccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhh
Q 015026          235 AKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (414)
Q Consensus       235 ~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~  309 (414)
                        .++.+||+|||+++......   .....+||+.|+|||++. +.++.++|||||||++|||++ |.+||.+.+...++
T Consensus       170 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         170 --EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             --TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             --CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence              67899999999998764432   234568999999999875 567899999999999999998 79999888887777


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..+..+..   ......+|+++.+||.+||+.||++|||+.|+++
T Consensus       248 ~~i~~~~~---~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         248 KLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHTTCC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCC---CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            76655432   2223578999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=388.74  Aligned_cols=252  Identities=26%  Similarity=0.321  Sum_probs=214.2

Q ss_pred             cceeeceeeeecCceEEEEEEEC-----CCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++++.||+|+||+||+|++.     .+++.||||++....  .......+.+|+.+++.+.+|||||++++++.++.
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            68999999999999999999863     566789999997654  34456789999999999977999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEee
Q 015026          171 YVYIAMELCEGGELLDRILAKK----------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~----------------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~  234 (414)
                      .++||||||++|+|.+++....                ...+++..+..++.||+.||.|||++||+||||||+|||++ 
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~-  179 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-  179 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc-
Confidence            9999999999999999986543                23589999999999999999999999999999999999998 


Q ss_pred             cCCCCCceeeccccccccCCCCc---cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhh-CCCCCCCCCchhhh
Q 015026          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (414)
Q Consensus       235 ~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~  309 (414)
                        .++.+||+|||+++.......   ....+||+.|+|||++. +.++.++|||||||++|||+| |.+||.+....+.+
T Consensus       180 --~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         180 --HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             --TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             --ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              578999999999987654332   23468899999999876 456889999999999999998 67777777776766


Q ss_pred             HHHhhcCCCCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ..++......  .....+|+++.+||.+||+.||++|||+.++++
T Consensus       258 ~~~i~~~~~~--~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         258 YKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCC--CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6666554322  222468899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-52  Score=389.98  Aligned_cols=261  Identities=21%  Similarity=0.303  Sum_probs=207.1

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.++|++++.||+|+||+||+|++..+|+.||||++.....     ...+.+|+++++.+.+|++|+.+.+++.+.+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            34689999999999999999999999999999998876432     2346789999999974555666777778899999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccC
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~  253 (414)
                      +||||+ +++|.+.+. .....+++..+..++.||+.||+|||++||+||||||+|||++..+.+..+||+|||+|+...
T Consensus        80 ivme~~-~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          80 MVMELL-GPSLEDLFN-FCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EEEECC-CCBHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEEEEc-CCchhhhhh-hccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            999999 556666554 345679999999999999999999999999999999999999865567789999999998765


Q ss_pred             CCC--------ccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchhhhHHHhh---cCC-CCC
Q 015026          254 PGK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---NKP-DFR  320 (414)
Q Consensus       254 ~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~-~~~  320 (414)
                      ...        .....+||+.|||||++.+. ++.++|||||||++|||++|..||.+.........+..   ... ...
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            432        23456899999999998765 68899999999999999999999987655443332211   110 111


Q ss_pred             CCCCCCCCHHHHHHHHHhhcCCccccCCHH---HHhCCcccccc
Q 015026          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA---QALSHPWVREG  361 (414)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rps~~---elL~hp~f~~~  361 (414)
                      ....+.+|+++.+||.+||+.||.+||++.   ++|+|+|.+..
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            122357899999999999999999999987   55778876543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=388.14  Aligned_cols=256  Identities=20%  Similarity=0.304  Sum_probs=217.3

Q ss_pred             cceeeceeeeecCceEEEEEEECC-----CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC
Q 015026           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (414)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~  170 (414)
                      ++|++++.||+|+||+||+|.+..     +++.||||++....  .......+.+|+.+++++. |||||++++++..++
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecCC
Confidence            689999999999999999998753     45789999997543  3345677899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          171 YVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                      ..++||||+++|+|.+++....        ...+++..+..++.||+.||.|||+++|+||||||+|||++   .++.+|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld---~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec---CCceEE
Confidence            9999999999999999885432        23478999999999999999999999999999999999998   688999


Q ss_pred             eeccccccccCCCCc---cccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhC-CCCCCCCCchhhhHHHhhcCC
Q 015026          243 ATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKP  317 (414)
Q Consensus       243 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg-~~Pf~~~~~~~~~~~i~~~~~  317 (414)
                      |+|||+|+.......   .....||+.|+|||.+.+. ++.++|||||||++|||+|| .+||.+.+..+.+..+..+..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            999999986543322   2345789999999987654 67889999999999999997 588888888888888776543


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC------Cccccc
Q 015026          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS------HPWVRE  360 (414)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~------hp~f~~  360 (414)
                         ....+.+|+.+.+||.+||+.||++|||+.++++      +|+|++
T Consensus       254 ---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         254 ---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             ---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence               2223578899999999999999999999999997      666654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-50  Score=377.08  Aligned_cols=247  Identities=21%  Similarity=0.250  Sum_probs=200.7

Q ss_pred             eeceeeeecCceEEEEEEECCCCC---EEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEc-CCEEEE
Q 015026           99 TIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNYVYI  174 (414)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~-~~~~~l  174 (414)
                      ...++||+|+||+||+|.+..++.   .||||+++..  ......+.+.+|+++|++|+ |||||++++++.. ++..++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence            346789999999999999876542   6899998643  24556788999999999995 9999999998764 678999


Q ss_pred             EEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCceeeccccccccCC
Q 015026          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (414)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~~~~  254 (414)
                      |||||++|+|.+++.. ....+++..+..++.|++.||.|||+.+|+||||||+|||++   +++.+||+|||+++....
T Consensus       107 v~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~---~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSSGGGCCTTT
T ss_pred             EEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC---CCCCEEEecccchhhccc
Confidence            9999999999998743 345678889999999999999999999999999999999998   578999999999987543


Q ss_pred             CCc-----cccCCCCCccccchhcc-ccCCCCcchhHHHHHHHHHhhCCCCCCCC-CchhhhHHHhhcCCCCCCCCCCCC
Q 015026          255 GKK-----FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWPSI  327 (414)
Q Consensus       255 ~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~  327 (414)
                      ...     .....||+.|+|||++. +.++.++||||||+++|||+||..||... +..++...+..+....   ..+.+
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~---~p~~~  259 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QPEYC  259 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC---CCTTC
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CcccC
Confidence            321     23457899999999865 55788999999999999999977777654 4445556666554322   22467


Q ss_pred             CHHHHHHHHHhhcCCccccCCHHHHhCC
Q 015026          328 SNSAKDFVKKLLVKDPRARLTAAQALSH  355 (414)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rps~~elL~h  355 (414)
                      ++++.+||.+||..||++|||+.|+++|
T Consensus       260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         260 PDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8999999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-50  Score=378.71  Aligned_cols=254  Identities=20%  Similarity=0.313  Sum_probs=207.6

Q ss_pred             cccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      +.++|++++.||+|+||+||+|++..+|+.||||++.....     ...+.+|+++++.|.+|+||+.+++++..+...+
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            35689999999999999999999999999999998865432     2346789999999986799999999999999999


Q ss_pred             EEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec--CCCCCceeeccccccc
Q 015026          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA--KEDSSLKATDFGLSDF  251 (414)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~--~~~~~vkl~DFG~a~~  251 (414)
                      +||||+ |++|.+++.. ....+++..+..++.|++.||+|||++||+||||||+|||++..  ..++.+||+|||+|+.
T Consensus        78 ~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999999 7899887744 34579999999999999999999999999999999999999742  2357899999999987


Q ss_pred             cCCC--------CccccCCCCCccccchhcccc-CCCCcchhHHHHHHHHHhhCCCCCCCCCchh---hhHHHhhcCC-C
Q 015026          252 IKPG--------KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKP-D  318 (414)
Q Consensus       252 ~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~i~~~~~-~  318 (414)
                      ....        ......+||+.|||||++.+. ++.++|||||||++|||++|..||.+.....   .+..+..... .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            5432        123457899999999988765 6889999999999999999999998654432   2233322211 1


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                      ......+.+|+++.+++..|+..+|++||+.+.+.+
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            111223568899999999999999999999876654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=371.94  Aligned_cols=247  Identities=22%  Similarity=0.272  Sum_probs=187.3

Q ss_pred             ccceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCC----
Q 015026           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN----  170 (414)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~----  170 (414)
                      .++|.+.+.||+|+||+||+|+.  +|+.||||++....    ........|+..+..+ +|||||++++++.+.+    
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcce
Confidence            35799999999999999999975  68999999986542    1122233445555567 4999999999987543    


Q ss_pred             EEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeecCCCCCcEEEeecCCCCCce
Q 015026          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL--------HGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~--------~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                      .+++|||||++|+|.+++.+.   .+++..+..++.|++.||.|||+        +|||||||||+||||+   .++.+|
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~---~~~~~K  148 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCC  148 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC---TTSCEE
T ss_pred             EEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc---CCCCeE
Confidence            689999999999999999543   58999999999999999999996        5999999999999998   688999


Q ss_pred             eeccccccccCCCC-----ccccCCCCCccccchhcccc-------CCCCcchhHHHHHHHHHhhCCCCCCCCCch----
Q 015026          243 ATDFGLSDFIKPGK-----KFQDIVGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKTED----  306 (414)
Q Consensus       243 l~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~elltg~~Pf~~~~~~----  306 (414)
                      |+|||+++......     .....+||+.|+|||++.+.       ++.++|||||||+||||+||..||......    
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999998765432     23457899999999998754       356789999999999999999887432211    


Q ss_pred             ----------hhhHHHh-hcCC--CCCCCC-CCCCCHHHHHHHHHhhcCCccccCCHHHHhC
Q 015026          307 ----------GIFKEVL-RNKP--DFRRKP-WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (414)
Q Consensus       307 ----------~~~~~i~-~~~~--~~~~~~-~~~~s~~~~~li~~~L~~dp~~Rps~~elL~  354 (414)
                                +...... ....  .++... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                      1111111 1111  111000 0112245889999999999999999999976

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-47  Score=368.88  Aligned_cols=266  Identities=25%  Similarity=0.423  Sum_probs=200.9

Q ss_pred             ccccc-cceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHcc----------CCCCc
Q 015026           91 DKDFD-RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA----------GHENV  159 (414)
Q Consensus        91 ~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~----------~hpnI  159 (414)
                      ++.+. ++|+++++||+|+||+||+|++..+|+.||||++.+..    ...+.+.+|+.+++.+.          +||||
T Consensus         7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_           7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            34443 47999999999999999999999999999999997643    34567889999998874          36889


Q ss_pred             eEEEEEEEc--CCEEEEEEeccCCCC-hHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEEeec
Q 015026          160 VKFYNAFED--DNYVYIAMELCEGGE-LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSA  235 (414)
Q Consensus       160 v~~~~~~~~--~~~~~lv~e~~~gg~-L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~-~~iiHrDlkp~NIll~~~  235 (414)
                      +++++++..  ....+++++++..+. ............+++..++.++.||+.||.|||+ .||+||||||+|||++..
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999988753  466777777665544 3344444556789999999999999999999998 899999999999999853


Q ss_pred             CCC---CCceeeccccccccCCCCccccCCCCCccccchhccc-cCCCCcchhHHHHHHHHHhhCCCCCCCCCch-----
Q 015026          236 KED---SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED-----  306 (414)
Q Consensus       236 ~~~---~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----  306 (414)
                      +..   ..++|+|||.|.....  .....+||+.|+|||++.+ .++.++||||+||++++|++|+.||......     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence            221   2489999999876543  3356789999999998654 5688999999999999999999999654321     


Q ss_pred             -hhhHHHhhc---------------------------CCCC-----------CCCCCCCCCHHHHHHHHHhhcCCccccC
Q 015026          307 -GIFKEVLRN---------------------------KPDF-----------RRKPWPSISNSAKDFVKKLLVKDPRARL  347 (414)
Q Consensus       307 -~~~~~i~~~---------------------------~~~~-----------~~~~~~~~s~~~~~li~~~L~~dp~~Rp  347 (414)
                       +.+......                           ....           ....+...++++.+||.+||.+||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             111111000                           0000           0001122457899999999999999999


Q ss_pred             CHHHHhCCccccccc
Q 015026          348 TAAQALSHPWVREGG  362 (414)
Q Consensus       348 s~~elL~hp~f~~~~  362 (414)
                      ||+|+|+||||++..
T Consensus       321 ta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         321 DAGGLVNHPWLKDTL  335 (362)
T ss_dssp             CHHHHHTCGGGTTCT
T ss_pred             CHHHHhcCcccCCCC
Confidence            999999999999653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.6e-27  Score=206.90  Aligned_cols=166  Identities=22%  Similarity=0.210  Sum_probs=122.8

Q ss_pred             eeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCC---------------ChHhHHHHHHHHHHHHHccCCCCceEE
Q 015026           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---------------LPIAVEDVKREVKILQALAGHENVVKF  162 (414)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~~hpnIv~~  162 (414)
                      |.++++||+|+||+||+|.+. +|+.||||+++.....               .........+|...+.++. |++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            468899999999999999984 7899999987532110               0112344567899999995 9999998


Q ss_pred             EEEEEcCCEEEEEEeccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCCCce
Q 015026          163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (414)
Q Consensus       163 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (414)
                      +++..    .++||||+++..+.+         +++..+..++.||+.+|.|||++||+||||||+|||++    +..++
T Consensus        80 ~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~  142 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIW  142 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEE
T ss_pred             EEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEE
Confidence            86532    279999998865432         45566788999999999999999999999999999998    34589


Q ss_pred             eeccccccccCCCCccccCCCCCcccc------chhccccCCCCcchhHHHHH
Q 015026          243 ATDFGLSDFIKPGKKFQDIVGSAYYVA------PEVLKRKSGPESDVWSIGVI  289 (414)
Q Consensus       243 l~DFG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwslG~i  289 (414)
                      |+|||+|.....+..       ..|..      .+.+...++.++|+||+.--
T Consensus       143 liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         143 IIDFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             ECCCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             EEECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            999999976543221       11221      12344567899999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.73  E-value=2.2e-08  Score=89.42  Aligned_cols=140  Identities=17%  Similarity=0.156  Sum_probs=94.9

Q ss_pred             ceeeceeeeecCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEEEEE
Q 015026           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (414)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (414)
                      .|+..+..+.++.+.||++.  .++..+++|........   ....+.+|..+++.|..+--+++++.+..+++..++||
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~   89 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence            46666665555667999885  56677888987654322   22346789999998876656788888888899999999


Q ss_pred             eccCCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 015026          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---------------------------------------  217 (414)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~~L~~LH~---------------------------------------  217 (414)
                      ++++|.++.+....       ......++.++...+.-||+                                       
T Consensus        90 ~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          90 SEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             ECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             Eecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            99999877554311       11122233333444444442                                       


Q ss_pred             --------------c------CCeecCCCCCcEEEeecCCCCCceeeccccccc
Q 015026          218 --------------H------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (414)
Q Consensus       218 --------------~------~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~~  251 (414)
                                    .      .++|+|+.|.|||++   +++.+-|+||+.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhccc
Confidence                          1      268999999999998   344556999997754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.34  E-value=3.4e-07  Score=86.72  Aligned_cols=82  Identities=16%  Similarity=0.267  Sum_probs=52.0

Q ss_pred             ceeeeecCceEEEEEEECCCCCEEEEEEeecc----CCCChHhHHHHHHHHHHHHHccCC--CCceEEEEEEEcCCEEEE
Q 015026          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKN----KMILPIAVEDVKREVKILQALAGH--ENVVKFYNAFEDDNYVYI  174 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~~~~~E~~il~~l~~h--pnIv~~~~~~~~~~~~~l  174 (414)
                      .+.||.|....||++.+..+++.|++|.-...    ...-+....+...|...|+.+..+  ..+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45689999999999988778889999964321    100112334566799988877544  345666644  3445678


Q ss_pred             EEeccCCCCh
Q 015026          175 AMELCEGGEL  184 (414)
Q Consensus       175 v~e~~~gg~L  184 (414)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=2.6e-06  Score=74.96  Aligned_cols=75  Identities=12%  Similarity=0.098  Sum_probs=53.2

Q ss_pred             eeeecCc-eEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEEEEEEcCCEEEEEEeccC
Q 015026          103 LLGHGQF-GYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVYIAMELCE  180 (414)
Q Consensus       103 ~lG~G~~-g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~~~~~~~~~~~lv~e~~~  180 (414)
                      .+..|.. +.||++.. ..+..+++|......      ...+..|+..|+.|..+ -.+++++.+..+++..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            3455554 67898864 556678889765432      23467788888877643 236778888888889999999998


Q ss_pred             CCCh
Q 015026          181 GGEL  184 (414)
Q Consensus       181 gg~L  184 (414)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8655

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.69  E-value=6.9e-05  Score=70.35  Aligned_cols=75  Identities=13%  Similarity=0.097  Sum_probs=52.9

Q ss_pred             ceeeeecCceEEEEEEECC-------CCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCCCCceEEEEEEEcCCEEE
Q 015026          101 GKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (414)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~hpnIv~~~~~~~~~~~~~  173 (414)
                      ++.|+.|---.+|++....       ..+.|.+++.....     ......+|..+++.+..+.-.+++++++.+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            4678889999999998653       34567777654221     223456899999999766555688887754    5


Q ss_pred             EEEeccCCCCh
Q 015026          174 IAMELCEGGEL  184 (414)
Q Consensus       174 lv~e~~~gg~L  184 (414)
                      +|+||++|.++
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            89999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.26  E-value=0.00043  Score=62.88  Aligned_cols=71  Identities=13%  Similarity=0.171  Sum_probs=46.7

Q ss_pred             cCceEEEEEEECCCCCEEEEEEeeccCCCChHhHHHHHHHHHHHHHccCC-CCceEEE-----EEEEcCCEEEEEEeccC
Q 015026          107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFY-----NAFEDDNYVYIAMELCE  180 (414)
Q Consensus       107 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~~h-pnIv~~~-----~~~~~~~~~~lv~e~~~  180 (414)
                      +.-..||++.. .+|+.|++|+.+....    ..+.+..|...+..|..+ --++...     ..+...+..+.|+++++
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            33468999974 6788899998765432    346678899999888532 1111111     12345677899999997


Q ss_pred             CC
Q 015026          181 GG  182 (414)
Q Consensus       181 gg  182 (414)
                      |.
T Consensus       108 G~  109 (325)
T d1zyla1         108 GR  109 (325)
T ss_dssp             CE
T ss_pred             Cc
Confidence            64

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.35  E-value=0.0036  Score=56.05  Aligned_cols=30  Identities=27%  Similarity=0.425  Sum_probs=25.1

Q ss_pred             cCCeecCCCCCcEEEeecCCCCCceeecccccc
Q 015026          218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (414)
Q Consensus       218 ~~iiHrDlkp~NIll~~~~~~~~vkl~DFG~a~  250 (414)
                      .|+||+|+.++||+++   .+..+-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFL---GDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcc---cccceeEecccccc
Confidence            4799999999999998   45556799999874